PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	McKean, C; Mensah, FK; Eadie, P; Bavin, EL; Bretherton, L; Cini, E; Reilly, S				McKean, Cristina; Mensah, Fiona K.; Eadie, Patricia; Bavin, Edith L.; Bretherton, Lesley; Cini, Eileen; Reilly, Sheena			Levers for Language Growth: Characteristics and Predictors of Language Trajectories between 4 and 7 Years	PLOS ONE			English	Article							SCHOOL READINESS; FOLLOW-UP; CHILDREN; KINDERGARTEN; VOCABULARY; OUTCOMES; DETERMINANTS; IMPAIRMENT; LITERACY; QUALITY	Background Evidence is required as to when and where to focus resources to achieve the greatest gains for children's language development. Key to these decisions is the understanding of individual differences in children's language trajectories and the predictors of those differences. To determine optimal timing we must understand if and when children's relative language abilities become fixed. To determine where to focus effort we must identify mutable factors, that is those with the potential to be changed through interventions, which are associated with significant differences in children's language scores and rate of progress. Methods Uniquely this study examined individual differences in language growth trajectories in a population sample of children between 4 and 7 years using the multilevel model for change. The influence of predictors, grouped with respect to their mutability and their proximity to the child (least-mutable, mutable-distal, mutable-proximal), were estimated. Results A significant degree of variability in rate of progress between 4 and 7 years was evident, much of which was systematically associated with mutable-proximal factors, that is, those factors with evidence that they are modifiable through interventions with the child or family, such as shared book reading, TV viewing and number of books in the home. Mutable-distal factors, such as family income, family literacy and neighbourhood disadvantage, hypothesised to be modifiable through social policy, were important predictors of language abilities at 4 years. Conclusions Potential levers for language interventions lie in the child's home learning environment from birth to age 4. However, the role of a family's material and cultural capital must not be ignored, nor should the potential for growth into the school years. Early Years services should acknowledge the effects of multiple, cascading and cumulative risks and seek to promote child language development through the aggregation of marginal gains in the preschool years and beyond.	[McKean, Cristina] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [McKean, Cristina; Mensah, Fiona K.; Bretherton, Lesley; Cini, Eileen; Reilly, Sheena] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Mensah, Fiona K.; Eadie, Patricia; Bretherton, Lesley] Univ Melbourne, Melbourne, Vic, Australia; [Bavin, Edith L.] La Trobe Univ, Melbourne, Vic, Australia; [Mensah, Fiona K.; Bretherton, Lesley] Royal Childrens Hosp, Melbourne, Vic, Australia; [Reilly, Sheena] Menzies Hlth Inst Queensland, Nathan, Qld, Australia	Newcastle University - UK; Murdoch Children's Research Institute; University of Melbourne; La Trobe University; Royal Children's Hospital Melbourne	McKean, C (corresponding author), Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	cristina.mckean@ncl.ac.uk	Mensah, Fiona K/G-3382-2018; Reilly, Sheena/A-7035-2016	Mensah, Fiona K/0000-0002-6951-9949; Reilly, Sheena/0000-0001-6506-4767; McKean, Cristina/0000-0001-9058-9813; Eadie, Tricia/0000-0001-5555-8325	Australian National Health and Medical Research Council [237106, 9436958, 1041947]; National Health and Medical Research Council [1023493, 1037449, 1041892]; Victorian Government's Operational Infrastructure Support Program	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	The Early Language Victoria Study was funded by the Australian National Health and Medical Research Council, https://www.nhmrc.gov.au (SR, ELB, PE, LB #237106, #9436958 and #1041947). This study was also supported by funding from the National Health and Medical Research Council funded Centre of Research Excellence in Child Language (CM, FKM, SR #1023493) and a National Health and Medical Research Council funded Early Career Fellowship (FKM #1037449), and a National Health and Medical Research Council funded Practitioner Fellowship (SR, #1041892). Research at the Murdoch Children's Research Institute is supported by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AUSTR BUR STAT, 2001, SOC IND AR; Barker DJP, 2003, EUR J EPIDEMIOL, V18, P733, DOI 10.1023/A:1025388901248; Beitchman J.H., 1996, LANGUAGE LEARNING BE, P493; Beitchman JH, 2008, J CHILD PSYCHOL PSYC, V49, P626, DOI 10.1111/j.1469-7610.2008.01878.x; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Catts HW, 2002, J SPEECH LANG HEAR R, V45, P1142, DOI 10.1044/1092-4388(2002/093); Dennison BA, 2004, ARCH PEDIAT ADOL MED, V158, P170, DOI 10.1001/archpedi.158.2.170; Dionne G, 2003, CHILD DEV, V74, P394, DOI 10.1111/1467-8624.7402005; Duncan GJ, 2007, DEV PSYCHOL, V43, P1428, DOI 10.1037/0012-1649.43.6.1428; Durkin K, 2010, CHILD LANG TEACH THE, V26, P107, DOI 10.1177/0265659010368750; Farkas G, 2004, SOC SCI RES, V33, P464, DOI 10.1016/j.ssresearch.2003.08.001; FERGUSSON DM, 1993, INT J EPIDEMIOL, V22, P891, DOI 10.1093/ije/22.5.891; Field F., 2010, FDN YEARS PREVENTING; Golova N, 1999, J AM ACAD PEDIAT, V103; High PC, 2000, PEDIATRICS, V105, P927; Johnson CJ, 2010, AM J SPEECH-LANG PAT, V19, P51, DOI 10.1044/1058-0360(2009/08-0083); Law J, 2013, EARLY LANGUAGE DELAY; Law J, 2008, J SPEECH LANG HEAR R, V51, P739, DOI 10.1044/1092-4388(2008/052); Law J, 2012, PEDIATRICS, V130, pE132, DOI 10.1542/peds.2011-1673; Law J, 2009, J SPEECH LANG HEAR R, V52, P1401, DOI 10.1044/1092-4388(2009/08-0142); Luyten H, 2011, J LEARN DISABIL-US, V44, P444, DOI 10.1177/0022219411410289; Miniscalco C, 2006, DEV MED CHILD NEUROL, V48, P361, DOI 10.1017/S0012162206000788; Mrazek P., 1994, REDUCING RISKS MENTA; Nutbrown C, 2005, EARLY LITERACY PRACT; Peisner-Feinberg ES, 2001, CHILD DEV, V72, P1534, DOI 10.1111/1467-8624.00364; Reilly S, 2006, J PAEDIATR CHILD H, V42, P764, DOI 10.1111/j.1440-1754.2006.00974.x; Reilly S, 2010, PEDIATRICS, V126, pE1530, DOI 10.1542/peds.2010-0254; Rice ML, 2008, J SPEECH LANG HEAR R, V51, P394, DOI 10.1044/1092-4388(2008/029); Rice ML, 2013, INT J SPEECH-LANG PA, V15, P223, DOI 10.3109/17549507.2013.783113; Schoon I, 2010, PEDIATRICS, V126, pE73, DOI 10.1542/peds.2009-3282; Semel E., 2006, CLIN EVALUATION LANG, V4th UK ed.; Shonkoff JP, 2000, NEURONS NEIGHBORHOOD; SILVA PA, 1987, DEV MED CHILD NEUROL, V29, P630; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; StataCorp, 2013, STATA STAT SOFTW REL; Taylor CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073046; Taylor CL, 2009, INT J SPEECH-LANG PA, V11, P341, DOI 10.1080/17549500903161561; Tomblin B, 2008, UNDERSTANDING DEV LA; Tomblin JB, 2003, J SPEECH LANG HEAR R, V46, P1283, DOI 10.1044/1092-4388(2003/100); Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; Ukoumunne OC, 2012, CHILD CARE HLTH DEV, V38, P341, DOI 10.1111/j.1365-2214.2011.01234.x; Wake M, 2008, WELL ARE AUSTR INFAN; Werker JF, ANN REV PSY IN PRESS; Wiig E.H., 2006, CELF PRESCHOOL 2 UK; Wright JC, 2001, CHILD DEV, V72, P1347, DOI 10.1111/1467-8624.t01-1-00352	45	52	52	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134251	10.1371/journal.pone.0134251	http://dx.doi.org/10.1371/journal.pone.0134251			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1VB	26241892	Green Published, gold			2022-12-27	WOS:000358942700036
J	Mendes, FA; Aguiar, JMC; Kahn, SA; Reis, AH; Dubois, LG; Romao, LF; Ferreira, LSS; Chneiweiss, H; Neto, VM; Abreu, JG				Mendes, Fabio A.; Aguiar, Juliana M. Coelho; Kahn, Suzana A.; Reis, Alice H.; Dubois, Luiz Gustavo; Romao, Luciana Ferreira; Ferreira, Lais S. S.; Chneiweiss, Herve; Moura Neto, Vivaldo; Abreu, Jose G.			Connective-Tissue Growth Factor (CTGF/CCN2) Induces Astrogenesis and Fibronectin Expression of Embryonic Neural Cells In Vitro	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; CHONDROCYTE-SPECIFIC GENE; FACTOR CTGF; FACTOR-BETA; ASTROCYTIC DIFFERENTIATION; TYROSINE PHOSPHORYLATION; MATRIX PRODUCTION; MESANGIAL CELLS; BONE-FORMATION; MAP KINASE	Connective-tissue growth factor (CTGF) is a modular secreted protein implicated in multiple cellular events such as chondrogenesis, skeletogenesis, angiogenesis and wound healing. CTGF contains four different structural modules. This modular organization is characteristic of members of the CCN family. The acronym was derived from the first three members discovered, cysteine-rich 61 (CYR61), CTGF and nephroblastoma overexpressed (NOV). CTGF is implicated as a mediator of important cell processes such as adhesion, migration, proliferation and differentiation. Extensive data have shown that CTGF interacts particularly with the TGF beta, WNT and MAPK signaling pathways. The capacity of CTGF to interact with different growth factors lends it an important role during early and late development, especially in the anterior region of the embryo. ctgf knockout mice have several cranio-facial defects, and the skeletal system is also greatly affected due to an impairment of the vascular-system development during chondrogenesis. This study, for the first time, indicated that CTGF is a potent inductor of gliogenesis during development. Our results showed that in vitro addition of recombinant CTGF protein to an embryonic mouse neural precursor cell culture increased the number of GFAP- and GFAP/Nestin-positive cells. Surprisingly, CTGF also increased the number of Sox2-positive cells. Moreover, this induction seemed not to involve cell proliferation. In addition, exogenous CTGF activated p44/42 but not p38 or JNK MAPK signaling, and increased the expression and deposition of the fibronectin extracellular matrix protein. Finally, CTGF was also able to induce GFAP as well as Nestin expression in a human malignant glioma stem cell line, suggesting a possible role in the differentiation process of gliomas. These results implicate ctgf as a key gene for astrogenesis during development, and suggest that its mechanism may involve activation of p44/42 MAPK signaling. Additionally, CTGF-induced differentiation of glioblastoma stem cells into	[Mendes, Fabio A.; Aguiar, Juliana M. Coelho; Kahn, Suzana A.; Reis, Alice H.; Ferreira, Lais S. S.; Abreu, Jose G.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Biol Celular & Desenvolvimento, Rio De Janeiro, RJ, Brazil; [Kahn, Suzana A.; Chneiweiss, Herve] Univ Paris 05, INSERM, Team Glial Plast, UMR894, Paris, France; [Dubois, Luiz Gustavo; Moura Neto, Vivaldo] Inst Estadual Cerebro Paulo Niemeyer IEC, Rio De Janeiro, RJ, Brazil; [Romao, Luciana Ferreira] Univ Fed Rio de Janeiro, Polo Xerem, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidade Federal do Rio de Janeiro	Abreu, JG (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Biol Celular & Desenvolvimento, Rio De Janeiro, RJ, Brazil.	garciajr@icb.ufrj.br	Abreu, Jose G/ABB-1199-2021; Ferreira, Laís S S/W-3640-2018; Abreu, Jose G/G-6159-2010; herve, chneiweiss/Q-6818-2019; Feijo Dubois, Luiz Gustavo/O-9904-2015	Abreu, Jose G/0000-0002-1363-1755; Ferreira, Laís S S/0000-0002-0152-459X; Abreu, Jose G/0000-0002-9875-7786; herve, chneiweiss/0000-0001-7675-5061; Feijo Dubois, Luiz Gustavo/0000-0002-9765-5315; Reis, Alice/0000-0002-7431-5502	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Programa de Nucleos de Excelencia (PRONEX)	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa de Nucleos de Excelencia (PRONEX)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (JGA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (JGA); Programa de Nucleos de Excelencia (PRONEX) (JGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Aguiar DP, 2011, BIOCHEM BIOPH RES CO, V413, P582, DOI 10.1016/j.bbrc.2011.09.005; Arnott JA, 2007, J CELL PHYSIOL, V210, P843, DOI 10.1002/jcp.20917; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Ball DK, 2003, J ENDOCRINOL, V176, pR1, DOI 10.1677/joe.0.176R001; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Brigstock DR, 2010, J CELL COMMUN SIGNAL, V4, P1, DOI 10.1007/s12079-009-0071-5; Chen YJ, 2002, KIDNEY INT, V62, P1149, DOI 10.1111/j.1523-1755.2002.kid567.x; Cooker LA, 2007, AM J PHYSIOL-RENAL, V293, pF157, DOI 10.1152/ajprenal.00508.2006; Crean JK, 2004, FASEB J, V18, P1541, DOI 10.1096/fj.04-1546fje; CREUZET C, 1995, J NEUROCHEM, V64, P1541; DALESSANDRO JS, 1994, GROWTH FACTORS, V11, P53, DOI 10.3109/08977199409015051; Folkins C, 2007, CANCER RES, V67, P3560, DOI 10.1158/0008-5472.CAN-06-4238; FRANZIER K, 1996, J INVEST DERMATOL, V107, P404; Freemantle SJ, 2002, ONCOGENE, V21, P2880, DOI 10.1038/sj.onc.1205408; Garcia-Abreu J, 2000, GLIA, V29, P260, DOI 10.1002/(SICI)1098-1136(20000201)29:3<260::AID-GLIA7>3.0.CO;2-I; Gomes FCA, 2005, INT J DEV NEUROSCI, V23, P413, DOI 10.1016/j.ijdevneu.2005.04.001; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; Grotendorst GR, 2005, FASEB J, V19, P729, DOI 10.1096/fj.04-3217com; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Hoshijima M, 2006, FEBS LETT, V580, P1376, DOI 10.1016/j.febslet.2006.01.061; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kawaki H, 2008, BIOCHEM BIOPH RES CO, V366, P450, DOI 10.1016/j.bbrc.2007.11.155; Kodama T, 2011, J CLIN INVEST, V121, P3343, DOI 10.1172/JCI44957; Kothapalli D, 1997, CELL GROWTH DIFFER, V8, P61; Lee SM, 2004, BIOCHEM BIOPH RES CO, V320, P1087, DOI 10.1016/j.bbrc.2004.06.060; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu B, 2006, J CELL BIOCHEM, V97, P1104, DOI 10.1002/jcb.20709; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Maeda A, 2009, J BIOCHEM, V145, P207, DOI 10.1093/jb/mvn159; Mendes FA, 2003, DEV BRAIN RES, V142, P111, DOI 10.1016/S0165-3806(03)00036-1; Mercurio S, 2004, DEVELOPMENT, V131, P2137, DOI 10.1242/dev.01045; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Nagai N, 2009, INVEST OPHTH VIS SCI, V50, P1903, DOI 10.1167/iovs.08-2383; Nagashima T, 2011, MOL ENDOCRINOL, V25, P1740, DOI 10.1210/me.2011-1045; Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x; Nakanishi T, 2000, ENDOCRINOLOGY, V141, P264, DOI 10.1210/endo.141.1.7267; Nishida T, 2000, J CELL PHYSIOL, V184, P197, DOI 10.1002/1097-4652(200008)184:2<197::AID-JCP7>3.0.CO;2-R; NORTHROP J, 1995, DEV BIOL, V172, P242, DOI 10.1006/dbio.1995.0019; Obayashi S, 2009, CELL MOL NEUROBIOL, V29, P423, DOI 10.1007/s10571-008-9338-2; Oka K, 2007, DEV BIOL, V303, P391, DOI 10.1016/j.ydbio.2006.11.025; Onofre GR, 2001, BRAZ J MED BIOL RES, V34, P251, DOI 10.1590/S0100-879X2001000200014; Osinde M, 2007, NEUROPHARMACOLOGY, V52, P1210, DOI 10.1016/j.neuropharm.2006.11.010; Pacheco MS, 2008, CELLS TISSUES ORGANS, V187, P199, DOI 10.1159/000112640; Patru C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-66; Phanish MK, 2005, NEPHRON EXP NEPHROL, V100, pE156, DOI 10.1159/000085445; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Rachfal AW, 2003, HEPATOL RES, V26, P1, DOI 10.1016/S1386-6346(03)00115-3; Rajan P, 1998, J NEUROSCI, V18, P3620; Romao LF, 2008, J NEUROCHEM, V106, P746, DOI 10.1111/j.1471-4159.2008.05428.x; Safadi FF, 2003, J CELL PHYSIOL, V196, P51, DOI 10.1002/jcp.10319; SANCHOTELLO M, 1995, GLIA, V15, P157, DOI 10.1002/glia.440150208; Shimo T, 1999, J BIOCHEM-TOKYO, V126, P137, DOI 10.1093/oxfordjournals.jbchem.a022414; Silvestre DC, 2011, STEM CELLS, V29, P440, DOI 10.1002/stem.600; Stipursky J, 2007, GLIA, V55, P1023, DOI 10.1002/glia.20522; Stratton R, 2002, FASEB J, V16, P1949, DOI 10.1096/fj.02-0204fje; Surveyor GA, 1999, GROWTH FACTORS, V17, P115, DOI 10.3109/08977199909103520; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Tan JTM, 2008, AM J PHYSIOL-CELL PH, V295, pC740, DOI 10.1152/ajpcell.00333.2007; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wang W, 2008, J CELL PHYSIOL, V214, P38, DOI 10.1002/jcp.21159; Weston BS, 2003, J AM SOC NEPHROL, V14, P601, DOI 10.1097/01.ASN.0000051600.53134.B9; Wu S, 2010, AM J RESP CELL MOL, V42, P552, DOI 10.1165/rcmb.2009-0068OC; Yang M, 2004, FASEB J, V18, P1920, DOI 10.1096/fj.04-2357fje; Yosimichi G, 2001, EUR J BIOCHEM, V268, P6058, DOI 10.1046/j.0014-2956.2001.02553.x; Yuan LQ, 2007, AMINO ACIDS, V32, P425, DOI 10.1007/s00726-006-0380-4	70	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133689	10.1371/journal.pone.0133689	http://dx.doi.org/10.1371/journal.pone.0133689			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241738	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942700018
J	Speare, R; Mendez, D; Judd, J; Reid, S; Tzipori, S; Massey, PD				Speare, Rick; Mendez, Diana; Judd, Jenni; Reid, Simon; Tzipori, Saul; Massey, Peter D.			Willingness to Consult a Veterinarian on Physician's Advice for Zoonotic Diseases: A Formal Role for Veterinarians in Medicine?	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; NEW-SOUTH-WALES; PRIMARY-CARE; HEALTH; AUSTRALIA; BRUCELLOSIS; LEPTOSPIROSIS; ZOONOSES; OUTBREAK; RISK	Physicians appear to find zoonotic diseases a challenge and consider that this topic belongs more to the veterinary profession. However, veterinarians have no formal role in clinical medicine. Data were collected as part of the Queensland Social Survey 2014 to determine the willingness of the public, if diagnosed with a zoonotic disease, to consult a veterinarian on the advice of a physician. Self-reported willingness to consult with a veterinarian at the respondent's own expense was 79.8% (95% CI: 81.96%-77.46%) (976/1223). If the cost was funded by Medicare, the Australian public health insurance scheme, 90.7% (95% CI: 92.18%-88.92%) (1109/1223) would be willing to consult a veterinarian. Therefore, a large majority of Australian residents would be willing to consult with a veterinarian on the advice of their physician if they had a zoonotic disease. Does this indicate a possible new role for veterinarians under Clinical One Health?	[Speare, Rick] Trop Hlth Solut, Townsville, Qld, Australia; [Speare, Rick; Mendez, Diana] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld 4811, Australia; [Judd, Jenni] James Cook Univ, Div Trop Hlth & Med, Townsville, Qld 4811, Australia; [Reid, Simon] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Tzipori, Saul] Tufts Univ, Cummings Sch Vet Med, Boston, MA 02111 USA; [Massey, Peter D.] Hunter New England Populat Hlth, Tamworth, NSW, Australia	James Cook University; James Cook University; University of Queensland; Tufts University	Speare, R (corresponding author), Trop Hlth Solut, Townsville, Qld, Australia.	rickspeare@gmail.com	Massey, Peter/AAZ-8001-2021; Massey, Peter/AAD-6176-2022; Reid, Simon/E-9884-2011	Massey, Peter/0000-0001-7194-1914; Reid, Simon/0000-0002-6103-4429; Speare, Rick/0000-0002-9993-1213	Tropical Health Solutions (THS); THS [AUD9500]	Tropical Health Solutions (THS); THS	This study was funded by a private company, Tropical Health Solutions (THS), owned by four people including the lead author, Rick Speare. The funder provided support in the form of salary for the author (RS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of RS are articulated in the 'author contributions' section. THS paid for the cost of the CATI survey (AUD9500) done by CQ University and paid the publication fee for the article.	[Anonymous], 2014, VET REC, V175, P394, DOI 10.1136/vr.g6175; [Anonymous], 2010, VET REC, V167, P638, DOI 10.1136/vr.c5436; [Anonymous], 2013, EMERG INFECT DIS, DOI [10.3201/eid1912.130265, DOI 10.3201/EID1912.130265]; Australian Bureau of Statistics, 2012, 2011 CENS POP HOUS 2; Australian Government Department of Health, 2014, MED BEN SCHED ALL HL; Baker MG, 2007, EPIDEMIOL INFECT, V135, P76, DOI 10.1017/S0950268806006534; Barrett MA, 2015, ECOHEALTH, V12, P212, DOI 10.1007/s10393-014-0964-5; Benetato MA, 2011, JAVMA-J AM VET MED A, V238, P31, DOI 10.2460/javma.238.1.31; Bordier M, 2013, ANIM HEALTH RES REV, V14, P40, DOI 10.1017/S1466252313000017; Cant RP, 2011, AUST HEALTH REV, V35, P468, DOI 10.1071/AH10938; Curtin R, 2005, PUBLIC OPIN QUART, V69, P87, DOI 10.1093/poq/nfi002; de Assis FL, 2013, EMERG INFECT DIS, V19, P2017, DOI 10.3201/eid1912.130589; Eales KM, 2010, AM J TROP MED HYG, V83, P876, DOI 10.4269/ajtmh.2010.10-0237; Ellis R, 2014, AM FAM PHYSICIAN, V90, P239; Grant S, 1999, EMERG INFECT DIS, V5, P159, DOI 10.3201/eid0501.990121; Grimmer-Somers K, 2008, AUST FAM PHYSICIAN, V37, P774; Grimmer-Somers K, 2010, AUST HEALTH REV, V34, P18, DOI 10.1071/AH09619; Heath TJ, 2008, AUST VET J, V86, P283, DOI 10.1111/j.1751-0813.2008.00314.x; Hill WA, 2012, JAVMA-J AM VET MED A, V240, P1432, DOI 10.2460/javma.240.12.1432; Jordan D, 2011, AUST VET J, V89, P152, DOI 10.1111/j.1751-0813.2011.00710.x; Kahn Laura H, 2007, Vet Ital, V43, P5; Kaplan B, 2011, VET ITAL, V47, P129; Khabbaz RF, 2014, LANCET, V384, P53, DOI 10.1016/S0140-6736(14)60890-4; Lappin MR, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-26; Lindahl C, 2013, J AGROMEDICINE, V18, P274, DOI 10.1080/1059924X.2013.796906; Lipton BA, 2008, JAVMA-J AM VET MED A, V233, P1242, DOI 10.2460/javma.233.8.1242; Massey PD, 2011, RURAL REMOTE HEALTH, V11; Mochizuki T, 2015, J DERMATOL, V42, P232, DOI 10.1111/1346-8138.12813; Mughini-Gras L, 2014, EPIDEMIOL INFECT, V142, P1172, DOI 10.1017/S0950268813001817; Nelson MI, 2015, TRENDS MICROBIOL, V23, P142, DOI 10.1016/j.tim.2014.12.002; O'Toole J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-71; Population Research Laboratory, 2014, FIN TECHN SAMPL REP; Reid SM, 2012, AVIAN DIS, V56, P1062, DOI 10.1637/10178-041012-Reg.1; Ridoutt C, 2014, AUST VET J, V92, P343, DOI 10.1111/avj.12203; Tiplady CM, 2012, AUST VET J, V90, P48, DOI 10.1111/j.1751-0813.2011.00843.x; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; von Matthiessen PW, 2003, AIDS, V17, P1404, DOI 10.1097/00002030-200306130-00021; Wieler LH, 2011, INT J MED MICROBIOL, V301, P635, DOI 10.1016/j.ijmm.2011.09.009; Woldemeskel M., 2013, Open Journal of Veterinary Medicine, V3, P213	39	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0131406	10.1371/journal.pone.0131406	http://dx.doi.org/10.1371/journal.pone.0131406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237399	Green Published, gold, Green Accepted			2022-12-27	WOS:000358942400006
J	Kumar, H; Wacklin, P; Nakphaichit, M; Loyttyniemi, E; Chowdhury, S; Shouche, Y; Matto, J; Isolauri, E; Salminen, S				Kumar, Himanshu; Wacklin, Pirjo; Nakphaichit, Massalin; Loyttyniemi, Eliisa; Chowdhury, Somak; Shouche, Yogesh; Matto, Jaana; Isolauri, Erika; Salminen, Seppo			Secretor Status Is Strongly Associated with Microbial Alterations Observed during Pregnancy	PLOS ONE			English	Article							GUT MICROBIOTA; BLOOD-GROUP; WEIGHT; WOMEN; GENOTYPE; DISEASE	During pregnancy there are significant changes in gut microbiota composition and activity. The impact of secretor status as determined by genotyping FUT2 (fucosyltransferase 2) gene was taken as one of the confounding factors associated with faecal microbiota changes during pregnancy. In this prospective study, we followed women during pregnancy (total = 123 of which secretors = 108, non-secretors = 15) and characterised their gut microbiota by quantitative polymerase chain reaction (qPCR), Fluorescence In situ Hybridisation (FISH), Denaturing Gradient Gel Electrophoresis (DGGE) and pyrosequencing. qPCR revealed that C. coccoides group counts decreased significantly in non-secretors in comparison to secretors (p = 0.02). Similar tendency was found by FISH analysis in Clostridium histolyticum and Lactobacillus-Enterococcus groups between the secretor and the non-secretor pregnant women. DGGE analysis showed significant decrease in richness of Clostridium sp. between secretor and non-secretor mothers during pregnancy. Pyrosequencing based analysis at phyla level showed that there is greater increase in Actinobacteria in secretors in comparison to non-secretors, whereas Proteobacteria showed more increase in non-secretors. Change in relative abundance of Clostridiaceae family from first to third trimester were significantly associated with secretor status of pregnant women (p = 0.05). Polyphasic approach for microbiota analysis points out that the host secretor status (FUT2 genotype) affects the gut microbiota during pregnancy. This may lead to altered infant gut microbiota colonization.	[Kumar, Himanshu; Salminen, Seppo] Univ Turku, Funt Foods Forum, FIN-20520 Turku, Finland; [Wacklin, Pirjo; Matto, Jaana] Finnish Red Cross Blood Serv, Helsinki, Finland; [Nakphaichit, Massalin] Kasetsart Univ, Fac Agroind, Bangkok 10900, Thailand; [Loyttyniemi, Eliisa] Univ Turku, Fac Med, Dept Stat, FIN-20520 Turku, Finland; [Chowdhury, Somak; Shouche, Yogesh] Natl Ctr Cell Sci, Microbial Culture Collect, Pune 411007, Maharashtra, India; [Isolauri, Erika] Univ Turku, Dept Paediat, FIN-20520 Turku, Finland	University of Turku; Kasetsart University; University of Turku; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); University of Turku	Kumar, H (corresponding author), Univ Turku, Funt Foods Forum, FIN-20520 Turku, Finland.	kumhim@utu.fi	kumar, Himanshu/ABE-7982-2020; Nakphaichit, Massalin/HDR-7404-2022	kumar, Himanshu/0000-0002-9749-8620; Nakphaichit, Massalin/0000-0002-1277-9299	TEKES - Finnish Funding Agency for Innovation [40052/11]; Academy of Finland [255736]	TEKES - Finnish Funding Agency for Innovation; Academy of Finland(Academy of Finland)	This study was funded by TEKES - Finnish Funding Agency for Innovation (40052/11) and Academy of Finland (255736).	Anderson KM, 2005, J BIOL CHEM, V280, P7720, DOI 10.1074/jbc.M414099200; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Biondi C, 1999, ANN CLIN BIOCHEM, V36, P391, DOI 10.1177/000456329903600314; Collado MC, 2010, AM J CLIN NUTR, V92, P1023, DOI 10.3945/ajcn.2010.29877; Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894; Endo A, 2014, ANAEROBE, V28, P149, DOI 10.1016/j.anaerobe.2014.06.006; Genc MR, 2011, BJOG-INT J OBSTET GY, V118, P154, DOI 10.1111/j.1471-0528.2010.02772.x; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Jaff MS, 2010, INT J NANOMED, V5, P901, DOI 10.2147/IJN.S13980; Jost T, 2014, CURR MICROBIOL, V68, P419, DOI 10.1007/s00284-013-0491-6; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Lee HA, 2013, J EPIDEMIOL, V23, P371, DOI 10.2188/jea.JE20120219; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Parmar AS, 2012, TISSUE ANTIGENS, V80, P488, DOI 10.1111/tan.12016; Prince AL, 2014, SEMIN REPROD MED, V32, P14, DOI 10.1055/s-0033-1361818; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Smyth DJ, 2011, DIABETES, V60, P3081, DOI 10.2337/db11-0638; Team RC, 2012, R LANG ENV STAT COMP; Wacklin P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094863; Wacklin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020113; Xiao JZ, 2010, APPL ENVIRON MICROB, V76, P54, DOI 10.1128/AEM.01683-09	24	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134623	10.1371/journal.pone.0134623	http://dx.doi.org/10.1371/journal.pone.0134623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26231005	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400141
J	Polanski, A; Marczyk, M; Pietrowska, M; Widlak, P; Polanska, J				Polanski, Andrzej; Marczyk, Michal; Pietrowska, Monika; Widlak, Piotr; Polanska, Joanna			Signal Partitioning Algorithm for Highly Efficient Gaussian Mixture Modeling in Mass Spectrometry	PLOS ONE			English	Article							IMPROVED PEAK DETECTION; LASER-DESORPTION/IONIZATION; FEATURE-EXTRACTION; EM ALGORITHM; QUANTIFICATION; SPECTRA; PATTERN; LIKELIHOOD; ALIGNMENT; VALUES	Mixture - modeling of mass spectra is an approach with many potential applications including peak detection and quantification, smoothing, de-noising, feature extraction and spectral signal compression. However, existing algorithms do not allow for automated analyses of whole spectra. Therefore, despite highlighting potential advantages of mixture modeling of mass spectra of peptide/protein mixtures and some preliminary results presented in several papers, the mixture modeling approach was so far not developed to the stage enabling systematic comparisons with existing software packages for proteomic mass spectra analyses. In this paper we present an efficient algorithm for Gaussian mixture modeling of proteomic mass spectra of different types (e.g., MALDI-ToF profiling, MALDI-IMS). The main idea is automated partitioning of protein mass spectral signal into fragments. The obtained fragments are separately decomposed into Gaussian mixture models. The parameters of the mixture models of fragments are then aggregated to form the mixture model of the whole spectrum. We compare the elaborated algorithm to existing algorithms for peak detection and we demonstrate improvements of peak detection efficiency obtained by using Gaussian mixture modeling. We also show applications of the elaborated algorithm to real proteomic datasets of low and high resolution.	[Polanski, Andrzej] Silesian Tech Univ, Inst Informat, Gliwice, Poland; [Marczyk, Michal; Polanska, Joanna] Silesian Tech Univ, Inst Automat Control, Gliwice, Poland; [Pietrowska, Monika; Widlak, Piotr] Maria Sklodowska Curie Mem Canc Ctr, Gliwice, Poland; [Pietrowska, Monika; Widlak, Piotr] Inst Oncol, Gliwice, Poland	Silesian University of Technology; Silesian University of Technology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Polanska, J (corresponding author), Silesian Tech Univ, Inst Automat Control, Gliwice, Poland.	joanna.polanska@polsl.pl	Marczyk, Michal/C-2556-2016; Polański, Andrzej/H-5323-2016; Widlak, Piotr/AAL-8075-2021; Polanska, Joanna/H-4513-2013	Marczyk, Michal/0000-0003-2508-5736; Polański, Andrzej/0000-0002-1793-9546; Widlak, Piotr/0000-0001-5099-4726; Polanska, Joanna/0000-0001-8004-9864; Pietrowska, Monika/0000-0001-9317-7822	National Science Centre [UMO-2013/08/M/ST6/00924, UMO-2011/01/B/ST6/06868]; National Centre for Research and Development [POIG.02.03.01-24-099/13]	National Science Centre(National Science Centre, Poland); National Centre for Research and Development(National Centre for Research & Development, Poland)	This paper was partially financially supported by the following grants funded by the National Science Centre (www.ncn.gov.pl): UMO-2013/08/M/ST6/00924 to JP and UMO-2011/01/B/ST6/06868 to AP, and by the National Centre for Research and Development (http://www.ncbir.pl): POIG.02.03.01-24-099/13 to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellew M, 2006, BIOINFORMATICS, V22, P1902, DOI 10.1093/bioinformatics/btl276; Biernacki C, 2004, STAT COMPUT, V14, P267, DOI 10.1023/B:STCO.0000035306.77434.31; Biernacki C, 2003, COMPUT STAT DATA AN, V41, P561, DOI 10.1016/S0167-9473(02)00163-9; Coombes KR, 2005, CANCER INFORM, V1, P41; Coombes KR, 2005, PROTEOMICS, V5, P4107, DOI 10.1002/pmic.200401261; Cruz-Marcelo A, 2008, BIOINFORMATICS, V24, P2129, DOI 10.1093/bioinformatics/btn398; de Noo ME, 2006, EUR J CANCER, V42, P1068, DOI 10.1016/j.ejca.2005.12.023; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dijkstra M, 2006, PROTEOMICS, V6, P5106, DOI 10.1002/pmic.200600181; Du P, 2006, BIOINFORMATICS, V22, P2059, DOI 10.1093/bioinformatics/btl355; Du P, 2007, BIOINFORMATICS, V23, P1394, DOI 10.1093/bioinformatics/btm083; Emanuele VA, 2009, PROTEOMICS, V9, P1754, DOI 10.1002/pmic.200701171; Falkner JA, 2007, J AM SOC MASS SPECTR, V18, P850, DOI 10.1016/j.jasms.2007.01.010; Gillette MA, 2005, J PROTEOME RES, V4, P1143, DOI 10.1021/pr0500962; Henson R., 2005, ENCY GENETICS GENOMI, V4, P105; Karlis D, 2003, COMPUT STAT DATA AN, V41, P577, DOI 10.1016/S0167-9473(02)00177-9; Karpievitch YV, 2007, BIOINFORMATICS, V23, P264, DOI 10.1093/bioinformatics/btl583; Kempka M, 2004, RAPID COMMUN MASS SP, V18, P1208, DOI 10.1002/rcm.1467; Lange Eva, 2006, Pac Symp Biocomput, P243, DOI 10.1142/9789812701626_0023; Leptos KC, 2006, PROTEOMICS, V6, P1770, DOI 10.1002/pmic.200500201; Li X, 2005, STAT BIOL HEALTH, P91; Mantini D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-101; McLachlan G., 2000, WILEY SER PROB STAT; Morris JS, 2005, BIOINFORMATICS, V21, P1764, DOI 10.1093/bioinformatics/bti254; Murray KK, 2013, PURE APPL CHEM, V85, P1515, DOI 10.1351/PAC-REC-06-04-06; Noy K, 2007, BIOINFORMATICS, V23, P2528, DOI 10.1093/bioinformatics/btm385; Pelikan R, 2010, IEEE ACM T COMPUT BI, V7, P126, DOI 10.1109/TCBB.2008.31; Pietrowska M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-60; Polanska J, 2012, EXPERT SYST, V29, P216, DOI 10.1111/j.1468-0394.2011.00582.x; Polanski A, 2013, STUDIA INFORM, V34, P1; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Spainhour JCG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111016; Tibshirani R, 2004, BIOINFORMATICS, V20, P3034, DOI 10.1093/bioinformatics/bth357; Tuszynski J, CAMASSCLASS PROCESSI; Wang Y, 2008, BIOINFORMATICS, V24, pI407, DOI 10.1093/bioinformatics/btn143; Wong JWH, 2005, BIOINFORMATICS, V21, P2088, DOI 10.1093/bioinformatics/bti300; Yang C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-4; Yasui Y, 2003, BIOSTATISTICS, V4, P449, DOI 10.1093/biostatistics/4.3.449	39	28	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134256	10.1371/journal.pone.0134256	http://dx.doi.org/10.1371/journal.pone.0134256			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230717	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400094
J	Arfmann-Knubel, S; Struck, B; Genrich, G; Helm, O; Sipos, B; Sebens, S; Schafer, H				Arfmann-Knuebel, Sarah; Struck, Birte; Genrich, Geeske; Helm, Ole; Sipos, Bence; Sebens, Susanne; Schaefer, Heiner			The Crosstalk between Nrf2 and TGF-beta 1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; E-CADHERIN EXPRESSION; CANCER-CELLS; TRANSCRIPTION FACTOR; PROTEASOME ACTIVITY; KEAP1-NRF2 PATHWAY; SIGNALING PATHWAY; OXIDATIVE STRESS; CARCINOMA-CELLS; EMERGING ROLE	Nrf2 and TGF-beta 1 both affect tumorigenesis in a dual fashion, either by preventing carcinogen induced carcinogenesis and suppressing tumor growth, respectively, or by conferring cytoprotection and invasiveness to tumor cells during malignant transformation. Given the involvement of Nrf2 and TGF-beta 1 in the adaptation of epithelial cells to persistent inflammatory stress, e.g. of the pancreatic duct epithelium during chronic pancreatitis, a crosstalk between Nrf2 and TGF-beta 1 can be envisaged. By using premalignant human pancreatic duct cells (HPDE) and the pancreatic ductal adenocarcinoma cell line Colo357, we could show that Nrf2 and TGF-beta 1 independently but additively conferred an invasive phenotype to HPDE cells, whereas acting synergistically in Colo357 cells. This was accompanied by differential regulation of EMT markers like vimentin, Slug, L1CAM and E-cadherin. Nrf2 activation suppressed E-cadherin expression through an as yet unidentified ARE related site in the E-cadherin promoter, attenuated TGF-beta 1 induced Smad2/3-activity and enhanced JNK-signaling. In Colo357 cells, TGF-beta 1 itself was capable of inducing Nrf2 whereas in HPDE cells TGF-beta 1 per-se did not affect Nrf2 activity, but enhanced Nrf2 induction by tBHQ. In Colo357, but not in HPDE cells, the effects of TGF-beta 1 on invasion were sensitive to Nrf2 knock-down. In both cell lines, E-cadherin re-expression inhibited the proinvasive effect of Nrf2. Thus, the increased invasion of both cell lines relates to the Nrf2-dependent downregulation of E-cadherin expression. In line, immunohistochemistry analysis of human pancreatic intraepithelial neoplasias in pancreatic tissues from chronic pancreatitis patients revealed strong Nrf2 activity already in premalignant epithelial duct cells, accompanied by partial loss of E-cadherin expression. Our findings indicate that Nrf2 and TGF-beta 1 both contribute to malignant transformation through distinct EMT related mechanisms accounting for an invasive phenotype. Provided a crosstalk between both pathways, Nrf2 and TGF-beta 1 mutually promote their tumorigenic potential, a condition manifesting already at an early stage during inflammation induced carcinogenesis of the pancreas.	[Arfmann-Knuebel, Sarah; Struck, Birte; Schaefer, Heiner] Dept Internal Med 1, Lab Mol Gastroenterol, D-24105 Kiel, Germany; [Genrich, Geeske; Helm, Ole; Sebens, Susanne] CAU Kiel, Inst Expt Med, Grp Inflammatory Carcinogenesis, D-24105 Kiel, Germany; [Sipos, Bence] Univ Tubingen Hosp, Dept Pathol & Neuropathol, D-72076 Tubingen, Germany	University of Kiel; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schafer, H (corresponding author), Dept Internal Med 1, Lab Mol Gastroenterol, UKSH Campus Kiel,Arnold Heller Str 3,Bldg 6, D-24105 Kiel, Germany.	hschaef@1med.uni-kiel.de	Sebens, Susanne/C-1222-2010; Schäfer, Heiner/C-1055-2011	Schafer, Heiner/0000-0001-6936-9090	Medical Faculty at the Kiel University; DFG-Cluster of Excellence "Inflammation at Interfaces"	Medical Faculty at the Kiel University; DFG-Cluster of Excellence "Inflammation at Interfaces"(German Research Foundation (DFG))	This study was funded by the Medical Faculty at the Kiel University (to BS) and the DFG-Cluster of Excellence "Inflammation at Interfaces" (SS & HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493; Bakin AV, 2005, FREE RADICAL BIO MED, V38, P375, DOI 10.1016/j.freeradbiomed.2004.10.033; Birnbaum DJ, 2012, CELL CYCLE, V11, P683, DOI 10.4161/cc.11.4.19130; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Chian S, 2014, BIOCHEM BIOPH RES CO, V447, P602, DOI 10.1016/j.bbrc.2014.04.039; Choi HK, 2009, TOXICOL APPL PHARM, V240, P377, DOI 10.1016/j.taap.2009.07.030; Dai JL, 1998, CANCER RES, V58, P4592; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Duong HQ, 2014, INT J ONCOL, V44, P959, DOI 10.3892/ijo.2013.2229; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Farrow B, 2002, SURG ONCOL, V10, P153, DOI 10.1016/S0960-7404(02)00015-4; Ganan-Gomez I, 2013, FREE RADICAL BIO MED, V65, P750, DOI 10.1016/j.freeradbiomed.2013.06.041; Geismann C, 2014, ONCOTARGETS THER, V7, P1497, DOI 10.2147/OTT.S36624; Geismann C, 2009, CANCER RES, V69, P4517, DOI 10.1158/0008-5472.CAN-08-3493; Goebel L, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2014.1000083; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Helm O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094357; Hilbig A, 2011, CURR PHARM BIOTECHNO, V12, P2158, DOI 10.2174/138920111798808356; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Hong SM, 2011, MODERN PATHOL, V24, P1237, DOI 10.1038/modpathol.2011.74; Hong YB, 2010, PANCREAS, V39, P463, DOI 10.1097/MPA.0b013e3181c31314; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Ji XJ, 2014, INT J CANCER, V135, P574, DOI 10.1002/ijc.28699; Joo YE, 2002, PANCREATOLOGY, V2, P129, DOI 10.1159/000055903; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007; Kim WD, 2012, J CELL SCI, V125, P1284, DOI 10.1242/jcs.095422; Kleeff J, 2007, INT J CANCER, V121, P699, DOI 10.1002/ijc.22871; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Liu N, 1998, AM J PATHOL, V153, P263, DOI 10.1016/S0002-9440(10)65567-8; Lu DY, 2012, NEURO-ONCOLOGY, V14, P1367, DOI 10.1093/neuonc/nos262; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Moon EJ, 2015, FREE RADICAL BIO MED, V79, P292, DOI 10.1016/j.freeradbiomed.2014.11.009; Muerkoster SS, 2008, INT J CANCER, V123, P1751, DOI 10.1002/ijc.23703; Murkoster SS, 2007, ONCOGENE, V26, P2759, DOI 10.1038/sj.onc.1210076; Muerkoster S, 2005, CANCER RES, V65, P1316, DOI 10.1158/0008-5472.CAN-04-1626; No Jae Hong, 2014, J Cancer Prev, V19, P111, DOI 10.15430/JCP.2014.19.2.111; Oh CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045870; Okita Y, 2013, J BIOL CHEM, V288, P20658, DOI 10.1074/jbc.M113.450478; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Pan H, 2013, WORLD NEUROSURG, V80, P363, DOI 10.1016/j.wneu.2011.06.063; PIGNATELLI M, 1994, J PATHOL, V174, P243, DOI 10.1002/path.1711740403; Rachakonda G, 2010, ONCOGENE, V29, P3703, DOI 10.1038/onc.2010.118; Rane SG, 2006, CYTOKINE GROWTH F R, V17, P107, DOI 10.1016/j.cytogfr.2005.09.003; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Sebens S, 2011, J BIOL CHEM, V286, P40911, DOI 10.1074/jbc.M111.274902; Shelton P, 2013, FASEB J, V27, P414, DOI 10.1096/fj.12-217257; Shen H, 2014, DIS ESOPHAGUS, V27, P685, DOI 10.1111/dote.12124; Singh A, 2010, ANTIOXID REDOX SIGN, V13, P1627, DOI 10.1089/ars.2010.3219; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; Soini Y, 2014, PATHOL RES PRACT, V210, P35, DOI 10.1016/j.prp.2013.10.001; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; VEZERIDIS MP, 1990, J SURG RES, V48, P51, DOI 10.1016/0022-4804(90)90145-R; Volonte D, 2013, MOL BIOL CELL, V24, P1852, DOI 10.1091/mbc.E12-09-0666; Yamadori T, 2012, ONCOGENE, V31, P4768, DOI 10.1038/onc.2011.628; Zhang LM, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-66; Zhou SN, 2013, CRIT REV ONCOL HEMAT, V88, P706, DOI 10.1016/j.critrevonc.2013.09.001	66	36	36	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0132978	10.1371/journal.pone.0132978	http://dx.doi.org/10.1371/journal.pone.0132978			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226105	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700013
J	Das, A; Holmes, TC; Sheeba, V				Das, Antara; Holmes, Todd C.; Sheeba, Vasu			dTRPA1 Modulates Afternoon Peak of Activity of Fruit Flies Drosophila melanogaster	PLOS ONE			English	Article							CIRCADIAN CLOCK; TEMPERATURE ENTRAINMENT; SEMINATURAL CONDITIONS; PACEMAKER NEURONS; LIGHT; CRYPTOCHROME; CHANNEL; BEHAVIOR; RHYTHMS; SENSOR	Daily rhythms in Drosophila under semi-natural conditions (or SN) have received much recent attention. One of the striking differences in the behaviour of wild type flies under SN is the presence of an additional peak of activity in the middle of the day. This is referred to as the afternoon peak (A-peak) and is absent under standard laboratory regimes using gated light and temperature cues. Although previous reports identified the physical factors that contribute towards the A-peak there is no evidence for underlying molecular mechanisms or pathways that control A-peak. We report that the A-peak is mediated by thermo-sensitive dTRPA1 (drosophila Transient Receptor Potential-A1) ion channels as this peak is absent in dTRPA1 null mutants. Further, when natural cycles of light and temperature are simulated in the lab, we find that the amplitude of the A-peak is dTRPA1-dependent. Although a few circadian neurons express dTRPA1, we show that modulation of A-peak is primarily influenced by non-CRY dTRPA1 expressing neurons. Hence, we propose that A-peak of activity observed under SN is a temperature sensitive response in flies that is elicited through dTRPA1 receptor signalling.	[Das, Antara; Sheeba, Vasu] Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, Bangalore 560064, Karnataka, India; [Sheeba, Vasu] Jawaharlal Nehru Ctr Adv Sci Res, Neurosci Unit, Bangalore 560064, Karnataka, India; [Holmes, Todd C.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); University of California System; University of California Irvine	Sheeba, V (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, PB 6436,Jakkur Post, Bangalore 560064, Karnataka, India.	sheeba@jncasr.ac.in	Das, Antara/AAW-9674-2021	Das, Antara/0000-0002-9593-8856; Vasu, Sheeba/0000-0003-2924-7130; Holmes, Todd/0000-0001-8152-8832	Ramanujan Fellowship (Department of Science and Technology, India); Council of Scientific and Industrial Research (India) fellowship; National Institute of Health [R01s NS046750, GM102965, GM107405]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102965, R01GM107405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046750] Funding Source: NIH RePORTER	Ramanujan Fellowship (Department of Science and Technology, India); Council of Scientific and Industrial Research (India) fellowship; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Ramanujan Fellowship (Department of Science and Technology, India) to VS; Council of Scientific and Industrial Research (India) fellowship to AD; and National Institute of Health R01s NS046750, GM102965, and GM107405 to TCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Busza A, 2007, J NEUROSCI, V27, P10722, DOI 10.1523/JNEUROSCI.2479-07.2007; De J, 2013, P NATL ACAD SCI USA, V110, P8984, DOI 10.1073/pnas.1220960110; Dubruille R, 2008, MOL NEUROBIOL, V38, P129, DOI 10.1007/s12035-008-8035-y; Fogle KJ, 2015, P NATL ACAD SCI USA, V112, P2245, DOI 10.1073/pnas.1416586112; Fogle KJ, 2011, SCIENCE, V331, P1409, DOI 10.1126/science.1199702; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hamasaka Y, 2010, GENES CELLS, V15, P1240, DOI 10.1111/j.1365-2443.2010.01456.x; Head LM, 2015, CURR BIOL, V25, P1063, DOI 10.1016/j.cub.2015.02.038; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Kang KJ, 2012, NATURE, V481, P76, DOI 10.1038/nature10715; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Lee Y, 2013, J NEUROSCI, V33, P6716, DOI 10.1523/JNEUROSCI.4237-12.2013; Menegazzi P, 2012, J BIOL RHYTHM, V27, P433, DOI 10.1177/0748730412463181; Miyasako Y, 2007, J BIOL RHYTHM, V22, P115, DOI 10.1177/0748730407299344; Montell C, 2011, PFLUG ARCH EUR J PHY, V461, P499, DOI 10.1007/s00424-010-0920-3; Neely GG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024343; Ni LN, 2013, NATURE, V500, P580, DOI 10.1038/nature12390; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Picot M, 2009, J NEUROSCI, V29, P8312, DOI 10.1523/JNEUROSCI.0279-08.2009; Prabhakaran PM, 2014, J COMP PHYSL A; Prabhakaran PM, 2013, J EXP BIOL, V216, P4691, DOI 10.1242/jeb.092270; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Rosenzweig M, 2008, P NATL ACAD SCI USA, V105, P14668, DOI 10.1073/pnas.0805041105; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Sehadova H, 2009, NEURON, V64, P251, DOI 10.1016/j.neuron.2009.08.026; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Tang X, 2013, J NEUROSCI, V33, P894, DOI 10.1523/JNEUROSCI.1894-12.2013; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Wolfgang W, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0959; Yoshii T, 2005, EUR J NEUROSCI, V22, P1176, DOI 10.1111/j.1460-9568.2005.04295.x; Yoshii T, 2004, J INSECT PHYSIOL, V50, P479, DOI 10.1016/j.jinsphys.2004.02.011; Yoshii T, 2015, J NEUROSCI, V35, P6131, DOI 10.1523/JNEUROSCI.0070-15.2015; Yoshii T, 2010, J BIOL RHYTHM, V25, P387, DOI 10.1177/0748730410381962; Yoshii T, 2009, J BIOL RHYTHM, V24, P452, DOI 10.1177/0748730409348551; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002	46	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134213	10.1371/journal.pone.0134213	http://dx.doi.org/10.1371/journal.pone.0134213			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226013	Green Published, gold			2022-12-27	WOS:000358837700062
J	Jayachandran, D; Lainez-Aguirre, J; Rundell, A; Vik, T; Hannemann, R; Reklaitis, G; Ramkrishna, D				Jayachandran, Devaraj; Lainez-Aguirre, Jose; Rundell, Ann; Vik, Terry; Hannemann, Robert; Reklaitis, Gintaras; Ramkrishna, Doraiswami			Model-Based Individualized Treatment of Chemotherapeutics: Bayesian Population Modeling and Dose Optimization	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; THIOPURINE METHYLTRANSFERASE; MAINTENANCE THERAPY; MERCAPTOPURINE METABOLISM; PREDICTIVE CONTROL; 6-MERCAPTOPURINE; RISK; PHARMACOKINETICS; PHARMACOGENETICS; MEDICINE	6-Mercaptopurine (6-MP) is one of the key drugs in the treatment of many pediatric cancers, auto immune diseases and inflammatory bowel disease. 6-MP is a prodrug, converted to an active metabolite 6-thioguanine nucleotide (6-TGN) through enzymatic reaction involving thiopurine methyltransferase (TPMT). Pharmacogenomic variation observed in the TPMT enzyme produces a significant variation in drug response among the patient population. Despite 6-MP's widespread use and observed variation in treatment response, efforts at quantitative optimization of dose regimens for individual patients are limited. In addition, research efforts devoted on pharmacogenomics to predict clinical responses are proving far from ideal. In this work, we present a Bayesian population modeling approach to develop a pharmacological model for 6-MP metabolism in humans. In the face of scarcity of data in clinical settings, a global sensitivity analysis based model reduction approach is used to minimize the parameter space. For accurate estimation of sensitive parameters, robust optimal experimental design based on D-optimality criteria was exploited. With the patient-specific model, a model predictive control algorithm is used to optimize the dose scheduling with the objective of maintaining the 6-TGN concentration within its therapeutic window. More importantly, for the first time, we show how the incorporation of information from different levels of biological chain-of response (i.e. gene expression-enzyme phenotype-drug phenotype) plays a critical role in determining the uncertainty in predicting therapeutic target. The model and the control approach can be utilized in the clinical setting to individualize 6-MP dosing based on the patient's ability to metabolize the drug instead of the traditional standard-dose-for-all approach.	[Jayachandran, Devaraj; Lainez-Aguirre, Jose; Hannemann, Robert; Reklaitis, Gintaras; Ramkrishna, Doraiswami] Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA; [Rundell, Ann; Hannemann, Robert] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Vik, Terry] James Whitcomb Riley Hosp Children, Indianapolis, IN 46202 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; James Whitcomb Riley Hospital Children	Ramkrishna, D (corresponding author), Purdue Univ, Sch Chem Engn, 480 Stadium Mall Way, W Lafayette, IN 47907 USA.	ramkrish@purdue.edu	Vik, Terry Allan/AAG-9422-2019; Reklaitis, Gintaras/AAJ-5106-2020	Vik, Terry Allan/0000-0002-9883-0568; 	Walther Cancer Institute;  [NSF-CBET-0941302]	Walther Cancer Institute; 	Funded by Walther Cancer Institute (http://www.walther.org/) and NSF-CBET-0941302. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 1998, ACTA PAEDIATR, V87, P108, DOI 10.1080/08035259850158001; [Anonymous], 2008, R LANGUAGE ENV STAT; Arico M, 2005, Leukemia, V19, P1145, DOI 10.1038/sj.leu.2403783; Armstrong L, 2011, ALIMENT PHARM THER, V34, P1106, DOI 10.1111/j.1365-2036.2011.04848.x; Belaiche J, 2001, SCAND J GASTROENTERO, V36, P71, DOI 10.1080/00365520150218084; Bishop C. M, 2006, PATTERN RECOGNITION; Blau G, 2008, COMPUT CHEM ENG, V32, P971, DOI 10.1016/j.compchemeng.2007.04.008; Campo PJ, ROBUST MODEL PREDICT; Chan K., 2000, SENSITIVITY ANAL; Chen MH, 1999, J COMPUT GRAPH STAT, V8, P69, DOI 10.2307/1390921; Chessells JM, 1997, BRIT J HAEMATOL, V98, P945, DOI 10.1046/j.1365-2141.1997.3113127.x; Cortese DA, 2007, CLIN PHARMACOL THER, V82, P491, DOI 10.1038/sj.clpt.6100390; Davies Stella M, 2006, Hematology Am Soc Hematol Educ Program, P111; Derijks LJJ, 2004, THER DRUG MONIT, V26, P311, DOI 10.1097/00007691-200406000-00016; Estlin EJ, 2000, BRIT J HAEMATOL, V110, P29, DOI 10.1046/j.1365-2141.2000.02028.x; Evans WE, 1998, NEW ENGL J MED, V338, P499, DOI 10.1056/NEJM199802193380803; Fransson M., 2007, STATISTICS, V2009; Gearry RB, 2005, INTERN MED J, V35, P580, DOI 10.1111/j.1445-5994.2005.00904.x; Hawwa AF, 2008, BRIT J CLIN PHARMACO, V66, P517, DOI 10.1111/j.1365-2125.2008.03248.x; Hawwa AF, 2008, BRIT J CLIN PHARMACO, V66, P826, DOI 10.1111/j.1365-2125.2008.03281.x; Hindorf U, 2006, GUT, V55, P1423, DOI 10.1136/gut.2005.074930; Hood E, 2003, ENVIRON HEALTH PERSP, V111, pA580, DOI 10.1289/ehp.111-a580; Jayachandran D, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2014.6; KOREN G, 1990, NEW ENGL J MED, V323, P17, DOI 10.1056/NEJM199007053230104; Lainez JM, 2011, PHARM BASED DESIGN I; Lainez JM, 2013, PHARMACOTHERAPY J HU; Lainez-Aguirre JM, 2012, TECHNOMETRI IN PRESS; Lainez-Aguirre JM, 2013, AICHE J, V59, P3296, DOI 10.1002/aic.14100; Langreth, 1999, Oncologist, V4, P426; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LENNARD L, 1987, CLIN PHARMACOL THER, V41, P18, DOI 10.1038/clpt.1987.4; LENNARD L, 1992, EUR J CLIN PHARMACOL, V43, P329, DOI 10.1007/BF02220605; LENNARD L, 1990, LANCET, V336, P225, DOI 10.1016/0140-6736(90)91745-V; LENNARD L, 1993, BRIT J CLIN PHARMACO, V36, P277, DOI 10.1111/j.1365-2125.1993.tb00365.x; LENNARD L, 1989, J CLIN ONCOL, V7, P1816, DOI 10.1200/JCO.1989.7.12.1816; Lennard L, 1990, J CLIN ONCOL, V8, P567; LILLEYMAN JS, 1994, LANCET, V343, P1188, DOI 10.1016/S0140-6736(94)92400-7; McLeod HL, 2000, LEUKEMIA, V14, P567, DOI 10.1038/sj.leu.2401723; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Morari M, 1999, COMPUT CHEM ENG, V23, P667, DOI 10.1016/S0098-1354(98)00301-9; Noble SL, 2010, J THEOR BIOL, V264, P990, DOI 10.1016/j.jtbi.2010.01.031; Rosenthal RE, 2011, GAMS USERS GUIDE; Schmiegelow K, 2009, LEUKEMIA, V23, P557, DOI 10.1038/leu.2008.316; SCHMIEGELOW K, 1995, J CLIN ONCOL, V13, P345, DOI 10.1200/JCO.1995.13.2.345; Schmiegelow K, 2009, BLOOD, V113, P6077, DOI 10.1182/blood-2008-11-187880; Shastry BS, 2006, PHARMACOGENOMICS J, V6, P16, DOI 10.1038/sj.tpj.6500338; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; Xu J, 2010, DEATHS FINAL DATA 20	48	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133244	10.1371/journal.pone.0133244	http://dx.doi.org/10.1371/journal.pone.0133244			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226448	gold, Green Published			2022-12-27	WOS:000358837700016
J	Penedos, A; Johnson, AL; Strong, E; Goldman, AS; Carballo, JA; Cha, RS				Penedos, Ana; Johnson, Anthony L.; Strong, Emily; Goldman, Alastair S.; Carballo, Jesus A.; Cha, Rita S.			Essential and Checkpoint Functions of Budding Yeast ATM and ATR during Meiotic Prophase Are Facilitated by Differential Phosphorylation of a Meiotic Adaptor Protein, Hop1	PLOS ONE			English	Article							DNA-DAMAGE-RESPONSE; FHA DOMAIN; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; INTERHOMOLOG RECOMBINATION; SQ/TQ CLUSTER; MEIOSIS; MEK1; KINASE; HOMOLOG	A hallmark of the conserved ATM/ATR signalling is its ability to mediate a wide range of functions utilizing only a limited number of adaptors and effector kinases. During meiosis, Tel1 and Mec1, the budding yeast ATM and ATR, respectively, rely on a meiotic adaptor protein Hop1, a 53BP1/Rad9 functional analog, and its associated kinase Mek1, a CHK2/Rad53-paralog, to mediate multiple functions: control of the formation and repair of programmed meiotic DNA double strand breaks, enforcement of inter-homolog bias, regulation of meiotic progression, and implementation of checkpoint responses. Here, we present evidence that the multi-functionality of the Tel1/Mec1-to-Hop1/Mek1 signalling depends on stepwise activation of Mek1 that is mediated by Tel1/Mec1 phosphorylation of two specific residues within Hop1: phosphorylation at the threonine 318 (T318) ensures the transient basal level Mek1 activation required for viable spore formation during unperturbed meiosis. Phosphorylation at the serine 298 (S298) promotes stable Hop1-Mek1 interaction on chromosomes following the initial phospho-T318 mediated Mek1 recruitment. In the absence of Dmc1, the phospho-S298 also promotes Mek1 hyper-activation necessary for implementing meiotic checkpoint arrest. Taking these observations together, we propose that the Hop1 phospho-T318 and phospho-S298 constitute key components of the Tel1/Mec1-based meiotic recombination surveillance (MRS) network and facilitate effective coupling of meiotic recombination and progression during both unperturbed and challenged meiosis.	[Carballo, Jesus A.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Penedos, Ana; Johnson, Anthony L.] Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, MRC, London NW7 1AA, England; [Cha, Rita S.] Bangor Univ, North West Canc Res Fund Inst, Sch Med Sci, Bangor LL57 2UW, Gwynedd, Wales; [Strong, Emily; Goldman, Alastair S.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Sussex; MRC National Institute for Medical Research; Bangor University; University of Sheffield	Carballo, JA (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	J.A.Carballo@sussex.ac.uk	; Carballo, Jesus/K-9899-2014	Goldman, Alastair/0000-0002-0516-3197; Krishnan, Emily/0000-0003-3443-6104; Carballo, Jesus/0000-0003-2259-3743; Penedos, Ana/0000-0002-1933-0726	MRC [U1175.01.005.00005.01]; MRC centre grant [G0801130]; Medical Research Council [G0801130] Funding Source: researchfish; MRC [G0801130] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC centre grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Research was partly funded by the MRC program grant U1175.01.005.00005.01 from RSC and by the MRC centre grant G0801130 from JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta I, 2011, MOL BIOL CELL, V22, P3478, DOI 10.1091/mbc.E11-06-0482; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Ali AAE, 2009, NUCLEIC ACIDS RES, V37, P1701, DOI 10.1093/nar/gkn1086; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Argunhan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065875; Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Busygina V, 2008, GENE DEV, V22, P786, DOI 10.1101/gad.1638708; Carballo JA, 2007, CHROMOSOME RES, V15, P539, DOI 10.1007/s10577-007-1145-y; Carballo JA, 2008, CELL, V132, P758, DOI 10.1016/j.cell.2008.01.035; Carballo JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003545; Cartagena-Lirola H, 2008, MOL CELL BIOL, V28, P4480, DOI 10.1128/MCB.00375-08; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Chuang CN, 2012, NUCLEIC ACIDS RES, V40, P11416, DOI 10.1093/nar/gks920; de los Santos T, 1999, J BIOL CHEM, V274, P1783, DOI 10.1074/jbc.274.3.1783; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Emili A, 1998, MOL CELL, V2, P183, DOI 10.1016/S1097-2765(00)80128-8; Falk JE, 2010, DEV CELL, V19, P599, DOI 10.1016/j.devcel.2010.09.006; Gray S, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130019; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Hollingsworth NM, 1997, GENETICS, V147, P33; HOLLINGSWORTH NM, 1990, CELL, V61, P73, DOI 10.1016/0092-8674(90)90216-2; Lao JP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003978; Lee H, 2008, MOL CELL, V30, P767, DOI 10.1016/j.molcel.2008.05.013; Lo YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085687; Lydall D, 1996, NATURE, V383, P840, DOI 10.1038/383840a0; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; Ontoso D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003262; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Shinohara M, 1997, GENETICS, V147, P1545; Tougan T, 2010, CELL CYCLE, V9, P4688, DOI 10.4161/cc.9.23.14050; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Tsubouchi H, 2006, GENE DEV, V20, P1766, DOI 10.1101/gad.1422506; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; Wan LH, 2004, MOL BIOL CELL, V15, P11, DOI 10.1091/mbc.E03-07-0499; Woltering D, 2000, MOL CELL BIOL, V20, P6646, DOI 10.1128/MCB.20.18.6646-6658.2000; Wu HY, 2010, CURR BIOL, V20, P1707, DOI 10.1016/j.cub.2010.09.016; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Yaffe MB, 2001, STRUCTURE, V9, pR33, DOI 10.1016/S0969-2126(01)00580-9	44	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134297	10.1371/journal.pone.0134297	http://dx.doi.org/10.1371/journal.pone.0134297			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225562	Green Published, Green Accepted, gold			2022-12-27	WOS:000358837700069
J	Liem, PH; Morimoto, N; Mahara, A; Jinno, C; Shima, K; Ogino, S; Sakamoto, M; Kakudo, N; Inoie, M; Kusumoto, K; Fujisato, T; Suzuki, S; Yamaoka, T				Pham Hieu Liem; Morimoto, Naoki; Mahara, Atsushi; Jinno, Chizuru; Shima, Koji; Ogino, Shuichi; Sakamoto, Michiharu; Kakudo, Natsuko; Inoie, Masukazu; Kusumoto, Kenji; Fujisato, Toshia; Suzuki, Shigehiko; Yamaoka, Tetsuji			Preparation of Inactivated Human Skin Using High Hydrostatic Pressurization for Full-Thickness Skin Reconstruction	PLOS ONE			English	Article							PRESSURE; BONE; DECELLULARIZATION; CELLS	We have reported that high-hydrostatic-pressure (HHP) technology is safe and useful for producing various kinds of decellularized tissue. However, the preparation of decellularized or inactivated skin using HHP has not been reported. The objective of this study was thus to prepare inactivated skin from human skin using HHP, and to explore the appropriate conditions of pressurization to inactivate skin that can be used for skin reconstruction. Human skin samples of 8 mm in diameter were packed in bags filled with normal saline solution (NSS) or distilled water (DW), and then pressurized at 0, 100, 150, 200 and 1000 MPa for 10 minutes. The viability of skin after HHP was evaluated using WST-8 assay. Outgrowth cells from pressurized skin and the viability of pressurized skin after cultivation for 14 days were also evaluated. The pressurized skin was subjected to histological evaluation using hematoxylin and eosin staining, scanning electron microscopy (SEM), immunohistochemical staining of type IV collagen for the basement membrane of epidermis and capillaries, and immunohistochemical staining of von Willebrand factor (vWF) for capillaries. Then, human cultured epidermis (CE) was applied on the pressurized skin and implanted into the subcutis of nude mice; specimens were subsequently obtained 14 days after implantation. Skin samples pressurized at more than 200 MPa were inactivated in both NSS and DW. The basement membrane and capillaries remained intact in all groups according to histological and immunohistological evaluations, and collagen fibers showed no apparent damage by SEM. CE took on skin pressurized at 150 and 200 MPa after implantation, whereas it did not take on skin pressurized at 1000 MPa. These results indicate that human skin could be inactivated after pressurization at more than 200 MPa, but skin pressurized at 1000 MPa had some damage to the dermis that prevented the taking of CE. Therefore, pressurization at 200 MPa is optimal for preparing inactivated skin that can be used for skin reconstruction.	[Pham Hieu Liem; Jinno, Chizuru; Ogino, Shuichi; Sakamoto, Michiharu; Suzuki, Shigehiko] Kyoto Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Kyoto, Japan; [Morimoto, Naoki; Kakudo, Natsuko; Kusumoto, Kenji] Kansai Med Univ, Dept Plast & Reconstruct Surg, Hirakata, Osaka, Japan; [Mahara, Atsushi; Yamaoka, Tetsuji] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biomed Engn, Suita, Osaka, Japan; [Shima, Koji; Fujisato, Toshia] Osaka Inst Technol, Dept Biomed Engn, Osaka 535, Japan; [Inoie, Masukazu] Japan Tissue Engn Co Ltd, Gamagori, Japan; [Pham Hieu Liem] Pham Ngoc Thach Univ Med, Dept Plast & Aesthet Surg, Ho Chi Minh City, Vietnam	Kyoto University; Kansai Medical University; National Cerebral & Cardiovascular Center - Japan; Osaka Institute of Technology	Morimoto, N (corresponding author), Kansai Med Univ, Dept Plast & Reconstruct Surg, Hirakata, Osaka, Japan.	morimotn@hirakata.kmu.ac.jp	Mahara, Atsushi/AAG-1301-2022; Mahara, Atsushi/AES-9161-2022	FUJISATO, Toshia/0000-0002-7206-093X; Inoie, Masukazu/0000-0002-8101-170X; Kakudo, Natsuko/0000-0001-9785-1490; Morimoto, Naoki/0000-0002-0712-3172; Ogino, Shuichi/0000-0003-1063-5272	Japan Society for Promotion of Science (JSPS) KAKENHI [24659782]; Japan Science and Technology Agency(JST); Japan Tissue Engineering Co., Ltd	Japan Society for Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(JST)(Japan Science & Technology Agency (JST)); Japan Tissue Engineering Co., Ltd	This study was supported partially by Japan Society for Promotion of Science (JSPS) KAKENHI Grant Number 24659782 (https://kaken.nii.ac.jp/d/p/24659782.en.html) and by the Adaptable and Seamless Technology transfer Program through target driven R & D from Japan Science and Technology Agency(JST)(http://www.jst.go.jp/a-step/kadai/h24-2fs.html). NM TY TF received those findings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Japan Tissue Engineering Co., Ltd provided support in the form of salaries for authors MI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Arneja Jugpal S, 2009, Plast Reconstr Surg, V124, p1e, DOI 10.1097/PRS.0b013e3181ab11be; Cardone F, 2006, BBA-PROTEINS PROTEOM, V1764, P558, DOI 10.1016/j.bbapap.2006.01.022; CASTILLA EE, 1981, BRIT J DERMATOL, V104, P307, DOI 10.1111/j.1365-2133.1981.tb00954.x; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Diehl P, 2005, INT J MOL MED, V16, P285; Diehl P, 2008, ANTICANCER RES, V28, P3877; Follonier S, 2012, APPL MICROBIOL BIOT, V93, P1805, DOI 10.1007/s00253-011-3854-6; Fujisato T, 2005, CARDIOVASCULAR REGENERATION THERAPIES USING TISSUE ENGINEERING APPROACHES, P83, DOI 10.1007/4-431-27378-6_7; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gonfiotti A, 2014, LANCET, V383, P238, DOI 10.1016/S0140-6736(13)62033-4; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; Hashimoto Y, 2011, BIOMATERIALS, V32, P7060, DOI 10.1016/j.biomaterials.2011.06.008; Hashimoto Y, 2010, BIOMATERIALS, V31, P3941, DOI 10.1016/j.biomaterials.2010.01.122; He M, 2013, TISSUE ENG PART B-RE, V19, P194, DOI [10.1089/ten.teb.2012.0340, 10.1089/ten.TEB.2012.0340]; Kanemura Y, 2002, J NEUROSCI RES, V69, P869, DOI 10.1002/jnr.10377; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Mahara A, 2015, BIOMATERIALS, V58, P54, DOI 10.1016/j.biomaterials.2015.04.031; Mahara A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/379607; Morimoto N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/587247; Naal FD, 2008, J BIOMED MATER RES B, V87B, P19, DOI 10.1002/jbm.b.31059; Nicoletti G, 2015, J TISSUE ENG REGEN M, V9, P460, DOI 10.1002/term.1939; Liem PH, 2013, J ARTIF ORGANS, V16, P332, DOI 10.1007/s10047-013-0708-2; Philandrianos C, 2012, BURNS, V38, P820, DOI 10.1016/j.burns.2012.02.008; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Rivalain N, 2010, BIOTECHNOL ADV, V28, P659, DOI 10.1016/j.biotechadv.2010.04.001; Schauwecker J, 2006, ANTICANCER RES, V26, P85; Schauwecker J, 2011, ANTICANCER RES, V31, P1235; Schiestl C, 2010, J PLAST RECONSTR AES, V63, P610, DOI 10.1016/j.bjps.2009.01.050; Schneider J, 2009, BURNS, V35, P51, DOI 10.1016/j.burns.2008.07.018; Suzuki S, 2013, J PLAST RECONSTR AES, V66, pE229, DOI 10.1016/j.bjps.2013.03.018; Wilson SL, 2013, J FUNCT BIOMATER, V4, P114, DOI 10.3390/jfb4030114; Yamaguchi T, 2008, CELL MOL BIOL LETT, V13, P49, DOI 10.2478/s11658-007-0034-x	32	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133979	10.1371/journal.pone.0133979	http://dx.doi.org/10.1371/journal.pone.0133979			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226373	gold, Green Published, Green Submitted			2022-12-27	WOS:000358837700045
J	Wilkerson, RC; Linton, YM; Fonseca, DM; Schultz, TR; Price, DC; Strickman, DA				Wilkerson, Richard C.; Linton, Yvonne-Marie; Fonseca, Dina M.; Schultz, Ted R.; Price, Dana C.; Strickman, Daniel A.			Making Mosquito Taxonomy Useful: A Stable Classification of Tribe Aedini that Balances Utility with Current Knowledge of Evolutionary Relationships	PLOS ONE			English	Article							RIFT-VALLEY FEVER; EASTERN EQUINE ENCEPHALITIS; ALLIED TAXA DIPTERA; PHYLOGENETIC-RELATIONSHIPS; YELLOW-FEVER; ARBOVIRUS SURVEILLANCE; WUCHERERIA-BANCROFTI; MORPHOLOGICAL DATA; SYNOPTIC CATALOG; GENERIC RANK	The tribe Aedini (Family Culicidae) contains approximately one-quarter of the known species of mosquitoes, including vectors of deadly or debilitating disease agents. This tribe contains the genus Aedes, which is one of the three most familiar genera of mosquitoes. During the past decade, Aedini has been the focus of a series of extensive morphology-based phylogenetic studies published by Reinert, Harbach, and Kitching (RH&K). Those authors created 74 new, elevated or resurrected genera from what had been the single genus Aedes, almost tripling the number of genera in the entire family Culicidae. The proposed classification is based on subjective assessments of the "number and nature of the characters that support the branches" subtending particular monophyletic groups in the results of cladistic analyses of a large set of morphological characters of representative species. To gauge the stability of RH&K's generic groupings we reanalyzed their data with unweighted parsimony jackknife and maximum-parsimony analyses, with and without ordering 14 of the characters as in RH&K. We found that their phylogeny was largely weakly supported and their taxonomic rankings failed priority and other useful taxon-naming criteria. Consequently, we propose simplified aedine generic designations that 1) restore a classification system that is useful for the operational community; 2) enhance the ability of taxonomists to accurately place new species into genera; 3) maintain the progress toward a natural classification based on monophyletic groups of species; and 4) correct the current classification system that is subject to instability as new species are described and existing species more thoroughly defined. We do not challenge the phylogenetic hypotheses generated by the above-mentioned series of morphological studies. However, we reduce the ranks of the genera and subgenera of RH&K to subgenera or informal species groups, respectively, to preserve stability as new data become available.	[Wilkerson, Richard C.; Linton, Yvonne-Marie; Schultz, Ted R.] Smithsonian Inst, Dept Entomol, Natl Museum Nat Hist, Washington, DC 20560 USA; [Linton, Yvonne-Marie] Smithsonian Inst, Museum Support Ctr, Walter Reed Biosystemat Unit, Suitland, MD USA; [Linton, Yvonne-Marie] Walter Reed Army Inst Res, Dept Entomol, Silver Spring, MD USA; [Linton, Yvonne-Marie] Uniformed Serv Univ Hlth Sci, Fac Preventat Med & Biometr, Bethesda, MD 20814 USA; [Fonseca, Dina M.; Price, Dana C.] Rutgers State Univ, Dept Entomol, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA; [Strickman, Daniel A.] Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Uniformed Services University of the Health Sciences - USA; Rutgers State University New Brunswick; Bill & Melinda Gates Foundation	Wilkerson, RC (corresponding author), Smithsonian Inst, Dept Entomol, Natl Museum Nat Hist, NHB 169, Washington, DC 20560 USA.	wilkersonr@si.edu	Fonseca, Dina/HHS-1320-2022; Linton, Yvonne/AAG-2353-2019; Linton, Yvonne-Marie/AAW-3992-2021; Fonseca, Dina Madeira/B-9951-2011	Fonseca, Dina Madeira/0000-0003-4726-7100	Direct For Biological Sciences [0949689, 1456964] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		ANDREADIS TG, 1994, J AM MOSQUITO CONTR, V10, P556; Andreadis TG, 1998, J MED ENTOMOL, V35, P296, DOI 10.1093/jmedent/35.3.296; Andreadis TG, 2014, VECTOR-BORNE ZOONOT, V14, P763, DOI 10.1089/vbz.2014.1669; [Anonymous], 2005, J MED ENTOMOL, V42, P511; Armstrong PM, 2010, EMERG INFECT DIS, V16, P1869, DOI 10.3201/eid1612.100640; ARNELL J H, 1976, Contributions of the American Entomological Institute, V13, P1; ARNELL J H, 1973, Contributions of the American Entomological Institute, V10, P1; Ashfaq M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097268; Belkin J.N., 1962, MOSQUITOES S PACIFIC, VI and II; Besansky NJ, 1997, MOL BIOL EVOL, V14, P442, DOI 10.1093/oxfordjournals.molbev.a025780; Black WC, 2004, J AM MOSQUITO CONTR, V20, P215; Carpenter S. J., 1955, MOSQUITOES N AM N ME; CDC, 2015, ARB CAT; Centers for Disease Control and Prevention (CDC), 2012, MOSQ SPEC WHICH W NI; Clements A., 2012, BIOL MOSQUITOES, V3; Cook S, 2005, J MED ENTOMOL, V42, P19, DOI 10.1603/0022-2585(2005)042[0019:MMFMIO]2.0.CO;2; Darsie RF, 2005, IDENTIFICATION GEOGR, Vxiv; DEQUEIROZ K, 1992, ANNU REV ECOL SYST, V23, P449, DOI 10.1146/annurev.ecolsys.23.1.449; Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281; Edwards FW, 1932, GENERA INSESTORUM DI; Ergunay K, 2013, VECTOR-BORNE ZOONOT, V13, P744, DOI 10.1089/vbz.2012.1288; Farris JS, 1996, CLADISTICS, V12, P99, DOI 10.1111/j.1096-0031.1996.tb00196.x; Fontenille D, 1998, EMERG INFECT DIS, V4, P289, DOI 10.3201/eid0402.980218; GAFFIGAN T V, 1985, Mosquito Systematics, V17, P52; GARGAN TP, 1988, AM J TROP MED HYG, V38, P440, DOI 10.4269/ajtmh.1988.38.440; GERMAIN M, 1980, AM J TROP MED HYG, V29, P929, DOI 10.4269/ajtmh.1980.29.929; Gjelsvik A, 1981, THEORY THIN WALLED B, DOI DOI 10.1115/1.3162198; Glaubrechet M, 2010, EVOLUTION ACTION CAS; Goloboff PA, 2003, CLADISTICS, V19, P324, DOI 10.1016/S0748-3007(03)00060-4; Goloboff P, 2008, CLADISTICS, V24, P91; Goloboff PA, 2014, CLADISTICS, V30, P260, DOI 10.1111/cla.12047; GORDON SW, 1992, AM J TROP MED HYG, V47, P742, DOI 10.4269/ajtmh.1992.47.742; GOULD DJ, 1982, MOSQ NEWS, V42, P560; Harbach RE, 2007, ZOOTAXA, P591; Harbach RE, 1998, SYST ENTOMOL, V23, P327, DOI 10.1046/j.1365-3113.1998.00072.x; HENNIG W, 1965, ANNU REV ENTOMOL, V10, P97, DOI 10.1146/annurev.en.10.010165.000525; Hennig W., 1981, INSECT PHYLOGENY; Huang Y.-M., 1990, Contributions of the American Entomological Institute, V26, P3; HUANG YM, 1986, J MED ENTOMOL, V23, P196, DOI 10.1093/jmedent/23.2.196; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; HURLBUT HS, 1956, AM J TROP MED HYG, V5, P76, DOI 10.4269/ajtmh.1956.5.76; HARINASUTA C., 1970, Southeast Asian Journal of Tropical Medicine and Public Health, V1, P233; Iyengar MOT, 1954, 66 S PAC COMM, P52; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Kaufman MG, 2014, ANNU REV ENTOMOL, V59, P31, DOI 10.1146/annurev-ento-011613-162012; Kluge AG, 1997, CLADISTICS, V13, P81, DOI 10.1111/j.1096-0031.1997.tb00242.x; Knight K. L., 1978, CATALOG MOSQUITOES S; Kumar A, 1998, INSECT MOL BIOL, V7, P367, DOI 10.1046/j.1365-2583.1998.740367.x; Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2; Liu H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-68; Liu H, 2010, EMERG INFECT DIS, V16, P514, DOI 10.3201/eid1603.091160; Marcondes CB, 2007, TRENDS PARASITOL, V23, P302, DOI 10.1016/j.pt.2007.04.011; Marks EN, 1947, U QUEENSLAND PAPERS, V2, P1; McIntosh B M, 1972, J S Afr Vet Med Assoc, V43, P391; MCINTOSH BM, 1980, S AFR MED J, V58, P127; McIntosh BM, 1971, J ENTOMOL SOC S AFR, P319; Miller BR, 1997, INSECT MOL BIOL, V6, P105, DOI 10.1111/j.1365-2583.1997.tb00078.x; MILLER BR, 1989, T ROY SOC TROP MED H, V83, P252, DOI 10.1016/0035-9203(89)90667-6; Mitchell CJ, 1998, J MED ENTOMOL, V35, P573, DOI 10.1093/jmedent/35.4.573; Niebylski ML, 1992, MMWR-MORBID MORTAL W, V41, P121; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Pages F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004691; Pauvolid-Correa A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002318; Polaszek A, 2006, TRENDS PARASITOL, V22, P8, DOI 10.1016/j.pt.2005.11.003; Polaszek A, 2007, TRENDS PARASITOL, V23, P303, DOI 10.1016/j.pt.2007.04.010; REINERT J F, 1982, Mosquito Systematics, V14, P101; Reinert J. F., 1990, Contributions of the American Entomological Institute, V26, P1; Reinert J.F., 1987, MOSQ SYST, V18, P307; Reinert JF, 2000, J AM MOSQUITO CONTR, V16, P175; Reinert JF, 2000, J AM MOSQUITO CONTR, V16, P57; Reinert JF, 2004, ZOOL J LINN SOC-LOND, V142, P289, DOI 10.1111/j.1096-3642.2004.00144.x; Reinert JF, 1979, MOSQ SYST, V11, P144; Reinert JF, 2008, ZOOL J LINN SOC-LOND, V153, P29, DOI 10.1111/j.1096-3642.2008.00382.x; Reinert JF, 2006, ZOOL J LINN SOC-LOND, V148, P1, DOI 10.1111/j.1096-3642.2006.00254.x; Reinert John F., 1999, Contributions of the American Entomological Institute, V31, P1; Reinert JF, 2009, ZOOL J LINN SOC-LOND, V157, P700, DOI 10.1111/j.1096-3642.2009.00570.x; RODANICHE ED, 1963, AM J TROP MED HYG, V12, P924; Savage HM, 2005, J MED ENTOMOL, V42, P923, DOI 10.1603/0022-2585(2005)042[0923:COMITA]2.0.CO;2; Savage HM, 2004, J AM MOSQUITO CONTR, V20, P208; Stone A., 1971, Proceedings of the Entomological Society of Washington, V73, P180; STONE A, 1970, P ENTOMOL SOC WASH, V72, P137; STONE A, 1967, P ENTOMOL SOC WASH, V69, P197; Stone A., 1959, SYNOPTIC CATALOG MOS; Stone A., 1977, CATALOG MOSQUITOES W; STONE ALAN, 1963, PROC ENTOMOL SOC WASHINGTON, V65, P117; STONE ALAN, 1961, PROC ENT SOC WASHINGTON, V63, P29; SUGURI S, 1985, JPN J EXP MED, V55, P61; Swofford D.L., 2002, PHYLOGENETIC ANAL US; TANAKA K, 1979, CONTRIB AM ENTOMOL I, V16, P987; Tao San-ju, 2003, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V17, P322; THIELE K, 1993, CLADISTICS, V9, P275, DOI 10.1111/j.1096-0031.1993.tb00226.x; TURELL MJ, 1988, J MED ENTOMOL, V25, P262, DOI 10.1093/jmedent/25.4.262; Turrell MJ, 2005, J MED ENTOMOL, V25, P262, DOI [10.1093/jmedent/25.4.262, DOI 10.1093/JMEDENT/25.4.262]; Vences M, 2013, ZOOTAXA, V3636, P201, DOI 10.11646/zootaxa.3636.2.1; Versteirt V, 2012, J MED ENTOMOL, V49, P1226, DOI 10.1603/ME11170; Wang Gang, 2012, PLoS ONE, V7, pe47051, DOI 10.1371/journal.pone.0047051; Wang ZS, 2009, CHINA PUB HLTH, V25, P769, DOI 10.3321/j.issn:1001-0580.2009.07.001; WARD R A, 1984, Mosquito Systematics, V16, P227; Ward Ronald A., 1992, Mosquito Systematics, V24, P177; WELLINGS FM, 1972, AM J TROP MED HYG, V21, P201, DOI 10.4269/ajtmh.1972.21.201; Wiley E. O., 2011, PHYLOGENETIC SYSTEMA; WILEY EO, 1979, SYST ZOOL, V28, P308; Wood D.M., 1989, Agriculture Canada Monograph, P1333; Wozniak A, 2001, J AM MOSQUITO CONTR, V17, P73	104	180	209	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133602	10.1371/journal.pone.0133602	http://dx.doi.org/10.1371/journal.pone.0133602			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226613	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700027
J	Geltmeier, A; Rinner, B; Bade, D; Meditz, K; Witt, R; Bicker, U; Bludszuweit-Philipp, C; Maier, P				Geltmeier, Annette; Rinner, Beate; Bade, Dennis; Meditz, Katharina; Witt, Reiner; Bicker, Uwe; Bludszuweit-Philipp, Catrin; Maier, Patrick			Characterization of Dynamic Behaviour of MCF7 and MCF10A Cells in Ultrasonic Field Using Modal and Harmonic Analyses	PLOS ONE			English	Article							BREAST-CANCER; EUROPEAN-SOCIETY; MALIGNANT-CELLS; MECHANICS; APOPTOSIS; NUCLEUS; RECOMMENDATIONS; DEFORMATION; MANAGEMENT	Treatment options specifically targeting tumour cells are urgently needed in order to reduce the side effects accompanied by chemo-or radiotherapy. Differences in subcellular structure between tumour and normal cells determine their specific elasticity. These structural differences can be utilised by low-frequency ultrasound in order to specifically induce cytotoxicity of tumour cells. For further evaluation, we combined in silico FEM (finite element method) analyses and in vitro assays to bolster the significance of low-frequency ultrasound for tumour treatment. FEM simulations were able to calculate the first resonance frequency of MCF7 breast tumour cells at 21 kHz in contrast to 34 kHz for the MCF10A normal breast cells, which was due to the higher elasticity and larger size of MCF7 cells. For experimental validation of the in silico-determined resonance frequencies, equipment for ultrasonic irradiation with distinct frequencies was constructed. Differences for both cell lines in their response to low-frequent ultrasonic treatment were corroborated in 2D and in 3D cell culture assays. Treatment with similar to 24.5 kHz induced the death of MCF7 cells and MDA-MB-231 metastases cells possessing a similar elasticity; frequencies of > 29 kHz resulted in cytotoxicity of MCF10A. Fractionated treatments by ultrasonic irradiation of suspension myeloid HL60 cells resulted in a significant decrease of viable cells, mostly significant after threefold irradiation in intervals of 3 h. Most importantly in regard to a clinical application, combined ultrasonic treatment and chemotherapy with paclitaxel showed a significantly increased killing of MCF7 cells compared to both monotherapies. In summary, we were able to determine for the first time for different tumour cell lines a specific frequency of low-intensity ultrasound for induction of cell ablation. The cytotoxic effect of ultrasonic irradiation could be increased by either fractionated treatment or in combination with chemotherapy. Thus, our results will open new perspectives in tumour treatment.	[Geltmeier, Annette; Bludszuweit-Philipp, Catrin] ASD Adv Simulat & Design GmbH, Rostock, Germany; [Rinner, Beate; Meditz, Katharina] Med Univ Graz, Med Res Ctr, Graz, Austria; [Bade, Dennis] Mechatron AG, Darmstadt, Germany; [Witt, Reiner; Bicker, Uwe; Maier, Patrick] Oncowave Med AG, Darmstadt, Germany; [Maier, Patrick] Heidelberg Univ, Med Fac Mannheim, Univ Med Mannheim, Dept Radiat Oncol, Mannheim, Germany	Medical University of Graz; Ruprecht Karls University Heidelberg	Maier, P (corresponding author), Oncowave Med AG, Darmstadt, Germany.	patrick.maier@oncowave.com		Rinner, Beate/0000-0002-6340-4905	Oncowave Medical AG; ASD Advanced Simulation Design GmbH; Mechatronic AG	Oncowave Medical AG; ASD Advanced Simulation Design GmbH; Mechatronic AG	This work was supported by Oncowave Medical AG. The funder provided support in the form of salaries for authors RW, UB and PM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. ASD Advanced Simulation & Design GmbH provided support in the form of salaries for authors AG and CBP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, and Mechatronic AG provided support in the form of a salary for author DB but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all of these authors are articulated in the Author Contributions section.	Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Ananthakrishnan R, 2006, J THEOR BIOL, V242, P502, DOI 10.1016/j.jtbi.2006.03.021; Bhimarao M, 2011, COLLAPSING CANC CELL; Biganzoli L, 2012, LANCET ONCOL, V13, pE148, DOI 10.1016/S1470-2045(11)70383-7; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Caille N, 2002, J BIOMECH, V35, P177, DOI 10.1016/S0021-9290(01)00201-9; Cardoso F, 2012, EUR J CANCER, V48, P3355, DOI 10.1016/j.ejca.2012.10.004; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Cukierman E, 2010, SEMIN CANCER BIOL, V20, P139, DOI 10.1016/j.semcancer.2010.04.004; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Feng Y, 2008, WORLD J GASTROENTERO, V14, P4873, DOI 10.3748/wjg.14.4873; Feng Y, 2010, J ULTRAS MED, V29, P963, DOI 10.7863/jum.2010.29.6.963; Feril LB, 2005, CANCER LETT, V221, P145, DOI 10.1016/j.canlet.2004.08.034; Funnell W Robert J, 2006, J Nanobiotechnology, V4, P10, DOI 10.1186/1477-3155-4-10; GEKKO K, 1979, J PHYS CHEM-US, V83, P2706, DOI 10.1021/j100484a006; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Guilak F, 2000, BIOCHEM BIOPH RES CO, V269, P781, DOI 10.1006/bbrc.2000.2360; Gutenberg A, 2013, J NEURO-ONCOL, V113, P163, DOI 10.1007/s11060-013-1110-x; Heidemann SR, 1999, J CELL BIOL, V145, P109, DOI 10.1083/jcb.145.1.109; Hrazdira I, 1998, Eur J Ultrasound, V8, P43, DOI 10.1016/S0929-8266(98)00049-4; Ketene AN, 2012, NANOMED-NANOTECHNOL, V8, P93, DOI 10.1016/j.nano.2011.05.012; Kha HN, 2004, MED ENG PHYS, V26, P677, DOI 10.1016/j.medengphy.2004.05.001; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Lee YJ, 2011, INT J BIOL SCI, V7, P102, DOI 10.7150/ijbs.7.102; Leelertyuth S, 2010, BIOINF BIOM ENG ICBB, P1; Lejbkowicz F, 1997, ENVIRON HEALTH PERSP, V105, P1575, DOI 10.2307/3433673; LEJBKOWICZ F, 1993, ULTRASOUND MED BIOL, V19, P75, DOI 10.1016/0301-5629(93)90020-O; Lens MB, 2003, EXPERT OPIN PHARMACO, V4, P2205, DOI 10.1517/14656566.4.12.2205; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Lim CT, 2006, J BIOMECH, V39, P195, DOI 10.1016/j.jbiomech.2004.12.008; Maier P, 2010, RADIAT RES, V173, P612, DOI 10.1667/RR1952.1; McGarry J G, 2004, Eur Cell Mater, V7, P27; McGarry MDJ, 2008, MED BIOL ENG COMPUT, V46, P759, DOI 10.1007/s11517-008-0356-5; Mills J P, 2004, Mech Chem Biosyst, V1, P169; Molavi M., 2006, 2006 IEEE International Symposium on Industrial Electronics, P3328, DOI 10.1109/ISIE.2006.295999; Moreno-Flores S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/44/445101; Nandakumar V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029230; Nikkhah M, 2011, J BIOMECH, V44, P762, DOI 10.1016/j.jbiomech.2010.11.002; Or M, 2009, ULTRASOUND MED BIOL, V35, P1015, DOI 10.1016/j.ultrasmedbio.2008.11.011; Park K, 2010, P NATL ACAD SCI USA, V107, P20691, DOI 10.1073/pnas.1011365107; Radmacher M, 2007, METHOD CELL BIOL, V83, P347, DOI 10.1016/S0091-679X(07)83015-9; Rowat AC, 2008, BIOESSAYS, V30, P226, DOI 10.1002/bies.20720; Shim S, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002180; Skorpikova J, 2001, FOLIA BIOL-PRAGUE, V47, P143; Slomka N, 2011, STUD MECHANOBIOL TIS, V4, P331, DOI 10.1007/8415_2010_31; SOULE HD, 1990, CANCER RES, V50, P6075; SQUIRE PG, 1979, ARCH BIOCHEM BIOPHYS, V196, P165, DOI 10.1016/0003-9861(79)90563-0; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Takeuchi S, 2006, ULTRASONICS, V44, pE345, DOI 10.1016/j.ultras.2006.07.007; ter Haar G, 2010, P I MECH ENG H, V224, P363, DOI 10.1243/09544119JEIM613; Vaziri A, 2007, J BIOMECH, V40, P2053, DOI 10.1016/j.jbiomech.2006.09.023; Vernerey FJ, 2011, COMPUT METHOD BIOMEC, V14, P433, DOI 10.1080/10255842.2010.531273; Zinin PV, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.021910; Zinin PV, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061907; Zwerger M, 2011, ANNU REV BIOMED ENG, V13, P397, DOI 10.1146/annurev-bioeng-071910-124736	55	37	37	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134999	10.1371/journal.pone.0134999	http://dx.doi.org/10.1371/journal.pone.0134999			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241649	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700089
J	Kawada, K; Borjigin, W; Nakamura, T				Kawada, Kiyokazu; Borjigin, Wuyunna; Nakamura, Toru			Agricultural Activities of a Meadow Eliminated Plant Litter from the Periphery of a Farmland in Inner Mongolia, China	PLOS ONE			English	Article							WIND EROSION; SHORT-TERM; SOIL; FIELD; DIVERSITY; DECOMPOSITION; VEGETATION; STEPPE; DYNAMICS; INVASION	The purpose of our investigation was to clarify the effects of agriculture on the process of loss of litter at the periphery of a farmland. This study revealed the generation process of an ecologically unusual phenomenon that is observed around cropland in semi-arid regions. We hypothesized that the vegetation around a farmland cannot supply plant litter to the ground surface because the ecological structure has been changed by agricultural activities. The study was conducted at Xilingol steppe, Xilingol League, Inner Mongolia Autonomous Region, China. Four study lines were established from the edge of an arable field to the surrounding meadow and parallel to the wind direction during the strong wind season. Key measurement for each line was set at the border between the farmland and steppe. Four study sites were set at intervals along each line. Plant litter, soil particle size distribution, plant species composition, plant volume, and species diversity were investigated. Despite using the same mowing method at the meadows of all study sites, the litter at the only periphery of the farmland completely disappeared. Soil particle size distribution in steppe, which was adjacent to the farmland, was similar to that of the farmland. Plant community structure at the periphery of the farmland was different from that of the far side from the farmland. This implies that soil scattered from the farmland affected the species composition of the steppe. Consequently, the change in plant community structure induced litter loss because of mowing. We concluded that plant litter was lost near the farmland because of the combined effects of farming and mowing. The results support our hypothesis that the vegetation around a farmland cannot supply plant litter because the ecological structure has been changed by agricultural activities.	[Kawada, Kiyokazu; Nakamura, Toru] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki, Japan; [Borjigin, Wuyunna] Dalian Nationalities Univ, Coll Environm & Resources, Dalian, Liaoning, Peoples R China	University of Tsukuba; Dalian Minzu University	Kawada, K (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Ibaraki, Japan.	kawada.kiyokazu.gu@u.tsukuba.ac.jp			Program to Disseminate Tenure Tracking System, MEXT, Japan; National Science Foundation of China [31170402, 31470504]; Key project of the Fundamental Research Funds for the Central Universities [DC201501070101]	Program to Disseminate Tenure Tracking System, MEXT, Japan; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key project of the Fundamental Research Funds for the Central Universities	This work was supported, in part, by Program to Disseminate Tenure Tracking System, MEXT, Japan, The National Science Foundation of China (31170402 and 31470504) and Key project of the Fundamental Research Funds for the Central Universities (DC201501070101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison M, 2006, BIOL CONSERV, V127, P177, DOI 10.1016/j.biocon.2005.08.008; Bansal S, 2014, PLANT ECOL, V215, P367, DOI 10.1007/s11258-014-0307-1; Barring L, 2003, CATENA, V52, P173, DOI 10.1016/S0341-8162(03)00013-4; Bonanomi G, 2006, ACTA OECOL, V30, P419, DOI 10.1016/j.actao.2006.06.007; Fink KA, 2011, BOTANY, V89, P157, DOI 10.1139/B11-004; Garcia-Palacios P, 2013, ECOL LETT, V16, P1045, DOI 10.1111/ele.12137; Gomes L, 2003, CATENA, V52, P235, DOI 10.1016/S0341-8162(03)00016-X; Gusewell S, 1998, J VEG SCI, V9, P861, DOI 10.2307/3237051; Handa IT, 2014, NATURE, V509, P218, DOI 10.1038/nature13247; Hill M.O., 1979, TWINSPAN FORTRAN PRO; Hill MO, 1979, DECORANA A FORTRAN P; Hoffmann C, 2011, AEOLIAN RES, V3, P343, DOI 10.1016/j.aeolia.2011.07.007; HOFSTEDE RGM, 1995, PLANT SOIL, V173, P111, DOI 10.1007/BF00155524; Kleijn D, 1996, J APPL ECOL, V33, P1433, DOI 10.2307/2404782; Kleijn D, 2000, J APPL ECOL, V37, P256, DOI 10.1046/j.1365-2664.2000.00486.x; Kleijn D, 1994, J APPL ECOL, V31, P1143; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Kong DL, 2011, PLANT SOIL, V346, P133, DOI 10.1007/s11104-011-0803-1; Liu S, 1993, IDENTIFICATION OUTDO; Ma Y, 1990, FLORA INTRAMONGOLICA; Ma Y, 1992, FLORA INTRAMONGOLICA; Ma Y, 1989, FLORA INTRAMONGOLICA; Ma Y. Q., 1994, FLORA INTRAMONGOLICA; Ma Y. Q., 1998, FLORA INTRAMONGOLICA; Makkonen M, 2012, ECOL LETT, V15, P1033, DOI 10.1111/j.1461-0248.2012.01826.x; MCCONNAUGHAY KDM, 1991, ECOLOGY, V72, P94, DOI 10.2307/1938905; Mendez MJ, 2010, SOIL TILL RES, V106, P311, DOI 10.1016/j.still.2009.10.010; Milcu A, 2011, OIKOS, V120, P1366, DOI 10.1111/j.1600-0706.2010.19418.x; Nakamura Toru, 2000, Grassland Science, V45, P342; Nan Zhibiao, 2005, Grassland Science, V51, P15, DOI 10.1111/j.1744-697X.2005.00003.x; Nordstrom KF, 2004, GEODERMA, V121, P157, DOI 10.1016/j.geoderma.2003.11.012; PENFOUND WILLIAM T., 1940, AMER MIDLAND NAT, V23, P165, DOI 10.2307/2485260; Ruprecht E, 2010, BIOL CONSERV, V143, P449, DOI 10.1016/j.biocon.2009.11.012; Schwartz RC, 1997, SOIL SCI, V162, P372, DOI 10.1097/00010694-199705000-00008; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Smith MD, 2005, WILSON BULL, V117, P258, DOI 10.1676/04-097.1; Tan YL, 2013, PLANT SOIL, V366, P107, DOI 10.1007/s11104-012-1401-6; Valko O, 2012, FLORA, V207, P303, DOI 10.1016/j.flora.2012.02.003; van Elsen T, 2000, AGR ECOSYST ENVIRON, V77, P101, DOI 10.1016/S0167-8809(99)00096-1; Wang J, 2011, J VEG SCI, V22, P367, DOI 10.1111/j.1654-1103.2011.01257.x; WILSON PJ, 1995, J APPL ECOL, V32, P295, DOI 10.2307/2405097; Yiruhan, 2001, Grassland Science, V47, P362; Zamani S, 2013, ARCH AGRON SOIL SCI, V59, P1743, DOI 10.1080/03650340.2012.748984; Zhang CL, 2011, SOIL TILL RES, V112, P140, DOI 10.1016/j.still.2010.12.003; Zhao HL, 2006, CATENA, V65, P71, DOI 10.1016/j.catena.2005.10.001	45	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0135077	10.1371/journal.pone.0135077	http://dx.doi.org/10.1371/journal.pone.0135077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241943	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942700093
J	Wang, J; Zhang, WW; Yu, CX; Zhang, X; Zhang, HQ; Guan, QB; Zhao, JJ; Xu, J				Wang, Jie; Zhang, Wenwen; Yu, Chunxiao; Zhang, Xu; Zhang, Haiqing; Guan, Qingbo; Zhao, Jiajun; Xu, Jin			Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation	PLOS ONE			English	Article							BONE-MINERAL DENSITY; SERUM FSH; CELLS; MASS; RESORPTION; ESTROGEN; RECEPTOR; FUSION; WOMEN; LH	Objective The objectives of this study were to observe the changes in follicle-stimulating hormone (FSH) and bone mineral density (BMD) in postmenopausal women, to research the relationship between FSH and postmenopausal osteoporosis, and to observe the effects of FSH on osteoclast differentiation in RAW264.7 cells. Methods We analyzed 248 postmenopausal women with normal bone metabolism. A radioimmunoassay (RIA) was used to detect serum FSH, luteinizing hormone (LH), and estradiol (E2). Dual-energy X-ray absorptiometry was used to measure forearm BMD. Then, we analyzed the age-related changes in serum FSH, LH and E2. Additionally, FSH serum concentrations were compared between a group of postmenopausal women with osteoporosis and a control group. Osteoclasts were induced from RAW264.7 cells in vitro by receptor activator of nuclear factor kappa B ligand (RANKL), and these cells were treated with 0, 5, 10, and 20 ng/ml FSH. After the osteoclasts matured, tartrate-resistant acid phosphatase (TRAP) staining was used to identify osteoclasts, and the mRNA expression levels of genes involved in osteoclastic phenotypes and function, such as receptor activator of NF-kappa B (Rank), Trap, matrix metalloproteinase-9 (Mmp-9) and Cathepsin K, were detected in different groups using real-time PCR (polymerase chain reaction). Results 1. FSH serum concentrations in postmenopausal women with osteoporosis increased notably compared with the control group. 2. RANKL induced RAW264.7 cell differentiation into mature osteoclasts in vitro. 3. FSH increased mRNA expression of genes involved in osteoclastic phenotypes and function, such as Rank, Trap, Mmp-9 and Cathepsin K, in a dose-dependent manner. Conclusions The circulating concentration of FSH may play an important role in the acceleration of bone loss in postmenopausal women. FSH increases osteoclastogenesis in vitro.	[Wang, Jie] Weifang Med Univ, Affiliated Hosp, Dept Endocrinol, Weifang, Shandong, Peoples R China; [Zhang, Wenwen; Yu, Chunxiao; Zhang, Xu; Zhang, Haiqing; Guan, Qingbo; Zhao, Jiajun; Xu, Jin] Shandong Univ, Shandong Prov Hosp, Dept Endocrinol, Jinan 250100, Shandong, Peoples R China; [Zhang, Wenwen; Yu, Chunxiao; Zhang, Xu; Zhang, Haiqing; Guan, Qingbo; Zhao, Jiajun; Xu, Jin] Shandong Clin Med Ctr Endocrinol & Metab, Jinan, Shandong, Peoples R China; [Zhang, Wenwen; Yu, Chunxiao; Zhang, Xu; Zhang, Haiqing; Guan, Qingbo; Zhao, Jiajun; Xu, Jin] Shandong Acad Clin Med, Inst Endocrinol & Metab, Jinan, Shandong, Peoples R China	Weifang Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Xu, J (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Endocrinol, Jinan 250100, Shandong, Peoples R China.	xujin@medmail.com.cn	Zhao, Jiajun/W-2963-2018	Zhao, Jiajun/0000-0003-3267-9292	National Natural Science Foundation [81370892]; Technology Development Plan Project of Shandong Province [2012GSF11823]; Shandong Province Young and Middle-Aged Scientists Research Awards Fund [2007BS03004]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Technology Development Plan Project of Shandong Province; Shandong Province Young and Middle-Aged Scientists Research Awards Fund	This work was supported by the National Natural Science Foundation (81370892, http://www.nsfc.gov.cn/), the Technology Development Plan Project of Shandong Province (2012GSF11823, http://www.sdstc.gov.cn/) and the Shandong Province Young and Middle-Aged Scientists Research Awards Fund (2007BS03004, http://www.sdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Manasi, 2010, Curr Osteoporos Rep, V8, P205, DOI 10.1007/s11914-010-0028-x; Anasti JN, 1998, OBSTET GYNECOL, V91, P12, DOI 10.1016/S0029-7844(97)00583-8; Ausmanas MK, 2007, CLIMACTERIC, V10, P427, DOI 10.1080/13697130701610780; Blair HC, 2011, ANN NY ACAD SCI, V1240, P26, DOI 10.1111/j.1749-6632.2011.06287.x; Cheung E, 2011, MATURITAS, V69, P50, DOI 10.1016/j.maturitas.2011.01.010; Danilovich N, 2000, ENDOCRINOLOGY, V141, P4295, DOI 10.1210/en.141.11.4295; Devleta B, 2004, J BONE MINER METAB, V22, P360, DOI 10.1007/s00774-004-0495-1; Gallagher CM, 2010, ENVIRON RES, V110, P105, DOI 10.1016/j.envres.2009.09.012; Garcia-Martin A, 2012, ENDOCRINE, V41, P302, DOI 10.1007/s12020-011-9541-7; Geng WX, 2013, BIOCHEM BIOPH RES CO, V434, P280, DOI 10.1016/j.bbrc.2013.02.116; Gourlay ML, 2012, BONE, V50, P311, DOI 10.1016/j.bone.2011.11.001; Imai Yuuki, 2014, Clin Calcium, V24, P815, DOI CliCa1406815819; Iqbal J, 2006, P NATL ACAD SCI USA, V103, P14925, DOI 10.1073/pnas.0606805103; Iqbal J, 2010, EUR J ENDOCRINOL, V163, P173, DOI 10.1530/EJE-10-0397; Pham L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216853; Liu S, 2010, J DENT RES, V89, P366, DOI 10.1177/0022034509358822; Liu SB, 2010, J ENDODONT, V36, P658, DOI 10.1016/j.joen.2010.01.011; Meena PD, 2007, OSTEOPOROSIS INT, V18, P923, DOI 10.1007/s00198-006-0318-4; Nicks Kristy M, 2010, Curr Osteoporos Rep, V8, P60, DOI 10.1007/s11914-010-0014-3; Qin WP, 2013, J BIOL CHEM, V288, P13511, DOI 10.1074/jbc.M113.454892; Rendina D, 2010, EUR J ENDOCRINOL, V163, P165, DOI 10.1530/EJE-10-0043; Ritter V, 2008, CALCIFIED TISSUE INT, V82, P383, DOI 10.1007/s00223-008-9134-5; Rouach V, 2011, J CELL BIOCHEM, V112, P128, DOI 10.1002/jcb.22908; Schroder HC, 2012, J CELL BIOCHEM, V113, P3197, DOI 10.1002/jcb.24196; Seibel MJ, 2006, CELL, V127, P1079, DOI 10.1016/j.cell.2006.12.002; Sowers MR, 2013, J CLIN ENDOCR METAB, V98, P2854, DOI 10.1210/jc.2012-4113; Sowers MR, 2006, J CLIN ENDOCR METAB, V91, P1261, DOI 10.1210/jc.2005-1836; Sun L, 2006, CELL, V125, P247, DOI 10.1016/j.cell.2006.01.051; Takito J, 2012, J CELL SCI, V125, P662, DOI 10.1242/jcs.090886; Tourkova IL, 2015, ANN NY ACAD SCI, V1335, P100, DOI 10.1111/nyas.12502; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Xu ZR, 2009, CLIN CHIM ACTA, V400, P8, DOI 10.1016/j.cca.2008.09.027; Zaidi Mone, 2009, Curr Rheumatol Rep, V11, P191; Zhang WW, 2014, J BIOMECH, V47, P1307, DOI 10.1016/j.jbiomech.2014.02.015; Zhu LL, 2012, BIOCHEM BIOPH RES CO, V422, P54, DOI 10.1016/j.bbrc.2012.04.104	35	43	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134986	10.1371/journal.pone.0134986	http://dx.doi.org/10.1371/journal.pone.0134986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241313	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942700087
J	Wu, TP; Liang, FW; Huang, YL; Chen, LH; Lu, TH				Wu, Tung-Pi; Liang, Fu-Wen; Huang, Ya-Li; Chen, Lea-Hua; Lu, Tsung-Hsueh			Maternal Mortality in Taiwan: A Nationwide Data Linkage Study	PLOS ONE			English	Article							PREGNANCY-RELATED DEATHS; UNITED-STATES	Background To examine the changes in the maternal mortality ratio (MMR) and causes of maternal death in Taiwan based on nationwide linked data sets. Methods We linked four population-based data sets (birth registration, birth notification, National Health Insurance inpatient claims, and cause of death mortality data) to identify maternal deaths for 2004-2011. Subsequently, we calculated the MMR (deaths per 100,000 live births) and the proportion of direct and indirect causes of maternal death by maternal age and year. Findings Based on the linked data sets, we identified 236 maternal death cases, of which only 102 were reported in officially published mortality data, with an underreporting rate of 57% [(236-102) x 100 / 236]. The age-adjusted MMR was 18.4 in 2004-2005 and decreased to 12.5 in 2008-2009; however, the MMR leveled off at 12.6 in 2010-2011. The MMR increased from 5.2 in 2008-2009 to 7.1 in 2010-2011 for patients aged 15-29 years. Women aged 15-29 years had relatively lower proportion in dying from direct causes (amniotic fluid embolism and obstetric hemorrhage) compared with their counterpart older women. Conclusions Approximately two-thirds of maternal deaths were not reported in officially published mortality data. Routine surveillance of maternal mortality by using enhanced methods is necessary to monitor the health status of reproductive-age women. Furthermore, a comprehensive maternal death review is necessary to explore the preventability of these maternal deaths.	[Wu, Tung-Pi] Sin Lau Christian Hosp, Dept Obstet & Gynecol, Tainan, Taiwan; [Liang, Fu-Wen; Lu, Tsung-Hsueh] Natl Cheng Kung Univ, NCKU Res Ctr Hlth Data, Tainan 70101, Taiwan; [Liang, Fu-Wen; Lu, Tsung-Hsueh] Natl Cheng Kung Univ, Dept Publ Hlth, Tainan 70101, Taiwan; [Huang, Ya-Li] Taipei Med Univ, Sch Med, Dept Publ Hlth, Coll Med, Taipei, Taiwan; [Chen, Lea-Hua] Minist Hlth & Welf, Dept Stat, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University; Taipei Medical University	Huang, YL (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Publ Hlth, Taipei, Taiwan.	ylhuang@tmu.edu.tw		Liang, Fu-Wen/0000-0002-3396-037X	Sin-Lau Christian Hospital [SLH-102-03]; Ministry of Health and Welfare [MOHW103-TDU-M-211-000016]; Department of Statistics, Ministry of Health and Welfare, Taipei, Taiwan, as part of the Taiwan Administrative Data Cohort Study Project	Sin-Lau Christian Hospital; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Department of Statistics, Ministry of Health and Welfare, Taipei, Taiwan, as part of the Taiwan Administrative Data Cohort Study Project	This study was financially supported by Sin-Lau Christian Hospital (SLH-102-03), the Ministry of Health and Welfare (MOHW103-TDU-M-211-000016), and the Department of Statistics, Ministry of Health and Welfare, Taipei, Taiwan, as part of the Taiwan Administrative Data Cohort Study Project.	Amarin Z, 2010, INT J GYNECOL OBSTET, V111, P152, DOI 10.1016/j.ijgo.2010.05.016; Berg CJ, 2005, OBSTET GYNECOL, V106, P1228, DOI 10.1097/01.AOG.0000187894.71913.e8; BOUVIERCOLLE MH, 1991, INT J EPIDEMIOL, V20, P717, DOI 10.1093/ije/20.3.717; Buescher Paul A, 2002, N C Med J, V63, P76; Callaghan WM, 2014, AM J OBSTET GYNECOL, V211, P581, DOI 10.1016/j.ajog.2014.07.041; Center of Intellegency Agency of the United States, WORLD FACTBOOK; Deneux-Tharaux C, 2005, OBSTET GYNECOL, V106, P684, DOI 10.1097/01.AOG.0000174580.24281.e6; Department of Household Registration Ministry of Internal AffairsTaiwan, TABL 11 NUMB BIRTH A; Directorate General of Budget Accounting and Statistics Executive Yuan Taiwan, NAT ACC STAT TABL; Gissler M, 1997, ACTA OBSTET GYN SCAN, V76, P651, DOI 10.3109/00016349709024605; Gissler M, 2007, EUR J OBSTET GYN R B, V133, P179, DOI 10.1016/j.ejogrb.2006.08.013; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Horon IL, 2005, AM J PUBLIC HEALTH, V95, P478, DOI 10.2105/AJPH.2004.040063; Hsieh WS, 2011, J WOMENS HEALTH, V20, P1083, DOI 10.1089/jwh.2011.2809; Kao SY, 1997, ACTA OBSTET GYN SCAN, V76, P629, DOI 10.3109/00016349709024602; Karimian-Teherani D, 2002, ACTA OBSTET GYN SCAN, V81, P323; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; MacKay AP, 2011, OBSTET GYNECOL, V118, P104, DOI 10.1097/AOG.0b013e31821fd49d; McCaw-Binns AM, 2015, INT J GYNECOL OBSTET, V128, P62, DOI 10.1016/j.ijgo.2014.07.023; Ministry of Health and Welfare,Taiwan, TABL 11 NUMB DEATHS; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; OECD, 2014, NAT INC PER CAP OECD; Pallin DJ, 2002, AM J PUBLIC HEALTH, V92, P1319, DOI 10.2105/AJPH.92.8.1319; Schuitemaker N, 1997, OBSTET GYNECOL, V90, P78, DOI 10.1016/S0029-7844(97)00128-2; Turner Linda A, 2002, Chronic Dis Can, V23, P22; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; Wu TP, 2015, TAIWAN J OB IN PRESS	27	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0132547	10.1371/journal.pone.0132547	http://dx.doi.org/10.1371/journal.pone.0132547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1UY	26237411	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942400007
J	Bu, CF; Zhang, KK; Zhang, CY; Wu, SF				Bu, Chongfeng; Zhang, Kankan; Zhang, Chunyun; Wu, Shufang			Key Factors Influencing Rapid Development of Potentially Dune-Stabilizing Moss-Dominated Crusts	PLOS ONE			English	Article							BIOLOGICAL SOIL CRUSTS; MICROBIOTIC CRUSTS; NEGEV-DESERT; CULTURE; RECOVERY	Biological soil crusts (BSCs) are a widespread photosynthetic ground cover in arid and semiarid areas. They have many positive ecological functions, such as increasing soil stability, and reducing water and wind erosion. Using artificial technology to achieve the rapid development of BSCs is expected to become a low-cost and highly beneficial ecological restoration measure. In the present study, typical moss-dominated crusts in a region characterized by mobile dunes (Mu Us Sandland, China) were collected, and a 40-day cultivation experiment was performed to investigate key factors, including watering frequency, light intensity and a nutrient addition, which affect the rapid development of moss crusts and their optimal combination. The results demonstrated that watering frequency and illumination had a significant positive effect (P=0.049, three-factor ANOVA) and a highly significant, complicated effect (P=0.000, three-factor ANOVA), respectively, on the plant density of bryophytes, and a highly significant positive effect on the chlorophyll a and exopolysaccharide contents (P=0.000, P=0.000; P=0.000, P=0.000; one-way ANOVA). Knop nutrient solution did not have a significant positive but rather negative effect on the promotion of moss-dominated crust development (P=0.270, three-factor ANOVA). Moss-dominated crusts treated with the combination of moderate-intensity light (6,000 lx) + high watering frequency (1 watering/2 days) - Knop had the highest moss plant densities, while the treatment with high-intensity light (12,000 lx) + high watering frequency (1 watering/2 days) + Knop nutrient solution had higher chlorophyll a contents than that under other treatments. It is entirely feasible to achieve the rapid development of moss crusts under laboratory conditions by regulating key factors and creating the right environment. Future applications may seek to use cultured bryophytes to control erosion in vulnerable areas with urgent needs.	[Bu, Chongfeng; Zhang, Kankan; Zhang, Chunyun; Wu, Shufang] Northwest A&F Univ, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China; [Bu, Chongfeng] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China; [Bu, Chongfeng] Minist Water Resources, Yangling 712100, Shaanxi, Peoples R China; [Wu, Shufang] Northwest A&F Univ, Coll Water Resources & Architectural Engn, Yangling 712100, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Northwest A&F University - China	Bu, CF (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China.	buchongfeng@163.com; wsfjs@163.com			National Natural Science Foundation of China [41071192, 40701096]; Foundation of State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau [K318009902-1405]; West Light Foundation of Chinese Academy of Science [2014-91]; Chinese Universities Scientific Fund [2014YQ006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau; West Light Foundation of Chinese Academy of Science(Chinese Academy of Sciences); Chinese Universities Scientific Fund	The National Natural Science Foundation of China (grant nos. 41071192 & 40701096), the Foundation of State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau (K318009902-1405), the West Light Foundation of Chinese Academy of Science (No. 2014-91) and the Chinese Universities Scientific Fund (grant no. 2014YQ006) provided funding for this research.	Ahmed MGU, 2010, KOREAN J HORTIC SCI, V28, P108; [Anonymous], 2003, BIOLOGICAL SOIL CRUS, DOI DOI 10.1007/978-3-642-56475-8; Asthana AK, 2011, NATL ACAD SCI LETT, V34, P23; BELNAP J, 1993, GREAT BASIN NAT, V53, P89; Belnap J., 2001, BIOL SOIL CRUSTS STR; Belnap J, 2000, BIOL FERT SOILS, V35, P128; Belnap J., 2003, BIOL SOIL CRUSTS STR, P3; BROTHERSON JD, 1983, J RANGE MANAGE, V36, P579, DOI 10.2307/3898344; Chen Yan-qin, 2009, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V29, P586; Chen YY, 2009, ANN BOT FENN, V46, P516, DOI 10.5735/085.046.0604; DeFalco LA, 2001, PLANT SOIL, V234, P1, DOI 10.1023/A:1010323001006; Duckett JG, 2004, J BRYOL, V26, P3, DOI 10.1179/037366803235001742; Elmarsdottir A, 2003, J APPL ECOL, V40, P815, DOI 10.1046/j.1365-2664.2003.00848.x; George DB, 2003, ARID LAND RES MANAG, V17, P113, DOI 10.1080/15324980301588; Gretarsdottir J, 2004, RESTOR ECOL, V12, P268, DOI 10.1111/j.1061-2971.2004.00371.x; Guo Yi-rui, 2008, Huanjing Kexue, V29, P1027; Harper KT, 2001, J ARID ENVIRON, V47, P347, DOI 10.1006/jare.2000.0713; Harris ESJ, 2008, BRYOLOGIST, V111, P169, DOI 10.1639/0007-2745(2008)111[169:ETUAFC]2.0.CO;2; Hu CX, 2002, J APPL PHYCOL, V14, P281, DOI 10.1023/A:1021128530086; [赵允格 Zhao Yunge], 2010, [生态学报, Acta Ecologica Sinica], V30, P4668; Kidron J, 2008, GEOMORPHOLOGY, V100, P444, DOI 10.1016/j.geomorph.2008.01.012; Kidron GJ, 2014, J HYDROL, V509, P398, DOI 10.1016/j.jhydrol.2013.11.041; Kidron GJ, 2010, CATENA, V82, P92, DOI 10.1016/j.catena.2010.05.006; Kidron GJ, 2009, EARTH SURF PROC LAND, V34, P1594, DOI 10.1002/esp.1843; Kidron GJ, 2000, GEOMORPHOLOGY, V36, P1, DOI 10.1016/S0169-555X(00)00043-X; Maestre FT, 2006, MICROB ECOL, V52, P365, DOI 10.1007/s00248-006-9017-0; Marsh J, 2006, CAN J BOT, V84, P717, DOI [10.1139/b06-026, 10.1139/B06-026]; Mikano Road Joint-Stock Company, 2004, Patent No. [CN1522562A, 1522562A]; Nehira K, 1964, B BIOL SOC HIROSHIMA, V31, P15; Prasse R, 2000, PLANT ECOL, V150, P65, DOI 10.1023/A:1026593429455; Qiao FL, 2002, DETERMINATION ANAL T; Stark LR, 2011, J ARID ENVIRON, V75, P457, DOI 10.1016/j.jaridenv.2010.12.015; Wang S. D., 2001, J DESERT RES, V21, P244; [徐杰 Xu Jie], 2005, [生态学报, Acta Ecologica Sinica], V25, P1247; Xu SJ, 2008, ENVIRON ENG SCI, V25, P1129, DOI 10.1089/ees.2006.0272; Yang JZ, 2010, THESIS NW AGR FOREST; Zaady E, 2000, SOIL BIOL BIOCHEM, V32, P959, DOI 10.1016/S0038-0717(00)00004-3; Zaady E, 2014, AEOLIAN RES, V13, P81, DOI 10.1016/j.aeolia.2014.04.002; [张元明 Zhang Yuanming], 2002, [生态学报, Acta Ecologica Sinica], V22, P1129; 胡春香, 2003, [自然科学进展, Progress in Natural Science], V13, P791	40	12	15	6	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134447	10.1371/journal.pone.0134447	http://dx.doi.org/10.1371/journal.pone.0134447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230324	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400122
J	Bu, SC; Kuijer, R; van der Worp, RJ; Li, XR; Hooymans, JMM; Los, LI				Bu, Shao Chong; Kuijer, Roel; van der Worp, Roelofje J.; Li, Xiao Rong; Hooymans, Johanna M. M.; Los, Leonoor I.			The Ultrastructural Localization of Type II, IV, and VI Collagens at the Vitreoretinal Interface	PLOS ONE			English	Article							RABBIT VITREOUS BODY; BASEMENT-MEMBRANE COMPONENT; AGE-DEPENDENT CHANGES; EXTRACELLULAR-MATRIX; BINDING-PROPERTIES; LIMITING MEMBRANE; VASCULAR REMNANTS; HUMAN PLACENTA; HUMAN-EYE; IN-VITRO	Background The vitreoretinal interface is the border of the cortical vitreous and the inner surface of the retina. The adhesion of the cortical vitreous to the ILM, namely vitreoretinal adhesion, involves a series of complex molecular adhesion mechanisms and has been considered as an important pathogenic factor in many vitreoretinal diseases. The presence of type VI collagen at the vitreoretinal interface and its possible interaction with collagens and glycoproteins indicates that type VI collagen may contribute to the vitreoretinal adhesion. Purpose To clarify the ultrastructural location of type VI collagen and its relationship to type II and IV collagens at the vitreoretinal interface. Methods The ultrastructural localization of type II, IV and VI collagens in the adult human vitreoretinal interface of five donor eyes was evaluated by transmission electron microscopy using immunogold labeling. Results In the pre-equatorial region, we observed densely packed vitreous lamellae with a partly intraretinal course containing type II and VI collagens, reticular structures containing type IV and VI collagens and a thin inner limiting membrane (ILM) containing type IV and VI collagens in a linear distribution pattern. From the anterior to the posterior retina, the linear pattern of type IV and VI collagen labeling gradually became more diffusely present throughout the entire thickness of the ILM. Conclusions The presence of type VI collagen in vitreous lamellae penetrating the ILM into the superficial retina suggests that type VI collagen may be involved in the organization of vitreous fibers into lamellae and in the adhesion of the vitreous fibers to the retina. The close relation of type VI to type IV collagen in the ILM suggests that type VI collagen is an important collagen type in the ILM. The topographic variations of type IV and VI collagens in the different regions of the ILM suggest a regional heterogeneity of the ILM. The reticular labeling pattern of type IV and VI collagens observed in the anterior vitreous are highly similar to labeling patterns of blood vessel walls. In the anterior vitreous, they may represent remnants of the regressed embryonic hyaloid blood vessel system. Their presence is in support of the theory on interactive remodeling of the developing vitreous as opposed to the main stream theory of displacement and compression of the primary by the secondary vitreous.	[Bu, Shao Chong; van der Worp, Roelofje J.; Hooymans, Johanna M. M.; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Kuijer, Roel] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands; [Bu, Shao Chong; Kuijer, Roel; van der Worp, Roelofje J.; Hooymans, Johanna M. M.; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, WJ Kolff Inst, NL-9713 AV Groningen, Netherlands; [Bu, Shao Chong; Li, Xiao Rong] Tianjin Med Univ, Hosp Eye, Tianjin 300384, Peoples R China	University of Groningen; University of Groningen; University of Groningen; Tianjin Medical University	Los, LI (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	l.i.los@umcg.nl	Kuijer, Roel/A-6690-2015	Kuijer, Roel/0000-0002-7637-4944; Bu, Shaochong/0000-0002-9060-7361	"Stichting Blindenhulp" of the Netherlands	"Stichting Blindenhulp" of the Netherlands	The study was financially supported by "Stichting Blindenhulp" of the Netherlands.	Aumailley M, 2000, J CELL SCI, V113, P259; AUMAILLEY M, 1989, EUR J BIOCHEM, V184, P241, DOI 10.1111/j.1432-1033.1989.tb15013.x; Bai XY, 2009, MATRIX BIOL, V28, P194, DOI 10.1016/j.matbio.2009.02.004; Barishak Y R, 1992, Dev Ophthalmol, V24, P1; BIDANSET DJ, 1992, J BIOL CHEM, V267, P5250; Bishop P, 1996, GRAEF ARCH CLIN EXP, V234, P710, DOI 10.1007/BF00292358; Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6; BONALDO P, 1990, BIOCHEMISTRY-US, V29, P1245, DOI 10.1021/bi00457a021; BREM RB, 1994, INVEST OPHTH VIS SCI, V35, P3466; BROWN JC, 1993, J CELL BIOL, V120, P557, DOI 10.1083/jcb.120.2.557; Candiello J, 2010, MATRIX BIOL, V29, P402, DOI 10.1016/j.matbio.2010.03.004; DESJARDINS M, 1989, J HISTOCHEM CYTOCHEM, V37, P885, DOI 10.1177/37.6.2723404; FOOS RY, 1972, INVEST OPHTH VISUAL, V11, P801; Gandorfer A, 2009, RETINA-J RET VIT DIS, V29, P1097, DOI 10.1097/IAE.0b013e3181aa8fb1; GLOOR BP, 1975, T OPHTHAL SOC UK, V95, P387; Groulx JF, 2011, MATRIX BIOL, V30, P195, DOI 10.1016/j.matbio.2011.03.002; Halfter W, 2008, EYE, V22, P1207, DOI 10.1038/eye.2008.19; Halfter W, 2005, INVEST OPHTH VIS SCI, V46, P1000, DOI 10.1167/iovs.04-1185; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; IIDA K, 1994, J ELECTRON MICROSC, V43, P367; Kagemann L, 2006, AM J OPHTHALMOL, V142, P862, DOI 10.1016/j.ajo.2006.05.059; Kampik Anselm, 2012, Retina, V32 Suppl 2, pS194, DOI 10.1097/IAE.0b013e31825bc20a; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; KIELTY CM, 1992, J CELL BIOL, V118, P979, DOI 10.1083/jcb.118.4.979; KISHI S, 1986, INT OPHTHALMOL, V9, P253, DOI 10.1007/BF00137539; KOHNO T, 1987, INVEST OPHTH VIS SCI, V28, P506; Kritzenberger M, 2011, HISTOPATHOLOGY, V58, P953, DOI 10.1111/j.1365-2559.2011.03820.x; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; Kuppermann BD, 2005, AM J OPHTHALMOL, V140, P585, DOI 10.1016/j.ajo.2005.06.022; Le Goff MM, 2008, EYE, V22, P1214, DOI 10.1038/eye.2008.21; Los LI, 1999, EXP EYE RES, V69, P343, DOI 10.1006/exer.1999.0708; Los LI, 2000, EXP EYE RES, V71, P153, DOI 10.1006/exer.2000.0865; Los LI, 2000, EXP EYE RES, V71, P143, DOI 10.1006/exer.2000.0864; LosI LI, 1997, DEV AGE RELATED REMO; MARSHALL GE, 1992, INVEST OPHTH VIS SCI, V33, P2546; Oliveira LB, 2001, RETINA-J RET VIT DIS, V21, P324, DOI 10.1097/00006982-200108000-00005; Ponsioen TL, 2008, INVEST OPHTH VIS SCI, V49, P4089, DOI 10.1167/iovs.07-1456; Ponsioen TL, 2008, MOL VIS, V14, P652; Ponsioen TL, 2010, PROG RETIN EYE RES, V29, P580, DOI 10.1016/j.preteyeres.2010.07.001; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Ramesh S, 2004, BRIT J OPHTHALMOL, V88, P697, DOI 10.1136/bjo.2003.031989; Russell Stephen R, 2012, Retina, V32 Suppl 2, pS181, DOI 10.1097/IAE.0b013e31825bf014; Sabatelli P, 2001, MATRIX BIOL, V20, P475, DOI 10.1016/S0945-053X(01)00160-3; Sabatelli P, 2012, MATRIX BIOL, V31, P187, DOI 10.1016/j.matbio.2011.12.003; Sakamoto T, 2011, RETINA-J RET VIT DIS, V31, P222, DOI 10.1097/IAE.0b013e3181facfa9; SANNES PL, 1984, J HISTOCHEM CYTOCHEM, V32, P827, DOI 10.1177/32.8.6747274; Sasaki T, 1998, EXP CELL RES, V238, P70, DOI 10.1006/excr.1997.3837; Savige J, 2010, INVEST OPHTH VIS SCI, V51, P1621, DOI 10.1167/iovs.08-3323; Schneider GB, 2001, J DENT RES, V80, P1540, DOI 10.1177/00220345010800061201; Sebag J, 1989, VITREOUS STRUCTURE F, pxi; Singh RP, 2014, BRIT J OPHTHALMOL, V98, P356, DOI 10.1136/bjophthalmol-2013-304219; Stalmans P, 2012, NEW ENGL J MED, V367, P606, DOI 10.1056/NEJMoa1110823; Tezel TH, 1998, RETINA-J RET VIT DIS, V18, P7; TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; TUCKWELL DS, 1994, J CELL SCI, V107, P993; Vergleichende A. J., 1927, UNTERSUCHUNGEN BAU E, P183; VONDERMARK H, 1984, EUR J BIOCHEM, V142, P493; Wang J, 2003, INVEST OPHTH VIS SCI, V44, P1793, DOI 10.1167/iovs.02-0802; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200; Yanoff M, 2004, OPHTHALMOLOGY, pxxii; ZHU D, 1994, J HISTOCHEM CYTOCHEM, V42, P577, DOI 10.1177/42.5.8157929	63	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134325	10.1371/journal.pone.0134325	http://dx.doi.org/10.1371/journal.pone.0134325			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230410	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400101
J	Edmunds, LR; Sharma, L; Wang, H; Kang, A; d'Souza, S; Lu, J; McLaughlin, M; Dolezal, JM; Gao, XL; Weintraub, ST; Ding, Y; Zeng, XM; Yates, N; Prochownik, EV				Edmunds, Lia R.; Sharma, Lokendra; Wang, Huabo; Kang, Audry; d'Souza, Sonia; Lu, Jie; McLaughlin, Michael; Dolezal, James M.; Gao, Xiaoli; Weintraub, Susan T.; Ding, Ying; Zeng, Xuemei; Yates, Nathan; Prochownik, Edward V.			c-Myc and AMPK Control Cellular Energy Levels by Cooperatively Regulating Mitochondrial Structure and Function	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GREEN FLUORESCENT PROTEIN; OXYGEN-FREE RADICALS; COMPLEX I DEFICIENCY; OXIDATIVE-PHOSPHORYLATION; DEHYDROGENASE ACTIVITY; GENE-EXPRESSION; MESSENGER-RNA; TUMOR-CELLS; TRANSCRIPTION	The c-Myc (Myc) oncoprotein and AMP-activated protein kinase (AMPK) regulate glycolysis and oxidative phosphorylation (Oxphos) although often for different purposes. Because Myc over-expression depletes ATP with the resultant activation of AMPK, we explored the potential co-dependency of and cross-talk between these proteins by comparing the consequences of acute Myc induction in ampk+/+ (WT) and ampk-/- (KO) murine embryo fibroblasts (MEFs). KO MEFs showed a higher basal rate of glycolysis than WT MEFs and an appropriate increase in response to activation of a Myc-estrogen receptor (MycER) fusion protein. However, KO MEFs had a diminished ability to increase Oxphos, mitochondrial mass and reactive oxygen species in response to MycER activation. Other differences between WT and KO MEFs, either in the basal state or following MycER induction, included abnormalities in electron transport chain function, levels of TCA cycle-related oxidoreductases and cytoplasmic and mitochondrial redox states. Transcriptional profiling of pathways pertinent to glycolysis, Oxphos and mitochondrial structure and function also uncovered significant differences between WT and KO MEFs and their response to MycER activation. Finally, an unbiased mass-spectrometry (MS)-based survey capable of quantifying similar to 40% of all mitochondrial proteins, showed about 15% of them to be AMPK- and/or Myc-dependent in their steady state. Significant differences in the activities of the rate-limiting enzymes pyruvate kinase and pyruvate dehydrogenase, which dictate pyruvate and acetyl coenzyme A abundance, were also differentially responsive to Myc and AMPK and could account for some of the differences in basal metabolite levels that were also detected by MS. Thus, Myc and AMPK are highly co-dependent and appear to engage in significant cross-talk across numerous pathways which support metabolic and ATP-generating functions.	[Edmunds, Lia R.; Sharma, Lokendra; Wang, Huabo; d'Souza, Sonia; Lu, Jie; Prochownik, Edward V.] UPMC, Sect Hematol Oncol, Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Edmunds, Lia R.; Kang, Audry; McLaughlin, Michael; Dolezal, James M.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Gao, Xiaoli; Weintraub, Susan T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Ding, Ying] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Zeng, Xuemei; Yates, Nathan] Univ Pittsburgh, Dept Cell Biol, Sch Med, Pittsburgh, PA USA; [Prochownik, Edward V.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA USA; [Prochownik, Edward V.] Univ Pittsburgh, Hillman Canc Ctr, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Health San Antonio; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), UPMC, Sect Hematol Oncol, Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA.	procev@chp.edu		Dolezal, James/0000-0002-6788-7203; Ding, Ying/0000-0003-1352-1000	Children's Hospital of Pittsburgh of UPMC Research Advisory Committee; RO1 grant [CA174713]; NATIONAL CANCER INSTITUTE [R01CA174713] Funding Source: NIH RePORTER	Children's Hospital of Pittsburgh of UPMC Research Advisory Committee; RO1 grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a pre-doctoral fellowship award to LRE from the Children's Hospital of Pittsburgh of UPMC Research Advisory Committee and by RO1 grant CA174713 to EVP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Alaynick WA, 2008, MITOCHONDRION, V8, P329, DOI 10.1016/j.mito.2008.02.001; Attie AD, 2003, NAT GENET, V34, P244, DOI 10.1038/ng0703-244; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Bayley JP, 2012, CURR OPIN ONCOL, V24, P62, DOI 10.1097/CCO.0b013e32834deb9e; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Cao Zhenbo, 2007, V44, P295; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Edmunds LR, 2014, J BIOL CHEM, V289, P25382, DOI 10.1074/jbc.M114.580662; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Gellerich FN, 2010, BBA-BIOENERGETICS, V1797, P1018, DOI 10.1016/j.bbabio.2010.02.005; Genova ML, 2008, BBA-BIOENERGETICS, V1777, P740, DOI 10.1016/j.bbabio.2008.04.007; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Graves JA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037699, DOI 10.1371/J0URNAL.P0NE.0037699]; Hann SR, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014399; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Iqbal MA, 2014, FEBS LETT, V588, P2685, DOI 10.1016/j.febslet.2014.04.011; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Janssen-Heininger YMW, 2013, J CELL BIOCHEM, V114, P1962, DOI 10.1002/jcb.24551; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Jiang K, 2006, PLANT PHYSIOL, V141, P397, DOI 10.1104/pp.106.078246; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Ju TC, 2011, J CELL BIOL, V194, P209, DOI 10.1083/jcb.201105010; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kazgan N, 2010, MOL BIOL CELL, V21, P3433, DOI 10.1091/mbc.E10-04-0347; Kim IY, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00175; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Kuehl WM, 2012, BLOOD, V120, P2351, DOI 10.1182/blood-2012-08-445262; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Lenaz G, 2010, BBA-BIOENERGETICS, V1797, P633, DOI 10.1016/j.bbabio.2010.01.025; Li FengZhen, 2005, Journal of Triticeae Crops, V25, P14; Li ZW, 2014, BBA-REV CANCER, V1846, P285, DOI 10.1016/j.bbcan.2014.07.008; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Matalon O, 2014, CURR OPIN STRUC BIOL, V26, P113, DOI 10.1016/j.sbi.2014.06.001; Meng FY, 2007, J AM SOC MASS SPECTR, V18, P226, DOI 10.1016/j.jasms.2006.09.014; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Miedel MT, 2014, METHODS, V68, P536, DOI 10.1016/j.ymeth.2014.04.019; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Miranda-Vizuete A, 2000, ANTIOXID REDOX SIGN, V2, P801, DOI 10.1089/ars.2000.2.4-801; Morgan HP, 2013, P NATL ACAD SCI USA, V110, P5881, DOI 10.1073/pnas.1217157110; MUNUJOS P, 1993, ANAL BIOCHEM, V212, P506, DOI 10.1006/abio.1993.1360; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; O'Neill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019; Olson AK, 2013, J MOL CELL CARDIOL, V55, P156, DOI 10.1016/j.yjmcc.2012.07.005; Pacilli A, 2013, JNCI-J NATL CANCER I, V105, P489, DOI 10.1093/jnci/djt030; Paredes RM, 2014, INT J NEUROPSYCHOPH, V17, P1139, DOI 10.1017/S1461145714000157; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Patel MS, 2001, EXP MOL MED, V33, P191, DOI 10.1038/emm.2001.32; Paweletz CP, 2010, J PROTEOME RES, V9, P1392, DOI 10.1021/pr900925d; Petrich AM, 2014, CANCER-AM CANCER SOC, V120, P3884, DOI 10.1002/cncr.28899; Pierron D, 2012, BBA-BIOENERGETICS, V1817, P590, DOI 10.1016/j.bbabio.2011.07.007; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Quintero M, 2006, P NATL ACAD SCI USA, V103, P5379, DOI 10.1073/pnas.0601026103; Raha S, 2001, AM J MED GENET, V106, P62, DOI 10.1002/ajmg.1398; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Rahl PB, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a020990; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Roberti M, 2009, BBA-BIOENERGETICS, V1787, P303, DOI 10.1016/j.bbabio.2009.01.013; Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4; Roussel MF, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014308; Russo GL, 2013, BIOCHEM PHARMACOL, V86, P339, DOI 10.1016/j.bcp.2013.05.023; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Sabo A, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014191; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Sanz P, 2008, CURR PROTEIN PEPT SC, V9, P478, DOI 10.2174/138920308785915254; Sarsour EH, 2009, ANTIOXID REDOX SIGN, V11, P2985, DOI [10.1089/ars.2009.2513, 10.1089/ARS.2009.2513]; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Scheller K, 2003, EXP PHYSIOL, V88, P129, DOI 10.1113/eph8802507; Schwarzlander M, 2008, J MICROSC-OXFORD, V231, P299, DOI 10.1111/j.1365-2818.2008.02030.x; Semenza G L, 2001, Novartis Found Symp, V240, P251; Shirwany NA, 2014, FRONT BIOSCI-LANDMRK, V19, P447, DOI 10.2741/4218; Sid B, 2013, BIOCHEM PHARMACOL, V86, P200, DOI 10.1016/j.bcp.2013.05.007; Sodir NM, 2011, ONCOTARGET, V2, P1307; Toyoda T, 2004, AM J PHYSIOL-ENDOC M, V287, pE166, DOI 10.1152/ajpendo.00487.2003; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020; Vander Heiden MG, 2011, COLD SH Q B, V76, P325, DOI 10.1101/sqb.2012.76.010900; Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216; Wahlstrom T, 2015, BBA-GENE REGUL MECH, V1849, P563, DOI 10.1016/j.bbagrm.2014.07.004; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; WARBURG O, 1956, SCIENCE, V124, P269; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wong Nicholas, 2013, Int J Cell Biol, V2013, P242513, DOI 10.1155/2013/242513; Yakubovskaya E, 2014, NUCLEIC ACIDS RES, V42, P4100, DOI 10.1093/nar/gkt1360; Yang WW, 2013, CANCER LETT, V339, P153, DOI 10.1016/j.canlet.2013.06.008; Zeng XM, 2011, J THORAC ONCOL, V6, P725, DOI 10.1097/JTO.0b013e31820c312e; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhang P, 2010, MOL ENDOCRINOL, V24, P1274, DOI 10.1210/me.2009-0437; Zhou JZ, 2015, ONCOGENE, V34, P1831, DOI 10.1038/onc.2014.113	110	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134049	10.1371/journal.pone.0134049	http://dx.doi.org/10.1371/journal.pone.0134049			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230505	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000358838400069
J	Liu, ZB; Benard, O; Syeda, MM; Schuster, VL; Chi, YL				Liu, Zhongbo; Benard, Outhiriaradjou; Syeda, Mahrukh M.; Schuster, Victor L.; Chi, Yuling			Inhibition of Prostaglandin Transporter (PGT) Promotes Perfusion and Vascularization and Accelerates Wound Healing in Non-Diabetic and Diabetic Rats	PLOS ONE			English	Article							IN-VITRO; KERATINOCYTE PROLIFERATION; ENDOTHELIAL DYSFUNCTION; CD34-POSITIVE CELLS; FOOT ULCERS; BLOOD-FLOW; EXPRESSION; MODEL; ANGIOGENESIS; LIMB	Peripheral ischemia, resulting from diminished arterial flow and defective local vascularization, is one of the main causes of impaired wound healing in diabetes. Vasodilatory prostaglandins (PGs), including PGE(2) and PGI(2), regulate blood flow in peripheral tissues. PGs also stimulate angiogenesis by inducing vascular endothelial growth factor. However, PG levels are reduced in diabetes mainly due to enhanced degradation. We hypothesized that inhibition of the prostaglandin transporter (PGT) (SLCO2A1), which mediates the degradation of PGs, would increase blood flow and stimulate vascularization, thereby mitigating peripheral ischemia and accelerating wound healing in diabetes. Here we report that inhibiting PGT with intravenously injected PGT inhibitor, T26A, increased blood flow in ischemic hind limbs created in non-diabetic rats and streptozotocin induced diabetic rats. Systemic, or combined with topical, T26A accelerated closure of cutaneous wounds. Immunohistochemical examination revealed that inhibition of PGT enhanced vascularization (marked by larger numbers of vessels formed by CD34+ cells), and accelerated re-epithelialization of cutaneous wounds. In cultured primary human bone marrow CD34+ cells and human epidermal keratinocytes (HEKs) either inhibiting or silencing PGT increased migration in both cell lines. Thus PGT directly regulates mobilization of endothelial progenitor cells (EPCs) and HEKs, which could contribute to PGT-mediated vascularization and re-epithelialization. At the molecular level, systemic inhibition of PGT raised circulating PGE(2). Taken together, our data demonstrate that PGT modulates arterial blood flow, mobilization of EPCs and HEKs, and vascularization and epithelialization in wound healing by regulating vasodilatory and pro-angiogenic PGs.	[Liu, Zhongbo; Benard, Outhiriaradjou; Syeda, Mahrukh M.; Schuster, Victor L.; Chi, Yuling] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Schuster, Victor L.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Chi, YL (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	yuling.chi@einstein.yu.edu	Liu, Zhongbo/U-3004-2017; Syeda, Mahrukh M/AAD-1927-2019	Syeda, Mahrukh M/0000-0002-4081-2068	American Heart Association [0735066N]; American Diabetes Association [1-11-JF-06]; National Institute of Diabetes and Digestive and Kidney Diseases [DK49688]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049688, P30DK041296] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by 0735066N, American Heart Association, http://www.heart.org/HEARTORG/, to YC; 1-11-JF-06, American Diabetes Association, http://www.diabetes.org/, to YC; and DK49688, The National Institute of Diabetes and Digestive and Kidney Diseases, http://www.niddk.nih. gov/Pages/default.aspx, to VLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh N, 2007, WOUND REPAIR REGEN, V15, P809, DOI 10.1111/j.1524-475X.2007.00312.x; BENAV P, 1995, FEBS LETT, V372, P83, DOI 10.1016/0014-5793(95)00956-A; Bitto A, 2008, J VASC SURG, V48, P1292, DOI 10.1016/j.jvs.2008.06.041; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; CARTER J, 1986, COMP BIOCHEM PHYS C, V83, P401, DOI 10.1016/0742-8413(86)90143-X; Chang HY, 2010, CIRCULATION, V121, P529, DOI 10.1161/CIRCULATIONAHA.109.862946; Chi YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131735; Chi YL, 2011, J PHARMACOL EXP THER, V339, P633, DOI 10.1124/jpet.111.181354; Conconi MT, 1996, ANN ANAT, V178, P229, DOI 10.1016/S0940-9602(96)80055-0; Cosentino F, 1998, J CARDIOVASC PHARM, V32, pS54; Dick F, 2008, CIRCULATION, V118, P1920, DOI 10.1161/CIRCULATIONAHA.108.787754; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Frykberg RG, 2002, AM FAM PHYSICIAN, V66, P1655; Guerci B, 2001, DIABETES METAB, V27, P436; Hishinuma T, 1999, PROSTAG OTH LIPID M, V58, P263, DOI 10.1016/S0090-6980(99)00029-5; Hishinuma T, 1996, PROSTAG LEUKOTR ESS, V54, P445, DOI 10.1016/S0952-3278(96)90029-0; Hogikyan RV, 1998, J CLIN ENDOCR METAB, V83, P1946, DOI 10.1210/jc.83.6.1946; HOLZER P, 1995, BRIT J PHARMACOL, V116, P2365, DOI 10.1111/j.1476-5381.1995.tb15081.x; JARABAK J, 1979, PROSTAGLANDINS, V18, P241, DOI 10.1016/0090-6980(79)90109-6; Kampfer H, 2005, DIABETES, V54, P1543, DOI 10.2337/diabetes.54.5.1543; Kawamoto A, 2006, CIRCULATION, V114, P2163, DOI 10.1161/CIRCULATIONAHA.106.644518; KOLLER A, 1990, CIRC RES, V67, P529, DOI 10.1161/01.RES.67.2.529; Lee CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017867; Liu ZJ, 2008, ANTIOXID REDOX SIGN, V10, P1869, DOI 10.1089/ars.2008.2121; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Lu R, 1996, J CLIN INVEST, V98, P1142, DOI 10.1172/JCI118897; Matsumoto T, 2006, AM J PATHOL, V169, P1440, DOI 10.2353/ajpath.2006.060064; Matsumura S, 2015, J DERMATOL SCI, V78, P215, DOI 10.1016/j.jdermsci.2015.02.021; Nomura T, 2004, MOL PHARMACOL, V65, P973, DOI 10.1124/mol.65.4.973; PECORARO RE, 1990, DIABETES CARE, V13, P513, DOI 10.2337/diacare.13.5.513; PENTLAND AP, 1986, J CLIN INVEST, V77, P246, DOI 10.1172/JCI112283; PERICO N, 1992, DIABETES, V41, P533, DOI 10.2337/diabetes.41.4.533; Rissanen TT, 2001, EUR J CLIN INVEST, V31, P651, DOI 10.1046/j.1365-2362.2001.00864.x; Ritz U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097369; Schanzer Andres, 2010, Curr Treat Options Cardiovasc Med, V12, P214, DOI 10.1007/s11936-010-0076-7; Sheikh AQ, 2014, AM J PHYSL CELL PHYS; Shirasaka Y, 2013, J ENDOCRINOL, V217, P265, DOI 10.1530/JOE-12-0339; Silvestre JS, 2014, ARTERIOSCLER THROMB; Sima AAF, 1996, J CLIN INVEST, V97, P1900, DOI 10.1172/JCI118621; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Spinella F, 2004, J BIOL CHEM, V279, P46700, DOI 10.1074/jbc.M408584200; Syeda MM, 2012, AM J PATHOL, V181, P334, DOI 10.1016/j.ajpath.2012.03.012; Szerafin T, 2006, CIRC RES, V99, pE12, DOI 10.1161/01.RES.0000241051.83067.62; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; WEEKS JR, 1972, ANNU REV PHARMACOLOG, V12, P317, DOI 10.1146/annurev.pa.12.040172.001533; Wentzel P, 1999, DIABETES, V48, P813, DOI 10.2337/diabetes.48.4.813; Wu ZW, 2014, J DERMATOL SCI, V75, P16, DOI 10.1016/j.jdermsci.2014.03.004; Yang Z, 2009, VASC PHARMACOL, V51, P268, DOI 10.1016/j.vph.2009.07.001	48	15	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133615	10.1371/journal.pone.0133615	http://dx.doi.org/10.1371/journal.pone.0133615			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230411	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400046
J	Nardone, V; Cistrone, L; Di Salvo, I; Ariano, A; Migliozzi, A; Allegrini, C; Ancillotto, L; Fulco, A; Russo, D				Nardone, Valentina; Cistrone, Luca; Di Salvo, Ivy; Ariano, Alessandro; Migliozzi, Antonello; Allegrini, Claudia; Ancillotto, Leonardo; Fulco, Antonio; Russo, Danilo			How to Be a Male at Different Elevations: Ecology of Intra-Sexual Segregation in the Trawling Bat Myotis daubentonii	PLOS ONE			English	Article							LONG-FINGERED BAT; HABITAT SELECTION; TEMPERATE BATS; DAILY TORPOR; FEMALE; ECHOLOCATION; PATTERNS; VESPERTILIONIDAE; THERMOREGULATION; HETEROTHERMY	Intra-sexual segregation is a form of social segregation widespread among vertebrates. In the bat Myotis daubentonii, males are disproportionately abundant at higher elevations, while females are restricted to lower altitude. Intra-male segregation is also known to occur yet its ecological and behavioural determinants are unclear. We studied male segregation along a river in Central Italy where we tested the following predictions: 1. Upstream (> 1000 m a.s.l.) males will rely on scarcer prey; 2. To deal with this limitation and exploit a cooler roosting environment, they will employ more prolonged and deeper torpor than downstream (< 900 m a.s.l.) males; 3. Body condition will be better in downstream males as they forage in more productive areas; 4. To cope with less predictable foraging opportunities, upstream males will use more habitat types. Consistent with our predictions, we found that prey were less common at higher altitudes, where bats exhibited prolonged and deeper torpor. Body condition was better in downstream males than in upstream males but not in all summer months. This result reflected a decrease in downstream males' body condition over the season, perhaps due to the energy costs of reduced opportunities to use torpor and/or intraspecific competition. Downstream males mainly foraged over selected riparian vegetation whereas upstream males used a greater variety of habitats. One controversial issue is whether upstream males are excluded from lower elevations by resident bats. We tested this by translocating 10 upstream males to a downstream roost: eight returned to the high elevation site in 1-2 nights, two persisted at low altitude but did not roost with resident bats. These results are consistent with the idea of segregation due to competition. Living at high altitude allows for more effective heterothermy and may thus be not detrimental for survival, but by staying at lower altitude males increase proximity to females and potentially benefit from summer mating opportunities.	[Nardone, Valentina; Di Salvo, Ivy; Ariano, Alessandro; Allegrini, Claudia; Ancillotto, Leonardo; Fulco, Antonio; Russo, Danilo] Univ Naples Federico II, Dipartimento Agr, Lab Ecol Applicata, Wildlife Res Unit, Naples, Italy; [Cistrone, Luca] Forestry & Conservat, Cassino, Italy; [Migliozzi, Antonello] Univ Naples Federico II, Dipartimento Agr, Lab Ecol Applicata, Naples, Italy; [Allegrini, Claudia; Ancillotto, Leonardo] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, I-00185 Rome, Italy; [Russo, Danilo] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Naples Federico II; University of Naples Federico II; Sapienza University Rome; University of Bristol	Russo, D (corresponding author), Univ Naples Federico II, Dipartimento Agr, Lab Ecol Applicata, Wildlife Res Unit, Naples, Italy.	danrusso@unina.it		Migliozzi, Antonello/0000-0001-9799-2939; Russo, Danilo/0000-0002-1934-7130				AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Almenar D, 2006, ACTA CHIROPTEROL, V8, P157, DOI 10.3161/1733-5329(2006)8[157:HSASUB]2.0.CO;2; Almenar David, 2009, Endangered Species Research, V8, P69, DOI 10.3354/esr00183; Altringham JD, 2011, BATS: FROM EVOLUTION TO CONSERVATION, 2ND EDITION, P1; Altringham JD, 1997, BIOL CONSERVATION DA; Altringham John D., 2005, P280; Ancillotto L, 2014, NATURWISSENSCHAFTEN, V101, P221, DOI 10.1007/s00114-014-1146-6; Angell RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054194; Anthony E. L. P., 1988, ECOLOGICAL BEHAV MET, P1; August TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112225; Becker NI, 2013, PHYSIOL BIOCHEM ZOOL, V86, P361, DOI 10.1086/670527; Biscardi S, 2007, J ZOOL, V273, P372, DOI 10.1111/j.1469-7998.2007.00337.x; Bon R, 1996, BEHAV PROCESS, V38, P131, DOI 10.1016/S0376-6357(96)00029-0; Bonenfant C, 2004, P ROY SOC B-BIOL SCI, V271, P883, DOI 10.1098/rspb.2003.2661; Boyles JG, 2011, PHYSIOL BIOCHEM ZOOL, V84, P115, DOI 10.1086/656724; Calenge C, 2005, ECOL MODEL, V186, P143, DOI 10.1016/j.ecolmodel.2004.12.005; Delettre YR, 2000, FRESHWATER BIOL, V44, P399, DOI 10.1046/j.1365-2427.2000.00578.x; Dietz M, 2006, J COMP PHYSIOL B, V176, P223, DOI 10.1007/s00360-005-0043-x; Dietz M, 2006, ACTA CHIROPTEROL, V8, P403, DOI 10.3161/1733-5329(2006)8[403:SSDPOF]2.0.CO;2; Dietz M, 2011, FOLIA ZOOL, V60, P5; Encarnacao JA, 2010, CAN J ZOOL, V88, P1192, DOI 10.1139/Z10-085; Encarnacao JA, 2005, MAMMAL REV, V35, P285, DOI 10.1111/j.1365-2907.2005.00066.x; Encarnacao JA, 2004, MAMMALIA, V68, P291, DOI 10.1515/mamm.2004.028; Encarnacao JA, 2012, J THERM BIOL, V37, P564, DOI 10.1016/j.jtherbio.2012.07.002; Encarnacao JA, 2012, CONSERV GENET, V13, P1433, DOI 10.1007/s10592-012-0375-5; Encarnacao JA, 2012, J ETHOL, V30, P271, DOI 10.1007/s10164-011-0323-8; Erickson JL, 2003, NORTHWEST SCI, V77, P126; GEIST V, 1978, Z SAUGETIERKD, V43, P223; Griffin DR, 1958, LISTENING DARK; Grindal SD, 1999, CAN J ZOOL, V77, P972, DOI 10.1139/cjz-77-6-972; HAMILTON IM, 1994, CAN J ZOOL, V72, P744, DOI 10.1139/z94-100; Holland RA, 2007, BEHAVIOUR, V144, P1053, DOI 10.1163/156853907781871842; KALKO EKV, 1989, BEHAV ECOL SOCIOBIOL, V24, P225, DOI 10.1007/BF00295202; Kriner E, 2014, MAMM BIOL, DOI [DOI 10.1016/J.MAMBI0.2014.10.005, 10.1016/j.mambio.2014.10.005]; Kunz T.H., 1988, P191; Leuzinger Yves, 1994, Mitteilungen der Naturforschenden Gesellschaft Schaffhausen, V39, P135; Lintott PR, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140200; McGuire LP, 2013, BIOL REV, V88, P767, DOI 10.1111/brv.12024; Park KJ, 1999, J ZOOL, V248, P419; Park KJ, 2000, FUNCT ECOL, V14, P580, DOI 10.1046/j.1365-2435.2000.00460.x; Parsons KN, 2003, ANIM CONSERV, V6, P283, DOI 10.1017/S1367943003003342; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; PINDER LCV, 1986, ANNU REV ENTOMOL, V31, P1, DOI 10.1146/annurev.en.31.010186.000245; Puechmaille SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103452; Racey P.A., 1988, P31; RAE JG, 1989, OHIO J SCI, V89, P5; Rebelo Hugo, 2009, Endangered Species Research, V8, P61, DOI 10.3354/esr00100; Ruckstuhl KE, 2007, INTEGR COMP BIOL, V47, P245, DOI 10.1093/icb/icm030; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; Russo D, 2003, ECOGRAPHY, V26, P197, DOI 10.1034/j.1600-0587.2003.03422.x; Russo D, 2002, MAMMALIA, V66, P543, DOI 10.1515/mamm.2002.66.4.543; Russo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048144; Russo D, 2011, MAMM BIOL, V76, P701, DOI 10.1016/j.mambio.2010.11.007; Rydell J, 1999, FUNCT ECOL, V13, P247, DOI 10.1046/j.1365-2435.1999.00304.x; SAETHER O A, 1979, Holarctic Ecology, V2, P65; Senior P, 2005, P ROY SOC B-BIOL SCI, V272, P2467, DOI 10.1098/rspb.2005.3237; Suba J, 2011, HYSTRIX, V22, P179, DOI 10.4404/Hystrix-22.1-4516; TAYLOR LR, 1963, J ANIM ECOL, V32, P99, DOI 10.2307/2520; Turbill C, 2006, J COMP PHYSIOL B, V176, P165, DOI 10.1007/s00360-005-0038-7; Turbill C, 2003, PHYSIOL BIOCHEM ZOOL, V76, P868, DOI 10.1086/378915; Vaughan N, 1997, MAMMAL REV, V27, P77, DOI 10.1111/j.1365-2907.1997.tb00373.x; Venturi F, 1982, ENCICLOPEDIA SCI ZOO, V2, P101; Vesterinen EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082168; Walker IR, 2006, QUATERNARY SCI REV, V25, P1911, DOI 10.1016/j.quascirev.2006.01.014; Wang L.C.H., 1989, Advances in Comparative and Environmental Physiology, V4, P361; Weckerly FW, 2001, J MAMMAL, V82, P825, DOI 10.1644/1545-1542(2001)082<0825:SSIREC>2.0.CO;2; White G.C., 1990, ANAL WILDLIFE RADIO; Willis C., 2006, FUNCTIONAL EVOLUTION, P38; Willis CKR, 2006, NATURWISSENSCHAFTEN, V93, P80, DOI 10.1007/s00114-005-0063-0; Willis CKR, 2005, CAN J ZOOL, V83, P871, DOI 10.1139/Z05-074; Willis CKR, 2003, J COMP PHYSIOL B, V173, P379, DOI 10.1007/s00360-003-0343-y; Zabala J, 2007, ANN ZOOL FENN, V44, P249	73	19	19	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134573	10.1371/journal.pone.0134573	http://dx.doi.org/10.1371/journal.pone.0134573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230548	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400136
J	Udomsinprasert, W; Poovorawan, Y; Chongsrisawat, V; Vejchapipat, P; Zhan, D; Honsawek, S				Udomsinprasert, Wanvisa; Poovorawan, Yong; Chongsrisawat, Voranush; Vejchapipat, Paisarn; Zhan, Dong; Honsawek, Sittisak			Telomere Length in Peripheral Blood Leukocytes Is Associated with Severity of Biliary Atresia	PLOS ONE			English	Article							LIVER-DISEASES; AGE; POLYMORPHISM; INSTABILITY; CIRRHOSIS; BIOLOGY; CELLS	Objective The purpose of this study was to investigate the association of telomere length in peripheral blood leukocytes with the severity of biliary atresia (BA). Methods One hundred and fourteen BA patients and 114 age-matched healthy controls were enrolled. Relative telomere length (RTL) was assessed using a quantitative real-time polymerase chain reaction. Multivariate regression analysis was used to estimate RTL as an independent risk factor of BA. Receiver operating characteristic curve analysis was used to calculate the accuracy of biomarkers in the prediction of liver cirrhosis. Results BA patients had significantly shorter telomeres than healthy controls (p < 0.0001). The RTL in BA patients with jaundice was considerably lower than that of patients without jaundice (p = 0.005). Moreover, RTL was markedly shorter in patients with cirrhosis (F4), as compared to patients with mild fibrosis (F2) and non-fibrosis (F0-F1, p < 0.0001). Logistic regression analysis indicated that short RTL was associated with a higher risk of liver cirrhosis in BA. Tertile analysis showed a dose-response effect for this association (p trend < 0.0001). Additionally, RTL in BA children revealed a negative correlation with age (r = -0.50, p < 0.001). We noted an association between reduction of RTL and liver stiffness scores, adjusted for age and gender (b = -0.01, p < 0.0001). Short RTL can be employed to distinguish cirrhosis patients from non-cirrhosis patients (AUC = 0.78). Further analysis showed a linear correlation between leukocyte RTL and liver RTL in BA patients (r = 0.83, p < 0.001). Conclusion The findings of this study provide evidence that telomere shortening is associated with an elevated risk of liver cirrhosis in BA.	[Udomsinprasert, Wanvisa; Honsawek, Sittisak] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Dept Biochem,Fac Med, Bangkok 10330, Thailand; [Poovorawan, Yong; Chongsrisawat, Voranush] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Ctr Excellence Clin Virol,Dept Pediat,Fac Med, Bangkok 10330, Thailand; [Vejchapipat, Paisarn] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Dept Surg,Fac Med, Bangkok 10330, Thailand	Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University; Thai Red Cross Society	Honsawek, S (corresponding author), Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Dept Biochem,Fac Med, Bangkok 10330, Thailand.	Sittisak.H@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Poovorawan, Yong/0000-0002-2337-6807; Udomsinprasert, Wanvisa/0000-0002-1132-7442	Thailand Research Fund [RSA5880019]; 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship	Thailand Research Fund(Thailand Research Fund (TRF)); 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship	This research has been supported by grants from the Thailand Research Fund (RSA5880019) and the 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship to WU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370; Bekaert S, 2005, ANTICANCER RES, V25, P3011; Boardman LA, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2014.3; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Carulli L, 2014, WORLD J GASTROENTERO, V20, P6287, DOI 10.3748/wjg.v20.i20.6287; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Coluzzi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110963; Corpechot C, 2006, HEPATOLOGY, V43, P1118, DOI 10.1002/hep.21151; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; De Meyer T, 2008, FRONT BIOSCI-LANDMRK, V13, P2960, DOI 10.2741/2901; Dlouha D, 2014, PHYSIOL RES, V63, pS343, DOI 10.33549/physiolres.932856; Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6; Honsawek S, 2013, CLIN BIOCHEM, V46, P214, DOI 10.1016/j.clinbiochem.2012.11.013; Invernizzi P, 2014, DIGEST LIVER DIS, V46, P363, DOI 10.1016/j.dld.2013.11.008; Kaewkiattiyot S, 2011, HEPATOL RES, V41, P1249, DOI 10.1111/j.1872-034X.2011.00870.x; KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774; Plentz RR, 2004, HEPATOLOGY, V40, P80, DOI 10.1002/hep.20271; Sanada Y, 2012, WORLD J SURG, V36, P908, DOI 10.1007/s00268-012-1453-z; Sasaki H, 2014, PEDIATR SURG INT, V30, P871, DOI 10.1007/s00383-014-3552-4; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Udomsinprasert W, 2012, WORLD J PEDIATR, V8, P328, DOI 10.1007/s12519-012-0377-x; Urabe Y, 1996, LIVER, V16, P293; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; Zhu HD, 2011, CLIN SCI, V120, P427, DOI 10.1042/CS20100385	24	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134689	10.1371/journal.pone.0134689	http://dx.doi.org/10.1371/journal.pone.0134689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230851	Green Submitted, gold, Green Published			2022-12-27	WOS:000358838400150
J	Wang, CX; Liu, X; Zhou, YM; Li, SM; Chen, YB; Wang, YN; Lou, TQ				Wang, Caixia; Liu, Xun; Zhou, Yongming; Li, Shaomin; Chen, Yanbing; Wang, Yanni; Lou, Tanqi			New Conclusions Regarding Comparison of Sevelamer and Calcium-Based Phosphate Binders in Coronary-Artery Calcification for Dialysis Patients: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							HEMODIALYSIS-PATIENTS; BONE TURNOVER; HYDROCHLORIDE; ACETATE; HYPERPHOSPHATEMIA; PROGRESSION; PROGNOSIS; MORTALITY; CARBONATE; RENAGEL	Background Sevelamer hydrochloride is used widely, but its impact upon cardiovascular calcification, cardiovascular mortality, all-cause mortality and hospitalization is not known. Outcomes Primary outcome was cardiovascular calcification (coronary artery calcification scores (CACS) and aortic calcification scores (ACS)). Secondary outcomes were serum characteristics, hospitalization, cardiovascular mortality and all-cause mortality. Risk ratio (RR), mean differences and standard mean difference with 95% confidence intervals (CIs) were pooled using random-or fixed-effects models. Results We identified 31 studies (on 23 randomized controlled trials with 4395 participants). An analysis pooling showed a significant decrease in serum levels of phosphate with calcium-based phosphate binders (CBPBs) by 0.17 mg/dL [mean difference (MD), 95% CI, 0.03, 0.31] than sevelamer. A significant difference in the change of CACS by -102.66 [MD: 95% CI, -159.51, -45.80] and ACS by -1008.73 [MD, 95% CI, -1664.75, -352.72] between sevelamer and CBPBs was observed. Prevalence of hypercalcemia (serum levels of calcium > 10.2-10.5 mg/dL and > 11.0 mg/dL) was significantly smaller for sevelamer (RR = 0.44, 95% CI, 0.33, 0.58; RR = 0.24, 95% CI, 0.14, 0.40). No significant difference was found in hospitalization, all-cause mortality or cardiovascular mortality. Conclusions This meta-analysis suggests that sevelamer benefits dialysis patients in terms of CACS, ACS and hypercalcemia.	[Wang, Caixia; Liu, Xun; Li, Shaomin; Wang, Yanni; Lou, Tanqi] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Nephrol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Yongming] Wuhan Univ Sci & Technol, Affiliated Tianyou Hosp, Dept Nephrol, Wuhan, Peoples R China; [Chen, Yanbing] Guangdong Women & Children Hosp, Ctr Med Genet, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Wuhan University of Science & Technology	Liu, X (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Nephrol, Guangzhou 510275, Guangdong, Peoples R China.	naturestyle@163.com; lou.tq@163.com			National Natural Science Foundation of China [813770866, 81070612]; China Postdoctoral Science Foundation [201104335, 20090460774]; Guangdong Science and Technology Plan [2011B031800084, 2013B021800190]; Fundamental Research Funds for the Central Universities [11ykpy38]; National Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China [2011BAI10B00]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangdong Science and Technology Plan; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China(Ministry of Science and Technology, China)	This study was supported by the National Natural Science Foundation of China (Grant No. 813770866 and 81070612), the China Postdoctoral Science Foundation (Grant No. 201104335 and 20090460774), Guangdong Science and Technology Plan (Grant No. 2011B031800084 and 2013B021800190), the Fundamental Research Funds for the Central Universities (Grant No. 11ykpy38), and the National Project of Scientific and Technical Supporting Programs Funded by Ministry of Science & Technology of China (Grant No. 2011BAI10B00).	Achenbach S, 2000, CIRCULATION, V102, P2823; Alonso A, 2004, AM J KIDNEY DIS, V43, P1, DOI 10.1053/j.ajkd.2003.09.009; Asmus HG, 2005, NEPHROL DIAL TRANSPL, V20, P1653, DOI 10.1093/ndt/gfh894; Barreto DV, 2008, NEPHRON CLIN PRACT, V110, pC273, DOI 10.1159/000170783; Barreto DVBR, 2005, J AM SOC NEPHROL; Bleyer AJ, 1999, AM J KIDNEY DIS, V33, P694, DOI 10.1016/S0272-6386(99)70221-0; Block GA, 2007, KIDNEY INT, V71, P438, DOI 10.1038/sj.ki.5002059; Block GA, 2005, KIDNEY INT, V68, P1815, DOI 10.1111/j.1523-1755.2005.00600.x; Braun J, 2004, CLIN NEPHROL, V62, P104; Brunner F P, 1992, Kidney Int Suppl, V38, pS4; Burke SK, 2003, ADV RENAL REPLACE TH, V10, P133, DOI 10.1053/jarr.2003.50016; Cancela ALE, 2011, NEPHRON CLIN PRACT, V117, pC74, DOI 10.1159/000319650; Chantrel F, 1999, NEPHROL DIAL TRANSPL, V14, P129, DOI 10.1093/ndt/14.1.129; Chertow GM, 1999, CLIN NEPHROL, V51, P18; Chertow GM, 2003, AM J NEPHROL, V23, P307, DOI 10.1159/000072822; Chertow GM, 2002, KIDNEY INT, V62, P245, DOI 10.1046/j.1523-1755.2002.00434.x; Chuanming Hao DJC A, 2010, NEPHRON CLINICAL PRA, P259; Curtin F, 2002, STAT MED, V21, P2131, DOI 10.1002/sim.1205; de Francisco ALM, 2010, NEPHROL DIAL TRANSPL, V25, P3707, DOI 10.1093/ndt/gfq292; Evenepoel P, 2009, NEPHROL DIAL TRANSPL, V24, P278, DOI 10.1093/ndt/gfn488; Ferramosca E, 2005, AM HEART J, V149, P820, DOI 10.1016/j.ahj.2004.07.023; Ferreira A, 2008, J AM SOC NEPHROL, V19, P405, DOI 10.1681/ASN.2006101089; Gallieni TCMS M, 2014, J AM SOC NEPHROL; Garg JP, 2005, ARTHRITIS RHEUM-US, V52, P290, DOI 10.1002/art.20781; Green JPHA, 2008, COCHRANE HANDBOOK FO; HERVA S DPAS, 2003, KIDNEY INT S, V63, P69; Jamal SA, 2009, NEPHROL DIAL TRANSPL, V24, P3168, DOI 10.1093/ndt/gfp350; Kakuta T, 2011, AM J KIDNEY DIS, V57, P422, DOI 10.1053/j.ajkd.2010.10.055; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Liberati A., 2009, J CLIN EPIDEMIOL, V62, pE1, DOI [DOI 10.1016/J.JCLINEPI.2009.06.006, 10.1016/j.jclinepi.2009.06.006]; Lin YF, 2010, J FORMOS MED ASSOC, V109, P663, DOI 10.1016/S0929-6646(10)60107-6; Liu YL, 2006, RENAL FAILURE, V28, P701, DOI 10.1080/08860220600925388; Malberti F, 2013, DRUGS, V73, P673, DOI 10.1007/s40265-013-0054-y; Manns B, 2004, KIDNEY INT, V66, P1239, DOI 10.1111/j.1523-1755.2004.00877.x; O'Rourke RA, 2000, J AM COLL CARDIOL, V36, P326, DOI 10.1016/S0735-1097(00)00831-7; Paolo Raggi SKBS, 2014, J AM SOC NEPHROL; Peter WLS, 2008, AM J KIDNEY DIS, V51, P445, DOI 10.1053/j.ajkd.2007.12.002; Peter WLS, 2009, CLIN J AM SOC NEPHRO, V4, P1954, DOI 10.2215/CJN.04100609; Qunibi W, 2008, AM J KIDNEY DIS, V51, P952, DOI 10.1053/j.ajkd.2008.02.298; Qunibi WY, 2004, KIDNEY INT, V65, P1914, DOI 10.1111/j.1523-1755.2004.00590.x; Raggi P, 2004, J HEART VALVE DIS, V13, P134; Rodrigo B, 2014, J AM SOC NEPHROL; Sadek T, 2003, NEPHROL DIAL TRANSPL, V18, P582, DOI 10.1093/ndt/18.3.582; Seabra VF, 2008, AM J KIDNEY DIS, V52, P272, DOI 10.1053/j.ajkd.2008.02.371; Shaheen FA, 2004, SAUDI MED J, V25, P785; Suki WN, 2008, J RENAL NUTR, V18, P91, DOI 10.1053/j.jrn.2007.10.019; Takei T, 2008, NEPHRON CLIN PRACT, V108, pC278, DOI 10.1159/000127361; Tonelli M, 2007, NEPHROL DIAL TRANSPL, V22, P2856, DOI 10.1093/ndt/gfm421; TZAMALOUKAS AH, 1992, ADV PERIT D, V8, P185	49	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133938	10.1371/journal.pone.0133938	http://dx.doi.org/10.1371/journal.pone.0133938			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230677	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400061
J	Abdi, E; Burdet, E; Bouri, M; Bleuler, H				Abdi, Elahe; Burdet, Etienne; Bouri, Mohamed; Bleuler, Hannes			Control of a Supernumerary Robotic Hand by Foot: An Experimental Study in Virtual Reality	PLOS ONE			English	Article							OPERATING-ROOM; OWNERSHIP; ILLUSION; SURGERY; INTEGRATION; EMBODIMENT; ENDOASSIST; SIGNALS; BRAIN; AESOP	In the operational theater, the surgical team could highly benefit from a robotic supplementary hand under the surgeon's full control. The surgeon may so become more autonomous; this may reduce communication errors with the assistants and take over difficult tasks such as holding tools without tremor. In this paper, we therefore examine the possibility to control a third robotic hand with one foot's movements. Three experiments in virtual reality were designed to assess the feasibility of this control strategy, the learning curve of the subjects in different tasks and the coordination of foot movements with the two natural hands. Results show that the limbs are moved simultaneously, in parallel rather than serially. Participants' performance improved within a few minutes of practice without any specific difficulty to complete the tasks. Subjective assessment by the subjects indicated that controlling a third hand by foot has been easy and required only negligible physical and mental efforts. The sense of ownership was reported to improve through the experiments. The mental burden was not directly related to the level of motion required by a task, but depended on the type of activity and practice. The most difficult task was moving two hands and foot in opposite directions. These results suggest that a combination of practice and appropriate tasks can enhance the learning process for controlling a robotic hand by foot.	[Abdi, Elahe; Bouri, Mohamed; Bleuler, Hannes] Ecole Polytech Fed Lausanne, Robot Syst Lab, Lausanne, Switzerland; [Burdet, Etienne] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Imperial College London	Abdi, E (corresponding author), Ecole Polytech Fed Lausanne, Robot Syst Lab, Lausanne, Switzerland.	elahe.abdi@epfl.ch	abdi, elahe/AAH-8291-2020	Burdet, Etienne/0000-0002-2123-0185; Abdi, Elahe/0000-0003-3748-0442	Laboratory of Robotic Systems, EPFL	Laboratory of Robotic Systems, EPFL	This research is financed by internal funds of the Laboratory of Robotic Systems, EPFL.	Aponte MV, 2009, LECT NOTES COMPUT SC, V5709, P24, DOI 10.1007/978-3-642-04052-8_3; Beckmeier L, 2014, ARCH GYNECOL OBSTET, V289, P341, DOI 10.1007/s00404-013-3004-8; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bozovic V., 2008, MED ROBOTICS; Carrozza MC, 2007, IEEE-ASME T MECH, V12, P1, DOI 10.1109/TMECH.2006.886250; Chang LH, 2014, CURR BIOL, V24, DOI 10.1016/j.cub.2014.10.041; DAGAN J, 1982, GASTROINTEST ENDOSC, V28, P97, DOI 10.1016/S0016-5107(82)73012-3; Dong-Soo Kwon S-YKaJK, 2008, MED ROBOTICS; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Folegatti A, 2012, CONSCIOUS COGN, V21, P799, DOI 10.1016/j.concog.2012.02.008; Gentile G, 2013, J NEUROSCI, V33, P13350, DOI 10.1523/JNEUROSCI.1363-13.2013; Gentile G, 2011, J NEUROPHYSIOL, V105, P910, DOI 10.1152/jn.00840.2010; Glenn W., 2001, MED PHYS SE, P195; Guterstam A, 2011, PLOS ONE, V6; Guterstam A, 2013, J COGNITIVE NEUROSCI, V25, P1078, DOI 10.1162/jocn_a_00393; Hatzinger M, 2006, J ENDOUROL, V20, P848, DOI 10.1089/end.2006.20.848; Hussain A, 2014, INT J CLIN PRACT, V68, P1376, DOI 10.1111/ijcp.12492; Jones S, 2006, NEUROSCI BIOBEHAV R, V30, P864, DOI 10.1016/j.neubiorev.2006.06.012; KAVOUSSI LR, 1995, J UROLOGY, V154, P2134, DOI 10.1016/S0022-5347(01)66715-6; Lingard L, 2002, ACAD MED, V77, P232, DOI 10.1097/00001888-200203000-00013; Llorens-Bonilla B, 2012, INT ROB SYST IROS 20; Long JA, 2007, J ENDOUROL, V21, P911, DOI 10.1089/end.2006.0328; Lopez C, 2008, NEUROPHYSIOL CLIN, V38, P149, DOI 10.1016/j.neucli.2007.12.006; Maselli A, 2013, FRONTIERS HUMAN NEUR, V7; Newport R, 2010, EXP BRAIN RES, V204, P385, DOI 10.1007/s00221-009-2104-y; Nurok Michael, 2011, Anesthesiol Clin, V29, P1, DOI 10.1016/j.anclin.2010.11.012; Parietti F, 2013, IEEE INT CONF ROBOT, P3880, DOI 10.1109/ICRA.2013.6631123; Perez-Marcos D, 2009, NEUROREPORT, V20, P589, DOI 10.1097/WNR.0b013e32832a0a2a; Peter Shokur SI, 2011, SOCIAL INTERACTION P; Pfister M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/769296; Polet R, 2004, J AM ASSOC GYN LAP, V11, P73, DOI 10.1016/S1074-3804(05)60015-1; Polet Roland, 2008, Surg Technol Int, V17, P187; Rane A, 2007, EUR UROL SUPPL, V6, P186, DOI 10.1016/S1569-9056(07)60650-2; Ritter EF, 2002, LEARNING CURVE INT E; SLATER M, 2008, FRONTIERS HUMAN NEUR; Tsakiris M, 2010, EXP BRAIN RES, V204, P343, DOI 10.1007/s00221-009-2039-3; UNGER SW, 1994, SURG ENDOSC-ULTRAS, V8, P1131, DOI 10.1007/BF00705739; van der Hoort B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020195; Voros S, 2010, IEEE-ASME T MECH, V15, P879, DOI 10.1109/TMECH.2010.2080683; Wagner AA, 2006, UROLOGY, V68, P70, DOI 10.1016/j.urology.2006.02.003	40	24	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134501	10.1371/journal.pone.0134501	http://dx.doi.org/10.1371/journal.pone.0134501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225938	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700102
J	Bedore, J; Martyn, AC; Li, AKC; Dolinar, EA; McDonald, IS; Coupland, SG; Prado, VF; Prado, MA; Hill, KA				Bedore, Jake; Martyn, Amanda C.; Li, Anson K. C.; Dolinar, Eric A.; McDonald, Ian S.; Coupland, Stuart G.; Prado, Vania F.; Prado, Marco A.; Hill, Kathleen A.			Whole-Retina Reduced Electrophysiological Activity in Mice Bearing Retina-Specific Deletion of Vesicular Acetylcholine Transporter	PLOS ONE			English	Article							AFFINITY CHOLINE TRANSPORTER; RETINOTOPIC MAP REFINEMENT; OSCILLATORY POTENTIALS; NEUROTRANSMITTER REGULATION; LEADING-EDGE; INNER RETINA; SILICONE OIL; ALPHA-WAVE; B-WAVE; A-WAVE	Background Despite rigorous characterization of the role of acetylcholine in retinal development, long-term effects of its absence as a neurotransmitter are unknown. One of the unanswered questions is how acetylcholine contributes to the functional capacity of mature retinal circuits. The current study investigates the effects of disrupting cholinergic signalling in mice, through deletion of vesicular acetylcholine transporter (VAChT) in the developing retina, pigmented epithelium, optic nerve and optic stalk, on electrophysiology and structure of the mature retina. Methods & Results A combination of electroretinography, optical coherence tomography imaging and histological evaluation assessed retinal integrity in mice bearing retina-targeted (embryonic day 12.5) deletion of VAChT (VAChT(Six3-Cre-flox/flox)) and littermate controls at 5 and 12 months of age. VAChT(Six3-Cre-flox/flox) mice did not show any gross changes in nuclear layer cellularity or synaptic layer thickness. However, VAChT(Six3-Cre-flox/flox) mice showed reduced electrophysiological response of the retina to light stimulus under scotopic conditions at 5 and 12 months of age, including reduced a-wave, b-wave, and oscillatory potential (OP) amplitudes and decreased OP peak power and total energy. Reduced a-wave amplitude was proportional to the reduction in b-wave amplitude and not associated with altered a-wave 10%-90% rise time or inner and outer segment thicknesses. Significance This study used a novel genetic model in the first examination of function and structure of the mature mouse retina with disruption of cholinergic signalling. Reduced amplitude across the electroretinogram wave form does not suggest dysfunction in specific retinal cell types and could reflect underlying changes in the retinal and/or extraretinal microenvironment. Our findings suggest that release of acetylcholine by VAChT is essential for the normal electrophysiological response of the mature mouse retina.	[Bedore, Jake; Li, Anson K. C.; Dolinar, Eric A.; McDonald, Ian S.; Hill, Kathleen A.] Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada; [Martyn, Amanda C.; Prado, Vania F.; Prado, Marco A.] Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, Mol Med, London, ON N6A 5B7, Canada; [Coupland, Stuart G.] Univ Ottawa, Ottawa Eye Inst, Ophthalmol Cellular & Mol Med, Ottawa, ON K1H 8L6, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Ottawa; Ottawa Hospital Research Institute	Hill, KA (corresponding author), Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada.	khill22@uwo.ca	Bedore, Jake/E-8011-2015; Prado, Marco Antonio Maximo/K-7638-2013; Prado, Vania Ferreira/K-7630-2013	Bedore, Jake/0000-0003-2152-6792; Prado, Marco Antonio Maximo/0000-0002-3028-5778; Prado, Vania Ferreira/0000-0003-4994-6393; Hill, Kathleen/0000-0002-7788-5105	National Sciences and Engineering Research Council [R3511A12, NSERC402524-2013 RGPIN]; Canadian Institutes of Health Research [MOP-126000, MOP-89910]; Canadian Foundation for Innovation [X3551A11]; Plunkett Foundation	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Plunkett Foundation	This work was supported by the following funding sources: National Sciences and Engineering Research Council (grants R3511A12 to KAH and NSERC402524-2013 RGPIN to VFP) as well as the Canadian Institutes of Health Research (MOP-126000 to MAP; MOP-89910 to VFP, Canadian Foundation for Innovation (grant X3551A11 to KAH) and Plunkett Foundation (to KAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NSERC website: www.nserc-crsng.gc.ca/index_eng.asp, CIHR website: http://www.cihr-irsc.gc.ca/e/193.html, (CFI) website: http://www.innovation.ca/, Plunkett Foundation website: http://www.fleetwoodcountrycruizein.com/plunkett_foundation/ plunkett_foundation.html.	Abd-El-Barr MM, 2009, J NEUROPHYSIOL, V102, P1945, DOI 10.1152/jn.00142.2009; Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Ackman JB, 2012, NATURE, V490, P219, DOI 10.1038/nature11529; Akula JD, 2007, INVEST OPHTH VIS SCI, V48, P5788, DOI 10.1167/iovs.07-0881; Bansal A, 2000, J NEUROSCI, V20, P7672; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Bytyqi AH, 2004, EUR J NEUROSCI, V20, P2953, DOI 10.1111/j.1460-9568.2004.03753.x; Daniele LL, 2008, AM J PHYSIOL-CELL PH, V295, pC451, DOI 10.1152/ajpcell.00124.2008; de Castro BM, 2009, MOL CELL BIOL, V29, P5238, DOI 10.1128/MCB.00245-09; Elstrott J, 2008, NEURON, V58, P499, DOI 10.1016/j.neuron.2008.03.013; ERICKSON JD, 1994, J BIOL CHEM, V269, P21929; Erickson JD, 2000, FASEB J, V14, P2450, DOI 10.1096/fj.00-0206rev; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Flurkey K, 2007, MOUSE BIOMEDICAL RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; Ford KJ, 2012, VISUAL NEUROSCI, V29, P61, DOI 10.1017/S0952523811000216; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Granit R, 1933, J PHYSIOL-LONDON, V77, P207, DOI 10.1113/jphysiol.1933.sp002964; HOOD DC, 1990, INVEST OPHTH VIS SCI, V31, P2070; HOOD DC, 1993, VISION RES, V33, P1605, DOI 10.1016/0042-6989(93)90027-T; HOOD DC, 1993, VISUAL NEUROSCI, V10, P857, DOI 10.1017/S0952523800006076; Hood DC, 1996, J OPT SOC AM A, V13, P623, DOI 10.1364/JOSAA.13.000623; HOOD DC, 1994, INVEST OPHTH VIS SCI, V35, P2948; Kolisnyk B, 2013, J NEUROSCI, V33, P14908, DOI 10.1523/JNEUROSCI.1933-13.2013; Koulen P, 1997, NEUROREPORT, V8, P2845, DOI 10.1097/00001756-199709080-00008; Laliberte AM, 2011, EXP EYE RES, V93, P833, DOI 10.1016/j.exer.2011.09.017; Lara A, 2010, MOL CELL BIOL, V30, P1746, DOI 10.1128/MCB.00996-09; Lee KA, 2010, BIOCHEMISTRY-US, V49, P2454, DOI 10.1021/bi1001085; Lei B, 2006, INVEST OPHTH VIS SCI, V47, P2732, DOI 10.1167/iovs.05-1461; LIPTON SA, 1989, TRENDS NEUROSCI, V12, P265, DOI 10.1016/0166-2236(89)90026-X; Marshel JH, 2012, NEURON, V76, P713, DOI 10.1016/j.neuron.2012.09.021; Martins RAP, 2008, BRAIN RES, V1192, P37, DOI 10.1016/j.brainres.2007.04.076; Martyn AC, 2012, P NATL ACAD SCI USA, V109, P17651, DOI 10.1073/pnas.1215381109; MASLAND RH, 1979, J CELL BIOL, V83, P159, DOI 10.1083/jcb.83.1.159; McKinnon SJ, 2009, EXP EYE RES, V88, P816, DOI 10.1016/j.exer.2008.12.002; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MEREDITH TA, 1985, BRIT J OPHTHALMOL, V69, P254, DOI 10.1136/bjo.69.4.254; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Pardue MT, 2014, DOC OPHTHALMOL, V128, P77, DOI 10.1007/s10633-013-9424-8; PENN RD, 1969, NATURE, V223, P201, DOI 10.1038/223201a0; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Ribeiro FM, 2005, J NEUROCHEM, V94, P86, DOI 10.1111/j.1471-4159.2005.03171.x; Ribeiro FM, 2003, J NEUROCHEM, V87, P136, DOI 10.1046/j.1471-4159.2003.01974.x; ROBSON JG, 1995, VISUAL NEUROSCI, V12, P837, DOI 10.1017/S0952523800009408; Robson JG, 1998, DOC OPHTHALMOL, V95, P187, DOI 10.1023/A:1001891904176; Robson JG, 2014, PROG RETIN EYE RES, V39, P1, DOI 10.1016/j.preteyeres.2013.12.003; Shatz CJ, 1996, J PHYSIOLOGY-PARIS, V90, P141, DOI 10.1016/S0928-4257(97)81413-1; Stacy RC, 2005, J NEUROSCI, V25, P9347, DOI 10.1523/JNEUROSCI.1800-05.2005; Sun C, 2008, P NATL ACAD SCI USA, V105, P13638, DOI 10.1073/pnas.0807178105; Syed MM, 2004, J PHYSIOL-LONDON, V560, P533, DOI 10.1113/jphysiol.2004.066597; THALER A, 1986, DOC OPHTHALMOL, V62, P41, DOI 10.1007/BF00140545; Tsui E, 2011, INVEST OPHTH VIS SCI, V52, P3539, DOI 10.1167/iovs.10-6399; Tzekov R, 1999, SURV OPHTHALMOL, V44, P53, DOI 10.1016/S0039-6257(99)00063-6; VANDERTORREN K, 1988, DOC OPHTHALMOL, V69, P153, DOI 10.1007/BF00153696; VANNORREN D, 1979, VISION RES, V19, P1433, DOI 10.1016/0042-6989(79)90219-0; Vistamehr S, 2004, VISUAL NEUROSCI, V21, P23, DOI 10.1017/S0952523804041033; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; WINKLER BS, 1972, VISION RES, V12, P1183, DOI 10.1016/0042-6989(72)90106-X; WONG ROL, 1995, J NEUROSCI, V15, P2696; Wong WT, 2001, NAT NEUROSCI, V4, P351, DOI 10.1038/85987; Wu DM, 2003, AM J PHYSIOL-HEART C, V284, pH2083, DOI 10.1152/ajpheart.01007.2002; Xu HP, 2015, DEV NEUROBIOL, V75, P621, DOI 10.1002/dneu.22288; Yamada ES, 2003, J COMP NEUROL, V461, P76, DOI 10.1002/cne.10672	63	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133989	10.1371/journal.pone.0133989	http://dx.doi.org/10.1371/journal.pone.0133989			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226617	Green Submitted, gold, Green Published			2022-12-27	WOS:000358837700047
J	Laiz-Carrion, R; Gerard, T; Uriarte, A; Malca, E; Quintanilla, JM; Muhling, BA; Alemany, F; Privoznik, SL; Shiroza, A; Lamkin, JT; Garcia, A				Laiz-Carrion, Raul; Gerard, Trika; Uriarte, Amaya; Malca, Estrella; Maria Quintanilla, Jose; Muhling, Barbara A.; Alemany, Francisco; Privoznik, Sarah L.; Shiroza, Akihiro; Lamkin, John T.; Garcia, Alberto			Trophic Ecology of Atlantic Bluefin Tuna (Thunnusthynnus) Larvae from the Gulf of Mexico and NW Mediterranean Spawning Grounds: A Comparative Stable Isotope Study	PLOS ONE			English	Article							SUMMER MESOSCALE FEATURES; AUXIS-ROCHEI LARVAE; TRICHODESMIUM SPP.; NITROGEN-FIXATION; RETENTION EFFICIENCY; THYNNUS LARVAE; LIFE-HISTORY; FISH LARVAE; FOOD WEBS; CARBON	The present study uses stable isotopes of nitrogen and carbon (delta(15)Nand delta C-13) as trophic indicators for Atlantic bluefin tuna larvae (BFT) (6-10 mm standard length) in the highly contrasting environmental conditions of the Gulf of Mexico (GOM) and the Balearic Sea (MED). These regions are differentiated by their temperature regime and relative productivity, with the GOM being significantly warmer and more productive. MED BFT larvae showed the highest delta N-15 signatures, implying an elevated trophic position above the underlying microzooplankton baseline. Ontogenetic dietary shifts were observed in the BFT larvae from the GOM and MED which indicates early life trophodynamics differences between these spawning habitats. Significant trophic differences between the GOM and MED larvae were observed in relation to delta N-15 signatures in favour of the MED larvae, which may have important implications in their growth during their early life stages. These low delta N-15 levels in the zooplankton from the GOM may be an indication of a shifting isotopic baseline in pelagic food webs due to diatrophic inputs by cyanobacteria. Lack of enrichment for delta N-15 in BFT larvae compared to zooplankton implies an alternative grazing pathway from the traditional food chain of phytoplankton-zooplankton-larval fish. Results provide insight for a comparative characterization of the trophic pathways variability of the two main spawning grounds for BFT larvae.	[Laiz-Carrion, Raul; Uriarte, Amaya; Maria Quintanilla, Jose; Garcia, Alberto] Inst Espanol Oceanog, Ctr Oceanog Malaga COM IEO, Fuengirola, Spain; [Gerard, Trika; Lamkin, John T.] Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, NOAA, Miami, FL USA; [Gerard, Trika; Malca, Estrella; Privoznik, Sarah L.; Shiroza, Akihiro] Univ Phoenix, Miramar, FL USA; [Malca, Estrella; Privoznik, Sarah L.; Shiroza, Akihiro] Univ Miami, Cooperat Inst Marine & Atmospher Studies, Miami, FL USA; [Muhling, Barbara A.] Princeton Univ Program Atmospher & Ocean Sci, Princeton, NJ USA; [Muhling, Barbara A.] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ USA; [Alemany, Francisco] Inst Espanol Oceanog, Ctr Oceanog Baleares COB IEO, Palma de Mallorca, Balearic Island, Spain	Spanish Institute of Oceanography; National Oceanic Atmospheric Admin (NOAA) - USA; University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; Spanish Institute of Oceanography	Laiz-Carrion, R (corresponding author), Inst Espanol Oceanog, Ctr Oceanog Malaga COM IEO, Fuengirola, Spain.	raul.laiz@ma.ieo.es	Malca, Estrella/D-7366-2012; García, Alberto/HDO-5321-2022; QUINTANILLA, JOSE MARIA/AAB-6818-2019; Uriarte, Amaya/L-2139-2018; LAIZ CARRION, RAUL/K-9809-2014	Malca, Estrella/0000-0002-9182-5854; QUINTANILLA, JOSE MARIA/0000-0003-1581-5248; Alemany, F. (Francisco)/0000-0001-6265-5545; Uriarte, Amaya/0000-0001-8711-9706; Muhling, Barbara/0000-0002-4555-6382; LAIZ CARRION, RAUL/0000-0003-4604-0430; Gerard, Trika/0000-0003-3214-241X; Shiroza, Akihiro/0000-0001-7766-6829	Assessment of the Atlantic bluefin TunA population breeding in the western MEditerranean (ATAME) - Spanish Ministry of Science and Innovation [CTM2011-29525-C04-02]; Accounting for the Influence of Feeding Success on the Growth and Survival of Bluefin Tuna Larvae in Stock Assessment Efforts [13BTRP009]; Spanish Institute of Oceanography of the Spanish Ministry of Economy and Competitively [FPI-IEO (2011/03)]	Assessment of the Atlantic bluefin TunA population breeding in the western MEditerranean (ATAME) - Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); Accounting for the Influence of Feeding Success on the Growth and Survival of Bluefin Tuna Larvae in Stock Assessment Efforts; Spanish Institute of Oceanography of the Spanish Ministry of Economy and Competitively	This work was supported by CTM2011-29525-C04-02 grant project, "Assessment of the Atlantic bluefin TunA population breeding in the western MEditerranean (ATAME)", funded by the Spanish Ministry of Science and Innovation and grant# 13BTRP009 to BM, "Accounting for the Influence of Feeding Success on the Growth and Survival of Bluefin Tuna Larvae in Stock Assessment Efforts" founded by National Oceanic and Atmospheric Administration-Bluefin Tuna Research Program (BTRP). A.U. was funded by a predoctoral fellowship FPI-IEO (2011/03) by the Spanish Institute of Oceanography of the Spanish Ministry of Economy and Competitively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldeco J, 2009, CIENC MAR, V35, P333, DOI 10.7773/cm.v35i4.1551; Alemany F, 2010, PROG OCEANOGR, V86, P21, DOI 10.1016/j.pocean.2010.04.014; Alvarez-Berastegui D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109338; Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; Bakun A, 2003, FISH OCEANOGR, V12, P458, DOI 10.1046/j.1365-2419.2003.00258.x; Bakun A, 2006, SCI MAR, V70, P105, DOI 10.3989/scimar.2006.70s2105; Bakun A, 2013, FISH FISH, V14, P424, DOI 10.1111/faf.12002; Balbin R, 2014, J MARINE SYST, V138, P70, DOI 10.1016/j.jmarsys.2013.07.004; Bard Francois Xavier, 1998, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V50, P319; Barnes C, 2007, FUNCT ECOL, V21, P356, DOI 10.1111/j.1365-2435.2006.01224.x; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Bode A, 2007, PROG OCEANOGR, V74, P115, DOI 10.1016/j.pocean.2007.04.005; BREMER JRA, 1999, ICCAT COLL VOL SCI P, V49, P457; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Catalan IA, 2011, J FISH BIOL, V78, P1545, DOI 10.1111/j.1095-8649.2011.02960.x; Catalan IA, 2007, SCI MAR, V71, P347, DOI 10.3989/scimar.2007.71n2347; CHECKLEY DM, 1984, MAR ECOL PROG SER, V18, P215, DOI 10.3354/meps018215; Cherel Y, 2010, LIMNOL OCEANOGR, V55, P324, DOI 10.4319/lo.2010.55.1.0324; Coll M, 2006, J MARINE SYST, V59, P63, DOI 10.1016/j.jmarsys.2005.09.001; Coombs SH, 1999, MAR BIOL, V134, P367, DOI 10.1007/s002270050553; Costalago D, 2012, MAR ECOL PROG SER, V460, P169, DOI 10.3354/meps09751; CURY P, 1994, CAN J FISH AQUAT SCI, V51, P1664, DOI 10.1139/f94-167; DEIBEL D, 1992, MAR ECOL PROG SER, V81, P25, DOI 10.3354/meps081025; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DIETRICH DE, 1994, J GEOPHYS RES-OCEANS, V99, P7599, DOI 10.1029/93JC03572; Dorado S, 2012, MAR ECOL PROG SER, V464, P37, DOI 10.3354/meps09854; Fernandez D, 2004, MAR ECOL PROG SER, V266, P89, DOI 10.3354/meps266089; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Fromentin JM, 2001, FISH RES, V53, P133, DOI 10.1016/S0165-7836(00)00299-X; Fry B, 2002, J N AM BENTHOL SOC, V21, P676, DOI 10.2307/1468438; Garcia A, 2013, FISH OCEANOGR, V22, P273, DOI 10.1111/fog.12021; Garcia A., 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V58, P535; Gasca R, 2003, MAR ECOL-P S Z N I, V24, P303, DOI 10.1046/j.1439-0485.2003.00834.x; Gasca R, 1999, B MAR SCI, V65, P75; Gasca R, 2001, B MAR SCI, V68, P397; Gutierrez-Rodriguez A, 2014, LIMNOL OCEANOGR, V59, P1590, DOI 10.4319/lo.2014.59.5.1590; Habtes S, 2014, LIMNOL OCEANOGR-METH, V12, P86, DOI 10.4319/lom.2014.12.86; Hood RR, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2002JC001753; KARL DM, 1995, NATURE, V373, P230, DOI 10.1038/373230a0; Kiljunen M, 2006, J APPL ECOL, V43, P1213, DOI 10.1111/j.1365-2664.2006.01224.x; Kloppmann MHF, 2002, MAR ECOL PROG SER, V235, P263, DOI 10.3354/meps235263; Laiz-Carrion R, 2011, J FISH BIOL, V79, P896, DOI 10.1111/j.1095-8649.2011.03048.x; Laiz-Carrion R, 2013, MAR ECOL PROG SER, V475, P203, DOI 10.3354/meps10108; Lenes JM, 2001, LIMNOL OCEANOGR, V46, P1261, DOI 10.4319/lo.2001.46.6.1261; Lindo-Atichati D, 2012, MAR ECOL PROG SER, V463, P245, DOI 10.3354/meps09860; Llopiz JK, 2015, DEEP-SEA RES PT II, V113, P113, DOI 10.1016/j.dsr2.2014.05.014; Llopiz JK, 2010, LIMNOL OCEANOGR, V55, P983, DOI 10.4319/lo.2010.55.3.0983; Logan JM, 2008, J ANIM ECOL, V77, P838, DOI 10.1111/j.1365-2656.2008.01394.x; Malzahn AM, 2009, SCI MAR, V73, P131, DOI 10.3989/scimar.2009.73s1131; Mather F.J., 1995, NOAA TECHNICAL MEMOR, V370, P1; McClelland JW, 2003, DEEP-SEA RES PT I, V50, P849, DOI 10.1016/S0967-0637(03)00073-6; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; Miller T., 2011, UNDERSTANDING WHAT D, P125; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Montoya JP, 2007, ECOL METHOD CONCEPT, P176, DOI 10.1002/9780470691854.ch7; Montoya JP, 2002, LIMNOL OCEANOGR, V47, P1617, DOI 10.4319/lo.2002.47.6.1617; Morote E, 2008, MAR ECOL PROG SER, V353, P243, DOI 10.3354/meps07206; Muhling BA, 2013, MAR ECOL PROG SER, V486, P257, DOI 10.3354/meps10397; Muhling BA, 2011, ICES J MAR SCI, V68, P1051, DOI 10.1093/icesjms/fsr008; Muhling BA, 2010, FISH OCEANOGR, V19, P526, DOI 10.1111/j.1365-2419.2010.00562.x; Mulholland MR, 2006, LIMNOL OCEANOGR, V51, P1762, DOI 10.4319/lo.2006.51.4.1762; Nakagawa Y, 2007, AQUACULTURE, V267, P83, DOI 10.1016/j.aquaculture.2007.02.024; Nishida T., 1998, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V48, P107; O'Reilly CM, 2002, LIMNOL OCEANOGR, V47, P306, DOI 10.4319/lo.2002.47.1.0306; OWENS NJP, 1987, ADV MAR BIOL, V24, P389; Pepin P, 2007, J PLANKTON RES, V29, P727, DOI 10.1093/plankt/fbm052; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pinot JM, 2002, PROG OCEANOGR, V55, P335, DOI 10.1016/S0079-6611(02)00139-8; Polunin N.V.C., 2008, HDB FISH BIOL FISHER, V1; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Power M, 2003, RAPID COMMUN MASS SP, V17, P1619, DOI 10.1002/rcm.1094; Reglero P, 2014, MAR ECOL PROG SER, V501, P207, DOI 10.3354/meps10666; Reglero P, 2012, MAR ECOL PROG SER, V463, P273, DOI 10.3354/meps09800; Reglero P, 2011, MAR ECOL PROG SER, V433, P205, DOI 10.3354/meps09187; RICHARDS WJ, 1989, RAP PROCES, V191, P169; RICHARDS WJ, 1993, B MAR SCI, V53, P475; Rooker JR, 2006, MAR ECOL PROG SER, V313, P249, DOI 10.3354/meps313249; Rooker JR, 2007, REV FISH SCI, V15, P265, DOI 10.1080/10641260701484135; Rooker JR, 2014, MAR ECOL PROG SER, V504, P265, DOI 10.3354/meps10781; ROOKER JR, 2004, COLLECT VOL SCI PAP, V56, P1115; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Suarez-Morales E., 2002, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V73, P19; Sweeting CJ, 2004, RAPID COMMUN MASS SP, V18, P2587, DOI 10.1002/rcm.1661; Takai N, 2002, LIMNOL OCEANOGR, V47, P730, DOI 10.4319/lo.2002.47.3.0730; Tanaka H, 2008, MAR BIOL, V154, P557, DOI 10.1007/s00227-008-0949-4; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; Tyrrell T, 2003, J PLANKTON RES, V25, P405, DOI 10.1093/plankt/25.4.405; UOTANI I, 1981, B JPN SOC SCI FISH, V47, P1165; UOTANI I, 1990, NIPPON SUISAN GAKK, V56, P713; Uriarte A, 2014, P 18 IB S MAR BIOL S, P103; Valls M, 2014, J MARINE SYST, V138, P160, DOI 10.1016/j.jmarsys.2014.04.007; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Varela JL, 2011, J EXP MAR BIOL ECOL, V406, P21, DOI 10.1016/j.jembe.2011.06.010; Velez-Belchi P, 2001, SCI MAR, V65, P291, DOI 10.3989/scimar.2001.65s1291; von Westernhagen H, 1998, ARCH FISH MAR RES, V46, P165; Walsh JJ, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2004JC002813; Wells RJD, 2009, J FISH BIOL, V75, P1719, DOI 10.1111/j.1095-8649.2009.02424.x; Wormuth John H., 2000, Gulf of Mexico Science, V18, P23	100	17	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133406	10.1371/journal.pone.0133406	http://dx.doi.org/10.1371/journal.pone.0133406			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225849	gold, Green Published			2022-12-27	WOS:000358837700021
J	Genc, B; Lagrimas, AKB; Kuru, P; Hess, R; Tu, MW; Menichella, DM; Miller, RJ; Paller, AS; Oezdinler, PH				Genc, Baris; Lagrimas, Amiko Krisa Bunag; Kuru, Pinar; Hess, Robert; Tu, Michael William; Menichella, Daniela Maria; Miller, Richard J.; Paller, Amy S.; Oezdinler, P. Hande			Visualization of Sensory Neurons and Their Projections in an Upper Motor Neuron Reporter Line	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; GENE-PRODUCT 9.5; SMALL-FIBER NEUROPATHY; PERIPHERAL-NERVE REGENERATION; CARBOXYL-TERMINAL HYDROLASE; TRANSGENIC MICE; CUTANEOUS INNERVATION; MYSTACIAL PAD; MOUSE MODEL; IN-VIVO	Visualization of peripheral nervous system axons and cell bodies is important to understand their development, target recognition, and integration into complex circuitries. Numerous studies have used protein gene product (PGP) 9.5 [a.k.a. ubiquitin carboxy-terminal hydrolase L1 (UCHL1)] expression as a marker to label sensory neurons and their axons. Enhanced green fluorescent protein (eGFP) expression, under the control of UCHL1 promoter, is stable and long lasting in the UCHL1-eGFP reporter line. In addition to the genetic labeling of corticospinal motor neurons in the motor cortex and degeneration-resistant spinal motor neurons in the spinal cord, here we report that neurons of the peripheral nervous system are also fluorescently labeled in the UCHL1-eGFP reporter line. eGFP expression is turned on at embryonic ages and lasts through adulthood, allowing detailed studies of cell bodies, axons and target innervation patterns of all sensory neurons in vivo. In addition, visualization of both the sensory and the motor neurons in the same animal offers many advantages. In this report, we used UCHL1-eGFP reporter line in two different disease paradigms: diabetes and motor neuron disease. eGFP expression in sensory axons helped determine changes in epidermal nerve fiber density in a high-fat diet induced diabetes model. Our findings corroborate previous studies, and suggest that more than five months is required for significant skin denervation. Crossing UCHL1-eGFP with hSOD1(G93A) mice generated hSOD1(G93A)-UeGFP reporter line of amyotrophic lateral sclerosis, and revealed sensory nervous system defects, especially towards disease end-stage. Our studies not only emphasize the complexity of the disease in ALS, but also reveal that UCHL1-eGFP reporter line would be a valuable tool to visualize and study various aspects of sensory nervous system development and degeneration in the context of numerous diseases.	[Genc, Baris; Lagrimas, Amiko Krisa Bunag; Kuru, Pinar; Hess, Robert; Tu, Michael William; Menichella, Daniela Maria; Oezdinler, P. Hande] Northwestern Univ, Davee Dept Neurol & Clin Neurol Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Miller, Richard J.] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA; [Miller, Richard J.; Paller, Amy S.; Oezdinler, P. Hande] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Paller, Amy S.] Northwestern Univ, Dept Dermatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Paller, Amy S.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Paller, Amy S.] Northwestern Univ, Skin Dis Res Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Paller, Amy S.] Northwestern Univ, Ctr Genet Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Oezdinler, P. Hande] Northwestern Univ, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University	Oezdinler, PH (corresponding author), Northwestern Univ, Davee Dept Neurol & Clin Neurol Sci, Feinberg Sch Med, Chicago, IL 60611 USA.	ozdinler@northwestern.edu	Bektaşoğlu, Pınar Kuru/K-8612-2013	Bektaşoğlu, Pınar Kuru/0000-0001-9889-9955; Paller, Amy/0000-0001-6187-6549	Les Turner ALS Foundation; Wenske Foundation; National Institute of Health [RO1NS085161-01, R21NS085750]; National Institute of Health Mechanisms of Aging and Dementia training grant [5T32AG020506-09]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS085750, R01NS085161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020506] Funding Source: NIH RePORTER	Les Turner ALS Foundation; Wenske Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health Mechanisms of Aging and Dementia training grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work has been supported by grants from Les Turner ALS Foundation (PHO), Wenske Foundation (PHO), National Institute of Health RO1NS085161-01 and R21NS085750 (PHO), and National Institute of Health Mechanisms of Aging and Dementia training grant 5T32AG020506-09 (BG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bannerman PG, 2007, J NEUROL SCI, V260, P23, DOI 10.1016/j.jns.2007.03.020; BRADLEY WG, 1983, ANN NEUROL, V14, P267, DOI 10.1002/ana.410140304; CALZADA B, 1994, ANN ANAT, V176, P437, DOI 10.1016/S0940-9602(11)80473-5; Chen YS, 2005, DIABETES, V54, P3112, DOI 10.2337/diabetes.54.11.3112; Dacci P, 2010, GLIA, V58, P2005, DOI 10.1002/glia.21069; DALSGAARD CJ, 1989, HISTOCHEMISTRY, V92, P385, DOI 10.1007/BF00492495; Day INM, 2010, PROG NEUROBIOL, V90, P327, DOI 10.1016/j.pneurobio.2009.10.020; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Esteve-Rudd J, 2010, BRAIN RES, V1352, P70, DOI 10.1016/j.brainres.2010.07.019; Fang X, 2006, J NEUROSCI, V26, P7281, DOI 10.1523/JNEUROSCI.1072-06.2006; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer LR, 2005, NEUROBIOL DIS, V19, P293, DOI 10.1016/j.nbd.2005.01.008; Fundin BT, 1997, J COMP NEUROL, V385, P185, DOI 10.1002/(SICI)1096-9861(19970825)385:2<185::AID-CNE2>3.0.CO;2-Y; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Guo YS, 2009, EXP MOL MED, V41, P140, DOI 10.3858/emm.2009.41.3.017; Hammad M, 2007, NEUROLOGY, V69, P2236, DOI 10.1212/01.wnl.0000286948.99150.16; HEADS T, 1991, ACTA NEUROPATHOL, V82, P316, DOI 10.1007/BF00308818; Hsieh ST, 2000, J NEUROPATH EXP NEUR, V59, P297, DOI 10.1093/jnen/59.4.297; Isaacs JD, 2007, J NEUROL NEUROSUR PS, V78, P750, DOI 10.1136/jnnp.2006.098798; Jackman A, 2000, J COMP NEUROL, V418, P281; Kang H, 2013, J NEUROSCI, V33, P19480, DOI 10.1523/JNEUROSCI.4067-13.2013; KARANTH SS, 1991, AM J ANAT, V191, P369, DOI 10.1002/aja.1001910404; KAWAMURA Y, 1981, J NEUROPATH EXP NEUR, V40, P667, DOI 10.1097/00005072-198111000-00008; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kennedy WR, 1996, NEUROLOGY, V47, P1042, DOI 10.1212/WNL.47.4.1042; Kent C, 1991, Brain Res Dev Brain Res, V58, P147; Kon Y, 1999, MOL REPROD DEV, V54, P333, DOI 10.1002/(SICI)1098-2795(199912)54:4&lt;333::AID-MRD3&gt;3.0.CO;2-8; KRAMMER HJ, 1993, ANN ANAT, V175, P321, DOI 10.1016/S0940-9602(11)80029-4; Lallemend F, 2012, TRENDS NEUROSCI, V35, P373, DOI 10.1016/j.tins.2012.03.006; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Luigetti M, 2012, NEUROL SCI, V33, P1095, DOI 10.1007/s10072-011-0909-5; McLenachan S, 2008, TRANSGENIC RES, V17, P1103, DOI 10.1007/s11248-008-9210-7; Mellgren SI, 2013, HAND CLINIC, V115, P171, DOI 10.1016/B978-0-444-52902-2.00010-2; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Ozdinler PH, 2011, J NEUROSCI, V31, P4166, DOI 10.1523/JNEUROSCI.4184-10.2011; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Pan CL, 2001, NEUROREPORT, V12, P787, DOI 10.1097/00001756-200103260-00034; Pan YA, 2003, J NEUROSCI, V23, P11479; Phillips RJ, 2004, J NEUROSCI METH, V133, P99, DOI 10.1016/j.jneumeth.2003.10.004; Pittenger GL, 2004, DIABETES CARE, V27, P1974, DOI 10.2337/diacare.27.8.1974; Price TJ, 2007, J PAIN, V8, P263, DOI 10.1016/j.jpain.2006.09.005; PROPERZI G, 1993, J PATHOL, V169, P269, DOI 10.1002/path.1711690215; Pugdahl K, 2007, J NEUROL NEUROSUR PS, V78, P746, DOI 10.1136/jnnp.2006.098533; RICE FL, 1993, J COMP NEUROL, V337, P366, DOI 10.1002/cne.903370303; Sekiguchi S, 2003, EXP ANIM TOKYO, V52, P365, DOI 10.1538/expanim.52.365; Sidebotham EL, 2001, PEDIATR SURG INT, V17, P304, DOI 10.1007/s003830100599; Stucky CL, 1999, J NEUROSCI, V19, P6497; THOMPSON RJ, 1983, BRAIN RES, V278, P224, DOI 10.1016/0006-8993(83)90241-X; TOHGI H, 1977, ACTA NEUROPATHOL, V38, P95, DOI 10.1007/BF00688554; Truini A, 2015, J NEUROL, V262, P1014, DOI 10.1007/s00415-015-7672-0; Verdu E, 1997, EXP NEUROL, V146, P187, DOI 10.1006/exnr.1997.6517; Vincent AM, 2009, DIABETES, V58, P2376, DOI 10.2337/db09-0047; Wang XQ, 2014, J INVEST DERMATOL, V134, P1446, DOI 10.1038/jid.2013.532; Webb CM, 2012, VET PATHOL, V49, P727, DOI 10.1177/0300985811414033; Weis J, 2011, NEUROLOGY, V76, P2024, DOI 10.1212/WNL.0b013e31821e553a; Wiese CB, 2013, GENESIS, V51, P852, DOI 10.1002/dvg.22716; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; WILSON POG, 1988, BRIT J EXP PATHOL, V69, P91; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Xu LL, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/305205; Yan Y, 2011, EXP NEUROL, V232, P7, DOI 10.1016/j.expneurol.2011.06.013; Yasvoina MV, 2013, J NEUROSCI, V33, P7890, DOI 10.1523/JNEUROSCI.2787-12.2013	65	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0132815	10.1371/journal.pone.0132815	http://dx.doi.org/10.1371/journal.pone.0132815			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222784	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800030
J	Yu, L; Yan, XM; Ye, CL; Zhao, HY; Chen, XY; Hu, F; Li, HX				Yu, Li; Yan, Xiaomei; Ye, Chenglong; Zhao, Haiyan; Chen, Xiaoyun; Hu, Feng; Li, Huixin			Bacterial Respiration and Growth Rates Affect the Feeding Preferences, Brood Size and Lifespan of Caenorhabditis elegans	PLOS ONE			English	Article							CARBON-DIOXIDE AVOIDANCE; COMMUNITY STRUCTURE; SOIL NEMATODES; BEHAVIOR; REPRODUCTION; EXTENSION; CEPHALOBIDAE; RESPONSES; SIGNALS; FOOD	Bacteria serve as live food and nutrients for bacterial-feeding nematodes (BFNs) in soils, and influence nematodes behavior and physiology through their metabolism. Five bacterial taxa (Bacillus amyloliquefaciens JX1, Variovorax sp. JX14, Bacillus megaterium JX15, Pseudomonas fluorescens Y1 and Escherichia coli OP50) and the typical BFN Caenorhabditis elegans were selected to study the effects of bacterial respiration and growth rates on the feeding preferences, brood size and lifespan of nematodes. P. fluorescens Y1 and E. coli OP50 were found to be more active, with high respiration and rapid growth, whereas B. amyloliquefaciens JX1 and B. megaterium JX15 were inactive. The nematode C. elegans preferred active P. fluorescens Y1 and E. coli OP50 obviously. Furthermore, worms that fed on these two active bacteria produced more offspring but had shorter lifespan, while inactive and less preferred bacteria had increased nematodes lifespan and decreased the brood size. Based on these results, we propose that the bacterial activity may influence the behavior and life traits of C. elegans in the following ways: (1) active bacteria reproduce rapidly and emit high levels of CO2 attracting C. elegans; (2) these active bacteria use more resources in the nematodes' gut to sustain their survival and reproduction, thereby reducing the worm's lifespan; (3) inactive bacteria may provide less food for worms than active bacteria, thus increasing nematodes lifespan but decreasing their fertility. Nematodes generally require a balance between their preferred foods and beneficial foods, only preferred food may not be beneficial for nematodes.	[Yu, Li; Yan, Xiaomei; Ye, Chenglong; Chen, Xiaoyun; Hu, Feng; Li, Huixin] Nanjing Agr Univ, Coll Resources & Environm Sci, Soil Ecol Lab, Nanjing 210095, Jiangsu, Peoples R China; [Zhao, Haiyan] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Li, HX (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Soil Ecol Lab, Nanjing 210095, Jiangsu, Peoples R China.	huixinli@njau.edu.cn	Li, huixin/H-5573-2011		National Natural Science Foundation of China [41271270]; Foundation of Graduate Creative Program of Jiangsu Province [CXLX13 277]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Graduate Creative Program of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (Grant No. 41271270), the Foundation of Graduate Creative Program of Jiangsu Province (Grant No. CXLX13 277) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada EAE, 2009, MOL CELLS, V28, P209, DOI 10.1007/s10059-009-0124-x; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Barnes AI, 2006, P ROY SOC B-BIOL SCI, V273, P939, DOI 10.1098/rspb.2005.3388; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; BENZER S, 1971, J AMER MED ASSOC, V218, P1015, DOI 10.1001/jama.218.7.1015; Bjornlund L, 2006, BIOL FERT SOILS, V43, P1, DOI 10.1007/s00374-005-0052-7; Bongers T, 1999, TRENDS ECOL EVOL, V14, P224, DOI 10.1016/S0169-5347(98)01583-3; Bongers T, 1998, APPL SOIL ECOL, V10, P239, DOI 10.1016/S0929-1393(98)00123-1; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Bonkowski M, 2000, APPL SOIL ECOL, V14, P37, DOI 10.1016/S0929-1393(99)00047-5; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Coolon JD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000503; Crawford D, 2007, AGING CELL, V6, P715, DOI 10.1111/j.1474-9726.2007.00327.x; Djigal D, 2004, PLANT SOIL, V262, P33, DOI 10.1023/B:PLSO.0000037022.16822.75; Djigal D, 2004, SOIL BIOL BIOCHEM, V36, P323, DOI 10.1016/j.soilbio.2003.10.007; DUSENBER.DB, 1974, J EXP ZOOL, V188, P41, DOI 10.1002/jez.1401880105; Gallagher T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059865; Garigan D, 2002, GENETICS, V161, P1101; Gomez F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-300; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Jiang Y, 2012, EUR J SOIL BIOL, V52, P20, DOI 10.1016/j.ejsobi.2012.05.003; Jousset A, 2009, ISME J, V3, P666, DOI 10.1038/ismej.2009.26; Kenyon C, 2010, ANN NY ACAD SCI, V1204, P156, DOI 10.1111/j.1749-6632.2010.05640.x; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Li HuiXin, 2001, Pedosphere, V11, P57; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; MacNeil LT, 2013, CELL, V153, P240, DOI 10.1016/j.cell.2013.02.049; Mukhopadhyay A, 2007, TRENDS CELL BIOL, V17, P65, DOI 10.1016/j.tcb.2006.12.004; Newsham KK, 2004, EUR J SOIL BIOL, V40, P1, DOI 10.1016/j.ejsobi.2004.01.004; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Portal-Celhay C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-49; Rankin CH, 2006, CURR BIOL, V16, pR89, DOI 10.1016/j.cub.2006.01.025; Rasmann S, 2012, J CHEM ECOL, V38, P615, DOI 10.1007/s10886-012-0118-6; Reinke SN, 2010, MOL GENET METAB, V100, P274, DOI 10.1016/j.ymgme.2010.03.013; Riddle Donald L., 1997, Cold Spring Harbor Monograph Series, V33, P739; Ronn R, 2002, APPL ENVIRON MICROB, V68, P6094, DOI 10.1128/AEM.68.12.6094-6105.2002; Saiki R, 2008, AGING CELL, V7, P291, DOI 10.1111/j.1474-9726.2008.00378.x; Salinas KA, 2007, PEDOBIOLOGIA, V51, P55, DOI 10.1016/j.pedobi.2006.12.003; Schlotz N, 2014, FEMS MICROBIOL ECOL, V90, P467, DOI 10.1111/1574-6941.12407; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Sicard M, 2007, ENVIRON MICROBIOL, V9, P12, DOI 10.1111/j.1462-2920.2006.01099.x; Smith EM, 2003, AQUAT MICROB ECOL, V30, P251, DOI 10.3354/ame030251; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Tan K, 2014, BEHAV ECOL SOCIOBIOL, V68, P13, DOI 10.1007/s00265-013-1617-3; Tan MW, 2000, CURR OPIN MICROBIOL, V3, P29, DOI 10.1016/S1369-5274(99)00047-8; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Veen GF, 2010, ECOLOGY, V91, P828, DOI 10.1890/09-0134.1; Vellucci VF, 2007, FUNGAL GENET BIOL, V44, P979, DOI 10.1016/j.fgb.2006.12.003; Venette RC, 1998, SOIL BIOL BIOCHEM, V30, P949, DOI 10.1016/S0038-0717(97)00176-4; Walker G, 2005, MECH AGEING DEV, V126, P929, DOI 10.1016/j.mad.2005.03.014; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	54	23	25	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134401	10.1371/journal.pone.0134401	http://dx.doi.org/10.1371/journal.pone.0134401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222828	gold, Green Submitted, Green Published			2022-12-27	WOS:000358836800140
J	Bingold, TM; Lefering, R; Zacharowski, K; Meybohm, P; Waydhas, C; Rosenberger, P; Scheller, B				Bingold, Tobias M.; Lefering, Rolf; Zacharowski, Kai; Meybohm, Patrick; Waydhas, Christian; Rosenberger, Peter; Scheller, Bertram		Divi Intensive Care Registry Grp	Individual Organ Failure and Concomitant Risk of Mortality Differs According to the Type of Admission to ICU - A Retrospective Study of SOFA Score of 23,795 Patients	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; HOSPITAL MORTALITY; ACUTE PHYSIOLOGY; DYSFUNCTION/FAILURE; REQUIREMENTS; MULTICENTER; SEPSIS; SAPS-3	Introduction Organ dysfunction or failure after the first days of ICU treatment and subsequent mortality with respect to the type of intensive care unit (ICU) admission is poorly elucidated. Therefore we analyzed the association of ICU mortality and admission for medical (M), scheduled surgery (ScS) or unscheduled surgery (US) patients mirrored by the occurrence of organ dysfunction/failure (OD/OF) after the first 72h of ICU stay. Methods For this retrospective cohort study (23,795 patients; DIVI registry; German Interdisciplinary Association for Intensive Care Medicine (DIVI)) organ dysfunction or failure were derived from the Sequential Organ Failure Assessment (SOFA) score (excluding the Glasgow Coma Scale). SOFA scores were collected on admission to ICU and 72h later. For patients with a length of stay of at least five days, a multivariate analysis was performed for individual OD/OF on day three. Results M patients had the lowest prevalence of cardiovascular failure (M 31%; ScS 35%; US 38%), and the highest prevalence of respiratory (M 24%; ScS 13%; US 17%) and renal failure (M 10%; ScS 6%; US 7%). Risk of death was highest for M-and ScS-patients in those with respiratory failure (OR; M 2.4; ScS 2.4; US 1.4) and for surgical patients with renal failure (OR; M 1.7; ScS 2.7; US 2.4). Conclusion The dynamic evolution of OD/OF within 72h after ICU admission and mortality differed between patients depending on their types of admission. This has to be considered to exclude a systematic bias during multi-center trials.	[Bingold, Tobias M.; Zacharowski, Kai; Meybohm, Patrick; Scheller, Bertram] Univ Hosp Frankfurt Main, Dept Anesthesiol Intens Care Med & Pain Therapy, D-60590 Frankfurt, Germany; [Lefering, Rolf] Univ Witten Herdecke, Cologne Merheim Med Ctr CMMC, Inst Res Operat Med IFOM, D-51109 Cologne, Germany; [Waydhas, Christian] Univ Hosp Essen, Dept Trauma Surg, D-45122 Essen, Germany; [Rosenberger, Peter] Univ Tubingen, Dept Anesthesiol & Intens Care Med, D-72076 Tubingen, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Witten Herdecke University; University of Duisburg Essen; Eberhard Karls University of Tubingen	Bingold, TM (corresponding author), Univ Hosp Frankfurt Main, Dept Anesthesiol Intens Care Med & Pain Therapy, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	tobias.bingold@kgu.de	Meybohm, Patrick/K-4066-2017; Bingold, Tobias/AAM-9204-2021	Meybohm, Patrick/0000-0002-2666-8696; Bingold, Tobias/0000-0002-4046-135X; Pauldurai, Jona/0000-0002-7217-0872				Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lone NI, 2012, AM J RESP CRIT CARE, V186, P640, DOI 10.1164/rccm.201201-0059OC; Martin J, 2004, ANASTH INTENSIVMED, V45, P207; Metnitz PGH, 2005, INTENS CARE MED, V31, P1336, DOI 10.1007/s00134-005-2762-6; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Ostermann M, 2008, CRIT CARE, V12, DOI 10.1186/cc7085; Valentin A, 2011, INTENS CARE MED, V37, P1575, DOI 10.1007/s00134-011-2300-7; Vincent JL, 2012, RESUSCITATION, V83, P537, DOI 10.1016/j.resuscitation.2012.02.024; Vincent JL, 2011, CRIT CARE MED, V39, P1050, DOI 10.1097/CCM.0b013e31820eda29; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Waydhas C., 2000, Intensivmedizin und Notfallmedizin, V37, P454, DOI 10.1007/s003900070059; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	16	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134329	10.1371/journal.pone.0134329	http://dx.doi.org/10.1371/journal.pone.0134329			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241475	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942700040
J	Mladenovic, D; Petronijevic, N; Stojkovic, T; Velimirovic, M; Jevtic, G; Hrncic, D; Radosavljevic, T; Rasic-Markovic, A; Maksic, N; Djuric, D; Stanojlovic, O				Mladenovic, Dusan; Petronijevic, Natasa; Stojkovic, Tihomir; Velimirovic, Milica; Jevtic, Gordana; Hrncic, Dragan; Radosavljevic, Tatjana; Rasic-Markovic, Aleksandra; Maksic, Nebojsa; Djuric, Dragan; Stanojlovic, Olivera			Finasteride Has Regionally Different Effects on Brain Oxidative Stress and Acetylcholinesterase Activity in Acute Thioacetamide-Induced Hepatic Encephalopathy in Rats	PLOS ONE			English	Article							ACUTE AMMONIA INTOXICATION; IN-VIVO; LIPID-PEROXIDATION; ENERGY-METABOLISM; LIVER-FAILURE; NEUROSTEROIDS; ALLOPREGNANOLONE; HYPERAMMONEMIA; CEREBELLUM; ACTIVATION	Finasteride (FIN) inhibits neurosteroid synthesis and potentially improves the course of hepatic encephalopathy (HE). This study aimed to investigate the effects of FIN on brain oxidative stress and acetylcholinesterase (AchE) activity in acute thioacetamide-induced HE in rats. Male Wistar rats were divided into groups: 1. control; 2. thioacetamide-treated group (TAA; 900 mg/kg); 3. finasteride-treated group (FIN; 150 mg/kg); 4. group treated with FIN and TAA (FIN+TAA). Daily doses of FIN (50 mg/kg) and TAA (300 mg/kg) were administered intraperitoneally during three days and in FIN+TAA group FIN was administered 2h before every dose of TAA. FIN pretreatment prevented TAA-induced rise in malondialdehyde level in the cortex due to restoration of catalase activity and increased expression of superoxide dismutase 1 (SOD1) and induced an increase in malondialdehyde level in the thalamus due to reduction of glutathione peroxidase (GPx) and glutathione reductase (GR) activity. Although FIN pretreatment did not affect malondialdehyde level in hippocampus and caudate nucleus, hippocampal SOD1 expression was higher (p<0.05) and GR activity lower in FIN+TAA vs. TAA group (p<0.05). GPx activity was lower in caudate nucleus in FIN + TAA vs. TAA group (p<0.01). FIN pretreatment prevented TAA-induced rise in AchE activity in the thalamus and caudate nucleus and AchE activity correlates inversely in the thalamus (p<0.05) and positively in caudate nucleus (p<0.01) with malondialdehyde level. FIN has regionally selective effects on oxidative stress and AchE activity in the brain in acute TAA-induced HE in rats. The prooxidant role of FIN in the thalamus may be causally linked with inhibition of AchE.	[Mladenovic, Dusan; Radosavljevic, Tatjana] Univ Belgrade, Fac Med, Inst Pathophysiol Ljubodrag Buba Mihailovic, Belgrade, Serbia; [Petronijevic, Natasa; Stojkovic, Tihomir; Velimirovic, Milica; Jevtic, Gordana] Univ Belgrade, Fac Med, Inst Med & Clin Biochem, Belgrade, Serbia; [Hrncic, Dragan; Rasic-Markovic, Aleksandra; Djuric, Dragan; Stanojlovic, Olivera] Univ Belgrade, Fac Med, Inst Med Physiol Richard Burian, Belgrade, Serbia; [Maksic, Nebojsa] Clin Ctr Serbia, Ctr Med Biochem, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade; Clinical Centre of Serbia	Stanojlovic, O (corresponding author), Univ Belgrade, Fac Med, Inst Med Physiol Richard Burian, Visegradska 26-2, Belgrade, Serbia.	solja@afrodita.rcub.bg.ac.rs	Radosavljević, Tatjana/AAE-2792-2020; Rasic Markovic, Aleksandra/AAA-9441-2022; Hrncic, Dragan/AAT-2544-2021; Velimirovic, Milica D/R-9449-2017; Rasic-Markovic, Aleksandra/AAT-5675-2021	Radosavljević, Tatjana/0000-0002-1701-3313; Rasic Markovic, Aleksandra/0000-0003-1131-2328; Hrncic, Dragan/0000-0003-0806-444X; Velimirovic, Milica D/0000-0002-0495-0316; Djuric, Dragan M./0000-0003-2196-9438; Stojkovic, Tihomir/0000-0002-2400-6066; Petronijevic, Natasa/0000-0002-4338-1953; Stanojlovic, Olivera/0000-0001-5317-3827	Ministry of Education and Science of Serbia [175032, 175058]	Ministry of Education and Science of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education and Science of Serbia, Grant No 175032 and 175058.	Ahboucha S, 2008, NEUROCHEM INT, V52, P575, DOI 10.1016/j.neuint.2007.05.004; Ahboucha S, 2012, NEUROCHEM INT, V60, P707, DOI 10.1016/j.neuint.2011.10.003; Albrecht J, 2010, BIOCHEM PHARMACOL, V80, P1303, DOI 10.1016/j.bcp.2010.07.024; Ali MI, 2013, EUR J PHARMACOL, V698, P397, DOI 10.1016/j.ejphar.2012.10.028; Alvarez VM, 2011, J NEUROSCI RES, V89, P2028, DOI 10.1002/jnr.22708; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Biagini G, 2010, CURR OPIN NEUROL, V23, P170, DOI 10.1097/WCO.0b013e32833735cf; Bishnoi M, 2008, PROG NEURO-PSYCHOPH, V32, P451, DOI 10.1016/j.pnpbp.2007.09.017; Bismuth M, 2011, EUR J GASTROEN HEPAT, V23, P8, DOI 10.1097/MEG.0b013e3283417567; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Cauli O, 2009, GASTROENTEROLOGY, V136, P1359, DOI 10.1053/j.gastro.2008.12.057; Cauli O, 2009, METAB BRAIN DIS, V24, P69, DOI 10.1007/s11011-008-9115-4; Cayatte C, 2006, MOL CELL PROTEOMICS, V5, P2031, DOI 10.1074/mcp.M600165-MCP200; Duborija-Kovacevic N, 2008, EUR J DRUG METAB PH, V33, P181; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Ena S, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00047; Finn DA, 2004, PHARMACOL THERAPEUT, V101, P91, DOI 10.1016/j.pharmthera.2003.10.006; Ford MA, 2005, ALCOHOL, V37, P23, DOI 10.1016/j.alcohol.2005.11.002; GAMMAL SH, 1989, MED CLIN N AM, V73, P793, DOI 10.1016/S0025-7125(16)30639-3; Garcia-Ayllon MS, 2008, BRAIN, V131, P2946, DOI 10.1093/brain/awn209; Gorg B, 2013, ARCH BIOCHEM BIOPHYS, V536, P158, DOI 10.1016/j.abb.2013.03.010; Gonzalez-Usano A, 2013, J NEUROCHEM, V125, P133, DOI 10.1111/jnc.12119; GOTH L, 1991, CLIN CHEM, V37, P2043; GUNZLER WA, 1974, Z KLIN CHEM KLIN BIO, V12, P444; Haussinger D, 2010, CURR OPIN CLIN NUTR, V13, P87, DOI 10.1097/MCO.0b013e328333b829; Haussinger D, 2005, METAB BRAIN DIS, V20, P285, DOI 10.1007/s11011-005-7908-2; Hermenegildo C, 2000, HEPATOLOGY, V31, P709, DOI 10.1002/hep.510310322; Kalb A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062679; Kosenko E, 2000, BRAIN RES, V880, P139, DOI 10.1016/S0006-8993(00)02785-2; Lassiter TL, 1998, DEV BRAIN RES, V105, P109, DOI 10.1016/S0165-3806(97)00177-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCANDLESS DW, 1985, J LAB CLIN MED, V106, P183; Mendez M, 2011, ACTA HISTOCHEM, V113, P358, DOI 10.1016/j.acthis.2010.01.009; Milatovic D, 2006, THESCIENTIFICWORLDJO, V6, P295, DOI 10.1100/tsw.2006.38; Mladenovic D, 2014, AM J PHYSIOL-GASTR L, V307, pG931, DOI 10.1152/ajpgi.00463.2013; Mladenovic D, 2012, CAN J PHYSIOL PHARM, V90, P1219, DOI [10.1139/Y2012-088, 10.1139/y2012-088]; Mladenovic D, 2012, MED CHEM, V8, P52, DOI 10.2174/157340612799278603; Mukai Y, 2008, BIOL PHARM BULL, V31, P1646, DOI 10.1248/bpb.31.1646; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Raso GM, 2011, J NEUROENDOCRINOL, V23, P591, DOI 10.1111/j.1365-2826.2011.02152.x; REHNCRONA S, 1980, J NEUROCHEM, V34, P1630, DOI 10.1111/j.1471-4159.1980.tb11254.x; Rodriguez-Rodriguez P, 2013, NEUROCHEM INT, V62, P750, DOI 10.1016/j.neuint.2013.02.005; Rosello DM, 2008, HEPATOL RES, V38, P1148, DOI 10.1111/j.1872-034X.2008.00377.x; Sathyasaikumar KV, 2007, NEUROCHEM RES, V32, P517, DOI 10.1007/s11064-006-9265-x; SUN M, 1978, ANAL BIOCHEM, V90, P81, DOI 10.1016/0003-2697(78)90010-6; Swapna I, 2007, BRAIN RES, V1153, P188, DOI 10.1016/j.brainres.2007.02.095; Traish AM, 2014, HORM MOL BIOL CLIN I, V20, P73, DOI 10.1515/hmbci-2014-0025; Ugale RR, 2007, BRAIN RES, V1184, P193, DOI 10.1016/j.brainres.2007.09.041; Wang XK, 2005, MOL BRAIN RES, V140, P120, DOI 10.1016/j.molbrainres.2005.07.018; Whittaker V. P., 1972, METHODS NEUROCHEMIST, V2, P1; Zarros A, 2008, METAB BRAIN DIS, V23, P255, DOI 10.1007/s11011-008-9091-8	53	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134434	10.1371/journal.pone.0134434	http://dx.doi.org/10.1371/journal.pone.0134434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241899	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942700044
J	Wang, YS; Mao, ZC; Yan, J; Cheng, XY; Liu, F; Xiao, L; Dai, LY; Luo, F; Xie, BY				Wang, Yunsheng; Mao, Zhenchuan; Yan, Jin; Cheng, Xinyue; Liu, Feng; Xiao, Luo; Dai, Liangying; Luo, Feng; Xie, Bingyan			Identification of MicroRNAs in Meloidogyne incognita Using Deep Sequencing	PLOS ONE			English	Article							SMALL RNAS; COMPUTATIONAL IDENTIFICATION; REGULATORY ROLES; GENOME; GENES; ALIGNMENT; PLANT; BIOGENESIS; 21U-RNAS; MIR-124	MicroRNAs play important regulatory roles in eukaryotic lineages. In this paper, we employed deep sequencing technology to sequence and identify microRNAs in M. incognita genome, which is one of the important plant parasitic nematodes. We identified 102 M. incognita microRNA genes, which can be grouped into 71 nonredundant miRNAs based on mature sequences. Among the 71 miRANs, 27 are known miRNAs and 44 are novel miRNAs. We identified seven miRNA clusters in M. incognita genome. Four of the seven clusters, miR-100/let-7, miR-71-1/miR-2a-1, miR-71-2/miR-2a-2 and miR-279/miR-2b are conserved in other species. We validated the expressions of 5 M. incognita microRNAs, including 3 known microRNAs (miR-71, miR-100b and let-7) and 2 novel microRNAs (NOVEL-1 and NOVEL-2), using RT-PCR. We can detect all 5 microRNAs. The expression levels of four microRNAs obtained using RT-PCR were consistent with those obtained by high-throughput sequencing except for those of let-7. We also examined how M. incognita miRNAs are conserved in four other nematodes species: C. elegans, A. suum, B. malayi and P. pacificus. We found that four microRNAs, miR-100, miR-92, miR-279 and miR-137, exist only in genomes of parasitic nematodes, but do not exist in the genomes of the free living nematode C. elegans. Our research created a unique resource for the research of plant parasitic nematodes. The candidate microRNAs could help elucidate the genomic structure, gene regulation, evolutionary processes, and developmental features of plant parasitic nematodes and nematode-plant interaction.	[Wang, Yunsheng; Yan, Jin; Xiao, Luo; Dai, Liangying] Hunan Agr Univ, Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Changsha, Hunan, Peoples R China; [Wang, Yunsheng; Mao, Zhenchuan; Liu, Feng; Xie, Bingyan] CAAS, Inst Vegetables & Flowers, Beijing, Peoples R China; [Cheng, Xinyue] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Luo, Feng] Clemson Univ, Sch Comp, Clemson, SC USA	Hunan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Beijing Normal University; Clemson University	Wang, YS (corresponding author), Hunan Agr Univ, Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Changsha, Hunan, Peoples R China.	wyunsheng@gmail.com; xieby@mail.caas.net.cn		Wang, Yunsheng/0000-0001-5003-4434	National Natural Science Foundation of China (NSFC) [30900925]; National Basic Research and Development Program of China [2009CB119000]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research and Development Program of China(National Basic Research Program of China)	This work was partially supported by National Natural Science Foundation of China (NSFC) (30900925) and National Basic Research and Development Program of China (2009CB119000).	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Boissonneault V, 2008, ANAL BIOCHEM, V381, P166, DOI 10.1016/j.ab.2008.06.026; Boulias K, 2012, CELL METAB, V15, P439, DOI 10.1016/j.cmet.2012.02.014; Burnside J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-185; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Dubreuil G, 2007, NEW PHYTOL, V176, P426, DOI 10.1111/j.1469-8137.2007.02181.x; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hsieh YW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002864; Huang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008206; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li Y, 2005, ACTA BIOCH BIOPH SIN, V37, P75, DOI 10.1093/abbs/37.2.75; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo WY, 2012, CELL, V148, P765, DOI 10.1016/j.cell.2011.12.024; Montgomery TA, 2012, PLOS GENET, V8, P72, DOI 10.1371/journal.pgen.1002616; Nagao A, 2010, RNA, V16, P2503, DOI 10.1261/rna.2270710; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Poole CB, 2010, MOL BIOCHEM PARASIT, V169, P87, DOI 10.1016/j.molbiopara.2009.10.004; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sarkies P, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002061; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Shi Z, 2013, GENOME RES, V23, P497, DOI 10.1101/gr.149112.112; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Trudgill DL, 2001, ANNU REV PHYTOPATHOL, V39, P53, DOI 10.1146/annurev.phyto.39.1.53; Tsuchida A, 2011, CANCER SCI, V102, P2264, DOI 10.1111/j.1349-7006.2011.02081.x; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Wang XW, 2005, BIOINFORMATICS, V21, P3610, DOI 10.1093/bioinformatics/bti562; Warf MB, 2011, RNA, V17, P563, DOI 10.1261/rna.2432311; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Winter AD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-4; Yousef M, 2009, FEBS J, V276, P2150, DOI 10.1111/j.1742-4658.2009.06933.x; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zheng YS, 2012, ONCOGENE, V31, P80, DOI 10.1038/onc.2011.208; ZUO T, 2010, J HENAN AGR SCI, V12	65	9	9	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133491	10.1371/journal.pone.0133491	http://dx.doi.org/10.1371/journal.pone.0133491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241472	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700016
J	Zhao, WY; Zhao, TQ; Chen, YJ; Zhao, FB; Gu, QQ; Williams, RW; Bhattacharya, SK; Lu, L; Sun, Y				Zhao, Wenyuan; Zhao, Tieqiang; Chen, Yuanjian; Zhao, Fengbo; Gu, Qingqing; Williams, Robert W.; Bhattacharya, Syamal K.; Lu, Lu; Sun, Yao			A Murine Hypertrophic Cardiomyopathy Model: The DBA/2J Strain	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; LEFT-VENTRICULAR HYPERTROPHY; TISSUE-REPAIR; MOUSE GENOME; RAT-HEART; MICE; MUTATIONS; POLYMORPHISM; PHENOTYPES; GENETICS	Familial hypertrophic cardiomyopathy (HCM) is attributed to mutations in genes that encode for the sarcomere proteins, especially Mybpc3 and Myh7. Genotype-phenotype correlation studies show significant variability in HCM phenotypes among affected individuals with identical causal mutations. Morphological changes and clinical expression of HCM are the result of interactions with modifier genes. With the exceptions of angiotensin converting enzyme, these modifiers have not been identified. Although mouse models have been used to investigate the genetics of many complex diseases, natural murine models for HCM are still lacking. In this study we show that the DBA/2J (D2) strain of mouse has sequence variants in Mybpc3 and Myh7, relative to widely used C57BL/6J (B6) reference strain and the key features of human HCM. Four-month-old of male D2 mice exhibit hallmarks of HCM including increased heart weight and cardiomyocyte size relative to B6 mice, as well as elevated markers for cardiac hypertrophy including beta-myosin heavy chain (MHC), atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and skeletal muscle alpha actin (alpha 1-actin). Furthermore, cardiac interstitial fibrosis, another feature of HCM, is also evident in the D2 strain, and is accompanied by up-regulation of type I collagen and a-smooth muscle actin (SMA)-markers of fibrosis. Of great interest, blood pressure and cardiac function are within the normal range in the D2 strain, demonstrating that cardiac hypertrophy and fibrosis are not secondary to hypertension, myocardial infarction, or heart failure. Because D2 and B6 strains have been used to generate a large family of recombinant inbred strains, the BXD cohort, the D2 model can be effectively exploited for in-depth genetic analysis of HCM susceptibility and modifier screens.	[Zhao, Wenyuan; Zhao, Tieqiang; Chen, Yuanjian; Zhao, Fengbo; Bhattacharya, Syamal K.; Sun, Yao] Univ Tennessee, Dept Med, HealthSci Ctr, Div Cardiovasc Dis, Memphis, TN 38104 USA; [Gu, Qingqing; Williams, Robert W.; Lu, Lu] Univ Tennessee, Hlth Sci Ctr, Dept Genet Genom & Informat, Memphis, TN 38163 USA; [Lu, Lu] Nantong Univ, Jiangsu Key Lab Neuroregenert, Nantong, Jiangsu, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Nantong University	Lu, L (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Genet Genom & Informat, Memphis, TN 38163 USA.	llu@uthsc.edu; yasun@uthsc.edu	Williams, Robert W./H-8789-2016	Williams, Robert W./0000-0001-8924-4447	NIH Heart, Lung and Blood Institute [R01-HL096503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096503] Funding Source: NIH RePORTER	NIH Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by NIH Heart, Lung and Blood Institute (R01-HL096503 to Yao Sun). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonne G, 1998, CIRC RES, V83, P580, DOI 10.1161/01.RES.83.6.580; Dhalla NS, 2012, HEART FAIL REV, V17, P671, DOI 10.1007/s10741-011-9278-7; Doolan G, 2004, INT J CARDIOL, V96, P157, DOI 10.1016/j.ijcard.2004.05.003; Enriquez AD, 2014, ANN GLOB HEALTH, V80, P35, DOI 10.1016/j.aogh.2013.12.004; Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; LIEBSON PR, 1990, AM J HYPERTENS, V3, P512, DOI 10.1093/ajh/3.6.512; Lopes LR, 2013, HEART, V99, P1800, DOI 10.1136/heartjnl-2013-303939; Marian AJ, 2002, CURR OPIN CARDIOL, V17, P242, DOI 10.1097/00001573-200205000-00006; MARIAN AJ, 1993, LANCET, V342, P1085, DOI 10.1016/0140-6736(93)92064-Z; Maron BJ, 2012, J AM COLL CARDIOL, V60, P705, DOI 10.1016/j.jacc.2012.02.068; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; MATSUSHIMA Y, 1984, EXP ANIM TOKYO, V33, P539, DOI 10.1538/expanim1978.33.4_539; Meng WX, 2014, AM J HYPERTENS, V27, P775, DOI 10.1093/ajh/hpt270; Mulligan MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034586; NEUMANN PE, 1991, P NATL ACAD SCI USA, V88, P5408, DOI 10.1073/pnas.88.12.5408; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; POLIKAR R, 1993, CIRCULATION, V87, P1435, DOI 10.1161/01.CIR.87.5.1435; Prinz C, 2013, EXPERT REV CARDIOVAS, V11, P495, DOI [10.1586/ERC.13.24, 10.1586/erc.13.24]; Rice R, 2010, J MOL CELL CARDIOL, V48, P979, DOI 10.1016/j.yjmcc.2009.11.018; Rosker C, 2011, CIRC RES, V109, P1120, DOI 10.1161/CIRCRESAHA.111.244798; Subasic K, 2013, NURS CLIN N AM, V48, P571, DOI 10.1016/j.cnur.2013.09.001; Sun Y, 2002, AM J PATHOL, V161, P1773, DOI 10.1016/S0002-9440(10)64454-9; Sun Y, 1996, J MOL CELL CARDIOL, V28, P851, DOI 10.1006/jmcc.1996.0080; Swaminathan S, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12106; Talishinsky A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044236; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; Veldink H, 2013, NEPHROL DIAL TRANSPL, V28, P1434, DOI 10.1093/ndt/gfs554; Wang XS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-O7; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WIGLE ED, 1995, CIRCULATION, V92, P1680, DOI 10.1161/01.CIR.92.7.1680; Wooten EC, 2013, CIRC-CARDIOVASC GENE, V6, P10, DOI 10.1161/CIRCGENETICS.112.965277; Zhao TQ, 2011, INT J CARDIOL, V152, P307, DOI 10.1016/j.ijcard.2010.07.024; Zhao WY, 2009, CARDIOVASC PATHOL, V18, P156, DOI 10.1016/j.carpath.2007.12.013	35	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133132	10.1371/journal.pone.0133132	http://dx.doi.org/10.1371/journal.pone.0133132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241864	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942700011
J	Bhowmik, P; Das Gupta, SK				Bhowmik, Priyanka; Das Gupta, Sujoy K.			Biochemical Characterization of a Mycobacteriophage Derived DnaB Ortholog Reveals New Insight into the Evolutionary Origin of DnaB Helicases	PLOS ONE			English	Article							HEPATITIS-C VIRUS; REPLICATIVE HELICASE; ESCHERICHIA-COLI; GENE-41 PROTEIN; MECHANISM; BINDING; TRANSLOCATION; ARCHAEA; TUBERCULOSIS; FAMILIES	The bacterial replicative helicases known as DnaB are considered to be members of the RecA superfamily. All members of this superfamily, including DnaB, have a conserved C-terminal domain, known as the RecA core. We unearthed a series of mycobacteriophage encoded proteins in which the RecA core domain alone was present. These proteins were phylogenetically related to each other and formed a distinct clade within the RecA superfamily. A mycobacteriophage encoded protein, Wildcat Gp80 that roots deep in the DnaB family, was found to possess a core domain having significant sequence homology (Expect value < 10(-5)) with members of this novel cluster. This indicated that Wildcat Gp80, and by extrapolation, other members of the DnaB helicase family, may have evolved from a single domain RecA core polypeptide belonging to this novel group. Biochemical investigations confirmed that Wildcat Gp80 was a helicase. Surprisingly, our investigations also revealed that a thioredoxin tagged truncated version of the protein in which the N-terminal sequences were removed was fully capable of supporting helicase activity, although its ATP dependence properties were different. DnaB helicase activity is thus, primarily a function of the RecA core although additional N-terminal sequences may be necessary for fine tuning its activity and stability. Based on sequence comparison and biochemical studies we propose that DnaB helicases may have evolved from single domain RecA core proteins having helicase activities of their own, through the incorporation of additional N-terminal sequences.	[Bhowmik, Priyanka; Das Gupta, Sujoy K.] Bose Inst, Dept Microbiol, Kolkata 700054, W Bengal, India	Department of Science & Technology (India); Bose Institute	Das Gupta, SK (corresponding author), Bose Inst, Dept Microbiol, P1-12 CIT Scheme VIIM, Kolkata 700054, W Bengal, India.	sujoy@jcbose.ac.in	Gupta, Sujoy K. Das/AAI-5764-2020					Beam CE, 2002, J BACTERIOL, V184, P6836, DOI 10.1128/JB.184.24.6836-6844.2002; Biswas EE, 1999, BIOCHEMISTRY-US, V38, P10919, DOI 10.1021/bi990048t; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; Davey MJ, 2003, CURR BIOL, V13, pR594, DOI 10.1016/S0960-9822(03)00523-2; DiRuggiero J, 1999, J MOL EVOL, V49, P474, DOI 10.1007/PL00006570; DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; DOOLITTLE RF, 1993, SCI AM, V269, P50, DOI 10.1038/scientificamerican1093-50; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Giri N, 2009, J BACTERIOL, V191, P959, DOI 10.1128/JB.00960-08; Haldenby S, 2009, BIOCHEM SOC T, V37, P102, DOI 10.1042/BST0370102; Hatfull GF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003953; Hatfull GF, 2012, ADV VIRUS RES, V82, P179, DOI 10.1016/B978-0-12-394621-8.00015-7; Hatfull GF, 2010, ANNU REV MICROBIOL, V64, P331, DOI 10.1146/annurev.micro.112408.134233; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Henikoff S, 1997, SCIENCE, V278, P609, DOI 10.1126/science.278.5338.609; HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028; Hingorani MM, 1997, P NATL ACAD SCI USA, V94, P5012, DOI 10.1073/pnas.94.10.5012; Homori K, 2000, J BIOL CHEM, V275, P33782; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Itsathitphaisarn O, 2012, CELL, V151, P267, DOI 10.1016/j.cell.2012.09.014; JACOBS WR, 1993, SCIENCE, V260, P819, DOI 10.1126/science.8484123; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; Leipe DD, 2000, GENOME RES, V10, P5; Leipe DD, 1999, NUCLEIC ACIDS RES, V27, P3389, DOI 10.1093/nar/27.17.3389; Levin MK, 1999, J BIOL CHEM, V274, P31839, DOI 10.1074/jbc.274.45.31839; Levin MK, 2002, J BIOL CHEM, V277, P29377, DOI 10.1074/jbc.M112315200; LIU CC, 1981, J BIOL CHEM, V256, P2813; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Makarova KS, 1999, GENOME RES, V9, P608; Mesa P, 2006, J MOL BIOL, V357, P1077, DOI 10.1016/j.jmb.2005.12.027; Mori T, 2002, P NATL ACAD SCI USA, V99, P17203, DOI 10.1073/pnas.262578499; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; Rashid N, 1999, FEBS LETT, V445, P111, DOI 10.1016/S0014-5793(99)00107-6; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saha A, 2005, APPL ENVIRON MICROB, V71, P7334, DOI 10.1128/AEM.71.11.7334-7344.2005; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scherzinger E, 1997, J BIOL CHEM, V272, P30228, DOI 10.1074/jbc.272.48.30228; Selmane T, 1999, FEBS LETT, V446, P30, DOI 10.1016/S0014-5793(99)00181-7; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Soultanas P, 2005, STRUCTURE, V13, P839, DOI 10.1016/j.str.2005.04.006; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; Wang JM, 2004, J STRUCT BIOL, V148, P259, DOI 10.1016/j.jsb.2004.07.003; YOUNG MC, 1994, J MOL BIOL, V235, P1436, DOI 10.1006/jmbi.1994.1099; YOUNG MC, 1994, J MOL BIOL, V235, P1447, DOI 10.1006/jmbi.1994.1100; Zhang H, 2014, FEBS J, V281, P1256, DOI 10.1111/febs.12703; Ziegelin G, 2003, NUCLEIC ACIDS RES, V31, P5917, DOI 10.1093/nar/gkg790	56	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134762	10.1371/journal.pone.0134762	http://dx.doi.org/10.1371/journal.pone.0134762			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237048	gold, Green Submitted, Green Published			2022-12-27	WOS:000358942400038
J	Chen, JJ; Chan, P; Paes, B; Mitchell, I; Li, A; Lanctot, KL				Chen, Jinghan Jenny; Chan, Parco; Paes, Bosco; Mitchell, Ian; Li, Abby; Lanctot, Krista L.		CARESS Investigators	Serious Adverse Events in the Canadian Registry of Children Receiving Palivizumab (CARESS) for Respiratory Syncytial Virus Prevention	PLOS ONE			English	Article							HUMANIZED MONOCLONAL-ANTIBODY; INVESTIGATORS COLLABORATIVE NETWORK; HIGH-RISK; PREMATURE-INFANTS; YOUNG-CHILDREN; SAFETY; HOSPITALIZATIONS; PROPHYLAXIS; INFECTIONS; DISEASE	Objectives To evaluate the safety and tolerability of palivizumab for RSV prophylaxis in high-risk children in everyday practice. Methods High-risk children prophylaxed against RSV infection were recruited into a prospective, observational, Canadian RSV Evaluation Study of Palivizumab (CARESS) registry with active, serious adverse event (SAE) monitoring from 2008 to 2013. SAE reports were systematically collected and assessed for severity and relationship to palivizumab. Data were analyzed by Chi-square or Fisher Exact Tests to examine group differences in proportions. Results 13025 infants received 57392 injections. Hospitalizations for respiratory-related illness (RIH) were reported in 915 patients, and SAEs other than RIH were reported in 52 patients. Of these, 6 (0.05%) patients had a total of 14 hypersensitivity reactions that were deemed possibly or probably related to palivizumab (incidence: 2.8 per 10,000 patient-months). The SAEs of 42 patients were assessed as not related to palivizumab. SAEs in the remaining 4 patients were not classifiable as their records were incomplete. There were no significant demographic predictors of SAE occurrence. Conclusions Under active surveillance, a small proportion of infants in the CARESS registry experienced SAEs that had a potential relationship with palivizumab and these appeared to be unpredictable in terms of onset. Palivizumab appears to be a safe and well-tolerated antibody for RSV prophylaxis in high-risk children in routine practice.	[Chen, Jinghan Jenny; Chan, Parco; Li, Abby; Lanctot, Krista L.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Med Outcomes & Res Econ MORE Res Grp, Toronto, ON, Canada; [Paes, Bosco] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Mitchell, Ian] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; University of Calgary	Lanctot, KL (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Med Outcomes & Res Econ MORE Res Grp, Toronto, ON, Canada.	krista.lanctot@sunnybrook.ca	l, l/GZH-2874-2022; Lanctot, Krista L./AAY-4820-2020; L, L/HGA-1686-2022; Paes, Bosco/AAS-2997-2021	Lanctot, Krista L./0000-0001-7024-6637; Paes, Bosco/0000-0002-3308-2706	AbbVie Canada	AbbVie Canada(AbbVie)	The discussed registry was funded by an investigator-initiated grant from AbbVie Canada; however, AbbVie Canada had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji APB, 2011, DRUG DESENSITIZATION; BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; BENTLEY DL, 1982, NUCLEIC ACIDS RES, V10, P1841, DOI 10.1093/nar/10.6.1841; Collins CL, 2002, J INFECTION, V45, P10, DOI 10.1053/jinf.2001.1016; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2; Geskey JM, 2007, BIOL-TARGETS THER, V1, P33; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; GLEZEN WP, 1981, J PEDIATR-US, V98, P708, DOI 10.1016/S0022-3476(81)80829-3; Groothius JR, 2001, PEDIATR INFECT DIS J, V20, P628, DOI 10.1097/00006454-200106000-00018; Groothuis JR, 2003, EUR J CLIN MICROBIOL, V22, P414, DOI 10.1007/s10096-003-0961-z; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Harding FA, 2010, MABS-AUSTIN, V2, P256, DOI 10.4161/mabs.2.3.11641; Henderson J, 2005, PEDIAT ALLERG IMM-UK, V16, P386, DOI 10.1111/j.1399-3038.2005.00298.x; International Council on harmonisation of technical requirements for pharmaceuticals for human use (ICH), 1998, STAT PRINC CLIN TRIA; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Kleyman K, 2012, MABS-AUSTIN, V4, P392, DOI 10.4161/mabs.19895; Lacaze-Masmonteil T, 2003, DRUG SAFETY, V26, P283, DOI 10.2165/00002018-200326040-00005; Lacaze-Masmonteil T, 2002, PEDIATR PULM, V34, P181, DOI 10.1002/ppul.10175; Langley JM, 1997, J PEDIATR-US, V131, P113, DOI 10.1016/S0022-3476(97)70133-1; Mitchell I, 2011, PEDIATR INFECT DIS J, V30, P651, DOI 10.1097/INF.0b013e31821146f7; Moore TJ, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e53; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Null D, 2005, PEDIATR INFECT DIS J, V24, P1021, DOI 10.1097/01.inf.0000183938.33484.bd; Pinquier D, 2009, ARCH PEDIATRIE, V16, P1443, DOI 10.1016/j.arcped.2009.08.008; PRESS EM, 1970, BIOCHEM J, V117, P641, DOI 10.1042/bj1170641; Regnier SA, 2013, PEDIATR INFECT DIS J, V32, P820, DOI 10.1097/INF.0b013e31829061e8; Saez-Llorens X, 1998, PEDIATR INFECT DIS J, V17, P787, DOI 10.1097/00006454-199809000-00007; Saji T, 2005, PEDIATR INT, V47, P397, DOI 10.1111/j.1442-200x.2005.02089.x; Sampalis JS, 2003, J PEDIATR-US, V143, pS150, DOI 10.1067/S0022-3476(03)00513-4; Simoes EAF, 2007, J PEDIATR-US, V151, P34, DOI 10.1016/j.jpeds.2007.02.032; Simon A, 2011, KLIN PADIATR, V223, P292, DOI 10.1055/s-0030-1270515; Subramanian KNS, 1998, PEDIATR INFECT DIS J, V17, P110, DOI 10.1097/00006454-199802000-00006; Szabo SM, 2012, PAEDIATR RESPIR REV, V13, pS9; TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P5194, DOI 10.1073/pnas.81.16.5194; The Uppsala Monitoring Centre, 2012, US WHO UMC SYST STAN; Thorburn K, 2009, ARCH DIS CHILD, V94, P99, DOI 10.1136/adc.2008.139188; Turti Tatyana V, 2012, BMC Res Notes, V5, P484, DOI 10.1186/1756-0500-5-484; US Department of Health and Human Services, 2007, GUID IND TOX GRAD SC; WANG EEL, 1995, J PEDIATR-US, V126, P212, DOI 10.1016/S0022-3476(95)70547-3; Wegzyn C, INFECT DIS THER; Welliver RC, 2010, CURR MED RES OPIN, V26, P2175, DOI 10.1185/03007995.2010.505126; Zomer-Kooijker K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087162	44	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134711	10.1371/journal.pone.0134711	http://dx.doi.org/10.1371/journal.pone.0134711			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237402	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942400034
J	Lin, YF; Chen, G; Fu, Z; Ma, L; Li, WR				Lin, Yifan; Chen, Gui; Fu, Zhen; Ma, Lian; Li, Weiran			Cone-Beam Computed Tomography Assessment of Lower Facial Asymmetry in Unilateral Cleft Lip and Palate and Non-Cleft Patients with Class III Skeletal Relationship	PLOS ONE			English	Article							TEMPOROMANDIBULAR-JOINT; MANDIBULAR ASYMMETRY; CRANIOFACIAL MORPHOLOGY; CEPHALOMETRIC RADIOGRAPHY; CONDYLAR POSITION; NORMAL OCCLUSION; DIVISION 1; INDIVIDUALS; ACCURACY; CHILDREN	Introduction To evaluate, using cone-beam computed tomography (CBCT), both the condylar-fossa relationships and the mandibular and condylar asymmetries between unilateral cleft lip and palate (UCLP) patients and non-cleft patients with class III skeletal relationship, and to investigate the factors of asymmetry contributing to chin deviation. Methods The UCLP and non-cleft groups consisted of 30 and 40 subjects, respectively, in mixed dentition with class III skeletal relationships. Condylar-fossa relationships and the dimensional and positional asymmetries of the condyles and mandibles were examined using CBCT. Intra-group differences were compared between two sides in both groups using a paired t-test. Furthermore, correlations between each measurement and chin deviation were assessed. Results It was observed that 90% of UCLP and 67.5% of non-cleft subjects had both condyles centered, and no significant asymmetry was found. The axial angle and the condylar center distances to the midsagittal plane were significantly greater on the cleft side than on the non-cleft side (P=0.001 and P=0.028, respectively) and were positively correlated with chin deviation in the UCLP group. Except for a larger gonial angle on the cleft side, the two groups presented with consistent asymmetries showing shorter mandibular bodies and total mandibular lengths on the cleft (deviated) side. The average chin deviation was 1.63 mm to the cleft side, and the average absolute chin deviation was significantly greater in the UCLP group than in the non-cleft group (P=0.037). Conclusion Compared with non-cleft subjects with similar class III skeletal relationships, the subjects with UCLP showed more severe lower facial asymmetry. The subjects with UCLP presented with more asymmetrical positions and rotations of the condyles on axial slices, which were positively correlated with chin deviation.	[Lin, Yifan; Chen, Gui; Fu, Zhen; Li, Weiran] Peking Univ, Dept Orthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China; [Ma, Lian] Peking Univ, Sch & Hosp Stomatol, Dept Oral Maxillofacial Surg, Beijing 100871, Peoples R China	Peking University; Peking University	Li, WR (corresponding author), Peking Univ, Dept Orthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.	weiranli2003@163.com	Li, weiran/R-6769-2019	Lin, Yifan/0000-0002-2614-9159				Abad-Santamaria L, 2014, IRISH J MED SCI, V183, P357, DOI 10.1007/s11845-013-1020-0; Baccetti T., 2005, SEMIN ORTHOD, V11, P119, DOI DOI 10.1053/J.S0D0.2005.04.005; BERGERSEN EO, 1980, ANGLE ORTHOD, V50, P230; BISHARA SE, 1974, INT J ORAL MAXILLOF, V3, P65, DOI 10.1016/S0300-9785(74)80081-5; Celikoglu M, 2013, AM J ORTHOD DENTOFAC, V144, P691, DOI 10.1016/j.ajodo.2013.07.009; Choi YK, 2013, KOREAN J ORTHOD, V43, P113, DOI 10.4041/kjod.2013.43.3.113; Dahlberg G, 1940, STAT METHODS MED BIO; Damstra J, 2012, CLIN ORAL INVEST, V16, P285, DOI 10.1007/s00784-011-0512-4; De Vos W, 2009, INT J ORAL MAX SURG, V38, P609, DOI 10.1016/j.ijom.2009.02.028; Dogan S, 2006, BRIT J ORAL MAX SURG, V44, P28, DOI 10.1016/j.bjoms.2005.07.023; Vitral RWF, 2011, AM J ORTHOD DENTOFAC, V140, P18, DOI 10.1016/j.ajodo.2009.07.030; Fraga MR, 2013, MED SCI MONITOR, V19, P903, DOI 10.12659/MSM.889528; Haraguchi S, 2002, ANGLE ORTHOD, V72, P28; Hassan B, 2009, EUR J ORTHODONT, V31, P129, DOI 10.1093/ejo/cjn088; Hilgers ML, 2005, AM J ORTHOD DENTOFAC, V128, P803, DOI 10.1016/j.ajodo.2005.08.034; Honey OB, 2007, AM J ORTHOD DENTOFAC, V132, P429, DOI 10.1016/j.ajodo.2005.10.032; Hwang HS, 2006, AM J ORTHOD DENTOFAC, V130, P779, DOI 10.1016/j.ajodo.2005.02.021; Ikeda K, 2009, AM J ORTHOD DENTOFAC, V135, P495, DOI 10.1016/j.ajodo.2007.05.021; Jena AK, 2011, ANGLE ORTHOD, V81, P872, DOI 10.2319/110610-646.1; Kamelchuk LS, 1996, CRANIO, V14, P23, DOI 10.1080/08869634.1996.11745945; Kim KS, 2013, KOREAN J ORTHOD, V43, P168, DOI 10.4041/kjod.2013.43.4.168; Kokich VG, 2010, AM J ORTHOD DENTOFAC, V137, pS16, DOI 10.1016/j.ajodo.2010.02.014; Kurt G, 2010, EUR J ORTHODONT, V32, P19, DOI 10.1093/ejo/cjp063; Kwon TG, 2006, INT J ORAL MAX SURG, V35, P43, DOI 10.1016/j.ijom.2005.04.006; Kyrkanides S, 2000, CLEFT PALATE-CRAN J, V37, P556, DOI 10.1597/1545-1569(2000)037<0556:CBAFSA>2.0.CO;2; KYRKANIDES S, 1995, CLEFT PALATE-CRAN J, V32, P428, DOI 10.1597/1545-1569(1995)032<0428:SAOTNC>2.3.CO;2; Lagravere MO, 2008, AM J ORTHOD DENTOFAC, V134, P112, DOI 10.1016/j.ajodo.2006.08.024; Laspos CP, 1997, CLEFT PALATE-CRAN J, V34, P410, DOI 10.1597/1545-1569(1997)034<0410:MAINAU>2.3.CO;2; Laspos CP, 1997, CLEFT PALATE-CRAN J, V34, P232, DOI 10.1597/1545-1569(1997)034<0232:MAMAII>2.3.CO;2; MARS M, 1992, CLEFT PALATE-CRAN J, V29, P405, DOI 10.1597/1545-1569(1992)029<0405:ASCISO>2.3.CO;2; Michiels G, 1994, Int J Adult Orthodon Orthognath Surg, V9, P95; MOLSTED K, 1990, CLEFT PALATE J, V27, P184, DOI 10.1597/1545-1569(1990)027<0184:AOTMIC>2.3.CO;2; Ozturk Y, 1996, CLEFT PALATE-CRAN J, V33, P32, DOI 10.1597/1545-1569_1996_033_0032_eocmic_2.3.co_2; PIRTTINIEMI PM, 1994, AM J ORTHOD DENTOFAC, V106, P191, DOI 10.1016/S0889-5406(94)70038-9; PULLINGER A, 1986, ORAL SURG ORAL MED O, V62, P719, DOI 10.1016/0030-4220(86)90270-7; Rodrigues AF, 2009, AM J ORTHOD DENTOFAC, V136, P199, DOI 10.1016/j.ajodo.2007.07.033; Ross R B, 1987, Cleft Palate J, V24, P5; Ross RB, 1987, CLEFT PALATE J, V24, P24; Ross RB, 1987, CLEFT PALATE J, V24, P71; Severt T R, 1997, Int J Adult Orthodon Orthognath Surg, V12, P171; Shetye PR, 2006, ANGLE ORTHOD, V76, P810, DOI 10.2319/032505-121; SMAHEL Z, 1986, CLEFT PALATE J, V23, P225; Smahel Z, 1998, CLEFT PALATE-CRAN J, V35, P240, DOI 10.1597/1545-1569(1998)035<0240:CICDDT>2.3.CO;2; Sukovic P, 2003, Orthod Craniofac Res, V6 Suppl 1, P31, DOI 10.1034/j.1600-0544.2003.259.x; Suri S, 2008, AM J ORTHOD DENTOFAC, V134, P418, DOI 10.1016/j.ajodo.2006.09.065; Trpkova B, 2003, AM J ORTHOD DENTOFAC, V123, P512, DOI 10.1016/S0889-5406(02)57034-7; Veli I, 2011, KOREAN J ORTHOD, V41, P431, DOI 10.4041/kjod.2011.41.6.431; Vitral RWF, 2002, AM J ORTHOD DENTOFAC, V121, P369, DOI 10.1067/mod.2002.121664	48	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0130235	10.1371/journal.pone.0130235	http://dx.doi.org/10.1371/journal.pone.0130235			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237311	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942400005
J	Odhiambo, JA; Norton, U; Ashilenje, D; Omondi, EC; Norton, JB				Odhiambo, Judith A.; Norton, Urszula; Ashilenje, Dennis; Omondi, Emmanuel C.; Norton, Jay B.			Weed Dynamics during Transition to Conservation Agriculture in Western Kenya Maize Production	PLOS ONE			English	Article							SMALLHOLDER FARMERS; TILLAGE; YIELD; MANAGEMENT; ADOPTION; ECOLOGY; GROWTH; CROP	Weed competition is a significant problem in maize (Zea mays, L.) production in Sub-Saharan Africa. Better understanding of weed management and costs in maize inter-cropped with beans (Phaseolus vulgaris, L.) during transition to conservation agricultural systems is needed. Changes in weed population and maize growth were assessed for a period of three years at Bungoma where crops are grown twice per year and at Trans-Nzoia where crops are grown once per year. Treatments included three tillage practices: minimum (MT), no-till (NT) and conventional (CT) applied to three cropping systems: continuous maize/bean intercropping (TYPICAL), maize/bean intercropping with relayed mucuna after bean harvest (RELAY) and maize, bean and mucuna planted in a strip intercropping arrangement (STRIP). Herbicides were used in NT, shallow hand hoeing and herbicides were used in MT and deep hoeing with no herbicides were used in CT. Weed and maize performance in the maize phase of each cropping system were assessed at both locations and costs of weed control were estimated at Manor House only. Weed density of grass and forb species declined significantly under MT and NT at Manor House and of grass species only at Mabanga. The greatest declines of more than 50% were observed as early as within one year of the transition to MT and NT in STRIP and TYPICAL cropping systems at Manor House. Transitioning to conservation based systems resulted in a decline of four out of five most dominant weed species. At the same time, no negative impact of MT or NT on maize growth was observed. Corresponding costs of weed management were reduced by $148.40 ha(-1) in MT and $149.60 ha(-1) in NT compared with CT. In conclusion, farmers can benefit from effective and less expensive weed management alternatives early in the process of transitioning to reduced tillage operations.	[Odhiambo, Judith A.; Norton, Urszula] Univ Wyoming, Dept Plant Sci, Dept 3354, Laramie, WY 82071 USA; [Norton, Urszula] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA; [Ashilenje, Dennis] Manor House Agr Ctr, Kitale 30200, Kenya; [Omondi, Emmanuel C.; Norton, Jay B.] Dept 3354, Dept Ecosyst Sci & Management, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming	Norton, U (corresponding author), Univ Wyoming, Dept Plant Sci, Dept 3354, 1000 E Univ Ave, Laramie, WY 82071 USA.	unorton@uwyo.edu	Norton, Urszula/AAX-6303-2021	Omondi, Emmanuel/0000-0002-3870-0809	United States Agency for International Development (USAID) through the Sustainable Agriculture and Natural Resource Management Collaborative Research Support Program (SANREM-CRSP) [EPP-A-00-04-00013-00]; Schlumberger Foundation Faculty for the Future Fellowship	United States Agency for International Development (USAID) through the Sustainable Agriculture and Natural Resource Management Collaborative Research Support Program (SANREM-CRSP)(United States Agency for International Development (USAID)); Schlumberger Foundation Faculty for the Future Fellowship(Schlumberger)	This research was funded by the United States Agency for International Development (USAID) through the Sustainable Agriculture and Natural Resource Management Collaborative Research Support Program (SANREM-CRSP) grant number EPP-A-00-04-00013-00 and a Schlumberger Foundation Faculty for the Future Fellowship. The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikins S. H. M., 2012, Agriculture and Biology Journal of North America, V3, P25, DOI 10.5251/abjna.2012.3.1.25.30; Andersson JA, 2014, AGR ECOSYST ENVIRON, V187, P116, DOI 10.1016/j.agee.2013.08.008; Baudron F, 2012, J DEV STUD, V48, P393, DOI 10.1080/00220388.2011.587509; Carsky RJ, 2001, SUSTAINING SOIL FERT, V58, P111, DOI 10.2136/SSSASPECPUB58.CH6; Chauhan BS, 2006, AUST J EXP AGR, V46, P1557, DOI 10.1071/EA05291; Chauhan BS, 2010, WEED RES, V50, P553, DOI 10.1111/j.1365-3180.2010.00807.x; Chikoye D., 2007, 16 INT PLANT PROTECT, P652; Corbeels M, 2014, AGR ECOSYST ENVIRON, V187, P155, DOI 10.1016/j.agee.2013.10.011; Dixit PN, 2011, EXP AGR, V47, P317, DOI 10.1017/S0014479710000773; Giller KE, 2011, FIELD CROP RES, V124, P468, DOI 10.1016/j.fcr.2011.04.010; Gopal R, 2010, TECHNICAL B INT MAIZ; Govaerts B, 2009, CRIT REV PLANT SCI, V28, P97, DOI 10.1080/07352680902776358; HALL MR, 1992, WEED SCI, V40, P441, DOI 10.1017/S0043174500051882; Ikuenobe CE, 2003, WEED RES, V43, P199, DOI 10.1046/j.1365-3180.2003.00334.x; Islam MR, 2011, CROP PASTURE SCI, V62, P374, DOI 10.1071/CP10244; Jaetzold R, 2005, FARM MANAGEMENT HDB, V2; Jordan-Meille L, 2004, PLANT SOIL, V265, P75, DOI 10.1007/s11104-005-0695-z; Kabamba H., 2009, Journal of Animal and Plant Sciences (JAPS), V3, P205; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Mandumbu R., 2012, Archives of Phytopathology and Plant Protection, V45, P2165, DOI 10.1080/03235408.2012.722842; Mashingaidze N, 2012, SOIL TILL RES, V124, P102, DOI 10.1016/j.still.2012.05.008; Mokhtarpour H., 2010, Communications in Biometry and Crop Science, V5, P19; Mugalavai EM, 2008, AGR FOREST METEOROL, V148, P1123, DOI 10.1016/j.agrformet.2008.02.013; Ndakidemi PA, 2006, AFR J BIOTECHNOL, V5, P2526; Ngome AFE, 2011, J AGR RURAL DEV TROP, V112, P1; Ngwira AR, 2013, RENEW AGR FOOD SYST, V28, P350, DOI 10.1017/S1742170512000257; Nyamangara J, 2014, AGR ECOSYST ENVIRON, V187, P146, DOI 10.1016/j.agee.2013.10.005; Odhiambo A., 2014, INT J PLANT SOIL SCI, V5, P127, DOI 10.9734/IJPSS/2015/14476; Odhiambo J. A., 2011, Archives of Phytopathology and Plant Protection, V44, P158, DOI 10.1080/03235400902952194; Pannell DJ, 2014, AGR ECOSYST ENVIRON, V187, P52, DOI 10.1016/j.agee.2013.10.014; R Core Team, 2021, R LANGUAGE ENV STAT; Riemens MM, 2007, WEED RES, V47, P442, DOI 10.1111/j.1365-3180.2007.00582.x; Rugare J.T., 2013, GLOB ADV RES J AGR S, V2, P231; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; Schlenker W, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014010; Thierfelder C, 2010, J CROP IMPROV, V24, P113, DOI 10.1080/15427520903558484; WRUCKE MA, 1985, WEED SCI, V33, P853, DOI 10.1017/S0043174500083491	37	12	12	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0133976	10.1371/journal.pone.0133976	http://dx.doi.org/10.1371/journal.pone.0133976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237404	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942400013
J	Al-Hamzawi, AO; Bruffaerts, R; Bromet, EJ; AlKhafaji, AM; Kessler, RC				Al-Hamzawi, Ali Obaid; Bruffaerts, Ronny; Bromet, Evelyn J.; AlKhafaji, Abdulzahra Mohammed; Kessler, Ronald C.			The Epidemiology of Major Depressive Episode in the Iraqi General Population	PLOS ONE			English	Article							MENTAL-HEALTH SURVEY; PSYCHIATRIC MORBIDITY; CHRONIC DISEASES; PREVALENCE; DISORDERS; WORLD; SERVICES; DISABILITY; WAR; ORGANIZATION	Objective To assess the prevalence, symptom severity, functional impairment, and treatment of major depressive episode (MDE) in the Iraqi general population. Methods The Iraq Mental Health Survey is a nationally representative face-to-face survey of 4,332 non-institutionalized adults aged 18+ interviewed in 2006-2007 as part of the WHO World Mental Health Surveys. Prevalence and correlates of DSM-IV MDE were determined with the WHO Composite International Diagnostic Interview (CIDI). Findings Lifetime and 12-month prevalence of MDE were 7.4% and 4.0%, respectively. Close to half (46%) of the 12-month MDE cases were severe/very severe. MDE was more common among women and those previously married. Median age of onset was 25.2. Only one-seventh of 12-month MDE cases received treatment despite being associated with very substantial role impairment (on average 70 days out of role in the past year). Conclusions MDE is a commonly occurring disorder in the Iraqi general population and is associated with considerable disability and low treatment. Efforts are needed to decrease the barriers to treatment and to educate general medical providers in Iraq about the recognition and treatment of depression.	[Al-Hamzawi, Ali Obaid; AlKhafaji, Abdulzahra Mohammed] Al Qadisia Univ, Coll Med, Diwania, Iraq; [Bruffaerts, Ronny] KULeuven UPC KUL, Univ Psychiat Ctr, Leuven, Belgium; [Bromet, Evelyn J.] SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA; [Kessler, Ronald C.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	University of Al-Qadisiyah; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; Harvard Medical School	Kessler, RC (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.	kessler@hcp.med.harvard.edu	Al-Hamzawi, Ali/T-3095-2017; BRUFFAERTS, RONNY/AAA-2364-2021	Al-Hamzawi, Ali/0000-0002-1241-0627; BRUFFAERTS, RONNY/0000-0002-0330-3694; Al-Hamzawi, Ali/0000-0002-8494-3633	United States National Institute of Mental Health [R01MH070884]; Mental Health Burden Study [HHSN271200700030C]; John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; US Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]; Fogarty International Center [FIRCA R03-TW006481]; Pan American Health Organization; Eli Lilly & Company Foundation; Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline; Bristol-Myers Squibb; Shire; Iraqi IMHS team; Japanese Fund through United Nations Development Group Iraq Trust Fund (UNDG ITF); European Fund through United Nations Development Group Iraq Trust Fund (UNDG ITF); FOGARTY INTERNATIONAL CENTER [R03TW006481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R13MH066849, R01MH069864, R01MH070884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016558] Funding Source: NIH RePORTER	United States National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Mental Health Burden Study; John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Pan American Health Organization; Eli Lilly & Company Foundation(Eli Lilly); Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline(GlaxoSmithKline); Bristol-Myers Squibb(Bristol-Myers Squibb); Shire; Iraqi IMHS team; Japanese Fund through United Nations Development Group Iraq Trust Fund (UNDG ITF); European Fund through United Nations Development Group Iraq Trust Fund (UNDG ITF); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This report is carried out in conjunction with the World Health Organization World Mental Health (WMH) Survey Initiative. The authors thank the WMH staff for assistance with instrumentation, fieldwork, and data analysis. These activities were supported by the United States National Institute of Mental Health (R01MH070884), the Mental Health Burden Study: Contract number HHSN271200700030C, the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, the Eli Lilly & Company Foundation, Ortho-McNeil Pharmaceutical, Inc., GlaxoSmithKline, Bristol-Myers Squibb, and Shire. A complete list of WMH publications can be found at http://www.hcp.med.harvard.edu/wmh/. Implementation of the Iraq Mental Health Survey (IMHS) and data entry were carried out by the staff of the Iraqi MOH and MOP with direct support from the Iraqi IMHS team with funding from both the Japanese and European Funds through United Nations Development Group Iraq Trust Fund (UNDG ITF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Hilfi TK, 2013, LANCET, V381, P939, DOI 10.1016/S0140-6736(13)60320-7; Al-Hamzawi AO, 2014, J PSYCHIATR RES, V53, P23, DOI 10.1016/j.jpsychires.2014.02.006; Al-Krenawi A, 2000, COMMUNITY MENT HLT J, V36, P501, DOI 10.1023/A:1001963714338; Alhasnawi S, 2009, WORLD PSYCHIATRY, V8, P97; AlMarri TSK, 2009, INT J PSYCHOL, V44, P222, DOI 10.1080/00207590801888752; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; American Psychiatric Association, 1994, DIAGN STAT MAN; Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; Atkinson M, 1997, AM J PSYCHIAT, V154, P99; Bener A, 2011, INT J SOC PSYCHIATR, V57, P480, DOI 10.1177/0020764010374415; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Cardozo BL, 2004, JAMA-J AM MED ASSOC, V292, P575, DOI 10.1001/jama.292.5.575; Daradkeh TK, 2002, J AFFECT DISORDERS, V72, P167, DOI 10.1016/S0165-0327(01)00452-9; de Graaf R, 2000, AM J EPIDEMIOL, V152, P1039, DOI 10.1093/aje/152.11.1039; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Dwairy M, 2002, CLIN PSYCHOL REV, V22, P343, DOI 10.1016/S0272-7358(01)00100-3; EATON WW, 1992, AM J EPIDEMIOL, V135, P1051, DOI 10.1093/oxfordjournals.aje.a116399; El-Islam M. F., 1982, TRANSCULT PSYCHIATRY, V19, P5, DOI DOI 10.1177/136346158201900101; Eloul Liyam, 2009, Sultan Qaboos Univ Med J, V9, P5; Farhood L, 2006, J TRANSCULT NURS, V17, P333, DOI 10.1177/1043659606291549; Farhood LF, 2012, SOC PSYCH PSYCH EPID, V47, P639, DOI 10.1007/s00127-011-0368-6; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Harkness J., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P91; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Heeringa S. G., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P14; Hicks MHR, 2011, LANCET, V378, P906, DOI 10.1016/S0140-6736(11)61023-4; Institute Research Triangle, 2005, SUDAAN; Jaalouk D, 2012, SOC PSYCH PSYCH EPID, V47, P1727, DOI 10.1007/s00127-012-0487-8; Jones GW, 1997, POPUL DEV REV, V23, P95, DOI 10.2307/2137462; Karam EG, 2012, PSYCHOL MED, V42, P2109, DOI 10.1017/S0033291712000268; Karam EG, 2006, LANCET, V367, P1000, DOI 10.1016/S0140-6736(06)68427-4; Karam EG, 1998, EUR ARCH PSY CLIN N, V248, P225, DOI 10.1007/s004060050042; Karam EG, 2008, PLOS MED, V5, P579, DOI 10.1371/journal.pmed.0050061; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P789, DOI 10.1001/archpsyc.60.8.789; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kessler RC, 2010, DEPRESS ANXIETY, V27, P351, DOI 10.1002/da.20634; Khatwa S A, 1999, J Egypt Public Health Assoc, V74, P333; Kilzieh N, 2008, INT J PSYCHIAT MED, V38, P169, DOI 10.2190/PM.38.2.d; Leon AC, 1997, INT J PSYCHIAT MED, V27, P93, DOI 10.2190/T8EM-C8YH-373N-1UWD; Modabernia MJ, 2008, CLIN PRACTICE EPIDEM, V4, P1; Mokdad AH, 2014, LANCET, V383, P309, DOI 10.1016/S0140-6736(13)62189-3; Morina N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022140; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Narimani M, 2011, J PSYCHIATR MENT HLT, V18, P368, DOI 10.1111/j.1365-2850.2011.01700.x; Nock MK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000123; Noorbala AA, 2004, BRIT J PSYCHIAT, V184, P70, DOI 10.1192/bjp.184.1.70; Noorbala AA, 2012, ARCH IRAN MED, V15, P201, DOI 012154/AIM.005; Pennell B. E., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P33; Priebe S, 2010, ARCH GEN PSYCHIAT, V67, P518, DOI 10.1001/archgenpsychiatry.2010.37; Rush A.J., 2000, INT J METH PSYCH RES, V9, P45, DOI [DOI 10.1002/MPR.79, 10.1002/mpr.79]; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Von Korff M, 2008, J CLIN EPIDEMIOL, V61, P1132, DOI 10.1016/j.jclinepi.2007.12.009; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; WHO, 2011, COUNTR HLTH INF SYST; WHO International Consortium in Psychiatric Epidemiology, B WORLD HTLH ORG, V78, P413; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1	61	13	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0131937	10.1371/journal.pone.0131937	http://dx.doi.org/10.1371/journal.pone.0131937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230265	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400011
J	Choi, HJ; Song, JM; Bondy, BJ; Compans, RW; Kang, SM; Prausnitz, MR				Choi, Hyo-Jick; Song, Jae-Min; Bondy, Brian J.; Compans, Richard W.; Kang, Sang-Moo; Prausnitz, Mark R.			Effect of Osmotic Pressure on the Stability of Whole Inactivated Influenza Vaccine for Coating on Microneedles	PLOS ONE			English	Article							ESCHERICHIA-COLI; A VIRUS; WATER PERMEABILITY; BILAYER THICKNESS; MOLECULAR-BIOLOGY; PROTEIN FUNCTION; LIPID-MEMBRANES; MATRIX PROTEIN; DELIVERY; VESICLES	Enveloped virus vaccines can be damaged by high osmotic strength solutions, such as those used to protect the vaccine antigen during drying, which contain high concentrations of sugars. We therefore studied shrinkage and activity loss of whole inactivated influenza virus in hyperosmotic solutions and used those findings to improve vaccine coating of microneedle patches for influenza vaccination. Using stopped-flow light scattering analysis, we found that the virus underwent an initial shrinkage on the order of 10% by volume within 5 s upon exposure to a hyperosmotic stress difference of 217 milliosmolarity. During this shrinkage, the virus envelope had very low osmotic water permeability (1-6x10(-4) cm s(-1)) and high Arrhenius activation energy (E-a = 15.0 kcal mol(-1)), indicating that the water molecules diffused through the viral lipid membranes. After a quasi-stable state of approximately 20 s to 2 min, depending on the species and hypertonic osmotic strength difference of disaccharides, there was a second phase of viral shrinkage. At the highest osmotic strengths, this led to an undulating light scattering profile that appeared to be related to perturbation of the viral envelope resulting in loss of virus activity, as determined by in vitro hemagglutination measurements and in vivo immunogenicity studies in mice. Addition of carboxymethyl cellulose effectively prevented vaccine activity loss in vitro and in vivo, believed to be due to increasing the viscosity of concentrated sugar solution and thereby reducing osmotic stress during coating of microneedles. These results suggest that hyperosmotic solutions can cause biphasic shrinkage of whole inactivated influenza virus which can damage vaccine activity at high osmotic strength and that addition of a viscosity enhancer to the vaccine coating solution can prevent osmotically driven damage and thereby enable preparation of stable microneedle coating formulations for vaccination.	[Choi, Hyo-Jick; Bondy, Brian J.; Prausnitz, Mark R.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Choi, Hyo-Jick] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada; [Song, Jae-Min] Sungshin Womens Univ, Dept Global Med Sci, Seoul, South Korea; [Compans, Richard W.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Kang, Sang-Moo] Georgia Inst Technol, Ctr Inflammat Immun, Atlanta, GA 30332 USA; [Kang, Sang-Moo] Georgia Inst Technol, Infect & Dept Biol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University of Alberta; Sungshin Women's University; Emory University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Prausnitz, MR (corresponding author), Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.	prausnitz@gatech.edu		Choi, Hyo-Jick/0000-0001-8233-5864; Prausnitz, Mark/0000-0002-9076-8448	National Institutes of Health (NIH) [EB006369, EB012495, AI0680003, AI105170, AI093772]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105170, R01AI093772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB012495, R01EB006369] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was financially supported by National Institutes of Health (NIH) grants EB006369 and EB012495 (M.R.P.) and AI0680003 (R.W.C.), and AI105170 and AI093772 (S.M.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zahrani S, 2012, EXPERT OPIN DRUG DEL, V9, P541, DOI 10.1517/17425247.2012.676038; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; BARNHART ER, 1975, VIROLOGY, V66, P563, DOI 10.1016/0042-6822(75)90228-7; BAYER ME, 1967, J BACTERIOL, V93, P1104, DOI 10.1128/JB.93.3.1104-1112.1967; Biebl R, 2009, J MAR BIOL ASSOC UK, V31, P307; BITTMAN R, 1976, BIOCHIM BIOPHYS ACTA, V433, P63, DOI 10.1016/0005-2736(76)90178-4; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; Borgnia MJ, 2001, P NATL ACAD SCI USA, V98, P2888, DOI 10.1073/pnas.051628098; BOROSKE E, 1981, BIOPHYS J, V34, P95, DOI 10.1016/S0006-3495(81)84839-4; Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107; CASS A, 1967, J GEN PHYSIOL, V50, P1765, DOI 10.1085/jgp.50.6.1765; Chen X, 2011, J CONTROL RELEASE, V152, P349, DOI 10.1016/j.jconrel.2011.02.026; Choi HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066316; Choi HJ, 2013, J CONTROL RELEASE, V166, P159, DOI 10.1016/j.jconrel.2012.12.002; Choi HJ, 2012, BIOMATERIALS, V33, P3756, DOI 10.1016/j.biomaterials.2012.01.054; CITOVSKY V, 1985, J BIOL CHEM, V260, P2072; COCKING EC, 1972, ANN REV PLANT PHYSIO, V23, P29, DOI 10.1146/annurev.pp.23.060172.000333; COLWELL WM, 1975, AVIAN DIS, V19, P781, DOI 10.2307/1589191; CORTESE JD, 1989, P NATL ACAD SCI USA, V86, P5773, DOI 10.1073/pnas.86.15.5773; Crowe JH, 2001, CRYOBIOLOGY, V43, P89, DOI 10.1006/cryo.2001.2353; CROWE LM, 1986, BIOCHIM BIOPHYS ACTA, V861, P131, DOI 10.1016/0005-2736(86)90411-6; DUWE HP, 1989, ANGEW MAKROMOL CHEM, V166, P1, DOI 10.1002/apmc.1989.051660101; Edens C, 2013, VACCINE, V31, P3403, DOI 10.1016/j.vaccine.2012.09.062; ELLIOTT JR, 1983, BIOCHIM BIOPHYS ACTA, V735, P95, DOI 10.1016/0005-2736(83)90264-X; FETTIPLACE R, 1980, PHYSIOL REV, V60, P510, DOI 10.1152/physrev.1980.60.2.510; FUJIYOSHI Y, 1994, EMBO J, V13, P318, DOI 10.1002/j.1460-2075.1994.tb06264.x; Gill HS, 2007, J CONTROL RELEASE, V117, P227, DOI 10.1016/j.jconrel.2006.10.017; Hackl W, 1998, PHYS REV LETT, V80, P1786, DOI 10.1103/PhysRevLett.80.1786; Helfer E, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021904; HELLEBUST JA, 1976, ANNU REV PLANT PHYS, V27, P485, DOI 10.1146/annurev.pp.27.060176.002413; HENDRY BM, 1978, BIOCHIM BIOPHYS ACTA, V513, P106, DOI 10.1016/0005-2736(78)90116-5; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Ivanovska IL, 2004, P NATL ACAD SCI USA, V101, P7600, DOI 10.1073/pnas.0308198101; Jensen MO, 2004, BBA-BIOMEMBRANES, V1666, P205, DOI 10.1016/j.bbamem.2004.06.009; Killian JA, 1998, BBA-REV BIOMEMBRANES, V1376, P401, DOI 10.1016/S0304-4157(98)00017-3; Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005; Kim YC, 2010, J CONTROL RELEASE, V142, P187, DOI 10.1016/j.jconrel.2009.10.013; Knaysi G, 1951, BACTERIAL PHYSL, P62; Kommareddy S, 2012, J PHARM SCI-US, V101, P1021, DOI 10.1002/jps.23019; Kunitz M, 1926, J GEN PHYSIOL, V9, P715, DOI 10.1085/jgp.9.6.715; LAMB RA, 1983, ANNU REV BIOCHEM, V52, P467, DOI 10.1146/annurev.bi.52.070183.002343; LATIMER P, 1972, BIOPHYS J, V12, P764, DOI 10.1016/S0006-3495(72)86120-4; LERUDULIER D, 1984, SCIENCE, V224, P1064, DOI 10.1126/science.224.4653.1064; Limozin L, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.168103; Lodish H, 2000, MOL CELL BIOL, V4th, P633; Loeb J, 1921, J GEN PHYSIOL, V4, P97, DOI 10.1085/jgp.4.1.97; LUCY JA, 1986, FEBS LETT, V199, P1, DOI 10.1016/0014-5793(86)81213-3; Pettis RJ, 2012, THER DELIV, V3, P357, DOI 10.4155/TDE.12.13; Powl AM, 2007, CURR TOP MEMBR, V58, P151, DOI 10.1016/S1063-5823(06)58006-8; PRITZEN C, 1988, BIOSCIENCE REP, V8, P55, DOI 10.1007/BF01128972; Quan FS, 2008, J VIROL, V82, P1350, DOI 10.1128/JVI.01615-07; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Quan FS, 2010, J VIROL, V84, P7760, DOI 10.1128/JVI.01849-09; Roberts PC, 1998, VIROLOGY, V240, P127, DOI 10.1006/viro.1997.8916; Roos WH, 2007, CELL MOL LIFE SCI, V64, P1484, DOI 10.1007/s00018-007-6451-1; Ruigrok RWH, 2000, VIROLOGY, V267, P289, DOI 10.1006/viro.1999.0134; Saluja V, 2010, J CONTROL RELEASE, V144, P127, DOI 10.1016/j.jconrel.2010.02.025; Scala AR, 1956, REVERSIBLE EFFECT HY, P289; SCHEIE PO, 1969, J BACTERIOL, V98, P335, DOI 10.1128/JB.98.2.335-340.1969; SCHULZE IT, 1972, VIROLOGY, V47, P181, DOI 10.1016/0042-6822(72)90251-6; Schwarz H, 1995, MICROBIOL-UK, V141, P3161, DOI 10.1099/13500872-141-12-3161; Sha BD, 1997, NAT STRUCT BIOL, V4, P239, DOI 10.1038/nsb0397-239; Sherman JM, 1934, J BACTERIOL, V27, P341, DOI 10.1128/JB.27.4.341-348.1934; Solon J, 2005, J GEN VIROL, V86, P3357, DOI 10.1099/vir.0.81129-0; Stauch O, 2002, BIOMACROMOLECULES, V3, P324, DOI 10.1021/bm015613y; Sullivan SP, 2010, NAT MED, V16, P915, DOI 10.1038/nm.2182; TOLSKAYA EA, 1966, VIROLOGY, V29, P613, DOI 10.1016/0042-6822(66)90285-6; Viallat A, 2004, BIOPHYS J, V86, P2179, DOI 10.1016/S0006-3495(04)74277-0; Vrdoljak A, 2012, J CONTROL RELEASE, V159, P34, DOI 10.1016/j.jconrel.2011.12.026; WAITE MRF, 1968, J VIROL, V2, P759, DOI 10.1128/JVI.2.7.759-760.1968; Wong YL, 2007, P NATL ACAD SCI USA, V104, P2591, DOI 10.1073/pnas.0611430104	72	18	20	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134431	10.1371/journal.pone.0134431	http://dx.doi.org/10.1371/journal.pone.0134431			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230936	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400118
J	de Sousa, DL; Lima, RA; Zanin, IC; Klein, MI; Janal, MN; Duarte, S				de Sousa, Denise Lins; Lima, Ramille Araujo; Zanin, Iriana Carla; Klein, Marlise I.; Janal, Malvin N.; Duarte, Simone			Effect of Twice-Daily Blue Light Treatment on Matrix-Rich Biofilm Development	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-MUTANS; VISIBLE-LIGHT; IN-VITRO; PORPHYROMONAS-GINGIVALIS; EXOPOLYSACCHARIDE MATRIX; PHOTODYNAMIC THERAPY; HYDROGEN-PEROXIDE; SUCROSE; STARCH	Background The use of blue light has been proposed as a direct means of affecting local bacterial infections, however the use of blue light without a photosensitizer to prevent the biofilm development has not yet been explored. The aim of this study was to determine how the twice-daily treatment with blue light affects the development and composition of a matrix-rich biofilm. Methodology/Principal Findings Biofilms of Streptococcus mutans UA159 were formed on saliva-coated hydroxyapatite discs for 5 days. The biofilms were exposed twice-daily to non-coherent blue light (Luma-Care; 420 nm) without a photosensitizer. The distance between the light and the sample was 1.0 cm; energy density of 72 J cm(-2); and exposure time of 12 min 56 s. Positive and negative controls were twice-daily 0.12% chlorhexidine (CHX) and 0.89% NaCl, respectively. Biofilms were analyzed for bacterial viability, dry-weight, and extra (EPS-insoluble and soluble) and intracellular (IPS) polysaccharides. Variable pressure scanning electron microscopy and confocal scanning laser microscopy were used to check biofilm morphology and bacterial viability, respectively. When biofilms were exposed to twice-daily blue light, EPS-insoluble was reduced significantly more than in either control group (CHX and 0.89% NaCl). Bacterial viability and dry weight were also reduced relative to the negative control (0.89% NaCl) when the biofilms were treated with twice-daily blue light. Different morphology was also visible when the biofilms were treated with blue light. Conclusions Twice-daily treatment with blue light without a photosensitizer is a promising mechanism for the inhibition of matrix-rich biofilm development.	[de Sousa, Denise Lins; Lima, Ramille Araujo; Zanin, Iriana Carla] Univ Fed Ceara, Dept Dent Clin, Sch Pharm Dent & Nursing, Fortaleza, Ceara, Brazil; [Klein, Marlise I.] State Univ Sao Paulo, Dept Biomat, Araraquara, SP, Brazil; [Janal, Malvin N.] NYU, Coll Dent, Dept Epidemiol & Hlth Promot, New York, NY USA; [Duarte, Simone] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10003 USA	Universidade Federal do Ceara; Universidade Estadual Paulista; New York University; New York University	Duarte, S (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10003 USA.	sduarte@nyu.edu	Lima, Ramille/AAK-9378-2021; Duarte, Simone/Y-2496-2019; Klein, Marlise Inêz/A-2550-2014; Janal, Malvin/AAA-2036-2020	Lima, Ramille/0000-0001-5764-7081; Duarte, Simone/0000-0002-4744-4026; Klein, Marlise Inêz/0000-0002-7916-1557; 	CAPES Foundation [Process 18494-12-9, 7715-13-7]	CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by CAPES Foundation from whom the first and second authors received a scholarship (Process 18494-12-9 and 7715-13-7, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires CP, 2008, CARIES RES, V42, P380, DOI 10.1159/000154783; Araujo NC, 2012, PHOTOMED LASER SURG, V30, P393, DOI 10.1089/pho.2011.3195; Bonomi HR, 2012, P NATL ACAD SCI USA, V109, P12135, DOI 10.1073/pnas.1121292109; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Bowen WH, 1999, CARIES RES, V33, P1, DOI 10.1159/000016489; Bumah VV, 2013, PHOTOMED LASER SURG, V31, P547, DOI 10.1089/pho.2012.3461; Chebath-Taub D, 2012, J PHOTOCH PHOTOBIO B, V116, P75, DOI 10.1016/j.jphotobiol.2012.08.004; Dai TH, 2013, PHOTOMED LASER SURG, V31, P531, DOI 10.1089/pho.2012.3365; Dai TH, 2013, ANTIMICROB AGENTS CH, V57, P1238, DOI 10.1128/AAC.01652-12; Dai TH, 2012, DRUG RESIST UPDATE, V15, P223, DOI 10.1016/j.drup.2012.07.001; DIBDIN GH, 1988, J DENT RES, V67, P890, DOI 10.1177/00220345880670060101; DIPERSIO JR, 1974, INFECT IMMUN, V10, P597, DOI 10.1128/IAI.10.3.597-604.1974; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Duarte S, 2008, ORAL MICROBIOL IMMUN, V23, P206, DOI 10.1111/j.1399-302X.2007.00412.x; Duarte S, 2006, FEMS MICROBIOL LETT, V257, P50, DOI 10.1111/j.1574-6968.2006.00147.x; Duarte S, 2006, ARCH ORAL BIOL, V51, P15, DOI 10.1016/j.archoralbio.2005.06.002; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Feuerstein O, 2006, J ANTIMICROB CHEMOTH, V57, P872, DOI 10.1093/jac/dkl070; Feuerstein O, 2005, PHOTOCHEM PHOTOBIOL, V81, P1186, DOI 10.1562/2005-04-06-RA-477; Feuerstein O, 2004, PHOTOCHEM PHOTOBIOL, V80, P412, DOI 10.1562/0031-8655(2004)080<0412:PEOVLO>2.0.CO;2; Feuerstein O, 2012, Adv Dent Res, V24, P103, DOI 10.1177/0022034512449469; Fontana CR, 2009, J PERIODONTAL RES, V44, P751, DOI 10.1111/j.1600-0765.2008.01187.x; Gomelsky M, 2011, TRENDS MICROBIOL, V19, P441, DOI 10.1016/j.tim.2011.05.002; Guffey JS, 2006, PHOTOMED LASER SURG, V24, P684, DOI 10.1089/pho.2006.24.684; Guggenheim B, 2001, J DENT RES, V80, P363, DOI 10.1177/00220345010800011201; HAMBLIN MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI DOI 10.1039/B311900A; HERLES S, 1994, J DENT RES, V73, P1748, DOI 10.1177/00220345940730111101; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Kim S, 2013, PHOTOMED LASER SURG, V31, P554, DOI 10.1089/pho.2012.3343; Klein MI, 2009, APPL ENVIRON MICROB, V75, P837, DOI 10.1128/AEM.01299-08; Koo H, 2013, J DENT RES, V92, P1065, DOI 10.1177/0022034513504218; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Paschoal M., 2013, LASER MED SCI, P1; Paschoal MA, 2014, PHOTOMED LASER SURG, V32, P175, DOI 10.1089/pho.2013.3656; Purcell EB, 2007, P NATL ACAD SCI USA, V104, P18241, DOI 10.1073/pnas.0705887104; Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004; Song HH, 2013, J PERIODONTAL IMPLAN, V43, P72, DOI 10.5051/jpis.2013.43.2.72; Steinberg D, 2008, ANTIMICROB AGENTS CH, V52, P2626, DOI 10.1128/AAC.01666-07; TAN KL, 1991, CLIN PERINATOL, V18, P423, DOI 10.1016/S0095-5108(18)30506-2; Teixeira AH, 2012, CARIES RES, V46, P549, DOI 10.1159/000341190; Vacca-Smith AM, 1998, ARCH ORAL BIOL, V43, P103, DOI 10.1016/S0003-9969(97)00111-8; Weber K, 2014, FEMS MICROBIOL LETT, V350, P175, DOI 10.1111/1574-6968.12334; Xiao J, 2010, J APPL MICROBIOL, V108, P2103, DOI 10.1111/j.1365-2672.2009.04616.x; Yoshida A, 2013, J PHOTOCH PHOTOBIO B, V129, P1, DOI 10.1016/j.jphotobiol.2013.09.003; Zanin ICJ, 2005, J ANTIMICROB CHEMOTH, V56, P324, DOI 10.1093/jac/dki232; ZERO DT, 1986, ARCH ORAL BIOL, V31, P229, DOI 10.1016/0003-9969(86)90054-3	46	29	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0131941	10.1371/journal.pone.0131941	http://dx.doi.org/10.1371/journal.pone.0131941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230333	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400012
J	Eitam, D; Kislev, M; Karty, A; Bar-Yosef, O				Eitam, David; Kislev, Mordechai; Karty, Adiel; Bar-Yosef, Ofer			Experimental Barley Flour Production in 12,500-Year-Old Rock-Cut Mortars in Southwestern Asia	PLOS ONE			English	Article								Experimental archaeology at a Natufian site in the Southern Levant documents for the first time the use of 12,500-year-old rock-cut mortars for producing wild barley flour, some 2,000 to 3,000 years before cereal cultivation. Our reconstruction involved processing wild barley on the prehistoric threshing floor, followed by use of the conical mortars (a common feature in Natufian sites), thereby demonstrating the efficient peeling and milling of hulled grains. This discovery complements nearly 80 years of investigations suggesting that the Natufians regularly harvested almost-ripe wild cereals using sickles hafted with flint blades. Sickles had been replicated in the past and tested in the field for harvesting cereals, thusly obtaining the characteristic sheen along the edge of the hafted flint blades as found in Natufian remnants. Here we report that Natufian wide and narrow conical mortars enabled the processing of wild barley for making the groats and fine flour that provided considerable quantities of nourishment. Dishes in the Early Natufian (15,000-13,500 CalBP) were groat meals and porridge and subsequently, in the Late Natufian (13,500-11,700 CalBP), we suggest that unleavened bread made from fine flour was added. These food preparing techniques widened the dietary breadth of the sedentary Natufian hunter-gatherers, paving the way to the emergence of farming communities, the hallmark of the Neolithic Revolution.	[Kislev, Mordechai] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Bar-Yosef, Ofer] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA	Bar Ilan University; Harvard University		david.eitam@mail.huji.ac.il						Cato MP, 1936, ON AGRICULTURE; Eitam D, 2013, THESIS HEBREW U; Eitam D., 2009, PALEORIENT, V35, P77, DOI DOI 10.3406/PALE0.2009.5279; Eitam D, 2008, JOURNAL OF THE ISRAE, V38, P133; Eitam D, 2009, ISRAEL EXPLOR J, V59, P63; Fuller DQ, 2012, VEG HIST ARCHAEOBOT, V21, P131, DOI 10.1007/s00334-011-0329-8; Gardiner A, 1920, THEBAN TOMBS; Garrod DAE, 1957, NATUFIAN CULTURE LIF; HARLAN JR, 1966, SCIENCE, V153, P1074, DOI 10.1126/science.153.3740.1074; Hayden B, 2012, J ARCHEOL METHOD TH, V19, P1; Helbuk H., 1969, PREHISTORY HUMAN ECO, P383; Henry DO, 1973, PALEST EXPLOR Q, V105, P129; Henry DO, 1986, PALEORIENT, V12, P5; Hillman G., 1985, B SUMERIAN AGR, V2, P1; Hillman G., 1984, B SUMERIAN AGR, V1, P114; Kislev ME, 2002, ISRAEL J PLANT SCI, V50, pS85, DOI 10.1560/QV07-WYET-WPQ5-QRDC; Meurers-Balke J., 1999, PREHISTORY AGR NEW E, P238; Nadel D, 2009, ARCHAEOL ETHNOL ANTH, V37, P37, DOI 10.1016/j.aeae.2009.08.012; Nadel D., 2011, FARMING, V3, P1, DOI [DOI 10.3828/bfarm.2011.3.1, 10.3828/bfarm.2011.3.1]; Pena-Chocarro L., 2009, FORAGERS FARMERS PAP, P103; Piperno DR, 2004, NATURE, V430, P670, DOI 10.1038/nature02734; Richter Tobias, 2012, NEO LITHICS, V12, P3; Rosen AM, 1993, CURRENT RES PHYTOLIT, P160; Rosenberg D., 2010, PALEORIENT, V36, P189, DOI [DOI 10.3406/PALEO.2010.5395, 10.3406/paleo.2010.5395]; Rosenberg D, 2013, EURASIAN PREHIST, V7, P61; Rosenberg D., 2008, LEVANT, V40, P167, DOI [10.1179/175638008X348025, DOI 10.1179/175638008X348025]; Samuel D., 2010, HORIZON STUDIES EGYP, P456; Steklis M., 1963, ISRAEL EXPLOR J, V13, P1; Tanno K, 2013, INT MONOGRAPHS PREHI, P83; Terradas X, 2013, STONE TOOLS TRANSITI, P449; Wright K., 1992, PALEORIENT, V18, P53, DOI 10.3406/pa-leo.1992.4573; Zeder MA, 2011, CURR ANTHROPOL, V52, pS221, DOI 10.1086/659307	32	18	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133306	10.1371/journal.pone.0133306	http://dx.doi.org/10.1371/journal.pone.0133306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230092	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400032
J	Sakamoto, T; Nishiyama, Y; Ikeda, A; Takahashi, H; Hyodo, S; Kagawa, N; Sakamoto, H				Sakamoto, Tatsuya; Nishiyama, Yudai; Ikeda, Aoi; Takahashi, Hideya; Hyodo, Susumu; Kagawa, Nao; Sakamoto, Hirotaka			Neurohypophysial Hormones Regulate Amphibious Behaviour in the Mudskipper Goby	PLOS ONE			English	Article							BREAM SPARUS-AURATA; RAPID MORPHOLOGICAL OSCILLATION; ESOPHAGEAL SPHINCTER MUSCLE; FLOUNDER PLATICHTHYS-FLESUS; DISTINCT PREOPTIC REGIONS; AFRICAN CICHLID FISH; ARGININE-VASOTOCIN; PERIOPHTHALMUS-MODESTUS; SEA BREAM; SOCIAL-BEHAVIOR	The neurohypophysial hormones, arginine vasotocin and isotocin, regulate both hydromineral balance and social behaviors in fish. In the amphibious mudskipper, Periophthalmus modestus, we previously found arginine-vasotocin-specific regulation of aggressive behavior, including migration of the submissive subordinate into water. This migration also implies the need for adaptation to dehydration. Here, we examined the effects of arginine vasotocin and isotocin administration on the amphibious behavior of individual mudskippers in vivo. The mudskippers remained in the water for an increased period of time after 1-8 h of intracerebroventricular (ICV) injection with 500 pg/g arginine vasotocin or isotocin. The 'frequency of migration' was decreased after ICV injection of arginine vasotocin or isotocin, reflecting a tendency to remain in the water. ICV injections of isotocin receptor antagonist with arginine vasotocin or isotocin inhibited all of these hormonal effects. In animals kept out of water, mRNA expression of brain arginine vasotocin and isotocin precursors increased 3- and 1.5-fold, respectively. Given the relatively wide distribution of arginine vasotocin fibres throughout the mudskipper brain, induction of arginine vasotocin and isotocin under terrestrial conditions may be involved also in the preference for an aquatic habitat as ligands for brain isotocin receptors.	[Sakamoto, Tatsuya; Nishiyama, Yudai; Ikeda, Aoi; Takahashi, Hideya; Sakamoto, Hirotaka] Okayama Univ, Fac Sci, Ushimado Marine Inst, Ushimado, Setouchi 7014303, Japan; [Hyodo, Susumu] Univ Tokyo, Atmosphere & Ocean Res Inst, Physiol Lab, Kashiwa, Chiba 2778564, Japan; [Kagawa, Nao] Kinki Univ, Fac Sci & Technol, Dept Life Sci, Higashiosaka, Osaka 5778502, Japan	Okayama University; University of Tokyo; Kindai University (Kinki University)	Sakamoto, T (corresponding author), Okayama Univ, Fac Sci, Ushimado Marine Inst, Ushimado, Setouchi 7014303, Japan.	ryu@uml.okayama-u.ac.jp	Sakamoto, Hirotaka/AAE-3720-2021	Sakamoto, Hirotaka/0000-0002-6224-4591; Hyodo, Susumu/0000-0001-8146-2386	Japan Society for the Promotion of Science (JSPS) [19570057, 22570065]; Grants-in-Aid for Scientific Research [26291065, 26650110] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by Japan Society for the Promotion of Science (JSPS): (http://www.jsps.go.jp/), 19570057 and 22570065 to TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers HE, 2012, HORM BEHAV, V61, P283, DOI 10.1016/j.yhbeh.2011.10.007; Martos-Sitcha JA, 2015, COMP BIOCHEM PHYS A, V182, P93, DOI 10.1016/j.cbpa.2014.12.027; Backstrom T, 2009, PHYSIOL BEHAV, V96, P470, DOI 10.1016/j.physbeh.2008.11.013; Balment RJ, 2006, GEN COMP ENDOCR, V147, P9, DOI 10.1016/j.ygcen.2005.12.022; Clayton D. A., 1993, OCEANOGRAPHY MARINE; DEMSKI LS, 1971, J COMP NEUROL, V143, P1, DOI 10.1002/cne.901430102; Fitts DA, 2005, PHYSIOL BEHAV, V86, P573, DOI 10.1016/j.physbeh.2005.08.027; Fitts DA, 2003, AM J PHYSIOL-REG I, V285, pR1331, DOI 10.1152/ajpregu.00254.2003; Godwin J, 2012, HORM BEHAV, V61, P230, DOI 10.1016/j.yhbeh.2011.12.016; Goodson JL, 2013, PSYCHONEUROENDOCRINO, V38, P465, DOI 10.1016/j.psyneuen.2012.12.005; Goodson JL, 2004, HORM BEHAV, V45, P136, DOI 10.1016/j.yhbeh.2003.08.006; Goodson JL, 2000, NATURE, V403, P769, DOI 10.1038/35001581; Goodson JL, 2001, BRAIN RES REV, V35, P246, DOI 10.1016/S0165-0173(01)00043-1; Graham JB, 1997, AIR BREATHING FISHES, DOI DOI 10.1016/B978-012294860-2/50006-4; Greenwood AK, 2008, P ROY SOC B-BIOL SCI, V275, P2393, DOI 10.1098/rspb.2008.0622; HAUSMANN H, 1995, FEBS LETT, V370, P227, DOI 10.1016/0014-5793(95)00832-T; HOLMQVIST BI, 1995, J CHEM NEUROANAT, V8, P125, DOI 10.1016/0891-0618(94)00041-Q; Huffman LS, 2012, J CHEM NEUROANAT, V44, P86, DOI 10.1016/j.jchemneu.2012.05.002; HYODO S, 1991, J COMP PHYSIOL B, V161, P549, DOI 10.1007/BF00260744; Kagawa N, 2013, J FISH BIOL, V82, P354, DOI 10.1111/j.1095-8649.2012.03490.x; Kagawa N, 2013, GEN COMP ENDOCR, V194, P257, DOI 10.1016/j.ygcen.2013.09.023; Kleszczynska A, 2006, COMP BIOCHEM PHYS A, V145, P268, DOI 10.1016/j.cbpa.2006.06.037; Kline RJ, 2011, J CHEM NEUROANAT, V42, P72, DOI 10.1016/j.jchemneu.2011.06.005; Konno N, 2010, PEPTIDES, V31, P1273, DOI 10.1016/j.peptides.2010.04.014; Konno N, 2010, ENDOCRINOLOGY, V151, P1089, DOI 10.1210/en.2009-1070; Larson ET, 2006, BEHAV BRAIN RES, V167, P94, DOI 10.1016/j.bbr.2005.08.020; LEE CGL, 1987, COMP BIOCHEM PHYS A, V87, P1009, DOI 10.1016/0300-9629(87)90028-4; Lee HJ, 2005, J EXP BIOL, V208, P169, DOI 10.1242/jeb.01361; Lema SC, 2015, J NEUROENDOCRINOL, V27, P142, DOI 10.1111/jne.12239; Lema SC, 2004, HORM BEHAV, V46, P628, DOI 10.1016/j.yhbeh.2004.07.003; Lema SC, 2014, INTEGR COMP BIOL, V54, P850, DOI 10.1093/icb/icu019; Lema SC, 2010, MOL CELL ENDOCRINOL, V321, P215, DOI 10.1016/j.mce.2010.02.015; MAHLMANN S, 1994, P NATL ACAD SCI USA, V91, P1342, DOI 10.1073/pnas.91.4.1342; Martos-Sitcha JA, 2014, GEN COMP ENDOCR, V197, P5, DOI 10.1016/j.ygcen.2013.11.026; Martos-Sitcha JA, 2015, J EXP BIOL, V218, P684, DOI 10.1242/jeb.114546; McKinley MJ, 2004, NEWS PHYSIOL SCI, V19, P1, DOI 10.1152/nips.01470.2003; Mancera JM, 2008, COMP BIOCHEM PHYS A, V149, P92, DOI 10.1016/j.cbpa.2007.10.016; Motohashi E, 2009, COMP BIOCHEM PHYS A, V154, P353, DOI 10.1016/j.cbpa.2009.07.003; Mukuda T, 2005, J EXP ZOOL PART A, V303A, P366, DOI 10.1002/jez.a.134; Nobata S, 2011, AM J PHYSIOL-REG I, V300, P1569, DOI 10.1152/ajpregu.00056.2011; Ojima D, 2010, GEN COMP ENDOCR, V168, P82, DOI 10.1016/j.ygcen.2010.04.007; Ojima D, 2009, COMP BIOCHEM PHYS A, V152, P293, DOI 10.1016/j.cbpa.2008.06.037; Sakamoto T, 2000, J EXP ZOOL, V286, P666, DOI 10.1002/(SICI)1097-010X(20000501)286:6<666::AID-JEZ14>3.0.CO;2-G; Sakamoto T, 2002, J COMP PHYSIOL B, V172, P447, DOI 10.1007/s00360-002-0274-z; Sakamoto T, 2002, J COMP PHYSIOL B, V172, P435, DOI 10.1007/s00360-002-0272-1; Sakamoto T, 2005, J MOL ENDOCRINOL, V34, P825, DOI 10.1677/jme.1.01768; Sakamoto T, 2011, PHYSIOL BEHAV, V104, P923, DOI 10.1016/j.physbeh.2011.06.002; Sakihara T, 2007, J COMP PHYSIOL B, V177, P927, DOI 10.1007/s00360-007-0191-2; Salek SJ, 2002, BEHAV BRAIN RES, V133, P177, DOI 10.1016/S0166-4328(02)00003-7; Semsar K, 2001, HORM BEHAV, V40, P21, DOI 10.1006/hbeh.2001.1663; Singh V, 2009, GEN COMP ENDOCR, V162, P172, DOI 10.1016/j.ygcen.2009.03.016; Takahashi H, 2006, J COMP PHYSIOL B, V176, P463, DOI 10.1007/s00360-006-0067-x; Takahashi H, 2006, LIFE SCI, V79, P1873, DOI 10.1016/j.lfs.2006.06.021; Takei Y, 2014, AM J PHYSIOL-REG I, V307, pR778, DOI 10.1152/ajpregu.00104.2014; Tsukada T, 2007, J EXP BIOL, V210, P3970, DOI 10.1242/jeb.010645; Warne J, 2002, EXPTL BIOL REV, P83; Warne JM, 2000, GEN COMP ENDOCR, V119, P77, DOI 10.1006/gcen.2000.7495; Warne JM, 2001, GEN COMP ENDOCR, V122, P312, DOI 10.1006/gcen.2001.7644; Watanabe Y, 2007, J COMP PHYSIOL B, V177, P867, DOI 10.1007/s00360-007-0184-1; Yamaguchi Y, 2012, GEN COMP ENDOCR, V178, P519, DOI 10.1016/j.ygcen.2012.07.008	60	15	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134605	10.1371/journal.pone.0134605	http://dx.doi.org/10.1371/journal.pone.0134605			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230718	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400138
J	Szentagotai-Tatar, A; Chis, A; Vulturar, R; Dobrean, A; Candea, DM; Miu, AC				Szentagotai-Tatar, Aurora; Chis, Adina; Vulturar, Romana; Dobrean, Anca; Candea, Diana Mirela; Miu, Andrei C.			Shame and Guilt-Proneness in Adolescents: Gene-Environment Interactions	PLOS ONE			English	Article							BDNF VAL66MET POLYMORPHISM; SELF-CONSCIOUS EMOTIONS; EARLY-LIFE STRESS; COGNITIVE VULNERABILITY; NEUROTROPHIC FACTOR; DEPRESSION; SEROTONIN; CHILDHOOD; 5-HTTLPR; EVENTS	Rooted in people's preoccupation with how they are perceived and evaluated, shame and guilt are self-conscious emotions that play adaptive roles in social behavior, but can also contribute to psychopathology when dysregulated. Shame and guilt-proneness develop during childhood and adolescence, and are influenced by genetic and environmental factors that are little known to date. This study investigated the effects of early traumatic events and functional polymorphisms in the brain-derived neurotrophic factor (BDNF) gene and the serotonin transporter gene promoter (5-HTTLPR) on shame and guilt in adolescents. A sample of N = 271 healthy adolescents between 14 and 17 years of age filled in measures of early traumatic events and proneness to shame and guilt, and were genotyped for the BDNF Val66Met and 5-HTTLPR polymorphisms. Results of moderator analyses indicated that trauma intensity was positively associated with guilt-proneness only in carriers of the low-expressing Met allele of BDNF Val66Met. This is the first study that identifies a gene-environment interaction that significantly contributes to guilt proneness in adolescents, with potential implications for developmental psychopathology.	[Szentagotai-Tatar, Aurora; Dobrean, Anca; Candea, Diana Mirela] Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, R-3400 Cluj Napoca, Cluj, Romania; [Chis, Adina; Vulturar, Romana] Iuliu Hatieganu Univ Med & Pharm, Dept Cell & Mol Biol, Cluj Napoca, Romania; [Miu, Andrei C.] Univ Babes Bolyai, Dept Psychol, Cognit Neurosci Lab, R-3400 Cluj Napoca, Cluj, Romania	Babes Bolyai University from Cluj; Iuliu Hatieganu University of Medicine & Pharmacy; Babes Bolyai University from Cluj	Szentagotai-Tatar, A (corresponding author), Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, R-3400 Cluj Napoca, Cluj, Romania.	auraszentagotai@psychology.ro	Vulturar, Romana C/C-5345-2011; Nechita, Diana/AAB-5024-2021; Dobrean, Anca/AAN-5464-2020; Tatar, Aurora Szentagotai/C-4045-2012; Miu, Andrei C./C-5184-2011; Vulturar, Romana/AAA-8604-2019; Dobrean, Anca/K-6562-2013	Vulturar, Romana C/0000-0003-2476-9706; Nechita, Diana/0000-0002-0750-8953; Miu, Andrei C./0000-0002-6459-5010; Chis, Adina/0000-0002-1651-0860; Dobrean, Anca/0000-0001-6089-1018	Romanian National Authority for Scientific Research, CNCS - UEFISCDI [PNII-ID-PCCE-2011-2-0045, PN-II-RU-PD-2012-3-0501]	Romanian National Authority for Scientific Research, CNCS - UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	This work was supported by grants from the Romanian National Authority for Scientific Research, CNCS - UEFISCDI (http://uefiscdi.gov.ro/), grants number PNII-ID-PCCE-2011-2-0045 (ACM) and PN-II-RU-PD-2012-3-0501 (AC). Although the Romanian National Authority for Scientific Research, CNCS - UEFISCDI, provided finding for the collection of data and the manuscript preparation, they had no role in the study design, the collection, analysis, or interpretation of data, the writing of the report, or the decision to submit the manuscript for publication.	Aiken L. S., 1991, MULTIPLE REGRESSION; ANDREWS B, 1995, J ABNORM PSYCHOL, V104, P277, DOI 10.1037/0021-843X.104.2.277; Andrews B, 2000, J ABNORM PSYCHOL, V109, P69, DOI 10.1037/0021-843X.109.1.69; Belden AC, 2015, JAMA PSYCHIAT, V72, P40, DOI 10.1001/jamapsychiatry.2014.1604; Bennett DS, 2010, CHILD MALTREATMENT, V15, P305, DOI 10.1177/1077559510379634; Blakemore SJ, 2014, ANNU REV PSYCHOL, V65, P187, DOI 10.1146/annurev-psych-010213-115202; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Briggs-Gowan MJ, 2010, J CHILD PSYCHOL PSYC, V51, P1132, DOI 10.1111/j.1469-7610.2010.02256.x; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Burghy CA, 2012, NAT NEUROSCI, V15, P1736, DOI 10.1038/nn.3257; Carnuta M, 2015, PSYCHONEUROENDOCRINO, V51, P176, DOI 10.1016/j.psyneuen.2014.09.026; Carver CS, 2011, J AFFECT DISORDERS, V132, P89, DOI 10.1016/j.jad.2011.02.001; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Claesson K, 2002, CLIN PSYCHOL PSYCHOT, V9, P277, DOI 10.1002/cpp.331; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Hooge IE, 2007, COGNITION EMOTION, V21, P1025, DOI 10.1080/02699930600980874; de Hooge IE, 2010, COGNITION EMOTION, V24, P111, DOI 10.1080/02699930802584466; Donatelli J.L., 2007, J CHILD FAM STUD, V16, DOI [10.1007/s10826-006-9130-1, DOI 10.1007/S10826-006-9130-1]; Drabant EM, 2012, AM J PSYCHIAT, V169, P397, DOI 10.1176/appi.ajp.2011.10111699; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Elzinga BM, 2011, PSYCHOPHARMACOLOGY, V214, P319, DOI 10.1007/s00213-010-1961-1; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Feiring C, 2002, DEV PSYCHOL, V38, P79, DOI 10.1037//0012-1649.38.1.79; Feiring Candice, 2002, Child Maltreat, V7, P26, DOI 10.1177/1077559502007001003; Ferguson TJ, 2000, GENET SOC GEN PSYCH, V126, P319; Fletcher KE, 2011, J CHILD ADOLESCENT T, V4, P339, DOI DOI 10.1080/19361521.2011.623146; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Gavazzi IG, 2011, EUR J DEV PSYCHOL, V8, P311, DOI 10.1080/17405629.2010.491303; Hayden EP, 2008, J AFFECT DISORDERS, V107, P227, DOI 10.1016/j.jad.2007.07.028; Hayden EP, 2013, DEV PSYCHOPATHOL, V25, P587, DOI 10.1017/S0954579413000035; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; HOGLUND CL, 1995, J FAM VIOLENCE, V10, P141, DOI 10.1007/BF02110597; Holmes A, 2003, NEUROPSYCHOPHARMACOL, V28, P2077, DOI 10.1038/sj.npp.1300266; Hosang GM, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-7; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Karabeg MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078238; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Lagattuta K. H., 2007, SELF CONSCIOUS EMOTI, P91; Lau JYF, 2010, NEUROIMAGE, V53, P952, DOI 10.1016/j.neuroimage.2009.11.026; Leary MR, 2004, PSYCHOL INQ, V15, P129; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174; Lester KJ, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.33; Lester KJ, 2013, BIOL MOOD ANXIETY DI, V3, DOI 10.1186/2045-5380-3-4; Lewis H., 1971, SHAME GUILT NEUROSIS; Lewis M., 2007, SELF CONSCIOUS EMOTI, P134; Lickel B, 2014, EMOTION, V14, P1049, DOI 10.1037/a0038235; Lovibond SH., 1995, MANUAL DEPRESSION AN, V56; Luby J, 2009, J CHILD PSYCHOL PSYC, V50, P1156, DOI 10.1111/j.1469-7610.2009.02077.x; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Mills RSL, 2015, CHILD PSYCHIAT HUM D, V46, P194, DOI 10.1007/s10578-013-0416-4; Mills RSL, 2005, DEV REV, V25, P26, DOI 10.1016/j.dr.2004.08.001; Miu AC, 2013, EMOTION, V13, P1012, DOI 10.1037/a0033383; Mongillo EA, 2009, J ABNORM CHILD PSYCH, V37, P455, DOI 10.1007/s10802-008-9283-z; Muris P, 2014, CLIN CHILD FAM PSYCH, V17, P19, DOI 10.1007/s10567-013-0137-z; Nugent NR, 2011, PSYCHOPHARMACOLOGY, V214, P175, DOI 10.1007/s00213-010-2151-x; Olthof T, 2004, COGNITION EMOTION, V18, P383, DOI 10.1080/02699930341000077; Orth U, 2010, J PERS SOC PSYCHOL, V99, P1061, DOI 10.1037/a0021342; PENNEBAKER JW, 1988, SOC SCI MED, V26, P327, DOI 10.1016/0277-9536(88)90397-8; Perea CS, 2012, J AFFECT DISORDERS, V136, P767, DOI 10.1016/j.jad.2011.09.043; Perroud N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.140; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Plomin R, 2013, PSYCHOL SCI, V24, P562, DOI 10.1177/0956797612457952; Rakow A, 2012, J FAM PSYCHOL, V25, P147; Rakow A, 2009, J CHILD FAM STUD, V18, P367, DOI 10.1007/s10826-008-9239-5; Rankin JL, 2004, J RES ADOLESCENCE, V14, P1, DOI 10.1111/j.1532-7795.2004.01401001.x; Roberts W, 2014, CAN J BEHAV SCI, V46, P465, DOI 10.1037/a0035057; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Roos S, 2014, DEV PSYCHOL, V50, P941, DOI 10.1037/a0033904; Rutter M, 1997, DEV PSYCHOPATHOL, V9, P335, DOI 10.1017/S0954579497002083; Scherer KR, 2009, EUR J PERSONALITY, V23, P265, DOI 10.1002/per.714; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sharpley CF, 2014, BEHAV BRAIN RES, V273, P89, DOI 10.1016/j.bbr.2014.07.030; Sheikh HI, 2008, PERS INDIV DIFFER, V45, P425, DOI 10.1016/j.paid.2008.05.020; Sheikh HI, 2010, PSYCHIAT GENET, V20, P109, DOI 10.1097/YPG.0b013e32833a2038; Smyth JM, 2008, J AM COLL HEALTH, V57, P69, DOI 10.3200/JACH.57.1.69-76; Somerville LH, 2013, PSYCHOL SCI, V24, P1554, DOI 10.1177/0956797613475633; Stuewig J, 2005, CHILD MALTREATMENT, V10, P324, DOI 10.1177/1077559505279308; Stuewig J, 2015, CHILD PSYCHIAT HUM D, V46, P217, DOI 10.1007/s10578-014-0467-1; Szabo M, 2010, J ADOLESCENCE, V33, P1, DOI 10.1016/j.adolescence.2009.05.014; Tangney J. P., 1991, TEST SELF CONSCIOUS; Tangney J.P., 2003, SHAME GUILT; Tangney JP, 1996, BEHAV RES THER, V34, P741, DOI 10.1016/0005-7967(96)00034-4; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; Tilghman-Osborne C, 2012, J ABNORM CHILD PSYCH, V40, P607, DOI 10.1007/s10802-011-9591-6; Tracy JL, 2004, PSYCHOL INQ, V15, P103, DOI 10.1207/s15327965pli1502_01; van Oostrom I, 2012, BIOL PSYCHOL, V89, P214, DOI 10.1016/j.biopsycho.2011.10.012; Vinkhuyzen AAE, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.27; Vulturar R, 2012, PSYCHOPHYSIOLOGY, V49, P1412, DOI 10.1111/j.1469-8986.2012.01445.x; Webb M, 2007, CHILD ABUSE NEGLECT, V31, P1143, DOI 10.1016/j.chiabu.2007.09.003; Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789; West SG, 1996, J PERS, V64, P1, DOI 10.1111/j.1467-6494.1996.tb00813.x; Westenberg PM, 2004, J CHILD PSYCHOL PSYC, V45, P481; [Anonymous], 2000, JAMA, V284, P3043, DOI 10.1001/jama.2013.281053; Zahn-Waxler Carolyn, 1995, P143	100	11	12	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134716	10.1371/journal.pone.0134716	http://dx.doi.org/10.1371/journal.pone.0134716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230319	gold, Green Submitted, Green Published			2022-12-27	WOS:000358838400155
J	Tsai, CF; Lee, YT; Lee, WJ; Hwang, JP; Wang, SJ; Fuh, JL				Tsai, Chia-Fen; Lee, Yao-Tung; Lee, Wei-Ju; Hwang, Jen-Ping; Wang, Shuu-Jiun; Fuh, Jong-Ling			Depression of Family Caregivers Is Associated with Disagreements on Life-Sustaining Preferences for Treating Patients with Dementia	PLOS ONE			English	Article							DECISION-MAKING; CARE; CONCORDANCE; AGREEMENT; ATTITUDES; VERSION; BURDEN; STATE	Background Family caregivers may not agree with patients with dementia regarding attitudes toward end-of-life preferences, and the effects of this type of disagreement are not well understood. This study sought to identify such a disagreement and its predictors. Methods A cross-sectional sample of 84 family caregivers and patients with dementia was recruited from memory clinics. We used the Mini-Mental State Examination, Neuropsychiatric Inventory, Clinical Dementia Rating, and Katz index of independence in activities of daily living to assess patient symptoms, functions, and severity of dementia. Caregivers completed questionnaires on perceived patient end-of-life care preferences, caregiver end-of-life care preferences for patients, Zarit Burden Interview (ZBI), Center for Epidemiological Studies-Depression Scale (CES-D), and knowledge of clinical complications of advanced dementia. Results The self-disclosure rates of patient preferences were 34.5% for tube feeding, 39.3% for cardiopulmonary resuscitation, and 45.2% for mechanical ventilation. For patients who had disclosed preferences, the disagreement rate between them and their caregivers was 48.3% for tube feeding, 48.5% for cardiopulmonary resuscitation, and 60.3% for mechanical ventilation. Caregiver depression (i.e., CES-D >= 16) was associated with disagreements on cardiopulmonary resuscitation (adjusted odds ratio (aOR) = 6.6, 95% CI = 1.4-31.1, P = 0.01) and mechanical ventilation (aOR = 14, 95% CI = 2.2-87.2, P = 0.005) preferences. Conclusion The preferences of end-of-life issues differed greatly between dementia patients and their caregivers. Depression in caregivers is associated with such discrepancy.	[Tsai, Chia-Fen; Hwang, Jen-Ping] Vet Gen Hosp, Neurol Inst, Dept Psychiat, Taipei, Taiwan; [Wang, Shuu-Jiun; Fuh, Jong-Ling] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan; [Tsai, Chia-Fen] Natl Yang Ming Univ, Sch Med, Inst Brain Sci, Taipei 112, Taiwan; [Lee, Wei-Ju] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Tsai, Chia-Fen; Lee, Wei-Ju; Hwang, Jen-Ping; Wang, Shuu-Jiun; Fuh, Jong-Ling] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Lee, Wei-Ju] Taichung Vet Gen Hosp, Dept Neurol, Taichung, Taiwan; [Lee, Yao-Tung] Taipei Med Univ, Shuang Ho Hosp, Dept Psychiat, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Taipei Medical University; Shuang Ho Hospital	Fuh, JL (corresponding author), 201 Sec 2,Shipai Rd, Taipei 112, Taiwan.	jlfuh@vghtpe.gov.tw		Lee, Wei-Ju/0000-0002-3720-4539	Ministry of Science and Technology of Taiwan [NSC 101-2314-B-075-037-MY2, 101-2314-B-075A-013, 102-2321-B-010-030]; Taipei Veterans General Hospital [V103E9-006, V103E3-005, V103C-083]; Ministry of Science and Technology support for the Centre for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan [NSC 102-2911-I-008-001]; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plan	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology support for the Centre for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This study was supported by the Ministry of Science and Technology of Taiwan (NSC 101-2314-B-075-037-MY2, 101-2314-B-075A-013, 102-2321-B-010-030), Taipei Veterans General Hospital (V103E9-006, V103E3-005, V103C-083), Ministry of Science and Technology support for the Centre for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 102-2911-I-008-001), Brain Research Center, National Yang-Ming University and a grant from Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGNOSTIC STAT MANU, V4th; Ayalon L, 2012, INT PSYCHOGERIATR, V24, P1798, DOI 10.1017/S1041610212000877; Bambauer Kara Zivin, 2007, Am J Hosp Palliat Care, V24, P185; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Borum ML, 2000, J AM GERIATR SOC, V48, pS194, DOI 10.1111/j.1532-5415.2000.tb03132.x; Di Giulio P, 2008, J PALLIAT MED, V11, P1023, DOI 10.1089/jpm.2008.0020; Fagerlin A, 2001, HEALTH PSYCHOL, V20, P166, DOI 10.1037/0278-6133.20.3.166; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fuh JL, 2001, INT PSYCHOGERIATR, V13, P121, DOI 10.1017/S1041610201007517; Jennings B, 2003, HASTINGS CENT REP, V33, pS24; KATZ S, 1983, NEW ENGL J MED, V309, P1218, DOI 10.1056/NEJM198311173092005; Kim SYH, 2002, AM J GERIAT PSYCHIAT, V10, P151, DOI 10.1176/appi.ajgp.10.2.151; Ko KT, 2008, AM J GERIAT PSYCHIAT, V16, P513, DOI 10.1097/JGP.0b013e318167ae5b; Kwok T, 2007, J ADV NURS, V58, P256, DOI 10.1111/j.1365-2648.2007.04230.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Luchins DJ, 1997, J AM GERIATR SOC, V45, P1054, DOI 10.1111/j.1532-5415.1997.tb05966.x; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meuser TM, 2001, GERONTOLOGIST, V41, P658, DOI 10.1093/geront/41.5.658; Mitchell SL, 2007, J AM GERIATR SOC, V55, P432, DOI 10.1111/j.1532-5415.2007.01086.x; Mitchell Susan L, 2009, N Engl J Med, V361, P1529, DOI 10.1056/NEJMoa0902234; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Neale R, 2001, INT J EPIDEMIOL, V30, P1383, DOI 10.1093/ije/30.6.1383; Pinquart M, 2003, J GERONTOL B-PSYCHOL, V58, pP112, DOI 10.1093/geronb/58.2.P112; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reamy AM, 2013, GERONTOLOGIST, V53, P293, DOI 10.1093/geront/gns078; Rurup ML, 2006, PATIENT EDUC COUNS, V61, P372, DOI 10.1016/j.pec.2005.04.016; Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493; Siminoff LA, 2006, PSYCHO-ONCOLOGY, V15, P528, DOI 10.1002/pon.989; Speice J, 2000, PSYCHO-ONCOL, V9, P101, DOI 10.1002/(SICI)1099-1611(200003/04)9:2<101::AID-PON435>3.0.CO;2-D; Swails P., 2009, DEMENTIA, V8, P117; Tang ST, 2005, J PAIN SYMPTOM MANAG, V30, P510, DOI 10.1016/j.jpainsymman.2005.05.019; Winter L, 2007, SOC SCI MED, V65, P1695, DOI 10.1016/j.socscimed.2007.06.012; Wu YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066252	34	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133711	10.1371/journal.pone.0133711	http://dx.doi.org/10.1371/journal.pone.0133711			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230958	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400052
J	Fahlgren, A; Bratengeier, C; Gelmi, A; Semeins, CM; Klein-Nulend, J; Jager, EWH; Bakker, AD				Fahlgren, Anna; Bratengeier, Cornelia; Gelmi, Amy; Semeins, Cornelis M.; Klein-Nulend, Jenneke; Jager, Edwin W. H.; Bakker, Astrid D.			Biocompatibility of Polypyrrole with Human Primary Osteoblasts and the Effect of Dopants	PLOS ONE			English	Article							CHONDROITIN SULFATE; CONDUCTING POLYMERS; SURFACE; EXPRESSION; ELECTROCHEMISTRY; DIFFERENTIATION; NANOPARTICLES; OSTEOCALCIN; INHIBITION; TOPOGRAPHY	Polypyrrole (PPy) is a conducting polymer that enables controlled drug release upon electrical stimulation. We characterized the biocompatibility of PPy with human primary osteoblasts, and the effect of dopants. We investigated the biocompatibility of PPy comprising various dopants, i.e. p-toluene sulfonate (PPy-pTS), chondroitin sulfate (PPy-CS), or dodecylbenzenesulfonate (PPy-DBS), with human primary osteoblasts. PPy-DBS showed the roughest appearance of all surfaces tested, and its wettability was similar to the gold-coated control. The average number of attached cells was 45% higher on PPy-DBS than on PPyCS or PPy-pTS, although gene expression of the proliferation marker Ki-67 was similar in osteoblasts on all surfaces tested. Osteoblasts seeded on PPy-DBS or gold showed similar vinculin attachment points, vinculin area per cell area, actin filament structure, and Feret's diameter, while cells seeded on PPY-CS or PPY-pTS showed disturbed focal adhesions and were enlarged with disorganized actin filaments. Osteoblasts grown on PPy-DBS or gold showed enhanced alkaline phosphatase activity and osteocalcin gene expression, but reduced osteopontin gene expression compared to cells grown on PPy-pTS and PPy-CS. In conclusion, PPy doped with DBS showed excellent biocompatibility, which resulted in maintaining focal adhesions, cell morphology, cell number, alkaline phosphatase activity, and osteocalcin gene expression. Taken together, conducting polymers doped with DBS are well tolerated by osteoblasts. Our results could provide a basis for the development of novel orthopedic or dental implants with controlled release of antibiotics and pharmaceutics that fight infections or focally enhance bone formation in a tightly controlled manner.	[Fahlgren, Anna; Bratengeier, Cornelia] Linkoping Univ, Div Orthopaed, Dept Clin & Expt Med, Linkoping, Sweden; [Gelmi, Amy; Jager, Edwin W. H.] Linkoping Univ, Dept Phys Chem & Biol, Biosensors & Bioelect Ctr, Linkoping, Sweden; [Semeins, Cornelis M.; Klein-Nulend, Jenneke; Bakker, Astrid D.] ACTA Univ Amsterdam, Dept Oral Cell Biol, Amsterdam, Netherlands; [Semeins, Cornelis M.; Klein-Nulend, Jenneke; Bakker, Astrid D.] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	Linkoping University; Linkoping University; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Fahlgren, A (corresponding author), Linkoping Univ, Div Orthopaed, Dept Clin & Expt Med, Linkoping, Sweden.	anna.fahlgren@liu.se	Jager, Edwin/F-1481-2013; Bakker, Astrid Diana/AAD-1286-2019	Jager, Edwin/0000-0002-2071-7768; Gelmi, Amy/0000-0003-1636-6448; Bratengeier, Cornelia/0000-0001-9302-0710; Fahlgren, Anna/0000-0002-0299-1763	VINNOVA [2012-04409]; Vetenskapradet [521-2013-2593]; Linkoping Initiative in Life Science Technologies (LIST)	VINNOVA(Vinnova); Vetenskapradet; Linkoping Initiative in Life Science Technologies (LIST)	This work was supported by VINNOVA (2012-04409, http://www.vinnova.se/sv/), Vetenskapradet (521-2013-2593, http://www.vr.se/), and Linkoping Initiative in Life Science Technologies (LIST) (https://www.liu.se/forskning/list?l = en&sc = true). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abtahi J, 2012, BONE, V50, P1148, DOI 10.1016/j.bone.2012.02.001; Arpornmaeklong P, 2009, STEM CELLS DEV, V18, P955, DOI 10.1089/scd.2008.0310; Ateh DD, 2006, J R SOC INTERFACE, V3, P741, DOI 10.1098/rsif.2006.0141; Balint R, 2014, ACTA BIOMATER, V10, P2341, DOI 10.1016/j.actbio.2014.02.015; Chang EJ, 2005, EXP CELL RES, V303, P197, DOI 10.1016/j.yexcr.2004.09.024; Chen JC, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029551; Costa DO, 2013, BIOMATERIALS, V34, P7215, DOI 10.1016/j.biomaterials.2013.06.014; Davies John E, 2003, J Dent Educ, V67, P932; Fonner JM, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034124; Gelmi A, 2014, J MATER CHEM B, V2, P3860, DOI 10.1039/c4tb00142g; Gelmi A, 2015, PROC SPIE, V9430, DOI 10.1117/12.2084165; Gelmi A, 2010, BIOMATERIALS, V31, P1974, DOI 10.1016/j.biomaterials.2009.11.040; Ghosh P, 2008, ADV DRUG DELIVER REV, V60, P1307, DOI 10.1016/j.addr.2008.03.016; Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012; Han DH, 2005, ELECTROCHIM ACTA, V50, P3085, DOI 10.1016/j.electacta.2004.10.085; HEINZE J, 1991, SYNTHETIC MET, V43, P2805, DOI 10.1016/0379-6779(91)91183-B; Hempel U, 2013, CLIN ORAL IMPLAN RES, V24, P174, DOI 10.1111/j.1600-0501.2011.02328.x; Hennig S, 2007, PAGANZ 07 POP APPR G; Hill DA, 2004, J CELL SCI, V117, P5847, DOI 10.1242/jcs.01502; Hojo H, 2015, REGEN THER, V1, P57, DOI 10.1016/j.reth.2014.10.002; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Kapustin AN, 2011, ARTERIOSCL THROM VAS, V31, P2169, DOI 10.1161/ATVBAHA.111.233601; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; La Noce M, 2014, EUR CELLS MATER, V28, P348, DOI 10.22203/eCM.v028a24; Liu WF, 2012, CARDIOVASC RES, V95, P215, DOI 10.1093/cvr/cvs168; Marra M, 2012, BIOTECHNOL ADV, V30, P302, DOI 10.1016/j.biotechadv.2011.06.018; Matschegewski C, 2012, MATERIALS, V5, P1176, DOI 10.3390/ma5071176; Mombelli A, 2012, CLIN ORAL IMPLAN RES, V23, P67, DOI 10.1111/j.1600-0501.2012.02541.x; Paino F, 2014, STEM CELLS, V32, P279, DOI 10.1002/stem.1544; Pecchi E, 2012, OSTEOARTHR CARTILAGE, V20, P127, DOI 10.1016/j.joca.2011.12.002; Santos A, 2011, CALCIFIED TISSUE INT, V89, P318, DOI 10.1007/s00223-011-9521-1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sirivisoot S, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/8/085101; Stoddart MJ., 2011, METHODS MOL BIOL; Svennersten K, 2011, LAB CHIP, V11, P3287, DOI 10.1039/c1lc20436j; Thompson BC, 2011, BIOMATERIALS, V32, P3822, DOI 10.1016/j.biomaterials.2011.01.053; TOURILLON G, 1983, J PHYS CHEM-US, V87, P2289, DOI 10.1021/j100236a010; Tsai SW, 2010, J BIOMED MATER RES A, V93A, P115, DOI 10.1002/jbm.a.32502; Vandrovcova M, 2011, PHYSIOL RES, V60, P403, DOI 10.33549/physiolres.932045; WARREN LF, 1987, J ELECTROCHEM SOC, V134, P101, DOI 10.1149/1.2100383; Yue C, 2015, J BIOMED MATER RES A, P1; ZACK GW, 1977, J HISTOCHEM CYTOCHEM, V25, P741, DOI 10.1177/25.7.70454; Zhang JY, 2013, BIOTECHNOL BIOENG, V110, P1466, DOI 10.1002/bit.24796; Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011	44	47	49	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134023	10.1371/journal.pone.0134023	http://dx.doi.org/10.1371/journal.pone.0134023			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225862	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700051
J	Northover, C; Thapar, A; Langley, K; van Goozen, SHM				Northover, Clare; Thapar, Anita; Langley, Kate; van Goozen, Stephanie H. M.			Pain Sensitivity in Adolescent Males with Attention-Deficit/Hyperactivity Disorder: Testing for Associations with Conduct Disorder and Callous and Unemotional Traits	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; PSYCHOPATHIC TRAITS; TOLERANCE; AGGRESSION; VALIDATION; CHILDREN; BEHAVIOR; ANXIETY; VIOLENT; EMPATHY	Background Reduced processing and experience of aversive emotional cues is a common component of theories on the development and persistence of aggression and antisocial behaviour. Yet physical pain, arguably the most basic aversive cue, has attracted comparatively little attention. Methods This study measured pain sensitivity and physiological response to painful stimuli (skin conductance level, SCL) in adolescent boys with Attention-Deficit/Hyperactivity Disorder (ADHD; n = 183), who are at high risk for antisocial behaviour. We compared boys with ADHD with and without a comorbid diagnosis of Conduct Disorder (CD) on pain sensitivity, and examined patterns of association between pain measures, on the one hand, and problem severity and callous and unemotional (CU) traits, on the other. Results Boys with comorbid CD exhibited a higher pain threshold and tolerance than boys with ADHD alone, but the groups did not differ in physiology at the time the pain threshold and tolerance were reported. Regression analyses showed that ADHD problem severity positively predicted pain sensitivity, whereas levels of CU traits negatively predicted pain sensitivity. Conclusions These findings on physical pain processing extend evidence of impairments in aversive cue processing among those at risk of antisocial behaviour. The study highlights the importance of considering comorbidity and heterogeneity of disorders when developing interventions. The current findings could be used to identify subgroups within those with ADHD who might be less responsive to interventions that use corrective feedback to obtain behaviour change.	[Northover, Clare; Langley, Kate; van Goozen, Stephanie H. M.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales; [Thapar, Anita; Langley, Kate] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Cardiff University	van Goozen, SHM (corresponding author), Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales.	vangoozens@cardiff.ac.uk	Thapar, Anita/AAH-5555-2020	Thapar, Anita/0000-0002-3689-737X; Langley, Kate/0000-0002-2033-2657	UK Medical Research Council [G1000632]; MRC [G1000632] Funding Source: UKRI; Medical Research Council [MR/L010305/1, G1000632] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research has been supported by a grant (G1000632) from the UK Medical Research Council awarded to A Thapar, SHM van Goozen, and K Langley. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Andershed H., 2002, PSYCHOPATHS CURRENT, P131, DOI DOI 10.1037/T07576-000; Andershed H, 2007, ASSESSMENT, V14, P144, DOI 10.1177/1073191106298286; Baker E, 2013, PSYCHOL SCI, V24, P1051, DOI 10.1177/0956797612465198; BERKOWITZ L, 1993, MOTIV EMOTION, V17, P277, DOI 10.1007/BF00992223; BIEDERMAN J, 1991, AM J PSYCHIAT, V148, P564; Blair J., 2005, PSYCHOPATH EMOTION B; Blair RJR, 2007, TRENDS COGN SCI, V11, P387, DOI 10.1016/j.tics.2007.07.003; Botvinick M, 2005, NEUROIMAGE, V25, P312, DOI 10.1016/j.neuroimage.2004.11.043; Brown JL, 2003, PSYCHOSOM MED, V65, P276, DOI 10.1097/01.PSY.0000030388.62434.46; Caes L, 2012, J PAIN, V13, P467, DOI 10.1016/j.jpain.2012.02.003; Cheng YW, 2012, DEV PSYCHOPATHOL, V24, P623, DOI 10.1017/S095457941200020X; Cohen J.E., 1988, STAT POWER ANAL BEHA; Decety J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00489; Fairchild G, 2008, BIOL PSYCHIAT, V63, P279, DOI 10.1016/j.biopsych.2007.06.019; Fairchild G, 2010, BIOL PSYCHIAT, V68, P272, DOI 10.1016/j.biopsych.2010.02.019; Fairchild G, 2009, J CHILD PSYCHOL PSYC, V50, P627, DOI 10.1111/j.1469-7610.2008.02020.x; FEDORA O, 1993, J CLIN PSYCHOL, V49, P326, DOI 10.1002/1097-4679(199305)49:3<326::AID-JCLP2270490304>3.0.CO;2-5; Franklin JC, 2011, PSYCHIAT RES, V189, P362, DOI 10.1016/j.psychres.2011.08.001; Frick PJ, 2014, PSYCHOL BULL, V140, P1, DOI 10.1037/a0033076; Garofalo John P, 2006, Pain Pract, V6, P186, DOI 10.1111/j.1533-2500.2006.00084.x; Geuter S, 2014, PAIN, V155, P994, DOI 10.1016/j.pain.2014.02.005; Goodman A, 2009, J AM ACAD CHILD PSY, V48, P400, DOI 10.1097/CHI.0b013e3181985068; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; HAIER RJ, 1984, PERS INDIV DIFFER, V5, P293, DOI 10.1016/0191-8869(84)90068-0; HARE R D, 1970, Journal of Abnormal Psychology, V76, P370, DOI 10.1037/h0030276; HARE RD, 1968, J ABNORM PSYCHOL, V73, P268, DOI 10.1037/h0025872; Hawes DJ, 2014, CLIN CHILD FAM PSYCH, V17, P248, DOI 10.1007/s10567-014-0167-1; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Johnson Malcolm H, 2005, Curr Pain Headache Rep, V9, P90, DOI 10.1007/s11916-005-0044-1; Kessler RC, 2009, PSYCHOL MED, V39, P137, DOI 10.1017/S0033291708003309; Lahey BB, 2012, J CHILD PSYCHOL PSYC, V53, P536, DOI 10.1111/j.1469-7610.2011.02509.x; Lamm C., J COGN NEUROSCI, V19, P42; Lykken D.T., 1995, ANTISOCIAL PERSONALI, DOI DOI 10.4324/9780203763551; Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003; Miller JD, 2014, J ABNORM PSYCHOL, V123, P205, DOI 10.1037/a0035072; Moriguchi Y, 2007, CEREB CORTEX, V17, P2223, DOI 10.1093/cercor/bhl130; Niel KA, 2007, PSYCHOL REP, V101, P141, DOI 10.2466/PR0.101.1.141-144; Parush S, 1997, DEV MED CHILD NEUROL, V39, P464, DOI 10.1111/j.1469-8749.1997.tb07466.x; Raine A, 1996, ANN NY ACAD SCI, V794, P46, DOI 10.1111/j.1749-6632.1996.tb32508.x; Raine A., 1997, PSYCHOPATHOLOGY CRIM; Reidy DE, 2009, AGGRESSIVE BEHAV, V35, P422, DOI 10.1002/ab.20315; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; Sagvolden T, 2000, NEUROSCI BIOBEHAV R, V24, P31, DOI 10.1016/S0149-7634(99)00058-5; Scherder EJA, 2008, EUR J PAEDIATR NEURO, V12, P461, DOI 10.1016/j.ejpn.2007.11.004; Seguin JR, 1996, J CHILD PSYCHOL PSYC, V37, P823, DOI 10.1111/j.1469-7610.1996.tb01478.x; Stray LL, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-18; Syngelaki EM, 2013, DEVELOPMENTAL SCI, V16, P84, DOI 10.1111/j.1467-7687.2012.01191.x; Thapar A, 2006, MOL PSYCHIATR, V11, P714, DOI 10.1038/sj.mp.4001831; Thompson T, 2008, PAIN, V134, P187, DOI 10.1016/j.pain.2007.04.018; Treister R, 2015, PAIN PRACT, V15, P4, DOI 10.1111/papr.12129; Treister R, 2012, PAIN, V153, P1807, DOI 10.1016/j.pain.2012.04.008; Tripp G, 2009, NEUROPHARMACOLOGY, V57, P579, DOI 10.1016/j.neuropharm.2009.07.026; van Goozen SHM, 2004, J CHILD PSYCHOL PSYC, V45, P884; van Goozen SHM, 2007, PSYCHOL BULL, V133, P149, DOI 10.1037/0033-2909.133.1.149; Vendruscolo LF, 2004, BRAIN RES, V1030, P277, DOI 10.1016/j.brainres.2004.10.016; Viding E, 2007, BRIT J PSYCHIAT, V190, pS33, DOI 10.1192/bjp.190.5.s33; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wood Patrick B, 2008, Expert Rev Neurother, V8, P781, DOI 10.1586/14737175.8.5.781; Younger J, 2009, CURR PAIN HEADACHE R, V13, P39, DOI 10.1007/s11916-009-0009-x	61	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134417	10.1371/journal.pone.0134417	http://dx.doi.org/10.1371/journal.pone.0134417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JT	26225935	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000358837700092
J	Orobaton, N; Abegunde, D; Shoretire, K; Abdulazeez, J; Fapohunda, B; Lamiri, G; Maishanu, A; Ganiyu, A; Ndifon, E; Gwamzhi, R; Osborne-Smith, M				Orobaton, Nosakhare; Abegunde, Dele; Shoretire, Kamil; Abdulazeez, Jumare; Fapohunda, Bolaji; Lamiri, Goli; Maishanu, Abubakar; Ganiyu, Akeem; Ndifon, Eric; Gwamzhi, Ringpon; Osborne-Smith, Matthew			A Report of At-Scale Distribution of Chlorhexidine Digluconate 7.1% Gel for Newborn Cord Care to 36,404 Newborns in Sokoto State, Nigeria: Initial Lessons Learned	PLOS ONE			English	Article								Background With an annual estimated 276,000 neonatal deaths, Nigeria has the second highest of any country in the world. Global progress in accelerating neonatal deaths is hinged to scaled-up interventions in Nigeria. We used routine data of chlorhexidine digluconate 7.1% gel utilized by 36,404 newborns delivered by 36,370 mothers, to study lessons associated with atscale distribution in Sokoto State, North West Nigeria. Methods and Findings Under state government leadership, a community-based distribution system overseen by 244 ward development committees and over 3,440 community-based health volunteers and community drug keepers, was activated to deliver two locally stored medicines to women when labor commenced. Newborns and their mothers were tracked through 28 days and 42 days respectively, including verbal autopsy results. 36,404 or 26.3% of expected newborns received the gel from April 2013 to December 2013 throughout all 244 wards in the State. 99.97% of newborns survived past 28 days. There were 124 pre-verified neonatal deaths reported. Upon verification using verbal autopsy procedures, 76 deaths were stillborn and 48 were previously live births. Among the previous 48 live births, the main causes of death were sepsis (40%), asphyxia (29%) and prematurity (8%). Underuse of logistics management information by government in procurement decisions and not accounting for differences in LGA population sizes during commodity distribution, severely limited program scalability. Conclusions Enhancements in the predictable availability and supply of chlorhexidine digluconate 7.1% gel to communities through better, evidence-based logistics management by the state public sector will most likely dramatically increase program scalability. Infections as a cause of mortality in babies delivered in home settings may be much higher than previously conceived. In tandem with high prevalence of stillborn deaths, delivery, interventions designed to increase mothers' timely and regular use of quality antenatal care, and increased facility-based based delivery, need urgent attention. We call for accelerated investments in community health volunteer programs and the requisite community measurement systems to better track coverage. We also advocate for the development, refinement and use of routine community-based verbal autopsies to track newborn and maternal survival.	[Orobaton, Nosakhare; Abegunde, Dele; Shoretire, Kamil; Abdulazeez, Jumare; Fapohunda, Bolaji; Maishanu, Abubakar; Ganiyu, Akeem; Ndifon, Eric; Gwamzhi, Ringpon] United States Agcy Int Dev, Targeted States High Impact Project, Sokoto, Nigeria; [Shoretire, Kamil] Jhpiego, Baltimore, MD USA; [Orobaton, Nosakhare; Abegunde, Dele; Abdulazeez, Jumare; Fapohunda, Bolaji; Maishanu, Abubakar; Ganiyu, Akeem; Ndifon, Eric; Gwamzhi, Ringpon] John Snow Inc, Res & Training Inst, Boston, MA USA; [Lamiri, Goli] European Union Support Immunizat Governance Niger, EU SIGN Project, Abuja, Nigeria; [Osborne-Smith, Matthew] Partners Hlth, Boston, MA USA	Jhpiego; Partners Healthcare System	Orobaton, N (corresponding author), United States Agcy Int Dev, Targeted States High Impact Project, Sokoto, Nigeria.	norobaton@jsi.com						Chlorhexidine Navi Care Program JSI Research & Training Institute I, CHLORH NEP PUBL PRIV; Dickson KE, 2014, LANCET, V384, P438, DOI 10.1016/S0140-6736(14)60582-1; Federal Republic of Nigeria, 2013, COUNTR IMPL PLAN PRI; Finlayson K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001373; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; JSI Research & Training Institute I, 2013, INTR CHLORH NEP; Lawn JE, 2004, LANCET, V364, P2020, DOI 10.1016/S0140-6736(04)17511-9; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Maron D.F., 2013, SCI AM, V309; Nasir SG, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001687; National Population Commission (NPC) [Nigeria] ICF International, 2014, NIG DEM HLTH SURV 20; National Population Commission (NPC) Sokoto State Nigeria, 2013, POP DAT EXP BIRTH LG; Olatunji Alabi, 2014, GLOBAL HLTH ACTION, P23368; Olatunji Alabi, 2014, INT J EPIDEMIOL, P1; Shah R, 2010, J HEALTH POPUL NUTR, V28, P610; Sokoto State Government Nigeria, 2015, GEN INF SOK STAT GOV; Sokpo Emmanuel, PRIMARY HLTH CARE ON; United Nations, 2014, MILL DEV GOALS REP 2; United Nations Development Programme Nigeria GoTFRo, 2007, NIG DELT PIL LOC DEV; USAID/Targeted States High Impact Project (TSHIP), 2014, ANN REPORT; Walsh, 2006, ROLE TRADITIONAL RUL; WHO, 2014, WHO TECH REP SER, V985, P1; World Bank, 2010, IMPR PRIM HLTH CAR D, P90; World Health Organization, 2012, SEL US ESS MED REP W, Vxiv; World Health Organization, 2013, US ESS MED REP 19 WH; World Health Organization Department of Maternal N, 2013, WHO REC POSTN CAR MO	26	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134040	10.1371/journal.pone.0134040	http://dx.doi.org/10.1371/journal.pone.0134040			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226017	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700052
J	Kerk, D; Silver, D; Uhrig, RG; Moorhead, GBG				Kerk, David; Silver, Dylan; Uhrig, R. Glen; Moorhead, Greg B. G.			"PP2C7s", Genes Most Highly Elaborated in Photosynthetic Organisms, Reveal the Bacterial Origin and Stepwise Evolution of PPM/PP2C Protein Phosphatases	PLOS ONE			English	Article							3RD METAL; EXPRESSION ANALYSIS; GENOME-WIDE; ATTED-II; ARABIDOPSIS; 2C; IDENTIFICATION; DOMAIN; SEQUENCE; MITOCHONDRIAL	Mg+2/Mn+2-dependent type 2C protein phosphatases (PP2Cs) are ubiquitous in eukaryotes, mediating diverse cellular signaling processes through metal ion catalyzed dephosphorylation of target proteins. We have identified a distinct PP2C sequence class ("PP2C7s") which is nearly universally distributed in Eukaryotes, and therefore apparently ancient. PP2C7s are by far most prominent and diverse in plants and green algae. Combining phylogenetic analysis, subcellular localization predictions, and a distillation of publically available gene expression data, we have traced the evolutionary trajectory of this gene family in photosynthetic eukaryotes, demonstrating two major sequence assemblages featuring a succession of increasingly derived sub-clades. These display predominant expression moving from an ancestral pattern in photosynthetic tissues toward non-photosynthetic, specialized and reproductive structures. Gene co-expression network composition strongly suggests a shifting pattern of PP2C7 gene functions, including possible regulation of starch metabolism for one homologue set in Arabidopsis and rice. Distinct plant PP2C7 sub-clades demonstrate novel amino terminal protein sequences upon motif analysis, consistent with a shifting pattern of regulation of protein function. More broadly, neither the major events in PP2C sequence evolution, nor the origin of the diversity of metal binding characteristics currently observed in different PP2C lineages, are clearly understood. Identification of the PP2C7 sequence clade has allowed us to provide a better understanding of both of these issues. Phylogenetic analysis and sequence comparisons using Hidden Markov Models strongly suggest that PP2Cs originated in Bacteria (Group II PP2C sequences), entered Eukaryotes through the ancestral mitochondrial endosymbiosis, elaborated in Eukaryotes, then re-entered Bacteria through an inter-domain gene transfer, ultimately producing bacterial Group I PP2C sequences. A key evolutionary event, occurring first in ancient Eukaryotes, was the acquisition of a conserved aspartate in classic Motif 5. This has been inherited subsequently by PP2C7s, eukaryotic PP2Cs and bacterial Group I PP2Cs, where it is crucial to the formation of a third metal binding pocket, and catalysis.	[Kerk, David; Silver, Dylan; Uhrig, R. Glen; Moorhead, Greg B. G.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Moorhead, GBG (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	moorhead@ucalgary.ca	Gruissem, Wilhelm/H-1752-2013	Uhrig, R Glen/0000-0003-2773-4381	Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Technology Futures; Killam Trusts	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Technology Futures; Killam Trusts	This work was supported by the Natural Sciences and Engineering Research Council of Canada (GBGM), Alberta Innovates Technology Futures (GBGM), and the Killam Trusts (GBGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Aravind L, 2003, CURR OPIN MICROBIOL, V6, P490, DOI 10.1016/j.mib.2003.09.003; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Arino J, 2011, EUKARYOT CELL, V10, P21, DOI 10.1128/EC.00249-10; Armant MA, 2002, GENOME BIOL, V3; Bellinzoni M, 2007, STRUCTURE, V15, P863, DOI 10.1016/j.str.2007.06.002; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bleichert F, 2006, P NATL ACAD SCI USA, V103, P9464, DOI 10.1073/pnas.0603673103; Bork P, 1996, PROTEIN SCI, V5, P1421, DOI 10.1002/pro.5560050720; Brautigan DL, 2013, FEBS J, V280, P324, DOI 10.1111/j.1742-4658.2012.08609.x; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cencil U, 2014, TRENDS PLANT SCI, V19, P18, DOI 10.1016/j.tplants.2013.08.004; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; Deutscher J, 2005, J MOL MICROB BIOTECH, V9, P125, DOI 10.1159/000089641; DiGuistini S, 2011, P NATL ACAD SCI USA, V108, P2504, DOI 10.1073/pnas.1011289108; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dunin-Horkawicz S, 2014, J MOL BIOL, V426, P1568, DOI 10.1016/j.jmb.2013.11.030; Dupeux F, 2011, PLANT PHYSIOL, V156, P106, DOI 10.1104/pp.110.170894; Facchinelli F, 2013, TRENDS PLANT SCI, V18, P673, DOI 10.1016/j.tplants.2013.09.006; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Fuchs S, 2013, FEBS J, V280, P681, DOI 10.1111/j.1742-4658.2012.08670.x; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Hao Q, 2011, MOL CELL, V42, P662, DOI 10.1016/j.molcel.2011.05.011; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hooper CM, 2014, BIOINFORMATICS, V30, P3356, DOI 10.1093/bioinformatics/btu550; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hu XB, 2006, PHYSIOL PLANTARUM, V127, P225, DOI 10.1111/j.1399-3054.2006.00671.x; Huang JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r99; Joshi M, 2007, BIOCHEM BIOPH RES CO, V356, P38, DOI 10.1016/j.bbrc.2007.02.108; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; Keeling Patrick J., 2009, V532, P501, DOI [10.1007/978-1-60327-853-9-29, 10.1007/978-1-60327-853-9_29]; Kennelly PJ, 2002, FEMS MICROBIOL LETT, V206, P1, DOI 10.1016/S0378-1097(01)00479-7; Kerk D, 2002, PLANT PHYSIOL, V129, P908, DOI 10.1104/pp.004002; Kerk David, 2007, V365, P347; Kerk D, 2008, PLANT PHYSIOL, V146, P351, DOI 10.1104/pp.107.111393; Kim KN, 1999, PLANT PHYSIOL, V121, P225, DOI 10.1104/pp.121.1.225; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Le Guezennec X, 2010, TRENDS BIOCHEM SCI, V35, P109, DOI 10.1016/j.tibs.2009.09.005; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Levdikov VM, 2012, J MOL BIOL, V415, P343, DOI 10.1016/j.jmb.2011.11.017; Lohmeier-Vogel EM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-120; Lu G, 2008, CLIN EXP PHARMACOL P, V35, P107, DOI 10.1111/j.1440-1681.2007.04843.x; Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; MCGOWAN CH, 1987, EUR J BIOCHEM, V166, P713, DOI 10.1111/j.1432-1033.1987.tb13570.x; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Miller MA, 2010, GATEWAY COMPUTING EN; Mittenhuber G, 2002, J MOL MICROB BIOTECH, V4, P427; Moliner C, 2010, FEMS MICROBIOL REV, V34, P281, DOI [10.1111/j.1574-6976.2009.00209.x, 10.1111/j.1574-6976.2010.00209.x]; Moorhead GBG, 2009, BIOCHEM J, V417, P401, DOI 10.1042/BJ20081986; Mutwil M, 2011, PLANT CELL, V23, P895, DOI 10.1105/tpc.111.083667; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Obayashi T, 2014, PLANT CELL PHYSIOL, V55, DOI 10.1093/pcp/pct178; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pane-Farre J, 2005, J MOL MICROB BIOTECH, V9, P65, DOI 10.1159/000088837; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Pertseva M N, 2009, Neurosci Behav Physiol, V39, P793, DOI 10.1007/s11055-009-9190-y; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Pullen KE, 2004, STRUCTURE, V12, P1947, DOI 10.1016/j.str.2004.09.008; Quin MB, 2012, STRUCTURE, V20, P350, DOI 10.1016/j.str.2012.01.003; Ramos CW, 2000, IUBMB LIFE, V50, P371, DOI 10.1080/152165400300089411; Rantanen MK, 2007, FEBS J, V274, P3128, DOI 10.1111/j.1742-4658.2007.05845.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Samol I, 2012, PLANT CELL, V24, P2596, DOI 10.1105/tpc.112.095703; Sato Y, 2013, NUCLEIC ACIDS RES, V41, pD1214, DOI 10.1093/nar/gks1122; Sato Y, 2011, NUCLEIC ACIDS RES, V39, pD1141, DOI 10.1093/nar/gkq1085; Schlicker C, 2008, J MOL BIOL, V376, P570, DOI 10.1016/j.jmb.2007.11.097; Schliebner I, 2008, CURR GENOMICS, V9, P184, DOI 10.2174/138920208784340740; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Shi L, 1998, FEMS MICROBIOL REV, V22, P229, DOI 10.1016/S0168-6445(98)00015-1; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silver DM, 2014, TRENDS PLANT SCI, V19, P471, DOI 10.1016/j.tplants.2014.01.008; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-435; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stern A, 2007, J MOL EVOL, V64, P61, DOI 10.1007/s00239-006-0033-y; Su JY, 2011, J BIOL CHEM, V286, P13481, DOI 10.1074/jbc.M109.036467; Tanoue K, 2013, BIOCHEMISTRY-US, V52, P5830, DOI 10.1021/bi4005649; Tanz SK, 2013, NUCLEIC ACIDS RES, V41, pD1185, DOI 10.1093/nar/gks1151; Tardif M, 2012, MOL BIOL EVOL, V29, P3625, DOI 10.1093/molbev/mss178; Tovar-Mendez A, 2014, PROTOPLASMA, V251, P265, DOI 10.1007/s00709-013-0526-7; Tyra HM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r212; Uhrig RG, 2013, PLANT PHYSIOL, V163, P1829, DOI 10.1104/pp.113.224378; Uhrig RG, 2013, TRENDS PLANT SCI, V18, P505, DOI 10.1016/j.tplants.2013.05.004; Voss M, 2011, CELL SIGNAL, V23, P114, DOI 10.1016/j.cellsig.2010.08.010; Wang S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01448; Wang S, 2011, BIOINFORMATICS, V27, P2537, DOI 10.1093/bioinformatics/btr432; Wei KF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-773; Xue TT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-550; Zhang WW, 2004, MICROBIOL-SGM, V150, P4189, DOI 10.1099/mic.0.27480-0	108	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0132863	10.1371/journal.pone.0132863	http://dx.doi.org/10.1371/journal.pone.0132863			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241330	Green Published, gold			2022-12-27	WOS:000358942700007
J	Yang, L; Wang, GS; Zhao, XY; Ye, S; Shen, P; Wang, WL; Zheng, SS				Yang, Liu; Wang, Guosheng; Zhao, Xinyi; Ye, Song; Shen, Peng; Wang, Weilin; Zheng, Shusen			A Novel WRN Frameshift Mutation Identified by Multiplex Genetic Testing in a Family with Multiple Cases of Cancer	PLOS ONE			English	Article							WERNER-SYNDROME; COLORECTAL-CANCER; PROSTATE-CANCER; BREAST-CANCER; ACMG RECOMMENDATIONS; CLINICAL ONCOLOGY; DICER1 MUTATIONS; PROTEIN FUNCTION; RISK ASSESSMENT; SUSCEPTIBILITY	Next-generation sequencing technology allows simultaneous analysis of multiple susceptibility genes for clinical cancer genetics. In this study, multiplex genetic testing was conducted in a Chinese family with multiple cases of cancer to determine the variations in cancer predisposition genes. The family comprises a mother and her five daughters, of whom the mother and the eldest daughter have cancer and the secondary daughter died of cancer. We conducted multiplex genetic testing of 90 cancer susceptibility genes using the peripheral blood DNA of the mother and all five daughters. WRN frameshift mutation is considered a potential pathogenic variation according to the guidelines of the American College of Medical Genetics. A novel WRN frameshift mutation (p.N1370Tfs*23) was identified in the three cancer patients and in the youngest unaffected daughter. Other rare non-synonymous germline mutations were also detected in DICER and ELAC2. Functional mutations in WRN cause Werner syndrome, a human autosomal recessive disease characterized by premature aging and associated with genetic instability and increased cancer risk. Our results suggest that the WRN frameshift mutation is important in the surveillance of other members of this family, especially the youngest daughter, but the pathogenicity of the novel WRN frameshift mutation needs to be investigated further. Given its extensive use in clinical genetic screening, multiplex genetic testing is a promising tool in clinical cancer surveillance.	[Yang, Liu; Shen, Peng] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Liu] Zhejiang Prov Peoples Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China; [Wang, Guosheng] Zhejiang Univ, Dept Med Oncol, Affiliated Hosp 1, Beilun Branch,Sch Med, Ningbo, Zhejiang, Peoples R China; [Zhao, Xinyi; Ye, Song; Wang, Weilin; Zheng, Shusen] Minist Publ Hlth, Key Lab Organ Transplantat, Key Lab Combined Multiorgan Transplantat, Hangzhou, Zhejiang, Peoples R China; [Ye, Song; Wang, Weilin; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Div Hepatobiliary & Pancreat Surg,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Provincial People's Hospital; Zhejiang University; Zhejiang University	Zheng, SS (corresponding author), Minist Publ Hlth, Key Lab Organ Transplantat, Key Lab Combined Multiorgan Transplantat, Hangzhou, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn	yang, liu/GVU-8760-2022; wei, jiang/GRX-7907-2022	Wang, Guosheng/0000-0002-9548-1657	National High Technology Research and Development Program of China (863 Program) [2012AA02A205]; National Natural Science Foundation of China [J20121214]; Science Technology Department of Zhejiang Province [2011C23088]; Medical Science Research Foundation of Health Bureau of Zhejiang Province [2012KYB070]; National ST Major Project [2012ZX10002017]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81121002]; Research Special Fund for Public Welfare Industry of Health [201202007]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Department of Zhejiang Province; Medical Science Research Foundation of Health Bureau of Zhejiang Province; National ST Major Project; Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Special Fund for Public Welfare Industry of Health	Supported by the National High Technology Research and Development Program of China (863 Program, No. 2012AA02A205), the National Natural Science Foundation of China (No. J20121214), the Financial Support of Science Technology Department of Zhejiang Province (No. 2011C23088), the Medical Science Research Foundation of Health Bureau of Zhejiang Province (No. 2012KYB070), the National S&T Major Project (No. 2012ZX10002017), the Project Supported by the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (No. 81121002), and the Research Special Fund for Public Welfare Industry of Health (No. 201202007).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Beuten J, 2010, CANCER EPIDEM BIOMAR, V19, P588, DOI 10.1158/1055-9965.EPI-09-0864; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Bruinooge SS, 2003, J CLIN ONCOL, V21, P2397, DOI 10.1200/JCO.2003.03.189; Cheng WH, 2006, NUCLEIC ACIDS RES, V34, P2751, DOI 10.1093/nar/gkl362; Daly MB, 2010, J NATL COMPR CANC NE, V8, P562, DOI 10.6004/jnccn.2010.0043; Domchek SM, 2013, J CLIN ONCOL, V31, P1267, DOI 10.1200/JCO.2012.46.9403; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; Dumont M, 2004, BBA-GENE STRUCT EXPR, V1679, P230, DOI 10.1016/j.bbaexp.2004.07.001; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Heitzer E, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-129; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Huo X, 2007, BREAST CANCER RES TR, V102, P329, DOI 10.1007/s10549-006-9332-7; Jin ZB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4517; Karow JK, 2000, CURR OPIN GENET DEV, V10, P32, DOI 10.1016/S0959-437X(99)00039-8; Karppinen SM, 2006, J MED GENET, V43, P856, DOI 10.1136/jmg.2006.041731; Khan NP, 2011, MOL CELL BIOCHEM, V355, P149, DOI 10.1007/s11010-011-0848-8; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurian AW, 2014, J CLIN ONCOL, V32, P2001, DOI 10.1200/JCO.2013.53.6607; Ladabaum U, 2011, ANN INTERN MED, V155, P69, DOI 10.7326/0003-4819-155-2-201107190-00002; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Matsumoto T, 1998, INT J MOL MED, V1, P71; Mohaghegh P, 2001, HUM MOL GENET, V10, P741, DOI 10.1093/hmg/10.7.741; Moser MJ, 2000, NUCLEIC ACIDS RES, V28, P648, DOI 10.1093/nar/28.2.648; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Offit K, 2013, J CLIN ONCOL, V31, P2743, DOI 10.1200/JCO.2013.49.7388; Orren DK, 2006, FRONT BIOSCI-LANDMRK, V11, P2657, DOI 10.2741/1999; Rebbeck TR, 2000, AM J HUM GENET, V67, P1014, DOI 10.1086/303096; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Robson ME, 2010, J CLIN ONCOL, V28, P893, DOI 10.1200/JCO.2009.27.0660; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shen JC, 2000, TRENDS GENET, V16, P213, DOI 10.1016/S0168-9525(99)01970-8; Slade I, 2011, J MED GENET, V48, P273, DOI 10.1136/jmg.2010.083790; Stacey SN, 2006, PLOS MED, V3, P1103, DOI 10.1371/journal.pmed.0030217; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Wu MK, 2013, J PATHOL, V230, P154, DOI 10.1002/path.4196	39	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133020	10.1371/journal.pone.0133020	http://dx.doi.org/10.1371/journal.pone.0133020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241669	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942700009
J	Callaway, CW; Elmer, J; Guyette, FX; Molyneaux, BJ; Anderson, KB; Empey, PE; Gerstel, SJ; Holquist, K; Repine, MJ; Rittenberger, JC				Callaway, Clifton W.; Elmer, Jonathan; Guyette, Francis X.; Molyneaux, Bradley J.; Anderson, Kacey B.; Empey, Philip E.; Gerstel, Stacy J.; Holquist, Kate; Repine, Melissa J.; Rittenberger, Jon C.			Dexmedetomidine Reduces Shivering during Mild Hypothermia in Waking Subjects	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; PERCUTANEOUS CORONARY INTERVENTION; TARGETED TEMPERATURE MANAGEMENT; RANDOMIZED CLINICAL-TRIAL; 4-DEGREES-C NORMAL SALINE; AGITATION-SEDATION SCALE; HOSPITAL CARDIAC-ARREST; HEALTHY-VOLUNTEERS; INTENSIVE-CARE; ADDITIVELY REDUCE	Background and Purpose Reducing body temperature can prolong tolerance to ischemic injury such as stroke or myocardial infarction, but is difficult and uncomfortable in awake patients because of shivering. We tested the efficacy and safety of the alpha-2-adrenergic agonist dexmedetomidine for suppressing shivering induced by a rapid infusion of cold intravenous fluids. Methods Ten subjects received a rapid intravenous infusion of two liters of cold (4 degrees C) isotonic saline on two separate test days, and we measured their core body temperature, shivering, hemodynamics and sedation for two hours. On one test day, fluid infusion was preceded by placebo infusion. On the other test day, fluid infusion was preceded by 1.0 mu g/kg bolus of dexmedetomidine over 10 minutes. Results All ten subjects experienced shivering on placebo days, with shivering beginning at a mean (SD) temperature of 36.6 (0.3)degrees C. The mean lowest temperature after placebo was 36.0 (0.3)degrees C (range 35.7-36.5 degrees C). Only 3/10 subjects shivered on dexmedetomidine days, and the mean lowest temperature was 35.7 (0.4)degrees C (range 35.0-36.3 degrees C). Temperature remained below 36 degrees C for the full two hours in 6/10 subjects. After dexmedetomidine, subjects had moderate sedation and a mean 26 (13) mmHg reduction in blood pressure that resolved within 90 minutes. Heart rate declined a mean 23 (11) bpm after both placebo and dexmedetomidine. Dexmedetomidine produced no respiratory depression. Conclusion Dexmedetomidine decreases shivering in normal volunteers. This effect is associated with decreased systolic blood pressure and sedation, but no respiratory depression.	[Callaway, Clifton W.; Elmer, Jonathan; Guyette, Francis X.; Gerstel, Stacy J.; Holquist, Kate; Repine, Melissa J.; Rittenberger, Jon C.] Univ Pittsburgh, Appl Physiol Lab, Dept Emergency Med, Pittsburgh, PA 15260 USA; [Elmer, Jonathan; Molyneaux, Bradley J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Anderson, Kacey B.; Empey, Philip E.] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rittenberger, JC (corresponding author), Univ Pittsburgh, Appl Physiol Lab, Dept Emergency Med, Pittsburgh, PA 15260 USA.	rittjc@upmc.edu	Empey, Philip/L-9604-2019; , Francis/AAE-1586-2022	Empey, Philip/0000-0001-7474-2339; 	Pittsburgh Emergency Medicine Foundation; National Heart, Lung and Blood Institute - NHLBI [5K12HL109068]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL109068] Funding Source: NIH RePORTER	Pittsburgh Emergency Medicine Foundation; National Heart, Lung and Blood Institute - NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Pittsburgh Emergency Medicine Foundation (www.pemf.net) (JCR), and National Heart, Lung and Blood Institute - NHLBI 5K12HL109068 (http://www.nhlbi.nih.gov/research/training/emergency-med-k12) (JE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badjatia N, 2008, STROKE, V39, P3242, DOI 10.1161/STROKEAHA.108.523654; Carollo DS, 2008, CURR OPIN ANESTHESIO, V21, P457, DOI 10.1097/ACO.0b013e328305e3ef; Choi HA, 2011, NEUROCRIT CARE, V14, P389, DOI 10.1007/s12028-010-9474-7; Clifton GL, 2012, J NEUROSURG, V117, P714, DOI 10.3171/2012.6.JNS111690; Dae MW, 2002, AM J PHYSIOL-HEART C, V282, pH1584, DOI 10.1152/ajpheart.00980.2001; De Georgia MA, 2004, NEUROLOGY, V63, P312, DOI 10.1212/01.WNL.0000129840.66938.75; De Wolf AM, 2001, ANESTH ANALG, V93, P1205, DOI 10.1097/00000539-200111000-00031; Dewhirst Elisabeth, 2011, J Pediatr Pharmacol Ther, V16, P113, DOI 10.5863/1551-6776-16.2.113; Dixon SR, 2002, J AM COLL CARDIOL, V40, P1928, DOI 10.1016/S0735-1097(02)02567-6; Doufas AG, 2003, STROKE, V34, P1218, DOI 10.1161/01.STR.0000068787.76670.A4; DYCK JB, 1993, ANESTHESIOLOGY, V78, P813, DOI 10.1097/00000542-199305000-00002; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Hemmen TM, 2010, STROKE, V41, P2265, DOI 10.1161/STROKEAHA.110.592295; Holliday SF, 2014, SCI WORLD J, DOI 10.1155/2014/805013; Hostler D, 2010, DRUG METAB DISPOS, V38, P781, DOI 10.1124/dmd.109.031377; Hostler D, 2009, APPL PHYSIOL NUTR ME, V34, P582, DOI 10.1139/H09-011; Iirola T, 2011, CRIT CARE, V15, DOI 10.1186/cc10518; Jakob SM, 2014, BRIT J ANAESTH, V112, P581, DOI 10.1093/bja/aeu032; Kandzari DE, 2004, AM J CARDIOL, V93, P636, DOI 10.1016/j.amjcard.2003.11.038; Kim F, 2005, CIRCULATION, V112, P715, DOI 10.1161/CIRCULATIONAHA.105.544528; Kim F, 2007, CIRCULATION, V115, P3064, DOI 10.1161/CIRCULATIONAHA.106.655480; Kimberger O, 2007, CRIT CARE, V11, DOI 10.1186/cc5709; Kollmar R, 2012, INT J STROKE, V7, P168, DOI 10.1111/j.1747-4949.2011.00707.x; Komatsu R, 2006, BRIT J ANAESTH, V96, P732, DOI 10.1093/bja/ael101; Kurz A, 1997, ANESTHESIOLOGY, V86, P1046, DOI 10.1097/00000542-199705000-00007; Lenhardt R, 2009, ANESTHESIOLOGY, V111, P110, DOI 10.1097/ALN.0b013e3181a979a3; Li WJ, 2009, J PHARMACEUT BIOMED, V50, P897, DOI 10.1016/j.jpba.2009.06.012; Liu Y, 2013, CASE REP MED, V2013, DOI 10.1155/2013/358182; Ly HQ, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.200502.049; Lyden Patrick D, 2005, J Stroke Cerebrovasc Dis, V14, P107, DOI 10.1016/j.jstrokecerebrovasdis.2005.01.001; Lyden PD, 2014, INT J STROKE, V9, P117, DOI 10.1111/ijs.12151; Madden CJ, 2013, J NEUROSCI, V33, P2017, DOI 10.1523/JNEUROSCI.4701-12.2013; MCCLEARY P, 1982, NEUROPHARMACOLOGY, V21, P1337, DOI 10.1016/0028-3908(82)90143-5; Moore TM, 2008, ANN EMERG MED, V51, P153, DOI 10.1016/j.annemergmed.2007.07.012; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; O'Brien C, 1998, MED SCI SPORT EXER, V30, P468, DOI 10.1097/00005768-199803000-00020; Paris A, 2005, ANESTH ANALG, V100, P102, DOI 10.1213/01.ANE.0000139355.86522.D1; Richards JR, 2015, DRUG ALCOHOL DEPEN, V150, P1, DOI 10.1016/j.drugalcdep.2015.01.040; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Rincon F, 2014, INT J STROKE, V9, P646, DOI 10.1111/ijs.12220; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Takada K, 2002, ANESTHESIOLOGY, V96, P1420, DOI 10.1097/00000542-200206000-00022; Talke P, 1997, ANESTHESIOLOGY, V87, P835, DOI 10.1097/00000542-199710000-00017; Valitalo PA, 2013, CLIN DRUG INVEST, V33, P579, DOI 10.1007/s40261-013-0101-1; Venn RM, 2002, BRIT J ANAESTH, V88, P669, DOI 10.1093/bja/88.5.669	45	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0129709	10.1371/journal.pone.0129709	http://dx.doi.org/10.1371/journal.pone.0129709			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237219	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000358942400004
J	Espinar, MJ; Miranda, IM; Costa-de-Oliveira, S; Rocha, R; Rodrigues, AG; Pina-Vaz, C				Espinar, Maria Jose; Miranda, Isabel M.; Costa-de-Oliveira, Sofia; Rocha, Rita; Rodrigues, Acacio G.; Pina-Vaz, Cidalia			Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum beta-Lactamases: Risk Factors and Molecular Epidemiology	PLOS ONE			English	Article							AMPLIFIED POLYMORPHIC DNA; INTENSIVE-CARE-UNIT; CTX-M ENZYMES; RENAL-TRANSPLANTATION; ANTIBIOTIC-RESISTANCE; ENTEROBACTERIACEAE; RECIPIENTS; COMMUNITY; RECURRENT; BACTEREMIA	Urinary tract infection (UTI) is a common complication after kidney transplantation, often associated to graft loss and increased healthcare costs. Kidney transplant patients (KTPs) are particularly susceptible to infection by Enterobacteriaceae-producing extended-spectrum beta-lactamases (ESBLs). A retrospective case-control study was conducted to identify independent risk factors for ESBL-producing Escherichia coli and Klebsiella pneumoniae in non-hospitalized KTPs with UTI. Forty-nine patients suffering from UTI by ESBL-producing bacteria (ESBL-P) as case group and the same number of patients with UTI by ESBL negative (ESBL-N) as control-group were compared. Clinical data, renal function parameters during UTI episodes, UTI recurrence and relapsing rate, as well as risk factors for recurrence, molecular characterization of isolates and the respective antimicrobial susceptibility profile were evaluated. Diabetes mellitus (p <0.007), previous antibiotic prophylaxis (p=0.017) or therapy (p<0.001), previous UTI (p=0.01), relapsing infection (p=0.019) and patients with delayed graft function after transplant (p=0.001) represented risk factors for infection by ESBL positive Enterobacteriaceae in KTPs. Interestingly, the period of time between data of transplantation and data of UTI was shorter in case of ESBL-P case-group (28.8 months) compared with ESBL-N control-group (50.9 months). ESBL-producing bacteria exhibited higher resistance to fluoroquinolones (p=0.002), trimethoprim-sulfamethoxazole (p<0.001) and gentamicin (p<0.001). Molecular analysis showed that bla(CTX-M) was the most common ESBL encoding gene (65.3%), although in 55.1% of the cases more than one ESBL gene was found. In 29.4% of K. pneumoniae isolates, three bla-genes (bla(CTX-M)-bla(TEM)-bla(SHV)) were simultaneously detected. Low estimated glomerular filtration rate (p=0.009) was found to be risk factor for UTI recurrence. Over 60% of recurrent UTI episodes were caused by genetically similar strains. UTI by ESBL-producing	[Espinar, Maria Jose; Miranda, Isabel M.; Costa-de-Oliveira, Sofia; Rocha, Rita; Rodrigues, Acacio G.; Pina-Vaz, Cidalia] Univ Porto, Fac Med, Dept Microbiol, P-4100 Oporto, Portugal; [Espinar, Maria Jose; Rodrigues, Acacio G.; Pina-Vaz, Cidalia] Hosp Sao Joao, Dept Clin Pathol, Oporto, Portugal; [Miranda, Isabel M.; Costa-de-Oliveira, Sofia; Pina-Vaz, Cidalia] Univ Porto, CINTESIS Ctr Hlth Technol & Serv Res, Fac Med, P-4100 Oporto, Portugal	Universidade do Porto; Sao Joao Hospital; Universidade do Porto	Pina-Vaz, C (corresponding author), Univ Porto, Fac Med, Dept Microbiol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	cpinavaz@yahoo.com	Pina-Vaz, Cidália/K-1835-2013; Miranda, Isabel M./B-2017-2009; Oliveira, Sofia/K-2156-2013; Rodrigues, Acacio G/K-1467-2013; Rocha, Rita/M-9564-2013	Pina-Vaz, Cidália/0000-0003-4936-1301; Miranda, Isabel M./0000-0003-4839-1613; Oliveira, Sofia/0000-0003-2899-6615; Rodrigues, Acacio G/0000-0003-4246-5212; Rocha, Rita/0000-0003-1193-8320				Abbott KC, 2004, AM J KIDNEY DIS, V44, P353, DOI 10.1053/j.ajkd.2004.04.040; Ariza-Heredia EJ, 2013, ANN TRANSPL, V18, P195, DOI 10.12659/AOT.883901; Bagattini M, 2006, J ANTIMICROB CHEMOTH, V57, P979, DOI 10.1093/jac/dkl077; Bodro M, 2015, AM J TRANSPLANT, V15, P1021, DOI 10.1111/ajt.13075; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; BRADFORD PA, 1995, ANTIMICROB AGENTS CH, V39, P899, DOI 10.1128/AAC.39.4.899; Bush K, 2011, ANNU REV MICROBIOL, V65, P455, DOI 10.1146/annurev-micro-090110-102911; Carattoli A, 2013, INT J MED MICROBIOL, V303, P298, DOI 10.1016/j.ijmm.2013.02.001; CLSI, 2011, M100S20 CLSI, P172; Coque TM, 2008, EURO SURVEILL, V13; D'Andrea MM, 2013, INT J MED MICROBIOL, V303, P305, DOI 10.1016/j.ijmm.2013.02.008; de Souza RM, 2008, NAT CLIN PRACT NEPHR, V4, P252, DOI 10.1038/ncpneph0781; Dhanji H, 2011, J ANTIMICROB CHEMOTH, V66, P297, DOI 10.1093/jac/dkq463; EISEN D, 1995, J CLIN MICROBIOL, V33, P713, DOI 10.1128/JCM.33.3.713-717.1995; Espinar MJ, 2011, J MED MICROBIOL, V60, P756, DOI 10.1099/jmm.0.024075-0; Goyal A, 2009, INDIAN J MED RES, V129, P695; Lautenbach E, 2001, CLIN INFECT DIS, V32, P1162, DOI 10.1086/319757; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2013, AM J KIDNEY DIS, V61, P686, DOI 10.1053/j.ajkd.2013.03.003; Lim JH, 2013, TRANSPL P, V45, P1584, DOI 10.1016/j.transproceed.2012.12.011; Linares L, 2008, AM J TRANSPLANT, V8, P1000, DOI 10.1111/j.1600-6143.2008.02197.x; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; Lucet JC, 1996, CLIN INFECT DIS, V22, P430, DOI 10.1093/clinids/22.3.430; Machado E, 2007, J ANTIMICROB CHEMOTH, V60, P1370, DOI 10.1093/jac/dkm381; Mendonca N, 2007, ANTIMICROB AGENTS CH, V51, P1946, DOI 10.1128/AAC.01412-06; Mitra Subhashis, 2011, Curr Infect Dis Rep, V13, P579, DOI 10.1007/s11908-011-0210-z; Mugnaioli C, 2006, ANTIMICROB AGENTS CH, V50, P2700, DOI 10.1128/AAC.00068-06; Nowrouzian F, 2003, PEDIATR RES, V54, P8, DOI 10.1203/01.PDR.0000069843.20655.EE; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pinheiro HS, 2010, TRANSPL P, V42, P486, DOI 10.1016/j.transproceed.2010.02.002; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Pournaras S, 2004, J ANTIMICROB CHEMOTH, V54, P574, DOI 10.1093/jac/dkh323; Ramadas P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091289; Rodriguez-Bano J, 2004, J CLIN MICROBIOL, V42, P1089, DOI 10.1128/JCM.42.3.1089-1094.2004; Rodriguez-Bano J, 2006, CLIN INFECT DIS, V43, P1407, DOI 10.1086/508877; Rodriguez-Bano J, 2010, J CLIN MICROBIOL, V48, P1726, DOI 10.1128/JCM.02353-09; Tumbarello M, 2007, ANTIMICROB AGENTS CH, V51, P1987, DOI 10.1128/AAC.01509-06; Vidal E, 2012, TRANSPL INFECT DIS, V14, P595, DOI 10.1111/j.1399-3062.2012.00744.x; WONG NACS, 1994, EPIDEMIOL INFECT, V113, P445, DOI 10.1017/S095026880006845X; Wu SW, 2013, J FORMOS MED ASSOC, V112, P138, DOI 10.1016/j.jfma.2012.01.010	40	42	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134737	10.1371/journal.pone.0134737	http://dx.doi.org/10.1371/journal.pone.0134737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237422	gold, Green Published, Green Submitted			2022-12-27	WOS:000358942400036
J	Abramczuk, E; Stepinska, J; Hryniewiecki, T				Abramczuk, Elzbieta; Stepinska, Janina; Hryniewiecki, Tomasz			Twenty-Year Experience in the Diagnosis and Treatment of Infective Endocarditis	PLOS ONE			English	Article							PROSTHETIC VALVE ENDOCARDITIS; LONG-TERM PROGNOSIS; CLINICAL-FEATURES; RISK-FACTORS; EPIDEMIOLOGY; REPLACEMENT; 10-YEAR; SURGERY; CULTURE; MICROBIOLOGY	Aims The aim of this study was to compare the etiology, clinical course, selected diagnostic methods and efficacy of the treatment used in patients with infective endocarditis (IE) in the nineteen eighties and nineties. Material and Methods The study group comprised 300 patients with infective endocarditis hospitalized in the Institute of Cardiology in Warsaw in the following years: from 1982 to 1987 (150 patients: 75 successive patients with IE on the prosthetic valve and 75 successive patients with IE on the native valve), as well as from 1990 to 2003 (150 patients: 75 successive patients with IE on the prosthetic valve and 75 successive patients with IE on the native valve). Results In the nineties, immunological symptoms, embolism formation and progressive heart failure were diagnosed decidedly more frequently. Early prosthetic valve endocarditis (PVE) (up to 60 days after operation) occurred significantly more frequently in the eighties. The quantity of negative blood cultures in PVE has not decreased, it is still observed in over 20% of cases. For 20 years the etiology of PVE has remained the same, the dominant pathogen remains Staphylococcus. The frequency of PVE caused by Streptococci has markedly reduced. In both the decades analyzed the etiology of native valve endocarditis (NVE) was similar. In the eighties Streptococcus was predominant. In successive years the number of infections caused by Staphylococci was the same as that caused by Streptococci. Conclusions The incidence of early PVE decreased in the nineties. More patients were treated surgically with lesser peri-operative mortality. A lower incidence of infective endocarditis on prosthetic valves caused by streptococci may signify better prophylaxis against infective endocarditis. Infective endocarditis with sterile blood cultures continues to occur frequently.	[Abramczuk, Elzbieta; Stepinska, Janina; Hryniewiecki, Tomasz] Inst Cardiol, Warsaw, Poland	Institute of Cardiology - Poland	Abramczuk, E (corresponding author), Inst Cardiol, Warsaw, Poland.	e.abramczuk@ikard.pl						Ako J, 2003, CIRC J, V67, P3, DOI 10.1253/circj.67.3; Alexiou C, 2000, ANN THORAC SURG, V69, P1448, DOI 10.1016/S0003-4975(00)01139-5; Bayer A, AM J MED, V96, P211; Castillo JC, 2000, HEART, V83, P525, DOI 10.1136/heart.83.5.525; Castillo JC, 2004, AM J CARDIOL, V93, P1185, DOI 10.1016/j.amjcard.2004.01.056; Castillo JC, 2002, AM J CARDIOL, V90, P1266, DOI 10.1016/S0002-9149(02)02851-5; Cecchi E, 2015, INT J CARDIOL, V190, P151, DOI 10.1016/j.ijcard.2015.04.123; Choussat R, 1999, EUR HEART J, V20, P232, DOI 10.1053/euhj.1998.1240; DELAHAYE F, 1995, EUR HEART J, V16, P48, DOI 10.1093/eurheartj/16.suppl_B.48; Delay D, 2000, ANN THORAC SURG, V70, P1219, DOI 10.1016/S0003-4975(00)01887-7; Dunne B, 2014, HEART LUNG CIRC, V23, P628, DOI 10.1016/j.hlc.2014.02.010; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; Fefer P, 2002, EUR J CLIN MICROBIOL, V21, P432, DOI 10.1007/s10096-002-0740-2; FOWLER VG, 1994, CURR OPIN CARDIOL, V9, P389, DOI 10.1097/00001573-199405000-00018; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; Horstkotte D, 2004, EUR HEART J, V25, P267, DOI 10.1016/j.ehj.2003.11.008; Hryniewiecki T, 2002, J HEART VALVE DIS, V11, P870; IVERT TSA, 1984, CIRCULATION, V69, P223, DOI 10.1161/01.CIR.69.2.223; Karchmer AW, 1992, INFECT ENDOCARDITIS, P225; KAY JH, 1961, NEW ENGL J MED, V264, P907, DOI 10.1056/NEJM196105042641804; KUYVENHOVEN JP, 1994, EUR J CARDIO-THORAC, V8, P420, DOI 10.1016/1010-7940(94)90083-3; Lamas CC, 1998, HEART, V79, P442, DOI 10.1136/hrt.79.5.442; Lytle BW, 1996, J THORAC CARDIOV SUR, V111, P198, DOI 10.1016/S0022-5223(96)70417-8; Mangoni ED, 2003, AM HEART J, V146, P311, DOI 10.1016/S0002-8703(02)94802-7; Marks DJB, 2015, QJM-INT J MED, V108, P219, DOI 10.1093/qjmed/hcu188; Morris AJ, 2003, CLIN INFECT DIS, V36, P697, DOI 10.1086/367842; Murtagh B, 2003, CURR OPIN CARDIOL, V18, P106, DOI 10.1097/00001573-200303000-00006; Netzer ROM, 2000, HEART, V84, P25, DOI 10.1136/heart.84.1.25; Netzer ROM, 2002, HEART, V88, P61, DOI 10.1136/heart.88.1.61; NISSEN H, 1992, EUR HEART J, V13, P872, DOI 10.1093/oxfordjournals.eurheartj.a060285; Pansini S, 1997, J HEART VALVE DIS, V6, P84; Pant S, 2015, J AM COLL CARDIOL, V65, P2070, DOI 10.1016/j.jacc.2015.03.518; Poesen K, 2014, ACTA CLIN BELG, V69, P183, DOI 10.1179/0001551214Z.00000000046; Prendergast BD, 2002, BRIT MED J, V325, P845, DOI 10.1136/bmj.325.7369.845; Raoult D, 1999, ANN INTERN MED, V131, P144, DOI 10.7326/0003-4819-131-2-199907200-00012; Renzulli A, 2000, EUR J CARDIO-THORAC, V17, P228, DOI 10.1016/S1010-7940(00)00342-0; Selton-Suty C, 2012, CLIN INFECT DIS, V54, P1230, DOI 10.1093/cid/cis199; Sexton Daniel J., 2003, Cardiology Clinics, V21, P273, DOI 10.1016/S0733-8651(03)00031-6; Thalme A, 1996, SCAND J INFECT DIS, V28, P407, DOI 10.3109/00365549609037928; TORNOS P, 1992, CHEST, V101, P37, DOI 10.1378/chest.101.1.37; Tornos P, 1995, EUR HEART J, V16, P1686; Tunkel A.R., 1992, INFECT ENDOCARDITIS, P85; Vlessis AA, 1996, ANN THORAC SURG, V61, P1217, DOI 10.1016/0003-4975(96)00029-X; VONREYN CF, 1981, ANN INTERN MED, V94, P505, DOI 10.7326/0003-4819-94-4-505; WALLACE AG, 1965, CIRCULATION, V31, P450, DOI 10.1161/01.CIR.31.3.450; Wallace SM, 2002, HEART, V88, P53, DOI 10.1136/heart.88.1.53; Watkin RW, 2003, J INFECTION, V47, P1, DOI 10.1016/S0163-4453(03)00003-3; Yankah AC, 2002, EUR J CARDIO-THORAC, V21, P260, DOI 10.1016/S1010-7940(01)01084-3	48	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134021	10.1371/journal.pone.0134021	http://dx.doi.org/10.1371/journal.pone.0134021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230402	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400068
J	Eikmeyer, FG; Heinl, S; Marx, H; Puhler, A; Grabherr, R; Schluter, A				Eikmeyer, Felix Gregor; Heinl, Stefan; Marx, Hans; Puehler, Alfred; Grabherr, Reingard; Schlueter, Andreas			Identification of Oxygen-Responsive Transcripts in the Silage Inoculant Lactobacillus buchneri CD034 by RNA Sequencing	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; AEROBIC STABILITY; PYRUVATE OXIDASE; GENE-EXPRESSION; GRASS-SILAGE; ACETIC-ACID; GROWTH; PLANTARUM; PHASE; STRESS	The Lactobacillus buchneri CD034 strain, known to improve the ensiling process of green fodder and the quality of the silage itself was transcriptionally analyzed by sequencing of transcriptomes isolated under anaerobic vs. aerobic conditions. L. buchneri CD034 was first cultivated under anaerobic conditions and then shifted to aerobic conditions by aeration with 21% oxygen. Cultivations already showed that oxygen was consumed by L. buchneri CD034 after aeration of the culture while growth of L. buchneri CD034 was still observed. RNA sequencing data revealed that irrespective of the oxygen status of the culture, the most abundantly transcribed genes are required for basic cell functions such as protein biosynthesis, energy metabolism and lactic acid fermentation. Under aerobic conditions, 283 genes were found to be transcriptionally up-regulated while 198 genes were found to be down-regulated (p-value < 0.01). Up-regulated genes i.a. play a role in oxygen consumption via oxidation of pyruvate or lactate (pox, lctO). Additionally, genes encoding proteins required for decomposition of reactive oxygen species (ROS) such as glutathione reductase or NADH peroxidase were also found to be up-regulated. Genes related to pH homeostasis and redox potential balance were found to be down-regulated under aerobic conditions. Overall, genes required for lactic acid fermentation were hardly affected by the growth conditions applied. Genes identified to be differentially transcribed depending on the aeration status of the culture are suggested to specify the favorable performance of the strain in silage formation.	[Eikmeyer, Felix Gregor; Puehler, Alfred; Schlueter, Andreas] Univ Bielefeld, Ctr Biotechnol, Inst Genome Res & Syst Biol, D-33615 Bielefeld, Germany; [Heinl, Stefan; Grabherr, Reingard] Univ Nat Resources & Life Sci, CD Lab Genet Engn Lact Acid Bacteria, Vienna, Austria; [Marx, Hans] Univ Nat Resources & Life Sci, CD Lab Biotechnol Glycerol, Vienna, Austria; [Heinl, Stefan; Marx, Hans; Grabherr, Reingard] Univ Nat Resources & Life Sci, Dept Biotechnol, BOKU VIBT, Vienna, Austria	University of Bielefeld; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Schluter, A (corresponding author), Univ Bielefeld, Ctr Biotechnol, Inst Genome Res & Syst Biol, D-33615 Bielefeld, Germany.	aschluet@cebitec.uni-bielefeld.de		Schluter, Andreas/0000-0003-4830-310X; Marx, Hans/0000-0002-0451-1719; Grabherr, Reingard/0000-0002-4501-927X; Puhler, Alfred/0000-0003-4723-2960	CLIB Graduate Cluster 'Industrial Biotechnology'; Ministry of Innovation, Science and Research of the German State of North Rhine-Westphalia; Bielefeld University; Deutsche Forschungsgemeinschaft	CLIB Graduate Cluster 'Industrial Biotechnology'; Ministry of Innovation, Science and Research of the German State of North Rhine-Westphalia; Bielefeld University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by CLIB Graduate Cluster 'Industrial Biotechnology' (www.graduatecluster.net), cofinanced by the Ministry of Innovation, Science and Research of the German State of North Rhine-Westphalia (www.wissenschaft.nrw.de) and Bielefeld University (www.uni-bielefeld.de), without grant number SH HM RG: Christian Doppler Forschungsgesellschaft (www.cdg.ac.at), without grant number FGE SH HM AP RG AS: Funding of the Article Processing Charge by the Deutsche Forschungsgemeinschaft (www.dfg.de) and the Open Access Publication Fund of Bielefeld University, without grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson KL, 2006, J BACTERIOL, V188, P6739, DOI 10.1128/JB.00609-06; Arena ME, 2008, J APPL MICROBIOL, V105, P158, DOI 10.1111/j.1365-2672.2008.03725.x; Azcarate-Peril MA, 2009, J DAIRY SCI, V92, P870, DOI 10.3168/jds.2008-1457; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barrangou R, 2012, LACTIC ACID BACTERIA: MICROBIOLOGICAL AND FUNCTIONAL ASPECTS, 4TH EDITION, P77; BOBILLO M, 1991, Food Microbiology (London), V8, P153, DOI 10.1016/0740-0020(91)90008-P; Burge SW, 2012, NUCL ACIDS RES, DOI 101093/nar/gks1005; Cesselin B, 2011, FOOD MICROBIOL FOOD, P111, DOI 10.1007/978-0-387-92771-8_6; Cohen DPA, 2006, PROTEOMICS, V6, P6485, DOI 10.1002/pmic.200600361; CONDON S, 1987, FEMS MICROBIOL LETT, V46, P269, DOI 10.1111/j.1574-6968.1987.tb02465.x; Danner H, 2003, APPL ENVIRON MICROB, V69, P562, DOI 10.1128/AEM.69.1.562-567.2003; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; Dien BS, 2006, BIOMASS BIOENERG, V30, P880, DOI 10.1016/j.biombioe.2006.02.004; Driehuis F, 2001, GRASS FORAGE SCI, V56, P330, DOI 10.1046/j.1365-2494.2001.00282.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eikmeyer FG, 2013, J BIOTECHNOL, V167, P334, DOI 10.1016/j.jbiotec.2013.07.021; Elferink SJWHO, 2001, APPL ENVIRON MICROB, V67, P125, DOI 10.1128/AEM.67.1.125-132.2001; Goffin P, 2006, APPL ENVIRON MICROB, V72, P7933, DOI 10.1128/AEM.00659-06; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; Grove A, 2011, CURR ISSUES MOL BIOL, V13, P1; Heinl S, 2012, J BIOTECHNOL, V161, P153, DOI 10.1016/j.jbiotec.2012.03.007; Heinl S, 2011, PLASMID, V66, P159, DOI 10.1016/j.plasmid.2011.08.002; Hertel C, 1998, APPL ENVIRON MICROB, V64, P1359; Hertzberger R, 2014, APPL ENVIRON MICROB, V80, P2229, DOI 10.1128/AEM.04272-13; Hilker R, 2014, BIOINFORMATICS, V30, P2247, DOI 10.1093/bioinformatics/btu205; Holzer M, 2003, TRENDS BIOTECHNOL, V21, P282, DOI 10.1016/S0167-7799(03)00106-9; Hynonen U, 2013, APPL MICROBIOL BIOT, V97, P5225, DOI 10.1007/s00253-013-4962-2; Ishak N, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-47; Khudyakov JI, 2012, P NATL ACAD SCI USA, V109, pE2173, DOI 10.1073/pnas.1112750109; Kim JH, 2009, MICROBIOL-SGM, V155, P1351, DOI 10.1099/mic.0.024653-0; Kleinschmit DH, 2006, J DAIRY SCI, V89, P4005, DOI 10.3168/jds.S0022-0302(06)72444-4; Laakso K, 2011, MICROB BIOTECHNOL, V4, P746, DOI 10.1111/j.1751-7915.2011.00275.x; Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, DETAILS FOR LACTOBAC; [LGC Standards American Type Culture Collection (ATCC)], LACT BUCHN HENN BERG; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093289; Lorquet F, 2004, J BACTERIOL, V186, P3749, DOI 10.1128/JB.186.12.3749-3759.2004; Lucas PM, 2007, MICROBIOL-SGM, V153, P2221, DOI 10.1099/mic.0.2007/006320-0; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Novichkov PS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-745; Pahlow G., 2003, SILAGE SCI TECHNOL, V42, P31, DOI [DOI 10.2134/AGRONMONOGR42.C2, 10.]; Pieterse B, 2006, J MICROBIOL METH, V64, P207, DOI 10.1016/j.mimet.2005.04.035; Quatravaux S, 2006, J APPL MICROBIOL, V101, P903, DOI 10.1111/j.1365-2672.2006.02955.x; Ravcheev DA, 2012, J BACTERIOL, V194, P1145, DOI 10.1128/JB.06412-11; Schwientek P, 2013, J BIOTECHNOL, V167, P166, DOI 10.1016/j.jbiotec.2012.10.019; Stevens MJA, 2010, APPL ENVIRON MICROB, V76, P3748, DOI 10.1128/AEM.00073-10; Suarez C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076170; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; Von Wright A, 2012, LACTIC ACID BACTERIA: MICROBIOLOGICAL AND FUNCTIONAL ASPECTS, 4TH EDITION, P1; Woolford M.K., 1998, MICROBIOLOGY FERMENT, P73, DOI [10.1007/978-1-4613-0309-1_3, DOI 10.1007/978-1-4613-0309-1_3]; Wu R, 2009, MOL CELL PROTEOMICS, V8, P2321, DOI 10.1074/mcp.M800483-MCP200; Zeng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060465; Zotta T, 2012, INT J FOOD MICROBIOL, V155, P51, DOI 10.1016/j.ijfoodmicro.2012.01.017	55	11	11	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134149	10.1371/journal.pone.0134149	http://dx.doi.org/10.1371/journal.pone.0134149			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230316	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400078
J	Helbig, AK; Stockl, D; Heier, M; Ladwig, KH; Meisinger, C				Helbig, A. Katharina; Stoeckl, Doris; Heier, Margit; Ladwig, Karl-Heinz; Meisinger, Christa			Symptoms of Insomnia and Sleep Duration and Their Association with Incident Strokes: Findings from the Population-Based MONICA/KORA Augsburg Cohort Study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; CAUSE-SPECIFIC MORTALITY; GERMAN HEALTH INTERVIEW; CARDIOVASCULAR-DISEASE; ISCHEMIC-STROKE; RISK-FACTOR; GENERAL-POPULATION; SEVERITY INDEX; QUALITY INDEX; HEART-DISEASE	Objective To examine the relationship between symptoms of insomnia and sleep duration and incident total (non-fatal plus fatal) strokes, non-fatal strokes, and fatal strokes in a large cohort of men and women from the general population in Germany. Methods In four population-based MONICA (monitoring trends and determinants in cardiovascular disease)/KORA (Cooperative Health Research in the Region of Augsburg) surveys conducted between 1984 and 2001, 17,604 men and women (aged 25 to 74 years) were asked about issues like sleep, health behavior, and medical history. In subsequent surveys and mortality follow-ups, incident stroke cases (cerebral hemorrhage, ischemic stroke, transient ischemic attack, unknown stroke type) were gathered prospectively until 2009. Sex-specific hazard ratios (HR) and their 95% confidence intervals (CI) were estimated using sequential Cox proportional hazards regression models. Results During a mean follow-up of 14 years, 917 strokes (710 non-fatal strokes and 207 fatal strokes) were observed. Trouble falling asleep and difficulty staying asleep were not significantly related to any incident stroke outcome in either sex in the multivariable models. Among men, the HR for the association between short (<= 5 hours) and long (>= 10 hours) daily sleep duration and total strokes were 1.44 (95% CI: 1.01-2.06) and 1.63 (95% CI: 1.16-2.29), after adjustment for basic confounding variables. As for non-fatal strokes and fatal strokes, in the analyses adjusted for age, survey, education, physical activity, alcohol consumption, smoking habits, body mass index, hypertension, diabetes, and dyslipidemia, the increased risks persisted, albeit somewhat attenuated, but no longer remained significant. Among women, in the multivariable analyses the quantity of sleep was also not related to any stroke outcome. Conclusion In the present study, symptoms of insomnia and exceptional sleep duration were not significantly predictive of incident total strokes, non-fatal strokes, and fatal strokes in either sex.	[Helbig, A. Katharina; Stoeckl, Doris; Heier, Margit; Ladwig, Karl-Heinz; Meisinger, Christa] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Ladwig, Karl-Heinz] Tech Univ Munich, Klinikum Rechts Isar, Dept Psychosomat Med & Psychotherapy, D-80290 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Helbig, AK (corresponding author), German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany.	Katharina.Helbig@helmholtz-muenchen.de	Heier, Margit/AAT-5280-2020; Meisinger, Christine/B-5358-2014; Ladwig, Karl-Heinz/B-5351-2014	Ladwig, Karl-Heinz/0000-0003-0710-1720; Meisinger, Christa/0000-0002-9026-6544	Helmholtz Zentrum Munchen, German Research Center for Environmental Health; German Federal Ministry of Education, Science, Research, and Technology; state of Bavaria	Helmholtz Zentrum Munchen, German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education, Science, Research, and Technology; state of Bavaria	The KORA (Cooperative Research in the Region of Augsburg) research platform is financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education, Science, Research, and Technology and by the state of Bavaria.	Aggarwal S, 2013, CLIN CARDIOL, V36, P671, DOI 10.1002/clc.22160; Aldabal Laila, 2011, Open Respir Med J, V5, P31, DOI 10.2174/1874306401105010031; Allison P, 2010, SURVIVAL ANAL USING; Altman NG, 2012, SLEEP MED, V13, P1261, DOI 10.1016/j.sleep.2012.08.005; Amagai Y, 2004, J EPIDEMIOL, V14, P124, DOI 10.2188/jea.14.124; Amagai Y, 2010, J EPIDEMIOL, V20, P106, DOI 10.2188/jea.JE20090053; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Backhaus J, 2002, J PSYCHOSOM RES, V53, P737, DOI 10.1016/S0022-3999(02)00330-6; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Birbaumer N., 2010, BIOL PSYCHOL, DOI [10.1007/978-3-540-95938-0, DOI 10.1007/978-3-540-95938-0]; BLIWISE DL, 1994, J CLIN EPIDEMIOL, V47, P35, DOI 10.1016/0895-4356(94)90031-0; Blomstrand A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005173; Budhiraja R, 2011, SLEEP, V34, P859, DOI 10.5665/SLEEP.1114; Busch MA, 2013, BUNDESGESUNDHEITSBLA, V56, P656, DOI 10.1007/s00103-012-1659-0; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cai H, 2015, SLEEP, V38, P529, DOI 10.5665/sleep.4564; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Chalmers J, 1999, J HYPERTENS, V17, P151; Chang JJ, 2012, J RURAL HEALTH, V28, P268, DOI 10.1111/j.1748-0361.2011.00398.x; Chaput JP, 2014, PHYSIOL BEHAV, V134, P86, DOI 10.1016/j.physbeh.2013.09.006; Chen JC, 2008, STROKE, V39, P3185, DOI 10.1161/STROKEAHA.108.521773; COX DR, 1972, J R STAT SOC B, V34, P187; Ellis JG, 2014, SLEEP, V37, P97, DOI 10.5665/sleep.3316; Elwood P, 2006, J EPIDEMIOL COMMUN H, V60, P69, DOI 10.1136/jech.2005.039057; Epstein JF, 2001, PUBLIC OPIN QUART, V65, P529, DOI 10.1086/323577; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; German Society for General Medicine and Family Medicine (DEGAM), 2012, STROK DEGAM GUID NUM; Gillum RF, 2001, INT J OBESITY, V25, P628, DOI 10.1038/sj.ijo.0801590; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Grandner MA, 2007, SLEEP MED REV, V11, P341, DOI 10.1016/j.smrv.2007.03.010; Grandner MA, 2012, J SLEEP RES, V21, P427, DOI 10.1111/j.1365-2869.2011.00990.x; Green MJ, 2012, SLEEP, V35, P815, DOI 10.5665/sleep.1882; Hamazaki Y, 2011, SCAND J WORK ENV HEA, V37, P411, DOI 10.5271/sjweh.3168; Hankerson SH, 2011, J NATL MED ASSOC, V103, P576, DOI 10.1016/S0027-9684(15)30383-7; Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Huang WS, 2013, SLEEP MED, V14, P1341, DOI 10.1016/j.sleep.2013.07.017; Icks A, 2009, DIABETOLOGIA, V52, P1836, DOI 10.1007/s00125-009-1434-4; Ikehara S, 2009, SLEEP, V32, P295, DOI 10.1093/sleep/32.3.295; Jackowska M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047292; Kakizaki M, 2013, J SLEEP RES, V22, P209, DOI 10.1111/j.1365-2869.2012.01053.x; Kim Y, 2013, PREV MED, V57, P377, DOI 10.1016/j.ypmed.2013.06.017; Kolominsky-Rabas PL, 2006, STROKE, V37, P1179, DOI 10.1161/01.STR.0000217450.21310.90; Kronholm E, 2011, SLEEP MED, V12, P215, DOI 10.1016/j.sleep.2010.07.021; Ladwig KH, 2004, ANN EPIDEMIOL, V14, P332, DOI 10.1016/j.annepidem.2003.09.003; Larsson SC, 2015, NEUROLOGY; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Leng Y, 2015, NEUROLOGY, V84, P1072, DOI 10.1212/WNL.0000000000001371; Lowel H, 2005, GESUNDHEITSWESEN, V67, pS13, DOI 10.1055/s-2005-858234; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Magee CA, 2012, J SLEEP RES, V21, P441, DOI 10.1111/j.1365-2869.2011.00993.x; Mallampalli MP, 2014, J WOMENS HEALTH, V23, P553, DOI 10.1089/jwh.2014.4816; Meisinger C, 2006, DIABETOLOGIA, V49, P1770, DOI 10.1007/s00125-006-0298-0; Meisinger C, 2006, J HYPERTENS, V24, P293, DOI 10.1097/01.hjh.0000200508.10324.8e; Meisinger C, 2005, DIABETOLOGIA, V48, P235, DOI 10.1007/s00125-004-1634-x; Meisinger C, 2002, ARCH INTERN MED, V162, P82, DOI 10.1001/archinte.162.1.82; Mezick EJ, 2011, SLEEP MED REV, V15, P51, DOI 10.1016/j.smrv.2010.03.001; Michal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104324; Morin CM, 2014, SLEEP, V37, P319, DOI 10.5665/sleep.3406; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM., 1993, INSOMNIA PSYCHOL ASS; Morphy H, 2007, SLEEP, V30, P274; Palma JA, 2013, SLEEP MED, V14, P229, DOI 10.1016/j.sleep.2012.11.019; Pan A, 2014, STROKE; Patel SR, 2006, SLEEP, V29, P881, DOI 10.1093/sleep/29.7.881; Patyar S, 2015, J STROKE CEREBROVASC, V24, P905, DOI 10.1016/j.jstrokecerebrovasdis.2014.12.038; Phillips CL, 2013, NAT SCI SLEEP, V5, P43, DOI 10.2147/NSS.S34841; Prasanna SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009016, 10.1371/journal.pone.0014189]; Qureshi AI, 1997, NEUROLOGY, V48, P904, DOI 10.1212/WNL.48.4.904; Rehm J, 2003, EUR ADDICT RES, V9, P157, DOI 10.1159/000072222; Robert Koch-Institut, 2005, USITC PUBL, V27; Rod NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091965; Rod NH, 2011, AM J EPIDEMIOL, V173, P300, DOI 10.1093/aje/kwq371; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Sabanayagam C, 2010, SLEEP, V33, P1037, DOI 10.1093/sleep/33.8.1037; Sattar N, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000099; Scherbakov N, 2013, INT J CARDIOL, V170, P89, DOI 10.1016/j.ijcard.2013.10.031; Schlack R, 2013, BUNDESGESUNDHEITSBLA, V56, P740, DOI 10.1007/s00103-013-1689-2; Sivertsen B, 2014, J SLEEP RES, V23, P124, DOI [10.1111/jsr.12102, 10.1111/jsr.12254]; Sofi F, 2014, EUR J PREV CARDIOL, V21, P57, DOI 10.1177/2047487312460020; Stone KL, 2009, J AM GERIATR SOC, V57, P604, DOI 10.1111/j.1532-5415.2008.02171.x; Tikk K, 2014, STROKE, V45, P2041, DOI 10.1161/STROKEAHA.114.005025; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; UN, 2013, WORLD POP AG 2013; Valipour A, 2012, Pneumologie, V66, P584, DOI 10.1055/s-0032-1325664; Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723; Vgontzas AN, 2013, SLEEP MED REV, V17, P241, DOI 10.1016/j.smrv.2012.09.005; von dem Knesebeck O, 1998, SUBJECTIVE HLTH ELDE; von Ruesten A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030972; von Zerssen D, 1976, PSYCHOMANUAL MAIN PA; Westerlund A, 2013, EUR J EPIDEMIOL, V28, P463, DOI 10.1007/s10654-013-9802-2; WRIGHT BM, 1970, LANCET, V1, P337; Wu MP, 2014, STROKE, V45, P1349, DOI 10.1161/STROKEAHA.113.003675	94	32	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134480	10.1371/journal.pone.0134480	http://dx.doi.org/10.1371/journal.pone.0134480			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230576	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400125
J	Kana, J; Tahovska, K; Kopacek, J; Santruckova, H				Kana, Jiri; Tahovska, Karolina; Kopacek, Jiri; Santruckova, Hana			Excess of Organic Carbon in Mountain Spruce Forest Soils after Bark Beetle Outbreak Altered Microbial N Transformations and Mitigated N-Saturation	PLOS ONE			English	Article							GROSS NITROGEN MINERALIZATION; BOHEMIAN FOREST; NATURAL DISTURBANCES; PLESNE LAKE; NITRATE; NITRIFICATION; DYNAMICS; BIOMASS; FUNGI; IMMOBILIZATION	Mountain forests in National park Bohemian Forest (Czech Republic) were affected by bark beetle attack and windthrows in 2004-2008, followed by an extensive tree dieback. We evaluated changes in the biochemistry of the uppermost soil horizons with the emphasis on carbon (C) and nitrogen (N) cycling in a near-natural spruce (Picea abies) mountain forest after the forest dieback, and compared it with an undisturbed control plot of similar age, climate, elevation, deposition, N-saturation level, and land use history. We hypothesised that the high litter input after forest dieback at the disturbed plot and its consequent decomposition might influence the availability of C for microorganisms, and consequently, N transformations in the soil. The concentrations of dissolved organic C (DOC) and N (DON) in soil water extracts rapidly increased at the disturbed plot for 3 yeas and then continually decreased. Net ammonification exhibited a similar trend as DOC and DON, indicating elevated mineralization. Despite the high ammonium concentrations found after the forest dieback (an increase from 0.5 mmol kg(-1) to 2-3 mmol kg(-1)), net nitrification was stable and low during these 3 years. After the DOC depletion and decrease in microbial biomass 5 years after the forest dieback, net nitrification started to rise, and nitrate concentrations increased from 0.2-1 mmol kg(-1) to 2-3 mmol kg(-1). Our results emphasize the key role of the availability of organic C in microbial N transformations, which probably promoted microbial heterotrophic activity at the expense of slow-growing nitrifiers.	[Kana, Jiri; Kopacek, Jiri] CAS, Inst Hydrobiol, Vvi, Biol Ctr, Ceske Budejovice, Czech Republic; [Kana, Jiri; Tahovska, Karolina; Santruckova, Hana] Univ South Bohemia Ceske Budejovice, Fac Sci, Dept Ecosyst Biol, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Kana, J (corresponding author), CAS, Inst Hydrobiol, Vvi, Biol Ctr, Ceske Budejovice, Czech Republic.	jiri.kana@centrum.cz	Kaňa, Jiří/C-4277-2014; Santruckova, Hana/D-7365-2016; Kopacek, Jiri/A-7373-2014; Tahovska, Karolina/A-7248-2012; Tahovská, Karolina/AAI-3219-2021	Santruckova, Hana/0000-0001-9947-5687; Kopacek, Jiri/0000-0002-4409-4032; Tahovska, Karolina/0000-0003-4499-9533; Tahovská, Karolina/0000-0003-4499-9533; Kana, Jiri/0000-0003-3596-4742	Czech Science Foundation [P504/12/1218]	Czech Science Foundation(Grant Agency of the Czech Republic)	This study was supported by the Czech Science Foundation, project number P504/12/1218. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, SOIL MICROBIOLOGY BI; Beggs KMH, 2011, ENVIRON SCI TECHNOL, V45, P5717, DOI 10.1021/es1042436; Bengtsson G, 2003, SOIL BIOL BIOCHEM, V35, P143, DOI 10.1016/S0038-0717(02)00248-1; Berg B., 2006, ADV ECOLOGICAL RES, V38; Berg B., 2008, PLANT LITTER DECOMPO, DOI [DOI 10.1007/978-3-662-05349-2, 10.1007/978-3-662-05349-2]; Berg Bjorn, 1997, Environmental Reviews, V5, P1, DOI 10.1139/er-5-1-1; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Byrd KB, 2000, CAN J BOT, V78, P149, DOI 10.1139/cjb-78-2-149; DAVIDSON EA, 1992, ECOLOGY, V73, P1148, DOI 10.2307/1940665; Ekstrom SM, 2011, ENVIRON SCI TECHNOL, V45, P4733, DOI 10.1021/es104126f; Evans CD, 2006, ECOSYSTEMS, V9, P453, DOI 10.1007/s10021-006-0051-z; Evans CD, 2012, GLOBAL CHANGE BIOL, V18, P3317, DOI 10.1111/j.1365-2486.2012.02794.x; Ferrenberg S, 2014, FRONT MICROB, P5, DOI [10.3389/fmicb.204.00681, DOI 10.3389/FMICB.204.00681]; Fisher R. F., 2000, ECOLOGY MANAGEMENT F, DOI DOI 10.1002/9781118422342; Griffin JM, 2012, OECOLOGIA, V170, P551, DOI 10.1007/s00442-012-2323-y; Griffin JM, 2011, FOREST ECOL MANAG, V261, P1077, DOI 10.1016/j.foreco.2010.12.031; HART SC, 1994, ECOLOGY, V75, P880, DOI 10.2307/1939413; Helms JR, 2008, LIMNOL OCEANOGR, V53, P955, DOI 10.4319/lo.2008.53.3.0955; Hogberg MN, 2007, BIOL FERT SOILS, V44, P363, DOI 10.1007/s00374-007-0215-9; Hogberg MN, 2010, NEW PHYTOL, V187, P485, DOI 10.1111/j.1469-8137.2010.03274.x; Huber C, 2005, J ENVIRON QUAL, V34, P1772, DOI 10.2134/jeq2004.0210; Huber C., 2004, WATER AIR SOIL POLL, V4, P391, DOI DOI 10.1023/B:WAF0.0000028367.69158.8D; Kana J, 2013, BIOGEOCHEMISTRY, V113, P369, DOI 10.1007/s10533-012-9765-5; Karlberg B., 1983, FOCUS, V6, P14; Kauffman SJ, 2003, BIOGEOCHEMISTRY, V63, P23, DOI 10.1023/A:1023335002926; Kop&aacute;cek J, 2013, SILVA GABRETA, V19, P105; Kopacek J, 2001, HYDROL EARTH SYST SC, V5, P391, DOI 10.5194/hess-5-391-2001; Kopacek J, 2001, COMMUN SOIL SCI PLAN, V32, P1431, DOI 10.1081/CSS-100104203; Kopacek J, 2015, BOREAL ENVIRON RES, V20, P305; Kopacek J, 2013, BIOGEOCHEMISTRY, V115, P33, DOI 10.1007/s10533-013-9892-7; Kopacek J, 2010, BOREAL ENVIRON RES, V15, P413; Manzoni S, 2012, NEW PHYTOL, V196, P79, DOI 10.1111/j.1469-8137.2012.04225.x; McHale MR, 2007, BIOGEOCHEMISTRY, V84, P311, DOI 10.1007/s10533-007-9124-0; Mikkelson KM, 2013, BIOGEOCHEMISTRY, V115, P1, DOI 10.1007/s10533-013-9875-8; Mikkelson KM, 2013, NAT CLIM CHANGE, V3, P218, DOI [10.1038/NCLIMATE1724, 10.1038/nclimate1724]; Morehouse K, 2008, FOREST ECOL MANAG, V255, P2698, DOI 10.1016/j.foreco.2008.01.050; Olsson BA, 1996, FOREST ECOL MANAG, V84, P135, DOI 10.1016/0378-1127(96)03730-9; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Porebska G, 2008, SCI TOTAL ENVIRON, V399, P105, DOI 10.1016/j.scitotenv.2008.03.029; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Santruckova H., 2001, SILVA GABRETA, V7, P79; Santruckova H, 2006, BIOLOGIA, V61, pS499, DOI 10.2478/s11756-007-0073-9; Santruckova H, 2009, BIOL FERT SOILS, V45, P395, DOI 10.1007/s00374-008-0349-4; Schelhaas MJ, 2003, GLOBAL CHANGE BIOL, V9, P1620, DOI 10.1046/j.1365-2486.2003.00684.x; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; SHAW A, 1988, INTRO USE FLOW INJEC; Ste-Marie C, 1999, SOIL BIOL BIOCHEM, V31, P1579, DOI 10.1016/S0038-0717(99)00086-3; Strauss EA, 2002, FRESHWATER BIOL, V47, P65, DOI 10.1046/j.1365-2427.2002.00776.x; Stursova M, 2014, ISME J, V8, P1920, DOI 10.1038/ismej.2014.37; Svoboda M, 2006, BIOLOGIA, V61, pS509, DOI 10.2478/s11756-007-0074-8; Svoboda M, 2006, BIOLOGIA, V61, pS523, DOI 10.2478/s11756-007-0075-7; Svoboda M, 2012, J VEG SCI, V23, P86, DOI 10.1111/j.1654-1103.2011.01329.x; Tahovska K, 2013, SOIL BIOL BIOCHEM, V59, P58, DOI 10.1016/j.soilbio.2012.12.015; Tahovska K, 2010, BOREAL ENVIRON RES, V15, P553; Taylor PG, 2010, NATURE, V464, P1178, DOI 10.1038/nature08985; Tejnecky V, 2013, SCI TOTAL ENVIRON, V442, P165, DOI 10.1016/j.scitotenv.2012.10.053; TUREK J, 2014, SILVA GABRETA, V20, P1; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P689, DOI 10.1016/0038-0717(87)90050-2; Vesely Josef, 1993, Journal of Paleolimnology, V8, P211; Vrba J, 2003, SCI TOTAL ENVIRON, V310, P73, DOI 10.1016/S0048-9697(02)00624-1; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; Zimmermann L, 2000, SILVA GABRETA, V4, P51	62	28	28	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134165	10.1371/journal.pone.0134165	http://dx.doi.org/10.1371/journal.pone.0134165			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230678	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400083
J	Araujo, IR; Ferrari, TCA; Teixeira-Carvalho, A; Campi-Azevedo, AC; Rodrigues, LV; Guimaraes, MH; Barros, TLS; Gelape, CL; Sousa, GR; Nunes, MCP				Araujo, Izabella Rodrigues; Abreu Ferrari, Teresa Cristina; Teixeira-Carvalho, Andrea; Campi-Azevedo, Ana Carolina; Rodrigues, Luan Vieira; Guimaraes Junior, Milton Henriques; Souza Barros, Thais Lins; Gelape, Claudio Leo; Sousa, Giovane Rodrigo; Pereira Nunes, Maria Carmo			Cytokine Signature in Infective Endocarditis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; C-REACTIVE PROTEIN; MONONUCLEAR-CELLS; FACTOR-ALPHA; TNF-ALPHA; PROFILE; INTERLEUKIN-10; DIAGNOSIS; FAMILY	Infective endocarditis (IE) is a severe disease with high mortality rate. Cytokines participate in its pathogenesis and may contribute to early diagnosis improving the outcome. This study aimed to evaluate the cytokine profile in IE. Serum concentrations of interleukin (IL)-1 beta, IL-6, IL-8, IL-10, IL-12 and tumor necrosis factor (TNF)-alpha were measured by cytometric bead array (CBA) at diagnosis in 81 IE patients, and compared with 34 healthy subjects and 30 patients with non-IE infections, matched to the IE patients by age and gender. Mean age of the IE patients was 47 +/- 17 years (range, 15-80 years), and 40 (50%) were male. The IE patients had significantly higher serum concentrations of IL-1 beta, IL-6, IL-8, IL-10 and TNF-alpha as compared to the healthy individuals. The median levels of IL-1 beta, TNF-alpha and IL-12 were higher in the IE than in the non-IE infections group. TNF-alpha and IL-12 levels were higher in staphylococcal IE than in the non-staphylococcal IE subgroup. There was a higher proportion of both low IL-10 producers and high producers of IL-1 beta, TNF-alpha and IL-12 in the staphylococcal IE than in the non-staphylococcal IE subgroup. This study reinforces a relationship between the expression of proinflammatory cytokines, especially IL-1 beta, IL-12 and TNF-alpha, and the pathogenesis of IE. A lower production of IL-10 and impairment in cytokine network may reflect the severity of IE and may be useful for risk stratification.	[Araujo, Izabella Rodrigues; Abreu Ferrari, Teresa Cristina; Rodrigues, Luan Vieira; Guimaraes Junior, Milton Henriques; Souza Barros, Thais Lins; Sousa, Giovane Rodrigo; Pereira Nunes, Maria Carmo] Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Programa Posgrad Infectol & Med Trop, Belo Horizonte, MG, Brazil; [Teixeira-Carvalho, Andrea; Campi-Azevedo, Ana Carolina] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Biomarcadores Diagnost & Monitoracao, Belo Horizonte, MG, Brazil; [Gelape, Claudio Leo] Univ Fed Minas Gerais, Fac Med, Dept Cirurgia, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Nunes, MCP (corresponding author), Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Programa Posgrad Infectol & Med Trop, Belo Horizonte, MG, Brazil.	mcarmo@waymail.com.br	Sousa, Giovane R./H-6102-2016; Nunes, Maria Carmo/AAV-5185-2020; Campi-Azevedo, Ana Carolina/ABE-8321-2021; Ferrari, Teresa C. A./D-5530-2014; Gelape, Claudio Leo/J-5834-2018	Sousa, Giovane R./0000-0003-0085-3882; Campi-Azevedo, Ana Carolina/0000-0001-6306-3605; Ferrari, Teresa C. A./0000-0001-9459-2294; Gelape, Claudio Leo/0000-0002-8287-0733				Alter P, 2002, AM J CARDIOL, V89, P1400, DOI 10.1016/S0002-9149(02)02353-6; Bustamante J, 2011, REV ESP CARDIOL, V64, P1056, DOI [10.1016/j.recesp.2011.02.024, 10.1016/j.rec.2011.02.027]; Capo C, 1999, CLIN EXP IMMUNOL, V115, P120; Capo C, 1996, INFECT IMMUN, V64, P1638, DOI 10.1128/IAI.64.5.1638-1642.1996; Capo C, 1996, INFECT IMMUN, V64, P4143, DOI 10.1128/IAI.64.10.4143-4147.1996; Chen R, 1999, CLIN CHEM, V45, P1693; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Gouriet F, 2006, CLIN VACCINE IMMUNOL, V13, P301, DOI 10.1128/CVI.13.2.301.2006; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; HEINLE S, 1994, AM J CARDIOL, V74, P799, DOI 10.1016/0002-9149(94)90438-3; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; Hoen B, 2013, NEW ENGL J MED, V369, P785, DOI 10.1056/NEJMc1307282; Jiang YL, 1999, INFECT IMMUN, V67, P2125, DOI 10.1128/IAI.67.5.2125-2130.1999; Kang BY, 2006, CURR MED CHEM, V13, P1149, DOI 10.2174/092986706776360879; Kelso A, 1998, IMMUNOL CELL BIOL, V76, P300, DOI 10.1046/j.1440-1711.1998.00757.x; KERN WV, 1993, INFECT IMMUN, V61, P5413, DOI 10.1128/IAI.61.12.5413-5416.1993; LI L, 1994, J IMMUNOL, V153, P3967; Moreillon P, 2002, INFECT DIS CLIN N AM, V16, P297, DOI 10.1016/S0891-5520(01)00009-5; Ng THS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00129; Nunes MCP AI, 2013, ADV INFECT DIS, V3, P115; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Nunes MCP, 2010, INT J INFECT DIS, V14, pE394, DOI 10.1016/j.ijid.2009.06.024; Peruhype-Magalhaes V, 2006, CLIN EXP IMMUNOL, V146, P124, DOI 10.1111/j.1365-2249.2006.03171.x; Rawczynska-Englert I, 2000, J HEART VALVE DIS, V9, P705; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Tarnok A, 2003, CLIN CHEM, V49, P1000, DOI 10.1373/49.6.1000; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; TUNKEL AR, 1992, NEW ENGL J MED, V326, P1215, DOI 10.1056/NEJM199204303261809; Watkin RW, 2007, J INFECTION, V55, P220, DOI 10.1016/j.jinf.2007.05.174; Weinstock M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110151	32	20	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133631	10.1371/journal.pone.0133631	http://dx.doi.org/10.1371/journal.pone.0133631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225421	gold, Green Submitted, Green Published			2022-12-27	WOS:000358837700028
J	Bukowczan, J; Warzecha, Z; Ceranowicz, P; Kusnierz-Cabala, B; Tomaszewska, R				Bukowczan, Jakub; Warzecha, Zygmunt; Ceranowicz, Piotr; Kusnierz-Cabala, Beata; Tomaszewska, Romana			Obestatin Accelerates the Recovery in the Course of Ischemia/Reperfusion-Induced Acute Pancreatitis in Rats	PLOS ONE			English	Article							GHRELIN GENE-PRODUCTS; GROWTH-HORMONE; NITRIC-OXIDE; SECRETION; MICROCIRCULATION; RECEPTOR; INJURY; GUT; INTERLEUKIN-1; REGENERATION	Objective Several previous studies have shown that obestatin exhibits protective and regenerative effects in some organs including the stomach, kidney, and the brain. In the pancreas, pretreatment with obestatin inhibits the development of cerulein-induced acute pancreatitis, and promotes survival of pancreatic beta cells and human islets. However, no studies investigated the effect of obestatin administration following the onset of experimental acute pancreatitis. Aim The aim of this study was to evaluate the impact of obestatin therapy in the course of ischemia/reperfusion-induced pancreatitis. Moreover, we tested the influence of ischemia/reperfusion-induced acute pancreatitis and administration of obestatin on daily food intake and pancreatic exocrine secretion. Methods Acute pancreatitis was induced by pancreatic ischemia followed by reperfusion of the pancreas. Obestatin (8nmol/kg/dose) was administered intraperitoneally twice a day, starting 24 hours after the beginning of reperfusion. The effect of obestatin in the course of necrotizing pancreatitis was assessed between 2 and 14 days, and included histological, functional, and biochemical analyses. Secretory studies were performed on the third day after sham-operation or induction of acute pancreatitis in conscious rats equipped with chronic pancreatic fistula. Results Treatment with obestatin ameliorated morphological signs of pancreatic damage including edema, vacuolization of acinar cells, hemorrhages, acinar necrosis, and leukocyte infiltration of the gland, and led to earlier pancreatic regeneration. Structural changes were accompanied by biochemical and functional improvements manifested by accelerated normalization of interleukin-1 beta level and activity of myeloperoxidase and lipase, attenuation of the decrease in pancreatic DNA synthesis, and by an improvement of pancreatic blood flow. Induction of acute pancreatitis by pancreatic ischemia followed by reperfusion significantly decreased daily food intake and pancreatic exocrine secretion. Administration of obestatin at doses used was without significant effect with regard to daily food intake or pancreatic exocrine secretion in sham-operated rats, as well as in rats with acute pancreatitis. On the other hand, obestatin abolished a statistical significance of difference in food intake between animals with AP and control animals without pancreatic fistula and induction of AP. Conclusion Treatment with the exogenous obestatin reduces severity of ischemia/reperfusion-induced acute pancreatitis and accelerates recovery in this disease. The involved mechanisms are likely to be multifactorial, and are mediated, at least in part, by anti-inflammatory properties of obestatin.	[Bukowczan, Jakub] Northumbria NHS Fdn Trust, Dept Endocrinol & Diabet Mellitus, North Shields, Tyne & Wear, England; [Warzecha, Zygmunt; Ceranowicz, Piotr] Jagiellonian Univ, Coll Med, Dept Physiol, Krakow, Poland; [Kusnierz-Cabala, Beata] Jagiellonian Univ, Coll Med, Dept Clin Biochem, Krakow, Poland; [Tomaszewska, Romana] Jagiellonian Univ, Dept Pathol, Coll Med, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Bukowczan, J (corresponding author), Northumbria NHS Fdn Trust, Dept Endocrinol & Diabet Mellitus, Rake Lane, North Shields, Tyne & Wear, England.	jakubbukowczan@gmail.com	Warzecha, Zygmunt/AAZ-2744-2020	Kusnierz-Cabala, Beata/0000-0001-8639-5688				Andican G, 2005, WORLD J GASTROENTERO, V11, P2340, DOI 10.3748/wjg.v11.i15.2340; Baragli I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064374; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Bukowczan J, 2015, CURR PHARM DESIGN, V21, P2284, DOI 10.2174/1381612821666150105152553; Bukowczan J, 2015, EUR J PHARMACOL, V760, P113, DOI 10.1016/j.ejphar.2015.04.016; Ceranowicz D, 2010, J PHYSIOL PHARMACOL, V61, P599; Ceranowicz P, 2015, J PHYSIOL PHARMACOL, V66, P11; Ceranowicz P, 2009, J PHYSIOL PHARMACOL, V60, P95; Ceranowicz P, 2008, J PHYSIOL PHARMACOL, V59, P103; Chen CY, 2009, PHARMACOL REV, V61, P430, DOI 10.1124/pr.109.001958; Chooklin S, 2009, HEPATOB PANCREAT DIS, V8, P627; Cuthbertson CM, 2006, BRIT J SURG, V93, P518, DOI 10.1002/bjs.5316; Dembinski A, 2004, J PHYSIOL PHARMACOL, V55, P811; Dembinski A, 2003, J PHYSIOL PHARMACOL, V54, P561; Dembinski A, 2001, J PHYSIOL PHARMACOL, V52, P221; Dembinski A, 2008, EUR J PHARMACOL, V591, P284, DOI 10.1016/j.ejphar.2008.06.059; Dembinski A, 2006, GROWTH HORM IGF RES, V16, P348, DOI 10.1016/j.ghir.2006.09.003; Dembinski A, 2011, MED SCI MONITOR, V17, pBR196, DOI 10.12659/MSM.881897; DINARELLO CA, 1991, BLOOD, V77, P1627; EVANDER A, 1982, DIGESTION, V24, P159, DOI 10.1159/000198792; Fabre A, 2014, J PEDIATR GASTR NUTR, V58, pE41, DOI [10.1097/MPG.0000000000000287, 10.1097/MPG.0000000000000307]; Fares A, 2013, J POSTGRAD MED, V59, P203, DOI 10.4103/0022-3859.118039; Favaro E, 2012, DIABETOLOGIA, V55, P1058, DOI 10.1007/s00125-011-2423-y; Gesmundo I, 2013, IUBMB LIFE, V65, P976, DOI 10.1002/iub.1226; GILES KW, 1965, NATURE, V206, P93, DOI 10.1038/206093a0; Hamada S, 2014, PANCREAS, V43, P1244, DOI 10.1097/MPA.0000000000000200; Hammer HF, 2014, WIEN MED WOCHENSCHR, V164, P57, DOI 10.1007/s10354-013-0260-y; Hartwig W, 1999, J APPL PHYSIOL, V87, P743, DOI 10.1152/jappl.1999.87.2.743; Hernandez-Barbachano E, 2006, PANCREAS, V32, P335, DOI 10.1097/01.mpa.0000220856.47754.c4; Jeyarajah R, 2014, CURR PROB SURG, V51, P370, DOI 10.1067/j.cpsurg.2014.07.002; Kapica M, 2007, J PHYSIOL PHARMACOL, V58, P123; Kingsnorth A, 1997, GUT, V40, P1; Koc M, 2014, PEPTIDES, V60, P23, DOI 10.1016/j.peptides.2014.07.019; Koehler JA, 2009, DIABETES, V58, P2148, DOI 10.2337/db09-0626; KONTUREK SJ, 1994, INT J PANCREATOL, V15, P19; Lacquaniti A, 2011, ANN NUTR METAB, V59, P193, DOI 10.1159/000334106; Li JB, 2011, ENDOCRINE, V39, P205, DOI 10.1007/s12020-011-9453-6; Mendez-Bailon M, 2015, PANCREATOLOGY, V15, P64, DOI 10.1016/j.pan.2014.11.004; Murtaugh LC, 2015, ANNU REV PHYSIOL, V77, P229, DOI 10.1146/annurev-physiol-021014-071727; NIEDERAU C, 1990, GASTROENTEROLOGY, V99, P1120, DOI 10.1016/0016-5085(90)90633-C; NORMAN J, 1995, SURGERY, V117, P648, DOI 10.1016/S0039-6060(95)80008-5; Plusczyk T, 2003, AM J PHYSIOL-GASTR L, V285, pG145, DOI 10.1152/ajpgi.00181.2002; Qi L, 2014, ANN SURG, V260, P169, DOI 10.1097/SLA.0000000000000328; Sah RP, 2013, CURR OPIN GASTROEN, V29, P523, DOI 10.1097/MOG.0b013e328363e399; Schanaider A, 2014, CLIN EXP MED; Schaser KD, 2005, AM J TRANSPLANT, V5, P341, DOI 10.1111/j.1600-6143.2004.00663.x; Tomaszewska Romana, 2000, Polish Journal of Pathology, V51, P179; Trovato L, 2014, FRONT HORM RES, V42, P175, DOI 10.1159/000358346; von Dobschuetz E, 2004, AM J PHYSIOL-GASTR L, V286, pG791, DOI 10.1152/ajpgi.00407.2003; Warzecha Z, 2011, J PHYSIOL PHARMACOL, V62, P207; Warzecha Z, 2010, J PHYSIOL PHARMACOL, V61, P419; Warzecha Z, 2001, EUR J PHARMACOL, V430, P113, DOI 10.1016/S0014-2999(01)01352-8; Zerem E, 2014, WORLD J GASTROENTERO, V20, P13879, DOI 10.3748/wjg.v20.i38.13879; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255	54	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134380	10.1371/journal.pone.0134380	http://dx.doi.org/10.1371/journal.pone.0134380			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226277	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700084
J	Kim, YW; Yun, SJ; Jeong, P; Kim, SK; Kim, SY; Yan, C; Seo, SP; Lee, SK; Kim, J; Kim, WJ				Kim, Young-Won; Yun, Seok Joong; Jeong, Phildu; Kim, Seon-Kyu; Kim, Seon-Young; Yan, Chunri; Seo, Sung Phil; Lee, Sang Keun; Kim, Jayoung; Kim, Wun-Jae			The c-MET Network as Novel Prognostic Marker for Predicting Bladder Cancer Patients with an Increased Risk of Developing Aggressive Disease	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TRANSITIONAL-CELL CARCINOMA; UROTHELIAL CARCINOMA; URINARY-BLADDER; BREAST-CANCER; EXPRESSION; AXL; MIGRATION; TUMOR; OVEREXPRESSION	Previous studies have shown that c-MET is overexpressed in cases of aggressive bladder cancer (BCa). Identification of crosstalk between c-MET and other RTKs such as AXL and PDGFR suggest that c-MET network genes (c-MET-AXL-PDGFR) may be clinically relevant to BCa. Here, we examine whether expression of c-MET network genes can be used to identify BCa patients at increased risk of developing aggressive disease. In vitro analysis, c-MET knockdown suppressed cell proliferation, invasion, and migration, and increased sensitivity to cisplatin-induced apoptosis. In addition, c-MET network gene (c-MET, AXL, and PDGFR) expression allowed discrimination of BCa tissues from normal control tissues and appeared to predict poor disease progression in non-muscle invasive BCa patients and poor overall survival in muscle invasive BCa patients. These results suggest that c-MET network gene expression is a novel prognostic marker for predicting which BCa patients have an increased risk of developing aggressive disease. These genes might be a useful marker for co-targeting therapy, and are expected to play an important role in improving both response to treatment and survival of BCa patients.	[Kim, Young-Won; Yun, Seok Joong; Jeong, Phildu; Yan, Chunri; Seo, Sung Phil; Lee, Sang Keun; Kim, Wun-Jae] Chungbuk Natl Univ, Coll Med, Dept Urol, Chongju, South Korea; [Kim, Seon-Kyu; Kim, Seon-Young] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon, South Korea; [Kim, Seon-Kyu] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea; [Kim, Seon-Young] Univ Sci & Technol, Dept Funct Genom, Taejon, South Korea; [Kim, Jayoung] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Kim, Jayoung] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Kim, Jayoung] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA	Chungbuk National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Harvard University; Harvard Medical School; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Kim, WJ (corresponding author), Chungbuk Natl Univ, Coll Med, Dept Urol, Chongju, South Korea.	Jayoung.Kim@cshs.org; wjkim@chungbuk.ac.kr		Kim, Seon-Kyu/0000-0002-4176-5187	National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2014R1A2A1A09006983]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A4A01008753]; NIH NCATS UCLA CTSI [UL1TR000124]; Steven Spielberg Discovery Fund in Prostate Cancer Research Career Development Award; IMAGINE NO IC Research Program Award;  [R01DK100974];  [U01 DK103260];  [U24 DK097154]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100974, U24DK097154, U01DK082316, U01DK103260] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) - Korean government (MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; NIH NCATS UCLA CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Steven Spielberg Discovery Fund in Prostate Cancer Research Career Development Award; IMAGINE NO IC Research Program Award; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP; http://www.msip.go.kr/web/main/main. do) (No. NRF-2014R1A2A1A09006983) and by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (http://www.moe.go.kr/main.do) (2012R1A1A4A01008753). Also, this work was partly supported by the R01DK100974; U01 DK103260; U24 DK097154; NIH NCATS UCLA CTSI UL1TR000124; a Steven Spielberg Discovery Fund in Prostate Cancer Research Career Development Award; an IMAGINE NO IC Research Program Award (to JK). JK is an American Urological Association Foundation Research Scholar and a Harvard Medical School Eleanor and Miles Shore Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena S, 2007, P NATL ACAD SCI USA, V104, P11412, DOI 10.1073/pnas.0703205104; Babjuk M, 2008, EUR UROL, V54, P303, DOI 10.1016/j.eururo.2008.04.051; Carvalho I, 2005, BREAST CANCER RES, V7, pR788, DOI 10.1186/bcr1304; Cheng HL, 2002, J CLIN ONCOL, V20, P1544, DOI 10.1200/JCO.20.6.1544; Chung BI, 2003, DNA CELL BIOL, V22, P533, DOI 10.1089/10445490360708946; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Comperat E, 2008, J UROLOGY, V179, P868, DOI 10.1016/j.juro.2007.10.079; Donnem T, 2008, J THORAC ONCOL, V3, P963, DOI 10.1097/JTO.0b013e3181834f52; Er EE, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004015; Fudge K, 1996, PROSTATE, V29, P282; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Greene Frederick L, 2002, Bull Am Coll Surg, V87, P13; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hofner T, 2013, J UROLOGY, V190, P2263, DOI 10.1016/j.juro.2013.06.053; Kim J, 2005, CANCER RES, V65, P8242, DOI 10.1158/0008-5472.CAN-05-0942; Kim J, 2011, IN VITRO CELL DEV-AN, V47, P2, DOI 10.1007/s11626-010-9350-y; Miyata Y, 2009, HUM PATHOL, V40, P496, DOI 10.1016/j.humpath.2008.09.011; NGUYEN PL, 1994, AM J CLIN PATHOL, V101, P166, DOI 10.1093/ajcp/101.2.166; Noon AR, 2013, NAT REV UROL, V10, P67, DOI 10.1038/nrurol.2012.252; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; Remon J, 2014, CANCER TREAT REV, V40, P93, DOI 10.1016/j.ctrv.2013.06.002; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; Scagliotti GV, 2013, CANCER TREAT REV, V39, P793, DOI 10.1016/j.ctrv.2013.02.001; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; Smith DC, 2013, J CLIN ONCOL, V31, P412, DOI 10.1200/JCO.2012.45.0494; Tsai YS, 2012, ADV UROL, V2012, DOI 10.1155/2012/181964; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; Xu X, 2013, MOL CELLS, V36, P62, DOI 10.1007/s10059-013-0044-7; Yeh CY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-139	30	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134552	10.1371/journal.pone.0134552	http://dx.doi.org/10.1371/journal.pone.0134552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225770	gold, Green Submitted, Green Published			2022-12-27	WOS:000358837700110
J	Rothermich, K; Pell, MD				Rothermich, Kathrin; Pell, Marc D.			Introducing RISC: A New Video Inventory for Testing Social Perception	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; PARALINGUISTIC CUES; PRETENSE THEORY; MIND DEFICITS; WHITE LIES; SARCASM; IRONY; DECEPTION; COGNITION; LAUGHTER	Indirect forms of speech, such as sarcasm, jocularity (joking), and 'white lies' told to spare another's feelings, occur frequently in daily life and are a problem for many clinical populations. During social interactions, information about the literal or nonliteral meaning of a speaker unfolds simultaneously in several communication channels (e.g., linguistic, facial, vocal, and body cues); however, to date many studies have employed uni-modal stimuli, for example focusing only on the visual modality, limiting the generalizability of these results to everyday communication. Much of this research also neglects key factors for interpreting speaker intentions, such as verbal context and the relationship of social partners. Relational Inference in Social Communication (RISC) is a newly developed (English-language) database composed of short video vignettes depicting sincere, jocular, sarcastic, and white lie social exchanges between two people. Stimuli carefully manipulated the social relationship between communication partners (e.g., boss/employee, couple) and the availability of contextual cues (e.g. preceding conversations, physical objects) while controlling for major differences in the linguistic content of matched items. Here, we present initial perceptual validation data (N = 31) on a corpus of 920 items. Overall accuracy for identifying speaker intentions was above 80% correct and our results show that both relationship type and verbal context influence the categorization of literal and nonliteral interactions, underscoring the importance of these factors in research on speaker intentions. We believe that RISC will prove highly constructive as a tool in future research on social cognition, inter-personal communication, and the interpretation of speaker intentions in both healthy adults and clinical populations.	[Rothermich, Kathrin; Pell, Marc D.] McGill Univ, Sch Commun Sci & Disorders, Montreal, PQ, Canada; [Rothermich, Kathrin; Pell, Marc D.] Ctr Res Brain Language & Mus, Montreal, PQ, Canada	McGill University	Rothermich, K (corresponding author), McGill Univ, Sch Commun Sci & Disorders, Montreal, PQ, Canada.	kathrin.rothermich@mail.mcgill.ca	Rothermich, Kathrin/Z-5320-2019; Pell, Marc D./AAL-3121-2021	Pell, Marc D./0000-0002-9947-1552	Fonds de recherche du Quebec - Sante [30095]; natural sciences and engineering research council of Canada;  [RGPIN 203708-11]	Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); natural sciences and engineering research council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); 	KR: Fonds de recherche du Quebec - Sante 30095 (http://www.frqs.gouv.qc.ca/); MDP: Discovery grant from the natural sciences and engineering research council of Canada; RGPIN 203708-11 (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Akel A, 2003, BRAIN RES REV, V43, P29, DOI 10.1016/S0165-0173(03)00190-5; ACKERMAN BP, 1983, J EXP CHILD PSYCHOL, V35, P487, DOI 10.1016/0022-0965(83)90023-1; ADACHI T, 1996, STUD LANG, V20, P1, DOI 10.1075/sl.20.1.02ada; Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; Alberts JK, 1996, WESTERN J COMM, V60, P337; Anolli L, 2000, J PSYCHOLINGUIST RES, V29, P275, DOI 10.1023/A:1005100221723; [Anonymous], 1998, COGN NEUROPSYCHIATRY, DOI [DOI 10.1080/135468098396206, 10.1080/135468098396206]; Argo JJ, 2012, J CONSUM RES, V38, P1093, DOI 10.1086/661640; Attardo S, 2003, HUMOR, V16, P243, DOI 10.1515/humr.2003.012; Baron-Cohen S., 2013, UNDERSTANDING OTHER; Baron-Cohen S., 1997, MINDBLINDNESS ESSAY; Bateson G., 1983, STEPS ECOLOGY MIND; BAXTER LA, 1992, HUM COMMUN RES, V18, P336, DOI 10.1111/j.1468-2958.1992.tb00556.x; Bok S, 1978, LYING MORAL CHOICE P; Bond CF, 2008, PSYCHOL BULL, V134, P477, DOI 10.1037/0033-2909.134.4.477; Bond CF, 2006, PERS SOC PSYCHOL REV, V10, P214, DOI 10.1207/s15327957pspr1003_2; Bowes A, 2011, DISCOURSE PROCESS, V48, P215, DOI 10.1080/0163853X.2010.532757; BOWLER DM, 1992, J CHILD PSYCHOL PSYC, V33, P877, DOI 10.1111/j.1469-7610.1992.tb01962.x; BRITON NJ, 1995, SEX ROLES, V32, P79, DOI 10.1007/BF01544758; Brown P, 1978, UNIVERSALS LANG, P56; BROWN R, 1989, LANG SOC, V18, P159, DOI 10.1017/S0047404500013464; Bryant GA, 2005, LANG SPEECH, V48, P257, DOI 10.1177/00238309050480030101; Bryant GA, 2009, RECOGNIZING VERBAL I, P37; Bryant GA, 2012, LANG LINGUIST COMPAS, V6, P673, DOI 10.1002/lnc3.364; BULLER DB, 1987, J NONVERBAL BEHAV, V11, P269, DOI 10.1007/BF00987257; Camden C., 1984, W J SPEECH COMMUN, V48, P309, DOI [DOI 10.1080/10570318409374167, https://doi.org/10.1080/10570318409374167]; CAPELLI CA, 1990, CHILD DEV, V61, P1824, DOI 10.1111/j.1467-8624.1990.tb03568.x; Caucci GM, 2012, HUMOR, V25, P1, DOI 10.1515/humor-2012-0001; Chakravarty S, 2013, LYING AND FRIENDSHIP; Cheang HS, 2008, SPEECH COMMUN, V50, P366, DOI 10.1016/j.specom.2007.11.003; Cheang HS, 2011, PRAGMAT COGN, V19, P203, DOI 10.1075/pc.19.2.02che; Cheang HS, 2009, J ACOUST SOC AM, V126, P1394, DOI 10.1121/1.3177275; CLARK HH, 1984, J EXP PSYCHOL GEN, V113, P121, DOI 10.1037/0096-3445.113.1.121; Colston HL, 2004, METAPHOR SYMBOL, V19, P289, DOI 10.1207/s15327868ms1904_3; COSER RL, 1959, HUM RELAT, V12, P171, DOI 10.1177/001872675901200205; Cutler Anne, 1974, 10 REG M CHIC LING S, V10, P117; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; DePaulo BM, 1998, J PERS SOC PSYCHOL, V74, P63, DOI 10.1037/0022-3514.74.1.63; DePaulo BM, 1996, J PERS SOC PSYCHOL, V71, P703, DOI 10.1037/0022-3514.71.4.703; DePaulo BM, 1996, J PERS SOC PSYCHOL, V70, P979, DOI 10.1037/0022-3514.70.5.979; DePaulo BM, 2003, PSYCHOL BULL, V129, P74, DOI 10.1037//0033-2909.129.1.74; DEWS S, 1995, DISCOURSE PROCESS, V19, P347, DOI 10.1080/01638539509544922; Dews S, 1999, J PRAGMATICS, V31, P1579, DOI 10.1016/S0378-2166(99)00005-3; Elamin M, 2012, J NEUROL NEUROSUR PS, V83, P1071, DOI 10.1136/jnnp-2012-302817; Feldman RS, 2002, BASIC APPL SOC PSYCH, P37; Filik R, 2014, J EXP PSYCHOL LEARN, V40, P811, DOI 10.1037/a0035658; Frith U, 2001, CURR DIR PSYCHOL SCI, V10, P151, DOI 10.1111/1467-8721.00137; Gibbs R.W., 2000, METAPHOR SYMBOL, V15, P5, DOI [DOI 10.1080/10926488.2000.9678862, 10.1207/S15327868MS1512_2, DOI 10.1207/S15327868MS1512_2]; Gibbs RW, 1999, BRAIN LANG, V68, P466, DOI 10.1006/brln.1999.2123; GIBBS RW, 1986, J EXP PSYCHOL GEN, V115, P3, DOI 10.1037/0096-3445.115.1.3; Giora R, 2007, METAPHOR SYMBOL, V22, P119, DOI 10.1080/10926480701235346; Goffman E., 1967, INTERACTION RITUAL E; Grice Paul., 1989, STUDIES WAY WORDS; Hagoort P, 2007, PHILOS T R SOC B, V362, P801, DOI 10.1098/rstb.2007.2089; Haiman J., 1998, TALK IS CHEAP SARCAS; Hall JA, 2008, PERS SOC PSYCHOL B, V34, P144, DOI 10.1177/0146167207309192; Hample D., 1980, SO SPEECH COMMUNICAT, V46, P33, DOI [DOI 10.1080/10417948009372474, 10.1080/10417948009372474]; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Hoitgraves TM, 2008, PERS SOC PSYCHOL REV, V12, P73, DOI 10.1177/1088868307309605; HOLTGRAVES T, 1986, J PERS SOC PSYCHOL, V51, P305, DOI 10.1037/0022-3514.51.2.305; Ibanez A, 2012, NEUROLOGY, V78, P1354, DOI 10.1212/WNL.0b013e3182518375; Ivanko SL, 2004, J LANG SOC PSYCHOL, V23, P244, DOI 10.1177/0261927x04266809; Ivanko SL, 2010, CONTEXT INCONGRUITY, P37; Jolliffe T, 1999, J AUTISM DEV DISORD, V29, P395, DOI 10.1023/A:1023082928366; Jorgensen J, 1996, J PRAGMATICS, V26, P613, DOI 10.1016/0378-2166(95)00067-4; JORGENSEN J, 1984, J EXP PSYCHOL GEN, V113, P112, DOI 10.1037/0096-3445.113.1.112; Katz AN, 2004, CURR DIR PSYCHOL SCI, V13, P186, DOI 10.1111/j.0963-7214.2004.00304.x; Katz AN, 1997, METAPHOR SYMBOL, V12, P37; KREUZ RJ, 1989, J EXP PSYCHOL GEN, V118, P374, DOI 10.1037/0096-3445.118.4.374; Kreuz RJ., 1996, METAPHOR IMPLICATION, P23; KUMONNAKAMURA S, 1995, J EXP PSYCHOL GEN, V124, P3, DOI 10.1037/0096-3445.124.1.3; Lampert MD, 2006, J PRAGMATICS, V38, P51, DOI 10.1016/j.pragma.2005.06.004; Levine EE, 2014, J EXP SOC PSYCHOL, V53, P107, DOI 10.1016/j.jesp.2014.03.005; Levine TR, 2010, COMMUN RES REP, V27, P271, DOI 10.1080/08824096.2010.496334; Martin I, 2005, APHASIOLOGY; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; McCornack S.A., 1986, COMMUNICATION YB, V9, P377, DOI [DOI 10.1080/23808985.1986.11678616, 10.1080/23808985.1986.11678616]; McDonald S, 1999, BRAIN LANG, V68, P486, DOI 10.1006/brln.1999.2124; McDonald S, 2003, J HEAD TRAUMA REHABI; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Millar MG, 1997, COMMUN RES, V24, P556, DOI 10.1177/009365097024005005; Milosky LM, 1994, THE PROSODY OF IRONY; Monetta L, 2009, CORTEX, V45, P972, DOI 10.1016/j.cortex.2009.02.021; OZONOFF S, 1991, J CHILD PSYCHOL PSYC, V32, P1081, DOI 10.1111/j.1469-7610.1991.tb00351.x; Palmer J., TAKING HUMOUR SERIOU; Pell MD, 2014, NEUROPSYCHOLOGY, V28, P905, DOI 10.1037/neu0000090; Peterson C, 1996, INT J PSYCHOL, V31, P279, DOI 10.1080/002075996401034; Pexman PM, 2000, DISCOURSE PROCESS, V29, P201, DOI 10.1207/S15326950dp2903_2; Pexman PM., 2004, DOES IRONY GO BETTER, P37, DOI [10.1207/s15327868ms1902, DOI 10.1207/S15327868MS1902]; Pexman PM, 2010, DOES SARCASM ALWAYS, P37; Rankin KP, 2009, NEUROIMAGE, V47, P2005, DOI 10.1016/j.neuroimage.2009.05.077; Rigoulot S, 2014, BRAIN RES, V1565, P48, DOI 10.1016/j.brainres.2014.04.022; Rockwell P, 2001, COMMUN RES REPORTS, V18, P44, DOI DOI 10.1080/08824090109384781; SAXE L, 1991, AM PSYCHOL, V46, P409, DOI 10.1037/0003-066X.46.4.409; Schaffer Rachel, 1982, PARASESSION LANGUAGE, P204; Schmid PC, 2011, SEX ROLES, V65, P102, DOI 10.1007/s11199-011-9979-3; SECKMAN MA, 1989, J CONTEMP ETHNOGR, V18, P327, DOI 10.1177/089124189018003004; Shany-Ur T, 2012, CORTEX, V48, P1329, DOI 10.1016/j.cortex.2011.08.003; Shapely M., 1987, PAPERS PRAGMATICS, V1, P66; Slugoski Ben R., 1988, J LANG SOC PSYCHOL, V7, P101, DOI DOI 10.1177/0261927X8800700202; Smoski MJ, 2003, COGNITION EMOTION, V17, P327, DOI 10.1080/02699930302296; SPENCE JT, 1975, J PERS SOC PSYCHOL, V32, P29, DOI 10.1037/h0076857; Sperber Dan, 1986, RELEVANCE COMMUNICAT, V142; Suls Jerry, 1983, HDB HUMOR RES; Tannen Deborah, 1991, YOU JUST DONT UNDERS; Thomas J. T., 2011, THESIS; Thomson R, 2001, BRIT J SOC PSYCHOL, V40, P193, DOI 10.1348/014466601164812; Turner RE, 1975, INFORM CONTROL CONVE, DOI 10.17161/STR.1808.6098; Van Swol LM, 2012, DISCOURSE PROCESS, V49, P79, DOI 10.1080/0163853X.2011.633331; Villar G, 2013, PSYCHIAT PSYCHOL LAW, V20, P123, DOI 10.1080/13218719.2011.633320; von Hippel W, 2005, PSYCHOL AGING, V20, P519, DOI 10.1037/0882-7974.20.3.519; Vrij A, 1996, J NONVERBAL BEHAV, P20; WAGNER HL, 1993, J NONVERBAL BEHAV, V17, P3, DOI 10.1007/BF00987006; Williams JA, 2009, PERCEPT MOTOR SKILL, V108, P565, DOI 10.2466/PMS.108.2.565-572; Winner E, 1998, BRAIN LANG, V62, P89, DOI 10.1006/brln.1997.1889; Winner E., 1988, POINT WORDS CHILDREN; Woodland J, 2011, METAPHOR SYMBOL, V26, P227, DOI 10.1080/10926488.2011.583197; ZUCKERMAN M, 1981, J NONVERBAL BEHAV, V6, P105, DOI 10.1007/BF00987286; Zuckerman M., 1985, MULTICHANNEL INTEGRA, P129; Zuckerman M, 1979, FACIAL VOCAL CUES DE	122	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133902	10.1371/journal.pone.0133902	http://dx.doi.org/10.1371/journal.pone.0133902			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JT	26226009	gold, Green Published, Green Submitted			2022-12-27	WOS:000358837700042
J	Stadlbauer, S; Rios, P; Ohmori, K; Suzuki, K; Kohn, M				Stadlbauer, Sven; Rios, Pablo; Ohmori, Ken; Suzuki, Keisuke; Koehn, Maja			Procyanidins Negatively Affect the Activity of the Phosphatases of Regenerating Liver	PLOS ONE			English	Article							CATECHIN-CLASS POLYPHENOLS; CELL-CYCLE ARREST; GREEN TEA; SYNTHETIC STRATEGY; (-)-EPIGALLOCATECHIN GALLATE; CANCER-CELLS; METASTASIS; INHIBITION; PROANTHOCYANIDINS; EPIGALLOCATECHIN-3-GALLATE	Natural polyphenols like oligomeric catechins (procyanidins) derived from green tea and herbal medicines are interesting compounds for pharmaceutical research due to their ability to protect against carcinogenesis in animal models. It is nevertheless still unclear how intracellular pathways are modulated by polyphenols. Monomeric polyphenols were shown to affect the activity of some protein phosphatases (PPs). The three phosphatases of regenerating liver (PRLs) are close relatives and promising therapeutic targets in cancer. In the present study we show that several procyanidins inhibit the activity of all three members of the PRL family in the low micromolar range, whereas monomeric epicatechins show weak inhibitory activity. Increasing the number of catechin units in procyanidins to more than three does not further enhance the potency. Remarkably, the tested procyanidins showed selectivity in vitro when compared to other PPs, and over 10-fold selectivity toward PRL-1 over PRL-2 and PRL-3. As PRL overexpression induces cell migration compared to control cells, the effect of procyanidins on this phenotype was studied. Treatment with procyanidin C2 led to a decrease in cell migration of PRL-1- and PRL-3-overexpressing cells, suggesting the compound-dependent inhibition of PRL-promoted cell migration. Treatment with procyanidin B3 led to selective suppression of PRL-1 overexpressing cells, thereby corroborating the selectivity toward PRL-1-over PRL-3 in vitro. Together, our results show that procyanidins negatively affect PRL activity, suggesting that PRLs could be targets in the polypharmacology of natural polyphenols. Furthermore, they are interesting candidates for the development of PRL-1 inhibitors due to their low cellular toxicity and the selectivity within the PRL family.	[Stadlbauer, Sven; Rios, Pablo; Koehn, Maja] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Ohmori, Ken; Suzuki, Keisuke] Tokyo Inst Technol, Dept Chem, Meguro Ku, Tokyo 1528551, Japan	European Molecular Biology Laboratory (EMBL); Tokyo Institute of Technology	Stadlbauer, S (corresponding author), European Mol Biol Lab, Genome Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	sven.stadlbauer@web.de; koehn@embl.de	Köhn, Maja/G-5131-2012	Köhn, Maja/0000-0001-8142-3504; Ohmori, Ken/0000-0002-8498-0821	Alexander von Humboldt-Foundation [1135581]; German Science Foundation (DFG) [KO 4013/1-1]; Japan Society for the Promotion of Science (JSPS); EMBL Protein Expression and Purification Core Facility; EMBL Chemical Biology Core Facility; EMBL Flow Cytometry Core laboratory	Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation); German Science Foundation (DFG)(German Research Foundation (DFG)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EMBL Protein Expression and Purification Core Facility; EMBL Chemical Biology Core Facility; EMBL Flow Cytometry Core laboratory	S. Stadlbauer thanks the Alexander von Humboldt-Foundation for a return fellowship (1135581). M.K. thanks the German Science Foundation (DFG) for support within the Emmy Noether program (KO 4013/1-1). This work was supported by a Grant-in-Aid for Specially Promoted Research (No. 23000006) from the Japan Society for the Promotion of Science (JSPS). The authors acknowledge the support of the EMBL Protein Expression and Purification Core Facility, the EMBL Chemical Biology Core Facility, and the EMBL Flow Cytometry Core laboratory.	Ahmad N, 1997, JNCI-J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881; Bessette DC, 2008, CANCER METAST REV, V27, P231, DOI 10.1007/s10555-008-9121-3; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; Dennis EG, 2012, TETRAHEDRON, V68, P340, DOI 10.1016/j.tet.2011.10.039; Deziel BA, 2010, J CELL BIOCHEM, V111, P742, DOI 10.1002/jcb.22761; Ferreira D, 2011, PLANTA MED, V77, P1071, DOI 10.1055/s-0030-1270908; Fujii W, 2013, TETRAHEDRON, V69, P3543, DOI 10.1016/j.tet.2013.02.087; Gopalakrishnan A, 2006, ARCH PHARM RES, V29, P633, DOI 10.1007/BF02968247; Gupta S, 2001, P NATL ACAD SCI USA, V98, P10350, DOI 10.1073/pnas.171326098; Hara Y., 2001, GREEN TEA HLTH BENEF; Hardy S, 2010, CANCER RES, V70, P8959, DOI 10.1158/0008-5472.CAN-10-2041; He Tai-ping, 2010, Zhong Yao Cai, V33, P771; Hemmersbach S, 2013, J AGR FOOD CHEM, V61, P7932, DOI 10.1021/jf402019f; Hoeger B, 2014, EUR J MED CHEM, V88, P89, DOI 10.1016/j.ejmech.2014.08.060; Ito Y, 2014, ANGEW CHEM INT EDIT, V53, P10129, DOI 10.1002/anie.201405600; Jankun J, 1997, NATURE, V387, P561, DOI 10.1038/42381; Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636; Kiss A, 2013, FEBS J, V280, P612, DOI 10.1111/j.1742-4658.2012.08498.x; Kozikowski AP, 2003, J ORG CHEM, V68, P1641, DOI 10.1021/jo020393f; Li M, 2014, J AGR FOOD CHEM, V62, P3768, DOI 10.1021/jf500246m; Li X, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003203; Liu YX, 2008, J ORG CHEM, V73, P4625, DOI 10.1021/jo8005649; Lu JW, 2012, CLIN TRANSL ONCOL, V14, P287, DOI 10.1007/s12094-012-0797-z; Ma JF, 2011, BIOCHEM BIOPH RES CO, V407, P98, DOI 10.1016/j.bbrc.2011.02.116; McParland V, 2011, BIOCHEMISTRY-US, V50, P7579, DOI 10.1021/bi201095z; Meyer C, 2014, ACS CHEM BIOL, V9, P769, DOI 10.1021/cb400903u; NAKAYAMA M, 1993, ANTIVIR RES, V21, P289, DOI 10.1016/0166-3542(93)90008-7; Nandakumar V, 2008, CANCER LETT, V269, P378, DOI 10.1016/j.canlet.2008.03.049; Nozaki A, 2009, CHEM PHARM BULL, V57, P224, DOI 10.1248/cpb.57.224; Ohmori K, 2004, P NATL ACAD SCI USA, V101, P12002, DOI 10.1073/pnas.0401651101; Ohmori K, 2011, ANGEW CHEM INT EDIT, V50, P4862, DOI 10.1002/anie.201007473; Ohmori K, 2011, CHEM REC, V11, P252, DOI 10.1002/tcr.201100026; Ohmori K, 2010, ORG BIOMOL CHEM, V8, P2693, DOI 10.1039/c003464a; Ohmori K, 2009, CHEM LETT, V38, P934, DOI 10.1246/cl.2009.934; Park YC, 2000, FEBS LETT, V465, P93, DOI 10.1016/S0014-5793(99)01735-4; Qian F, 2007, MOL MED, V13, P151, DOI 10.2119/2006-00076.Qian; Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044; Rios P, 2014, ANTIOXID REDOX SIGN, V20, P2251, DOI 10.1089/ars.2013.5709; Rios P, 2013, FEBS J, V280, P505, DOI 10.1111/j.1742-4658.2012.08565.x; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Siddiqui IA, 2011, FASEB J, V25, P1198, DOI 10.1096/fj.10-167924; Singh AP, 2009, PHYTOTHER RES, V23, P1066, DOI 10.1002/ptr.2667; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; Sotoud H, 2013, J BIOMOL SCREEN, V18, P899, DOI 10.1177/1087057113486000; Stadlbauer S, 2012, CHEM COMMUN, V48, P8425, DOI 10.1039/c2cc33704e; Trnkova L, 2011, J MOL STRUCT, V985, P243, DOI 10.1016/j.molstruc.2010.11.001; Verstraeten SV, 2015, FOOD FUNCT, V6, P32, DOI [10.1039/c4fo00647j, 10.1039/C4FO00647J]; Wang Y, 2012, ONCOGENE, V31, P818, DOI 10.1038/onc.2011.281; Wegner Adam M., 2007, V365, P61; Zimmerman MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058300	50	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134336	10.1371/journal.pone.0134336	http://dx.doi.org/10.1371/journal.pone.0134336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226290	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700074
J	Wagner, K; Groger, M; McCook, O; Scheuerle, A; Asfar, P; Stahl, B; Huber-Lang, M; Ignatius, A; Jung, B; Duechs, M; Moller, P; Georgieff, M; Calzia, E; Radermacher, P; Wagner, F				Wagner, Katja; Groeger, Michael; McCook, Oscar; Scheuerle, Angelika; Asfar, Pierre; Stahl, Bettina; Huber-Lang, Markus; Ignatius, Anita; Jung, Birgit; Duechs, Matthias; Moeller, Peter; Georgieff, Michael; Calzia, Enrico; Radermacher, Peter; Wagner, Florian			Blunt Chest Trauma in Mice after Cigarette Smoke-Exposure: Effects of Mechanical Ventilation with 100% O-2	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; INDUCED LUNG INJURY; HEMORRHAGIC-SHOCK; SYSTEMIC INFLAMMATION; ALVEOLAR MACROPHAGES; MURINE MODEL; MOUSE MODEL; HYPEROXIA; OXYGEN; INHIBITION	Cigarette smoking (CS) aggravates post-traumatic acute lung injury and increases ventilator-induced lung injury due to more severe tissue inflammation and apoptosis. Hyper-inflammation after chest trauma is due to the physical damage, the drop in alveolar PO2, and the consecutive hypoxemia and tissue hypoxia. Therefore, we tested the hypotheses that 1) CS exposure prior to blunt chest trauma causes more severe post-traumatic inflammation and thereby aggravates lung injury, and that 2) hyperoxia may attenuate this effect. Immediately after blast wave-induced blunt chest trauma, mice (n=32) with or without 3-4 weeks of CS exposure underwent 4 hours of pressure-controlled, thoraco-pulmonary compliance-titrated, lung-protective mechanical ventilation with air or 100% O-2. Hemodynamics, lung mechanics, gas exchange, and acid-base status were measured together with blood and tissue cytokine and chemokine concentrations, heme oxygenase-1 (HO-1), activated caspase-3, and hypoxia-inducible factor 1-alpha (HIF-1 alpha) expression, nuclear factor-kappa B (NF-kappa B) activation, nitrotyrosine formation, purinergic receptor 2X(4) (P2XR(4)) and 2X(7) (P2XR(7)) expression, and histological scoring. CS exposure prior to chest trauma lead to higher pulmonary compliance and lower PaO2 and Horovitz-index, associated with increased tissue IL-18 and blood MCP-1 concentrations, a 2-4-fold higher inflammatory cell infiltration, and more pronounced alveolar membrane thickening. This effect coincided with increased activated caspase-3, nitrotyrosine, P2XR(4), and P2XR(7) expression, NF-kappa B activation, and reduced HIF-1 alpha expression. Hyperoxia did not further affect lung mechanics, gas exchange, pulmonary and systemic cytokine and chemokine concentrations, or histological scoring, except for some patchy alveolar edema in CS exposed mice. However, hyperoxia attenuated tissue HIF-1 alpha, nitrotyrosine, P2XR(7), and P2XR(4) expression, while it increased HO-1 formation in CS exposed mice. Overall, CS exposure aggravated post-traumatic inflammation, nitrosative stress and thereby organ dysfunction and injury; short-term, lung-protective, hyperoxic mechanical ventilation have no major beneficial effect despite attenuation of nitrosative stress, possibly due to compensation of by regional alveolar hypoxia and/or consecutive hypoxemia, resulting in down-regulation of HIF-1 alpha expression.	[Wagner, Katja; Groeger, Michael; McCook, Oscar; Stahl, Bettina; Calzia, Enrico; Radermacher, Peter; Wagner, Florian] Inst Anasthesiol Pathophysiol & Verfahrensentwick, Ulm, Germany; [Wagner, Katja; Georgieff, Michael; Wagner, Florian] Univ Ulm Klinikum, Anasthesiol Klin, Ulm, Germany; [Scheuerle, Angelika; Moeller, Peter] Univ Ulm Klinikum, Inst Pathol, Ulm, Germany; [Asfar, Pierre] Univ Angers, Dept Reanimat Med & Med Hyperbare, Ctr Hosp Univ,CNRS UMR 6214,INSERM U1083, Lab HIFIH,UPRES EA 3859,PRES UNAM,IFR 132, Angers, France; [Huber-Lang, Markus] Univ Ulm Klinikum, Klin Unfall Hand Plast & Wiederherstellungschirur, Ulm, Germany; [Ignatius, Anita] Univ Ulm Klinikum, Inst Unfallchirurg Forsch & Biomech, Ulm, Germany; [Jung, Birgit; Duechs, Matthias] Boehringer Ingelheim Pharma GmbH & Co KG, Abt Resp Dis Res, Biberach, Germany	Ulm University; Ulm University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Ulm University; Ulm University; Boehringer Ingelheim	Radermacher, P (corresponding author), Inst Anasthesiol Pathophysiol & Verfahrensentwick, Ulm, Germany.	peter.radermacher@uni-ulm.de	Ignatius, Anita/M-6012-2013; van Griensven, Martijn/F-5808-2012; McCook, Oscar/AAF-1647-2020; Huber-Lang, Markus/AAJ-2209-2020; Asfar, Pierre/K-1402-2015	Ignatius, Anita/0000-0002-4782-1979; van Griensven, Martijn/0000-0001-5104-9881; McCook, Oscar/0000-0001-7879-7695; 	Deutsche Forschungsgemeinschaft [Klinische Forschergruppe 200, DFG RA 396/9-2]; Ministry of Science, Research and the Arts of Baden-Wurttemberg [Az:32-729.55-0/239-5/32-7533.-6-10/15/1]; Boehringer Ingelheim Pharma GmbH Co. KG	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Science, Research and the Arts of Baden-Wurttemberg; Boehringer Ingelheim Pharma GmbH Co. KG(Boehringer Ingelheim)	Supported by a grant of the Deutsche Forschungsgemeinschaft (Klinische Forschergruppe 200 "Die Entzundungsantwort nach muskuloskelettalem Trauma"; DFG RA 396/9-2) and a grant from the Ministry of Science, Research and the Arts of Baden-Wurttemberg (Az:32-729.55-0/239-5/32-7533.-6-10/15/1) to P.R. (Boehringer Ingelheim Ulm University BioCenter). The Deutsche Forschungsgemeinschaft had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Boehringer Ingelheim Pharma GmbH & Co. KG provided support in the form of salaries for authors B.J. and M.D., but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of B.J. and M.D. are articulated in the "author contributions" section.	Albaiceta GM, 2008, J TRAUMA, V64, P470, DOI 10.1097/TA.0b013e31814931ac; Barth E, 2008, CRIT CARE MED, V36, P495, DOI 10.1097/01.CCM.0B013E318161FC45; Bitterman H, 1996, AM J PHYSIOL-HEART C, V271, pH203, DOI 10.1152/ajpheart.1996.271.1.H203; Blasiole B, 2013, ANESTHESIOLOGY, V118, P649, DOI 10.1097/ALN.0b013e318280a42d; Buras JA, 2006, CRIT CARE MED, V34, P2624, DOI 10.1097/01.CCM.0000239438.22758.E0; Calfee CS, 2011, AM J RESP CRIT CARE, V183, P1660, DOI 10.1164/rccm.201011-1802OC; Calvert JW, 2006, J APPL PHYSIOL, V101, P853, DOI 10.1152/japplphysiol.00268.2006; Cannizzaro V, 2009, RESP PHYSIOL NEUROBI, V165, P61, DOI 10.1016/j.resp.2008.10.006; Chao J, 2011, AM J RESP CELL MOL, V45, P53, DOI 10.1165/rcmb.2010-0264OC; Chao J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-54; Chiao CW, 2008, J PHARMACOL EXP THER, V326, P864, DOI 10.1124/jpet.107.135350; Cicko S, 2010, J IMMUNOL, V185, P688, DOI 10.4049/jimmunol.0904042; DANTZKER DR, 1975, J APPL PHYSIOL, V38, P886, DOI 10.1152/jappl.1975.38.5.886; Dolinay T, 2012, AM J RESP CRIT CARE, V185, P1225, DOI 10.1164/rccm.201201-0003OC; Efrati S, 2008, NEPHROL DIAL TRANSPL, V23, P2213, DOI 10.1093/ndt/gfn093; Eltom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024097; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Feinman R, 2010, AM J PHYSIOL-GASTR L, V299, pG833, DOI 10.1152/ajpgi.00065.2010; Fisarkova B, 2004, PHYSIOL RES, V53, P487; Frohlich S, 2013, AM J RESP CELL MOL, V48, P271, DOI 10.1165/rcmb.2012-0137TR; Geldmacher H, 2008, DEUT MED WOCHENSCHR, V133, P2609, DOI 10.1055/s-0028-1105858; Geraghty P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00267; Gonzalez NC, 2010, ADV EXP MED BIOL, V662, P27, DOI 10.1007/978-1-4419-1241-1_3; Gould NS, 2010, AM J RESP CRIT CARE, V182, P1114, DOI 10.1164/rccm.201003-0442OC; Guan SP, 2013, BRIT J PHARMACOL, V168, P1707, DOI 10.1111/bph.12054; Hafner S, 2015, SHOCK, V43, P140, DOI 10.1097/SHK.0000000000000277; Hauser B, 2009, CRIT CARE MED, V37, P2465, DOI 10.1097/CCM.0b013e3181aee8ad; Hirsch J, 2014, CRIT CARE, V18, DOI 10.1186/cc13795; Hoth JJ, 2009, SHOCK, V31, P376, DOI 10.1097/SHK.0b013e3181862279; Hou LC, 2009, SHOCK, V32, P451, DOI 10.1097/SHK.0b013e31819c391a; Hsieh SJ, 2014, CRIT CARE MED, V42, P2058, DOI 10.1097/CCM.0000000000000418; Jiang H, 2012, ACTA PHARMACOL SIN, V33, P635, DOI 10.1038/aps.2012.5; Jiang H, 2010, ACTA BIOCH BIOPH SIN, V42, P483, DOI 10.1093/abbs/gmq041; Kallet RH, 2013, RESP CARE, V58, P123, DOI 10.4187/respcare.01963; Kawano A, 2012, BIOCHEM BIOPH RES CO, V420, P102, DOI 10.1016/j.bbrc.2012.02.122; Knoferl MW, 2003, SHOCK, V19, P519, DOI 10.1097/01.shk.0000070739.34700.f6; Kolliputi N, 2010, J IMMUNOL, V184, P5819, DOI 10.4049/jimmunol.0902766; Kotani N, 1999, ANESTHESIOLOGY, V91, P1823, DOI 10.1097/00000542-199912000-00037; Lee SH, 2014, CLIN BIOCHEM, V47, P552, DOI 10.1016/j.clinbiochem.2014.01.012; Lucattelli M, 2011, AM J RESP CELL MOL, V44, P423, DOI 10.1165/rcmb.2010-0038OC; Madjdpour C, 2003, AM J PHYSIOL-LUNG C, V284, pL360, DOI 10.1152/ajplung.00158.2002; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; McGrath-Morrow SA, 2011, AM J RESP CELL MOL, V45, P610, DOI 10.1165/rcmb.2010-0259OC; Meier J, 2004, SHOCK, V22, P240, DOI 10.1097/01.shk.0000131192.02909.4c; Metzen E, 2003, MOL BIOL CELL, V14, P3470, DOI 10.1091/mbc.e02-12-0791; Moncao-Ribeiro LC, 2011, RESP PHYSIOL NEUROBI, V179, P314, DOI 10.1016/j.resp.2011.09.015; Muller HC, 2010, THORAX, V65, P1077, DOI 10.1136/thx.2010.135996; Muller T, 2011, AM J RESP CELL MOL, V44, P456, DOI 10.1165/rcmb.2010-0129OC; Muller-Redetzky HC, 2014, CRIT CARE, V18, DOI 10.1186/cc13830; O'Donnell DE, 2006, EUR RESPIR REV, V15, P61, DOI 10.1183/09059180.00010002; Ohata Y, 2011, CIRC J, V75, P945, DOI 10.1253/circj.CJ-09-0575; Papandrinopoulou D, 2012, PULM MED, V2012, DOI 10.1155/2012/542769; Park JW, 2013, EUR J PHARMACOL, V706, P76, DOI 10.1016/j.ejphar.2013.02.049; Quinn DA, 2002, J APPL PHYSIOL, V93, P517, DOI 10.1152/japplphysiol.00570.2001; Reiss LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024527; Rossi JL, 2007, AM J PHYSIOL-LUNG C, V292, pL1327, DOI 10.1152/ajplung.00380.2006; Schmidt E P, 2010, J Cell Death, V3, P41; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Shah CV, 2008, CRIT CARE MED, V36, P2309, DOI 10.1097/CCM.0b013e318180dc74; Sinclair SE, 2004, CRIT CARE MED, V32, P2496, DOI 10.1097/01.CCM.0000148231.04642.8D; Sukhotnik I, 2009, CRIT CARE MED, V37, P1054, DOI 10.1097/CCM.0b013e31819d0f5c; Suresh MV, 2014, CRIT CARE MED, V42, pE642, DOI 10.1097/CCM.0000000000000488; Thakur VS, 2014, TOXICOL LETT, V230, P322, DOI 10.1016/j.toxlet.2014.03.006; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; Uematsu S, 2013, CRIT CARE MED, V41, P151, DOI 10.1097/CCM.0b013e318267606f; Vlaar APJ, 2010, INTENS CARE MED, V36, P879, DOI 10.1007/s00134-010-1802-z; Vlahos R, 2006, PULM PHARMACOL THER, V19, P12, DOI 10.1016/j.pupt.2005.02.006; Vuichard D, 2005, CLIN EXP IMMUNOL, V141, P248, DOI 10.1111/j.1365-2249.2005.02835.x; Wagner F, 2011, J TRAUMA, V71, P1659, DOI 10.1097/TA.0b013e318228842e; Wagner F, 2011, SHOCK, V35, P396, DOI 10.1097/SHK.0b013e3181ffff0e; Wagner K, 2013, INTENS CARE MED EXP, V1, DOI 10.1186/2197-425X-1-2; Waisman D, 2003, AM J PHYSIOL-HEART C, V285, pH643, DOI 10.1152/ajpheart.00900.2002; Waisman D, 2012, SHOCK, V37, P95, DOI 10.1097/SHK.0b013e3182356fc3; Weinhold K, 2010, CELL MOL LIFE SCI, V67, P2631, DOI 10.1007/s00018-010-0355-1; Wilson MR, 2012, CRIT CARE MED, V40, P2850, DOI 10.1097/CCM.0b013e31825b91ef; Wollin L, 2010, PULM PHARMACOL THER, V23, P345, DOI 10.1016/j.pupt.2010.03.008; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688; Yasuo M, 2011, EUR RESPIR J, V37, P775, DOI 10.1183/09031936.00022910	79	22	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0132810	10.1371/journal.pone.0132810	http://dx.doi.org/10.1371/journal.pone.0132810			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225825	Green Submitted, gold, Green Published			2022-12-27	WOS:000358837700011
J	Song, SS; Wang, BS; Zhang, X; Hao, LL; Hu, XL; Li, ZX; Sun, SL				Song, Shanshan; Wang, Baosheng; Zhang, Xin; Hao, Liliang; Hu, Xianliang; Li, Zhongxiang; Sun, Shaolong			Long-Term Diabetes Mellitus Is Associated with an Increased Risk of Pancreatic Cancer: A Meta-Analysis	PLOS ONE			English	Article							GROWTH-FACTOR-I; MEDICAL HISTORY; PHYSICAL-ACTIVITY; LIFE-STYLE; COHORT; INSULIN; SURVIVAL; ALCOHOL; SMOKING; GLUCOSE	Purpose Previous studies have shown a bidirectional relationship between diabetes and pancreatic cancer (PC). In particular, new-onset diabetes might be induced by PC, and people with long-term diabetes might be at increased risk for the development of PC. The purpose of our study was to examine whether long-term diabetes represented an independent risk factor for PC development. Methodology A literature search was performed by searching electronic databases for studies published before July 1, 2014, and relative risks (RRs) and corresponding 95% confidence intervals (CIs) were calculated. Data pertaining to diabetes were recorded at both individual and study levels, with RRs calculated separately to analyze the relationship between the duration of diabetes and the development of PC. Results Forty-four studies were included in this meta-analysis, including 18 studies with a case-control design, 5 with a nested case-control design and 21 with a cohort design. The overall summary estimate for the relationship between the population with a duration of diabetes >= 2 years and PC was 1.64 (1.52-1.78). The pooled RR (95% CI) of PC for the population with a duration of diabetes >= 5 years was 1.58 (1.42-1.75). For the population with a duration of diabetes >= 10 years, the RR (95% CI) of PC was 1.50 (1.28-1.75). Conclusions Our study suggests that long-term diabetes mellitus is associated with an increased risk of PC. However, the level of risk is negatively correlated with increasing diabetes mellitus duration.	[Song, Shanshan; Wang, Baosheng; Zhang, Xin; Hao, Liliang; Hu, Xianliang; Li, Zhongxiang; Sun, Shaolong] China Med Univ, Shengjing Hosp, Dept Pancreas & Breast Surg, Shenyang, Liaoning, Peoples R China	China Medical University	Sun, SL (corresponding author), China Med Univ, Shengjing Hosp, Dept Pancreas & Breast Surg, Shenyang, Liaoning, Peoples R China.	sj_sunsl@126.com			Science and Technology Department of Liaoning Province [2013225021]	Science and Technology Department of Liaoning Province	This work was supported by a grant from the Science and Technology Department of Liaoning Province (2013225021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI HO, 1991, CANCER CAUSE CONTROL, V2, P307, DOI 10.1007/BF00051670; Alderson P, 2004, COCHRANE LIB, P102; Anderson LN, 2009, CANCER CAUSE CONTROL, V20, P825, DOI 10.1007/s10552-009-9303-5; [Anonymous], 2000, 3 S SYST REV BAS JUL; Arano T, 2011, INT J CANCER, V129, P2226, DOI 10.1002/ijc.25861; Arnold LD, 2009, CANCER EPIDEM BIOMAR, V18, P2397, DOI 10.1158/1055-9965.EPI-09-0080; Aschner P, 2014, DIABETES RES CLIN PR, V103, P238, DOI 10.1016/j.diabres.2013.11.010; Asiyanbola B, 2009, J GASTROINTEST SURG, V13, P752, DOI 10.1007/s11605-008-0762-x; Atchison EA, 2011, INT J CANCER, V128, P635, DOI 10.1002/ijc.25362; Attner B, 2012, CANCER CAUSE CONTROL, V23, P769, DOI 10.1007/s10552-012-9946-5; Bao Y, 2013, CANCER EPIDEM BIOMAR, V22, P855, DOI 10.1158/1055-9965.EPI-12-1458; Barb D, 2006, EXPERT OPIN INV DRUG, V15, P917, DOI 10.1517/13543784.15.8.917; Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; Batabyal P, 2014, ANN SURG ONCOL, V21, P2453, DOI 10.1245/s10434-014-3625-6; Ben QW, 2011, EUR J CANCER, V47, P1928, DOI 10.1016/j.ejca.2011.03.003; Ben QW, 2011, EUR J CANCER, V47, P248, DOI 10.1016/j.ejca.2010.07.010; Bonelli L, 2003, PANCREAS, V27, P143, DOI 10.1097/00006676-200308000-00007; Bosetti C, 2012, NUTR CANCER, V64, P643, DOI 10.1080/01635581.2012.676141; BOULWARE SD, 1994, J CLIN INVEST, V93, P1131, DOI 10.1172/JCI117065; Ceni E, 2005, WORLD J GASTROENTERO, V11, P1122, DOI 10.3748/wjg.v11.i8.1122; Chari ST, 2014, J PANCREAS, V15, P528; Cheon YK, 2014, GUT LIVER, V8, P205, DOI 10.5009/gnl.2014.8.2.205; Chodick G, 2010, CANCER CAUSE CONTROL, V21, P879, DOI 10.1007/s10552-010-9515-8; CHOW WH, 1995, J NATL CANCER I, V87, P930, DOI 10.1093/jnci/87.12.930; Colhoun HM, 2009, DIABETOLOGIA, V52, P1755, DOI 10.1007/s00125-009-1453-1; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; CUZICK J, 1989, INT J CANCER, V43, P415, DOI 10.1002/ijc.2910430312; DEMESQUITA HBB, 1992, INT J CANCER, V52, P17, DOI 10.1002/ijc.2910520105; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eijgenraam P, 2013, BRIT J CANCER, V109, P2924, DOI 10.1038/bjc.2013.629; Elena JW, 2013, CANCER CAUSE CONTROL, V24, P13, DOI 10.1007/s10552-012-0078-8; FARROW DC, 1990, INT J CANCER, V45, P816, DOI 10.1002/ijc.2910450504; Frye JNR, 2000, AUST NZ J SURG, V70, P722, DOI 10.1046/j.1440-1622.2000.01940.x; Giovannucci E, 2000, CANCER EPIDEM BIOMAR, V9, P345; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Griffiths RI, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-613; Gudjonsson B, 2009, EUR J GASTROEN HEPAT, V21, P1379, DOI 10.1097/MEG.0b013e328323aab7; GULLO L, 1994, NEW ENGL J MED, V331, P81, DOI 10.1056/NEJM199407143310203; Hemminki K, 2010, ONCOLOGIST, V15, P548, DOI 10.1634/theoncologist.2009-0300; Henry SA, 2013, J PANCREAS, V14, P243, DOI 10.6092/1590-8577/1317; HIATT RA, 1988, INT J CANCER, V41, P794, DOI 10.1002/ijc.2910410603; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; JAIN M, 1991, INT J CANCER, V47, P384, DOI 10.1002/ijc.2910470313; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Khan Mmh, 2006, Asian Pac J Cancer Prev, V7, P253; Knol MJ, 2008, AM J EPIDEMIOL, V168, P1073, DOI 10.1093/aje/kwn217; Kong D, 2014, PHARMACOL THERAPEUT, V14, P101; Kuang TT, 2009, J DIGEST DIS, V10, P26, DOI 10.1111/j.1751-2980.2008.00359.x; Lee CT, 1996, J GASTROEN HEPATOL, V11, P491, DOI 10.1111/j.1440-1746.1996.tb00296.x; Li DH, 2011, CANCER CAUSE CONTROL, V22, P189, DOI 10.1007/s10552-010-9686-3; Li W, 2011, ONCOL REP, V25, P1279, DOI 10.3892/or.2011.1150; Lipworth L, 2011, DIABETES-METAB RES, V27, P255, DOI 10.1002/dmrr.1162; Lo AC, 2007, PANCREAS, V35, P120, DOI 10.1097/mpa.0b013e318053e7d3; Luo JH, 2007, CANCER CAUSE CONTROL, V18, P603, DOI 10.1007/s10552-007-9002-z; Luo JH, 2013, CANCER CAUSE CONTROL, V24, P577, DOI 10.1007/s10552-012-9996-8; Maisonneuve P, 2010, ANN EPIDEMIOL, V20, P92, DOI 10.1016/j.annepidem.2009.11.010; Ollberding NJ, 2012, CANCER EPIDEM BIOMAR, V21, P810, DOI 10.1158/1055-9965.EPI-11-1105; Otake S, 2010, WORLD J GASTROENTERO, V16, P1252, DOI 10.3748/wjg.v16.i10.1252; Pollak M, 2008, BEST PRACT RES CL EN, V22, P625, DOI 10.1016/j.beem.2008.08.004; SHIBATA A, 1994, INT J CANCER, V58, P46, DOI 10.1002/ijc.2910580109; Stevens RJ, 2009, INT J CANCER, V124, P2400, DOI 10.1002/ijc.24196; Stolzenberg-Solomon RZ, 2002, CANCER CAUSE CONTROL, V13, P417, DOI 10.1023/A:1015729615148; Tamayo T, 2014, DIABETES RES CLIN PR, V103, P206, DOI 10.1016/j.diabres.2013.11.007; Toriola AT, 2014, BRIT J CANCER, V111, P181, DOI 10.1038/bjc.2014.224; Wang Z, 2014, DIABETES RES CLIN PR, V106, P19, DOI 10.1016/j.diabres.2014.04.007; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wotton CJ, 2011, DIABETOLOGIA, V54, P527, DOI 10.1007/s00125-010-1987-2; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yeh HC, 2012, DIABETES CARE, V35, P113, DOI 10.2337/dc11-0255; Yisahak SF, 2014, DIABETES RES CLIN PR, V103, P223, DOI 10.1016/j.diabres.2013.11.009	70	61	66	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134321	10.1371/journal.pone.0134321	http://dx.doi.org/10.1371/journal.pone.0134321			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222906	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800130
J	Guo, J; Chen, X; Shi, Y; Lan, YQ; Qin, C				Guo, Jing; Chen, Xue; Shi, Ying; Lan, Yeqing; Qin, Chao			Rapid Photodegradation of Methyl Orange (MO) Assisted with Cu(II) and Tartaric Acid	PLOS ONE			English	Article							PHOTO-FENTON; DEGRADATION; WATER; CR(VI)	Cu(II) and organic carboxylic acids, existing extensively in soil and aquatic environments, can form complexes that may play an important role in the photodegradation of organic contaminants. In this paper, the catalytic role of Cu(II) in the removal of methyl orange (MO) in the presence of tartaric acid with light was investigated through batch experiments. The results demonstrate that the introduction of Cu(II) could markedly enhance the photodegradation of MO. In addition, high initial concentrations of Cu(II) and tartaric acid benefited the decomposition of MO. The most rapid removal of MO assisted by Cu(II) was achieved at pH 3. The formation of Cu(II)-tartaric acid complexes was assumed to be the key factor, generating hydroxyl radicals (center dot OH) and other oxidizing free radicals under irradiation through a ligand-to-metal charge-transfer pathway that was responsible for the efficient degradation of MO. Some intermediates in the reaction system were also detected to support this reaction mechanism.	[Guo, Jing; Chen, Xue; Shi, Ying; Lan, Yeqing; Qin, Chao] Nanjing Agr Univ, Coll Sci, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Lan, YQ (corresponding author), Nanjing Agr Univ, Coll Sci, Nanjing 210095, Jiangsu, Peoples R China.	lanyq102@njau.edu.cn			National Natural Science Foundation of China [21377056]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 21377056)(http://www.nsfc.gov.cn/).	Balmer ME, 1999, ENVIRON SCI TECHNOL, V33, P2418, DOI 10.1021/es9808705; Boye B, 2002, ENVIRON SCI TECHNOL, V36, P3030, DOI 10.1021/es0103391; Cavalcante RP, 2013, ENVIRON SCI POLLUT R, V20, P2352, DOI 10.1007/s11356-012-1110-y; Deng NS, 1998, CHEMOSPHERE, V36, P3101, DOI 10.1016/S0045-6535(98)00014-9; Garcia-Segura S, 2013, ELECTROCHIM ACTA, V113, P609, DOI 10.1016/j.electacta.2013.09.097; Guo J, 2011, J HAZARD MATER, V186, P2083, DOI 10.1016/j.jhazmat.2010.12.112; Klamerth N, 2010, ENVIRON SCI TECHNOL, V44, P1792, DOI 10.1021/es903455p; LEGRINI O, 1993, CHEM REV, V93, P671, DOI 10.1021/cr00018a003; Li H, 2014, SEP PURIF TECHNOL, V132, P168, DOI 10.1016/j.seppur.2014.05.015; Li Y, 2014, ENVIRON ENG SCI, V31, P447, DOI 10.1089/ees.2013.0407; Liu HN, 2007, J HAZARD MATER, V144, P180, DOI 10.1016/j.jhazmat.2006.10.009; Quici N, 2007, APPL CATAL B-ENVIRON, V71, P117, DOI 10.1016/j.apcatb.2006.09.001; Shah AD, 2013, ENVIRON SCI TECHNOL, V47, P2799, DOI 10.1021/es304893m; Sheikhshoaie I, 2009, CURR ORG CHEM, V13, P149, DOI 10.2174/138527209787193747; Silva C. G., 2003, J PHOTOCH PHOTOBIO A, V155, P133, DOI DOI 10.1016/S1010-6030(02)00374-X; Tian XF, 2010, GEODERMA, V159, P270, DOI 10.1016/j.geoderma.2010.07.019; Wei J, 2002, ENV ANAL CHEM; Wu Y, 2012, ENVIRON SCI POLLUT R, V19, P2313, DOI 10.1007/s11356-012-0740-4; Xu ZH, 2015, ULTRASON SONOCHEM, V27, P287, DOI 10.1016/j.ultsonch.2015.05.039; Xu ZH, 2013, J ALLOY COMPD, V546, P112, DOI 10.1016/j.jallcom.2012.08.087; ZUO YG, 1992, ENVIRON SCI TECHNOL, V26, P1014, DOI 10.1021/es00029a022	21	5	5	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134298	10.1371/journal.pone.0134298	http://dx.doi.org/10.1371/journal.pone.0134298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241043	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942700038
J	Sinha, AK; AbdElgawad, H; Zinta, G; Dasan, AF; Rasoloniriana, R; Asard, H; Blust, R; De Boeck, G				Sinha, Amit Kumar; AbdElgawad, Hamada; Zinta, Gaurav; Dasan, Antony Franklin; Rasoloniriana, Rindra; Asard, Han; Blust, Ronny; De Boeck, Gudrun			Nutritional Status as the Key Modulator of Antioxidant Responses Induced by High Environmental Ammonia and Salinity Stress in European Sea Bass (Dicentrarchus labrax)	PLOS ONE			English	Article								Salinity fluctuation is one of the main factors affecting the overall fitness of marine fish. In addition, water borne ammonia may occur simultaneously with salinity stress. Additionally, under such stressful circumstances, fish may encounter food deprivation. The physiological and ion-osmo regulatory adaptive capacities to cope with all these stressors alone or in combination are extensively addressed in fish. To date, studies revealing the modulation of antioxidant potential as compensatory response to multiple stressors are rather lacking. Therefore, the present work evaluated the individual and combined effects of salinity challenge, ammonia toxicity and nutritional status on oxidative stress and antioxidant status in a marine teleost, European sea bass (Dicentrarchus labrax). Fish were acclimated to normal seawater (32 ppt), to brackish water (20 ppt and 10 ppt) and to hypo-saline water (2.5 ppt). Following acclimation to different salinities for two weeks, fish were exposed to high environmental ammonia (HEA, 20 mg/L representing 50% of 96h LC50 value for ammonia) for 12 h, 48 h, 84 h and 180 h, and were either fed (2% body weight) or fasted (unfed for 7 days prior to HEA exposure). Results show that in response to decreasing salinities, oxidative stress indices such as xanthine oxidase activity, levels of hydrogen peroxide (H2O2) and lipid peroxidation (malondialdehyde, MDA) increased in the hepatic tissue of fasted fish but remained unaffected in fed fish. HEA exposure at normal salinity (32 ppt) and at reduced salinities (20 ppt and 10 ppt) increased ammonia accumulation significantly (84 h-180 h) in both feeding regimes which was associated with an increment of H2O2 and MDA contents. Unlike in fasted fish, H2O2 and MDA levels in fed fish were restored to control levels (84 h-180 h); with a concomitant increase in superoxide dismutase (SOD), catalase (CAT), components of the glutathione redox cycle (reduced glutathione, glutathione peroxidase and glutathione reductase), ascorbate peroxidase (APX) activity and reduced ascorbate (ASC) content. On the contrary, fasted fish could not activate many of these protective systems and rely mainly on CAT and ASC dependent pathways as antioxidative sentinels. The present findings exemplify that in fed fish single factors and a combination of HEA exposure and reduced seawater salinities (upto 10 ppt) were insufficient to cause oxidative damage due to the highly competent antioxidant system compared to fasted fish. However, the impact of HEA exposure at a hypo-saline environment (2.5 ppt) also defied antioxidant defence system in fed fish, suggesting this combined factor is beyond the tolerance range for both feeding groups. Overall, our results indicate that the oxidative stress mediated by the experimental conditions were exacerbated during starvation, and also suggest that feed deprivation particularly at reduced seawater salinities can instigate fish more susceptible to ammonia toxicity.	[Sinha, Amit Kumar; Dasan, Antony Franklin; Rasoloniriana, Rindra; Blust, Ronny; De Boeck, Gudrun] Univ Antwerp, Dept Biol, Syst Physiol & Ecotoxicol Res, B-2020 Antwerp, Belgium; [AbdElgawad, Hamada; Zinta, Gaurav; Asard, Han] Univ Antwerp, Dept Biol, Mol Plant Physiol & Biotechnol Grp, B-2020 Antwerp, Belgium; [AbdElgawad, Hamada] Univ Beni Sueif, Fac Sci, Dept Bot, Bani Suwayf, Egypt	University of Antwerp; University of Antwerp; Egyptian Knowledge Bank (EKB); Beni Suef University	Sinha, AK (corresponding author), Univ Antwerp, Dept Biol, Syst Physiol & Ecotoxicol Res, B-2020 Antwerp, Belgium.	sinha_cife@rediffmail.com	De Boeck, Gudrun/A-1938-2015; Zinta, Gaurav/A-1530-2015; AbdElgawad, Hamada/N-2488-2017	De Boeck, Gudrun/0000-0003-0941-3488; Zinta, Gaurav/0000-0002-5503-8618; Sinha, Amit Kumar/0000-0003-0419-7640; AbdElgawad, Hamada/0000-0001-9764-9006	Fonds Wetenschappelijk Onderzoek-Vlaanderen [FWO] [12A8814N]; GOA-BOF-UA	Fonds Wetenschappelijk Onderzoek-Vlaanderen [FWO](FWO); GOA-BOF-UA	AKS is a research fellow supported by the Fonds Wetenschappelijk Onderzoek-Vlaanderen [FWO Grant 12A8814N]. This research was also supported by GOA-BOF-UA-2007 grant to H.A.		0	52	58	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0135091	10.1371/journal.pone.0135091	http://dx.doi.org/10.1371/journal.pone.0135091			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241315	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700095
J	Sours, C; Zhuo, JC; Roys, S; Shanmuganathan, K; Gullapalli, RP				Sours, Chandler; Zhuo, Jiachen; Roys, Steven; Shanmuganathan, Kathirkamanthan; Gullapalli, Rao P.			Disruptions in Resting State Functional Connectivity and Cerebral Blood Flow in Mild Traumatic Brain Injury Patients	PLOS ONE			English	Article							NEUROPSYCHOLOGICAL ASSESSMENT METRICS; MODE NETWORK CONNECTIVITY; DEFAULT-MODE; HEAD-INJURY; PERFUSION; DEFICITS; RELIABILITY; PERFORMANCE; TASK; RECOVERY	Mild traumatic brain injury (mTBI) is often occult to conventional imaging techniques. However, there is growing evidence that mTBI patients who lack evidence of structural intracranial injury may develop post-concussive syndrome (PCS). We investigated longitudinal alterations in resting state functional connectivity (rs-FC) in brain networks in a population of 28 patients compared to 28 matched control participants. Rs-FC and cerebral blood flow (CBF) within the nodes of the Default Mode Network (DMN) and Task Positive Network (TPN) were assessed at three time points including acute, sub-acute, and chronic stages following mTBI. Participants received the Automated Neuropsychological Assessment Metrics (ANAM) to assess cognitive performance. Main findings indicate that despite normalized cognitive performance, chronic mTBI patients demonstrate increased rs-FC between the DMN and regions associated with the salience network (SN) and TPN compared to the control populations, as well as reduced strength of rs-FC within the DMN at the acute stage of injury. In addition, chronic mTBI patients demonstrate an imbalance in the ratio of CBF between nodes of the DMN and TPN. Furthermore, preliminary exploratory analysis suggests that compared to those without chronic PCS, patients with chronic PCS reveal an imbalance in the ratio of CBF between the DMN nodes and TPN nodes across multiple stages of recovery. Findings suggest that the altered network perfusion with the associated changes in rs-FC may be a possible predictor of which mTBI patients will develop chronic PCS.	[Sours, Chandler; Zhuo, Jiachen; Roys, Steven; Gullapalli, Rao P.] Univ Maryland, Sch Med, Magnet Resonance Res Ctr, Baltimore, MD 21201 USA; [Sours, Chandler; Zhuo, Jiachen; Roys, Steven; Shanmuganathan, Kathirkamanthan; Gullapalli, Rao P.] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Sours, C (corresponding author), Univ Maryland, Sch Med, Magnet Resonance Res Ctr, Baltimore, MD 21201 USA.	csours001@umm.edu			Department of Defense [W81XWH-08-1-0725, W81XWH-12-1-0098]; National Institute of Neurological Disorders and Stroke [1F31NS081984]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS081984] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support for this work was in part provided by the Department of Defense (W81XWH-08-1-0725 & W81XWH-12-1-0098 to RPG). CS was supported by an predoctoral grant from the National Institute of Neurological Disorders and Stroke (1F31NS081984). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; De Havas JA, 2012, NEUROIMAGE, V59, P1745, DOI 10.1016/j.neuroimage.2011.08.026; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Franco AR, 2013, BRAIN CONNECT, V3, P363, DOI 10.1089/brain.2012.0134; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Jann K, 2013, BRAIN TOPOGR, V26, P569, DOI 10.1007/s10548-013-0280-3; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kindler J, 2013, SCHIZOPHR B; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044556; Liu TT, 2013, NEUROIMAGE, V80, P339, DOI 10.1016/j.neuroimage.2013.04.071; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Mannfolk P, 2011, J MAGN RESON IMAGING, V34, P511, DOI 10.1002/jmri.22654; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCrea M., 2000, STANDARDIZED ASSESSM; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Ponsford J, 2013, J NEUROTRAUMA; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Prakash RS, 2012, BEHAV BRAIN RES, V230, P192, DOI 10.1016/j.bbr.2012.01.058; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; Reich S, 2005, VALIDATION ANAM TEST; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Sours C, 2014, BRAIN IMAGING BEHAV; Sours C, 2015, BRAIN CONNECT, V5, P442, DOI 10.1089/brain.2014.0333; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Wang JJ, 2003, J MAGN RESON IMAGING, V18, P404, DOI 10.1002/jmri.10372; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Woodward ND, 2011, SCHIZOPHR RES, V130, P86, DOI 10.1016/j.schres.2011.03.010; World Health Organization, 2010, INT CLASS DIS; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	67	55	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134019	10.1371/journal.pone.0134019	http://dx.doi.org/10.1371/journal.pone.0134019			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241476	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942700032
J	Tieu, HV; Liu, TY; Hussen, S; Connor, M; Wang, L; Buchbinder, S; Wilton, L; Gorbach, P; Mayer, K; Griffith, S; Kelly, C; Elharrar, V; Phillips, G; Cummings, V; Koblin, B; Latkin, C				Tieu, Hong-Van; Liu, Ting-Yuan; Hussen, Sophia; Connor, Matthew; Wang, Lei; Buchbinder, Susan; Wilton, Leo; Gorbach, Pamina; Mayer, Kenneth; Griffith, Sam; Kelly, Corey; Elharrar, Vanessa; Phillips, Gregory; Cummings, Vanessa; Koblin, Beryl; Latkin, Carl		HPTN061	Sexual Networks and HIV Risk among Black Men Who Have Sex with Men in 6 US Cities	PLOS ONE			English	Article							OLDER PARTNER SELECTION; AFRICAN-AMERICAN MEN; MIXING PATTERNS; INFECTION; TRANSMISSION; DISPARITIES; BEHAVIORS; SPREAD	Background Sexual networks may place U.S. Black men who have sex with men (MSM) at increased HIV risk. Methods Self-reported egocentric sexual network data from the prior six months were collected from 1,349 community-recruited Black MSM in HPTN 061, a multi-component HIV prevention intervention feasibility study. Sexual network composition, size, and density (extent to which members are having sex with one another) were compared by self-reported HIV serostatus and age of the men. GEE models assessed network and other factors associated with having a Black sex partner, having a partner with at least two age category difference (age difference between participant and partner of at least two age group categories), and having serodiscordant/serostatus unknown unprotected anal/vaginal intercourse (SDUI) in the last six months. Results Over half had exclusively Black partners in the last six months, 46% had a partner of at least two age category difference, 87% had <= 5 partners. Nearly 90% had sex partners who were also part of their social networks. Among HIV-negative men, not having anonymous/exchange/trade partners and lower density were associated with having a Black partner; larger sexual network size and having non-primary partners were associated with having a partner with at least two age category difference; and having anonymous/exchange/trade partners was associated with SDUI. Among HIV-positive men, not having non-primary partners was associated with having a Black partner; no sexual network characteristics were associated with having a partner with at least two age category difference and SDUI. Conclusions Black MSM sexual networks were relatively small and often overlapped with the social networks. Sexual risk was associated with having non-primary partners and larger network size. Network interventions that engage the social networks of Black MSM, such as interventions utilizing peer influence, should be developed to address stable partnerships, number of partners, and serostatus disclosure.	[Tieu, Hong-Van; Koblin, Beryl] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Infect Dis Prevent, New York, NY 10021 USA; [Tieu, Hong-Van] Columbia Univ, Dept Med, Med Ctr, Div Infect Dis, New York, NY USA; [Liu, Ting-Yuan; Connor, Matthew; Wang, Lei; Kelly, Corey] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Hussen, Sophia] Emory Sch Med, Div Infect Dis, Atlanta, GA USA; [Buchbinder, Susan] San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA USA; [Wilton, Leo] SUNY Binghamton, Dept Human Dev, Binghamton, NY USA; [Wilton, Leo] Univ Johannesburg, Fac Humanities, Johannesburg, South Africa; [Gorbach, Pamina] Univ Calif Los Angeles, David Geffen Sch Med, Dept Epidemiol, Sch Publ Hlth,Div InfectiousDis, Los Angeles, CA 90095 USA; [Mayer, Kenneth] Fenway Community Hlth Ctr, Boston, MA USA; [Griffith, Sam] FHI 360, Res Triangle Pk, NC USA; [Elharrar, Vanessa] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA; [Phillips, Gregory] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Epidemiol & Biostat, Washington, DC USA; [Cummings, Vanessa] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Latkin, Carl] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	New York Blood Center; Columbia University; Fred Hutchinson Cancer Center; Emory University; San Francisco Department of Public Health; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University of Johannesburg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; FHI 360; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); George Washington University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Tieu, HV (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Infect Dis Prevent, New York, NY 10021 USA.	htieu@nybloodcenter.org	DSILVA, BROOKE/HCI-4879-2022	Phillips II, Gregory/0000-0001-8396-1170	National Institute of Allergy and Infectious Disease (NIAID); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH) [UM1 AI068619, UM1 AI068617, UM1 AI068613]; Fenway Institute Clinical Research Site (CRS): Harvard University CFAR [P30 AI060354]; CTU for HIV Prevention and Microbicide Research [UM1 AI069480]; George Washington University CRS: District of Columbia Developmental CFAR [P30 AI087714]; Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU [5U01 AI069466]; ARRA [3U01 AI069466-03S1]; Hope Clinic of the Emory Vaccine Center CRS; Ponce de Leon Center CRS: Emory University HIV/AIDS CTU [5U01 AI069418]; CFAR [P30 AI050409]; CTSA [UL1 RR025008]; San Francisco Vaccine and Prevention CRS: ARRA [3U01 AI069496-03S1, 3U01 AI069496-03S2]; UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU [U01 AI069424]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD045810] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069418, UM1AI069418, UM1AI069480, UM1AI069496, UM1AI068619, U01AI069424, P30AI060354, UM1AI068617, UM1AI069470, UM1AI068613, P30AI087714, U01AI069496, U01AI069466, P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA031035] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fenway Institute Clinical Research Site (CRS): Harvard University CFAR; CTU for HIV Prevention and Microbicide Research; George Washington University CRS: District of Columbia Developmental CFAR; Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU; ARRA; Hope Clinic of the Emory Vaccine Center CRS; Ponce de Leon Center CRS: Emory University HIV/AIDS CTU; CFAR; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); San Francisco Vaccine and Prevention CRS: ARRA; UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	HPTN 061 grant support was provided by the National Institute of Allergy and Infectious Disease (NIAID), National Institute on Drug Abuse (NIDA) and National Institute of Mental Health (NIMH): Cooperative Agreements UM1 AI068619, UM1 AI068617, and UM1 AI068613. Additional site funding - Fenway Institute Clinical Research Site (CRS): Harvard University CFAR (P30 AI060354) and CTU for HIV Prevention and Microbicide Research (UM1 AI069480); George Washington University CRS: District of Columbia Developmental CFAR (P30 AI087714); Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU (5U01 AI069466) and ARRA funding (3U01 AI069466-03S1); Hope Clinic of the Emory Vaccine Center CRS and The Ponce de Leon Center CRS: Emory University HIV/AIDS CTU (5U01 AI069418), CFAR (P30 AI050409) and CTSA (UL1 RR025008); San Francisco Vaccine and Prevention CRS: ARRA funding (3U01 AI069496-03S1, 3U01 AI069496-03S2); UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU (U01 AI069424). The funder had a role in the design of the study by providing input into the design. The funder did not have a role in the data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora AA, 2005, J INFECT DIS, V191, pS115, DOI 10.1086/425280; Berry M, 2007, AIDS, V21, P2349, DOI 10.1097/QAD.0b013e3282f12f41; Bingham TA, 2003, AIDS EDUC PREV, V15, P39, DOI 10.1521/aeap.15.1.5.39.23613; Bocour A, 2011, JAIDS-J ACQ IMM DEF, V58, P417, DOI 10.1097/QAI.0b013e318230e6d9; Bohl DD, 2011, SEX TRANSM INFECT, V87, P616, DOI 10.1136/sextrans-2011-050103; Brewer RA, 2013, J ACQUIR IMMUNE DEFI; Burt RS, 2013, ANNU REV PSYCHOL, V64, P527, DOI 10.1146/annurev-psych-113011-143828; BURT RS, 1984, SOC NETWORKS, V6, P293, DOI 10.1016/0378-8733(84)90007-8; Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P250; Chen I, 2015, J ACQUIR IMMUNE DEFI; Doherty IA, 2005, J INFECT DIS, V191, pS42, DOI 10.1086/425277; Doherty IA, 2009, JAIDS-J ACQ IMM DEF, V52, P114, DOI 10.1097/QAI.0b013e3181ab5e10; Dyer TP, 2012, J URBAN HEALTH, V89, P697, DOI 10.1007/s11524-012-9674-x; Eaton LA, AM J PUBLIC HEALTH, V100, P503, DOI [10.2105/AJPH.2008., DOI 10.2105/AJPH.2008]; Friedman MR, 2015, EFFECTS SYNDEMICS HI; Friedman SR, 1997, AM J PUBLIC HEALTH, V87, P1289, DOI 10.2105/AJPH.87.8.1289; German D, 2011, JAIDS-J ACQ IMM DEF, V57, P77, DOI 10.1097/QAI.0b013e318211b41e; Tieu HV, 2011, SEX TRANSM DIS, V38, P548, DOI 10.1097/OLQ.0b013e318203e2d7; Hurt CB, 2012, JAIDS-J ACQ IMM DEF, V61, P515, DOI 10.1097/QAI.0b013e31827076a4; Jolly AM, 2002, SEX TRANSM INFECT, V78, pI145, DOI 10.1136/sti.78.suppl_1.i145; Jolly AM, 2001, J URBAN HEALTH, V78, P433, DOI 10.1093/jurban/78.3.433; Joseph HA, 2011, SEX TRANSM INFECT, V87, P442, DOI 10.1136/sextrans-2011-050010; KLOVDAHL AS, 1985, SOC SCI MED, V21, P1203, DOI 10.1016/0277-9536(85)90269-2; Knoke D., 2008, SOCIAL NETWORK ANAL; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Koblin BA, 2003, AM J PUBLIC HEALTH, V93, P926, DOI 10.2105/AJPH.93.6.926; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Magnus M, 2010, AIDS PATIENT CARE ST, V24, P615, DOI 10.1089/apc.2010.0111; Malebranche DJ, 2003, AM J PUBLIC HEALTH, V93, P862, DOI 10.2105/AJPH.93.6.862; Mannheimer SB, 2014, JAIDS-J ACQ IMM DEF, V67, P438, DOI 10.1097/QAI.0000000000000334; Marks G, 2010, SEX TRANSM DIS, V37, P325, DOI 10.1097/OLQ.0b013e3181c95dac; Marzinke MA, 2014, CLIN INFECT DIS, V58, P117, DOI 10.1093/cid/cit672; Maulsby C, 2014, AIDS BEHAV, V18, P10, DOI 10.1007/s10461-013-0476-2; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Mimiaga MJ, 2009, J URBAN HLTH; Morris M, 2004, NETWORK EPIDEMIOLOGY; Newcomb ME, J ACQUIR IMMUNE DEFI; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Oster AM, 2011, AIDS, V25, P2157, DOI 10.1097/QAD.0b013e32834bfde9; Oster AM, 2011, AIDS, V25, P1103, DOI 10.1097/QAD.0b013e3283471efa; Oster AM, 2011, AM J PUBLIC HEALTH, V101, P137, DOI 10.2105/AJPH.2009.185850; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raymond HF, 2009, AIDS BEHAV; Rosenberg ES, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-189; Rothenberg R, 2007, SEX TRANSM INFECT, V83, P10, DOI 10.1136/sti.2006.017269; Rothenberg RB, 2000, AIDS, V14, P2191, DOI 10.1097/00002030-200009290-00016; Rothenberg R, 2009, CURR OPIN HIV AIDS, V4, P260, DOI 10.1097/COH.0b013e32832c7cfc; Schneider John A, 2013, Am J Public Health, V103, pe28, DOI 10.2105/AJPH.2012.301003; Shah NS, 2013, AIDS BEHAV; Sifakis F, 2010, AIDS BEHAV, V14, P904, DOI 10.1007/s10461-007-9317-5; Stall R, 2003, AM J PUBLIC HEALTH, V93, P939, DOI 10.2105/AJPH.93.6.939; Sullivan PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090514; Tieu HV, 2010, J URBAN HEALTH, V87, P113, DOI 10.1007/s11524-009-9416-x; UNAIDS Reference Group on Estimates MaP, 2013, CONS CONC PARTN 2009; UNAIDS Reference Grp Estimates Mod, 2010, LANCET, V375, P621, DOI 10.1016/S0140-6736(09)62040-7; Voetsch AC, 2012, SEX TRANSM DIS, V39, P229, DOI 10.1097/OLQ.0b013e31823d2b24; Wasserman S., 1994, SOCIAL NETWORKS, V8, P825; Wei CY, 2011, AIDS BEHAV, V15, P22, DOI 10.1007/s10461-010-9683-2; Wejnert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076878; Winter AK, 2012, JAIDS-J ACQ IMM DEF, V60, P525, DOI 10.1097/QAI.0b013e318257d0ac; Wohlfeiler D, 2005, SEX TRANSM DIS, V32, pS48, DOI 10.1097/01.olq.0000175394.81945.68; Wylie JL, 2005, J INFECT DIS, V191, P899, DOI 10.1086/427661	65	44	46	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134085	10.1371/journal.pone.0134085	http://dx.doi.org/10.1371/journal.pone.0134085			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1VB	26241742	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700034
J	Christofzik, D; Schwendicke, F; Florke, C; Hartl, A; Dorfer, C; Grossner-Schreiber, B				Christofzik, David; Schwendicke, Falk; Floerke, Christian; Haertl, Alexander; Doerfer, Christof; Groessner-Schreiber, Birte			In Vitro Comparison of Raypex 6 and Endopilot Using a Novel, Computer-Aided Measurement System, for Determining the Working Length	PLOS ONE			English	Article							ELECTRONIC APEX LOCATORS; ROOT-CANAL INSTRUMENTATION; VIVO ACCURACY; APICAL LIMIT; RATIO METHOD; OBTURATION; ZX; PROPEX	Introduction Experimental evaluation of endometric devices usually relies on visual, subjective detection of the apical constriction to determine the accuracy of measurements. The aim of the present study was to analyze the accuracy of measurements of Raypex 6 and EndoPilot using a novel, objective image-analysis system. Methods Onehundred and twenty teeth were randomized and allocated to three groups: After coronal flaring, either Raypex 6 or EndoPilot were used to determine the endodontic working length during instrumentation using manual files (RPM and EPM group respectively). In addition, EndoPilot was used for continuous, automatic measurement during rotating instrumentation (EPA group). If the working length had been reached according to endometric results, the files were fixed in place. Tooth and file were then embedded and prepared for analysis. Subsequently, the distance between the tip of the file and the apical constriction (D-AC) or the apical foramen (D-AF) was calculated using trigonometric analysis and the position of the file relative to AC and AF was analyzed. Results Both inter-and intra-examiner-reliability of the trigonometric analysis were nearly perfect (ICC = 0.999, p<0.001). D-AC was not significantly different between groups (p>0.05, t-test). D-AF was significantly decreased when EPA had been used compared to EPM (p<0.05, Exact-test). EPA resulted in files being positioned beyond AF significantly more often than the other two methods (p<0.01). Conclusions All methods allowed reliable detection of AC. However, EPA significantly increased the risk of overpreparation. Objective, digital assessment based on image analysis was suitable to compare the accuracy of different endometric devices.	[Christofzik, David; Floerke, Christian; Doerfer, Christof; Groessner-Schreiber, Birte] Univ Kiel, Clin Conservat Dent & Periodontol, Sch Dent Med, Kiel, Germany; [Schwendicke, Falk] Charite, Dept Operat & Prevent Dent, Charite Ctr 3, D-13353 Berlin, Germany; [Haertl, Alexander] Univ Miami, Dept Comp Sci, Coral Gables, FL 33124 USA	University of Kiel; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Miami	Christofzik, D (corresponding author), Univ Kiel, Clin Conservat Dent & Periodontol, Sch Dent Med, Kiel, Germany.	david.christofzik@uksh.de	Doerfer, Christof/E-4041-2010	Doerfer, Christof/0000-0002-2508-8075; Schwendicke, Falk/0000-0003-1223-1669				Bergenholtz G, 1979, J Endod, V5, P310, DOI 10.1016/S0099-2399(79)80080-1; Chugal NM, 2003, ORAL SURG ORAL MED O, V96, P81, DOI 10.1016/S1079-2104(02)91703-8; Dunlap CA, 1998, J ENDODONT, V24, P48, DOI 10.1016/S0099-2399(98)80214-8; Ebrahim Aqeel Khalil, 2007, Aust Endod J, V33, P7, DOI 10.1111/j.1747-4477.2007.00049.x; ElAyouti A, 2001, J ENDODONT, V27, P49, DOI 10.1097/00004770-200101000-00018; ERIKSEN HM, 1991, ENDOD DENT TRAUMATOL, V7, P189; GREEN D., 1956, ORAL SURG ORAL MED AND ORAL PATHOL, V9, P1224, DOI 10.1016/0030-4220(56)90192-X; GREEN D., 1960, ORAL SURG ORAL MED AND ORAL PATHOL, V13, P728, DOI 10.1016/0030-4220(60)90373-X; Hellwig E., 2009, EINFUHRUNG ZAHNERHAL; Hoer D, 2004, INT ENDOD J, V37, P125, DOI 10.1111/j.0143-2885.2004.00764.x; Hor D, 2005, INT ENDOD J, V38, P855, DOI 10.1111/j.1365-2591.2005.01004.x; HUANG L, 1987, J ENDODONT, V13, P60, DOI 10.1016/S0099-2399(87)80156-5; KATZ A, 1991, ORAL SURG ORAL MED O, V72, P238, DOI 10.1016/0030-4220(91)90169-D; KELLER ME, 1991, J ENDODONT, V17, P271, DOI 10.1016/S0099-2399(06)81865-0; Klinke T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031766; KOBAYASHI C, 1994, J ENDODONT, V20, P111, DOI 10.1016/S0099-2399(06)80053-1; Lauper R, 1996, J ENDODONT, V22, P260, DOI 10.1016/S0099-2399(06)80145-7; Liang YH, 2012, CLIN ORAL INVEST, V16, P1619, DOI 10.1007/s00784-011-0671-3; Marending M, 2012, INT ENDOD J, V45, P169, DOI 10.1111/j.1365-2591.2011.01967.x; Markula-Liegau A., 1996, THESIS ERLANGEN; Moura-Netto C, 2013, BRAZ ORAL RES, V27, P26, DOI 10.1590/S1806-83242012005000029; Mull J Paras, 2012, J Conserv Dent, V15, P178, DOI 10.4103/0972-0707.94585; NAIR PNR, 1987, J ENDODONT, V13, P29, DOI 10.1016/S0099-2399(87)80089-4; Pagavino G, 1998, J ENDODONT, V24, P438, DOI 10.1016/S0099-2399(98)80029-0; Plotino G, 2006, INT ENDOD J, V39, P408, DOI 10.1111/j.1365-2591.2006.01095.x; Ricucci D, 1998, INT ENDOD J, V31, P384; Ricucci D, 1998, INT ENDOD J, V31, P394; Schaeffer MA, 2005, J ENDODONT, V31, P271, DOI 10.1097/01.don.0000140585.52178.78; Schlumbohm G, 2008, INVENTORVERFAHREN ZU; Schlumbohm G, 2012, INVENTORVERFAHREN ZU; Somma F, 2012, INT ENDOD J, V45, P552, DOI 10.1111/j.1365-2591.2011.02010.x; Stavileci M, 2013, MED SCI MONIT BASIC, V19, P163, DOI 10.12659/MSMBR.889350	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134383	10.1371/journal.pone.0134383	http://dx.doi.org/10.1371/journal.pone.0134383			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237310	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942400026
J	Kanda, E; Muneyuki, T; Suwa, K; Nakajima, K				Kanda, Eiichiro; Muneyuki, Toshitaka; Suwa, Kaname; Nakajima, Kei			Alcohol and Exercise Affect Declining Kidney Function in Healthy Males Regardless of Obesity: A Prospective Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; RICH RED WINE; POSTMENOPAUSAL WOMEN; METABOLIC SYNDROME; RENAL DYSFUNCTION; JAPANESE ADULTS; UNITED-STATES; RISK-FACTORS; DISEASE; CONSUMPTION	Background Although lifestyle is associated with metabolic syndrome and cardiovascular diseases, there has been no sufficient evidence of lifestyles on incident chronic kidney disease (CKD). The purpose of this prospective cohort study is to investigate the effects of lifestyles on kidney function in healthy people. Methods A total of 7473 healthy people were enrolled in this Saitama Cardiometabolic Disease and Organ Impairment Study, Japan. Data on alcohol consumption, exercise frequency, and sleep duration were collected. The outcome event was incident CKD or decrease in estimated glomerular filtration rate (eGFR) by >25% in 3 years. Results Subjects were classified into four groups according to body mass index and gender. Mean +/- standard deviation of age was 38.8+/-10.5 years; eGFR, 78.1+/-15.2 ml/min/1.73m(2). In the male groups, multivariate logistic regression models showed that the outcome events were associated with a small amount of alcohol consumed (20 to 140g of alcohol/week) (ref. more than 140g of alcohol/week); non-obese male, adjusted odds ratio 1.366 (95% confidence interval, 1.086, 1.718); obese male (body mass index >= 25), 1.634 (1.160, 2.302); and with frequent exercise (twice a week or more) (ref. no exercise); non-obese male, 1.417 (1.144, 1.754); obese male, 1.842 (1.317, 2.577). Sleep duration was not associated with the outcome events. Conclusion These findings suggest that, regardless of obesity, a small amount of alcohol consumed and high exercise frequency were associated with the increased risk of loss of kidney function in the male groups.	[Kanda, Eiichiro] Tokyo Kyosai Hosp, Dept Nephrol, Meguro Ku, Tokyo, Japan; [Kanda, Eiichiro] Tokyo Med & Dent Univ, Ctr Life Sci & Bioeth, Bunkyo Ku, Tokyo, Japan; [Muneyuki, Toshitaka] Saitama Citizens Med Ctr, Saitama, Japan; [Muneyuki, Toshitaka] Funabashi City Rehabil Hosp, Dept Rehabil, Funabashi, Chiba, Japan; [Suwa, Kaname] Saitama Hlth Promot Corp, Saitama, Japan; [Nakajima, Kei] Josai Univ, Fac Pharmaceut Sci, Dept Med Dietet, Div Clin Nutr, Sakado, Saitama 35002, Japan; [Nakajima, Kei] Kuki Gen Hosp, Dept Metab, Kuki, Saitama, Japan	Tokyo Medical & Dental University (TMDU); Josai University	Kanda, E (corresponding author), Tokyo Kyosai Hosp, Dept Nephrol, Meguro Ku, Tokyo, Japan.	tokyo.kyosai.kanda@gmail.com	Matsuo, Keitaro/H-6758-2019; Nakajima, Kei/AAF-2801-2019	Matsuo, Keitaro/0000-0003-1761-6314; Nakajima, Kei/0000-0002-1788-3896	Saitama Health Promotion Corporation	Saitama Health Promotion Corporation	Saitama Health Promotion Corporation provided support in the form of salaries for one author [KS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	August P, 1999, J CLIN ENDOCR METAB, V84, P1862, DOI 10.1210/jc.84.6.1862; Burchfiel CM, 1997, ARTERIOSCL THROM VAS, V17, P760, DOI 10.1161/01.ATV.17.4.760; Cheungpasitporn W, 2015, QJM-INT J MED, V108, P539, DOI 10.1093/qjmed/hcu247; Dubey RK, 2001, AM J PHYSIOL-RENAL, V280, pF365, DOI 10.1152/ajprenal.2001.280.3.F365; Eidemak I, 1997, NEPHRON, V75, P36, DOI 10.1159/000189497; Emanuele MA, 2001, ALCOHOL RES HEALTH, V25, P282; Estruch R, 2004, ATHEROSCLEROSIS, V175, P117, DOI 10.1016/j.atherosclerosis.2004.03.006; Estruch R, 2011, NUTR METAB CARDIOVAS, V21, P46, DOI 10.1016/j.numecd.2009.07.006; Femia R, 2006, ARTERIOSCL THROM VAS, V26, P1607, DOI 10.1161/01.ATV.0000222929.99098.1f; Ferreira MP, 2008, J AM DIET ASSOC, V108, P1668, DOI 10.1016/j.jada.2008.07.011; GAVALER JS, 1993, ALCOHOL CLIN EXP RES, V17, P786, DOI 10.1111/j.1530-0277.1993.tb00842.x; GAVALER JS, 1992, ALCOHOL CLIN EXP RES, V16, P87, DOI 10.1111/j.1530-0277.1992.tb00642.x; GAZIANO JM, 1993, NEW ENGL J MED, V329, P1829, DOI 10.1056/NEJM199312163292501; Heiwe S, 2014, AM J KIDNEY DIS, V64, P383, DOI 10.1053/j.ajkd.2014.03.020; Knight EL, 2003, NEPHROL DIAL TRANSPL, V18, P1549, DOI 10.1093/ndt/gfg228; Komura Hiroshi, 2013, BMC Res Notes, V6, P463, DOI 10.1186/1756-0500-6-463; Leehey DJ, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-62; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Menon V, 2010, NEPHROL DIAL TRANSPL, V25, P3301, DOI 10.1093/ndt/gfq188; Middlekauff HR, 1997, CIRC RES, V80, P62, DOI 10.1161/01.RES.80.1.62; Muneyuki T, 2013, OPEN J ENDOCRINE MET, V3; Muneyuki T, 2013, KIDNEY INT, V84, P1254, DOI 10.1038/ki.2013.222; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Plantinga L, 2011, AM J KIDNEY DIS, V58, P554, DOI 10.1053/j.ajkd.2011.05.024; Ricardo AC, 2013, CLIN J AM SOC NEPHRO, V8, P602, DOI 10.2215/CJN.00600112; Rodrigo R, 2004, NEPHROL DIAL TRANSPL, V19, P2237, DOI 10.1093/ndt/gfh369; Rodrigo R, 2002, LIFE SCI, V71, P2881, DOI 10.1016/S0024-3205(02)02140-9; Ryu S, 2008, J AM SOC NEPHROL, V19, P1798, DOI 10.1681/ASN.2007121286; Schaeffner ES, 2005, ARCH INTERN MED, V165, P1048, DOI 10.1001/archinte.165.9.1048; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Tokashiki K, 2009, CLIN EXP NEPHROL, V13, P55, DOI 10.1007/s10157-008-0085-y; Tozawa M, 2007, HYPERTENS RES, V30, P937, DOI 10.1291/hypres.30.937; Verzola D, 2009, BIOCHEM BIOPH RES CO, V387, P531, DOI 10.1016/j.bbrc.2009.07.056; White SL, 2009, NEPHROL DIAL TRANSPL, V24, P2464, DOI 10.1093/ndt/gfp114; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Yamamoto R, 2012, AM J KIDNEY DIS, V59, P343, DOI 10.1053/j.ajkd.2011.08.032	36	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134937	10.1371/journal.pone.0134937	http://dx.doi.org/10.1371/journal.pone.0134937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237314	Green Submitted, gold, Green Published			2022-12-27	WOS:000358942400040
J	Lu, QS; Li, JP; Senkowski, C; Tang, ZQ; Wang, JH; Huang, TH; Wang, X; Terry, K; Brower, S; Glasgow, W; Chen, HB; Jiang, SW				Lu, Qinsheng; Li, Jinping; Senkowski, Christopher; Tang, Zuoqing; Wang, Jianhao; Huang, Tianhe; Wang, Xue; Terry, Karen; Brower, Steven; Glasgow, Wayne; Chen, Haibin; Jiang, Shi-Wen			Promoter Hypermethylation and Decreased Expression of Syncytin-1 in Pancreatic Adenocarcinomas	PLOS ONE			English	Article							TROPHOBLAST CELL-FUSION; HERV-W FAMILY; ENDOGENOUS RETROVIRUSES; ENDOMETRIAL CARCINOMA; BEWO CELLS; CANCER; METHYLATION; GENES; APOPTOSIS; HYPOMETHYLATION	Syncytin-1 is a member of human endogenous retroviral W gene family (HERVW1). Known to be expressed in human placental trophoblast, syncytin-1 protein mediates the fusion of cytotrophoblasts for the formation of syncytiotrophoblasts, the terminally differentiated form of trophoblast lineage. In addition, in vitro studies indicate that syncytin-1 possessed nonfusogenic functions such as those for immune suppression, cell cycle regulation and anti-apoptotic activities. Overexpression of syncytin-1 has been observed in various malignant tissues including breast, endometrial and ovarian cancers. It was reported that syncytin-1 gene expression is associated with dynamic changes of DNA hypomethylation in the 5' LTR. In this study, applying the real-time PCR, Western blot analysis and immunohistochemistry methods, we demonstrate a constitutive expression of syncytin-1 in normal pancreas tissues as well as normal tissues adjacent to cancer lesions. Moreover, a reduced expression is found in the pancreatic adenocarcinoma tissues. The expression levels of syncytin-1 are not correlated with the stage, historical grade and gender, but inversely correlated with patients' age. Furthermore, COBRA and bisulfite sequencing results indicated that the lower expression of syncytin-1 is correlated with the hypermethylation of two CpG dinucleotides in the 5' LTR of syncytin-1 gene. The nonfusogenic function of syncytin-1 in normal pancreas as well as its role(s) in the pathogenesis and progression of pancreatic cancers remains to be investigated. Identification of the two CpG dinucleotides around transcription start site as key epigenetic elements has provided valuable information for further studies on the epigenetic regulation of syncytin-1 in pancreatic cancer cells.	[Lu, Qinsheng; Chen, Haibin] Shantou Univ, Coll Med, Dept Histol & Embryol, Shantou, Guangdong, Peoples R China; [Lu, Qinsheng; Li, Jinping; Huang, Tianhe; Wang, Xue; Glasgow, Wayne; Jiang, Shi-Wen] Mercer Univ, Sch Med, Dept Biomed Sci, Savannah, GA USA; [Senkowski, Christopher; Terry, Karen] Mem Hlth Univ Med Ctr, Curtis & Elizabeth Anderson Canc Inst, Dept Surg, Savannah, GA 31404 USA; [Tang, Zuoqing] Capital Med Univ, Sch Basic Med Sci, Dept Med Genet, Beijing, Peoples R China; [Wang, Jianhao] Changzhou Univ, Sch Pharmaceut Engn & Life Sci, Changzhou, Jiangsu, Peoples R China; [Brower, Steven] Beth Israel Deaconess Med Ctr, Dept Surg & Surg Oncol, New York, NY 10003 USA; [Jiang, Shi-Wen] Wenzhou Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Wenzhou 325027, Peoples R China; [Li, Jinping; Jiang, Shi-Wen] Mem Hlth Univ Med Ctr, Dept Obstet & Gynecol, Savannah, GA 31404 USA	Shantou University; Mercer University; Capital Medical University; Changzhou University; Harvard University; Beth Israel Deaconess Medical Center; Wenzhou Medical University	Chen, HB (corresponding author), Shantou Univ, Coll Med, Dept Histol & Embryol, Shantou, Guangdong, Peoples R China.	chenhb@stu.edu.cn; Jiang_S@mercer.edu	Huang, Tianhe/U-8565-2017	Huang, Tianhe/0000-0002-2737-4016	Memorial Health University Medical Center/Curtis and Elizabeth Anderson Cancer Institute Pancreatic Cancer Research Program; ACI Excellence through Discovery Laboratory Research Fund; ACI/MUSM Profession Development Fund; Distinguished Cancer Scholar Program of Georgia Research Alliance; Georgia Research Alliance; Collaborative Research Fund of Shantou University Medical College; Mercer University Seed Grant; Beijing Natural Science Foundation [7142026]; Mercer University Seed Grant and Start-up Fund	Memorial Health University Medical Center/Curtis and Elizabeth Anderson Cancer Institute Pancreatic Cancer Research Program; ACI Excellence through Discovery Laboratory Research Fund; ACI/MUSM Profession Development Fund; Distinguished Cancer Scholar Program of Georgia Research Alliance; Georgia Research Alliance; Collaborative Research Fund of Shantou University Medical College; Mercer University Seed Grant; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Mercer University Seed Grant and Start-up Fund	This study is supported by Memorial Health University Medical Center/Curtis and Elizabeth Anderson Cancer Institute Pancreatic Cancer Research Program (Li, J.; Jiang, S.-W; Brower. S.); The ACI Excellence through Discovery Laboratory Research Fund (Li, J.; Jiang, S.-W; Brower, S.; Glasgow, W.); ACI/MUSM Profession Development Fund (Li J.; Jiang, S.-W.); Distinguished Cancer Scholar Program of Georgia Research Alliance (Jiang, S.-W); Research Award from Georgia Research Alliance (Jiang, S.-W.); Collaborative Research Fund of Shantou University Medical College (Jiang, S.-W.; Chen, H.); Mercer University Seed Grant (Li, J.; Jiang, S.-W.); Beijing Natural Science Foundation 7142026 (Tang, Z.; Jiang, S.-W.); and Mercer University Seed Grant and Start-up Fund (Li, J.; Jiang, S.-W).	Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bjerregaard B, 2006, CELL MOL LIFE SCI, V63, P1906, DOI 10.1007/s00018-006-6201-9; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; Bonnaud B, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-57; Dupressoir A, 2012, PLACENTA, V33, P663, DOI 10.1016/j.placenta.2012.05.005; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Fukushige S, 2014, CANCER LETT, V342, P231, DOI 10.1016/j.canlet.2012.03.022; Gimenez J, 2010, NUCLEIC ACIDS RES, V38, P2229, DOI 10.1093/nar/gkp1214; Gimenez J, 2009, DNA RES, V16, P195, DOI 10.1093/dnares/dsp011; Hruban RH, 2007, GASTROENTEROL CLIN N, V36, P831, DOI 10.1016/j.gtc.2007.08.012; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Huang Q, 2014, CELL MOL LIFE SCI, V71, P3151, DOI 10.1007/s00018-013-1533-8; Huang Q, 2013, CELL SIGNAL, V25, P1027, DOI 10.1016/j.cellsig.2013.01.008; Knerr I, 2007, APOPTOSIS, V12, P37, DOI 10.1007/s10495-006-0329-9; Knerr I, 2008, J CELL BIOCHEM, V105, P766, DOI 10.1002/jcb.21874; Kudo Y, 2003, BBA-MOL BASIS DIS, V1638, P63, DOI 10.1016/S0925-4439(03)00043-7; Langbein M, 2008, MOL REPROD DEV, V75, P175, DOI 10.1002/mrd.20729; Larsen JM, 2009, CANCER LETT, V280, P44, DOI 10.1016/j.canlet.2009.02.008; Larsson LI, 2007, HUM PATHOL, V38, P726, DOI 10.1016/j.humpath.2006.10.018; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Macaulay EC, 2011, MAMM GENOME, V22, P722, DOI 10.1007/s00335-011-9355-1; Mallet F, 2004, P NATL ACAD SCI USA, V101, P1731, DOI 10.1073/pnas.0305763101; Mangeney M, 2007, P NATL ACAD SCI USA, V104, P20534, DOI 10.1073/pnas.0707873105; Matouskova M, 2006, EXP CELL RES, V312, P1011, DOI 10.1016/j.yexcr.2005.12.010; Menendez L, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-12; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Muniraj T, 2013, DM-DIS MON, V59, P368, DOI 10.1016/j.disamonth.2013.08.001; Okahara G, 2004, GENOMICS, V84, P982, DOI 10.1016/j.ygeno.2004.09.004; Piperi Christina, 2008, J Biomol Tech, V19, P281; Prudhomme S, 2004, J VIROL, V78, P12157, DOI 10.1128/JVI.78.22.12157-12168.2004; SAKAI T, 1991, AM J HUM GENET, V48, P880; Shiroma T, 2001, J HUM GENET, V46, P619, DOI 10.1007/s100380170012; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Strick R, 2007, J MOL MED, V85, P23, DOI 10.1007/s00109-006-0104-y; Strissel PL, 2008, INT J CANCER, V123, P2871, DOI 10.1002/ijc.23900; Strissel PL, 2012, ONCOTARGET, V3, P1204; Sun Y, 2010, LEUKEMIA RES, V34, P1195, DOI 10.1016/j.leukres.2010.03.016; Tolosa JM, 2012, PLACENTA, V33, P933, DOI 10.1016/j.placenta.2012.08.004; Trejbalova K, 2011, NUCLEIC ACIDS RES, V39, P8728, DOI 10.1093/nar/gkr562; Vargas A, 2011, REPROD SCI, V18, P1085, DOI 10.1177/1933719111404608; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Yi JM, 2004, ZOOL SCI, V21, P649, DOI 10.2108/zsj.21.649; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200; Zhou HY, 2014, CURR PHARM DESIGN, V20, P1786, DOI 10.2174/13816128113199990540; Zhuang XW, 2014, CURR PHARM DESIGN, V20, P1796, DOI 10.2174/13816128113199990541	49	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134412	10.1371/journal.pone.0134412	http://dx.doi.org/10.1371/journal.pone.0134412			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230721	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400116
J	Melling, N; Harutyunyan, L; Hube-Magg, C; Kluth, M; Simon, R; Lebok, P; Minner, S; Tsourlakis, MC; Koop, C; Graefen, M; Adam, M; Haese, A; Wittmer, C; Steurer, S; Izbicki, J; Sauter, G; Wilczak, W; Schlomm, T; Krech, T				Melling, Nathaniel; Harutyunyan, Levon; Hube-Magg, Claudia; Kluth, Martina; Simon, Ronald; Lebok, Patrick; Minner, Sarah; Tsourlakis, Maria Christina; Koop, Christina; Graefen, Markus; Adam, Meike; Haese, Alexander; Wittmer, Corinna; Steurer, Stefan; Izbicki, Jakob; Sauter, Guido; Wilczak, Waldemar; Schlomm, Thorsten; Krech, Till			High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; TUMOR-SUPPRESSOR GENES; EARLY PSA RECURRENCE; DELETION; REARRANGEMENT; FUSION; PTEN; CENTROSOME; LOCALIZES; LANDSCAPE	Hook microtubule-tethering protein 3 (HOOK3) is an adaptor protein for microtubule-dependent intracellular vesicle and protein trafficking. In order to assess the role of HOOK3 in prostate cancer we analyzed HOOK3 expression by immunohistochemistry on a TMA containing more than 12,400 prostate cancers. Results were compared to tumor phenotype and PSA recurrence as well as aberrations possibly defining relevant molecular subtypes such as ERG status and deletions of 3p13, 5q21, 6q15 and PTEN. HOOK3 immunostaining was negative in normal luminal cells of prostate epithelium, whereas 53.3% of 10,572 interpretable cancers showed HOOK3 expression, which was considered low in 36.4% and high in 16.9% of cases. High-level HOOK3 expression was linked to advanced tumor stage, high Gleason score, high proliferation index, positive lymph node stage, and PSA recurrence (p<0.0001 each). The prognostic role of HOOK3 expression was independent of established clinico-pathological parameters both in preoperative and postoperative settings. Comparisons with molecular features were performed to draw conclusions on the potential function of HOOK3 in the prostate. A strong association with all examined deletions is consistent with a role of HOOK3 for maintaining genomic integrity by contributing to proper centrosome assembly. Finding HOOK3 expression in 74% of ERG positive but in only 38% of ERG negative cancers (p<0.0001) further suggests functional interactions between these genes. In conclusion, the results of our study identify HOOK3 as a strong candidate prognostic marker with a possible role in maintaining genomic integrity in prostate cancer, which may have potential for inclusion into clinical routine assays.	[Melling, Nathaniel; Harutyunyan, Levon; Hube-Magg, Claudia; Kluth, Martina; Simon, Ronald; Lebok, Patrick; Minner, Sarah; Tsourlakis, Maria Christina; Koop, Christina; Wittmer, Corinna; Steurer, Stefan; Sauter, Guido; Wilczak, Waldemar; Krech, Till] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany; [Melling, Nathaniel; Izbicki, Jakob] Univ Med Ctr Hamburg Eppendorf, Gen Visceral & Thorac Surg Dept & Clin, Hamburg, Germany; [Graefen, Markus; Adam, Meike; Haese, Alexander; Schlomm, Thorsten] Univ Med Ctr Hamburg Eppendorf, Prostate Canc Ctr, Martini Clin, Hamburg, Germany; [Schlomm, Thorsten] Univ Med Ctr Hamburg Eppendorf, Sect Translat Prostate Canc Res, Dept Urol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Simon, R (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany.	r.simon@uke.de		Schlomm, Thorsten/0000-0001-9557-4653				Banck MS, 2013, J CLIN INVEST, V123, P2502, DOI 10.1172/JCI67963; Becker-Santos DD, 2012, CARCINOGENESIS, V33, P2558, DOI 10.1093/carcin/bgs285; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Brase JC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-507; Burkhardt L, 2013, CANCER RES, V73, P2795, DOI 10.1158/0008-5472.CAN-12-1342; Ciampi R, 2007, ENDOCR-RELAT CANCER, V14, P445, DOI 10.1677/ERC-07-0039; Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127; Epstein JI, 2012, EUR UROL, V61, P1019, DOI 10.1016/j.eururo.2012.01.050; Fielding AB, 2008, J CELL BIOL, V180, P681, DOI 10.1083/jcb.200710074; Gaillard CLB, 2011, MOL BIOL CELL, V22, P4549, DOI 10.1091/mbc.E11-05-0405; Ge XC, 2010, NEURON, V65, P191, DOI 10.1016/j.neuron.2010.01.011; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kluth M, 2013, MODERN PATHOL, V26, P975, DOI 10.1038/modpathol.2012.236; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kramer H, 1999, GENETICS, V151, P675; Krohn A, 2013, J PATHOL, V231, P130, DOI 10.1002/path.4223; Krohn A, 2012, AM J PATHOL, V181, P401, DOI 10.1016/j.ajpath.2012.04.026; Lim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053702; Mao XY, 2011, AM J CANCER RES, V1, P604; McCall P, 2008, BRIT J CANCER, V99, P1296, DOI 10.1038/sj.bjc.6604680; Minner S, 2011, CLIN CANCER RES, V17, P5878, DOI 10.1158/1078-0432.CCR-11-1251; Minner S, 2010, CLIN CANCER RES, V16, P1553, DOI 10.1158/1078-0432.CCR-09-2546; Schlomm T, 2008, UROLOGE, V47, P1193, DOI 10.1007/s00120-008-1834-y; Sircar K, 2009, J PATHOL, V218, P505, DOI 10.1002/path.2559; Szebenyi G, 2007, TRAFFIC, V8, P32, DOI 10.1111/j.1600-0854.2006.00511.x; Toma MI, 2010, ANAL QUANT CYTOL, V32, P1; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Xu L, 2008, MOL BIOL CELL, V19, P5059, DOI 10.1091/mbc.E08-05-0473	30	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134614	10.1371/journal.pone.0134614	http://dx.doi.org/10.1371/journal.pone.0134614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230842	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400139
J	Rehle, T; Johnson, L; Hallett, T; Mahy, M; Kim, A; Odido, H; Onoya, D; Jooste, S; Shisana, O; Puren, A; Parekh, B; Stover, J				Rehle, Thomas; Johnson, Leigh; Hallett, Timothy; Mahy, Mary; Kim, Andrea; Odido, Helen; Onoya, Dorina; Jooste, Sean; Shisana, Olive; Puren, Adrian; Parekh, Bharat; Stover, John			A Comparison of South African National HIV Incidence Estimates: A Critical Appraisal of Different Methods	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; UNAIDS ESTIMATION; INSIGHTS; TRENDS; MODEL	Background The interpretation of HIV prevalence trends is increasingly difficult as antiretroviral treatment programs expand. Reliable HIV incidence estimates are critical to monitoring transmission trends and guiding an effective national response to the epidemic. Methods and Findings We used a range of methods to estimate HIV incidence in South Africa: (i) an incidence testing algorithm applying the Limiting-Antigen Avidity Assay (LAg-Avidity EIA) in combination with antiretroviral drug and HIV viral load testing; (ii) a modelling technique based on the synthetic cohort principle; and (iii) two dynamic mathematical models, the EPP/Spectrum model package and the Thembisa model. Overall, the different incidence estimation methods were in broad agreement on HIV incidence estimates among persons aged 15-49 years in 2012. The assay-based method produced slightly higher estimates of incidence, 1.72% (95% CI 1.38 - 2.06), compared with the mathematical models, 1.47%(95% CI 1.23 - 1.72) in Thembisa and 1.52% (95% CI 1.43 - 1.62) in EPP/Spectrum, and slightly lower estimates of incidence compared to the synthetic cohort, 1.9% (95% CI 0.8 - 3.1) over the period from 2008 to 2012. Among youth aged 15-24 years, a declining trend in HIV incidence was estimated by all three mathematical estimation methods. Conclusions The multi-method comparison showed similar levels and trends in HIV incidence and validated the estimates provided by the assay-based incidence testing algorithm. Our results confirm that South Africa is the country with the largest number of new HIV infections in the world, with about 1 000 new infections occurring each day among adults aged 15-49 years in 2012.	[Rehle, Thomas; Onoya, Dorina; Jooste, Sean; Shisana, Olive] Human Sci Res Council, Cape Town, South Africa; [Rehle, Thomas; Johnson, Leigh] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Hallett, Timothy] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Mahy, Mary] UNAIDS, Geneva, Switzerland; [Kim, Andrea] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA USA; [Odido, Helen] UNAIDS, Pretoria, South Africa; [Shisana, Olive] Univ Cape Town, Dept Psychiat & Mental Hlth, ZA-7925 Cape Town, South Africa; [Puren, Adrian] Natl Inst Communicable Dis, Johannesburg, South Africa; [Stover, John] Futures Inst, Glastonbury, CT USA	Human Sciences Research Council-South Africa; University of Cape Town; Imperial College London; UNAIDS; Centers for Disease Control & Prevention - USA; University of Cape Town; National Institute for Communicable Diseases (NICD)	Rehle, T (corresponding author), Human Sci Res Council, Cape Town, South Africa.	trehle@hsrc.ac.za	Puren, Adrian/AAC-2065-2020; Onoya, Dorina/AAW-2839-2020; Puren, Adrian/W-1679-2018	Puren, Adrian/0000-0001-7531-4010; Onoya, Dorina/0000-0002-2664-7342; Puren, Adrian/0000-0001-7531-4010; PAREKH, BHARAT/0000-0002-1088-4263; Wallace, Melissa/0000-0001-7007-1910; Hallett, Timothy/0000-0002-9681-0424	Swiss Agency for Development and Cooperation; United States Centers for Disease Control and Prevention (CDC); President's Emergency Plan for AIDS Relief (PEPFAR) through CDC [5U2GPS000570-05, 3U2GGH00357-02, U2GPS001328]; United Nations Children's Fund; South African National AIDS Council; Bill and Melinda Gates Foundation; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI	Swiss Agency for Development and Cooperation; United States Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); President's Emergency Plan for AIDS Relief (PEPFAR) through CDC; United Nations Children's Fund; South African National AIDS Council; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The 2005 survey was commissioned by the Nelson Mandela Foundation, with additional financial support from the Swiss Agency for Development and Cooperation and the United States Centers for Disease Control and Prevention (CDC). The surveys in 2008 and 2012 were mainly funded by the President's Emergency Plan for AIDS Relief (PEPFAR) through CDC under the terms of Cooperative Agreement Numbers 5U2GPS000570-05, 3U2GGH00357-02 and U2GPS001328, with additional financial support from the United Nations Children's Fund, the South African National AIDS Council, and the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, COMMUNICATION; Atun R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001045; Bao L, 2012, SEX TRANSM INFECT, V88, pI3, DOI 10.1136/sextrans-2012-050637; Brown T, 2010, SEX TRANSM INFECT, V86, pI3, DOI 10.1136/sti.2010.044784; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Duong YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114947; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Duong YT, 2014, J CLIN MICROBIOL, DOI [10.1128/JCM.01989-14, DOI 10.1128/JCM.01989-14.AUG]; Fogel JM, 2013, J INFECT DIS, V208, P1624, DOI 10.1093/infdis/jit390; Hallett TB, 2008, PLOS MED, V5, P611, DOI 10.1371/journal.pmed.0050080; Hallett TB, 2010, AIDS, V24, P147, DOI 10.1097/QAD.0b013e32833062dc; Hatano H, 2014, 21 C RETR OPP INF MA; Hogan DR, 2012, SEX TRANSM INFECT, V88, pI52, DOI 10.1136/sextrans-2012-050652; Johnson LF, 2012, J R SOC INTERFACE, V9, P1544, DOI 10.1098/rsif.2011.0826; Johnson LF, 2012, S AFR J HIV MED, P22; Johnson LF, 2009, DEMOGR RES, V21, P289, DOI 10.4054/DemRes.2009.21.11; Johnson LFD, 2021, THEMBISA VERSION 4 4; Kahle EM, 2014, JAIDS-J ACQ IMM DEF, V65, pE90, DOI 10.1097/QAI.0b013e3182a2db02; Kassanjee R, 2014, INDEPENDENT ASSESSME; Kassanjee R, 2012, EPIDEMIOLOGY, V23, P721, DOI 10.1097/EDE.0b013e3182576c07; Kim AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017535; Kirkwood BR, 2003, ESSENTIAL MED STAT; Konikoff J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082772; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; Longosz AF, 2014, INCORRECT IDENTIFICA; Marzinke MA, 2014, CLIN INFECT DIS, V58, P117, DOI 10.1093/cid/cit672; National Department of Health, 2013, DISTR HLTH INF SYST; National Department of Health, 2012, NAT ANT SENT HIV SYP; Phillips AE, 2010, INT J EPIDEMIOL, V39, P1541, DOI 10.1093/ije/dyq114; Rehle T, 2007, SAMJ S AFR MED J, V97, P194; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; Shisana O, 2014, S AFRICAN NATL HIV P; South African National AIDS Council, 2011, NAT STRAT PLAN HIV S; Stover J, 2012, SEX TRANSM INFECT, V88, pI11, DOI 10.1136/sextrans-2012-050640; UNAIDS, 2014, UNAIDS GAP REP; WHO Technical Working Group on HIV Incidence Assays, 2011, WHEN AND HOW TO USE; WHO/UNAIDS, 2013, TECHN UPD HIV INC AS	38	44	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133255	10.1371/journal.pone.0133255	http://dx.doi.org/10.1371/journal.pone.0133255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230949	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400030
J	Jain, N; Bhargava, A; Rathi, M; Dilip, RV; Panwar, J				Jain, Navin; Bhargava, Arpit; Rathi, Mohit; Dilip, R. Venkataramana; Panwar, Jitendra			Removal of Protein Capping Enhances the Antibacterial Efficiency of Biosynthesized Silver Nanoparticles	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; MECHANISM; TOXICITY; IONS; SURFACTANTS; NANOSILVER; POLYMERS; BACTERIA; RELEASE	The present study demonstrates an economical and environmental affable approach for the synthesis of "protein-capped" silver nanoparticles in aqueous solvent system. A variety of standard techniques viz. UV-visible spectroscopy, transmission electron microscopy (TEM), energy dispersive spectroscopy (EDS) and X-ray diffraction (XRD) measurements were employed to characterize the shape, size and composition of nanoparticles. The synthesized nanoparticles were found to be homogenous, spherical, mono-dispersed and covered with multi-layered protein shell. In order to prepare bare silver nanoparticles, the protein shell was removed from biogenic nanoparticles as confirmed by UV-visible spectroscopy, FTIR and photoluminescence analysis. Subsequently, the antibacterial efficacy of protein-capped and bare silver nanoparticles was compared by bacterial growth rate and minimum inhibitory concentration assay. The results revealed that bare nanoparticles were more effective as compared to the protein-capped silver nanoparticles with varying antibacterial potential against the tested Gram positive and negative bacterial species. Mechanistic studies based on ROS generation and membrane damage suggested that protein-capped and bare silver nanoparticles demonstrate distinct mode of action. These findings were strengthened by the TEM imaging along with silver ion release measurements using inductively coupled plasma atomic emission spectroscopy (ICP-AES). In conclusion, our results illustrate that presence of protein shell on silver nanoparticles can decrease their bactericidal effects. These findings open new avenues for surface modifications of nanoparticles to modulate and enhance their functional properties.	[Jain, Navin; Bhargava, Arpit; Rathi, Mohit; Dilip, R. Venkataramana; Panwar, Jitendra] Birla Inst Technol & Sci, Dept Biol Sci, Ctr Biotechnol, Pilani 333031, Rajasthan, India	Birla Institute of Technology & Science Pilani (BITS Pilani)	Panwar, J (corresponding author), Birla Inst Technol & Sci, Dept Biol Sci, Ctr Biotechnol, Pilani 333031, Rajasthan, India.	drjitendrapanwar@yahoo.co.in		Jain, Navin/0000-0002-8207-2491	University Grant Commission, Government of India [42-185/2013(SR)]	University Grant Commission, Government of India(University Grants Commission, India)	This research work was financially supported by University Grant Commission (www.ugc.ac.in), Government of India under Major Project Scheme [F. No. 42-185/2013(SR)].	Ahamed M, 2008, TOXICOL APPL PHARM, V233, P404, DOI 10.1016/j.taap.2008.09.015; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Amato E, 2011, LANGMUIR, V27, P9165, DOI 10.1021/la201200r; Andersson DI, 2011, FEMS MICROBIOL REV, V35, P901, DOI 10.1111/j.1574-6976.2011.00289.x; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Arora S, 2008, TOXICOL LETT, V179, P93, DOI 10.1016/j.toxlet.2008.04.009; Bartlomiejczyk T, 2013, ANN AGR ENV MED, V20, P48; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brett DW, 2006, OSTOMY WOUND MANAG, V52, P34; Buege J A, 1978, Methods Enzymol, V52, P302; Calzolai L, 2010, NANO LETT, V10, P3101, DOI 10.1021/nl101746v; Chang QY, 2007, LANGMUIR, V23, P11197, DOI 10.1021/la701006r; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; Choi O, 2008, WATER RES, V42, P3066, DOI 10.1016/j.watres.2008.02.021; Cui L, 2013, ANAL CHEM, V85, P5436, DOI 10.1021/ac400245j; Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5; de Lima R, 2012, J APPL TOXICOL, V32, P867, DOI 10.1002/jat.2780; Dimkpa CO, 2011, J HAZARD MATER, V188, P428, DOI 10.1016/j.jhazmat.2011.01.118; FALES FW, 1951, J BIOL CHEM, V193, P113; Farmer EE, 2013, ANNU REV PLANT BIOL, V64, P429, DOI 10.1146/annurev-arplant-050312-120132; Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Gericke M, 2006, HYDROMETALLURGY, V83, P132, DOI 10.1016/j.hydromet.2006.03.019; HOCHMAN A, 1991, BIOCHIM BIOPHYS ACTA, V1077, P299, DOI 10.1016/0167-4838(91)90544-A; Holt KB, 2005, BIOCHEMISTRY-US, V44, P13214, DOI 10.1021/bi0508542; Hwang ET, 2008, SMALL, V4, P746, DOI 10.1002/smll.200700954; Jain N, 2013, APPL MICROBIOL BIOT, V97, P859, DOI 10.1007/s00253-012-3934-2; Jain N, 2011, NANOSCALE, V3, P635, DOI 10.1039/c0nr00656d; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kvitek L, 2008, J PHYS CHEM C, V112, P5825, DOI 10.1021/jp711616v; Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5; Li ZQ, 2010, ENVIRON SCI TECHNOL, V44, P3462, DOI 10.1021/es9031198; Liu JY, 2010, ACS NANO, V4, P6903, DOI 10.1021/nn102272n; Lok CN, 2006, J PROTEOME RES, V5, P916, DOI 10.1021/pr0504079; Love SA, 2012, ANNU REV ANAL CHEM, V5, P181, DOI 10.1146/annurev-anchem-062011-143134; Lu WT, 2010, CHEM PHYS LETT, V487, P92, DOI 10.1016/j.cplett.2010.01.027; Lu XM, 2009, ANNU REV PHYS CHEM, V60, P167, DOI 10.1146/annurev.physchem.040808.090434; Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y; Mijnendonckx K, 2013, BIOMETALS, V26, P609, DOI 10.1007/s10534-013-9645-z; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Neal AL, 2008, ECOTOXICOLOGY, V17, P362, DOI 10.1007/s10646-008-0217-x; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h; Pradeep T, 2009, THIN SOLID FILMS, V517, P6441, DOI 10.1016/j.tsf.2009.03.195; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Reidy B, 2013, MATERIALS, V6, P2295, DOI 10.3390/ma6062295; Rico CM, 2013, ENVIRON SCI TECHNOL, V47, P5635, DOI 10.1021/es401032m; Sayes CM, 2005, BIOMATERIALS, V26, P7587, DOI 10.1016/j.biomaterials.2005.05.027; Shaligram NS, 2009, PROCESS BIOCHEM, V44, P939, DOI 10.1016/j.procbio.2009.04.009; Shankar SS, 2003, J MATER CHEM, V13, P1822, DOI 10.1039/b303808b; Sheehy K, 2015, J COLLOID INTERF SCI, V443, P56, DOI 10.1016/j.jcis.2014.11.074; Shoults-Wilson WA, 2011, NANOTOXICOLOGY, V5, P432, DOI 10.3109/17435390.2010.537382; Somasundaran P, 2004, J COSMET SCI, V55, pS1; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Suchomel P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119202; Travan A, 2009, BIOMACROMOLECULES, V10, P1429, DOI 10.1021/bm900039x; Vigneshwaran N, 2006, COLLOID SURFACE B, V53, P55, DOI 10.1016/j.colsurfb.2006.07.014; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w; Xu HY, 2012, BIOMETALS, V25, P45, DOI 10.1007/s10534-011-9482-x; Yang XY, 2012, ENVIRON SCI TECHNOL, V46, P1119, DOI 10.1021/es202417t; Zhou Y, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-19	62	38	38	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134337	10.1371/journal.pone.0134337	http://dx.doi.org/10.1371/journal.pone.0134337			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226385	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700075
J	Nakanishi, N; Camara, AC; Yuan, DC; Gold, DA; Jacobs, DK				Nakanishi, Nagayasu; Camara, Anthony C.; Yuan, David C.; Gold, David A.; Jacobs, David K.			Gene Expression Data from the Moon Jelly, Aurelia, Provide Insights into the Evolution of the Combinatorial Code Controlling Animal Sense Organ Development	PLOS ONE			English	Article							EYES ABSENT; PAX-6-EYA-DACH NETWORK; CRANIAL PLACODES; PAX GENES; CONSERVATION; SPECIFICATION; PATTERNS; FAMILIES; MEDUSAE; SYSTEM	In Bilateria, Pax6, Six, Eya and Dach families of transcription factors underlie the development and evolution of morphologically and phyletically distinct eyes, including the compound eyes in Drosophila and the camera-type eyes in vertebrates, indicating that bilaterian eyes evolved under the strong influence of ancestral developmental gene regulation. However the conservation in eye developmental genetics deeper in the Eumetazoa, and the origin of the conserved gene regulatory apparatus controlling eye development remain unclear due to limited comparative developmental data from Cnidaria. Here we show in the eye-bearing scyphozoan cnidarian Aurelia that the ectodermal photosensory domain of the developing medusa sensory structure known as the rhopalium expresses sine oculis (so)/six1/2 and eyes absent/eya, but not optix/six3/6 or pax (A&B). In addition, the so and eya co-expression domain encompasses the region of active cell proliferation, neurogenesis, and mechanoreceptor development in rhopalia. Consistent with the role of so and eya in rhopalial development, developmental transcriptome data across Aurelia life cycle stages show upregulation of so and eya, but not optix or pax (A&B), during medusa formation. Moreover, pax6 and dach are absent in the Aurelia genome, and thus are not required for eye development in Aurelia. Our data are consistent with so and eya, but not optix, pax or dach, having conserved functions in sensory structure specification across Eumetazoa. The lability of developmental components including Pax genes relative to so-eya is consistent with a model of sense organ development and evolution that involved the lineage specific modification of a combinatorial code that specifies animal sense organs.	[Nakanishi, Nagayasu; Camara, Anthony C.; Yuan, David C.; Gold, David A.; Jacobs, David K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90089 USA	University of California System; University of California Los Angeles	Jacobs, DK (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90089 USA.	djacobs@ucla.edu	Gold, David/I-5398-2012	Gold, David/0000-0003-0135-4022	UCLA Edwin W. Pauley fellowship; NIH Genomic Analysis and Interpretation Training Grant [T32HG002536]; NASA Astrobiology Institute Grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER	UCLA Edwin W. Pauley fellowship; NIH Genomic Analysis and Interpretation Training Grant; NASA Astrobiology Institute Grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the UCLA Edwin W. Pauley fellowship (to N.N.), NIH Genomic Analysis and Interpretation Training Grant T32HG002536 (to D.A.G.), and a NASA Astrobiology Institute Grant (to DKJ). https://astrobiology.nasa.gov/nai/ in http://www.complex-life.org/.	Arendt D, 2002, DEVELOPMENT, V129, P1143; Arendt D, 2001, PHILOS T R SOC B, V356, P1545, DOI 10.1098/rstb.2001.0971; Baker CVH, 2001, DEV BIOL, V232, P1, DOI 10.1006/dbio.2001.0156; Bebenek IG, 2004, DEV GENES EVOL, V214, P342, DOI 10.1007/s00427-004-0407-3; Blumer MJF, 1995, ZOOMORPHOLOGY, V115, P221, DOI 10.1007/BF00393802; Brekhman V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1320-z; Carl M, 2002, DEVELOPMENT, V129, P4057; Darwin C., 1859, PRESERVATION FAVOURE, Vix; Denker E, 2008, DEV BIOL, V315, P99, DOI 10.1016/j.ydbio.2007.12.023; Donner AL, 2004, INT J DEV BIOL, V48, P743, DOI 10.1387/ijdb.041877ad; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fortunato SAV, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-23; Fuchs B, 2014, CURR BIOL, V24, P263, DOI 10.1016/j.cub.2013.12.003; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Graziussi DF, 2012, J EXP ZOOL PART B, V318B, P257, DOI 10.1002/jez.b.22442; Grimmelikhuijzen CJP, 2002, CAN J ZOOL, V80, P1690, DOI 10.1139/Z02-137; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hernandez-Nicaise M.-L., 1991, P359; Hill A, 2010, DEV BIOL, V343, P106, DOI 10.1016/j.ydbio.2010.03.010; HORRIDGE A, 1956, Q J MICROSC SCI, V97, P59; HORRIDGE GA, 1959, J EXP BIOL, V36, P72; Horstmann E, 1934, PFLUG ARCH GES PHYS, V234, P406, DOI 10.1007/BF01766923; Hoshiyama D, 1998, J MOL EVOL, V47, P640, DOI 10.1007/PL00006421; Hroudova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036420; HYMAN LH, 1940, INVERTEBRATES PROTOZ; Jacobs DK, 2007, INTEGR COMP BIOL, V47, P712, DOI 10.1093/icb/icm094; Kawakami K, 1996, FEBS LETT, V393, P259, DOI 10.1016/0014-5793(96)00899-X; Kozmik Z, 2003, DEV CELL, V5, P773, DOI 10.1016/S1534-5807(03)00325-3; Kozmik Z, 2007, DEV BIOL, V306, P143, DOI 10.1016/j.ydbio.2007.03.009; Leys SP, 2001, BIOL BULL-US, V201, P323, DOI 10.2307/1543611; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Mackie GO., 1971, SAL ACT 1 S INT ZOOF, P269; Martin-Duran JM, 2012, DEV GENES EVOL, V222, P45, DOI 10.1007/s00427-012-0389-5; Martin VJ, 2002, CAN J ZOOL, V80, P1703, DOI 10.1139/Z02-136; Medina M, 2001, P NATL ACAD SCI USA, V98, P9707, DOI 10.1073/pnas.171316998; Nakanishi N, 2010, EVOL DEV, V12, P404, DOI 10.1111/j.1525-142X.2010.00427.x; Nakanishi N, 2009, DEV GENES EVOL, V219, P301, DOI 10.1007/s00427-009-0291-y; Nordstrom K, 2003, P ROY SOC B-BIOL SCI, V270, P2349, DOI 10.1098/rspb.2003.2504; Pappu KS, 2004, INT J DEV BIOL, V48, P913, DOI 10.1387/ijdb.041875kp; Passano L.M., 1973, Publications Seto Mar Biol Lab, V20, P615; PASSANO LM, 1965, AM ZOOL, V5, P465; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Schafer E.A., 1878, PHILOS T ROY SOC LON, V169, P563; Schlosser G, 2008, DEV BIOL, V320, P199, DOI 10.1016/j.ydbio.2008.05.523; Schlosser G, 2007, INTEGR COMP BIOL, V47, P343, DOI 10.1093/icb/icm031; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; Schmich J, 1998, CELL TISSUE RES, V294, P169, DOI 10.1007/s004410051167; Schroth W, 2005, MAR BIOTECHNOL, V7, P449, DOI 10.1007/s10126-004-4095-9; Seimiya M, 2000, DEVELOPMENT, V127, P1879; Steinmetz PRH, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-14; Stierwald M, 2004, DEV BIOL, V274, P70, DOI 10.1016/j.ydbio.2004.06.018; Suga H, 2010, P NATL ACAD SCI USA, V107, P14263, DOI 10.1073/pnas.1008389107; TAKASU N, 1984, ZOOL SCI, V1, P367; Taverna E, 2010, NEURON, V67, P906, DOI 10.1016/j.neuron.2010.08.027; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; von Salvini-Plawen L., 1977, Evolutionary Biology (New York), V10, P207; Wallberg A, 2004, CLADISTICS, V20, P558, DOI 10.1111/j.1096-0031.2004.00041.x; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xu PX, 1997, DEVELOPMENT, V124, P219; Yamasu T., 1973, Publications Seto Mar Biol Lab, V20, P757; Yoshida M., 1980, P343; Yuan D, 2008, DEV GENES EVOL, V218, P525, DOI 10.1007/s00427-008-0254-8	66	10	11	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0132544	10.1371/journal.pone.0132544	http://dx.doi.org/10.1371/journal.pone.0132544			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225420	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700008
J	Qin, Y; Zhou, Y; Chen, SH; Zhao, XL; Ran, L; Zeng, XL; Wu, Y; Chen, JL; Kang, C; Shu, FR; Zhang, QY; Mi, MT				Qin, Yu; Zhou, Yong; Chen, Shi-Hui; Zhao, Xiao-Lan; Ran, Li; Zeng, Xiang-Long; Wu, Ying; Chen, Jun-Li; Kang, Chao; Shu, Fu-Rong; Zhang, Qian-Yong; Mi, Man-Tian			Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial	PLOS ONE			English	Article							INSULIN SENSITIVITY; ENERGY-EXPENDITURE; ADIPONECTIN; OBESITY; ACID; MARKERS; OMEGA-3-FATTY-ACIDS; INFLAMMATION; EXPRESSION; INDUCTION	Fish oil has been used effectively in the treatment of cardiovascular disease via triglyceride reduction and inflammation modulation. This study aimed to assess the effects of fish oil on patients with nonalcoholic fatty liver disease (NAFLD) associated with hyperlipidemia. Eighty participants with NAFLD associated with hyperlipidemia were randomly assigned to consume fish oil (n=40, 4 g/d) or corn oil capsules (n=40, 4 g/d) for 3 months in a double-blind, randomized clinical trial. Blood levels of lipids, glucose and insulin, liver enzymes, kidney parameters and cytokines at baseline and the end of the study were measured. Seventy people finished the trial. Plasma concentrations of eicosapentaenoic acid and docosahexaenoic acid significantly increased in the fish oil group after intervention. After adjustment for age, gender and BMI, fish oil significantly decreased fasting serum concentrations of total cholesterol, triglyceride, apolipoprotein B and glucose (by (mean +/- SD) 0.49 +/- 0.43 mmol/L, 0.58 +/- 0.89 mmol/L, 0.28 +/- 0.33 g/L and 0.76 +/- 0.56 mmol/L, respectively, P<0.05), as well as alanine aminotransferase and gamma-glutamyl transpeptidase levels (by (median (interquartile)) 9.0(0.5, 21.5) and 7.0(2.2, 20.0) IU/L, respectively, P<0.05), significantly increased serum adiponectin levels (by 1.29 +/- 0.62 mu g/mL, P<0.001), and reduced serum levels of tumor necrosis factor a, leukotrienes B4, fibroblast growth factor 21 (FGF21), cytokeratin 18 fragment M30 and prostaglandin E2 (by 1.70 +/- 1.18 pg/mL, 0.59 +/- 0.28 ng/mL, 121 +/- 31 pg/mL, 83 +/- 60 IU/L and 10.9 +/- 2.3 pg/mL, respectively, P<0.001). Corn oil had no effect except for increasing serum creatinine concentrations by 7.7 +/- 8.9 mu mol/L (P=0.008). The effects of fish oil on lipids, glucose and gamma-glutamyl transpeptidase were positively correlated with the reductions of serum FGF21 and prostaglandin E2 concentrations after adjustment for age, gender and BMI (r=0.275 to 0.360 and 0.261 to 0.375, respectively, P<0.05). In conclusion, our findings suggest that fish oil can benefit metabolic abnormalities associated with NAFLD treatment.	[Qin, Yu; Zhou, Yong; Chen, Shi-Hui; Ran, Li; Zeng, Xiang-Long; Wu, Ying; Chen, Jun-Li; Kang, Chao; Shu, Fu-Rong; Zhang, Qian-Yong; Mi, Man-Tian] Third Mil Med Univ, Chongqing Med Nutr Res Ctr, Chongqing Key Lab Nutr & Food Safety, Res Ctr Nutr & Food Safety,Inst Mil Prevent Med, Chongqing, Peoples R China; [Zhao, Xiao-Lan] Third Mil Med Univ, Dept Hlth Examinat Ctr, Southwest Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University	Zhang, QY (corresponding author), Third Mil Med Univ, Chongqing Med Nutr Res Ctr, Chongqing Key Lab Nutr & Food Safety, Res Ctr Nutr & Food Safety,Inst Mil Prevent Med, Chongqing, Peoples R China.	zqianyong@sina.com; mimantian@hotmail.com		kang, chao/0000-0001-9602-9251	National Natural Science Foundation of China [30972469, 81273059]; National Science-Technology Support Plan Projects of China [2012BAI35B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science-Technology Support Plan Projects of China	This work was supported by the National Natural Science Foundation of China (No.30972469; No.81273059) and the National Science-Technology Support Plan Projects of China (No.2012BAI35B02). The authors received no other specific funding for this work.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bender N, 2014, OBES REV, V15, P657, DOI 10.1111/obr.12189; Bisgaard A, 2014, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2014-7; Bouzianas DG, 2013, NUTR REV, V71, P753, DOI 10.1111/nure.12073; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; De Rosa A, 2013, EUR J ENDOCRINOL, V169, P37, DOI 10.1530/EJE-12-1039; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Eto K, 2010, DIABETES RES CLIN PR, V89, P52, DOI 10.1016/j.diabres.2010.03.019; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Gammelmark A, 2012, NUTR RES, V32, P15, DOI 10.1016/j.nutres.2011.12.007; Giannini C, 2013, J CLIN ENDOCR METAB, V98, P2993, DOI 10.1210/jc.2013-1250; Gray B, 2013, EUR J CLIN NUTR, V67, P1234, DOI 10.1038/ejcn.2013.197; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guebre-Egziabher F, 2013, NUTRITION, V29, P730, DOI 10.1016/j.nut.2012.10.011; Guleria Ashwani, 2013, Trop Gastroenterol, V34, P74; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Li HT, 2013, J HEPATOL, V58, P557, DOI 10.1016/j.jhep.2012.10.029; Li HT, 2010, J HEPATOL, V53, P934, DOI 10.1016/j.jhep.2010.05.018; Li K, 2009, EUR J ENDOCRINOL, V161, P391, DOI 10.1530/EJE-09-0335; Lin ZF, 2015, CIRCULATION, V131, P1861, DOI 10.1161/CIRCULATIONAHA.115.015308; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Liu J, 2015, METABOLISM, V64, P380, DOI 10.1016/j.metabol.2014.11.009; Masood A, 2005, J LIPID RES, V46, P2299, DOI 10.1194/jlr.D500022-JLR200; Mraz M, 2009, CLIN ENDOCRINOL, V71, P369, DOI 10.1111/j.1365-2265.2008.03502.x; Nobili V, 2013, NUTR METAB CARDIOVAS, V23, P1066, DOI 10.1016/j.numecd.2012.10.010; Nobili V, 2011, ARCH DIS CHILD, V96, P350, DOI 10.1136/adc.2010.192401; Parker HM, 2012, J HEPATOL, V56, P944, DOI 10.1016/j.jhep.2011.08.018; Qin Y, 2014, J NUTR, V144, P49, DOI 10.3945/jn.113.182725; Salas-Salvado J, 2006, INT J OBESITY, V30, P1714, DOI 10.1038/sj.ijo.0803348; Samson SL, 2011, DIABETOLOGIA, V54, P3093, DOI 10.1007/s00125-011-2317-z; Shapiro H, 2011, CLIN NUTR, V30, P6, DOI 10.1016/j.clnu.2010.06.001; Siriwardhana N, 2012, ADV FOOD NUTR RES, V65, P211, DOI 10.1016/B978-0-12-416003-3.00013-5; Villarroya J, 2014, LIPIDS, V49, P1081, DOI 10.1007/s11745-014-3948-x; von Frankenberg AD, 2014, BRIT J NUTR, V112, P1235, DOI 10.1017/S0007114514002013; Weitz D, 2010, CARDIOL REV, V18, P258, DOI 10.1097/CRD.0b013e3181ea0de0; Wong CY, 2010, DIABETIC MED, V27, P54, DOI 10.1111/j.1464-5491.2009.02869.x; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yang ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026359; Yilmaz Y, 2010, EUR J CLIN INVEST, V40, P887, DOI 10.1111/j.1365-2362.2010.02338.x	42	55	57	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133496	10.1371/journal.pone.0133496	http://dx.doi.org/10.1371/journal.pone.0133496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226139	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700023
J	Liu, HT; Chen, SH; Chancellor, MB; Kuo, HC				Liu, Hsin-Tzu; Chen, Sung-Ho; Chancellor, Michael B.; Kuo, Hann-Chorng			Presence of Cleaved Synaptosomal-Associated Protein-25 and Decrease of Purinergic Receptors P2X3 in the Bladder Urothelium Influence Efficacy of Botulinum Toxin Treatment for Overactive Bladder Syndrome	PLOS ONE			English	Article							INTRAVESICAL ONABOTULINUMTOXINA INJECTION; LIPOSOME-ENCAPSULATED ONABOTULINUMTOXINA; NEUROGENIC DETRUSOR OVERACTIVITY; LOWER URINARY-TRACT; NERVE-FIBERS; DOUBLE-BLIND; A TOXIN; NEUROTOXIN; RELEASE; ATP	Objectives To evaluate whether botulinum toxin A (BoNT-A) injection and Lipotoxin (liposomes with 200 U of BoNT-A) instillation target different proteins, including P2X3, synaptic vesicle glycoprotein 2A, and SNAP-25, in the bladder mucosa, leading to different treatment outcomes. Materials and Methods This was a retrospective study performed in a tertiary teaching hospital. We evaluated the clinical results of 27 OAB patients treated with intravesical BoNT-A injection (n = 16) or Lipotoxin instillation (n = 11). Seven controls were treated with saline. Patients were injected with 100 U of BoNT-A or Lipotoxinin a single intravesical instillation. The patients enrolled in this study all had bladder biopsies performed at baseline and one month after BoNT-A therapy. Treatment outcome was measured by the decreases in urgency and frequency episodes at 1 month. The functional protein expressions in the urothelium were measured at baseline and after 1 month. The Wilcoxon signed-rank test and ordinal logistic regression were used to compare the treatment outcomes. Results Both BoNT-A injection and Lipotoxin instillation treatments effectively decreased the frequency of urgency episodes in OAB patients. Lipotoxin instillation did not increase postvoid residual volume. BoNT-A injection effectively cleaved SNAP-25 (p < 0.01). Liposome encapsulated BoNT-A decreased urothelial P2X3 expression in the five responders (p = 0.04), while SNAP-25 was not significantly cleaved. Conclusions The results of this study provide a possible mechanism for the therapeutic effects of BoNT-A for the treatment of OAB via different treatment forms. BoNT-A and Lipotoxin treatments effectively decreased the frequency of urgency episodes in patients with OAB.	[Liu, Hsin-Tzu] Tzu Chi Univ, PhD Program Pharmacol & Toxicol, Hualien, Taiwan; [Liu, Hsin-Tzu] Tzu Chi Gen Hosp, Dept Med Res, Voiding Dysfunct Therapeut Ctr, Hualien, Taiwan; [Chen, Sung-Ho] Tzu Chi Univ, Dept Pharmacol, Hualien, Taiwan; [Chancellor, Michael B.] Oakland Univ, William Beaumont Sch Med, William Beaumont Hosp Res Inst, Dept Urol, Royal Oak, MI USA; [Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; [Kuo, Hann-Chorng] Tzu Chi Univ, Hualien, Taiwan	Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Oakland University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University	Kuo, HC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan.	hck@tzuchi.com.tw			Buddhist Tzu Chi General Hospital [TCRD-19901-02]; National Science Council of Taiwan [NSC 101-2314-B-303-003-MY3]	Buddhist Tzu Chi General Hospital; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grands from Buddhist Tzu Chi General Hospital (TCRD-19901-02) and the National Science Council of Taiwan (NSC 101-2314-B-303-003-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolidis A, 2006, EUR UROL, V49, P644, DOI 10.1016/j.eururo.2005.12.010; Apostolidis A, 2005, J UROLOGY, V174, P977, DOI 10.1097/01.ju.0000169481.42259.54; Brady CM, 2004, EUR UROL, V46, P247, DOI 10.1016/j.eururo.2003.12.017; Chancellor MB, 2008, NAT CLIN PRACT UROL, V5, P319, DOI 10.1038/ncpuro1124; Chuang YC, 2014, J UROLOGY, V192, P1743, DOI 10.1016/j.juro.2014.07.008; Chuang YC, 2009, J UROLOGY, V182, P1393, DOI 10.1016/j.juro.2009.06.024; Chuang YC, 2009, J UROLOGY, V182, P786, DOI 10.1016/j.juro.2009.03.083; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Coelho A, 2012, EUR UROL, V61, P1186, DOI [10.1016/j.eururo.2012.03.009, 10.1016/j.eururo.2012.01.046]; Coelho A, 2012, J UROLOGY, V187, P1121, DOI 10.1016/j.juro.2011.10.130; Coelho A, 2010, EUR UROL, V57, P884, DOI 10.1016/j.eururo.2009.12.022; Collins VM, 2013, BJU INT, V112, P1018, DOI 10.1111/bju.12266; Cruz F, 2014, NEUROUROL URODYNAM, V33, P31, DOI 10.1002/nau.22445; Denys P, 2012, EUR UROL, V61, P520, DOI 10.1016/j.eururo.2011.10.028; Dolly JO, 2014, NEUROUROL URODYNAM, V33, pS14, DOI 10.1002/nau.22634; Fraser MO, 2003, UROLOGY, V61, P656, DOI 10.1016/S0090-4295(02)02281-1; Hanna-Mitchell AT, 2015, NEUROUROL URODYNAM, V34, P79, DOI 10.1002/nau.22508; Ikeda Y, 2012, EUR UROL, V62, P1157, DOI 10.1016/j.eururo.2012.03.031; Kuo HC, 2014, EUR UROL, V65, P1117, DOI 10.1016/j.eururo.2014.01.036; Kuo HC, 2011, NEUROUROL URODYNAM, V30, P1497, DOI 10.1002/nau.21132; Kuo HC, 2004, UROLOGY, V63, P868, DOI 10.1016/j.urology.2003.12.007; Kuo HC, 2005, UROLOGY, V66, P94, DOI 10.1016/j.urology.2005.02.002; Lawrence GW, 2010, J PHARMACOL EXP THER, V334, P1080, DOI 10.1124/jpet.110.169342; Liao CH, 2013, J UROLOGY, V189, P1804, DOI 10.1016/j.juro.2012.11.089; Nitti VW, 2013, J UROLOGY, V189, P2186, DOI 10.1016/j.juro.2012.12.022; Pyle RA, 2000, J BIOL CHEM, V275, P17195, DOI 10.1074/jbc.M000674200; Schulte-Baukloh H, 2007, BJU INT, V100, P1075, DOI 10.1111/j.1464-410X.2007.07137.x; Schulte-Baukloh H, 2013, UROLOGY, V81, P1052, DOI 10.1016/j.urology.2012.12.021; SIMPSON LL, 1979, REV INFECT DIS, V1, P656; Tyagi P, 2004, J UROLOGY, V171, P483, DOI 10.1097/01.ju.0000102360.11785.d7; Yiangou Y, 2001, BJU INT, V87, P774, DOI 10.1046/j.1464-410x.2001.02190.x; Yiangou Yiangos, 2011, J Pain Res, V4, P347, DOI 10.2147/JPR.S25189	32	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134803	10.1371/journal.pone.0134803	http://dx.doi.org/10.1371/journal.pone.0134803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241848	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700067
J	Liu, ML; Wu, L; Ming, QS				Liu, Mingli; Wu, Lang; Ming, Qingsen			How Does Physical Activity Intervention Improve Self-Esteem and Self-Concept in Children and Adolescents? Evidence from a Meta-Analysis	PLOS ONE			English	Article							BODY-COMPOSITION; OVERWEIGHT CHILDREN; PUBLIC-HEALTH; DEPRESSION; EXERCISE; PROGRAM; ANXIETY; PARTICIPATION; VALIDATION; SYMPTOMS	Objective To perform a systematic review and meta-analysis for the effects of physical activity intervention on self-esteem and self-concept in children and adolescents, and to identify moderator variables by meta-regression. Design A meta-analysis and meta-regression. Method Relevant studies were identified through a comprehensive search of electronic databases. Study inclusion criteria were: (1) intervention should be supervised physical activity, (2) reported sufficient data to estimate pooled effect sizes of physical activity intervention on self-esteem or self-concept, (3) participants' ages ranged from 3 to 20 years, and (4) a control or comparison group was included. For each study, study design, intervention design and participant characteristics were extracted. R software (version 3.1.3) and Stata (version 12.0) were used to synthesize effect sizes and perform moderation analyses for determining moderators. Results Twenty-five randomized controlled trial (RCT) studies and 13 non-randomized controlled trial (non-RCT) studies including a total of 2991 cases were identified. Significant positive effects were found in RCTs for intervention of physical activity alone on general self outcomes (Hedges' g = 0.29, 95% confidence interval [CI]: 0.14 to 0.45; p = 0.001), self-concept (Hedges' g = 0.49, 95% CI: 0.10 to 0.88, p = 0.014) and self-worth (Hedges' g = 0.31, 95% CI: 0.13 to 0.49, p = 0.005). There was no significant effect of intervention of physical activity alone on any outcomes in non-RCTs, as well as in studies with intervention of physical activity combined with other strategies. Meta-regression analysis revealed that higher treatment effects were associated with setting of intervention in RCTs (beta = 0.31, 95% CI: 0.07 to 0.55, p = 0.013). Conclusion Intervention of physical activity alone is associated with increased self-concept and self-worth in children and adolescents. And there is a stronger association with school-based and gymnasium-based intervention compared with other settings.	[Liu, Mingli; Ming, Qingsen] Cent South Univ, Xiangya Hosp 2, Inst Med Psychol, Changsha 410011, Hunan, Peoples R China; [Liu, Mingli] Hunan Univ Sci & Technol, Sch Educ, Xiangtan 411201, Hunan, Peoples R China; [Wu, Lang] Mayo Clin, Ctr Clin & Translat Sci, Rochester, MN 55905 USA	Central South University; Hunan University of Science & Technology; Mayo Clinic	Liu, ML (corresponding author), Cent South Univ, Xiangya Hosp 2, Inst Med Psychol, Changsha 410011, Hunan, Peoples R China.	mlliupsy@163.com	Wu, Lang/M-4053-2017; Liu, Millie/GXG-8603-2022		Hunan Provincial Education Department [914 \ B41120]	Hunan Provincial Education Department(Hunan Provincial Education Department)	This research was supported by Scientific Research Fund of Hunan Provincial Education Department (grant number 914 vertical bar B41120) (URL: http://gov.hnedu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2011, J PEDIATR PSYCHOL, V36, P385, DOI 10.1093/jpepsy/jsq107; ALPERT B, 1990, HEALTH PSYCHOL, V9, P48, DOI 10.1037/0278-6133.9.1.48; Annesi JJ, 2006, J PSYCHOSOM RES, V61, P515, DOI 10.1016/j.jpsychores.2006.04.009; Atlas WHO, 2005, CHILD AD MENT HLTH R; Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006; Baumeister R. F., 1998, HDB SOCIAL PSYCHOL, V1-2, P680; BECKER BJ, 1988, BRIT J MATH STAT PSY, V41, P257, DOI 10.1111/j.2044-8317.1988.tb00901.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Belfer ML, 2008, J CHILD PSYCHOL PSYC, V49, P226, DOI 10.1111/j.1469-7610.2007.01855.x; Borenstein M., 2009, INTRO METAANALYSIS; Brown HE, 2013, SPORTS MED, V43, P195, DOI 10.1007/s40279-012-0015-8; Buffart LM, 2014, J SCI MED SPORT, V17, P67, DOI 10.1016/j.jsams.2013.02.015; Butler Richard J, 2005, Child Adolesc Ment Health, V10, P190, DOI 10.1111/j.1475-3588.2005.00368.x; CAMPBELL JD, 1990, J PERS SOC PSYCHOL, V59, P538, DOI 10.1037/0022-3514.59.3.538; CROCKER J, 1989, PSYCHOL REV, V96, P608, DOI 10.1037/0033-295X.96.4.608; Davis CL, 2011, HEALTH PSYCHOL, V30, P91, DOI 10.1037/a0021766; Dishman R, 1986, MENTAL HLTH, P303; DISHMAN RK, 1995, QUEST, V47, P362, DOI 10.1080/00336297.1995.10484164; Dishman RK, 2006, HEALTH PSYCHOL, V25, P396, DOI 10.1037/0278-6133.25.3.396; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ekeland E, 2005, BRIT J SPORT MED, V39, P792, DOI 10.1136/bjsm.2004.017707; Green JPHaS, 2008, COCHRANE HDB SYSTEMA; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Hassmen P, 2000, PREV MED, V30, P17, DOI 10.1006/pmed.1999.0597; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HILYER JC, 1982, J COUNS PSYCHOL, V29, P292, DOI 10.1037/0022-0167.29.3.292; Hoagwood K, 2003, J SCHOOL PSYCHOL, V41, P3, DOI 10.1016/S0022-4405(02)00141-3; Holley J, 2011, BRIT J CLIN PSYCHOL, V50, P84, DOI 10.1348/014466510X496220; Hutzler Y, 1998, PERCEPT MOTOR SKILL, V86, P111, DOI 10.2466/pms.1998.86.1.111; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Jelalian E, 2011, CHILD HEALTH CARE, V40, P197, DOI 10.1080/02739615.2011.590391; Larun L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004691.pub2; Lee A, 2009, J CLIN CHILD ADOLESC, V38, P219, DOI 10.1080/15374410802698396; Lubans DR, 2010, PSYCHOL SPORT EXERC, V11, P497, DOI 10.1016/j.psychsport.2010.06.009; Marsh HW, 1990, EDUC PSYCHOL REV, V2, P77, DOI 10.1007/BF01322177; Mazzoni ER, 2009, ADAPT PHYS ACT Q, V26, P259, DOI 10.1123/apaq.26.3.259; McGee R, 2000, J ADOLESCENCE, V23, P569, DOI 10.1006/jado.2000.0344; McGee R, 2001, J ABNORM CHILD PSYCH, V29, P281, DOI 10.1023/A:1010353711369; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; O'Brien E.J., 2006, SELF ESTEEM ISSUES A, P306; Orth U, 2008, J PERS SOC PSYCHOL, V95, P695, DOI 10.1037/0022-3514.95.3.695; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; PERCY LE, 1981, PERCEPT MOTOR SKILL, V52, P42, DOI 10.2466/pms.1981.52.1.42; Robinson TN, 2010, ARCH PEDIAT ADOL MED, V164, P995, DOI 10.1001/archpediatrics.2010.197; Rosenberg M, 1985, SELF CONCEPT PSYCHOL, P205; Schranz N, 2014, BRIT J SPORT MED, V48, P1482, DOI 10.1136/bjsports-2013-092209; Seabra AC, 2014, SCAND J MED SCI SPOR, V24, P10, DOI 10.1111/sms.12268; SHAVELSON RJ, 1976, REV EDUC RES, V46, P407, DOI 10.3102/00346543046003407; Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x; Staiano AE, 2013, OBESITY, V21, P598, DOI 10.1002/oby.20282; Trzesniewski KH, 2006, DEV PSYCHOL, V42, P381, DOI 10.1037/0012-1649.42.2.381; Van Wely L, 2014, CLIN REHABIL, V28, P972, DOI 10.1177/0269215513500971; Velez A, 2010, J STRENGTH COND RES, V24, P1065, DOI 10.1519/JSC.0b013e3181cc230a; Weintraub DL, 2008, ARCH PEDIAT ADOL MED, V162, P232, DOI 10.1001/archpediatrics.2007.43	56	184	189	8	154	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134804	10.1371/journal.pone.0134804	http://dx.doi.org/10.1371/journal.pone.0134804			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1VB	26241879	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700068
J	Avni, T; Lador, A; Lev, S; Leibovici, L; Paul, M; Grossman, A				Avni, Tomer; Lador, Adi; Lev, Shaul; Leibovici, Leonard; Paul, Mical; Grossman, Alon			Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HEMODYNAMIC SUPPORT; SEVERE SEPSIS; NOREPINEPHRINE; DOPAMINE; EPINEPHRINE; DOBUTAMINE; MANAGEMENT; TERLIPRESSIN; INFUSION; PHENYLEPHRINE	Objective International guidelines recommend dopamine or norepinephrine as first-line vasopressor agents in septic shock. Phenylephrine, epinephrine, vasopressin and terlipressin are considered second-line agents. Our objective was to assess the evidence for the efficiency and safety of all vasopressors in septic shock. Methods Systematic review and meta-analysis. We searched electronic database of MEDLINE, CENTRAL, LILACS and conference proceedings up to June 2014. We included randomized controlled trials comparing different vasopressors for the treatment of adult patients with septic shock. Primary outcome was all-cause mortality. Other clinical and hemodynamic measurements were extracted as secondary outcomes. Risk ratios (RR) and mean differences with 95% confidence intervals (CI) were pooled. Results Thirty-two trials (3,544 patients) were included. Compared to dopamine (866 patients, 450 events), norepinephrine (832 patients, 376 events) was associated with decreased all-cause mortality, RR 0.89 (95% CI 0.81-0.98), corresponding to an absolute risk reduction of 11% and number needed to treat of 9. Norepinephrine was associated with lower risk for major adverse events and cardiac arrhythmias compared to dopamine. No other mortality benefit was demonstrated for the comparisons of norepinephrine to epinephrine, phenylephrine and vasopressin / terlipressin. Hemodynamic data were similar between the different vasopressors, with some advantage for norepinephrine in central venous pressure, urinary output and blood lactate levels. Conclusions Evidence suggests a survival benefit, better hemodynamic profile and reduced adverse events rate for norepinephrine over dopamine. Norepinephrine should be regarded as the first line vasopressor in the treatment of septic shock.	[Avni, Tomer; Lador, Adi; Leibovici, Leonard; Grossman, Alon] Beilinson Med Ctr, Rabin Med Ctr, Med E, Petah Tiqwa, Israel; [Avni, Tomer; Lador, Adi; Lev, Shaul; Leibovici, Leonard; Grossman, Alon] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Lador, Adi] Beilinson Med Ctr, Rabin Med Ctr, Intens Care Unit, Petah Tiqwa, Israel; [Paul, Mical] Technion Israel Inst Technol, Rambam Med Ctr, Infect Dis Unit, Haifa, Israel; [Paul, Mical] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Avni, T (corresponding author), Beilinson Med Ctr, Rabin Med Ctr, Med E, Petah Tiqwa, Israel.	tomerav@clalit.org.il	Lador, Adi/AAV-2380-2021	Lador, Adi/0000-0001-9678-7474				Agrawal A, 2011, SAUDI J ANAESTH, V5, P162, DOI 10.4103/1658-354X.82784; Albanese J, 2005, CRIT CARE MED, V33, P1897, DOI 10.1097/01.CCM.0000178182.37639.D6; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; Annane D, 2007, LANCET, V370, P676, DOI 10.1016/S0140-6736(07)61344-0; Arnold RC, 2009, SHOCK, V32, P35, DOI 10.1097/SHK.0b013e3181971d47; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chen H, 2012, JIANGXI MEDICAL JOUR, V47, P565; De Backer D, 2003, CRIT CARE MED, V31, P1659, DOI 10.1097/01.CCM.0000063045.77339.B6; De Backer D, 2012, CRIT CARE MED, V40, P725, DOI 10.1097/CCM.0b013e31823778ee; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Duranteau J, 1999, CRIT CARE MED, V27, P893, DOI 10.1097/00003246-199905000-00021; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; Guerin JP, 2005, SHOCK, V23, P18, DOI 10.1097/01.shk.0000150549.45338.6c; Havel C, 2011, COCHRANE DB SYST REV, V5; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; High K, 2008, J HEBEI MED, V30, P1188; Hollenberg SM, 2004, CRIT CARE MED, V32, P1928, DOI 10.1097/01.CCM.0000139761.05492.D6; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Jain G, 2010, INDIAN J CRIT CARE M, V14, P29, DOI 10.4103/0972-5229.63033; Lauzier F, 2006, INTENS CARE MED, V32, P1782, DOI 10.1007/s00134-006-0378-0; Levy B, 1997, INTENS CARE MED, V23, P282, DOI 10.1007/s001340050329; Liu P, 2010, CLIN ED GEN PRACTICE, V8, P265; Malay MB, 1999, J TRAUMA, V47, P699, DOI 10.1097/00005373-199910000-00014; MARIK PE, 1994, JAMA-J AM MED ASSOC, V272, P1354, DOI 10.1001/jama.272.17.1354; MARTIN C, 1993, CHEST, V103, P1826, DOI 10.1378/chest.103.6.1826; Mathur SK, 2007, INDIAN J CRIT CARE M, V11, P186, DOI 10.4103/0972-5229.37713; Morelli A, 2011, CRIT CARE, V15, DOI 10.1186/cc10453; Morelli A, 2009, CRIT CARE, V13, DOI 10.1186/cc7990; Morelli A, 2008, CRIT CARE, V12, DOI 10.1186/cc7121; Myburgh JA, 2008, INTENS CARE MED, V34, P2226, DOI 10.1007/s00134-008-1219-0; Patel BM, 2002, ANESTHESIOLOGY, V96, P576, DOI 10.1097/00000542-200203000-00011; Patel GP, 2010, SHOCK, V33, P375, DOI 10.1097/SHK.0b013e3181c6ba6f; Plotkin L. L., 2007, Anesteziologiya i Reanimatologiya, P47; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; RUOKONEN E, 1993, CRIT CARE MED, V21, P1296; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; SCHREUDER WO, 1989, CHEST, V95, P1282, DOI 10.1378/chest.95.6.1282; Seguin P, 2002, CLIN PHARMACOL THER, V71, P381, DOI 10.1067/mcp.2002.122471; Sharshar T, 2003, CRIT CARE MED, V31, P1752, DOI 10.1097/01.CCM.0000063046.82359.4A; Svoboda P, 2012, HEPATO-GASTROENTEROL, V59, P1043, DOI 10.5754/hge10550; Vasu TS, 2011, J INTENSIVE CARE MED, V27, P172, DOI [10.1177/0885066610396312, DOI 10.1177/0885066610396312]; Wu J, 2010, CHIN ARCH GEN SURG E, V4, P117; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602; Zhou SX, 2002, ACTA PHARMACOL SIN, V23, P654; Zhuangyu Y, 2011, SHANDONG MED J, V51, P93	47	132	146	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0129305	10.1371/journal.pone.0129305	http://dx.doi.org/10.1371/journal.pone.0129305			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237037	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942400003
J	Giaimo, S; Baudisch, A				Giaimo, Stefano; Baudisch, Annette			The Effect of Post-Reproductive Lifespan on the Fixation Probability of Beneficial Mutations	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; SURVIVAL PROBABILITY; MUTANT-GENE; LONGEVITY; FECUNDITY; HISTORY	Post-reproductive lifespan is a common trait among mammals and is usually considered to be neutral; i.e. with no influence on population dynamics. Here, we explore the role of post-reproductive lifespan in the fixation probability of beneficial genetic variation. We compare two separate, stationary populations living in a constant environment that are equivalent except for the average time their respective members spend in the post-reproductive stage of life. Using a recently derived approximation, we show that fixation of a beneficial mutation is more likely in the population with greater post-reproductive longevity. This finding is surprising, as the population with more prolonged post-reproductive lifespan has smaller effective size and the classic population-genetic model would suggest that decreasing effective size reduces fixation chances of beneficial mutations. Yet, as we explain, in the age-structured case, when effective size gets smaller because of longer post-reproductive lifespan but census size is kept equal, a beneficial mutation has a higher likelihood to get fixed because it finds itself at higher initial frequency.	[Giaimo, Stefano; Baudisch, Annette] Max Planck Inst Demog Res, Max Planck Res Grp, Modeling Evolut Aging, Rostock, Germany	Max Planck Society	Giaimo, S (corresponding author), Max Planck Inst Demog Res, Max Planck Res Grp, Modeling Evolut Aging, Rostock, Germany.	giaimo@demogr.mpg.de	Baudisch, Annette/ABA-2290-2020	Baudisch, Annette/0000-0002-4202-089X	Max Planck Research Group Modeling the Evolution of Aging at the Max Planck Institute for Demographic Research	Max Planck Research Group Modeling the Evolution of Aging at the Max Planck Institute for Demographic Research	This research was funded by the Max Planck Research Group Modeling the Evolution of Aging at the Max Planck Institute for Demographic Research.	Araki H, 2007, MOL ECOL, V16, P953, DOI 10.1111/j.1365-294X.2006.03206.x; ATHREYA KB, 1993, J MATH BIOL, V32, P45, DOI 10.1007/BF00160373; Bromham L, 1996, J MOL EVOL, V43, P610, DOI 10.1007/BF02202109; Bromham L, 2009, BIOL LETTERS, V5, P401, DOI 10.1098/rsbl.2009.0136; Charlesworth B, 2001, GENET RES, V77, P153, DOI 10.1017/S0016672301004979; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Cohen AA, 2004, BIOL REV, V79, P733, DOI 10.1017/S1464793103006432; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Engen S, 2005, GENETICS, V170, P941, DOI 10.1534/genetics.104.028233; Engen S, 2005, MATH BIOSCI, V195, P210, DOI 10.1016/j.mbs.2005.02.003; ESHEL I, 1984, J MATH BIOL, V19, P201, DOI 10.1007/BF00277746; Felsenstein J, 1971, INBREEDING VARIANCE, V68, P581; Fisher RA, 1930, GENETICAL THEORY NAT; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hawkes K, 2004, NATURE, V428, P128, DOI 10.1038/428128a; Hawks J, 2008, RECENT ADVANCES IN PALAEODEMOGRAPHY, P9, DOI 10.1007/978-1-4020-6424-1_1; HOPPE FM, 1992, J MATH BIOL, V30, P567, DOI 10.1007/BF00948891; JORDE PE, 1995, GENETICS, V139, P1077; Keyfitz N, 2005, STAT BIOL HEALTH, P1, DOI 10.1007/b139042; Kim PS, 2012, P ROY SOC B-BIOL SCI, V279, P4880, DOI 10.1098/rspb.2012.1751; KIMURA M, 1962, GENETICS, V47, P713; Lande R., 2003, OXFORD SERIES ECOLOG; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; Nunney L, 1996, BIOL J LINN SOC, V59, P411, DOI 10.1111/j.1095-8312.1996.tb01474.x; NUNNEY L, 1991, P ROY SOC B-BIOL SCI, V246, P71, DOI 10.1098/rspb.1991.0126; ORIVE ME, 1993, THEOR POPUL BIOL, V44, P316, DOI 10.1006/tpbi.1993.1031; Vindenes Y, 2010, EVOLUTION, V64, P1063, DOI 10.1111/j.1558-5646.2009.00868.x; Wright S, 1931, GENETICS, V16, P0097	28	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133820	10.1371/journal.pone.0133820	http://dx.doi.org/10.1371/journal.pone.0133820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230256	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400055
J	King, BA; Parra, C; Li, YM; Helton, KJ; Qaddoumi, I; Wilson, MW; Ogg, RJ				King, Benjamin A.; Parra, Carlos; Li, Yimei; Helton, Kathleen J.; Qaddoumi, Ibrahim; Wilson, Matthew W.; Ogg, Robert J.			Spatiotemporal Patterns of Tumor Occurrence in Children with Intraocular Retinoblastoma	PLOS ONE			English	Article							BILATERAL RETINOBLASTOMA; TEMPORAL EXPRESSION; RETINAL DEVELOPMENT; R PACKAGE; CELL; ORIGIN; ANGIOGENESIS; TOPOGRAPHY; DISEASE; OPSINS	Purpose To accurately map the retinal area covered by tumor in a prospectively enrolled cohort of children diagnosed with retinoblastoma. Methods Orbital MRI in 106 consecutive retinoblastoma patients (44 bilateral) was analyzed. For MRI-visible tumors, the polar angle and angle of eccentricity of points defining tumor perimeter on the retina were determined by triangulation from images in three orthogonal planes. The centroid of the mapped area was calculated to approximate tumor origin, and the location and cumulative tumor burden were analyzed in relation to mutation type (germline vs. somatic), tumor area, and patient age at diagnosis. Location of small tumors undetected by MRI was approximated with fundoscopic images. Results Mapping was successful for 129 tumors in 91 eyes from 67 patients (39 bilateral, 43 germline mutation). Cumulative tumor burden was highest within the macula and posterior pole and was asymmetrically higher within the inferonasal periphery. Tumor incidence was lowest in the superotemporal periphery. Tumor location varied with age at diagnosis in a complex pattern. Tumor location was concentrated in the macula and superonasal periphery in patients <5.6 months, in the inferotemporal quadrant of the posterior pole in patients 5.6-8.8 months, in the inferonasal quadrant in patients 8.8-13.2 months, and in the nasal and superotemporal periphery in patients >13.2 months. The distribution of MRI-invisible tumors was consistent with the asymmetry of mapped tumors. Conclusions MRI-based mapping revealed a previously unrecognized pattern of retinoblastoma localization that evolves with age at diagnosis. The structured spatiotemporal distribution of tumors may provide valuable clues about cellular or molecular events associated with tumorigenesis in the developing retina.	[King, Benjamin A.; Wilson, Matthew W.] Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Hamilton Eye Inst, Memphis, TN 38163 USA; [King, Benjamin A.; Parra, Carlos; Helton, Kathleen J.; Ogg, Robert J.] St Jude Childrens Res Hosp, Dept Radiol Sci, Memphis, TN 38105 USA; [Parra, Carlos] Univ Memphis, Dept Biomed Engn, Memphis, TN 38152 USA; [Li, Yimei] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Qaddoumi, Ibrahim] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Wilson, Matthew W.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA	University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Memphis; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Ogg, RJ (corresponding author), St Jude Childrens Res Hosp, Dept Radiol Sci, 332 N Lauderdale St, Memphis, TN 38105 USA.	Robert.ogg@stjude.org	Qaddoumi, Ibrahim/N-8101-2018		NIH Grant [HD049888]; Research to Prevent Blindness; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049888] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work received support from an NIH Grant (HD049888) and an Unrestricted Grant from the Research to Prevent Blindness.	Abramson DH, 1998, ACTA OPHTHALMOL SCAN, V76, P334, DOI 10.1034/j.1600-0420.1998.760316.x; Abramson DH, 2004, ARCH OPHTHALMOL-CHIC, V122, P1324, DOI 10.1001/archopht.122.9.1324; Abramson DH, 1996, RETINA-J RET VIT DIS, V16, P232, DOI 10.1097/00006982-199616030-00009; Agostinelli C, 2017, R PACKAGE CIRCULAR C; Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036; Anand-Apte B, 2010, ENCY EYE, P9; Arean C, 2010, ARCH OPHTHALMOL-CHIC, V128, P223, DOI 10.1001/archophthalmol.2009.386; Baddeley A, 2005, J R STAT SOC B, V67, P617, DOI 10.1111/j.1467-9868.2005.00519.x; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baddeley A, 2011, STAT SCI, V26, P613, DOI 10.1214/11-STS367; Bai SW, 2011, INVEST OPHTH VIS SCI, V52, P4560, DOI 10.1167/iovs.10-5487; Barb SM, 2011, INVEST OPHTH VIS SCI, V52, P2619, DOI 10.1167/iovs.10-5600; BOGENMANN E, 1988, SCIENCE, V240, P76, DOI 10.1126/science.2451289; Brinkert AW, 1998, OPHTHALMIC GENET, V19, P63, DOI 10.1076/opge.19.2.63.2320; BUCKLEY EG, 1992, J PEDIATR OPHTHALMOL, V29, P103; Bumsted K, 1997, J COMP NEUROL, V378, P117; CAVENEE WK, 1985, SCIENCE, V228, P501, DOI 10.1126/science.3983638; Chen D, 2004, CANCER CELL, V5, P539, DOI 10.1016/j.ccr.2004.05.025; Eklund Aron, 2013, BEE SWARM PLOT ALTER; Hall LS, 1999, J AAPOS, V3, P138, DOI 10.1016/S1091-8531(99)70058-3; Hatterer E, 2011, NEUROSCI RES, V70, P172, DOI 10.1016/j.neures.2011.02.008; HOLBEK S, 1989, ACTA OPHTHALMOL, V67, P560; Hu M, 1999, DEV BIOL, V207, P309, DOI 10.1006/dbio.1998.9031; Hughes S, 2000, INVEST OPHTH VIS SCI, V41, P1217; HURWITZ RL, 1990, J CLIN INVEST, V85, P1872, DOI 10.1172/JCI114648; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lees Jonathan M., 2013, GEOMAP TOPOGRAPHIC G; Lemon J., 2006, R R NEWS; Li L, 2011, INVEST OPHTH VIS SCI, V52, P8393, DOI 10.1167/iovs.11-8139; Linn Murphree A, 2005, Ophthalmol Clin North Am, V18, P41; Little MP, 2012, INT J CANCER, V130, P631, DOI 10.1002/ijc.26039; Lupo G, 2006, NAT REV NEUROSCI, V7, P103, DOI 10.1038/nrn1843; Marback EF, 2003, BRIT J OPHTHALMOL, V87, P1224, DOI 10.1136/bjo.87.10.1224; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; MUNIER FL, 1994, OPHTHALMIC GENET, V15, P101, DOI 10.3109/13816819409057835; Peters MA, 2002, DEV BIOL, V251, P59, DOI 10.1006/dbio.2002.0791; Pilhofer A, 2013, J STAT SOFTW, V53, P1; Pinheiro J., NLME LINEAR NONLINEA; PROVIS JM, 1985, J COMP NEUROL, V233, P429, DOI 10.1002/cne.902330403; R Core Team, 2018, R LANGUAGE ENV STAT; RICKMAN DW, 1995, VISUAL NEUROSCI, V12, P215, DOI 10.1017/S0952523800007896; Rodriguez-Galindo Carlos, 2007, Curr Treat Options Neurol, V9, P294, DOI 10.1007/s11940-007-0015-4; Rootman DB, 2013, BRIT J OPHTHALMOL, V97, P59, DOI 10.1136/bjophthalmol-2012-302133; RUBENFELD M, 1986, OPHTHALMOLOGY, V93, P1016; Snyder J., 1987, MAP PROJECT WORKING, P191; Urbanek S., 2013, IPLOTS IPLOTS INTERA; Urbanek Simon, 2012, R GRAPHICS DEVICE US; VANEY DI, 1985, PROC R SOC SER B-BIO, V224, P475, DOI 10.1098/rspb.1985.0045; Xiao M, 2000, J COMP NEUROL, V425, P545; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733	51	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132932	10.1371/journal.pone.0132932	http://dx.doi.org/10.1371/journal.pone.0132932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230335	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400023
J	Mainassara, HB; Lagare, A; Tempia, S; Sidiki, A; Issaka, B; Sidikou, BA; Oukem-Boyer, OOM				Mainassara, Halima Boubacar; Lagare, Adamou; Tempia, Stefano; Sidiki, Ali; Issaka, Bassira; Sidikou, Bibata Abdou; Oukem-Boyer, Odile Ouwe Missi			Influenza Sentinel Surveillance among Patients with Influenza-Like-Illness and Severe Acute Respiratory Illness within the Framework of the National Reference Laboratory, Niger, 2009-2013	PLOS ONE			English	Article							VIRUS SUBTYPE H1N1; SYNCYTIAL VIRUS; EPIDEMIOLOGY; CIRCULATION; COUNTRIES; MORTALITY; AFRICA	Background Little is known about the epidemiology of influenza in Africa, including Niger. We documented the epidemiology of seasonal and pandemic influenza among outpatients with influenza-like-illness (ILI) and inpatients with severe acute respiratory illness (SARI) presenting at selected sentinel sites in Niger from April 2009 through April 2013. Methods Patients meeting the ILI or the SARI case definitions and presenting at the outpatient or inpatient departments of selected sentinel sites were enrolled. Epidemiological data and nasopharyngeal swabs were collected. The respiratory samples were tested by real-time reverse transcription polymerase chain reaction. Results From April 2009 to April 2013, laboratory results were obtained from 1176 ILI and 952 SARI cases, of which 146 (12%) and 54 (6%) tested positive for influenza virus, respectively. The influenza positivity rate was highest in the 5-14 year age-group (32/130; 24% among ILI patients and 6/61; 10% among SARI patients) followed by the 1-4 year age-group (69/438; 16% among ILI patients and 32/333; 9% among SARI patients). Of the 200 influenza positive cases 104 (52%) were A(H1N1)pdm09, 62 (31%) were A(H3N2) and 34 (17%) were B. Influenza viruses were detected predominantly from November to April with peak viral activity observed in February. Conclusions The Niger sentinel surveillance system allowed to monitor the circulation of seasonal influenza as well as the introduction and spread of influenza A(H1N1)pdm09 in the country. Continuous influenza surveillance is needed to better understand the epidemiology of seasonal influenza and monitor the emergence of influenza strains with pandemic potential.	[Mainassara, Halima Boubacar; Lagare, Adamou; Sidiki, Ali; Issaka, Bassira; Sidikou, Bibata Abdou; Oukem-Boyer, Odile Ouwe Missi] Ctr Rech Med & Sanitaire CERMES, Niamey, Niger; [Tempia, Stefano] Ctr Res Dis Prevent, Influenza Div, Atlanta, GA USA; [Tempia, Stefano] Ctr Res Dis Prevent, Influenza Div, Pretoria, South Africa		Mainassara, HB (corresponding author), Ctr Rech Med & Sanitaire CERMES, Niamey, Niger.	halima@cermes.org; adamsyn03@gmail.com			National Ministry of Public Health; Division International of Pasteur Institute of Paris; Sanofi-Pasteur; Direction de la Cooperation Internationale of Monaco	National Ministry of Public Health; Division International of Pasteur Institute of Paris; Sanofi-Pasteur; Direction de la Cooperation Internationale of Monaco	The World Health Organization and CDC Atlanta afforded reagents, rRT-PCR machine and technical support. Financial support was obtained from the National Ministry of Public Health, the Division International of Pasteur Institute of Paris, Sanofi-Pasteur and the Direction de la Cooperation Internationale of Monaco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barakat A, 2012, J INFECT DIS, V206, pS94, DOI 10.1093/infdis/jis547; Barakat A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024579; Bonney JHK, 2012, J INFECT DIS, V206, pS108, DOI 10.1093/infdis/jis577; Dalhatu IT, 2009, J INFECT DIS S1, V206, pS121; Heraud JM, 2012, J INFECT DIS, V206, pS5, DOI 10.1093/infdis/jis541; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Niang MN, 2012, J INFECT DIS, V206, pS129, DOI 10.1093/infdis/jis576; Nzussouo NT, 2012, J INFECT DIS, V206, pS101, DOI 10.1093/infdis/jis572; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; World Health Organization, INFL OVERV; World Health Organization, WHO GLOB INFL; World Health Organization, FLUNET; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	17	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133178	10.1371/journal.pone.0133178	http://dx.doi.org/10.1371/journal.pone.0133178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230666	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400027
J	Tepper, N; Shlomi, T				Tepper, Naama; Shlomi, Tomer			Efficient Modeling of MS/MS Data for Metabolic Flux Analysis	PLOS ONE			English	Article							BIDIRECTIONAL REACTION STEPS; MASS-SPECTROMETRY; NETWORKS; FRAMEWORK; EMU	Metabolic flux analysis (MFA) is a widely used method for quantifying intracellular metabolic fluxes. It works by feeding cells with isotopic labeled nutrients, measuring metabolite isotopic labeling, and computationally interpreting the measured labeling data to estimate flux. Tandem mass-spectrometry (MS/MS) has been shown to be useful for MFA, providing positional isotopic labeling data. Specifically, MS/MS enables the measurement of a metabolite tandem mass-isotopomer distribution, representing the abundance in which certain parent and product fragments of a metabolite have different number of labeled atoms. However, a major limitation in using MFA with MS/MS data is the lack of a computationally efficient method for simulating such isotopic labeling data. Here, we describe the tandemer approach for efficiently computing metabolite tandem mass-isotopomer distributions in a metabolic network, given an estimation of metabolic fluxes. This approach can be used by MFA to find optimal metabolic fluxes, whose induced metabolite labeling patterns match tandem mass-isotopomer distributions measured by MS/MS. The tandemer approach is applied to simulate MS/MS data in a small-scale metabolic network model of mammalian methionine metabolism and in a large-scale metabolic network model of E. coli. It is shown to significantly improve the running time by between two to three orders of magnitude compared to the state-of-the-art, cumomers approach. We expect the tandemer approach to promote broader usage of MS/MS technology in metabolic flux analysis. Implementation is freely available at www.cs.technion.ac.il/similar to tomersh/methods.html	[Tepper, Naama; Shlomi, Tomer] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Shlomi, T (corresponding author), Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel.	tomersh@cs.technion.ac.il						Antoniewicz MR, 2007, METAB ENG, V9, P68, DOI 10.1016/j.ymben.2006.09.001; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Boghigian BA, 2010, METAB ENG, V12, P81, DOI 10.1016/j.ymben.2009.10.004; Choi J, 2012, ANAL CHEM, V84, P4628, DOI 10.1021/ac300611n; Choi J, 2011, METAB ENG, V13, P225, DOI 10.1016/j.ymben.2010.11.006; Jeffrey FMH, 2002, ANAL BIOCHEM, V300, P192, DOI 10.1006/abio.2001.5457; Jin ES, 2004, ANAL BIOCHEM, V327, P149, DOI 10.1016/j.ab.2003.12.036; KAHN AB, 1962, COMMUN ACM, V5, P558, DOI 10.1145/368996.369025; Mollney M, 1999, BIOTECHNOL BIOENG, V66, P86, DOI 10.1002/(SICI)1097-0290(1999)66:2<86::AID-BIT2>3.0.CO;2-A; Rantanen A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-266; Ruhl M, 2012, BIOTECHNOL BIOENG, V109, P763, DOI 10.1002/bit.24344; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Schellenberger J, 2012, BMC SYSTEMS BIOL, V6; Shlomi T, 2014, ANAL CHEM; Sillers R, 2009, BIOTECHNOL BIOENG, V102, P38, DOI 10.1002/bit.22058; Srour O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-129; Tepper N, 2013, BIOINFORMATICS, V29, P3045, DOI 10.1093/bioinformatics/btt516; Weitzel M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-315; Wiechert W, 1999, BIOTECHNOL BIOENG, V66, P69; Wiechert W, 2002, GENET ENG P, V24, P215; Wiechert W, 1997, BIOTECHNOL BIOENG, V55, P118, DOI 10.1002/(SICI)1097-0290(19970705)55:1<118::AID-BIT13>3.0.CO;2-I; Wiechert W, 2001, METAB ENG, V3, P265, DOI 10.1006/mben.2001.0188; Wiechert W, 2001, METAB ENG, V3, P195, DOI 10.1006/mben.2001.0187; Young JD, 2008, BIOTECHNOL BIOENG, V99, P686, DOI 10.1002/bit.21632	24	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0130213	10.1371/journal.pone.0130213	http://dx.doi.org/10.1371/journal.pone.0130213			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230524	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400004
J	Almog, A; Besamusca, F; MacMahon, M; Garlaschelli, D				Almog, Assaf; Besamusca, Ferry; MacMahon, Mel; Garlaschelli, Diego			Mesoscopic Community Structure of Financial Markets Revealed by Price and Sign Fluctuations	PLOS ONE			English	Article							RANDOM-MATRIX THEORY; CROSS CORRELATIONS; COMPARING CLUSTERINGS; BRAIN NETWORKS; MODULARITY	The mesoscopic organization of complex systems, from financial markets to the brain, is an intermediate between the microscopic dynamics of individual units (stocks or neurons, in the mentioned cases), and the macroscopic dynamics of the system as a whole. The organization is determined by "communities" of units whose dynamics, represented by time series of activity, is more strongly correlated internally than with the rest of the system. Recent studies have shown that the binary projections of various financial and neural time series exhibit nontrivial dynamical features that resemble those of the original data. This implies that a significant piece of information is encoded into the binary projection (i.e. the sign) of such increments. Here, we explore whether the binary signatures of multiple time series can replicate the same complex community organization of the financial market, as the original weighted time series. We adopt a method that has been specifically designed to detect communities from cross-correlation matrices of time series data. Our analysis shows that the simpler binary representation leads to a community structure that is almost identical with that obtained using the full weighted representation. These results confirm that binary projections of financial time series contain significant structural information.	[Almog, Assaf; Besamusca, Ferry; MacMahon, Mel; Garlaschelli, Diego] Leiden Univ, Leiden Inst Phys, Inst Lorentz Theoret Phys, NL-2333 CA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Almog, A (corresponding author), Leiden Univ, Leiden Inst Phys, Inst Lorentz Theoret Phys, Niels Bohrweg 2, NL-2333 CA Leiden, Netherlands.	almog@lorentz.leidenuniv.nl	Garlaschelli, Diego/P-2795-2019; Garlaschelli, Diego/O-4862-2014	Garlaschelli, Diego/0000-0001-6035-1783	Dutch Econophysics Foundation (Stichting Econophysics, Leiden, the Netherlands); EU project MULTIPLEX [317532]; Netherlands Organization for Scientific Research (NWO/OCW)	Dutch Econophysics Foundation (Stichting Econophysics, Leiden, the Netherlands)(Netherlands Government); EU project MULTIPLEX; Netherlands Organization for Scientific Research (NWO/OCW)(Netherlands Organization for Scientific Research (NWO))	AA and DG acknowledge support from the Dutch Econophysics Foundation (Stichting Econophysics, Leiden, the Netherlands). This work was also supported by the EU project MULTIPLEX (contract 317532) and the Netherlands Organization for Scientific Research (NWO/OCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almog A, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/9/093015; Basu B, 2010, NEW ECON WINDOWS, P1, DOI 10.1007/978-88-470-1501-2; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boguna M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016106; Bouchaud J., 2003, THEORY FINANCIAL RIS; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fenn DJ, 2012, QUANT FINANC, V12, P1493, DOI 10.1080/14697688.2012.668288; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Heimo T, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/08/P08007; Isogai T, 2014, J COMPLEX NETW, V2, P557, DOI 10.1093/comnet/cnu023; La Spada G, 2008, EUR PHYS J B, V64, P607, DOI 10.1140/epjb/e2008-00244-4; Laloux L, 1999, PHYS REV LETT, V83, P1467, DOI 10.1103/PhysRevLett.83.1467; MacMahon M, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.021006; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; Mantegna RN, 1999, INTRO ECONOPHYSICS C; Mehta M. L., 1991, RANDOM MATRICES; Meila M, 2003, LECT NOTES ARTIF INT, V2777, P173, DOI 10.1007/978-3-540-45167-9_14; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman M.E.J., 2010, NETWORKS INTRO; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Petersen AM, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.066121; Piccardi C, 2011, INT J MOD PHYS C, V22, P35, DOI 10.1142/S012918311101604X; Plerou V, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066126; Plerou V, 1999, PHYS REV LETT, V83, P1471, DOI 10.1103/PhysRevLett.83.1471; Potters M, 2005, ACTA PHYS POL B, V36, P2767; Reichardt J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.218701; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Utsugi A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.026110	31	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133679	10.1371/journal.pone.0133679	http://dx.doi.org/10.1371/journal.pone.0133679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226226	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700034
J	Bejaoui, M; Pantazi, E; De Luca, V; Panisello, A; Folch-Puy, E; Hotter, G; Capasso, C; Supuran, CT; Rossello-Catafau, J				Bejaoui, Mohamed; Pantazi, Eirini; De Luca, Viviana; Panisello, Arnau; Folch-Puy, Emma; Hotter, Georgina; Capasso, Clemente; Supuran, Claudiu T.; Rossello-Catafau, Joan			Carbonic Anhydrase Protects Fatty Liver Grafts against Ischemic Reperfusion Damage	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; OF-WISCONSIN SOLUTION; RAT-LIVER; IGL-1 SOLUTION; THERAPEUTIC APPLICATIONS; STEATOTIC LIVERS; PRESERVATION; KINASE; TRANSPLANTATION; INHIBITORS	Carbonic anhydrases (CAs) are ubiquitous metalloenzymes that catalyze the reversible hydration of carbon dioxide to bicarbonate and a proton. CAs are involved in numerous physiological and pathological processes, including acid-base homeostasis, electrolyte balance, oxygen delivery to tissues and nitric oxide generation. Given that these processes are found to be dysregulated during ischemia reperfusion injury (IRI), and taking into account the high vulnerability of steatotic livers to preservation injury, we hypothesized a new role for CA as a pharmacological agent able to protect against ischemic damage. Two different aspects of the role of CA II in fatty liver grafts preservation were evaluated: 1) the effect of its addition to Institut Georges Lopez (IGL-1) storage solution after cold ischemia; 2) and after 24h of cold storage followed by two hours of normothermic ex-vivo perfusion. In all cases, liver injury, CA II protein concentration, CA II mRNA levels and CA II activity were determined. In case of the ex-vivo perfusion, we further assessed liver function (bile production, bromosulfophthalein clearance) and Western blot analysis of phosphorylated adenosine monophosphate activated protein kinase (AMPK), mitogen activated protein kinases family (MAPKs) and endoplasmic reticulum stress (ERS) parameters (GRP78, PERK, IRE, eIF2 alpha and ATF6). We found that CA II was downregulated after cold ischemia. The addition of bovine CA II to IGL-1 preservation solution efficiently protected steatotic liver against cold IRI. In the case of reperfusion, CA II protection was associated with better function, AMPK activation and the prevention of ERS and MAPKs activation. Interestingly, CA II supplementation was not associated with enhanced CO2 hydration. The results suggest that CA II modulation may be a promising target for fatty liver graft preservation.	[Bejaoui, Mohamed; Pantazi, Eirini; Panisello, Arnau; Folch-Puy, Emma; Hotter, Georgina; Rossello-Catafau, Joan] IDIBAPS, Spanish Natl Res Council IIBB CSIC, Inst Biomed Res Barcelona, Dept Expt Pathol, Barcelona, Spain; [De Luca, Viviana; Capasso, Clemente] CNR, Inst Biosci & Bioresources IBBR, Naples, Italy; [Supuran, Claudiu T.] Univ Florence, Neurofarba Dept, Florence, Italy; [Rossello-Catafau, Joan] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); University of Florence; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Rossello-Catafau, J (corresponding author), IDIBAPS, Spanish Natl Res Council IIBB CSIC, Inst Biomed Res Barcelona, Dept Expt Pathol, Barcelona, Spain.	jrcbam@iibb.csic.es	Mohamed, Bejaoui/AAJ-2952-2020; Puy, Emma Folch/AAX-5558-2020; Capasso, Clemente/P-3522-2016; Hotter, Georgina/R-1156-2018; De Luca, Viviana/Q-2911-2016; Folch Puy, Emma/Q-3157-2017	Mohamed, Bejaoui/0000-0003-1075-6170; Puy, Emma Folch/0000-0002-6277-9027; Capasso, Clemente/0000-0003-3314-2411; Folch Puy, Emma/0000-0002-6277-9027; DE LUCA, Viviana/0000-0003-3406-833X	Fondo de Investigaciones Sanitarias [PI12/00519]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	EP is a fellowship-holder of the "Agencia de Gestio d'Ajuts Universitaris i de Recerca" (2012FI_B00382), Generalitat de Catalunya, Barcelona, Catalonia, Spain. This work was supported by the "Fondo de Investigaciones Sanitarias" (PI12/00519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamand R, 2009, AM J PHYSIOL-HEART C, V297, pH2068, DOI 10.1152/ajpheart.00525.2009; Alchera E, 2008, HEPATOLOGY, V48, P230, DOI 10.1002/hep.22249; Anderson CD, 2011, LIVER TRANSPLANT, V17, P189, DOI 10.1002/lt.22220; Bejaoui M, 2015, WORLD J GASTROENTERO, V21, P396, DOI 10.3748/wjg.v21.i2.396; Ben Abdennebi H, 1998, TRANSPLANT INT, V11, P223, DOI 10.1007/s001470050132; Mosbah I, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.29; Ben Mosbah I, 2007, LIVER TRANSPLANT, V13, P410, DOI 10.1002/lt.21059; Ben Mosbah I, 2006, LIVER TRANSPLANT, V12, P1215, DOI 10.1002/lt.20788; Bouma HR, 2010, TRANSPLANTATION, V90, P353, DOI 10.1097/TP.0b013e3181e7a3aa; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chida J, 2012, ANAL CHIM ACTA, V727, P8, DOI 10.1016/j.aca.2012.03.022; Chirica LC, 1997, EUR J BIOCHEM, V244, P755, DOI 10.1111/j.1432-1033.1997.00755.x; Clanachan AS, 2003, TRANSPLANTATION, V75, P173, DOI 10.1097/01.TP.0000040429.40245.3A; Deschenes M, 2013, LIVER TRANSPLANT, V19, pS6, DOI 10.1002/lt.23746; Guan LY, 2014, WORLD J GASTRO SURG, V6, P122, DOI 10.4240/wjgs.v6.i7.122; Hao Mao-Lin, 2014, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V30, P48; King LA, 2009, J HEPATO-BILIARY-PAN, V16, P763, DOI 10.1007/s00534-009-0155-x; Kobayashi M, 2002, SURGERY, V131, P344, DOI 10.1067/msy.2002.121097; Mosbah IB, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.12; Noh MR, 2015, BBA-MOL BASIS DIS, V1852, P1895, DOI 10.1016/j.bbadis.2015.06.004; Papanikolaou V, 2002, LIVER TRANSPLANT, V8, P1028, DOI 10.1053/jlts.2002.36243; Saidi Reza F, 2013, Int J Organ Transplant Med, V4, P46; Scozzafava A, 2013, EXPERT OPIN THER PAT, V23, P725, DOI 10.1517/13543776.2013.790957; Supuran CT, 2008, CURR PHARM DESIGN, V14, P603, DOI 10.2174/138161208783877884; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Supuran CT, 2011, FUTURE MED CHEM, V3, P1165, DOI [10.4155/fmc.11.69, 10.4155/FMC.11.69]; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; Thiry A, 2006, TRENDS PHARMACOL SCI, V27, P566, DOI 10.1016/j.tips.2006.09.002; Verran D, 2003, LIVER TRANSPLANT, V9, P500, DOI 10.1053/jlts.2003.50099; Yeh CH, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/130636; Yoshinari D, 2001, TRANSPLANTATION, V72, P22, DOI 10.1097/00007890-200107150-00007; Zaouali MA, 2010, TRANSPL P, V42, P159, DOI 10.1016/j.transproceed.2009.12.035; Zaouali MA, 2013, J PINEAL RES, V55, P65, DOI 10.1111/jpi.12051; Zaouali MA, 2010, WORLD J GASTROENTERO, V16, P5693, DOI 10.3748/wjg.v16.i45.5693	34	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134499	10.1371/journal.pone.0134499	http://dx.doi.org/10.1371/journal.pone.0134499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225852	gold, Green Submitted, Green Published			2022-12-27	WOS:000358837700101
J	Czembor, E; Stepien, L; Waskiewicz, A				Czembor, Elzbieta; Stepien, Lukasz; Waskiewicz, Agnieszka			Effect of Environmental Factors on Fusarium Species and Associated Mycotoxins in Maize Grain Grown in Poland	PLOS ONE			English	Article							FUMONISIN B-1 PRODUCTION; EAR ROT RESISTANCE; F-PROLIFERATUM; NATURAL OCCURRENCE; WATER ACTIVITY; HEAD BLIGHT; WHEAT; VERTICILLIOIDES; CONTAMINATION; INFECTION	Maize is one of the most important crops and Poland is the fifth largest producing country in Europe. Diseases caused by Fusarium spp. can affect the yield and grain quality of maize because of contamination with numerous mycotoxins produced by these fungi. The present study was performed to identify the prevailing Fusarium species and the environmental factors affecting their frequencies and the contamination of grain with the main mycotoxins deoxynivalenol (DON), zearalenone (ZON) and fumonisin B1 (FB1). Thirty kernel samples were collected in three locations in 2011 and in seven locations in 2012 from three hybrids. On average, 25.24% kernels were colonized by Fusarium spp. (424 strains were isolated). Fusarium verticillioides and F. temperatum were the most prevalent species, F. subglutinans, F. proliferatum and F. graminearum were in minor abundance. In total, 272 isolates of F. verticillioides and 81 isolates of F. temperatum were identified. Fusarium temperatum frequency ranged from 1.70% to 28.57% and differences between locations were significant. Fumonisin B1 was found in all tested samples. DON was found in 66.67% and ZON in 43.33% of samples. Rainfall amount positively affected F. temperatum and F. subglutinans frequency in opposite to mean temperatures in July. On the other hand, relationships between frequency of these species and historical data from 1950-2000 for annual temperature range were negative in contrast to the coldest quarter temperatures.	[Czembor, Elzbieta] Plant Breeding & Acclimatizat Inst NRI, Grasses & Legumes Dept, Radzikow, Poland; [Stepien, Lukasz] Polish Acad Sci, Inst Plant Genet, Dept Pathogen Genet & Plant Resistance, Poznan, Poland; [Waskiewicz, Agnieszka] Poznan Univ Life Sci, Dept Chem, Poznan, Poland	Institute of Plant Breeding & Acclimatization; Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences; Poznan University of Life Sciences	Czembor, E (corresponding author), Plant Breeding & Acclimatizat Inst NRI, Grasses & Legumes Dept, Radzikow, Poland.	e.czembor@ihar.edu.pl	Stepien, Lukasz/G-2322-2012	Stepien, Lukasz/0000-0001-9740-9520; Czembor, Elzbieta/0000-0002-3021-3053; , Agnieszka/0000-0003-4113-1595	Polish Ministry of Agriculture and Rural Development [HORzg 8421/1]; Statutory fund of the Institute of Plant Genetics, Polish Academy of Sciences, Poznan, Poland	Polish Ministry of Agriculture and Rural Development; Statutory fund of the Institute of Plant Genetics, Polish Academy of Sciences, Poznan, Poland	This work was supported by the Polish Ministry of Agriculture and Rural Development (project HORzg 8421/1 "Plant improvement for sustainable agroecosystems, high-quality food and crop production for non-food purposes) and Statutory fund of the Institute of Plant Genetics, Polish Academy of Sciences, Poznan, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguin O, 2014, PLANT PATHOL, V63, P946, DOI 10.1111/ppa.12151; Arino A, 2007, J FOOD PROTECT, V70, P151, DOI 10.4315/0362-028X-70.1.151; Bakan B, 2002, J AGR FOOD CHEM, V50, P728, DOI 10.1021/jf0108258; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Berek L, 2001, TOXICOL IN VITRO, V15, P25, DOI 10.1016/S0887-2333(00)00055-2; Blandino M, 2009, WORLD MYCOTOXIN J, V2, P409, DOI 10.3920/WMJ2008.1098; Blandino M, 2008, C PLANT PATHOLOGY J; Blaszczyk L, 2004, CELL MOL BIOL LETT, V9, P869; Bottalico A., 1998, Journal of Plant Pathology, V80, P85; Boutigny AL, 2012, PLANT PATHOL, V61, P522, DOI 10.1111/j.1365-3059.2011.02544.x; Butron A, 2006, J AGR FOOD CHEM, V54, P6113, DOI 10.1021/jf0611163; Cao A, 2013, INT J FOOD MICROBIOL, V164, P15, DOI 10.1016/j.ijfoodmicro.2013.03.012; Chelkowski J, 1987, Mycotoxin Res, V3, P111, DOI 10.1007/BF03191997; Chelkowski J, 2012, WORLD MYCOTOXIN J, V5, P133, DOI 10.3920/WMJ2011.1304; Chelkowski J., 1989, Fusarium: mycotoxins, taxonomy and pathogenicity., P53; COOK RJ, 1976, PHYTOPATHOLOGY, V66, P193, DOI 10.1094/Phyto-66-193; Covarelli L, 2011, FOOD CHEM TOXICOL, V49, P2365, DOI 10.1016/j.fct.2011.06.047; Czembor E, 2014, PLANT DIS, V98, P1001, DOI 10.1094/PDIS-11-13-1184-PDN; Czembor E, 2013, B IHAR, V270, P55; Doohan FM, 2003, EUR J PLANT PATHOL, V109, P755, DOI 10.1023/A:1026090626994; Dorn B, 2011, J APPL MICROBIOL, V111, P693, DOI 10.1111/j.1365-2672.2011.05091.x; Dorn B, 2009, EUR J PLANT PATHOL, V125, P51, DOI 10.1007/s10658-009-9457-8; Duncan KE, 2010, MOL PLANT MICROBE IN, V23, P6, DOI 10.1094/MPMI-23-1-0006; Eckard S, 2011, TOXINS, V3, P949, DOI 10.3390/toxins3080949; Golinski P, 2010, FOOD ADDIT CONTAM A, V27, P1015, DOI 10.1080/19440041003702208; Gortz A, 2004, CEREAL RES COMMUN, V36, P617; Jurado M, 2006, Mycotoxin Res, V22, P87, DOI 10.1007/BF02956769; Krska R, 1996, J AGR FOOD CHEM, V44, P3665, DOI 10.1021/jf960064m; LEBARS J, 1994, J AOAC INT, V77, P517; Lemmens-Gruber R, 2000, MYCOPATHOLOGIA, V149, P5, DOI 10.1023/A:1007293812007; LESLIE JF, 1995, CAN J BOT, V73, pS282, DOI 10.1139/b95-258; Leslie JF, 2006, FUSARIUM LAB MANUAL; Lew H, 1991, Mycotoxin Res, V7 Suppl 1, P71, DOI 10.1007/BF03192189; Loffler M, 2010, THEOR APPL GENET, V120, P1053, DOI 10.1007/s00122-009-1233-9; Logrieco A, 2002, EUR J PLANT PATHOL, V108, P597, DOI 10.1023/A:1020679029993; Marin S, 1996, CAN J MICROBIOL, V42, P1045, DOI 10.1139/m96-134; Marin S, 1999, INT J FOOD MICROBIOL, V51, P159, DOI 10.1016/S0168-1605(99)00115-4; Meissle M, 2010, J APPL ENTOMOL, V134, P357, DOI 10.1111/j.1439-0418.2009.01491.x; Milevoj L, 1997, CEREAL RES COMMUN, V25, P603; Miller JD, 2001, ENVIRON HEALTH PERSP, V109, P321, DOI 10.2307/3435025; Mule G, 2004, EUR J PLANT PATHOL, V110, P495, DOI 10.1023/B:EJPP.0000032389.84048.71; Munkvold GP, 1997, PHYTOPATHOLOGY, V87, P1071, DOI [10.1094/PHYTO.1997.87.10.1071, 10.1094/PHYTO.1997.87.2.209]; Munkvold GP, 2003, EUR J PLANT PATHOL, V109, P705, DOI 10.1023/A:1026078324268; Munkvold GP, 2003, ANNU REV PHYTOPATHOL, V41, P99, DOI 10.1146/annurev.phyto.41.052002.095510; MUNOZ L, 1990, J AGR FOOD CHEM, V38, P1004, DOI 10.1021/jf00094a019; Nedelnik J., 2000, 6 EUR FUS SEM 11 16, P111; Oldenburg E, 2005, Mycotoxin Res, V21, P105, DOI 10.1007/BF02954430; Perkowski J, 1997, CEREAL RES COMMUN, V25, P379; Presello DA, 2011, EUPHYTICA, V178, P23, DOI 10.1007/s10681-010-0255-3; Presello DA, 2005, EUPHYTICA, V143, P1, DOI 10.1007/s10681-005-6149-0; Ramirez ML, 2006, EUR J PLANT PATHOL, V115, P139, DOI 10.1007/s10658-006-0009-1; Reid LM, 1999, PHYTOPATHOLOGY, V89, P1028, DOI 10.1094/PHYTO.1999.89.11.1028; Robertson LA, 2006, CROP SCI, V46, P353, DOI 10.2135/cropsci2005.0139; Rotter BA, 1996, J TOXICOL ENV HEALTH, V48, P1, DOI 10.1080/009841096161447; Samapundo S, 2005, J FOOD PROTECT, V68, P1054, DOI 10.4315/0362-028X-68.5.1054; Scauflaire J, 2012, FUNGAL BIOL-UK, V116, P1073, DOI 10.1016/j.funbio.2012.07.011; Scauflaire J, 2012, EUR J PLANT PATHOL, V133, P911, DOI 10.1007/s10658-012-9958-8; Scauflaire J, 2011, MYCOLOGIA, V103, P586, DOI 10.3852/10-135; Stepien L, 2004, CELL MOL BIOL LETT, V9, P819; Stepien L, 2010, WORLD MYCOTOXIN J, V3, P107, DOI 10.3920/WMJ2009.1193; Stepien L, 2012, J APPL GENET, V53, P227, DOI 10.1007/s13353-012-0085-1; Sutton J. C., 1982, Canadian Journal of Plant Pathology, V4, P195; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tomczak M, 2002, EUR J PLANT PATHOL, V108, P625, DOI 10.1023/A:1020639315880; Torres MR, 2003, INT J FOOD MICROBIOL, V81, P185, DOI 10.1016/S0168-1605(02)00226-X; Velluti A, 2000, INT J FOOD MICROBIOL, V59, P59, DOI 10.1016/S0168-1605(00)00289-0; Vigier B, 1997, CAN J PLANT PATHOL, V19, P60, DOI 10.1080/07060669709500574; Voss K A, 2006, Mycotoxin Res, V22, P61, DOI 10.1007/BF02954559; Waskiewicz A, 2013, FOOD ADDIT CONTAM A, V30, P1332, DOI 10.1080/19440049.2013.796095; Waskiewicz A, 2013, TOXINS, V5, P488, DOI 10.3390/toxins5030488; Waskiewicz A, 2012, ARH HIG RADA TOKSIKO, V63, P437, DOI 10.2478/10004-1254-63-2012-2230; Zhang X, 2014, ANN APPL BIOL, V164, P384, DOI 10.1111/aab.12107; Zijlstra C, 2011, PEST MANAG SCI, V67, P616, DOI 10.1002/ps.2134	73	57	60	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133644	10.1371/journal.pone.0133644	http://dx.doi.org/10.1371/journal.pone.0133644			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225823	Green Submitted, gold, Green Published			2022-12-27	WOS:000358837700031
J	Ko, BK; Choi, S; Cui, LG; Lee, YH; Hwang, IS; Kim, KT; Shim, H; Lee, JS				Ko, Bong-Kook; Choi, Soyoung; Cui, Lei Guang; Lee, Young-Ha; Hwang, In-Sik; Kim, Kyu-Tae; Shim, Hyunbo; Lee, Jong-Seo			Affinity Maturation of Monoclonal Antibody 1E11 by Targeted Randomization in CDR3 Regions Optimizes Therapeutic Antibody Targeting of HER2-Positive Gastric Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; BREAST-CANCER; TRASTUZUMAB; COMBINATION; PERTUZUMAB; HER2; HUMANIZATION; INHIBITION; RESIDUES; SURVIVAL	Anti-HER2 murine monoclonal antibody 1E11 has strong and synergistic anti-tumor activity in HER2-overexpressing gastric cancer cells when used in combination with trastuzumab. We presently optimized this antibody for human therapeutics. First, the complementarity determining regions (CDRs) of the murine antibody were grafted onto human germline immunoglobulin variable genes. No difference in affinity and biological activity was observed between chimeric 1E11 (ch1E11) and humanized 1E11 (hz1E11). Next, affinity maturation of hz1E11 was performed by the randomization of CDR-L3 and H3 residues followed by stringent biopanning selection. Milder selection pressure favored the selection of more diverse clones, whereas higher selection stringency resulted in the convergence of the panning output to a smaller number of clones with improved affinity. Clone 1A12 had four amino acid substitutions in CDR-L3, and showed a 10-fold increase in affinity compared to the parental clone and increased potency in an in vitro anti-proliferative activity assay with HER2-overepxressing gastric cancer cells. Clone 1A12 inhibited tumor growth of NCI-N87 xenograft model with similar efficacy to trastuzumab alone, and the combination treatment of 1A12 and trastuzumab completely removed the established tumors. These results suggest that humanized and affinity matured monoclonal antibody 1A12 is a highly optimized molecule for future therapeutic development against HER2-positive tumors.	[Ko, Bong-Kook; Choi, Soyoung; Cui, Lei Guang; Lee, Young-Ha; Hwang, In-Sik; Kim, Kyu-Tae; Lee, Jong-Seo] AbClon Inc, Therapeut Antibody Res Ctr, Seoul, South Korea; [Shim, Hyunbo] Ewha Womans Univ, Dept Bioinspired Sci, Seoul, South Korea; [Shim, Hyunbo] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Kim, KT (corresponding author), AbClon Inc, Therapeut Antibody Res Ctr, Seoul, South Korea.	ktkim@abclon.com; hshim@ewha.ac.kr		Ko, Bong-Kook/0000-0002-8688-3179	AbClon Inc.; National Research Foundation of Korea (NRF) [NRF-2013M3A6A4044991]	AbClon Inc.; National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This study was supported by AbClon Inc., and by National Research Foundation of Korea (NRF) grant to HS for Medicinal Bioconvergence Research Center (NRF-2013M3A6A4044991). The commercial funder (AbClon Inc.) provided support in the form of salaries for authors (BKK, SC, LGC, YHL, ISH, KTK, and JSL) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro JC, 2008, FRONT BIOSCI-LANDMRK, V13, P1619, DOI 10.2741/2786; Andris-Widhopf J, 2001, PHAGE DISPLAY LAB MA; Bang YJ, 2010, LANCET, V376, P1302; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Baselga J, 2010, J CLIN ONCOL, V28, P1138, DOI 10.1200/JCO.2009.24.2024; Ben-Kasus T, 2009, P NATL ACAD SCI USA, V106, P3294, DOI 10.1073/pnas.0812059106; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Garcia I, 2003, ANN SURG ONCOL, V10, P234, DOI 10.1245/ASO.2003.05.010; Hayashi M, 2008, CLIN CANCER RES, V14, P7843, DOI 10.1158/1078-0432.CCR-08-1064; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; Hwang WYK, 2005, METHODS, V36, P35, DOI 10.1016/j.ymeth.2005.01.004; Igawa T, 2011, MABS-AUSTIN, V3, P243, DOI 10.4161/mabs.3.3.15234; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kamat V, 2008, CANCER BIOL THER, V7, P726, DOI 10.4161/cbt.7.5.6097; Kawa S, 2011, MABS-AUSTIN, V3, P479, DOI 10.4161/mabs.3.5.17228; KELLEY RF, 1993, BIOCHEMISTRY-US, V32, P6828, DOI 10.1021/bi00078a005; Ko BK, 2015, MOL ONCOL, V9, P398, DOI 10.1016/j.molonc.2014.09.007; Makabe K, 2008, J BIOL CHEM, V283, P1156, DOI 10.1074/jbc.M706190200; Martin ACR, 1996, PROTEINS, V25, P130, DOI 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Pedersen MW, 2010, CANCER RES, V70, P588, DOI 10.1158/0008-5472.CAN-09-1417; Pelat T, 2008, J MOL BIOL, V384, P1400, DOI 10.1016/j.jmb.2008.10.033; Scheuer W, 2009, CANCER RES, V69, P9330, DOI 10.1158/0008-5472.CAN-08-4597; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Tan P, 2002, J IMMUNOL, V169, P1119, DOI 10.4049/jimmunol.169.2.1119; Tvorogov D, 2010, CANCER CELL, V18, P630, DOI 10.1016/j.ccr.2010.11.001; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wong SE, 2011, PROTEINS, V79, P821, DOI 10.1002/prot.22920; Wu XP, 2003, J CLIN IMMUNOL, V23, P235, DOI 10.1023/A:1024571714867; Yin J, 2003, J MOL BIOL, V330, P651, DOI 10.1016/S0022-2836(03)00631-4; Zhang AL, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-20	36	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134600	10.1371/journal.pone.0134600	http://dx.doi.org/10.1371/journal.pone.0134600			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225765	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700120
J	Valenzano, MC; DiGuilio, K; Mercado, J; Teter, M; To, J; Ferraro, B; Mixson, B; Manley, I; Baker, V; Moore, BA; Wertheimer, J; Mullin, JM				Valenzano, Mary Carmen; DiGuilio, Katherine; Mercado, Joanna; Teter, Mimi; To, Julie; Ferraro, Brendan; Mixson, Brittany; Manley, Isabel; Baker, Valerissa; Moore, Beverley A.; Wertheimer, Joshua; Mullin, James M.			Remodeling of Tight Junctions and Enhancement of Barrier Integrity of the CACO-2 Intestinal Epithelial Cell Layer by Micronutrients	PLOS ONE			English	Article							ZINC SUPPLEMENTATION; IN-VITRO; BUTYRATE; PERMEABILITY; EXPRESSION; QUERCETIN; ACTIVATION; OCCLUDIN; MONOLAYERS; CLAUDIN-4	The micronutrients zinc, quercetin, butyrate, indole and berberine were evaluated for their ability to induce remodeling of epithelial tight junctions (TJs) and enhance barrier integrity in the CACO-2 gastrointestinal epithelial cell culture model. All five of these chemically very diverse micronutrients increased transepithelial electrical resistance (R-t) significantly, but only berberine also improved barrier integrity to the non-electrolyte D-mannitol. Increases of Rt as much as 200% of untreated controls were observed. Each of the five micronutrients also induced unique, signature-like changes in TJ protein composition, suggesting multiple pathways (and TJ arrangements) by which TJ barrier function can be enhanced. Decreases in abundance by as much as 90% were observed for claudin-2, and increases of over 300% could be seen for claudins -5 and -7. The exact effects of the micronutrients on barrier integrity and TJ protein composition were found to be highly dependent on the degree of differentiation of the cell layer at the time it was exposed to the micronutrient. The substratum to which the epithelial layer adheres was also found to regulate the response of the cell layer to the micronutrient. The implications of these findings for therapeutically decreasing morbidity in Inflammatory Bowel Disease are discussed.	[Valenzano, Mary Carmen; DiGuilio, Katherine; Mercado, Joanna; Mixson, Brittany; Mullin, James M.] Lankenau Inst Med Res, Wynnewood, PA 19096 USA; [Mullin, James M.] Lankenau Med Ctr, Div Gastroenterol, Wynnewood, PA 19096 USA; [Teter, Mimi; To, Julie; Ferraro, Brendan; Manley, Isabel; Baker, Valerissa] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Moore, Beverley A.; Wertheimer, Joshua] Janssen Res & Dev LLC, Spring House, PA 19477 USA	Lankenau Medical Center; Lankenau Institute for Medical Research; Lankenau Medical Center; Drexel University; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Mullin, JM (corresponding author), Lankenau Inst Med Res, Wynnewood, PA 19096 USA.	mullinj@mlhs.org	Mullin, James M./AAD-9348-2020	Mullin, James/0000-0001-5285-7530	Sharpe Strumia Foundation; Commonwealth of Pennsylvania, Ben Franklin Technology Development Authority	Sharpe Strumia Foundation; Commonwealth of Pennsylvania, Ben Franklin Technology Development Authority	This project was financed by grants from the Sharpe Strumia Foundation and from the Commonwealth of Pennsylvania, Ben Franklin Technology Development Authority.	Amasheh M, 2008, J NUTR, V138, P1067, DOI 10.1093/jn/138.6.1067; Amasheh M, 2012, ANN NY ACAD SCI, V1258, P100, DOI 10.1111/j.1749-6632.2012.06609.x; Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Bzik VA, 2012, J PHARM PHARMACOL, V64, P644, DOI 10.1111/j.2042-7158.2011.01441.x; Cao M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061944; Carr G, 2010, J MEMBRANE BIOL, V237, P115, DOI 10.1007/s00232-010-9312-z; Carrasco-Pozo C, 2013, J AGR FOOD CHEM, V61, P5291, DOI 10.1021/jf400150p; Chuenkitiyanon S, 2010, INT J TOXICOL, V29, P418, DOI 10.1177/1091581810366487; Eamin EE, 2013, J NUTR, V143, P1872, DOI 10.3945/jn.113.179549; Edelblum KL, 2009, CURR OPIN PHARMACOL, V9, P715, DOI 10.1016/j.coph.2009.06.022; Finamore A, 2008, J NUTR, V138, P1664, DOI 10.1093/jn/138.9.1664; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; GRASSET E, 1984, AM J PHYSIOL, V247, pC260, DOI 10.1152/ajpcell.1984.247.3.C260; Gu LL, 2009, FITOTERAPIA, V80, P241, DOI 10.1016/j.fitote.2009.02.005; Guttman JA, 2009, BBA-BIOMEMBRANES, V1788, P832, DOI 10.1016/j.bbamem.2008.10.028; Hering NA, 2009, DIGEST DIS, V27, P450, DOI 10.1159/000233283; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Ma X, 2012, J ANIM SCI, V90, P266, DOI 10.2527/jas.50965; Macfarlane GT, 2011, J CLIN GASTROENTEROL, V45, pS120, DOI 10.1097/MCG.0b013e31822fecfe; Mariadason JM, 2000, J CELL PHYSIOL, V183, P347, DOI 10.1002/(SICI)1097-4652(200006)183:3<347::AID-JCP7>3.0.CO;2-W; McGilligan VE, 2007, FOOD CHEM TOXICOL, V45, P1593, DOI 10.1016/j.fct.2007.02.021; Mercado J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078775; Mullin JM, 2005, DRUG DISCOV TODAY, V10, P395, DOI 10.1016/S1359-6446(05)03379-9; Ning L, 2010, EUR J PHARM SCI, V40, P1, DOI 10.1016/j.ejps.2010.02.001; Ohata A, 2005, NUTRITION, V21, P838, DOI 10.1016/j.nut.2004.12.004; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; PETERSON MD, 1992, J CELL SCI, V102, P581; Ploger S, 2012, ANN NY ACAD SCI, V1258, P52, DOI 10.1111/j.1749-6632.2012.06553.x; Rodriguez P, 1996, GUT, V39, P416, DOI 10.1136/gut.39.3.416; Sawada N, 2013, PATHOL INT, V63, P1, DOI 10.1111/pin.12021; Sazawal S, 1997, AM J CLIN NUTR, V66, P413, DOI 10.1093/ajcn/66.2.413; SCHEPPACH W, 1992, GASTROENTEROLOGY, V103, P51, DOI 10.1016/0016-5085(92)91094-K; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Shimada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080604; Sturniolo GC, 2002, J LAB CLIN MED, V139, P311, DOI 10.1067/mlc.2002.123624; Suzuki T, 2009, J NUTR, V139, P965, DOI 10.3945/jn.108.100867; Tan S, 2002, INT J CANCER, V98, P523, DOI 10.1002/ijc.10236; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; Van Deun K, 2008, BRIT J NUTR, V100, P480, DOI 10.1017/S0007114508921693; Wang HB, 2012, DIGEST DIS SCI, V57, P3126, DOI 10.1007/s10620-012-2259-4; Wang XX, 2013, DIGEST DIS SCI, V58, P77, DOI 10.1007/s10620-012-2328-8; Yin L, 2001, J BIOL CHEM, V276, P44641, DOI 10.1074/jbc.M105170200; YOKOYAMA MT, 1979, AM J CLIN NUTR, V32, P173; Zhang BK, 2009, BRIT J NUTR, V102, P687, DOI 10.1017/S0007114509289033; Zhong W, 2010, AM J PHYSIOL-GASTR L, V298, P18	46	86	88	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133926	10.1371/journal.pone.0133926	http://dx.doi.org/10.1371/journal.pone.0133926			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226276	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700044
J	Wen, CJ; Mu, YF				Wen, Chengjian; Mu, Yifen			Power and Performance Management in Nonlinear Virtualized Computing Systems via Predictive Control	PLOS ONE			English	Article							RESOURCE-ALLOCATION	The problem of power and performance management captures growing research interest in both academic and industrial field. Virtulization, as an advanced technology to conserve energy, has become basic architecture for most data centers. Accordingly, more sophisticated and finer control are desired in virtualized computing systems, where multiple types of control actions exist as well as time delay effect, which make it complicated to formulate and solve the problem. Furthermore, because of improvement on chips and reduction of idle power, power consumption in modern machines shows significant nonlinearity, making linear power models(which is commonly adopted in previous work) no longer suitable. To deal with this, we build a discrete system state model, in which all control actions and time delay effect are included by state transition and performance and power can be defined on each state. Then, we design the predictive controller, via which the quadratic cost function integrating performance and power can be dynamically optimized. Experiment results show the effectiveness of the controller. By choosing a moderate weight, a good balance can be achieved between performance and power: 99.76% requirements can be dealt with and power consumption can be saved by 33% comparing to the case with open loop controller.	[Wen, Chengjian] Beihang Univ, Dept Comp Sci & Engn, Beijing 100191, Peoples R China; [Mu, Yifen] Chinese Acad Sci, Inst Syst Sci, Key Lab Syst & Control, Acad Math & Syst Sci, Beijing, Peoples R China	Beihang University; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS	Mu, YF (corresponding author), Chinese Acad Sci, Inst Syst Sci, Key Lab Syst & Control, Acad Math & Syst Sci, Beijing, Peoples R China.	mu@amss.ac.cn			National Natural Science Foundation of China [61304159, 61374168]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by National Natural Science Foundation of China under Grant 61304159 and 61374168. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers S, 2010, COMMUN ACM, V53, P86, DOI 10.1145/1735223.1735245; Ardagna D, 2007, J PARALLEL DISTR COM, V67, P259, DOI 10.1016/j.jpdc.2006.10.006; Cardosa M, 2009, 2009 IFIP/IEEE INTERNATIONAL SYMPOSIUM ON INTEGRATED NETWORK MANAGEMENT (IM 2009) VOLS 1 AND 2, P327, DOI 10.1109/INM.2009.5188832; Gandhi A, 2009, PERF E R SI, V37, P157; Govindan S, 2009, EUROSYS'09: PROCEEDINGS OF THE FOURTH EUROSYS CONFERENCE, P317; Jadbabaie A, 2003, IEEE T AUTOMAT CONTR, V48, P988, DOI 10.1109/TAC.2003.812781; Kalyvianaki E, 2009, ACM/IEEE SIXTH INTERNATIONAL CONFERENCE ON AUTONOMIC COMPUTING AND COMMUNICATIONS (ICAC '09), P117; Khargharia B, 2008, CLUSTER COMPUT, V11, P167, DOI 10.1007/s10586-007-0043-6; Kjaer Martin Ansbjerg, 2009, IEEE Transactions on Network and Service Management, V6, P226, DOI 10.1109/TNSM.2009.04.090403; Koomey J., 2011, GROWTH DATA CTR ELEC; Krishnan Bhavani, 2010, Performance Evaluation Review, V38, P56, DOI 10.1145/1925019.1925031; Kusic D., 2011, IEEE Transactions on Network and Service Management, V8, P245, DOI 10.1109/TNSM.2011.0726.100045; Kusic D, 2009, CLUSTER COMPUT, V12, P1, DOI 10.1007/s10586-008-0070-y; Lim H, 2011, P 2011 USENIX C USEN, P5; Ma K, 2011, ISCA 2011: PROCEEDINGS OF THE 38TH ANNUAL INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE, P449; Moore JD, 2005, P ANN C USENIX ANN T, P5; Qin SJ, 2003, CONTROL ENG PRACT, V11, P733, DOI 10.1016/S0967-0661(02)00186-7; Raghavendra R, 2008, ACM SIGPLAN NOTICES, V43, P48, DOI 10.1145/1353536.1346289; RICHALET J, 1993, AUTOMATICA, V29, P1251, DOI 10.1016/0005-1098(93)90049-Y; Standard Performance Evaluation Corporation, SPEC POWERSSJ2008 BE; Tesauro G, 2005, 3RD INTERNATIONAL CONFERENCE ON AUTONOMIC COMPUTING, PROCEEDINGS, P65; TSITSIKLIS JN, 1986, IEEE T AUTOMAT CONTR, V31, P803, DOI 10.1109/TAC.1986.1104412; Vengerov D, 2007, ENG APPL ARTIF INTEL, V20, P383, DOI 10.1016/j.engappai.2006.06.019; Wang L, 2012, NONLINEAR DYNAM, V67, P2009, DOI 10.1007/s11071-011-0125-0; Wang L, 2009, ASIAN J CONTROL, V11, P281, DOI 10.1002/asjc.104; Wang YF, 2008, REAL TIM SYST SYMP P, P303, DOI 10.1109/RTSS.2008.20; Wen CJ, 2013, CHIN CONTR CONF, P2591; Wen CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057551; Wen CJ, 2010, 2010 IEEE ACM INT C, P163; Xu CZ, 2008, COMPUTER, V41, P66, DOI 10.1109/MC.2008.93; Xu J., 2007, P 4 INT C AUT COMP I, P25, DOI [10.1109/ICAC.2007.28, DOI 10.1109/ICAC.2007.28]; Xu W, 2006, IEEE IFIP NETW OPER, P115, DOI 10.1109/NOMS.2006.1687544	32	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134017	10.1371/journal.pone.0134017	http://dx.doi.org/10.1371/journal.pone.0134017			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225769	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700050
J	Bungert, M; Koppe, G; Niedtfeld, I; Vollstaedt-Klein, S; Schmahl, C; Lis, S; Bohus, M				Bungert, Melanie; Koppe, Georgia; Niedtfeld, Inga; Vollstaedt-Klein, Sabine; Schmahl, Christian; Lis, Stefanie; Bohus, Martin			Pain Processing after Social Exclusion and Its Relation to Rejection Sensitivity in Borderline Personality Disorder	PLOS ONE			English	Article							SIGNAL-DETECTION ANALYSIS; SELF-INJURIOUS-BEHAVIOR; BRAIN RESPONSES; PHYSICAL PAIN; PERCEPTION; CORTEX; PROPRIOCEPTION; DISSOCIATION; METAANALYSIS; THRESHOLDS	Objective There is a general agreement that physical pain serves as an alarm signal for the prevention of and reaction to physical harm. It has recently been hypothesized that "social pain," as induced by social rejection or abandonment, may rely on comparable, phylogenetically old brain structures. As plausible as this theory may sound, scientific evidence for this idea is sparse. This study therefore attempts to link both types of pain directly. We studied patients with borderline personality disorder (BPD) because BPD is characterized by opposing alterations in physical and social pain; hyposensitivity to physical pain is associated with hypersensitivity to social pain, as indicated by an enhanced rejection sensitivity. Method Twenty unmedicated female BPD patients and 20 healthy participants (HC, matched for age and education) played a virtual ball-tossing game (cyberball), with the conditions for exclusion, inclusion, and a control condition with predefined game rules. Each cyberball block was followed by a temperature stimulus (with a subjective pain intensity of 60% in half the cases). The cerebral responses were measured by functional magnetic resonance imaging. The Adult Rejection Sensitivity Questionnaire was used to assess rejection sensitivity. Results Higher temperature heat stimuli had to be applied to BPD patients relative to HCs to reach a comparable subjective experience of painfulness in both groups, which suggested a general hyposensitivity to pain in BPD patients. Social exclusion led to a subjectively reported hypersensitivity to physical pain in both groups that was accompanied by an enhanced activation in the anterior insula and the thalamus. In BPD, physical pain processing after exclusion was additionally linked to enhanced posterior insula activation. After inclusion, BPD patients showed reduced amygdala activation during pain in comparison with HC. In BPD patients, higher rejection sensitivity was associated with lower activation differences during pain processing following social exclusion and inclusion in the insula and in the amygdala. Discussion Despite the similar behavioral effects in both groups, BPD patients differed from HC in their neural processing of physical pain depending on the preceding social situation. Rejection sensitivity further modulated the impact of social exclusion on neural pain processing in BPD, but not in healthy controls.	[Bungert, Melanie; Koppe, Georgia; Niedtfeld, Inga; Schmahl, Christian; Lis, Stefanie; Bohus, Martin] Heidelberg Univ, Dept Psychosomat Med & Psychotherapy, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany; [Vollstaedt-Klein, Sabine] Heidelberg Univ, Dept Addict Behav & Addict Med, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Bungert, M (corresponding author), Heidelberg Univ, Dept Psychosomat Med & Psychotherapy, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany.	melanie.bungert@zi-mannheim.de	Koppe, Georgia/ABD-4179-2020; Schmahl, Christian/E-8760-2012; Niedtfeld, Inga/GLV-3573-2022; Vollstädt-Klein, Sabine/C-6744-2012	Koppe, Georgia/0000-0003-2941-9238; Vollstädt-Klein, Sabine/0000-0002-6210-672X; Schmahl, Christian/0000-0003-0141-0821; Niedtfeld, Inga/0000-0002-6118-1664	Deutsche Forschungsgemeinschaft [KFO-256 BO 1487/11-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by a grant from the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/) to Martin Bohus: KFO-256 BO 1487/11-1.	Bar KJ, 2007, BIOL PSYCHIAT, V62, P1281, DOI 10.1016/j.biopsych.2007.02.011; Battle CL, 2004, J PERS DISORD, V18, P193, DOI 10.1521/pedi.18.2.193.32777; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berenson KR, 2009, J RES PERS, V43, P1064, DOI 10.1016/j.jrp.2009.07.007; Bernstein MJ, 2012, PERS SOC PSYCHOL B, V38, P185, DOI 10.1177/0146167211422449; Boettger MK, 2013, PSYCHOSOM MED, V75, P281, DOI 10.1097/PSY.0b013e3182881a9c; Bohus M, 2000, PSYCHIAT RES, V95, P251, DOI 10.1016/S0165-1781(00)00179-7; Bohus M, 2009, INTERAKTIVES FERTIGK; Bohus M, 2007, PSYCHOPATHOLOGY, V40, P126, DOI 10.1159/000098493; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; Cacioppo S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02027; Cardenas-Morales L, 2011, PSYCHIAT RES, V186, P458, DOI 10.1016/j.psychres.2010.07.050; Carpenter RW, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0335-2; Derogatis LR, 1993, BSI BRIEF SYMPTOM IN; DeWall CN, 2006, J PERS SOC PSYCHOL, V91, P1, DOI 10.1037/0022-3514.91.1.1; Dickens C, 2003, PSYCHOSOM MED, V65, P369, DOI 10.1097/01.PSY.0000041622.69462.06; Domsalla M, 2014, SOC COGN AFFECT NEUR, V9, P1789, DOI 10.1093/scan/nst176; Downey G, 1996, J PERS SOC PSYCHOL, V70, P1327, DOI 10.1037/0022-3514.70.6.1327; Ducasse D, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0443-2; Eisenberger NI, 2006, PAIN, V126, P132, DOI 10.1016/j.pain.2006.06.024; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; First M. B., 1997, USERS GUIDE FOR THE; Hayes A. F., 2013, INTRODUCTION TO MEDI; HERPERTZ S, 1995, ACTA PSYCHIAT SCAND, V91, P57, DOI 10.1111/j.1600-0447.1995.tb09743.x; Kemperman I, 1997, PSYCHIAT RES, V70, P175, DOI 10.1016/S0165-1781(97)00034-6; Kleindienst N, 2008, J NERV MENT DIS, V196, P230, DOI 10.1097/NMD.0b013e3181663026; Klossika I, 2006, PAIN, V124, P264, DOI 10.1016/j.pain.2006.08.007; Kraus A, 2009, BIOL PSYCHIAT, V65, P819, DOI 10.1016/j.biopsych.2008.10.028; Kross E, 2011, P NATL ACAD SCI USA, V108, P6270, DOI 10.1073/pnas.1102693108; Lawrence KA, 2011, J PERS DISORD, V25, P702, DOI 10.1521/pedi.2011.25.5.702; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lin CS, 2013, BRAIN RES, V1493, P40, DOI 10.1016/j.brainres.2012.11.035; Loranger A. W., 1999, INTERNATIONAL PERSON; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Ludascher P, 2007, PSYCHIAT RES, V149, P291, DOI 10.1016/j.psychres.2005.04.009; MacDonald G, 2005, PSYCHOL BULL, V131, P202, DOI 10.1037/0033-2909.131.2.202; MacDonald Geoff., 2005, SOCIAL OUTCAST OSTRA, P77; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Niedtfeld I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033293; Niedtfeld I, 2010, BIOL PSYCHIAT, V68, P383, DOI 10.1016/j.biopsych.2010.04.015; Pavony MT, 2014, PERSONAL DISORD, V5, P164, DOI 10.1037/per0000017; Pavony MT, 2013, J PERS DISORD, V27, P208, DOI 10.1521/pedi.2013.27.2.208; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Peyron R, 1999, BRAIN, V122, P1765, DOI 10.1093/brain/122.9.1765; Ploner M, 2004, NERVENARZT, V75, P962, DOI 10.1007/s00115-004-1739-y; Pomares FB, 2013, NEUROIMAGE, V64, P466, DOI 10.1016/j.neuroimage.2012.09.038; Porro CA, 2003, NEUROSCIENTIST, V9, P354, DOI 10.1177/1073858403253660; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Renneberg B, 2012, CLIN PSYCHOL PSYCHOT, V19, P473, DOI 10.1002/cpp.772; Ruocco AC, 2010, PSYCHIAT RES-NEUROIM, V181, P233, DOI 10.1016/j.pscychresns.2009.12.001; RUSS MJ, 1992, BIOL PSYCHIAT, V32, P501, DOI 10.1016/0006-3223(92)90218-O; Schmahl C, 2006, ARCH GEN PSYCHIAT, V63, P659, DOI 10.1001/archpsyc.63.6.659; Schmahl C, 2004, PAIN, V110, P470, DOI 10.1016/j.pain.2004.04.035; Schmahl C, 2010, WORLD J BIOL PSYCHIA, V11, P364, DOI 10.3109/15622970701849952; Schneider P, 2014, EUR NEUROPSYCHOPHARM, V24, P290, DOI 10.1016/j.euroneuro.2013.04.004; Simons LE, 2014, HUM BRAIN MAPP, V35, P527, DOI 10.1002/hbm.22199; Staebler K, 2011, PSYCHOL MED, V41, P1929, DOI 10.1017/S0033291711000080; Staebler K, 2011, CLIN PSYCHOL PSYCHOT, V18, P275, DOI 10.1002/cpp.705; Stiglmayr C, 2009, PSYCHOPATHOLOGY, V42, P370, DOI 10.1159/000236908; Way BM, 2009, P NATL ACAD SCI USA, V106, P15079, DOI 10.1073/pnas.0812612106; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams KD, 2007, ANNU REV PSYCHOL, V58, P425, DOI 10.1146/annurev.psych.58.110405.085641; Williams KD, 2006, BEHAV RES METHODS, V38, P174, DOI 10.3758/BF03192765; Zanarini MC, 1997, AM J PSYCHIAT, V154, P1101	65	35	36	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133693	10.1371/journal.pone.0133693	http://dx.doi.org/10.1371/journal.pone.0133693			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1VB	26241850	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942700019
J	Chen, XG; Yu, B; Zhou, DJ; Zhou, W; Gong, J; Li, SY; Stanton, B				Chen, Xinguang; Yu, Bin; Zhou, Dunjin; Zhou, Wang; Gong, Jie; Li, Shiyue; Stanton, Bonita			A Comparison of the Number of Men Who Have Sex with Men among Rural-To-Urban Migrants with Non-Migrant Rural and Urban Residents in Wuhan, China: A GIS/GPS-Assisted Random Sample Survey Study	PLOS ONE			English	Article							RISK BEHAVIORS; HIV PREVALENCE; MONEY BOYS; INFECTION; HEALTH; MSM; PREVENTION; SHANGHAI; SCALE	Background Mobile populations and men who have sex with men (MSM) play an increasing role in the current HIV epidemic in China and across the globe. While considerable research has addressed both of these at-risk populations, more effective HIV control requires accurate data on the number of MSM at the population level, particularly MSM among migrant populations. Methods Survey data from a random sample of male rural-to-urban migrants (aged 18-45, n=572) in Wuhan, China were analyzed and compared with those of randomly selected non-migrant urban (n=566) and rural counterparts (580). The GIS/GPS technologies were used for sampling and the survey estimation method was used for data analysis. Results HIV-related risk behaviors among rural-to-urban migrants were similar to those among the two comparison groups. The estimated proportion of MSM among migrants [95% CI] was 5.8% [4.7, 6.8], higher than 2.8% [1.2, 4.5] for rural residents and 1.0% [0.0, 2.4] for urban residents, respectively. Among these migrants, the MSM were more likely than non-MSM to be older in age, married, and migrated to more cities. They were also more likely to co-habit with others in rental properties located in new town and neighborhoods with fewer old acquaintances and more entertainment establishments. In addition, they were more likely to engage in commercial sex and less likely to consistently use condoms. Conclusion Findings of this study indicate that compared to rural and urban populations, the migrant population in Wuhan consists of a higher proportion of MSM who also exhibit higher levels of HIV-related risk behaviors. More effective interventions should target this population with a focus on neighborhood factors, social capital and collective efficacy for risk reduction.	[Chen, Xinguang; Yu, Bin] Univ Florida, Dept Epidemiol, Gainesville, FL 32610 USA; [Chen, Xinguang; Zhou, Dunjin; Zhou, Wang; Gong, Jie] Wuhan Ctr Dis Prevent & Control, Wuhan, Peoples R China; [Chen, Xinguang; Li, Shiyue] Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Peoples R China; [Chen, Xinguang; Stanton, Bonita] Wayne State Univ, Pediat Prevent Res Ctr, Detroit, MI USA	State University System of Florida; University of Florida; Wuhan University; Wayne State University	Chen, XG (corresponding author), Univ Florida, Dept Epidemiol, Gainesville, FL 32610 USA.	jimax.chen@ufl.edu			National Institute of Mental Health at National Institute of Health [R01 MH08632]	National Institute of Mental Health at National Institute of Health	This work was supported by National Institute of Mental Health (http://www.nimh.nih.gov/index.shtml) at National Institute of Health through a research grant [R01 MH08632, PI: XC]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099591; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Baggaley RF, 2010, INT J EPIDEMIOL; Bauermeister JA, 2014, CURR HIV RES, V11, P520, DOI 10.2174/1570162X12666140129100411; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Centers for Disease Control and Prevention, 2012, DIAGN HIV INF AIDS U; Centers for Disease Control and Prevention, YOUT RISK BEH SURV S; Chen X, 2009, HEALTH EDUC RES, V24, P306, DOI 10.1093/her/cyn020; Chen XG, 2015, SOC INDIC RES, V120, P669, DOI 10.1007/s11205-014-0611-0; Chen XG, 2011, HUM ORGAN, V70, P22, DOI 10.17730/humo.70.1.k76047734m703500; Chen XG, 2009, AM J HEALTH BEHAV, V33, P15; Chow EPF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/607261; Cochran WG, 1977, SAMPLING TECHNIQUES, Vxvi; DOLL LS, 1992, J SEX RES, V29, P1, DOI 10.1080/00224499209551630; Fan S, 2012, AIDS PATIENT CARE ST, V26, P148, DOI 10.1089/apc.2011.0277; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; He N, 2007, AIDS CARE, V19, P109, DOI 10.1080/09540120600888394; He N, 2005, SEX TRANSM DIS, V32, P286, DOI 10.1097/01.olq.0000152219.58592.9b; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hesketh T, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-29; Huang YP, 2014, MATER RES INNOV, V18, P2, DOI 10.1179/1432891714Z.000000000664; Hubei Emergency Management, 2014, CONTR PREV HIV AIDS; Kjaerulff TM, 2014, ALCOHOL ALCOHOLISM; Lambdin B, 2012, 19 INT AIDS C US; Landry PF, 2005, POLIT ANAL, V13, P1, DOI 10.1093/pan/mpi001; Lau JTF, 2008, SEX TRANSM DIS, V35, P406, DOI 10.1097/OLQ.0b013e318164467f; Levy P, 1999, SAMPLING POPULATIONS; Li XM, 2004, AIDS EDUC PREV, V16, P538, DOI 10.1521/aeap.16.6.538.53787; Lin DH, 2005, DRUG ALCOHOL DEPEN, V79, P103, DOI 10.1016/j.drugalcdep.2005.01.003; Liu C, 2011, J PUBLIC HLTH PREVEN, V22, P15; Liu HJ, 2005, AIDS PATIENT CARE ST, V19, P49, DOI 10.1089/apc.2005.19.49; Liu PL, 2010, CHINESE J DIS CONTRO, V14, P917; Luan RS, 2005, EUR J EPIDEMIOL, V20, P581, DOI 10.1007/s10654-005-4305-4; Mansergh G, 2006, FIELD METHOD, V18, P135, DOI 10.1177/1525822X05282267; Mao HY, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005351; National Bureau of Statistics of China, 2010, TAB 2010 POP CENS PE; National Bureau of Statistics of the People's Republic of China, 2013, 2012 NAT RUR TO URB; National Bureau of Statistics of the People's Republic of China, 2014, 2013 NAT RUR TO URB; National Health and Family Planning Commission of China, 2014, 2014 CHIN AIDS RESP; Nehl EJ, 2012, AIDS CARE, V24, P324, DOI 10.1080/09540121.2011.608792; Pronyk PM, 2008, SOC SCI MED, V67, P1559, DOI 10.1016/j.socscimed.2008.07.022; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Reich-Schupke S, 2008, J DTSCH DERMATOL GES, V6, P569, DOI [10.1111/j.1610-0387.2007.06604.x, 10.1111/j.1610-0387.2008.06737_supp.x, 10.1111/j.1610-0387.2008.06737.x]; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Siller AB, 2006, P 31 ANN SAS US GROU; Song Y, 2011, AIDS CARE, V23, P179, DOI 10.1080/09540121.2010.487088; State Council AIDS Working Committee Office (SCAWCO), 2012, 2012 CHIN AIDS RESP; Statistical Bureau of Wuhan, 2012, WUH STAT YB 2012; Tao T, 2011, J PUBLIC HLTH PREVEN, V22, P5; Tilling K, 2001, INT J EPIDEMIOL, V30, P12, DOI 10.1093/ije/30.1.12; Wei CY, 2009, AM J PUBLIC HEALTH, V99, P1978, DOI 10.2105/AJPH.2008.150037; Weitzman ER, 2003, HEALTH PLACE, V9, P1, DOI 10.1016/S1353-8292(02)00014-X; Wong DFK, 2007, INT J SOC WELF, V16, P32, DOI 10.1111/j.1468-2397.2007.00475.x; Xu JJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/725361; Yang HM, 2005, SEX TRANSM DIS, V32, P270, DOI 10.1097/01.olq.0000162360.11910.5a; Yang T, 2009, PUBLIC HEALTH, V123, P743, DOI 10.1016/j.puhe.2009.09.021; Zeng G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/602719; Zeng YL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/498987; Zhang B, 2002, CHIN J AIDS STD, V8, P197; Zhang DP, 2007, J INFECTION, V55, P456, DOI 10.1016/j.jinf.2007.06.015; Zhang L, 2013, SEX TRANSM DIS, V40, P136, DOI 10.1097/OLQ.0b013e318281134f; Zhang L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058440, 10.1371/journal.pone.0066496]; Zhang W, 2014, CHINESE J SOCIAL MED, V31, P112; Zhao J, 2012, SEX TRANSM DIS, V39, P942, DOI 10.1097/OLQ.0b013e31826f356f; Zheng LJ, 2012, SEX TRANSM DIS, V39, P886, DOI 10.1097/OLQ.0b013e31826ae85e; Zhuang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031986; Zulu K, 2006, AIDS, P13	70	19	19	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134712	10.1371/journal.pone.0134712	http://dx.doi.org/10.1371/journal.pone.0134712			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1VB	26241900	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942700060
J	Dold, L; Ahlenstiel, G; Althausen, E; Luda, C; Schwarze-Zander, C; Boesecke, C; Wasmuth, JC; Rockstroh, JK; Spengler, U				Dold, Leona; Ahlenstiel, Golo; Althausen, Eva; Luda, Carolin; Schwarze-Zander, Carolynne; Boesecke, Christoph; Wasmuth, Jan-Christian; Rockstroh, Juergen Kurt; Spengler, Ulrich			Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART)	PLOS ONE			English	Article							ANTIGEN CLASS-I; HEPATITIS-C; REPLICATION CAPACITY; DISEASE PROGRESSION; VIRAL REPLICATION; HIV-INFECTION; INITIATION; ALLELES; GENOTYPE; OUTCOMES	Background and aims HLA class I alleles, in particular HLA-B*57, constitute the most consistent host factor determining outcomes in untreated HCV- and HIV-infection. In this prospective cohort study, we analysed the impact of HLA class I alleles on all-cause mortality in patients with HIV-, HCV-and HIV/HCV-co-infection receiving HAART. Methods In 2003 HLA-A and B alleles were determined and patients were prospectively followed in 3-month intervals until 2013 or death. HLA-A and B alleles were determined by strand-specific oligonucleotide hybridisation and PCR in 468 Caucasian patients with HCV-(n=120), HIV- (n=186) and HIV/HCV-infection (n=162). All patients with HIV-infection were on HAART. In each patient group, HLA class I-associated survival was analysed by Kaplan-Meier method and Cox regression analysis. Results At recruitment the proportion of patients carrying a HLA-B*57 allele differed between HIV-(12.9%) and HCV-infection (4.2%). Kaplan Meier analysis revealed significantly increased mortality in HLA-B*57-positive patients with HIV-infection (p=0.032) and HIV/HCV-co-infection (p=0.004), which was apparently linked to non-viral infections. Cox logistic regression analysis confirmed HLA-B*57 (p=0.001), serum gamma-glutamyltranspeptidase (p=0.003), serum bilirubin (p=0.022) and CD4 counts (p=0.041) as independent predictors of death in HIV-infected patients. Conclusion Differences in the prevalence of HLA-B*57 at study entry between HIV- and HCV-infected patients may reflect immune selection in the absence of antiviral therapy. When patients were treated with HAART, however, HLA-B*57 was associated with increased mortality and risk to die from bacterial infections and sepsis, suggesting an ambiguous role of HLAB*57 for survival in HIV/HCV infection depending on the circumstances.	[Dold, Leona; Althausen, Eva; Luda, Carolin; Schwarze-Zander, Carolynne; Boesecke, Christoph; Wasmuth, Jan-Christian; Rockstroh, Juergen Kurt; Spengler, Ulrich] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Ahlenstiel, Golo] Univ Sydney, Westmead Clin Sch, Sydney, NSW 2006, Australia; [Dold, Leona; Althausen, Eva; Luda, Carolin; Schwarze-Zander, Carolynne; Boesecke, Christoph; Wasmuth, Jan-Christian; Rockstroh, Juergen Kurt; Spengler, Ulrich] German Ctr Infect Res DZIF, Cologne, Germany	University of Bonn; University of Sydney; German Center for Infection Research; University of Cologne	Dold, L (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.	Leona.Dold@ukb.uni-bonn.de	Ahlenstiel, Golo/U-1990-2017	Ahlenstiel, Golo/0000-0003-0026-1457	German Ministry for Research and Education (Bundesministerium fur Forschung und Bildung: Kompetenznetz HIV/AIDS); German center for infection research (DZIF)	German Ministry for Research and Education (Bundesministerium fur Forschung und Bildung: Kompetenznetz HIV/AIDS); German center for infection research (DZIF)	This work was supported by research grants to J.R. and U.S. from the German Ministry for Research and Education (Bundesministerium fur Forschung und Bildung: Kompetenznetz HIV/AIDS), and the German center for infection research (DZIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2007, CLIN VACCINE IMMUNOL, V14, P1266, DOI 10.1128/CVI.00169-07; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Bailey JR, 2009, J VIROL, V83, P88, DOI 10.1128/JVI.01958-08; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boesecke C, 2012, SEMIN LIVER DIS, V32, P130, DOI 10.1055/s-0032-1316468; Boutwell CL, 2009, J VIROL, V83, P2460, DOI 10.1128/JVI.01970-08; Brockman MA, 2010, J VIROL, V84, P11937, DOI 10.1128/JVI.01086-10; Brumme ZL, 2007, J INFECT DIS, V195, P1694, DOI 10.1086/516789; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Feuth T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059302; Frater AJ, 2007, J VIROL, V81, P6742, DOI 10.1128/JVI.00022-07; French AL, 2013, J INFECT DIS, V208, P679, DOI 10.1093/infdis/jit225; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Gonzalez VD, 2009, J VIROL, V83, P11407, DOI 10.1128/JVI.01211-09; Goulder PJR, 2012, IMMUNITY, V37, P426, DOI 10.1016/j.immuni.2012.09.005; Kim AY, 2011, GASTROENTEROLOGY, V140, P686, DOI 10.1053/j.gastro.2010.09.042; Kuniholm MH, 2011, J VIROL, V85, P10826, DOI 10.1128/JVI.00804-11; Kuniholm MH, 2010, HEPATOLOGY, V51, P1514, DOI 10.1002/hep.23515; Lederman MM, 2013, ADV IMMUNOL, V119, P51, DOI 10.1016/B978-0-12-407707-2.00002-3; Lo Re III V, 2014, ANN INTERN MED, V160, P369; Lopez-Larrea C, 2005, ARTHRITIS RHEUM-US, V52, P275, DOI 10.1002/art.20722; Lopez-Medrano F, 2011, TRANSPLANTATION, V92, P543, DOI 10.1097/TP.0b013e318225dbae; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; McKiernan SM, 2004, HEPATOLOGY, V40, P108, DOI 10.1002/hep.20261; Norris S, 2004, LIVER TRANSPLANT, V10, P1271, DOI 10.1002/lt.20233; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Qurishi N, 2003, LANCET, V362, P1708, DOI 10.1016/S0140-6736(03)14844-1; Rauch A, 2008, CLIN INFECT DIS, V46, P1921, DOI 10.1086/588479; Shata Mohamed Tarek M, 2013, J Clin Pathol, V66, P967, DOI 10.1136/jclinpath-2013-201581	31	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134158	10.1371/journal.pone.0134158	http://dx.doi.org/10.1371/journal.pone.0134158			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241854	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700035
J	Spronken, MI; Short, KR; Herfst, S; Bestebroer, TM; Vaes, VP; van der Hoeven, B; Koster, AJ; Kremers, GJ; Scott, DP; Gultyaev, AP; Sorell, EM; de Graaf, M; Barcena, M; Rimmelzwaan, GF; Fouchier, RA				Spronken, Monique I.; Short, Kirsty R.; Herfst, Sander; Bestebroer, Theo M.; Vaes, Vincent P.; van der Hoeven, Barbara; Koster, Abraham J.; Kremers, Gert-Jan; Scott, Dana P.; Gultyaev, Alexander P.; Sorell, Erin M.; de Graaf, Miranda; Barcena, Montserrat; Rimmelzwaan, Guus F.; Fouchier, Ron A.			Optimisations and Challenges Involved in the Creation of Various Bioluminescent and Fluorescent Influenza A Virus Strains for In Vitro and In Vivo Applications	PLOS ONE			English	Article							ELECTRON-MICROSCOPY; PACKAGING SIGNALS; INFECTION; GENERATION; REPLICATION; PROTEIN; EXPRESSION; VECTORS; HEMAGGLUTININ; PROTECTION	Bioluminescent and fluorescent influenza A viruses offer new opportunities to study influenza virus replication, tropism and pathogenesis. To date, several influenza A reporter viruses have been described. These strategies typically focused on a single reporter gene (either bioluminescent or fluorescent) in a single virus backbone. However, whilst bioluminescence is suited to in vivo imaging, fluorescent viruses are more appropriate for microscopy. Therefore, the ideal reporter virus varies depending on the experiment in question, and it is important that any reporter virus strategy can be adapted accordingly. Herein, a strategy was developed to create five different reporter viruses in a single virus backbone. Specifically, enhanced green fluorescent protein (eGFP), far-red fluorescent protein (fRFP), near-infrared fluorescent protein (iRFP), Gaussia luciferase (gLUC) and firefly luciferase (fLUC) were inserted into the PA gene segment of A/PR/8/34 (H1N1). This study provides a comprehensive characterisation of the effects of different reporter genes on influenza virus replication and reporter activity. In vivo reporter gene expression, in lung tissues, was only detected for eGFP, fRFP and gLUC expressing viruses. In vitro, the eGFP-expressing virus displayed the best reporter stability and could be used for correlative light electron microscopy (CLEM). This strategy was then used to create eGFP-expressing viruses consisting entirely of pandemic H1N1, highly pathogenic avian influenza (HPAI) H5N1 and H7N9. The HPAI H5N1 eGFP-expressing virus infected mice and reporter gene expression was	[Spronken, Monique I.; Short, Kirsty R.; Herfst, Sander; Bestebroer, Theo M.; Vaes, Vincent P.; Gultyaev, Alexander P.; Sorell, Erin M.; de Graaf, Miranda; Rimmelzwaan, Guus F.; Fouchier, Ron A.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Short, Kirsty R.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [van der Hoeven, Barbara; Koster, Abraham J.; Barcena, Montserrat] Leiden Univ, Med Ctr, Sect Electron Microscopy, Dept Mol Cell Biol, Leiden, Netherlands; [Kremers, Gert-Jan] Erasmus Univ, Dept Pathol, Med Ctr, Erasmus Opt Imaging Ctr, NL-3000 DR Rotterdam, Netherlands; [Scott, Dana P.] NIAID, Rocky Mt Vet Branch, Div Intramural Res, NIH, Hamilton, MT USA; [Gultyaev, Alexander P.] Leiden Univ, Leiden Inst Adv Comp Sci, Leiden, Netherlands; [Sorell, Erin M.] George Washington Univ, Dept Hlth Policy & Management, Milken Inst Sch Publ Hlth, Washington, DC USA	Erasmus University Rotterdam; Erasmus MC; University of Queensland; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Leiden University; Leiden University - Excl LUMC; George Washington University	Fouchier, RA (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	r.fouchier@erasmusmc.nl	Fouchier, Ron A/A-1911-2014; de Graaf, Miranda/AFM-6878-2022; Barcena, Montserrat/B-5823-2012; de Graaf, Miranda/K-1262-2018; Koster, Abraham/I-7665-2017	Fouchier, Ron A/0000-0001-8095-2869; de Graaf, Miranda/0000-0002-7831-0098; Barcena, Montserrat/0000-0002-7719-4443; de Graaf, Miranda/0000-0002-7831-0098; Koster, Abraham/0000-0003-1717-2549; Herfst, Sander/0000-0001-9866-8903; Short, Kirsty/0000-0003-4963-6184	NIAID/NIH [HHSN266200700010C, HSN272201400008C]; European Union [278976]; NHMRC CJ Martin post-doctoral fellowship [1054081]; NWO-MEERVOUD grant [836.10.003]	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Union(European Commission); NHMRC CJ Martin post-doctoral fellowship(National Health and Medical Research Council (NHMRC) of Australia); NWO-MEERVOUD grant	RF is supported by NIAID/NIH contract HHSN266200700010C, HSN272201400008C and Framework Seven program ANTIGONE (278976) of the European Union. KRS is supported by an NHMRC CJ Martin post-doctoral fellowship (1054081). MB is supported by an NWO-MEERVOUD grant (836.10.003).	Avilov SV, 2012, J VIROL, V86, P1433, DOI 10.1128/JVI.05820-11; Belicha-Villanueva A, 2012, J VIROL, V86, P5926, DOI 10.1128/JVI.06384-11; Beyleveld G, 2013, ANTIVIR RES, V100, P120, DOI 10.1016/j.antiviral.2013.07.018; Bodewes R, 2012, J GEN VIROL, V93, P1645, DOI 10.1099/vir.0.042671-0; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; de Wit E, 2005, J VIROL, V79, P12401, DOI 10.1128/JVI.79.19.12401-12407.2005; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; de Wit E, 2006, VACCINE, V24, P6647, DOI 10.1016/j.vaccine.2006.06.001; de Wit E, 2010, J VIROL, V84, P1597, DOI 10.1128/JVI.01783-09; Desdouits M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079628; Eckert N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097695; Faas FGA, 2012, J CELL BIOL, V198, P457, DOI 10.1083/jcb.201201140; Falzarano D, 2014, ANTIVIR RES, V103, P78, DOI 10.1016/j.antiviral.2014.01.003; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Fujii K, 2005, J VIROL, V79, P3766, DOI 10.1128/JVI.79.6.3766-3774.2005; Fukuyama S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7600; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Heaton NS, 2013, J VIROL, V87, P8272, DOI 10.1128/JVI.00969-13; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x; Karlsson EA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7378; Keawcharoen J, 2010, VACCINE, V28, P5803, DOI 10.1016/j.vaccine.2010.06.072; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; Lakdawala SS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003971; Li JW, 2013, BIOENGINEERED, V4, P9, DOI 10.4161/bioe.21950; Li Y, 2010, J VIROL, V84, P7204, DOI 10.1128/JVI.00203-10; Liang YY, 2005, J VIROL, V79, P10348, DOI 10.1128/JVI.79.16.10348-10355.2005; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Mariati, 2010, PROTEIN EXPRES PURIF, V69, P9, DOI 10.1016/j.pep.2009.08.010; Martinez-Sobrido L, 2010, J VIROL, V84, P2157, DOI 10.1128/JVI.01433-09; McDonald K, 2010, METHOD CELL BIOL, V96, P671, DOI 10.1016/S0091-679X(10)96028-7; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; NEUMANN G, 1995, J GEN VIROL, V76, P1709, DOI 10.1099/0022-1317-76-7-1709; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Nogales A, 2015, VIROLOGY, V476, P206, DOI 10.1016/j.virol.2014.12.006; Pan WQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3369; Pena L, 2013, J VIROL, V87, P5118, DOI 10.1128/JVI.02490-12; Pfeiffer BD, 2012, P NATL ACAD SCI USA, V109, P6626, DOI 10.1073/pnas.1204520109; Poussard A, 2012, JOVE-J VIS EXP, DOI 10.3791/4429; Rimmelzwaan GF, 2007, VIRUS RES, V129, P175, DOI 10.1016/j.virusres.2007.07.007; Rimmelzwaan GF, 2011, VACCINE, V29, P3424, DOI 10.1016/j.vaccine.2011.02.082; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shcherbakova DM, 2012, ANGEW CHEM INT EDIT, V51, P10724, DOI 10.1002/anie.201200408; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Sun CQ, 2014, J VIROL, V88, P2035, DOI 10.1128/JVI.02990-13; Sutton TC, 2014, VIRUS RES, V189, P14, DOI 10.1016/j.virusres.2014.05.003; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tran V, 2013, J VIROL, V87, P13321, DOI 10.1128/JVI.02381-13; van Riel D, 2010, AM J PATHOL, V177, P2185, DOI 10.2353/ajpath.2010.100401; Watanabe T, 2003, J VIROL, V77, P10575, DOI 10.1128/JVI.77.19.10575-10583.2003; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; Weigert R, 2013, J CELL BIOL, V201, P969, DOI 10.1083/jcb.201212130; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Ye SY, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.4	54	23	24	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133888	10.1371/journal.pone.0133888	http://dx.doi.org/10.1371/journal.pone.0133888			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241861	gold, Green Published, Green Submitted			2022-12-27	WOS:000358942700027
J	Wu, HL; Chang, WK; Hu, KH; Langford, RM; Tsou, MY; Chang, KY				Wu, Hsin-Lun; Chang, Wen-Kuei; Hu, Ken-Hua; Langford, Richard M.; Tsou, Mei-Yung; Chang, Kuang-Yi			A Quantile Regression Approach to Estimating the Distribution of Anesthetic Procedure Time during Induction	PLOS ONE			English	Article							OPERATING-ROOM; DAY STARTS; VARIABILITY; STRATEGIES; EFFICIENCY	Although procedure time analyses are important for operating room management, it is not easy to extract useful information from clinical procedure time data. A novel approach was proposed to analyze procedure time during anesthetic induction. A two-step regression analysis was performed to explore influential factors of anesthetic induction time (AIT). Linear regression with stepwise model selection was used to select significant correlates of AIT and then quantile regression was employed to illustrate the dynamic relationships between AIT and selected variables at distinct quantiles. A total of 1,060 patients were analyzed. The first and second-year residents (R1-R2) required longer AIT than the third and fourth-year residents and attending anesthesiologists (p = 0.006). Factors prolonging AIT included American Society of Anesthesiologist physical status. III, arterial, central venous and epidural catheterization, and use of bronchoscopy. Presence of surgeon before induction would decrease AIT (p < 0.001). Types of surgery also had significant influence on AIT. Quantile regression satisfactorily estimated extra time needed to complete induction for each influential factor at distinct quantiles. Our analysis on AIT demonstrated the benefit of quantile regression analysis to provide more comprehensive view of the relationships between procedure time and related factors. This novel two-step regression approach has potential applications to procedure time analysis in operating room management.	[Wu, Hsin-Lun; Chang, Wen-Kuei; Hu, Ken-Hua; Tsou, Mei-Yung; Chang, Kuang-Yi] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei 112, Taiwan; [Wu, Hsin-Lun; Chang, Wen-Kuei; Hu, Ken-Hua; Tsou, Mei-Yung; Chang, Kuang-Yi] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Wu, Hsin-Lun] Hsinchu Mackay Mem Hosp, Dept Anesthesiol, Hsinchu, Taiwan; [Langford, Richard M.] Univ London, Queen Mary Coll, Barts & London Sch Med & Dent, Pain & Anaesthesia Res Ctr,William Harvey Res Ins, London EC1A 7BE, England	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; University of London; Queen Mary University London	Chang, KY (corresponding author), Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei 112, Taiwan.	kychang@vghtpe.gov.tw			Taipei Veterans General Hospital, Taipei, Taiwan [V97A-109]; Anesthesiology Research and Development Foundation, Taipei, Taiwan [ARDF9905]	Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital); Anesthesiology Research and Development Foundation, Taipei, Taiwan	This study was supported by grants from Taipei Veterans General Hospital, Taipei, Taiwan (V97A-109) (www.vghtpe.gov.tw) and Anesthesiology Research and Development Foundation, Taipei, Taiwan (ARDF9905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum MG, 2004, ANN THORAC SURG, V78, P287, DOI 10.1016/j.athoracsur.2003.11.058; Davis EA, 2006, ANESTH ANALG, V103, P932, DOI 10.1213/01.ane.0000232444.52274.7a; Dexter EU, 2009, ANESTH ANALG, V108, P1257, DOI 10.1213/ane.0b013e31819a6dd4; Dexter F, 1999, ANESTHESIOLOGY, V91, P262, DOI 10.1097/00000542-199907000-00035; Dexter Franklin, 2006, Health Care Manag Sci, V9, P325, DOI 10.1007/s10729-006-9997-9; Dexter F, 2009, ANESTH ANALG, V108, P1262, DOI 10.1213/ane.0b013e31819775cd; DUAN N, 1983, J AM STAT ASSOC, V78, P605, DOI 10.2307/2288126; Eappen S, 2004, ANESTHESIOLOGY, V101, P1210, DOI 10.1097/00000542-200411000-00022; Hao L, 2007, QUANTILE REGRESSION; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; McIntosh C, 2006, ANESTH ANALG, V103, P1499, DOI 10.1213/01.ane.0000244535.54710.28; Nargozian Charles D, 2004, Curr Opin Anaesthesiol, V17, P511, DOI 10.1097/00001503-200412000-00011; Overdyk FJ, 1998, ANESTH ANALG, V86, P896, DOI 10.1097/00000539-199804000-00039; Peat J., 2005, MED STAT GUIDE DATA; Schuster M, 2008, BRIT J ANAESTH, V101, P640, DOI 10.1093/bja/aen239; Strum DP, 2000, ANESTHESIOLOGY, V92, P1454, DOI 10.1097/00000542-200005000-00036; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481	17	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134838	10.1371/journal.pone.0134838	http://dx.doi.org/10.1371/journal.pone.0134838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241647	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700073
J	Buiten, MS; de Bie, MK; Rotmans, JI; Dekker, FW; van Buren, M; Rabelink, TJ; Cobbaert, CM; Schalij, MJ; van der Laarse, A; Jukema, JW				Buiten, Maurits S.; de Bie, Mihyly K.; Rotmans, Joris I.; Dekker, Friedo W.; van Buren, Marjolijn; Rabelink, Ton J.; Cobbaert, Christa M.; Schalij, Martin J.; van der Laarse, Arnoud; Jukema, J. Wouter			Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease	PLOS ONE			English	Article							HIGH-SENSITIVITY ASSAY; CHRONIC KIDNEY-DISEASE; MYOCARDIAL-INFARCTION; HEMODIALYSIS-PATIENTS; DIALYSIS PATIENTS; ASYMPTOMATIC PATIENTS; PROGNOSTIC VALUE; ASSOCIATION; AUTOANTIBODIES; METAANALYSIS	Background Serum troponin assays, widely used to detect acute cardiac ischemia, might be useful biomarkers to detect chronic cardiovascular disease (CVD). Cardiac-specific troponin-I (cTnI) and troponin-T (cTnT) generally detect myocardial necrosis equally well. In dialysis patients however, serum cTnT levels are often elevated, unlike cTnI levels. The present study aims to elucidate the associations of cTnI and cTnT with CVD in clinically stable dialysis patients. Methods Troponin levels were measured using 5th generation hs-cTnT assays (Roche) and STAT hs-cTnI assays (Abbott) in a cohort of dialysis patients. Serum troponin levels were divided into tertiles with the lowest tertile as a reference value. Serum troponins were associated with indicators of CVD such as left ventricular mass index (LVMI), left ventricular ejection fraction (LVEF) and the presence of coronary artery disease (CAD). Associations were explored using regression analysis. Results We included 154 consecutive patients, 68+/-7 years old, 77% male, 70% hemodialysis. Median serum cTnT was 51ng/L (exceeding the 99th percentile of the healthy population in 98%) and median serum cTnI was 13ng/L (elevated in 20%). A high cTnI (T3) was significantly associated with a higher LVMI (Beta 31.60; p=0.001) and LVEF (Beta -4.78; p=0.005) after adjusting for confounders whereas a high serum cTnT was not. CAD was significantly associated with a high cTnT (OR 4.70 p=0.02) but not with a high cTnI. Unlike cTnI, cTnT was associated with residual renal function (Beta:-0.09; p=0.006). Conclusion In the present cohort, serum cTnI levels showed a stronger association with LVMI and LVEF than cTnT. However, cTnT was significantly associated with CAD and residual renal function, unlike cTnI. Therefore, cTnI seems to be superior to cTnT as a marker of left ventricular dysfunction in asymptomatic dialysis patients, while cTnT might be better suited to detect CAD in these patients.	[Buiten, Maurits S.; de Bie, Mihyly K.; Schalij, Martin J.; van der Laarse, Arnoud; Jukema, J. Wouter] Leiden Univ, Med Ctr LUMC, Dept Cardiol, Leiden, Netherlands; [Rotmans, Joris I.; Rabelink, Ton J.] LUMC, Dept Nephrol, Leiden, Netherlands; [Dekker, Friedo W.] LUMC, Dept Clin Epidemiol, Leiden, Netherlands; [van Buren, Marjolijn] HAGA, Dept Nephrol, The Hague, Netherlands; [Cobbaert, Christa M.; van der Laarse, Arnoud] LUMC, Dept Clin Chem & Lab Med, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	Jukema, JW (corresponding author), Leiden Univ, Med Ctr LUMC, Dept Cardiol, Leiden, Netherlands.	j.w.jukema@lumc.nl	Rabelink, Ton J./A-5316-2008; Rotmans, Joris I./G-8866-2014; Jukema, J. Wouter/ABD-6503-2021; Dekker, Friedo W/B-6452-2011	Rabelink, Ton J./0000-0001-6780-5186; Rotmans, Joris I./0000-0001-9682-6234; Jukema, J. Wouter/0000-0002-3246-8359; Dekker, Friedo W/0000-0002-2433-2494; van Buren, Marjolijn/0000-0002-1822-6863; Cobbaert, Christa/0000-0003-3565-1404	Boston Scientific (Natick, Massachusetts, USA); Medtronic (Minneapolis, Minnesota, USA); Biotronik (Berlin, Germany)	Boston Scientific (Natick, Massachusetts, USA); Medtronic (Minneapolis, Minnesota, USA)(Medtronic); Biotronik (Berlin, Germany)	The department of Cardiology in the LUMC received unrestricted grants from Boston Scientific (Natick, Massachusetts, USA) and Medtronic (Minneapolis, Minnesota, USA). The ICD-2 study is supported by an unrestricted educational research grant from Biotronik (Berlin, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam EA, 2014, CIRCULATION, V23, P2014, DOI DOI 10.1161/CIR.0000000000000133; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Artunc F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047610; Basit M, 2007, AM J CLIN PATHOL, V128, P164, DOI 10.1309/LR7FC0LUGLHT8X6J; Cardinaels EPM, 2013, CLIN CHEM, V59, P1083, DOI 10.1373/clinchem.2012.200543; Chin CWL, 2014, EUR HEART J, V35, P2312, DOI 10.1093/eurheartj/ehu189; Cobbaert CM, 2014, INT J CARDIOL, V172, pE3, DOI 10.1016/j.ijcard.2013.12.141; Collins Allan J, 2014, Am J Kidney Dis, V63, pA7, DOI 10.1053/j.ajkd.2013.11.001; Coudrey L, 1998, ARCH INTERN MED, V158, P1173, DOI 10.1001/archinte.158.11.1173; de Bie MK, 2008, CURR MED RES OPIN, V24, P2151, DOI 10.1185/03007990802237343; de Bie MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067936; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; deFilippi C, 2003, JAMA-J AM MED ASSOC, V290, P353, DOI 10.1001/jama.290.3.353; Diris JHC, 2004, CIRCULATION, V109, P23, DOI 10.1161/01.CIR.0000109483.45211.8F; Eriksson S, 2005, CLIN CHEM, V51, P839, DOI 10.1373/clinchem.2004.040063; Eriksson S, 2005, NEW ENGL J MED, V352, P98, DOI 10.1056/NEJM200501063520123; Fouque D, 2007, NEPHROL DIAL TRANSPL, V22, P45, DOI 10.1093/ndt/gfm020; Franekova J, 2015, CLIN CHIM ACTA, V446, P128, DOI 10.1016/j.cca.2015.03.046; Gaze DC, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2014-000108; Gillis JM, 2013, CLIN CHEM, V59, P442, DOI 10.1373/clinchem.2012.192211; Goser S, 2006, CIRCULATION, V114, P1693, DOI 10.1161/CIRCULATIONAHA.106.635664; Hayashi T, 2008, NEPHROL DIAL TRANSPL, V23, P2936, DOI 10.1093/ndt/gfn181; Jacobs LH, 2009, ANN CLIN BIOCHEM, V46, P283, DOI 10.1258/acb.2009.008197; Jung HH, 2004, NEPHROL DIAL TRANSPL, V19, P3117, DOI 10.1093/ndt/gfh488; Khan NA, 2005, CIRCULATION, V112, P3088, DOI 10.1161/CIRCULATIONAHA.105.560128; Krintus M, 2014, CLIN CHEM LAB MED, V52, P1657, DOI 10.1515/cclm-2014-0107; Kumar N, 2011, NEPHROL DIAL TRANSPL, V26, P665, DOI 10.1093/ndt/gfq442; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lowbeer C, 1999, NEPHROL DIAL TRANSPL, V14, P1948, DOI 10.1093/ndt/14.8.1948; Mallamaci F, 2002, AM J KIDNEY DIS, V40, P68, DOI 10.1053/ajkd.2002.33914; Mallamaci F, 2002, KIDNEY INT, V62, P1884, DOI 10.1046/j.1523-1755.2002.00641.x; Michos ED, 2014, ANN INTERN MED, V161, P491, DOI 10.7326/M14-0743; Mishra RK, 2013, AM J KIDNEY DIS, V61, P701, DOI 10.1053/j.ajkd.2012.11.034; Moore JK, 2013, CLIN TOXICOL, V51, P532, DOI 10.3109/15563650.2013.816853; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Ungerer JPJ, 2012, CLIN CHEM, V58, P274, DOI 10.1373/clinchem.2011.175059; Wang AYM, 2012, SEMIN DIALYSIS, V25, P388, DOI 10.1111/j.1525-139X.2012.01099.x; Wayand D, 2000, CLIN CHEM, V46, P1345; Wong SL, 2014, CAN J CARDIOL, V30, DOI 10.1016/j.cjca.2014.03.037; Wu AHB, 1998, CLIN CHEM, V44, P1198; Wu AHB, 1999, CLIN CHIM ACTA, V284, P161, DOI 10.1016/S0009-8981(99)00078-9; Ziebig R, 2003, CLIN CHEM, V49, P1191, DOI 10.1373/49.7.1191	42	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134245	10.1371/journal.pone.0134245	http://dx.doi.org/10.1371/journal.pone.0134245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237313	gold, Green Submitted, Green Published			2022-12-27	WOS:000358942400019
J	Kaeidi, A; Azizi, H; Javan, M; Soleimani, SMA; Fathollahi, Y; Semnanian, S				Kaeidi, Ayat; Azizi, Hossein; Javan, Mohammad; Soleimani, S. Mohammad Ahmadi; Fathollahi, Yaghoub; Semnanian, Saeed			Direct Facilitatory Role of Paragigantocellularis Neurons in Opiate Withdrawal-Induced Hyperactivity of Rat Locus Coeruleus Neurons: An In Vitro Study	PLOS ONE			English	Article							ELEMENT-BINDING-PROTEIN; NUCLEUS PARAGIGANTOCELLULARIS; CHRONIC MORPHINE; CERULEUS NEURONS; HORSERADISH-PEROXIDASE; POTASSIUM CHANNELS; INDUCED ACTIVATION; DEPENDENT RATS; BRAIN-SLICES; SINGLE-UNIT	Studies have shown that following opiate withdrawal, the spontaneous discharge rate of locus coeruleus (LC) neurons remarkably increases. Combination of intrinsic mechanisms with extrinsic excitatory modulations mediates the withdrawal-induced hyperactivity of LC neurons. The nucleus paragigantocellularis (PGi) provides the main excitatory inputs to LC and plays a pivotal role in opiate withdrawal. In the present study the direct facilitatory role of PGi on opiate withdrawal-induced hyperactivity of LC neurons was investigated using a newly developed brain slice, containing both LC and PGi. HRP retrograde neuronal tracing was used to verify the existence of both LC and PGi neurons in the developed slice. The spontaneous discharge rate (SDR), resting membrane potential (RMP) and spontaneous excitatory post-synaptic currents (sEPSCs) were recorded in LC neurons using whole cell patch clamp recording. Results showed that the net SDR and the net RMP of LC neurons in slices containing both LC and PGi neurons are significantly higher than slices lacking intact (uncut) PGi inputs. Also, the frequency of sEPSCs in those LC neurons receiving PGi inputs significantly increased compared to the slices containing no intact PGi inputs. Altogether, our results propose that increase in PGi-mediated excitatory transmission might facilitate the opiate withdrawal-induced hyperactivity of LC neurons.	[Kaeidi, Ayat; Azizi, Hossein; Javan, Mohammad; Soleimani, S. Mohammad Ahmadi; Fathollahi, Yaghoub; Semnanian, Saeed] Tarbiat Modares Univ, Fac Med Sci, Dept Physiol, Tehran, Iran	Tarbiat Modares University	Semnanian, S (corresponding author), Tarbiat Modares Univ, Fac Med Sci, Dept Physiol, POB 14115-331, Tehran, Iran.	ssemnan@modares.ac.ir	Kaeidi, Ayat/O-3477-2017; Soleimani, Seyed Mohammad Ahmadi/M-4154-2018; Azizi, Hossein/AAG-1330-2019; fathollahi, yaghoub/C-1670-2010; Javan, Mohammad/C-6758-2008	Kaeidi, Ayat/0000-0002-3292-2603; Azizi, Hossein/0000-0001-8489-0861; Javan, Mohammad/0000-0003-2045-6171; fathollahi, yghoub/0000-0002-3695-4805; Ahmadi Soleimani, Seyed Mohammad/0000-0003-3288-945X	Iran National Science Foundation (INSF); Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran	Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF)); Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran	This study was supported by grants from the Iran National Science Foundation (INSF) and Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHAJANIAN GK, 1978, NATURE, V276, P186, DOI 10.1038/276186a0; AGHAJANIAN GK, 1994, BRAIN RES, V636, P126, DOI 10.1016/0006-8993(94)90186-4; AKAOKA H, 1991, J NEUROSCI, V11, P3830; ANDRADE R, 1983, EUR J PHARMACOL, V91, P161, DOI 10.1016/0014-2999(83)90461-2; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; ASTONJONES G, 1986, SCIENCE, V234, P734, DOI 10.1126/science.3775363; AstonJones G, 1997, BRAIN RES, V765, P331, DOI 10.1016/S0006-8993(97)00682-3; ASTONJONES G, 1991, PROG BRAIN RES, V88, P47; Bell JA, 1998, BRAIN RES, V788, P237, DOI 10.1016/S0006-8993(98)00003-1; Cao JL, 2010, P NATL ACAD SCI USA, V107, P17011, DOI 10.1073/pnas.1010077107; CHRISTIE MJ, 1987, MOL PHARMACOL, V32, P633; DUMAN RS, 1988, J PHARMACOL EXP THER, V246, P1033; ENNIS M, 1988, J NEUROSCI, V8, P3644; GUITART X, 1990, J NEUROSCI, V10, P2649; GUITART X, 1989, J NEUROSCI, V9, P4371; Haghparast A, 1998, BRAIN RES, V814, P71, DOI 10.1016/S0006-8993(98)01029-4; Ivanov A, 2001, J NEUROPHYSIOL, V85, P2388, DOI 10.1152/jn.2001.85.6.2388; KOGAN JH, 1992, EUR J PHARMACOL, V211, P47, DOI 10.1016/0014-2999(92)90261-2; KRISTENSSON K, 1971, BRAIN RES, V32, P399, DOI 10.1016/0006-8993(71)90332-5; LaneLadd SB, 1997, J NEUROSCI, V17, P7890; LAVAIL JH, 1974, J COMP NEUROL, V157, P303, DOI 10.1002/cne.901570304; MATSUOKA I, 1994, EUR J PHARM-MOLEC PH, V268, P215, DOI 10.1016/0922-4106(94)90191-0; Mazei-Robison MS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012070; Mesulam M, 1982, TRACING NEURAL CONNE, P1; NESTLER EJ, 1989, BRAIN RES, V476, P230, DOI 10.1016/0006-8993(89)91243-2; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; NESTLER EJ, 1988, MOL PHARMACOL, V33, P127; RASMUSSEN K, 1990, J NEUROSCI, V10, P2308; RASMUSSEN K, 1989, BRAIN RES, V505, P346, DOI 10.1016/0006-8993(89)91466-2; Rasmussen K, 1996, NEUROPSYCHOPHARMACOL, V15, P497, DOI 10.1016/S0893-133X(96)00094-2; Saiepour MH, 2001, EUR J PHARMACOL, V411, P85, DOI 10.1016/S0014-2999(00)00862-1; Torrecilla M, 2002, J NEUROSCI, V22, P4328, DOI 10.1523/JNEUROSCI.22-11-04328.2002; TUNG CS, 1990, ACTA PHYSIOL SCAND, V138, P581, DOI 10.1111/j.1748-1716.1990.tb08888.x; Van Bockstaele EJ, 2010, BRAIN RES, V1314, P162, DOI 10.1016/j.brainres.2009.09.036; van der Want JJL, 1997, BRAIN RES PROTOC, V1, P269, DOI 10.1016/S1385-299X(96)00042-6; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; WILLIAMS JT, 1982, NATURE, V299, P74, DOI 10.1038/299074a0; Zachariou V, 2008, BIOL PSYCHIAT, V63, P1013, DOI 10.1016/j.biopsych.2007.11.021; Zhu H, 2010, EUR J PHARMACOL, V636, P65, DOI 10.1016/j.ejphar.2010.03.033	39	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134873	10.1371/journal.pone.0134873	http://dx.doi.org/10.1371/journal.pone.0134873			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230639	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400181
J	Kayvanpour, E; Mansi, T; Sedaghat-Hamedani, F; Amr, A; Neumann, D; Georgescu, B; Seegerer, P; Kamen, A; Haas, J; Frese, KS; Irawati, M; Wirsz, E; King, V; Buss, S; Mereles, D; Zitron, E; Keller, A; Katus, HA; Comaniciu, D; Meder, B				Kayvanpour, Elham; Mansi, Tommaso; Sedaghat-Hamedani, Farbod; Amr, Ali; Neumann, Dominik; Georgescu, Bogdan; Seegerer, Philipp; Kamen, Ali; Haas, Jan; Frese, Karen S.; Irawati, Maria; Wirsz, Emil; King, Vanessa; Buss, Sebastian; Mereles, Derliz; Zitron, Edgar; Keller, Andreas; Katus, Hugo A.; Comaniciu, Dorin; Meder, Benjamin			Towards Personalized Cardiology: Multi-Scale Modeling of the Failing Heart	PLOS ONE			English	Article							CARDIAC RESYNCHRONIZATION THERAPY; ELECTROMECHANICAL MODEL; 12-LEAD ECG; PREDICTION; FRAMEWORK; ELECTROPHYSIOLOGY; UNCERTAINTY; MECHANICS; FAILURE; CRT	Background Despite modern pharmacotherapy and advanced implantable cardiac devices, overall prognosis and quality of life of HF patients remain poor. This is in part due to insufficient patient stratification and lack of individualized therapy planning, resulting in less effective treatments and a significant number of non-responders. Methods and Results State-of-the-art clinical phenotyping was acquired, including magnetic resonance imaging (MRI) and biomarker assessment. An individualized, multi-scale model of heart function covering cardiac anatomy, electrophysiology, biomechanics and hemodynamics was estimated using a robust framework. The model was computed on n=46 HF patients, showing for the first time that advanced multi-scale models can be fitted consistently on large cohorts. Novel multi-scale parameters derived from the model of all cases were analyzed and compared against clinical parameters, cardiac imaging, lab tests and survival scores to evaluate the explicative power of the model and its potential for better patient stratification. Model validation was pursued by comparing clinical parameters that were not used in the fitting process against model parameters. Conclusion This paper illustrates how advanced multi-scale models can complement cardiovascular imaging and how they could be applied in patient care. Based on obtained results, it becomes conceivable that, after thorough validation, such heart failure models could be applied for patient management and therapy planning in the future, as we illustrate in one patient of our cohort who received CRT-D implantation.	[Kayvanpour, Elham; Sedaghat-Hamedani, Farbod; Amr, Ali; Haas, Jan; Frese, Karen S.; Irawati, Maria; Buss, Sebastian; Mereles, Derliz; Zitron, Edgar; Katus, Hugo A.; Meder, Benjamin] Heidelberg Univ, Dept Med 3, Heidelberg, Germany; [Kayvanpour, Elham; Sedaghat-Hamedani, Farbod; Amr, Ali; Haas, Jan; Frese, Karen S.; Katus, Hugo A.; Meder, Benjamin] DZHK German Ctr Cardiovasc Res, Heidelberg, Germany; [Mansi, Tommaso; Neumann, Dominik; Georgescu, Bogdan; Seegerer, Philipp; Kamen, Ali; Comaniciu, Dorin] Siemens Corp, Corp Technol, Imaging & Comp Vis, Princeton, NJ USA; [Wirsz, Emil] Siemens AG, Corp Technol, Erlangen, Germany; [King, Vanessa] Siemens Corp, Corp Technol, Sensor Technol, Princeton, NJ USA; [Keller, Andreas] Biomarker Discovery Ctr Heidelberg, Heidelberg, Germany; [Keller, Andreas] Univ Saarland, Dept Human Genet, Homburg, Germany; [Katus, Hugo A.; Meder, Benjamin] Klaus Tschira Inst Computat Cardiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; Siemens AG; Siemens AG; Siemens Germany; Siemens AG; Saarland University	Meder, B (corresponding author), Heidelberg Univ, Dept Med 3, Heidelberg, Germany.	Benjamin.Meder@med.uni-heidelberg.de	Seegerer, Philipp/AAE-3706-2020; Keller, Andreas/ABB-6412-2021	Seegerer, Philipp/0000-0002-4707-7991; Keller, Andreas/0000-0002-5361-0895; Comaniciu, Dorin/0000-0002-5238-8647; Mereles, Derliz/0000-0001-9601-7103	DZHK (German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research); European Union [GA 306031]	DZHK (German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	This work has been supported by the DZHK (German Centre for Cardiovascular Research), by the BMBF (German Ministry of Education and Research), and by the European Union FP7 (BestAgeing, GA 306031). This work was in part conducted within an industry supported project (Siemens AG, Siemens Research Project). Siemens provided support in the form of salaries for authors TM, DN, BG, PS, AK, EW, VK and DC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; Allard J, 2007, STUD HEALTH TECHNOL, V125, P13; ARTS T, 1979, ANN BIOMED ENG, V7, P299, DOI 10.1007/BF02364118; Ashikaga H, 2013, HEART RHYTHM, V10, P1109, DOI 10.1016/j.hrthm.2013.04.015; Baillargeon B, 2014, EUR J MECH A-SOLID, V48, P38, DOI 10.1016/j.euromechsol.2014.04.001; Boulakia M, 2010, ANN BIOMED ENG, V38, P1071, DOI 10.1007/s10439-009-9873-0; Campbell SG, 2011, J R SOC INTERFACE, V8, P1550, DOI 10.1098/rsif.2011.0184; Comas O, 2008, LECT NOTES COMPUT SC, V5104, P28, DOI 10.1007/978-3-540-70521-5_4; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; Dye C., 2013, RESEARCH FOR UNIVERS; Georgescu B RS, 2013, MICCAI WORKSHOP2013; Guetter C, 2011, I S BIOMED IMAGING, P590, DOI 10.1109/ISBI.2011.5872476; Holzapfel GA, 2009, PHILOS T R SOC A, V367, P3445, DOI 10.1098/rsta.2009.0091; Hunter PJ, 2003, NAT REV MOL CELL BIO, V4, P237, DOI 10.1038/nrm1054; Huntjens PR, 2014, EUROPACE, V16, P62, DOI 10.1093/europace/euu231; Kerckhoffs RCP, 2008, PROG BIOPHYS MOL BIO, V97, P543, DOI 10.1016/j.pbiomolbio.2008.02.024; Kerckhoffs RCP, 2007, ANN BIOMED ENG, V35, P1, DOI 10.1007/s10439-006-9212-7; Konukoglu E, 2011, PROG BIOPHYS MOL BIO, V107, P134, DOI 10.1016/j.pbiomolbio.2011.07.002; Krishnamurthy A, 2013, J COMPUT PHYS, V244, P4, DOI 10.1016/j.jcp.2012.09.015; Kuijpers NHL, 2012, J CARDIOVASC TRANSL, V5, P159, DOI 10.1007/s12265-012-9346-y; Land S, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0076; Lecoq G, 2005, EUR HEART J, V26, P1094, DOI 10.1093/eurheartj/ehi146; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Mansi T, 2010, APPLICATION TO TETRA; Marchesseau S, 2013, MED IMAGE ANAL, V17, P816, DOI 10.1016/j.media.2013.04.012; Marchesseau S, 2013, BIOMECH MODEL MECHAN, V12, P815, DOI 10.1007/s10237-012-0446-z; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mitchell CC, 2003, B MATH BIOL, V65, P767, DOI 10.1016/S0092-8240(03)00041-7; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; Mollema SA, 2007, AM J CARDIOL, V100, P1665, DOI 10.1016/j.amjcard.2007.06.071; Neumann D, 2014, I S BIOMED IMAGING, P935, DOI 10.1109/ISBI.2014.6868025; Neumann D, 2014, LECT NOTES COMPUT SC, V8674, P9, DOI 10.1007/978-3-319-10470-6_2; Ng J, 2012, J AM COLL CARDIOL, V60, P423, DOI 10.1016/j.jacc.2012.03.029; Niederer SA, 2008, PROG BIOPHYS MOL BIO, V96, P90, DOI 10.1016/j.pbiomolbio.2007.08.001; Niederer SA, 2011, CARDIOVASC RES, V89, P336, DOI 10.1093/cvr/cvq318; NIELSEN PMF, 1991, AM J PHYSIOL, V260, pH1365, DOI 10.1152/ajpheart.1991.260.4.H1365; Nordsletten DA, 2011, PROG BIOPHYS MOL BIO, V104, P77, DOI 10.1016/j.pbiomolbio.2009.11.001; Potse M, 2014, EUROPACE EUROPEAN PA, V16, piv56, DOI [10.1093/europace/euu257, DOI 10.1093/EUR0PACE/EUU257]; Powell MJD, 2006, NONCON OPTIM ITS APP, V83, P255; Rapaka S, 2012, LECT NOTES COMPUT SC, V7511, P33, DOI 10.1007/978-3-642-33418-4_5; Relan J, 2011, INTERFACE FOCUS, V1, P396, DOI 10.1098/rsfs.2010.0041; Seegerer P, 2015, LECT NOTES COMPUT SC, V8896, P204, DOI 10.1007/978-3-319-14678-2_21; Segers P, 2008, JOURNAL OF ENGINEERI, V222, P417; Sermesant A, 2006, IEEE T MED IMAGING, V25, P612, DOI 10.1109/TMI.2006.872746; Sermesant M, 2012, MED IMAGE ANAL, V16, P201, DOI 10.1016/j.media.2011.07.003; Sermesant Maxime, 2008, Heart Fail Clin, V4, P289, DOI 10.1016/j.hfc.2008.02.014; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Tobon-Gomez C, 2013, MED BIOL ENG COMPUT, V51, P1235, DOI 10.1007/s11517-013-1044-7; Trayanova NA, 2011, CIRC RES, V108, P113, DOI 10.1161/CIRCRESAHA.110.223610; Vogel B, 2013, EUR HEART J, V34, P2812, DOI 10.1093/eurheartj/eht256; Wallman M, 2014, MED IMAGE ANAL, V18, P228, DOI 10.1016/j.media.2013.10.006; Xi JH, 2013, MED IMAGE ANAL, V17, P133, DOI 10.1016/j.media.2012.08.001; Zettinig O, 2014, MED IMAGE ANAL, V18, P1361, DOI 10.1016/j.media.2014.04.011; Zettinig O, 2013, LECT NOTES COMPUT SC, V7945, P249, DOI 10.1007/978-3-642-38899-6_30; Zheng YF, 2008, IEEE T MED IMAGING, V27, P1668, DOI 10.1109/TMI.2008.2004421; Zhou LF, 2014, CIRC-ARRHYTHMIA ELEC, V7, P143, DOI 10.1161/CIRCEP.113.000600	56	50	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134869	10.1371/journal.pone.0134869	http://dx.doi.org/10.1371/journal.pone.0134869			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230546	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400180
J	Vincenzi, B; Di Maio, M; Silletta, M; D'Onofrio, L; Spoto, C; Piccirillo, MC; Daniele, G; Comito, F; Maci, E; Bronte, G; Russo, A; Santini, D; Perrone, F; Tonini, G				Vincenzi, Bruno; Di Maio, Massimo; Silletta, Marianna; D'Onofrio, Loretta; Spoto, Chiara; Piccirillo, Maria Carmela; Daniele, Gennaro; Comito, Francesca; Maci, Eliana; Bronte, Giuseppe; Russo, Antonio; Santini, Daniele; Perrone, Francesco; Tonini, Giuseppe			Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis	PLOS ONE			English	Article							TUMOR RESPONSE; SOLID TUMORS; TRANSARTERIAL CHEMOEMBOLIZATION; EUROPEAN ASSOCIATION; ARTERIAL CHEMOEMBOLIZATION; CLINICAL-OUTCOMES; PREDICT SURVIVAL; LIVER	Background The European Association for the Study of the Liver (EASL) criteria and the modified Response Evaluation Criteria in Solid Tumors (mRECIST) are currently adopted to evaluate radiological response in patients affected by HCC and treated with loco-regional procedures. Several studies explored the validity of these measurements in predicting survival but definitive data are still lacking. Aim To conduct a systematic review of studies exploring mRECIST and EASL criteria usefulness in predictive radiological response in HCC undergoing loco-regional therapies and their validity in predicting survival. Methods A comprehensive search of the literature was performed in electronic databases EMBASE, MEDLINE, COCHRANE LIBRARY, ASCO conferences and EASL conferences up to June 10, 2014. Our overall search strategy included terms for HCC, mRECIST, and EASL. Loco-regional procedures included transarterial embolization (TAE), transarterial chemoembolization (TACE) and cryoablation. Inter-method agreement between EASL and mRECIST was assessed using the k coefficient. For each criteria, overall survival was described in responders vs. non-responders patients, considering all target lesions response. Results Among 18 initially found publications, 7 reports including 1357 patients were considered eligible. All studies were published as full-text articles. Proportion of responders according to mRECIST and EASL criteria was 62.4% and 61.3%, respectively. In the pooled population, 1286 agreements were observed between the two methods (kappa statistics 0.928, 95% confidence interval 0.912-0.944). HR for overall survival (responders versus non responders) according to mRECIST and EASL was 0.39 (95% confidence interval 0.26-0.61, p<0.0001) and 0.38 (95% confidence interval 0.24-0.61, p<0.0001), respectively. Conclusion In this literature-based meta-analysis, mRECIST and EASL criteria showed very good concordance in HCC patients undergoing loco-regional treatments. Objective response according to both criteria confirms a strong prognostic value in terms of overall survival. This prognostic value appears to be very similar between the two criteria.	[Vincenzi, Bruno; Silletta, Marianna; D'Onofrio, Loretta; Spoto, Chiara; Comito, Francesca; Maci, Eliana; Santini, Daniele; Tonini, Giuseppe] Univ Campus Biomed, Med Oncol, Rome, Italy; [Di Maio, Massimo; Piccirillo, Maria Carmela; Daniele, Gennaro; Perrone, Francesco] NCI, Clin Trials Unit, Naples, Italy; [Bronte, Giuseppe; Russo, Antonio] Univ Palermo, Dept Surg Oncol & Oral Sci, Palermo, Italy; [Di Maio, Massimo] Univ Turin, Dept Oncol, San Luigi Gonzaga Hosp, I-10043 Orbassano, TO, Italy	University Campus Bio-Medico - Rome Italy; IRCCS Fondazione Pascale; University of Palermo; Azienda Ospedaliero-Universitaria San Luigi Gonzaga; University of Turin	Vincenzi, B (corresponding author), Univ Campus Biomed, Med Oncol, Rome, Italy.	b.vincenzi@unicampus.it; antonio.russo@usa.net	D'Onofrio, Loretta/AAC-5131-2022; DI MAIO, Massimo/AAB-6074-2019; COMITO, FRANCESCA/AAC-1313-2019; Daniele, Gennaro/AAC-1927-2019; Perrone, Francesco/AAB-8283-2022; Di Maio, Massimo/K-9990-2016	DI MAIO, Massimo/0000-0001-8906-3785; Perrone, Francesco/0000-0002-9738-0526; Di Maio, Massimo/0000-0001-8906-3785; , Loretta D'Onofrio/0000-0002-3071-7788; Santini, Daniele/0000-0002-9118-3337; Vincenzi, Bruno/0000-0001-8222-9025; COMITO, FRANCESCA/0000-0002-8591-0788; Daniele, Gennaro/0000-0001-5360-1895; Bronte, Giuseppe/0000-0002-2306-2445; Tonini, Giuseppe/0000-0003-4442-8677				[Anonymous], 1991, PRACTICAL STATISTICS; Boatta Emanuele, 2013, Indian J Radiol Imaging, V23, P126, DOI 10.4103/0971-3026.116564; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Choi J, 2014, J HEPATOL, V60, P1212, DOI 10.1016/j.jhep.2014.01.014; Duke E, 2010, J VASC INTERV RADIOL, V21, P515, DOI 10.1016/j.jvir.2009.11.020; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Gillmore R, 2011, J HEPATOL, V55, P1309, DOI 10.1016/j.jhep.2011.03.007; Gonzalez-Guindalini FD, 2013, RADIOGRAPHICS, V33, P1781, DOI 10.1148/rg.336135511; Jung ES, 2013, J HEPATOL, V58, P1181, DOI 10.1016/j.jhep.2013.01.039; Kim BK, 2013, EUR J CANCER, V49, P826, DOI 10.1016/j.ejca.2012.08.022; Kim CJ, 2014, LIVER INT, V34, P305, DOI 10.1111/liv.12270; Lee IJ., 2013, ASCO MEETING ABSTRAC, V31, P217; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Li HZ, 2013, EUR J GASTROEN HEPAT, V25, P620, DOI 10.1097/MEG.0b013e32835ced13; Lin MD, 2012, J VASC INTERV RADIOL, V23, P1629, DOI 10.1016/j.jvir.2012.08.028; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Maida M, 2013, FUTURE ONCOL, V9, P845, DOI [10.2217/FON.13.33, 10.2217/fon.13.33]; Meza-Junco J, 2012, CANCER TREAT REV, V38, P54, DOI 10.1016/j.ctrv.2011.05.002; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Prajapati HJ, 2013, ANN ONCOL, V24, P965, DOI 10.1093/annonc/mds605; Price TR, 2012, CANCER-AM CANCER SOC, V118, P3191, DOI 10.1002/cncr.26404; Riaz A, 2010, JAMA-J AM MED ASSOC, V303, P1062, DOI 10.1001/jama.2010.262; Ribero D, 2008, ANN SURG ONCOL, V15, P986, DOI 10.1245/s10434-007-9731-y; Sato Y, 2013, UPSALA J MED SCI, V118, P16, DOI 10.3109/03009734.2012.729104; Shim JH, 2012, RADIOLOGY, V262, P708, DOI 10.1148/radiol.11110282; Shuster A, 2013, J VASC INTERV RADIOL, V24, P805, DOI 10.1016/j.jvir.2013.01.499	28	84	90	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133488	10.1371/journal.pone.0133488	http://dx.doi.org/10.1371/journal.pone.0133488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230853	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400040
J	Wang, C; Ding, MZ; Kluger, BM				Wang, Chao; Ding, Mingzhou; Kluger, Benzi M.			Functional Roles of Neural Preparatory Processes in a Cued Stroop Task Revealed by Linking Electrophysiology with Behavioral Performance	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; PREFRONTAL CORTEX; EXECUTIVE CONTROL; CONFLICT; INHIBITION; COMPONENTS; SWITCH; ACTIVATION; ATTENTION	It is well established that cuing facilitates behavioral performance and that different aspects of instructional cues evoke specific neural preparatory processes in cued task-switching paradigms. To deduce the functional role of these neural preparatory processes the majority of studies vary aspects of the experimental paradigm and describe how these variations alter markers of neural preparatory processes. Although these studies provide important insights, they also have notable limitations, particularly in terms of understanding the causal or functional relationship of neural markers to cognitive and behavioral processes. In this study, we sought to address these limitations and uncover the functional roles of neural processes by examining how variability in the amplitude of neural preparatory processes predicts behavioral performance to subsequent stimuli. To achieve this objective 16 young adults were recruited to perform a cued Stroop task while their brain activity was measured using high-density electroencephalography. Four temporally overlapping but functionally and topographically distinct cue-triggered event related potentials (ERPs) were identified: 1) A left-frontotemporal negativity (250-700 ms) that was positively associated with word-reading performance; 2) a midline-frontal negativity (450-800 ms) that was positively associated with color-naming and incongruent performance; 3) a left-frontal negativity (450-800 ms) that was positively associated with switch trial performance; and 4) a centroparietal positivity (450-800 ms) that was positively associated with performance for almost all trial types. These results suggest that at least four dissociable cognitive processes are evoked by instructional cues in the present task, including: 1) domain-specific task facilitation; 2) switch-specific task-set reconfiguration; 3) preparation for response conflict; and 4) proactive attentional control. Examining the relationship between ERPs and behavioral performance provides a functional link between neural markers and the cognitive processes they index.	[Wang, Chao; Ding, Mingzhou] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL USA; [Kluger, Benzi M.] Univ Colorado Denver, Dept Neurol, Aurora, CO 80045 USA	State University System of Florida; University of Florida; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Kluger, BM (corresponding author), Univ Colorado Denver, Dept Neurol, Aurora, CO 80045 USA.	benzi.kluger@ucdenver.edu	Wang, Chao/M-3165-2016	Wang, Chao/0000-0002-1313-2569	U. S. Army Research Laboratory; U. S. Army Research Office [W911NF-10-1-0192]; National Institutes of Health through the KL2 program [NIH/NCATS 8 KL2 TR000156-05]; National Institute of Aging [K02NS080885, R21AG044862]; National Science Foundation [BCS-1439188]; National Institute of Neurological Disorders and Stroke; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, KL2TR000156, KL2TR001080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS080885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG044862] Funding Source: NIH RePORTER	U. S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); U. S. Army Research Office; National Institutes of Health through the KL2 program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Science Foundation(National Science Foundation (NSF)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the U. S. Army Research Laboratory and the U. S. Army Research Office under contract/grant W911NF-10-1-0192, the National Institutes of Health through the KL2 program (NIH/NCATS 8 KL2 TR000156-05), the National Institute of Neurological Disorders and Stroke and National Institute of Aging under Award Numbers K02NS080885 and R21AG044862, and the National Science Foundation under grant BCS-1439188. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KL, 2011, NEUROSCIENCE, V180, P165, DOI 10.1016/j.neuroscience.2011.02.004; Astle DE, 2006, BRAIN RES, V1125, P94, DOI 10.1016/j.brainres.2006.09.092; Banich MT, 2000, J COGNITIVE NEUROSCI, V12, P988, DOI 10.1162/08989290051137521; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brass M, 2002, CEREB CORTEX, V12, P908, DOI 10.1093/cercor/12.9.908; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cohen JD, 1999, J ABNORM PSYCHOL, V108, P120, DOI 10.1037/0021-843X.108.1.120; Correa A, 2009, J COGNITIVE NEUROSCI, V21, P1461, DOI 10.1162/jocn.2009.21136; Coste CP, 2011, CEREB CORTEX, V21, P2612, DOI 10.1093/cercor/bhr050; De Baene W, 2011, COGN AFFECT BEHAV NE, V11, P600, DOI 10.3758/s13415-011-0055-9; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Donohue SE, 2008, J COGNITIVE NEUROSCI, V20, P694, DOI 10.1162/jocn.2008.20042; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Fassbender C, 2006, HUM BRAIN MAPP, V27, P819, DOI 10.1002/hbm.20223; Green JJ, 2008, PLOS BIOL, V6, P730, DOI 10.1371/journal.pbio.0060081; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; HOLM S, 1979, SCAND J STAT, V6, P65; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Karayanidis F, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00025; Karayanidis F, 2011, PSYCHOPHYSIOLOGY, V48, P559, DOI 10.1111/j.1469-8986.2010.01115.x; Kiesel A, 2010, PSYCHOL BULL, V136, P849, DOI 10.1037/a0019842; Koch I, 2005, PSYCHON B REV, V12, P107, DOI 10.3758/BF03196354; Koch I, 2010, PSYCHON B REV, V17, P1, DOI 10.3758/PBR.17.1.1; Lavric A, 2008, EUR J NEUROSCI, V28, P1016, DOI 10.1111/j.1460-9568.2008.06372.x; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mayr U, 2000, J EXP PSYCHOL GEN, V129, P4, DOI 10.1037/0096-3445.129.1.4; Mayr U, 2006, J COGNITIVE NEUROSCI, V18, P14, DOI 10.1162/089892906775250085; Meiran N, 2000, PSYCHOL RES-PSYCH FO, V63, P234, DOI 10.1007/s004269900004; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Mueller SC, 2007, BRAIN RES, V1157, P56, DOI 10.1016/j.brainres.2007.04.046; Nicholson R, 2006, BRAIN RES, V1095, P107, DOI 10.1016/j.brainres.2006.04.016; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; Piguet C, 2013, NEUROIMAGE, V82, P489, DOI 10.1016/j.neuroimage.2013.06.015; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 1999, J COGNITIVE NEUROSCI, V11, P371, DOI 10.1162/089892999563481; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rubinstein JS, 2001, J EXP PSYCHOL HUMAN, V27, P763, DOI 10.1037//0096-1523.27.4.763; Ruge H, 2013, HUM BRAIN MAPP, V34, P12, DOI 10.1002/hbm.21420; Ruge H, 2009, NEUROPSYCHOLOGIA, V47, P1670, DOI 10.1016/j.neuropsychologia.2009.02.004; Rushworth MFS, 2005, EXP PSYCHOL, V52, P83, DOI 10.1027/1618-3169.52.2.83; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Sohn MH, 2007, P NATL ACAD SCI USA, V104, P10330, DOI 10.1073/pnas.0703225104; Stern ER, 2007, BRAIN RES, V1176, P92, DOI 10.1016/j.brainres.2007.07.060; Tsuchida A, 2013, CORTEX, V49, P1790, DOI 10.1016/j.cortex.2012.10.014; Vanderhasselt MA, 2006, EXP BRAIN RES, V169, P279, DOI 10.1007/s00221-005-0344-z; Wen XT, 2012, J NEUROSCI, V32, P1284, DOI 10.1523/JNEUROSCI.2817-11.2012; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X; West R, 2011, PSYCHOPHYSIOLOGY, V48, P612, DOI 10.1111/j.1469-8986.2010.01123.x; Whitmer AJ, 2012, COGN AFFECT BEHAV NE, V12, P661, DOI 10.3758/s13415-012-0118-6; Wylie GR, 2006, CEREB CORTEX, V16, P394, DOI 10.1093/cercor/bhi118; Xu J, 2014, NEUROSCIENCE, V263, P181, DOI 10.1016/j.neuroscience.2014.01.020; Yehene E, 2008, J COGNITIVE NEUROSCI, V20, P1079, DOI 10.1162/jocn.2008.20077	54	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134686	10.1371/journal.pone.0134686	http://dx.doi.org/10.1371/journal.pone.0134686			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230662	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400148
J	Albert, J; Rooman, M				Albert, Jaroslav; Rooman, Marianne			Is the Cell Nucleus a Necessary Component in Precise Temporal Patterning?	PLOS ONE			English	Article							IMPORTIN-ALPHA; NOISE-REDUCTION; TRANSPORT; DELAY; RNA; MECHANISM; RATES	One of the functions of the cell nucleus is to help regulate gene expression by controlling molecular traffic across the nuclear envelope. Here we investigate, via stochastic simulation, what effects, if any, does segregation of a system into the nuclear and cytoplasmic compartments have on the stochastic properties of a motif with a negative feedback. One of the effects of the nuclear barrier is to delay the nuclear protein concentration, allowing it to behave in a switch-like manner. We found that this delay, defined as the time for the nuclear protein concentration to reach a certain threshold, has an extremely narrow distribution. To show this, we considered two models. In the first one, the proteins could diffuse freely from cytoplasm to nucleus (simple model); and in the second one, the proteins required assistance from a special class of proteins called importins. For each model, we generated fifty parameter sets, chosen such that the temporal profiles they effectuated were very similar, and whose average threshold time was approximately 150 minutes. The standard deviation of the threshold times computed over one hundred realizations were found to be between 1.8 and 7.16 minutes across both models. To see whether a genetic motif in a prokaryotic cell can achieve this degree of precision, we also simulated five variations on the coherent feed-forward motif (CFFM), three of which contained a negative feedback. We found that the performance of these motifs was nowhere near as impressive as the one found in the eukaryotic cell; the best standard deviation was 6.6 minutes. We argue that the significance of these results, the fact and necessity of spatio-temporal precision in the developmental stages of eukaryotes, and the absence of such a precision in prokaryotes, all suggest that the nucleus has evolved, in part, under the selective pressure to achieve highly predictable phenotypes.	[Albert, Jaroslav; Rooman, Marianne] Univ Libre Bruxelles, BioModeling BioInformat & BioProc, Brussels, Belgium; [Albert, Jaroslav] Vrije Univ Brussel, Appl Phys Res Grp, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Albert, J (corresponding author), Univ Libre Bruxelles, BioModeling BioInformat & BioProc, Brussels, Belgium.	jalbert@ulb.ac.be			Belgian Fund for Scientific Research (FNRS); Interuniversity Attraction Poles program of the Belgian Science Policy Office [IAP P7-35]; Onderzoeksraad of the Vrije Universiteit Brussel through the strategic research programme "Applied Physics and Systems Biology"	Belgian Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles program of the Belgian Science Policy Office; Onderzoeksraad of the Vrije Universiteit Brussel through the strategic research programme "Applied Physics and Systems Biology"	JA was supported by Belgian Fund for Scientific Research (FNRS); Interuniversity Attraction Poles program of the Belgian Science Policy Office, under grant IAP P7-35 (www.belspo.be); and Onderzoeksraad of the Vrije Universiteit Brussel (www.vub.ac.be) through the strategic research programme "Applied Physics and Systems Biology."	Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Audibert A, 2002, MOL CELL BIOL, V22, P6706, DOI 10.1128/MCB.22.19.6706-6718.2002; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bel G, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016003; Bolouri H, 2003, P NATL ACAD SCI USA, V100, P9371, DOI 10.1073/pnas.1533293100; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Bundschuh R, 2003, J THEOR BIOL, V220, P261, DOI 10.1006/jtbi.2003.3164; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; de-Leon SBT, 2009, DEV BIOL, V325, P317, DOI 10.1016/j.ydbio.2008.10.043; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Eldar A, 2010, NATURE REV, V467; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Ghim CM, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-94; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Joshi A, 2012, FEBS J, V279, P3501, DOI 10.1111/j.1742-4658.2012.08571.x; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Komorowski M, 2013, BIOPHYS J, V104, P1783, DOI 10.1016/j.bpj.2013.02.027; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Little SC, 2013, CELL, V154, P789, DOI 10.1016/j.cell.2013.07.025; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Mather W, 2014, SYNCHRONIZATION DEGR, V113; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Okada N, 2008, J CELL MOL MED, V12, P1863, DOI 10.1111/j.1582-4934.2008.00437.x; Pilpel Y, 2011, METHODS MOL BIOL, V759, P407, DOI 10.1007/978-1-61779-173-4_23; Quensel C, 2004, MOL CELL BIOL, V24, P10246, DOI 10.1128/MCB.24.23.10246-10255.2004; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; Rooman M, 2014, J THEOR BIOL, V354, P113, DOI 10.1016/j.jtbi.2014.03.007; Sturrock M, J MATH BIOL; Sturrock M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0988; Sturrock M, 2012, B MATH BIOL, V74, P1531, DOI 10.1007/s11538-012-9725-1; Swain PS, 2004, J MOL BIOL, V344, P965, DOI 10.1016/j.jmb.2004.09.073; Terry J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016980, DOI 10.1371/JOURNAL.PONE.0016980]; Timney BL, 2006, J CELL BIOL, V175, P579, DOI 10.1083/jcb.200608141; Vargas DY, 2005, P NATL ACAD SCI USA, V102, P17008, DOI 10.1073/pnas.0505580102; Wagner A, 2005, MOL BIOL EVOL, V22, P1365, DOI 10.1093/molbev/msi126; Yasuharaa N, 2009, SEMIN CELL DEV BIOL, V20, P590, DOI 10.1016/j.semcdb.2009.05.003; You P, 2013, IN VITRO CELL DEV-AN, V49, P346, DOI 10.1007/s11626-013-9599-z; Zavala E, 2014, BIOPHYS J, V106, P467, DOI 10.1016/j.bpj.2013.12.010; Zienkiewicz J, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000386	42	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134239	10.1371/journal.pone.0134239	http://dx.doi.org/10.1371/journal.pone.0134239			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226505	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700066
J	Sciascia, QL; Pacheco, D; McCoard, SA				Sciascia, Quentin L.; Pacheco, David; McCoard, Susan A.			Administration of Exogenous Growth Hormone Is Associated with Changes in Plasma and Intracellular Mammary Amino Acid Profiles and Abundance of the Mammary Gland Amino Acid Transporter SLC3A2 in Mid-Lactation Dairy Cows	PLOS ONE			English	Article							RECOMBINANT BOVINE SOMATOTROPIN; REAL-TIME PCR; STATISTICAL-ANALYSIS; PROTEIN-SYNTHESIS; MAMMALIAN TARGET; MILK-PRODUCTION; LATE LACTATION; NITRIC-OXIDE; METABOLISM; TISSUE	The objectives of this study were to (1) identify changes in plasma and mammary intracellular amino acid (AA) profiles in dairy cows treated with growth hormone (GH), and (2) evaluate the expression of mammary gland genes involved in the transport of AA identified in (1). Eight non-pregnant (n = 4 per group) lactating dairy cows were treated with a single subcutaneous injection of either a slow-release formulation of commercially available GH (Lactotropin 500 mg) or physiological saline solution. Six days after treatment, cows were milked and blood collected from the jugular vein for the analysis of free AA in the plasma. Cows were euthanized and mammary tissue harvested. Treatment with GH increased milk, protein, fat and lactose yields, with no effect on dry matter intake. Plasma concentrations of lysine and group I AA decreased significantly, and arginine, methionine, tyrosine and arginine-family AA tended to decrease in GH-treated cows. Concentrations of intracellular glycine, serine and glutamate increased significantly, with a trend for decreased arginine observed in the mammary gland of GH-treated cows. A trend for increased concentrations of intracellular total AA, NEAA and arginine-family AA were observed in the mammary gland of GH-treated cows. Variance in the concentration of plasma methionine, tyrosine, valine, alanine, ornithine, BCAA, EAA was significantly different between treatments. Variance in the concentration of intracellular lysine, valine, glutamine, EAA and group II was significantly different between treatments. AA changes were associated with increased mRNA abundance of the mammary gland AA transporter SLC3A2. We propose that these changes occur to support increased milk protein and fatty acid production in the mammary gland of GH-treated cows via potential mTOR pathway signaling.	[Sciascia, Quentin L.] Leibniz Inst Farm Anim Biol FBN, Dept Nutr Physiol Oskar Kellner, Dummerstorf, Germany; [Pacheco, David; McCoard, Susan A.] AgRes Grasslands, Anim Nutr & Hlth Grp, Palmerston North 4442, New Zealand	Forschungsinstitut fur Nutztierbiologie (FBN); AgResearch - New Zealand	Pacheco, D (corresponding author), AgRes Grasslands, Anim Nutr & Hlth Grp, Private Bag 11008, Palmerston North 4442, New Zealand.	David.Pacheco@agresearch.co.nz	Pacheco, David/I-2362-2013	Pacheco, David/0000-0002-9307-9197; mccoard, susan/0000-0002-4806-0323	Ministry of Business, Innovation, and Employment [CX10X0702]; AgResearch Capability Fund	Ministry of Business, Innovation, and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); AgResearch Capability Fund	The data presented and discussed was obtained with financial support from the Ministry of Business, Innovation, and Employment (funding number: CX10X0702) and the AgResearch Capability Fund (Maori PhD fellowship for Q Sciascia). The animal trial, from which the tissues used in this experiment were derived, was conducted as part of a Joint Venture between AgResearch Limited New Zealand and Primary Industries Research Victoria, Australia. The funders provided support in the form of salaries for authors SAM & DP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aleman G, 2009, METABOLISM, V58, P594, DOI 10.1016/j.metabol.2008.12.003; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Appuhamy JADRN, 2012, J NUTR, V142, P484, DOI 10.3945/jn.111.152595; BAUMRUCKER CR, 1985, J DAIRY SCI, V68, P2436, DOI 10.3168/jds.S0022-0302(85)81119-X; Bequette BJ, 1998, J DAIRY SCI, V81, P2540, DOI 10.3168/jds.S0022-0302(98)70147-X; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; BLACK AL, 1955, BIOCHIM BIOPHYS ACTA, V17, P346, DOI 10.1016/0006-3002(55)90382-6; BURTON JL, 1994, CAN J ANIM SCI, V74, P167, DOI 10.4141/cjas94-027; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chiofalo V, 1999, SMALL RUMINANT RES, V34, P119, DOI 10.1016/S0921-4488(99)00061-9; DISENHAUS C, 1995, SMALL RUMINANT RES, V15, P139, DOI 10.1016/0921-4488(94)00019-4; Fuchs BC, 2007, AM J PHYSIOL-CELL PH, V293, pC55, DOI 10.1152/ajpcell.00330.2006; Hanigan MD, 2002, J THEOR BIOL, V217, P311, DOI 10.1006/jtbi.2002.3037; HANIGAN MD, 1992, J DAIRY SCI, V75, P161, DOI 10.3168/jds.S0022-0302(92)77750-9; Hayashi AA, 2009, J DAIRY SCI, V92, P1889, DOI 10.3168/jds.2008-1334; Lacasse P, 1996, J DAIRY SCI, V79, P1369, DOI 10.3168/jds.S0022-0302(96)76494-9; Lapierre H, 2012, J ANIM SCI, V90, P1708, DOI 10.2527/jas.2011-4645; Laplante M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011593; Littell RC, 1998, J ANIM SCI, V76, P1216; Mabjeesh SJ, 2000, J DAIRY SCI, V83, P996, DOI 10.3168/jds.S0022-0302(00)74964-2; MCDOWELL GH, 1987, AUST J BIOL SCI, V40, P295, DOI 10.1071/BI9870295; MEPHAM TB, 1982, J DAIRY SCI, V65, P287, DOI 10.3168/jds.S0022-0302(82)82191-7; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Pacheco D, 2010, EFFECT GROWTH HORMON; Papes F, 2001, FEBS LETT, V488, P34, DOI 10.1016/S0014-5793(00)02401-7; PEEL CJ, 1983, J DAIRY SCI, V66, P776, DOI 10.3168/jds.S0022-0302(83)81857-8; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Sallam SMA, 2005, SMALL RUMINANT RES, V56, P165, DOI 10.1016/j.smallrumres.2004.06.010; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sciascia Q, 2013, J DAIRY SCI, V96, P2327, DOI 10.3168/jds.2012-6267; Shennan DB, 1997, P NUTR SOC, V56, P177, DOI 10.1079/PNS19970020; van der Linden DS, 2013, J ANIM SCI, V91, P644, DOI 10.2527/jas.2012-5629; Wright TC, 2006, J DAIRY SCI, V89, P2552, DOI 10.3168/jds.S0022-0302(06)72331-1; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Yao K, 2008, J NUTR, V138, P867, DOI 10.1093/jn/138.5.867	37	8	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134323	10.1371/journal.pone.0134323	http://dx.doi.org/10.1371/journal.pone.0134323			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226162	gold, Green Published, Green Submitted			2022-12-27	WOS:000358837700073
J	Wang, XP; Lei, F; Du, F; Chai, YS; Jiang, JF; Wang, YG; Yu, X; Yan, XJ; Xing, DM; Du, LJ				Wang, Xin-Pei; Lei, Fan; Du, Feng; Chai, Yu-Shuang; Jiang, Jing-Fei; Wang, Yu-Gang; Yu, Xuan; Yan, Xiao-Jin; Xing, Dong-Ming; Du, Li-Jun			Protection of Gastrointestinal Mucosa from Acute Heavy Alcohol Consumption: The Effect of Berberine and Its Correlation with TLR2, 4/IL1 beta-TNF alpha Signaling	PLOS ONE			English	Article							TIGHT JUNCTION BARRIER; NECROSIS-FACTOR-ALPHA; CEREBRAL-ISCHEMIA; EPITHELIAL-CELLS; TNF-ALPHA; ETHANOL; ACTIVATION; EXPRESSION; OCCLUDIN; COLITIS	The purpose of the present study is to confirm the protective effect of berberine (BBR) on gastrointestinal injury caused by acute heavy alcohol exposure, an effect that has not been reported previously. Our research details how BBR protects against gastrointestinal injuries from acute alcohol exposure using both in vivo and in vitro experiments. Acute high alcohol concentrations lead to obvious damage to the gastrointestinal mucosa, resulting in necrosis of the intestinal mucosa. Oral administration of BBR was able to significantly reduce this alcohol-induced damage, inhibit increases of alcohol-induced TNF alpha and IL-1 beta expression in gastrointestinal mucosa as well as their upstream signals TLR2 and TLR4, and regulate cytokines that modulate tight junctions. Alcohol consumption is a popular human social behavior worldwide, and the present study reports a comprehensive mechanism by which BBR protects against gastrointestinal injuries from alcohol stress, providing people with a novel application of BBR.	[Wang, Xin-Pei; Chai, Yu-Shuang; Jiang, Jing-Fei; Yu, Xuan; Yan, Xiao-Jin; Xing, Dong-Ming; Du, Li-Jun] Tsinghua Univ, MOE Key Lab Prot Sci, Lab Mol Pharmacol & Pharmaceut Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Lei, Fan] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Du, Feng] Tulane Univ, Dept Math, New Orleans, LA 70118 USA; [Wang, Yu-Gang] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Tsinghua University; Tsinghua University; Tulane University; University of Texas System; UTMD Anderson Cancer Center	Du, LJ (corresponding author), Tsinghua Univ, MOE Key Lab Prot Sci, Lab Mol Pharmacol & Pharmaceut Sci, Sch Life Sci, Beijing 100084, Peoples R China.	lijundu@mail.tsinghua.edu.cn		Wang, Xinpei/0000-0002-1219-3423; Yu, Xuan/0000-0001-6826-7260	National Natural Science Foundation of China [90713043, 30973896, 30801523, 81073092]; National S& T Major Special Project for New Drug R&D Program of China [2012ZX09103-201-041, 2012ZX09102-201-008, 2011ZX09101-002-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S& T Major Special Project for New Drug R&D Program of China	This work was supported by the National Natural Science Foundation of China (90713043, 30973896, 30801523 and 81073092) and the National S& T Major Special Project for New Drug R&D Program of China (2012ZX09103-201-041, 2012ZX09102-201-008 and 2011ZX09101-002-11). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Anderson P, 2014, ALCOHOL ALCOHOLISM, V49, P531, DOI 10.1093/alcalc/agu043; Bailey KL, 2010, ALCOHOL CLIN EXP RES, V34, P51, DOI 10.1111/j.1530-0277.2009.01065.x; Bergmann MM, 2013, INT J EPIDEMIOL, V42, P1772, DOI 10.1093/ije/dyt154; Bhutada P, 2011, BEHAV BRAIN RES, V220, P30, DOI 10.1016/j.bbr.2011.01.022; Chai YS, 2013, EUR J PHARMACOL, V708, P44, DOI 10.1016/j.ejphar.2013.02.041; Cicero AF, 2009, CLIN LIPIDOL, V4, P553, DOI 10.2217/CLP.09.41; Coltart C, 2011, LANCET, V378, P1215, DOI 10.1016/S0140-6736(11)61461-X; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; Domitrovic R, 2011, TOXICOLOGY, V280, P33, DOI 10.1016/j.tox.2010.11.005; Ferrari P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005245; Ferrier L, 2006, AM J PATHOL, V168, P1148, DOI 10.2353/ajpath.2006.050617; Findley MK, 2009, IUBMB LIFE, V61, P431, DOI 10.1002/iub.175; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gmel G, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-24; HALLEUX C, 1991, IN VITRO CELL DEV B, V27, P293; Heberlein A, 2014, ALCOHOL, V48, P671, DOI 10.1016/j.alcohol.2014.08.003; Hong JS, 2012, J NEUROSCI RES, V90, P489, DOI 10.1002/jnr.22756; Hou JH, 2006, J BIOL CHEM, V281, P36117, DOI 10.1074/jbc.M608853200; Hu J, 2012, EUR J PHARMACOL, V674, P132, DOI 10.1016/j.ejphar.2011.11.014; Jiang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054234; Kheir MM, 2010, FOOD CHEM TOXICOL, V48, P1105, DOI 10.1016/j.fct.2010.01.033; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Lee CH, 2007, PHARMACOL RES, V56, P193, DOI 10.1016/j.phrs.2007.06.003; Lee IA, 2010, EUR J PHARMACOL, V648, P162, DOI 10.1016/j.ejphar.2010.08.046; Lehnert M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/283756; Lippai D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070945; Liu LZ, 2010, MOL CELL ENDOCRINOL, V317, P148, DOI 10.1016/j.mce.2009.12.027; Liu MY, 2003, ALCOHOL, V30, P61, DOI 10.1016/S0741-8329(03)00094-6; Liu YT, 2010, DRUG METAB DISPOS, V38, P1779, DOI 10.1124/dmd.110.033936; Markov A G, 2007, Ross Fiziol Zh Im I M Sechenova, V93, P1043; Morrow CMK, 2010, PHILOS T R SOC B, V365, P1679, DOI 10.1098/rstb.2010.0025; Murthy KNC, 2012, EUR J PHARMACOL, V688, P14, DOI 10.1016/j.ejphar.2012.05.004; Nagatake T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090638; Nagyoszi P, 2010, NEUROCHEM INT, V57, P556, DOI 10.1016/j.neuint.2010.07.002; Pan GY, 2002, PHARMACOL TOXICOL, V91, P193, DOI 10.1034/j.1600-0773.2002.t01-1-910403.x; Pandey SC, 2012, BRIT J PHARMACOL, V165, P1316, DOI 10.1111/j.1476-5381.2011.01695.x; Pang MY, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-55; Pascual M, 2011, BRAIN BEHAV IMMUN, V25, pS80, DOI 10.1016/j.bbi.2011.02.012; Patil JB, 2010, EUR J PHARMACOL, V645, P70, DOI 10.1016/j.ejphar.2010.07.037; Pedersen SL, 2013, ALCOHOL CLIN EXP RES, V37, P1056, DOI 10.1111/acer.12068; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Saitou M, 1998, J CELL BIOL, V141, P397, DOI 10.1083/jcb.141.2.397; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Serretti A, 2006, NEUROSCI LETT, V406, P107, DOI 10.1016/j.neulet.2006.07.003; Shackelford C, 2002, TOXICOL PATHOL, V30, P93, DOI 10.1080/01926230252824761; Soellner R, 2014, J PUBLIC HEALTH-HEID, V22, P57, DOI 10.1007/s10389-013-0593-4; Suenaert P, 2002, AM J GASTROENTEROL, V97, P2000; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Tamai H, 2000, ALCOHOL CLIN EXP RES, V24, P390, DOI 10.1111/j.1530-0277.2000.tb04629.x; Ueyama Takashi, 2001, Acta Anatomica Nipponica, V76, P435; Wang Y, 2014, MOL MED REP, V9, P2352, DOI 10.3892/mmr.2014.2126; Wang YG, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023495, 10.1371/journal.pone.0020422]; Yan F, 2012, AM J PHYSIOL-GASTR L, V302, pG504, DOI 10.1152/ajpgi.00312.2011; Yazir Y, 2012, ALCOHOL, V46, P649, DOI 10.1016/j.alcohol.2012.06.003; Yuki T, 2011, J IMMUNOL, V187, P3230, DOI 10.4049/jimmunol.1100058; Zhang XL, 2012, BRAIN RES, V1459, P61, DOI 10.1016/j.brainres.2012.03.065; Zuo F, 2006, DRUG METAB DISPOS, V34, P2064, DOI 10.1124/dmd.106.011361	59	15	18	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134044	10.1371/journal.pone.0134044	http://dx.doi.org/10.1371/journal.pone.0134044			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226164	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700053
J	Malfait, B; Staes, F; de Vries, A; Smeets, A; Hawken, M; Robinson, MA; Vanrenterghem, J; Verschueren, S				Malfait, Bart; Staes, Filip; de Vries, Aijse; Smeets, Annemie; Hawken, Malcolm; Robinson, Mark A.; Vanrenterghem, Jos; Verschueren, Sabine			Dynamic Neuromuscular Control of the Lower Limbs in Response to Unexpected Single-Planar versus Multi-Planar Support Perturbations in Young, Active Adults	PLOS ONE			English	Article							CRUCIATE LIGAMENT INJURIES; POSTURAL RESPONSES; JOINT STABILITY; VIDEO ANALYSIS; TEAM HANDBALL; KNEE AXIS; ANTERIOR; FEMALE; RISK; BASKETBALL	Purpose An anterior cruciate ligament (ACL) injury involves a multi-planar injury mechanism. Nevertheless, unexpected multi-planar perturbations have not been used to screen athletes in the context of ACL injury prevention yet could reveal those more at risk. The objective of this study was to compare neuromuscular responses to multi-planar (MPP) and single-planar perturbations (SPP) during a stepping-down task. These results might serve as a basis for future implementation of external perturbations in ACL injury screening programs. Methods Thirteen young adults performed a single leg stepping-down task in eight conditions (four MPP and four SPP with a specified amplitude and velocity). The amplitudes of vastus lateralis (VL), vastus medialis (VM), hamstrings lateralis (HL), hamstrings medialis (HM) EMG activity, medio-lateral and anterior-posterior centre of mass (COM) displacements, the peak knee flexion and abduction angles were compared between conditions using an one-way ANOVA. Number of stepping responses were monitored during all conditions. Results Significantly greater muscle activity levels were found in response to the more challenging MPP and SPP compared to the less challenging conditions (p < 0.05). No differences in neuromuscular activity were found between the MPP conditions and their equivalents in the SPP. Eighteen stepping responses were monitored in the SPP versus nine in the MPP indicating that the overall neuromuscular control was even more challenged during the SPP which was supported by greater COM displacements in the SPP. Conclusion The more intense MPP and SPP evoked different neuromuscular responses resulting in greater muscle activity levels compared to small perturbations. Based on the results of COM displacements and based on the amount of stepping responses, dynamic neuromuscular control of the knee joint appeared less challenged during the MPP. Therefore, future work should investigate extensively if other neuromuscular differences (i.e. co-activation patterns and kinetics) exist between MPP and SPP. In addition, future work should examine the influence on the neuromuscular control of the magnitude of the perturbations and the magnitude of stepping height and stepping distance.	[Malfait, Bart; Staes, Filip; de Vries, Aijse; Smeets, Annemie; Verschueren, Sabine] Katholieke Univ Leuven, Musculoskeletal Rehabil Res Grp, Dept Rehabil Sci & Physiotherapy, Fac Kinesiol & Rehabil Sci, Leuven, Belgium; [Hawken, Malcolm; Robinson, Mark A.; Vanrenterghem, Jos] Liverpool John Moores Univ, Fac Sci, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England	KU Leuven; Liverpool John Moores University	Verschueren, S (corresponding author), Katholieke Univ Leuven, Musculoskeletal Rehabil Res Grp, Dept Rehabil Sci & Physiotherapy, Fac Kinesiol & Rehabil Sci, Leuven, Belgium.	sabine.verschueren@faber.kuleuven.be	Verschueren, Sabine/K-4213-2015; Smeets, Annemie/ACW-6678-2022; Robinson, Mark A./H-7108-2019	Verschueren, Sabine/0000-0003-2592-494X; Smeets, Annemie/0000-0003-4569-8652; Robinson, Mark A./0000-0002-5627-492X; Staes, Filip/0000-0002-1569-6333; Vanrenterghem, Jos/0000-0002-1682-8430				Agel J, 2005, AM J SPORT MED, V33, P524, DOI 10.1177/0363546504269937; Alentorn-Geli E, 2009, KNEE SURG SPORT TR A, V17, P705, DOI 10.1007/s00167-009-0813-1; ARENDT E, 1995, AM J SPORT MED, V23, P694, DOI 10.1177/036354659502300611; Benoit DL, 2003, GAIT POSTURE, V18, P56, DOI 10.1016/S0966-6362(02)00194-7; Besier TF, 2003, J BIOMECH, V36, P1159, DOI 10.1016/S0021-9290(03)00087-3; Besier TF, 2001, MED SCI SPORT EXER, V33, P1176; BEYNNON B, 1992, INT ORTHOP, V16, P1; Bisseling RW, 2006, J BIOMECH, V39, P2438, DOI 10.1016/j.jbiomech.2005.07.021; Brown LA, 2001, GAIT POSTURE, V14, P256, DOI 10.1016/S0966-6362(01)00131-X; BUTLER DL, 1980, J BONE JOINT SURG AM, V62, P259, DOI 10.2106/00004623-198062020-00013; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Oliveira ASC, 2012, J NEUROPHYSIOL, V108, P1895, DOI 10.1152/jn.00217.2012; Chen CL, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-50; Chen CL, 2013, GAIT POSTURE, V37, P296, DOI 10.1016/j.gaitpost.2012.07.007; DEMPSTER WT, 1967, AM J ANAT, V120, P33, DOI 10.1002/aja.1001200104; Fauth ML, 2010, J STRENGTH COND RES, V24, P1131, DOI 10.1519/JSC.0b013e3181cc2353; Ford KR, 2003, MED SCI SPORT EXER, V35, P1745, DOI 10.1249/01.MSS.0000089346.85744.D9; Griffin L Y, 2000, J Am Acad Orthop Surg, V8, P141; Hewett TE, 2006, AM J SPORT MED, V34, P299, DOI 10.1177/0363546505284183; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Hewett TE, 2011, EXERC SPORT SCI REV, V39, P161, DOI 10.1097/JES.0b013e3182297439; HORAK FB, 1989, J NEUROPHYSIOL, V62, P841, DOI 10.1152/jn.1989.62.4.841; Landry SC, 2007, AM J SPORT MED, V35, P1888, DOI 10.1177/0363546507300823; Lees A, 2007, MED ENG PHYS, V29, P629, DOI 10.1016/j.medengphy.2006.06.004; Lephart SM, 1998, SPORTS MED, V25, P149, DOI 10.2165/00007256-199825030-00002; Li G, 1999, J BIOMECH, V32, P395, DOI 10.1016/S0021-9290(98)00181-X; Lloyd DG, 2001, J BIOMECH, V34, P1257, DOI 10.1016/S0021-9290(01)00095-1; Malanga GA, 2003, ARCH PHYS MED REHAB, V84, P592, DOI 10.1053/apmr.2003.50026; Malfait B, 2014, MED SCI SPORT EXER, V46, P678, DOI 10.1249/MSS.0000000000000170; Markolf KL, 1995, J ORTHOPAED RES, V13, P930, DOI 10.1002/jor.1100130618; Myer GD, 2005, J ELECTROMYOGR KINES, V15, P181, DOI 10.1016/j.jelekin.2004.08.006; Myer GD, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-39; Oliveira AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059029; Olsen OE, 2004, AM J SPORT MED, V32, P1002, DOI 10.1177/0363546503261724; Quatman CE, 2010, SPORTS MED, V40, P729, DOI 10.2165/11534950-000000000-00000; Riemann BL, 2002, J ATHL TRAINING, V37, P71; Robertson DGE, 2003, J ELECTROMYOGR KINES, V13, P569, DOI 10.1016/S1050-6411(03)00080-4; Robinson MA, 2015, J ELECTROMYOGR KINES, V25, P14, DOI 10.1016/j.jelekin.2014.10.018; Robinson MA, 2012, J BIOMECH, V45, P1941, DOI 10.1016/j.jbiomech.2012.05.017; Stensrud S, 2011, BRIT J SPORT MED, V45, P589, DOI 10.1136/bjsm.2010.078287; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; Szturm T, 1998, J VESTIBUL RES-EQUIL, V8, P381, DOI 10.1016/S0957-4271(97)00087-6; Vanrenterghem J, 2012, J BIOMECH, V45, P2444, DOI 10.1016/j.jbiomech.2012.06.029; Wikstrom EA, 2006, SPORTS MED, V36, P393, DOI 10.2165/00007256-200636050-00003; Zebis MK, 2009, AM J SPORT MED, V37, P1967, DOI 10.1177/0363546509335000	46	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133147	10.1371/journal.pone.0133147	http://dx.doi.org/10.1371/journal.pone.0133147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222790	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000358836800040
J	Lee, SK; Bae, SY; Lee, JH; Lee, HC; Yi, H; Kil, WH; Lee, JE; Kim, SW; Nam, SJ				Lee, Se Kyung; Bae, Soo Youn; Lee, Jun Ho; Lee, Hyun-Chul; Yi, Hawoo; Kil, Won Ho; Lee, Jeong Eon; Kim, Seok Won; Nam, Seok Jin			Distinguishing Low-Risk Luminal A Breast Cancer Subtypes with Ki-67 and p53 Is More Predictive of Long-Term Survival	PLOS ONE			English	Article							PROGESTERONE-RECEPTOR; RECURRENCE SCORE; ESTROGEN-RECEPTOR; TUMOR PHENOTYPE; OVEREXPRESSION; THERAPY; ACCUMULATION; EXPRESSION; DIVERSITY	Overexpression of p53 is the most frequent genetic alteration in breast cancer. Recently, many studies have shown that the expression of mutant p53 differs for each subtype of breast cancer and is associated with different prognoses. In this study, we aimed to determine the suitable cut-off value to predict the clinical outcome of p53 overexpression and its usefulness as a prognostic factor in each subtype of breast cancer, especially in luminal A breast cancer. Approval was granted by the Institutional Review Board of Samsung Medical Center. We analyzed a total of 7,739 patients who were surgically treated for invasive breast cancer at Samsung Medical Center between Dec 1995 and Apr 2013. Luminal A subtype was defined as ER&PR + and HER2- and was further subclassified according to Ki-67 and p53 expression as follows: luminal A (Ki-67-,p53-), luminal A (Ki-67+, p53-), luminal A (Ki-67-, p53+) and luminal A (Ki-67+, p53+). Low-risk luminal A subtype was defined as negative for both Ki-67 and p53 (luminal A [ki-67-,p53-]), and others subtypes were considered to be high-risk luminal A breast cancer. A cut-off value of 10% for p53 was a good predictor of clinical outcome in all patients and luminal A breast cancer patients. The prognostic role of p53 overexpression for OS and DFS was only significant in luminal A subtype. The combination of p53 and Ki-67 has been shown to have the best predictive power as calculated by the area under curve (AUC), especially for long-term overall survival. In this study, we have shown that overexpression of p53 and Ki-67 could be used to discriminate low-risk luminal A subtype in breast cancer. Therefore, using the combination of p53 and Ki-67 expression in discriminating low-risk luminal A breast cancer may improve the prognostic power and provide the greatest clinical utility.	[Lee, Se Kyung; Bae, Soo Youn; Lee, Jun Ho; Lee, Hyun-Chul; Yi, Hawoo; Kil, Won Ho; Lee, Jeong Eon; Kim, Seok Won; Nam, Seok Jin] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Breast & Endocrine Surg,Dept Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Nam, SJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Breast & Endocrine Surg,Dept Surg, Seoul, South Korea.	seokjin.nam@samsung.com		Bae, Soo Youn/0000-0003-0551-7618				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Ahn SH, 2013, J BREAST CANCER, V16, P386, DOI 10.4048/jbc.2013.16.4.386; Allison KH, 2012, BREAST CANCER RES TR, V131, P413, DOI 10.1007/s10549-011-1416-3; Allred DC, 1998, MODERN PATHOL, V11, P155; Asad J, 2008, AM J SURG, V196, P527, DOI 10.1016/j.amjsurg.2008.06.021; Ciriello G, 2013, BREAST CANCER RES TR, V141, P409, DOI 10.1007/s10549-013-2699-3; Coutant C, 2011, CLIN CANCER RES, V17, P2591, DOI 10.1158/1078-0432.CCR-10-1045; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Desmedt C, 2012, CURR OPIN ONCOL, V24, P597, DOI 10.1097/CCO.0b013e328359554e; Dumay A, 2013, INT J CANCER, V132, P1227, DOI 10.1002/ijc.27767; Ellis MJ, 2013, CANCER DISCOV, V3, P27, DOI 10.1158/2159-8290.CD-12-0462; Feeley LP, 2014, MODERN PATHOL, V27, P554, DOI 10.1038/modpathol.2013.153; Flanagan MB, 2008, MODERN PATHOL, V21, P1255, DOI 10.1038/modpathol.2008.54; FRIEDRICHS K, 1993, CANCER, V72, P3641, DOI 10.1002/1097-0142(19931215)72:12<3641::AID-CNCR2820721215>3.0.CO;2-8; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Guarneri V, 2010, INT J BIOL MARKER, V25, P104, DOI 10.1177/172460081002500208; Hasebe T, 2010, MODERN PATHOL, V23, P662, DOI 10.1038/modpathol.2010.47; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kikuchi S, 2013, ANTICANCER RES, V33, P3891; Kim HS, 2010, BREAST CANCER RES TR, V121, P777, DOI 10.1007/s10549-009-0560-5; Lara JF, 2011, CLIN CANCER RES, V17, P5170, DOI 10.1158/1078-0432.CCR-11-0484; MARKS JR, 1994, ANN SURG, V219, P332, DOI 10.1097/00000658-199404000-00002; Mattes MD, 2013, CANCER INVEST, V31, P604, DOI 10.3109/07357907.2013.849725; Millar EKA, 2011, BRIT J CANCER, V105, P272, DOI 10.1038/bjc.2011.228; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Talley LI, 2008, BIOTECH HISTOCHEM, V83, P5, DOI 10.1080/10520290701822436; Yamamoto M, 2014, CANCER SCI, V105, P81, DOI 10.1111/cas.12302; Yamashita H, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1536	31	16	19	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0124658	10.1371/journal.pone.0124658	http://dx.doi.org/10.1371/journal.pone.0124658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241661	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942700001
J	Srikulnath, K; Uno, Y; Nishida, C; Ota, H; Matsuda, Y				Srikulnath, Kornsorn; Uno, Yoshinobu; Nishida, Chizuko; Ota, Hidetoshi; Matsuda, Yoichi			Karyotype Reorganization in the Hokou Gecko (Gekko hokouensis, Gekkonidae): The Process of Microchromosome Disappearance in Gekkota	PLOS ONE			English	Article							DIPLOID CHROMOSOME-NUMBER; SEX-CHROMOSOMES; DIPLODACTYLINAE GEKKONIDAE; EVOLUTIONARY RELATIONSHIPS; BANDING-PATTERNS; SQUAMATA; REPTILIA; LIZARDS; HOMOLOGY; REVEALS	The Hokou gecko (Gekko hokouensis: Gekkonidae, Gekkota, Squamata) has the chromosome number 2n = 38, with no microchromosomes. For molecular cytogenetic characterization of the gekkotan karyotype, we constructed a cytogenetic map for G. hokouensis, which retains the ancestral karyotype of Gekkota, with 86 functional genes, and compared it with cytogenetic maps for four Toxicofera species that have many microchromosomes (Elaphe quadrivirgata, Varanus salvator macromaculatus, Leiolepis reevesii rubritaeniata, and Anolis carolinensis) and that for a lacertid species (Lacerta agilis) with only one pair of autosomal microchromosomes. Ten pairs of G. hokouensis chromosomes [GHO1, 2, 3, Z(4), 6, 7, 8, 13, 14, and 15] showed highly conserved linkage homology with macrochromosomes and/or macrochromosome arms of the four Toxicofera species and corresponded to eight L. agilis macrochromosomes (LAG). However, GHO5, GHO9, GHO10, GHO11, and LAG6 were composed of chromosome segments that have a homology with Toxicofera microchromosomes, and no homology was found in the chromosomes between G. hokouensis and L. agilis. These results suggest that repeated fusions of microchromosomes may have occurred independently in each lineage of Gekkota and Lacertidae, leading to the disappearance of microchromosomes and appearance of small-sized macrochromosomes.	[Srikulnath, Kornsorn; Uno, Yoshinobu; Matsuda, Yoichi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Lab Anim Genet,Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Srikulnath, Kornsorn] Kasetsart Univ, Fac Sci, Dept Genet, Lab Anim Cytogenet & Comparat Genom, Bangkok, Thailand; [Srikulnath, Kornsorn] Kasetsart Univ, Natl Res Univ Kasetsart Univ CASTNAR, Ctr Adv Studies Trop Nat Resources, NRU KU, Bangkok, Thailand; [Nishida, Chizuko] Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, Kita Ku, Sapporo, Hokkaido 060, Japan; [Ota, Hidetoshi] Univ Hyogo, Inst Nat & Environm Sci, Sanda, Hyogo, Japan; [Ota, Hidetoshi] Museum Nat & Human Act, Sanda, Hyogo, Japan	Nagoya University; Kasetsart University; Kasetsart University; Hokkaido University; University of Hyogo	Srikulnath, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Lab Anim Genet,Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	kornsorn.s@ku.ac.th; yoimatsu@agr.nagoya-u.ac.jp	Srikulnath, Kornsorn/GLU-1326-2022	Srikulnath, Kornsorn/0000-0002-5985-7258; Uno, Yoshinobu/0000-0001-9609-1186	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [23113004, 22370081]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid for Scientific Research on Innovative Areas (No. 23113004) and Scientific Research (B) (No. 22370081) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Aprea G, 2013, AFR ZOOL, V48, P96; BICKHAM JW, 1983, CYTOLOGIA, V48, P177, DOI 10.1508/cytologia.48.177; BICKHAM JW, 1976, CHROMOSOMA, V54, P201, DOI 10.1007/BF00293451; COHEN M M, 1970, Cytogenetics (Basel), V9, P81, DOI 10.1159/000130080; Cole CJ, 1997, HERPETOLOGICA, V53, P229; Gamble T, 2008, ZOOL SCR, V37, P355, DOI 10.1111/j.1463-6409.2008.00330.x; Giovannotti M, 2009, CYTOGENET GENOME RES, V127, P224, DOI 10.1159/000295002; Gornung E, 2013, COMP CYTOGENET, V7, P153, DOI 10.3897/CompCytogen.v7i2.4881; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HUANG CC, 1967, CHROMOSOMA, V22, P1, DOI 10.1007/BF00291283; HUANG CC, 1971, CYTOGENETICS, V10, P10, DOI 10.1159/000130122; Kawai A, 2009, CHROMOSOMA, V118, P43, DOI 10.1007/s00412-008-0176-2; KING M, 1990, AUST J ZOOL, V38, P219, DOI 10.1071/ZO9900219; KING M, 1987, AUST J ZOOL, V35, P507, DOI 10.1071/ZO9870507; KING M, 1973, CYTOLOGIA, V38, P205, DOI 10.1508/cytologia.38.205; Koubova M, 2014, CHROMOSOME RES, V22, P441, DOI 10.1007/s10577-014-9430-z; Matsubara K, 2006, P NATL ACAD SCI USA, V103, P18190, DOI 10.1073/pnas.0605274103; Matsubara K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-604; MATSUDA Y, 1995, ELECTROPHORESIS, V16, P261, DOI 10.1002/elps.1150160142; Matsuda Y, 2005, CHROMOSOME RES, V13, P601, DOI 10.1007/s10577-005-0986-5; MCBEE K, 1984, J HERPETOL, V18, P83, DOI 10.2307/1563677; MCBEE K, 1987, J HERPETOL, V21, P68, DOI 10.2307/1564380; Norris TB, 2004, CYTOGENET GENOME RES, V105, P93, DOI 10.1159/000078014; Odierna G, 2002, MOL PHYLOGENET EVOL, V23, P37, DOI 10.1006/mpev.2001.1077; ODIERNA G, 1987, Amphibia-Reptilia, V8, P373, DOI 10.1163/156853887X00144; Odierna G., 1993, Amphibia-Reptilia, V14, P1, DOI 10.1163/156853893X00147; Odierna Gaetano, 1995, Amphibia-Reptilia, V16, P293, DOI 10.1163/156853895X00091; Olmo E., 1992, Revista Espanola de Herpetologia, V6, P81; OLMO E, 1987, CHROMOSOMA, V96, P33, DOI 10.1007/BF00285880; Ota H., 1989, P222; OTA H, 1989, HERPETOLOGICA, V45, P438; OTA H, 1992, CARYOLOGIA, V45, P43, DOI 10.1080/00087114.1992.10797209; Pellegrino KCM, 2009, CYTOGENET GENOME RES, V127, P191, DOI 10.1159/000295175; Pincheira-Donoso D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059741; Pokorna M, 2012, CHROMOSOMA, V121, P409, DOI 10.1007/s00412-012-0371-z; Pokorna M, 2011, CHROMOSOMA, V120, P455, DOI 10.1007/s00412-011-0322-0; Pokorna M, 2010, CHROMOSOME RES, V18, P809, DOI 10.1007/s10577-010-9154-7; Pokorna MJ, 2015, CHROMOSOME RES, V23, P299, DOI 10.1007/s10577-015-9468-6; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Ruiz-Herrera A, 2008, CYTOGENET GENOME RES, V122, P219, DOI 10.1159/000167807; SCHMID M, 1994, J HERED, V85, P255, DOI 10.1093/oxfordjournals.jhered.a111452; Shedlock Andrew M., 2009, P375; Shibaike Y, 2009, CYTOGENET GENOME RES, V127, P182, DOI 10.1159/000303334; Signorino G., 2005, CHROMOREP REPTILE CH; Srikulnath K, 2009, CYTOGENET GENOME RES, V125, P213, DOI 10.1159/000230005; Srikulnath K, 2014, CHROMOSOMA, V123, P563, DOI 10.1007/s00412-014-0467-8; Srikulnath K, 2013, CHROMOSOME RES, V21, P805, DOI 10.1007/s10577-013-9398-0; Srikulnath K, 2011, GENET MOL BIOL, V34, P582, DOI 10.1590/S1415-47572011005000042; Srikulnath K, 2009, CHROMOSOME RES, V17, P975, DOI 10.1007/s10577-009-9101-7; Toda M, 2001, ZOOL SCR, V30, P1, DOI 10.1046/j.1463-6409.2001.00053.x; Toda M, 2008, COPEIA, P452, DOI 10.1643/CH-06-281; Trifonov VA, 2011, CHROMOSOME RES, V19, P843, DOI 10.1007/s10577-011-9241-4; Uno Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053027; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Yonenaga-Yassuda Y, 2005, GENET MOL BIOL, V28, P700, DOI 10.1590/S1415-47572005000500009; YONENAGAYASSUDA Y, 1995, CYTOGENET CELL GENET, V70, P29, DOI 10.1159/000133985; Young MJ, 2013, CHROMOSOME RES, V21, P361, DOI 10.1007/s10577-013-9362-z	58	39	40	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134829	10.1371/journal.pone.0134829	http://dx.doi.org/10.1371/journal.pone.0134829			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241471	gold, Green Published, Green Submitted			2022-12-27	WOS:000358942700072
J	Bevilacqua, CB; Basu, S; Pereira, A; Tseng, TM; Zimmer, PD; Burgos, NR				Bevilacqua, Caroline Borges; Basu, Supratim; Pereira, Andy; Tseng, Te-Ming; Zimmer, Paulo Dejalma; Burgos, Nilda Roma			Analysis of Stress-Responsive Gene Expression in Cultivated and Weedy Rice Differing in Cold Stress Tolerance	PLOS ONE			English	Article							ORYZA-SATIVA L.; GENOME-WIDE ANALYSIS; HEAT-SHOCK PROTEINS; TRANSCRIPTION FACTOR; LOW-TEMPERATURE; INDICA RICE; GLUTAMATE-DEHYDROGENASE; SUBMERGENCE TOLERANCE; ASCORBATE PEROXIDASE; MOLECULAR RESPONSES	Rice (Oryza sativa L.) cultivars show impairment of growth in response to environmental stresses such as cold at the early seedling stage. Locally adapted weedy rice is able to survive under adverse environmental conditions, and can emerge in fields from greater soil depth. Cold-tolerant weedy rice can be a good genetic source for developing cold-tolerant, weed-competitive rice cultivars. An in-depth analysis is presented here of diverse indica and japonica rice genotypes, mostly weedy rice, for cold stress response to provide an understanding of different stress adaptive mechanisms towards improvement of the rice crop performance in the field. We have tested a collection of weedy rice genotypes to: 1) classify the subspecies (ssp.) grouping (japonica or indica) of 21 accessions; 2) evaluate their sensitivity to cold stress; and 3) analyze the expression of stress-responsive genes under cold stress and a combination of cold and depth stress. Seeds were germinated at 25 degrees C at 1.5- and 10-cm sowing depth for 10d. Seedlings were then exposed to cold stress at 10 degrees C for 6, 24 and 96h, and the expression of cold-, anoxia-, and submergence-inducible genes was analyzed. Control plants were seeded at 1.5cm depth and kept at 25 degrees C. The analysis revealed that cold stress signaling in indica genotypes is more complex than that of japonica as it operates via both the CBF-dependent and CBF-independent pathways, implicated through induction of transcription factors including OsNAC2, OsMYB46 and OsF-BOX28. When plants were exposed to cold + sowing depth stress, a complex signaling network was induced that involved cross talk between stresses mediated by CBF-dependent and CBF-independent pathways to circumvent the detrimental effects of stresses. The experiments revealed the importance of the CBF regulon for tolerance to both stresses in japonica and indica ssp. The mechanisms for cold tolerance differed among weedy indica genotypes and also between weedy indica and cultivated japonica ssp. as indicated by the up/downregulation of various stress-responsive pathways identified from gene expression analysis. The cold-stress response is described in relation to the stress signaling pathways, showing complex adaptive mechanisms in different genotypes.	[Bevilacqua, Caroline Borges; Zimmer, Paulo Dejalma] Univ Fed Pelotas, Capao Do Leao, RS, Brazil; [Basu, Supratim; Pereira, Andy; Tseng, Te-Ming; Burgos, Nilda Roma] Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA	Universidade Federal de Pelotas; University of Arkansas System; University of Arkansas Fayetteville	Burgos, NR (corresponding author), Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA.	nburgos@uark.edu	Tseng, Te-Ming/AAJ-5860-2021; Pereira, Andy/AAF-4781-2020	Pereira, Andy/0000-0003-1378-4273; Tseng, Te-Ming Paul/0000-0002-8102-8149	National Research Initiative (NRI), United States of America [2009-35320-05036]; National Science Foundation (NSF), United States of America [DBI-0922747]; CNPq, Brasil; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	National Research Initiative (NRI), United States of America; National Science Foundation (NSF), United States of America(National Science Foundation (NSF)); CNPq, Brasil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by The National Research Initiative (NRI), United States of America, Grant #2009-35320-05036: NRB, The National Science Foundation (NSF), United States of America, Grant #DBI-0922747: AP and CNPq, Brasil: PDZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed A, 2012, PLANT CELL PHYSIOL, V53, P1445, DOI 10.1093/pcp/pcs089; Allagulova CR, 2003, BIOCHEMISTRY-MOSCOW+, V68, P945, DOI 10.1023/A:1026077825584; Andaya VC, 2003, J EXP BOT, V54, P2579, DOI 10.1093/jxb/erg243; Baek JS, 2012, RICE, V5, DOI 10.1186/1939-8433-5-21; Baruah AR, 2009, EUPHYTICA, V165, P459, DOI 10.1007/s10681-008-9753-y; Basu S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/706890; BECK E, 1989, ANNU REV PLANT PHYS, V40, P95, DOI 10.1146/annurev.pp.40.060189.000523; BOARD JE, 1980, AGRON J, V72, P483, DOI 10.2134/agronj1980.00021962007200030019x; Bosetti F, 2012, BREEDING SCI, V62, P209, DOI 10.1270/jsbbs.62.209; Caverzan A, 2012, GENET MOL BIOL, V35, P1011, DOI 10.1590/S1415-47572012000600016; Cheng C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-175; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; CHRISTIE PJ, 1991, PLANT PHYSIOL, V95, P699, DOI 10.1104/pp.95.3.699; Cosgrove DJ, 1999, ANNU REV PLANT PHYS, V50, P391, DOI 10.1146/annurev.arplant.50.1.391; Cruz Renata Pereira da, 2004, Sci. agric. (Piracicaba, Braz.), V61, P1, DOI 10.1590/S0103-90162004000100001; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; DOLFERUS R, 1994, PLANT PHYSIOL, V105, P1075, DOI 10.1104/pp.105.4.1075; Druka A, 2002, P NATL ACAD SCI USA, V99, P850, DOI 10.1073/pnas.022627999; Dubois M, 2013, PLANT PHYSIOL, V162, P319, DOI 10.1104/pp.113.216341; DUMAS B, 1993, CR ACAD SCI III-VIE, V316, P793; EHLERINGER JR, 1993, ANNU REV ECOL SYST, V24, P411, DOI 10.1146/annurev.es.24.110193.002211; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Franco-Zorrilla JM, 2014, P NATL ACAD SCI USA, V111, P2367, DOI 10.1073/pnas.1316278111; Frank G, 2009, J EXP BOT, V60, P3891, DOI 10.1093/jxb/erp234; Fukao T, 2011, PLANT CELL, V23, P412, DOI 10.1105/tpc.110.080325; Ganguly M, 2012, PLANT SIGNAL BEHAV, V7, P502, DOI 10.4161/psb.19646; Gealy DR, 2013, PLANT SOIL, V370, P277, DOI 10.1007/s11104-013-1587-2; Gealy DR, 2000, WEED TECHNOL, V14, P406, DOI 10.1614/0890-037X(2000)014[0406:EORROS]2.0.CO;2; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Gregorio G.B., 1997, IRRI DISCUSSION PAPE, P1; Gross BL, 2009, NEW PHYTOL, V184, P842, DOI 10.1111/j.1469-8137.2009.02957.x; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Herbek JH, 1988, SOYBEAN PRODUCTION; Himmelbach A, 2010, PLANT CELL, V22, P937, DOI 10.1105/tpc.109.067934; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Huang J, 2000, PLANTA, V211, P467, DOI 10.1007/s004250000311; Ismond KP, 2003, PLANT PHYSIOL, V132, P1292, DOI 10.1104/pp.103.022244; Jacobs BC, 1999, J AGRON CROP SCI, V182, P79, DOI 10.1046/j.1439-037x.1999.00259.x; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Karki S, 2013, RICE, V6, DOI 10.1186/1939-8433-6-28; Kaw R. N., 1986, Rice genetics. Proceedings of the International Rice Genetics Symposium, 27-31 May, 1985, Manila, Philippines., P593; Kim WC, 2014, PLANT MOL BIOL, V85, P589, DOI 10.1007/s11103-014-0205-x; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kumar RG, 2000, PLANT SCI, V156, P23, DOI 10.1016/S0168-9452(00)00224-7; Lasanthi-Kudahettige R, 2007, PLANT PHYSIOL, V144, P218, DOI 10.1104/pp.106.093997; Lata C, 2011, ABIOTIC STRESS RESPONSE IN PLANTS - PHYSIOLOGICAL, BIOCHEMICAL AND GENETIC PERSPECTIVES, P269; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lee BH, 2002, PLANT CELL, V14, P1235, DOI 10.1105/tpc.010433; Lee SJ, 2010, PLANT PHYSIOL, V153, P716, DOI 10.1104/pp.110.154617; Levitt J., 1980, RESPONSES PLANTS ENV, V1, P496; Lim CJ, 2007, BIOCHEM BIOPH RES CO, V362, P431, DOI 10.1016/j.bbrc.2007.08.007; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loreti E, 2005, PLANT PHYSIOL, V137, P1130, DOI 10.1104/pp.104.057299; Lourenco T, 2013, PLANT MOL BIOL, V83, P351, DOI 10.1007/s11103-013-0092-6; Mackill DJ, 1997, CROP SCI, V37, P1340, DOI 10.2135/cropsci1997.0011183X003700040051x; Malone Gaspar, 2007, Rev. bras. sementes, V29, P61, DOI 10.1590/S0101-31222007000100009; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Matsukura S, 2010, MOL GENET GENOMICS, V283, P185, DOI 10.1007/s00438-009-0506-y; Miflin BJ, 2002, J EXP BOT, V53, P979, DOI 10.1093/jexbot/53.370.979; Moons A, 1997, PLANT CELL, V9, P2243, DOI 10.1105/tpc.9.12.2243; Mori M, 2011, BREEDING SCI, V61, P61, DOI 10.1270/jsbbs.61.61; Nahar K., 2009, BOT RES INT, V2, P295, DOI DOI 10.1142/S1793536909000047; Nakamura C, 2012, TROPICAL AGR RES EXT, V14, P25; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Pegoraro C, 2013, THEOR EXP PLANT PHYS, V25, P261, DOI 10.1590/S2197-00252013000400004; da Cruz RP, 2006, GENET MOL BIOL, V29, P314, DOI 10.1590/S1415-47572006000200020; Pnueli L, 2003, PLANT J, V34, P187, DOI 10.1046/j.1365-313X.2003.01715.x; Ramankutty N, 2002, GLOBAL ECOL BIOGEOGR, V11, P377, DOI 10.1046/j.1466-822x.2002.00294.x; Roychoudhury A, 2008, PLANT CELL REP, V27, P1395, DOI 10.1007/s00299-008-0556-3; Roychoudhury A, 2009, ACTA PHYSIOL PLANT, V31, P915, DOI 10.1007/s11738-009-0305-4; Sanghera GS, 2011, CURR GENOMICS, V12, P30, DOI 10.2174/138920211794520178; Sasidharan R, 2011, CRIT REV PLANT SCI, V30, P548, DOI 10.1080/07352689.2011.615706; Satake T., 1976, CLIMATE AND RICE, P281; Sato A, 2006, J AM SOC HORTIC SCI, V131, P185, DOI 10.21273/JASHS.131.2.185; Sato Y, 2011, PLANT CELL REP, V30, P399, DOI 10.1007/s00299-010-0985-7; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shi JL, 2012, MOL BREEDING, V29, P743, DOI 10.1007/s11032-011-9587-5; Shimono H, 2005, AGRON J, V97, P1524, DOI 10.2134/agronj2005.0043; Shinozaki K, 1996, CURR OPIN BIOTECH, V7, P161, DOI 10.1016/S0958-1669(96)80007-3; Shivrain VK, 2009, WEED SCI, V57, P94, DOI 10.1614/WS-08-112.1; Skopelitis DS, 2006, PLANT CELL, V18, P2767, DOI 10.1105/tpc.105.038323; Soltani A, 2002, SEED SCI TECHNOL, V30, P51; SOUZA P. R., 1990, LAVOURA ARROZEIRA, V43, P9; Srivastava A.K., 2006, ENG PRINCIPLES AGR M, V2nd; Steffens B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00685; Steponkus P.L., 1993, ADV LOW TEMPERATURE, V2, P211; Sthapit BR, 1998, CROP SCI, V38, P660, DOI 10.2135/cropsci1998.0011183X003800030007x; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Su CF, 2010, PLANT PHYSIOL, V153, P145, DOI 10.1104/pp.110.153015; Vannini C, 2004, PLANT J, V37, P115, DOI 10.1046/j.1365-313X.2003.01938.x; Vaughan LK, 2001, WEED SCI, V49, P468, DOI 10.1614/0043-1745(2001)049[0468:IARRFI]2.0.CO;2; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Xu LM, 2008, PLANT SCI, V174, P340, DOI 10.1016/j.plantsci.2007.12.003; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yu SM, 1996, PLANT MOL BIOL, V30, P1277, DOI 10.1007/BF00019558; Yu ZM, 2011, PLANT J, V66, P725, DOI 10.1111/j.1365-313X.2011.04533.x; Zhang H, 2011, PLANT SIGNAL BEHAV, V6, P861, DOI 10.4161/psb.6.6.15223; Zhang JA, 2011, PLANT PHYSIOL BIOCH, V49, P33, DOI 10.1016/j.plaphy.2010.09.014; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zimmermann G, 2006, PLANT PHYSIOL, V142, P181, DOI 10.1104/pp.106.083824	105	28	31	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132100	10.1371/journal.pone.0132100	http://dx.doi.org/10.1371/journal.pone.0132100			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230579	Green Submitted, gold, Green Published			2022-12-27	WOS:000358838400015
J	Cao, QQ; Wang, RQ; Zhang, HJ; Ge, XL; Liu, J				Cao, Qingqing; Wang, Renqing; Zhang, Haijie; Ge, Xiuli; Liu, Jian			Distribution of Organic Carbon in the Sediments of Xinxue River and the Xinxue River Constructed Wetland, China	PLOS ONE			English	Article							FRESH-WATER WETLANDS; LIGHT-FRACTION; GLOBAL DISTRIBUTION; METHANE EMISSION; HEAVY-FRACTION; MATTER; NITROGEN; MINERALIZATION; VEGETATION; LABILE	Wetland ecosystems are represented as a significant reservoir of organic carbon and play an important role in mitigating the greenhouse effect. In order to compare the compositions and distribution of organic carbon in constructed and natural river wetlands, sediments from the Xinxue River Constructed Wetland and the Xinxue River, China, were sampled at two depths (0-15 cm and 15-25 cm) in both upstream and downstream locations. Three types of organic carbon were determined: light fraction organic carbon, heavy fraction organic carbon, and dissolved organic carbon. The results show that variations in light fraction organic carbon are significantly larger between upstream and downstream locations than they are between the two wetland types; however, the opposite trend is observed for the dissolved organic carbon. There are no significant differences in the distribution of heavy fraction organic carbon between the discrete variables (e.g., between the two depths, the two locations, or the two wetland types). However, there are significant cross-variable differences; for example, the distribution patterns of heavy fraction organic carbon between wetland types and depths, and between wetland types and locations. Correlation analysis reveals that light fraction organic carbon is positively associated with light fraction nitrogen in both wetlands, while heavy fraction organic carbon is associated with both heavy fraction nitrogen and the moisture content in the constructed wetland. The results of this study demonstrate that the constructed wetland, which has a relatively low background value of heavy fraction organic carbon, is gradually accumulating organic carbon of different types, with the level of accumulation dependent on the balance between carbon accumulation and carbon decomposition. In contrast, the river wetland has relatively stable levels of organic carbon.	[Cao, Qingqing; Wang, Renqing; Zhang, Haijie; Liu, Jian] Shandong Univ, Inst Environm Res, Jinan 250100, Peoples R China; [Wang, Renqing] Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China; [Ge, Xiuli] Qilu Univ Technol, Sch Environm Sci & Engn, Jinan 250353, Peoples R China	Shandong University; Shandong University; Qilu University of Technology	Liu, J (corresponding author), Shandong Univ, Inst Environm Res, Jinan 250100, Peoples R China.	ecology@sdu.edu.cn	Liu, Jian/AAG-9184-2019; Liu, Jian/T-1760-2017	Liu, Jian/0000-0003-1920-2641; Liu, Jian/0000-0003-1920-2641	National Water Special Project [2012ZX07203-004]; National Natural Science Foundation of China [31200426, 31400356]	National Water Special Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by "National Water Special Project" (No. 2012ZX07203-004) and "National Natural Science Foundation of China" (No. 31200426; No. 31400356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Angers DA, 2008, SOIL SCI SOC AM J, V72, P1370, DOI 10.2136/sssaj2007.0342; [Anonymous], 2007, US FOREST CARBON CLI; ASELMANN I, 1989, J ATMOS CHEM, V8, P307, DOI 10.1007/BF00052709; BALDOCK JA, 1992, BIOGEOCHEMISTRY, V16, P1, DOI 10.1007/BF02402261; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; BOONE RD, 1994, SOIL BIOL BIOCHEM, V26, P1459, DOI 10.1016/0038-0717(94)90085-X; Brander LM, 2006, ENVIRON RESOUR ECON, V33, P223, DOI 10.1007/s10640-005-3104-4; Braskerud BC, 2001, J ENVIRON QUAL, V30, P1447, DOI 10.2134/jeq2001.3041447x; Brevik EC, 2004, CATENA, V57, P221, DOI 10.1016/j.catena.2003.12.001; Bridgham SD, 2006, WETLANDS, V26, P889, DOI 10.1672/0277-5212(2006)26[889:TCBONA]2.0.CO;2; Bridgham SD, 1998, ECOLOGY, V79, P1545, DOI 10.1890/0012-9658(1998)079[1545:CNAPMI]2.0.CO;2; CHIOU CT, 1986, ENVIRON SCI TECHNOL, V20, P502, DOI 10.1021/es00147a010; Clay GD, 2009, J HYDROL, V367, P41, DOI 10.1016/j.jhydrol.2008.12.022; Compton JE, 2002, SOIL BIOL BIOCHEM, V34, P933, DOI 10.1016/S0038-0717(02)00025-1; Dittmar T, 2008, LIMNOL OCEANOGR-METH, V6, P230, DOI 10.4319/lom.2008.6.230; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Furukawa K, 1997, ESTUAR COAST SHELF S, V44, P301, DOI 10.1006/ecss.1996.0120; Gosselink J.G., 2000, WETLANDS; Gregorich EG, 1996, SOIL SCI, V161, P680, DOI 10.1097/00010694-199610000-00005; Haynes RJ, 2000, SOIL BIOL BIOCHEM, V32, P211, DOI 10.1016/S0038-0717(99)00148-0; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; Huang LB, 2012, ECOL INFORM, V10, P49, DOI 10.1016/j.ecoinf.2011.11.001; Hui Y., 2009, WSEAS ISAA, V6, P1790; Jastrow J. D., 1997, SOIL PROCESSES CARBO; Jin XB, 2008, BIOL FERT SOILS, V44, P997, DOI 10.1007/s00374-008-0310-6; Jokic A, 2003, GEOCHIM COSMOCHIM AC, V67, P2585, DOI 10.1016/S0016-7037(03)00101-7; Jones DL, 2006, SOIL BIOL BIOCHEM, V38, P991, DOI 10.1016/j.soilbio.2005.08.012; KADLEC RH, 1990, J HYDRAUL ENG-ASCE, V116, P691, DOI 10.1061/(ASCE)0733-9429(1990)116:5(691); Kansiime Frank, 2007, Wetlands Ecology and Management, V15, P443, DOI 10.1007/s11273-007-9043-9; Kayranli B, 2010, WETLANDS, V30, P111, DOI 10.1007/s13157-009-0003-4; Lal R, 2008, PHILOS T R SOC B, V363, P815, DOI 10.1098/rstb.2007.2185; Lehmann J, 2007, NATURE, V447, P143, DOI 10.1038/447143a; Matthews E, 1987, GLOBAL BIOGEOCHEM CY, V1, P61, DOI 10.1029/GB001i001p00061; Moran MA, 1997, LIMNOL OCEANOGR, V42, P1307, DOI 10.4319/lo.1997.42.6.1307; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Robertson MM, 2004, GEOFORUM, V35, P361, DOI 10.1016/j.geoforum.2003.06.002; Roulet N, 2006, NATURE, V444, P283, DOI 10.1038/444283a; Sakadevan K, 1998, WATER RES, V32, P393, DOI 10.1016/S0043-1354(97)00271-6; Schuyt KD, 2005, ECOL ECON, V53, P177, DOI 10.1016/j.ecolecon.2004.08.003; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Sohi SP, 2001, SOIL SCI SOC AM J, V65, P1121, DOI 10.2136/sssaj2001.6541121x; SOLLINS P, 1984, SOIL BIOL BIOCHEM, V16, P31, DOI 10.1016/0038-0717(84)90122-6; Tan Z, 2007, SOIL TILL RES, V92, P53, DOI 10.1016/j.still.2006.01.003; Thomas GW, 1996, METHODS SOIL ANAL PA, P475; Tiner R.W., 1999, WETLAND INDICATORS G; Waldrop MP, 2006, ECOSYSTEMS, V9, P921, DOI 10.1007/s10021-004-0149-0; WESTRICH JT, 1984, LIMNOL OCEANOGR, V29, P236, DOI 10.4319/lo.1984.29.2.0236; Whiting GJ, 2001, TELLUS B, V53, P521, DOI 10.1034/j.1600-0889.2001.530501.x; Yang YS, 2009, PLANT SOIL, V323, P153, DOI 10.1007/s11104-009-9921-4; YAVITT JB, 1987, BIOGEOCHEMISTRY, V4, P141, DOI 10.1007/BF02180152; Zhang DQ, 2009, ECOL ENG, V35, P1367, DOI 10.1016/j.ecoleng.2009.07.007; [张建 ZHANG Jian], 2008, [中国给水排水, China Water & Wastewater], V24, P49; ZHANG W.J, 2005, ENV SCI, V26, P56, DOI DOI 10.1007/s10971-005-6694-y; [张文菊 Zhang Wenju], 2004, [地球科学进展, Advance in Earth Sciences], V19, P558	55	15	15	9	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134713	10.1371/journal.pone.0134713	http://dx.doi.org/10.1371/journal.pone.0134713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230255	Green Submitted, gold, Green Published			2022-12-27	WOS:000358838400154
J	Gong, XQ; Yang, JE; Tang, JM; Gu, C; Huang, LJ; Zheng, Y; Liang, HQ; Wang, M; Wu, CC; Chen, Y; Zhang, MY; Yu, ZJ; Mao, QG				Gong, Xianqiong; Yang, Jiaen; Tang, Jinmo; Gu, Chong; Huang, Lijian; Zheng, Ying; Liang, Huiqing; Wang, Min; Wu, Chuncheng; Chen, Yue; Zhang, Manying; Yu, Zhijian; Mao, Qianguo			A Mechanistic Assessment of the Discordance between Normal Serum Alanine Aminotransferase Levels and Altered Liver Histology in Chronic Hepatitis B	PLOS ONE			English	Article							PERSISTENTLY NORMAL ALT; ASIAN-AMERICANS; VIRUS INFECTION; CUTOFF VALUES; CARRIERS; DNA; DISEASE; UPDATE; PHASE; HBEAG	To understand the mechanisms underlying the discordance between normal serum alanine aminotransferase (ALT) levels and significant alterations in liver histology of chronic hepatitis B virus (HBV) infection with persistent normal ALT (PNALT) or minimally elevated ALT. A total of 300 treatment-naive chronic HBV-infected patients with PNALT (ALT <= upper limit of normal [ULN, 40 U/ml]) or minimally elevated ALT (1-2xULN) were retrospectively enrolled. All patients underwent liver biopsy and histological changes were analyzed along with biochemical and HBV markers. Among 300 participants, 177 were HBeAg-positive and 123 HBeAg-negative. Significant histologic abnormalities were found in 42.9% (76/177) and 52.8% (65/123) of HBeAg-positive and HBeAg-negative patients, respectively. Significant fibrosis, which is a marker of prior injury, was more frequently detected than significant necroinflammation (suggesting active liver injury) in both HBeAg-positive and -negative groups, suggesting that liver injury occurred intermittently in our cohort. No significant differences were noticed in the percentage of patients with severe fibrosis between HBeAg-positive and negative phases or between ages 30 and 40 and over 40, suggesting that the fibrosis was possibly carried over from an early phase. Finally, lowering ALT ULN (30 U/L for men, 19 U/L for women) alone was not adequate to increase the sensitivity of ALT detection of liver injury. However, the study was limited to a small sample size of 13 HBeAg-positive patients with ALT in the revised normal range. We detected significant liver pathology in almost 50% of chronic HBV infected patients with PNALT (ALT <= 40 U/ml) or minimally elevated ALT. We postulated that small-scale intermittent liver injury was possibly responsible for the discordance between normal serum ALT and significant liver changes in our cohort.	[Gong, Xianqiong; Yang, Jiaen; Tang, Jinmo; Gu, Chong; Huang, Lijian; Zheng, Ying; Liang, Huiqing; Wang, Min; Wu, Chuncheng; Chen, Yue; Zhang, Manying; Mao, Qianguo] Xiamen Hosp Tradit Chinese Med, Hepatol Unit, Xiamen, Fujian, Peoples R China; [Yu, Zhijian] Shenzhen Nanshan Hosp, Shenzhen Key Lab Endogenous Infect, Shenzhen, Guangdong, Peoples R China		Mao, QG (corresponding author), Xiamen Hosp Tradit Chinese Med, Hepatol Unit, Xiamen, Fujian, Peoples R China.	maoqg1962@163.com			Xiamen Science and Technology program [3502Z20134022]; Youth Foundation of Health Department of Fujian Province [2013-2-96]; Medical Innovation Project of Fujian Province [2014-CXB-45]; Shenzhen Scientific. Research Program of the People's Republic of China [JCYJ20130402151227167]	Xiamen Science and Technology program; Youth Foundation of Health Department of Fujian Province; Medical Innovation Project of Fujian Province; Shenzhen Scientific. Research Program of the People's Republic of China	This work was supported by grants from Xiamen Science and Technology program (No. 3502Z20134022), Youth Foundation of Health Department of Fujian Province (No. 2013-2-96), Medical Innovation Project of Fujian Province (No. 2014-CXB-45), and Shenzhen Scientific. Research Program of the People's Republic of China (No. JCYJ20130402151227167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahtab M, 2011, DIGESTION, V83, P60, DOI 10.1159/000319758; Andreani T, 2007, CLIN GASTROENTEROL H, V5, P636, DOI 10.1016/j.cgh.2007.01.005; Assy N, 2009, WORLD J GASTROENTERO, V15, P3025, DOI 10.3748/wjg.15.3025; Bertoletti A, 2015, CELL MOL IMMUNOL, V12, P258, DOI 10.1038/cmi.2014.79; Chen EQ, 2010, DIGEST DIS SCI, V55, P432, DOI 10.1007/s10620-009-0724-5; Gui HL, 2010, J VIRAL HEPATITIS, V17, P44, DOI 10.1111/j.1365-2893.2010.01270.x; Hsu YN, 2014, DIGEST DIS SCI, V59, P865, DOI 10.1007/s10620-014-3054-1; Ijaz B, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-86; Kennedy PTF, 2012, GASTROENTEROLOGY, V143, P637, DOI 10.1053/j.gastro.2012.06.009; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Lee JK, 2010, HEPATOLOGY, V51, P1577, DOI 10.1002/hep.23505; Liao BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078672; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Nguyen MH, 2009, AM J GASTROENTEROL, V104, P2206, DOI 10.1038/ajg.2009.248; Ocama Ponsiano, 2005, Am J Med, V118, P1413, DOI 10.1016/j.amjmed.2005.06.021; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Papatheodoridis GV, 2012, J HEPATOL, V57, P196, DOI 10.1016/j.jhep.2011.11.030; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Seto WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032622; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080585; Zoulim F, 2012, GUT, V61, P333, DOI 10.1136/gutjnl-2011-300937	24	13	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134532	10.1371/journal.pone.0134532	http://dx.doi.org/10.1371/journal.pone.0134532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230094	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400131
J	Kakigi, C; Kasuga, T; Wang, SY; Singh, K; Hiratsuka, Y; Murakami, A; Lin, SC				Kakigi, Caitlin; Kasuga, Toshimitsu; Wang, Sophia Y.; Singh, Kuldev; Hiratsuka, Yoshimune; Murakami, Akira; Lin, Shan C.			Hypothyroidism and Glaucoma in The United States	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; ASSOCIATION; POPULATION; VALIDITY; RISK	Purpose To investigate the association between hypothyroidism and glaucomatous disease. Methods This cross-sectional study included all subjects above the age of 40 years from two nationwide surveys: the 2008 National Health Interview Survey (NHIS) as well as the 2007 and 2008 National Health and Nutrition Examination Survey (NHANES). The presence or absence of glaucoma, thyroid disease and other demographic and health-related information including comorbidities was ascertained via interview. Blood samples were collected from NHANES subjects and analyzed for thyrotropin (TSH). Results A total of 13,599 and 3,839 NHIS and NHANES participants respectively were analyzed to assess for a possible relationship between self-reported glaucoma, and self-reported hypothyroidism as well as self-reported thyroid disease. The unadjusted odds ratio (OR) for NHIS showed a significant association between self-reported glaucoma and self-reported hypothyroidism (OR 1.46, 95% confidence interval [CI] 1.07-1.99). Multivariate logistic regression analysis adjusted for age, gender, race, comorbidities, and health-related behavior, however, showed no association between self-reported glaucoma and hypothyroidism or thyroid disease in both surveys (OR 1.60, 95% CI 0.87-2.95 for NHIS; OR 1.05, 95% CI 0.59-1.88 for NHANES). Conclusion A previously reported association between hypothyroidism and glaucomatous disease was not confirmed in two large U.S. health survey populations. While such an association was noted in the univariate analysis for the NHIS survey, such a relationship was not found in the multivariate analysis after adjustment for potential confounding variables.	[Kakigi, Caitlin; Kasuga, Toshimitsu; Wang, Sophia Y.; Lin, Shan C.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Kasuga, Toshimitsu; Hiratsuka, Yoshimune; Murakami, Akira] Juntendo Univ, Sch Med, Dept Ophthalmol, Tokyo 113, Japan; [Singh, Kuldev] Stanford Univ, Dept Ophthalmol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Juntendo University; Stanford University	Lin, SC (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.	LinS@vision.ucsf.edu		Wang, Sophia/0000-0003-0916-9403	NIH-NEI - Core Grant for Vision Research [EY002162]; That Man May See, Inc; Research to prevent Blindness; NATIONAL EYE INSTITUTE [P30EY002162] Funding Source: NIH RePORTER	NIH-NEI - Core Grant for Vision Research; That Man May See, Inc; Research to prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH-NEI EY002162 - Core Grant for Vision Research; That Man May See, Inc (http://thatmanmaysee.org/); and Research to prevent Blindness.(http://www.rpbusa.org/rpb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boles Carenini B, 1997, ACTA OPHTHALMOL SC S, P47; Brix TH, 2001, THYROID, V11, P769, DOI 10.1089/10507250152484619; Calissendorff J, 2011, BRIT J OPHTHALMOL, V95, P592, DOI 10.1136/bjo.2010.195032; Centanni M, 1997, EUR J ENDOCRINOL, V136, P595, DOI 10.1530/eje.0.1360595; Cross JM, 2008, BRIT J OPHTHALMOL, V92, P1503, DOI 10.1136/bjo.2008.147165; Gillow JT, 1997, EYE, V11, P113, DOI 10.1038/eye.1997.22; Hertel G, 1920, KLIN MONBL AUGENHEIL, V64, P390; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Karadimas P, 2001, AM J OPHTHALMOL, V131, P126, DOI 10.1016/S0002-9394(00)00724-8; Kim M, 2012, JPN J OPHTHALMOL, V56, P324, DOI 10.1007/s10384-012-0153-4; Lee a J, 2004, EYE, V18, P600; Lin HC, 2010, OPHTHALMOLOGY, V117, P1960, DOI 10.1016/j.ophtha.2010.02.005; McDaniel D, 1996, J Am Optom Assoc, V67, P109; Motsko SP, 2008, OPHTHALMOLOGY, V115, P1581, DOI 10.1016/j.ophtha.2008.01.016; Munoz-Negrete FJ, 2000, OPHTHALMOLOGICA, V214, P347, DOI 10.1159/000027518; Patty L, 2012, OPHTHALMOLOGY, V119, P1725, DOI 10.1016/j.ophtha.2012.02.029; RITCH R, 1994, OPHTHALMOLOGY, V101, P623; SMITH KD, 1992, CAN J OPHTHALMOL, V27, P345; SMITH KD, 1993, OPHTHALMOLOGY, V100, P1580; SMITH KD, 1992, CAN J OPHTHALMOL, V27, P341	20	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133688	10.1371/journal.pone.0133688	http://dx.doi.org/10.1371/journal.pone.0133688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230664	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400049
J	Kawalec, M; Boratynska-Jasinska, A; Beresewicz, M; Dymkowska, D; Zablocki, K; Zablocka, B				Kawalec, Maria; Boratynska-Jasinska, Anna; Beresewicz, Malgorzata; Dymkowska, Dorota; Zablocki, Krzysztof; Zablocka, Barbara			Mitofusin 2 Deficiency Affects Energy Metabolism and Mitochondrial Biogenesis in MEF Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; REAL-TIME; MFN2; GENE; EXPRESSION; DNA; MUTATION	Mitofusin 2 (Mfn2), mitochondrial outer membrane protein which is involved in rearrangement of these organelles, was first described in pathology of hypertension and diabetes, and more recently much attention is paid to its functions in Charcot-Marie-Tooth type 2A neuropathy (CMT2A). Here, cellular energy metabolism was investigated in mouse embryonic fibroblasts (MEF) differing in the presence of the Mfn2 gene; control (MEFwt) and with Mfn2 gene depleted MEFMfn2-/-. These two cell lines were compared in terms of various parameters characterizing mitochondrial bioenergetics. Here, we have shown that relative rate of proliferation of MEFMfn2-/- cells versus control fibroblasts depend on serum supplementation of the growth media. Moreover, MEFMfn2-/- cells exhibited significantly increased respiration rate in comparison to MEFwt, regardless of serum supplementation of the medium. This effect was correlated with increased level of mitochondrial markers (TOM20 and NAO) as well as mitochondrial transcription factor A (TFAM) and peroxisome proliferator- activated receptor gamma coactivator 1-alpha (PGC-1 alpha) protein levels and unchanged total ATP content. Interestingly, mitochondrial DNA content in MEFMfn2-/- cells was not reduced. Fundamentally, these results are in contrast to a commonly accepted belief that mitofusin 2 deficiency inevitably results in debilitation of mitochondrial energy metabolism. However, we suggest a balance between negative metabolic consequences of mitofusin 2 deficiency and adaptive processes exemplified by increased level of PGC-1 alpha and TFAM transcription factor which prevent an excessive depletion of mtDNA and severe impairment of cell metabolism.	[Kawalec, Maria; Boratynska-Jasinska, Anna; Beresewicz, Malgorzata; Zablocka, Barbara] PAS, Mol Biol Unit, Mossakowski Med Res Ctr, Warsaw, Poland; [Dymkowska, Dorota; Zablocki, Krzysztof] PAS, Dept Biochem, Nencki Inst Expt Biol, Warsaw, Poland	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Zablocki, K (corresponding author), PAS, Dept Biochem, Nencki Inst Expt Biol, Warsaw, Poland.	k.zablocki@nencki.gov.pl	Boratyńska-Jasińska, Anna/AAQ-9352-2021; Beresewicz Haller, Malgorzata/AAG-2147-2020; Dymkowska, Dorota/AAB-5193-2021; Zablocki, Krzysztof/R-4181-2016	Beresewicz Haller, Malgorzata/0000-0002-2204-5184; Dymkowska, Dorota/0000-0003-4798-4062; Zablocka, Barbara/0000-0003-3116-7295; Boratynska-Jasinska, Anna/0000-0003-1337-3175; Zablocki, Krzysztof/0000-0002-9987-1257	Narodowe Centrum Nauki grant [NN402474640]	Narodowe Centrum Nauki grant(National Science Centre, Poland)	This work was supported by Narodowe Centrum Nauki grant number NN402474640. BioTech Poland Sp. z o.o. provided the access to the xCELLigence RTCA DP Instrument.	[Anonymous], [No title captured]; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Cartoni R, 2010, BRAIN, V133, P1460, DOI 10.1093/brain/awq082; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Chen KH, 2014, FASEB J, V28, P382, DOI 10.1096/fj.13-230037; Cossarizza A., 2001, CURR PROTOC CYTOM, DOI [10.1002/0471142956.cy0914s13, DOI 10.1002/0471142956.CY0914S13]; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Ding YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121328; Dorn GW, 2013, CIRC J, V77, P1370, DOI 10.1253/circj.CJ-13-0453; Filadi R, 2015, P NATL ACAD SCI USA, V112, pE2174, DOI 10.1073/pnas.1504880112; Ghezzi D, 2012, ADV EXP MED BIOL, V748, P65, DOI 10.1007/978-1-4614-3573-0_4; Huang PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020655; Kang D, 2005, ANN NY ACAD SCI, V1042, P101, DOI 10.1196/annals.1338.010; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; KunzSchughart LA, 1997, AM J PHYSIOL-CELL PH, V273, pC1487, DOI 10.1152/ajpcell.1997.273.5.C1487; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loiseau D, 2007, ANN NEUROL, V61, P315, DOI 10.1002/ana.21086; Moniri MR, 2015, CYTOTECHNOLOGY, V67, P379, DOI 10.1007/s10616-014-9692-5; Myers MB, 2009, BIOTECHNIQUES, V47, P867, DOI 10.2144/000113222; Onopiuk M, 2009, BIOCHEM BIOPH RES CO, V386, P463, DOI 10.1016/j.bbrc.2009.06.053; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Pitceathly RDS, 2012, NEUROLOGY, V79, P1145, DOI 10.1212/WNL.0b013e3182698d8d; Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323; Sabar M, 2005, PLANT J, V44, P893, DOI 10.1111/j.1365-313X.2005.02577.x; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Segales J, 2013, AM J PHYSIOL-ENDOC M, V305, pE1208, DOI 10.1152/ajpendo.00546.2012; Son MJ, 2015, CELL DEATH DIFFER, V22, P1957, DOI 10.1038/cdd.2015.43; Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126; Vielhaber S, 2013, ACTA NEUROPATHOL, V125, P245, DOI 10.1007/s00401-012-1036-y; Williamson J.R., 1969, METHOD ENZYMOL, V13, P434, DOI 10.1016/0076-687913072-4; Yan LJ, 2009, ANAL BIOCHEM, V389, P143, DOI 10.1016/j.ab.2009.03.043; Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004	34	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134162	10.1371/journal.pone.0134162	http://dx.doi.org/10.1371/journal.pone.0134162			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230519	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400081
J	Zhang, LY; Guo, SH; Wu, B				Zhang, Lingyan; Guo, Shuhai; Wu, Bo			The Source, Spatial Distribution and Risk Assessment of Heavy Metals in Soil from the Pearl River Delta Based on the National Multi-Purpose Regional Geochemical Survey	PLOS ONE			English	Article							MAGNETIC-PROPERTIES; CONTAMINATION; MERCURY; MULTIVARIATE; SEDIMENTS; POLLUTION; ELEMENTS; TREND; CHINA	The data on the heavy metal content at different soil depths derived from a multi-purpose regional geochemical survey in the Pearl River Delta (PRD) were analyzed using ArcGIS 10.0. By comparing their spatial distributions and areas, the sources of heavy metals (Cd, Hg, As and Pb) were quantitatively identified and explored. Netted measuring points at 25 x25 km were set over the entire PRD according to the geochemical maps. Based on the calculation data obtained from different soil depths, the concentrations of As and Cd in a large area of the PRD exceeded the National Second-class Standard. The spatial disparity of the geometric centers in the surface soil and deep soil showed that As in the surface soil mainly came from parent materials, while Cd had high consistency in different soil profiles because of deposition in the soil forming process. The migration of Cd also resulted in a considerable ecological risk to the Beijiang and Xijiang River watershed. The potential ecological risk index followed the order Cd >= Hg > Pb > As. According to the sources, the distribution trends and the characteristics of heavy metals in the soil from the perspective of the whole area, the Cd pollution should be repaired, especially in the upper reaches of the Xijiang and Beijiang watershed to prevent risk explosion while the pollution of Hg and Pb should be controlled in areas with intense human activity, and supervision during production should be strengthened to maintain the ecological balance of As.	[Zhang, Lingyan; Guo, Shuhai; Wu, Bo] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China; [Zhang, Lingyan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Guo, SH (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China.	shuhaiguo@iae.ac.cn			Special Public Welfare Scientific Project of the Ministry of Land and Resources. Multi-source Data Fusion and Regionalization of Agricultural Land with Heavy Metal Exceeding the Standard [201511082-05]; Science and Technology Service Network of Chinese Academic of Sciences. The Study of Soil Environment Regionalization on the Provincial Scale [KFJ-EW-STS-013]	Special Public Welfare Scientific Project of the Ministry of Land and Resources. Multi-source Data Fusion and Regionalization of Agricultural Land with Heavy Metal Exceeding the Standard; Science and Technology Service Network of Chinese Academic of Sciences. The Study of Soil Environment Regionalization on the Provincial Scale	Author SHG receives the following funding: (1) the Special Public Welfare Scientific Project of the Ministry of Land and Resources. Multi-source Data Fusion and Regionalization of Agricultural Land with Heavy Metal Exceeding the Standard (No. 201511082-05), (2) Science and Technology Service Network of Chinese Academic of Sciences. The Study of Soil Environment Regionalization on the Provincial Scale (KFJ-EW-STS-013).	Ahn JS, 2005, ENVIRON GEOCHEM HLTH, V27, P147, DOI 10.1007/s10653-005-0121-8; Bai JM, 2014, ENVIRON MONIT ASSESS, V186, P8051, DOI 10.1007/s10661-014-4050-9; Bian Y, 2014, J APPL GEOPHYS, V107, P36, DOI 10.1016/j.jappgeo.2014.05.003; Biasioli M, 2012, CHEMOSPHERE, V88, P1241, DOI 10.1016/j.chemosphere.2012.03.081; Blundell A, 2009, EARTH-SCI REV, V95, P158, DOI 10.1016/j.earscirev.2009.05.001; Boruvka L, 2005, GEODERMA, V128, P289, DOI 10.1016/j.geoderma.2005.04.010; CHEN JS, 1991, WATER AIR SOIL POLL, V57-8, P699, DOI 10.1007/BF00282934; Chen LG, 2012, CHEMOSPHERE, V88, P612, DOI 10.1016/j.chemosphere.2012.03.041; [成杭新 Cheng Hangxin], 2005, [第四纪研究, Quaternary Sciences], V25, P285; China Geological Survey, 2005, CRIT NAT MULT REG GE; China National Environmental Monitoring Centre, 1990, SOIL EL BACKGR VAL C; Dou M, 2013, ENVIRON MONIT ASSESS, V185, P7501, DOI 10.1007/s10661-013-3115-5; Duan DD, 2014, CHEMOSPHERE, V103, P35, DOI 10.1016/j.chemosphere.2013.11.011; Fialova H, 2006, J APPL GEOPHYS, V59, P273, DOI 10.1016/j.jappgeo.2005.10.006; Godin P, 1986, THESIS I NATL AGRONO; Gowd SS, 2010, J HAZARD MATER, V174, P113, DOI 10.1016/j.jhazmat.2009.09.024; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; Hou EQ, 2014, FORESTS, V5, P885, DOI 10.3390/f5050885; Li M, 2014, J GEOCHEM EXPLOR, V139, P21, DOI 10.1016/j.gexplo.2013.06.002; Li RZ, 2010, CHINESE GEOGR SCI, V20, P9, DOI 10.1007/s11769-010-0009-0; Lin CJ, 1999, ATMOS ENVIRON, V33, P2067, DOI 10.1016/S1352-2310(98)00387-2; Lindberg S, 2007, AMBIO, V36, P19, DOI 10.1579/0044-7447(2007)36[19:ASOPAU]2.0.CO;2; Liu HY, 2005, SCI TOTAL ENVIRON, V339, P153, DOI 10.1016/j.scitotenv.2004.07.030; Lowers HA, 2007, GEOCHIM COSMOCHIM AC, V71, P2699, DOI 10.1016/j.gca.2007.03.022; Lu AX, 2012, SCI TOTAL ENVIRON, V425, P66, DOI 10.1016/j.scitotenv.2012.03.003; Martin JAR, 2006, ENVIRON POLLUT, V144, P1001, DOI 10.1016/j.envpol.2006.01.045; Roussel C, 2000, J ENVIRON QUAL, V29, P182, DOI 10.2134/jeq2000.00472425002900010023x; Selin NE, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003040; Sterckeman T, 2000, ENVIRON POLLUT, V107, P377, DOI 10.1016/S0269-7491(99)00165-7; Tian HZ, 2010, ATMOS CHEM PHYS, V10, P11905, DOI 10.5194/acp-10-11905-2010; Wang Y, 2014, J GEOCHEM EXPLOR, V138, P72, DOI 10.1016/j.gexplo.2013.12.012; Xi XH, 2011, MULTIPURPOSE REGIONA; Yu H, 2014, J GEOCHEM EXPLOR, V146, P136, DOI 10.1016/j.gexplo.2014.08.010; Yu JB, 2002, CHINESE GEOGR SCI, V12, P268, DOI 10.1007/s11769-002-0013-0; Zheng JY, 2011, SCI TOTAL ENVIRON, V412, P214, DOI 10.1016/j.scitotenv.2011.10.024	35	16	18	3	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132040	10.1371/journal.pone.0132040	http://dx.doi.org/10.1371/journal.pone.0132040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230506	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400014
J	Bach, DR; Furl, N; Barnes, G; Dolan, RJ				Bach, Dominik R.; Furl, Nicholas; Barnes, Gareth; Dolan, Raymond J.			Sustained Magnetic Responses in Temporal Cortex Reflect Instantaneous Significance of Approaching and Receding Sounds	PLOS ONE			English	Article							LOOMING SIGNALS; MULTISENSORY INTEGRATION; AUDITORY-CORTEX; RHESUS-MONKEYS; HUMAN AMYGDALA; PERCEPTION; ARRIVAL; BRAIN; TIME; MODALITY	Rising sound intensity often signals an approaching sound source and can serve as a powerful warning cue, eliciting phasic attention, perception biases and emotional responses. How the evaluation of approaching sounds unfolds over time remains elusive. Here, we capitalised on the temporal resolution of magnetoencephalograpy (MEG) to investigate in humans a dynamic encoding of perceiving approaching and receding sounds. We compared magnetic responses to intensity envelopes of complex sounds to those of white noise sounds, in which intensity change is not perceived as approaching. Sustained magnetic fields over temporal sensors tracked intensity change in complex sounds in an approximately linear fashion, an effect not seen for intensity change in white noise sounds, or for overall intensity. Hence, these fields are likely to track approach/recession, but not the apparent ( instantaneous) distance of the sound source, or its intensity as such. As a likely source of this activity, the bilateral inferior temporal gyrus and right temporo-parietal junction emerged. Our results indicate that discrete temporal cortical areas parametrically encode behavioural significance in moving sound sources where the signal unfolded in a manner reminiscent of evidence accumulation. This may help an understanding of how acoustic percepts are evaluated as behaviourally relevant, where our results highlight a crucial role of cortical areas.	[Bach, Dominik R.; Furl, Nicholas; Barnes, Gareth; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Bach, Dominik R.] Univ Zurich, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland; [Furl, Nicholas] Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge, England	University of London; University College London; University of Zurich; University of Cambridge	Bach, DR (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.	dominik.bach@uzh.ch	Barnes, Gareth/ABB-7650-2020; Bach, Dominik R/B-4302-2019	Barnes, Gareth/0000-0002-5396-7712; Bach, Dominik R/0000-0003-3717-2036; furl, nicholas/0000-0003-2488-1343	Wellcome Trust [098362/Z/12/Z, 091593/Z/10/Z]; Swiss National Science Foundation [PA117384]; Medical Research Council [MR/K005464/1]; MRC [MR/K005464/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Wellcome Trust [RJD, Senior Investigator Award 098362/Z/12/Z], the Swiss National Science Foundation [DRB, Advanced Postdoctoral Mobility Fellowship PA117384], and the Medical Research Council [GB, Partnership Grant MR/K005464/1]. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust [091593/Z/10/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KC, 1999, J NEUROSCI, V19, P2681; Bach DR, 2008, CEREB CORTEX, V18, P145, DOI 10.1093/cercor/bhm040; Bach DR, 2009, INT J PSYCHOPHYSIOL, V74, P28, DOI 10.1016/j.ijpsycho.2009.06.004; Cappe C, 2009, NEUROPSYCHOLOGIA, V47, P1045, DOI 10.1016/j.neuropsychologia.2008.11.003; Cappe C, 2012, J NEUROSCI, V32, P1171, DOI 10.1523/JNEUROSCI.5517-11.2012; Clarke SE, 2013, P NATL ACAD SCI USA, V110, P13624, DOI 10.1073/pnas.1306428110; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; EDWORTHY J, 1991, HUM FACTORS, V33, P205, DOI 10.1177/001872089103300206; Friston KJ, 2008, NEUROIMAGE, V39, P1104, DOI 10.1016/j.neuroimage.2007.09.048; Ghazanfar AA, 2002, P NATL ACAD SCI USA, V99, P15755, DOI 10.1073/pnas.242469699; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gordon MS, 2013, ATTEN PERCEPT PSYCHO, V75, P738, DOI 10.3758/s13414-013-0424-2; Gordon MS, 2005, PERCEPT PSYCHOPHYS, V67, P580, DOI 10.3758/BF03193516; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Leo F, 2011, EXP BRAIN RES, V213, P193, DOI 10.1007/s00221-011-2742-8; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Maier JX, 2008, CURR BIOL, V18, P963, DOI 10.1016/j.cub.2008.05.043; Maier JX, 2007, J NEUROSCI, V27, P4093, DOI 10.1523/JNEUROSCI.0330-07.2007; Maier JX, 2004, NEURON, V43, P177, DOI 10.1016/j.neuron.2004.06.027; Neuhoff JG, 1998, NATURE, V395, P123, DOI 10.1038/25862; Neuhoff JG, 2001, ECOL PSYCHOL, V13, P87, DOI 10.1207/S15326969ECO1302_2; Neuhoff JG, 2009, J EXP PSYCHOL HUMAN, V35, P225, DOI 10.1037/a0013159; Romei V, 2009, CURR BIOL, V19, P1799, DOI 10.1016/j.cub.2009.09.027; Sacco T, 2010, SCIENCE, V329, P649, DOI 10.1126/science.1183165; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; SCHIFF W, 1990, J EXP PSYCHOL HUMAN, V16, P303, DOI 10.1037/0096-1523.16.2.303; Seifritz E, 2002, CURR BIOL, V12, P2147, DOI 10.1016/S0960-9822(02)01356-8; Stein BE, 2009, EXP BRAIN RES, V198, P113, DOI 10.1007/s00221-009-1880-8; Sutherland CAM, 2014, COGNITION, V132, P312, DOI 10.1016/j.cognition.2014.04.011; Tajadura-Jimenez A, 2010, EMOTION, V10, P216, DOI 10.1037/a0018422; Tyll S, 2013, NEUROIMAGE, V65, P13, DOI 10.1016/j.neuroimage.2012.09.056; Uppenkamp S, 2014, HEARING RES, V307, P65, DOI 10.1016/j.heares.2013.08.005; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	35	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134060	10.1371/journal.pone.0134060	http://dx.doi.org/10.1371/journal.pone.0134060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226395	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000358837700055
J	Chukwuma, VU; Hicar, MD; Chen, XM; Nicholas, KJ; Joyner, A; Kalams, SA; Landucci, G; Forthal, DN; Spearman, PW; Crowe, JE				Chukwuma, Valentine U.; Hicar, Mark D.; Chen, Xuemin; Nicholas, Katherine J.; Joyner, Amanda; Kalams, Spyros A.; Landucci, Gary; Forthal, Donald N.; Spearman, Paul W.; Crowe, James E., Jr.			Association of V(H)4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MONOCLONAL-ANTIBODIES; MATRIX PROTEIN; B-CELLS; MEMBRANE-BINDING; STRUCTURAL BASIS; IGG ANTIBODIES; LIFE-CYCLE; P17; PARTICLES	The human antibody response against HIV-1 infection recognizes diverse antigenic subunits of the virion, and includes a high level of antibodies to the Gag protein. We report here the isolation and characterization of a subset of Gag-specific human monoclonal antibodies (mAbs) that were prevalent in the antibody repertoire of an HIV-infected individual. Several lineages of Gag-specifc mAbs were encoded by a single antibody heavy chain variable region, V(H)4-59, and a representative antibody from this group designated mAb 3E4 recognized a linear epitope on the globular head of the p17 subunit of Gag. We found no evidence that mAb 3E4 exhibited any function in laboratory studies aimed at elucidating the immunologic activity, including assays for neutralization, Ab-dependent cell-mediated virus inhibition, or enhanced T cell reactivity caused by Gag-3E4 complexes. The findings suggest this immunodominant epitope in Gag protein, which is associated with V(H)4-59 germline gene usage, may induce a high level of B cells that encode binding but non-functional antibodies that occupy significant repertoire space following HIV infection. The studies define an additional specific molecular mechanism in the immune distraction activity of the HIV virion.	[Chukwuma, Valentine U.; Nicholas, Katherine J.; Joyner, Amanda; Kalams, Spyros A.; Crowe, James E., Jr.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Hicar, Mark D.; Crowe, James E., Jr.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Kalams, Spyros A.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Crowe, James E., Jr.] Vanderbilt Univ, Vanderbilt Vaccine Ctr, Microbiol & Immunol, Nashville, TN 37235 USA; [Chen, Xuemin; Spearman, Paul W.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Chen, Xuemin; Spearman, Paul W.] Emory Univ, Sch Med, Dept Microbiol, Atlanta, GA USA; [Chen, Xuemin; Spearman, Paul W.] Emory Univ, Sch Med, Dept Immunol, Atlanta, GA USA; [Spearman, Paul W.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Landucci, Gary; Forthal, Donald N.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Emory University; Emory University; Emory University; Children's Healthcare of Atlanta (CHOA); University of California System; University of California Irvine	Crowe, JE (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.	james.crowe@vanderbilt.edu	Crowe, James/B-5549-2009	Crowe, James/0000-0002-0049-1079	NIAID, NIH [U01 AI-078407, P30 AI-054999]; Vanderbilt-Meharry Center for AIDS Research [P30 AI-054999]; Emory Center for AIDS Research [P30-AI50409]; Pediatric Infectious Diseases Society-St. Jude Children's Research Hospital Fellowship Program in Basic Research; NIH [K08 AI 083078]; IDSA ERF; Wyeth Vaccines Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125119, U01AI078407, P30AI054999, K08AI083078, R01AI084834, P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111027] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Vanderbilt-Meharry Center for AIDS Research; Emory Center for AIDS Research; Pediatric Infectious Diseases Society-St. Jude Children's Research Hospital Fellowship Program in Basic Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IDSA ERF; Wyeth Vaccines Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by U01 AI-078407 (NIAID, NIH), P30 AI-054999 (NIAID, NIH; the Vanderbilt-Meharry Center for AIDS Research), and P30-AI50409 (Emory Center for AIDS Research). MDH was supported by a Pediatric Infectious Diseases Society-St. Jude Children's Research Hospital Fellowship Program in Basic Research and NIH K08 AI 083078, and portions of this work were performed as the Young Investigator Award recipient of the IDSA ERF and NFID sponsored by Wyeth Vaccines Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avnir Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004103; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Binley JM, 1997, J VIROL, V71, P2799, DOI 10.1128/JVI.71.4.2799-2809.1997; Chan CH, 2001, BLOOD, V97, P1023, DOI 10.1182/blood.V97.4.1023; CHARGELEGUE D, 1995, CLIN EXP IMMUNOL, V99, P175, DOI 10.1111/j.1365-2249.1995.tb05529.x; De Francesco MA, 1998, AIDS, V12, P245, DOI 10.1097/00002030-199803000-00001; De Francesco MA, 2002, P NATL ACAD SCI USA, V99, P9972, DOI 10.1073/pnas.142274699; Doan LX, 2005, REV MED VIROL, V15, P75, DOI 10.1002/rmv.449; FERNS RB, 1989, AIDS, V3, P829, DOI 10.1097/00002030-198912000-00008; Finn JA, 2013, CURR OPIN IMMUNOL, V25, P613, DOI 10.1016/j.coi.2013.09.010; Forthal DN, 2001, J VIROL, V75, P6953, DOI 10.1128/JVI.75.15.6953-6961.2001; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; GELDERBLOM HR, 1991, AIDS, V5, P617, DOI 10.1097/00002030-199106000-00001; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Gorny MK, 2009, MOL IMMUNOL, V46, P917, DOI 10.1016/j.molimm.2008.09.005; Hicar MD, 2010, JAIDS-J ACQ IMM DEF, V54, P223, DOI 10.1097/QAI.0b013e3181dc98a3; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Jalaguier P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028314; Joyner AS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002234; Kageyama S, 1996, ACTA VIROL, V40, P195; Li S, 2010, NEW MICROBIOL, V33, P13; Nicholas KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084185; NIEDRIG M, 1988, J GEN VIROL, V69, P2109, DOI 10.1099/0022-1317-69-8-2109; Ota A, 1998, HYBRIDOMA, V17, P73, DOI 10.1089/hyb.1998.17.73; PAPSIDERO LD, 1989, J VIROL, V63, P267, DOI 10.1128/JVI.63.1.267-272.1989; Perez M, 2010, BRIT J DERMATOL, V162, P611, DOI 10.1111/j.1365-2133.2009.09576.x; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; ROBEY WG, 1985, SCIENCE, V228, P593, DOI 10.1126/science.2984774; SHANG F, 1991, J VIROL, V65, P4798, DOI 10.1128/JVI.65.9.4798-4804.1991; SPEARMAN P, 1994, J VIROL, V68, P3232, DOI 10.1128/JVI.68.5.3232-3242.1994; Spearman P, 1997, J VIROL, V71, P6582, DOI 10.1128/JVI.71.9.6582-6592.1997; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Truong C, 1997, J MED VIROL, V51, P145, DOI 10.1002/(SICI)1096-9071(199703)51:3&lt;145::AID-JMV2&gt;3.0.CO;2-6; Weitkamp JH, 2005, J IMMUNOL, V174, P3454, DOI 10.4049/jimmunol.174.6.3454; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; YU XF, 1992, J VIROL, V66, P5667, DOI 10.1128/JVI.66.9.5667-5670.1992	37	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133509	10.1371/journal.pone.0133509	http://dx.doi.org/10.1371/journal.pone.0133509			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226263	Green Published, gold			2022-12-27	WOS:000358837700024
J	Lewis, J; Mengersen, K; Buys, L; Vine, D; Bell, J; Morris, P; Ledwich, G				Lewis, Jim; Mengersen, Kerrie; Buys, Laurie; Vine, Desley; Bell, John; Morris, Peter; Ledwich, Gerard			Systems Modelling of the Socio-Technical Aspects of Residential Electricity Use and Network Peak Demand	PLOS ONE			English	Article							BAYESIAN NETWORKS; ENERGY-CONSUMPTION; SUSTAINABILITY; COMPLEX	Provision of network infrastructure to meet rising network peak demand is increasing the cost of electricity. Addressing this demand is a major imperative for Australian electricity agencies. The network peak demand model reported in this paper provides a quantified decision support tool and a means of understanding the key influences and impacts on network peak demand. An investigation of the system factors impacting residential consumers' peak demand for electricity was undertaken in Queensland, Australia. Technical factors, such as the customers' location, housing construction and appliances, were combined with social factors, such as household demographics, culture, trust and knowledge, and Change Management Options (CMOs) such as tariffs, price, managed supply, etc., in a conceptual 'map' of the system. A Bayesian network was used to quantify the model and provide insights into the major influential factors and their interactions. The model was also used to examine the reduction in network peak demand with different market-based and government interventions in various customer locations of interest and investigate the relative importance of instituting programs that build trust and knowledge through well designed customer-industry engagement activities. The Bayesian network was implemented via a spreadsheet with a tickbox interface. The model combined available data from industry-specific and public sources with relevant expert opinion. The results revealed that the most effective intervention strategies involve combining particular CMOs with associated education and engagement activities. The model demonstrated the importance of designing interventions that take into account the interactions of the various elements of the socio-technical system. The options that provided the greatest impact on peak demand were Off-Peak Tariffs and Managed Supply and increases in the price of electricity. The impact in peak demand reduction differed for each of the locations and highlighted that household numbers, demographics as well as the different climates were significant factors. It presented possible network peak demand reductions which would delay any upgrade of networks, resulting in savings for Queensland utilities and ultimately for households. The use of this systems approach using Bayesian networks to assist the management of peak demand in different modelled locations in Queensland provided insights about the most important elements in the system and the intervention strategies that could be tailored to the targeted customer segments.	[Lewis, Jim; Mengersen, Kerrie; Bell, John; Ledwich, Gerard] Queensland Univ Technol, Fac Sci & Engn, Brisbane, Qld 4001, Australia; [Buys, Laurie; Vine, Desley; Morris, Peter] Queensland Univ Technol, Creat Ind Fac, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Lewis, J (corresponding author), Queensland Univ Technol, Fac Sci & Engn, Brisbane, Qld 4001, Australia.	james.lewis@connect.qut.edu.au	Mengersen, Kerrie/AHC-4096-2022; Ledwich, Gerard F/I-9684-2012	Ledwich, Gerard F/0000-0001-7474-0309; Lewis, Jim/0000-0003-4484-8567; Buys, Laurie/0000-0001-8917-0863; Vine, Desley/0000-0002-8414-9210; Mengersen, Kerrie/0000-0001-8625-9168	Australian Research Council's Linkage Project funding scheme [LP110201139]	Australian Research Council's Linkage Project funding scheme(Australian Research Council)	This research was supported under Australian Research Council's Linkage Project funding scheme (project number LP110201139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and views expressed in this article are those of the authors and are not necessarily those of the Australian Research Council.	Aguilera PA, 2011, ENVIRON MODELL SOFTW, V26, P1376, DOI 10.1016/j.envsoft.2011.06.004; Bednarski M, 2004, ENG APPL ARTIF INTEL, V17, P327, DOI 10.1016/j.engappai.2004.03.011; Buys L, 2014, J ENVIRON MANAGE, V133, P184, DOI 10.1016/j.jenvman.2013.12.013; Buys L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121195; Cain J, 2001, PLANNING IMPROVEMENT; Choy S. Low, 2009, 18 WORLD IMACS C MOD; Crosbie T., 2006, ENERGY ENV, V17, P735, DOI DOI 10.1260/0958-305X.17.5.735; DEEDI, 2009, EN CONS DEM MAN PROG; Energex Limited Ergon Energy Corporation, 2014, REW BAS TAR TRIAL SU; Ergon Energy, 2012, INTERNAL REPORT; Faruqui A., 2007, ELECT J, V20, P68, DOI DOI 10.1016/J.TEJ.2007.08.003; Fenton N, 2013, RISK ASSESSMENT DECI, Vxix, P503; Getoor L, 2004, ARTIF INTELL MED, V30, P233, DOI 10.1016/j.artmed.2003.11.003; Gyamfi S, 2011, ENERG POLICY, V39, P2993, DOI 10.1016/j.enpol.2011.03.012; Jensen F. V., 2007, BAYESIAN NETWORKS DE, DOI DOI 10.1007/978-0-387-68282-2; Johnson S, 2010, ECOL MODEL, V221, P641, DOI 10.1016/j.ecolmodel.2009.11.012; Kahneman D., 1982, JUDGEMENT UNCERTAINT; Keirstead J, 2006, ENERG POLICY, V34, P3065, DOI 10.1016/j.enpol.2005.06.004; Keshtkar AR, 2013, ECOL MODEL, V268, P48, DOI 10.1016/j.ecolmodel.2013.08.003; Kurtz CF, 2003, IBM SYST J, V42, P462, DOI 10.1147/sj.423.0462; Lengler R, 2007, IASTED P C GRAPH VIS, P6; LUTZENHISER L, 1992, ENERGY, V17, P47, DOI 10.1016/0360-5442(92)90032-U; LUTZENHISER L, 1993, ANNU REV ENERG ENV, V18, P247, DOI 10.1146/annurev.energy.18.1.247; Lutzenhiser L, 2008, BEH EN CLIM CHANG C; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Pitchforth J, 2013, EXPERT SYST APPL, V40, P162, DOI 10.1016/j.eswa.2012.07.026; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Simshauser P., 2011, ELECT J, V24, P72, DOI DOI 10.1016/J.TEJ.2010.12.001; Smith C, 2012, DIVERS DISTRIB, V18, P818, DOI 10.1111/j.1472-4642.2011.00871.x; Spees K, 2007, ELECT J, V20, P69, DOI DOI 10.1016/J.TEJ.2007.01.006; Steg L, 2008, ENERG POLICY, V36, P4449, DOI 10.1016/j.enpol.2008.09.027; Stephenson J, 2010, ENERG POLICY, V38, P6120, DOI 10.1016/j.enpol.2010.05.069; Strengers Y, 2012, ENERG POLICY, V44, P226, DOI 10.1016/j.enpol.2012.01.046; Uusitalo L, 2007, ECOL MODEL, V203, P312, DOI 10.1016/j.ecolmodel.2006.11.033; Wilson C, 2007, ANNU REV ENV RESOUR, V32, P169, DOI 10.1146/annurev.energy.32.053006.141137; Wilson CM, 2010, OXFORD ECON PAP, V62, P647, DOI 10.1093/oep/gpq006	36	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134086	10.1371/journal.pone.0134086	http://dx.doi.org/10.1371/journal.pone.0134086			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JT	26226511	gold, Green Submitted, Green Published			2022-12-27	WOS:000358837700056
J	Ni, F; Kondrashkina, E; Wang, QH				Ni, Fengyun; Kondrashkina, Elena; Wang, Qinghua			Structural and Functional Studies of Influenza Virus A/H6 Hemagglutinin	PLOS ONE			English	Article							RECEPTOR-BINDING PROPERTIES; WILD AQUATIC BIRDS; A VIRUS; HUMAN INFECTION; HUMAN H1; SPECIFICITY; ORIGIN; H6; DETERMINANTS; PREFERENCES	In June 2013, the first human infection by avian influenza A(H6N1) virus was reported in Taiwan. This incident raised the concern for possible human epidemics and pandemics from H6 viruses. In this study, we performed structural and functional investigation on the hemagglutinin (HA) proteins of the human-infecting A/Taiwan/2/2013(H6N1) (TW H6) virus and an avian A/chicken/Guangdong/S1311/2010(H6N6) (GD H6) virus that transmitted efficiently in guinea pigs. Our results revealed that in the presence of HA(1) Q226, the triad of HA(1) S137, E190 and G228 in GD H6 HA allows the binding to both avian-and human-like receptors with a slight preference for avian receptors. Its conservation among the majority of H6 HAs provides an explanation for the broader host range of this subtype. Furthermore, the triad of N137, V190 and S228 in TW H6 HA may alleviate the requirement for a hydrophobic residue at HA(1) 226 of H2 and H3 HAs when binding to human-like receptors. Consequently, TW H6 HA has a slight preference for human receptors, thus may represent an intermediate towards a complete human adaptation. Importantly, the triad observed in TW H6 HA is detected in 74% H6 viruses isolated from Taiwan in the past 14 years, suggesting an elevated threat of H6 viruses from this region to human health. The novel roles of the triad at HA(1) 137, 190 and 228 of H6 HA in binding to receptors revealed here may also be used by other HA subtypes to achieve human adaptation, which needs to be further tested in laboratory and closely monitored in field surveillance.	[Ni, Fengyun; Wang, Qinghua] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Kondrashkina, Elena] Northwestern Univ, Synchrotron Res Ctr, Life Sci Collaborat Access Team, Argonne, IL USA	Baylor College of Medicine; Northwestern University	Wang, QH (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	qinghuaw@bcm.edu			National Institutes of Health [R01-AI067839]; Gillson-Longenbaugh Foundation; Welch Foundation [Q-1826]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gillson-Longenbaugh Foundation; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	QW acknowledges support from the National Institutes of Health (R01-AI067839), the Gillson-Longenbaugh Foundation, and The Welch Foundation (Q-1826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bottcher-Friebertshauser E, 2014, CURR TOP MICROBIOL, V385, P3, DOI 10.1007/82_2014_384; Byrd-Leotis L, 2014, P NATL ACAD SCI USA, V111, pE2241, DOI 10.1073/pnas.1323162111; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng KH, 2014, ARCH VIROL, V159, P2275, DOI 10.1007/s00705-014-2058-7; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gambaryan AS, 1997, VIROLOGY, V232, P345, DOI 10.1006/viro.1997.8572; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gillim-Ross L, 2008, J VIROL, V82, P10854, DOI 10.1128/JVI.01206-08; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; He JL, 2015, VIRUS RES, V197, P101, DOI 10.1016/j.virusres.2014.12.010; Ito T, 1997, J VIROL, V71, P3357, DOI 10.1128/JVI.71.4.3357-3362.1997; Jernigan D, 2013, MMWR-MORBID MORTAL W, V62, P366; Kayali G, 2010, ZOONOSES PUBLIC HLTH, V57, P265, DOI 10.1111/j.1863-2378.2009.01231.x; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lin TW, 2009, VIROLOGY, V392, P73, DOI 10.1016/j.virol.2009.06.028; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; NAEVE CW, 1984, J VIROL, V51, P567, DOI 10.1128/JVI.51.2.567-569.1984; Nam JH, 2011, J VIROL, V85, P13271, DOI 10.1128/JVI.05038-11; Ni FY, 2013, VIROLOGY, V446, P112, DOI 10.1016/j.virol.2013.07.035; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Qi L, 2014, MBIO, V5, DOI 10.1128/mBio.02116-14; ROGERS GN, 1985, J BIOL CHEM, V260, P7362; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; ROGERS GN, 1989, VIROLOGY, V173, P317, DOI 10.1016/0042-6822(89)90249-3; Shi WF, 2013, PROTEIN CELL, V4, P846, DOI 10.1007/s13238-013-3083-0; Shi Y, 2014, NAT REV MICROBIOL, V12, P822, DOI 10.1038/nrmicro3362; Shi Y, 2013, SCIENCE, V342, P243, DOI 10.1126/science.1242917; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Tharakaraman K, 2013, CELL, V153, P1486, DOI 10.1016/j.cell.2013.05.034; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Tzarum N, 2015, CELL HOST MICROBE, V17, P369, DOI 10.1016/j.chom.2015.02.005; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Wang F., 2015, EMBO J; Wang GJ, 2014, J VIROL, V88, P3953, DOI 10.1128/JVI.03292-13; Wei SH, 2013, LANCET RESP MED, V1, P771, DOI 10.1016/S2213-2600(13)70221-2; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Xiong XL, 2014, CURR TOP MICROBIOL, V385, P63, DOI 10.1007/82_2014_423; Xiong XL, 2013, NATURE, V499, P496, DOI 10.1038/nature12372; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144; Yang H, 2015, J VIROL, V89, P4612, DOI 10.1128/JVI.03456-14; Yang H, 2015, VIROLOGY, V477, P18, DOI 10.1016/j.virol.2014.12.024; Yang H, 2013, J VIROL, V87, P12433, DOI 10.1128/JVI.01854-13; Yuan J, 2013, CLIN INFECT DIS, V57, P1367, DOI 10.1093/cid/cit479; Zhang GH, 2011, INFECT GENET EVOL, V11, P1174, DOI 10.1016/j.meegid.2011.02.023; Zhang W, 2013, SCIENCE, V340, P1463, DOI 10.1126/science.1236787	63	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134576	10.1371/journal.pone.0134576	http://dx.doi.org/10.1371/journal.pone.0134576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226046	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700112
J	Pedro, SLS; Alves, JMP; Barreto, AS; Lima, AOD				Sao Pedro, Simone Lima; Pereira Alves, Joao Marcelo; Barreto, Andre Silva; de Souza Lima, Andre Oliveira			Evidence of Positive Selection of Aquaporins Genes from Pontoporia blainvillei during the Evolutionary Process of Cetaceans	PLOS ONE			English	Article							AMINO-ACID SITES; PHYLOGENETIC ANALYSIS; WATER CHANNEL; SWISS-MODEL; KIDNEY; EXPRESSION; MEMBRANE; CLONING; OSMOREGULATION; COMPLEXES	Background Marine mammals are well adapted to their hyperosmotic environment. Several morphological and physiological adaptations for water conservation and salt excretion are known to be present in cetaceans, being responsible for regulating salt balance. However, most previous studies have focused on the unique renal physiology of marine mammals, but the molecular bases of these mechanisms remain poorly explored. Many genes have been identified to be involved in osmotic regulation, including the aquaporins. Considering that aquaporin genes were potentially subject to strong selective pressure, the aim of this study was to analyze the molecular evolution of seven aquaporin genes (AQP1, AQP2, AQP3, AQP4, AQP6, AQP7, and AQP9) comparing the lineages of cetaceans and terrestrial mammals. Results Our results demonstrated strong positive selection in cetacean-specific lineages acting only in the gene for AQP2 (amino acids 23, 83, 107,179, 180, 181, 182), whereas no selection was observed in terrestrial mammalian lineages. We also analyzed the changes in the 3D structure of the aquaporin 2 protein. Signs of strong positive selection in AQP2 sites 179, 180, 181, and 182 were unexpectedly identified only in the baiji lineage, which was the only river dolphin examined in this study. Positive selection in aquaporins AQP1 (45), AQP4 (74), AQP7 (342, 343, 356) was detected in cetaceans and artiodactyls, suggesting that these events are not related to maintaining water and electrolyte homeostasis in seawater. Conclusions Our results suggest that the AQP2 gene might reflect different selective pressures in maintaining water balance in cetaceans, contributing to the passage from the terrestrial environment to the aquatic. Further studies are necessary, especially those including other freshwater dolphins, who exhibit osmoregulatory mechanisms different from those of marine cetaceans for the same essential task of maintaining serum electrolyte balance.	[Sao Pedro, Simone Lima; de Souza Lima, Andre Oliveira] Univ Vale Itajai, Ctr Ciencias Tecnol Terra & Mar, Genet Mol Lab, Itajai, SC, Brazil; [Pereira Alves, Joao Marcelo] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, SP, Brazil; [de Souza Lima, Andre Oliveira] Univ Vale Itajai, Ctr Ciencias Tecnol Terra & Mar, Lab Informat Biodiversidade & Geomat, Itajai, SC, Brazil	Universidade do Vale do Itajai; Universidade de Sao Paulo; Universidade do Vale do Itajai	Lima, AOD (corresponding author), Univ Vale Itajai, Ctr Ciencias Tecnol Terra & Mar, Genet Mol Lab, Itajai, SC, Brazil.	andreolima@gmail.com	Alves, Joao M.P./G-8927-2011; Barreto, A. S./A-7707-2010; Lima, Andre O S/J-3626-2014	Alves, Joao M.P./0000-0001-5914-2087; Barreto, A. S./0000-0002-6606-0028; Lima, Andre O S/0000-0003-2261-2801	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Brazil) [563337/2010-9, 565062/2010-7]; Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC - Brazil) [8588/2011-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Brazil) [2013/14622-3]; Conselho Tecnico-Cientifico da Educacao Superior (CAPES - Brazil) [563337/2010-9]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC - Brazil); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Tecnico-Cientifico da Educacao Superior (CAPES - Brazil)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Brazil, http://www.cnpq.br/) - Grant Process 563337/2010-9; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Brazil, http://www.cnpq.br/) - Grant Process 565062/2010-7; Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC - Brazil, http://www.fapesc.sc.gov.br/) - Grant Process 8588/2011-0; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Brazil,http://www.fapesp.br/) - Grant Process 2013/14622-3 - JMPA support; Conselho Tecnico-Cientifico da Educacao Superior (CAPES - Brazil, http://www.capes.gov.br/) - Grant-Process 563337/2010-9 - SLSP support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre Peter, 2006, Proc Am Thorac Soc, V3, P5, DOI 10.1513/pats.200510-109JH; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; BESTER M N, 1975, Madoqua Series II, V4, P69; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bininda-Emonds ORP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-156; Birukawa N, 2005, ZOOL SCI, V22, P1245, DOI 10.2108/zsj.22.1245; Cassens I, 2000, P NATL ACAD SCI USA, V97, P11343, DOI 10.1073/pnas.97.21.11343; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cauet E, 2005, J CHEM THEORY COMPUT, V1, P472, DOI 10.1021/ct049875k; Cohen E, 2012, ORNITHOL HERPETOL S, VS1, P1, DOI DOI 10.4172/2161-0983.S1-001; Costa DP, 2002, ENCY MARINE MAMMALS, P801; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Gatesy J, 2013, MOL PHYLOGENET EVOL, V66, P479, DOI 10.1016/j.ympev.2012.10.012; Geisler JH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-112; GRAUR D, 1985, J MOL EVOL, V22, P53, DOI 10.1007/BF02105805; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo A, 2014, ZOOLOGICAL STUDIES, V53, P1; Hamilton H, 2001, P ROY SOC B-BIOL SCI, V268, P549, DOI 10.1098/rspb.2000.1385; Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413; HUI CA, 1981, PHYSIOL ZOOL, V54, P430, DOI 10.1086/physzool.54.4.30155836; Ishibashi K, 1997, J BIOL CHEM, V272, P20782, DOI 10.1074/jbc.272.33.20782; ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269; Ishibashi K, 2011, AM J PHYSIOL-REG I, V300, pR566, DOI [10.1152/ajpregu.90464.2008, 10.1007/978-94-024-1057-0_2]; Ishibashi K, 2009, CLIN EXP NEPHROL, V13, P107, DOI 10.1007/s10157-008-0118-6; Kovacs, 2006, MARINE MAMMALS EVOLU, P312, DOI [10.1016/B978-012088552-7/50013-8, DOI 10.1016/B978-012088552-7/50013-8]; Maluf NSR, 1998, ANAT RECORD, V250, P34; McClellan DA, 2001, MOL BIOL EVOL, V18, P917, DOI 10.1093/oxfordjournals.molbev.a003892; Ortiz RM, 2001, J EXP BIOL, V204, P1831; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Reeves R. R., 2012, PONTOPORIA BLAINVILL; Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Secchi E.R., 2012, IUCN RED LIST THREAT; SECCHI ER, 2002, LATIN AM J AQUATIC M, V1, P11; Spaulding M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007062; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suzuki M, 2008, J COMP PHYSIOL B, V178, P149, DOI 10.1007/s00360-007-0204-1; Vahedi-Faridi A, 2013, MICROSCOPY-JPN, V62, P95, DOI 10.1093/jmicro/dfs091; VARDY PH, 1981, J MORPHOL, V167, P13, DOI 10.1002/jmor.1051670103; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Xu Shixia, 2013, BMC Evolutionary Biology, V13, P1; Yamamoto T, 1998, KIDNEY INT, V54, P1041, DOI 10.1046/j.1523-1755.1998.00123.x; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	49	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134516	10.1371/journal.pone.0134516	http://dx.doi.org/10.1371/journal.pone.0134516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226365	Green Submitted, gold, Green Published			2022-12-27	WOS:000358837700105
J	Yoo, SW; Guevara, P; Jeong, Y; Yoo, K; Shin, JS; Mangin, JF; Seong, JK				Yoo, Sang Wook; Guevara, Pamela; Jeong, Yong; Yoo, Kwangsun; Shin, Joseph S.; Mangin, Jean-Francois; Seong, Joon-Kyung			An Example-Based Multi-Atlas Approach to Automatic Labeling of White Matter Tracts	PLOS ONE			English	Article							FIBER TRACTOGRAPHY; DIFFUSION MRI; SEGMENTATION; TRACKING; BRAIN	We present an example-based multi-atlas approach for classifying white matter (WM) tracts into anatomic bundles. Our approach exploits expert-provided example data to automatically classify the WM tracts of a subject. Multiple atlases are constructed to model the example data from multiple subjects in order to reflect the individual variability of bundle shapes and trajectories over subjects. For each example subject, an atlas is maintained to allow the example data of a subject to be added or deleted flexibly. A voting scheme is proposed to facilitate the multi-atlas exploitation of example data. For conceptual simplicity, we adopt the same metrics in both example data construction and WM tract labeling. Due to the huge number of WM tracts in a subject, it is time-consuming to label each WM tract individually. Thus, the WM tracts are grouped according to their shape similarity, and WM tracts within each group are labeled simultaneously. To further enhance the computational efficiency, we implemented our approach on the graphics processing unit (GPU). Through nested cross-validation we demonstrated that our approach yielded high classification performance. The average sensitivities for bundles in the left and right hemispheres were 89.5% and 91.0%, respectively, and their average false discovery rates were 14.9% and 14.2%, respectively.	[Yoo, Sang Wook; Seong, Joon-Kyung] Korea Univ, Dept Biomed Engn, Seoul, South Korea; [Yoo, Sang Wook; Shin, Joseph S.] Korea Adv Inst Sci & Technol, Dept Comp Sci, Taejon 305701, South Korea; [Guevara, Pamela] CEA, I2BM, Gif Sur Yvette, France; [Guevara, Pamela; Mangin, Jean-Francois] Inst Federat Rech 49, Gif Sur Yvette, France; [Guevara, Pamela; Mangin, Jean-Francois] Univ Concepcion, Concepcion, Chile; [Jeong, Yong; Yoo, Kwangsun] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Shin, Joseph S.] Handong Global Univ, Pohang, South Korea	Korea University; Korea Advanced Institute of Science & Technology (KAIST); CEA; UDICE-French Research Universities; Universite Paris Saclay; Universidad de Concepcion; Korea Advanced Institute of Science & Technology (KAIST); Handong Global University	Seong, JK (corresponding author), Korea Univ, Dept Biomed Engn, Seoul, South Korea.	jkseong@korea.ac.kr	Yoo, Kwangsun/F-1408-2014; Mangin, Jean-Francois/AAI-8983-2020; Guevara, Pamela/B-2300-2019; Jeong, Yong/C-1677-2011; Guevara, Pamela/AAZ-6221-2021; Shin, Sung Yong/C-1955-2011	Yoo, Kwangsun/0000-0002-5213-4575; Guevara, Pamela/0000-0001-9988-400X; Jeong, Yong/0000-0002-5907-3787; Guevara, Pamela/0000-0001-9988-400X; Yoo, Sang Wook/0000-0002-5404-4397	National Research Foundation of Korea (NRF) [NRF-2012R1A1B3004157]; Korea 565 Health Technology R&D Project through the Korea Health Industry Development 566 Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea 567 [HI14C2768]; Institute for Information & communications Technology Promotion(IITP) grant - Korea government (MSIP) [B0101-15-247]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea 565 Health Technology R&D Project through the Korea Health Industry Development 566 Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea 567; Institute for Information & communications Technology Promotion(IITP) grant - Korea government (MSIP)	This work was partially supported by the National Research Foundation of Korea (NRF) (No. NRF-2012R1A1B3004157), a grant of the Korea 565 Health Technology R&D Project through the Korea Health Industry Development 566 Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea 567 (grant number: HI14C2768), and by Institute for Information & communications Technology Promotion(IITP) grant funded by the Korea government (MSIP) (No. B0101-15-247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Bazin PL, 2011, NEUROIMAGE, V58, P458, DOI 10.1016/j.neuroimage.2011.06.020; Berman JI, 2005, NEUROIMAGE, V27, P862, DOI 10.1016/j.neuroimage.2005.05.018; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Ceritoglu C, 2009, NEUROIMAGE, V47, P618, DOI 10.1016/j.neuroimage.2009.04.057; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Dodero L, 2015, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00087; Duda R.O., 2006, PATTERN CLASSIFICATI; Fowlkes C, 2004, IEEE T PATTERN ANAL, V26, P214, DOI 10.1109/TPAMI.2004.1262185; Garyfallidis E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00175; Glenn OA, 2003, J MAGN RESON IMAGING, V18, P641, DOI 10.1002/jmri.10420; Goh A, 2009, LECT NOTES COMPUT SC, V5761, P877, DOI 10.1007/978-3-642-04268-3_108; Goldberg-Zimring D, 2005, J NEUROIMAGING, V15, p68S, DOI 10.1177/1051228405283363; Goodlett CB, 2009, NEUROIMAGE, V45, pS133, DOI 10.1016/j.neuroimage.2008.10.060; Guevara P, 2012, NEUROIMAGE, V61, P1083, DOI 10.1016/j.neuroimage.2012.02.071; Guevara P, 2011, NEUROIMAGE, V54, P1975, DOI 10.1016/j.neuroimage.2010.10.028; Guevara P, 2009, MICCAI 2009 WORKSH D; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jin Y, 2014, NEUROIMAGE, V100, P75, DOI 10.1016/j.neuroimage.2014.04.048; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Labra N, 2014, IEEE ENG MED BIO, P2376, DOI 10.1109/EMBC.2014.6944099; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Li H, 2010, NEUROIMAGE, V49, P1249, DOI 10.1016/j.neuroimage.2009.08.017; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Maddah M, 2008, MED IMAGE ANAL, V12, P191, DOI 10.1016/j.media.2007.10.003; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nvidia, 2022, CUD 11 2; O'Donnell LJ, 2006, AM J NEURORADIOL, V27, P1032; O'Donnell LJ, 2007, IEEE T MED IMAGING, V26, P1562, DOI 10.1109/TMI.2007.906785; O'Donnell LJ, 2012, NEUROIMAGE, V60, P456, DOI 10.1016/j.neuroimage.2011.11.014; Pagani E, 2005, NEUROIMAGE, V26, P258, DOI 10.1016/j.neuroimage.2005.01.008; Perrin M, 2005, LECT NOTES COMPUT SC, V3565, P52; Perrin M, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/368406; Poupon C., 2006, P 12 ANN M ORG HUM B; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Santos-Pereira CM, 2002, COMPSTAT 2002: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P291; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tunc B, 2014, NEUROIMAGE, V102, P596, DOI 10.1016/j.neuroimage.2014.08.021; Visser E, 2011, NEUROIMAGE, V54, P303, DOI 10.1016/j.neuroimage.2010.07.038; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang Q, 2013, HUM BRAIN MAPP, V34, P2089, DOI 10.1002/hbm.22051; Wang XG, 2011, NEUROIMAGE, V54, P290, DOI 10.1016/j.neuroimage.2010.07.050; Wassermann D, 2010, NEUROIMAGE, V51, P228, DOI 10.1016/j.neuroimage.2010.01.004; Wu X, 2012, MAGN RESON IMAGING, V30, P485, DOI 10.1016/j.mri.2011.12.017; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Zhang YJ, 2010, NEUROIMAGE, V52, P1289, DOI 10.1016/j.neuroimage.2010.05.049	57	26	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133337	10.1371/journal.pone.0133337	http://dx.doi.org/10.1371/journal.pone.0133337			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225419	Green Submitted, gold, Green Published			2022-12-27	WOS:000358837700018
J	Bucukovski, J; Latorre-Margalef, N; Stallknecht, DE; Miller, BL				Bucukovski, Joseph; Latorre-Margalef, Neus; Stallknecht, David E.; Miller, Benjamin L.			A Multiplex Label-Free Approach to Avian Influenza Surveillance and Serology	PLOS ONE			English	Article							ARRAYED IMAGING REFLECTOMETRY; PROTEIN MICROARRAY; VIRUS; RESPONSES; ANTIBODIES; INFECTION; VACCINE; ASSAYS	l;Influenza serology has traditionally relied on techniques such as hemagglutination inhibition, microneutralization, and ELISA. These assays are complex, challenging to implement in a format allowing detection of several types of antibody-analyte interactions at once (multiplex), and troublesome to implement in the field. As an alternative, we have developed a hemagglutinin microarray on the Arrayed Imaging Reflectometry (AIR) platform. AIR provides sensitive, rapid, and label-free multiplex detection of targets in complex analyte samples such as serum. In preliminary work, we demonstrated the application of this array to the testing of human samples from a vaccine trial. Here, we report the application of an expanded label-free hemagglutinin microarray to the analysis of avian serum samples. Samples from influenza virus challenge experiments in mallards yielded strong, selective detection of antibodies to the challenge antigen in most cases. Samples acquired in the field from mallards were also analyzed, and compared with viral hemagglutinin inhibition and microneutralization assays. We find that the AIR hemagglutinin microarray can provide a simple and robust alternative to standard methods, offering substantially greater information density from a simple workflow.	[Bucukovski, Joseph; Miller, Benjamin L.] Univ Rochester, Dept Biomed Engn, Rochester, NY 14642 USA; [Bucukovski, Joseph; Miller, Benjamin L.] Univ Rochester, Dept Dermatol, Rochester, NY 14627 USA; [Latorre-Margalef, Neus; Stallknecht, David E.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Athens, GA USA	University of Rochester; University of Rochester; University System of Georgia; University of Georgia	Miller, BL (corresponding author), Univ Rochester, Dept Biomed Engn, Rochester, NY 14642 USA.	Benjamin_Miller@urmc.rochester.edu			NIH, NIAID Respiratory Pathogens Research Center [HHSN272201200005C]; Wenner-Gren Foundations, Sweden; Swedish Research Council	NIH, NIAID Respiratory Pathogens Research Center; Wenner-Gren Foundations, Sweden; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This project has been funded in whole or in part with federal funds from the NIH, NIAID Respiratory Pathogens Research Center, under contract HHSN272201200005C. The findings and conclusions in this report are the authors' and do not necessarily reflect the views of the funding agency. N. Latorre-Margalef was supported by postdoctoral grants from the Wenner-Gren Foundations, Sweden, and the Swedish Research Council. The following reagents were obtained through the NIH Biodefense and Emerging Infections Research Resources Repository, NIAID, NIH: Polyclonal Anti-Influenza Virus H3 Hemagglutinin (HA), A/Hong Kong/1/68 (H3N2), (antiserum, Goat), NR-3118; Polyclonal Anti-Influenza Virus H1 Hemagglutinin (HA), A/Brisbane/59/2007 (H1N1), (antiserum, Goat), NR-28613; Polyclonal Anti-Influenza Virus H6 Hemagglutinin (HA), A/Teal/HK/W312/97 (H6N1), (antiserum, Goat), NR-663; Polyclonal Anti-Influenza Virus H2 Hemagglutinin (HA), A/Singapore/1/57 (H2N2), (antiserum, Goat), NR-4523; Polyclonal Anti-Influenza Virus H9 Hemagglutinin (HA), A/Chicken/HK/G9/97 (H9N2), (antiserum, Goat), NR-668; Polyclonal Anti-Influenza Virus H7 Hemagglutinin (HA), A/Netherlands/219/03 (H7N7), (antiserum, Goat), NR-9226; Polyclonal Anti-Influenza Virus H5 Hemagglutinin (HA), A/HK/213/03 (H5N1), (antiserum, Goat), NR-163; Polyclonal Anti-Influenza Virus B Hemagglutinin (HA), B/Florida/04/2006, (antiserum, Goat), NR-28669.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Brown JD, 2012, J WILDLIFE DIS, V48, P991, DOI 10.7589/2011-09-280; Carney PJ, 2010, CLIN VACCINE IMMUNOL, V17, P1407, DOI 10.1128/CVI.00509-09; Carter JA, 2011, BIOSENS BIOELECTRON, V26, P3944, DOI 10.1016/j.bios.2011.02.025; Desbien AL, 2013, BIOTECHNIQUES, V54, P345, DOI 10.2144/000114041; Freidl GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108043; Gall A, 2009, J CLIN MICROBIOL, V47, P327, DOI 10.1128/JCM.01330-08; Katz JM, 2011, EXPERT REV ANTI-INFE, V9, P669, DOI [10.1586/ERI.11.51, 10.1586/eri.11.51]; Koopmans M, 2012, CLIN MICROBIOL INFEC, V18, P797, DOI 10.1111/j.1469-0691.2011.03701.x; Lebarbenchon C, 2012, J VET DIAGN INVEST, V24, P161, DOI 10.1177/1040638711416626; Legutki JB, 2010, VACCINE, V28, P4529, DOI 10.1016/j.vaccine.2010.04.061; Mace CR, 2008, LANGMUIR, V24, P12754, DOI 10.1021/la801712m; Mace CR, 2008, BIOSENS BIOELECTRON, V24, P334, DOI 10.1016/j.bios.2008.05.003; Mace CR, 2006, ANAL CHEM, V78, P5578, DOI 10.1021/ac060473+; Mace CR, 2011, TALANTA, V83, P1000, DOI 10.1016/j.talanta.2010.11.002; Price JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064555; Ramey AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095620; Rosenberger CM, 2014, J GEN VIROL, V95, P350, DOI 10.1099/vir.0.058438-0; Sriram R, 2011, ANAL CHEM, V83, P3750, DOI 10.1021/ac2001302; Washington JA, 1996, MED MICROBIOLOGY; Webster RG, 2002, VACCINE, V20, pS16, DOI 10.1016/S0264-410X(02)00123-8; Wilcox BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024010; Yadav AR, 2014, ANAL CHEM, V86, P1067, DOI 10.1021/ac402603j	23	15	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134484	10.1371/journal.pone.0134484	http://dx.doi.org/10.1371/journal.pone.0134484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241048	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700046
J	Gold, DA; Nakanishi, N; Hensley, NM; Cozzolino, K; Tabatabaee, M; Martin, M; Hartenstein, V; Jacobs, DK				Gold, David A.; Nakanishi, Nagayasu; Hensley, Nicholai M.; Cozzolino, Kira; Tabatabaee, Mariam; Martin, Michelle; Hartenstein, Volker; Jacobs, David K.			Structural and Developmental Disparity in the Tentacles of the Moon Jellyfish Aurelia sp.1	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; CHARACTER EVOLUTION; CATCH TENTACLES; STEM-CELLS; CNIDARIA; ULTRASTRUCTURE; HYDROZOA; GENE; EXPRESSION; CHRYSAORA	Tentacles armed with stinging cells (cnidocytes) are a defining trait of the cnidarians, a phylum that includes sea anemones, corals, jellyfish, and hydras. While cnidarian tentacles are generally characterized as structures evolved for feeding and defense, significant variation exists between the tentacles of different species, and within the same species across different life stages and/or body regions. Such diversity suggests cryptic distinctions exist in tentacle function. In this paper, we use confocal and transmission electron microscopy to contrast the structure and development of tentacles in the moon jellyfish, Aurelia species 1. We show that polyp oral tentacles and medusa marginal tentacles display markedly different cellular and muscular architecture, as well as distinct patterns of cellular proliferation during growth. Many structural differences between these tentacle types may reflect biomechanical solutions to different feeding strategies, although further work would be required for a precise mechanistic understanding. However, differences in cell proliferation dynamics suggests that the two tentacle forms lack a conserved mechanism of development, challenging the textbook-notion that cnidarian tentacles can be homologized into a conserved bauplan.	[Gold, David A.; Nakanishi, Nagayasu; Hensley, Nicholai M.; Cozzolino, Kira; Tabatabaee, Mariam; Martin, Michelle; Jacobs, David K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biolol, Los Angeles, CA 90095 USA; [Hartenstein, Volker] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Jacobs, DK (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biolol, Los Angeles, CA 90095 USA.	djacobs@ucla.edu	Hensley, Nicholai/AAN-1233-2020; Gold, David/I-5398-2012	Hensley, Nicholai/0000-0003-0681-0808; Gold, David/0000-0003-0135-4022	NASA Astrobiology Institute - Foundations of Complex Life: Evolution, Preservation and Detection on Earth and Beyond; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054814] Funding Source: NIH RePORTER	NASA Astrobiology Institute - Foundations of Complex Life: Evolution, Preservation and Detection on Earth and Beyond; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NASA Astrobiology Institute - Foundations of Complex Life: Evolution, Preservation and Detection on Earth and Beyond. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai MN, 1997, FUNCTIONAL BIOL SCYP; Bosch TCG, 2010, DEV GROWTH DIFFER, V52, P15, DOI 10.1111/j.1440-169X.2009.01143.x; Bouillon J., 2000, THALASSIA SALENTINA, V24, P3, DOI DOI 10.1285/I15910725V24P3; Broun M, 2005, DEVELOPMENT, V132, P2907, DOI 10.1242/dev.01848; Brusca RC, 2003, INVERTEBRATES; Buchsbaum R., 1969, ANIMALS BACKBONES; CALDER DR, 1971, T AM MICROSC SOC, V90, P269, DOI 10.2307/3225186; CAMPBELL RD, 1975, CELL TISSUE RES, V159, P445; Cartwright P, 1999, P NATL ACAD SCI USA, V96, P2183, DOI 10.1073/pnas.96.5.2183; Cartwright P, 2010, INTEGR COMP BIOL, V50, P456, DOI 10.1093/icb/icq089; CHAPMAN DM, 1965, AM ZOOL, V5, P455; Chapman DM, 2001, CAN J ZOOL, V79, P623, DOI 10.1139/cjz-79-4-623; CHAPMAN DM, 1970, CAN J ZOOLOG, V48, P931, DOI 10.1139/z70-168; Chapman DM, 1999, MICROANATOMY BELL RI, DOI [10.1139/z98-193, DOI 10.1139/Z98-193]; CHIA FS, 1984, J MORPHOL, V180, P69, DOI 10.1002/jmor.1051800108; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Collins AG, 2008, J MAR BIOL ASSOC UK, V88, P1673, DOI 10.1017/S0025315408001732; COSTELLO JH, 1994, MAR BIOL, V121, P327, DOI 10.1007/BF00346741; Dabiri JO, 2005, J EXP BIOL, V208, P1257, DOI 10.1242/jeb.01519; Daly M., 2003, Zoologische Verhandelingen (Leiden), V345, P89; Dawson MN, 2001, BIOL BULL, V200, P92, DOI 10.2307/1543089; Denker E, 2008, DEV BIOL, V315, P99, DOI 10.1016/j.ydbio.2007.12.023; Fritz AE, 2013, DEVELOPMENT, V140, P2212, DOI 10.1242/dev.088260; Galliot B, 2010, TRENDS CELL BIOL, V20, P514, DOI 10.1016/j.tcb.2010.05.006; Ghisalberti M, 2014, CURR BIOL, V24, P305, DOI 10.1016/j.cub.2013.12.017; Gilbert SF, 1996, DEV BIOL, V173, P357, DOI 10.1006/dbio.1996.0032; Gold DA, 2013, DEV GENES EVOL, V223, P53, DOI 10.1007/s00427-012-0429-1; Govindarajan AF, 2006, MOL PHYLOGENET EVOL, V38, P820, DOI 10.1016/j.ympev.2005.11.012; HYMAN LH, 1940, INVERTEBRATES PROTOZ; Jacobs DK, 2011, KEY TRANSITIONS IN ANIMAL EVOLUTION, P175; Jacobs DK, 2007, INTEGR COMP BIOL, V47, P712, DOI 10.1093/icb/icm094; Jahnel SM, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-44; Kayal E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-5; Kunzel T, 2010, DEV BIOL, V348, P120, DOI 10.1016/j.ydbio.2010.08.017; Marques AC, 2004, INVERTEBR BIOL, V123, P23; Matus DQ, 2007, EVOL DEV, V9, P25, DOI 10.1111/j.1525-142X.2006.00135.x; Moore J., 2006, INTRO INVERTEBRATES; Nakanishi N, 2008, DEV GENES EVOL, V218, P511, DOI 10.1007/s00427-008-0239-7; Nakanishi N, 2009, DEV GENES EVOL, V219, P301, DOI 10.1007/s00427-009-0291-y; Pearse V., 1987, LIVING INVERTEBRATES; Pechenik JA, 2005, BIOL INVERTEBRATES; PERKINS FO, 1971, J ULTRA MOL STRUCT R, V35, P431, DOI 10.1016/S0022-5320(71)80004-7; PETERSEN KW, 1990, ZOOL J LINN SOC-LOND, V100, P101, DOI 10.1111/j.1096-3642.1990.tb01862.x; Philipp I, 2009, P NATL ACAD SCI USA, V106, P4290, DOI 10.1073/pnas.0812847106; Romanes G.J., 1885, JELLY FISH STAR FISH; Sakaguchi M, 1999, COMP BIOCHEM PHYS A, V122, P261, DOI 10.1016/S1095-6433(99)00009-4; Satterlie RA, 2014, BIOL B; SCHUCHERT P, 1993, Z ZOOL SYST EVOL, V31, P161; Smith KM, 2000, DEVELOPMENT, V127, P4743; SOUTHWARD AJ, 1955, J MAR BIOL ASSOC UK, V34, P201, DOI 10.1017/S0025315400027570; SPANGENBURG DOROTHY BRESLIN, 1964, TRANS AMER MICROSCOP SOC, V83, P448, DOI 10.2307/3224766; Steele RE, 2011, TRENDS GENET, V27, P7, DOI 10.1016/j.tig.2010.10.002; Takashima S, 2013, DEV GENES EVOL, V223, P85, DOI 10.1007/s00427-012-0422-8; THIEL HJALMAR, 1966, SYMP ZOOL SOC LONDON, V16, P77; WATSON GM, 1983, TISSUE CELL, V15, P939, DOI 10.1016/0040-8166(83)90059-9; Wikramanayake AH, 2003, NATURE, V426, P446, DOI 10.1038/nature02113; WILLIAMS RB, 1991, HYDROBIOLOGIA, V216, P539, DOI 10.1007/BF00026511; Yuan D, 2008, DEV GENES EVOL, V218, P525, DOI 10.1007/s00427-008-0254-8; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	60	13	13	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134741	10.1371/journal.pone.0134741	http://dx.doi.org/10.1371/journal.pone.0134741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241309	Green Published, gold			2022-12-27	WOS:000358942700063
J	Lindgren, KP; Wiers, RW; Teachman, BA; Gasser, ML; Westgate, EC; Cousijn, J; Enkema, MC; Neighbors, C				Lindgren, Kristen P.; Wiers, Reinout W.; Teachman, Bethany A.; Gasser, Melissa L.; Westgate, Erin C.; Cousijn, Janna; Enkema, Matthew C.; Neighbors, Clayton			Attempted Training of Alcohol Approach and Drinking Identity Associations in US Undergraduate Drinkers: Null Results from Two Studies	PLOS ONE			English	Article							COGNITIVE BIAS MODIFICATION; AUTOMATIC ACTION-TENDENCIES; IMPLICIT COGNITION; ATTENTIONAL BIAS; CONSUMPTION; INTERVENTION; DETERMINANTS; VALIDATION; DISORDERS; EXPOSURE	There is preliminary evidence that approach avoid training can shift implicit alcohol associations and improve treatment outcomes. We sought to replicate and extend those findings in US undergraduate social drinkers (Study 1) and at-risk drinkers (Study 2). Three adaptations of the approach avoid task (AAT) were tested. The first adaptation - the approach avoid training - was a replication and targeted implicit alcohol approach associations. The remaining two adaptations - the general identity and personalized identity trainings - targeted implicit drinking identity associations, which are robust predictors of hazardous drinking in US undergraduates. Study 1 included 300 undergraduate social drinkers. They were randomly assigned to real or sham training conditions for one of the three training adaptations, and completed two training sessions, spaced one week apart. Study 2 included 288 undergraduates at risk for alcohol use disorders. The same training procedures were used, but the two training sessions occurred within a single week. Results were not as expected. Across both studies, the approach avoid training yielded no evidence of training effects on implicit alcohol associations or alcohol outcomes. The general identity training also yielded no evidence of training effects on implicit alcohol associations or alcohol outcomes with one exception; individuals who completed real training demonstrated no changes in drinking refusal self-efficacy whereas individuals who completed sham training had reductions in self-efficacy. Finally, across both studies, the personalized identity training yielded no evidence of training effects on implicit alcohol associations or alcohol outcomes. Despite having relatively large samples and using a well-validated training task, study results indicated all three training adaptations were ineffective at this dose in US undergraduates. These findings are important because training studies are costly and labor-intensive. Future research may benefit from focusing on more severe populations, pairing training with other interventions, increasing training dose, and increasing gamification of training tasks.	[Lindgren, Kristen P.; Gasser, Melissa L.; Westgate, Erin C.] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [Wiers, Reinout W.; Cousijn, Janna] Univ Amsterdam, Dept Dev Psychol, ADAPT Lab, Amsterdam, Netherlands; [Teachman, Bethany A.; Westgate, Erin C.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA; [Cousijn, Janna] Univ Utrecht, Dept Dev & Expt Psychol, Consortium Individual Dev, Utrecht, Netherlands; [Enkema, Matthew C.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Neighbors, Clayton] Univ Houston, Dept Psychol, Houston, TX USA	University of Washington; University of Washington Seattle; University of Amsterdam; University of Virginia; Utrecht University; University of Washington; University of Washington Seattle; University of Houston System; University of Houston	Lindgren, KP (corresponding author), Univ Washington, Dept Psychiat, Seattle, WA 98195 USA.	KPL9716@uw.edu	Westgate, Erin/T-5190-2019; Wiers, Reinout/AAB-4008-2021	Westgate, Erin/0000-0002-9116-6246; Wiers, Reinout/0000-0002-4312-9766; Cousijn, Janna/0000-0002-7699-2582; Lindgren, Kristen/0000-0002-0244-1016	NIAAA [R00 AA 17669]; National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R00AA017669, T32AA007455, R01AA021763] Funding Source: NIH RePORTER	NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by NIAAA R00 AA 17669. Manuscript preparation was also supported by National Institute on Alcohol Abuse and Alcoholism. (NIAAA) R01 21763. NIAAA had no role in the study design, collection, analysis or interpretation of the data, writing the manuscript, or the decision to submit the paper for publication.	Banes KE, 2014, DRUG ALCOHOL DEPEN, V139, P41, DOI 10.1016/j.drugalcdep.2014.02.706; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Boendermaker WJ, J BEHAV THE IN PRESS; Boffo M, TRIALS, V16, P576; Carroll K, 1997, IMPROVING COMPLIANCE; Clarke PJF, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-8; Clerkin EM, 2011, J BEHAV THER EXP PSY, V42, P337, DOI 10.1016/j.jbtep.2011.01.003; Clerkin EM, 2010, J ANXIETY DISORD, V24, P300, DOI 10.1016/j.janxdis.2010.01.001; Cohen E, 2007, DRUG ALCOHOL DEPEN, V86, P214, DOI 10.1016/j.drugalcdep.2006.06.008; COLLINS RL, 1985, J CONSULT CLIN PSYCH, V53, P189, DOI 10.1037/0022-006X.53.2.189; Dennis TA, 2014, CLIN PSYCHOL SCI; Eberl C, 2014, ALCOHOL CLIN EXP RES, V38, P587, DOI 10.1111/acer.12281; Eberl C, 2013, DEV COGN NEUROS-NETH, V4, P38, DOI 10.1016/j.dcn.2012.11.002; Fadardi JS, 2009, DRUG ALCOHOL DEPEN, V101, P137, DOI 10.1016/j.drugalcdep.2008.11.015; Gray HM, 2011, ADDICT BEHAV, V36, P919, DOI 10.1016/j.addbeh.2011.05.003; Green Jennifer S, 2012, J Exp Psychopathol, V3, P479; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Hingson R, 2005, ANNU REV PUBL HEALTH, V26, P259, DOI 10.1146/annurev.publhealth.26.021304.144652; Ilgen MA, 2011, ADDICT BEHAV, V36, P1349, DOI 10.1016/j.addbeh.2011.07.036; Johnston LD, 2014, MONITORING FUTURE NA, P84; Karoly P, 1980, IMPROVING LONG TERM, P195; Kerst WF, 2014, HEALTH PSYCHOL, V33, P1232, DOI 10.1037/a0035708; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Kuckertz JM, 2014, BEHAV RES THER, V53, P30, DOI 10.1016/j.brat.2013.12.003; Larimer ME, 1998, HARM REDUCTION, P69; Lemke S, 2002, J SUBST ABUSE TREAT, V22, P33, DOI 10.1016/S0740-5472(01)00209-4; Lindgren KP, 2013, PSYCHOL ADDICT BEHAV, V27, P1, DOI 10.1037/a0027640; Lindgren KP, 2013, ADDICT BEHAV, V38, P2163, DOI 10.1016/j.addbeh.2013.01.026; Lindgren KP, 2009, J STUD ALCOHOL DRUGS, V70, P583, DOI 10.15288/jsad.2009.70.583; MILLER WR, 1985, PSYCHOL BULL, V98, P84, DOI 10.1037/0033-2909.98.1.84; Naar-King S, 2011, MOTIVATIONAL INTERVI; Oishi S, 2007, J PERS SOC PSYCHOL, V93, P131, DOI 10.1037/0022-3514.93.1.131; Ostafin BD, 2006, PSYCHOL ADDICT BEHAV, V20, P322, DOI 10.1037/0893-164X.20.3.322; Parker JD, 2002, J BEHAV HEALTH SER R, V29, P288, DOI 10.1007/BF02287369; Rehm J, 2009, CONT DRUG PROBS, V36, P575, DOI DOI 10.1177/009145090903600313; Rehm J, 2014, ADDICTION, V109, P880, DOI 10.1111/add.12498; Reich RR, 2010, PSYCHOL ADDICT BEHAV, V24, P13, DOI 10.1037/a0016556; Rinck M, 2007, J BEHAV THER EXP PSY, V38, P105, DOI 10.1016/j.jbtep.2006.10.001; Roefs A, 2011, PSYCHOL BULL, V137, P149, DOI 10.1037/a0021729; Rooke SE, 2008, ADDICT BEHAV, V33, P1314, DOI 10.1016/j.addbeh.2008.06.009; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schoenmakers TM, 2010, DRUG ALCOHOL DEPEN, V109, P30, DOI 10.1016/j.drugalcdep.2009.11.022; SINGLETON EG, 1995, NIDA RES MONOGR, V153, P289; Stacy AW, 2010, ANNU REV CLIN PSYCHO, V6, P551, DOI 10.1146/annurev.clinpsy.121208.131444; Steinman SA, J BEHAV THE IN PRESS; Steinman SA, 2014, J CONSULT CLIN PSYCH, V82, P404, DOI 10.1037/a0036023; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; STRYKER S, 1994, SOC PSYCHOL QUART, V57, P16, DOI 10.2307/2786972; White HR, 2004, ALCOHOL RES HEALTH, V28, P182; WHITE HR, 1989, J STUD ALCOHOL, V50, P30, DOI 10.15288/jsa.1989.50.30; Wiers RW, 2009, GENES BRAIN BEHAV, V8, P101, DOI 10.1111/j.1601-183X.2008.00454.x; Wiers RW, 2006, CURR DIR PSYCHOL SCI, V15, P292, DOI 10.1111/j.1467-8721.2006.00455.x; Wiers RW, 2015, ADDICT BEHAV, V40, P21, DOI 10.1016/j.addbeh.2014.08.010; Wiers RW, 2013, CLIN PSYCHOL SCI, V1, P192, DOI 10.1177/2167702612466547; Wiers RW, 2011, PSYCHOL SCI, V22, P490, DOI 10.1177/0956797611400615; Wiers RW, 2010, ADDICTION, V105, P279, DOI 10.1111/j.1360-0443.2009.02775.x; Young RM, 2007, ADDICT BEHAV, V32, P862, DOI 10.1016/j.addbeh.2006.07.001	58	50	50	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134642	10.1371/journal.pone.0134642	http://dx.doi.org/10.1371/journal.pone.0134642			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1VB	26241316	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700055
J	Tzeng, J; Byun, J; Park, JY; Yamamoto, T; Schesing, K; Tian, B; Sadoshima, J; Oka, S				Tzeng, John; Byun, Jaemin; Park, Ji Yeon; Yamamoto, Takanobu; Schesing, Kevin; Tian, Bin; Sadoshima, Junichi; Oka, Shin-ichi			An Ideal PPAR Response Element Bound to and Activated by PPAR alpha	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; BINDING-SITES; RECEPTOR PPAR; GENE; MICE; RXR; DNA; ADIPOGENESIS; HETERODIMERS; METABOLISM	Peroxisome proliferator-activated receptor-alpha (PPAR alpha), a nuclear receptor, plays an important role in the transcription of genes involved in fatty acid metabolism through heterodimerization with the retinoid x receptor (RXR). The consensus sequence of the PPAR response element (PPRE) is composed of two AGGTCA-like sequences directionally aligned with a single nucleotide spacer. PPAR alpha and RXR bind to the 5' and 3' hexad sequences, respectively. However, the precise sequence definition of the PPRE remains obscure, and thus, the consensus sequence currently available remains AGGTCANAGGTCA with unknown redundancy. The vague PPRE sequence definition poses an obstacle to understanding how PPAR alpha regulates fatty acid metabolism. Here we show that, rather than the generally accepted 6-bp sequence, PPAR alpha actually recognized a 12-bp DNA sequence, of which the preferred binding sequence was WAWVTRGGBBAH. Additionally, the optimized RXR alpha hexad binding sequence was RGKTYA. Thus, the optimal PPAR alpha/RXR alpha heterodimer binding sequence was WAWVTRGGBBAHRGKTYA. The single nucleotide substitution, which reduces binding of RXR alpha to DNA, attenuated PPAR alpha-induced transcriptional activation, but this is not always true for PPAR alpha. Using the definition of the PPRE sequence, novel PPREs were successfully identified. Taken altogether, the provided PPRE sequence definition contributes to the understanding of PPAR alpha signaling by identifying PPAR alpha direct target genes with functional PPAR alpha response elements.	[Tzeng, John; Byun, Jaemin; Yamamoto, Takanobu; Schesing, Kevin; Sadoshima, Junichi; Oka, Shin-ichi] Rutgers Biomed Hlth Sci, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; [Park, Ji Yeon; Tian, Bin] Rutgers Biomed Hlth Sci, Dept Biochem & Mol Biol, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Oka, S (corresponding author), Rutgers Biomed Hlth Sci, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA.	okash@njms.rutgers.edu	Masutani, Hiroshi/B-5114-2014	Sadoshima, Junichi/0000-0003-3724-4132	American Heart Association (AHA) [12SDG11890014]; AHA; Glorney-Raisbeck Medical Student Grant; Foundation Leducq Transatlantic Networks; US Public Health Service [HL9469]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091469, R01HL102738, R01HL067724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023039] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); AHA(American Heart Association); Glorney-Raisbeck Medical Student Grant; Foundation Leducq Transatlantic Networks; US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by American Heart Association (AHA) Scientist Developmental Grant 12SDG11890014 (SO), an AHA student scholarship (KS), the Glorney-Raisbeck Medical Student Grant (KS), Foundation Leducq Transatlantic Networks (JS), and US Public Health Service Grant HL9469 (JS).	Adhikary T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016344; Castelein H, 1997, BIOCHEM BIOPH RES CO, V233, P91, DOI 10.1006/bbrc.1997.6395; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Degenhardt T, 2006, J BIOL CHEM, V281, P39607, DOI 10.1074/jbc.M605623200; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Ijpenberg A, 1997, J BIOL CHEM, V272, P20108, DOI 10.1074/jbc.272.32.20108; JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252; Kolwicz SC, 2011, CARDIOVASC RES, V90, P194, DOI 10.1093/cvr/cvr071; LEE SST, 1995, MOL CELL BIOL, V15, P3012; LEROY P, 1991, P NATL ACAD SCI USA, V88, P10138, DOI 10.1073/pnas.88.22.10138; Li HZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1632; Loichot C, 2006, AM J PHYSIOL-HEART C, V291, pH161, DOI 10.1152/ajpheart.01065.2004; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McKenna NJ, 2009, MOL ENDOCRINOL, V23, P740, DOI 10.1210/me.2009-0135; NAKSHATRI H, 1994, J BIOL CHEM, V269, P890; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Oka S, 2011, CELL METAB, V14, P598, DOI 10.1016/j.cmet.2011.10.001; PALMER CNA, 1995, J BIOL CHEM, V270, P16114, DOI 10.1074/jbc.270.27.16114; Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839; Schoonjans K, 1996, J LIPID RES, V37, P907; Smeets PJH, 2008, CARDIOVASC RES, V78, P79, DOI 10.1093/cvr/cvn001; van der Meer DLM, 2010, NUCLEIC ACIDS RES, V38, P2839, DOI 10.1093/nar/gkq012	25	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134996	10.1371/journal.pone.0134996	http://dx.doi.org/10.1371/journal.pone.0134996			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241474	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700088
J	Zou, Y; Bao, JJ; Pan, XF; Lu, Y; Liao, SH; Wang, XC; Wang, GY; Lin, DJ				Zou, Yong; Bao, Junjie; Pan, Xingfei; Lu, Ying; Liao, Sihong; Wang, Xicheng; Wang, Guoying; Lin, Dongjun			NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; RECEPTOR NKP30; CYTOKINE; LIGAND; IL-32; ACTIVATION	Background and Aims Previous work conducted by our group has shown that the accumulation of hepatic natural killer (NK) cells and the up-regulation of natural cytotoxicity receptors (NKP30 and NKP46) on NK cells from patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) were correlated with disease progression in HBV-ACLF. The natural cytotoxicity receptors expressed on NK cells are believed to be probable candidates involved in the NK cell-mediated hepatocyte damage in HBV-ACLF. However, the underlying mechanisms remain to be elucidated. In the present study, we aimed to discover the role of NKP30-B7-H6 interaction in NK cells-mediated hepatocyte damage in HBV-ACLF. Methods Hepatic expressions of B7-H6 and interleukin-32 (IL-32) were examined by immunochemistry staining in samples from patients with HBV-ACLF or mild chronic hepatitis B (CHB). The cytotoxicity of NK-92 cell against target cells (Huh-7 and LO2) was evaluated by CCK8 assay. Expression of IL-32 in liver NK cell, T cells and NK-92 cell line was detected by the flow cytometric analysis. The effect of IL-32 on the apoptosis of Huh7 cells was evaluated using Annexin V/PI staining analysis. Results An enhancement of hepatic B7-H6 and IL-32 expression was associated with the severity of liver injury in HBV-ACLF. And there was a positive association between hepatic B7-H6 and IL-32 expression. Expressions of IL-32 in liver NK cells and T cells were increased in HBV-ACLF patients. In vitro NK-92 cells are highly capable of killing the high B7-H6 expressing Huh7 cells and B7-H6-tansfected hepatocyte line LO2 cells dependent on NKP30 and B7-H6 interaction. Furthermore, NK-92 cells exhibited elevated IL-32 expression when stimulated with anti-NKP30 antibodies or when co-cultured with Huh7 cells. IL-32 can induce the apoptosis of Huh7 cells in a dose-dependent manner. Conclusion Our results suggest that NKP30-B7-H6 interaction can aggravate hepatocyte damage, probably through up-regulation of IL-32 expression in HBV-ACLF.	[Zou, Yong; Lu, Ying; Liao, Sihong; Lin, Dongjun] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Blood Transfus, Guangzhou 510275, Guangdong, Peoples R China; [Bao, Junjie] Guangzhou Women & Childrens Med Ctr, Dept Obstet, Preterm Birth Prevent & Treatment Res Unit, Guangzhou, Guangdong, Peoples R China; [Pan, Xingfei] Guangzhou Med Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Wang, Xicheng] Zhangqiu Peoples Hosp, Dept Oncol, Jinan, Peoples R China; [Wang, Guoying] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Liver Transplantat Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Dongjun] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hematol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University	Zou, Y (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Blood Transfus, Guangzhou 510275, Guangdong, Peoples R China.	zouyong0205@163.com; wanggy3@126.com; dongjunlin0205@163.com			National Natural Science Fund of China [81000180]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Fund of China (Grant No.81000180).	Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Cheon S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.159756; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; DAHL CA, 1992, J IMMUNOL, V148, P597; Dinarello CA, 2006, ANN RHEUM DIS, V65, P61, DOI 10.1136/ard.2006.058511; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Jung MY, 2011, J IMMUNOL, V186, P6848, DOI 10.4049/jimmunol.1003996; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Li YL, 2011, J EXP MED, V208, P703, DOI 10.1084/jem.20102548; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Liu M, 2001, Expert Rev Mol Med, V2001, P1, DOI 10.1017/S1462399401002812; Liu Q, 2007, J GASTROEN HEPATOL, V22, P2101, DOI 10.1111/j.1440-1746.2006.04362.x; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Marsden PA, 2003, J CLIN INVEST, V112, P58, DOI 10.1172/JCI200318114; Nold MF, 2008, J IMMUNOL, V181, P557, DOI 10.4049/jimmunol.181.1.557; Pan XF, 2011, MOL IMMUNOL, V48, P1573, DOI 10.1016/j.molimm.2011.03.012; Park MH, 2012, IMMUNOLOGY, V135, P63, DOI 10.1111/j.1365-2567.2011.03513.x; Roth E, 2004, J IMMUNOL, V172, P1588, DOI 10.4049/jimmunol.172.3.1588; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Shoda H, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2074; Wu ZG, 2010, LIVER INT, V30, P782, DOI 10.1111/j.1478-3231.2010.02262.x; Xu QH, 2012, J INFECTION, V65, P336, DOI 10.1016/j.jinf.2012.05.009; Zhang Z, 2008, J HEPATOL, V49, P396, DOI 10.1016/j.jhep.2008.05.017; Zou Y, 2010, J IMMUNOL, V184, P466, DOI 10.4049/jimmunol.0900687	24	10	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134568	10.1371/journal.pone.0134568	http://dx.doi.org/10.1371/journal.pone.0134568			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241657	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700049
J	Knight, D; Iliadi, KG; Iliadi, N; Wilk, R; Hu, J; Krause, HM; Taylor, P; Moran, MF; Boulianne, GL				Knight, David; Iliadi, Konstantin G.; Iliadi, Natalia; Wilk, Ronit; Hu, Jack; Krause, Henry M.; Taylor, Paul; Moran, Michael F.; Boulianne, Gabrielle L.			Distinct Regulation of Transmitter Release at the Drosophila NMJ by Different Isoforms of nemy	PLOS ONE			English	Article							LARVAL NEUROMUSCULAR-JUNCTION; SYNAPTIC-TRANSMISSION; VESICLE POOLS; OCTOPAMINE; MUTANT; NEUROPEPTIDE; MEMORY; MELANOGASTER; DOPAMINE; PLASTICITY	Synaptic transmission is highly plastic and subject to regulation by a wide variety of neuromodulators and neuropeptides. In the present study, we have examined the role of isoforms of the cytochrome b561 homologue called no extended memory (nemy) in regulation of synaptic strength and plasticity at the neuromuscular junction (NMJ) of third instar larvae in Drosophila. Specifically, we generated two independent excisions of nemy that differentially affect the expression of nemy isoforms. We show that the nemy(45) excision, which specifically reduces the expression of the longest splice form of nemy, leads to an increase in stimulus evoked transmitter release and altered synaptic plasticity at the NMJ. Conversely, the nemy(26.2) excision, which appears to reduce the expression of all splice forms except the longest splice isoform, shows a reduction in stimulus evoked transmitter release, and enhanced synaptic plasticity. We further show that nemy45 mutants have reduced levels of amidated peptides similar to that observed in peptidyl-glycine hydryoxylating mono-oxygenase (PHM) mutants. In contrast, nemy26.2 mutants show no defects in peptide amidation but rather display a decrease in Tyramine beta hydroxylase activity (T beta H). Taken together, these results show non-redundant roles for the different nemy isoforms and shed light on the complex regulation of neuromodulators.	[Knight, David; Iliadi, Konstantin G.; Boulianne, Gabrielle L.] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Dev & Stem Cell Biol, Toronto, ON M5G 0A4, Canada; [Moran, Michael F.; Boulianne, Gabrielle L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Hu, Jack; Krause, Henry M.] Univ Toronto, Dept Mol Genet, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Taylor, Paul; Moran, Michael F.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Boulianne, GL (corresponding author), Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Dev & Stem Cell Biol, Toronto, ON M5G 0A4, Canada.	gboul@sickkids.ca	Knight, David/U-4162-2017; Moran, Michael/GYD-3631-2022	Krause, Henry/0000-0002-6182-7074	Natural Sciences and Engineering Council of Canada; Canadian Institutes of Health Research (FRN) [14143]	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (FRN)(Canadian Institutes of Health Research (CIHR))	This work was supported by grants to GLB from the Natural Sciences and Engineering Council of Canada and the Canadian Institutes of Health Research (FRN#14143). GLB is the recipient of a Tier I Canada Research Chair in Molecular and Developmental Neurobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; Bousquet-Moore D, 2010, J NEUROSCI RES, V88, P2535, DOI 10.1002/jnr.22404; BREEN CA, 1983, NATURE, V303, P716, DOI 10.1038/303716a0; Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; Chen A, 2013, GENETICS, V193, P159, DOI 10.1534/genetics.112.142042; Chen X, 2012, J CELL BIOL, V196, P529, DOI 10.1083/jcb.201109044; Curran KP, 2012, INVERTEBR NEUROSCI, V12, P81, DOI 10.1007/s10158-012-0140-y; DeZazzo J, 1999, J NEUROSCI, V19, P8740, DOI 10.1523/JNEUROSCI.19-20-08740.1999; Dunn TW, 2005, PEPTIDES, V26, P269, DOI 10.1016/j.peptides.2004.09.010; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; Erion R, 2012, J BIOL CHEM, V287, P32406, DOI 10.1074/jbc.M112.360875; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; Feng YF, 2004, J NEUROGENET, V18, P377, DOI 10.1080/01677060490894522; FLEMING PJ, 1991, AM J CLIN NUTR, V54, pS1173, DOI 10.1093/ajcn/54.6.1173s; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hess CR, 2008, J BIOL CHEM, V283, P3042, DOI 10.1074/jbc.M705911200; Hewes RS, 1998, J NEUROSCI, V18, P7138; Hoang B, 2001, DEV BIOL, V229, P55, DOI 10.1006/dbio.2000.9983; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Iliadi KG, 2008, P NATL ACAD SCI USA, V105, P19986, DOI 10.1073/pnas.0810698105; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; Jiang N, 2000, DEV BIOL, V226, P118, DOI 10.1006/dbio.2000.9832; Kamyshev NG, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-9; Karunanithi S, 2002, J NEUROSCI, V22, P10267; Klose MK, 2010, J NEUROSCI, V30, P14724, DOI 10.1523/JNEUROSCI.3612-10.2010; Knight D, 2007, DEV NEUROBIOL, V67, P1598, DOI 10.1002/dneu.20532; Knight D, 2010, J NEUROSCI, V30, P5047, DOI 10.1523/JNEUROSCI.6241-09.2010; Kolhekar AS, 1997, J NEUROSCI, V17, P1363, DOI 10.1523/jneurosci.17-04-01363.1997; Koon AC, 2012, J NEUROSCI, V32, P6312, DOI 10.1523/JNEUROSCI.6517-11.2012; Koon AC, 2011, NAT NEUROSCI, V14, P190, DOI 10.1038/nn.2716; Kuromi H, 2003, J NEUROCYTOL, V32, P551, DOI 10.1023/B:NEUR.0000020610.13554.3c; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; Kuromi H, 2002, NEURON, V35, P333, DOI 10.1016/S0896-6273(02)00777-8; Lee MG, 2011, NEUROREPORT, V22, P609, DOI 10.1097/WNR.0b013e3283495a6e; Liu WJ, 2008, BIOCHEM BIOPH RES CO, V372, P798, DOI 10.1016/j.bbrc.2008.05.119; Monastirioti M, 1996, J NEUROSCI, V16, P3900; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; Nishikawa K, 1999, BRAIN RES, V837, P67, DOI 10.1016/S0006-8993(99)01676-5; Park D, 2008, MOL CELL BIOL, V28, P410, DOI 10.1128/MCB.01104-07; Park D, 2011, CURR BIOL, V21, P1515, DOI 10.1016/j.cub.2011.08.015; QUINN WG, 1979, NATURE, V277, P212, DOI 10.1038/277212a0; Saito TH, 2010, J NEUROPHYSIOL, V104, P3518, DOI 10.1152/jn.01027.2009; Saraswati S, 2004, J NEUROBIOL, V58, P425, DOI 10.1002/neu.10298; Selcho M, 2012, J COMP NEUROL, V520, P3764, DOI 10.1002/cne.23152; Shakiryanova D, 2011, P NATL ACAD SCI USA, V108, P4477, DOI 10.1073/pnas.1017837108; Taghert PH, 2012, NEURON, V76, P82, DOI 10.1016/j.neuron.2012.08.035; Taghert PH, 2001, J NEUROSCI, V21, P6673, DOI 10.1523/JNEUROSCI.21-17-06673.2001; Taghert PH, 1999, MICROSC RES TECHNIQ, V45, P80, DOI 10.1002/(SICI)1097-0029(19990415)45:2<80::AID-JEMT3>3.0.CO;2-X; Van Swinderen B, 2011, P ROY SOC B-BIOL SCI, V278, P906, DOI 10.1098/rspb.2010.2564; Vautrin J, 2003, SYNAPSE, V47, P184, DOI 10.1002/syn.10161; Verlinden H, 2010, J INSECT PHYSIOL, V56, P854, DOI 10.1016/j.jinsphys.2010.05.018; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Wilk R., 2010, SITU HYBRIDIZATION F; Wu CL, 2013, CURR BIOL, V23, P2346, DOI 10.1016/j.cub.2013.09.056; Wu Wen-Hui, 2012, Exp Neurobiol, V21, P101, DOI 10.5607/en.2012.21.3.101; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	59	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0132548	10.1371/journal.pone.0132548	http://dx.doi.org/10.1371/journal.pone.0132548			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237434	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942400008
J	Sheft, S; Shafiro, V; Wang, E; Barnes, LL; Shah, RC				Sheft, Stanley; Shafiro, Valeriy; Wang, Emily; Barnes, Lisa L.; Shah, Raj C.			Relationship between Auditory and Cognitive Abilities in Older Adults	PLOS ONE			English	Article							IN-NOISE PERCEPTION; HEARING-LOSS; ALZHEIMERS-DISEASE; WORKING-MEMORY; SHORT-TERM; INDIVIDUAL-DIFFERENCES; AFRICAN-AMERICANS; SPEECH-PERCEPTION; COMPLEX SPAN; RISK-FACTORS	Objective The objective was to evaluate the association of peripheral and central hearing abilities with cognitive function in older adults. Methods Recruited from epidemiological studies of aging and cognition at the Rush Alzheimer's Disease Center, participants were a community-dwelling cohort of older adults (range 63-98 years) without diagnosis of dementia. The cohort contained roughly equal numbers of Black (n=61) and White (n=63) subjects with groups similar in terms of age, gender, and years of education. Auditory abilities were measured with pure-tone audiometry, speech-in-noise perception, and discrimination thresholds for both static and dynamic spectral patterns. Cognitive performance was evaluated with a 12-test battery assessing episodic, semantic, and working memory, perceptual speed, and visuospatial abilities. Results Among the auditory measures, only the static and dynamic spectral-pattern discrimination thresholds were associated with cognitive performance in a regression model that included the demographic covariates race, age, gender, and years of education. Subsequent analysis indicated substantial shared variance among the covariates race and both measures of spectral-pattern discrimination in accounting for cognitive performance. Among cognitive measures, working memory and visuospatial abilities showed the strongest interrelationship to spectral-pattern discrimination performance. Conclusions For a cohort of older adults without diagnosis of dementia, neither hearing thresholds nor speech-in-noise ability showed significant association with a summary measure of global cognition. In contrast, the two auditory metrics of spectral-pattern discrimination ability significantly contributed to a regression model prediction of cognitive performance, demonstrating association of central auditory ability to cognitive status using auditory metrics that avoided the confounding effect of speech materials.	[Sheft, Stanley; Shafiro, Valeriy; Wang, Emily] Rush Univ, Med Ctr, Dept Commun Disorders & Sci, Chicago, IL 60612 USA; [Barnes, Lisa L.; Shah, Raj C.] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA; [Barnes, Lisa L.] Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA; [Barnes, Lisa L.] Rush Univ, Dept Behav Sci, Med Ctr, Chicago, IL 60612 USA	Rush University; Rush University; Rush University; Rush University	Sheft, S (corresponding author), Rush Univ, Med Ctr, Dept Commun Disorders & Sci, Chicago, IL 60612 USA.	ssheft@gmail.com	Shah, Raj/AAS-2210-2021	Shah, Raj/0000-0001-9706-9730; Wang, Emily/0000-0001-6020-6228; Shafiro, Valeriy/0000-0002-5722-748X	National Institute on Deafness and Other Communication Disorders [R15DC011916]; National Institute on Aging [R01AG022018, R01AG017917, P30AG010161]; Illinois Department of Public Health; NATIONAL INSTITUTE ON AGING [P30AG010161, R01AG022018, R01AG017917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R15DC011916] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Illinois Department of Public Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by R15DC011916 from the National Institute on Deafness and Other Communication Disorders, www.nidcd.nih.gov, to SS; R01AG022018 from the National Institute on Aging, www.nia.nih.gov, to LLB; R01AG017917 from the National Institute on Aging, www.nia.nih.gov, to Rush Alzheimer's Disease Center; P30AG010161 from the National Institute on Aging, www.nia.nih.gov, to Rush Alzheimer's Disease Center; and the Illinois Department of Public Health, www.idphgrants.com, to Rush Alzheimer's Disease Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd M, 2008, INT J AUDIOL, V47, pS53, DOI 10.1080/14992020802301142; Anderson S, 2013, HEARING RES, V300, P18, DOI 10.1016/j.heares.2013.03.006; [Anonymous], 1994, ASSESSMENT CLIN MANU; Anstey KJ, 2003, J EXP PSYCHOL GEN, V132, P470, DOI 10.1037/0096-3445.132.3.470; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barnes LL, 2012, J INT NEUROPSYCH SOC, V18, P856, DOI 10.1017/S1355617712000628; Barnes LL, 2014, HEALTH AFFAIR, V33, P580, DOI 10.1377/hlthaff.2013.1353; Barnes LL, 2011, J GERONTOL B-PSYCHOL, V66, P354, DOI 10.1093/geronb/gbr016; Bennett DA, 2006, NEUROEPIDEMIOLOGY, V27, P169, DOI 10.1159/000096129; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Besser J, 2012, J SPEECH LANG HEAR R, V55, P194, DOI 10.1044/1092-4388(2011/11-0008); Brickman AM, 2006, APPL NEUROPSYCHOL, V13, P91, DOI 10.1207/s15324826an1302_4; BYRNE D, 1994, J ACOUST SOC AM, V96, P2108, DOI 10.1121/1.410152; CHABA, 1988, J ACOUST SOC AM, V83, P859, DOI [DOI 10.1121/1.395965, 10.1121/1.395965]; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Etymotic Research, 2001, QUICK SPEECH IN NOIS; Fogerty D, 2010, J ACOUST SOC AM, V127, P2509, DOI 10.1121/1.3316291; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fostick Leah, 2013, Journal of Basic and Clinical Physiology and Pharmacology, V24, P175, DOI 10.1515/jbcpp-2013-0048; Fullgrabe C, 2015, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00347; Fyffe DC, 2011, J INT NEUROPSYCH SOC, V17, P625, DOI 10.1017/S1355617711000476; Gatehouse Stuart, 2003, Int J Audiol, V42 Suppl 1, pS77, DOI 10.3109/14992020309074648; GATES GA, 1995, ARCH NEUROL-CHICAGO, V52, P626, DOI 10.1001/archneur.1995.00540300108020; GATES GA, 1990, EAR HEARING, V11, P247, DOI 10.1097/00003446-199008000-00001; Gates GA, 2011, ARCH OTOLARYNGOL, V137, P390, DOI 10.1001/archoto.2011.28; Gates GA, 2010, COGN BEHAV NEUROL, V23, P218, DOI 10.1097/WNN.0b013e3181d748d7; GENNIS V, 1991, ARCH INTERN MED, V151, P2259, DOI 10.1001/archinte.151.11.2259; Glymour MM, 2008, NEUROPSYCHOL REV, V18, P194, DOI 10.1007/s11065-008-9066-x; Gussekloo J, 2005, AM J GERIAT PSYCHIAT, V13, P781, DOI 10.1176/appi.ajgp.13.9.781; Hofer SM, 2003, PSYCHOL AGING, V18, P285, DOI 10.1037/0882-7974.18.2.285; Humes LE, 2007, J AM ACAD AUDIOL, V18, P590, DOI 10.3766/jaaa.18.7.6; Humes LE, 2013, ATTEN PERCEPT PSYCHO, V75, P508, DOI 10.3758/s13414-012-0406-9; Humes LE, 2012, J AM ACAD AUDIOL, V23, P635, DOI 10.3766/jaaa.23.8.5; Humes LE, 2010, SPRINGER HANDB AUDIT, V34, P211, DOI 10.1007/978-1-4419-0993-0_8; Humes LE, 2002, J ACOUST SOC AM, V112, P1112, DOI 10.1121/1.1499132; Idrizbegovic E, 2011, AGE AGEING, V40, P249, DOI 10.1093/ageing/afq168; Iliadou Vassiliki, 2003, Ann Gen Hosp Psychiatry, V2, P12, DOI 10.1186/1475-2832-2-12; KURYLO DD, 1993, NEUROLOGY, V43, P1893, DOI 10.1212/WNL.43.10.1893; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin FR, 2011, J GERONTOL A-BIOL, V66, P582, DOI 10.1093/gerona/glr002; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Nimon K., 2010, MULTIPLE LINEAR REGR, V36, P10, DOI DOI 10.2106/JBJS.M.00521; Peelle JE, 2011, J NEUROSCI, V31, P12638, DOI 10.1523/JNEUROSCI.2559-11.2011; Pratt SR, 2009, J SPEECH LANG HEAR R, V52, P973, DOI 10.1044/1092-4388(2009/08-0026); RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Raven JC., 1992, MANUAL RAVENS PROGR; Redick TS, 2013, PSYCHON B REV, V20, P1102, DOI 10.3758/s13423-013-0453-9; Ronnberg J, 2011, J SPEECH LANG HEAR R, V54, P705, DOI 10.1044/1092-4388(2010/09-0088); Schneider BA, 2011, AUDIOL RES, V1, P34, DOI 10.4081/audiores.2011.e10; Schneider BA, 2002, CAN J EXP PSYCHOL, V56, P139, DOI 10.1037/h0087392; Schoof T, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00307; Sheft S., 2012, SPEECH PERCEPTION AU, P481; Smith A., 1982, SYMBOL DIGIT MODALIT; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; STROUSE AL, 1995, EAR HEARING, V16, P230, DOI 10.1097/00003446-199504000-00010; Tay T, 2006, GERONTOLOGY, V52, P386, DOI 10.1159/000095129; UHLMANN RF, 1989, JAMA-J AM MED ASSOC, V261, P1916, DOI 10.1001/jama.261.13.1916; Unsworth N, 2007, PSYCHOL BULL, V133, P1038, DOI 10.1037/0033-2909.133.6.1038; VANROOIJ JCGM, 1992, J ACOUST SOC AM, V91, P1028, DOI 10.1121/1.402628; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 1997, WECHSLER ADULT INTEL; Wilson RS, 2003, J CLIN EXP NEUROPSYC, V25, P634, DOI 10.1076/jcen.25.5.634.14572; Wilson RS, 2002, PSYCHOL AGING, V17, P179, DOI 10.1037/0882-7974.17.2.179	65	19	20	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134330	10.1371/journal.pone.0134330	http://dx.doi.org/10.1371/journal.pone.0134330			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1UY	26237423	gold, Green Published, Green Submitted			2022-12-27	WOS:000358942400022
J	Acar, OA; van den Ende, J				Acar, Oguz Ali; van den Ende, Jan			Understanding Fear of Opportunism in Global Prize-Based Science Contests: Evidence for Gender and Age Differences	PLOS ONE			English	Article							EMOTIONAL EXPERIENCE; INNOVATION CONTESTS; PERSONALITY; UNCERTAINTY; TRUST; LIFE	Global prize-based science contests have great potential for tapping into diverse knowledge on a global scale and overcoming important scientific challenges. A necessary step for knowledge to be utilized in these contests is for that knowledge to be disclosed. Knowledge disclosure, however, is paradoxical in nature: in order for the value of knowledge to be assessed, inventors must disclose their knowledge, but then the person who receives that knowledge does so at no cost and may use it opportunistically. This risk of potential opportunistic behavior in turn makes the inventor fearful of disclosing knowledge, and this is a major psychological barrier to knowledge disclosure. In this project, we investigated this fear of opportunism in global prize-based science contests by surveying 630 contest participants in the InnoCentive online platform for science contests. We found that participants in these science contests experience fear of opportunism to varying degrees, and that women and older participants have significantly less fear of disclosing their scientific knowledge. Our findings highlight the importance of taking differences in such fears into account when designing global prize-based contests so that the potential of the contests for reaching solutions to important and challenging problems can be used more effectively.	[Acar, Oguz Ali] Kings Coll London, Dept Management, London WC2R 2LS, England; [Acar, Oguz Ali; van den Ende, Jan] Erasmus Univ, Rotterdam Sch Management, Dept Technol & Operat Management, Rotterdam, Netherlands	University of London; King's College London; Erasmus University Rotterdam	Acar, OA (corresponding author), Kings Coll London, Dept Management, London WC2R 2LS, England.	oguz.acar@kcl.ac.uk	Acar, Oguz Ali/AAJ-1066-2021; Acar, Oguz/AAL-2365-2021	Acar, Oguz Ali/0000-0003-1993-0921; 	Erasmus Research Institute of Management	Erasmus Research Institute of Management	This research was made possible by the generous funding of the Erasmus Research Institute of Management to OAA (http://www.erim.eur.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, INNOV TECHNOL GOV GL, DOI DOI 10.1162/ITGG.2007.2.3.15; Anton JJ, 2002, REV ECON STUD, V69, P513, DOI 10.1111/1467-937X.t01-1-00020; Arrow K., 1962, RATE DIRECTION INVEN, P609, DOI DOI 10.1515/9781400879762-024; Boudreau KJ, 2011, MANAGE SCI, V57, P843, DOI 10.1287/mnsc.1110.1322; Carson SJ, 2006, ACAD MANAGE J, V49, P1058, DOI 10.2307/20159816; Carstensen LL, 2011, PSYCHOL AGING, V26, P21, DOI 10.1037/a0021285; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; Chan L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001016; Costa PT, 2001, J PERS SOC PSYCHOL, V81, P322, DOI [10.1037/0022-3514.81.2.322, 10.1037//0022-3514.81.2.322]; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; DASGUPTA P, 1994, RES POLICY, V23, P487; Ding WW, 2006, SCIENCE, V313, P665, DOI 10.1126/science.1124832; Fedoroff NV, 2012, SCIENCE, V335, P503, DOI 10.1126/science.1219498; FEINGOLD A, 1994, PSYCHOL BULL, V116, P429, DOI 10.1037/0033-2909.116.3.429; Handelsman J, 2005, SCIENCE, V309, P1190, DOI 10.1126/science.1113252; Hill BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065782; Jeppesen LB, 2010, ORGAN SCI, V21, P1016, DOI 10.1287/orsc.1090.0491; JOHN G, 1984, J MARKETING RES, V21, P278, DOI 10.2307/3151604; Kanfer R, 2004, ACAD MANAGE REV, V29, P440, DOI 10.2307/20159053; Lakhani KR, 2013, NAT BIOTECHNOL, V31, P108, DOI 10.1038/nbt.2495; Lang FR, 2002, PSYCHOL AGING, V17, P125, DOI 10.1037//0882-7974.17.1.125; Masum H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003244; MORGAN RM, 1994, J MARKETING, V58, P20, DOI 10.2307/1252308; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Murray F, 2007, ORGAN SCI, V18, P1006, DOI 10.1287/orsc.1070.0325; Murray F, 2012, RES POLICY, V41, P1779, DOI 10.1016/j.respol.2012.06.013; Nambisan S, 2010, ORGAN SCI, V21, P554, DOI 10.1287/orsc.1090.0460; Niederle M, 2011, ANNU REV ECON, V3, P601, DOI 10.1146/annurev-economics-111809-125122; Robinson SL, 1996, ADMIN SCI QUART, V41, P574, DOI 10.2307/2393868; Rogelberg SG, 2007, ORGAN RES METHODS, V10, P195, DOI 10.1177/1094428106294693; Sansom C, 2011, NAT BIOTECHNOL, V29, P201, DOI 10.1038/nbt.1792; Sauermann H, 2013, RES POLICY, V42, P273, DOI 10.1016/j.respol.2012.05.003; Stone AA, 2010, P NATL ACAD SCI USA, V107, P9985, DOI 10.1073/pnas.1003744107; Terwiesch C, 2008, MANAGE SCI, V54, P1529, DOI 10.1287/mnsc.1080.0884; Travis J, 2008, SCIENCE, V319, P1750, DOI 10.1126/science.319.5871.1750; Vesterlund L, 2005, Q J ECON, P1067	36	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134898	10.1371/journal.pone.0134898	http://dx.doi.org/10.1371/journal.pone.0134898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230086	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400186
J	Maeshima, H; Yamashita, Y; Fujimura, T; Okada, M; Okanoya, K				Maeshima, Hiroaki; Yamashita, Yuichi; Fujimura, Tomomi; Okada, Masato; Okanoya, Kazuo			Modulation of Emotional Category Induced by Temporal Factors in Emotion Recognition	PLOS ONE			English	Article							RECOGNIZING FACIAL EXPRESSIONS; VERBAL INTERFERENCE; REACTION-TIMES; PERCEPTION; INFORMATION; LANGUAGE; DISCRIMINATION; BRAIN; FACE; REPRESENTATIONS	Categorical perception (CP), the perceptual experience whereby continuous sensory phenomena are perceived as distinct and separate percepts, is one of the most characteristic features of information processing in human cognition. CP is considered as the result of the integration of the top-down processing including background knowledge and verbal labeling and the bottom-up processing such as physical characteristics of the sensory signal. However, the underlying mechanisms governing the integration remain unclear. To address this issue, we focused on the temporal characteristics of CP of facial expression. In the current study, we investigated the contributions of temporal factors in CP processes, using facial expression recognition tasks as an example of CP. Participants completed an identification task and a discrimination task, well-established tasks for evaluating CP of facial expressions, with variable temporal parameters, that is, duration of stimulus presentation and delay time (interval between stimulus and response). The results demonstrated that the emotionally ambiguous stimuli are categorized more distinctively with the extension of delay length, not of stimulus duration. In contrast, the category boundary for facial expressions shifted toward "happy" with extention in stimulus duration, not in delay length. This dissociation between the impact of stimulus duration and delay suggests that there are two processes contributing to CP of facial emotion; one process may reflect the internal processing associated with the length of the delay period including verbal labeling of the stimuli, and the other process may reflect the temporal summation of stimulus inputs, associated with stimulus duration. These findings suggest that paying more attention to temporal factors in CP could be useful for further study of the mechanisms underlying CP.	[Maeshima, Hiroaki; Okanoya, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Maeshima, Hiroaki; Yamashita, Yuichi; Fujimura, Tomomi; Okada, Masato; Okanoya, Kazuo] ERATO, Okanoya Emot Informat Project, JST, Wako, Saitama, Japan; [Yamashita, Yuichi; Fujimura, Tomomi; Okada, Masato; Okanoya, Kazuo] RIKEN, Cognit & Behav Joint Res Lab, Brain Sci Inst, Wako, Saitama, Japan; [Yamashita, Yuichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Funct Brain Res, Kodaira, Tokyo 1870031, Japan; [Fujimura, Tomomi] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan; [Okada, Masato] Univ Tokyo, Grad Sch Frontier Sci, Dept Complex Sci & Engn, Kashiwa, Chiba, Japan	University of Tokyo; Japan Science & Technology Agency (JST); RIKEN; National Center for Neurology & Psychiatry - Japan; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Maeshima, H (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan.	antillas106@gmail.com	Fujimura, Tomomi/N-6040-2016	Fujimura, Tomomi/0000-0002-4506-4337	Japan Science and Technology Agency, Exploratory Research for Advanced Technology, Okanoya Emotional Information Project	Japan Science and Technology Agency, Exploratory Research for Advanced Technology, Okanoya Emotional Information Project	This work was supported by the Japan Science and Technology Agency, Exploratory Research for Advanced Technology, Okanoya Emotional Information Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003; BORNSTEIN MH, 1984, PSYCHOL RES-PSYCH FO, V46, P207, DOI 10.1007/BF00308884; Bradley BP, 1998, COGNITION EMOTION, V12, P737, DOI 10.1080/026999398379411; Brosch T, 2010, COGNITION EMOTION, V24, P377, DOI 10.1080/02699930902975754; Calder AJ, 1996, VIS COGN, V3, P81, DOI 10.1080/713756735; Calvo MG, 2009, COGNITION EMOTION, V23, P782, DOI 10.1080/02699930802151654; Campanella S, 2002, J COGNITIVE NEUROSCI, V14, P210, DOI 10.1162/089892902317236858; Carmicheal L, 1932, J EXP PSYCHOL, V15, P73, DOI 10.1037/h0072671; Dailey MN, 2002, J COGNITIVE NEUROSCI, V14, P1158, DOI 10.1162/089892902760807177; DILOLLO V, 1977, NATURE, V267, P241, DOI 10.1038/267241a0; Eastwood JD, 2003, PERCEPT PSYCHOPHYS, V65, P352, DOI 10.3758/BF03194566; Ekman P., 1976, PICTURES FACIAL AFFE; ETCOFF NL, 1992, COGNITION, V44, P227, DOI 10.1016/0010-0277(92)90002-Y; FISKE ST, 1980, J PERS SOC PSYCHOL, V38, P889, DOI 10.1037/0022-3514.38.6.889; Fujimura T, 2012, COGNITION EMOTION, V26, P587, DOI 10.1080/02699931.2011.595391; Fujimura T, 2010, PERCEPTION, V39, P543, DOI 10.1068/p6257; Goldstone RL, 2010, WIRES COGN SCI, V1, P69, DOI 10.1002/wcs.26; GOREA A, 1986, J OPT SOC AM A, V3, P52, DOI 10.1364/JOSAA.3.000052; Harris RJ, 2012, P NATL ACAD SCI USA, V109, P21164, DOI 10.1073/pnas.1212207110; Hu ZH, 2014, PSYCHON B REV, V21, P1214, DOI 10.3758/s13423-014-0603-8; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; JULESZ B, 1981, ANNU REV PSYCHOL, V32, P575, DOI 10.1146/annurev.ps.32.020181.003043; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; KIRITA T, 1995, ACTA PSYCHOL, V89, P149, DOI 10.1016/0001-6918(94)00021-8; Kotsoni E, 2001, PERCEPTION, V30, P1115, DOI 10.1068/p3155; Leppanen JM, 2003, J PSYCHOPHYSIOL, V17, P113, DOI 10.1027//0269-8803.17.3.113; LIBERMAN AM, 1957, J EXP PSYCHOL, V54, P358, DOI 10.1037/h0044417; Liu BC, 1999, BRAIN TOPOGR, V11, P291, DOI 10.1023/A:1022258620435; Lupyan G, 2009, PSYCHON B REV, V16, P711, DOI 10.3758/PBR.16.4.711; MEDIN DL, 1978, PSYCHOL REV, V85, P207, DOI 10.1037/0033-295X.85.3.207; Moriguchi Y, 2005, NEUROREPORT, V16, P133, DOI 10.1097/00001756-200502080-00012; MURPHY GL, 1985, PSYCHOL REV, V92, P289, DOI 10.1037/0033-295X.92.3.289; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nisbett RE, 2003, P NATL ACAD SCI USA, V100, P11163, DOI 10.1073/pnas.1934527100; Ogawa T, 1999, PERCEPT MOTOR SKILL, V89, P557; OTOOLE AJ, 1994, MEM COGNITION, V22, P208, DOI 10.3758/BF03208892; Pollak SD, 2002, P NATL ACAD SCI USA, V99, P9072, DOI 10.1073/pnas.142165999; Roberson D, 2000, MEM COGNITION, V28, P977, DOI 10.3758/BF03209345; Roberson D, 2007, MEM COGNITION, V35, P1814, DOI 10.3758/BF03193512; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; Sauter DA, 2011, EMOTION, V11, P1479, DOI 10.1037/a0025336; Schyns PG, 2007, CURR BIOL, V17, P1580, DOI 10.1016/j.cub.2007.08.048; Shioiri T, 1999, PSYCHIAT CLIN NEUROS, V53, P45, DOI 10.1046/j.1440-1819.1999.00469.x; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Suzuki A, 2007, JAPANESE J RES EMOTI, V14, P3, DOI [10.4092/jsre.14.3, DOI 10.4092/JSRE.14.3]; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Tracy JL, 2008, EMOTION, V8, P81, DOI 10.1037/1528-3542.8.1.81; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Winawer J, 2007, P NATL ACAD SCI USA, V104, P7780, DOI 10.1073/pnas.0701644104; WISNIEWSKI EJ, 1994, COGNITIVE SCI, V18, P221, DOI 10.1207/s15516709cog1802_2; Young AW, 1997, COGNITION, V63, P271, DOI 10.1016/S0010-0277(97)00003-6	52	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0131636	10.1371/journal.pone.0131636	http://dx.doi.org/10.1371/journal.pone.0131636			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230992	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400009
J	Penna, M; Moreno-Gomez, FN				Penna, Mario; Moreno-Gomez, Felipe N.			Contrasting Propagation of Natural Calls of Two Anuran Species from the South American Temperate Forest	PLOS ONE			English	Article							EVOKED VOCAL RESPONSES; ADVERTISEMENT CALLS; SOUND-TRANSMISSION; FROG; HABITAT; NOISE; SONG; EVOLUTION; COMMUNICATION; SEGREGATION	The acoustic adaptation hypothesis predicts that sound communication signals have an optimal relationship with animals' native environments. However, species sharing a habitat produce signals stratified in the spectral domain and exhibit different temporal patterns resulting in acoustic niche partitioning. The diversity generated is likely to affect differently the characteristics of propagating signals. We recorded at various distances from the sound source calls of the frogs Eupsophus calcaratus and E. emiliopugini in the austral temperate forest where they communicate and breed syntopically. The calls of E. calcaratus have higher frequency components and lower amplitude relative to calls of E. emiliopugini, and the acoustic active space for the signals of E. calcaratus is restricted relative to E. emiliopugini. The signals of both species experience similar attenuation patterns, but calls of E. calcaratus are affected by spectral degradation to a larger extent, with linear decreases in spectral cross-correlation and in the amplitude ratio between the first two harmonics. The calls of E. emiliopugini are affected by temporal degradation as a linear decrease in amplitude modulation depth of their pulsed structure. Further studies are needed to assess the relative importance of selective and phylogenetic factors on the divergent propagation patterns reported.	[Penna, Mario; Moreno-Gomez, Felipe N.] Univ Chile, Fac Med, Inst Biomed Sci, Program Physiol & Biophys, Santiago, Chile	Universidad de Chile	Penna, M (corresponding author), Univ Chile, Fac Med, Inst Biomed Sci, Program Physiol & Biophys, Independencia 838000, Santiago, Chile.	mpenna@med.uchile.cl	Moreno-Gómez, Felipe N/N-7148-2014; Moreno-Gómez, Felipe N./Q-5072-2019	Moreno-Gómez, Felipe N/0000-0001-5715-309X; Moreno-Gómez, Felipe N./0000-0001-5715-309X	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1110939]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was funded by Proyecto 1110939 Fondo Nacional de Desarrollo Cientifico y Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D.M., 2010, LME4 MIXED EFFECTS M; Boncoraglio G, 2007, FUNCT ECOL, V21, P134, DOI 10.1111/j.1365-2435.2006.01207.x; Bosch J, 2004, CAN J ZOOL, V82, P880, DOI 10.1139/Z04-060; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Bradbury Jack W., 1998, pi; BRENOWITZ EA, 1986, BRAIN BEHAV EVOLUT, V28, P32, DOI 10.1159/000118690; BROWN CH, 1984, Z TIERPSYCHOL, V65, P273; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; Charlton BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045420; Correa C, 2006, REV CHIL HIST NAT, V79, P435, DOI 10.4067/S0716-078X2006000400003; Couldridge VCK, 2004, J EXP BIOL, V207, P2777, DOI 10.1242/jeb.01092; EMBLETON TFW, 1976, J ACOUST SOC AM, V59, P267, DOI 10.1121/1.380882; Erdtmann LK, 2013, ETHOL ECOL EVOL, V25, P1, DOI 10.1080/03949370.2012.744356; Ey E, 2009, BIOACOUSTICS, V19, P21, DOI 10.1080/09524622.2009.9753613; FORREST TG, 1994, AM ZOOL, V34, P644; Garcia-Rutledge EJ, 2001, HERPETOLOGICA, V57, P104; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Gingras B, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-134; Kime NM, 2000, BEHAV ECOL, V11, P71, DOI 10.1093/beheco/11.1.71; Kuczynski MC, 2010, J EXP BIOL, V213, P2840, DOI 10.1242/jeb.044628; Luther D, 2009, BEHAV ECOL, V20, P864, DOI 10.1093/beheco/arp074; Malone JH, 2014, EVOLUTION, V68, P1306, DOI 10.1111/evo.12366; Moreno-Gomez FN, 2013, BIOL J LINN SOC, V110, P814, DOI 10.1111/bij.12156; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Mouterde SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102842; Parris KM, 2002, ECOL MODEL, V156, P213, DOI 10.1016/S0304-3800(02)00170-9; Penna M, 1998, BEHAV ECOL SOCIOBIOL, V42, P371, DOI 10.1007/s002650050452; Penna M, 2006, J ACOUST SOC AM, V119, P1227, DOI 10.1121/1.2149769; Penna M, 2005, ANIM BEHAV, V70, P639, DOI 10.1016/j.anbehav.2004.11.022; Penna M, 2005, HERPETOLOGICA, V61, P1, DOI 10.1655/04-21; Penna M, 2004, J ACOUST SOC AM, V116, P1254, DOI 10.1121/1.1768257; Penna M, 1999, BEHAV ECOL SOCIOBIOL, V47, P94, DOI 10.1007/s002650050654; Penna M, 1996, ANIM BEHAV, V51, P255, DOI 10.1006/anbe.1996.0026; PENNA M, 1990, J HERPETOL, V24, P23, DOI 10.2307/1564285; Penna M, 2007, ANIM BEHAV, V74, P45, DOI 10.1016/j.anbehav.2006.11.010; Penna M, 2007, ETHOLOGY, V113, P313, DOI 10.1111/j.1439-0310.2007.01339.x; Penna M, 2014, J COMP PHYSIOL A, V200, P171, DOI 10.1007/s00359-013-0875-x; Penna M, 2013, J COMP PHYSIOL A, V199, P723, DOI 10.1007/s00359-013-0831-9; Penna M, 2012, J ACOUST SOC AM, V132, P4025, DOI 10.1121/1.4763982; PIERCY JE, 1977, J ACOUST SOC AM, V61, P1403, DOI 10.1121/1.381455; Pinheiro J, 2020, R PACKAGE VERSION 31; Pinheiro J, 2010, MIXED EFFECTS MODELS; R Core Team, 2021, R LANGUAGE ENV STAT; ROBISSON P, 1991, BEHAVIOUR, V119, P302, DOI 10.1163/156853991X00490; ROMER H, 1992, BEHAV ECOL SOCIOBIOL, V29, P437, DOI 10.1007/BF00170174; Romer H, 1998, SPR HDB AUD, V10, P63; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schmidt AKD, 2013, BEHAV ECOL, V24, P470, DOI 10.1093/beheco/ars187; SHY E, 1983, BEHAV ECOL SOCIOBIOL, V12, P71, DOI 10.1007/BF00296935; SORJONEN J, 1986, BEHAVIOUR, V98, P274, DOI 10.1163/156853986X01008; Sueur J, 2003, NATURWISSENSCHAFTEN, V90, P322, DOI 10.1007/s00114-003-0432-5; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Zaveri M, 1988, ACOUSTIC NOISE MEASU; ZIMMERMAN BL, 1983, HERPETOLOGICA, V39, P235	54	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134498	10.1371/journal.pone.0134498	http://dx.doi.org/10.1371/journal.pone.0134498			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230852	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400128
J	Pompey, JM; Foda, B; Singh, U				Pompey, Justine M.; Foda, Bardees; Singh, Upinder			A Single RNaseIII Domain Protein from Entamoeba histolytica Has dsRNA Cleavage Activity and Can Help Mediate RNAi Gene Silencing in a Heterologous System	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; TRYPANOSOMA-BRUCEI; INTERFERENCE PATHWAYS; PROTOZOAN PARASITE; C-ELEGANS; DICER; DISTINCT; BINDING; ROLES; RIBONUCLEASE	Dicer enzymes process double-stranded RNA (dsRNA) into small RNAs that target gene silencing through the RNA interference (RNAi) pathway. Dicer enzymes are complex, multidomain RNaseIII proteins, however structural minimalism of this protein has recently emerged in parasitic and fungal systems. The most minimal Dicer, Saccharomyces castellii Dicer1, has a single RNaseIII domain and two double stranded RNA binding domains. In the protozoan parasite Entamoeba histolytica 27nt small RNAs are abundant and mediate silencing, yet no canonical Dicer enzyme has been identified. Although EhRNaseIII does not exhibit robust dsRNA cleavage in vitro, it can process dsRNA in the RNAi-negative background of Saccharomyces cerevisiae, and in conjunction with S. castellii Argonaute1 can partially reconstitute the RNAi pathway. Thus, although EhRNaseIII lacks the domain architecture of canonical or minimal Dicer enzymes, it has dsRNA processing activity that contributes to gene silencing via RNAi. Our data advance the understanding of small RNA biogenesis in Entamoeba as well as broaden the spectrum of non-canonical Dicer enzymes that contribute to the RNAi pathway.	[Pompey, Justine M.; Singh, Upinder] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Foda, Bardees; Singh, Upinder] Stanford Univ, Sch Med, Dept Internal Med, Div Infect Dis, Stanford, CA 94305 USA; [Foda, Bardees] Natl Res Ctr, Mol Genet & Enzymol Dept, Dokki, Egypt	Stanford University; Stanford University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Singh, U (corresponding author), Stanford Univ, Sch Med, Dept Internal Med, Div Infect Dis, Stanford, CA 94305 USA.	usingh@stanford.edu	Foda, Bardees/B-2182-2019	Foda, Bardees/0000-0001-8869-3697; Singh, Upinder/0000-0003-0630-0306	National Institutes of Health [AI53724, AI085178, T32 AI07328]; American Society for Microbiology Watkins Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053724, R21AI085178, T32AI007328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society for Microbiology Watkins Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (AI53724 to US, AI085178 to US, and T32 AI07328 to JMP) and American Society for Microbiology Watkins Fellowship to JMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed M, 2005, EXP PARASITOL, V110, P265, DOI 10.1016/j.exppara.2005.02.023; Astromskas E, 2007, YEAST, V24, P499, DOI 10.1002/yea.1488; Baxt LA, 2010, EUKARYOT CELL, V9, P1283, DOI 10.1128/EC.00015-10; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blaszczyk J, 2004, STRUCTURE, V12, P457, DOI 10.1016/j.str.2004.02.004; Blaszczyk J, 2001, STRUCTURE, V9, P1225, DOI 10.1016/S0969-2126(01)00685-2; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Colmenares SU, 2007, MOL CELL, V27, P449, DOI 10.1016/j.molcel.2007.07.007; Dang YK, 2011, EUKARYOT CELL, V10, P1148, DOI 10.1128/EC.05109-11; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Ehrenkaufer GM, 2007, CELL MICROBIOL, V9, P1426, DOI 10.1111/j.1462-5822.2006.00882.x; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; GUNZL A, 1995, J BIOL CHEM, V270, P17287, DOI 10.1074/jbc.270.29.17287; Ji XH, 2008, CURR TOP MICROBIOL, V320, P99; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012; Kloc A, 2008, TRENDS GENET, V24, P511, DOI 10.1016/j.tig.2008.08.002; Kohrer K., 1991, METHOD ENZYMOL, V194, P398, DOI DOI 10.1016/0076-6879(91)94030-G; Kolev NG, 2011, EUKARYOT CELL, V10, P1156, DOI 10.1128/EC.05114-11; Lamontagne B, 2001, Curr Issues Mol Biol, V3, P71; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Li LD, 2011, METHODS MOL BIOL, V764, P169, DOI 10.1007/978-1-61779-188-8_11; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; MacFarlane RC, 2007, EUKARYOT CELL, V6, P2139, DOI 10.1128/EC.00174-07; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Morf L, 2013, NUCLEIC ACIDS RESEAR, V9, P2013; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Parker GS, 2006, RNA, V12, P807, DOI 10.1261/rna.2338706; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Parrish S, 2001, RNA, V7, P1397; Patrick KL, 2009, P NATL ACAD SCI USA, V106, P17933, DOI 10.1073/pnas.0907766106; Pompey JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106477; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Shi HF, 2006, RNA, V12, P2063, DOI 10.1261/rna.246906; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Suk K, 2011, NUCLEIC ACIDS RES, V39, pE43, DOI 10.1093/nar/gkq1321; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Weinberg DE, 2011, CELL, V146, P262, DOI 10.1016/j.cell.2011.06.021; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Zhang HB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-53; Zhang HB, 2011, J BIOL CHEM, V286, P44467, DOI 10.1074/jbc.M111.278184; Zhang HB, 2011, FUTURE MICROBIOL, V6, P103, DOI [10.2217/fmb.10.154, 10.2217/FMB.10.154]; Zhang HB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000219; Zhang HP, 2008, STAT INTERFACE, V1, P1	57	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133740	10.1371/journal.pone.0133740	http://dx.doi.org/10.1371/journal.pone.0133740			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230096	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400054
J	Zangrillo, A; Musu, M; Greco, T; Di Prima, AL; Matteazzi, A; Testa, V; Nardelli, P; Febres, D; Monaco, F; Calabro, MG; Ma, J; Finco, G; Landoni, G				Zangrillo, Alberto; Musu, Mario; Greco, Teresa; Di Prima, Ambra Licia; Matteazzi, Andrea; Testa, Valentina; Nardelli, Pasquale; Febres, Daniela; Monaco, Fabrizio; Calabro, Maria Grazia; Ma, Jun; Finco, Gabriele; Landoni, Giovanni			Additive Effect on Survival of Anaesthetic Cardiac Protection and Remote Ischemic Preconditioning in Cardiac Surgery: A Bayesian Network Meta-Analysis of Randomized Trials	PLOS ONE			English	Article							BYPASS GRAFT-SURGERY; REDUCES MYOCARDIAL INJURY; SEVOFLURANE VS. PROPOFOL; AORTIC-VALVE-REPLACEMENT; CORONARY SURGERY; VOLATILE ANESTHETICS; DOUBLE-BLIND; CARDIOPROTECTIVE PROPERTIES; SUFENTANIL ANESTHESIA; ISOFLURANE	Introduction Cardioprotective properties of volatile agents and of remote ischemic preconditioning have survival effects in patients undergoing cardiac surgery. We performed a Bayesian network meta-analysis to confirm the beneficial effects of these strategies on survival in cardiac surgery, to evaluate which is the best strategy and if these strategies have additive or competitive effects. Methods Pertinent studies were independently searched in BioMedCentral, MEDLINE/PubMed, Embase, and the Cochrane Central Register (updated November 2013). A Bayesian network meta-analysis was performed. Four groups of patients were compared: total intravenous anesthesia (with or without remote ischemic preconditioning) and an anesthesia plan including volatile agents (with or without remote ischemic preconditioning). Mortality was the main investigated outcome. Results We identified 55 randomized trials published between 1991 and 2013 and including 6,921 patients undergoing cardiac surgery. The use of volatile agents (posterior mean of odds ratio = 0.50, 95% CrI 0.28-0.91) and the combination of volatile agents with remote preconditioning (posterior mean of odds ratio = 0.15, 95% CrI 0.04-0.55) were associated with a reduction in mortality when compared to total intravenous anesthesia. Posterior distribution of the probability of each treatment to be the best one, showed that the association of volatile anesthetic and remote ischemic preconditioning is the best treatment to improve short- and long-term survival after cardiac surgery, suggesting an additive effect of these two strategies. Conclusions In patients undergoing cardiac surgery, the use of volatile anesthetics and the combination of volatile agents with remote preconditioning reduce mortality when compared to TIVA and have additive effects. It is necessary to confirm these results with large, multicenter, randomized, double-blinded trials comparing these different strategies in cardiac and non-cardiac surgery, to establish which volatile agent is more protective than the others and how to best apply remote ischemic preconditioning.	[Zangrillo, Alberto; Di Prima, Ambra Licia; Matteazzi, Andrea; Testa, Valentina; Nardelli, Pasquale; Febres, Daniela; Monaco, Fabrizio; Calabro, Maria Grazia; Landoni, Giovanni] IRCCS San Raffaele Sci Inst, Dept Anesthesia & Intens Care, Milan, Italy; [Zangrillo, Alberto; Greco, Teresa; Landoni, Giovanni] Univ Vita Salute San Raffaele, Milan, Italy; [Musu, Mario; Finco, Gabriele] Univ Cagliari, Dept Med Sci M Aresu, Cagliari, Italy; [Ma, Jun] Capital Med Univ, Beijing Anzhen Hosp, Ctr Anesthesiol, Beijing, Peoples R China	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Cagliari; Capital Medical University	Landoni, G (corresponding author), IRCCS San Raffaele Sci Inst, Dept Anesthesia & Intens Care, Milan, Italy.	landoni.giovanni@hsr.it	Giovanni, Landoni/AAH-1881-2019; Zangrillo, Alberto/AAH-2037-2019; Monaco, Fabrizio/GZA-9167-2022; Finco, Gabriele/AFL-9587-2022; Finco, Gabriele/AAH-1697-2022; Di Prima, Ambra Licia/AAN-2489-2020	Giovanni, Landoni/0000-0002-8594-5980; Zangrillo, Alberto/0000-0002-7687-7648; Monaco, Fabrizio/0000-0001-5186-1976; Finco, Gabriele/0000-0002-3059-9865; Finco, Gabriele/0000-0002-3059-9865; Di Prima, Ambra Licia/0000-0002-9516-1493; Calabro, Maria Grazia/0000-0003-1843-3165; MUSU, MARIO/0000-0003-4882-2014; Nardelli, Pasquale/0000-0003-0407-9871	AbbVie	AbbVie(AbbVie)	The authors of this manuscript have the following competing interests: GL received modest speaker fees from AbbVie. All other authors have declared that no competing interests exist. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Adamakis S, 2012, ARXIV 1102 0242V3; Amr YM, 2010, SEMIN CARDIOTHORAC V, V14, P205, DOI 10.1177/1089253210376839; Ballester M, 2011, EUR J ANAESTH, V28, P874, DOI 10.1097/EJA.0b013e32834bea2a; Bein B, 2005, ANESTH ANALG, V100, P610, DOI 10.1213/01.ANE.0000145012.27484.A7; Belhomme D, 1999, CIRCULATION, V100, P340; Bignami E, 2012, ACTA ANAESTH SCAND, V56, P482, DOI 10.1111/j.1399-6576.2011.02570.x; Bignami E, 2013, J CARDIOTHOR VASC AN, V27, P50, DOI 10.1053/j.jvca.2012.06.007; Biondi-Zoccai GGL, 2005, INT J EPIDEMIOL, V34, P224, DOI 10.1093/ije/dyh311; Cavalca V, 2008, ANESTHESIOLOGY, V108, P988, DOI 10.1097/ALN.0b013e318173efb4; Choi YS, 2011, J THORAC CARDIOV SUR, V142, P148, DOI 10.1016/j.jtcvs.2010.11.018; Conzen PF, 2003, ANESTHESIOLOGY, V99, P826, DOI 10.1097/00000542-200310000-00013; Cromheecke S, 2006, ANESTH ANALG, V103, P289, DOI 10.1213/01.ane.0000226097.22384.f4; De Hert S, 2009, ANAESTHESIA, V64, P953, DOI 10.1111/j.1365-2044.2009.06008.x; De Hert SG, 2004, ANESTHESIOLOGY, V101, P299, DOI 10.1097/00000542-200408000-00009; De Hert SG, 2004, ANESTHESIOLOGY, V101, P9, DOI 10.1097/00000542-200407000-00005; De Hert SG, 2003, ANESTHESIOLOGY, V99, P314, DOI 10.1097/00000542-200308000-00013; Dias S, NICE DSU TECHNICAL S; Domanski MJ, 2011, JAMA-J AM MED ASSOC, V305, P585, DOI 10.1001/jama.2011.99; Flier S, 2010, BRIT J ANAESTH, V105, P122, DOI 10.1093/bja/aeq111; Garcia C, 2005, BRIT J ANAESTH, V94, P159, DOI 10.1093/bja/aei026; Gozdzik W, 2012, BRIT J ANAESTH, V108, P43; Greco T, 2013, HEART LUNG VESSEL, V5, P219; Greco T, 2015, THE ATTRACTIVENESS O; Guarracino F, 2006, J CARDIOTHOR VASC AN, V20, P477, DOI 10.1053/j.jvca.2006.05.012; Hellstrom J, 2012, SCAND CARDIOVASC J, V46, P262, DOI 10.3109/14017431.2012.676209; HELMAN JD, 1992, ANESTHESIOLOGY, V77, P47, DOI 10.1097/00000542-199207000-00008; Heusch G, 2002, J MOL CELL CARDIOL, V34, P1279, DOI 10.1006/jmcc.2002.2093; Heusch G, 2012, CIRC RES, V110, P111, DOI 10.1161/CIRCRESAHA.111.259556; Higgins JPT, THE COCHRANE HANDBOO; Hong DM, 2010, ANAESTH INTENS CARE, V38, P924, DOI 10.1177/0310057X1003800518; Hong DM, 2014, EUR HEART J, V35, P176, DOI 10.1093/eurheartj/eht346; Hong DM, 2012, CIRC J, V76, P884, DOI 10.1253/circj.CJ-11-1068; Howie MB, 1996, ANESTH ANALG, V83, P941, DOI 10.1097/00000539-199611000-00009; Huang ZY, 2011, CLIN SCI, V121, P57, DOI 10.1042/CS20100435; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Jovic M, 2012, CELL PHYSIOL BIOCHEM, V29, P131, DOI 10.1159/000337594; Kendall JB, 2004, ANAESTHESIA, V59, P545, DOI 10.1111/j.1365-2044.2004.03713.x; Kim JC, 2012, CHEST, V142, P467, DOI 10.1378/chest.11-2246; Konstantinov IE, 2004, PHYSIOL GENOMICS, V19, P143, DOI 10.1152/physiolgenomics.00046.2004; Kottenberg E, 2012, ACTA ANAESTH SCAND, V56, P30, DOI 10.1111/j.1399-6576.2011.02585.x; Kottenberg E, 2014, J THORAC CARDIOV SUR, V147, P376, DOI 10.1016/j.jtcvs.2013.01.005; Landoni G, 2013, BRIT J ANAESTH, V111, P886, DOI 10.1093/bja/aet231; Landoni G, 2011, ACTA ANAESTH SCAND, V55, P259, DOI 10.1111/j.1399-6576.2010.02381.x; Landoni G, 2007, J CARDIOTHOR VASC AN, V21, P672, DOI 10.1053/j.jvca.2006.11.017; Landoni G, 2007, J CARDIOTHOR VASC AN, V21, P502, DOI 10.1053/j.jvca.2007.02.013; Lee MC, 2006, EUR J ANAESTH, V23, P841, DOI 10.1017/S0265021506000354; LEUNG JM, 1991, ANESTHESIOLOGY, V74, P838, DOI 10.1097/00000542-199105000-00007; Li L, 2010, J SURG RES, V164, pE21, DOI 10.1016/j.jss.2010.06.016; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lomivorotov VV, 2012, INTERACT CARDIOV TH, V15, P18, DOI 10.1093/icvts/ivs118; Lucchinetti E, 2007, ANESTHESIOLOGY, V106, P444, DOI 10.1097/00000542-200703000-00008; Meco M, 2007, EUR J CARDIO-THORAC, V32, P319, DOI 10.1016/j.ejcts.2007.05.005; Meybohm P, 2013, PLOS ONE, V31; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Musialowicz T, 2007, EUR J ANAESTH, V24, P571, DOI 10.1017/S0265021506002213; Rahman IA, 2010, CIRCULATION, V122, pS53, DOI 10.1161/CIRCULATIONAHA.109.926667; Royse CF, 2011, ANAESTHESIA, V66, P455, DOI 10.1111/j.1365-2044.2011.06704.x; Saxena P, 2013, INTERACT CARDIOV TH, V17, P653, DOI 10.1093/icvts/ivt279; Schoen J, 2011, BRIT J ANAESTH, V106, P840, DOI 10.1093/bja/aer091; Soro M, 2012, EUR J ANAESTH, V29, P561, DOI 10.1097/EJA.0b013e3283560aea; Story DA, 2001, ANESTHESIOLOGY, V95, P842, DOI 10.1097/00000542-200110000-00010; Swyers T, 2014, PERFUSION-UK, V29, P10, DOI 10.1177/0267659113503975; Tempe DK, 2011, J CARDIOTHOR VASC AN, V25, P59, DOI 10.1053/j.jvca.2010.03.002; Thielmann M, 2013, LANCET, V382, P597, DOI 10.1016/S0140-6736(13)61450-6; Thielmann M, 2010, BASIC RES CARDIOL, V105, P657, DOI 10.1007/s00395-010-0104-5; Tritapepe L, 2007, EUR J ANAESTH, V24, P323, DOI 10.1017/S0265021506001931; Tritapepe L, 2003, EUR J ANAESTH, V20, pA16; Wagner R, 2010, INTERACT CARDIOV TH, V11, P758, DOI 10.1510/icvts.2010.243600; Williams JM, 2012, HEART ASIA, V4, P97, DOI 10.1136/heartasia-2012-010122; Wu QP, 2011, CIRC J, V75, P1885, DOI 10.1253/circj.CJ-10-1130; Xie JJ, 2012, HEART, V98, P384, DOI 10.1136/heartjnl-2011-300860; Yang LJ, 2014, J CARDIOTHOR VASC AN, V28, P682, DOI 10.1053/j.jvca.2013.05.035; Yildirim V, 2009, HEART SURG FORUM, V12, pE1, DOI 10.1532/HSF98.20081137; Young PJ, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0256-6; Zhou CH, 2013, J CARDIOTHOR VASC AN, V27, P305, DOI 10.1053/j.jvca.2012.09.028; Zimmerman RF, 2011, KIDNEY INT, V80, P861, DOI 10.1038/ki.2011.156	76	48	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134264	10.1371/journal.pone.0134264	http://dx.doi.org/10.1371/journal.pone.0134264			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26231003	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400097
J	Eskridge, BE; Valle, E; Schlupp, I				Eskridge, Brent E.; Valle, Elizabeth; Schlupp, Ingo			Emergence of Leadership within a Homogeneous Group	PLOS ONE			English	Article							DECISION-MAKING; PERSONALITY-DIFFERENCES; EVOLUTION; BEHAVIOR; POPULATIONS; BOLDNESS; FOLLOW; SIZE	Large scale coordination without dominant, consistent leadership is frequent in nature. How individuals emerge from within the group as leaders, however transitory this position may be, has become an increasingly common question asked. This question is further complicated by the fact that in many of these aggregations, differences between individuals are minor and the group is largely considered to be homogeneous. In the simulations presented here, we investigate the emergence of leadership in the extreme situation in which all individuals are initially identical. Using a mathematical model developed using observations of natural systems, we show that the addition of a simple concept of leadership tendencies which is inspired by observations of natural systems and is affected by experience can produce distinct leaders and followers using a nonlinear feedback loop. Most importantly, our results show that small differences in experience can promote the rapid emergence of stable roles for leaders and followers. Our findings have implications for our understanding of adaptive behaviors in initially homogeneous groups, the role experience can play in shaping leadership tendencies, and the use of self-assessment in adapting behavior and, ultimately, self-role-assignment.	[Eskridge, Brent E.] Southern Nazarene Univ, Dept Comp Sci & Network Engn, Bethany, OK 73008 USA; [Valle, Elizabeth] Southern Nazarene Univ, Dept Biol, Bethany, OK USA; [Schlupp, Ingo] Southern Nazarene Univ, Dept Comp Sci & Network Engn, Bethany, OK USA		Eskridge, BE (corresponding author), Southern Nazarene Univ, Dept Comp Sci & Network Engn, Bethany, OK 73008 USA.	beskridge@snu.edu	Schlupp, Ingo/C-3913-2012	Schlupp, Ingo/0000-0002-2460-5667	National Science Foundation [BCS-1124837]; Direct For Social, Behav & Economic Scie [1124837] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This material is based upon work supported by the National Science Foundation under Grant No. BCS-1124837 (URL: http://www.nsf.gov/awardsearch/showAward?AWD_ID=1124837). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acre J, 2014, GECCO'14: PROCEEDINGS OF THE 2014 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P137, DOI 10.1145/2576768.2598355; BERNSTEIN C, 1988, J ANIM ECOL, V57, P1007, DOI 10.2307/5108; Bonabeau E, 1996, B MATH BIOL, V58, P661, DOI 10.1007/BF02459478; Brown C, 2004, ANIM BEHAV, V68, P1325, DOI 10.1016/j.anbehav.2004.04.004; Dingemanse NJ, 2013, ANIM BEHAV, V85, P1031, DOI 10.1016/j.anbehav.2012.12.032; Dyer JRG, 2009, BEHAV ECOL, V20, P165, DOI 10.1093/beheco/arn129; Eskridge BE, 2012, INT C SIM SYNTH LIV, V13, P155; Fawcett TW, 2010, P ROY SOC B-BIOL SCI, V277, P1427, DOI 10.1098/rspb.2009.2088; Gautrais J, 2002, J THEOR BIOL, V215, P363, DOI 10.1006/jtbi.2001.2506; Gautrais J, 2010, BEHAV PROCESS, V84, P664, DOI 10.1016/j.beproc.2010.03.002; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Johnstone RA, 2011, P NATL ACAD SCI USA, V108, P8373, DOI 10.1073/pnas.1102191108; Katsnelson E, 2012, P ROY SOC B-BIOL SCI, V279, P1176, DOI 10.1098/rspb.2011.1734; King AJ, 2009, CURR BIOL, V108, P8373; Kurvers RHJM, 2010, ECOL LETT, V13, P829, DOI 10.1111/j.1461-0248.2010.01473.x; Mitri S, 2013, BIOL REV, V88, P31, DOI 10.1111/j.1469-185X.2012.00236.x; Modlmeier AP, 2014, ANIM BEHAV, V89, P53, DOI 10.1016/j.anbehav.2013.12.020; Montiglio PO, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0343; Nakayama S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1724; Nakayama S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036606; Oosten JE, 2010, BEHAV ECOL SOCIOBIOL, V64, P793, DOI 10.1007/s00265-009-0896-1; Petit O, 2009, P ROY SOC B-BIOL SCI, V276, P3495, DOI 10.1098/rspb.2009.0983; Petit O, 2010, BEHAV PROCESS, V84, P635, DOI 10.1016/j.beproc.2010.04.009; Pillot MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014487; Pillot MH, 2009, BEHAV PROCESS, P235; Pruitt JN, 2014, ANIM BEHAV, V93, P87, DOI 10.1016/j.anbehav.2014.04.017; Pyritz LW, 2011, INT J PRIMATOL, V32, P1268, DOI 10.1007/s10764-011-9524-9; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Seeley TD, 2006, AM SCI, V94, P220, DOI 10.1511/2006.59.220; Sih A, 2015, TRENDS ECOL EVOL, V30, P50, DOI 10.1016/j.tree.2014.11.004; Stueckle S, 2008, ANIM BEHAV, V75, P1995, DOI 10.1016/j.anbehav.2007.12.012; Sueur C, 2011, INT J PRIMATOL, V32, P1413, DOI 10.1007/s10764-011-9520-0; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Theraulaz G, 1998, P ROY SOC B-BIOL SCI, V265, P327, DOI 10.1098/rspb.1998.0299; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001; Wray MK, 2011, BEHAV ECOL SOCIOBIOL, V65, P2061, DOI 10.1007/s00265-011-1215-1; Zeileis A, 2003, COMPUT STAT DATA AN, V44, P109, DOI 10.1016/S0167-9473(03)00030-6	39	3	3	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134222	10.1371/journal.pone.0134222	http://dx.doi.org/10.1371/journal.pone.0134222			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JT	26226381	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700065
J	Gurt, I; Artsi, H; Cohen-Kfir, E; Hamdani, G; Ben-Shalom, G; Feinstein, B; El-Haj, M; Dresner-Pollak, R				Gurt, Irina; Artsi, Hanna; Cohen-Kfir, Einav; Hamdani, Gilad; Ben-Shalom, Gal; Feinstein, Ben; El-Haj, Madi; Dresner-Pollak, Rivka			The Sirt1 Activators SRT2183 and SRT3025 Inhibit RANKL-Induced Osteoclastogenesis in Bone Marrow-Derived Macrophages and Down-Regulate Sirt3 in Sirt1 Null Cells	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-KINASE ACTIVATION; BETA-CATENIN; DIFFERENTIATION; RESVERATROL; MICE; TRANSCRIPTION; ACETYLATION; MECHANISM; SRT1720	Increased osteoclast-mediated bone resorption is characteristic of osteoporosis, malignant bone disease and inflammatory arthritis. Targeted deletion of Sirtuin1 (Sirt1), a key player in aging and metabolism, in osteoclasts results in increased osteoclast-mediated bone resorption in vivo, making it a potential novel therapeutic target to block bone resorption. Sirt1 activating compounds (STACs) were generated and were investigated in animal disease models and in humans however their mechanism of action was a source of controversy. We studied the effect of SRT2183 and SRT3025 on osteoclastogenesis in bonemarrow derived macrophages (BMMs) in vitro, and discovered that these STACs inhibit RANKL-induced osteoclast differentiation, fusion and resorptive capacity without affecting osteoclast survival. SRT2183 and SRT3025 activated AMPK, increased Sirt1 expression and decreased RelA/p65 lysine310 acetylation, critical for NF-kappa B activation, and an established Sirt1 target. However, inhibition of osteoclastogenesis by these STACs was also observed in BMMs derived from sirt1 knock out (sirt1(-/-)) mice lacking the Sirt1 protein, in which neither AMPK nor RelA/p65 lysine 310 acetylation was affected, confirming that these effects require Sirt1, but suggesting that Sirt1 is not essential for inhibition of osteoclastogenesis by these STACs under these conditions. In sirt1 null osteoclasts treated with SRT2183 or SRT3025 Sirt3 was found to be down-regulated. Our findings suggest that SRT2183 and SRT3025 activate Sirt1 and inhibit RANKL-induced osteoclastogenesis in vitro however under conditions of Sirt1 deficiency can affect Sirt3. As aging is associated with reduced Sirt1 level and activity, the influence of STACs on Sirt3 needs to be investigated in vivo in animal and human disease models of aging and osteoporosis.	[Gurt, Irina; Artsi, Hanna; Cohen-Kfir, Einav; Hamdani, Gilad; Ben-Shalom, Gal; Dresner-Pollak, Rivka] Hadassah Hebrew Univ Med Ctr, Dept Med, Endocrinol & Metab Serv, Jerusalem, Israel; [Feinstein, Ben] Hebrew Univ Jerusalem, Einstein Inst Math, Jerusalem, Israel; [El-Haj, Madi] Hadassah Hebrew Univ Med Ctr, Dept Orthoped, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Dresner-Pollak, R (corresponding author), Hadassah Hebrew Univ Med Ctr, Dept Med, Endocrinol & Metab Serv, Jerusalem, Israel.	rivkap@hadassah.org.il			Israel Science Foundation [842/10]; Ministry of Health, Israel [3_3926]; Hadassah Women Organization research fund Joint Research Fund of Hadassah; Hebrew University	Israel Science Foundation(Israel Science Foundation); Ministry of Health, Israel; Hadassah Women Organization research fund Joint Research Fund of Hadassah; Hebrew University	The Israel Science Foundation Grant 842/10 (http://www.isf.org.il/english), The Chief Scientist, Ministry of Health, Israel, Grant 3_3926 (http://www.old.health.gov.il/english/Pages_E/default.asp?maincat=12&catId=20&PageId=79) Hadassah Women Organization research fund Joint Research Fund of Hadassah and the Hebrew University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bess E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020848; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Bowers JL, 2000, ENDOCRINOLOGY, V141, P3657, DOI 10.1210/en.141.10.3657; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cohen-Kfir E, 2011, ENDOCRINOLOGY, V152, P4514, DOI 10.1210/en.2011-1128; Deng FY, 2008, PROTEOMICS, V8, P4259, DOI 10.1002/pmic.200700480; Deng FY, 2011, J BONE MINER RES, V26, P2695, DOI 10.1002/jbmr.471; Edwards JR, 2013, J BONE MINER RES, V28, P960, DOI 10.1002/jbmr.1824; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gertz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049761; Nguyen GTT, 2013, ACTA CRYSTALLOGR D, V69, P1423, DOI 10.1107/S0907444913015448; Han LM, 2010, NUCLEIC ACIDS RES, V38, P7458, DOI 10.1093/nar/gkq609; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Hubbard BP, 2014, TRENDS PHARMACOL SCI, V35, P146, DOI 10.1016/j.tips.2013.12.004; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Huber JL, 2010, FUTURE MED CHEM, V2, P1751, DOI 10.4155/FMC.10.257; Indo Y, 2013, J BONE MINER RES, V28, P2392, DOI 10.1002/jbmr.1976; Iyer S, 2014, J BIOL CHEM, V289, P24069, DOI 10.1074/jbc.M114.561803; Jin L, 2009, PROTEIN SCI, V18, P514, DOI 10.1002/pro.50; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kang H, 2013, J BIOL CHEM, V288, P12187, DOI 10.1074/jbc.M112.430389; Kartner N, 2010, J BIOL CHEM, V285, P37476, DOI 10.1074/jbc.M110.123281; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Mercken EM, 2014, AGING CELL, V13, P787, DOI 10.1111/acel.12220; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; National Institute of Mental Health, 2011, PHAS 1B STUD ASS SAF; National Institute of Mental Health, 2011, U VIRG STUD HLTH MAL; National Institute of Mental Health, 2009, CLIN STUD ASS SAF TO; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Sebastian C, 2012, J BIOL CHEM, V287, P42444, DOI 10.1074/jbc.R112.402768; Shakibaei M, 2011, J BIOL CHEM, V286, P11492, DOI 10.1074/jbc.M110.198713; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yang HH, 2012, SCI WORLD J, P1, DOI 10.1100/2012/149132; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	47	23	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134391	10.1371/journal.pone.0134391	http://dx.doi.org/10.1371/journal.pone.0134391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226624	Green Submitted, gold, Green Published			2022-12-27	WOS:000358837700087
J	Shorter, JR; Geisz, M; Ozsoy, E; Magwire, MM; Carbone, MA; Mackay, TFC				Shorter, John R.; Geisz, Matthew; Ozsoy, Ergi; Magwire, Michael M.; Carbone, Mary Anna; Mackay, Trudy F. C.			The Effects of Royal Jelly on Fitness Traits and Gene Expression in Drosophila melanogaster	PLOS ONE			English	Article							TRADE-OFF; LIFE-SPAN; LONGEVITY; HONEYBEES; FECUNDITY; GENOMICS; SIZE	Royal Jelly (RJ) is a product made by honey bee workers and is required for queen differentiation and accompanying changes in queen body size, development time, lifespan and reproductive output relative to workers. Previous studies have reported similar changes in Drosophila melanogaster in response to RJ. Here, we quantified viability, development time, body size, productivity, lifespan and genome wide transcript abundance of D. melanogaster reared on standard culture medium supplemented with increasing concentrations of RJ. We found that lower concentrations of RJ do induce significant differences in body size in both sexes; higher concentrations reduce size, increase mortality, shorten lifespan and reduce productivity. Increased concentrations of RJ also consistently lengthened development time in both sexes. RJ is associated with changes in expression of 1,581 probe sets assessed using Affymetrix Drosophila 2.0 microarrays, which were enriched for genes associated with metabolism and amino acid degradation. The transcriptional changes are consistent with alterations in cellular processes to cope with excess nutrients provided by RJ, including biosynthesis and detoxification, which might contribute to accelerated senescence and reduced lifespan.	[Shorter, John R.; Geisz, Matthew; Carbone, Mary Anna; Mackay, Trudy F. C.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Shorter, John R.; Magwire, Michael M.; Carbone, Mary Anna; Mackay, Trudy F. C.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Shorter, John R.; Carbone, Mary Anna; Mackay, Trudy F. C.] N Carolina State Univ, Genet Program, Raleigh, NC 27695 USA; [Ozsoy, Ergi] Hacettepe Univ, Dept Biol, Ankara, Turkey	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Hacettepe University	Shorter, JR (corresponding author), N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	john_shorter@ncsu.edu		shorter, john/0000-0003-4732-5526	National Institutes of Health [R01 GM45146]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM45146 to TFCM.	Antonov AV, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r179; Azab KS, 2011, N AM J MED SCI, V3, P268, DOI 10.4297/najms.2011.3268; Chen SL, 2002, BEE WORLD, V83, P69, DOI 10.1080/0005772X.2002.11099543; COLHOUN EH, 1960, NATURE, V188, P854, DOI 10.1038/188854a0; Djawdan M, 1996, PHYSIOL ZOOL, V69, P1176, DOI 10.1086/physzool.69.5.30164252; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; European-Food-Safety-Authority, 2011, EFSA J, P2083; Guo H, 2007, J NUTR SCI VITAMINOL, V53, P345, DOI 10.3177/jnsv.53.345; Herb BR, 2012, NAT NEUROSCI, V15, P1371, DOI 10.1038/nn.3218; Honda Y, 2011, PLOS ONE, V6; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Inoue S, 2003, EXP GERONTOL, V38, P965, DOI 10.1016/S0531-5565(03)00165-7; Kamakura M, 2001, J NUTR SCI VITAMINOL, V47, P394, DOI 10.3177/jnsv.47.394; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Kayashima Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2107, DOI 10.1271/bbb.120496; Kohguchi M, 2004, FOOD SCI TECHNOL RES, V10, P420, DOI 10.3136/fstr.10.420; Kohno K, 2004, BIOSCI BIOTECH BIOCH, V68, P138, DOI 10.1271/bbb.68.138; Kubo T, 1996, J BIOCHEM-TOKYO, V119, P291, DOI 10.1093/oxfordjournals.jbchem.a021237; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Maleszka R, 2008, EPIGENETICS-US, V3, P188, DOI 10.4161/epi.3.4.6697; MANGEL M, 1994, BEHAV ECOL, V5, P412, DOI 10.1093/beheco/5.4.412; Miyatake T, 1997, HEREDITY, V78, P93, DOI 10.1038/hdy.1997.11; Morita H, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-77; Nakaya M, 2007, BIOSCI BIOTECH BIOCH, V71, P253, DOI 10.1271/bbb.60453; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Park HM, 2012, J MED FOOD, V15, P568, DOI 10.1089/jmf.2011.1888; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; PARTRIDGE L, 1987, J INSECT PHYSIOL, V33, P745, DOI 10.1016/0022-1910(87)90060-6; R Core Team, 2012, R LANG ENV STAT COMP; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SAS Institute Inc, 2011, BAS SAS 9 3 PROC GUI; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHI Y, 2012, PLOS ONE, V7; Spannhoff A, 2011, EMBO REP, V12, P238, DOI 10.1038/embor.2011.9; Tokunaga KH, 2004, BIOL PHARM BULL, V27, P189, DOI 10.1248/bpb.27.189; Townsend GF, 1940, BIOCHEM J, V34, P1155, DOI 10.1042/bj0341155; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zhao FY, 2013, EUR FOOD RES TECHNOL, V236, P799, DOI 10.1007/s00217-013-1939-4; Zheng HQ, 2011, APIDOLOGIE, V42, P39, DOI 10.1051/apido/2010033	46	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134612	10.1371/journal.pone.0134612	http://dx.doi.org/10.1371/journal.pone.0134612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226016	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700122
J	Wiezik, M; Svitok, M; Wiezikova, A; Dovciak, M				Wiezik, Michal; Svitok, Marek; Wiezikova, Adela; Dovciak, Martin			Identifying Shifts in Leaf-Litter Ant Assemblages (Hymenoptera: Formicidae) across Ecosystem Boundaries Using Multiple Sampling Methods	PLOS ONE			English	Article							PITFALL TRAPS; SPECIES RICHNESS; HABITAT COMPLEXITY; FOREST SUCCESSION; PLANT DIVERSITY; 4 DECADES; COMMUNITIES; VEGETATION; TEMPERATE; PATTERNS	Global or regional environmental changes in climate or land use have been increasingly implied in shifts in boundaries (ecotones) between adjacent ecosystems such as beech or oak-dominated forests and forest-steppe ecotones that frequently co-occur near the southern range limits of deciduous forest biome in Europe. Yet, our ability to detect changes in biological communities across these ecosystems, or to understand their environmental drivers, can be hampered when different sampling methods are required to characterize biological communities of the adjacent but ecologically different ecosystems. Ants (Hymenoptera: Formicidae) have been shown to be particularly sensitive to changes in temperature and vegetation and they require different sampling methods in closed vs. open habitats. We compared ant assemblages of closed-forests (beech-or oak-dominated) and open forest-steppe habitats in southwestern Carpathians using methods for closed-forest (litter sifting) and open habitats (pitfall trapping), and developed an integrated sampling approach to characterize changes in ant assemblages across these adjacent ecosystems. Using both methods, we collected 5,328 individual ant workers from 28 species. Neither method represented ant communities completely, but pitfall trapping accounted for more species (24) than litter sifting (16). Although pitfall trapping characterized differences in species richness and composition among the ecosystems better, with beech forest being most species poor and ecotone most species rich, litter sifting was more successful in identifying characteristic litter-dwelling species in oak-dominated forest. The integrated sampling approach using both methods yielded more accurate characterization of species richness and composition, and particularly so in species-rich forest-steppe habitat where the combined sample identified significantly higher number of species compared to either of the two methods on their own. Thus, an integrated sampling approach should be used to fully characterize changes in ant assemblages across ecosystem boundaries, or with vegetation change over time, and particularly so in species-rich habitats such as forest-steppe ecotones.	[Wiezik, Michal] Tech Univ Zvolen, Fac Ecol & Environm Sci, Dept Appl Ecol, Zvolen, Slovakia; [Svitok, Marek; Wiezikova, Adela] Tech Univ Zvolen, Fac Ecol & Environm Sci, Dept Biol & Gen Ecol, Zvolen, Slovakia; [Svitok, Marek] Eawag Swiss Fed Inst Aquat Sci & Technol, Ctr Ecol Evolut & Biogeochem, Dept Aquat Ecol, Kastanienbaum, Switzerland; [Dovciak, Martin] SUNY Syracuse, Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA	Technical University Zvolen; Technical University Zvolen; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Wiezik, M (corresponding author), Tech Univ Zvolen, Fac Ecol & Environm Sci, Dept Appl Ecol, Zvolen, Slovakia.	wiezik@tuzvo.sk	Wieziková, Adela/CAH-2427-2022; Svitok, Marek/A-4843-2013	Wieziková, Adela/0000-0003-4848-5177; Svitok, Marek/0000-0003-2710-8102	Slovak Grant Agency for Science (VEGA) [1/0186/14, 2/0052/15]	Slovak Grant Agency for Science (VEGA)(Vedecka grantova agentura MSVVaS SR a SAV (VEGA))	The study was co-funded by research grants no. 1/0186/14 and 2/0052/15 of the Slovak Grant Agency for Science (VEGA).	ADIS J, 1979, ZOOL ANZ, V202, P177; Allen CD, 1998, P NATL ACAD SCI USA, V95, P14839, DOI 10.1073/pnas.95.25.14839; Andersen Alan N., 2000, P25; ANDERSEN AN, 1991, AUST J ECOL, V16, P273, DOI 10.1111/j.1442-9993.1991.tb01054.x; Andersen AN, 2004, FRONT ECOL ENVIRON, V2, P291; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2004, DISTLM V 5 FORTRAN C; [Anonymous], 2006, 92006 EEA; [Anonymous], 2014, R LANG ENV STAT COMP; Arnan X, 2014, J ANIM ECOL, V83, P1398, DOI 10.1111/1365-2656.12227; Bestelmeyer Brandon T., 2000, P122; Bouget C., 2009, FOREST INSECT STUDIE; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Calixto AA, 2007, SOUTHWEST ENTOMOL, V32, P87, DOI 10.3958/0147-1724-32.2.87; Canty A., 2015, BOOT BOOTSTRAP R S P; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Chen YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116113; CZECHOWSKI W, 1990, Fragmenta Faunistica (Warsaw), V34, P133; Dahms Henriette, 2005, Myrmecologische Nachrichten, V7, P9; Dauber J, 2005, BASIC APPL ECOL, V6, P83, DOI 10.1016/j.baae.2004.09.011; Dekoninck W, 2008, EUR J ENTOMOL, V105, P681, DOI 10.14411/eje.2008.092; Dekoninck W, 2010, RESTOR ECOL, V18, P681, DOI 10.1111/j.1526-100X.2008.00499.x; Diamond SE, 2012, GLOBAL CHANGE BIOL, V18, P448, DOI 10.1111/j.1365-2486.2011.02542.x; Dovciak M, 2005, ECOL MONOGR, V75, P363, DOI 10.1890/03-0802; Dovciak M, 2014, NEW FOREST, V45, P733, DOI 10.1007/s11056-014-9419-7; Dovciak M, 2010, ECOL LETT, V13, P1300, DOI 10.1111/j.1461-0248.2010.01524.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dunn RR, 2009, ECOL LETT, V12, P324, DOI 10.1111/j.1461-0248.2009.01291.x; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; Fox J., 2019, R COMPANION APPL REG, V.; Franklin K, 2012, BIOL CONSERV, V148, P96, DOI 10.1016/j.biocon.2012.01.045; Frelich LE, 2012, PHILOS T R SOC B, V367, P2955, DOI 10.1098/rstb.2012.0235; Gibb H, 2010, OECOLOGIA, V164, P1061, DOI 10.1007/s00442-010-1703-4; Gomez C, 2003, BIODIVERS CONSERV, V12, P2135, DOI 10.1023/A:1024142415454; Gotelli NJ, 2011, MYRMECOL NEWS, V15, P13; GREENSLA.PJ, 1973, INSECT SOC, V20, P343, DOI 10.1007/BF02226087; GREENSLADE PJM, 1977, INSECT SOC, V24, P163, DOI 10.1007/BF02227169; Groc S, 2014, MYRMECOL NEWS, V19, P43; Holecova M, 2012, BIODIVERSITY SOIL MI; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hrvol J, 2009, BIOLOGIA, V64, P605, DOI 10.2478/s11756-009-0091-x; Jouquet P, 2006, APPL SOIL ECOL, V32, P153, DOI 10.1016/j.apsoil.2005.07.004; King JR, 2005, ENVIRON ENTOMOL, V34, P1566, DOI 10.1603/0046-225X-34.6.1566; Korpel S, 1989, VIRGIN FORESTS SLOVA; Krell FT, 2005, PEDOBIOLOGIA, V49, P175, DOI 10.1016/j.pedobi.2004.10.005; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lassau SA, 2004, ECOGRAPHY, V27, P157, DOI 10.1111/j.0906-7590.2004.03675.x; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; Majer J. D., 1996, P MUSEUM VICTORIA, V56, P323; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Mette T, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00115.1; Oksanen J., 2019, VEGAN COMMUNITY ECOL; OLSON DM, 1991, BIOTROPICA, V23, P166, DOI 10.2307/2388302; Ottonetti L, 2006, RESTOR ECOL, V14, P60, DOI 10.1111/j.1526-100X.2006.00105.x; Palladini JD, 2007, FOREST ECOL MANAG, V242, P619, DOI 10.1016/j.foreco.2007.01.074; Pekar S, 2002, PEDOBIOLOGIA, V46, P539, DOI 10.1078/0031-4056-00158; Pinheiro J, 2015, NLME LINEAR NONLINEA; Quinn GP, 2003, EXPT DESIGN DATA ANA; Resasco J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088029; Retana J, 2000, OECOLOGIA, V123, P436, DOI 10.1007/s004420051031; Robertson HG, 2002, BIODIVERS CONSERV, V11, P1637, DOI 10.1023/A:1016883901065; Sabu TK, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.9801; Saniga M, 2014, IFOREST, V7, P324, DOI 10.3832/ifor0996-007; SEIFERT B, 2007, AMEISEN MITTEL NORDE; Sorensen Th, 1948, K DANSKE VIDENSK SEL, V5, P1, DOI DOI 10.3109/00016924809131205; SPENCE JR, 1994, CAN ENTOMOL, V126, P881, DOI 10.4039/Ent126881-3; Tausan I, 2013, BRUKENTHAL ACTA MUSE, V8, P461; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Underwood EC, 2006, BIOL CONSERV, V132, P166, DOI 10.1016/j.biocon.2006.03.022; Wallwork J A, 1970, ECOLOGY SOIL ANIMALS; Wang CL, 2001, ENVIRON ENTOMOL, V30, P842, DOI 10.1603/0046-225X-30.5.842; Wiezik M, 2013, BIODIVERS CONSERV, V22, P2305, DOI 10.1007/s10531-013-0446-z; Wiezik M, 2011, TUEXENIA, P301	77	15	15	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134502	10.1371/journal.pone.0134502	http://dx.doi.org/10.1371/journal.pone.0134502			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226140	gold, Green Published, Green Submitted			2022-12-27	WOS:000358837700103
J	Wu, Y; Ji, GJ; Zang, YF; Liao, W; Jin, Z; Liu, YL; Li, K; Zeng, YW; Fang, F				Wu, Yun; Ji, Gong-Jun; Zang, Yu-Feng; Liao, Wei; Jin, Zhen; Liu, Ya-Li; Li, Ke; Zeng, Ya-Wei; Fang, Fang			Local Activity and Causal Connectivity in Children with Benign Epilepsy with Centrotemporal Spikes	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; CHILDHOOD EPILEPSY; FUNCTIONAL CONNECTIVITY; ROLANDIC EPILEPSY; BASAL GANGLIA; LANGUAGE; NETWORK; FMRI; ATTENTION; DISORDER	The aim of the current study was to localize the epileptic focus and characterize its causal relation with other brain regions, to understand the cognitive deficits in children with benign childhood epilepsy with centrotemporal spikes (BECTS). Resting-state functional magnetic resonance imaging (fMRI) was performed in 37 children with BECTS and 25 children matched for age, sex and educational achievement. We identified the potential epileptogenic zone (EZ) by comparing the amplitude of low frequency fluctuation (ALFF) of spontaneous blood oxygenation level dependent fMRI signals between the groups. Granger causality analysis was applied to explore the causal effect between EZ and the whole brain. Compared with controls, children with BECTS had significantly increased ALFF in the right postcentral gyrus and bilateral calcarine, and decreased ALFF in the left anterior cingulate cortex, bilateral putaman/caudate, and left cerebellum. ALFF values in the putaman/caudate were positively correlated with verbal IQ scores in patients. The ALFF values in cerebellum and performance IQ scores were negatively correlated in patients. These results suggest that ALFF disturbances in the putaman/caudate and cerebellum play an important role in BECTS cognitive dysfunction. Compared with controls, the patients showed increased driving effect from the EZ to the right medial frontal cortex and posterior cingulate cortex and decreased causal effects from the EZ to left inferior frontal gyrus. The causal effect of the left inferior frontal gyrus negatively correlated with disease duration, which suggests a relation between the epileptiform activity and language impairment. All together, these findings provide additional insight into the neurophysiological mechanisms of epilepitogenisis and cognitive dysfunction associated with BECTS.	[Wu, Yun; Fang, Fang] Capital Med Univ, Beijing Childrens Hosp, Dept Neurol, Beijing, Peoples R China; [Ji, Gong-Jun] Anhui Med Univ, Dept Med Psychol, Lab Cognit Neuropsychol, Hefei, Peoples R China; [Ji, Gong-Jun; Zang, Yu-Feng; Liao, Wei] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Ji, Gong-Jun; Zang, Yu-Feng; Liao, Wei] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China; [Ji, Gong-Jun; Zang, Yu-Feng; Liao, Wei] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China; [Jin, Zhen; Liu, Ya-Li; Li, Ke; Zeng, Ya-Wei] Peoples Liberat Army, Hosp 306, fMRI Ctr, Beijing, Peoples R China	Capital Medical University; Anhui Medical University; Hangzhou Normal University; Hangzhou Normal University	Wu, Y (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Dept Neurol, Beijing, Peoples R China.	brain136@126.com; 13910150389@163.com		JI, Gong-Jun/0000-0002-7073-5534	Natural Science Foundation of China [81341041, 81401400, 81471653]; National Key Basic Research Program of China (973 Program) [2012CB720704]; 'Qian Jiang Distinguished Professor' program	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); 'Qian Jiang Distinguished Professor' program	This work was supported by the Natural Science Foundation of China (Grant no. 81341041) to YW, National Key Basic Research Program of China (973 Program) 2012CB720704 to ZJ, Natural Science Foundation of China (Grant nos. 81401400 to GJ and 81471653 to WL), and the 'Qian Jiang Distinguished Professor' program to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 2004, NEUROIMAGE, V22, P42, DOI 10.1016/j.neuroimage.2003.12.031; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Archer JS, 2003, EPILEPSIA, V44, P200, DOI 10.1046/j.1528-1157.2003.02502.x; Bedoin N, 2012, EPILEPSY BEHAV, V25, P81, DOI 10.1016/j.yebeh.2012.05.025; Bedoin N, 2011, EPILEPSY BEHAV, V21, P42, DOI 10.1016/j.yebeh.2011.02.026; Bennett-Back O, 2011, PEDIATR NEUROL, V44, P187, DOI 10.1016/j.pediatrneurol.2010.10.003; Berg AT, 1999, EPILEPSIA, V40, P439, DOI 10.1111/j.1528-1157.1999.tb00738.x; Besseling RMH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083568; Besseling RMH, 2013, EPILEPSY RES, V107, P253, DOI 10.1016/j.eplepsyres.2013.10.008; Besseling RMH, 2013, NEUROIMAGE-CLIN, V2, P239, DOI 10.1016/j.nicl.2013.01.004; Boor R, 2007, CLIN NEUROPHYSIOL, V118, P901, DOI 10.1016/j.clinph.2006.11.272; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cadotte AJ, 2009, IEEE T NEUR SYS REH, V17, P214, DOI 10.1109/TNSRE.2008.2006220; Cerminara C, 2010, EPILEPSY BEHAV, V19, P69, DOI 10.1016/j.yebeh.2010.07.008; Chan SH, 2013, BRAIN LANG, V125, P283, DOI 10.1016/j.bandl.2011.11.005; Chen G, 2009, P INT SOC MAG RESON, V17; Clarke T, 2007, EPILEPSIA, V48, P2258; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Deltour L, 2007, EPILEPTIC DISORD, V9, P424; Deshpande G, 2012, BRAIN CONNECT, V2, P235, DOI 10.1089/brain.2012.0091; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Guo ZL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044847, 10.1371/journal.pone.0028196]; Hamilton JP, 2011, MOL PSYCHIATR, V16, P763, DOI 10.1038/mp.2010.46; Haneef Z, 2014, EPILEPSIA, V55, P137, DOI 10.1111/epi.12476; Haneef Z, 2012, EPILEPSY BEHAV, V25, P350, DOI 10.1016/j.yebeh.2012.07.019; Jenison RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109689; Ji GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063183; Kay BP, 2013, EPILEPSIA, V54, P461, DOI 10.1111/epi.12057; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kim EH, 2014, EPILEPSY BEHAV, V37, P54, DOI 10.1016/j.yebeh.2014.05.030; Koziol LF, 2014, CEREBELLUM, V13, P151, DOI 10.1007/s12311-013-0511-x; Lengler U, 2007, EPILEPSY RES, V75, P29, DOI 10.1016/j.eplepsyres.2007.03.016; Lin JJ, 2012, EPILEPSIA, V53, P677, DOI 10.1111/j.1528-1167.2012.03422.x; Liu XJ, 2012, NEUROSCI LETT, V507, P1, DOI 10.1016/j.neulet.2011.10.016; Luo C, 2011, EPILEPSIA, V52, P1092, DOI 10.1111/j.1528-1167.2011.03045.x; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; Lv ZX, 2014, EPILEPSY BEHAV, V35, P64, DOI 10.1016/j.yebeh.2014.04.001; Masterton RAJ, 2010, NEUROIMAGE, V51, P252, DOI 10.1016/j.neuroimage.2010.01.109; McGill ML, 2012, EPILEPSY BEHAV, V23, P353, DOI 10.1016/j.yebeh.2012.01.013; Moeller F, 2008, NEUROIMAGE, V39, P1839, DOI 10.1016/j.neuroimage.2007.10.058; Monjauze C, 2011, EPILEPSIA, V52, pE79, DOI 10.1111/j.1528-1167.2011.03105.x; Nadine O, 2014, EPILEPSY BEHAV, V33, P12, DOI 10.1016/j.yebeh.2014.01.008; Newman LA, 2015, J PHYSIOL-PARIS, V109, P95, DOI 10.1016/j.jphysparis.2014.06.004; Northcott E, 2007, EPILEPSY RES, V75, P57, DOI 10.1016/j.eplepsyres.2007.04.004; Overvliet GM, 2011, J NEUROL SCI, V304, P71, DOI 10.1016/j.jns.2011.02.009; Palaniyappan L, 2013, NEURON, V79, P814, DOI 10.1016/j.neuron.2013.06.027; Panayiotopoulos CP, 2008, BRAIN, V131, P2264, DOI 10.1093/brain/awn162; Pinton F, 2006, EPILEPTIC DISORD, V8, P11; Rektor I, 2013, BRAIN TOPOGR, V26, P355, DOI 10.1007/s10548-012-0272-8; Rektor I, 2012, EPILEPSY BEHAV, V25, P56, DOI 10.1016/j.yebeh.2012.04.125; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Riva D, 2007, EPILEPSY BEHAV, V10, P278, DOI 10.1016/j.yebeh.2006.12.003; Rushworth MFS, 2007, CURR OPIN NEUROBIOL, V17, P220, DOI 10.1016/j.conb.2007.03.001; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Sanchez-Carpintero R, 2003, EPILEPSIA, V44, P1340, DOI 10.1046/j.1528-1157.2003.16403.x; Seghier ML, 2010, CEREB CORTEX, V20, P570, DOI 10.1093/cercor/bhp123; Song M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017294; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Staden U, 1998, NEUROPEDIATRICS, V29, P242, DOI 10.1055/s-2007-973569; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Tana M G, 2010, Comput Intell Neurosci, P329213, DOI 10.1155/2010/329213; Tang YL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/960395; Tedesco AM, 2011, BRAIN, V134, P3669, DOI 10.1093/brain/awr266; Tettamanti M, 2005, NEUROREPORT, V16, P397, DOI 10.1097/00001756-200503150-00018; Vaessen MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090068; Volkl-Kernstock S, 2006, EPILEPSY RES, V72, P39, DOI 10.1016/j.eplepsyres.2006.07.004; Woodward KE, 2014, BRAIN CONNECT, V4, P91, DOI 10.1089/brain.2013.0178; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang TH, 2013, HUM BRAIN MAPP, V34, P1761, DOI 10.1002/hbm.22025; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zang ZX, 2012, J NEUROSCI METH, V203, P418, DOI 10.1016/j.jneumeth.2011.10.006; Zhang ZQ, 2010, HUM BRAIN MAPP, V31, P1851, DOI 10.1002/hbm.20982; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	74	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134361	10.1371/journal.pone.0134361	http://dx.doi.org/10.1371/journal.pone.0134361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225427	gold, Green Submitted, Green Published			2022-12-27	WOS:000358837700078
J	Luo, Y; She, DL; Xiong, H; Yang, L; Fu, SJ				Luo, You; She, Dong-Li; Xiong, Hu; Yang, Li; Fu, Sheng-Jun			Diagnostic Value of Liquid-Based Cytology in Urothelial Carcinoma Diagnosis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							URINARY CYTOLOGY; BLADDER-CANCER; FOLLOW-UP; UCYT PLUS; MARKERS; SURVEILLANCE; FLUORESCENCE; PERFORMANCE; IMMUNOCYT; UROVYSION	Objective To evaluate the value of liquid-based cytology (LBC) in the diagnosis of urothelial carcinoma. Method Diagnostic studies were searched for the diagnostic value of LBC in urothelial carcinoma in PubMed, Embase, Cochrane Library, Web of Science, CBM and CNKI. The latest retrieval date was September 2014. The data were extracted and the quality of the included studies was independently assessed by 2 reviewers. Stata 13 software was used to perform the statistical analysis. The research was conducted in compliance with the PRISMA statement. Result Nineteen studies, which included 8293 patients, were evaluated. The results of the meta-analysis showed that the pooled sensitivity and specificity of LBC were 0.58 (0.51-0.65) and 0.96 (0.93-0.98), respectively. The diagnostic odds ratio (DOR) was 31 (18-56) and the area under the curve (AUC) of summary receiver operating characteristic (SROC) was 0.83 (0.80-0.86). The post-test probability was 80% when a positive diagnosis was made. Compared with high grade urothelial carcinoma (HGUC), the sensitivity of detecting low-grade urothelial carcinoma (LGUC) was significantly lower, risk ratio of sensitivity was 0.54 (0.43-0.66), P<0.001. However, no significant sensitivity improvement was observed with LBC when compared with traditional cytospin cytology, risk ratio was 1.03 (0.94-1.14), P = 0.524. Conclusion Despite LBC having a pooled 58% positive rate for urothelial carcinoma diagnosis in our meta-analysis, no significant improvement in sensitivity was observed based on the studies evaluated. Further research is needed to validate these findings.	[Luo, You; She, Dong-Li; Xiong, Hu; Yang, Li; Fu, Sheng-Jun] Lanzhou Univ, Hosp 2, Gansu Nephrourol Clin Ctr, Inst Urol,Dept Urol,Key Lab Urol Dis Gansu Prov, Lanzhou 730000, Peoples R China	Lanzhou University	Fu, SJ (corresponding author), Lanzhou Univ, Hosp 2, Gansu Nephrourol Clin Ctr, Inst Urol,Dept Urol,Key Lab Urol Dis Gansu Prov, Lanzhou 730000, Peoples R China.	fubeta@163.com	Luo, You/ABE-4922-2020	Luo, You/0000-0001-5185-2180				Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Dimashkieh H, 2013, CANCER CYTOPATHOL, V121, P591, DOI 10.1002/cncy.21327; Gregoire M, 1997, J UROLOGY, V157, P1660, DOI 10.1016/S0022-5347(01)64827-4; Hwang EC, 2007, INT J UROL, V14, P626, DOI 10.1111/j.1442-2042.2006.01731.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KANNAN V, 1993, ACTA CYTOL, V37, P899; Kim DY, 2007, KOREAN J LAB MED, V27, P50, DOI 10.3343/kjlm.2007.27.1.50; Kim JY, 2014, KOREAN J UROL, V55, P390, DOI 10.4111/kju.2014.55.6.390; Li H, 2014, HEBEI MED J, V36, P3079; Li HX, 2013, DIAGN CYTOPATHOL, V41, P852, DOI 10.1002/dc.22969; Li HX, 2010, ANAL QUANT CYTOL, V32, P45; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu RL, 2012, INT UROL NEPHROL, V44, P1375, DOI 10.1007/s11255-012-0174-4; Lodde M, 2004, UROLOGY, V63, P878, DOI 10.1016/j.urology.2003.12.023; Lodde M, 2003, UROLOGY, V61, P243, DOI 10.1016/S0090-4295(02)02073-3; Lodde M, 2006, UROLOGY, V67, P950, DOI 10.1016/j.urology.2005.11.057; Lokeshwar VB, 2005, UROLOGY, V66, P35, DOI 10.1016/j.urology.2005.08.064; Lu DY, 2009, DIAGN CYTOPATHOL, V37, P16, DOI 10.1002/dc.20957; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mian C, 2006, CANCER CYTOPATHOL, V108, P60, DOI 10.1002/cncr.21712; Nassar H, 2003, DIAGN CYTOPATHOL, V28, P115, DOI 10.1002/dc.10245; Piaton E, 2005, BRIT J CANCER, V93, P242, DOI 10.1038/sj.bjc.6602684; Piaton E, 2014, CANCER CYTOPATHOL, V122, P211, DOI 10.1002/cncy.21376; Raisi O, 2012, DIAGN CYTOPATHOL, V40, P608, DOI 10.1002/dc.21716; Raitanen MP, 2002, EUR UROL, V41, P284, DOI 10.1016/S0302-2838(02)00006-4; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Saeb-Parsy K, 2012, BRIT J CANCER, V107, P1384, DOI 10.1038/bjc.2012.381; Shen Z, 2013, J CONT UROL REPROD O, V5, P274; Sng KK, 2007, ACTA CYTOL, V51, P782, DOI 10.1159/000325842; Son SM, 2012, KOREAN J PATHOL, V46, P68, DOI 10.4132/KoreanJPathol.2012.46.1.68; Sullivan PS, 2009, CANCER CYTOPATHOL, V117, P167, DOI 10.1002/cncy.20026; van Hemel BM, 2013, CANCER CYTOPATHOL, V121, P410, DOI 10.1002/cncy.21301; van Rhijn BWG, 2005, EUR UROL, V47, P736, DOI 10.1016/j.eururo.2005.03.014; Voss JS, 2008, AM J CLIN PATHOL, V130, P428, DOI 10.1309/VP1XQ5GPQ687W1HU; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wright RG, 2001, CYTOPATHOLOGY, V12, P306, DOI 10.1046/j.1365-2303.2001.00341.x; Xin W, 2003, DIAGN CYTOPATHOL, V29, P125, DOI 10.1002/dc.10311; Ye J, 2011, SHANDONG MED J, V51, P55; [赵焕 ZHAO Huan], 2008, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V31, P662	39	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134940	10.1371/journal.pone.0134940	http://dx.doi.org/10.1371/journal.pone.0134940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241896	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700084
J	Devieux, JG; Saxena, A; Rosenberg, R; Klausner, JD; Jean-Gilles, M; Madhivanan, P; Gaston, S; Rubens, M; Theodore, H; Deschamps, MM; Koenig, SP; Pape, JW				Devieux, Jessy G.; Saxena, Anshul; Rosenberg, Rhonda; Klausner, Jeffrey D.; Jean-Gilles, Michele; Madhivanan, Purnima; Gaston, Stephanie; Rubens, Muni; Theodore, Harry; Deschamps, Marie-Marcelle; Koenig, Serena P.; Pape, Jean William			Knowledge, Attitudes, Practices and Beliefs about Medical Male Circumcision (MMC) among a Sample of Health Care Providers in Haiti	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HIV PREVENTION; PROSTATE-CANCER; ACCEPTABILITY; HIV/AIDS; MEN; INFECTION; IMPLEMENTATION; TRANSMISSION; PROTECTION	Background Haiti has the highest number of people living with HIV infection in the Caribbean/Latin America region. Medical male circumcision (MMC) has been recommended to help prevent the spread of HIV. We sought to assess knowledge, attitudes, practices and beliefs about MMC among a sample of health care providers in Haiti. Methods A convenience sample of 153 health care providers at the GHESKIO Centers in Haiti responded to an exploratory survey that collected information on several topics relevant to health providers about MMC. Descriptive statistics were calculated for the responses and multivariable logistic regression was conducted to determine opinions of health care providers about the best age to perform MMC on males. Bayesian network analysis and sensitivity analysis were done to identify the minimum level of change required to increase the acceptability of performing MMC at age less than 1 year. Results The sample consisted of medical doctors (31.0%), nurses (49.0%), and other health care professionals (20.0%). Approximately 76% showed willingness to offer MMC services if they received training. Seventy-six percent believed that their male patients would accept circumcision, and 59% believed infancy was the best age for MMC. More than 90% of participants said that MMC would reduce STIs. Physicians and nurses who were willing to offer MMC if provided with adequate training were 2.5 (1.15-5.71) times as likely to choose the best age to perform MMC as less than one year. Finally, if the joint probability of choosing "the best age to perform MMC" as one year or older and having the mistaken belief that "MMC prevents HIV entirely" is reduced by 63% then the probability of finding that performing MMC at less than one year acceptable to health care providers is increased by 35%. Conclusion Participants demonstrated high levels of knowledge and positive attitudes towards MMC. Although this study suggests that circumcision is acceptable among certain health providers in Haiti, studies with larger and more representative samples are needed to confirm this finding.	[Devieux, Jessy G.; Saxena, Anshul; Rosenberg, Rhonda; Jean-Gilles, Michele; Madhivanan, Purnima; Rubens, Muni] Florida Int Univ, AIDS Prevent Program, Miami, FL 33199 USA; [Klausner, Jeffrey D.] Univ Calif Los Angeles, Los Angeles, CA USA; [Gaston, Stephanie; Theodore, Harry; Deschamps, Marie-Marcelle; Pape, Jean William] Haitian Study Grp Kaposis Sarcoma & Opportunist I, Port Au Prince, Haiti; [Koenig, Serena P.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Pape, Jean William] Weill Cornell Med Coll, Ctr Global Hlth, New York, NY USA	State University System of Florida; Florida International University; University of California System; University of California Los Angeles; Harvard University; Brigham & Women's Hospital; Cornell University	Devieux, JG (corresponding author), Florida Int Univ, AIDS Prevent Program, Miami, FL 33199 USA.	devieuxj@fiu.edu	Madhivanan, Purnima/AAH-4849-2019; Rubens, Muni/J-3503-2019	Madhivanan, Purnima/0000-0001-7818-3394; Rubens, Muni/0000-0003-1812-9753	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R21 HD076685]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD076685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069421, U01AI069421] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Grant Number R21 HD076685 to Dr. Jessy Devieux. This grant supported a percentage of Time and Effort for Drs. Devieux, Rosenberg, Klausner, Jean-Gilles, Madhivanan, Mr. Saxena and Ms. Gaston. The other authors did not have current funding sources for this study.	Albero G, 2012, SEX TRANSM DIS, V39, P104, DOI 10.1097/OLQ.0b013e3182387abd; American Academy of Pediatrics Task Force On Circumcision, 2012, PEDIATRICS, V130, P585, DOI DOI 10.1542/PEDS.2012-1989; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2014, 21 C RETR OPP INF CR, P501; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bektas HA, 2007, AIDS CARE, V19, P888, DOI 10.1080/09540120701203352; Bicer S, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.26258; Brito MO, 2010, AIDS CARE, V22, P1530, DOI 10.1080/09540121.2010.484455; Brito MO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007687; Carbery B, 2012, AIDS EDUC PREV, V24, P377, DOI 10.1521/aeap.2012.24.4.377; Carvalho J. E. S., 2014, SEXUAL RISK BEHAV AD, P1; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Colin JM, 2014, CULTURAL CLIN CARE H; Ferlay J., 2015, INT J CANCER, V136, pE359; Gostin LO, 2008, JAMA-J AM MED ASSOC, V300, P2539, DOI 10.1001/jama.2008.752; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hallett TB, 2011, SEX TRANSM INFECT, V87, P88, DOI 10.1136/sti.2010.043372; Hatzold K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085051; Holschneider SOM, 2003, J ADOLESCENT HEALTH, V33, P31, DOI 10.1016/S1054-139X(02)00418-4; Jennings L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079524; Kebaabetswe P, 2003, SEX TRANSM INFECT, V79, P214, DOI 10.1136/sti.79.3.214; Klausner JD, 2013, SEX TRANSM DIS, V40, P526, DOI 10.1097/01.OLQ.0000431046.28649.23; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; Madhivanan P, 2008, AIDS, V22, P983, DOI 10.1097/QAD.0b013e3282ffde52; Mavhu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082911; MITACEK EJ, 1986, INT J CANCER, V38, P9, DOI 10.1002/ijc.2910380103; Morris Brian J, 2014, ISRN Urol, V2014, P684706, DOI 10.1155/2014/684706; Morris BJ, 2014, CUAJ-CAN UROL ASSOC, V8, P396, DOI 10.5489/cuaj.2490; Morris BJ, 2014, J MED ETHICS, V40, P463, DOI 10.1136/medethics-2013-101614; Morris BJ, 2013, J SEX MED, V10, P2644, DOI 10.1111/jsm.12293; Morris BJ, 2012, ASIAN J ANDROL, V14, P661, DOI 10.1038/aja.2012.47; Morris BJ, 2012, AIDS CARE, V24, P1565, DOI 10.1080/09540121.2012.661836; Morris BJ, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-20; Pearl J., 2011, BAYESIAN NETWORKS; Peltzer K, 2008, AFR J TRADIT COMPLEM, V5, P346; Perchal P, 2011, INT AIDS SOC C IT RO; Phillips AA, 2007, CANCER INVEST, V25, P476, DOI 10.1080/07357900701359841; Qian H-Z, 2014, 21 C RETR OPP INF CR, P505; Ramkissoon A, 2011, 6 IAS C; Sawires SR, 2007, LANCET, V369, P708, DOI 10.1016/S0140-6736(07)60323-7; Sgaier SK, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001641; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Starzyk EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115891; Tobian AAR, 2010, ARCH PEDIAT ADOL MED, V164, P78, DOI 10.1001/archpediatrics.2009.232; Tobian AAR, 2009, CURR OPIN HIV AIDS, V4, P294, DOI 10.1097/COH.0b013e32832c1881; UNAIDS, 2013, HIV AIDS EST HAIT; Wamai RG, 2015, GLOB PUBLIC HEALTH, V10, P639, DOI 10.1080/17441692.2014.989532; Wamai RG, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-49; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; WHO, 2007, GLOB PREV MAL CIRC; World Health Organization, 2012, VOL MED MAL CIRC HIV; World Health Organization; Johns Hopkins Program for International Education in Gynecology and Obstetrics, 2010, MAN EARL INF MAL CIR; Wright JL, 2012, CANCER-AM CANCER SOC, V118, P4437, DOI 10.1002/cncr.26653; Wynn A, 2010, RAPID SCALE UP HIGH; Zetola N, 2012, SEX TRANSM DIS, V39, P114, DOI 10.1097/OLQ.0b013e318242b4f3	55	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134667	10.1371/journal.pone.0134667	http://dx.doi.org/10.1371/journal.pone.0134667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1UY	26237217	gold, Green Published, Green Submitted			2022-12-27	WOS:000358942400032
J	Enarson, PM; Gie, RP; Mwansambo, CC; Chalira, AE; Lufesi, NN; Maganga, ER; Enarson, DA; Cameron, NA; Graham, SM				Enarson, Penelope M.; Gie, Robert P.; Mwansambo, Charles C.; Chalira, Alfred E.; Lufesi, Norman N.; Maganga, Ellubey R.; Enarson, Donald A.; Cameron, Neil A.; Graham, Stephen M.			Potentially Modifiable Factors Associated with Death of Infants and Children with Severe Pneumonia Routinely Managed in District Hospitals in Malawi	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; TUBERCULOSIS PATIENTS; CHILDHOOD PNEUMONIA; REDUCES MORTALITY; NATIONAL CAUSES; ILL CHILDREN; COTRIMOXAZOLE; ETIOLOGY; IMPACT; CARE	Objective To investigate recognised co-morbidities and clinical management associated with inpatient pneumonia mortality in Malawian district hospitals. Methods Prospective cohort study, of patient records, carried out in Malawi between 1st October 2000 and 30th June 2003. The study included all children aged 0-59 months admitted to the paediatric wards in sixteen district hospitals throughout Malawi with severe and very severe pneumonia. We compared individual factors between those that survived (n = 14 076) and those that died (n = 1 633). Results From logistic regression analysis, predictors of death in hospital, adjusted for age, sex and severity grade included comorbid conditions of meningitis (OR = 2.49, 95% CI 1.50-4.15), malnutrition (OR = 2.37, 95% CI 1.94-2.88) and severe anaemia (OR = 1.41, 95% CI 1.03-1.92). Requiring supplementary oxygen (OR = 2.16, 95% CI 1.85-2.51) and intravenous fluids (OR = 3.02, 95% CI 2.13-4.28) were associated with death while blood transfusion was no longer significant (OR = 1.10, 95% CI 0.77-1.57) when the model included severe anaemia. Conclusions This study identified a number of challenges to improve outcome for Malawian infants and children hospitalised with pneumonia. These included improved assessment of co-morbidities and more rigorous application of standard case management.	[Enarson, Penelope M.; Enarson, Donald A.; Graham, Stephen M.] Int Union TB & Lung Dis, Paris, France; [Enarson, Penelope M.; Gie, Robert P.; Enarson, Donald A.] Univ Stellenbosch, Desmond Tutu TB Ctr, ZA-7505 Tygerberg, South Africa; [Gie, Robert P.] Univ Stellenbosch, Dept Paediat & Child Hlth, Fac Med & Hlth Sci, ZA-7505 Tygerberg, South Africa; [Mwansambo, Charles C.; Chalira, Alfred E.; Lufesi, Norman N.] Minist Hlth, Lilongwe, Malawi; [Maganga, Ellubey R.] UNICEF Malawi, Lilongwe, Malawi; [Cameron, Neil A.] Univ Stellenbosch, Div Community Hlth, Dept Interdisciplinary Sci, Fac Med & Hlth Sci, ZA-7505 Tygerberg, South Africa; [Graham, Stephen M.] Univ Melbourne, Ctr Int Child Hlth, Dept Paediat, Melbourne, Vic, Australia; [Graham, Stephen M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia	Stellenbosch University; Stellenbosch University; Stellenbosch University; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Enarson, PM (corresponding author), Int Union TB & Lung Dis, Paris, France.	pennyenarson@theunion.org		Graham, Stephen/0000-0003-3525-2294	MoH of Malawi; Bill and Melinda Gates Foundation [413]	MoH of Malawi; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The CLHP was primarly funded by the MoH of Malawi, who contributed 69% of the running costs comprising facilities and human resources that are part of the existing health system. The Bill and Melinda Gates Foundation funded the remaining 31% of the costs, 21% of which was investment and 79% operating costs. The Bill & Melinda Gates Foundation grant ID#: 413 http://www.gatesfoundation.org/Pages/home.aspx). The external funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Duke T, 2006, J TROP PEDIATRICS, V52, P1, DOI 10.1093/tropej/fmk006; Duke T, 2003, LANCET, V361, P763, DOI 10.1016/S0140-6736(03)12661-X; Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2; Enarson PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102955; Enarson PM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000137; Enarson Penny M, 2010, Expert Rev Respir Med, V4, P211, DOI 10.1586/ers.10.14; English M, 1996, T ROY SOC TROP MED H, V90, P658, DOI 10.1016/S0035-9203(96)90423-X; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; Everett DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044250; Fasawe O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057778; Fenn B, 2005, INT J EPIDEMIOL, V34, P368, DOI 10.1093/ije/dyh335; Government of Malawi, 2011, CLIN MAN HIV CHILDR; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Graham SM, 2008, B WORLD HEALTH ORGAN, V86, P349, DOI 10.2471/BLT.07.048512; Graham SM, 2011, PEDIATR INFECT DIS J, V30, P33, DOI 10.1097/INF.0b013e3181fcabe4; Jackson S, 2013, CROAT MED J, V54, P110, DOI 10.3325/cmj.2013.54.110; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Mwaungulu FBD, 2004, B WORLD HEALTH ORGAN, V82, P354; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Oliwa JN, 2015, LANCET RESP MED, V3, P235, DOI 10.1016/S2213-2600(15)00028-4; Rice AL, 2000, B WORLD HEALTH ORGAN, V78, P1207; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Schumacher RF, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.073; Subhi R, 2009, LANCET INFECT DIS, V9, P219, DOI 10.1016/S1473-3099(09)70071-4; Swann O, 2014, PEDIATR INFECT DIS J, V33, P560, DOI 10.1097/INF.0000000000000210; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C; Zachariah R, 2003, AIDS, V17, P1053, DOI 10.1097/00002030-200305020-00015	34	14	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0133365	10.1371/journal.pone.0133365	http://dx.doi.org/10.1371/journal.pone.0133365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237222	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942400011
J	Ghosh, A; Marquez-Lago, TT				Ghosh, Atiyo; Marquez-Lago, Tatiana T.			Simulating Stochastic Reaction-Diffusion Systems on and within Moving Boundaries	PLOS ONE			English	Article								Chemical reactions inside cells are generally considered to happen within fixed-size compartments. However, cells and their compartments are highly dynamic. Thus, such stringent geometrical assumptions may not reflect biophysical reality, and can highly bias conclusions from simulation studies. In this work, we present an intuitive algorithm for particle-based diffusion in and on moving boundaries, for both point particles and spherical particles. We first benchmark our proposed stochastic method against solutions of partial differential equations in appropriate scenarios, and further demonstrate that moving boundaries can give rise to super-diffusive motion as well as time-inhomogeneous reaction rates. Finally, we conduct a numerical experiment representing photobleaching of diffusing fluorescent proteins in dividing Saccharomyces cerevisiae cells to demonstrate that moving boundaries might cause important effects neglected in previously published studies of cell compartmentalization.	[Ghosh, Atiyo; Marquez-Lago, Tatiana T.] Okinawa Inst Sci & Technol, Integrat Syst Biol Unit, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University	Marquez-Lago, TT (corresponding author), Okinawa Inst Sci & Technol, Integrat Syst Biol Unit, Okinawa, Japan.	tatiana.marquezlago@gmail.com		Ghosh, Atiyo/0000-0003-1606-8520	Okinawa Institute of Science and Technology	Okinawa Institute of Science and Technology(Okinawa Institute of Science & Technology Graduate University)	This work was supported by core funding from the Okinawa Institute of Science and Technology given to TML (Integrative Systems Biology Unit).	Andrews SS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000705; Baker RE, 2010, B MATH BIOL, V72, P719, DOI 10.1007/s11538-009-9467-x; Boettcher B, 2012, J CELL BIOL, V197, P921, DOI 10.1083/jcb.201112117; Burrage K, 2011, DESIGN AND ANALYSIS OF BIOMOLECULAR CIRCUITS:ENGINEERING APPROACHES TO SYSTEMS AND SYNTHETIC BIOLOGY, P43, DOI 10.1007/978-1-4419-6766-4_2; Crampin EJ, 1999, B MATH BIOL, V61, P1093, DOI 10.1006/bulm.1999.0131; Donev A, 2010, J COMPUT PHYS, V229, P3214, DOI 10.1016/j.jcp.2009.12.038; FREEDMAN D, 1981, Z WAHRSCHEINLICHKEIT, V57, P453, DOI 10.1007/BF01025868; Gehlen LR, 2011, CURR BIOL, V21, P25, DOI 10.1016/j.cub.2010.12.016; Isaacson SA, 2009, SIAM J APPL MATH, V70, P77, DOI 10.1137/070705039; Leier A, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3634003; Li B. Q., 2006, CO FL SO ME, V578, DOI 10.1007/1-84628-205-5; Luedeke C, 2005, J CELL BIOL, V169, P897, DOI 10.1083/jcb.200412143; Macklin P, 2008, J SCI COMPUT, V35, P266, DOI 10.1007/s10915-008-9190-z; Marquez-Lago TT, 2012, IET SYST BIOL, V6, P134, DOI 10.1049/iet-syb.2011.0049; Notelaers K, 2012, BBA-BIOMEMBRANES, V1818, P3131, DOI 10.1016/j.bbamem.2012.08.010; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; van Zon JS, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2137716; Zavala E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003725	18	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133401	10.1371/journal.pone.0133401	http://dx.doi.org/10.1371/journal.pone.0133401			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230406	gold, Green Submitted, Green Published			2022-12-27	WOS:000358838400035
J	Goldhammer, JE; Marhefka, GD; Daskalakis, C; Berguson, MW; Bowen, JE; Diehl, JT; Sun, JZ				Goldhammer, Jordan E.; Marhefka, Gregary D.; Daskalakis, Constantine; Berguson, Mark W.; Bowen, John E.; Diehl, James T.; Sun, Jianzhong			The Effect of Aspirin on Bleeding and Transfusion in Contemporary Cardiac Surgery	PLOS ONE			English	Article							ARTERY-BYPASS-SURGERY; VEIN GRAFT PATENCY; ANTIPLATELET THERAPY; BLOOD-LOSS; CORONARY; OUTCOMES; GUIDELINE; MORTALITY; SOCIETY; TRIAL	Objective Despite evidence that preoperative aspirin improves outcomes in cardiac surgery, recommendations for aspirin use are inconsistent due to aspirin's anti-platelet effect and concern for bleeding. The purpose of this study was to investigate preoperative aspirin use and its effect on bleeding and transfusion in cardiac surgery. Methods This retrospective study involved consecutive patients (n=1571) who underwent CABG, valve, or combined CABG and valve surgery at a single center between March 2007 and July 2012. Of all patients, 728 met the inclusion criteria and were divided into two groups: those using (n=603) or not using (n=125) aspirin within 5 days of surgery. Data were collected on chest tube drainage, re-operation for bleeding, and transfusion of red blood cells (RBCs), fresh frozen plasma (FFP), and platelets. Results No significant difference was observed between the two groups in chest tube drainage or re-operation for bleeding. An increase in patients transfused with RBCs was observed in the aspirin group (61.9 vs 51.2%, adjusted OR 1.77, p=0.027); however, among those transfused RBCs, no significant difference in mean units transfused or massive transfusion was observed. No significant difference was seen in transfusion requirement of FFP or platelets. Conclusions In patients undergoing CABG, valve, or combined CABG/valve surgery, preoperative aspirin, within 5 days of surgery, was associated with an increased probability of receiving an RBC transfusion. Preoperative aspirin was not associated with an increase in chest tube drainage, re-operation for bleeding complications, or transfusion of FFP or platelets.	[Goldhammer, Jordan E.; Berguson, Mark W.; Sun, Jianzhong] Thomas Jefferson Univ, Dept Anesthesiol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Marhefka, Gregary D.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Med, Div Cardiol, Philadelphia, PA 19107 USA; [Daskalakis, Constantine] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Div Biostat, Philadelphia, PA 19107 USA; [Bowen, John E.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Diehl, James T.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Surg, Div Cardiothorac Surg, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University; Jefferson University; Jefferson University	Goldhammer, JE (corresponding author), Thomas Jefferson Univ, Dept Anesthesiol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.	jordan.goldhammer@jefferson.edu						Al-Atassi T, 2012, CIRCULATION, V126, pS239, DOI 10.1161/CIRCULATIONAHA.111.084772; Biancari F, 2012, EUR J CARDIO-THORAC, V41, P50, DOI 10.1016/j.ejcts.2011.04.023; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Bybee KA, 2005, CIRCULATION, V112, pI286, DOI 10.1161/CIRCULATIONAHA.104.522805; Cao LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030094; Cao LH, 2012, ANN SURG, V255, P399, DOI 10.1097/SLA.0b013e318234313b; Carless PA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001888.pub4; CHESEBRO JH, 1982, NEW ENGL J MED, V307, P73, DOI 10.1056/NEJM198207083070201; Dacey LJ, 2000, ANN THORAC SURG, V70, P1986, DOI 10.1016/S0003-4975(00)02133-0; Ferraris VA, 2005, ANN THORAC SURG, V79, P1454, DOI 10.1016/j.athoracsur.2005.01.008; FERRARIS VA, 1988, ANN THORAC SURG, V45, P71, DOI 10.1016/S0003-4975(10)62401-0; Ferraris VA, 2012, ANN THORAC SURG, V94, P1761, DOI 10.1016/j.athoracsur.2012.07.086; GOLDMAN S, 1989, CIRCULATION, V80, P1190, DOI 10.1161/01.CIR.80.5.1190; GOLDMAN S, 1991, CIRCULATION, V84, P520, DOI 10.1161/01.CIR.84.2.520; GOLDMAN S, 1988, CIRCULATION, V77, P1324, DOI 10.1161/01.CIR.77.6.1324; Hillis LD, 2011, CIRCULATION, V124, P2610, DOI 10.1161/CIR.0b013e31823b5fee; Jacob M, 2011, CIRCULATION, V123, P577, DOI 10.1161/CIRCULATIONAHA.110.957373; KALLIS P, 1994, EUR J CARDIO-THORAC, V8, P404, DOI 10.1016/1010-7940(94)90081-7; Karthik S, 2004, ANN THORAC SURG, V78, P527, DOI 10.1016/j.athoracsur.2004.02.088; Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798; Maxwell MJ, 2006, CONTIN ED ANAESTH CR, V6, P225, DOI DOI 10.1093/BJACEACCP/MKL053; Ngaage DL, 2010, EUR J CARDIO-THORAC, V37, P1375, DOI 10.1016/j.ejcts.2009.11.055; Ravn HB, 2011, J CARDIOTHOR VASC AN, V25, P36, DOI 10.1053/j.jvca.2010.05.006; SETHI GK, 1990, J AM COLL CARDIOL, V15, P15, DOI 10.1016/0735-1097(90)90168-O; Sun JC, 2010, CIRCULATION, V122, P2680; Weightman WM, 2002, J CARDIOTHOR VASC AN, V16, P54, DOI 10.1053/jcan.2002.29674; Yao LN, 2015, ANN SURG, V261, P207, DOI 10.1097/SLA.0000000000000641	27	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134670	10.1371/journal.pone.0134670	http://dx.doi.org/10.1371/journal.pone.0134670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230605	Green Submitted, gold, Green Published			2022-12-27	WOS:000358838400147
J	Rong, XF; Ji, YH; Fang, YW; Jiang, YX; Lu, Y				Rong, Xianfang; Ji, Yinghong; Fang, Yanwen; Jiang, Yongxiang; Lu, Yi			Long-Term Visual Outcomes of Secondary Intraocular Lens Implantation in Children with Congenital Cataracts	PLOS ONE			English	Article							INFANT APHAKIA TREATMENT; SURGERY; PERIOD; COMPLICATIONS; STRABISMUS; GLAUCOMA; ACUITY; CORTEX; AGE; EYE	Aim The aim of this study was to evaluate the long-term visual outcomes and factors affecting visual results in children undergoing secondary intraocular lens (IOL) implantation following primary congenital cataract extraction. Methods Children with congenital cataracts who underwent secondary IOL implantation for aphakia at the Eye and ENT Hospital of Fudan University between January 1, 2001, and December 31, 2007, were retrospectively reviewed. One eye was randomly selected in children with bilateral cataracts. Laterality, type of cataract (total or partial opacity), sex, age at primary and secondary surgeries, visual axis opacity (VAO), compliance with amblyopia therapy, postoperative ocular complications, refractive error, ocular alignment, and best corrected visual acuity (BCVA) at last follow-up were recorded; potential factors that might have affected the visual results were evaluated. Results Seventy-six bilateral and 34 unilateral congenital cataract cases were analyzed; the mean ages of the children were 12.70 +/- 5.06 and 12.50 +/- 2.71 years at final follow-up, the mean follow-up periods from IOL implantation were 94.93 +/- 24.22 and 109.09 +/- 18.89 months, and the mean BCVA (Log MAR) values were 0.51 +/- 0.37 and 1.05 +/- 0.46, respectively. Final BCVA after secondary IOL implantation was significantly associated with laterality, type of cataract, age at primary cataract extraction, compliance with amblyopia therapy, and refractive correction after surgery. No significant associations were found between BCVA and sex, age at secondary IOL implantation, VAO, or other ocular complications. The most common ocular complications were VAO and elevated intraocular pressure after surgery. There were no other complications, with the exception of one eye with IOL dislocation. Conclusions The results indicate that the important determinants of long-term visual outcomes in children with congenital cataracts undergoing secondary IOL implantation are laterality, cataract type, age at initial cataract extraction, compliance with amblyopia therapy, and refractive error.	[Rong, Xianfang; Ji, Yinghong; Fang, Yanwen; Jiang, Yongxiang; Lu, Yi] Fudan Univ, Dept Ophthalmol & Vis Sci, Eye & ENT Hosp, Shanghai 200433, Peoples R China; [Rong, Xianfang; Ji, Yinghong; Fang, Yanwen; Jiang, Yongxiang; Lu, Yi] State Hlth Minist, Key Lab Myopia, Shanghai, Peoples R China; [Rong, Xianfang; Ji, Yinghong; Fang, Yanwen; Jiang, Yongxiang; Lu, Yi] Key Lab Visual Impairment & Restorat Shanghai, Shanghai, Peoples R China	Fudan University	Lu, Y (corresponding author), Fudan Univ, Dept Ophthalmol & Vis Sci, Eye & ENT Hosp, Shanghai 200433, Peoples R China.	luyiox@163.com			National Natural Science Foundation of China [81300806, 81300745]; Cutting-Edge Technology Combined PR Project of Shanghai Shen Kang Hospital Development Centre Program [SHDC12012104]; Key-Collabotative Project of Health Bureau of Pudong New Area [PW2011D-7]; Program of Science and Technology Commission of Shanghai Municipality [124119a9900]; Youth Foundation Project of Shanghai Municipal Health Bureau [20124y041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cutting-Edge Technology Combined PR Project of Shanghai Shen Kang Hospital Development Centre Program; Key-Collabotative Project of Health Bureau of Pudong New Area; Program of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Youth Foundation Project of Shanghai Municipal Health Bureau	This study was supported by grants from the National Natural Science Foundation of China (No. 81300806 and 81300745), the Cutting-Edge Technology Combined PR Project of Shanghai Shen Kang Hospital Development Centre Program (No. SHDC12012104), Key-Collabotative Project of Health Bureau of Pudong New Area (No. PW2011D-7), Program of Science and Technology Commission of Shanghai Municipality (No. 124119a9900) and the Youth Foundation Project of Shanghai Municipal Health Bureau (20124y041). The funding organizations had no role in designing or conducting this research.	Alagaratnam J, 2002, EYE, V16, P557, DOI 10.1038/sj.eye.6700149; Basti S, 1996, OPHTHALMOLOGY, V103, P713; Birch EE, 2012, J AAPOS, V16, P156, DOI 10.1016/j.jaapos.2011.11.007; Borisovsky G, 2013, GRAEF ARCH CLIN EXP, V251, P2205, DOI 10.1007/s00417-013-2327-2; Bothun ED, 2013, OPHTHALMOLOGY, V120, P1227, DOI 10.1016/j.ophtha.2012.11.039; BRADFORD GM, 1994, AM J OPHTHALMOL, V117, P58, DOI 10.1016/S0002-9394(14)73015-6; Chak M, 2006, INVEST OPHTH VIS SCI, V47, P4262, DOI 10.1167/iovs.05-1160; Drews-Botsch CD, 2012, INVEST OPHTH VIS SCI, V53, P3368, DOI 10.1167/iovs.11-8457; ELSTON JS, 1992, BRIT J OPHTHALMOL, V76, P327, DOI 10.1136/bjo.76.6.327; GORDON RA, 1985, ARCH OPHTHALMOL-CHIC, V103, P785; Horton JC, 1997, J NEUROSCI, V17, P3684; Kim DH, 2012, ACTA OPHTHALMOL, V90, P231, DOI 10.1111/j.1755-3768.2010.01872.x; Lambert SR, 2014, JAMA OPHTHALMOL, V132, P676, DOI 10.1001/jamaophthalmol.2014.531; Lambert SR, 2013, AM J OPHTHALMOL, V156, P355, DOI 10.1016/j.ajo.2013.03.013; Lambert SR, 2006, J AAPOS, V10, P30, DOI 10.1016/j.jaapos.2005.10.002; Lambert SR, 1996, SURV OPHTHALMOL, V40, P427, DOI 10.1016/S0039-6257(96)82011-X; Lee SJ, 2014, INT J OPHTHALMOL-CHI, V7, P522, DOI 10.3980/j.issn.2222-3959.2014.03.25; LORENZ B, 1991, GRAEF ARCH CLIN EXP, V229, P123, DOI 10.1007/BF00170543; Magli A, 2013, GRAEF ARCH CLIN EXP, V251, P309, DOI 10.1007/s00417-012-1979-7; Nihalani BR, 2011, J AAPOS, V15, P435, DOI 10.1016/j.jaapos.2011.05.019; PARKS MM, 1993, OPHTHALMOLOGY, V100, P826; Plager DA, 2011, OPHTHALMOLOGY, V118, P2330, DOI 10.1016/j.ophtha.2011.06.017; Sjostrand J, 2011, ACTA OPHTHALMOL, V89, P30, DOI 10.1111/j.1755-3768.2009.01618.x; Tatham A, 2010, EYE, V24, P1366, DOI 10.1038/eye.2010.46; Vaegan Taylor D, 1979, T OPHTHAL SOC UK, V99, P432; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Wilson ME, 1996, OPHTHALMOLOGY, V103, P1719, DOI 10.1016/S0161-6420(96)30436-3	27	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134864	10.1371/journal.pone.0134864	http://dx.doi.org/10.1371/journal.pone.0134864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230501	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400179
J	Ye, JQ; Gaur, M; Zhang, Y; Sievers, RE; Woods, BJ; Aurigui, J; Bernstein, HS; Yeghiazarians, Y				Ye, Jianqin; Gaur, Meenakshi; Zhang, Yan; Sievers, Richard E.; Woods, Brandon J.; Aurigui, Julian; Bernstein, Harold S.; Yeghiazarians, Yerem			Treatment with hESC-Derived Myocardial Precursors Improves Cardiac Function after a Myocardial Infarction	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; RAT HEARTS; TRANSPLANTATION; CARDIOMYOCYTES; THERAPY; PROTECTION; INJECTION; CYTOKINES; REPAIR	Background We previously reported the generation of a reporter line of human embryonic stem cells (hESCs) with enhanced green fluorescent protein (eGFP) expression driven by the alpha-myosin heavy chain (alpha MHC) promoter. The GFP(+)/alpha MHC+ cells derived from this cell line behave as multipotent, human myocardial precursors (hMPs) in vitro. In this study, we evaluated the therapeutic effects of GFP(+)/alpha MHC+ cells isolated from the reporter line in a mouse model of myocardial infarction (MI). Methods MI was generated in immunodeficient mice. hMPs were injected into murine infarcted hearts under ultrasound guidance at 3 days post-MI. Human fetal skin fibroblasts (hFFs) were injected as control. Cardiac function was evaluated by echocardiography. Infarct size, angiogenesis, apoptosis, cell fate, and teratoma formation were analyzed by immunohistochemical staining. Results Compared with control, hMPs resulted in improvement of cardiac function post-MI with smaller infarct size, induced endogenous angiogenesis, and reduced apoptosis of host cardiomyocytes at the peri-infarct zone at 28 days post-MI. Conclusion Intramyocardial injection of hMPs improved cardiac function post-MI. The engraftment rate of these cells in the myocardium post-MI was low, suggesting that the majority of effect occurs via paracrine mechanisms.	[Ye, Jianqin; Gaur, Meenakshi; Zhang, Yan; Sievers, Richard E.; Woods, Brandon J.; Yeghiazarians, Yerem] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Aurigui, Julian; Bernstein, Harold S.; Yeghiazarians, Yerem] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Bernstein, Harold S.; Yeghiazarians, Yerem] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yeghiazarians, Y (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	yeghiaza@medicine.ucsf.edu	ye, jian/GQH-3702-2022		California Institute of Regenerative Medicine [RC1-00104-1]	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine)	This work was supported by a grant from the California Institute of Regenerative Medicine to HSB and YY (RC1-00104-1).	Bartunek J, 2013, J AM COLL CARDIOL, V61, P2329, DOI 10.1016/j.jacc.2013.02.071; Bernstein H. S., 2010, J VIS EXP; Bernstein HS, 2012, REGEN MED, V7, P697, DOI [10.2217/RME.12.46, 10.2217/rme.12.46]; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; Ebelt H, 2007, STEM CELLS, V25, P236, DOI 10.1634/stemcells.2006-0374; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Ritner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016004; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Springer ML, 2005, AM J PHYSIOL-HEART C, V289, pH1307, DOI 10.1152/ajpheart.00164.2005; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Sui RQ, 2011, STEM CELL REV REP, V7, P172, DOI 10.1007/s12015-010-9131-8; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; van Laake LW, 2010, CELL MOL LIFE SCI, V67, P277, DOI 10.1007/s00018-009-0179-z; van Laake LW, 2009, STEM CELL RES, V3, P106, DOI 10.1016/j.scr.2009.05.004; Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301; Ye JQ, 2014, J CARDIOVASC PHARM, V63, P85, DOI 10.1097/FJC.0b013e318299ebc0; Ye JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030329; Yeghiazarians Y, 2012, CYTOTHERAPY, V14, P223, DOI 10.3109/14653249.2011.623690; Yeghiazarians Y, 2009, MOL THER, V17, P1250, DOI 10.1038/mt.2009.85	28	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0131123	10.1371/journal.pone.0131123	http://dx.doi.org/10.1371/journal.pone.0131123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230835	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400007
J	Zhao, JN; Zhang, XX; He, XC; Yang, GR; Zhang, XQ; Li, HC				Zhao, Jiang-nan; Zhang, Xian-xin; He, Xiao-chun; Yang, Guo-ru; Zhang, Xiao-qi; Li, Huai-chen			The Relationship between Extensively Drug-Resistant Tuberculosis and Multidrug-Resistant Gram-Negative Bacilli	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; INFECTIONS; MANAGEMENT; CIRRHOSIS; ALBUMIN	Objective The relationship between extensively drug-resistant tuberculosis (XDR-TB) and multidrug-resistant Gram-negative bacilli (MDR-GNB) is unclear. Identification of the relationship between XDR-TB and MDR-GNB would have important implications for patient care. Methods We conducted a retrospective study reviewing the records of patients admitted with a confirmed pulmonary TB from 2011 to 2014. To identify the relationship between XDR-TB and MDR-GNB, univariable comparison and multivariable logistic regression were performed. Results Among 2962 pulmonary TB patients, 45(1.5%) patients had a diagnosis of XDR-TB. A total of 165 MDR-GNB strains were detected in 143 (4.8%) pulmonary TB patients. XDR-TB patients had a significantly higher occurrence of MDR-GNB than non-XDR-TB patients (24.4% vs. 4.5%; P<0.001). Age (OR 1.02, 95% CI 1.01-1.03), hypoalbuminemia (OR 1.48, 95% CI 1.18-1.85), chronic renal failure (OR 6.67, 95% CI 1.42-31.47), chronic hepatic insufficiency (OR 1.99, 95% CI 1.15-3.43), presence of XDR-TB (OR 6.56, 95% CI 1.61-26.69), and duration of TB diagnostic delay (OR 1.01, 95% CI 1.00-1.02) were the independent risk factors for MDR-GNB infection. Conclusions Patients with XDR-TB have a significantly higher risk of being affected by MDR-GNB pathogen. The underlying mechanism association warrant further studies.	[Zhao, Jiang-nan; He, Xiao-chun; Li, Huai-chen] Shandong Univ, Prov Hosp, Dept Resp Med, Jinan 250100, Peoples R China; [Zhang, Xian-xin] Shandong Prov Chest Hosp, Dept Resp Med, Jinan, Peoples R China; [Yang, Guo-ru] Chest Specially Hosp Weifang, Dept Resp Med, Weifang, Peoples R China; [Zhang, Xiao-qi] Chest Specially Hosp Weifang, Dept TB Med, Weifang, Peoples R China	Shandong University; Shandong University	Li, HC (corresponding author), Shandong Univ, Prov Hosp, Dept Resp Med, Jinan 250100, Peoples R China.	zjn911016@126.com			Science and technology development plan of Shandong Province [2009GG10002054]	Science and technology development plan of Shandong Province	This work was supported by Science and technology development plan of Shandong Province (Grant Number: 2009GG10002054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, Wkly Epidemiol Rec, V81, P430; [Anonymous], 2009, GUID SURV DRUG RES T; Arruda EAG, 1999, INFECT CONT HOSP EP, V20, P620, DOI 10.1086/501683; Bastos ML, 2014, CLIN INFECT DIS, V59, P1364, DOI 10.1093/cid/ciu619; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P301; Chang KC, 2013, RESPIROLOGY, V18, P8, DOI 10.1111/j.1440-1843.2012.02257.x; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; D'Agata EMC, 2004, INFECT CONT HOSP EP, V25, P842, DOI 10.1086/502306; Daley CL, 2014, CLIN INFECT DIS, V59, P1064, DOI 10.1093/cid/ciu578; de Sande-Bruinsma NV, 2008, EMERG INFECT DIS, V14, P1722, DOI 10.3201/eid1411.070467; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Hsueh PR, 2005, INT J ANTIMICROB AG, V26, P463, DOI 10.1016/j.ijantimicag.2005.08.016; Jalan R, 2013, J HEPATOL, V59, P918, DOI 10.1016/j.jhep.2013.08.001; Jalan R, 2009, HEPATOLOGY, V50, P555, DOI 10.1002/hep.22913; Karyadi E, 2000, J NUTR, V130, P2953, DOI 10.1093/jn/130.12.2953; Kim HR, 2011, J HOSP INFECT, V77, P134, DOI 10.1016/j.jhin.2010.07.004; Kim HR, 2007, CLIN INFECT DIS, V45, P1290, DOI 10.1086/522537; Lai CC, 2011, J ANTIMICROB CHEMOTH, V66, P1374, DOI 10.1093/jac/dkr103; Lam E, 2014, EMERG INFECT DIS, V20, P400, DOI 10.3201/eid2003.130951; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; ONWUBALILI JK, 1988, EUR J CLIN NUTR, V42, P363; Pop-Vicas AE, 2005, CLIN INFECT DIS, V40, P1792, DOI 10.1086/430314; Safdar N, 2002, ANN INTERN MED, V136, P834, DOI 10.7326/0003-4819-136-11-200206040-00013; Shen GH, 2012, INT J ANTIMICROB AG, V39, P201, DOI 10.1016/j.ijantimicag.2011.11.014; Siege JD, 2006, MANAGEMENT MULTIDRUG; Simonsen GS, 2004, B WORLD HEALTH ORGAN, V82, P928; Temple B, 2008, CLIN INFECT DIS, V47, P1126, DOI 10.1086/592252; Wong SSY, 2007, PERITON DIALYSIS INT, V27, pS272; World Health Organization, 2014, GLOB TUB REP; Zumla A, 2012, J INFECT DIS, V205, pS228, DOI 10.1093/infdis/jir858	32	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134998	10.1371/journal.pone.0134998	http://dx.doi.org/10.1371/journal.pone.0134998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230499	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400190
J	de Souza, LM; Le Guen, V; Cerqueira-Silva, CBM; Silva, CC; Mantello, CC; Conson, ARO; Vianna, JPG; Zucchi, MI; Scaloppi, EJ; Fialho, JD; de Moraes, MLT; Goncalves, PD; de Souza, AP				de Souza, Livia Moura; Le Guen, Vincent; Moreno Cerqueira-Silva, Carlos Bernardo; Silva, Carla Cristina; Mantello, Camila Campos; Oliveira Conson, Andre Ricardo; Gomes Vianna, Joao Paulo; Zucchi, Maria Imaculada; Scaloppi Junior, Erivaldo Jose; Fialho, Josefino de Freitas; Teixeira de Moraes, Mario Luis; Goncalves, Paulo de Souza; de Souza, Anete Pereira			Genetic Diversity Strategy for the Management and Use of Rubber Genetic Resources: More than 1,000 Wild and Cultivated Accessions in a 100-Genotype Core Collection	PLOS ONE			English	Article							HEVEA-BRASILIENSIS; IDENTIFICATION; CONSERVATION; POPULATIONS; INFERENCE; PROGRAM; MARKERS	The rubber tree [Hevea brasiliensis (Willd. ex Adr. de Juss.) Muell. Arg.] is the only plant species worldwide that is cultivated for the commercial production of natural rubber. This study describes the genetic diversity of the Hevea spp. complex that is available in the main ex situ collections of South America, including Amazonian populations that have never been previously described. Genetic data were analyzed to determine the genetic structure of the wild populations, quantify the allelic diversity and suggest the composition of a core collection to capture the maximum genetic diversity within a minimal sample size. A total of 1,117 accessions were genotyped with 13 microsatellite markers. We identified a total of 408 alleles, 319 of which were shared between groups and 89 that were private in different groups of accessions. In a population structure and principal component analysis, the level of clustering reflected a primary division into the following two subgroups: cluster 1, which consisted of varieties from the advanced breeding germplasm that originated from the Wickham and Mato Grosso accessions; and cluster 2, which consisted of the wild germplasm from the Acre, Amazonas, Para and Rondonia populations and Hevea spp. The analyses revealed a high frequency of gene flow between the groups, with the genetic differentiation coefficient (GST) estimated to be 0.018. Additionally, no distinct separation among the H. brasiliensis accessions and the other species from Amazonas was observed. A core collection of 99 accessions was identified that captured the maximum genetic diversity. Rubber tree breeders can effectively utilize this core collection for cultivar improvement. Furthermore, such a core collection could provide resources for forming an association panel to evaluate traits with agronomic and commercial importance. Our study generated a molecular database that should facilitate the management of the Hevea germplasm and its use for subsequent genetic and genomic breeding.	[de Souza, Livia Moura; Moreno Cerqueira-Silva, Carlos Bernardo; Silva, Carla Cristina; Mantello, Camila Campos; Oliveira Conson, Andre Ricardo; Gomes Vianna, Joao Paulo; de Souza, Anete Pereira] Univ Estadual Campinas, UNICAMP, Mol Biol & Genet Engn Ctr CBMEG, Campinas, SP, Brazil; [Le Guen, Vincent] UMR AGAP, Ctr Cooperat Int Rech Agron Dev CIRAD, Montpellier, Herault, France; [Moreno Cerqueira-Silva, Carlos Bernardo] State Univ Southwest Bahia UESB, Dept Exact & Nat Sci, Lab Appl Mol Genet, Itapetinga, BA, Brazil; [Gomes Vianna, Joao Paulo; Zucchi, Maria Imaculada] Agencia Paulista Tecnol Agronegocios, Polo Reg Noroeste Paulista, Votuporanga, SP, Brazil; [Fialho, Josefino de Freitas] Embrapa Cerrados EMBRAPA, Planaltina, DF, Brazil; [Teixeira de Moraes, Mario Luis] Univ Estadual Paulista, UNESP, Fac Engn Ilha Solteira, Dept Fitotecnia, Ilha Solteira, SP, Brazil; [Scaloppi Junior, Erivaldo Jose; Goncalves, Paulo de Souza] Rubber Res Adv Ctr CAPSA, Agron Inst IAC, Votuporanga, SP, Brazil; [de Souza, Anete Pereira] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Plant Biol, Campinas, SP, Brazil	Universidade Estadual de Campinas; CIRAD; Universite de Montpellier; Universidade Estadual do Sudoeste da Bahia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas	de Souza, AP (corresponding author), Univ Estadual Campinas, UNICAMP, Mol Biol & Genet Engn Ctr CBMEG, Campinas, SP, Brazil.	anete@unicamp.br	Conson, Andre Ricardo Olivei RO/Q-1916-2018; Le Guen, Vincent/I-2229-2012; Zucchi, Maria Imaculada/AAC-8157-2019; Zucchi, Maria Imaculada/D-2637-2012; Viana, João Paulo JPGV Gomes/K-1178-2012; Conson, Andre Ricardo Oliveira/O-1609-2019; DE SOUZA, ANETE PEREIRA/B-8663-2012	Conson, Andre Ricardo Olivei RO/0000-0002-8131-7127; Zucchi, Maria Imaculada/0000-0002-4863-1843; Zucchi, Maria Imaculada/0000-0002-4863-1843; Viana, João Paulo JPGV Gomes/0000-0002-9217-9604; Conson, Andre Ricardo Oliveira/0000-0002-8131-7127; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; Scaloppi Junior, Erivaldo Jose/0000-0002-8050-2187; Campos Mantello, Camila/0000-0002-9716-0400; Da Silva, Carla/0000-0003-4779-0014	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/50392-1, 2012/50491-8, 2011/50188-0, 2009/52975-0, 2012/05473-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [478701/2012-8, 402954/2012-2]; Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors gratefully acknowledge the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2007/50392-1; 2012/50491-8) for financial support and scholarships to CCM (2011/50188-0), CCS (2009/52975-0), and LMS (2012/05473-1), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for financial support (478701/2012-8; 402954/2012-2) and research fellowships to APS and PSG, and the Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES) for financial support (Computational Biology Program and CAPES-Agropolis Program) and a graduate scholarship to AROC.	[Anonymous], 2014, J BIOL AGR HEALTHC, V4, P132; Balas FC, 2014, TREE GENET GENOMES, V10, P703, DOI 10.1007/s11295-014-0715-3; BALDWIN JT, 1947, J HERED, V38, P54, DOI 10.1093/oxfordjournals.jhered.a105691; Belaj A, 2012, TREE GENET GENOMES, V8, P365, DOI 10.1007/s11295-011-0447-6; BESSE P, 1994, THEOR APPL GENET, V88, P199, DOI 10.1007/BF00225898; BROWN AHD, 1989, GENOME, V31, P818, DOI 10.1139/g89-144; Clement-Demange A., 1998, Symposium on natural rubber (Hevea brasiliensis). Volume 1. General, soils and fertilization, and breeding and selection sessions, Ho Chi Minh City, Vietnam, 14-15 October 1997., P71; Clement-Demange Andre, 2001, P455; Cochard B, 2009, TREE GENET GENOMES, V5, P493, DOI 10.1007/s11295-009-0203-3; Cubry P, 2013, GENET RESOUR CROP EV, V60, P483, DOI 10.1007/s10722-012-9851-5; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Falush D, 2003, GENETICS, V164, P1567; Feng SP, 2009, MOL BREEDING, V23, P85, DOI 10.1007/s11032-008-9216-0; Goncalves PS, 1981, EXPEDICAO INT AMAZON; Graudal L., 1999, DFSC SERIES TECHNICA; Greene SL, 1996, CROP SCI, V36, P1398, DOI 10.2135/cropsci1996.0011183X003600050051x; Gross BL, 2012, J AM SOC HORTIC SCI, V137, P333, DOI 10.21273/JASHS.137.5.333; Halle F, 1974, AMAZONIE BRESILIENNE; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Lam LV, 2009, MOL BIOTECHNOL, V42, P292, DOI 10.1007/s12033-009-9159-7; Le Cunff L, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-31; Le Guen V, 2009, TREE GENET GENOMES, V5, P673, DOI 10.1007/s11295-009-0218-9; Lekawipat N., 2003, Journal of Rubber Research, V6, P36; Lins ACR, 1981, REPORT ACRE TEAM JOI, P24; Mantello Camila C, 2012, BMC Res Notes, V5, P329, DOI 10.1186/1756-0500-5-329; Marcano M, 2007, THEOR APPL GENET, V114, P877, DOI 10.1007/s00122-006-0486-9; Paiva J, 1994, SILVAE GENET, V43, P306; Paiva J, 1981, COLETA MAT SEXUADO A; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier X., 2006, DARWIN SOFTWARE; Pires JM, 2002, TAXONOMIA FITOGEOGRA; Pritchard JK, 2000, GENETICS, V155, P945; Priyadarshan PM, 2003, GENET RESOUR CROP EV, V50, P101, DOI 10.1023/A:1022972320696; Rands R.D., 1955, PROGR REPORT COOPERA; Richards CM, 2009, J AM SOC HORTIC SCI, V134, P228, DOI 10.21273/JASHS.134.2.228; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Saha T, 2005, PLANT BREEDING, V124, P86, DOI 10.1111/j.1439-0523.2004.01053.x; SCHOEN DJ, 1993, P NATL ACAD SCI USA, V90, P10623, DOI 10.1073/pnas.90.22.10623; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Seguin Marc, 2003, P277; Seibert RJ, 1948, MISSOURI BOT GARD SA, V35, P61; Shan F, 2007, GENET RESOUR CROP EV, V54, P519, DOI 10.1007/s10722-006-0008-2; Souza LM, 2009, CONSERV GENET RESOUR, V1, P75, DOI 10.1007/s12686-009-9018-7; Van Helten VM, 1918, ARCH RUBBERCULT NED, V2, P87; van Treuren R, 2010, GENET RESOUR CROP EV, V57, P853, DOI 10.1007/s10722-009-9525-0; Yeang HY, 1999, ANN BOT-LONDON, V84, P681, DOI 10.1006/anbo.1999.0959; Zhang DP, 2009, TREE GENET GENOMES, V5, P1, DOI 10.1007/s11295-008-0163-z	47	17	18	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134607	10.1371/journal.pone.0134607	http://dx.doi.org/10.1371/journal.pone.0134607			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225861	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700121
J	Garcia, S; Petrini, K; Rubin, GS; Da Cruz, L; Nardini, M				Garcia, Sara; Petrini, Karin; Rubin, Gary S.; Da Cruz, Lyndon; Nardini, Marko			Visual and Non-Visual Navigation in Blind Patients with a Retinal Prosthesis	PLOS ONE			English	Article							PATH-INTEGRATION; OCCIPITAL CORTEX; TACTILE ACUITY; SPACE; INFORMATION; COGNITION; ABILITY; HUMANS	Human adults with normal vision can combine visual landmark and non-visual self-motion cues to improve their navigational precision. Here we asked whether blind individuals treated with a retinal prosthesis could also benefit from using the resultant new visual signal together with non-visual information when navigating. Four patients (blind for 15-52 years) implanted with the Argus II retinal prosthesis (Second Sight Medical Products Inc. Sylmar, CA), and five age-matched and six younger controls, participated. Participants completed a path reproduction and a triangle completion navigation task, using either an indirect visual landmark and non-visual self-motion cues or non-visual self-motion cues only. Control participants wore goggles that approximated the field of view and the resolution of the Argus II prosthesis. In both tasks, control participants showed better precision when navigating with reduced vision, compared to without vision. Patients, however, did not show similar improvements when navigating with the prosthesis in the path reproduction task, but two patients did show improvements in the triangle completion task. Additionally, all patients showed greater precision than controls in both tasks when navigating without vision. These results indicate that the Argus II retinal prosthesis may not provide sufficiently reliable visual information to improve the precision of patients on tasks, for which they have learnt to rely on non-visual senses.	[Garcia, Sara; Petrini, Karin; Rubin, Gary S.; Da Cruz, Lyndon; Nardini, Marko] UCL, Inst Ophthalmol, London, England; [Petrini, Karin] Univ Bath, Dept Psychol, Bath BA2 7AY, Avon, England; [Rubin, Gary S.; Da Cruz, Lyndon] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England; [Rubin, Gary S.; Da Cruz, Lyndon] UCL Inst Ophthalmol, London, England; [Da Cruz, Lyndon] Moorfields Eye Hosp NHS Fdn Trust, Vitreoretinal Serv, London, England; [Nardini, Marko] Univ Durham, Dept Psychol, Durham DH1 3LE, England	University of London; University College London; University of Bath; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Durham University	Garcia, S (corresponding author), UCL, Inst Ophthalmol, London, England.	sara.garcia.12@ucl.ac.uk	Nardini, Marko/C-1905-2008	Nardini, Marko/0000-0001-6614-7775; Garcia, Sara/0000-0001-6254-6015; Petrini, Karin/0000-0001-5354-5600	James S. McDonnell Foundation 21st Century Science Scholar in Understanding Human Cognition Program; NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital; University College London	James S. McDonnell Foundation 21st Century Science Scholar in Understanding Human Cognition Program; NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital; University College London(General Electric)	This work was supported by the James S. McDonnell Foundation 21st Century Science Scholar in Understanding Human Cognition Program, and the NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and University College London.	Alary F, 2009, NEUROPSYCHOLOGIA, V47, P2037, DOI 10.1016/j.neuropsychologia.2009.03.014; Bates SL, 2014, NEUROBIOL AGING, V35, P2761, DOI 10.1016/j.neurobiolaging.2014.04.003; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burgess N, 2008, ANN NY ACAD SCI, V1124, P77, DOI 10.1196/annals.1440.002; Chebat DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126307; Cheng K, 2007, PSYCHOL BULL, V133, P625, DOI 10.1037/0033-2909.133.4.625; Ernst M. O., 2006, HUMAN BODY PERCEPTIO, P105; Foo P, 2005, J EXP PSYCHOL LEARN, V31, P195, DOI 10.1037/0278-7393.31.2.195; Fornos AP, 2012, INVEST OPHTH VIS SCI, V53, P2720, DOI 10.1167/iovs.11-9344; Fortin M, 2008, BRAIN, V131, P2995, DOI 10.1093/brain/awn250; GALLISTEL CR, 1990, COGNITION, V37, P1, DOI 10.1016/0010-0277(90)90016-D; Goldreich D, 2003, J NEUROSCI, V23, P3439; Humayun MS, 2012, OPHTHALMOLOGY, V119, P779, DOI 10.1016/j.ophtha.2011.09.028; Kalia AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072170; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Lewald J, 2013, NEUROPSYCHOLOGIA, V51, P181, DOI 10.1016/j.neuropsychologia.2012.11.017; LOOMIS JM, 1993, J EXP PSYCHOL GEN, V122, P73, DOI 10.1037/0096-3445.122.1.73; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; MITTELSTAEDT ML, 1980, NATURWISSENSCHAFTEN, V67, P566, DOI 10.1007/BF00450672; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Nardini M, 2008, CURR BIOL, V18, P689, DOI 10.1016/j.cub.2008.04.021; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petrini K, 2014, J VISION, V14, P1345, DOI [10.1167/14.10.1345, DOI 10.1167/14.10.1345]; Petrini K, 2014, DEVELOPMENTAL SCI, V17, P376, DOI 10.1111/desc.12127; Proulx MJ, 2014, NEUROSCI BIOBEHAV R, V41, P16, DOI 10.1016/j.neubiorev.2012.11.017; Ptito M, 2008, EXP BRAIN RES, V184, P193, DOI 10.1007/s00221-007-1091-0; Renier LA, 2010, NEURON, V68, P138, DOI 10.1016/j.neuron.2010.09.021; Rousseeuw PJ, 1999, TECHNOMETRICS, V41, P212, DOI 10.2307/1270566; Tcheang L, 2011, P NATL ACAD SCI USA, V108, P1152, DOI 10.1073/pnas.1011843108; Verboven S, 2005, CHEMOMETR INTELL LAB, V75, P127, DOI 10.1016/j.chemolab.2004.06.003; Voss P, 2004, CURR BIOL, V14, P1734, DOI 10.1016/j.cub.2004.09.051; Weaver KE, 2007, J COGNITIVE NEUROSCI, V19, P315, DOI 10.1162/jocn.2007.19.2.315	32	19	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134369	10.1371/journal.pone.0134369	http://dx.doi.org/10.1371/journal.pone.0134369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JT	26225762	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000358837700080
J	McCabe, MS; Cormican, P; Keogh, K; O'Connor, A; O'Hara, E; Palladino, RA; Kenny, DA; Waters, SM				McCabe, Matthew Sean; Cormican, Paul; Keogh, Kate; O'Connor, Aaron; O'Hara, Eoin; Alejandro Palladino, Rafael; Kenny, David Anthony; Waters, Sinead Mary			Illumina MiSeq Phylogenetic Amplicon Sequencing Shows a Large Reduction of an Uncharacterised Succinivibrionaceae and an Increase of the Methanobrevibacter gottschalkii Clade in Feed Restricted Cattle	PLOS ONE			English	Article							VOLATILE FATTY-ACIDS; METHANE EMISSIONS; SP-NOV; RUMEN; PROPIONATE; COMMUNITY; DISCOVERY; DIGESTION; ECOSYSTEM; GENOMES	Periodic feed restriction is used in cattle production to reduce feed costs. When normal feed levels are resumed, cattle catch up to a normal weight by an acceleration of normal growth rate, known as compensatory growth, which is not yet fully understood. Illumina Miseq Phylogenetic marker amplicon sequencing of DNA extracted from rumen contents of 55 bulls showed that restriction of feed (70% concentrate, 30% grass silage) for 125 days, to levels that caused a 60% reduction of growth rate, resulted in a large increase of relative abundance of Methanobrevibacter gottschalkii clade (designated as OTU-M7), and a large reduction of an uncharacterised Succinivibrionaceae species (designated as OTU-S3004). There was a strong negative Spearman correlation (rho = -0.72, P = <1x10(-20)) between relative abundances of OTU-3004 and OTU-M7 in the liquid rumen fraction. There was also a significant increase in acetate:propionate ratio (A:P) in feed restricted animals that showed a negative Spearman correlation (rho = -0.69, P = <1x10(-20)) with the relative abundance of OTU-S3004 in the rumen liquid fraction but not the solid fraction, and a strong positive Spearman correlation with OTU-M7 in the rumen liquid (rho = 0.74, P = <1x10(-20)) and solid (rho = 0.69, P = <1x10(-20)) fractions. Reduced A:P ratios in the rumen are associated with increased feed efficiency and reduced production of methane which has a global warming potential (GWP 100 years) of 28. Succinivibrionaceae growth in the rumen was previously suggested to reduce methane emissions as some members of this family utilise hydrogen, which is also utilised by methanogens for methanogenesis, to generate succinate which is converted to propionate. Relative abundance of OTU-S3004 showed a positive Spearman correlation with propionate (rho = 0.41, P = <0.01) but not acetate in the liquid rumen fraction.	[McCabe, Matthew Sean; Cormican, Paul; Keogh, Kate; O'Hara, Eoin; Kenny, David Anthony; Waters, Sinead Mary] Anim & Grassland Res & Innovat Ctr, Anim & Biosci Res Dept, Dunsany, County Meath, Ireland; [O'Connor, Aaron] Univ Coll Dublin, Coll Life Sci, UCD Sch Agr Food Sci & Vet Med, Dublin 2, Ireland; [Alejandro Palladino, Rafael] Univ Buenos Aires, Dept Anim Prod, Buenos Aires, DF, Argentina	Teagasc; University College Dublin; University of Buenos Aires	McCabe, MS (corresponding author), Anim & Grassland Res & Innovat Ctr, Anim & Biosci Res Dept, Dunsany, County Meath, Ireland.	matthew.mccabe@teagasc.ie	Keogh, Kate/AAY-2455-2020; Kenny, David/B-1653-2013	Keogh, Kate/0000-0001-8338-5177; Kenny, David/0000-0001-9204-098X	Science Foundation Ireland [SFI 09/RFP/GEN2447]; Teagasc Walsh Fellowship Funding (Teagasc project) [RMIS 6341]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Teagasc Walsh Fellowship Funding (Teagasc project)	This study was supported by the Science Foundation Ireland (http://www.sfi.ie) (Contract number SFI 09/RFP/GEN2447-awarded to SMW) and Teagasc Walsh Fellowship Funding (www.teagasc.ie) (Teagasc project RMIS 6341-awarded to SMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MIN 17 STAT SOFTW; [Anonymous], 2015, PLOS ONE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; BLACKBURN TH, 1963, APPL MICROBIOL, V11, P132, DOI 10.1128/AEM.11.2.132-135.1963; BLAXTER KL, 1965, BRIT J NUTR, V19, P511, DOI 10.1079/BJN19650046; Borrel G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-679; BROTZ PG, 1987, J MICROBIOL METH, V6, P139, DOI 10.1016/0167-7012(87)90009-1; CALDWELL DR, 1966, APPL MICROBIOL, V14, P794, DOI 10.1128/AEM.14.5.794-801.1966; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Christophersen CT, 2008, J ANIM SCI, V86, P384, DOI 10.2527/jas.2007-0373; Creevey CJ, 2014, MICROB BIOTECHNOL, V7, P467, DOI 10.1111/1751-7915.12141; Czerkawski J. W., 1986, INTRO RUMEN STUDIES; Del Pozo MV, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-73; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DINIUS DA, 1976, J ANIM SCI, V42, P229, DOI 10.2527/jas1976.421229x; Dworkin M, 2006, PROKARYOTES, V3, P419; Evans JD, 1997, APPL ENVIRON MICROB, V63, P4853, DOI 10.1128/AEM.63.12.4853-4858.1997; Flint HJ, 1997, TRENDS MICROBIOL, V5, P483, DOI 10.1016/S0966-842X(97)01159-1; GALYEAN ML, 1991, PHYSIOLOGICAL ASPECTS OF DIGESTION AND METABOLISM IN RUMINANTS, P483; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hippe H, 1999, INT J SYST BACTERIOL, V49, P779, DOI 10.1099/00207713-49-2-779; Hogg BW, 1991, GROWTH REGULATION FA; HUNGATE RE, 1966, RUMEN ITS MICROBES; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Janssen PH, 2010, ANIM FEED SCI TECH, V160, P1, DOI 10.1016/j.anifeedsci.2010.07.002; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; Keogh K, 2014, P WORLD C GEN APPL L; Keogh K, 2014, EFFECT FEED RESTRICT, P89; Keogh K, 2012, P AGR RES FOR TULL, P44; Kim M, 2011, FOLIA MICROBIOL, V56, P453, DOI 10.1007/s12223-011-0066-5; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; LEAHY SC, 2010, PLOS ONE, V5; Lee PC, 1999, ENZYME MICROB TECH, V24, P549, DOI 10.1016/S0141-0229(98)00156-2; Li MJ, 2012, VET MICROBIOL, V155, P72, DOI 10.1016/j.vetmic.2011.08.007; MEISKE JC, 1958, J ANIM SCI, V17, P774, DOI 10.2527/jas1958.173774x; Michalet-Doreau B, 2001, ANIM RES, V50, P451, DOI 10.1051/animres:2001107; O'Shea E, 2014, P AGR RES FOR TULL, P148; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Pope PB, 2011, SCIENCE, V333, P646, DOI 10.1126/science.1205760; Poulsen M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2432; R Core Team, 2012, R LANG ENV STAT COMP; Rea S, 2007, INT J SYST EVOL MICR, V57, P450, DOI 10.1099/ijs.0.63984-0; Reeve JN, 1997, J BACTERIOL, V179, P5975, DOI 10.1128/jb.179.19.5975-5986.1997; Reti KL, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-8; RUSSELL JB, 1981, J DAIRY SCI, V64, P1153, DOI 10.3168/jds.S0022-0302(81)82694-X; SCHEIFINGER CC, 1973, APPL MICROBIOL, V26, P789, DOI 10.1128/AEM.26.5.789-795.1973; Shi WB, 2014, GENOME RES, V24, P1517, DOI 10.1101/gr.168245.113; VANGYLSWYK NO, 1995, INT J SYST BACTERIOL, V45, P297, DOI 10.1099/00207713-45-2-297; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WARNER ACI, 1962, J GEN MICROBIOL, V28, P129, DOI 10.1099/00221287-28-1-129; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhang S, 2013, J ANIM SCI, V91, P1696, DOI 10.2527/jas.2012-5774	56	57	60	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133234	10.1371/journal.pone.0133234	http://dx.doi.org/10.1371/journal.pone.0133234			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226343	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700015
J	Boumans, MLLM; Krings, M; Wagner, H				Boumans, Mark L. L. M.; Krings, Markus; Wagner, Hermann			Muscular Arrangement and Muscle Attachment Sites in the Cervical Region of the American Barn Owl (Tyto furcata pratincola)	PLOS ONE			English	Article							ANTERIOR PRESACRAL REGION; SPLENIUS-CAPITIS; HEAD MOVEMENTS; NECK; ANATOMY; COLUMN; MORPHOLOGY; HOMOLOGIES; DIAPSIDA; BEHAVIOR	Owls have the largest head rotation capability amongst vertebrates. Anatomical knowledge of the cervical region is needed to understand the mechanics of these extreme head movements. While data on the morphology of the cervical vertebrae of the barn owl have been provided, this study is aimed to provide an extensive description of the muscle arrangement and the attachment sites of the muscles on the owl's head-neck region. The major cervical muscles were identified by gross dissection of cadavers of the American barn owl (Tyto furcata pratincola), and their origin, courses, and insertion were traced. In the head-neck region nine superficial larger cervical muscles of the craniocervical, dorsal and ventral subsystems were selected for analysis, and the muscle attachment sites were illustrated in digital models of the skull and cervical vertebrae of the same species as well as visualised in a two-dimensional sketch. In addition, fibre orientation and lengths of the muscles and the nature (fleshy or tendinous) of the attachment sites were determined. Myological data from this study were combined with osteological data of the same species. This improved the anatomical description of the cervical region of this species. The myological description provided in this study is to our best knowledge the most detailed documentation of the cervical muscles in a strigiform species presented so far. Our results show useful information for researchers in the field of functional anatomy, biomechanical modelling and for evolutionary and comparative studies.	[Boumans, Mark L. L. M.; Krings, Markus; Wagner, Hermann] Rhein Westfal TH Aachen, Inst Zool, Aachen, Germany	RWTH Aachen University	Wagner, H (corresponding author), Rhein Westfal TH Aachen, Inst Zool, Aachen, Germany.	wagner@bio2.rwth-aachen.de			RWTH Aachen University	RWTH Aachen University	The research was funded by RWTH Aachen University.	BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; Baumel J.J, 1993, HDB AVIAN ANATOMY NO; Boas J.E.V., 1929, K DANSK VIDENSK SELS, V9, P101; BOCK W J, 1972, Anatomischer Anzeiger, V130, P222; Bout RG, 1997, J MORPHOL, V231, P287, DOI 10.1002/(SICI)1097-4687(199703)231:3<287::AID-JMOR7>3.0.CO;2-8; Brause C, 2009, IBIS, V151, P633, DOI 10.1111/j.1474-919X.2009.00947.x; Burk C.M., 1893, MYOLOGY PIGEON COLUM; BURTON P J K, 1974, Bulletin of the British Museum (Natural History) Zoology, V27, P1; BURTON PJK, 1971, IBIS, V113, P19, DOI 10.1111/j.1474-919X.1971.tb05120.x; Cobley MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072187; de Kok-Mercado F, 2013, SCIENCE, V339, P514; Desselberger H, 1930, J F ORNITHOL, P86; DULAC S, 1990, J NEUROPHYSIOL, V63, P131, DOI 10.1152/jn.1990.63.1.131; Dzemski G, 2007, J MORPHOL, V268, P701, DOI 10.1002/jmor.10542; Faulwetter S, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.263.4261; Fisher HI, 1955, MYOLOGY WHOOPING CRA; FRITSCH E, 1988, IBIS, V130, P124, DOI 10.1111/j.1474-919X.1988.tb00962.x; GANS C, 1991, J BIOMECH, V24, P53, DOI 10.1016/0021-9290(91)90377-Y; Ghetie VCS., 1976, ANATOMICAL ATLAS DOM; HOYTE DAN, 1966, AM J PHYS ANTHROPOL, V24, P205, DOI 10.1002/ajpa.1330240209; JENNI L, 1981, Journal fuer Ornithologie, V122, P37, DOI 10.1007/BF01643442; Kaupp BF, 1918, ANATOMY DOMESTIC FOW; Krings M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091653; KURODA NAGAHISA, 1962, MISC REPTS YAMASHINA S INST ORNITHOL AND ZOOL, V3, P189; LANDOLT R, 1985, NETH J ZOOL, V35, P611; Lautenschlager S, 2014, J ANAT, V224, P412, DOI 10.1111/joa.12153; MASINO T, 1993, J NEUROSCI, V13, P351; MASINO T, 1990, NATURE, V345, P434, DOI 10.1038/345434a0; Ohayon S, 2006, J COMP PHYSIOL A, V192, P927, DOI 10.1007/s00359-006-0130-9; Palmgren P, 1949, ORNITHOLOGIE ALS BIO, P192; Proctor NS, 1993, MANUAL ORNITHOLOGY; Shufeldt R.W., 1890, MYOLOGY RAVEN CORVUS; Snively E, 2014, J ZOOL, V292, P290, DOI 10.1111/jzo.12109; Snively E, 2007, ZOOL J LINN SOC-LOND, V151, P759, DOI 10.1111/j.1096-3642.2007.00334.x; STEINBACH MJ, 1973, VISION RES, V13, P889, DOI 10.1016/0042-6989(73)90055-2; Taylor MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078214; Taylor MP, 2013, PEERJ, V1, DOI 10.7717/peerj.36; Tsuihiji T, 2005, J MORPHOL, V263, P151, DOI 10.1002/jmor.10294; Tsuihiji T, 2007, J MORPHOL, V268, P986, DOI 10.1002/jmor.10565; Van der Leeuw AHJ, 2001, NETH J ZOOL, V51, P243, DOI 10.1163/156854201750385172; VIDAL PP, 1986, EXP BRAIN RES, V61, P549; Virchow H, 1926, UEBER BEWEGUNGSMOGLI, P38; Wedel Mathew J., 2002, Paleobios, V22, P1; ZUSI R L, 1985, Records of the Australian Museum, V37, P229; ZUSI R L, 1984, Smithsonian Contributions to Zoology, P1; Zusi R.L., 1969, OSTEOLOGY MYOLOGY HE; Zusi RL., 1962, STRUCTURAL ADAPTATIO; Zweers G., 1994, P201; ZWEERS GA, 1987, ACTA MORPHOL NEER SC, V25, P131	49	6	7	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134272	10.1371/journal.pone.0134272	http://dx.doi.org/10.1371/journal.pone.0134272			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222908	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800120
J	Hamers, AAJ; van Dam, L; Duarte, JMT; Vos, M; Marinkovic, G; van Tiel, CM; Meijer, SL; van Stalborch, AM; Huveneers, S; Velde, AAT; de Jonge, WJ; de Vries, CJM				Hamers, Anouk A. J.; van Dam, Laura; Duarte, Jose M. Teixeira; Vos, Mariska; Marinkovic, Goran; van Tiel, Claudia M.; Meijer, Sybren L.; van Stalborch, Anne-Marieke; Huveneers, Stephan; Velde, Anje A. te; de Jonge, Wouter J.; de Vries, Carlie J. M.			Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFkB Activity in Macrophages	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ESTABLISHED EXPERIMENTAL COLITIS; INTESTINAL EPITHELIAL-CELLS; REGULATORY T-CELLS; FACTOR-KAPPA-B; CROHNS-DISEASE; ULCERATIVE-COLITIS; ORPHAN RECEPTOR; TRANSGENIC MICE; GENE-EXPRESSION	Nuclear receptor Nur77, also referred to as NR4A1 or TR3, plays an important role in innate and adaptive immunity. Nur77 is crucial in regulating the T helper 1/regulatory T-cell balance, is expressed in macrophages and drives M2 macrophage polarization. In this study we aimed to define the function of Nur77 in inflammatory bowel disease. In wild-type and Nur77(-/-) mice, colitis development was studied in dextran sodium sulphate (DSS)- and 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced models. To understand the underlying mechanism, Nur77 was overexpressed in macrophages and gut epithelial cells. Nur77 protein is expressed in colon tissues from Crohn's disease and Ulcerative colitis patients and colons from colitic mice in inflammatory cells and epithelium. In both mouse colitis models inflammation was increased in Nur77(-/-) mice. A higher neutrophil influx and enhanced IL-6, MCP-1 and KC production was observed in Nur77-deficient colons after DSS-treatment. TNBS-induced influx of T-cells and inflammatory monocytes into the colon was higher in Nur77(-/-) mice, along with increased expression of MCP-1, TNF alpha and IL-6, and decreased Foxp3 RNA expression, compared to wild-type mice. Overexpression of Nur77 in lipopolysaccharide activated RAW macrophages resulted in up-regulated IL-10 and downregulated TNF alpha, MIF-1 and MCP-1 mRNA expression through NFkB repression. Nur77 also strongly decreased expression of MCP-1, CXCL1, IL-8, MIP-1 alpha and TNFa in gut epithelial Caco-2 cells. Nur77 overexpression suppresses the inflammatory status of both macrophages and gut epithelial cells and together with the in vivo mouse data this supports that Nur77 has a protective function in experimental colitis. These findings may have implications for development of novel targeted treatment strategies regarding inflammatory bowel disease and other inflammatory diseases.	[Hamers, Anouk A. J.; van Dam, Laura; Vos, Mariska; Marinkovic, Goran; van Tiel, Claudia M.; de Vries, Carlie J. M.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Duarte, Jose M. Teixeira; Velde, Anje A. te; de Jonge, Wouter J.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst, NL-1105 AZ Amsterdam, Netherlands; [Meijer, Sybren L.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [van Stalborch, Anne-Marieke; Huveneers, Stephan] Univ Amsterdam, Dept Mol Cell Biol, Sanquin Res, NL-1105 AZ Amsterdam, Netherlands; [van Stalborch, Anne-Marieke; Huveneers, Stephan] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; University of Amsterdam	de Vries, CJM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.j.devries@amc.uva.nl	Marinkovic, Goran/ABC-6786-2020; Duarte, José Maurício Barbanti/AAG-5149-2019	Duarte, José Maurício Barbanti/0000-0002-7805-0265; Meijer, Sybren/0000-0002-6953-2406; Marinkovic, Goran/0000-0002-3581-9900; Huveneers, Stephan/0000-0002-1091-475X; van Dam, Laura/0000-0001-6373-7673	Netherlands Heart Foundation, The Hague [2008B037]; VIDI [91796310]; GlaxoSmithKline corporation; VENI [863.10.003]	Netherlands Heart Foundation, The Hague(Netherlands Heart Foundation); VIDI(Netherlands Organization for Scientific Research (NWO)); GlaxoSmithKline corporation(GlaxoSmithKline); VENI(Netherlands Organization for Scientific Research (NWO))	This study was supported by the Netherlands Heart Foundation, The Hague; grant #2008B037 (https://www.hartstichting.nl/wetenschappers/subsidiewijzer). Wouter de Jonge was supported by a VIDI grant 91796310, and receives financial support from GlaxoSmithKline corporation (http://www.nwo.nl/financiering/onze-financieringsinstrumenten/nwo/vernieuwingsimpuls/vidi/index.html) (http://www.gsk.com/). Stephan Huveneers was supported by a VENI grant #863.10.003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Alzoghaibi Mohammed Abdullah, 2005, Saudi J Gastroenterol, V11, P63; Arkenbout EK, 2002, CIRCULATION, V106, P1530, DOI 10.1161/01.CIR.0000028811.03056.BF; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P1559, DOI 10.1111/j.1572-0241.2006.00603.x; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Burisch J, 2013, J CROHNS COLITIS, V7, P322, DOI 10.1016/j.crohns.2013.01.010; Camoglio L, 1998, INFLAMM BOWEL DIS, V4, P285, DOI 10.1002/ibd.3780040406; Camoglio L, 2000, EUR J IMMUNOL, V30, P1486, DOI 10.1002/(SICI)1521-4141(200005)30:5<1486::AID-IMMU1486>3.0.CO;2-8; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Chen HZ, 2012, GUT, V61, P714, DOI 10.1136/gutjnl-2011-300783; Clayburgh DR, 2004, LAB INVEST, V84, P282, DOI 10.1038/labinvest.3700050; COOPER HS, 1993, LAB INVEST, V69, P238; Daig R, 1996, GUT, V38, P216, DOI 10.1136/gut.38.2.216; Dassopoulos T, 2013, GASTROENTEROLOGY, V145, P1464, DOI 10.1053/j.gastro.2013.10.046; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Diatchenko L, 2005, J LEUKOCYTE BIOL, V78, P1366, DOI 10.1189/jlb.0405211; Edens HA, 2002, J IMMUNOL, V169, P476, DOI 10.4049/jimmunol.169.1.476; Fassett MS, 2012, P NATL ACAD SCI USA, V109, P3891, DOI 10.1073/pnas.1200090109; Foell D, 2008, J PATHOL, V216, P183, DOI 10.1002/path.2394; Goddard LM, 2014, CELL, V156, P549, DOI 10.1016/j.cell.2013.12.025; Groeneweg M, 2006, J LIPID RES, V47, P2259, DOI 10.1194/jlr.M600181-JLR200; Hamers AAJ, 2014, INFECT IMMUN, V82, P253, DOI 10.1128/IAI.00721-13; Hamers AAJ, 2012, CIRC RES, V110, P428, DOI 10.1161/CIRCRESAHA.111.260760; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hansen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081491; Harant H, 2004, NUCLEIC ACIDS RES, V32, P5280, DOI 10.1093/nar/gkh856; He X, 2013, SCI REP-UK, V3, DOI 10.1038/srep03416; Henderson P, 2011, INFLAMM BOWEL DIS, V17, P382, DOI 10.1002/ibd.21379; Hilgendorf I, 2014, CIRC RES, V114, P1611, DOI 10.1161/CIRCRESAHA.114.303204; ISHIOKA T, 1987, CRIT REV TOXICOL, V17, P215, DOI 10.3109/10408448709071209; Kim P, 2010, NAT METHODS, V7, P303, DOI [10.1038/NMETH.1440, 10.1038/nmeth.1440]; Kucharzik T, 2005, GUT, V54, P1565, DOI 10.1136/gut.2004.061168; KUMAR NB, 1982, AM J SURG PATHOL, V6, P523, DOI 10.1097/00000478-198209000-00004; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Loftus CG, 2007, INFLAMM BOWEL DIS, V13, P254, DOI 10.1002/ibd.20029; Lundin A, 2008, CELL MICROBIOL, V10, P1093, DOI 10.1111/j.1462-5822.2007.01108.x; MacDonald TT, 2012, DIGEST DIS, V30, P392, DOI 10.1159/000338136; MACDONALD TT, 1990, CLIN EXP IMMUNOL, V81, P301; Marinkovic G, 2014, INFLAMM BOWEL DIS, V20, P1487, DOI 10.1097/MIB.0000000000000122; Marsal J, 2012, J INTERN MED, V272, P411, DOI 10.1111/j.1365-2796.2012.02588.x; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Monteleone G, 2004, J BIOL CHEM, V279, P3925, DOI 10.1074/jbc.M303654200; Muzes G, 2012, WORLD J GASTROENTERO, V18, P5688, DOI 10.3748/wjg.v18.i40.5688; Natoli M, 2012, TOXICOL IN VITRO, V26, P1243, DOI 10.1016/j.tiv.2012.03.009; Neurath M, 2000, Int Rev Immunol, V19, P51, DOI 10.3109/08830180009048389; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Nikolaus S, 1998, GUT, V42, P470, DOI 10.1136/gut.42.4.470; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pei LM, 2006, MOL ENDOCRINOL, V20, P786, DOI 10.1210/me.2005-0331; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Pols TWH, 2007, CURR OPIN LIPIDOL, V18, P515, DOI 10.1097/MOL.0b013e3282ef77d1; Pols TWH, 2010, ARTERIOSCL THROM VAS, V30, P1591, DOI 10.1161/ATVBAHA.110.205674; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Roulis M, 2011, P NATL ACAD SCI USA, V108, P5396, DOI 10.1073/pnas.1007811108; Scharl M, 2012, CURR OPIN GASTROEN, V28, P301, DOI 10.1097/MOG.0b013e328353e61e; Sekiya T, 2013, NAT IMMUNOL, V14, P230, DOI 10.1038/ni.2520; Sekiya T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1272; Shao Q, 2010, J MOL CELL CARDIOL, V49, P304, DOI 10.1016/j.yjmcc.2010.03.023; Soderholm JD, 1999, GUT, V44, P96, DOI 10.1136/gut.44.1.96; Stuber E, 1996, J EXP MED, V183, P693, DOI 10.1084/jem.183.2.693; Varga T, 2013, J IMMUNOL, V191, P5695, DOI 10.4049/jimmunol.1301445; Velde AAT, 2006, INFLAMM BOWEL DIS, V12, P995, DOI 10.1097/01.mib.0000227817.54969.5e; Verstege MI, 2008, J HISTOCHEM CYTOCHEM, V56, P233, DOI 10.1369/jhc.7A7308.2007; Wang Y, 2011, J DIGEST DIS, V12, P286, DOI 10.1111/j.1751-2980.2011.00505.x; Wansa KDSA, 2003, J BIOL CHEM, V278, P24776, DOI 10.1074/jbc.M300088200; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; You B, 2009, CIRC RES, V104, P742, DOI 10.1161/CIRCRESAHA.108.192286; Yu CH, 2014, EUR J PHARMACOL, V741, P90, DOI 10.1016/j.ejphar.2014.07.039; Zhao DZ, 2011, P NATL ACAD SCI USA, V108, P12066, DOI 10.1073/pnas.1018438108; Zheng J, 2008, INFECT IMMUN, V76, P4498, DOI 10.1128/IAI.01317-07; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	79	42	43	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133598	10.1371/journal.pone.0133598	http://dx.doi.org/10.1371/journal.pone.0133598			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241646	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700017
J	Saravia, G; Civeira, F; Hurtado-Roca, Y; Andres, E; Leon, M; Pocovi, M; Ordovas, J; Guallar, E; Fernandez-Ortiz, A; Casasnovas, JA; Laclaustra, M				Saravia, Gabriela; Civeira, Fernando; Hurtado-Roca, Yamilee; Andres, Eva; Leon, Montserrat; Pocovi, Miguel; Ordovas, Jose; Guallar, Eliseo; Fernandez-Ortiz, Antonio; Antonio Casasnovas, Jose; Laclaustra, Martin			Glycated Hemoglobin, Fasting Insulin and the Metabolic Syndrome in Males. Cross-Sectional Analyses of the Aragon Workers' Health Study Baseline	PLOS ONE			English	Article							CARDIOVASCULAR RISK; DIABETES-MELLITUS; HYPERINSULINEMIA; ASSOCIATION; RESISTANCE; GLUCOSE; A1C; SENSITIVITY; DEFINITION; CRITERION	Background and Aims Glycated hemoglobin (HbA1c) is currently used to diagnose diabetes mellitus, while insulin has been relegated to research. Both, however, may help understanding the metabolic syndrome and profiling patients. We examined the association of HbA1c and fasting insulin with clustering of metabolic syndrome criteria and insulin resistance as two essential characteristics of the metabolic syndrome. Methods We used baseline data from 3200 non-diabetic male participants in the Aragon Workers' Health Study. We conducted analysis to estimate age-adjusted odds ratios (ORs) across tertiles of HbA1c and insulin. Fasting glucose and Homeostatic model assessment - Insulin Resistance were used as reference. Here we report the uppermost-to-lowest tertile ORs (95% CI). Results Mean age (SD) was 48.5 (8.8) years and 23% of participants had metabolic syndrome. The ORs for metabolic syndrome criteria tended to be higher across HbA1c than across glucose, except for high blood pressure. Insulin was associated with the criteria more strongly than HbA1c and similarly to Homeostatic model assessment - Insulin Resistance (HOMA-IR). For metabolic syndrome, the OR of HbA1c was 2.68, of insulin, 11.36, of glucose, 7.03, and of HOMA-IR, 14.40. For the clustering of 2 or more non-glycemic criteria, the OR of HbA1c was 2.10, of insulin, 8.94, of glucose, 1.73, and of HOMA-IR, 7.83. All ORs were statistically significant. The areas under the receiver operating characteristics curves for metabolic syndrome were 0.670 (across HbA1c values) and 0.770 (across insulin values), and, for insulin resistance, 0.647 (HbA1c) and 0.995 (insulin). Among non-metabolic syndrome patients, a small insulin elevation identified risk factor clustering. Conclusions HbA1c and specially insulin levels were associated with metabolic syndrome criteria, their clustering, and insulin resistance. Insulin could provide early information in subjects prone to develop metabolic syndrome.	[Saravia, Gabriela; Hurtado-Roca, Yamilee; Ordovas, Jose; Fernandez-Ortiz, Antonio; Laclaustra, Martin] Spanish Natl Ctr Cardiovasc Res CNIC, Dept Epidemi Atherothrombosis & Imaging, Madrid, Spain; [Civeira, Fernando; Leon, Montserrat; Pocovi, Miguel; Antonio Casasnovas, Jose] Inst Aragones Ciencias Salud I CS, Zaragoza, Spain; [Hurtado-Roca, Yamilee] Boca Raton Clin Res Global Peru, Lima, Peru; [Andres, Eva] CIBER Epidemiol Salud Publ, Inst Invest Octubre 12, Madrid, Spain; [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Med, Baltimore, MD USA; [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Fernandez-Ortiz, Antonio] Univ Complutense, Hosp Clin San Carlos, E-28040 Madrid, Spain; [Laclaustra, Martin] Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, Sch Med, Madrid, Spain; [Laclaustra, Martin] St Louis Univ, Dept Epidemiol, St Louis, MO 63103 USA	Centro Nacional de Investigaciones Cardiovasculares (CNIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Complutense University of Madrid; Hospital Clinico San Carlos; Autonomous University of Madrid; Saint Louis University	Laclaustra, M (corresponding author), Spanish Natl Ctr Cardiovasc Res CNIC, Dept Epidemi Atherothrombosis & Imaging, Madrid, Spain.	mlaclaustra@cnic.es	Fernandez-Ortiz, Antonio/B-2227-2017; Lenguas, José Antonio Casasnovas/F-4038-2010; Laclaustra, Martín/C-6709-2015	Fernandez-Ortiz, Antonio/0000-0002-3239-1910; Lenguas, José Antonio Casasnovas/0000-0002-9887-2629; Laclaustra, Martín/0000-0003-3963-0846; HURTADO-ROCA, YAMILEE/0000-0003-1993-6223	Instituto de Salud Carlos III [FIS CP08/00112]; Peruvian government [088-FINCyT-BDE-2014]; Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III [PI14/00009, PI12/01087, PI12/01703, PI10/00021]; Fondo Europeo de Desarrollo Regional; RETIC RIC from Instituto de Salud Carlos III [RD12/0042/0055]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Peruvian government; Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional(European Commission); RETIC RIC from Instituto de Salud Carlos III(Instituto de Salud Carlos III)	M. Laclaustra was supported in part by grant FIS CP08/00112 from Instituto de Salud Carlos III. Y. Hurtado-Roca was supported by Scholarship No 088-FINCyT-BDE-2014 from Peruvian government. This study was supported in part by grants PI14/00009, PI12/01087, PI12/01703, PI10/00021 (Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III), co-funding by Fondo Europeo de Desarrollo Regional (FEDER 2007-2013), and RETIC RIC RD12/0042/0055 from Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Fabiola M S, 2006, Acta Med Indones, V38, P179; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Antuna-Puente B, 2011, DIABETES METAB, V37, P179, DOI 10.1016/j.diabet.2011.01.002; Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; Burchfiel CM, 1996, ANN EPIDEMIOL, V6, P490, DOI 10.1016/S1047-2797(96)00103-2; Casasnovas JA, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-45; de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Dilley J, 2007, DIABETES CARE, V30, P1527, DOI 10.2337/dc06-2414; FERRANNINI E, 1991, DIABETOLOGIA, V34, P416, DOI 10.1007/BF00403180; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Howard G, 1998, ANN EPIDEMIOL, V8, P358, DOI 10.1016/S1047-2797(98)00002-7; Janghorbani M, 2012, DIABETES METAB SYND, V6, P136, DOI 10.1016/j.dsx.2012.09.011; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Kawada T, 2012, J OCCUP ENVIRON MED, V54, P984, DOI 10.1097/JOM.0b013e31825335ae; Kim HK, 2012, DIABETES RES CLIN PR, V95, P333, DOI 10.1016/j.diabres.2011.10.012; Kim SH, 2011, DIABETIC MED, V28, P1487, DOI 10.1111/j.1464-5491.2011.03409.x; LAAKSO M, 1993, AM J EPIDEMIOL, V137, P959, DOI 10.1093/oxfordjournals.aje.a116768; Laclaustra M, 2007, NUTR METAB CARDIOVAS, V17, P125, DOI [10.1016/j.numecd.2006.10.005, 10.1038/ki.2008.517]; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ong KL, 2010, DIABETES CARE, V33, P1856, DOI 10.2337/dc10-0190; Park SH, 2012, J KOREAN MED SCI, V27, P1057, DOI 10.3346/jkms.2012.27.9.1057; R Core Team, 2021, R LANGUAGE ENV STAT; Rutter MK, 2008, CIRCULATION, V117, P1003, DOI 10.1161/CIRCULATIONAHA.107.727727; Sacks DB, 2012, DIABETES CARE, V35, P2674, DOI 10.2337/dc12-1348; Sacks David B, 2011, Diabetes Care, V34, pe61, DOI 10.2337/dc11-9998; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Staten MA, 2010, DIABETES CARE, V33, P205, DOI 10.2337/dc09-1206; Succurro E, 2011, AM J CARDIOL, V107, P1650, DOI 10.1016/j.amjcard.2011.01.055; Sung KC, 2007, DIABETIC MED, V24, P848, DOI 10.1111/j.1464-5491.2007.02146.x; Turchiano M, 2012, ARCH PEDIAT ADOL MED, V166, P1030, DOI 10.1001/archpediatrics.2012.1263; Voidonikola PT, 2008, OBESITY, V16, P2658, DOI 10.1038/oby.2008.431; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068	34	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0132244	10.1371/journal.pone.0132244	http://dx.doi.org/10.1371/journal.pone.0132244			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241903	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700004
J	Chen, SC; Chen, CF; Huang, JC; Lee, MY; Chen, JH; Chang, JM; Hwang, SJ; Chen, HC				Chen, Szu-Chia; Chen, Chien-Fu; Huang, Jiun-Chi; Lee, Mei-Yueh; Chen, Jui-Hsin; Chang, Jer-Ming; Hwang, Shang-Jyh; Chen, Hung-Chun			Link between Peripheral Artery Disease and Heart Rate Variability in Hemodialysis Patients	PLOS ONE			English	Article							ANKLE-BRACHIAL INDEX; STAGE RENAL-DISEASE; BLOOD-PRESSURE INDEX; SPECTRAL-ANALYSIS; ARTERIOVENOUS-FISTULA; ENDOTHELIAL FUNCTION; DIABETIC-PATIENTS; RISK; MORTALITY; FAILURE	Peripheral artery disease (PAD) and low heart rate variability (HRV) are highly prevalent in hemodialysis patients, and both are associated with increased cardiovascular morbidity and mortality. This study aims to examine the suggested relationship between PAD and HRV, and the relationship of parameters before and after hemodialysis. This study enrolled 161 maintenance hemodialysis patients. PAD was defined as ABI < 0.9 in either leg. HRV was performed to assess changes before and after hemodialysis. The change in HRV (Delta HRV) was defined as post-hemodialysis HRV minus pre-hemodialysis HRV. Patients' clinical parameters were collected from the dialysis records. All HRV parameters except high frequency (HF) % were lower in patients with PAD than patients without PAD, though not achieving significant level. In patients without PAD, HF (P = 0.013), low frequency (LF) % (P = 0.028) and LF/HF (P = 0.034) were significantly elevated after hemodialysis, whereas no significant HRV parameters change was noted in patients with PAD. Serum intact parathyroid hormone was independently associated with Delta HF (beta = -0.970, P = 0.032) and Delta LF% (beta = -12.609, P = 0.049). Uric acid level (beta = -0.154, P = 0.027) was negatively associated with Delta LF/HF in patients without PAD. Our results demonstrated that some of the HRV parameters were significantly increased after hemodialysis in patients without PAD, but not in patients with PAD, reflecting a state of impaired sympatho-vagal equilibrium. Severity of secondary hyperparathyroidism and hyperuricemia contributed to lesser HRV parameters increase after hemodialysis in patients without PAD.	[Chen, Szu-Chia; Huang, Jiun-Chi; Chang, Jer-Ming; Hwang, Shang-Jyh; Chen, Hung-Chun] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Nephrol, Kaohsiung, Taiwan; [Chen, Chien-Fu] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Neurol, Kaohsiung, Taiwan; [Lee, Mei-Yueh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Endocrinol & Metab, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Szu-Chia] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Chen, Szu-Chia; Huang, Jiun-Chi; Lee, Mei-Yueh; Chang, Jer-Ming] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Jui-Hsin] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Nursing, Kaohsiung, Taiwan; [Chen, Szu-Chia; Chang, Jer-Ming; Hwang, Shang-Jyh; Chen, Hung-Chun] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University	Chang, JM (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Nephrol, Kaohsiung, Taiwan.	jemich@kmu.edu.tw	蘇, 河名/AAE-9843-2019; Huang, Jiun-Chi/AAI-2494-2021	Huang, Jiun-Chi/0000-0002-5897-2860	Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung [kmhk-103-001]	Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung	The research presented in this article is supported by the grant from Kaohsiung Municipal Hsiao-Kang Hospital (kmhk-103-001), Kaohsiung Medical University, Kaohsiung, and the statistical work by the Department of Research Education and Training at Kaohsiung Municipal Hsiao-Kang Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso Y, 1998, DIABETES CARE, V21, P1173, DOI 10.2337/diacare.21.7.1173; Barnas MGW, 1999, J AM SOC NEPHROL, V10, P2577; BERGER RD, 1989, AM J PHYSIOL, V256, pH142, DOI 10.1152/ajpheart.1989.256.1.H142; Boaz M, 2005, CLIN NEPHROL, V63, P98; Brown MD, 2005, MICROCIRCULATION, V12, P373, DOI 10.1080/10739680590934817; Bruno RM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00284; Camm AJ, 1996, CIRCULATION, V93, P1043; Canani LH, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-54; Chen CJ, 2009, CLIN NEUROPHYSIOL, V120, P348, DOI 10.1016/j.clinph.2008.10.155; Chen SC, 2009, CLIN NEPHROL, V72, P501; Chen SC, 2010, NEPHROLOGY, V15, P294, DOI 10.1111/j.1440-1797.2010.01187.x; Chen SC, 2009, CLIN J AM SOC NEPHRO, V4, P128, DOI 10.2215/CJN.03080608; Daugirdas JT, 2001, AM J KIDNEY DIS, V38, pS11, DOI 10.1053/ajkd.2001.28090; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Dietrich DF, 2006, EUROPACE, V8, P521, DOI 10.1093/europace/eul063; Doehner W, 2002, CIRCULATION, V105, P2619, DOI 10.1161/01.CIR.0000017502.58595.ED; Dumaine RL, 2009, AM HEART J, V158, P141, DOI 10.1016/j.ahj.2009.05.011; Eggers PW, 1999, KIDNEY INT, V56, P1524, DOI 10.1046/j.1523-1755.1999.00668.x; Fishbane S, 1996, AM J KIDNEY DIS, V27, P668, DOI 10.1016/S0272-6386(96)90101-8; FOUAD FM, 1984, AM J PHYSIOL, V246, pH838, DOI 10.1152/ajpheart.1984.246.6.H838; Fukuta H, 2003, NEPHROL DIAL TRANSPL, V18, P318, DOI 10.1093/ndt/18.2.318; Goernig M, 2008, PACE, V31, P858, DOI 10.1111/j.1540-8159.2008.01100.x; Gotch FA, 2001, SEMIN DIALYSIS, V14, P252, DOI 10.1046/j.1525-139X.2001.00064.x; Grandaliano G, 2003, KIDNEY INT, V64, P715, DOI 10.1046/j.1523-1755.2003.00120.x; Grandi NC, 2011, HEART, V97, P1215, DOI 10.1136/hrt.2011.223529; Guerin AP, 2000, NEPHROL DIAL TRANSPL, V15, P1014, DOI 10.1093/ndt/15.7.1014; Johnson RJ, 2005, HYPERTENSION, V45, P18, DOI 10.1161/01.HYP.0000150785.39055.e8; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; KLEIGER RE, 1991, AM J CARDIOL, V68, P626, DOI 10.1016/0002-9149(91)90355-O; KUO TBJ, 1993, AM J PHYSIOL, V264, pH2208, DOI 10.1152/ajpheart.1993.264.6.H2208; Kuo TBJ, 1999, AM J PHYSIOL-HEART C, V277, pH2233, DOI 10.1152/ajpheart.1999.277.6.H2233; Li X, 2011, CLIN AUTON RES, V21, P143, DOI 10.1007/s10286-010-0112-4; Liu CC, 2003, AM J PHYSIOL-HEART C, V285, pH2188, DOI 10.1152/ajpheart.00256.2003; Longenecker JC, 2009, MED PRIN PRACT, V18, P85, DOI 10.1159/000189804; MOLGAARD H, 1991, AM J CARDIOL, V68, P777, DOI 10.1016/0002-9149(91)90653-3; O'Hare A, 2001, J AM SOC NEPHROL, V12, P2838, DOI 10.1681/ASN.V12122838; Oikawa K, 2009, INT J CARDIOL, V131, P370, DOI 10.1016/j.ijcard.2007.10.033; Ono K, 2003, J AM SOC NEPHROL, V14, P1591, DOI 10.1097/01.ASN.0000065547.98258.3D; Polak G, 2004, AUTON NEUROSCI-BASIC, V115, P94, DOI 10.1016/j.autneu.2004.08.002; Rajagopalan S, 2006, CIRCULATION, V114, P1914, DOI 10.1161/CIRCULATIONAHA.105.607390; Saito M, 2003, ATHEROSCLEROSIS, V167, P73, DOI 10.1016/S0021-9150(02)00380-5; Tejera E, 2012, HYPERTENS PREGNANCY, V31, P59, DOI 10.3109/10641955.2010.544802; Tong YQ, 2007, AM J NEPHROL, V27, P63, DOI 10.1159/000099013; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Zhang J, 2013, CLIN J AM SOC NEPHRO, V8, P1378, DOI 10.2215/CJN.10381012; Zitt E, 2008, KIDNEY BLOOD PRESS R, V31, P217, DOI 10.1159/000141926	46	36	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0120459	10.1371/journal.pone.0120459	http://dx.doi.org/10.1371/journal.pone.0120459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237669	gold, Green Submitted, Green Published			2022-12-27	WOS:000358942400001
J	Kang, S; Kim, HS; Han, I				Kang, Seungcheol; Kim, Han-Soo; Han, Ilkyu			Unplanned Excision of Extremity Soft Tissue Sarcoma in Korea: A Nationwide Study Based on a Claims Registry	PLOS ONE			English	Article							LYMPH-NODE EVALUATION; RESIDUAL DISEASE; HOSPITAL TYPE; HEALTH; SYSTEM; IMPACT	Unplanned excision of extremity soft tissue sarcoma (STS) is common and has detrimental effects not only on patients' oncologic outcomes but also on functional and economic issues. However, no study has analyzed a nationwide population-based database. To estimate the incidence and treatment pattern of unplanned excision in extremity STS in the Korean population, a nationwide epidemiologic study was performed using the Korean Health Insurance Review and Assessment Service database, a centralized nationwide healthcare claims registry of Korea that covers the entire Korean population. Among 1,517 patients with extremity STS in the 4-year study period, 553 (36.5%) underwent unplanned excision (unplanned group). About 80% of unplanned excisions were performed in tertiary or general hospitals. Of the unplanned group, 240 (43.4%) underwent re-excision with or without radiation therapy and/or chemotherapy, and 51 (9.2%) did not undergo re-excision but were treated with radiation therapy and/or chemotherapy; whereas, 262 (47.4%) did not undergo any further treatment following unplanned excision. This study is the first nationwide population-based study on the unplanned excision of extremity STS. The results may have implications in establishing preventive or therapeutic measures to reduce the burden of unplanned excision of extremity STS.	[Kang, Seungcheol; Kim, Han-Soo; Han, Ilkyu] Seoul Natl Univ Hosp, Dept Orthopaed Surg, Seoul 110744, South Korea; [Kang, Seungcheol; Kim, Han-Soo; Han, Ilkyu] Seoul Natl Univ, Canc Hosp, Musculoskeletal Tumor Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Han, I (corresponding author), Seoul Natl Univ Hosp, Dept Orthopaed Surg, Seoul 110744, South Korea.	hik19@snu.ac.kr		HAN, ILKYU/0000-0001-9841-3775				Bauer HCF, 2001, ACTA ORTHOP SCAND, V72, P150, DOI 10.1080/000164701317323408; Bilimoria KY, 2008, ARCH SURG-CHICAGO, V143, P671, DOI 10.1001/archsurg.143.7.671; BORING CC, 1993, CA-CANCER J CLIN, V43, P7, DOI 10.3322/canjclin.43.1.7; Chun CB, 2009, HLTH SYST TRANSIT, V11, P1; Davis AM, 1997, J SURG ONCOL, V66, P81, DOI 10.1002/(SICI)1096-9098(199710)66:2<81::AID-JSO2>3.0.CO;2-H; Demetri GD, 2010, J NATL COMPR CANC NE, V8, P630, DOI 10.6004/jnccn.2010.0049; Dudeja V, 2012, ANN SURG ONCOL, V19, P365, DOI 10.1245/s10434-011-1973-z; Fletcher CD., 2002, WHO CLASSIFICATION T; GIULIANO AE, 1985, J CLIN ONCOL, V3, P1344, DOI 10.1200/JCO.1985.3.10.1344; Gong HS, 2009, J BONE JOINT SURG AM, V91A, P2376, DOI 10.2106/JBJS.H.01871; Health Insurance Review and Assessment Service, 2013, HLTH INS STAT YB; Hsieh MC, 2012, CANCER-AM CANCER SOC, V118, P1675, DOI 10.1002/cncr.26473; Kang HY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-230; Kang S, 2015, CANCER RES TREAT; Kang S, 2013, UNPLANNED EXCISION S; Kang S, 2013, SURG ONCOL, V22, pE17, DOI 10.1016/j.suronc.2013.02.006; Kim DS, 2010, SOC WORK PUBLIC HLTH, V25, P127, DOI 10.1080/19371910903070333; Kim HS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-205; Kim JY, 2005, STRATEGIES ENHANCE U; Kim YB, 2008, INT J RADIAT ONCOL, V70, P139, DOI 10.1016/j.ijrobp.2007.05.067; Lewis JJ, 2000, ANN SURG, V231, P655, DOI 10.1097/00000658-200005000-00005; Mankin HJ, 1996, J BONE JOINT SURG AM, V78A, P656, DOI 10.2106/00004623-199605000-00004; MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P1121, DOI 10.2106/00004623-198264080-00002; Maretty-Nielsen K, 2014, ACTA ONCOL, V53, P1188, DOI 10.3109/0284186X.2014.888494; Maretty-Nielsen Katja, 2013, Clin Epidemiol, V5, P45, DOI 10.2147/CLEP.S41835; NICE, 2005, REF GUID SUSP CANC, V27, P43; Noria S, 1996, J BONE JOINT SURG AM, V78A, P650, DOI 10.2106/00004623-199605000-00003; Park B, 2002, STRATEGIES IMPROVE V; Park SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080174; Park YT, 2012, HEALTHC INFORM RES, V18, P215, DOI 10.4258/hir.2012.18.3.215; ROSS JA, 1993, CANCER, V72, P486, DOI 10.1002/1097-0142(19930715)72:2<486::AID-CNCR2820720226>3.0.CO;2-R; Trovik Clement S., 2001, Acta Orthopaedica Scandinavica, V72, P1, DOI 10.1080/000164701753740096	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134354	10.1371/journal.pone.0134354	http://dx.doi.org/10.1371/journal.pone.0134354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237049	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942400024
J	Li, DH; Shi, W; Munroe, TA; Gong, L; Kong, XY				Li, Dong-He; Shi, Wei; Munroe, Thomas A.; Gong, Li; Kong, Xiao-Yu			Concerted Evolution of Duplicate Control Regions in the Mitochondria of Species of the Flatfish Family Bothidae (Teleostei: Pleuronectiformes)	PLOS ONE			English	Article							DNA-SEQUENCE; GENOME; REPLICATION; SNAKE; REARRANGEMENTS; PLATYSTERNON; MITOGENOME; PHYLOGENY; ORIGINS; TURTLE	Mitogenomes of flatfishes (Pleuronectiformes) exhibit the greatest diversity of gene rearrangements in teleostean fishes. Duplicate control regions (CRs) have been found in the mito-genomes of two flatfishes, Samariscus latus (Samaridae) and Laeops lanceolata (Bothidae), which is rare in teleosts. It has been reported that duplicate CRs have evolved in a concerted fashion in fishes and other animals, however, whether concerted evo-lution exists in flatfishes remains unknown. In this study, based on five newly sequenced and six previously reported mitogenomes of lefteye flounders in the Bothidae, we explored whether duplicate CRs and concerted evolution exist in these species. Results based on the present study and previous reports show that four out of eleven bothid species examined have duplicate CRs of their mitogenomes. The core regions of the duplicate CRs of mitogenomes in the same species have identical, or nearly identical, sequences when compared to each other. This pattern fits the typical characteristics of concerted evolution. Additionally, phylogenetic and ancestral state reconstruction analysis also provided evidence to support the hypothesis that duplicate CRs evolved concertedly. The core region of concerted evolution is situated at the conserved domains of the CR of the mitogenome from the termination associated sequences (TASs) to the conserved sequence blocks (CSBs). Commonly, this region is con-sidered to regulate mitochondrial replication and transcription. Thus, we hypothesize that the cause of concerted evolution of the duplicate CRs in the mtDNAs of these four bothids may be related to some function of the conserved sequences of the CRs during mitochondrial rep-lication and transcription. We hope our results will provide fresh insight into the molecular mechanisms related to replication and evolution of mitogenomes.	[Li, Dong-He; Shi, Wei; Gong, Li; Kong, Xiao-Yu] Chinese Acad Sci, Key Lab Trop Marine Bio resources & Ecol, South China Sea Inst Oceanol, Guangzhou 510301, Guangdong, Peoples R China; [Li, Dong-He; Shi, Wei; Gong, Li; Kong, Xiao-Yu] Chinese Acad Sci, Guangdong Prov Key Lab Appl Marine Biol, South China Sea Inst Oceanol, Guangzhou 510301, Guangdong, Peoples R China; [Li, Dong-He; Shi, Wei; Gong, Li] South China Sea Bioresource Exploitat & Utilizat, Guangzhou 510301, Guangdong, Peoples R China; [Li, Dong-He; Gong, Li] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Munroe, Thomas A.] NOAA, Natl Systemat Lab NMFS, Smithsonian Inst NHB, Washington, DC 20013 USA	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian National Museum of Natural History	Shi, W (corresponding author), Chinese Acad Sci, Key Lab Trop Marine Bio resources & Ecol, South China Sea Inst Oceanol, Guangzhou 510301, Guangdong, Peoples R China.	shiwei@scsio.ac.cn; xykong@scsio.ac.cn	Gong, lI/ABE-4558-2021		Natural Science Foundation of China [31471979, 41206134, 30870283]; Science and Technology Planning Project of Guangdong Province, China [2014B030301064]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China	This work was supported by the Natural Science Foundation of China (grant numbers 31471979, 41206134, 30870283) and Science and Technology Planning Project of Guangdong Province, China (2014B030301064).	Abbott CL, 2005, MOL ECOL, V14, P3605, DOI 10.1111/j.1365-294X.2005.02672.x; Arndt A, 1998, MOL BIOL EVOL, V15, P1009, DOI 10.1093/oxfordjournals.molbev.a025999; Betancur R, 2014, MOL PHYLOGENET EVOL, V73, P18, DOI 10.1016/j.ympev.2014.01.006; Betancur R, 2013, SYST BIOL, V62, P763, DOI 10.1093/sysbio/syt039; Boore JL, 2000, COMP GENOMICS, V1, P133, DOI DOI 10.1007/978-94-011-4309-7_13; Brown TA, 2006, CELL CYCLE, V5, P917, DOI 10.4161/cc.5.9.2710; Campbell MA, 2014, GENE, V551, P176, DOI 10.1016/j.gene.2014.08.053; Campbell MA, 2014, MOL PHYLOGENET EVOL, V75, P149, DOI 10.1016/j.ympev.2014.02.011; Campbell MA, 2013, MOL PHYLOGENET EVOL, V69, P664, DOI 10.1016/j.ympev.2013.07.011; CHAPLEAU F, 1993, B MAR SCI, V52, P516; Clayton DA, 2003, IUBMB LIFE, V55, P213, DOI 10.1080/1521654031000134824; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Dubey B, 2012, MOL BIOL REP, V39, P7403, DOI 10.1007/s11033-012-1572-5; Eberhard JR, 2001, MOL BIOL EVOL, V18, P1330, DOI 10.1093/oxfordjournals.molbev.a003917; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; Fonseca MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106654; Gong L, 2016, MITOCHONDRIAL DNA A, V27, P3089, DOI 10.3109/19401736.2014.1003922; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kumazawa Y, 1996, MOL BIOL EVOL, V13, P1242, DOI 10.1093/oxfordjournals.molbev.a025690; Kumazawa Y, 1998, GENETICS, V150, P313; Lee JS, 2001, GENE, V280, P1, DOI 10.1016/S0378-1119(01)00765-X; Li S.-Z., 1995, FAUNA SINICA OSTEICH; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Lunt DH, 1997, NATURE, V387, P247, DOI 10.1038/387247a0; Morris-Pocock JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-14; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Ogoh K, 2004, GENE, V327, P131, DOI 10.1016/j.gene.2003.11.011; Ogoh K, 2007, MOL BIOL EVOL, V24, P74, DOI 10.1093/molbev/msl132; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parham JF, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-11; Parham JF, 2006, MOL PHYLOGENET EVOL, V38, P50, DOI 10.1016/j.ympev.2005.07.015; Peng QL, 2006, GENE, V380, P14, DOI 10.1016/j.gene.2006.04.001; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schirtzinger EE, 2012, MOL PHYLOGENET EVOL, V64, P342, DOI 10.1016/j.ympev.2012.04.009; Schwarzhans, 1999, COMP MORPHOLOGICAL T; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Shao RF, 2005, MOL BIOL EVOL, V22, P620, DOI 10.1093/molbev/msi047; Shi W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-352; Shi W, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-173; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatarenkov A, 2007, P R SOC B, V274, P1795, DOI 10.1098/rspb.2007.0169; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876	49	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134580	10.1371/journal.pone.0134580	http://dx.doi.org/10.1371/journal.pone.0134580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237419	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942400029
J	Belichenko, PV; Kleschevnikov, AM; Becker, A; Wagner, GE; Lysenko, LV; Yu, YE; Mobley, WC				Belichenko, Pavel V.; Kleschevnikov, Alexander M.; Becker, Ann; Wagner, Grant E.; Lysenko, Larisa V.; Yu, Y. Eugene; Mobley, William C.			Down Syndrome Cognitive Phenotypes Modeled in Mice Trisomic for All HSA 21 Homologues	PLOS ONE			English	Article							TS65DN MOUSE MODEL; LONG-TERM POTENTIATION; OBSESSIVE-COMPULSIVE DISORDER; SYNAPTIC PLASTICITY; MENTAL-RETARDATION; WORKING-MEMORY; CRITICAL REGION; OBJECT RECOGNITION; ANIMAL-MODEL; YOUNG-ADULTS	Down syndrome (DS), trisomy for chromosome 21, is the most common genetic cause of intellectual disability. The genomic regions on human chromosome 21 (HSA21) are syntenically conserved with regions on mouse chromosomes 10, 16, and 17 (Mmu10, Mmu16, and Mmu17). Recently, we created a genetic model of DS which carries engineered duplications of all three mouse syntenic regions homologous to HSA21. This 'triple trisomic' or TTS model thus represents the most complete and accurate murine model currently available for experimental studies of genotype-phenotype relationships in DS. Here we extended our initial studies of TTS mice. Locomotor activity, stereotypic and repetitive behavior, anxiety, working memory, long-term memory, and synaptic plasticity in the dentate gyrus were examined in the TTS and wild-type (WT) control mice. Changes in locomotor activity were most remarkable for a significant increase in ambulatory time and a reduction in average velocity of TTS mice. No changes were detected in repetitive and stereotypic behavior and in measures of anxiety. Working memory showed no changes when tested in Y-maze, but deficiency in a more challenging T-maze test was detected. Furthermore, long-term object recognition memory was significantly reduced in the TTS mice. These changes were accompanied by deficient long-term potentiation in the dentate gyrus, which was restored to the WT levels following blockade of GABAA receptors with picrotoxin (100 mu M). TTS mice thus demonstrated a number of phenotypes characteristic of DS and may serve as a new standard by which to evaluate and direct findings in other less complete models of DS.	[Belichenko, Pavel V.; Kleschevnikov, Alexander M.; Becker, Ann; Wagner, Grant E.; Lysenko, Larisa V.; Mobley, William C.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Yu, Y. Eugene] Roswell Pk Canc Inst, Genet Program, Buffalo, NY 14263 USA; [Yu, Y. Eugene] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	University of California System; University of California San Diego; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Kleschevnikov, AM (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA.	akleschevnikov@ucsd.edu	Lysenko, Larisa/ABF-2485-2020; Lysenko, Larisa/C-1802-2014	Lysenko, Larisa/0000-0002-0861-2904	National Institute of Health [R01NS066072, R01HL091519]; Hillblom Foundation; LuMind Foundation; Cure Alzheimer's Fund; Jerome Lejeune Foundation; Down Syndrome Research and Treatment Center at the University of California, San Diego; Children's Guild Foundation; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066072] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hillblom Foundation; LuMind Foundation; Cure Alzheimer's Fund; Jerome Lejeune Foundation; Down Syndrome Research and Treatment Center at the University of California, San Diego; Children's Guild Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institute of Health, grants R01NS066072 (WCM and EY); R01HL091519 (EY); The L.L. Hillblom Foundation (WCM); The LuMind Foundation (PVB, WCM, AMK); The Cure Alzheimer's Fund (AMK); The Jerome Lejeune Foundation (AMK); The Down Syndrome Research and Treatment Center at the University of California, San Diego (PVB, AMK); The Children's Guild Foundation (EY).	Aldridge K, 2007, AM J MED GENET A, V143A, P1060, DOI 10.1002/ajmg.a.31721; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Azkona G, 2010, GENES BRAIN BEHAV, V9, P160, DOI 10.1111/j.1601-183X.2009.00538.x; Baddeley A, 2007, J INTELL DISABIL RES, V51, P925, DOI 10.1111/j.1365-2788.2007.00979.x; Belichenko NP, 2009, J NEUROSCI, V29, P5938, DOI 10.1523/JNEUROSCI.1547-09.2009; Belichenko PV, 2007, J COMP NEUROL, V504, P329, DOI 10.1002/cne.21433; Belichenko PV, 2009, J COMP NEUROL, V512, P453, DOI 10.1002/cne.21895; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Braudeau J, 2011, J PSYCHOPHARMACOL, V25, P1030, DOI 10.1177/0269881111405366; Capone G, 2006, AM J MED GENET C, V142C, P158, DOI 10.1002/ajmg.c.30097; Carlesimo GA, 1997, NEUROPSYCHOLOGIA, V35, P71, DOI 10.1016/S0028-3932(96)00055-3; Cooper A, 2012, P NATL ACAD SCI USA, V109, P2642, DOI 10.1073/pnas.1109099109; Cooper JD, 2001, P NATL ACAD SCI USA, V98, P10439, DOI 10.1073/pnas.181219298; Costa ACS, 1999, PHYSIOL BEHAV, V68, P211, DOI 10.1016/S0031-9384(99)00178-X; Costa ACS, 2005, NEUROSCI LETT, V382, P317, DOI 10.1016/j.neulet.2005.03.031; Costa ACS, 2008, NEUROPSYCHOPHARMACOL, V33, P1624, DOI 10.1038/sj.npp.1301535; Cramer N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/101542; CRONK CE, 1978, PEDIATRICS, V61, P564; Das I, 2011, DIS MODEL MECH, V4, P596, DOI 10.1242/dmm.007716; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; DAVISSON MT, 1990, PROG CLIN BIOL RES, V360, P263; De S, 2010, CURR OPIN CELL BIOL, V22, P326, DOI 10.1016/j.ceb.2010.04.004; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; Deitz SL, 2011, GENETICS, V189, P1487, DOI 10.1534/genetics.111.131391; Demas GE, 1996, BEHAV BRAIN RES, V82, P85, DOI 10.1016/S0166-4328(97)81111-4; Demas GE, 1998, BEHAV BRAIN RES, V90, P199, DOI 10.1016/S0166-4328(97)00116-2; Di Filippo M, 2010, BIOL PSYCHIAT, V67, P666, DOI 10.1016/j.biopsych.2009.08.018; Dierssen M, 2001, PHYSIOL BEHAV, V73, P859, DOI 10.1016/S0031-9384(01)00523-6; Dierssen M, 2012, NAT REV NEUROSCI, V13, P844, DOI 10.1038/nrn3314; Dierssen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017010; DOUGLASS HM, 1995, J AM ACAD CHILD PSY, V34, P1424, DOI 10.1097/00004583-199511000-00008; Driscoll LL, 2004, BEHAV NEUROSCI, V118, P1196, DOI 10.1037/0735-7044.118.6.1196; Duchon A, 2011, MAMM GENOME, V22, P674, DOI 10.1007/s00335-011-9356-0; Ekstein S, 2011, J CHILD NEUROL, V26, P1290, DOI 10.1177/0883073811405201; Escorihuela RM, 1998, NEUROSCI LETT, V247, P171, DOI 10.1016/S0304-3940(98)00317-6; ESCORIHUELA RM, 1995, NEUROSCI LETT, V199, P143, DOI 10.1016/0304-3940(95)12052-6; Evans DW, 2000, CHILD DEV, V71, P288, DOI 10.1111/1467-8624.00144; Faizi M, 2011, NEUROBIOL DIS, V43, P397, DOI 10.1016/j.nbd.2011.04.011; Fernandez F, 2007, NEUROSCI LETT, V421, P137, DOI 10.1016/j.neulet.2007.04.075; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Fuchs C, 2012, LAB INVEST, V92, P1648, DOI 10.1038/labinvest.2012.117; Galante M, 2009, HUM MOL GENET, V18, P1449, DOI 10.1093/hmg/ddp055; Galdzicki Z, 2003, GENES BRAIN BEHAV, V2, P167, DOI 10.1034/j.1601-183X.2003.00024.x; Galdzicki Z, 2001, BRAIN RES REV, V35, P115, DOI 10.1016/S0926-6410(00)00074-4; Garcia-Cerro S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106572; Gardiner K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-244; Gathercole SE, 2006, J CHILD PSYCHOL PSYC, V47, P4, DOI 10.1111/j.1469-7610.2005.01446.x; Gribble SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060482; Haw CM, 1996, MOVEMENT DISORD, V11, P395, DOI 10.1002/mds.870110408; Haydar TF, 1996, J NEUROSCI, V16, P6175; HOLTZMAN DM, 1992, EMBO J, V11, P619, DOI 10.1002/j.1460-2075.1992.tb05094.x; Hunter CL, 2003, BEHAV BRAIN RES, V138, P121, DOI 10.1016/S0166-4328(02)00275-9; Hyde LA, 2001, BEHAV BRAIN RES, V118, P53, DOI 10.1016/S0166-4328(00)00313-2; Jarrold C, 1999, Downs Syndr Res Pract, V6, P61, DOI 10.3104/reviews.97; Kaur G, 2014, J NEUROSCI, V34, P5099, DOI 10.1523/JNEUROSCI.5338-13.2014; Kerins Gerard, 2008, Downs Syndr Res Pract, V12, P141, DOI 10.3104/reports.2009; Kleschevnikov AM, 2012, PROG BRAIN RES, V197, P199, DOI 10.1016/B978-0-444-54299-1.00010-8; Kleschevnikov AM, 2012, J NEUROSCI, V32, P9217, DOI 10.1523/JNEUROSCI.1673-12.2012; Kleschevnikov AM, 2012, NEUROBIOL DIS, V45, P683, DOI 10.1016/j.nbd.2011.10.009; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; LACEYCASEM ML, 1994, CRIT REV NEUROBIOL, V8, P293; Lalo E, 2005, NEUROPHYSIOL CLIN, V35, P81, DOI 10.1016/j.neucli.2005.03.002; Lana-Elola E, 2011, DIS MODEL MECH, V4, P586, DOI 10.1242/dmm.008078; Lanfranchi S, 2009, CHILD NEUROPSYCHOL, V15, P397, DOI 10.1080/09297040902740652; LAUTESLAGER PEM, 1995, MED SPORT SCI, V40, P75; LEJEUNE J., 1959, ARCH FRANC PEDIATRIE, V16, P962; Levkovitz Y, 1999, J NEUROSCI, V19, P10977, DOI 10.1523/JNEUROSCI.19-24-10977.1999; Liu CH, 2011, DEV NEUROSCI-BASEL, V33, P404, DOI 10.1159/000329422; Lockrow J, 2011, BEHAV BRAIN RES, V221, P610, DOI 10.1016/j.bbr.2010.03.036; Londei T, 1998, BEHAV BRAIN RES, V94, P249, DOI 10.1016/S0166-4328(97)00162-9; Lott IT, 2012, PROG BRAIN RES, V197, P101, DOI 10.1016/B978-0-444-54299-1.00006-6; Lysenko LV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114521; Martinez-Cue C, 2005, BEHAV BRAIN RES, V163, P174, DOI 10.1016/j.bbr.2005.04.016; Morice E, 2008, LEARN MEMORY, V15, P492, DOI 10.1101/lm.969608; Mouton-Liger F, 2014, NEUROBIOL DIS, V63, P92, DOI 10.1016/j.nbd.2013.11.016; MYERS BA, 1991, J NERV MENT DIS, V179, P609, DOI 10.1097/00005053-199110000-00004; Nicolas LB, 2006, EUR J PHARMACOL, V547, P106, DOI 10.1016/j.ejphar.2006.07.015; Niesman IR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-39; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Olson LE, 2007, HUM MOL GENET, V16, P774, DOI 10.1093/hmg/ddm022; Olson LE, 2011, AM J MED GENET A, V155A, P2436, DOI 10.1002/ajmg.a.34203; Pereira PL, 2009, HUM MOL GENET, V18, P4756, DOI 10.1093/hmg/ddp438; Popov VI, 2011, J COMP NEUROL, V519, P1338, DOI 10.1002/cne.22573; Potier MC, 2014, CNS NEUROL DISORD-DR, V13, P8, DOI 10.2174/18715273113126660185; PRASHER VP, 1995, J AUTISM DEV DISORD, V25, P453, DOI 10.1007/BF02179379; Pritchard MA, 1999, J NEURAL TRANSM-SUPP, P293; Rachidi M, 2007, NEUROSCI RES, V59, P349, DOI 10.1016/j.neures.2007.08.007; de Asua DR, 2014, RES DEV DISABIL, V35, P2942, DOI 10.1016/j.ridd.2014.07.038; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Reinholdt LG, 2011, MAMM GENOME, V22, P685, DOI 10.1007/s00335-011-9357-z; Roper RJ, 2006, PLOS GENET, V2, P231, DOI 10.1371/journal.pgen.0020050; Rueda N, 2010, J ALZHEIMERS DIS, V21, P277, DOI 10.3233/JAD-2010-100240; Ruparelia A, 2013, DEV DISABIL RES REV, V18, P43, DOI 10.1002/ddrr.1127; Sago H, 2000, PEDIATR RES, V48, P606, DOI 10.1203/00006450-200011000-00009; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Sahun I, 2014, GENETICS, V197, P899, DOI 10.1534/genetics.114.165241; Salehi A, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000258; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Siarey RJ, 1997, NEUROPHARMACOLOGY, V36, P1549, DOI 10.1016/S0028-3908(97)00157-3; Siarey RJ, 2005, NEUROPHARMACOLOGY, V49, P122, DOI 10.1016/j.neuropharm.2005.02.012; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Smith GK, 2014, HIPPOCAMPUS, V24, P354, DOI 10.1002/hipo.22229; Somers JM, 2006, CAN J PSYCHIAT, V51, P100, DOI 10.1177/070674370605100206; Souchet B, 2014, NEUROBIOL DIS, V69, P65, DOI 10.1016/j.nbd.2014.04.016; Stasko MR, 2004, BEHAV BRAIN RES, V154, P1, DOI 10.1016/j.bbr.2004.01.012; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Turner CA, 2001, BEHAV GENET, V31, P393, DOI 10.1023/A:1012226603255; Vicari S, 2000, NEUROPSYCHOLOGIA, V38, P240, DOI 10.1016/S0028-3932(99)00081-0; Whitney KN, 2012, BEHAV BRAIN RES, V232, P202, DOI 10.1016/j.bbr.2012.03.042; Woods-Kettelberger A, 1997, Expert Opin Investig Drugs, V6, P1369, DOI 10.1517/13543784.6.10.1369; Yu T, 2010, BRAIN RES, V1366, P162, DOI 10.1016/j.brainres.2010.09.107; Yu T, 2010, HUM MOL GENET, V19, P2780, DOI 10.1093/hmg/ddq179; Zhang L, 2014, HUM MOL GENET, V23, P578, DOI 10.1093/hmg/ddt446; Zhang L, 2012, BIOENGINEERED, V3, P8, DOI 10.4161/bbug.3.1.17696; Zohar AH, 1999, CHILD ADOL PSYCH CL, V8, P445	118	40	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134861	10.1371/journal.pone.0134861	http://dx.doi.org/10.1371/journal.pone.0134861			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230397	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400178
J	Briner, AE; Lugli, GA; Milani, C; Duranti, S; Turroni, F; Gueimonde, M; Margolles, A; van Sinderen, D; Ventura, M; Barrangou, R				Briner, Alexandra E.; Lugli, Gabriele Andrea; Milani, Christian; Duranti, Sabrina; Turroni, Francesca; Gueimonde, Miguel; Margolles, Abelardo; van Sinderen, Douwe; Ventura, Marco; Barrangou, Rodolphe			Occurrence and Diversity of CRISPR-Cas Systems in the Genus Bifidobacterium	PLOS ONE			English	Article							COMPARATIVE GENOMICS; ACQUIRED-RESISTANCE; RNA; EVOLUTION; CLASSIFICATION; ENDONUCLEASE; SEQUENCES; LOCI	CRISPR-Cas systems constitute adaptive immune systems for antiviral defense in bacteria. We investigated the occurrence and diversity of CRISPR-Cas systems in 48 Bifidobacterium genomes to gain insights into the diversity and co-evolution of CRISPR-Cas systems within the genus and investigate CRISPR spacer content. We identified the elements necessary for the successful targeting and inference of foreign DNA in select Type II CRISPR-Cas systems, including the tracrRNA and target PAM sequence. Bifidobacterium species have a very high frequency of CRISPR-Cas occurrence (77%, 37 of 48). We found that many Bifidobacterium species have unusually large and diverse CRISPR-Cas systems that contain spacer sequences showing homology to foreign genetic elements like prophages. A large number of CRISPR spacers in bifidobacteria show perfect homology to prophage sequences harbored in the chromosomes of other species of Bifidobacterium, including some spacers that self-target the chromosome. A correlation was observed between strains that lacked CRISPR-Cas systems and the number of times prophages in that chromosome were targeted by other CRISPR spacers. The presence of prophage-targeting CRISPR spacers and prophage content may shed light on evolutionary processes and strain divergence. Finally, elements of Type II CRISPR-Cas systems, including the tracrRNA and crRNAs, set the stage for the development of genome editing and genetic engineering tools.	[Briner, Alexandra E.; Barrangou, Rodolphe] N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA; [Lugli, Gabriele Andrea; Milani, Christian; Duranti, Sabrina; Ventura, Marco] Univ Parma, Dept Life Sci, Lab Probiogenom, I-43100 Parma, Italy; [Turroni, Francesca; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Turroni, Francesca; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Gueimonde, Miguel; Margolles, Abelardo] Spanish Natl Res Council IPLA CSIC, Dairy Res Inst Asturias, Villaviciosa, Asturias, Spain	University of North Carolina; North Carolina State University; University of Parma; University College Cork; University College Cork; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA)	Barrangou, R (corresponding author), N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA.	rbarran@ncsu.edu	Van Sinderen, Douwe/A-6778-2015; Gueimonde, Miguel/A-2106-2008; Turroni, Francesca/K-9660-2016; Lugli, Gabriele Andrea/AAV-5150-2021; Duranti, Sabrina/AAI-7916-2020; Barrangou, Rodolphe/I-2878-2014; Lugli, Gabriele Andrea/GRX-2617-2022; Margolles, Abelardo/H-3871-2012; ventura, marco/M-8230-2015; Milani, Christian/ABA-8160-2020	Van Sinderen, Douwe/0000-0003-1823-7957; Gueimonde, Miguel/0000-0002-0192-901X; Turroni, Francesca/0000-0001-5363-0231; Lugli, Gabriele Andrea/0000-0002-3024-0537; Duranti, Sabrina/0000-0002-7724-5669; Barrangou, Rodolphe/0000-0002-0648-3504; Lugli, Gabriele Andrea/0000-0002-3024-0537; Margolles, Abelardo/0000-0003-2278-1816; Milani, Christian/0000-0002-5062-3164; Crawley, Alexandra/0000-0002-3970-9506	North Carolina State University; GenProbio srl; Science Foundation Ireland (SFI), through the Irish Government's National Development Plan [SFI/12/RC/2273]	North Carolina State University; GenProbio srl; Science Foundation Ireland (SFI), through the Irish Government's National Development Plan(Science Foundation Ireland)	This study was supported by startup funds from North Carolina State University. The authors thank GenProbio srl for financial support of the Laboratory of Probiogenomics. DvS is a member of the Alimentary pharmabiotic Centre funded by Science Foundation Ireland (SFI), through the Irish Government's National Development Plan (Grant number SFI/12/RC/2273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2015, CURR OPIN IMMUNOL, V32, P36, DOI 10.1016/j.coi.2014.12.008; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Barrangou R, 2012, ANNU REV FOOD SCI T, V3, P143, DOI 10.1146/annurev-food-022811-101134; Barrangou R, 2009, J BACTERIOL, V191, P4144, DOI 10.1128/JB.00155-09; Bottacini F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-170; Bottacini F, 2010, MICROBIOL-SGM, V156, P3243, DOI 10.1099/mic.0.039545-0; Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Duranti S, 2015, ENV MICROBI IN PRESS; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas Giedrius, 2012, Proc Natl Acad Sci U S A, V109, pE2579; Gomaa AA, 2014, MBIO, V5, DOI 10.1128/mBio.00928-13; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Lee JH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-247; Levin BR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003312; Lugli GA, 2014, APPL ENVIRON MICROB, V80, P6383, DOI 10.1128/AEM.02004-14; Mahony J, 2015, CURR OPIN BIOTECH, V32, P8, DOI [10.1016/j.copbio.2014.09.006, 10.1016/j.copbio.2014.09.00]; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Milani C, 2014, APPL ENVIRON MICROB, V80, P6290, DOI 10.1128/AEM.02308-14; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Pertzev AV, 2006, NUCLEIC ACIDS RES, V34, P3708, DOI 10.1093/nar/gkl459; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Ventura M, 2005, APPL ENVIRON MICROB, V71, P8692, DOI 10.1128/AEM.71.12.8692-8705.2005; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Ventura M, 2010, ANTON LEEUW INT J G, V98, P39, DOI 10.1007/s10482-010-9426-4; Ventura M, 2009, APPL ENVIRON MICROB, V75, P6929, DOI 10.1128/AEM.01112-09; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596	45	51	55	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133661	10.1371/journal.pone.0133661	http://dx.doi.org/10.1371/journal.pone.0133661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230606	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400048
J	Fan, XL; Jin, T; Zhao, SC; Liu, CY; Han, JM; Jiang, XM; Jiang, YF				Fan, Xueli; Jin, Tao; Zhao, Songchen; Liu, Caiyun; Han, Jinming; Jiang, Xinmei; Jiang, Yanfang			Circulating CCR7+ICOS+ Memory T Follicular Helper Cells in Patients with Multiple Sclerosis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; B-CELLS; EXPRESSION; FOLLICLES; DISEASE; CCR7; ASSOCIATION; ANTIBODIES; CHEMOKINES; ROLES	Objective This study is aimed at examining the potential roles of circulating memory T follicular helper (Tfh) cells in patients with multiple sclerosis (MS). Methods The numbers of different subsets of circulating memory Tfh cells in 25 patients with relapsed MS before and after treatment as well as 14 healthy controls (HC) were examined by flow cytometry. The levels of plasma IL-21 in all patients and cerebrospinal fluid (CSF) IL-21 in some MS patients and controls with non-inflammatory neuronal diseases (NND) were measured by ELISA. Results In comparison with that in the HC, the numbers of circulating CD3+CD4+CXCR5+CD45RA-, ICOS+, CCR7+ and CCR7+ ICOS+ memory Tfh cells and the levels of plasma IL-21 significantly increased in MS patients, but significantly decreased in the patients with complete remission (CR). The levels of CSF IL-21 were significantly higher in the MS patients than that in the NND patients. The numbers of CCR7+ICOS+ memory Tfh cells were positively correlated with the EDSS scores, the levels of plasma and CSF IL-21, IgG, MBP-Ab or MOG-Ab. Conclusions Our findings indicated that circulating memory Tfh cells, especially CCR7+ICOS+ memory Tfh cells, may be associated with the relapse of MS and may serve as a new therapeutic target.	[Fan, Xueli; Jin, Tao; Liu, Caiyun; Han, Jinming; Jiang, Xinmei] Jilin Univ, Hosp 1, Dept Neurol, Ctr Neurosci, Changchun 130023, Peoples R China; [Zhao, Songchen; Jiang, Yanfang] Jilin Univ, Hosp 1, Genet Diag Ctr, Changchun 130023, Peoples R China; [Jiang, Yanfang] Jilin Univ, Hosp 1, Minist Educ, Key Lab Zoonosis Res, Changchun 130023, Peoples R China; [Jiang, Yanfang] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Peoples R China	Jilin University; Jilin University; Jilin University	Jiang, XM (corresponding author), Jilin Univ, Hosp 1, Dept Neurol, Ctr Neurosci, Changchun 130023, Peoples R China.	1115764585@qq.com; yanfangjiang@hotmail.com	Han, Jinming/R-6607-2019	Han, Jinming/0000-0002-6084-3275; Liu, Caiyun/0000-0002-3724-5840	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060268] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR060268] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Anolik JH, 2009, IMMUNOL RES, V45, P144, DOI 10.1007/s12026-009-8096-7; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Cardona AE, 2008, J LEUKOCYTE BIOL, V84, P587, DOI 10.1189/jlb.1107763; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Christensen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057820; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Feng XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051982; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Jadidi-Niaragh F, 2011, SCAND J IMMUNOL, V74, P1, DOI 10.1111/j.1365-3083.2011.02536.x; Kivisakk P, 2004, ANN NEUROL, V55, P627, DOI 10.1002/ana.20049; Krumbholz M, 2014, SEMIN IMMUNOPATHOL, V36, P339, DOI 10.1007/s00281-014-0424-x; Li Y, 2011, J NEUROIMMUNOL, V234, P155, DOI 10.1016/j.jneuroim.2011.03.009; Li YJ, 2015, J NEUROIMMUNOL, V278, P239, DOI 10.1016/j.jneuroim.2014.11.011; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Ma CS, 2014, IMMUNOL CELL BIOL, V92, P64, DOI 10.1038/icb.2013.55; Ma J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/827480; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Moschovakis GL, 2012, EUR J IMMUNOL, V42, P1949, DOI 10.1002/eji.201242614; Nohra R, 2010, GENES IMMUN, V11, P279, DOI 10.1038/gene.2009.111; O'Connor KC, 2005, J IMMUNOL, V175, P1974, DOI 10.4049/jimmunol.175.3.1974; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ray A, 2011, J NEUROIMMUNOL, V230, P1, DOI 10.1016/j.jneuroim.2010.10.037; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sellebjerg F, 2005, EUR J NEUROL, V12, P939, DOI 10.1111/j.1468-1331.2005.01352.x; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Tellier J, 2013, CELL MOL LIFE SCI, V70, P4771, DOI 10.1007/s00018-013-1420-3; Tsai LM, 2014, IMMUNOL CELL BIOL, V92, P57, DOI 10.1038/icb.2013.68; Tzartos JS, 2011, AM J PATHOL, V178, P794, DOI 10.1016/j.ajpath.2010.10.043; Vojdani A, 2003, J INTERN MED, V254, P363, DOI 10.1046/j.1365-2796.2003.01203.x; Warnatz K, 2006, BLOOD, V107, P3045, DOI 10.1182/blood-2005-07-2955	38	8	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134523	10.1371/journal.pone.0134523	http://dx.doi.org/10.1371/journal.pone.0134523			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26231034	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400130
J	Farace, C; Oliver, JA; Melguizo, C; Alvarez, P; Bandiera, P; Rama, AR; Malaguarnera, G; Ortiz, R; Madeddu, R; Prados, J				Farace, Cristiano; Oliver, Jaime Antonio; Melguizo, Consolacion; Alvarez, Pablo; Bandiera, Pasquale; Rama, Ana Rosa; Malaguarnera, Giulia; Ortiz, Raul; Madeddu, Roberto; Prados, Jose			Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; NUCLEAR LOCALIZED DECORIN; GENE-EXPRESSION PROFILE; EXTRACELLULAR-MATRIX; TUMOR MICROENVIRONMENT; DEVELOPMENTAL BIOLOGY; ADJUVANT TEMOZOLOMIDE; GROWTH-FACTORS; ORAL-CANCER; IDENTIFICATION	The presence of cancer stem cells (CSCs) or tumor-initiating cells can lead to cancer recurrence in a permissive cell-microenvironment interplay, promoting invasion in glioblastoma (GBM) and neuroblastoma (NB). Extracellular matrix (ECM) small leucine-rich proteoglycans (SLRPs) play multiple roles in tissue homeostasis by remodeling the extracellular matrix (ECM) components and modulating intracellular signaling pathways. Due to their pan-inhibitory properties against receptor tyrosine kinases (RTKs), SLRPs are reported to exert anticancer effects in vitro and in vivo. However, their roles seem to be tissue-specific and they are also involved in cancer cell migration and drug resistance, paving the way to complex different scenarios. The aim of this study was to determine whether the SLRPs decorin (DCN) and lumican (LUM) are recruited in cell plasticity and microenvironmental adaptation of differentiated cancer cells induced towards stem-like phenotype. Floating neurospheres were generated by applying CSC enrichment medium (neural stem cell serum-free medium, NSC SFM) to the established SF-268 and SK-N-SH cancer cell lines, cellular models of GBM and NB, respectively. In both models, the time-dependent synergistic activation of DCN and LUM was observed. The highest DCN and LUM mRNA/protein expression was detected after cell exposure to NSC SFM for 8/12 days, considering these cells as SLRP-expressing (SLRP+) CSC-like. Ultrastructural imaging showed the cellular heterogeneity of both the GBM and NB neurospheres and identified the inner living cells. Parental cell lines of both GBM and NB grew only in soft agar + NSC SFM, whereas the secondary neurospheres (originated from SLRP+ t(8) CSC-like) showed lower proliferation rates than primary neurospheres. Interestingly, the SLRP+ CSC-like from the GBM and NB neurospheres were resistant to temozolomide (TMZ) at concentrations >750 mu M. Our results suggest that GBM and NB CSC-like promote the activation of huge quantities of SLRP in response to CSC enrichment, simultaneously acquiring TMZ resistance, cellular heterogeneity, and a quiescent phenotype, suggesting a novel pivotal role for SLRP in drug resistance and cell plasticity of CSC-like, allowing cell survival and ECM/niche modulation potential.	[Farace, Cristiano; Bandiera, Pasquale; Madeddu, Roberto] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Oliver, Jaime Antonio; Melguizo, Consolacion; Alvarez, Pablo; Rama, Ana Rosa; Ortiz, Raul; Prados, Jose] Inst Biopathol & Regenerat Med IBIMER, Granada, Spain; [Melguizo, Consolacion; Prados, Jose] Univ Granada, Dept Anat & Embryol, Granada, Spain; [Melguizo, Consolacion; Alvarez, Pablo; Rama, Ana Rosa; Ortiz, Raul; Prados, Jose] SAS Univ Granada, Biosanitary Inst Granada ibs Granada, Granada, Spain; [Rama, Ana Rosa; Ortiz, Raul] Univ Jaen, Dept Hlth Sci, Jaen, Spain; [Malaguarnera, Giulia] Univ Catania, Res Ctr Great Senescence, Catania, Italy; [Madeddu, Roberto] Natl Inst Biostruct & Biosyst INBB, Rome, Italy	University of Sassari; University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Universidad de Jaen; University of Catania	Farace, C (corresponding author), Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.	cfarace@uniss.it; rmadeddu@uniss.it	Bandiera, Pasquale/F-4276-2017; Ballesteros, Ana Rosa Rama/AAG-7976-2020; Madeddu, Roberto/J-4206-2014; Prados, Jose/J-7116-2017; Melguizo, Consolación/E-9842-2016; ORTIZ, RAUL/GOH-0599-2022; Ortiz Quesada, Raúl/J-7256-2017; Malaguarnera, Giulia/ABD-4968-2020	Bandiera, Pasquale/0000-0002-0589-4539; Ballesteros, Ana Rosa Rama/0000-0002-3698-2013; Prados, Jose/0000-0003-4303-7746; Melguizo, Consolación/0000-0003-3990-806X; Ortiz Quesada, Raúl/0000-0001-8409-5235; Malaguarnera, Giulia/0000-0003-3655-4307; Madeddu, Roberto/0000-0002-2016-0357; FARACE, Cristiano/0000-0002-6534-0087	Fundacio la Marato TV3 [111431]	Fundacio la Marato TV3	This study was supported by Fundacio la Marato TV3, Project no 111431.	Asara Y, 2013, INT J MOL SCI, V14, P16600, DOI 10.3390/ijms140816600; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Beier D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-128; Biglari A, 2004, CANCER GENE THER, V11, P721, DOI 10.1038/sj.cgt.7700783; Bleau AM, 2014, HISTOL HISTOPATHOL, V29, P1499, DOI 10.14670/HH-29.1499; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Brizzi MF, 2012, CURR OPIN CELL BIOL, V24, P645, DOI 10.1016/j.ceb.2012.07.001; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chaichana K, 2006, STEM CELLS, V24, P2851, DOI 10.1634/stemcells.2006-0399; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Chong HC, 2012, J ONCOL, V2012, DOI 10.1155/2012/351089; Daquinag AC, 2011, CELL STEM CELL, V9, P74, DOI 10.1016/j.stem.2011.05.017; Dil N, 2012, HEAD NECK ONCOL, V4, DOI 10.1186/1758-3284-4-11; Dil N, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-44; Edwards IJ, 2012, NAT REV UROL, V9, P196, DOI 10.1038/nrurol.2012.19; El Behi M, 2013, EMBO MOL MED, V5, P1835, DOI 10.1002/emmm.201302655; Engel S, 1999, J NEUROIMMUNOL, V99, P13, DOI 10.1016/S0165-5728(99)00062-4; Feugaing DDS, 2007, BIOCHIMIE, V89, P637, DOI 10.1016/j.biochi.2006.12.012; Feugaing DDS, 2013, EUR J CELL BIOL, V92, P1, DOI 10.1016/j.ejcb.2012.08.004; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Galli Rossella, 2013, Methods Mol Biol, V986, P267, DOI 10.1007/978-1-62703-311-4_17; Gammon L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062493; Gutenberg A, 2013, ACTA NEUROCHIR, V155, P429, DOI 10.1007/s00701-012-1583-y; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hua YQ, 2012, CANCER-AM CANCER SOC, V118, P5140, DOI 10.1002/cncr.27496; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Jogi A, 2004, EXP CELL RES, V295, P469, DOI 10.1016/j.yexcr.2004.01.013; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kajiyama H, 2007, INT J ONCOL, V31, P277; Kallmann BA, 2002, FASEB J, V16, P589, DOI 10.1096/fj.01-0594fje; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kasamatsu A, 2015, BIOCHEM BIOPH RES CO, V457, P71, DOI 10.1016/j.bbrc.2014.12.093; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Leygue E, 1998, CANCER RES, V58, P1348; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matsuda Y, 2008, INT J ONCOL, V33, P1177, DOI 10.3892/ijo_00000107; MAUVIEL A, 1995, J BIOL CHEM, V270, P11692, DOI 10.1074/jbc.270.19.11692; Mazzoleni S, 2010, CANCER RES, V70, P7500, DOI 10.1158/0008-5472.CAN-10-2353; Moore N, 2011, J ONCOL, V2011, DOI 10.1155/2011/396076; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Naito Z, 2002, INT J ONCOL, V20, P943; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Nikitovic D, 2011, INT J BIOCHEM CELL B, V43, P928, DOI 10.1016/j.biocel.2011.03.008; Oe T, 2005, J NEUROCHEM, V94, P1264, DOI 10.1111/j.1471-4159.2005.03273.x; Oike T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078943; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Persano L, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.153; Pietras A, 2008, J PATHOL, V214, P482, DOI 10.1002/path.2304; Pope WB, 2012, AM J NEURORADIOL, V33, P1059, DOI 10.3174/ajnr.A2917; Prindull G, 2004, BLOOD, V103, P2892, DOI 10.1182/blood-2003-08-2807; Puglisi MA, 2013, WORLD J GASTROENTERO, V19, P2997, DOI 10.3748/wjg.v19.i20.2997; Qiang L, 2009, CANCER LETT, V279, P13, DOI 10.1016/j.canlet.2009.01.016; Qiu ZK, 2014, CHIN J CANCER, V33, DOI 10.5732/cjc.012.10236; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sailer MHM, 2013, J CELL SCI, V126, P3533, DOI 10.1242/jcs.125757; Santra M, 2006, J CEREBR BLOOD F MET, V26, P1311, DOI 10.1038/sj.jcbfm.9600285; Schatton T, 2009, ANN NY ACAD SCI, V1176, P154, DOI 10.1111/j.1749-6632.2009.04568.x; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; SCHOLZEN T, 1994, J BIOL CHEM, V269, P28270; Seya T, 2006, ONCOL REP, V16, P1225; Shekhani MT, 2013, AM J STEM CELLS, V2, P52; Shi MF, 2010, CELL MOL LIFE SCI, V67, P3915, DOI 10.1007/s00018-010-0420-9; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sottoriva A, 2010, CANCER RES, V70, P46, DOI 10.1158/0008-5472.CAN-09-3663; Stichel CC, 1995, BRAIN RES, V704, P263, DOI 10.1016/0006-8993(95)01131-5; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Van Bockstal Mieke, 2014, Oncoscience, V1, P634; Walton JD, 2004, NEOPLASIA, V6, P838, DOI 10.1593/neo.04310; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; Yamamoto T, 2012, CANCER LETT, V320, P31, DOI 10.1016/j.canlet.2012.01.023; Yamano Y, 2010, INT J CANCER, V126, P437, DOI 10.1002/ijc.24704; Yang ZX, 2013, HEPATO-GASTROENTEROL, V60, P349, DOI 10.5754/hge12642; Zafiropoulos A, 2008, MOL CANCER RES, V6, P785, DOI 10.1158/1541-7786.MCR-07-0165; Zagris N, 2011, INT J DEV BIOL, V55, P633, DOI 10.1387/ijdb.113321nz	84	33	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134111	10.1371/journal.pone.0134111	http://dx.doi.org/10.1371/journal.pone.0134111			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230845	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400073
J	Gracia, E; Ortego, J; Godoy, JA; Perez-Garcia, JM; Blanco, G; Delgado, MD; Penteriani, V; Almodovar, I; Botella, F; Sanchez-Zapata, JA				Gracia, Eva; Ortego, Joaquin; Antonio Godoy, Jose; Manuel Perez-Garcia, Juan; Blanco, Guillermo; Delgado, Maria del Mar; Penteriani, Vincenzo; Almodovar, Irene; Botella, Francisco; Antonio Sanchez-Zapata, Jose			Genetic Signatures of Demographic Changes in an Avian Top Predator during the Last Century: Bottlenecks and Expansions of the Eurasian Eagle Owl in the Iberian Peninsula	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASE; POPULATION-STRUCTURE; BUBO-BUBO; MICROSATELLITE MARKERS; BREEDING PERFORMANCE; NATAL PHILOPATRY; RANGE EXPANSION; SIZE; DIVERSITY; FRAGMENTATION	The study of the demographic history of species can help to understand the negative impact of recent population declines in organisms of conservation concern. Here, we use neutral molecular markers to explore the genetic consequences of the recent population decline and posterior recovery of the Eurasian eagle owl (Bubo bubo) in the Iberian Peninsula. During the last century, the species was the object of extermination programs, suffering direct persecution by hunters until the 70's. Moreover, during the last decades the eagle owl was severely impacted by increased mortality due to electrocution and the decline of its main prey species, the European rabbit (Oryctolagus cuniculus). In recent times, the decrease of direct persecution and the implementation of some conservation schemes have allowed the species' demographic recovery. Yet, it remains unknown to which extent the past population decline and the later expansion have influenced the current species' pattern of genetic diversity. We used eight microsatellite markers to genotype 235 eagle owls from ten Spanish subpopulations and analyse the presence of genetic signatures attributable to the recent population fluctuations experienced by the species. We found moderate levels of differentiation among the studied subpopulations and Bayesian analyses revealed the existence of three genetic clusters that grouped subpopulations from central, south-western and southeastern Spain. The observed genetic structure could have resulted from recent human-induced population fragmentation, a patchy distribution of prey populations and/or the philopatric behaviour and habitat selection of the species. We detected an old population bottleneck, which occurred approximately 10,000 years ago, and significant signatures of recent demographic expansions. However, we did not find genetic signatures for a recent bottleneck, which may indicate that population declines were not severe enough to leave detectable signals on the species genetic makeup or that such signals have been eroded by the rapid demographic recovery experienced by the species in recent years.	[Gracia, Eva; Manuel Perez-Garcia, Juan; Almodovar, Irene; Botella, Francisco; Antonio Sanchez-Zapata, Jose] Miguel Hernandez Univ, Dept Appl Biol, Ecol Area, Elche, Spain; [Ortego, Joaquin] CSIC UCLM JCCM, Hunting Resources Res Inst, Genet & Cultural Biodivers Grp, Ciudad Real, Spain; [Ortego, Joaquin; Antonio Godoy, Jose] CSIC, Donana Biol Stn, Dept Integrat Ecol, E-41080 Seville, Spain; [Blanco, Guillermo] CSIC, Natl Museum Nat Hist, Dept Evolutionary Ecol, Madrid, Spain; [Delgado, Maria del Mar] Univ Helsinki, Dept Biosci, Metapopulat Res Grp, Helsinki, Finland; [Delgado, Maria del Mar; Penteriani, Vincenzo] Univ Oviedo, UO CSIC PA, UMIB, Res Unit Biodivers, Mieres, Spain; [Penteriani, Vincenzo] CSIC, Donana Biol Stn, Dept Conservat Biol, E-41080 Seville, Spain	Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); University of Helsinki; Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Gracia, E (corresponding author), Miguel Hernandez Univ, Dept Appl Biol, Ecol Area, Elche, Spain.	egracia@umh.es	Graciá, Eva/H-2270-2015; Godoy, José Antonio/B-9288-2008; Sanchez-Zapata, Jose Antonio/H-1413-2015; Botella, Francisco/F-7626-2011; Ortego, Joaquin/F-4936-2010; Botella, Francisco/P-7790-2019; Blanco, Guillermo/L-3170-2014; Pérez-García, Juan Manuel/A-7037-2012	Graciá, Eva/0000-0003-0790-163X; Godoy, José Antonio/0000-0001-7502-9471; Sanchez-Zapata, Jose Antonio/0000-0001-8230-4953; Botella, Francisco/0000-0002-1877-5360; Ortego, Joaquin/0000-0003-2709-429X; Botella, Francisco/0000-0002-1877-5360; Blanco, Guillermo/0000-0001-5742-4929; Pérez-García, Juan Manuel/0000-0002-1191-0187	Consejeria de Medio Ambiente, of the Junta de Andalucia [700/2005/M/00]; Conselleria de Medio Ambiente of the Generalitat Valenciana	Consejeria de Medio Ambiente, of the Junta de Andalucia(Junta de Andalucia); Conselleria de Medio Ambiente of the Generalitat Valenciana	Consejeria de Medio Ambiente, of the Junta de Andalucia, financially supported the study in the Donana area (research project no. 700/2005/M/00). Conselleria de Medio Ambiente of the Generalitat Valenciana partially funded the field work during 2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Allendorf F. W., 2012, CONSERV GENET; Baker CS, 2013, MAR ECOL PROG SER, V494, P291, DOI 10.3354/meps10508; Beaumont MA, 1999, GENETICS, V153, P2013; Blanco JC, 1998, MAMIFEROS ESPANA; Busch JD, 2007, MOL ECOL, V16, P2450, DOI 10.1111/j.1365-294X.2007.03283.x; Campioni L, 2013, OECOLOGIA, V172, P371, DOI 10.1007/s00442-012-2493-7; Carr D, 2007, J WILDLIFE MANAGE, V71, P1853, DOI 10.2193/2006-274; Casas-Marce M, 2013, MOL ECOL, V22, P5503, DOI 10.1111/mec.12498; Chikhi L, 2010, GENETICS, V186, P983, DOI 10.1534/genetics.110.118661; Cornuet JM, 1996, GENETICS, V144, P2001; Del Hoyo J, 1999, HDB BIRDS WORLD, V5; Delgado MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077557; Delgado MD, 2010, J ANIM ECOL, V79, P620, DOI 10.1111/j.1365-2656.2009.01655.x; Delgado MM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2851; Delibes-Mateos M, 2007, BIOL CONSERV, V137, P149, DOI 10.1016/j.biocon.2007.01.024; Dixon MD, 2011, J MAMMAL, V92, P1343, DOI 10.1644/10-MAMM-A-426.1; DONAZAR JA, 1990, J ORNITHOL, V131, P439, DOI 10.1007/BF01639820; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Falush D, 2003, GENETICS, V164, P1567; Fernandez-de-Simon J, 2014, ACTA OECOL, V60, P1, DOI 10.1016/j.actao.2014.06.006; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Gonzalez J.L., 1980, Boletin de la Estacion Central de Ecologia, V9, P63; Graham K, 2005, BIOL CONSERV, V122, P159, DOI 10.1016/j.biocon.2004.06.006; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Hagen SB, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0092; Herrlinger E., 1973, BONNER ZOOLOGICAL MO, V4; HIRONS G J M, 1985, Journal of Zoology Series B, V1, P21; Hoban S, 2013, METHODS ECOL EVOL, V4, P299, DOI 10.1111/2041-210x.12025; Hsu YC, 2003, MOL ECOL NOTES, V3, P595, DOI 10.1046/j.1471-8286.2003.00523.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Isaksson M, 2002, MOL ECOL NOTES, V2, P91, DOI 10.1046/j.1471-8286.2002.00156.x; Leon-Ortega M, 2014, ARDEOLA, V61, P45, DOI 10.13157/arla.61.1.2014.45; Perez-Garcia J, 2010, J RAPTOR RES, V44, P161, DOI 10.3356/JRR-09-30.1; Martinez JA, 2001, J ORNITHOL, V142, P204, DOI 10.1007/BF01651788; Martinez JA, 2003, ATLAS AVES REPRODUCT; Martinez JA, 2006, BIRD CONSERV INT, V16, P265, DOI 10.1017/S0959270906000402; Martinez-Abrain A, 2009, ANIM CONSERV, V12, P204, DOI 10.1111/j.1469-1795.2009.00239.x; Martinez-Cruz B, 2007, MOL ECOL, V16, P477, DOI 10.1111/j.1365-294X.2007.03147.x; Martinez-Cruz B, 2004, MOL ECOL, V13, P2243, DOI 10.1111/j.1365-294X.2004.02220.x; McEachern MB, 2011, CONSERV GENET, V12, P285, DOI 10.1007/s10592-010-0139-z; Mendez M, 2014, EVOL APPL, V7, P506, DOI 10.1111/eva.12154; Mikkola H., 1983, P1; Mira S, 2013, IBIS, V155, P485, DOI 10.1111/ibi.12065; Mock KE, 2004, CONSERV GENET, V5, P631, DOI 10.1007/s10592-004-1849-x; Moilanen A, 1998, ECOLOGY, V79, P2503, DOI 10.1890/0012-9658(1998)079[2503:MDEOHQ]2.0.CO;2; Moleon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022851; Moleon M, 2009, J BIOGEOGR, V36, P1502, DOI 10.1111/j.1365-2699.2009.02078.x; Moleon M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002307; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Niethammer G., 1964, Falke, V11, P189; Omote K, 2012, ZOOL SCI, V29, P299, DOI 10.2108/zsj.29.299; Ortego J, 2007, ORNIS FENNICA, V84, P78; Ovenden JR, 2007, MOL ECOL, V16, P127, DOI 10.1111/j.1365-294X.2006.03132.x; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Penteriani V, 2005, IBIS, V147, P155, DOI 10.1111/j.1474-919x.2004.00381.x; Penteriani V, 2011, ECOGRAPHY, V34, P729, DOI 10.1111/j.1600-0587.2010.06773.x; Perez-Garcia JM, 2012, BIRD STUDY, V59, P22, DOI 10.1080/00063657.2011.613111; Perez-Garcia JM, 2011, BIRD CONSERV INT, V21, P296, DOI 10.1017/S0959270911000062; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Pruett CL, 2011, AM MIDL NAT, V166, P415, DOI 10.1674/0003-0031-166.2.415; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Selas V, 1997, ORNIS FENNICA, V74, P113; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Storz JF, 2002, EVOLUTION, V56, P154; Thode AB, 2002, MOL ECOL NOTES, V2, P446, DOI 10.1046/j.1471-8286.2002.00267.x; Tucker JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052803; Valkama J, 2005, BIOL REV, V80, P171, DOI 10.1017/S146479310400658X; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Venturas M, 2013, PLANT ECOL, V214, P317, DOI 10.1007/s11258-013-0170-5; Villafuerte R, 1998, BIOL CONSERV, V84, P181, DOI 10.1016/S0006-3207(97)00094-3; Wang JL, 1998, HEREDITY, V81, P174, DOI 10.1046/j.1365-2540.1998.00390.x; White C.M., 1994, NEW WORLD VULTURES G; WIENS JA, 1995, IBIS, V137, pS97, DOI 10.1111/j.1474-919X.1995.tb08464.x; Wright S, 1943, GENETICS, V28, P114; Zhang BW, 2007, MOL BIOL EVOL, V24, P1801, DOI 10.1093/molbev/msm099	88	7	7	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133954	10.1371/journal.pone.0133954	http://dx.doi.org/10.1371/journal.pone.0133954			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230922	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400063
J	Guzman-Silva, A; de Lara, LGV; Torres-Jacome, J; Vargaz-Guadarrama, A; Flores-Flores, M; Said, EP; Lagunas-Martinez, A; Mendoza-Milla, C; Tanzi, F; Moccia, F; Berra-Romani, R				Guzman-Silva, Alejandro; Vazquez de Lara, Luis G.; Torres-Jacome, Julin; Vargaz-Guadarrama, Ajelet; Flores-Flores, Marycruz; Pezzat Said, Elias; Lagunas-Martinez, Alfredo; Mendoza-Milla, Criselda; Tanzi, Franco; Moccia, Francesco; Berra-Romani, Roberto			Lung Beractant Increases Free Cytosolic Levels of Ca2+ in Human Lung Fibroblasts	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; PULMONARY SURFACTANT; INOSITOL TRISPHOSPHATE; CALCIUM OSCILLATIONS; CHANNELS; STORE; RELEASE; CONSEQUENCES; PATHOGENESIS; NEUTROPHILS	Beractant, a natural surfactant, induces an antifibrogenic phenotype and apoptosis in normal human lung fibroblasts (NHLF). As intracellular Ca2+ signalling has been related to programmed cell death, we aimed to assess the effect of beractant on intracellular Ca2+ concentration ([Ca2+](i)) in NHLF in vitro. Cultured NHLF were loaded with Fura-2 AM(3 mu M) and Ca2+ signals were recorded by microfluorimetric techniques. Beractant causes a concentration-dependent increase in [Ca2+] i with a EC50 of 0.82 mu g/ml. The application of beractant, at a concentration of 500 mu g/ml, which has been shown to exert an apoptotic effect in human fibroblasts, elicited different patterns of Ca2+ signals in NHLF: a) a single Ca2+ spike which could be followed by b) Ca2+ oscillations, c) a sustained Ca2+ plateau or d) a sustained plateau overlapped by Ca2+ oscillations. The amplitude and pattern of Ca2+ transients evoked by beractant were dependent on the resting [Ca2+](i). Pharmacological manipulation revealed that beractant activates a Ca2+ signal through Ca2+ release from intracellular stores mediated by phospholipase C beta (PLC beta), Ca2+ release from inositol 1,4,5-trisphosphate receptors (IP(3)Rs) and Ca2+ influx via a store-operated pathway. Moreover, beractant-induced Ca2+ release was abolished by preventing membrane depolarization upon removal of extracellular Na+ and Ca2+. Finally, the inhibition of store-operated channels prevented beractant-induced NHLF apoptosis and downregulation of alpha(1)(I) procollagen expression. Therefore, beractant utilizes SOCE to exert its pro-apoptotic and antifibrinogenic effect on NHLF.	[Guzman-Silva, Alejandro; Vargaz-Guadarrama, Ajelet; Flores-Flores, Marycruz; Berra-Romani, Roberto] Benemerita Univ Autonoma Puebla, Sch Med, Dept Biomed, Puebla, Puebla, Mexico; [Vazquez de Lara, Luis G.; Pezzat Said, Elias] Benemerita Univ Autonoma Puebla, Sch Med, Expt Med Lab, Puebla, Puebla, Mexico; [Torres-Jacome, Julin] Benemerita Univ Autonoma Puebla, Inst Physiol, Puebla, Puebla, Mexico; [Lagunas-Martinez, Alfredo] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico; [Mendoza-Milla, Criselda] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico; [Tanzi, Franco; Moccia, Francesco] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, Lab Gen Physiol, I-27100 Pavia, Italy	Benemerita Universidad Autonoma de Puebla; Benemerita Universidad Autonoma de Puebla; Benemerita Universidad Autonoma de Puebla; Instituto Nacional de Salud Publica; University of Pavia	Berra-Romani, R (corresponding author), Benemerita Univ Autonoma Puebla, Sch Med, Dept Biomed, Puebla, Puebla, Mexico.	rberra001@hotmail.com	Berra-Romani, Roberto/R-6894-2018; Vargaz Guadarrama, Verónica Ajelet/AAF-3913-2021; Moccia, Francesco/AAX-6447-2020; torres, julian/ABB-9917-2020; MENDOZA-MILLA, CRISELDA/AAC-5311-2020	Berra-Romani, Roberto/0000-0003-4884-0925; Vargaz Guadarrama, Verónica Ajelet/0000-0001-8616-429X; Moccia, Francesco/0000-0003-0010-0098; MENDOZA-MILLA, CRISELDA/0000-0003-0304-2313; Guzman, Alejandro/0000-0001-5449-5553; Torres-Jacome, Julian/0000-0002-8575-2839; Flores Flores, Marycruz/0000-0001-6975-5645	Vicerrectoria de Investigacion y Estudios de Posgrado de la Benemerita Universidad Autonoma de Puebla, Puebla, Mexico [BERR-SAL11-I]	Vicerrectoria de Investigacion y Estudios de Posgrado de la Benemerita Universidad Autonoma de Puebla, Puebla, Mexico	This work was supported by Vicerrectoria de Investigacion y Estudios de Posgrado de la Benemerita Universidad Autonoma de Puebla, Puebla, Mexico, Grant No. BERR-SAL11-I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agassandian M, 2013, BBA-MOL CELL BIOL L, V1831, P612, DOI 10.1016/j.bbalip.2012.09.010; Akella A, 2013, INDIAN J EXP BIOL, V51, P5; Almirza WHM, 2012, CELL CALCIUM, V51, P12, DOI 10.1016/j.ceca.2011.10.001; AMBLER SK, 1988, J BIOL CHEM, V263, P1952; Berra-Romani R, 2008, CELL CALCIUM, V44, P298, DOI 10.1016/j.ceca.2007.12.007; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Berra-Romani R, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S40; Berra-Romani R, 2012, J VASC RES, V49, P65, DOI 10.1159/000329618; Berridge MJ, 2007, BIOCHEM SOC SYMP, V74, P1, DOI 10.1002/9780470514696.ch1; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berroneau Matthieu, 2012, Bulletin de la Societe Herpetologique de France, P1; Bootman MD, 1996, CURR BIOL, V6, P855, DOI 10.1016/S0960-9822(02)00609-7; Boston ME, 2004, EXP BIOL MED, V229, P99, DOI 10.1177/153537020422900112; BYRON KL, 1989, J BIOL CHEM, V264, P18234; Castro R, 2008, INFLAMM RES, V57, P489, DOI 10.1007/s00011-008-6214-y; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chacon-Cruz E, 2000, PEDIATR RES, V47, P405, DOI 10.1203/00006450-200003000-00020; Chen JB, 2010, J CELL PHYSIOL, V223, P68, DOI 10.1002/jcp.22010; De Lara LV, 2000, AM J PHYSIOL-LUNG C, V279, pL950, DOI 10.1152/ajplung.2000.279.5.L950; Diambra L, 2009, CHAOS, V19, DOI 10.1063/1.3147425; Dragoni S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091099; Dragoni S, 2013, STEM CELLS DEV, V22, P2561, DOI 10.1089/scd.2013.0032; Dragoni S, 2011, STEM CELLS, V29, P1898, DOI 10.1002/stem.734; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Fukami K, 2010, PROG LIPID RES, V49, P429, DOI 10.1016/j.plipres.2010.06.001; Glasser JR, 2012, MICROBES INFECT, V14, P17, DOI 10.1016/j.micinf.2011.08.019; Guerreiro Serge, 2011, Handb Exp Pharmacol, P135, DOI 10.1007/978-3-642-13443-2_5; Gurung IS, 2008, BRIT J PHARMACOL, V154, P882, DOI 10.1038/bjp.2008.97; Harari S, 2010, ALLERGY, V65, P537, DOI 10.1111/j.1398-9995.2009.02305.x; Ishida S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086410; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Janssen LJ, 2015, AM J RESP CELL MOL, V53, P135, DOI 10.1165/rcmb.2014-0269TR; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; Lopez-Rodriguez E, 2014, BBA-BIOMEMBRANES, V1838, P1568, DOI 10.1016/j.bbamem.2014.01.028; MAEDA N, 1991, J BIOL CHEM, V266, P1109; Mahaut-Smith MP, 1999, J PHYSIOL-LONDON, V515, P385, DOI 10.1111/j.1469-7793.1999.385ac.x; Misquitta CM, 2005, BIOCHEM J, V388, P291, DOI 10.1042/BJ20041568; Moccia F, 2012, CURR MED CHEM, V19, P5802, DOI 10.2174/092986712804143240; Moccia F, 2003, J CELL PHYSIOL, V194, P139, DOI 10.1002/jcp.10198; Moccia F, 2014, ANTI-CANCER AGENT ME, V14, P296, DOI 10.2174/18715206113139990315; Moccia Francesco, 2012, World J Biol Chem, V3, P127, DOI 10.4331/wjbc.v3.i7.127; Moccia F, 2012, CURR SIGNAL TRANSD T, V7, P161, DOI 10.2174/157436212800376672; Mukherjee S, 2013, INT J BIOCHEM CELL B, V45, P1516, DOI 10.1016/j.biocel.2013.04.018; Naon D, 2014, BBA-MOL CELL RES, V1843, P2184, DOI 10.1016/j.bbamcr.2014.05.011; Oelberg DG, 2000, MOL GENET METAB, V70, P295, DOI 10.1006/mgme.2000.3022; Ong HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047146; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Potenza DM, 2014, CELL CALCIUM, V56, P225, DOI 10.1016/j.ceca.2014.07.010; PRENTKI M, 1988, J BIOL CHEM, V263, P11044; Putney JW, 2008, J PHYSIOL-LONDON, V586, P3055, DOI 10.1113/jphysiol.2008.153221; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Shuttleworth TJ, 1996, BIOCHEM J, V313, P815, DOI 10.1042/bj3130815; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Thomassen MJ, 1996, AM J PHYSIOL-LUNG C, V270, pL159, DOI 10.1152/ajplung.1996.270.1.L159; Thurley K, 2012, BBA-GEN SUBJECTS, V1820, P1185, DOI 10.1016/j.bbagen.2011.10.007; TOESCU EC, 1993, J BIOL CHEM, V268, P18654; Tzouvelekis A, 2015, THER CLIN RISK MANAG, V11, P359, DOI 10.2147/TCRM.S69716; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200; Zuo YY, 2008, BBA-BIOMEMBRANES, V1778, P1947, DOI 10.1016/j.bbamem.2008.03.021	64	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134564	10.1371/journal.pone.0134564	http://dx.doi.org/10.1371/journal.pone.0134564			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230503	Green Submitted, gold, Green Published			2022-12-27	WOS:000358838400135
J	Hammerl, EE; Baier, MA; Reinhard, KJ				Hammerl, Emily E.; Baier, Melissa A.; Reinhard, Karl J.			Agave Chewing and Dental Wear: Evidence from Quids	PLOS ONE			English	Article							RIO ZAPE; PHYTOLITHS; DIET; MICROWEAR; DURANGO; REGION; CAVE	Agave quid chewing is examined as a potential contributing behavior to hunter-gatherer dental wear. It has previously been hypothesized that the contribution of Agave quid chewing to dental wear would be observed in communities wherever phytolith-rich desert succulents were part of subsistence. Previous analysis of coprolites from a prehistoric agricultural site, La Cueva de los Muertos Chiquitos in Durango, Mexico, showed that Agave was a consistent part of a diverse diet. Therefore, quids recovered at this site ought to be useful materials to test the hypothesis that dental wear was related to desert succulent consumption. The quids recovered from the site were found to be largely derived from chewing Agave. In this study, the quids were found to be especially rich in phytoliths, and analysis of dental casts made from impressions left in the quids revealed flat wear and dental attrition similar to that of Agave-reliant hunter-gatherers. Based on evidence obtained from the analysis of quids, taken in combination with results from previous studies, it is determined that Agave quid chewing was a likely contributing factor to dental wear in this population. As such, our method provides an additional avenue of dental research in areas where quids are present.	[Hammerl, Emily E.] Univ Nebraska, Dept Anthropol, Lincoln, NE 68588 USA; [Hammerl, Emily E.] Univ Nebraska, Forens Sci Program, Lincoln, NE USA; [Baier, Melissa A.] Natl Pk Serv, Buffalo Natl River, Harrison, AR USA; [Reinhard, Karl J.] Univ Nebraska, Sch Nat Resources, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; United States Department of the Interior; University of Nebraska System; University of Nebraska Lincoln	Hammerl, EE (corresponding author), Univ Nebraska, Dept Anthropol, Lincoln, NE 68588 USA.	ehammerl2@unl.edu	Reinhard, Karl/AAT-7881-2020		Undergraduate Creative Activities and Research Experience, University of Nebraska-Lincoln	Undergraduate Creative Activities and Research Experience, University of Nebraska-Lincoln	This work was supported by the Undergraduate Creative Activities and Research Experience, University of Nebraska-Lincoln. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER G, 1959, NATURE, V184, P1583, DOI 10.1038/1841583b0; Bell WH, 1944, AM ANTIQUITY, V10, P150, DOI 10.2307/275111; BROOKS RH, 1962, AM ANTIQUITY, V27, P356, DOI 10.2307/277801; Bryant Jr VM, 2008, PAPERS NATURAL RESOU, V19; Byers D, 1967, PREHISTORY TEHUACAN, V1; Callen E.O., 1967, PREHISTORY TEHUACAN, VVolume 1, P261; Castetter EF, 1935, U NM B 266 ETHNOBOTA, V1; Danielson DR, 1998, AM J PHYS ANTHROPOL, V107, P297, DOI 10.1002/(SICI)1096-8644(199811)107:3<297::AID-AJPA6>3.0.CO;2-M; Fish S. K., 1985, Desert Plants, V7, P107; Fish S.K., 1990, ARCHAEOLOGY REGIONS, P189; Fish Suzanne K., 1992, MARANA COMMUNITY HOH, P73; FOX CL, 1994, J ARCHAEOL SCI, V21, P29, DOI 10.1006/jasc.1994.1005; Gugel IL, 2001, AM J PHYS ANTHROPOL, V114, P124, DOI 10.1002/1096-8644(200102)114:2&lt;124::AID-AJPA1012&gt;3.0.CO;2-S; HARTNADY P, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P267; Holt B, 1993, PHYTOLITHARIEN NEWSL, V7; Jimenez FA, 2012, J PARASITOL, V98, P304, DOI 10.1645/GE-2915.1; Lalueza C, 1996, AM J PHYS ANTHROPOL, V101, P101; Lucas PW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0923; MARKS M, 1988, PLAINS ANTHROPOL, V33, P75; Meade T, 1994, DIETARY ANAL COPROLI; Middleton W., 1993, PHYTOLITHARIEN NEWSL, V7, P8; Mulholland S. C., 1992, PHYTOLITH SYSTEMATIC, P65; Pearson OM, 2014, J HUMAN EVOLUTION; Reed Alan D., 1978, Southwestern Lore, V44, P1; Reinhard K, 2001, BRIT ARCHAEOL REP IN, VS934, P113; Reinhard K. J, 2002, BILBY RES CTR OCCASI, V1, P135; Reinhard KJ, 2012, CURR ANTHROPOL, V53, P506, DOI 10.1086/665923; Reinhard KJ, 2005, J ARCHAEOL SCI, V32, P981, DOI 10.1016/j.jas.2005.01.014; Reinhard KJ, 1989, TEXAS ARKANSAS ARCHA, P93; Robson J, 1986, GUILA NAQUITZ ARCHAI; Sanson GD, 2007, J ARCHAEOL SCI, V34, P526, DOI 10.1016/j.jas.2006.06.009; Schmidt CW, 2001, AM J PHYS ANTHROPOL, V114, P139, DOI 10.1002/1096-8644(200102)114:2&lt;139::AID-AJPA1013&gt;3.0.CO;2-9; SCOTT EC, 1979, AM J PHYS ANTHROPOL, V51, P213, DOI 10.1002/ajpa.1330510208; SMITH BH, 1984, AM J PHYS ANTHROPOL, V63, P39, DOI 10.1002/ajpa.1330630107; Smith CE, 1967, PREHISTORY TEHUACAN, V1; Turner C, 1967, REPORTS U CALIF ARCH, V70, P1; TURPIN SA, 1986, PLAINS ANTHROPOL, V31, P295	37	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133710	10.1371/journal.pone.0133710	http://dx.doi.org/10.1371/journal.pone.0133710			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230855	Green Published, gold			2022-12-27	WOS:000358838400051
J	Kang, JY; Lim, SJ; Kwon, O; Lee, SG; Kim, HH; Oh, DB				Kang, Ji-Yeon; Lim, Se-Jong; Kwon, Ohsuk; Lee, Seung-Goo; Kim, Ha Hyung; Oh, Doo-Byoung			Enhanced Bacterial alpha(2,6)-Sialyltransferase Reaction through an Inhibition of Its Inherent Sialidase Activity by Dephosphorylation of Cytidine-5'-Monophosphate	PLOS ONE			English	Article							PHOTOBACTERIUM-DAMSELA ALPHA-2,6-SIALYLTRANSFERASE; BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; N-GLYCAN ANALYSIS; SIALYLTRANSFERASE; CELLS	Bacterial alpha(2,6)-sialyltransferases (STs) from Photobacterium damsela, Photobacterium sp. JT-ISH-224, and P. leiognathi JT-SHIZ-145 were recombinantly expressed in Escherichia coli and their ST activities were compared directly using a galactosylated bi-antennary N-glycan as an acceptor substrate. In all ST reactions, there was an increase of sialylated glycans at shorter reaction times and later a decrease in prolonged reactions, which is related with the inherent sialidase activities of bacterial STs. These sialidase activities are greatly increased by free cytidine monophosphate (CMP) generated from a donor substrate CMP-N-acetylneuraminic acid (CMP-Neu5Ac) during the ST reactions. The decrease of sialylated glycans in prolonged ST reaction was prevented through an inhibition of sialidase activity by simple treatment of alkaline phosphatase (AP), which dephosphorylates CMP to cytidine. Through supplemental additions of AP and CMP-Neu5Ac to the reaction using the recombinant alpha(2,6)-ST from P. leiognathi JT-SHIZ-145 (P145-ST), the content of bi-sialylated N-glycan increased up to similar to 98% without any decrease in prolonged reactions. This optimized P145-ST reaction was applied successfully for alpha(2,6)-sialylation of asialofetuin, and this resulted in a large increase in the populations of multi-sialylated N-glycans compared with the reaction without addition of AP and CMP-Neu5Ac. These results suggest that the optimized reaction using the recombinant P145-ST readily expressed from E. coli has a promise for economic glycan synthesis and glyco-conjugate remodeling.	[Kang, Ji-Yeon; Lim, Se-Jong; Kwon, Ohsuk; Lee, Seung-Goo; Oh, Doo-Byoung] KRIBB, Synth Biol & Bioengn Res Ctr, Taejon, South Korea; [Lim, Se-Jong; Kwon, Ohsuk; Lee, Seung-Goo; Oh, Doo-Byoung] Univ Sci & Technol, Biosyst & Bioengn Program, Taejon, South Korea; [Kim, Ha Hyung] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chung Ang University	Oh, DB (corresponding author), KRIBB, Synth Biol & Bioengn Res Ctr, Taejon, South Korea.	dboh@kribb.re.kr	Lee, Seung-Goo/AAR-9823-2021; Lee, Seung-Goo/AAS-1613-2021	Lee, Seung-Goo/0000-0003-4539-9812; Oh, Doo-Byoung/0000-0002-4432-0941	Ministry of Trade, Industry Energy [10048311]; National Research Foundation of Korea [NRF-2013M3A9B6075888]; Next-Generation BioGreen 21 Program of the Rural Development Administration [PJ011078]; Intelligent Synthetic Biology Center of Global Frontier Project in Republic of Korea [2011-0031944]	Ministry of Trade, Industry Energy; National Research Foundation of Korea(National Research Foundation of Korea); Next-Generation BioGreen 21 Program of the Rural Development Administration; Intelligent Synthetic Biology Center of Global Frontier Project in Republic of Korea	This work was supported by the grants from the Ministry of Trade, Industry & Energy [10048311], the National Research Foundation of Korea [NRF-2013M3A9B6075888], the Next-Generation BioGreen 21 Program of the Rural Development Administration [PJ011078], and the Intelligent Synthetic Biology Center of Global Frontier Project [2011-0031944] in Republic of Korea.	Air GM, 2014, CURR OPIN VIROL, V7, P128, DOI 10.1016/j.coviro.2014.06.004; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Barb AW, 2012, BIOCHEMISTRY-US, V51, P4618, DOI 10.1021/bi300319q; Barb AW, 2009, BIOCHEMISTRY-US, V48, P9705, DOI 10.1021/bi901430h; Cheng JS, 2010, GLYCOBIOLOGY, V20, P260, DOI 10.1093/glycob/cwp172; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; Kakuta Y, 2008, GLYCOBIOLOGY, V18, P66, DOI 10.1093/glycob/cwm119; Kim HG, 2003, BIOCHEM BIOPH RES CO, V305, P488, DOI 10.1016/S0006-291X(03)00795-2; Lee KJ, 2015, J BIOCHEM, V157, P35, DOI 10.1093/jb/mvu051; Lee KJ, 2013, GLYCOCONJUGATE J, V30, P537, DOI 10.1007/s10719-012-9453-7; Lee SG, 2002, BIOTECHNOL BIOENG, V80, P516, DOI 10.1002/bit.10398; Mine T, 2010, GLYCOBIOLOGY, V20, P158, DOI 10.1093/glycob/cwp157; Mun JY, 2013, ANAL CHEM, V85, P7462, DOI 10.1021/ac401431u; Sun MC, 2008, BIOTECHNOL LETT, V30, P671, DOI 10.1007/s10529-007-9588-y; Tsai TI, 2013, J AM CHEM SOC, V135, P14831, DOI 10.1021/ja4075584; Tsukamoto H, 2008, J BIOCHEM, V143, P187, DOI 10.1093/jb/mvm208; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yamamoto T, 2007, GLYCOBIOLOGY, V17, P1167, DOI 10.1093/glycob/cwm086	18	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133739	10.1371/journal.pone.0133739	http://dx.doi.org/10.1371/journal.pone.0133739			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26231036	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400053
J	Possati-Resende, JC; Fregnani, JHTG; Kerr, LM; Mauad, EC; Longatto, A; Scapulatempo-Neto, C				Possati-Resende, Julio C.; Fregnani, Jose H. T. G.; Kerr, Ligia M.; Mauad, Edmundo C.; Longatto-Filho, Adhemar; Scapulatempo-Neto, Cristovam			The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL	PLOS ONE			English	Article							HYBRID CAPTURE 2; RISK HUMAN-PAPILLOMAVIRUS; ATYPICAL SQUAMOUS-CELLS; COBAS 4800 HPV; UNDETERMINED SIGNIFICANCE; FOLLOW-UP; PERFORMANCE; COLPOSCOPY; TRIAGE; TECHNOLOGIES	The objective of this study was to compare the accuracies of double staining for p16/Ki-67 and the molecular test for high-risk HPV (hr-HPV) to identify high-grade cervical intraepithelial neoplasia (CIN2/CIN3) in women with cervical cytology of atypical squamous cells of undetermined significance (ASC-US) and low-grade squamous intraepithelial lesion (LSIL). Data were collected from 201 women who underwent cervical cytology screening in the Barretos Cancer Hospital and their results were categorized as ASC-US (n= 96) or LSIL (n=105). All patients underwent colposcopy with or without cervical biopsy for diagnosis of CIN2/CIN3. The hr-HPV test (Cobas 4800 test) and immunocytochemistry were performed to detect biomarkers p16/Ki-67 (CINtec PLUS test). Two samples (1 ASC-US/1 LSIL) were excluded from the analysis due to inconclusive results of the histologic examination. There were 8 cases of CIN2/CIN3 among 95 women with ASC-US (8.4%), and 23 cases of CIN2/CIN3 among 104 women with LSIL (22.1%). In the group of women with ASC-US, the sensitivity and specificity in diagnosing CIN2/CIN3 were 87.5% and 79.5% for the HPV test and 62.5% and 93.1% for p16/Ki-67. Among women with LSIL, the sensitivity and specificity in the diagnosis of CIN2/CIN3 were 87% and 34.7% for the HPV test and 69.6% and 75.3% for immunocytochemistry. Superior performance was observed for p16/Ki-67 double staining, especially among women under 30 for whom the test had an area under the ROC curve of 0.762 (p<0.001). Both p16/Ki-67 double staining and the hr-HPV DNA test had similar performance in predicting high-grade cervical intraepithelial neoplasia among women with ASC-US. The best performance was observed in women aged >30 years. In younger women (<= 30 years) with LSIL, p16/Ki-67 had greater accuracy in identifying precursor lesions. Among women > 30 years diagnosed with LSIL, the two methods showed similar performance.	[Possati-Resende, Julio C.; Mauad, Edmundo C.] Barretos Canc Hosp, Canc Prevent Dept, Barretos, SP, Brazil; [Fregnani, Jose H. T. G.] Barretos Canc Hosp, Teaching & Res Inst, Barretos, SP, Brazil; [Kerr, Ligia M.; Scapulatempo-Neto, Cristovam] Barretos Canc Hosp, Dept Pathol, Barretos, SP, Brazil; [Longatto-Filho, Adhemar; Scapulatempo-Neto, Cristovam] Barretos Canc Hosp, Ctr Mol Oncol, Barretos, SP, Brazil; [Longatto-Filho, Adhemar] Univ Sao Paulo, Sch Med, Lab Med Invest LIM 14, Sao Paulo, Brazil	Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Universidade de Sao Paulo	Possati-Resende, JC (corresponding author), Barretos Canc Hosp, Canc Prevent Dept, Barretos, SP, Brazil.	julio.possati@uol.com.br	longatto-filho, adhemar/D-7039-2013; Fregnani, José H/H-4238-2012; Filho, Adhemar Longatto/A-2889-2016; Longatto-Filho, Adhemar/N-3397-2019; Possati-Resende, Julio Cesar/C-8575-2016	longatto-filho, adhemar/0000-0002-5779-9752; Fregnani, José H/0000-0002-5235-6469; Longatto-Filho, Adhemar/0000-0002-5779-9752; Scapulatempo-Neto, Cristovam/0000-0002-8920-6579; Possati-Resende, Julio Cesar/0000-0002-7869-3885				Allen K, 2002, RISK MANAGEMENT CYTO; Bornstein J, 2012, OBSTET GYNECOL, V120, P166, DOI 10.1097/AOG.0b013e318254f90c; Brown CA, 2012, J ONCOL, V2012, DOI 10.1155/2012/289315; Cox JT, 2003, AM J OBSTET GYNECOL, V188, P1406, DOI 10.1067/mob.2003.461; Cuzick J, 2013, BRIT J CANCER, V108, P908, DOI 10.1038/bjc.2013.22; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Cuzick J, 2012, VACCINE, V30, pF107, DOI 10.1016/j.vaccine.2012.05.088; de Oliveira CM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-357; Dona MG, 2012, GYNECOL ONCOL, V126, P198, DOI 10.1016/j.ygyno.2012.05.004; Edgerton N, 2013, DIAGN CYTOPATHOL, V41, P35, DOI 10.1002/dc.21757; Kisser A, 2015, BJOG-INT J OBSTET GY, V122, P64, DOI 10.1111/1471-0528.13076; Lapierre SG, 2012, J CLIN MICROBIOL, V50, P1240, DOI 10.1128/JCM.06656-11; Loghavi S, 2013, DIAGN CYTOPATHOL, V41, P582, DOI 10.1002/dc.22900; Lonky NM, 1999, AM J OBSTET GYNECOL, V181, P560, DOI 10.1016/S0002-9378(99)70493-X; Lindemann MLM, 2012, J MOL DIAGN, V14, P65, DOI 10.1016/j.jmoldx.2011.09.005; Mitchell MF, 1998, OBSTET GYNECOL, V91, P626, DOI 10.1016/S0029-7844(98)00006-4; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Sankaranarayanan R, 1988, IARC SCI PUBLICATION, V15; Sawaya GF, 1999, OBSTET GYNECOL, V94, P307, DOI 10.1016/S0029-7844(99)00289-6; Schmidt D, 2011, CANCER CYTOPATHOL, V119, P158, DOI 10.1002/cncy.20140; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stoler MH, 2011, AM J CLIN PATHOL, V135, P468, DOI 10.1309/AJCPZ5JY6FCVNMOT; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Waldstrom M, 2013, CANCER CYTOPATHOL, V121, P136, DOI 10.1002/cncy.21233; Walker JL, 2006, AM J OBSTET GYNECOL, V195, P341, DOI 10.1016/j.ajog.2006.02.047; Wentzensen N, 2012, CLIN CANCER RES, V18, P4154, DOI 10.1158/1078-0432.CCR-12-0270; White C, 2013, J CLIN MICROBIOL, V51, P3415, DOI 10.1128/JCM.01949-13; Wong AA, 2012, J CLIN MICROBIOL, V50, P25, DOI 10.1128/JCM.05400-11; Wright TC, 2002, JAMA-J AM MED ASSOC, V287, P2120, DOI 10.1001/jama.287.16.2120	29	35	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134445	10.1371/journal.pone.0134445	http://dx.doi.org/10.1371/journal.pone.0134445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230097	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400120
J	Zhang, M; Wang, LH; Guo, R; Liang, S; Jiang, XF; Zhang, M; Li, B				Zhang, Miao; Wang, Lihua; Guo, Rui; Liang, Sheng; Jiang, Xufeng; Zhang, Min; Li, Biao			Molecular In Vivo Imaging Using a Noninvasive Cardiac-Specific MLC-2v Promoter Driven Dual-Gene Recombinant Lentivirus Monitoring System	PLOS ONE			English	Article							MUSCLE-SPECIFIC EXPRESSION; REPORTER GENE; SYMPORTER; MOUSE	Background Our study aimed to demonstrate the feasibility of using the sodium/iodide symporter (NIS) to monitor vascular endothelial growth factor (VEGF(165)) expression in vivo. Methods We constructed a recombinant lentivirus plasmid with the MLC-2v promoter driving the sodium/iodide symporter (NIS) reporter gene linked to the VEGF(165) gene. Expression of NIS and VEGF gene were identified by Western blot. On days 2 and 54, Tc-99m-MIBI imaging was used to evaluate changes in myocardial ischemia. Noninvasive I-125 micro-SPECT/CT imaging was used to assess the expression of NIS reporter gene dynamically over the next 2 months. Results Western blot analysis showed that both NIS and VEGF(165) were highly expressed in rat cardiomyoblast H9C2 cells transduced with Lenti-MLC-2v-NIS-VEGF(165). I-125 micro-SPECT/CT reporter imaging showed higher uptake in mouse myocardium transduced with Lenti-MLC-2v-VEGF(165)-IRES-NIS. NIS expression peaked on day 1 after transduction followed by a progressive decline to negligible levels by day 21. On day 1, mean I-125 activity value in group 1 was higher than that in group 2 (P<0.05). The mean I-125 activity value in group 3 was statically lower than that in group 1 and 2 (P<0.01). On day 60, I-125 uptakes in test and positive control groups became very low, and no significant differences in the mean I-125 activity values were detected between group 1 and group 2 (P = 0.531 > 0.05). In group 1 (test group), Tc-99m-MIBI SPECT/CT revealed improvements in perfusion and wall thickening in the apical anterior wall. Mean IOD values of NIS and CD34 were significantly higher in group 1 than group 3 (P<0.05). Our study proved mean I-125 uptake was significantly correlated with mean IOD value of NIS and CD34 (P<0.05). Conclusion This study demonstrates the feasibility of using the NIS gene to monitor VEGF(165) expression in a mouse myocardial ischemia model.	[Zhang, Miao; Wang, Lihua; Guo, Rui; Jiang, Xufeng; Zhang, Min; Li, Biao] Shanghai Jiao Tong Univ, Sch Med, Dept Nucl Med, Rui Jin Hosp, Shanghai 200030, Peoples R China; [Liang, Sheng] Shanghai Jiao Tong Univ, Sch Med, Dept Nucl Med, Xin Hua Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Nucl Med, Rui Jin Hosp, Shanghai 200030, Peoples R China.	lb10363@rjh.com.cn			National Natural Science Foundation of China [NSFC 30900375]; Shanghai Outstanding Academic Leaders Project [11XD1403700]; China National leading clinical discipline project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Outstanding Academic Leaders Project; China National leading clinical discipline project	This work was funded by National Natural Science Foundation of China (NSFC 30900375, http://isisn.nsfc.gov.cn/egrantweb/), Shanghai Outstanding Academic Leaders Project (11XD1403700, http://www.stcsm.gov.cn/) and China National leading clinical discipline project.	Brader P, 2013, J NUCL MED, V54, P167, DOI 10.2967/jnumed.111.099788; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; Forouzanfar MH, 2012, GLOB HEART, V7, P331, DOI 10.1016/j.gheart.2012.10.003; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Guo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102011; Higuchi T, 2009, J NUCL MED, V50, P1088, DOI 10.2967/jnumed.108.060665; James ML, 2012, PHYSIOL REV, V92, P897, DOI 10.1152/physrev.00049.2010; Kang JH, 2005, J NUCL MED, V46, P479; Lee KH, 2005, J NUCL MED, V46, P652; LEE KJ, 1992, J BIOL CHEM, V267, P15875; LEE KJ, 1994, MOL CELL BIOL, V14, P1220, DOI 10.1128/MCB.14.2.1220; Lei Han, 2010, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V24, P232; Miyagawa M, 2005, CARDIOVASC RES, V65, P195, DOI 10.1016/j.cardiores.2004.10.001; Patrick PS, 2014, P NATL ACAD SCI USA, V111, P415, DOI 10.1073/pnas.1319000111; Perin EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022949; Rao VP, 2007, TRANSPLANTATION, V84, P1662, DOI 10.1097/01.tp.0000295932.26883.ba; Ricci D, 2008, EUR J CARDIO-THORAC, V33, P32, DOI 10.1016/j.ejcts.2007.09.033; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Su H, 2004, P NATL ACAD SCI USA, V101, P16280, DOI 10.1073/pnas.0407449101; Vadysirisack DD, 2006, J NUCL MED, V47, P182; Velazquez EJ, 2012, CIRC-CARDIOVASC IMAG, V5, P271, DOI 10.1161/CIRCIMAGING.111.964650; Wu JC, 2004, CIRCULATION, V110, P685, DOI 10.1161/01.CIR.0000138153.02213.22; Zhang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092326	23	0	0	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133952	10.1371/journal.pone.0133952	http://dx.doi.org/10.1371/journal.pone.0133952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230833	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400062
J	Zhao, YQ; Zhou, M; Gao, Y; Liu, HY; Yang, WY; Yue, JH; Chen, DK				Zhao, Yanqing; Zhou, Ming; Gao, Yang; Liu, Heyuan; Yang, Wenyu; Yue, Jinhua; Chen, Dekun			Shifted T Helper Cell Polarization in a Murine Staphylococcus aureus Mastitis Model	PLOS ONE			English	Article							BOVINE MAMMARY-GLAND; ANTIMICROBIAL SUSCEPTIBILITY; BACTERIAL CAUSES; RISK-FACTORS; DAIRY FARMS; IMMUNITY; PREVALENCE; COWS; CYTOKINES; IL-17	Mastitis, one of the most costly diseases in dairy ruminants, is an inflammation of the mammary gland caused by pathogenic infection. The mechanisms of adaptive immunity against pathogens in mastitis have not been fully elucidated. To investigate T helper cell-mediated adaptive immune responses, we established a mastitis model by challenge with an inoculum of 4 x 10(6) colony-forming units of Staphylococcus aureus in the mammary gland of lactating mice, followed by quantification of bacterial burden and histological analysis. The development of mastitis was accompanied by a significant increase in both Th17 and Th1 cells in the mammary gland. Moreover, the relative expression of genes encoding cytokines and transcription factors involved in the differentiation and function of these T helper cells, including Il17, Rorc, Tgfb, Il1b, Il23, Ifng, Tbx21, and Il12, was greatly elevated in the infected mammary gland. IL-17 is essential for neutrophil recruitment to infected mammary gland via CXC chemokines, whereas the excessive IL-17 production contributes to tissue damage in mastitis. In addition, a shift in T helper cell polarization toward Th2 and Treg cells was observed 5 days post-infection, and the mRNA expression of the anti-inflammatory cytokine Il10 was markedly increased at day 7 post-infection. These results indicate that immune clearance of Staphylococcus aureus in mastitis is facilitated by the enrichment of Th17, Th1 and Th2 cells in the mammary gland mediated by pro-inflammatory cytokine production, which is tightly regulated by Treg cells and the anti-inflammatory cytokine IL-10.	[Zhao, Yanqing; Zhou, Ming; Gao, Yang; Liu, Heyuan; Yang, Wenyu; Yue, Jinhua; Chen, Dekun] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Chen, DK (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	chendekun163@163.com			Specialized Research Fund for the Doctoral Program of Higher Education [20120204110031]; Science and Technology Co-ordinate Innovation Project of Shaanxi Province, China [2013KTZB02-02-03]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science and Technology Co-ordinate Innovation Project of Shaanxi Province, China	This study was supported by the Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20120204110031, http://www.cutech.edu.cn/cn/zxgz/2012/12/1354173228992896.htm) and Science and Technology Co-ordinate Innovation Project of Shaanxi Province, China (Grant No. 2013KTZB02-02-03, http://www.shaanxi.gov.cn/0/xxgk/1/2/4/430/1374/1396/1412/39702.htm). DKC received the funding, who conceived and designed theexperiments and contributed to the writing of the manuscript.	Allen JE, 2014, SEMIN IMMUNOL, V26, P329, DOI 10.1016/j.smim.2014.06.003; Alluwaimi AM, 2004, RES VET SCI, V77, P211, DOI 10.1016/j.rvsc.2004.04.006; Bannerman DD, 2009, J ANIM SCI, V87, P10, DOI 10.2527/jas.2008-1187; Barlow J, 2011, J MAMMARY GLAND BIOL, V16, P383, DOI 10.1007/s10911-011-9235-z; Basu R, 2013, IMMUNOL REV, V252, P89, DOI 10.1111/imr.12035; Bedoya SK, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/986789; Bharathan M, 2011, J MAMMARY GLAND BIOL, V16, P409, DOI 10.1007/s10911-011-9233-1; Bougarn S, 2011, CYTOKINE, V56, P749, DOI 10.1016/j.cyto.2011.09.020; Brouillette E, 2005, MICROBES INFECT, V7, P560, DOI 10.1016/j.micinf.2004.11.008; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Contreras A, 2007, SMALL RUMINANT RES, V68, P145, DOI 10.1016/j.smallrumres.2006.09.011; Darling AR, 2014, CLIN IMMUNOL, V150, P153, DOI 10.1016/j.clim.2013.11.010; Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005; Green M, 2013, VET REC, V173, P517, DOI 10.1136/vr.f7029; Haftu R, 2012, TROP ANIM HEALTH PRO, V44, P1765, DOI 10.1007/s11250-012-0135-z; HASEGAWA T, 1993, J VET MED SCI, V55, P169, DOI 10.1292/jvms.55.169; Hogeveen H, 2011, P 50 ANN M NAT MAST; Jing XQ, 2012, J ANIM VET ADV, V11, P475; Jing XQ, 2012, ASIAN J ANIM VET ADV, V7, P1266, DOI 10.3923/ajava.2012.1266.1278; Kurebayashi Y, 2013, GENES CELLS, V18, P247, DOI 10.1111/gtc.12039; Marogna G, 2012, SMALL RUMINANT RES, V102, P74, DOI 10.1016/j.smallrumres.2011.08.013; Nagahata H, 2011, J VET MED SCI, V73, P885, DOI 10.1292/jvms.10-0379; Niteesh Kumar, 2013, International Journal of Herbal Medicine, V1, P1; Notebaert S, 2006, VET QUART, V28, P2, DOI 10.1080/01652176.2006.9695201; Paape M, 2002, J MAMMARY GLAND BIOL, V7, P109, DOI 10.1023/A:1020343717817; Pereira UP, 2011, VET MICROBIOL, V148, P117, DOI 10.1016/j.vetmic.2010.10.003; Prenafeta A, 2010, VET IMMUNOL IMMUNOP, V134, P208, DOI 10.1016/j.vetimm.2009.09.020; Rainard P, 2006, VET RES, V37, P369, DOI 10.1051/vetres:2006007; Rainard P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063471; Regassa A, 2013, TROP ANIM HEALTH PRO, V45, P1589, DOI 10.1007/s11250-013-0403-6; Rivas AL, 2000, CAN J VET RES, V64, P232; Slight SR, 2013, AM J PATHOL, V183, P1397, DOI 10.1016/j.ajpath.2013.07.008; Soltys J, 1999, INFECT IMMUN, V67, P6293; Sordillo LM, 2002, J MAMMARY GLAND BIOL, V7, P135, DOI 10.1023/A:1020347818725; Sordillo LM, 2011, J MAMMARY GLAND BIOL, V16, P271, DOI 10.1007/s10911-011-9239-8; Srinivasan P, 2013, Pak J Biol Sci, V16, P1776, DOI 10.3923/pjbs.2013.1776.1780; Tao WJ, 2007, VET IMMUNOL IMMUNOP, V120, P201, DOI 10.1016/j.vetimm.2007.06.019; Viguier C, 2009, TRENDS BIOTECHNOL, V27, P486, DOI 10.1016/j.tibtech.2009.05.004; Wenz JR, 2010, J DAIRY SCI, V93, P2458, DOI 10.3168/jds.2009-2819; Whelehan CJ, 2011, VET IMMUNOL IMMUNOP, V140, P181, DOI 10.1016/j.vetimm.2010.11.013; Wilson CR, 2013, CAN VET J, V54, P292; Zeryehun T, 2013, J ANIM PLANT SCI, V23, P50; Zhu YH, 2014, APPL ENVIRON MICROB, V80, P1787, DOI 10.1128/AEM.03668-13	43	23	23	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134797	10.1371/journal.pone.0134797	http://dx.doi.org/10.1371/journal.pone.0134797			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230498	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400168
J	Marzagalli, M; Casati, L; Moretti, RM; Marelli, MM; Limonta, P				Marzagalli, Monica; Casati, Lavinia; Moretti, Roberta M.; Marelli, Marina Montagnani; Limonta, Patrizia			Estrogen Receptor beta Agonists Differentially Affect the Growth of Human Melanoma Cell Lines	PLOS ONE			English	Article							BREAST-CANCER CELLS; ER-BETA; PROSTATE-CANCER; TRANSCRIPTIONAL ACTIVITY; DNA METHYLATION; GENE-EXPRESSION; PROLIFERATION; ISOFORMS; BIOLOGY; ALPHA	Background Cutaneous melanoma is an aggressive malignancy; its incidence is increasing worldwide and its prognosis remains poor. Clinical observations indicate that estrogen receptor beta (ER beta) is expressed in melanoma tissues and its expression decreases with tumor progression, suggesting its tumor suppressive function. These experiments were performed to investigate the effects of ER beta activation on melanoma cell growth. Methods and Results Protein expression was analyzed by Western blot and immunofluorescence assays. Cell proliferation was assessed by counting the cells by hemocytometer. ER beta transcriptional activity was evaluated by gene reporter assay. Global DNA methylation was analyzed by restriction enzyme assay and ER beta isoforms were identified by qRT-PCR. We demonstrated that ER beta is expressed in a panel of human melanoma cell lines (BLM, WM115, A375, WM1552). In BLM (NRAS-mutant) cells, ER beta agonists significantly and specifically inhibited cell proliferation. ER beta activation triggered its cytoplasmic-to-nuclear translocation and transcriptional activity. Moreover, the antiproliferative activity of ER beta agonists was associated with an altered expression of G1-S transition-related proteins. In these cells, global DNA was found to be hypomethylated when compared to normal melanocytes; this DNA hypomethylation status was reverted by ER beta activation. ER beta agonists also decreased the proliferation of WM115 (BRAF V600D-mutant) cells, while they failed to reduce the growth of A375 and WM1552 (BRAF V600E-mutant) cells. Finally, we could observe that ER beta isoforms are expressed at different levels in the various cell lines. Specific oncogenic mutations or differential expression of receptor isoforms might be responsible for the different responses of cell lines to ER beta agonists. Conclusions Our results demonstrate that ER beta is expressed in melanoma cell lines and that ER beta agonists differentially regulate the proliferation of these cells. These data confirm the notion that melanoma is a heterogeneous tumor and that genetic profiling is mandatory for the development of effective personalized therapeutic approaches for melanoma patients.	[Marzagalli, Monica; Moretti, Roberta M.; Marelli, Marina Montagnani; Limonta, Patrizia] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Casati, Lavinia] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy	University of Milan; University of Milan	Limonta, P (corresponding author), Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.	patrizia.limonta@unimi.it	Moretti, Roberta Manuela/G-7514-2012; Marzagalli, Monica/AAS-2938-2020; marelli, marina montagnani/G-7521-2012	Moretti, Roberta Manuela/0000-0001-6456-5869; marelli, marina montagnani/0000-0002-3739-6278; Casati, Lavinia/0000-0001-9044-6767; Marzagalli, Monica/0000-0001-7684-606X	Fondazione Banca del Monte di Lombardia; PRIN-MIUR [NFEB9L_004]	Fondazione Banca del Monte di Lombardia; PRIN-MIUR(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	Funding was provided by Fondazione Banca del Monte di Lombardia 2012, http://www.fbml.it/ (P.L., L.C., R.M.M., M.M.M.); PRIN-MIUR 2010-20112010, NFEB9L_004, http://prin.miur.it/ (P.L., R.M.M., M.M.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkhem T, 1998, MOL PHARMACOL, V54, P105, DOI 10.1124/mol.54.1.105; Besaratinia A, 2014, J MOL CELL BIOL, V6, P356, DOI 10.1093/jmcb/mju027; Bilal I, 2014, WORLD J CLIN ONCOL, V5, P705, DOI 10.5306/wjco.v5.i4.705; Calabrese EJ, 2013, ENVIRON POLLUT, V182, P452, DOI 10.1016/j.envpol.2013.07.046; Calabrese EJ, 2005, CRIT REV TOXICOL, V35, P463, DOI 10.1080/10408440591034502; Campbell-Thompson M, 2001, CANCER RES, V61, P632; Casati L, 2014, CELL ADHES MIGR, V8, P595, DOI 10.4161/19336918.2014.972785; Charn TH, 2010, MOL ENDOCRINOL, V24, P47, DOI 10.1210/me.2009-0252; Chaudhary SC, 2014, CANCER PREV RES, V7, P186, DOI 10.1158/1940-6207.CAPR-13-0276; Chen J, 2014, RECHARGEABLE SENSOR NETWORKS: TECHNOLOGY, THEORY, AND: APPLICATION: INTRODUCING ENERGY HARVESTING TO SENSOR NETWORKS, P1, DOI 10.1142/8911; Ciucci A, 2014, GYNECOL ONCOL, V132, P351, DOI 10.1016/j.ygyno.2013.12.027; Collins F, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-330; Dahlman-Wright K, 2006, PHARMACOL REV, V58, P773, DOI 10.1124/pr.58.4.8; de Giorgi V, 2013, BRIT J DERMATOL, V168, P513, DOI 10.1111/bjd.12056; De Giorgi V, 2011, EXPERT REV ANTICANC, V11, P739, DOI [10.1586/ERA.11.42, 10.1586/era.11.42]; de Giorgi V, 2009, ARCH DERMATOL, V145, P30, DOI 10.1001/archdermatol.2008.537; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dey P, 2014, ONCOGENE, V33, P4213, DOI 10.1038/onc.2013.384; Dey P, 2013, J MOL ENDOCRINOL, V51, pT61, DOI 10.1530/JME-13-0150; Dey P, 2012, MOL ENDOCRINOL, V26, P1991, DOI 10.1210/me.2012.1227; Docquier A, 2013, MOL ENDOCRINOL, V27, P1429, DOI 10.1210/me.2012-1351; Dondi D, 2010, ENDOCR-RELAT CANCER, V17, P731, DOI 10.1677/ERC-10-0032; Ecsedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096612; Ecsedi SI, 2013, INT J CLIN EXP PATHO, V6, P2943; Ekedahl H, 2013, BRIT J DERMATOL, V169, P1049, DOI 10.1111/bjd.12504; Foster JS, 2001, TRENDS ENDOCRIN MET, V12, P320, DOI 10.1016/S1043-2760(01)00436-2; Hapangama DK, 2015, HUM REPROD UPDATE, V21, P174, DOI 10.1093/humupd/dmu053; Harrison ME, 2014, EXP MOL PATHOL, V97, P211, DOI 10.1016/j.yexmp.2014.07.006; Hartman J, 2009, CANCER RES, V69, P6100, DOI 10.1158/0008-5472.CAN-09-0506; Heinzerling L, 2013, BRIT J CANCER, V108, P2164, DOI 10.1038/bjc.2013.143; Jilaveanu LB, 2009, CLIN DERMATOL, V27, P614, DOI 10.1016/j.clindermatol.2008.09.020; Joosse A, 2011, J INVEST DERMATOL, V131, P719, DOI 10.1038/jid.2010.354; Leung AM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00110; Leung YK, 2006, P NATL ACAD SCI USA, V103, P13162, DOI 10.1073/pnas.0605676103; Leung YK, 2006, NEOPLASIA, V8, P242, DOI 10.1593/neo.05853; Leung YK, 2012, STEROIDS, V77, P727, DOI 10.1016/j.steroids.2012.03.008; Leung YK, 2010, ENDOCR-RELAT CANCER, V17, P675, DOI 10.1677/ERC-09-0294; Lewies A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00215; Liu XW, 2014, CELL CYCLE, V13, DOI [10.4161/cc.26971, 10.4161/cc.28607]; Liu XY, 2015, MOL MED REP, V11, P1516, DOI 10.3892/mmr.2014.2811; Liu ZG, 2013, ENDOCRINE, V44, P517, DOI 10.1007/s12020-013-9916-z; Lo JA, 2014, SCIENCE, V346, P945, DOI 10.1126/science.1253735; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Manente AG, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.32; Martini PGV, 2000, MOL CELL BIOL, V20, P6224, DOI 10.1128/MCB.20.17.6224-6232.2000; Marzioni M, 2012, DIGEST LIVER DIS, V44, P134, DOI 10.1016/j.dld.2011.06.014; McPherson SJ, 2010, P NATL ACAD SCI USA, V107, P3123, DOI 10.1073/pnas.0905524107; Moore JT, 1998, BIOCHEM BIOPH RES CO, V247, P75, DOI 10.1006/bbrc.1998.8738; Moretti RM, 2002, J CLIN ENDOCR METAB, V87, P3791, DOI 10.1210/jc.87.8.3791; Moretti RM, 2010, ENDOCRINOLOGY, V151, P4643, DOI 10.1210/en.2010-0163; Moschetta M, 2012, CANCER RES, V72, P1814, DOI 10.1158/0008-5472.CAN-11-1919; Nair HB, 2011, STEROIDS, V76, P792, DOI 10.1016/j.steroids.2011.02.038; Nakamura Y, 2013, PROSTATE, V73, P590, DOI 10.1002/pros.22599; Nilsson S, 2011, CLIN PHARMACOL THER, V89, P44, DOI 10.1038/clpt.2010.226; Nilsson S, 2011, NAT REV DRUG DISCOV, V10, P778, DOI 10.1038/nrd3551; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Pasquali S, 2014, CANCER TREAT REV, V40, P893, DOI 10.1016/j.ctrv.2014.06.008; Piccolella M, 2014, PHARMACOL RES, V79, P13, DOI 10.1016/j.phrs.2013.10.002; Pinton G, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-227; Pinton G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014110; Ramsey TL, 2004, ENDOCRINOLOGY, V145, P149, DOI 10.1210/en.2003-1043; Rizza P, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3619; Ruddy SC, 2014, MOL CANCER THER, V13, P1882, DOI 10.1158/1535-7163.MCT-13-1066; Sareddy GR, 2012, MOL CANCER THER, V11, P1174, DOI 10.1158/1535-7163.MCT-11-0960; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Schmidt AN, 2006, EXP DERMATOL, V15, P971, DOI 10.1111/j.1600-0625.2006.00502.x; Scoggins CR, 2006, ANN SURG, V243, P693, DOI 10.1097/01.sla.0000216771.81362.6b; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; VANMUIJEN GNP, 1991, CLIN EXP METASTAS, V9, P259, DOI 10.1007/BF01753729; Voskoboynik M, 2014, BIOCHEM RES INT, V2014, DOI 10.1155/2014/307059; Vujic I, 2015, ONCOTARGET, V6, P969, DOI 10.18632/oncotarget.2824; Wang J, 2015, BREAST CANCER RES TR, V152, P255, DOI 10.1007/s10549-015-3467-3; Warner M, 2010, BIOCHEM BIOPH RES CO, V396, P63, DOI 10.1016/j.bbrc.2010.02.144; Wu ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089806; Xie YX, 2007, TOXICOLOGY, V236, P7, DOI 10.1016/j.tox.2007.03.021; Yakimchuk K, 2014, BLOOD, V123, P2054, DOI 10.1182/blood-2013-07-517292; Yang GS, 2007, CHINESE MED J-PEKING, V120, P1611, DOI 10.1097/00029330-200709020-00012; Zhao CY, 2009, ENDOCRINE, V36, P224, DOI 10.1007/s12020-009-9233-8; Zhou JH, 2014, AM J DERMATOPATH, V36, P74, DOI 10.1097/DAD.0b013e3182914c64	81	28	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134396	10.1371/journal.pone.0134396	http://dx.doi.org/10.1371/journal.pone.0134396			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225426	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700088
J	Wu, F; Song, HB; Zhang, Y; Zhang, YZ; Mu, Q; Jiang, M; Wang, F; Zhang, W; Li, L; Li, HJ; Wang, YS; Zhang, MX; Li, SW; Yang, LJ; Meng, Y; Tang, DQ				Wu, Fei; Song, Haibo; Zhang, Yuan; Zhang, Yuzhu; Mu, Qian; Jiang, Miao; Wang, Fang; Zhang, Wen; Li, Liang; Li, Huanjie; Wang, Yunshan; Zhang, Mingxiang; Li, Shiwu; Yang, Lijun; Meng, Yan; Tang, Dongqi			Irisin Induces Angiogenesis in Human Umbilical Vein Endothelial Cells In Vitro and in Zebrafish Embryos In Vivo via Activation of the ERK Signaling Pathway	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; EXPRESSION; GROWTH; MOUSE; DIFFERENTIATION; ADIPOCYTES; MARKERS; MODEL; FAT; JNK	As a link between exercise and metabolism, irisin is assumed to be involved in increased total body energy expenditure, reduced body weight, and increased insulin sensitivity. Although our recent evidence supported the contribution of irisin to vascular endothelial cell (ECs) proliferation and apoptosis, further research of irisin involvement in the angiogenesis of ECs was not conclusive. In the current study, it was found that irisin promoted Human Umbilical Vein Endothelial Cell (HUVEC) angiogenesis via increasing migration and tube formation, and attenuated chemically-induced intersegmental vessel (ISV) angiogenic impairment in transgenic TG (fli1:GFP) zebrafish. It was further demonstrated that expression of matrix metalloproteinase (MMP) 2 and 9 were also up-regulated in endothelial cells. We also found that irisin activated extracellular signal-related kinase (ERK) signaling pathways. Inhibition of ERK signaling by using U0126 decreased the pro-migration and proangiogenic effect of irisin on HUVEC. Also, U0126 inhibited the elevated expression of MMP-2 and MMP-9 when they were treated with irisin. In summary, these findings provided direct evidence that irisin may play a pivotal role in maintaining endothelium homeostasis by promoting endothelial cell angiogenesis via the ERK signaling pathway.	[Wu, Fei; Song, Haibo; Zhang, Yuan; Zhang, Yuzhu; Mu, Qian; Jiang, Miao; Wang, Fang; Zhang, Wen; Li, Liang; Tang, Dongqi] Shandong Univ, Hosp 2, Ctr Stem Cell & Regenerat Med, Jinan 250012, Peoples R China; [Li, Huanjie; Wang, Yunshan] Shandong Univ, Jinan Cent Hosp, Jinan 250012, Peoples R China; [Zhang, Mingxiang] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250012, Peoples R China; [Li, Shiwu; Yang, Lijun] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Meng, Yan] Shandong Univ, Hosp 2, Dept Urol, Jinan 250012, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; State University System of Florida; University of Florida; Shandong University	Meng, Y (corresponding author), Shandong Univ, Hosp 2, Dept Urol, Jinan 250012, Peoples R China.	mengyan2000@126.com; tangdq@sdu.edu.cn	Zhang, Yuan/B-3806-2019		Taishan Scholar Special Funding of Shandong Province [21300084963048]	Taishan Scholar Special Funding of Shandong Province	This work was supported by Taishan Scholar Special Funding of Shandong Province (Grant number 21300084963048) to DT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2010, CLIN EXP METASTAS, V27, P419, DOI 10.1007/s10585-010-9312-5; Albrecht-Schgoer K, 2012, CIRCULATION, V126, P2491, DOI 10.1161/CIRCULATIONAHA.111.076950; Aronis K, 2013, INTERNATIONAL JOURNA; Biscetti F, 2009, NUTR METAB CARDIOVAS, V19, P751, DOI 10.1016/j.numecd.2009.04.011; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Choi YK, 2013, DIABETES RES CLIN PR, V100, P96, DOI 10.1016/j.diabres.2013.01.007; Colaianni G, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/902186; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Dong FY, 2014, CANCER BIOL THER, V15, P1479, DOI 10.4161/15384047.2014.955728; Ebrahimian TG, 2005, ARTERIOSCL THROM VAS, V25, P65, DOI 10.1161/01.ATV.0000149377.90852.d8; Ellis LM, 2001, SEMINARS ONCOLOGY; Gannon NP, 2015, INT J CANCER, V136, pE197, DOI 10.1002/ijc.29142; Hashemi MS, 2013, NEUROSCIENCE, V231, P296, DOI 10.1016/j.neuroscience.2012.11.041; HERRON GS, 1986, J BIOL CHEM, V261, P2814; Hunter J, 2007, CLIN ORTHOP RELAT R, P27, DOI 10.1097/BLO.0b013e31803dd01c; Iacobazzi D, 2015, CELL PHYSIOL BIOCHEM, V36, P384, DOI 10.1159/000430257; Jin YJ, 2011, CELL SIGNAL, V23, P125, DOI 10.1016/j.cellsig.2010.08.012; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim BS, 2014, BIOCHEM BIOPH RES CO, V450, P1333, DOI 10.1016/j.bbrc.2014.06.137; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Li SW, 2010, PROTEIN EXPRES PURIF, V72, P157, DOI 10.1016/j.pep.2010.04.004; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; Lu J, 2010, CANCER RESEARCH SUPP, V70, P5760; Moon HS, 2013, METABOLISM, V62, P1131, DOI 10.1016/j.metabol.2013.04.007; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Park YS, 2015, J CELL PHYSIOL, V230, P140, DOI 10.1002/jcp.24690; Pourgholami MH, 2010, BIOCHEM BIOPH RES CO, V397, P729, DOI 10.1016/j.bbrc.2010.06.019; Singhal V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100218; Song HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110273; Tal TL, 2014, REPROD TOXICOL, V48, P51, DOI 10.1016/j.reprotox.2014.05.014; Williams SB, 1998, CIRCULATION, V97, P1695, DOI 10.1161/01.CIR.97.17.1695; Wood JM, 2000, CANCER RES, V60, P2178; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Zhang CB, 2015, CELL BIOCHEM BIOPHYS, V71, P1319, DOI 10.1007/s12013-014-0351-4; Zhang M, 2014, EUR REV MED PHARMACO, V18, P1567; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	40	71	76	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134662	10.1371/journal.pone.0134662	http://dx.doi.org/10.1371/journal.pone.0134662			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241478	Green Submitted, gold, Green Published			2022-12-27	WOS:000358942700056
J	Yang, H; Luo, P; Wang, J; Mou, CX; Mo, L; Wang, ZY; Fu, Y; Lin, HH; Yang, YP; Bhatta, LD				Yang, Hao; Luo, Peng; Wang, Jun; Mou, Chengxiang; Mo, Li; Wang, Zhiyuan; Fu, Yao; Lin, Honghui; Yang, Yongping; Bhatta, Laxmi Dutt			Ecosystem Evapotranspiration as a Response to Climate and Vegetation Coverage Changes in Northwest Yunnan, China	PLOS ONE			English	Article							SURFACE-ENERGY-BALANCE; WATER YIELD; DROUGHT; FOREST; BIODIVERSITY; IMPACTS; TEMPERATURE; CATCHMENT; PRECIPITATION; CONSERVATION	Climate and human-driven changes play an important role in regional droughts. Northwest Yunnan Province is a key region for biodiversity conservation in China, and it has experienced severe droughts since the beginning of this century; however, the extent of the contributions from climate and human-driven changes remains unclear. We calculated the ecosystem evapotranspiration (ET) and water yield (WY) of northwest Yunnan Province, China from 2001 to 2013 using meteorological and remote sensing observation data and a Surface Energy Balance System(SEBS) model. Multivariate regression analyses were used to differentiate the contribution of climate and vegetation coverage to ET. The results showed that the annual average vegetation coverage significantly increased over time with a mean of 0.69 in spite of the precipitation fluctuation. Afforestation/reforestation and other management efforts attributed to vegetation coverage increase in NW Yunnan. Both ET and WY considerably fluctuated with the climate factors, which ranged from 623.29 mm to 893.8 mm and -51.88 mm to 384.40 mm over the time period. Spatially, ET in the southeast of NW Yunnan (mainly in Lijiang) increased significantly, which was in line with the spatial trend of vegetation coverage. Multivariate linear regression analysis indicated that climatic factors accounted for 85.18% of the ET variation, while vegetation coverage explained 14.82%. On the other hand, precipitation accounted for 67.5% of the WY. We conclude that the continuous droughts in northwest Yunnan were primarily climatically driven; however, man-made land cover and vegetation changes also increased the vulnerability of local populations to drought. Because of the high proportion of the water yield consumed for subsistence and poor infrastructure for water management, local populations have been highly vulnerable to climate drought conditions. We suggest that conservation of native vegetation and development of water-conserving agricultural practices should be implemented as adaptive strategies to mitigate climate change.	[Yang, Hao; Luo, Peng; Wang, Jun; Mou, Chengxiang; Mo, Li] Chinese Acad Sci, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu Inst Biol, Chengdu, Peoples R China; [Yang, Hao; Wang, Jun; Lin, Honghui] Sichuan Univ, Coll Life Sci, Chengdu 610064, Peoples R China; [Luo, Peng] Chinese Acad Sci, Ecol Restorat & Biodivers Conservat Key Lab Sichu, Chengdu Inst Biol, Chengdu, Peoples R China; [Wang, Jun; Mou, Chengxiang; Mo, Li] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Zhiyuan] Yunnan Acad Agr Sci, Kunming, Peoples R China; [Fu, Yao; Yang, Yongping] Chinese Acad Sci, Kunming Inst Bot, Kunming, Peoples R China; [Bhatta, Laxmi Dutt] Int Ctr Integrated Mt Dev, Kathmandu, Nepal	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Sichuan University; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Yunnan Academy of Agricultural Sciences; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Luo, P (corresponding author), Chinese Acad Sci, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu Inst Biol, Chengdu, Peoples R China.	luopeng@cib.ac.cn			National Natural Science Foundation of China [31170432]; Basic Study Project of Science & Technology Ministry [2012FY110300]; International Center for Integrated Mountain Development (HICAP); CEPF Project of Shan Shui Conservation Center [201204003]; John D. and Catherine T. MacArthur foundation [104115]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Study Project of Science & Technology Ministry; International Center for Integrated Mountain Development (HICAP); CEPF Project of Shan Shui Conservation Center; John D. and Catherine T. MacArthur foundation	This research was funded by the National Natural Science Foundation of China (31170432), the Basic Study Project of Science & Technology Ministry (2012FY110300), the International Center for Integrated Mountain Development (HICAP), the CEPF Project of Shan Shui Conservation Center (201204003), and the John D. and Catherine T. MacArthur foundation (104115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhaier F, 2012, HYDROL EARTH SYST SC, V16, P1833, DOI 10.5194/hess-16-1833-2012; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Allen RG, 2007, J IRRIG DRAIN ENG, V133, P380, DOI 10.1061/(ASCE)0733-9437(2007)133:4(380); Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Belal AA, 2014, ARAB J GEOSCI, V7, P35, DOI 10.1007/s12517-012-0707-2; Berrang-Ford L, 2011, GLOBAL ENVIRON CHANG, V21, P25, DOI 10.1016/j.gloenvcha.2010.09.012; Brandt JS, 2013, BIOL CONSERV, V158, P116, DOI 10.1016/j.biocon.2012.07.026; Brandt JS, 2012, REMOTE SENS ENVIRON, V121, P358, DOI 10.1016/j.rse.2012.02.010; Brown AE, 2005, J HYDROL, V310, P28, DOI 10.1016/j.jhydrol.2004.12.010; Cai GY, 2011, IFIP ADV INF COMM TE, V345, P243; Cao Gong-xiang, 2013, Yingyong Shengtai Xuebao, V24, P2089; Chen F, 2014, RANGELAND J, V36, P185, DOI 10.1071/RJ13098; Chen MP, 2015, CLIMATIC CHANGE, V128, P367, DOI 10.1007/s10584-014-1163-7; Chen X, 2014, ATMOS CHEM PHYS, V14, P13097, DOI 10.5194/acp-14-13097-2014; Cook BI, 2009, P NATL ACAD SCI USA, V106, P4997, DOI 10.1073/pnas.0810200106; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; Delworth TL, 2014, NAT GEOSCI, V7, P583, DOI 10.1038/NGEO2201; Du H, 2014, RESOURCES ENV YANGTZ, V23, P715; Elhag M, 2011, WATER RESOUR MANAG, V25, P2731, DOI 10.1007/s11269-011-9835-9; Frayer J, 2014, FORESTS, V5, P3257, DOI 10.3390/f5123257; Frayer J, 2014, LAND USE POLICY, V36, P248, DOI 10.1016/j.landusepol.2013.08.005; Fu CB, 2003, GLOBAL PLANET CHANGE, V37, P219, DOI 10.1016/S0921-8181(02)00207-2; Fu GB, 2009, CLIMATIC CHANGE, V97, P193, DOI 10.1007/s10584-009-9579-1; Gitay H, 2002, CLIMATE CHANGE BIODI; Gutman G, 1998, INT J REMOTE SENS, V19, P1533, DOI 10.1080/014311698215333; Houghton RA, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001970; Huang XH, 2014, SCI WORLD J, DOI 10.1155/2014/954849; Jing X, 2011, MATH COMPUT MODEL, V54, P1079, DOI 10.1016/j.mcm.2010.11.038; Li S, 2013, HYDROL PROCESS, V27, P3981, DOI 10.1002/hyp.9541; Li Z., 2015, SPATIAL TEMPORAL VAR, P61; Li ZX, 2011, QUATERN INT, V236, P127, DOI 10.1016/j.quaint.2010.05.017; Licata JA, 2008, FOREST ECOL MANAG, V255, P753, DOI 10.1016/j.foreco.2007.09.061; [刘建刚 Liu Jiangang], 2011, [防灾减灾工程学报, Journal of Disaster Prevention and Mitigation Engineering], V31, P196; Liu LY, 2009, ENVIRON MONIT ASSESS, V153, P339, DOI 10.1007/s10661-008-0360-0; Liu ML, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003687; Liu Y, 2013, HYDROL EARTH SYST SC, V17, P4957, DOI 10.5194/hess-17-4957-2013; Lu JM, 2012, SCI CHINA EARTH SCI, V55, P98, DOI 10.1007/s11430-011-4348-1; Lu Z, 2011, MUNICH PERSONAL REPE, P1; Lyon B, 2005, J AM WATER RESOUR AS, V41, P1457, DOI 10.1111/j.1752-1688.2005.tb03812.x; Ma W, 2011, HYDROL EARTH SYST SC, V15, P1403, DOI 10.5194/hess-15-1403-2011; Macfarlane C, 2010, FOREST ECOL MANAG, V260, P96, DOI 10.1016/j.foreco.2010.04.005; Melick D, 2006, MT RES DEV, V26, P292, DOI 10.1659/0276-4741(2006)26[292:ELBAAM]2.0.CO;2; Morell V, 2008, SCIENCE, V320, P1442, DOI 10.1126/science.320.5882.1442; Polasky S, 2011, ENVIRON RESOUR ECON, V48, P219, DOI 10.1007/s10640-010-9407-0; Qin TL, 2014, J APPL MATH, DOI 10.1155/2014/673485; Qiu J, 2010, NATURE, V465, P142, DOI 10.1038/465142a; Quality and Technical Supervision Bureau of Yunnan Province, 2013, DB53T1862013 QUAL TE; Rosenberg NJ, 1999, CLIMATIC CHANGE, V42, P677, DOI 10.1023/A:1005424003553; Scoot DF, 2000, REANALYSIS S AFRICAN; State Forestry Administration of the People's Republic of China, 2009, 7 NAT FOR RES INV RE; Statistic Bureau of Yunnan Province, 2001, YUNN STAT YB; Stone R, 2010, SCIENCE, V327, P1311, DOI 10.1126/science.327.5971.1311; Su YF, 2012, REG ENVIRON CHANGE, V12, P855, DOI 10.1007/s10113-012-0304-7; Su Z, 2003, INT GEOSCI REMOTE SE, P1166; Su Z, 2002, HYDROL EARTH SYST SC, V6, P85, DOI 10.5194/hess-6-85-2002; Su Z, 2001, ADV EARTH OBSERVATIO, V01-02, P91; Sun G, 2005, J HYDROL, V308, P258, DOI 10.1016/j.jhydrol.2004.11.021; Tan ZH, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL050006; Tang ZY, 2006, FRONT ECOL ENVIRON, V4, P347, DOI 10.1890/1540-9295(2006)004[0347:BICM]2.0.CO;2; Wang Y, 2007, SCI TECHNOLOGY DALI, V2, P9; Wang ZX, 2010, J ENVIRON DEV, V19, P28, DOI 10.1177/1070496509338838; Water Resources Department of Yunnan Province, 2001, YUNN PROV WAT RES B; Weiss M, 2009, ECOL SOC, V14; Weyerhaeuser H, 2005, AGR SYST, V85, P234, DOI 10.1016/j.agsy.2005.06.008; World Meteorological Organization, 1976, 449 WORLD MET ORG, P6; Wu BF, 2004, INT GEOSCI REMOTE SE, P4352; Wu H, 2013, GREENPEACE, V1, P56; Xu JC, 2004, BIODIVERS CONSERV, V13, P959, DOI 10.1023/B:BIOC.0000014464.80847.02; Xu X, 2012, HYDROL EARTH SYST SC, V16, P43, DOI 10.5194/hess-16-43-2012; Yang DW, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR006948; Yang JW., 2002, FOR RESOUR MANAG, V3, P61; Yang XF, 2009, ECOL SOC, V14; Yang YM, 2004, BIODIVERS CONSERV, V13, P813, DOI 10.1023/B:BIOC.0000011728.46362.3c; Yin H, 2013, J ARID METEOROL, V31, P182, DOI DOI 10.11755/J.ISSN.1006-7639(2013)-01-0182; Yu HY, 2010, P NATL ACAD SCI USA, V107, P22151, DOI 10.1073/pnas.1012490107; Zhang JL, 2014, INT J APPL EARTH OBS, V31, P25, DOI 10.1016/j.jag.2014.01.006; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325; Zhang W. J., 2012, ENV SKEPT CRIT, V1, P34; [张远东 Zhang Yuandong], 2011, [生态学报, Acta Ecologica Sinica], V31, P7601; Zhao CH, 2013, ADV METEOROL, V2013, DOI 10.1155/2013/295856	80	17	21	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134795	10.1371/journal.pone.0134795	http://dx.doi.org/10.1371/journal.pone.0134795			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237220	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942400039
J	Jiang, YH; Jiang, P; Yang, JL; Ma, DF; Lin, HQ; Su, WG; Wang, Z; Li, X				Jiang, Yue-Hua; Jiang, Ping; Yang, Jin-long; Ma, Du-Fang; Lin, Hai-Qing; Su, Wen-ge; Wang, Zhen; Li, Xiao			Cardiac Dysregulation and Myocardial Injury in a 6-Hydroxydopamine-Induced Rat Model of Sympathetic Denervation	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RENAL DENERVATION; AUTONOMIC DENERVATION; TYROSINE-HYDROXYLASE; ARTERIAL-PRESSURE; DIABETIC-RATS; NERVE; VAGAL; ELECTROCARDIOGRAM; MODULATION	Background Cardiac sympathetic denervation is found in various cardiac pathologies; however, its relationship with myocardial injury has not been thoroughly investigated. Methods Twenty-four rats were assigned to the normal control group (NC), sympathectomy control group (SC), and a sympathectomy plus mecobalamin group (SM). Sympathectomy was induced by injection of 6-OHDA, after which, the destruction and distribution of sympathetic and vagal nerve in the left ventricle (LV) myocardial tissue were determined by immunofluorescence and ELISA. Heart rate variability (HRV), ECG and echocardiography, and assays for myocardial enzymes in serum before and after sympathectomy were examined. Morphologic changes in the LV by HE staining and transmission electron microscope were used to estimate levels of myocardial injury and concentrations of inflammatory cytokines were used to reflect the inflammatory reaction. Results Injection of 6-OHDA decreased NE (933.1 +/- 179 ng/L for SC vs. 3418.1 +/- 443.6 ng/L for NC, P < 0.01) and increased NGF (479.4 +/- 56.5 ng/mL for SC vs. 315.85 +/- 28.6 ng/mL for NC, P < 0.01) concentrations. TH expression was reduced, while ChAT expression showed no change. Sympathectomy caused decreased HRV and abnormal ECG and echocardiography results, and histopathologic examinations showed myocardial injury and increased collagen deposition as well as inflammatory cell infiltration in the cardiac tissue of rats in the SC and SM groups. However, all pathologic changes in the SM group were less severe compared to those in the SC group. Conclusions Chemical sympathectomy with administration of 6-OHDA caused dysregulation of the cardiac autonomic nervous system and myocardial injuries. Mecobalamin alleviated inflammatory and myocardial damage by protecting myocardial sympathetic nerves.	[Jiang, Yue-Hua; Yang, Jin-long; Lin, Hai-Qing; Su, Wen-ge; Wang, Zhen; Li, Xiao] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Jinan, Shandong, Peoples R China; [Jiang, Ping; Ma, Du-Fang] Shandong Univ Tradit Chinese Med, Jinan, Shandong, Peoples R China	Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine	Li, X (corresponding author), Shandong Univ Tradit Chinese Med, Affiliated Hosp, Jinan, Shandong, Peoples R China.	ljy6617@163.com		Yang, Jinlong/0000-0002-5355-1493; Jiang, Yue-Hua/0000-0003-0156-0715	Chinese national natural science foundation [81072962]; Shan Dong Province "Taishan Scholar" Construction Project [2012-55]	Chinese national natural science foundation(National Natural Science Foundation of China (NSFC)); Shan Dong Province "Taishan Scholar" Construction Project	This work was funded by Chinese national natural science foundation #81072962 and Shan Dong Province "Taishan Scholar" Construction Project Awards #2012-55.	AKTAS M, 1993, VET RES COMMUN, V17, P353, DOI 10.1007/BF01839386; Aronson D, 2001, J CARDIOVASC ELECTR, V12, P294, DOI 10.1046/j.1540-8167.2001.00294.x; Arvidsson U, 1997, J COMP NEUROL, V378, P454; Aubert AE, 1999, COMPUT METH PROG BIO, V60, P197, DOI 10.1016/S0169-2607(99)00017-6; Boettger S, 2006, CLIN NEUROPHYSIOL, V117, P2715, DOI 10.1016/j.clinph.2006.08.009; Bonnemeier H, 2003, J CARDIOVASC ELECTR, V14, P791, DOI 10.1046/j.1540-8167.2003.03078.x; BOTTING JH, 1983, BRIT J PHARMACOL, V79, P265, DOI 10.1111/j.1476-5381.1983.tb10520.x; Brum PC, 2002, AM J PHYSIOL-HEART C, V283, pH1838, DOI 10.1152/ajpheart.01063.2001; Burgi K, 2011, AM J PHYSIOL-REG I, V300, pR264, DOI 10.1152/ajpregu.00687.2009; Camm AJ, 1996, CIRCULATION, V93, P1043; DiBona GF, 2004, AM J PHYSIOL-RENAL, V286, pF1209, DOI 10.1152/ajprenal.00010.2004; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Facoetti A, 2006, EUR J HISTOCHEM, V50, P133; Franco LG, 2009, ACTA CIR BRAS, V24, P36, DOI 10.1590/S0102-86502009000100008; GAUTHIER P, 1972, CIRC RES, V31, P207, DOI 10.1161/01.RES.31.2.207; Hage FG, 2011, CIRC-CARDIOVASC IMAG, V4, P79, DOI 10.1161/CIRCIMAGING.111.963967; Herring N, 2015, EXP PHYSIOL, V100, P354, DOI 10.1113/expphysiol.2014.080184; Herring N, 2012, J MOL CELL CARDIOL, V52, P667, DOI 10.1016/j.yjmcc.2011.11.016; HILL R, 1960, BRIT J EXP PATHOL, V41, P633; Jacob F, 2003, AM J PHYSIOL-HEART C, V284, pH2302, DOI 10.1152/ajpheart.01029.2002; Joers V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104850; Joers V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035371; KANAKIS SJ, 1985, DEV BRAIN RES, V20, P197, DOI 10.1016/0165-3806(85)90106-3; Karason K, 1999, AM J CARDIOL, V83, P1242, DOI 10.1016/S0002-9149(99)00066-1; Kawamura M, 1999, NEUROCHEM RES, V24, P25, DOI 10.1023/A:1020919828028; Kleinbongard P, 2010, PHARMACOL THERAPEUT, V127, P295, DOI 10.1016/j.pharmthera.2010.05.002; KLINE RL, 1980, CAN J PHYSIOL PHARM, V58, P1384, DOI 10.1139/y80-209; Koitabashi N, 2011, J CLIN INVEST, V121, P2301, DOI 10.1172/JCI44824; KOIZUMI K, 1982, P NATL ACAD SCI-BIOL, V79, P2116, DOI 10.1073/pnas.79.6.2116; Kong X, 2014, J RENIN-ANGIO-ALDO S, V15, P259, DOI 10.1177/1470320313489061; KORSCHING S, 1985, J NEUROSCI, V5, P1058; KOSTRZEWA RM, 1974, PHARMACOL REV, V26, P199; LAVALLEE M, 1985, CIRC RES, V57, P383, DOI 10.1161/01.RES.57.3.383; Levick SP, 2010, HYPERTENSION, V55, P270, DOI 10.1161/HYPERTENSIONAHA.109.142042; Li W, 2004, AM J PHYSIOL-HEART C, V286, pH2229, DOI 10.1152/ajpheart.00768.2003; Lurie K G, 1988, Am J Cardiovasc Pathol, V2, P181; Mabe AM, 2009, CARDIOVASC RES, V82, P93, DOI 10.1093/cvr/cvp029; Machado CRS, 2000, HUM PATHOL, V31, P3, DOI 10.1016/S0046-8177(00)80191-4; Mizukami H, 2011, EUR J CLIN INVEST, V41, P442, DOI 10.1111/j.1365-2362.2010.02430.x; Nazari A, 2013, J BIOPHOTONICS, V6, P171, DOI 10.1002/jbio.201200012; NORMANN SJ, 1961, CIRC RES, V9, P282, DOI 10.1161/01.RES.9.2.282; Okada K, 2010, EXP NEUROL, V222, P191, DOI 10.1016/j.expneurol.2009.12.017; Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177; Picklo MJ, 1997, J AUTONOM NERV SYST, V62, P111, DOI 10.1016/S0165-1838(96)00121-X; Piya MK, 2011, METABOLISM, V60, P1115, DOI 10.1016/j.metabol.2010.12.004; Roach D, 2004, J AM COLL CARDIOL, V43, P2271, DOI 10.1016/j.jacc.2004.01.050; Rubart M, 2005, J CLIN INVEST, V115, P2305, DOI 10.1172/JCI26381; Salman IM, 2010, INDIAN J MED RES, V131, P76; SAMBHI MP, 1960, CIRC RES, V8, P129, DOI 10.1161/01.RES.8.1.129; Schneider R, 2010, HISTOL HISTOPATHOL, V25, P1581, DOI 10.14670/HH-25.1581; SONOBE M, 1988, HORM METAB RES, V20, P717, DOI 10.1055/s-2007-1010925; STEIN PK, 1995, AM HEART J, V129, P975, DOI 10.1016/0002-8703(95)90119-1; Sun Yu, 2005, Acta Neurol Taiwan, V14, P48; Tarvainen MP, 2002, IEEE T BIO-MED ENG, V49, P172, DOI 10.1109/10.979357; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Utsunomiya K, 1998, EUR J NUCL MED, V25, P1643, DOI 10.1007/s002590050343; XQ S, 1989, EXPT ZOOLOGY MED; YANOWITZ F, 1966, CIRC RES, V18, P416, DOI 10.1161/01.RES.18.4.416; Zulfiqar U, 2010, AM J CARDIOL, V105, P1181, DOI 10.1016/j.amjcard.2009.12.022	59	17	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133971	10.1371/journal.pone.0133971	http://dx.doi.org/10.1371/journal.pone.0133971			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230083	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400065
J	Kowalska, A; Palyga, I; Gasior-Perczak, D; Walczyk, A; Trybek, T; Sluszniak, A; Mezyk, R; Gozdz, S				Kowalska, Aldona; Palyga, Iwona; Gasior-Perczak, Danuta; Walczyk, Agnieszka; Trybek, Tomasz; Sluszniak, Anna; Mezyk, Ryszard; Gozdz, Stanislaw			The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid Cancer	PLOS ONE			English	Article							LOW-RISK PATIENTS; SERUM THYROGLOBULIN; HUMAN THYROTROPIN; RADIOIODINE ABLATION; HORMONE WITHDRAWAL; REMNANT ABLATION; CARCINOMA; MANAGEMENT; DIAGNOSIS; RHTSH	Background The treatment of differentiated thyroid cancer (DTC) ends in full recovery in 80% of cases. However, in 20% of cases local recurrences or distant metastases are observed, for this reason DTC patients are under life-long follow-up. The most sensitive marker for recurrence is stimulated thyroglobulin (Tg) which, together with neck ultrasound (US), enables correct diagnosis in nearly all cases of the active disease. For many years the only known stimulation was a 4-5 week withdrawal from the L-T4 therapy (THW). For the last couple of years stimulation with the use of recombinant human TSH (rhTSH) has been available. This method of stimulation may have a significant influence in obtaining the Tg level. However, it is important to determine the cut-off level for rhTSH-stimulated Tg (rhTSH/Tg). Materials and Methods This is a retrospective analysis of consecutive patients from one facility who have qualified over a period of two years for repeated radioiodine therapy (RIA). In our facility the ablation effectiveness evaluation is always carried out with the use of rhTSH, with the repeated therapy following THW. Such a procedure enables two Tg measurements in the same patient after both types of stimulation within 4-5 weeks. The obtained values were compared, cutoff levels in THW conditions were used (2.0 ng/ml for patients in remission and 10.0 ng/ml for patients with an active disease). In order to determine the cut-off level for rhTSH/Tg, regression analysis and ROC curves were used. Results In 63 patients the Tg measurement of both methods of stimulation were obtained. It was observed that there was a high correlation between rhTSH/Tg and THW/Tg. However, the rhTSH/Tg level was significantly lower than THW/Tg. The rhTSH/Tg cut-off levels which corresponded to the 2.0 ng/ml and 10.0 ng/ml limits for THW/Tg were calculated and the values were 0.6 ng/ml and 2.3 ng/ml respectively. Conclusions The method of stimulation has a significant impact on the obtained Tg concentrations. The assumed THW/Tg cut off levels must not be transferred to rhTSH/Tg.	[Kowalska, Aldona; Palyga, Iwona; Gasior-Perczak, Danuta; Walczyk, Agnieszka; Trybek, Tomasz; Mezyk, Ryszard] Holycross Canc Ctr, Dept Endocrinol, Kielce, Poland; [Sluszniak, Anna] Holycross Canc Ctr, Lab Tumor Markers, Kielce, Poland; [Gozdz, Stanislaw] Holycross Canc Ctr, Dept Clin Oncol, Kielce, Poland		Kowalska, A (corresponding author), Holycross Canc Ctr, Dept Endocrinol, Kielce, Poland.	aldonako@onkol.kielce.pl	Kielce, SCO/O-6702-2016; Gąsior-Perczak, Danuta/AAM-2668-2020; Walczyk, Agnieszka/ABC-3334-2020; Gozdz, Stanislaw/D-3300-2013	Gąsior-Perczak, Danuta/0000-0003-0936-4890; Palyga, Iwona/0000-0001-5333-6112; Gozdz, Stanislaw/0000-0001-6902-3807; KOWALSKA, ALDONA/0000-0001-5647-5898; Walczyk, Agnieszka/0000-0002-5083-659X	Holycross Cancer Centre	Holycross Cancer Centre	The study was funded by Holycross Cancer Centre.	Aschebrook-Kilfoy B, 2011, THYROID, V21, P125, DOI 10.1089/thy.2010.0021; Barbaro D, 2006, NUCL MED COMMUN, V27, P627, DOI 10.1097/00006231-200608000-00005; Chianelli M, 2009, EUR J ENDOCRINOL, V160, P431, DOI 10.1530/EJE-08-0669; David A, 2005, THYROID, V15, P267, DOI 10.1089/thy.2005.15.267; Gharib H, 2010, J ENDOCRINOL INVEST, V33, P51; Haugen BR, 2002, THYROID, V12, P37, DOI 10.1089/105072502753451959; Haugen BR, 1999, J CLIN ENDOCR METAB, V84, P3877, DOI 10.1210/jc.84.11.3877; Kowalska A, 2013, THYROID RES, V6, pA30, DOI DOI 10.1186/1756-6614-6-S2-A30; Mallick U, 2012, NEW ENGL J MED, V366, P1674, DOI 10.1056/NEJMoa1109589; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; Mazzaferri EL, 2002, J CLIN ENDOCR METAB, V87, P1490, DOI 10.1210/jc.87.4.1490; Momesso DP, 2014, ENDOCRIN METAB CLIN, V43, P401, DOI 10.1016/j.ecl.2014.02.010; Nakabashi CCD, 2014, EUR THYROID J, V3, P43, DOI 10.1159/000360077; Pacini F, 2003, J CLIN ENDOCR METAB, V88, P3668, DOI 10.1210/jc.2002-021925; Pacini F, 2001, J CLIN ENDOCR METAB, V86, P5686, DOI 10.1210/jc.86.12.5686; PACINI F, 1980, CLIN ENDOCRINOL, V13, P107, DOI 10.1111/j.1365-2265.1980.tb01030.x; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Schlumberger M, 2003, THYROID TUMORS, P163; Schlumberger M, 2012, NEW ENGL J MED, V366, P1663, DOI 10.1056/NEJMoa1108586; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Sipos JA, 2010, CLIN ONCOL-UK, V22, P395, DOI 10.1016/j.clon.2010.05.004; Taieb D, 2009, CLIN ENDOCRINOL, V71, P115, DOI 10.1111/j.1365-2265.2008.03424.x; Torlontano M, 2003, EUR J ENDOCRINOL, V148, P19, DOI 10.1530/eje.0.1480019; Wojciechowska U, 2014, CANCER IN POLAND IN	24	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133852	10.1371/journal.pone.0133852	http://dx.doi.org/10.1371/journal.pone.0133852			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230494	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400058
J	Roerdink, M; Daffertshofer, A; Marmelat, V; Beek, PJ				Roerdink, Melvyn; Daffertshofer, Andreas; Marmelat, Vivien; Beek, Peter J.			How to Sync to the Beat of a Persistent Fractal Metronome without Falling Off the Treadmill?	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; TO-STRIDE FLUCTUATIONS; HUMAN GAIT; NONLINEAR DYNAMICS; HUMAN LOCOMOTION; HUMAN WALKING; VARIABILITY; INTERVAL; DISEASE; COMPLEXITY	In rehabilitation, rhythmic acoustic cues are often used to improve gait. However, stride-time fluctuations become anti-persistent with such pacing, thereby deviating from the characteristic persistent long-range correlations in stride times of self-paced walking healthy adults. Recent studies therefore experimented with metronomes with persistence in interbeat intervals and successfully evoked persistent stride-time fluctuations. The objective of this study was to examine how participants couple their gait to a persistent metronome, evoking persistently longer or shorter stride times over multiple consecutive strides, without wandering off the treadmill. Twelve healthy participants walked on a treadmill in self-paced, isochronously paced and non-isochronously paced conditions, the latter with anti-persistent, uncorrelated and persistent correlations in interbeat intervals. Stride-to-stride fluctuations of stride times, stride lengths and stride speeds were assessed with detrended fluctuation analysis, in conjunction with an examination of the coupling between stride times and stride lengths. Stride-speed fluctuations were anti-persistent for all conditions. Stride-time and stride-length fluctuations were persistent for self-paced walking and anti-persistent for isochronous pacing. Both stride times and stride lengths changed from anti-persistence to persistence over the four non-isochronous metronome conditions, accompanied by an increasingly stronger coupling between these gait parameters, with peak values for the persistent metronomes. These results revealed that participants were able to follow the beat of a persistent metronome without falling off the treadmill by strongly coupling stride-length fluctuations to the stride-time fluctuations elicited by persistent metronomes, so as to prevent large positional displacements along the treadmill. For self-paced walking, in contrast, this coupling was very weak. In combination, these results challenge the premise that persistent metronomes in gait rehabilitation would evoke stride-to-stride dynamics reminiscent of self-paced walking healthy adults. Future studies are recommended to include an analysis of the interrelation between stride times and stride lengths in addition to the correlational structure of either one in isolation.	[Roerdink, Melvyn; Daffertshofer, Andreas; Beek, Peter J.] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Dept Human Movement Sci, Fac Behav & Movement Sci, Amsterdam, Netherlands; [Marmelat, Vivien] Univ Montpellier, Movement Hlth Lab, Euromov, F-34059 Montpellier, France	Vrije Universiteit Amsterdam; Universite de Montpellier	Roerdink, M (corresponding author), Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Dept Human Movement Sci, Fac Behav & Movement Sci, Amsterdam, Netherlands.	m.roerdink@vu.nl		Daffertshofer, Andreas/0000-0001-9107-3552; Beek, Peter/0000-0002-0917-8548; Roerdink, Melvyn/0000-0002-8534-1124	Netherlands Organisation for Scientific Research (NWO) [400-08-127]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Andreas Daffertshofer received financial support from the Netherlands Organisation for Scientific Research (NWO grant #400-08-127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bank PJM, 2011, EXP BRAIN RES, V209, P159, DOI 10.1007/s00221-010-2531-9; Damouras S, 2010, GAIT POSTURE, V31, P336, DOI 10.1016/j.gaitpost.2009.12.002; Delignieres D, 2009, J APPL PHYSIOL, V106, P1272, DOI 10.1152/japplphysiol.90757.2008; Dingwell JB, 2010, GAIT POSTURE, V32, P348, DOI 10.1016/j.gaitpost.2010.06.004; Dutta S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00274; Glass L., 1988, CLOCK CHAOS RHYTHMS; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Goldberger AL, 1997, PERSPECT BIOL MED, V40, P543; Goldberger Ary L, 2006, Proc Am Thorac Soc, V3, P467, DOI 10.1513/pats.200603-028MS; Harbourne RT, 2009, PHYS THER, V89, P267, DOI 10.2522/ptj.20080130; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hausdorff JM, 2000, J APPL PHYSIOL, V88, P2045, DOI 10.1152/jappl.2000.88.6.2045; Hove MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032600; Hunt N, 2014, SCI REP-UK, V4, DOI 10.1038/srep05879; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; Kaipust JP, 2013, ANN BIOMED ENG, V41, P1595, DOI 10.1007/s10439-012-0654-9; Kantz H., 2004, NONLINEAR TIME SERIE; Marmelat V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091949; Mazaheri M, 2014, GAIT POSTURE, V40, P182, DOI 10.1016/j.gaitpost.2014.03.183; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Peper CE, 2012, GAIT POSTURE, V36, P378, DOI 10.1016/j.gaitpost.2012.03.032; Pierrynowski MR, 2005, GAIT POSTURE, V22, P46, DOI 10.1016/j.gaitpost.2004.06.007; Rhea CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106755; Rhea CK, 2014, HUM MOVEMENT SCI, V36, P20, DOI 10.1016/j.humov.2014.04.006; Roerdink M, 2008, J BIOMECH, V41, P2628, DOI 10.1016/j.jbiomech.2008.06.023; Roerdink M, 2014, MED BIOL ENG COMPUT, V52, P963, DOI 10.1007/s11517-014-1195-1; Roerdink M, 2011, GAIT POSTURE, V33, P690, DOI 10.1016/j.gaitpost.2011.03.001; Roerdink M, 2009, NEUROREHAB NEURAL RE, V23, P668, DOI 10.1177/1545968309332879; Schaefer A, 2014, J NEUROSCI METH, V222, P118, DOI 10.1016/j.jneumeth.2013.10.017; Sejdic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043104; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Terrier P, 2005, HUM MOVEMENT SCI, V24, P97, DOI 10.1016/j.humov.2005.03.002; Terrier P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00230; Terrier P, 2012, HUM MOVEMENT SCI, V31, P1585, DOI 10.1016/j.humov.2012.05.004; Uchitomi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072176; van Orden G., 2009, HDB PHILOS SCI, V10, P639, DOI DOI 10.1016/B978-0-444-52076-0.50022-5	41	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134148	10.1371/journal.pone.0134148	http://dx.doi.org/10.1371/journal.pone.0134148			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230254	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400077
J	Sampangi, S; Kassianos, AJ; Wang, XJ; Beagley, KW; Klein, T; Afrin, S; Healy, H; Wilkinson, R				Sampangi, Sandeep; Kassianos, Andrew J.; Wang, Xiangju; Beagley, Kenneth W.; Klein, Travis; Afrin, Sadia; Healy, Helen; Wilkinson, Ray			The Mechanisms of Human Renal Epithelial Cell Modulation of Autologous Dendritic Cell Phenotype and Function	PLOS ONE			English	Article							TUBULAR CELLS; EXPRESSION; GLOMERULONEPHRITIS; RECRUITMENT; INHIBITION; RESPONSES; RECEPTOR; SUBSETS; DISEASE; ACID	Proximal tubule epithelial cells (PTEC) of the kidney line the proximal tubule downstream of the glomerulus and play a major role in the re-absorption of small molecular weight proteins that may pass through the glomerular filtration process. In the perturbed disease state PTEC also contribute to the inflammatory disease process via both positive and negative mechanisms via the production of inflammatory cytokines which chemo-attract leukocytes and the subsequent down-modulation of these cells to prevent uncontrolled inflammatory responses. It is well established that dendritic cells are responsible for the initiation and direction of adaptive immune responses. Both resident and infiltrating dendritic cells are localised within the tubulointerstitium of the renal cortex, in close apposition to PTEC, in inflammatory disease states. We previously demonstrated that inflammatory PTEC are able to modulate autologous human dendritic cell phenotype and functional responses. Here we extend these findings to characterise the mechanisms of this PTEC immune-modulation using primary human PTEC and autologous monocyte-derived dendritic cells (MoDC) as the model system. We demonstrate that PTEC express three inhibitory molecules: (i) cell surface PD-L1 that induces MoDC expression of PD-L1; (ii) intracellular IDO that maintains the expression of MoDC CD14, drives the expression of CD80, PD-L1 and IL-10 by MoDC and inhibits T cell stimulatory capacity; and (iii) soluble HLA-G (sHLA-G) that inhibits HLA-DR and induces IL-10 expression by MoDC. Collectively the results demonstrate that primary human PTEC are able to modulate autologous DC phenotype and function via multiple complex pathways. Further dissection of these pathways is essential to target therapeutic strategies in the treatment of inflammatory kidney disorders.	[Sampangi, Sandeep; Kassianos, Andrew J.; Wang, Xiangju; Afrin, Sadia; Healy, Helen; Wilkinson, Ray] Pathol Queensland, Conjoint Kidney Res Lab, Brisbane, Qld, Australia; [Kassianos, Andrew J.; Wang, Xiangju; Healy, Helen; Wilkinson, Ray] Royal Brisbane & Womens Hosp, Dept Renal Med, Brisbane, Qld, Australia; [Sampangi, Sandeep; Beagley, Kenneth W.; Klein, Travis; Afrin, Sadia; Wilkinson, Ray] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Wilkinson, Ray] Univ Queensland, Sch Med, Brisbane, Qld, Australia	Royal Brisbane & Women's Hospital; Queensland University of Technology (QUT); University of Queensland	Wilkinson, R (corresponding author), Pathol Queensland, Conjoint Kidney Res Lab, Brisbane, Qld, Australia.	ray.wilkinson@qimr.edu.au	Beagley, Kenneth/J-1129-2012; Healy, Helen/G-2686-2010; Kassianos, Andrew/I-6767-2015; Klein, Travis/J-1117-2012	Beagley, Kenneth/0000-0003-3112-6557; Healy, Helen/0000-0003-4342-5300; Kassianos, Andrew/0000-0002-0994-3588; Klein, Travis/0000-0002-6669-7766; Afrin, Sadia/0000-0003-0501-2847	Pathology Queensland; Kidney Research Foundation; Royal Brisbane and Women's Hospital Foundation	Pathology Queensland; Kidney Research Foundation; Royal Brisbane and Women's Hospital Foundation	Funding was provided by Pathology Queensland to RW and AK, Kidney Research Foundation to SS, and Royal Brisbane and Women's Hospital Foundation to RW and AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carosella ED, 2008, TRENDS IMMUNOL, V29, P125, DOI 10.1016/j.it.2007.11.005; Carosella ED, 2011, CELL MOL LIFE SCI, V68, P337, DOI 10.1007/s00018-010-0577-2; Chen YW, 2006, NEPHRON EXP NEPHROL, V102, pE81, DOI 10.1159/000089686; Crispim JCO, 2008, TRANSPL IMMUNOL, V18, P361, DOI 10.1016/j.trim.2007.10.010; Ding HL, 2005, CLIN IMMUNOL, V115, P184, DOI 10.1016/j.clim.2005.01.005; Diwakar R, 2007, AM J PHYSIOL-RENAL, V292, pF1464, DOI 10.1152/ajprenal.00069.2006; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Fiore N, 2008, MOL IMMUNOL, V45, P259, DOI 10.1016/j.molimm.2007.04.029; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Glynne PA, 1999, KIDNEY INT, V55, P2573, DOI 10.1046/j.1523-1755.1999.00456.x; Harris RC, 2006, ANNU REV MED, V57, P365, DOI 10.1146/annurev.med.57.121304.131342; Heyliger SO, 1999, LIFE SCI, V64, P1177, DOI 10.1016/S0024-3205(99)00049-1; Hou WP, 2009, CLIN EXP IMMUNOL, V156, P363, DOI 10.1111/j.1365-2249.2009.03902.x; Kassianos AJ, 2015, KIDNEY INT, V87, P1153, DOI 10.1038/ki.2014.407; Kassianos AJ, 2013, AM J PHYSIOL-RENAL, V305, pF1391, DOI 10.1152/ajprenal.00318.2013; Kassianos AJ, 2013, NEPHROL DIAL TRANSPL, V28, P303, DOI 10.1093/ndt/gfs136; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kronsteiner B, 2011, CELL IMMUNOL, V267, P30, DOI 10.1016/j.cellimm.2010.11.001; Mohib K, 2008, AM J PHYSIOL-RENAL, V295, pF226, DOI 10.1152/ajprenal.00567.2007; Morita T, 2001, ANN CLIN BIOCHEM, V38, P242, DOI 10.1258/0004563011900461; Rebmann V, 2009, HUM IMMUNOL, V70, P995, DOI 10.1016/j.humimm.2009.07.016; Sampangi S, 2015, NEPHROL DIA IN PRESS; Segerer S, 2008, KIDNEY INT, V74, P37, DOI 10.1038/ki.2008.99; Shalamanova L, 2007, AM J PHYSIOL-RENAL, V292, pF1846, DOI 10.1152/ajprenal.00265.2006; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; Wilkinson R, 2011, NEPHROL DIAL TRANSPL, V26, P1483, DOI 10.1093/ndt/gfq677	27	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134688	10.1371/journal.pone.0134688	http://dx.doi.org/10.1371/journal.pone.0134688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230727	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400149
J	Azarbaijani, BA; Sheikhi, M; Oskam, IC; Nurmio, M; Laine, T; Tinkanen, H; Makinen, S; Tanbo, TG; Hovatta, O; Jahnukainen, K				Azarbaijani, Babak Asadi; Sheikhi, Mona; Oskam, Irma C.; Nurmio, Mirja; Laine, Tiina; Tinkanen, Helena; Makinen, Sirpa; Tanbo, Tom G.; Hovatta, Outi; Jahnukainen, Kirsi			Effect of Previous Chemotherapy on the Quality of Cryopreserved Human Ovarian Tissue In Vitro	PLOS ONE			English	Article							CHILDHOOD-CANCER SURVIVOR; PRIMORDIAL FOLLICLES; FERTILITY PRESERVATION; DEVELOPMENTAL COMPETENCE; PHYSIOLOGICAL FUNCTIONS; FEMALE REPRODUCTION; MOUSE OOCYTES; CYCLOPHOSPHAMIDE; CONTAMINATION; VITRIFICATION	Background Cryopreservation of ovarian tissue has been widely accepted as an option for fertility preservation among cancer patients. Some patients are exposed to chemotherapy prior to ovarian tissue cryopreservation. Consequently, assessment of the developmental capacity of human ovarian tissue after chemotherapy is of primary importance. Materials In order to study the impact of previous chemotherapy on in vitro development and viability of ovarian follicles, quality control samples from 34 female cancer patients at median age of 15 years (range 1-35), cryopreserved for fertility preservation before (n = 14) or after (n = 20) initiation of chemotherapy, were thawed and cultured for 7 days. The morphology and developmental stages of ovarian follicles were studied by light microscopy before and after culture. Possible associations between follicular densities, age and exposure to alkylating agents, expressed as cyclophosphamide equivalent dose (CED) were tested. Results Exposure to chemotherapy significantly impaired the survival and development of ovarian follicles in culture. After seven days, significantly higher densities of intermediary, primary and secondary follicles and lower densities of atretic follicles was detected in the samples collected before chemotherapy. Increasing dose of alkylating agents was identified by multivariate linear regression analysis as an independent predictor of a higher density of atretic follicles, whereas increasing age of the patient predicted a better outcome with less follicle atresia and a higher density of maturing follicles. Conclusion This study provides quantitative in vitro evidence of the impact of chemotherapy on developmental capacity of cryopreserved human ovarian tissue. The results indicate that fertility preservation should be carried out, if possible, before initiation of alkylating agents in order to guarantee better in vitro survival of ovarian follicles. In addition, ovarian samples from younger girls show lower viability and fewer developing follicles in culture.	[Azarbaijani, Babak Asadi; Tanbo, Tom G.] Oslo Univ Hosp, Women & Childrens Div, Rikshosp, Oslo, Norway; [Azarbaijani, Babak Asadi; Tanbo, Tom G.] Univ Oslo, Oslo, Norway; [Sheikhi, Mona; Hovatta, Outi] Karolinska Univ Hosp, Karolinska Inst, Div Obstet & Gynecol, Stockholm, Sweden; [Sheikhi, Mona] Stockholm IVF, Stockholm, Sweden; [Oskam, Irma C.] Univ Oslo, Fac Vet Med & Biosci, Oslo, Norway; [Nurmio, Mirja] Univ Turku, Dept Physiol & Pediat, Turku, Finland; [Laine, Tiina; Jahnukainen, Kirsi] Univ Helsinki, Cent Hosp, Dept Pediat, Helsinki, Finland; [Laine, Tiina; Jahnukainen, Kirsi] Univ Helsinki, Div Obstet & Gynecol, Helsinki, Finland; [Tinkanen, Helena] Tampere Univ, Cent Hosp, SF-33520 Tampere, Finland; [Makinen, Sirpa] Family Federat Finland, Fertil Clin, Helsinki, Finland; [Jahnukainen, Kirsi] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Jahnukainen, Kirsi] Univ Hosp, Stockholm, Sweden	University of Oslo; National Hospital Norway; University of Oslo; Karolinska Institutet; Karolinska University Hospital; University of Oslo; University of Turku; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Tampere University; Tampere University Hospital; Family Federation of Finland; Karolinska Institutet	Azarbaijani, BA (corresponding author), Oslo Univ Hosp, Women & Childrens Div, Rikshosp, Oslo, Norway.	basad@ous-hf.no		Nurmio, Mirja/0000-0002-3278-639X	Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, Norway; Swedish Childhood Cancer Foundation; Finnish Cancer Society; Finnish Pediatric Research Foundation; Paulo Foundation; Vare Foundation for Pediatric Cancer Research; Academy of Finland; Swedish Research Council; ALF Stockholm County; Karolinska Institute	Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, Norway; Swedish Childhood Cancer Foundation(European Commission); Finnish Cancer Society; Finnish Pediatric Research Foundation; Paulo Foundation; Vare Foundation for Pediatric Cancer Research; Academy of Finland(Academy of Finland); Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF Stockholm County; Karolinska Institute(Karolinska Institutet)	This research was supported by grants from the Norwegian National Advisory Unit on Women's Health, Oslo University Hospital, Norway; the Swedish Childhood Cancer Foundation; the Finnish Cancer Society; the Finnish Pediatric Research Foundation; the Paulo Foundation; the Vare Foundation for Pediatric Cancer Research; the Academy of Finland; The Swedish Research Council; ALF Stockholm County and the Karolinska Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039034; Anderson RA, 2014, HUM REPROD, V29, P97, DOI 10.1093/humrep/det388; Bastings L, 2013, HUM REPROD UPDATE, V19, P483, DOI 10.1093/humupd/dmt020; Carlsson IB, 2006, HUM REPROD, V21, P2223, DOI 10.1093/humrep/del165; Carlsson IB, 2006, REPRODUCTION, V131, P641, DOI 10.1530/rep.1.00868; Donnez J, 2013, NAT REV ENDOCRINOL, V9, P735, DOI 10.1038/nrendo.2013.205; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; Gougeon A, 1989, Acta Eur Fertil, V20, P185; Green DM, 2014, PEDIATR BLOOD CANCER, V61, P53, DOI 10.1002/pbc.24679; HAIEMEDER C, 1993, INT J RADIAT ONCOL, V25, P419, DOI 10.1016/0360-3016(93)90062-Z; HALES BF, 1982, CANCER RES, V42, P3016; Hovatta O, 1996, HUM REPROD, V11, P1268; Jadoul P, 2010, HUM REPROD UPDATE, V16, P617, DOI 10.1093/humupd/dmq010; Jahnukainen K, 2013, LEUKEMIA, V27, P1183, DOI 10.1038/leu.2012.279; Keros V, 2009, HUM REPROD, V24, P1670, DOI 10.1093/humrep/dep079; Kerr JB, 2012, MOL CELL, V48, P343, DOI 10.1016/j.molcel.2012.08.017; Kim SS, 2012, J ASSIST REPROD GEN, V29, P465, DOI 10.1007/s10815-012-9786-y; Lass A, 1997, HUM REPROD, V12, P294, DOI 10.1093/humrep/12.2.294; McDermott EM, 1996, ANN RHEUM DIS, V55, P224, DOI 10.1136/ard.55.4.224; McLaughlin M, 2014, MOL HUM REPROD, V20, P736, DOI 10.1093/molehr/gau037; Meirow D, 2001, HUM REPROD UPDATE, V7, P535, DOI 10.1093/humupd/7.6.535; Meirow D, 2008, HUM REPROD, V23, P1007, DOI 10.1093/humrep/den055; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; Newton H, 1996, HUM REPROD, V11, P1487; O'Brien MJ, 2003, BIOL REPROD, V68, P1682, DOI 10.1095/biolreprod.102.013029; Oktay K, 2009, PEDIATR BLOOD CANCER, V53, P267, DOI 10.1002/pbc.22003; Oktem O, 2007, CANCER RES, V67, P10159, DOI 10.1158/0008-5472.CAN-07-2042; Oktem O, 2007, CANCER-AM CANCER SOC, V110, P2222, DOI 10.1002/cncr.23071; Oskam IC, 2010, FERTIL STERIL, V93, P2764, DOI 10.1016/j.fertnstert.2010.02.003; Perez GI, 2000, BIOL REPROD, V63, P1358, DOI 10.1095/biolreprod63.5.1358; Rosendahl M, 2013, J ASSIST REPROD GEN, V30, P11, DOI 10.1007/s10815-012-9912-x; Rosendahl M, 2010, FERTIL STERIL, V94, P156, DOI 10.1016/j.fertnstert.2009.02.043; Sanders JE, 1996, BLOOD, V87, P3045, DOI 10.1182/blood.V87.7.3045.bloodjournal8773045; Schmidt KT, 2013, REPROD BIOMED ONLINE, V26, P272, DOI 10.1016/j.rbmo.2012.12.001; Schmidt KLT, 2003, HUM REPROD, V18, P1158, DOI 10.1093/humrep/deg246; Scott JE, 2004, REPROD BIOMED ONLINE, V9, P287, DOI 10.1016/S1472-6483(10)62143-8; Sheikhi M, 2013, FERTIL STERIL, V100, P170, DOI 10.1016/j.fertnstert.2013.03.018; Sklar CA, 2006, J NATL CANCER I, V98, P890, DOI 10.1093/jnci/djj243; Tao T, 2008, J ASSIST REPROD GEN, V25, P287, DOI 10.1007/s10815-008-9236-z; Telfer EE, 2008, HUM REPROD, V23, P1151, DOI 10.1093/humrep/den070; Xu M, 2009, HUM REPROD, V24, P2531, DOI 10.1093/humrep/dep228; Zheng WJ, 2014, MOL HUM REPROD, V20, P286, DOI 10.1093/molehr/gau007; Zheng WJ, 2014, HUM MOL GENET, V23, P920, DOI 10.1093/hmg/ddt486	43	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133985	10.1371/journal.pone.0133985	http://dx.doi.org/10.1371/journal.pone.0133985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226487	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000358837700046
J	Mahata, B; Biswas, S; Rayman, P; Chahlavi, A; Ko, J; Bhattacharjee, A; Li, YT; Li, YT; Das, T; Sa, G; Raychaudhuri, B; Vogelbaum, MA; Tannenbaum, C; Finke, JH; Biswas, K				Mahata, Barun; Biswas, Soumika; Rayman, Patricia; Chahlavi, Ali; Ko, Jennifer; Bhattacharjee, Ashish; Li, Yu-Teh; Li, Yuntao; Das, Tanya; Sa, Gaurisankar; Raychaudhuri, Baisakhi; Vogelbaum, Michael A.; Tannenbaum, Charles; Finke, James H.; Biswas, Kaushik			GBM Derived Gangliosides Induce T Cell Apoptosis through Activation of the Caspase Cascade Involving Both the Extrinsic and the Intrinsic Pathway	PLOS ONE			English	Article							PRIMARY INTRACRANIAL TUMORS; CARCINOMA PATIENTS; HUMAN GLIOMAS; CYTOKINE PRODUCTION; IMMUNE-RESPONSES; LYMPHOCYTES; CANCER; BRAIN; GLIOBLASTOMAS; MECHANISMS	Previously we demonstrated that human glioblastoma cell lines induce apoptosis in peripheral blood T cells through partial involvement of secreted gangliosides. Here we show that GBM-derived gangliosides induce apoptosis through involvement of the TNF receptor and activation of the caspase cascade. Culturing T lymphocytes with GBM cell line derived gangliosides (10-20 mu g/ml) demonstrated increased ROS production as early as 18 hrs as indicated by increased uptake of the dye H(2)DCFDA while western blotting demonstrated mitochondrial damage as evident by cleavage of Bid to t-Bid and by the release of cytochrome-c into the cytosol. Within 48-72 hrs apoptosis was evident by nuclear blebbing, trypan blue positivity and annexinV/7AAD staining. GBM-ganglioside induced activation of the effector caspase-3 along with both initiator caspases (-9 and -8) in T cells while both the caspase-8 and -9 inhibitors were equally effective in blocking apoptosis (60% protection) confirming the role of caspases in the apoptotic process. Ganglioside-induced T cell apoptosis did not involve production of TNF-alpha since anti-human TNF alpha antibody was unable to protect T cells from nuclear blebbing and subsequent cell death. However, confocal microscopy demonstrated co-localization of GM2 ganglioside with the TNF receptor and co-immunoprecipitation experiments showed recruitment of death domains FADD and TRADD with the TNF receptor post ganglioside treatment, suggesting direct interaction of gangliosides with the TNF receptor. Further confirmation of the interaction between GM2 and TNFR1 was obtained from confocal microscopy data with wild type and TNFR1 KO (TALEN mediated) Jurkat cells, which clearly demonstrated co-localization of GM2 and TNFR1 in the wild type cells but not in the TNFR1 KO clones. Thus, GBM-ganglioside can mediate T cell apoptosis by interacting with the TNF receptor followed by activation of both the extrinsic and the intrinsic pathway of caspases.	[Mahata, Barun; Das, Tanya; Sa, Gaurisankar; Biswas, Kaushik] Bose Inst, Div Mol Med, Kolkata, India; [Biswas, Soumika; Rayman, Patricia; Li, Yuntao; Das, Tanya; Sa, Gaurisankar; Tannenbaum, Charles; Finke, James H.] Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44106 USA; [Chahlavi, Ali] St Vincents Med Ctr, Spine & Brain Inst, Jacksonville, FL USA; [Ko, Jennifer] Cleveland Clin, Inst Pathol, Cleveland, OH 44106 USA; [Bhattacharjee, Ashish] Natl Inst Technol, Dept Biotechnol, Durgapur, India; [Li, Yu-Teh] Tulane Univ, Sch Med, Dept Biochem, New Orleans, LA 70112 USA; [Raychaudhuri, Baisakhi; Vogelbaum, Michael A.] Cleveland Clin, Neurol Inst, Brain Tumor & Neurooncol Ctr, Cleveland, OH 44106 USA	Department of Science & Technology (India); Bose Institute; Cleveland Clinic Foundation; Cleveland Clinic Foundation; National Institute of Technology (NIT System); National Institute of Technology Durgapur; Tulane University; Cleveland Clinic Foundation	Biswas, K (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	kaushik@jcbose.ac.in	Biswas, Kaushik/AAR-1446-2020	Biswas, Kaushik/0000-0003-2502-9515; Mahata, Barun/0000-0002-1614-0791	Bose Institute; Frank Rudy Fund for Cancer Research;  [R01-CA116255]; NATIONAL CANCER INSTITUTE [R01CA116255] Funding Source: NIH RePORTER	Bose Institute(Department of Science & Technology (India)); Frank Rudy Fund for Cancer Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by internal funding from the Bose Institute (K Biswas), the Frank Rudy Fund for Cancer Research (JH Finke), and by R01-CA116255 (JH Finke). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avradopoulos K, 1997, ANN SURG ONCOL, V4, P184, DOI 10.1007/BF02303803; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Biswas K, 2006, CANCER RES, V66, P6816, DOI 10.1158/0008-5472.CAN-06-0250; Biswas S, 2009, J IMMUNOL, V183, P5050, DOI 10.4049/jimmunol.0900259; BODMER S, 1989, J IMMUNOL, V143, P3222; Chahlavi A, 2005, CANCER RES, V65, P5428, DOI 10.1158/0008-5472.CAN-04-4395; Coussens LM, 2008, CURR OPIN GENET DEV, V18, P1, DOI 10.1016/j.gde.2008.04.001; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Das T, 2008, J IMMUNOL, V180, P4687, DOI 10.4049/jimmunol.180.7.4687; Das T, 2008, CANCER RES, V68, P2014, DOI 10.1158/0008-5472.CAN-07-6037; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; Didenko VV, 2002, J NEUROSURG, V96, P580, DOI 10.3171/jns.2002.96.3.0580; Dix AR, 1999, J NEUROIMMUNOL, V100, P216, DOI 10.1016/S0165-5728(99)00203-9; DUMONTET C, 1994, CANCER IMMUNOL IMMUN, V38, P311, DOI 10.1007/BF01525509; El Andaloussi A, 2007, J NEURO-ONCOL, V83, P145, DOI 10.1007/s11060-006-9314-y; ELLIOTT LH, 1984, J IMMUNOL, V132, P1208; Finke J, 1999, IMMUNOL TODAY, V20, P158, DOI 10.1016/S0167-5699(98)01435-2; Finke JH, 2008, CLIN CANCER RES, V14, P6674, DOI 10.1158/1078-0432.CCR-07-5212; Finke JH, 2004, UROLOGE A, V43, pS131, DOI 10.1007/s00120-004-0600-z; FONTANA A, 1991, CIBA F SYMP, V157, P232; Gastman BR, 2000, BLOOD, V95, P2015, DOI 10.1182/blood.V95.6.2015; Gastman BR, 1999, CANCER RES, V59, P5356; Haymaker C, 2012, ONCOIMMUNOLOGY, V1, P735, DOI 10.4161/onci.20823; Heitger A, 1996, BBA-LIPID LIPID MET, V1303, P161, DOI 10.1016/0005-2760(96)00091-4; HISHII M, 1995, NEUROSURGERY, V37, P1160, DOI 10.1227/00006123-199512000-00016; Irani DN, 1996, J IMMUNOL, V157, P4333; Julien T, 2000, SURG NEUROL, V53, P360, DOI 10.1016/S0090-3019(00)00178-6; KIKUCHI K, 1983, J NEUROSURG, V59, P790, DOI 10.3171/jns.1983.59.5.0790; Kim Y, 2013, NAT BIOTECHNOL, V31, P251, DOI 10.1038/nbt.2517; Ko JS, 2009, CLIN CANCER RES, V15, P2148, DOI 10.1158/1078-0432.CCR-08-1332; Kudo D, 2003, CANCER RES, V63, P1676; KUPPNER MC, 1989, J NEUROSURG, V71, P211, DOI 10.3171/jns.1989.71.2.0211; LADISCH S, 1985, ANAL BIOCHEM, V146, P220, DOI 10.1016/0003-2697(85)90419-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mahata B, 2015, SCI REP-UK, V5, DOI 10.1038/srep09048; Malisan F, 2002, BBA-MOL CELL BIOL L, V1585, P179, DOI 10.1016/S1388-1981(02)00339-6; McKallip R, 1999, J IMMUNOL, V163, P3718; Morford LA, 1999, J NEUROSURG, V91, P935, DOI 10.3171/jns.1999.91.6.0935; NAKAMURA O, 1991, ACTA NEUROCHIR, V109, P34, DOI 10.1007/BF01405694; PALMA L, 1978, J NEUROSURG, V49, P854, DOI 10.3171/jns.1978.49.6.0854; Ravindranath MH, 2004, BIOCHEM BIOPH RES CO, V324, P154, DOI 10.1016/j.bbrc.2004.09.029; Raychaudhuri B, 2011, NEURO-ONCOLOGY, V13, P591, DOI 10.1093/neuonc/nor042; Retter MW, 2005, CANCER RES, V65, P6425, DOI 10.1158/0008-5472.CAN-05-0300; ROSZMAN TL, 1982, CANCER, V50, P1273, DOI 10.1002/1097-0142(19821001)50:7<1273::AID-CNCR2820500709>3.0.CO;2-5; Sa G, 2009, CANCER RES, V69, P3095, DOI 10.1158/0008-5472.CAN-08-3776; TSUCHIDA T, 1987, J NATL CANCER I, V78, P55, DOI 10.1093/jnci/78.1.55; Uzzo RG, 1999, CLIN CANCER RES, V5, P1219; Wagener R, 1999, ACTA NEUROCHIR, V141, P1339, DOI 10.1007/s007010050439; Walker DG, 2006, J NEUROIMMUNOL, V175, P59, DOI 10.1016/j.jneuroim.2006.03.006; Walker PR, 2003, BRAIN RES REV, V42, P97, DOI 10.1016/S0165-0173(03)00141-3; Whiteside TL, 1998, CANCER IMMUNOL IMMUN, V46, P175, DOI 10.1007/s002620050476; Whiteside TL., 2009, ORAL ONCOL S, VS1368-8375	53	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134425	10.1371/journal.pone.0134425	http://dx.doi.org/10.1371/journal.pone.0134425			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226135	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700093
J	Panzer, K; Yilmaz, P; Weiss, M; Reich, L; Richter, M; Wiese, J; Schmaljohann, R; Labes, A; Imhoff, JF; Glockner, FO; Reich, M				Panzer, Katrin; Yilmaz, Pelin; Weiss, Michael; Reich, Lothar; Richter, Michael; Wiese, Jutta; Schmaljohann, Rolf; Labes, Antje; Imhoff, Johannes F.; Gloeckner, Frank Oliver; Reich, Marlis			Identification of Habitat-Specific Biomes of Aquatic Fungal Communities Using a Comprehensive Nearly Full-Length 18S rRNA Dataset Enriched with Contextual Data	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; ORGANIC-CARBON DOC; MARINE FUNGI; DEEP-SEA; EUKARYOTIC COMMUNITY; MICROBIAL EUKARYOTES; LEAF-LITTER; DIVERSITY; SEDIMENTS; ECOSYSTEM	Molecular diversity surveys have demonstrated that aquatic fungi are highly diverse, and that they play fundamental ecological roles in aquatic systems. Unfortunately, comparative studies of aquatic fungal communities are few and far between, due to the scarcity of adequate datasets. We combined all publicly available fungal 18S ribosomal RNA (rRNA) gene sequences with new sequence data from a marine fungi culture collection. We further enriched this dataset by adding validated contextual data. Specifically, we included data on the habitat type of the samples assigning fungal taxa to ten different habitat categories. This dataset has been created with the intention to serve as a valuable reference dataset for aquatic fungi including a phylogenetic reference tree. The combined data enabled us to infer fungal community patterns in aquatic systems. Pairwise habitat comparisons showed significant phylogenetic differences, indicating that habitat strongly affects fungal community structure. Fungal taxonomic composition differed considerably even on phylum and class level. Freshwater fungal assemblage was most different from all other habitat types and was dominated by basal fungal lineages. For most communities, phylogenetic signals indicated clustering of sequences suggesting that environmental factors were the main drivers of fungal community structure, rather than species competition. Thus, the diversification process of aquatic fungi must be highly clade specific in some cases. The combined data enabled us to infer fungal community patterns in aquatic systems. Pairwise habitat comparisons showed significant phylogenetic differences, indicating that habitat strongly affects fungal community structure. Fungal taxonomic composition differed considerably even on phylum and class level. Freshwater fungal assemblage was most different from all other habitat types and was dominated by basal fungal lineages. For most communities, phylogenetic signals indicated clustering of sequences suggesting that environmental factors were the main drivers of fungal community structure, rather than species competition. Thus, the diversification process of aquatic fungi must be highly clade specific in some cases.	[Panzer, Katrin; Reich, Marlis] Univ Bremen, Mol Ecol, FB2, D-28359 Bremen, Germany; [Panzer, Katrin; Gloeckner, Frank Oliver] Jacobs Univ Bremen gGmbH, Dept Life Sci & Chem, D-28759 Bremen, Germany; [Yilmaz, Pelin; Richter, Michael; Gloeckner, Frank Oliver] Max Planck Inst Marine Microbiol, Microbial Genom & Bioinformat Res Grp, D-28359 Bremen, Germany; [Weiss, Michael] Univ Tubingen, Dept Biol, D-72076 Tubingen, Germany; [Reich, Lothar] Potsdam Transfer, D-14482 Potsdam, Germany; [Wiese, Jutta; Schmaljohann, Rolf; Labes, Antje; Imhoff, Johannes F.] GEOMAR Helmholtz Ctr Ocean Res Kiel, Marine Microbiol, D-24105 Kiel, Germany	University of Bremen; Jacobs University; Max Planck Society; Eberhard Karls University of Tubingen; University of Potsdam; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Reich, M (corresponding author), Univ Bremen, Mol Ecol, FB2, Leobener Str 2, D-28359 Bremen, Germany.	reich@uni-bremen.de	Labes, Antje/AGK-3198-2022; Imhoff, Johannes F./AAB-8765-2022; Weiß, Michael/F-6206-2012; Reich, Marlis/AAC-4604-2021; Wiese, Jutta/B-9076-2012; Imhoff, Johannes F./D-2515-2010	Labes, Antje/0000-0002-4807-3378; Imhoff, Johannes F./0000-0001-8789-0728; Weiß, Michael/0000-0002-4869-9186; Reich, Marlis/0000-0001-7537-5809; Imhoff, Johannes F./0000-0001-8789-0728; Yilmaz, Pelin/0000-0003-4724-323X	University of Bremen, Germany; German Research Foundation (DFG)	University of Bremen, Germany; German Research Foundation (DFG)(German Research Foundation (DFG))	The study was supported by the University of Bremen, Germany (http://www.uni-bremen.de/). Sanger sequencing partly supported by the German Research Foundation (DFG) (http://www.dfg.de/en/) Cluster of Excellence "Inflammation at Interfaces" and "Future Ocean".	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amend AS, 2012, ISME J, V6, P1291, DOI 10.1038/ismej.2011.193; Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; [Anonymous], 2015, PRACTICAL GUIDE SYSM, DOI [10.1016/c2013-0-14457-1, DOI 10.1016/C2013-0-14457-1, DOI 10.1016/C2013-0-10998-1]; Arfi Y, 2012, FUNGAL ECOL, V5, P282, DOI 10.1016/j.funeco.2011.09.004; Arfi Y, 2012, FEMS MICROBIOL ECOL, V79, P433, DOI 10.1111/j.1574-6941.2011.01236.x; Avramidis P, 2013, FRESEN ENVIRON BULL, V22, P1628; Bachy C, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00106; BALDY V, 1995, OIKOS, V74, P93, DOI 10.2307/3545678; Barr DJS, 2001, MYCOTA, V7, P93; Bass D, 2007, P ROY SOC B-BIOL SCI, V274, P3069, DOI 10.1098/rspb.2007.1067; Bellemain E, 2013, ENVIRON MICROBIOL, V15, P1176, DOI 10.1111/1462-2920.12020; Bianchi TS, 2011, P NATL ACAD SCI USA, V108, P19473, DOI 10.1073/pnas.1017982108; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Burgaud G, 2009, ENVIRON MICROBIOL, V11, P1588, DOI 10.1111/j.1462-2920.2009.01886.x; Burke C, 2011, ISME J, V5, P590, DOI 10.1038/ismej.2010.164; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chukanhom Kanit, 2004, Mycoscience, V45, P42, DOI 10.1007/s10267-003-0153-9; Danger M, 2013, FUNGAL ECOL, V6, P453, DOI 10.1016/j.funeco.2013.05.007; Danielsen L, 2012, ECOL EVOL, V2, P1935, DOI 10.1002/ece3.305; Duarte S, 2015, FUNGAL DIVERS, V70, P127, DOI 10.1007/s13225-014-0300-y; Evans SN, 2012, J R STAT SOC B, V74, P569, DOI 10.1111/j.1467-9868.2011.01018.x; FINDLAY RH, 1990, MAR ECOL PROG SER, V62, P121, DOI 10.3354/meps062121; FISHER SG, 1973, ECOL MONOGR, V43, P421, DOI 10.2307/1942301; Gao Z, 2010, ISME J, V4, P111, DOI 10.1038/ismej.2009.87; Gessner MO, 1999, OIKOS, V85, P377, DOI 10.2307/3546505; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gleason Frank H., 2008, Fungal Biology Reviews, V22, P17, DOI 10.1016/j.fbr.2008.02.001; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goh TK, 1996, J IND MICROBIOL BIOT, V17, P328, DOI 10.1007/BF01574764; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Goncalves VN, 2012, FEMS MICROBIOL ECOL, V82, P459, DOI 10.1111/j.1574-6941.2012.01424.x; Gutierrez MH, 2011, MAR BIOL, V158, P205, DOI 10.1007/s00227-010-1552-z; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hedges JI, 1999, AM J SCI, V299, P529, DOI 10.2475/ajs.299.7-9.529; Hyde KD, 2013, FUNGAL DIVERS, V63, P1, DOI 10.1007/s13225-013-0263-4; Jebaraj CS, 2010, FEMS MICROBIOL ECOL, V71, P399, DOI 10.1111/j.1574-6941.2009.00804.x; Jobard M, 2010, AQUAT SCI, V72, P255, DOI 10.1007/s00027-010-0133-z; Jones EBG, 2012, MAR FRESHW BOTANY; Jones EBG, 2012, MAR FRESHW BOTANY, P49; Jones EBG, 2011, BOT MAR, V54, P343, DOI 10.1515/BOT.2011.043; Jones EBG, 1971, METHOD MICROBIOL, P731; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Kagami M, 2012, MICROB ECOL, V63, P358, DOI 10.1007/s00248-011-9913-9; Kirchman D.L., 2008, MICROBIAL ECOLOGY OC, Vsecond; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Konopka A, 2009, ISME J, V3, P1223, DOI 10.1038/ismej.2009.88; Lai XT, 2007, ISME J, V1, P756, DOI 10.1038/ismej.2007.51; Le Calvez T, 2009, APPL ENVIRON MICROB, V75, P6415, DOI 10.1128/AEM.00653-09; Lefevre E, 2007, ENVIRON MICROBIOL, V9, P61, DOI 10.1111/j.1462-2920.2006.01111.x; Lefevre E, 2012, AQUAT MICROB ECOL, V67, P91, DOI 10.3354/ame01592; Livermore JA, 2013, ENVIRON MICROBIOL, V15, P2333, DOI 10.1111/1462-2920.12106; Logares R, 2009, TRENDS MICROBIOL, V17, P414, DOI 10.1016/j.tim.2009.05.010; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Magnes M, 1991, BIBL MYCOL, V991, P1, DOI DOI 10.1007/S13225-015-0331-Z; Maheshwari R, 2000, MICROBIOL MOL BIOL R, V64, P461, DOI 10.1128/MMBR.64.3.461-488.2000; Manohar CS, 2013, FEMS MICROBIOL LETT, V341, P69, DOI 10.1111/1574-6968.12087; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; Monchy S, 2011, ENVIRON MICROBIOL, V13, P1433, DOI 10.1111/j.1462-2920.2011.02444.x; MONK KA, 1990, BIOTROPICA, V22, P16, DOI 10.2307/2388715; Morshed A, 2013, IEEE INT CONF TRUST, P1907, DOI 10.1109/TrustCom.2013.279; Nagahama T, 2011, ENVIRON MICROBIOL, V13, P2359, DOI 10.1111/j.1462-2920.2011.02507.x; Nakagiri A, 2012, MAR FRESHW BOTANY, P501; Nikolcheva LG, 2003, APPL ENVIRON MICROB, V69, P2548, DOI 10.1128/AEM.69.5.2548-2554.2003; Ohm R.A., 2012, PLOS PATHOGENS, V8; Orsi W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056335; Otto S, 1998, PROG OCEANOGR, V42, P127, DOI 10.1016/S0079-6611(98)00031-7; Panno L, 2013, NEW BIOTECHNOL, V30, P685, DOI 10.1016/j.nbt.2013.01.010; Panzer K., 2015, DRYAD DIGITAL REPOSI; Prosser JI, 2012, FEMS MICROBIOL ECOL, V81, P507, DOI 10.1111/j.1574-6941.2012.01435.x; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Raghukumar C, 2012, BIOL MARINE FUNGI; Richards TA, 2012, ANNU REV MAR SCI, V4, P495, DOI 10.1146/annurev-marine-120710-100802; Sakayaroj J, 2010, FUNGAL DIVERS, V42, P27, DOI 10.1007/s13225-009-0013-9; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Shearer CA, 2007, BIODIVERS CONSERV, V16, P49, DOI 10.1007/s10531-006-9120-z; Singh P, 2011, MICROB ECOL, V61, P507, DOI 10.1007/s00248-010-9765-8; Sowerby A, 2010, EUR J SOIL SCI, V61, P697, DOI 10.1111/j.1365-2389.2010.01276.x; Sparrow F.K., 1960, AQUATIC PHYCOMYCETES; Sridhar KR, 2012, MAR FRESHW BOTANY, P475; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stoeck T, 2006, PROTIST, V157, P31, DOI 10.1016/j.protis.2005.10.004; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P5656, DOI 10.1128/AEM.69.9.5656-5663.2003; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Taib N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058950; Takishita K, 2007, EXTREMOPHILES, V11, P563, DOI 10.1007/s00792-007-0068-z; Team RDC, 2019, R LANG ENV STAT COMP; Tian F, 2009, POLAR BIOL, V32, P93, DOI 10.1007/s00300-008-0509-x; Velmurugan N, 2012, MAR FRESHW BOTANY, P441; Wang X., 2014, PLOS ONE, V9; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Wiese J, 2011, MAR DRUGS, V9, P561, DOI 10.3390/md9040561; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823; Yuen TK, 1999, MICROB ECOL, V37, P257, DOI 10.1007/s002489900151; Zuccaro A, 2003, MYCOL RES, V107, P1451, DOI 10.1017/S0953756203008657	98	44	45	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134377	10.1371/journal.pone.0134377	http://dx.doi.org/10.1371/journal.pone.0134377			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226014	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700082
J	Tian, SY				Tian, Suyan			Identification of Subtype-Specific Prognostic Genes for Early-Stage Lung Adenocarcinoma and Squamous Cell Carcinoma Patients Using an Embedded Feature Selection Algorithm	PLOS ONE			English	Article							RNA-SEQ; CLASSIFICATION; EXPRESSION; REGULARIZATION; PROFILES; NETWORK	The existence of fundamental differences between lung adenocarcinoma (AC) and squamous cell carcinoma (SCC) in their underlying mechanisms motivated us to postulate that specific genes might exist relevant to prognosis of each histology subtype. To test on this research hypothesis, we previously proposed a simple Cox-regression model based feature selection algorithm and identified successfully some subtype-specific prognostic genes when applying this method to real-world data. In this article, we continue our effort on identification of subtype-specific prognostic genes for AC and SCC, and propose a novel embedded feature selection method by extending Threshold Gradient Descent Regularization (TGDR) algorithm and minimizing on a corresponding negative partial likelihood function. Using real-world datasets and simulated ones, we show these two proposed methods have comparable performance whereas the new proposal is superior in terms of model parsimony. Our analysis provides some evidence on the existence of such subtype-specific prognostic genes, more investigation is warranted.	Jilin Univ, Hosp 1, Div Clin Epidemiol, Changchun 130023, Jilin, Peoples R China	Jilin University	Tian, SY (corresponding author), Jilin Univ, Hosp 1, Div Clin Epidemiol, Changchun 130023, Jilin, Peoples R China.	stian@rockefeller.edu	Tian, Suyan/W-3273-2019	Tian, Suyan/0000-0002-5942-1542	Natural Science Foundation of China [31401123]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (No 31401123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-hamo R, 2013, SYST BIOMED, V1, P83, DOI DOI 10.4161/sysb.25983; Bianchi F, 2007, J CLIN INVEST, V117, P3436, DOI 10.1172/JCI32007; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Friedman JH, 2004, TECHNICAL REPORT; Guo Nancy Lan, 2011, International Journal of Computational Biology and Drug Design, V4, P19, DOI 10.1504/IJCBDD.2011.038655; Kikuchi T, 2003, ONCOGENE, V22, P2192, DOI 10.1038/sj.onc.1206288; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Ma SG, 2005, BIOINFORMATICS, V21, P4356, DOI 10.1093/bioinformatics/bti724; Ma SG, 2007, BIOINFORMATICS, V23, P466, DOI 10.1093/bioinformatics/btl632; Ma SG, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-271; Mramor M, 2007, BIOINFORMATICS, V23, P2147, DOI 10.1093/bioinformatics/btm312; Parmigiani G, 2004, CLIN CANCER RES, V10, P2922, DOI 10.1158/1078-0432.CCR-03-0490; Sanchez-Palencia A, 2011, INT J CANCER, V129, P355, DOI 10.1002/ijc.25704; Shi XJ, 2014, BRIEF BIOINFORM, V15, P671, DOI 10.1093/bib/bbt044; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tarca AL, 2013, SYST BIOMED, V1, P1; Tian S., 2013, SYST BIOMED, V1, P278, DOI [10.4161/sysb.25979, DOI 10.4161/SYSB.25979]; Tian SY, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0051-z; Tian SY, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-97; Vaporciyan A, 2010, 78 CANC LUNG HOLLAND; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang P, 2005, CHEST, V128, P452, DOI 10.1378/chest.128.1.452; Zhang A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110052; Zhao Q, 2014, BRIEF BIOINFORM, V16; Zhao SD, 2014, BIOINFORMATICS, V30, P3062, DOI 10.1093/bioinformatics/btu488; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	29	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134630	10.1371/journal.pone.0134630	http://dx.doi.org/10.1371/journal.pone.0134630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226392	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700125
J	Alawieh, A; Sabra, M; Sabra, Z; Tomlinson, S; Zaraket, FA				Alawieh, Ali; Sabra, Mohammed; Sabra, Zahraa; Tomlinson, Stephen; Zaraket, Fadi A.			Molecular Architecture of Spinal Cord Injury Protein Interaction Network	PLOS ONE			English	Article							FUNCTIONAL RECOVERY; PROTEOMIC ANALYSIS; DATABASE; ORGANIZATION; INFLAMMATION; PERMEABILITY; MECHANISMS; NEUROTROPHIN-3; DEGENERATION; APOPTOSIS	Spinal cord injury (SCI) is associated with complex pathophysiological processes that follow the primary traumatic event and determine the extent of secondary damage and functional recovery. Numerous reports have used global and hypothesis-driven approaches to identify protein changes that contribute to the overall pathology of SCI in an effort to identify potential therapeutic interventions. In this study, we use a semi-automatic annotation approach to detect terms referring to genes or proteins dysregulated in the SCI literature and develop a curated SCI interactome. Network analysis of the SCI interactome revealed the presence of a rich-club organization corresponding to a "powerhouse" of highly interacting hub-proteins. Studying the modular organization of the network have shown that rich-club proteins cluster into modules that are specifically enriched for biological processes that fall under the categories of cell death, inflammation, injury recognition and systems development. Pathway analysis of the interactome and the rich-club revealed high similarity indicating the role of the rich-club proteins as hubs of the most prominent pathways in disease pathophysiology and illustrating the centrality of pro-and anti-survival signal competition in the pathology of SCI. In addition, evaluation of centrality measures of single nodes within the rich-club have revealed that neuronal growth factor (NGF), caspase 3, and H-Ras are the most central nodes and potentially an interesting targets for therapy. Our integrative approach uncovers the molecular architecture of SCI interactome, and provide an essential resource for evaluating significant therapeutic candidates.	[Alawieh, Ali; Sabra, Zahraa; Tomlinson, Stephen] Med Univ S Carolina, Dept Neurosci, Inst Neurosci, Charleston, SC 29425 USA; [Alawieh, Ali; Sabra, Mohammed; Sabra, Zahraa; Zaraket, Fadi A.] Amer Univ Beirut, Dept Elect & Comp Engn, Beirut, Lebanon; [Tomlinson, Stephen] Med Univ S Carolina, Childrens Res Inst, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Tomlinson, Stephen] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; American University of Beirut; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Tomlinson, S (corresponding author), Med Univ S Carolina, Dept Neurosci, Inst Neurosci, Charleston, SC 29425 USA.	tomlinss@musc.edu; fz11@aub.edu.lb	Alawieh, Ali/AAM-1898-2020; Alawieh, Ali/AAM-1420-2020	Alawieh, Ali/0000-0003-2601-8850; 	Veterans Affairs merit awards [BX001218, RX001141]; Farouk Jabre Award [2013/14]; Veterans Affairs [I01RX001141] Funding Source: NIH RePORTER	Veterans Affairs merit awards(US Department of Veterans Affairs); Farouk Jabre Award; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Affairs merit awards [BX001218 and RX001141] to S.T. and the Farouk Jabre Award [2013/14] to F.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SK, 2000, NEUROSCIENCE, V99, P179, DOI 10.1016/S0306-4522(00)00165-2; Ankeny DP, 2009, NEUROSCIENCE, V158, P1112, DOI 10.1016/j.neuroscience.2008.07.001; [Anonymous], 2009, ON DEGR SEP PAR SPIN; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bauer-Mehren A, 2010, BIOINFORMATICS, V26, P2924, DOI 10.1093/bioinformatics/btq538; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Belcastro V, 2011, NUCLEIC ACIDS RES, V39, P8677, DOI 10.1093/nar/gkr593; Bhat A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116404; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Cai JJ, 2010, GENOME BIOL EVOL, V2, P815, DOI 10.1093/gbe/evq064; Chen AS, 2013, NEUROCHEM RES, V38, P2247, DOI 10.1007/s11064-013-1132-y; Choo AM, 2007, J NEUROSURG-SPINE, V6, P255, DOI 10.3171/spi.2007.6.3.255; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Demchak Barry, 2014, F1000Res, V3, P151, DOI 10.12688/f1000research.4492.2; Ding QX, 2006, PROTEOMICS, V6, P505, DOI 10.1002/pmic.200500296; Ditunno JF, 2004, SPINAL CORD, V42, P383, DOI 10.1038/sj.sc.3101603; Figley SA, 2014, J NEUROTRAUM, V31, P541, DOI 10.1089/neu.2013.3034; Grill R, 1997, J NEUROSCI, V17, P5560; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang SK, 2006, PROTEOMICS, V6, P2797, DOI 10.1002/pmic.200500621; Konganti K, 2013, EVOL BIOINFORM, V9, P355, DOI 10.4137/EBO.S12012; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li JJ, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145487; McAuley JJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2773951; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Schwab JM, 2006, PROG NEUROBIOL, V78, P91, DOI 10.1016/j.pneurobio.2005.12.004; Sengupta MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110885; Shanahan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036579; Sharma HS, 2003, ACT NEUR S, V86, P383; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Sporns O, 2006, BIOSYSTEMS, V85, P55, DOI 10.1016/j.biosystems.2006.02.008; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wuchty S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000335; Xu W, 2005, SPINAL CORD, V43, P204, DOI 10.1038/sj.sc.3101674	46	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0135024	10.1371/journal.pone.0135024	http://dx.doi.org/10.1371/journal.pone.0135024			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241741	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942700090
J	Weber, KS; Jensen, JL; Johnson, SM				Weber, K. Scott; Jensen, Jamie L.; Johnson, Steven M.			Anticipation of Personal Genomics Data Enhances Interest and Learning Environment in Genomics and Molecular Biology Undergraduate Courses	PLOS ONE			English	Article							MEDICINE; FDA	An important discussion at colleges is centered on determining more effective models for teaching undergraduates. As personalized genomics has become more common, we hypothesized it could be a valuable tool to make science education more hands on, personal, and engaging for college undergraduates. We hypothesized that providing students with personal genome testing kits would enhance the learning experience of students in two undergraduate courses at Brigham Young University: Advanced Molecular Biology and Genomics. These courses have an emphasis on personal genomics the last two weeks of the semester. Students taking these courses were given the option to receive personal genomics kits in 2014, whereas in 2015 they were not. Students sent their personal genomics samples in on their own and received the data after the course ended. We surveyed students in these courses before and after the two-week emphasis on personal genomics to collect data on whether anticipation of obtaining their own personal genomic data impacted undergraduate student learning. We also tested to see if specific personal genomic assignments improved the learning experience by analyzing the data from the undergraduate students who completed both the pre- and post-course surveys. Anticipation of personal genomic data significantly enhanced student interest and the learning environment based on the time students spent researching personal genomic material and their self-reported attitudes compared to those who did not anticipate getting their own data. Personal genomics homework assignments significantly enhanced the undergraduate student interest and learning based on the same criteria and a personal genomics quiz. We found that for the undergraduate students in both molecular biology and genomics courses, incorporation of personal genomic testing can be an effective educational tool in undergraduate science education.	[Weber, K. Scott; Johnson, Steven M.] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA; [Jensen, Jamie L.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA	Brigham Young University; Brigham Young University	Weber, KS (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA.	scott_weber@byu.edu	Johnson, Steven M/B-3940-2013; Weber, Scott/O-1022-2014	Weber, Scott/0000-0003-3688-2191; Johnson, Steven/0000-0002-7399-8153	College of Life Sciences at Brigham Young University	College of Life Sciences at Brigham Young University	This work was supported by an internal grant from the College of Life Sciences at Brigham Young University. It provided support in the form of a Teaching Enhancement Grant that allowed for the purchase of the personal genomic kits that were distributed to the students.	Annas GJ, 2014, NEW ENGL J MED, V370, P2248, DOI 10.1056/NEJMc1404692; Bloss CS, 2011, NEW ENGL J MED, V364, P524, DOI 10.1056/NEJMoa1011893; Boguski MS, 2013, GENOME MED, V5, DOI 10.1186/gm426; Daley LAA, 2013, GENET TEST MOL BIOMA, V17, P446, DOI 10.1089/gtmb.2012.0404; Duster T, 2010, THE CHRONICALS OF HI; Eccles JS, 2002, ANNU REV PSYCHOL, V53, P109, DOI 10.1146/annurev.psych.53.100901.135153; Frey N., 2010, J ENGLISH JOURNAL, V100, P30, DOI DOI 10.2307/20787688; Green RC, 2014, NATURE, V505, P286, DOI 10.1038/505286a; Guttmacher AE, 2007, NAT REV GENET, V8, P151, DOI 10.1038/nrg2007; Hooker GW, 2014, J GENET COUNS, V23, P445, DOI 10.1007/s10897-014-9689-4; Nicholls SG, 2013, GENOME, V56, P626, DOI 10.1139/gen-2013-0070; Ormond KE, 2011, GENET MED, V13, P400, DOI 10.1097/GIM.0b013e31820562f6; Parker LS, 2014, J MICROBIOL BIOL EDU, V15, P191, DOI 10.1128/jmbe.v15i2.856; Phimister EG, 2012, NEW ENGL J MED, V366, P757, DOI 10.1056/NEJMe1200749; Redfield RJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001356; Rogers JC, 2011, J GENET COUNS, V20, P231, DOI 10.1007/s10897-011-9352-2; Salari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068853; Salari K, 2011, ACAD MED, V86, P925, DOI 10.1097/ACM.0b013e3182223acf; Salari K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000138; Schiefele U., 1999, SCI STUD READ, V3, P257, DOI [DOI 10.1207/S1532799XSSR0303_4, 10.1207/s1532799xssr0303_4]; Vernez SL, 2013, GENOME MED, V5, DOI 10.1186/gm428; Walt DR, 2011, GENET MED, V13, P63, DOI 10.1097/GIM.0b013e3181f872ac; Williams K.C., 2011, RES HIGHER ED J, V12, P1, DOI [DOI 10.5430/ILTIE.V4N, DOI 10.1080/15389588.2010.515631]; Wilson BJ, 2015, RISK MANAG HEALTHC P, V8, P9, DOI 10.2147/RMHP.S58728; Wood WB, 2009, ANNU REV CELL DEV BI, V25, P93, DOI 10.1146/annurev.cellbio.24.110707.175306; Zhang TR, 2014, J MICROBIOL BIOL EDU, V15, P197, DOI 10.1128/jmbe.v15i2.773	26	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133486	10.1371/journal.pone.0133486	http://dx.doi.org/10.1371/journal.pone.0133486			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241308	gold, Green Published, Green Submitted			2022-12-27	WOS:000358942700015
J	Wu, JJ; Xiong, ST; Jing, J; Chen, X; Wang, WM; Gui, JF; Mei, J				Wu, Junjie; Xiong, Shuting; Jing, Jing; Chen, Xin; Wang, Weimin; Gui, Jian-Fang; Mei, Jie			Comparative Transcriptome Analysis of Differentially Expressed Genes and Signaling Pathways between XY and YY Testis in Yellow Catfish	PLOS ONE			English	Article							SEX-DETERMINING REGION; GERM-CELL DEVELOPMENT; TYROSINE PHOSPHORYLATION; ONCORHYNCHUS-MYKISS; MICRORNA TARGETS; BOAR SPERMATOZOA; RAINBOW-TROUT; FISH; MARKERS; ACTIVATION	YY super-males have rarely been detected in nature and only been artificially created in some fish species including tilapia and yellow catfish (Pelteobagrusfulvidraco), which provides a promising model for testis development and spermatogenesis. In our previous study, significant differences in morphology and miRNA expression were detected between XY and YY testis of yellow catfish. Here, solexa sequencing technology was further performed to compare mRNA expression between XY and YY testis. Compared with unigenes expressed in XY testis, 1146 and 1235 unigenes have significantly higher and lower expression in YY testis, respectively. 605 differentially expressed unigenes were annotated to 1604 GO terms with 319 and 286 genes having relative higher expression in XY and YY testis. KEGG analysis suggested different levels of PI3K-AKT and G protein-coupled receptor (GPCR) signaling pathways between XY and YY testis. Down-regulation of miR-141/429 in YY testis was speculated to promote testis development and maturation, and several factors in PI3K-AKT and GPCR signaling pathways were found as predicted targets of miR-141/429, several of which were confirmed by dual-luciferase reporter assays. Our study provides a comparative transcriptome analysis between XY and YY testis, and reveals interactions between miRNAs and their target genes that are possibly involved in regulating testis development and spermatogenesis.	[Wu, Junjie; Xiong, Shuting; Jing, Jing; Chen, Xin; Wang, Weimin; Gui, Jian-Fang; Mei, Jie] Huazhong Agr Univ, Freshwater Aquaculture Collaborat Innovat Ctr Hub, Key Lab Freshwater Anim Breeding, Coll Fisheries,Minist Agr, Wuhan 430070, Peoples R China; [Gui, Jian-Fang] Chinese Acad Sci, Univ Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; University of Chinese Academy of Sciences, CAS	Gui, JF (corresponding author), Huazhong Agr Univ, Freshwater Aquaculture Collaborat Innovat Ctr Hub, Key Lab Freshwater Anim Breeding, Coll Fisheries,Minist Agr, Wuhan 430070, Peoples R China.	jfgui@ihb.ac.cn; jmei@mail.hzau.edu.cn			National Natural Science Foundation of China [31301931]; Fundamental Research Funds for the Central Universities [52204-12018, 2013PY068]; State Key Laboratory of Freshwater Ecology and Biotechnology [2015FB03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (31301931), the Fundamental Research Funds for the Central Universities (52204-12018, 2013PY068), and State Key Laboratory of Freshwater Ecology and Biotechnology (2015FB03).	Abu-Halima M, 2013, FERTIL STERIL, V99, P1249, DOI 10.1016/j.fertnstert.2012.11.054; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLISS CI, 1953, BIOMETRICS, V9, P176, DOI 10.2307/3001850; Chen SL, 2014, NAT GENET, V46, P253, DOI 10.1038/ng.2890; Chen X, 2015, MAR BIOTECHNOL, V17, P190, DOI 10.1007/s10126-014-9607-7; Ciraolo E, 2010, MOL BIOL CELL, V21, P704, DOI 10.1091/mbc.E09-08-0744; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cutting A, 2013, DEV DYNAM, V242, P380, DOI 10.1002/dvdy.23944; Dan C, 2013, INT J BIOL SCI, V9, P1043, DOI 10.7150/ijbs.7203; Lacerda SMDN, 2014, GEN COMP ENDOCR, V207, P56, DOI 10.1016/j.ygcen.2014.06.018; Enright AJ, 2004, GENOME BIOL, V5; Galas JE, 2009, ANN NY ACAD SCI, V1163, P398, DOI 10.1111/j.1749-6632.2008.03663.x; Gennotte V, 2012, THERIOGENOLOGY, V78, P210, DOI 10.1016/j.theriogenology.2012.02.002; Gui JF, 2012, CHINESE SCI BULL, V57, P1751, DOI 10.1007/s11434-012-5213-0; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Harayama H, 2005, J ANDROL, V26, P732, DOI 10.2164/jandrol.05053; Harayama H, 2004, MOL REPROD DEV, V69, P436, DOI 10.1002/mrd.20176; Hattori RS, 2012, P NATL ACAD SCI USA, V109, P2955, DOI 10.1073/pnas.1018392109; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Herrera AA, 2001, SCI DILIMAN, V13, P33; Heule C, 2014, GENETICS, V196, P579, DOI 10.1534/genetics.114.161158; Jing J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107946; Kamiya T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002798; Kobayashi Y, 2013, SEX DEV, V7, P115, DOI 10.1159/000342009; Kotula-Balak M, 2008, COMP BIOCHEM PHYS A, V149, P188, DOI 10.1016/j.cbpa.2007.11.009; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Long JA., 2010, RISE FISHES 500 MILL; Lu JG, 2014, PHYSIOL GENOMICS, V46, P798, DOI 10.1152/physiolgenomics.00088.2014; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Mei J, 2015, SCI CHINA LIFE SCI, V58, P124, DOI 10.1007/s11427-014-4797-9; Mei J, 2014, INT J BIOL SCI, V10, P15, DOI 10.7150/ijbs.7490; Myosho T, 2012, GENETICS, V191, P163, DOI 10.1534/genetics.111.137497; Nanda I, 2002, P NATL ACAD SCI USA, V99, P11778, DOI 10.1073/pnas.182314699; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Takehana Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5157; Tan WX, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.112896; Tomes CN, 1996, MOL REPROD DEV, V43, P196, DOI 10.1002/(SICI)1098-2795(199602)43:2&lt;196::AID-MRD9&gt;3.0.CO;2-M; Wang D, 2009, ANIM GENET, V40, P978, DOI 10.1111/j.1365-2052.2009.01941.x; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wu W, 2013, HUM REPROD, V28, P1827, DOI 10.1093/humrep/det099; Xia W, 2007, MOL CELL ENDOCRINOL, V263, P156, DOI 10.1016/j.mce.2006.09.014; Xiong ST, 2015, GEN COMP ENDOCR, V216, P90, DOI 10.1016/j.ygcen.2015.04.015; Yano A, 2012, CURR BIOL, V22, P1423, DOI 10.1016/j.cub.2012.05.045	46	22	23	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134626	10.1371/journal.pone.0134626	http://dx.doi.org/10.1371/journal.pone.0134626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241040	gold, Green Submitted, Green Published			2022-12-27	WOS:000358942700054
J	Abraham, BG; Sarkisyan, KS; Mishin, AS; Santala, V; Tkachenko, NV; Karp, M				Abraham, Bobin George; Sarkisyan, Karen S.; Mishin, Alexander S.; Santala, Ville; Tkachenko, Nikolai V.; Karp, Matti			Fluorescent Protein Based FRET Pairs with Improved Dynamic Range for Fluorescence Lifetime Measurements	PLOS ONE			English	Article							ENERGY-TRANSFER; IMAGING MICROSCOPY; FORSTER DISTANCES; MONOMERIC RED; SENSOR; CELLS; ENVIRONMENT; EXCITATION	Fluorescence Resonance Energy Transfer (FRET) using fluorescent protein variants is widely used to study biochemical processes in living cells. FRET detection by fluorescence lifetime measurements is the most direct and robust method to measure FRET. The traditional cyan-yellow fluorescent protein based FRET pairs are getting replaced by green-red fluorescent protein variants. The green-red pair enables excitation at a longer wavelength which reduces cellular autofluorescence and phototoxicity while monitoring FRET. Despite the advances in FRET based sensors, the low FRET efficiency and dynamic range still complicates their use in cell biology and high throughput screening. In this paper, we utilized the higher lifetime of NowGFP and screened red fluorescent protein variants to develop FRET pairs with high dynamic range and FRET efficiency. The FRET variations were analyzed by proteolytic activity and detected by steady-state and time-resolved measurements. Based on the results, NowGFP-tdTomato and NowGFP-mRuby2 have shown high potentials as FRET pairs with large fluorescence lifetime dynamic range. The in vitro measurements revealed that the NowGFP-tdTomato has the highest Forster radius for any fluorescent protein based FRET pairs yet used in biological studies. The developed FRET pairs will be useful for designing FRET based sensors and studies employing Fluorescence Lifetime Imaging Microscopy (FLIM).	[Abraham, Bobin George; Santala, Ville; Tkachenko, Nikolai V.; Karp, Matti] Tampere Univ Technol, Dept Chem & Bioengn, FIN-33101 Tampere, Finland; [Sarkisyan, Karen S.; Mishin, Alexander S.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia	Tampere University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Abraham, BG (corresponding author), Tampere Univ Technol, Dept Chem & Bioengn, POB 541, FIN-33101 Tampere, Finland.	bobin.georgeabraham@tut.fi	Abraham, Bobin George/AAX-2600-2020; Mishin, Alexander/L-9420-2014; Sarkisyan, Karen S/M-6821-2015; Sarkisyan, Karen/AAA-5784-2021; Karp, Matti/G-4227-2014; Tkachenko, Nikolai V./G-4232-2014	Mishin, Alexander/0000-0002-4935-7030; Sarkisyan, Karen S/0000-0002-5375-6341; Sarkisyan, Karen/0000-0002-5375-6341; Karp, Matti/0000-0001-6686-4416; Tkachenko, Nikolai V./0000-0002-8504-2335; George Abraham, Bobin/0000-0002-1373-4244; Santala, Ville/0000-0002-9084-931X	BGA; Finnish Cultural Foundation (Suomen Kulttuurirahasto); Russian Foundation for Basic Research [13-04-01878-A]	BGA; Finnish Cultural Foundation (Suomen Kulttuurirahasto)(Finnish Cultural Foundation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	LASKEMO graduate school is acknowledged for financial support by BGA. MK acknowledges the sabbatical year funding from Finnish Cultural Foundation (Suomen Kulttuurirahasto). KSS and ASM are supported by Russian Foundation for Basic Research (grant 13-04-01878-A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham BG, 2014, ANAL BIOANAL CHEM, V406, P7195, DOI 10.1007/s00216-014-8165-1; Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Akrap N, 2010, ANAL BIOCHEM, V402, P105, DOI 10.1016/j.ab.2010.03.026; Bayle V, 2008, PLANT PHYSIOL, V148, P51, DOI 10.1104/pp.108.117358; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Borst JW, 2005, J FLUORESC, V15, P153, DOI 10.1007/s10895-005-2523-5; Broussard JA, 2013, NAT PROTOC, V8, P265, DOI 10.1038/nprot.2012.147; Chang CW, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3257254; Chen YE, 2004, MICROSC RES TECHNIQ, V63, P72, DOI 10.1002/jemt.10430; Dewitt S, 2009, J CELL BIOL, V184, P197, DOI 10.1083/jcb.200806047; Eisenstein M, 2006, NAT METHODS, V3, P647, DOI 10.1038/nmeth0806-647; Evers TH, 2007, J MOL BIOL, V374, P411, DOI 10.1016/j.jmb.2007.09.021; Evers TH, 2006, BIOCHEMISTRY-US, V45, P13183, DOI 10.1021/bi061288t; Fritz RD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004135; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Hink MA, 2003, J FLUORESC, V13, P185, DOI 10.1023/A:1022947411788; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Kolossov VL, 2008, EXP BIOL MED, V233, P238, DOI 10.3181/0707-RM-192; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Lleres David, 2007, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1210s42; McGinty J, 2009, LAB TECH BIOCHEM MOL, V33, P133, DOI 10.1016/S0075-7535(08)00004-1; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Padilla-Parra S, 2009, BIOPHYS J, V97, P2368, DOI 10.1016/j.bpj.2009.07.044; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Pelet S, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2203664; Pepperkok R, 1999, CURR BIOL, V9, P269, DOI 10.1016/S0960-9822(99)80117-1; Piatkevich KD, 2011, METHOD CELL BIOL, V102, P431, DOI 10.1016/B978-0-12-374912-3.00017-1; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Pliss A, 2012, ACS CHEM BIOL, V7, P1385, DOI 10.1021/cb300065w; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Sarkisyan KS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00608; Sarkisyan KS, BIOPHYSICAL IN PRESS; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbakova DM, 2012, ANGEW CHEM INT EDIT, V51, P10724, DOI 10.1002/anie.201200408; Shcherbo D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-24; Suhling K, 2002, BIOPHYS J, V83, P3589, DOI 10.1016/S0006-3495(02)75359-9; Suhling K, 2014, FLUORESCENCE LIFETIM, P23; Sun YS, 2011, NAT PROTOC, V6, P1324, DOI 10.1038/nprot.2011.364; Thaler C, 2005, BIOPHYS J, V89, P2736, DOI 10.1529/biophysj.105.061853; Tramier M, 2006, MICROSC RES TECHNIQ, V69, P933, DOI 10.1002/jemt.20370; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; van Dongen EMWM, 2007, J AM CHEM SOC, V129, P3494, DOI 10.1021/ja069105d; van Munster EB, 2005, ADV BIOCHEM ENG BIOT, V95, P143; Veselov AA, 2012, ANAL BIOANAL CHEM, V402, P1149, DOI 10.1007/s00216-011-5564-4; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	46	21	21	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134436	10.1371/journal.pone.0134436	http://dx.doi.org/10.1371/journal.pone.0134436			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237400	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942400027
J	Bolignano, D; D'Arrigo, G; Pisano, A; Coppolino, G				Bolignano, Davide; D'Arrigo, Graziella; Pisano, Anna; Coppolino, Giuseppe			Pentoxifylline for Anemia in Chronic Kidney Disease: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ERYTHROPOIETIN-RESISTANT ANEMIA; IMPROVES HEMOGLOBIN; DOUBLE-BLIND; ALPHA; INTERLEUKIN-6; TRIAL	Background Pentoxifylline (PTX) is a promising therapeutic approach for reducing inflammation and improving anemia associated to various systemic disorders. However, whether this agent may be helpful for anemia management also in CKD patients is still object of debate. Study Design Systematic review and meta-analysis. Population Adults with CKD (any KDOQI stage, including ESKD patients on regular dialysis) and anemia (Hb<13 g/dL in men or < 12 g/dL in women). Search Strategy and Sources Cochrane CENTRAL, EMBASE, Ovid-MEDLINE and PubMed were searched for studies providing data on the effects of PTX on anemia parameters in CKD patients without design or follow-up restriction. Intervention PTX derivatives at any dose regimen. Outcomes Hemoglobin, hematocrit, ESAs dosage and resistance (ERI), iron indexes (ferritin, serum iron, TIBC, transferrin and serum hepcidin) and adverse events. Results We retrieved 11 studies (377 patients) including seven randomized controlled trials (all comparing PTX to placebo or standard therapy) one retrospective case-control study and three prospective uncontrolled studies. Overall, PTX increased hemoglobin in three uncontrolled studies but such improvement was not confirmed in a meta-analysis of seven studies (299 patients) (MD 0.12 g/dL, 95% CI -0.22 to 0.47). Similarly, there were no conclusive effects of PTX on hematocrit, ESAs dose, ferritin and TSAT in pooled analyses. Data on serum iron, ERI, TIBC and hepcidin were based on single studies. No evidence of increased rate of adverse events was also noticed. Limitations Small sample size and limited number of studies. High heterogeneity among studies with respect to CKD and anemia severity, duration of intervention and responsiveness/current therapy with iron or ESAs. Conclusions There is currently no conclusive evidence supporting the utility of pentoxifylline for improving anemia control in CKD patients. Future trials designed on hard, patient-centered outcomes with larger sample size and longer follow-up are advocated.	[Bolignano, Davide; D'Arrigo, Graziella; Pisano, Anna] CNR Inst Clin Physiol, Reggio Di Calabria, Italy; [Coppolino, Giuseppe] Univ Hosp, Nephrol & Dialysis Unit, Catanzaro, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Bolignano, D (corresponding author), CNR Inst Clin Physiol, Reggio Di Calabria, Italy.	davide.bolignano@gmail.com	Pisano, Anna/AAG-7772-2019; Bolignano, Davide/AAB-3232-2019; Coppolino, Giuseppe/ABA-7713-2021; Coppolino, Giuseppe/K-7294-2012	Bolignano, Davide/0000-0003-3032-245X; Coppolino, Giuseppe/0000-0001-8000-0681; Coppolino, Giuseppe/0000-0001-8000-0681	Kosmos Hospital srl	Kosmos Hospital srl	Support: The Authors wish to thank Kosmos Hospital srl (Dr. Ferruccio Galeso) for covering publication fees.	Antunes SA, 2014, INT J ARTIF ORGANS, V37, P521, DOI 10.5301/ijao.5000340; Assem M, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/530949; Babitt JL, 2012, J AM SOC NEPHROL, V23, P1631, DOI 10.1681/ASN.2011111078; Betjes MGH, 2013, NAT REV NEPHROL, V9, P255, DOI 10.1038/nrneph.2013.44; Champion S, 2014, CARDIOVASC THER, V32, P159, DOI 10.1111/1755-5922.12076; Clement FM, 2010, AM J KIDNEY DIS, V56, P1050, DOI 10.1053/j.ajkd.2010.07.015; Cooper A, 2004, J AM SOC NEPHROL, V15, P1877, DOI 10.1097/01.asn.0000131523.17045.56; Cooper AC, 2003, J AM SOC NEPHROL, V14, P1776, DOI 10.1097/01.ASN.0000071514.36428.61; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ferrari P, 2010, NEPHROLOGY, V15, P344, DOI 10.1111/j.1440-1797.2009.01203.x; Gonzalez-Espinoza L, 2012, NEPHROL DIAL TRANSPL, V27, P2023, DOI 10.1093/ndt/gfr579; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Horl WH, 2013, NAT REV NEPHROL, V9, P291, DOI 10.1038/nrneph.2013.21; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Jennings DL, 2013, ASAIO J, V59, P526, DOI 10.1097/MAT.0b013e31829f0eb1; Johnson DW, 2015, AM J KIDNEY DIS, V65, P49, DOI 10.1053/j.ajkd.2014.06.020; Kreth S, 2010, SHOCK, V34, P10, DOI 10.1097/SHK.0b013e3181cdc3e2; Mohammadpour AH, 2014, SAUDI J KIDNEY DIS T, V25, P73, DOI 10.4103/1319-2442.124492; Mora-Gutierrez JM, 2013, NEFROLOGIA, V33, P524, DOI 10.3265/Nefrologia.pre2013.Apr.11654; Mortazavi Mojgan, 2012, Med Arh, V66, P84; Navarro JF, 1999, SCAND J UROL NEPHROL, V33, P121; Pammi M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004205.pub3; Perkins RM, 2009, AM J KIDNEY DIS, V53, P606, DOI 10.1053/j.ajkd.2008.11.026; Rattanasompattikul M, 2013, J CACHEXIA SARCOPENI, V4, P247, DOI 10.1007/s13539-013-0115-9; Raza Azra, 2000, Hematology, V5, P275; Rho M, 2011, SEMIN DIALYSIS, V24, P378, DOI 10.1111/j.1525-139X.2011.00894.x; Sherer JT, 2000, ANN PHARMACOTHER, V34, P1070; Solomon SD, 2010, NEW ENGL J MED, V363, P1146, DOI 10.1056/NEJMoa1005109; Stauffer ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084943; Szczech LA, 2008, KIDNEY INT, V74, P791, DOI 10.1038/ki.2008.295; Tonelli M, 2003, KIDNEY INT, V64, P295, DOI 10.1046/j.1523-1755.2003.00079.x; Vilayur E, 2009, NAT REV NEPHROL, V5, P375, DOI 10.1038/nrneph.2009.76	32	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134104	10.1371/journal.pone.0134104	http://dx.doi.org/10.1371/journal.pone.0134104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237421	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942400015
J	Roybal, KT; Mace, EM; Clark, DJ; Leard, AD; Herman, A; Verkade, P; Orange, JS; Wulfing, C				Roybal, Kole T.; Mace, Emily M.; Clark, Danielle J.; Leard, Alan D.; Herman, Andrew; Verkade, Paul; Orange, Jordan S.; Wuelfing, Christoph			Modest Interference with Actin Dynamics in Primary T Cell Activation by Antigen Presenting Cells Preferentially Affects Lamellal Signaling	PLOS ONE			English	Article							KINASE C-THETA; IMMUNOLOGICAL SYNAPSE; SPATIOTEMPORAL ORGANIZATION; RETROGRADE FLOW; CDC42 ACTIVITY; CALCIUM-ENTRY; RECEPTOR; CYTOSKELETON; POLYMERIZATION; COSTIMULATION	Dynamic subcellular distributions of signaling system components are critical regulators of cellular signal transduction through their control of molecular interactions. Understanding how signaling activity depends on such distributions and the cellular structures driving them is required for comprehensive insight into signal transduction. In the activation of primary murine T cells by antigen presenting cells (APC) signaling intermediates associate with various subcellular structures, prominently a transient, wide, and actin-associated lamellum extending from an interdigitated T cell: APC interface several micrometers into the T cell. While actin dynamics are well established as general regulators of cellular organization, their role in controlling signaling organization in primary T cell: APC couples and the specific cellular structures driving it is unresolved. Using modest interference with actin dynamics with a low concentration of Jasplakinolide as corroborated by costimulation blockade we show that T cell actin preferentially controls lamellal signaling localization and activity leading downstream to calcium signaling. Lamellal localization repeatedly related to efficient T cell function. This suggests that the transient lamellal actin matrix regulates T cell signaling associations that facilitate T cell activation.	[Roybal, Kole T.; Wuelfing, Christoph] UT Southwestern Med Ctr, Dept Immunol, Dallas, TX 75390 USA; [Mace, Emily M.; Orange, Jordan S.] Univ Penn, Childrens Hosp Philadelphia, Abramson Res Ctr, Philadelphia, PA 19104 USA; [Clark, Danielle J.; Herman, Andrew; Wuelfing, Christoph] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Leard, Alan D.; Verkade, Paul] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Wuelfing, Christoph] UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Bristol; University of Bristol; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wulfing, C (corresponding author), UT Southwestern Med Ctr, Dept Immunol, Dallas, TX 75390 USA.	Christoph.Wuelfing@bristol.co.uk	Verkade, Paul/N-7240-2014	Verkade, Paul/0000-0002-2497-1026; Wuelfing, Christoph/0000-0002-6156-9861; Mace, Emily/0000-0003-0226-7393; orange, jordan/0000-0001-7117-7725	National Institutes of Health (NIH) Ruth L. Kirschstein research service award [2T32AI005284-32]; NIH [A1-97981]; NSF [1121793]; BBSRC [BB/L014181/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L014181/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI005284] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Ruth L. Kirschstein research service award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a National Institutes of Health (NIH) Ruth L. Kirschstein research service award (2T32AI005284-32) to K. R. and NIH (A1-97981) and NSF (1121793) funding to C. W.	Babich A, 2013, IMMUNOL REV, V256, P80, DOI 10.1111/imr.12123; Babich A, 2012, J CELL BIOL, V197, P775, DOI 10.1083/jcb.201201018; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Davis MM, 2003, ANNU REV BIOCHEM, V72, P717, DOI 10.1146/annurev.biochem.72.121801.161625; Dombroski D, 2005, J IMMUNOL, V174, P1385, DOI 10.4049/jimmunol.174.3.1385; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Griffiths GM, 2010, J CELL BIOL, V189, P397, DOI 10.1083/jcb.201002027; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Kim Y, 2014, BRIEF BIOINFORM, V15, P212, DOI 10.1093/bib/bbt028; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Lyubchenko TA, 2003, J PHYSIOL-LONDON, V547, P835, DOI 10.1113/jphysiol.2002.033522; McDonald Kent L, 2007, Methods Mol Biol, V369, P143; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Nolz JC, 2007, J IMMUNOL, V179, P1104, DOI 10.4049/jimmunol.179.2.1104; Paster W, 2013, J IMMUNOL, V190, P3749, DOI 10.4049/jimmunol.1203389; Purtic B, 2005, P NATL ACAD SCI USA, V102, P2904, DOI 10.1073/pnas.0406867102; Rak GD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001151; Rosado JA, 2000, J BIOL CHEM, V275, P7527, DOI 10.1074/jbc.275.11.7527; Roybal KT, 2013, IMMUNOL REV, V256, P133, DOI 10.1111/imr.12103; Salazar-Fontana LI, 2003, J IMMUNOL, V171, P2225, DOI 10.4049/jimmunol.171.5.2225; Sharpe AH, 2009, IMMUNOL REV, V229, P5, DOI 10.1111/j.1600-065X.2009.00784.x; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Singleton K, 2006, J IMMUNOL, V177, P4402, DOI 10.4049/jimmunol.177.7.4402; Singleton KL, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001821; Singleton KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000199; Tskvitaria-Fuller I, 2003, J IMMUNOL, V171, P2287, DOI 10.4049/jimmunol.171.5.2287; Tskvitaria-Fuller I, 2007, J IMMUNOL METHODS, V319, P64, DOI 10.1016/j.jim.2006.10.017; Tskvitaria-Fuller I, 2006, J IMMUNOL, V177, P1708, DOI 10.4049/jimmunol.177.3.1708; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Yi J, 2012, MOL BIOL CELL, V23, P834, DOI 10.1091/mbc.E11-08-0731; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068	38	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0133231	10.1371/journal.pone.0133231	http://dx.doi.org/10.1371/journal.pone.0133231			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237588	Green Submitted, gold, Green Published			2022-12-27	WOS:000358942400009
J	Zavallo, D; Debat, HJ; Conti, G; Manacorda, CA; Rodriguez, MC; Asurmendi, S				Zavallo, Diego; Julio Debat, Humberto; Conti, Gabriela; Augusto Manacorda, Carlos; Cecilia Rodriguez, Maria; Asurmendi, Sebastian			Differential mRNA Accumulation upon Early Arabidopsis thaliana Infection with ORMV and TMV-Cg Is Associated with Distinct Endogenous Small RNAs Level	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; ABIOTIC STRESS RESPONSES; TRANS-ACTING SIRNAS; DNA-METHYLATION; TRANSCRIPTIONAL REGULATION; REGULATORY NETWORKS; PLANT DEVELOPMENT; TARGET GENES; MICRORNAS; EXPRESSION	Small RNAs (sRNAs) play important roles in plant development and host-pathogen interactions. Several studies have highlighted the relationship between viral infections, endogenous sRNA accumulation and transcriptional changes associated with symptoms. However, few studies have described a global analysis of endogenous sRNAs by comparing related viruses at early stages of infection, especially before viral accumulation reaches systemic tissues. An sRNA high-throughput sequencing of Arabidopsis thaliana leaf samples infected either with Oilseed rape mosaic virus (ORMV) or crucifer-infecting Tobacco mosaic virus (TMV-Cg) with slightly different symptomatology at two early stages of infection (2 and 4dpi) was performed. At early stages, both viral infections strongly alter the patterns of several types of endogenous sRNA species in distal tissues with no virus accumulation suggesting a systemic signaling process foregoing to virus spread. A correlation between sRNAs derived from protein coding genes and the associated mRNA transcripts was also detected, indicating that an unknown recursive mechanism is involved in a regulatory circuit encompassing this sRNA/mRNA equilibrium. This work represents the initial step in uncovering how differential accumulation of endogenous sRNAs contributes to explain the massive alteration of the transcriptome associated with plant-virus interactions.	[Zavallo, Diego; Conti, Gabriela; Augusto Manacorda, Carlos; Cecilia Rodriguez, Maria; Asurmendi, Sebastian] CICVyA INTA, Inst Biotecnol, Hurlingham, Buenos Aires, Argentina; [Zavallo, Diego; Conti, Gabriela; Cecilia Rodriguez, Maria; Asurmendi, Sebastian] Consejo Nacl Invest Cient ficas Tecn CONICET, Buenos Aires, DF, Argentina; [Julio Debat, Humberto] Ctr Invest Agropecuarias CIAP, Inst Patol Vegetal IPAVE, INTA, Cordoba, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto Nacional de Tecnologia Agropecuaria (INTA)	Asurmendi, S (corresponding author), CICVyA INTA, Inst Biotecnol, Hurlingham, Buenos Aires, Argentina.	asurmendi.sebastian@inta.gob.ar	Debat, Humberto Julio/GXF-9011-2022; Debat, Humberto/Y-6380-2019; Asurmendi, Sebastian/AAJ-1400-2021	Debat, Humberto/0000-0003-3056-3739; Zavallo, Diego/0000-0002-9021-2175; Asurmendi, Sebastian/0000-0001-9516-5948; Conti, Gabriela/0000-0003-4221-3760	Instituto Nacional de Tecnologia Agropecuaria (INTA) [PE 1131022]; ANPCyT PICT [2011-939]	Instituto Nacional de Tecnologia Agropecuaria (INTA); ANPCyT PICT(ANPCyT)	This work was supported by the Instituto Nacional de Tecnologia Agropecuaria (INTA) [PE 1131022] and by ANPCyT PICT 2011-939. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Manacorda CA, 2013, MOL PLANT MICROBE IN, V26, P1486, DOI 10.1094/MPMI-07-13-0190-R; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Bazzini AA, 2007, P NATL ACAD SCI USA, V104, P12157, DOI 10.1073/pnas.0705114104; Bazzini AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028466; Bazzini AA, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-152; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Callebaut I, 1999, FEBS LETT, V446, P189, DOI 10.1016/S0014-5793(99)00132-5; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chellappan P, 2005, P NATL ACAD SCI USA, V102, P10381, DOI 10.1073/pnas.0504439102; Chen DJ, 2011, RNA, V17, P1012, DOI 10.1261/rna.2589011; Csorba T, 2007, J VIROL, V81, P11768, DOI 10.1128/JVI.01230-07; Debat HJ, 2014, PLANT MOL BIOL REP, V32, P1257, DOI 10.1007/s11105-014-0727-z; Di Serio F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007539; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Donaire L, 2009, VIROLOGY, V392, P203, DOI 10.1016/j.virol.2009.07.005; Du P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002176; Duplan V, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00042; Eamens AL, 2009, RNA, V15, P2219, DOI 10.1261/rna.1646909; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; German-Retana S, 2008, MOL PLANT PATHOL, V9, P127, DOI [10.1111/j.1364-3703.2007.00451.x, 10.1111/J.1364-3703.2007.00451.X]; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Guo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116175; Harvey JJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014639; Havecker ER, 2010, PLANT CELL, V22, P321, DOI 10.1105/tpc.109.072199; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Hu QA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019549; Iwakawa H, 2013, MOL CELL, V52, P591, DOI 10.1016/j.molcel.2013.10.033; Jay F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002035; Jeong DH, 2013, J PLANT BIOL, V56, P187, DOI 10.1007/s12374-013-0213-4; Jinling Liu, 2007, Journal of Genetics and Genomics, V34, P765, DOI 10.1016/S1673-8527(07)60087-3; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Koo JC, 2004, PLANT J, V37, P439, DOI 10.1046/j.1365-313X.2003.01869.x; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; LEISNER SM, 1993, PLANT CELL, V5, P191, DOI 10.1105/tpc.5.2.191; Li SB, 2013, CELL, V153, P562, DOI 10.1016/j.cell.2013.04.005; Li W, 2012, PLANT PHYSIOL, V158, P1279, DOI 10.1104/pp.111.188789; Liang G, 2010, PLANT SIGNAL BEHAV, V5, P1257, DOI 10.4161/psb.5.10.12608; Lin KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011928; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Lopez-Gomollon S, 2012, PLANTA, V236, P1875, DOI 10.1007/s00425-012-1734-7; Mansilla C, 2009, MOL PLANT PATHOL, V10, P59, DOI 10.1111/j.1364-3703.2008.00506.x; Martinez G, 2014, NUCLEIC ACIDS RES, V42, P1553, DOI 10.1093/nar/gkt968; Miozzi L, 2013, VIRUS RES, V178, P287, DOI 10.1016/j.virusres.2013.09.029; Mitter N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076276; Mohorianu I, 2011, PLANT J, V67, P232, DOI 10.1111/j.1365-313X.2011.04586.x; Morin PE, 1996, P NATL ACAD SCI USA, V93, P10604, DOI 10.1073/pnas.93.20.10604; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Pallas V, 2011, J GEN VIROL, V92, P2691, DOI 10.1099/vir.0.034603-0; Palukaitis P, 2013, CURR OPIN PLANT BIOL, V16, P513, DOI 10.1016/j.pbi.2013.06.004; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Saze H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3301; Seguin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088513; Sullivan CS, 2007, METHOD ENZYMOL, V427, P3, DOI 10.1016/S0076-6879(07)27001-6; Tagami Y, 2007, DNA RES, V14, P227, DOI 10.1093/dnares/dsm022; Thatcher SR, 2015, PLANT CELL ENVIRON, V38, P188, DOI 10.1111/pce.12393; Varallyay E, 2010, EMBO J, V29, P3507, DOI 10.1038/emboj.2010.215; Vaucheret H, 2006, MOL CELL, V22, P129, DOI 10.1016/j.molcel.2006.03.011; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vogler H, 2007, J VIROL, V81, P10379, DOI 10.1128/JVI.00727-07; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang MB, 2012, MOL PLANT MICROBE IN, V25, P1275, DOI 10.1094/MPMI-04-12-0093-CR; Wang XG, 2013, P NATL ACAD SCI USA, V110, P15467, DOI 10.1073/pnas.1315399110; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhu H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-149	72	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134719	10.1371/journal.pone.0134719	http://dx.doi.org/10.1371/journal.pone.0134719			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237414	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942400035
J	Carrascosa, JM; Cuevas, R; Gonzalez, R; Azcorra, A; Garcia, D				Carrascosa, Juan Miguel; Cuevas, Ruben; Gonzalez, Roberto; Azcorra, Arturo; Garcia, David			Quantifying the Economic and Cultural Biases of Social Media through Trending Topics	PLOS ONE			English	Article							NEWS COVERAGE	Online social media has recently irrupted as the last major venue for the propagation of news and cultural content, competing with traditional mass media and allowing citizens to access new sources of information. In this paper, we study collectively filtered news and popular content in Twitter, known as Trending Topics (TTs), to quantify the extent to which they show similar biases known for mass media. We use two datasets collected in 2013 and 2014, including more than 300.000 TTs from 62 countries. The existing patterns of leader-follower relationships among countries reveal systemic biases known for mass media: Countries concentrate their attention to small groups of other countries, generating a pattern of centralization in which TTs follow the gradient of wealth across countries. At the same time, we find subjective biases within language communities linked to the cultural similarity of countries, in which countries with closer cultures and shared languages tend to follow each other's TTs. Moreover, using a novel methodology based on the Google News service, we study the influence of mass media in TTs for four countries. We find that roughly half of the TTs in Twitter overlap with news reported by mass media, and that the rest of TTs are more likely to spread internationally within Twitter. Our results confirm that online social media have the power to independently spread content beyond mass media, but at the same time social media content follows economic incentives and is subject to cultural factors and language barriers.	[Carrascosa, Juan Miguel; Cuevas, Ruben; Azcorra, Arturo] Univ Carlos III Madrid, Madrid, Spain; [Gonzalez, Roberto] NEC Labs, Baden, Switzerland; [Azcorra, Arturo] Inst IMDEA Networks, Madrid, Spain; [Garcia, David] ETH, Zurich, Switzerland	Universidad Carlos III de Madrid; Swiss Federal Institutes of Technology Domain; ETH Zurich	Garcia, D (corresponding author), ETH, Zurich, Switzerland.	dgarcia@ethz.ch	Azcorra, Arturo/AAA-4627-2019; Cuevas, Rubén/G-6917-2015; Garcia, David/A-2113-2014	Azcorra, Arturo/0000-0002-5298-1248; Cuevas, Rubén/0000-0002-1440-8360; Garcia, David/0000-0002-2820-9151	SNSF project [CR21I1_146499]; European Union [318398, 607728]; EU [653417]; Regional Government of Madrid [S2009/TIC-1468, P2013/ICE-2958]	SNSF project; European Union(European Commission); EU(European Commission); Regional Government of Madrid	DG acknowledges funding from the SNSF project CR21I1_146499. JMC and RC acknowledge funding from the European Union's FP7 program under the project eCOUSIN (318398) and the EU-H2020 ReCRED project (653417). RG acknowledge funding from the European Union's FP7 program under the project METRICS (607728). AA and RC acknowledge funding from the Regional Government of Madrid under the MEDIANET Project (S2009/TIC-1468) and BRADE project (P2013/ICE-2958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; An J., 2014, P 2 ACM C ONL SOC NE, DOI [10.1145/2660460.2660469, DOI 10.1145/2660460.2660469]; An JS, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds/s13688-014-0012-2; [Anonymous], 2013, 22 INT C WORLD WID W, DOI DOI 10.1145/2488388.2488447; Bakshy E., 2015, SCIENCE; Bernstein M.S., 2011, P 5 INT AAAI C WEBL, P50; Bessi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118093; Borge-Holthoefer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023883; Carrascosa J, DATASET QUANTIFYING, DOI DOI 10.6084/M9.FIGSHARE.1381869; CHANG TK, 1987, COMMUN RES, V14, P396, DOI 10.1177/009365087014004002; Chomsky N, 2015, PARIS ATTACKS SHOW H; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Crane R, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.056101; Ferrara E., 2013, P 1 ACM C ONL SOC NE, P213, DOI DOI 10.1145/2512938.2512956; GALTUNG J, 1965, J PEACE RES, P64; Garas A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00402; Garcia D, 2014, GENDER ASYMMETRIES R, P131; Garcia D, 2013, ADV COMPLEX SYST, V16, DOI 10.1142/S0219525913500379; Garcia-Gavilanes R, 2013, P ICWSM, V13; Garrett RK, 2009, J COMPUT-MEDIAT COMM, V14, P265, DOI 10.1111/j.1083-6101.2009.01440.x; Gomez-Rodriguez M, 2014, QUANTIFYING INFORM O, P170; Hannak A., 2013, P 22 INT C WORLD WID, P527, DOI [https://doi.org/10.1145/2488388.2488435, 10.1145/2488388.2488435]; Herman E.S., 1988, POLITICAL EC MASS ME; Hofstede G, 2011, ONLINE READINGS PSYC, V2, P1, DOI [10.9707/2307-0919.1014, DOI 10.9707/2307-0919.1014]; Huberman BA, 2013, J STAT PHYS, V151, P329, DOI 10.1007/s10955-012-0596-5; Ishii K., 1996, INT COMMUNICATION GA, V57, P135, DOI [10.1177/001654929605700205, DOI 10.1177/001654929605700205]; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kozinets RV, 2002, J MARKETING RES, V39, P61, DOI 10.1509/jmkr.39.1.61.18935; Kwak H., 2010, WEB C 2010 P WORLD W, P591; Kwak H, 2014, LECT NOTES COMPUT SC, V8851, P300, DOI 10.1007/978-3-319-13734-6_22; Lehmann J., 2012, P 21 INT C WORLD WID, P251, DOI [10.1145/2187836.2187871, DOI 10.1145/2187836.2187871]; Llorente A, 2014, ARXIV141131402014; Magno G, 2014, LECT NOTES COMPUT SC, V8851, P121, DOI 10.1007/978-3-319-13734-6_9; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Oliveira JG, 2005, NATURE, V437, P1251, DOI 10.1038/4371251a; OSTGAARD E, 1965, J PEACE RES, P39; Pariser E., 2011, FILTER BUBBLE WHAT I; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Saez-Trumper D, 2013, PROCEEDINGS OF THE 22ND ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM'13), P1679, DOI 10.1145/2505515.2505623; Shirky C., 2008, HERE COMES EVERYBODY; Singer P, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P517, DOI 10.1145/2567948.2576943; Tufekci Z, 2014, POLICY INTERNET, V6, P202, DOI 10.1002/1944-2866.POI362; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Wagner C, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds/s13688-014-0036-7; Wallace I, 2002, GLOBAL EC SYSTEM; WALLERSTEIN I, 1993, J PEACE RES, V30, P1, DOI 10.1177/0022343393030001001; Wilkinson D, 2012, J AM SOC INF SCI TEC, V63, P1631, DOI 10.1002/asi.22713; Wu H.D., 1998, INT COMMUN GAZ, V60, P493, DOI [10.1177/0016549298060006003, DOI 10.1177/0016549298060006003]; Zuckerman E, 2014, POLICY INTERNET, V6, P151, DOI 10.1002/1944-2866.POI360	50	14	15	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134407	10.1371/journal.pone.0134407	http://dx.doi.org/10.1371/journal.pone.0134407			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230656	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400115
J	Choi, YJ; Thines, M				Choi, Young-Joon; Thines, Marco			Host Jumps and Radiation, Not Co-Divergence Drives Diversification of Obligate Pathogens. A Case Study in Downy Mildews and Asteraceae	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; EVOLUTION; HISTORY; GENERA; HYALOPERONOSPORA; RECONSTRUCTION; COSPECIATION; ASSOCIATIONS; COPHYLOGENY; COEVOLUTION	Even though the microevolution of plant hosts and pathogens has been intensely studied, knowledge regarding macro-evolutionary patterns is limited. Having the highest species diversity and host-specificity among Oomycetes, downy mildews are a useful a model for investigating long-term host-pathogen coevolution. We show that phylogenies of Bremia and Asteraceae are significantly congruent. The accepted hypothesis is that pathogens have diverged contemporarily with their hosts. But maximum clade age estimation and sequence divergence comparison reveal that congruence is not due to long-term coevolution but rather due to host-shift driven speciation (pseudo-cospeciation). This pattern results from parasite radiation in related hosts, long after radiation and speciation of the hosts. As large host shifts free pathogens from hosts with effector triggered immunity subsequent radiation and diversification in related hosts with similar innate immunity may follow, resulting in a pattern mimicking true co-divergence, which is probably limited to the terminal nodes in many pathogen groups.	[Choi, Young-Joon; Thines, Marco] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Fac Biosci, D-60438 Frankfurt, Germany; [Choi, Young-Joon; Thines, Marco] Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany; [Thines, Marco] Integrat Fungal Res Cluster IPF, D-60325 Frankfurt, Germany; [Thines, Marco] Senckenberg Gesell Nat Forsch, D-60325 Frankfurt, Germany	Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Gesellschaft fur Naturforschung (SGN)	Choi, YJ (corresponding author), Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Fac Biosci, D-60438 Frankfurt, Germany.	youngjoon.choi@senckenberg.de; marco.thines@senckenberg.de			Alexander von Humboldt foundation; LOEWE excellence program of the German state of Hessen; Biodiversity and Climate Research Centre (BiK-F)	Alexander von Humboldt foundation(Alexander von Humboldt Foundation); LOEWE excellence program of the German state of Hessen; Biodiversity and Climate Research Centre (BiK-F)	YJC was supported by a fellowship from the Alexander von Humboldt foundation (http://www.humboldt-foundation.de/web/home.html). This work was supported by the LOEWE excellence program of the German state of Hessen, in the framework of the Integrative Fungal Research Cluster (IPF) and the Biodiversity and Climate Research Centre (BiK-F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Barreda VD, 2010, SCIENCE, V329, P1621, DOI 10.1126/science.1193108; Barreda VD, 2012, ANN BOT-LONDON, V109, P127, DOI 10.1093/aob/mcr240; Choi YJ, 2015, MOL ECOL RESOUR, V15, P1275, DOI 10.1111/1755-0998.12398; Choi YJ, 2011, ORG DIVERS EVOL, V11, P193, DOI 10.1007/s13127-011-0043-5; Choi YJ, 2011, FUNGAL BIOL-UK, V115, P102, DOI 10.1016/j.funbio.2010.10.010; Coates ME, 2010, ANNU REV PHYTOPATHOL, V48, P329, DOI 10.1146/annurev-phyto-080508-094422; Conow C, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-16; de Vienne DM, 2013, NEW PHYTOL, V198, P347, DOI 10.1111/nph.12150; de Vienne DM, 2009, J EVOLUTION BIOL, V22, P2532, DOI 10.1111/j.1420-9101.2009.01878.x; de Vienne DM, 2007, BIOINFORMATICS, V23, P3119, DOI 10.1093/bioinformatics/btm500; Desprez-Loustau ML, 2011, MYCOSCIENCE, V52, P165, DOI 10.1007/s10267-010-0100-5; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fahrenholz H, 1913, ZOOL ANZ, V41, P371; GAUMANN E, 1923, BEITR KRYPTOGAMENFL, V5, P1; Gaumann E., 1919, MITT NAT FORSCH GES, V1918, P45; GAUMANN E, 1918, BOT ZENTRALBLATT S, V35, P395; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Goker M, 2007, FUNGAL GENET BIOL, V44, P105, DOI 10.1016/j.fgb.2006.07.005; Goker M, 2009, MYCOL RES, V113, P308, DOI 10.1016/j.mycres.2008.11.006; Goker M., 2004, Mycological Progress, V3, P83, DOI 10.1007/s11557-006-0079-7; HAFNER MS, 1988, NATURE, V332, P258, DOI 10.1038/332258a0; HAFNER MS, 1994, SCIENCE, V265, P1087, DOI 10.1126/science.8066445; Hirose S, 2005, MYCOL RES, V109, P912, DOI 10.1017/S0953756205003527; Hughes J, 2007, SYST BIOL, V56, P232, DOI 10.1080/10635150701311370; Jackson AP, 2004, EVOLUTION, V58, P1909, DOI 10.1111/j.0014-3820.2004.tb00479.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kilian N., 2009, SYSTEMATICS EVOLUTIO; King TA, 2007, INT J PARASITOL, V37, P663, DOI 10.1016/j.ijpara.2006.11.015; Legendre P, 2002, SYST BIOL, V51, P217, DOI 10.1080/10635150252899734; Matari NH, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-101; Matsuda S, 2003, MOL PHYLOGENET EVOL, V27, P314, DOI 10.1016/S1055-7903(02)00401-3; McLeish MJ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-1; Meier-Kolthoff JP, 2007, BIOINFORMATICS, V23, P898, DOI 10.1093/bioinformatics/btm027; Merkle D, 2005, THEOR BIOSCI, V123, P277, DOI 10.1016/j.thbio.2005.01.003; Merkle D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S60; Navarro E, 2003, PLANT SOIL, V254, P207, DOI 10.1023/A:1024978409187; Oliva R, 2010, CELL MICROBIOL, V12, P705, DOI 10.1111/j.1462-5822.2010.01471.x; PAGE RDM, 1994, CLADISTICS, V10, P155, DOI 10.1006/clad.1994.1010; Panero JL, 2008, MOL PHYLOGENET EVOL, V47, P757, DOI 10.1016/j.ympev.2008.02.011; Perlman SJ, 2003, EVOLUTION, V57, P544, DOI 10.1111/j.0014-3820.2003.tb01546.x; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Rambaut A., 2002, TREEANNOTATOR VERSIO; Ravensdale M, 2011, MOL PLANT PATHOL, V12, P93, DOI 10.1111/j.1364-3703.2010.00657.x; Refregier G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-100; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; Ronquist F, 1995, CLADISTICS, V11, P73, DOI 10.1111/j.1096-0031.1995.tb00005.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roy BA, 2001, EVOLUTION, V55, P41, DOI 10.1111/j.0014-3820.2001.tb01271.x; Runge F, 2012, PLANT DIS, V96, P55, DOI 10.1094/PDIS-01-11-0035; Runge F, 2011, EUR J PLANT PATHOL, V129, P135, DOI 10.1007/s10658-010-9714-x; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stassen JHM, 2012, MOL PLANT PATHOL, V13, P719, DOI 10.1111/j.1364-3703.2011.00780.x; Swofford D., 2002, PAUP 4 0 B10 PHYLOGE; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thines M, 2010, EUR J PLANT PATHOL, V128, P81, DOI 10.1007/s10658-010-9632-y; Thines M, 2010, CURR OPIN PLANT BIOL, V13, P427, DOI 10.1016/j.pbi.2010.04.001; Tremetsberger K, 2013, ORG DIVERS EVOL, V13, P1, DOI 10.1007/s13127-012-0094-2; Voglmayr H, 2003, MYCOL RES, V107, P1132, DOI 10.1017/S0953756203008438; Voglmayr H, 2004, MYCOL RES, V108, P1011, DOI 10.1017/S0953756204000954; Voglmayr H, 2008, MYCOL RES, V112, P487, DOI 10.1016/j.mycres.2007.10.009; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yi M, 2013, ANNU REV PHYTOPATHOL, V51, P587, DOI 10.1146/annurev-phyto-081211-172916; Zhang JW, 2011, TAXON, V60, P15, DOI 10.1002/tax.601003	67	34	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133655	10.1371/journal.pone.0133655	http://dx.doi.org/10.1371/journal.pone.0133655			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230508	gold, Green Submitted, Green Published			2022-12-27	WOS:000358838400047
J	Flores-Hernandez, S; Saturno-Hernandez, PJ; Reyes-Morales, H; Barrientos-Gutierrez, T; Villalpando, S; Hernandez-Avila, M				Flores-Hernandez, Sergio; Saturno-Hernandez, Pedro J.; Reyes-Morales, Hortensia; Barrientos-Gutierrez, Tonatiuh; Villalpando, Salvador; Hernandez-Avila, Mauricio			Quality of Diabetes Care: The Challenges of an Increasing Epidemic in Mexico. Results from Two National Health Surveys (2006 and 2012)	PLOS ONE			English	Article							INTENSIVE GLUCOSE CONTROL; OF-CARE; CARDIOVASCULAR-DISEASE; TYPE-2; MANAGEMENT; MELLITUS; COMPLICATIONS; IMPROVEMENT; PREVENTION; COUNTRIES	Background The quality of diabetes care remains suboptimal according to numerous studies assessing the achievement of quality indicators for diabetes care in various healthcare settings. We report about global and specific quality indicators for diabetes care and their association to glycemic control at the population level in two national health surveys in Mexico. Methods We conducted a cross-sectional analysis of the 2006 and 2012 National Health Surveys in Mexico. We examined quality of care for 2,965 and 4,483 adults (>= 20 years) with diagnosed type 2 diabetes using fourteen simple and two composite indicators derived from self-reported information. In a subsample for both surveys, glycated hemoglobin (HbA1c) was measured at the time of the interview. We obtained survey weight-adjusted estimators using multiple regression models (logistic and linear) with combined data files, including survey year as covariate to assess change. Results Global quality of care in 2012 was 40.8%, with a relative improvement of 11.7% between 2006 and 2012. Detections of cardiovascular disease risk factors (dyslipidemia and hypertension) were the indicators with the highest improvement, while non-pharmaceutical treatment and diabetic foot exams showed minor changes. We found a significant association between the quality of the process of diabetes care and glycemic control (OR 2.53, 95% CI 1.63-3.94). Age more than 65 years old, the type of health subsystem, gender (males), and high socio-economic status were also significantly associated to glycemic control. Conclusions Quality diabetes care and glycemic control improved and are significantly associated. However, according to international standards, the current situation remains suboptimal. A more holistic approach is needed, with an emphasis on improving quality in outpatient care.	[Flores-Hernandez, Sergio] Ctr Invest Evaluac & Encuestas, Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Saturno-Hernandez, Pedro J.] Inst Nacl Salud Publ, Direcc Ctr Invest Evaluac & Encuestas, Cuernavaca, Morelos, Mexico; [Reyes-Morales, Hortensia] Hosp Infantil Mexico Dr Federico Gomez, Direcc Invest, Mexico City, DF, Mexico; [Barrientos-Gutierrez, Tonatiuh] Inst Nacl Salud Publ, Ctr Invest Salud Poblac, Cuernavaca, Morelos, Mexico; [Villalpando, Salvador] Inst Nacl Salud Publ, Ctr Invest Salud & Nutr, Cuernavaca, Morelos, Mexico; [Hernandez-Avila, Mauricio] Inst Nacl Salud Publ, Direcc Gen, Cuernavaca, Morelos, Mexico	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; Hospital Infantil de Mexico Federico Gomez; Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica	Flores-Hernandez, S (corresponding author), Ctr Invest Evaluac & Encuestas, Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico.	sergio.flores@insp.mx	Villalpando, Salvador/AAS-3874-2021	Villalpando, Salvador/0000-0001-6429-3816; Barrientos-Gutierrez, Tonatiuh/0000-0002-0826-9106				Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; [Anonymous], GBD PROF MEX GLOB BU; [Anonymous], 2013, INF EL FED C UN SIT; Barquera S, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-3; Benoit SR, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-36; Bruno Graziella, 2012, Diabetes Care, V35, pe64; Buenas Pr&aacute;cticas en la Seguridad Social, 2012, PROGR MAN INT DIAB E; Carter JS, 2000, ARCH INTERN MED, V160, P3471, DOI 10.1001/archinte.160.22.3471; Centers for Disease Control and Prevention, 2012, DIAB REP CARD 2012; Hernandez-Romieu AC, 2011, SALUD PUBLICA MEXICO, V53, P34, DOI 10.1590/S0036-36342011000100006; Cordova-Villalobos JA, 2008, SALUD PUBLICA MEXICO, V50, P419, DOI 10.1590/s0036-36342008000500015; Diabetes UK, CAR CON CAMP STAT NA; Fowles JB, 1999, INT J QUAL HEALTH C, V11, P407, DOI 10.1093/intqhc/11.5.407; Gagliardino J J, 2001, Rev Panam Salud Publica, V10, P309, DOI 10.1590/S1020-49892001001100003; Gakidou E, 2011, B WORLD HEALTH ORGAN, V89, P172, DOI 10.2471/BLT.10.080820; Gil-Velazquez Luisa Estela, 2013, Rev Med Inst Mex Seguro Soc, V51, P58; Gudbjornsdottir S, 2003, DIABETES CARE, V26, P1270, DOI 10.2337/diacare.26.4.1270; Hernandez-Avila M, 2013, SALUD PUBLICA MEXICO, V55, pS129, DOI 10.21149/spm.v55s2.5108; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; International Diabetes Federation, 2006, IDF DIAB ATL 2; International Diabetes Federation, 2011, GLOB DIAB PLAN 2011; International Diabetes Federation, 2013, IDF DIABETES ATLAS; International Diabetes Federation, 2014, IDF DIABETES ATLAS U; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Ismail-Beigi F, 2011, ANN INTERN MED, V154, P554, DOI 10.7326/0003-4819-154-8-201104190-00007; Jimenez-Corona A, 2013, SALUD PUBLICA MEXICO, V55, pS137, DOI 10.21149/spm.v55s2.5109; Kontopantelis E, 2015, DIABETOLOGIA, V58, P505, DOI 10.1007/s00125-014-3473-8; Kontopantelis E, 2013, BMJ QUAL SAF, V22, P53, DOI 10.1136/bmjqs-2012-001033; Lee S, 2007, 2007 CAL HLTH INT SU; Mannucci E, 2013, DIABETES CARE, V36, pS259, DOI 10.2337/dcS13-2018; Miller ME, 2014, DIABETES CARE, V37, P634, DOI 10.2337/dc13-1545; National Center for Quality Assurance, 2013, 20135155 NAT CTR QUA, P51; National Institute for Clinical Excellence, MAN TYP 2 DIAB NIC C; Olaiz-Fernandez G, 2006, ENCUESTA NACL SALUD; Olaiz-Fernandez G, 2007, SALUD PUBLICA MEXICO, V49, pS331, DOI 10.1590/S0036-36342007000900004; Ortiz-Dominguez ME, 2011, SALUD PUBLICA MEXICO, V53, pS436, DOI 10.1590/S0036-36342011001000007; Perez-Cuevas R, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-50; Reeves D, 2007, MED CARE, V45, P489, DOI 10.1097/MLR.0b013e31803bb479; Reyes-Morales H, 2009, FAM MED, V41, P277; Romero-Martinez M, 2013, SALUD PUBLICA MEXICO, V55, pS332, DOI 10.21149/spm.v55s2.5132; Saluwe A., 2013, HLTH GLANC OECD IND, DOI [DOI 10.1787/HEALTH_GLANCE-2013-EN, 10.1787/health_glance-2013-en]; Sattar N, 2012, DIABETES OBES METAB, P1, DOI [10.1111/dom.12018, DOI 10.1111/D0M.12018]; Saturno PJ, 2004, REV CALIDAD ASISTENC, V19, P407, DOI DOI 10.1016/S1134-282X(04)77732-5; Saturno PJ, 2008, METODOS HERRAMIENTAS; Secretar&iacute;a de salud, GUIAS PRACT CLIN DIA; Secretar&iacute;a de Salud, 2007, DIABETES MELLITUS; Shaw J., 2012, DIABETES SILENT PAND; Sistema Nacional de Informaci&oacute;n en Salud, EST TEM DEF; Stone MA, 2013, DIABETES CARE, V36, P2628, DOI 10.2337/dc12-1759; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; TRIAD Study Grp, 2010, DIABETES CARE, V33, P940, DOI 10.2337/dc09-1802; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2; Villarreal H&eacute;ctor J, 2015, HLTH POLICY PLANNING, P1, DOI [10.1093/heapol/czv015, DOI 10.1093/HEAP0L/CZV015]; Wandurraga EA, 2014, REV ASOCIACION LATIN, V4, P106	55	34	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133958	10.1371/journal.pone.0133958	http://dx.doi.org/10.1371/journal.pone.0133958			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230991	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400064
J	Gupta, R; Bisaria, VS; Sharma, S				Gupta, Rashi; Bisaria, V. S.; Sharma, Shilpi			Effect of Agricultural Amendments on Cajanus cajan (Pigeon Pea) and Its Rhizospheric Microbial Communities - A Comparison between Chemical Fertilizers and Bioinoculants	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; PLANT-GROWTH; PSEUDOMONAS-FLUORESCENS; BIOCONTROL AGENTS; NOSZ GENES; SOIL; INOCULATION; ABUNDANCE; BACTERIA; BACILLUS	Inoculation of leguminous seeds with bioinoculants has been practiced in agriculture for decades to ameliorate grain yield by enhanced growth parameters and soil fertility. However, effective enhancement of plant growth parameters results not only from the direct effects these bioinoculants impose on them but also from their non-target effects. The ability of bioinoculants to reduce the application of chemicals for obtaining optimum yield of legume appears to be of great ecological and economic importance. In the present study, we compared the influence of seed inoculation of Cajanus cajan with a microbial consortium, comprising Bacillus megaterium, Pseudomonas fluorescens and Trichoderma harzianum, with that of application of chemical fertilizers on plant's growth parameters and its rhizospheric microbial communities. Real-time PCR assay was carried out to target the structure (16S rRNA) and function (nitrogen cycle) of rhizospheric microbiota, using both DNA and RNA as markers. The results showed that the microbial consortium was the most efficient in increasing grain yield (2.5-fold), even better than the recommended dose of chemical fertilizers (by 1.2-fold) and showed enhancement in nifH and amoA transcripts by 2.7- and 2.0-fold, respectively. No adverse effects of bioinoculants' application were observed over the rhizospheric microbial community, rendering the consortium to be safe for release in agricultural fields.	[Gupta, Rashi; Bisaria, V. S.; Sharma, Shilpi] Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi 110016, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Sharma, S (corresponding author), Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi 110016, India.	shilpi@dbeb.iitd.ac.in	Gupta, Rashi/R-4479-2019	Gupta, Dr. Rashi/0000-0002-9187-7451; Sharma, Shilpi/0000-0001-5868-2372	Department of Biotechnology, Govt. of India [BT/PR5499/AGR/21/355/2012]	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	Department of Biotechnology, Govt. of India grant ref BT/PR5499/AGR/21/355/2012.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Anandaraj B., 2010, J BIOSCI TECHNOL, V1, P95; Babic KH, 2008, ENVIRON MICROBIOL, V10, P2922, DOI 10.1111/j.1462-2920.2008.01762.x; Barea JM, 2005, J EXP BOT, V56, P1761, DOI 10.1093/jxb/eri197; Bjorklof K, 2003, MICROBIAL ECOL, V45, P39, DOI 10.1007/s00248-002-2018-8; Burgmann H, 2005, ENVIRON MICROBIOL, V7, P1711, DOI 10.1111/j.1462-2920.2005.00818.x; Chowdhury SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068818; Coelho MRR, 2009, APPL SOIL ECOL, V42, P48, DOI 10.1016/j.apsoil.2009.01.010; Coelho MRR, 2008, FEMS MICROBIOL LETT, V279, P15, DOI 10.1111/j.1574-6968.2007.00975.x; Das P, 2012, SAUDI J KIDNEY DIS T, V23, P1008, DOI 10.4103/1319-2442.100883; Ejaz S, 2004, EXP ONCOL, V26, P98; Fischer D, 2012, PLANT SOIL, V356, P83, DOI 10.1007/s11104-011-0812-0; Gil SV, 2009, MICROBIOL RES, V164, P196, DOI 10.1016/j.micres.2006.11.022; Gupta R, 2014, APPL SOIL ECOL, V76, P26, DOI 10.1016/j.apsoil.2013.12.001; Gupta R, 2012, PLANT SOIL, V358, P136, DOI 10.1007/s11104-012-1293-5; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; Herschkovitz Y, 2005, MICROB ECOL, V50, P277, DOI 10.1007/s00248-004-0148-x; Kandeler E, 2006, APPL ENVIRON MICROB, V72, P5957, DOI 10.1128/AEM.00439-06; Kim Hoon, 2000, Agricultural Chemistry and Biotechnology, V43, P147; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Kumar H, 2010, CROP PROT, V29, P591, DOI 10.1016/j.cropro.2010.01.002; Kushwaha D. S., 2011, Journal of Environmental Research and Development, V5, P631; Lian LH, 2007, LETT APPL MICROBIOL, V45, P262, DOI 10.1111/j.1472-765X.2007.02184.x; Little TM, 1978, AGR EXPT; Lopez-Gutierrez JC, 2004, J MICROBIOL METH, V57, P399, DOI 10.1016/j.mimet.2004.02.009; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Miller SA, 2009, ANNU REV PHYTOPATHOL, V47, P15, DOI 10.1146/annurev-phyto-080508-081743; Mishra PK, 2011, ARCH MICROBIOL, V193, P497, DOI 10.1007/s00203-011-0693-x; Mohammadi K., 2012, Journal of Agricultural and Biological Science, V7, P307; MOLLA MAZ, 1984, PLANT SOIL, V78, P393, DOI 10.1007/BF02450372; Morgan JAW, 2005, J EXP BOT, V56, P1729, DOI 10.1093/jxb/eri205; Nihorimbere V, 2011, BIOTECHNOL AGRON SOC, V15, P327; Niranjana SR, 2009, INT J PEST MANAGE, V55, P317, DOI 10.1080/09670870902919147; Rainey FA, 1996, MICROBIOL-UK, V142, P2087, DOI 10.1099/13500872-142-8-2087; Raja P., 2006, Journal of Biological Sciences, V6, P815; Rajendran G, 2008, BIORESOURCE TECHNOL, V99, P4544, DOI 10.1016/j.biortech.2007.06.057; Reddy B. P., 2009, International Journal of PharmTech Research, V1, P227; Sandheep A R, 2013, Pak J Biol Sci, V16, P580, DOI 10.3923/pjbs.2013.580.584; Sarma M.V.R.K., 2009, INT J BIOL LIFE SCI, V5, P25; Sharma S, 2012, J MICROBIOL METH, V91, P62, DOI 10.1016/j.mimet.2012.07.016; Timms-Wilson TM, 2004, PLANT SOIL, V266, P57; Trabelsi D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/863240; Winding A, 2004, FEMS MICROBIOL ECOL, V47, P129, DOI 10.1016/S0168-6496(03)00261-7	44	15	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132770	10.1371/journal.pone.0132770	http://dx.doi.org/10.1371/journal.pone.0132770			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26231030	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400020
J	Kondo, M; Yamato, M; Takagi, R; Namiki, H; Okano, T				Kondo, Makoto; Yamato, Masayuki; Takagi, Ryo; Namiki, Hideo; Okano, Teruo			Membrane-Permeable Calpain Inhibitors Promote Rat Oral Mucosal Epithelial Cell Proliferation by Inhibiting IL-1 alpha Signaling	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; NECROSIS-FACTOR-ALPHA; HUMAN KERATINOCYTES; ACTIVATING FACTOR; GROWTH; EXPRESSION; INVITRO; SHEETS; ENZYME	To standardise regenerative medicine using cultured cells, the use of serum-free, chemically defined media will be necessary. We have reported that IL-1 alpha inhibits the growth of epithelial cells in culture and that recombinant IL-1 receptor antagonist (IL-1RA) significantly promotes epithelial cell growth in no feeder layer condition. In this study, we examined inhibitors of calpain, a cysteine proteinase that plays crucial roles in various cellular functions, including IL-1 alpha maturation and secretion. The culturing of epithelial cells in serum-free media supplemented with a membrane-permeable calpain inhibitor significantly promoted growth while suppressing IL-1 alpha maturation and secretion. By contrast, non-membrane-permeable calpain inhibitor treatment did not have these effects. Interestingly, immunoblotting analysis revealed that immature, untruncated, IL-1 alpha expression was also downregulated by cell-permeable calpain inhibitor treatment, and the difference in IL-1 alpha gene expression increased from day 2 to day 6. Although IL-1RA has been reported to promote epithelial cell growth, we detected no synergistic promotion of epithelial cell growth using a calpain inhibitor and IL-1RA. These findings indicate that calpain inhibitors promote epithelial cell proliferation by inhibiting IL-1 alpha maturation at an early phase of epithelial cell culture and by suppressing the positive feedback-mediated amplification of IL-1 alpha signalling.	[Kondo, Makoto; Yamato, Masayuki; Takagi, Ryo; Okano, Teruo] Tokyo Womens Med Univ, TWIns, Inst Adv Biomed Engn & Sci, Shinjuku Ku, Tokyo 1628666, Japan; [Kondo, Makoto; Namiki, Hideo] Waseda Univ, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan	Tokyo Women's Medical University; Waseda University	Yamato, M (corresponding author), Tokyo Womens Med Univ, TWIns, Inst Adv Biomed Engn & Sci, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	yamato.masayuki@twmu.ac.jp	Kondo, Makoto/AAE-2471-2019	Kondo, Makoto/0000-0002-5978-0043; Okano, Teruo/0000-0002-4470-9842	Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds for Promoting Science and Technology, "The Cell Sheet Tissue Engineering Center" from the MEXT; Global COE program, "The Multidisciplinary Education and Research Center for the Establishment of Regenerative Medicine" from MEXT [K08]; JSPS from the Japanese Society for the Promotion of Science [DC1: 22-3791]	Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds for Promoting Science and Technology, "The Cell Sheet Tissue Engineering Center" from the MEXT; Global COE program, "The Multidisciplinary Education and Research Center for the Establishment of Regenerative Medicine" from MEXT; JSPS from the Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds for Promoting Science and Technology, "The Cell Sheet Tissue Engineering Center" from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (to TO); the Global COE program, "The Multidisciplinary Education and Research Center for the Establishment of Regenerative Medicine" (K08) from MEXT (to MY) (http://www.jsps.go.jp/j-globalcoe/05_kyoten_k.html); and JSPS research fellowship (DC1: 22-3791) from the Japanese Society for the Promotion of Science (to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bygrave FL, 1996, CELL CALCIUM, V19, P547, DOI 10.1016/S0143-4160(96)90064-0; CARTER DB, 1990, NATURE, V344, P633, DOI 10.1038/344633a0; DELUCA M, 1990, TRANSPLANTATION, V50, P454, DOI 10.1097/00007890-199009000-00019; DINARELLO CA, 1987, J IMMUNOL, V139, P1902; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; GALLICO GG, 1989, PLAST RECONSTR SURG, V84, P1; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; Hata K, 1996, Hum Cell, V9, P91; KOBAYASHI Y, 1990, P NATL ACAD SCI USA, V87, P5548, DOI 10.1073/pnas.87.14.5548; Kondo M, 2014, J BIOMED MATER RES A, V102, P1829, DOI 10.1002/jbm.a.34849; Kondo M, 2013, BIOMATERIALS, V34, P121, DOI 10.1016/j.biomaterials.2012.09.036; KUPPER TS, 1986, J EXP MED, V164, P2095, DOI 10.1084/jem.164.6.2095; KUTSCH CL, 1993, J INVEST DERMATOL, V101, P79, DOI 10.1111/1523-1747.ep12360119; Lamb R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052494; LUGER TA, 1981, J IMMUNOL, V127, P1493; MULLERGLAUSER W, 1983, ARCH ORAL BIOL, V28, P765, DOI 10.1016/0003-9969(83)90113-9; Murakami D, 2006, BIOMATERIALS, V27, P5518, DOI 10.1016/j.biomaterials.2006.05.042; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Ohki T, 2012, GASTROENTEROLOGY, DOI [10.1053/j.gastro.2012.04.050, DOI 10.1053/J.GASTR0.2012.04.050]; PHILLIPS TJ, 1989, J AM ACAD DERMATOL, V21, P191, DOI 10.1016/S0190-9622(89)70160-2; PILLAI S, 1989, J CLIN INVEST, V83, P816, DOI 10.1172/JCI113963; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Seitz CS, 2000, CANCER RES, V60, P4085; Sorimachi H, 2011, P JPN ACAD B-PHYS, V87, P287, DOI 10.2183/pjab.87.287; Sultana T, 2003, INT J ANDROL, V26, P37, DOI 10.1046/j.1365-2605.2003.00386.x; Tsai CY, 1997, J CRANIO MAXILL SURG, V25, P4, DOI 10.1016/S1010-5182(97)80017-0; UEDA M, 1995, ANN PLAS SURG, V35, P498, DOI 10.1097/00000637-199511000-00009; WATANABE N, 1994, CYTOKINE, V6, P597, DOI 10.1016/1043-4666(94)90046-9	29	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134240	10.1371/journal.pone.0134240	http://dx.doi.org/10.1371/journal.pone.0134240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230502	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400091
J	Liu, XD; Wang, XR; Lin, SH; Song, QK; Lao, XQ; Yu, ITS				Liu, Xudong; Wang, Xiaorong; Lin, Sihao; Song, Qingkun; Lao, Xiangqian; Yu, Ignatius Tak-Sun			Reproducibility and Validity of a Food Frequency Questionnaire for Assessing Dietary Consumption via the Dietary Pattern Method in a Chinese Rural Population	PLOS ONE			English	Article							RELATIVE VALIDITY; CORRELATION-COEFFICIENTS; PREGNANT-WOMEN; AGREEMENT; STABILITY; AREA; FFQ	Objective This study was conducted to assess the reproducibility and validity of a food frequency questionnaire (FFQ) that was developed to assess the overall dietary consumption via dietary pattern method in a rural population in southwest China. Methods A total of 179 participants aged between 40 and 70 years old were included in this study. Participants administered FFQ at baseline (FFQ1) and one year later (FFQ2) to assess the reproducibility. Six 3-day 24-hour recalls (24HRs) were completed between the administrations of two FFQs to determine the validity. Dietary patterns from three separate dietary sources were derived by using principle component factor analysis. Comparisons between dietary pattern scores were made by using Pearson or intraclass correlation coefficient, cross-classification analysis, weighted kappa (kappa) statistic and Bland-Altman analysis. The de-attenuated method was adopted to correct the monthly and seasonally variation and the partial correlation analysis was used correct the influence by total energy intake. Results Two major dietary factors, labeled as prudent pattern and processed food pattern, were identified. The prudent pattern was characterized by higher factor loadings of wheat, rice, fresh vegetables, bean products, nuts, red meat, white meat and fresh eggs; and the processed food pattern was characterized by higher factor loadings of pickled vegetables, preserved vegetables and salted meat. Between Two FFQs, intraclass correlation coefficients were 0.57 for prudent pattern and 0.55 for processed food pattern, partial Pearson correlation coefficients were 0.51 for the prudent pattern and 0.56 for the processed food pattern; weighted. statistic ranged from 0.45 (for the prudent pattern) to 0.56 (for the processed food pattern). Between FFQs and 24HRs, de-attenuated correlation coefficients ranged from 0.54 to 0.78 for the prudent pattern and from 0.55 to 0.61 for the processed food pattern; partial Pearson correlation coefficients ranged from 0.41 to 0.56 for the prudent pattern and from 0.42 to 0.44 for the processed food pattern; weighted. statistic ranged from 0.42 to 0.46 for prudent pattern and from 0.43 to 0.60 for processed food pattern. The Bland-Altman plots and limits of agreement indicated that the deviation/divergence was not obvious for both of the patterns between FFQ1 and FFQ2 and between FFQs and 24HRs. Conclusion The study suggests that the FFQ is reasonably reproducible and valid to assess the overall dietary consumption via dietary pattern methods in the Chinese rural population.	[Liu, Xudong; Wang, Xiaorong; Lin, Sihao; Lao, Xiangqian] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Wang, Xiaorong; Lin, Sihao; Yu, Ignatius Tak-Sun] Hong Kong Occupat & Environm Hlth Acad, Hong Kong, Hong Kong, Peoples R China; [Song, Qingkun] Capital Med Univ, Ctr Canc, Beijing Shijitan Hosp, Beijing Key Lab Canc Therapeut Vaccine, Beijing, Peoples R China	Chinese University of Hong Kong; Capital Medical University	Wang, XR (corresponding author), Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	xrwang2000@yahoo.com	Yu, Ignatius Tak Sun/A-9936-2008; Lao, Xiang Qian/M-5817-2017; wang, xiao/HGB-7081-2022	Lao, Xiang Qian/0000-0002-2645-0128; wang, xiao/0000-0002-4088-3341	World Cancer Research Fund, International [2010/240]	World Cancer Research Fund, International(World Cancer Research Fund International (WCRF))	This work was supported by Xiaorong Wang, World Cancer Research Fund, International (No. 2010/240). The funder had no role in the design, analysis or writing of this article.	Ambrosini GL, 2011, BRIT J NUTR, V105, P625, DOI 10.1017/S0007114510004137; Asghari G, 2012, BRIT J NUTR, V108, P1109, DOI 10.1017/S0007114511006313; Beck KL, 2012, J ACAD NUTR DIET, V112, P1177, DOI 10.1016/j.jand.2012.05.012; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bravi F, 2012, ANN ONCOL, V23, P765, DOI 10.1093/annonc/mdr295; Chinese Society of Nutrition, 2011, DIETARY GUIDELINES C; Crozier SR, 2008, BRIT J NUTR, V99, P869, DOI 10.1017/S0007114507831746; Crozier SR, 2009, J NUTR, V139, P1956, DOI 10.3945/jn.109.109579; Field A., 2012, DISCOVERING STAT USI; Forman MR, 1999, PUBLIC HEALTH NUTR, V2, P301, DOI 10.1017/S1368980099000403; Gao Jian, 2011, Acta Nutrimenta Sinica, V33, P452; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Khani BR, 2004, J NUTR, V134, P1541, DOI 10.1093/jn/134.6.1541; Li M, 2014, ACTA OBSTET GYN SCAN, V93, P1141, DOI 10.1111/aogs.12460; Loy SL, 2013, INT J FOOD SCI NUTR, V64, P668, DOI 10.3109/09637486.2013.787398; Masson LF, 2003, PUBLIC HEALTH NUTR, V6, P313, DOI 10.1079/PHN2002429; Nanri A, 2012, J EPIDEMIOL, V22, P205, DOI 10.2188/jea.JE20110087; National Cancer Institute, 2010, DIET HIST QUESTIONNA; Nelson M, 1998, PUBLIC HEALTH NUTR, V1, P231, DOI 10.1079/PHN19980039; Nettleton JA, 2009, AM J CLIN NUTR, V90, P647, DOI 10.3945/ajcn.2009.27597; Newby PK, 2006, J NUTR, V136, P626, DOI 10.1093/jn/136.3.626; Okubo H, 2010, PUBLIC HEALTH NUTR, V13, P1080, DOI 10.1017/S1368980009993211; POSNER BM, 1992, J AM DIET ASSOC, V92, P738; ROSNER B, 1988, AM J EPIDEMIOL, V127, P377, DOI 10.1093/oxfordjournals.aje.a114811; Sharma S, 1996, EUR J CLIN NUTR, V50, P479; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738; Song FY, 2005, WORLD J GASTROENTERO, V11, P4078, DOI 10.3748/wjg.v11.i26.4078; Viera AJ, 2005, FAM MED, V37, P360; Villegas R, 2007, BRIT J NUTR, V97, P993, DOI 10.1017/S0007114507669189; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd, DOI DOI 10.1093/ACPROF:OSO/9780199754038.001.0001; Xia W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019656; Yang YX., 2009, CHINA FOOD COMPOSITI; Zhai Feng-ying, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P485; Zhang M, 2005, Asia Pac J Public Health, V17, P29, DOI 10.1177/101053950501700108; Zheng S., 2006, MODERN PREV MED, V33, P393; Zhuang MQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048341	39	32	33	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134627	10.1371/journal.pone.0134627	http://dx.doi.org/10.1371/journal.pone.0134627			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230275	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400143
J	Srivastava, A; Golden, KL; Sanchez, CA; Liu, K; Fong, PY; Li, XH; Cowan, DS; Rabinovitch, PS; Reid, BJ; Blount, PL; Odze, RD				Srivastava, Amitabh; Golden, Kevin L.; Sanchez, Carissa A.; Liu, Karen; Fong, Pui Yee; Li, Xiaohong; Cowan, David S.; Rabinovitch, Peter S.; Reid, Brian J.; Blount, Patricia L.; Odze, Robert D.			High Goblet Cell Count Is Inversely Associated with Ploidy Abnormalities and Risk of Adenocarcinoma in Barrett's Esophagus	PLOS ONE			English	Article							COLUMNAR EPITHELIUM; INTESTINAL METAPLASIA; GRADE DYSPLASIA; PROGRESSION; CANCER; PREDICTORS; MECHANISMS; DIAGNOSIS; JUNCTION; MUCIN	Purpose Goblet cells may represent a potentially successful adaptive response to acid and bile by producing a thick mucous barrier that protects against cancer development in Barrett's esophagus (BE). The aim of this study was to determine the relationship between goblet cells (GC) and risk of progression to adenocarcinoma, and DNA content flow cytometric abnormalities, in BE patients. Experimental Design Baseline mucosal biopsies (N=2988) from 213 patients, 32 of whom developed cancer during the follow up period, enrolled in a prospective dynamic cohort of BE patients were scored in a blinded fashion, for the total number (#) of GC, mean # of GC/crypt (GC density), # of crypts with >= 1 GC, and the proportion of crypts with >= 1 GC, in both dysplastic and non-dysplastic epithelium separately. The relationship between these four GC parameters and DNA content flow cytometric abnormalities and adenocarcinoma outcome was compared, after adjustment for age, gender, and BE segment length. Results High GC parameters were inversely associated with DNA content flow cytometric abnormalities, such as aneuploidy, ploidy >2.7N, and an elevated 4N fraction >6%, and with risk of adenocarcinoma. However, a Kaplan-Meier analysis showed that the total # of GC and the total # crypts with >= 1 GC were the only significant GC parameters (p<0.001 and 0.003, respectively). Conclusions The results of this study show, for the first time, an inverse relationship between high GC counts and flow cytometric abnormalities and risk of adenocarcinoma in BE. Further studies are needed to determine if GC depleted foci within esophageal columnar mucosa are more prone to neoplastic progression or whether loss of GC occurs secondary to underlying genetic abnormalities.	[Srivastava, Amitabh; Golden, Kevin L.; Odze, Robert D.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Sanchez, Carissa A.; Fong, Pui Yee; Li, Xiaohong; Cowan, David S.; Reid, Brian J.; Blount, Patricia L.] Fred Hutchinson Canc Res Ctr, Dept Human Biol, Seattle, WA 98104 USA; [Sanchez, Carissa A.; Li, Xiaohong; Cowan, David S.; Reid, Brian J.] Fred Hutchinson Canc Res Ctr, Dept Publ Hlth Sci, Seattle, WA 98104 USA; [Liu, Karen] Fred Hutchinson Canc Res Ctr, Dept Vaccine, Infect Dis Inst, Seattle, WA 98104 USA; [Rabinovitch, Peter S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Reid, Brian J.; Blount, Patricia L.] Univ Washington, Dept Med, Seattle, WA USA; [Reid, Brian J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Harvard University; Brigham & Women's Hospital; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Odze, RD (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	rodze@partners.org			National Institute of Health [P01 CA91955]; NATIONAL CANCER INSTITUTE [P01CA091955] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institute of Health P01 CA91955, BJR.	BANSAL A, 2011, GASTROENTEROLOGY S1, V140, pS306; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhat S, 2011, J NATL CANCER I, V103, P1049, DOI 10.1093/jnci/djr203; Chandrasoma P, 2007, DIS ESOPHAGUS, V20, P36, DOI 10.1111/j.1442-2050.2007.00638.x; Chaves P, 2007, MODERN PATHOL, V20, P788, DOI 10.1038/modpathol.3800787; Dixon J, 2001, AM J GASTROENTEROL, V96, P2575, DOI 10.1111/j.1572-0241.2001.04159.x; Fijneman RJA, 2008, CANCER SCI, V99, P2113, DOI 10.1111/j.1349-7006.2008.00924.x; HAGGITT RC, 1978, AM J CLIN PATHOL, V70, P1; Hahn HP, 2009, AM J SURG PATHOL, V33, P1006, DOI 10.1097/PAS.0b013e31819f57e9; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Jovov B, 2007, AM J PHYSIOL-GASTR L, V293, pG1106, DOI 10.1152/ajpgi.00158.2007; Kelty CJ, 2007, SCAND J GASTROENTERO, V42, P1271, DOI 10.1080/00365520701420735; Lao-Sirieix P, 2008, DIS ESOPHAGUS, V21, P529, DOI 10.1111/j.1442-2050.2007.00807.x; Leers JM, 2008, GASTROENTEROLOGY, V134, pA380; LEVINE DS, 1993, GASTROENTEROLOGY, V105, P40, DOI 10.1016/0016-5085(93)90008-Z; LEVINE DS, 1989, LAB INVEST, V60, P418; LEVINE DS, 1989, GASTROENTEROLOGY, V96, P355, DOI 10.1016/S0016-5085(89)91559-X; Liu W, 2009, AM J GASTROENTEROL, V104, P816, DOI 10.1038/ajg.2009.85; Menke V, 2010, DIS MODEL MECH, V3, P104, DOI 10.1242/dmm.003012; Nancarrow DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022513; Ostrowski J, 2007, J MOL MED, V85, P733, DOI 10.1007/s00109-007-0176-3; PARAF F, 1995, AM J SURG PATHOL, V19, P183, DOI 10.1097/00000478-199502000-00007; Rabinovitch PS, 2001, AM J GASTROENTEROL, V96, P3071, DOI 10.1111/j.1572-0241.2001.05261.x; Reid BJ, 2000, AM J GASTROENTEROL, V95, P1669, DOI 10.1111/j.1572-0241.2000.02196.x; REID BJ, 1988, HUM PATHOL, V19, P166, DOI 10.1016/S0046-8177(88)80344-7; Reid BJ, 2011, CLIN CANCER RES, V17, P3512, DOI 10.1158/1078-0432.CCR-09-2358; Reid BJ, 2010, NAT REV CANCER, V10, P87, DOI 10.1038/nrc2773; Riddell RH, 2009, AM J GASTROENTEROL, V104, P2588, DOI 10.1038/ajg.2009.390; Romagnoli S, 2001, LAB INVEST, V81, P241, DOI 10.1038/labinvest.3780232; SHANKEY TV, 1993, CYTOMETRY, V14, P472, DOI 10.1002/cyto.990140503; Sharma P, 2004, GASTROENTEROLOGY, V127, P310, DOI 10.1053/j.gastro.2004.04.010; SKINNER DB, 1983, ANN SURG, V198, P554, DOI 10.1097/00000658-198310000-00016; Srivastava A, 2007, AM J GASTROENTEROL, V102, P483, DOI 10.1111/j.1572-0241.2007.01073.x; Takubo K, 2009, HUM PATHOL, V40, P65, DOI 10.1016/j.humpath.2008.06.008; Themeau T, 2013, PACKAGE SURVIVAL; Tobey NA, 2007, AM J PHYSIOL-GASTR L, V293, pG264, DOI 10.1152/ajpgi.00047.2007; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Yang K, 2008, CANCER RES, V68, P7313, DOI 10.1158/0008-5472.CAN-08-0598	38	18	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133403	10.1371/journal.pone.0133403	http://dx.doi.org/10.1371/journal.pone.0133403			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230607	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400037
J	Wang, SZ; Chen, WY; Xiao, WF; Yang, CD; Xin, Y; Qiu, JR; Hu, WM; Ying, W; Fu, YP; Tong, JX; Hu, GC; Chen, ZZ; Fang, XP; Yu, H; Lai, WG; Ruan, SL; Ma, HS				Wang, Shuzhen; Chen, Wenyue; Xiao, Wenfei; Yang, Changdeng; Xin, Ya; Qiu, Jieren; Hu, Weimin; Ying, Wu; Fu, Yaping; Tong, Jianxin; Hu, Guocheng; Chen, Zhongzhong; Fang, Xianping; Yu, Hong; Lai, Wenguo; Ruan, Songlin; Ma, Huasheng			Differential Proteomic Analysis Using iTRAQ Reveals Alterations in Hull Development in Rice (Oryza sativa L.)	PLOS ONE			English	Article							QUANTITATIVE PROTEOMICS; GRAIN WIDTH; PALEA DEVELOPMENT; MAJOR QTL; GENE; LEMMA; ANNOTATION; WEIGHT; RESOURCE; GENOMICS	Rice hull, the outer cover of the rice grain, determines grain shape and size. Changes in the rice hull proteome in different growth stages may reflect the underlying mechanisms involved in grain development. To better understand these changes, isobaric tags for relative and absolute quantitative (iTRAQ) MS/MS was used to detect statistically significant changes in the rice hull proteome in the booting, flowering, and milk-ripe growth stages. Differentially expressed proteins were analyzed to predict their potential functions during development. Gene ontology (GO) terms and pathways were used to evaluate the biological mechanisms involved in rice hull at the three growth stages. In total, 5,268 proteins were detected and characterized, of which 563 were differentially expressed across the development stages. The results showed that the flowering and milk-ripe stage proteomes were more similar to each other (r=0.61) than either was to the booting stage proteome. A GO enrichment analysis of the differentially expressed proteins was used to predict their roles during rice hull development. The potential functions of 25 significantly differentially expressed proteins were used to evaluate their possible roles at various growth stages. Among these proteins, an unannotated protein (Q7X8A1) was found to be overexpressed especially in the flowering stage, while a putative uncharacterized protein (B8BF94) and an aldehyde dehydrogenase (Q9FPK6) were overexpressed only in the milk-ripe stage. Pathways regulated by differentially expressed proteins were also analyzed. Magnesium-protoporphyrin IX monomethyl ester [ oxidative] cyclase (Q9SDJ2), and two magnesium-chelatase subunits, ChlD (Q6ATS0), and ChlI (Q53RM0), were associated with chlorophyll biosynthesis at different developmental stages. The expression of Q9SDJ2 in the flowering and milk-ripe stages was validated by qRT-PCR. The 25 candidate proteins may be pivotal markers for controlling rice hull development at various growth stages and chlorophyll biosynthesis pathway related proteins, especially magnesium-protoporphyrin IX monomethylester [oxidative] cyclase (Q9SDJ2), may provide new insights into the molecular mechanisms of rice hull development and chlorophyll associated regulation.	[Wang, Shuzhen; Chen, Wenyue; Xiao, Wenfei; Xin, Ya; Qiu, Jieren; Ying, Wu; Tong, Jianxin; Chen, Zhongzhong; Fang, Xianping; Yu, Hong; Lai, Wenguo; Ruan, Songlin; Ma, Huasheng] Hangzhou Acad Agr Sci, Inst Biotechnol, Lab Plant Mol Biol & Prote, Hangzhou 310024, Zhejiang, Peoples R China; [Wang, Shuzhen; Yang, Changdeng; Fu, Yaping; Hu, Guocheng] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China; [Wang, Shuzhen; Hu, Weimin] Zhejiang Univ, Coll Agr & Biotechnol, Dept Agron, Hangzhou 310012, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Zhejiang University	Ruan, SL (corresponding author), Hangzhou Acad Agr Sci, Inst Biotechnol, Lab Plant Mol Biol & Prote, Hangzhou 310024, Zhejiang, Peoples R China.	ruansl1@hotmail.com; hzhsma@163.com		Chen, Zhongzhong/0000-0001-6662-5837	Great Project of Science and Technology of Hangzhou City [20131812A02]; Zhejiang Provincial Natural Science Foundation of China [LR12C13001]; Open Project of State Key Laboratory of Rice Biology [12020313]	Great Project of Science and Technology of Hangzhou City; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Open Project of State Key Laboratory of Rice Biology	This work was supported by the Great Project of Science and Technology of Hangzhou City (Research Grant #20131812A02 to SLR), Zhejiang Provincial Natural Science Foundation of China (Research Grant #LR12C13001 to SLR) and the Open Project of State Key Laboratory of Rice Biology (Research Grant #12020313 to SZW and SLR).	Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Ashikari M, 2006, TRENDS PLANT SCI, V11, P344, DOI 10.1016/j.tplants.2006.05.008; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; Cao PJ, 2012, RICE, V5, DOI 10.1186/1939-8433-5-17; Chen M, 2014, ANNU REV BIOCHEM, V83, P317, DOI 10.1146/annurev-biochem-072711-162943; Deswal R, 2013, PHYSIOL MOL BIOL PLA, V19, P461, DOI 10.1007/s12298-013-0198-y; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerber L, 2014, NEW PHYTOLOGIST; Ghosh D, 2013, MOL CELL PROTEOMICS, V12, P1865, DOI 10.1074/mcp.M112.023085; Guo SB, 2013, RICE SCI, V20, P95, DOI 10.1016/S1672-6308(13)60111-0; Hong LL, 2010, J GENET GENOMICS, V37, P101, DOI 10.1016/S1673-8527(09)60029-1; Huang RY, 2013, TRENDS PLANT SCI, V18, P218, DOI 10.1016/j.tplants.2012.11.001; Huang XH, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-22; Jin Y, 2011, DEV BIOL, V359, P277, DOI 10.1016/j.ydbio.2011.08.023; Kambiranda D, 2014, J PROTEOME RES, V13, P555, DOI 10.1021/pr400731p; Komatsu M, 2003, DEVELOPMENT, V130, P3841, DOI 10.1242/dev.00564; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Latterich M, 2008, EUR J CANCER, V44, P2737, DOI 10.1016/j.ejca.2008.09.007; Li JB, 2009, RICE SCI, V16, P79, DOI 10.1016/S1672-6308(08)60061-X; Li XJ, 2012, PLANT MOL BIOL, V78, P351, DOI 10.1007/s11103-011-9868-8; Liu GT, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-110; Lu C, 2013, RICE SCI, V20, P191, DOI 10.1016/S1672-6308(13)60122-5; Luo LL, 2014, RICE SCI, V21, P29, DOI 10.1016/S1672-6308(13)60156-0; Monahan LG, 2014, MBIO, V5, DOI 10.1128/mBio.00935-14; Morgat A, 2012, NUCLEIC ACIDS RES, V40, pD761, DOI 10.1093/nar/gkr1023; Mulukutla BC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098756; Normile D, 2008, SCIENCE, V321, P330, DOI 10.1126/science.321.5887.330; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Poulsen ET, 2014, J PROTEOME RES; Prasad K, 2005, PLANT J, V43, P915, DOI 10.1111/j.1365-313X.2005.02504.x; Ruan YL, 2014, ANNU REV PLANT BIOL, V65, P33, DOI 10.1146/annurev-arplant-050213-040251; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Sasaya T, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00409; Satoh M, 2013, PLANT PHYSIOLOGY AND; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; TeSlaa T, 2014, METHOD ENZYMOL, V542, P91, DOI 10.1016/B978-0-12-416618-9.00005-4; Wang SS, 2011, THEOR APPL GENET, V122, P1489, DOI 10.1007/s00122-011-1548-1; Wei XJ, 2013, PLANT CELL REP, V32, P1455, DOI 10.1007/s00299-013-1457-7; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Wilm M, 2009, PROTEOMICS, V9, P4590, DOI 10.1002/pmic.200900299; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yoshida A, 2009, P NATL ACAD SCI USA, V106, P20103, DOI 10.1073/pnas.0907896106; Yu XR, 2014, RICE SCI, V21, P142, DOI 10.1016/S1672-6308(13)60176-6; Zeiger E, 2012, PLANT PHYSIOL, P484; Zhang Quanfang, 2007, Journal of Genetics and Genomics, V34, P519, DOI 10.1016/S1673-8527(07)60057-5; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	49	11	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133696	10.1371/journal.pone.0133696	http://dx.doi.org/10.1371/journal.pone.0133696			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230730	gold, Green Submitted, Green Published			2022-12-27	WOS:000358838400050
J	Duprez, W; Bachu, P; Stoermer, MJ; Tay, S; McMahon, RM; Fairlie, DP; Martin, JL				Duprez, Wilko; Bachu, Prabhakar; Stoermer, Martin J.; Tay, Stephanie; McMahon, Roisin M.; Fairlie, David P.; Martin, Jennifer L.			Virtual Screening of Peptide and Peptidomimetic Fragments Targeted to Inhibit Bacterial Dithiol Oxidase DsbA	PLOS ONE			English	Article							DISULFIDE BOND FORMATION; CRYSTAL-STRUCTURE; ANTIMICROBIAL AGENTS; CONFORMER GENERATION; CLINICAL PIPELINE; IN-VIVO; PROTEIN; ANTIBIOTICS; VIRULENCE; MECHANISM	Antibacterial drugs with novel scaffolds and new mechanisms of action are desperately needed to address the growing problem of antibiotic resistance. The periplasmic oxidative folding system in Gram-negative bacteria represents a possible target for anti-virulence antibacterials. By targeting virulence rather than viability, development of resistance and side effects (through killing host native microbiota) might be minimized. Here, we undertook the design of peptidomimetic inhibitors targeting the interaction between the two key enzymes of oxidative folding, DsbA and DsbB, with the ultimate goal of preventing virulence factor assembly. Structures of DsbB - or peptides - complexed with DsbA revealed key interactions with the DsbA active site cysteine, and with a hydrophobic groove adjacent to the active site. The present work aimed to discover peptidomimetics that target the hydrophobic groove to generate non-covalent DsbA inhibitors. The previously reported structure of a Proteus mirabilis DsbA active site cysteine mutant, in a non-covalent complex with the heptapeptide PWATCDS, was used as an in silico template for virtual screening of a peptidomimetic fragment library. The highest scoring fragment compound and nine derivatives were synthesized and evaluated for DsbA binding and inhibition. These experiments discovered peptidomimetic fragments with inhibitory activity at millimolar concentrations. Although only weakly potent relative to larger covalent peptide inhibitors that interact through the active site cysteine, these fragments offer new opportunities as templates to build non-covalent inhibitors. The results suggest that non-covalent peptidomimetics may need to interact with sites beyond the hydrophobic groove in order to produce potent DsbA inhibitors.	[Duprez, Wilko; Bachu, Prabhakar; Stoermer, Martin J.; Tay, Stephanie; McMahon, Roisin M.; Fairlie, David P.; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia	University of Queensland	Martin, JL (corresponding author), Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia.	j.martin@imb.uq.edu.au	McMahon, Roisin/A-9823-2014; Fairlie, David P/F-8865-2014; Stoermer, Martin J/E-2317-2012; Martin, Jennifer L./A-6039-2010	McMahon, Roisin/0000-0001-5437-0355; Fairlie, David P/0000-0002-7856-8566; Stoermer, Martin J/0000-0003-3445-2104; Martin, Jennifer L./0000-0002-9225-8863	Australian Research Council Laureate Fellowship [FL0992138]	Australian Research Council Laureate Fellowship(Australian Research Council)	Australian Research Council Laureate Fellowship FL0992138 to JLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2015, ANGEW CHEM INT EDIT, V54, P2179, DOI 10.1002/anie.201410341; [Anonymous], OMEGA 2 4, V6; Bader M, 1998, J BIOL CHEM, V273, P10302, DOI 10.1074/jbc.273.17.10302; Bals R, 1998, J CLIN INVEST, V102, P874, DOI 10.1172/JCI2410; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Butler MS, 2013, J ANTIBIOT, V66, P571, DOI 10.1038/ja.2013.86; Butler MS, 2012, CURR DRUG TARGETS, V13, P373; Butler MS, 2011, J ANTIBIOT, V64, P413, DOI 10.1038/ja.2011.44; CASEWELL MW, 1987, J ANTIMICROB CHEMOTH, V19, P1, DOI 10.1093/jac/19.1.1; Chongsiriwatana NP, 2008, P NATL ACAD SCI USA, V105, P2794, DOI 10.1073/pnas.0708254105; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Duprez W, 2015, J MED CHEM, V58, P577, DOI 10.1021/jm500955s; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Fernandes PA, 2004, CHEM-EUR J, V10, P257, DOI 10.1002/chem.200305343; Ford C. W., 2001, Current Drug Targets - Infectious Disorders, V1, P181, DOI 10.2174/1568005014606099; Frech C, 1996, EMBO J, V15, P392, DOI 10.1002/j.1460-2075.1996.tb00369.x; Gaisford S, 2006, PHARM ISOTHERMAL CAL; Giuliani A, 2011, CELL MOL LIFE SCI, V68, P2255, DOI 10.1007/s00018-011-0717-3; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hawkins PCD, 2012, J CHEM INF MODEL, V52, P2919, DOI 10.1021/ci300314k; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Heras B, 2015, BRIT J CLIN PHARMACO, V79, P208, DOI 10.1111/bcp.12356; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Inaba K, 2008, BBA-MOL CELL RES, V1783, P520, DOI 10.1016/j.bbamcr.2007.11.006; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Inaba K, 2009, J BIOCHEM, V146, P591, DOI 10.1093/jb/mvp102; Inaba K, 2009, EMBO J, V28, P779, DOI 10.1038/emboj.2009.21; Ireland PM, 2014, ANTIOXID REDOX SIGN, V20, P606, DOI 10.1089/ars.2013.5375; Ito K, 2008, CURR OPIN STRUC BIOL, V18, P450, DOI 10.1016/j.sbi.2008.02.002; Jones D, 2011, NAT REV DRUG DISCOV, V10, P161, DOI 10.1038/nrd3400; Jones D, 2010, NAT REV DRUG DISCOV, V9, P751, DOI 10.1038/nrd3289; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; Kranz JK, 2011, METHOD ENZYMOL, V493, P277, DOI 10.1016/B978-0-12-381274-2.00011-X; Kurth F, 2014, J BIOL CHEM, V289, P19810, DOI 10.1074/jbc.M114.552380; Kurth F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080210; Latham PW, 1999, NAT BIOTECHNOL, V17, P755, DOI 10.1038/11686; Lee IH, 1997, INFECT IMMUN, V65, P2898, DOI 10.1128/IAI.65.7.2898-2903.1997; Liskamp RMJ, 2011, CHEMBIOCHEM, V12, P1626, DOI 10.1002/cbic.201000717; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255; Malojcic G, 2008, FEBS LETT, V582, P3301, DOI 10.1016/j.febslet.2008.07.063; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; Moellering RC, 2011, INT J ANTIMICROB AG, V37, P2, DOI 10.1016/j.ijantimicag.2010.08.018; Morel Chantal M, 2010, BMJ, V340, pc2115, DOI 10.1136/bmj.c2115; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Niu YH, 2012, J MED CHEM, V55, P4003, DOI 10.1021/jm300274p; Novak R, 2010, CURR OPIN INVEST DR, V11, P182; Palomino JC, 2013, FUTURE MICROBIOL, V8, P1071, DOI 10.2217/fmb.13.85; PCAST, 2014, REP PRES COMB ANT RE; Pollaro L, 2010, MEDCHEMCOMM, V1, P319, DOI 10.1039/c0md00111b; Projan SJ, 2008, DRUG DISCOV TODAY, V13, P279, DOI 10.1016/j.drudis.2008.03.010; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Regeimbal J, 2002, J BIOL CHEM, V277, P32706, DOI 10.1074/jbc.M205433200; Rotem S, 2009, BBA-BIOMEMBRANES, V1788, P1582, DOI 10.1016/j.bbamem.2008.10.020; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Schrodinger LLC, 2010, AXPYMOL MOL GRAPH PL; Schrodinger LLC, 2010, JYMOL MOL GRAPH DEV; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Steenbergen JN, 2005, J ANTIMICROB CHEMOTH, V55, P283, DOI 10.1093/jac/dkh546; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; Ung P, 2011, J MED CHEM, V54, P1111, DOI 10.1021/jm1012984; Vaara M, 2009, CURR OPIN PHARMACOL, V9, P571, DOI 10.1016/j.coph.2009.08.002; Venugopal AA, 2012, CLIN INFECT DIS, V54, P568, DOI 10.1093/cid/cir830; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Vivian JP, 2009, J MOL BIOL, V394, P931, DOI 10.1016/j.jmb.2009.09.065; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n; World Health Organization, 2014, ANT RES GLOB REP SUR	67	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133805	10.1371/journal.pone.0133805	http://dx.doi.org/10.1371/journal.pone.0133805			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225423	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700038
J	Goliasch, G; Zotter-Tufaro, C; Aschauer, S; Duca, F; Koell, B; Kammerlander, AA; Ristl, R; Lang, IM; Maurer, G; Mascherbauer, J; Bonderman, D				Goliasch, Georg; Zotter-Tufaro, Caroline; Aschauer, Stefan; Duca, Franz; Koell, Benedikt; Kammerlander, Andreas A.; Ristl, Robin; Lang, Irene M.; Maurer, Gerald; Mascherbauer, Julia; Bonderman, Diana			Outcome in Heart Failure with Preserved Ejection Fraction: The Role of Myocardial Structure and Right Ventricular Performance	PLOS ONE			English	Article							SOCIETY-OF-CARDIOLOGY; EUROPEAN-SOCIETY; TASK-FORCE; PULMONARY-HYPERTENSION; MAGNETIC-RESONANCE; SYSTOLIC FUNCTION; ASSOCIATION; DYSFUNCTION; GUIDELINES; ECHOCARDIOGRAPHY	Background Heart failure with preserved ejection fraction (HFpEF) is recognized as a major cause of cardiovascular morbidity and mortality. Thus, a profound understanding of the pathophysiologic changes in HFpEF is needed to identify risk factors and potential treatment targets in this specific patient population. Therefore, we aimed to comprehensively assess the impact of left-and right-ventricular function and hemodynamics on long-term mortality and morbidity in order to improve risk prediction in patients with HFpEF. Methods and Results We prospectively included 142 consecutive patients with HFpEF into our observational, non-interventional registry. Echocardiography, cardiac magnetic resonance imaging and invasive hemodynamic assessments including myocardial biopsy were performed at baseline. We detected significant correlations between left ventricular extracellular matrix and left ventricular end-diastolic diameter (r = -0.64; p = 0.03) and stroke volume (r = -0.53; p = 0.04). Hospitalization for heart failure and/or cardiac death was observed over a median follow up of 10 months. The strongest risk factors were reduced right ventricular function (adj. HR 6.62; 95% CI 3.1214.02; p<0.001), systolic pulmonary arterial pressure (adj. HR per 1-SD 1.55; 95% CI 1.152.09; p = 0.004) and the pulmonary artery wedge pressure (adj. HR per 1-SD 1.51; 95% CI 1.09-2.08; p = 0.012). The area under the ROC curve for right ventricular function was 0.63, for systolic pulmonary arterial pressure 0.75, and for pulmonary artery wedge pressure 0.68. Conclusion The current study emphasizes the importance of right ventricular function and pulmonary pressures on outcome in patients with HFpEF providing pathophysiological insights into the hemodynamic changes in HFpEF.	[Goliasch, Georg; Zotter-Tufaro, Caroline; Aschauer, Stefan; Duca, Franz; Koell, Benedikt; Kammerlander, Andreas A.; Lang, Irene M.; Maurer, Gerald; Mascherbauer, Julia; Bonderman, Diana] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Vienna, Austria; [Ristl, Robin] Med Univ Vienna, Sect Med Stat, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Goliasch, G (corresponding author), Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Vienna, Austria.	georg.goliasch@meduniwien.ac.at; diana.bonderman@meduniwien.ac.at	Kammerlander, Andreas/F-7391-2018	Kammerlander, Andreas/0000-0002-7632-9879; Lang, Irene/0000-0003-0485-2692; Mascherbauer, Julia/0000-0001-7478-1450; Goliasch, Georg/0000-0002-6219-6104; Aschauer, Stefan/0000-0003-2220-9182; Ristl, Robin/0000-0002-4163-9236; Maurer, Gerald/0000-0002-9043-7657	Bayer Healthcare; United Therapeutics; Actelion; AOP; GSK; Pfizer	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); United Therapeutics; Actelion; AOP; GSK(GlaxoSmithKline); Pfizer(Pfizer)	DB and IML have received grants and consulting fees from Bayer Healthcare, United Therapeutics, Actelion, AOP, GSK, and Pfizer.	Andersen MJ, 2015, CIRC-HEART FAIL, V8, P542, DOI 10.1161/CIRCHEARTFAILURE.114.002114; Ather S, 2012, J AM COLL CARDIOL, V59, P998, DOI 10.1016/j.jacc.2011.11.040; Burke MA, 2014, CIRC-HEART FAIL, V7, P288, DOI 10.1161/CIRCHEARTFAILURE.113.000854; Funk GC, 2008, CHEST, V133, P1354, DOI 10.1378/chest.07-2685; GARVEY W, 1987, STAIN TECHNOL, V62, P365, DOI 10.3109/10520298709108026; Gerges C, 2013, CHEST, V143, P758, DOI 10.1378/chest.12-1653; Ghio S, 2001, J AM COLL CARDIOL, V37, P183, DOI 10.1016/S0735-1097(00)01102-5; Kapoor JR, 2010, AM HEART J, V159, P75, DOI 10.1016/j.ahj.2009.10.026; Kass David A., 2000, Cardiology Clinics, V18, P571, DOI 10.1016/S0733-8651(05)70162-4; Kramer CM, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-35; Lam CSP, 2009, J AM COLL CARDIOL, V53, P1119, DOI 10.1016/j.jacc.2008.11.051; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lund LH, 2014, EUR J HEART FAIL, V16, P992, DOI 10.1002/ejhf.137; Mascherbauer J, 2013, CIRC-CARDIOVASC IMAG, V6, P1056, DOI 10.1161/CIRCIMAGING.113.000633; McManus DD, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005694; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Melenovsky V, 2014, EUROPEAN HEART J; Mohammed SF, 2015, CIRCULATION, V131, P550, DOI 10.1161/CIRCULATIONAHA.114.009625; Mohammed SF, 2014, CIRCULATION, V130, P2310, DOI 10.1161/CIRCULATIONAHA.113.008461; Olsson LG, 2006, J AM COLL CARDIOL, V47, P1997, DOI 10.1016/j.jacc.2006.01.060; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zakeri R, 2014, CIRC-HEART FAIL, V7, P123, DOI 10.1161/CIRCHEARTFAILURE.113.000568; Zile MR, 2015, CIRCULATION, V131, P1247, DOI 10.1161/CIRCULATIONAHA.114.013215	27	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134479	10.1371/journal.pone.0134479	http://dx.doi.org/10.1371/journal.pone.0134479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225557	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700099
J	Hanrahan, D; Sexton, P; Hui, K; Teitcher, J; Sugarman, J; London, AJ; Barnes, M; Purpura, J; Klitzman, R				Hanrahan, Donna; Sexton, Patrina; Hui, Katrina; Teitcher, Jennifer; Sugarman, Jeremy; London, Alex John; Barnes, Mark; Purpura, James; Klitzman, Robert			Linguistic and Cultural Challenges in Communication and Translation in US-Sponsored HIV Prevention Research in Emerging Economies	PLOS ONE			English	Article							RESEARCH ETHICS COMMITTEES; INFORMED-CONSENT; TRIALS	Linguistic and cultural differences can impede comprehension among potential research participants during the informed consent process, but how researchers and IRBs respond to these challenges in practice is unclear. We conducted in-depth interviews with 15 researchers, research ethics committee (REC) chairs and members from 8 different countries with emerging economies, involved in HIV-related research sponsored by HIV Prevention Trials Network (HPTN), regarding the ethical and regulatory challenges they face in this regard. In the interviews, problems with translating study materials often arose as major concerns. Four sets of challenges were identified concerning linguistic and cultural translations of informed consent documents and other study materials, related to the: (1) context, (2) process, (3) content and (4) translation of these documents. Host country contextual issues included low literacy rates, education (e.g., documents may need to be written below 5th grade reading level), and experiences with research, and different views of written documentation. Certain terms and concepts may not exist in other languages, or have additional connotations that back translations do not always reveal. Challenges arise because of not only the content of word-for-word, literal translation, but the linguistic form of the language, such as tone (e.g., appropriate forms of politeness vs. legalese, seen as harsh), syntax, manner of questions posed, and the concept of the consent); and the contexts of use affect meaning. Problems also emerged in bilateral communications - US IRBs may misunderstand local practices, or communicate insufficiently the reasons for their decisions to foreign RECs. In sum, these data highlight several challenges that have received little, if any, attention in past literature on translation of informed consent and study materials, and have crucial implications for improving practice, education, research and policy, suggesting several strategies, including needs for broader open-source multilingual lexicons, and more awareness of the complexities involved.	[Hanrahan, Donna; Sexton, Patrina; Hui, Katrina; Teitcher, Jennifer] Columbia Univ, New York, NY USA; [Sugarman, Jeremy] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA; [London, Alex John] Carnegie Mellon Univ, Ctr Eth & Policy, Pittsburgh, PA 15213 USA; [Barnes, Mark] Harvard Univ, Sch Law, Cambridge, MA 02138 USA; [Barnes, Mark] Partner Ropes & Gray LLC, Boston, MA USA; [Purpura, James] Columbia Univ, Teachers Coll, Appl Linguist & TESOL Program, New York, NY 10027 USA; [Klitzman, Robert] Columbia Univ, Masters Bioeth Program, New York, NY 10027 USA	Columbia University; Johns Hopkins University; Carnegie Mellon University; Harvard University; Columbia University; Columbia University Teachers College; Columbia University	Klitzman, R (corresponding author), Columbia Univ, Masters Bioeth Program, New York, NY 10027 USA.	rlk2@.cumc.columbia.edu		Sugarman, Jeremy/0000-0001-7022-8332; Hui, Katrina/0000-0002-5472-3779; London, Alex/0000-0002-6450-0309	National Institute of Allergy and Infectious Diseases (NIAID) [U01 AI068619]; National Institute on Drug Abuse (NIDA); Ropes Gray LLC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Ropes Gray LLC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Work on this manuscript was supported by Grant Number U01 AI068619 from the National Institute of Allergy and Infectious Diseases (NIAID), with additional support from the National Institute on Drug Abuse (NIDA). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID, NIDA, or the National Institutes of Health. NIAID Website: http://www.niaid.nih.gov/Pages/default.aspx. NIDA Website: http://www.drugabuse.gov/. NIH Website: http://www.nih.gov/. Ropes & Gray LLC provided support in the form of salaries for author [MB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Angeles-Llerenas AR, 2009, DEV WORLD BIOETH, V9, P18, DOI 10.1111/j.1471-8847.2007.00208.x; Arda B, 2000, J MED ETHICS, V26, P459, DOI 10.1136/jme.26.6.459; Becker A.L., 1995, TRANSLATION ESSAYS M; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Comrie B, 2009, WORDS MAJOR LANGUAGE; Elsayed Dya Eldin M, 2004, Dev World Bioeth, V4, P154, DOI 10.1111/j.1471-8731.2004.00090.x; Geertz Clifford, 1973, INTERPRETATION CULTU; Hafeez TL, 1972, J CROSS CULTURAL PSY, V3, P41; Hymes D, 2001, LINGUISTIC ANTHR REA, P60; Katz J, 1994, J Contemp Health Law Policy, V10, P69; KAUFERT JM, 1984, SOC SCI MED, V18, P283, DOI 10.1016/0277-9536(84)90092-3; Keymanthri M, 2007, BMC MED ETHICS, V8, P1; Klitzman R, 2008, DEV WORLD BIOETH, V8, P207, DOI 10.1111/j.1471-8847.2007.00189.x; Krosin MT, 2006, CLIN TRIALS, V3, P306, DOI 10.1191/1740774506cn150oa; Mack N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073799; Macpherson C C, 2001, Dev World Bioeth, V1, P57, DOI 10.1111/1471-8847.00008; Maneesriwongul W, 2004, J ADV NURS, V48, P175, DOI 10.1111/j.1365-2648.2004.03185.x; Marshall PA, 2006, J EMPIR RES HUM RES, V1, P25, DOI 10.1525/jer.2006.1.1.25; Matar A, 2013, J EMPIR RES HUM RES, V8, P32, DOI 10.1525/jer.2013.8.1.32; Meaning PP, 2006, INTRO LANGUAGE LINGU, P137; Nida E., 2006, PLIEGOS YUSTE, V4, P11; Paasche-Orlow MK, 2003, NEW ENGL J MED, V348, P721, DOI 10.1056/NEJMsa021212; Penn C, 2010, PATIENT EDUC COUNS, V80, P191, DOI 10.1016/j.pec.2009.10.019; Purpura JE, 2004, ASSESSING GRAMMER; Ramirez C., 2013, TOOLKIT DEV BILINGUA; Schaffner C, 2004, J PRAGMATICS, V36, P1253, DOI 10.1016/j.pragma.2003.10.012; Sexton P, 2014, DEV WORLD BIOETH; Stevenson A., 2002, OXFORD ENGLISH DICT; Strauss A., 1990, BASICS QUALITATIVE R; Tsvetaeva M, 1972, NEIZDANNYE PISMA; WAGER E, 1995, BMJ-BRIT MED J, V311, P734, DOI 10.1136/bmj.311.7007.734; Wierzbicka A, 1995, SEMANTICS CULTURE CO	32	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133394	10.1371/journal.pone.0133394	http://dx.doi.org/10.1371/journal.pone.0133394			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JT	26225759	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700020
J	Wei, JY; Bai, DD; Yang, LY				Wei, Jinyu; Bai, Dongdong; Yang, Liying			Polymer Photovoltaic Cells with Rhenium Oxide as Anode Interlayer	PLOS ONE			English	Article							SOLAR-CELLS; DEGRADATION; LAYER	The effect of a new transition metal oxide, rhenium oxide (ReO3), on the performance of polymer solar cells based on regioregular poly(3-hexylthiophene) (P3HT) and methanofullerene [6,6]-phenyl C-61-butyric acid methyl ester (PCBM) blend as buffer layer was investigated. The effect of the thickness of ReO3 layer on electrical characteristics of the polymer solar cells was studied. It is found that insertion of ReO3 interfacial layer results in the decreased performance for P3HT: PCBM based solar cells. In order to further explore the mechanism of the decreasing of the open-circuit voltage (V-oc), the X-ray photoelectron spectroscopy (XPS) is used to investigate the ReO3 oxidation states. Kelvin Probe method showed that the work function of the ReO3 is estimated to be 5.13eV after thermal evaporation. The results indicated the fact that a portion of ReO3 decomposed during thermal evaporation process, resulting in the formation of a buffer layer with a lower work function. As a consequence, a higher energy barrier was generated between the ITO and the active layer.	[Wei, Jinyu; Bai, Dongdong] Tianjin Univ Technol, Sch Management, Tianjin, Peoples R China; [Yang, Liying] Tianjin Univ Technol, Sch Mat Sci & Engn, Minist Educ, Key Lab Display Mat & Photoelect Devices, Tianjin, Peoples R China	Tianjin University of Technology; Tianjin University of Technology	Yang, LY (corresponding author), Tianjin Univ Technol, Sch Mat Sci & Engn, Minist Educ, Key Lab Display Mat & Photoelect Devices, Tianjin, Peoples R China.	liyingyang@tjut.edu.cn			National Science Foundation of China [60976048]; Tianjin Natural Science Council [10ZCKFGX01900]; Tianjin Key Discipline of Material Physics and Chemistry	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Natural Science Council; Tianjin Key Discipline of Material Physics and Chemistry	This research was partly supported by grants from the National Science Foundation of China (Grant No. 60976048), Tianjin Natural Science Council (Grant No. 10ZCKFGX01900), and the Tianjin Key Discipline of Material Physics and Chemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen FC, 2008, J APPL PHYS, V103, DOI 10.1063/1.2937202; Chung J, 2008, ORG ELECTRON, V9, P869, DOI 10.1016/j.orgel.2008.06.009; Hains AW, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2834697; Ikeda H, 2006, SID INT S, V37, P923; Irwin MD, 2008, P NATL ACAD SCI USA, V105, P2783, DOI 10.1073/pnas.0711990105; Kawano K, 2006, SOL ENERG MAT SOL C, V90, P3520, DOI 10.1016/j.solmat.2006.06.041; Kemerink M, 2004, J PHYS CHEM B, V108, P18820, DOI 10.1021/jp0464674; Leem DS, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2754635; Li G, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2212270; Shrotriya V, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2174093; WAGNER CD, HDB XRAY PHOTOELECTR; Yan H, 2005, J AM CHEM SOC, V127, P3172, DOI 10.1021/ja044455q	12	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133725	10.1371/journal.pone.0133725	http://dx.doi.org/10.1371/journal.pone.0133725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226439	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700036
J	Adkins-Regan, E				Adkins-Regan, Elizabeth			Hit or Miss: Fertilization Outcomes of Natural Inseminations by Japanese Quail	PLOS ONE			English	Article							POSTCOPULATORY SEXUAL SELECTION; SPERM-STORAGE TUBULES; COTURNIX-JAPONICA; MATING SUCCESS; DOMESTIC-FOWL; TESTES SIZE; BIRDS; FEMALE; SPERMATOZOA; COMPETITION	Variation in fertilization success underlies sexual selection, yet mating does not guarantee fertilization. The relationship between natural inseminations and fertilization success is essential for understanding sexual selection, yet that relationship and its underlying mechanisms are poorly understood in sperm-storing vertebrates such as birds. Here the relationship is analyzed in mating trials using Japanese quail (Coturnix japonica), which show striking variation in the fertilizing success of inseminations. Failures of males' inseminations to fertilize eggs were mainly due to failures prior to sperm-egg contact. Fertilization probabilities on any given day were unrelated to whether the female had laid an egg the previous day, arguing against stimulation of sperm release from sperm storage tubules by the events of the daily egg-laying cycle. Instead, an unfertilized egg laid between two fertilized eggs predicted a longer sperm storage interval. Both sexes gained similar numbers of fertilized eggs by mating with a second partner the next day, but males, unlike females in a previous study, did not gain by having two females to mate with at the same time. Instead, they were both behaviorally and sperm limited, whereas females gain by mating twice in quick succession. Even double inseminations often failed to fertilize any eggs, and multiple matings would be needed for an entire clutch to be fertilized with high certainty. Paradoxically, this low and probabilistic fertilization success co-occurs with other notable characteristics of male quail suggestive of past sexual selection for increased success, including vigorous copulatory behavior, forced copulations, foamy secretion aiding in sperm competition, large testes and unusual sperm morphology.	[Adkins-Regan, Elizabeth] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA; [Adkins-Regan, Elizabeth] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Cornell University; Cornell University	Adkins-Regan, E (corresponding author), Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA.	er12@cornell.edu			NSF grant [IBN 0130986]	NSF grant(National Science Foundation (NSF))	This work was funded by NSF grant IBN 0130986 to EA-R. NSF URL: http://www.nsf.gov/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins EK, 1974, PHYSIOL BEHAV, V13, P75; Adkins-Regan E, 1999, AUK, V116, P184, DOI 10.2307/4089465; Adkins-Regan E, 2014, BEHAV PROCESS, V108, P71, DOI 10.1016/j.beproc.2014.09.027; ADKINSREGAN E, 1995, ANIM BEHAV, V50, P1405, DOI 10.1016/0003-3472(95)80055-7; ARNOLD SJ, 1994, AM NAT, V144, pS126, DOI 10.1086/285656; Bakst MR, 2011, J ANIM SCI, V89, P1323, DOI 10.2527/jas.2010-3663; BAKST MR, 1994, BIOL REPROD, V50, P987, DOI 10.1095/biolreprod50.5.987; Bakst MR, 1998, J EXP ZOOL, V282, P618, DOI 10.1002/(SICI)1097-010X(199811/12)282:4/5&lt;618::AID-JEZ11&gt;3.0.CO;2-M; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Birkhead TR, 2010, J ZOOL, V281, P78, DOI 10.1111/j.1469-7998.2010.00701.x; BIRKHEAD TR, 1995, ANIM BEHAV, V49, P451, DOI 10.1006/anbe.1995.0058; BIRKHEAD TR, 1994, IBIS, V136, P101, DOI 10.1111/j.1474-919X.1994.tb08137.x; BIRKHEAD TR, 1994, J REPROD FERTIL, V101, P353, DOI 10.1530/jrf.0.1010353; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; BIRKHEAD TR, 1993, BIOL J LINN SOC, V50, P295, DOI 10.1111/j.1095-8312.1993.tb00933.x; Birkhead TR, 1992, SPERM COMPETITION BI; Birkhead TR, 1998, SPERM COMPETITION SE; BOBR LW, 1964, J REPROD FERTIL, V8, P39, DOI 10.1530/jrf.0.0080039; BURKE WH, 1969, POULTRY SCI, V48, P408, DOI 10.3382/ps.0480408; Collet JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2973; COMPTON MM, 1979, POULTRY SCI, V58, P187, DOI 10.3382/ps.0580187; Domjan M, 2003, J COMP PSYCHOL, V117, P391, DOI 10.1037/0735-7036.117.4.391; Etches R. J., 1996, REPROD POULTRY; Ferree ED, 2014, ANIM BEHAV, V90, P11, DOI 10.1016/j.anbehav.2014.01.009; Finseth FR, 2013, J EVOLUTION BIOL, V26, P1875, DOI 10.1111/jeb.12189; Forstmeier W, 2014, TRENDS ECOL EVOL, V29, P456, DOI 10.1016/j.tree.2014.05.005; Froman DP, 2002, P ROY SOC B-BIOL SCI, V269, P607, DOI 10.1098/rspb.2001.1925; Garamszegi LZ, 2005, HORM BEHAV, V47, P389, DOI 10.1016/j.yhbeh.2004.11.008; GOWATY PA, 1984, BEHAV ECOL SOCIOBIOL, V15, P91, DOI 10.1007/BF00299374; Griffith SC, 2007, AM NAT, V169, P274, DOI 10.1086/510601; Griffith SC, 2010, ANIM BEHAV, V79, P261, DOI 10.1016/j.anbehav.2009.11.031; GRIGG GW, 1957, POULTRY SCI, V36, P450, DOI 10.3382/ps.0360450; Hasson O, 2009, BIOL REV, V84, P225, DOI 10.1111/j.1469-185X.2008.00068.x; Ito T, 2011, ENDOCRINOLOGY, V152, P3952, DOI 10.1210/en.2011-0237; West-Eberhard MJ, 2014, NEUROSCI BIOBEHAV R, V46, P501, DOI 10.1016/j.neubiorev.2014.06.015; Jones R.C., 1993, Oxford Reviews of Reproductive Biology, V15, P233; KENNEY AM, 1979, BRAIN BEHAV EVOLUT, V16, P176, DOI 10.1159/000121835; Ketterson Ellen D., 1998, Ornithological Monographs, V49, P81; Korn N, 2000, POULTRY SCI, V79, P407, DOI 10.1093/ps/79.3.407; Krakauer AH, 2008, CONDOR, V110, P1, DOI 10.1525/cond.2008.110.1.1; Madge S., 2002, PHEASANTS PARTRIDGES; MOLLER AP, 1991, AM NAT, V137, P882, DOI 10.1086/285199; Morrow EH, 2002, J EVOLUTION BIOL, V15, P702, DOI 10.1046/j.1420-9101.2002.00445.x; NICHOLS CR, 1991, THESIS U BRIT COLUMB; Persaud KN, 2005, J COMP PSYCHOL, V119, P440, DOI 10.1037/0735-7036.119.4.440; Pischedda A, 2012, P NATL ACAD SCI USA, V109, P2049, DOI 10.1073/pnas.1110841109; Pitcher TE, 2005, J EVOLUTION BIOL, V18, P557, DOI 10.1111/j.1420-9101.2004.00874.x; Pizzari T, 2000, NATURE, V405, P787, DOI 10.1038/35015558; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rodriguez-Teijeiro JD, 2003, ETHOLOGY, V109, P291, DOI 10.1046/j.1439-0310.2003.00873.x; Sasanami T, 2013, J REPROD DEVELOP, V59, P334, DOI 10.1262/jrd.2013-038; SCHEIN MW, 1972, ANIM BEHAV, V20, P61, DOI 10.1016/S0003-3472(72)80173-8; SITTMANN KURT, 1965, BRIT POULTRY SCI, V6, P245, DOI 10.1080/00071666508415580; Stepinska U, 2007, REPROD BIOL PHYLOGEN, P149; Torok J, 2003, P ROY SOC B-BIOL SCI, V270, P641, DOI 10.1098/rspb.2002.2257; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Wilcox AJ, 2001, CONTRACEPTION, V63, P211, DOI 10.1016/S0010-7824(01)00191-3; Williams T., 2012, PHYSL ADAPTATIONS BR; WISHART GJ, 1987, J REPROD FERTIL, V80, P493, DOI 10.1530/jrf.0.0800493; Wishart GJ, 1999, POULTRY SCI, V78, P428, DOI 10.1093/ps/78.3.428; Wolff JO, 2002, BEHAV PROCESS, V58, P105, DOI 10.1016/S0376-6357(02)00022-0; Woolfenden BE, 2002, BEHAV ECOL SOCIOBIOL, V52, P417, DOI 10.1007/s00265-002-0529-4	62	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0131786	10.1371/journal.pone.0131786	http://dx.doi.org/10.1371/journal.pone.0131786			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222780	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800019
J	Zhang, X; Xiong, SJ; Ma, Y; Han, T; Chen, XY; Wan, F; Lu, YT; Yan, SH; Wang, Y				Zhang, Xin; Xiong, Shijiang; Ma, Yue; Han, Ting; Chen, Xinyu; Wan, Fang; Lu, Yating; Yan, Songhe; Wang, Yan			A Cone-Beam Computed Tomographic Study on Mandibular First Molars in a Chinese Subpopulation	PLOS ONE			English	Article							CANAL MORPHOLOGY; 3-DIMENSIONAL ANALYSIS; PERMANENT MOLARS; ROOT CANALS; POPULATION	The purpose of this study was to conduct a cone-beam computed tomographic (CBCT) investigation on the root and canal configuration of the mandibular first molars, especially the morphology of the disto-lingual (DL) root, in a Chinese subpopulation. A total of 910 CBCT images of the mandibular first molars were collected from 455 patients who underwent CBCT examinations as a preoperative assessment for implants or orthodontic treatment. The following information was analyzed and evaluated: tooth position, gender, root and root canal number per tooth, root canal type of the mesial root(s) and distal root(s), angle of the DL root canal curvature, distance between two distal canal orifices in the teeth with DL root, and angle of disto-buccal canal orifice-disto-lingual canal orifice-mesio-lingual canal orifice (DB-DL-ML). Most of the mandibular first molars (64.9%, n = 591) had two roots with three root canals, and most of the mesial root canals (87.7%, n = 798) were type VI. The prevalence of the DL root was 22.1%(n = 201). The right side had a higher prevalence of DL root than the left side (p<0.05). Additionally, the curvature of the DL root canal were greater in the bucco-lingual (BL) orientation (30.10 degrees+/-14.02 degrees) than in the mesio-distal (MD) orientation (14.03 degrees+/-8.56 degrees) (p<0.05). Overall there was a high prevalence of DL root in the mandibular first molars, and most of the DL roots were curved in different degrees. This study provided detailed information about the root canal morphology of the mandibular first molars in a Chinese subpopulation.	[Zhang, Xin; Xiong, Shijiang; Ma, Yue; Chen, Xinyu; Wan, Fang; Lu, Yating; Yan, Songhe; Wang, Yan] Shandong Univ, Sch & Hosp Stomatol, VIP Ctr, Jinan 250100, Shangdong, Peoples R China; [Zhang, Xin; Xiong, Shijiang; Ma, Yue; Chen, Xinyu; Wan, Fang; Lu, Yating; Yan, Songhe; Wang, Yan] Shandong Univ, Sch & Hosp Stomatol, Shandong Prov Key Lab Oral Biomed, Jinan 250100, Shangdong, Peoples R China; [Han, Ting] Shandong Univ, Sch & Hosp Stomatol, Dept Endodont, Jinan 250100, Shangdong, Peoples R China	Shandong University; Shandong University; Shandong University	Wang, Y (corresponding author), Shandong Univ, Sch & Hosp Stomatol, VIP Ctr, Jinan 250100, Shangdong, Peoples R China.	wangyan1965@sdu.edu.cn	HAN, TINGTING/GQZ-8692-2022	Xiong, Shijiang/0000-0001-5239-7837	Shandong University [2015JC014]	Shandong University	This work was supported by the Fundamental Research Funds of Shandong University (http://www.xsyjb.sdu.edu.cn/), Grant # 2015JC014 to YW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella F, 2012, INT ENDOD J, V45, P963, DOI 10.1111/j.1365-2591.2012.02075.x; Ahmed HA, 2007, INT ENDOD J, V40, P766, DOI 10.1111/j.1365-2591.2007.01283.x; Al-Qudah AA, 2009, INT ENDOD J, V42, P775, DOI 10.1111/j.1365-2591.2009.01578.x; BYSTROM A, 1987, Endodontics and Dental Traumatology, V3, P58; Chandra SS, 2011, ORAL SURG ORAL MED O, V112, pE77, DOI 10.1016/j.tripleo.2011.02.016; Chen G, 2009, INT ENDOD J, V42, P1044, DOI 10.1111/j.1365-2591.2009.01619.x; CURZON MEJ, 1973, J DENT RES, V52, P181, DOI 10.1177/00220345730520011901; De Moor RJG, 2004, INT ENDOD J, V37, P789, DOI 10.1111/j.1365-2591.2004.00870.x; Ferraz J A, 1993, Braz Dent J, V3, P113; Grande NM, 2006, INT ENDOD J, V39, P755, DOI 10.1111/j.1365-2591.2006.01143.x; Grande NM, 2012, ANN I SUPER SANITA, V48, P26, DOI 10.4415/ANN_12_01_05; Gu YC, 2010, J ENDODONT, V36, P1341, DOI 10.1016/j.joen.2010.04.025; Gu YC, 2010, J ENDODONT, V36, P990, DOI 10.1016/j.joen.2010.02.030; Gulabivala K, 2001, INT ENDOD J, V34, P359, DOI 10.1046/j.1365-2591.2001.00399.x; Huang RY, 2010, INT ENDOD J, V43, P478, DOI 10.1111/j.1365-2591.2010.01702.x; Huang RY, 2007, J PERIODONTOL, V78, P1485, DOI 10.1902/jop.2007.060419; Jang JK, 2013, CLIN ORAL INVEST, V17, P105, DOI 10.1007/s00784-012-0687-3; Matherne RP, 2008, J ENDODONT, V34, P87, DOI 10.1016/j.joen.2007.10.016; Neelakantan P, 2010, J ENDODONT, V36, P1547, DOI 10.1016/j.joen.2010.05.008; Pattanshetti N, 2008, INT ENDOD J, V41, P755, DOI 10.1111/j.1365-2591.2008.01427.x; Plotino G, 2006, J AM DENT ASSOC, V137, P1555, DOI 10.14219/jada.archive.2006.0091; REICHART PA, 1981, COMMUNITY DENT ORAL, V9, P191, DOI 10.1111/j.1600-0528.1981.tb01053.x; SCHNEIDER SW, 1971, ORAL SURG ORAL MED O, V32, P271, DOI 10.1016/0030-4220(71)90230-1; Song JS, 2010, J ENDODONT, V36, P653, DOI 10.1016/j.joen.2009.10.007; Song JS, 2009, ORAL SURG ORAL MED O, V107, pE56, DOI 10.1016/j.tripleo.2008.09.004; Sperber GH, 1998, INT ENDOD J, V31, P117; Tu MG, 2009, J ENDODONT, V35, P503, DOI 10.1016/j.joen.2008.12.013; VERTUCCI FJ, 1984, ORAL SURG ORAL MED O, V58, P589, DOI 10.1016/0030-4220(84)90085-9; Wang Y, 2010, J ENDODONT, V36, P1786, DOI 10.1016/j.joen.2010.08.016; Yamada Masashi, 2011, Bull Tokyo Dent Coll, V52, P77; Zelada G, 2002, J ENDODONT, V28, P540, DOI 10.1097/00004770-200207000-00014; Zhang R, 2011, INT ENDOD J, V44, P990, DOI 10.1111/j.1365-2591.2011.01904.x	32	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134919	10.1371/journal.pone.0134919	http://dx.doi.org/10.1371/journal.pone.0134919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241480	Green Submitted, gold, Green Published			2022-12-27	WOS:000358942700080
J	Hiroshima, Y; Zhao, M; Zhang, Y; Zhang, N; Maawy, A; Murakami, T; Mii, S; Uehara, F; Yamamoto, M; Miwa, S; Yano, S; Momiyama, M; Mori, R; Matsuyama, R; Chishima, T; Tanaka, K; Ichikawa, Y; Bouvet, M; Endo, I; Hoffman, RM				Hiroshima, Yukihiko; Zhao, Ming; Zhang, Yong; Zhang, Nan; Maawy, Ali; Murakami, Takashi; Mii, Sumiyuki; Uehara, Fuminari; Yamamoto, Mako; Miwa, Shinji; Yano, Shuya; Momiyama, Masashi; Mori, Ryutaro; Matsuyama, Ryusei; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Bouvet, Michael; Endo, Itaru; Hoffman, Robert M.			Tumor-Targeting Salmonella typhimurium A1-R Arrests a Chemo-Resistant Patient Soft-Tissue Sarcoma in Nude Mice	PLOS ONE			English	Article							HUMAN PANCREATIC-CANCER; LUNG METASTASIS; MOUSE MODEL; EFFICACY; CHEMOTHERAPY; THERAPY; MUTANT; CELLS; CYCLE	A patient-derived nude-mouse model of soft-tissue sarcoma has been established and treated in the following groups: (1) untreated controls; (2) gemcitabine (GEM) (80 mg/kg, ip, weekly, 3 weeks); (3) Pazopanib (100 mg/kg, orally, daily, 3 weeks) and (4) Salmonella typhimurium A1-R (5 x 10(7) CFU/body, ip, weekly, 3 weeks). The sarcoma was resistant to GEM (p = 0.879). Pazopanib tended to reduce the tumor volume compared to the untreated mice, but there was no significant difference (p = 0.115). S. typhimurium A1-R significantly inhibited tumor growth compared to the untreated mice (p = 0.001). S. typhimurium A1-R was the only effective treatment for the soft-tissue sarcoma nude mouse model among all treatments including a newly approved multiple tyrosine kinase inhibitor; Pazopanib. These results suggest tumor-targeting S. typhimurium A1-R is a promising treatment for chemo-resistant soft-tissue sarcoma.	[Hiroshima, Yukihiko; Zhao, Ming; Zhang, Yong; Zhang, Nan; Murakami, Takashi; Mii, Sumiyuki; Uehara, Fuminari; Yamamoto, Mako; Miwa, Shinji; Yano, Shuya; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Hiroshima, Yukihiko; Maawy, Ali; Murakami, Takashi; Mii, Sumiyuki; Uehara, Fuminari; Yamamoto, Mako; Miwa, Shinji; Yano, Shuya; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hiroshima, Yukihiko; Murakami, Takashi; Momiyama, Masashi; Mori, Ryutaro; Matsuyama, Ryusei; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Endo, Itaru] Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Yokohama, Kanagawa 232, Japan	Anti Cancer Inc; University of California System; University of California San Diego; Yokohama City University	Hoffman, RM (corresponding author), AntiCancer Inc, San Diego, CA 92111 USA.	all@anticancer.com	Miwa, Shinji/AAI-9309-2020; Yano, Shuya/AAL-8028-2020; Zhang, Nan/GXH-0361-2022	Miwa, Shinji/0000-0002-5962-8287; Murakami, Takashi/0000-0002-9429-5705; UEHARA, FUMINARI/0000-0001-6567-2113	National Cancer Institute [CA183280]; JSPS KAKENHI [26830081, 26462070, 24592009]; NATIONAL CANCER INSTITUTE [R43CA183280] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by National Cancer Institute grant numbers CA183280 and JSPS KAKENHI grant numbers 26830081 to YH, 26462070 to IE and 24592009 to KT. AntiCancer, Inc., provided support in the form of salaries for authors [MZ, YZ, NZ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clark MA, 2005, NEW ENGL J MED, V353, P701, DOI 10.1056/NEJMra041866; EVANS DB, 1992, ARCH SURG-CHICAGO, V127, P1335; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; Hayashi K, 2009, J CELL BIOCHEM, V106, P992, DOI 10.1002/jcb.22078; Hayashi K, 2009, CELL CYCLE, V8, P870, DOI 10.4161/cc.8.6.7891; Hiroshima Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117417; Hiroshima Y, 2014, J CELL BIOCHEM, V115, P1254, DOI 10.1002/jcb.24769; Hiroshima Y, 2013, CELL CYCLE, V12, P2774, DOI 10.4161/cc.25872; Kimura H, 2010, CELL PROLIFERAT, V43, P41, DOI 10.1111/j.1365-2184.2009.00652.x; Momiyama M, 2012, CELL CYCLE, V11, P628, DOI 10.4161/cc.11.3.19116; Nagakura C, 2009, ANTICANCER RES, V29, P1873; Roberts NJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008982; van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; Yam C, 2010, J SURG RES, V164, P248, DOI 10.1016/j.jss.2009.02.023; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Yano S, 2014, CELL CYCLE, V13, P3958, DOI 10.4161/15384101.2014.964115; Yano S, 2014, CELL CYCLE, V13, P2110, DOI 10.4161/cc.29156; Zhang Y, 2012, ANTICANCER RES, V32, P2501; Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102; Zhao M, 2007, P NATL ACAD SCI USA, V104, P10170, DOI 10.1073/pnas.0703867104; Zhao M, 2006, CANCER RES, V66, P7647, DOI 10.1158/0008-5472.CAN-06-0716; Zhao M, 2012, CELL CYCLE, V11, P187, DOI 10.4161/cc.11.1.18667	22	63	63	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134324	10.1371/journal.pone.0134324	http://dx.doi.org/10.1371/journal.pone.0134324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237416	gold, Green Published, Green Submitted			2022-12-27	WOS:000358942400021
J	Baptista, I; Ritsema, C; Geissen, V				Baptista, Isaurinda; Ritsema, Coen; Geissen, Violette			Effect of Integrated Water-Nutrient Management Strategies on Soil Erosion Mediated Nutrient Loss and Crop Productivity in Cabo Verde Drylands	PLOS ONE			English	Article							LAND DEGRADATION; CONSERVATION MEASURES; CENTRAL HIGHLANDS; SANTIAGO ISLAND; RAINWATER-USE; RUNOFF; NITROGEN; DESERTIFICATION; MAIZE; LIVELIHOODS	Soil erosion, runoff and related nutrient losses are a big risk for soil fertility in Cabo Verde drylands. In 2012, field trials were conducted in two agro-ecological zones to evaluate the effects of selected techniques of soil-water management combined with organic amendments (T1: compost/manure + soil surfactant; T2: compost/animal or green manure + pigeon-pea hedges + soil surfactant; T3: compost/animal or green manure + mulch + pigeon-pea hedges) on nitrogen (N) and phosphorus (P) losses in eroded soil and runoff and on crop yields. Three treatments and one control (traditional practice) were tested in field plots at three sites with a local maize variety and two types of beans. Runoff and eroded soil were collected after each erosive rain, quantified, and analysed for NO3-N and PO4-P concentrations. In all treatments runoff had higher concentrations of NO3-N (2.20-4.83 mg L-1) than of PO4-P (0.02-0.07 mg L-1), and the eroded soil had higher content of PO4-P (5.27-18.8 mg g(-1)) than of NO3-N (1.30-8.51 mg g(-1)). The control had significantly higher losses of both NO3-N (5.4, 4.4 and 19 kg ha(-1)) and PO4-P (0.2, 0.1 and 0.4 kg ha(-1)) than the other treatments. T3 reduced soil loss, runoff and nutrient losses to nearly a 100% while T1 and T2 reduced those losses from 43 to 88%. The losses of NO3-N and PO4-P were highly correlated with the amounts of runoff and eroded soil. Nutrient losses from the applied amendments were low (5.7% maximum), but the losses in the control could indicate long-term nutrient depletion in the soil (19 and 0.4 kg ha(-1) of NO3-N and PO4-P, respectively). T1-T3 did not consistently increase crop yield or biomass in all three sites, but T1 increased both crop yield and biomass. We conclude that T3 (combining crop-residue mulch with organic amendment and runoff hedges) is the best treatment for steep slope areas but, the pigeon-pea hedges need to be managed for higher maize yield. T1 (combining organic amendment with soil surfactant) could be a better choice for flatter areas with deeper soils.	[Baptista, Isaurinda] INIDA, Inst Nacl Invest & Desenvolvimento Agr, Praia, Cape Verde; [Baptista, Isaurinda; Ritsema, Coen; Geissen, Violette] Wageningen Univ WUR, Soil Phys & Sustainable Land Management Grp SLM, Wageningen, Netherlands; [Geissen, Violette] Univ Bonn, INRES, Bonn, Germany	Wageningen University & Research; University of Bonn	Baptista, I (corresponding author), INIDA, Inst Nacl Invest & Desenvolvimento Agr, Praia, Cape Verde.	ibaptista@inida.gov.cv			Netherlands Universities Foundation for International Cooperation (NUFFIC) [NFP-PhD-10/132]	Netherlands Universities Foundation for International Cooperation (NUFFIC)	The study was funded by the Netherlands Universities Foundation for International Cooperation (NUFFIC) through the NFP-PhD-10/132. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi O. A., 2013, International Journal of Agriculture and Forestry, V3, P40; Adimassu Z, 2014, LAND DEGRAD DEV, V25, P554, DOI 10.1002/ldr.2182; Adu-Gyamfi JJ, 2007, PLANT SOIL, V295, P127, DOI 10.1007/s11104-007-9270-0; Araya A, 2010, AGR WATER MANAGE, V97, P841, DOI 10.1016/j.agwat.2010.01.012; Araya T, 2011, SOIL USE MANAGE, V27, P404, DOI 10.1111/j.1475-2743.2011.00347.x; Baptista I, 2015, GEODERMA, V237, P283, DOI 10.1016/j.geoderma.2014.09.015; Baptista I, 1996, THESIS U GEORGIA ATH, P222; Baptista I, 2000, P WORKSH INTERCRSP P; Baptista I, 2003, TECHNOLOGY ADAPTATIO; Baptista I, 2015, LAND-BASEL, V4, P22, DOI 10.3390/land4010022; Bationo A, 1998, AGR ECOSYST ENVIRON, V71, P19, DOI 10.1016/S0167-8809(98)00129-7; Bhatti A.U, 2007, PAKIS J AGRIC RES, V20, P3; Blake G. R., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P363; Bossio D, 2010, AGR WATER MANAGE, V97, P536, DOI 10.1016/j.agwat.2008.12.001; Buerkert A, 2002, EXP AGR, V38, P163, DOI 10.1017/S0014479702000236; Cooper PJM, 2012, AGR ECOSYST ENVIRON, V126, P24; Dass A, 2011, NUTR CYCL AGROECOSYS, V89, P45, DOI 10.1007/s10705-010-9375-3; Drechsel P., 2004, Research Report - International Water Management Institute; FAO, 2014, EV CROP PROD; Han JG, 2010, AGR WATER MANAGE, V97, P757, DOI 10.1016/j.agwat.2010.01.007; Huang MX, 2015, CATENA, V128, P195, DOI 10.1016/j.catena.2015.02.010; INIDA, 1997, MAN FERT SOL FERT CU; INIDA, 2006, AV PROD CULT SEQ; INMG, 2010, DAD AN PLUV REF EST; Jackson ML, 1982, SOIL CHEM ANAL; Khan F., 2014, American Journal of Plant Sciences, V5, P2582; Kogbe J. O. S., 2003, African Journal of Biotechnology, V2, P345; Lal R, 1998, J SUSTAIN AGR, V11, P2; Lal R, 2009, AGRON SUSTAIN DEV, V29, P7, DOI 10.1051/agro:2008060; Liniger Hanspeter, 2007, LAND IS GREEN CAS ST; LOPES VL, 1993, ENVIRON MANAGE, V17, P51, DOI 10.1007/BF02393794; Mando A, 1997, SOIL TECHNOL, V11, P121, DOI 10.1016/S0933-3630(97)00003-2; Mannaerts CM, 1993, THESIS ITC NETHERLAN; MITTAL SP, 1992, AGROFOREST SYST, V19, P207, DOI 10.1007/BF00118778; Modesto V. C., 2014, American Journal of Plant Sciences, V5, P497, DOI 10.4236/ajps.2014.54064; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Novara A, 2013, SOLID EARTH, V4, P255, DOI 10.5194/se-4-255-2013; O'Geen AT, 2006, ANR PUBLICATION, V8194; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; Pimentel David, 2006, Environment Development and Sustainability, V8, P119, DOI 10.1007/s10668-005-1262-8; Querido A, 1999, THESIS INT I AEROSPA; Reed MS, 2015, J ENVIRON MANAGE, V151, P472, DOI 10.1016/j.jenvman.2014.11.010; Rockstrom J, 2009, SOIL TILL RES, V103, P23, DOI 10.1016/j.still.2008.09.013; Rockstrom J, 2003, PHYS CHEM EARTH, V28, P869, DOI 10.1016/j.pce.2003.08.009; Rockstrom J, 2010, AGR WATER MANAGE, V97, P543, DOI 10.1016/j.agwat.2009.09.009; Roose E, 2004, B EROSION, V22, P74; Ryan J. G., 2001, FUTURE CHALLENGES OP; Salak J, 2010, SOIL FERTILITY GUIDE; Schwilch G, 2009, LAND DEGRAD DEV, V20, P308, DOI 10.1002/ldr.920; Schwilch G, 2012, DESIRE GREENER LAND; Sharma AR, 2010, NUTR CYCL AGROECOSYS, V86, P39, DOI 10.1007/s10705-009-9272-9; Smolikowski B, 2001, AGR ECOSYST ENVIRON, V87, P67, DOI 10.1016/S0167-8809(00)00292-9; Stroosnijder L, 1996, ECOL MODEL, V92, P79, DOI 10.1016/0304-3800(95)00197-2; Stroosnijder L, 2003, S WORKSH BLOEMF S AF; Stroosnijder L, 2012, CURR OPIN ENV SUST, V4, P1; Tavares J, 2010, THESIS BOURGOGNE U D, P226; Tavares JDP, 2015, CATENA, V128, P214, DOI 10.1016/j.catena.2014.10.005; Tavares JD, 2014, LAND DEGRAD DEV, V25, P45, DOI 10.1002/ldr.2273; Tesfaye A, 2014, LAND DEGRAD DEV, V25, P71, DOI 10.1002/ldr.2187; Tiscareno-Lopez M, 2004, J AM WATER RESOUR AS, V40, P401, DOI 10.1111/j.1752-1688.2004.tb01038.x; Varela AC, 2012, THESIS UNICV PRAIA; Wu W, 2015, SCI TOTAL ENVIRON, V512, P415, DOI 10.1016/j.scitotenv.2014.12.101; Xia LZ, 2013, CATENA, V110, P86, DOI 10.1016/j.catena.2013.05.009; Zhang SL, 2011, NUTR CYCL AGROECOSYS, V89, P427, DOI 10.1007/s10705-010-9406-0; Zhao GJ, 2013, LAND DEGRAD DEV, V24, P499, DOI 10.1002/ldr.2246; ZOBISCH MA, 1995, SOIL TILL RES, V33, P109, DOI 10.1016/0167-1987(94)00441-G; Zougmore R, 2004, NUTR CYCL AGROECOSYS, V70, P261, DOI 10.1007/s10705-004-0533-3; Zougmore R, 2003, SOIL USE MANAGE, V19, P257, DOI 10.1079/SUM2003199; Zougmore R, 2009, ARID LAND RES MANAG, V23, P85, DOI 10.1080/15324980802599142; Zougmoru R., 2014, AGR FOOD SECURITY, V3, P1, DOI [10.1186/2048-7010-3-16, DOI 10.1186/2048-7010-3-16]	71	16	16	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134244	10.1371/journal.pone.0134244	http://dx.doi.org/10.1371/journal.pone.0134244			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230549	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400092
J	Crona, J; Ljungstrom, V; Welin, S; Walz, MK; Hellman, P; Bjorklund, P				Crona, Joakim; Ljungstrom, Viktor; Welin, Staffan; Walz, Martin K.; Hellman, Per; Bjorklund, Peyman			Bioinformatic Challenges in Clinical Diagnostic Application of Targeted Next Generation Sequencing: Experience from Pheochromocytoma	PLOS ONE			English	Article							MUTATIONS; PARAGANGLIOMA; GENE; SUSCEPTIBILITY; EXOME; IDENTIFICATION; SDHB	Background Recent studies have demonstrated equal quality of targeted next generation sequencing (NGS) compared to Sanger Sequencing. Whereas these novel sequencing processes have a validated robust performance, choice of enrichment method and different available bioinformatic software as reliable analysis tool needs to be further investigated in a diagnostic setting. Methods DNA from 21 patients with genetic variants in SDHB, VHL, EPAS1, RET, (n=17) or clinical criteria of NF1 syndrome (n=4) were included. Targeted NGS was performed using Truseq custom amplicon enrichment sequenced on an Illumina MiSEQ instrument. Results were analysed in parallel using three different bioinformatics pipelines; (1) Commercially available MiSEQ Reporter, fully automatized and integrated software, (2) CLC Genomics Workbench, graphical interface based software, also commercially available, and ICP (3) an in-house scripted custom bioinformatic tool. Results A tenfold read coverage was achieved in between 95-98% of targeted bases. All workflows had alignment of reads to SDHA and NF1 pseudogenes. Compared to Sanger sequencing, variant calling revealed a sensitivity ranging from 83 to 100% and a specificity of 99.9-100%. Only MiSEQ reporter identified all pathogenic variants in both sequencing runs. Conclusions We conclude that targeted next generation sequencing have equal quality compared to Sanger sequencing. Enrichment specificity and the bioinformatic performance need to be carefully assessed in a diagnostic setting. As acceptable accuracy was noted for a fully automated bioinformatic workflow, we suggest that processing of NGS data could be performed without expert bioinformatics skills utilizing already existing commercially available bioinformatics tools.	[Crona, Joakim; Hellman, Per; Bjorklund, Peyman] Uppsala Univ, Dept Surg Sci, SE-75185 Uppsala, Sweden; [Ljungstrom, Viktor] Uppsala Univ, Dept Immunol Genet & Pathol, SE-75185 Uppsala, Sweden; [Welin, Staffan] Uppsala Univ, Dept Med Sci, SE-75185 Uppsala, Sweden; [Walz, Martin K.] Univ Duisburg Essen, Acad Teaching Hosp, Kliniken Essen Mitte, Dept Surg, DE-45136 Essen, Germany; [Walz, Martin K.] Univ Duisburg Essen, Acad Teaching Hosp, Kliniken Essen Mitte, Ctr Minimal Invas Surg, DE-45136 Essen, Germany	Uppsala University; Uppsala University; Uppsala University; Kliniken Essen-Mitte; University of Duisburg Essen; Kliniken Essen-Mitte; University of Duisburg Essen	Crona, J (corresponding author), Uppsala Univ, Dept Surg Sci, SE-75185 Uppsala, Sweden.	joakim.crona@surgsci.uu.se	Hellman, Per/AAL-9817-2021; Walz, Martin/AHE-7790-2022; Crona, Joakim/D-3474-2013	Hellman, Per/0000-0002-5322-5073; Crona, Joakim/0000-0003-0677-4894	Swedish Cancer Society; Selander Foundation; Lions Cancer Foundation, Uppsala	Swedish Cancer Society(Swedish Cancer Society); Selander Foundation; Lions Cancer Foundation, Uppsala	This work was supported by grants from Swedish Cancer Society (PB), Selander Foundation (PB, PH) and Lions Cancer Foundation, Uppsala (JC, PH). PB is a Swedish Cancer Society Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akerstrom T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041926; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Bayley JP, 2010, LANCET ONCOL, V11, P366, DOI 10.1016/S1470-2045(10)70007-3; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Burnichon N, 2012, HUM MOL GENET, V6, P6; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Casey R, 2014, J CLIN ENDOCR METAB, V99, pE1392, DOI 10.1210/jc.2013-4536; Chan M, 2012, J MOL DIAGN, V14, P602, DOI 10.1016/j.jmoldx.2012.06.003; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Crona J, 2015, CLIN CANC RES; Crona J, 2013, FAM CANCER, V7, P7; Crona J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086756; Crona J, 2013, J CLIN ENDOCR METAB, V98, pE1266, DOI 10.1210/jc.2012-4257; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; Erlic Z, 2009, CLIN CANCER RES, V15, P6378, DOI 10.1158/1078-0432.CCR-09-1237; Feliubadalo L, 2012, EUR J HUM GENET, V19, P27; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Garrison E, 2012, 12073907 ARXIV, V1207, P3907; Grossmann V, 2013, J MOL DIAGN, V13, P00057; Halbritter J, 2012, J MED GENET, V49, P756, DOI 10.1136/jmedgenet-2012-100973; Jacob HJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006468; Jafri M, 2013, CLIN ENDOCRINOL, V78, P898, DOI 10.1111/cen.12074; Jafri M, 2012, EUR J ENDOCRINOL, V166, P151, DOI 10.1530/EJE-11-0497; Korf B R, 2001, Curr Neurol Neurosci Rep, V1, P162, DOI 10.1007/s11910-001-0012-z; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Ladroue C, 2008, NEW ENGL J MED, V359, P2685, DOI 10.1056/NEJMoa0806277; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Letouze E, 2013, CANCER CELL, V21, P00183; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068102, 10.1371/journal.pone.0067744]; Liu XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075619; Martucci VL, 2014, CURR PROB CANCER, V38, P7, DOI 10.1016/j.currproblcancer.2014.01.001; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Pritchard CC, 2012, J MOL DIAGN, V14, P357, DOI 10.1016/j.jmoldx.2012.03.002; Qin YJ, 2010, NAT GENET, V42, P229, DOI 10.1038/ng.533; Rattenberry E, 2013, J CLIN ENDOCR METAB, V10, P10; Sboner A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-125; Sikkema-Raddatz B, 2013, HUM MUTAT, V8, P2233; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Welander J, 2014, J CLIN ENDOCR METAB, V99, pE1352, DOI 10.1210/jc.2013-4375; Zhuang ZP, 2012, NEW ENGL J MED, V367, P922, DOI 10.1056/NEJMoa1205119	46	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133210	10.1371/journal.pone.0133210	http://dx.doi.org/10.1371/journal.pone.0133210			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230854	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400029
J	Cui, Y; Tian, SS; Qiao, N; Wang, C; Wang, T; Huang, JJ; Sun, CM; Liang, J; Liu, XM				Cui, Yan; Tian, Shuang-Shuang; Qiao, Nan; Wang, Cong; Wang, Tong; Huang, Jian-Jun; Sun, Chen-Ming; Liang, Jie; Liu, Xiao-Meng			Associations of Individual-Related and Job-Related Risk Factors with Nonfatal Occupational Injury in the Coal Workers of Shanxi Province: A Cross-Sectional Study	PLOS ONE			English	Article							LIFE-STYLE; AGE; BURNOUT; QUESTIONNAIRE; FATALITIES; EMPLOYEES; BEHAVIOR; INDUSTRY; STRESS; MINERS	Objectives To assess the relationships between the risk factors and the incidence of nonfatal occupational injury of coal mine workers of Shanxi Province. Methods A cross-sectional study was conducted from July 2013 to December 2013, and 4319 workers were recruited from more than 200,000 coal mine employees who are exposed to continuous potential risk of occupational injuries by using a two-stage stratified cluster sampling method. Trained interviewers having necessary medical knowledge conducted face-to-face interviews with the participants. Univariate and multivariable logistic regression models were used to estimate the odds ratio (OR) and the 95% confidence interval (CI). Results A total number of 3618 effective respondents were got from 4319 participants (83.77%) and the mean age of the participants was 41.5 years with the standard deviation of 8.65. Significant crude odds ratios were observed for all factors considered except for marital status, education, work duration, BMI, EPQ-RSC(P) scale and EPQ-RSC(L) scale. Results from multivariable logistic regression model showed significant adjusted odds ratios for risk factors including gender (female vs male 0.275, 0.094-0.800), age (>= 55 vs <= 25yr 0.169, 0.032-0.900), work type (light physical labor vs heavy physical labor 0.504, 0.328-0.774), workplace (underground auxiliary vs underground front-line 0.595, 0.385-0.919), length of shiftwork experience (0 similar to 5yr vs no shift 2.075, 1.287-3.344 and >= 15yr vs no shift 2.076, 1.230-3.504) and EPQ-RSC(E) score (extraversion vs introversion 0.538, 0.334-0.867). Conclusions Several risk factors of nonfatal occupational injury were identified including male, age, heavy physical labor, underground front-line, length of shiftwork experience and introversion. The coal mining enterprises should pay attention to controlling the hazards associated with frontline physical work. Workers' behaviors, life styles and personality traits should also be considered, so that the enterprises could set achievable targets for workers and lessen the exposed period to the risky underground workstation.	[Cui, Yan; Tian, Shuang-Shuang; Qiao, Nan; Wang, Cong; Wang, Tong; Liang, Jie; Liu, Xiao-Meng] Shanxi Med Univ, Sch Publ Hlth, Dept Hlth Stat, Taiyuan, Peoples R China; [Tian, Shuang-Shuang] Taiyuan Xinghualing Dist Food & Drug Adm, Dept Hlth Stat, Taiyuan, Peoples R China; [Huang, Jian-Jun] Gen Hosp, Datong Coal Min Grp, Dept Neurosurg, Taiyuan, Peoples R China; [Sun, Chen-Ming] Gen Hosp, Datong Coal Min Grp, Dept Urol, Taiyuan, Peoples R China; [Wang, Tong; Huang, Jian-Jun] Ctr Postgrad Educ Innovat Shanxi Prov, Taiyuan, Peoples R China	Shanxi Medical University	Wang, T (corresponding author), Shanxi Med Univ, Sch Publ Hlth, Dept Hlth Stat, Taiyuan, Peoples R China.	13835120380@163.com; tmhjj1958@163.com	wang, tong/I-6454-2018	wang, tong/0000-0002-9403-7167; Liang, Jie/0000-0002-0767-3908	National Natural Science Foundation of China [81473073]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by grants from the National Natural Science Foundation of China (81473073) URLs: (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderaw Z, 2011, J TROP MED-US, V2011, DOI 10.1155/2011/657275; Ahola K, 2013, J OCCUP HEALTH, V55, P450, DOI 10.1539/joh.13-0021-OA; Andersen LP, 2008, SAFETY SCI, V46, P255, DOI 10.1016/j.ssci.2007.06.014; [Anonymous], 2006, REPUBLIC; [Anonymous], 1986, Ministry of Labour and Social Security of the People's Republic of China, P6441, Patent No. 644186; [Anonymous], 2012, INJ EXP SAND GRAV MI; [Anonymous], 2013, NONF OCC INJ ILLN RE; Arlinghaus A, 2012, AM J EPIDEMIOL, V176, P597, DOI 10.1093/aje/kws219; Barling J., 2004, PSYCHOL WORKPLACE SA, P3; Bhattacherjee A, 2011, 34 INT C SAF MIN RES, P481; Bhattacherjee A, 2009, J GEOLOGY MINING RES, V1, P025; Boniface R, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.120.3420; Chau N, 2008, INT ARCH OCC ENV HEA, V81, P379, DOI 10.1007/s00420-007-0223-y; Chau N, 2009, OCCUP MED-OXFORD, V59, P114, DOI 10.1093/occmed/kqp002; Chau N, 2014, AM J IND MED, V57, P172, DOI 10.1002/ajim.22259; CHU JP, 2011, CHINA J HLTH PSYCHOL, V19, P664; COSTA G, 1989, ERGONOMICS, V32, P373, DOI 10.1080/00140138908966104; Gauchard GC, 2003, OCCUP ENVIRON MED, V60, P330, DOI 10.1136/oem.60.5.330; Ghosh AK, 2004, J OCCUP HEALTH, V46, P470, DOI 10.1539/joh.46.470; Gorgens-Ekermans G, 2012, J CLIN NURS, V21, P2275, DOI 10.1111/j.1365-2702.2012.04171.x; Gonzalez-Delgado M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121490; Groves WA, 2007, J SAFETY RES, V38, P461, DOI 10.1016/j.jsr.2007.03.011; Horberry T, 2013, ERGONOMICS, V56, P556, DOI 10.1080/00140139.2012.718800; Hutchinson TA, 2014, W INDIAN MED J, V63, P262, DOI 10.7727/wimj.2013.330; Ishtiaq M, 2014, J MED SCI, V22, P21; Khanzode VV, 2012, SAFETY SCI, V50, P1355, DOI 10.1016/j.ssci.2011.12.015; Kipping RR, 2015, EUR J PUBLIC HEALTH, V25, P44, DOI 10.1093/eurpub/cku078; Kouvonen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077178; Kunar BM, 2008, J OCCUP HEALTH, V50, P236, DOI 10.1539/joh.L7054; LANDEN DD, 1995, PUBLIC HEALTH REP, V110, P350; Li XR, 2015, INT J ENV RES PUB HE, V12, P2984, DOI 10.3390/ijerph120302984; Li Y, 2008, CHIN OCCUP MED, V135, P417; Margolis KA, 2010, SAFETY SCI, V48, P417, DOI 10.1016/j.ssci.2009.12.015; Marusic A, 2001, NORD J PSYCHIAT, V55, P157; MITCHELL OS, 1988, MON LABOR REV, V111, P8; Nakata A, 2005, IND HEALTH, V43, P89, DOI 10.2486/indhealth.43.89; Onder M, 2010, IND HEALTH, V48, P872, DOI 10.2486/indhealth.MS1136; Pordanjani RT, 2013, JOHE SUMMER 2013, V2, P93; Salminen S, 2010, J SLEEP RES, V19, P207, DOI 10.1111/j.1365-2869.2009.00780.x; Shao T, 2004, J ENV OCCUP MED, V21, P326; Sun GF, 2012, OCCUPATIONAL HLTH OC; Tucker P, 1998, J Occup Health Psychol, V3, P265, DOI 10.1037/1076-8998.3.3.265; Wagstaff AS, 2011, SCAND J WORK ENV HEA, V37, P173, DOI 10.5271/sjweh.3146; Xie ZY, 2011, J ADV NURS, V67, P1537, DOI 10.1111/j.1365-2648.2010.05576.x; Yumang-Ross DJ, 2014, WORKPLACE HEALTH SAF, V62, P256, DOI 10.3928/21650799-20140514-07	45	15	15	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134367	10.1371/journal.pone.0134367	http://dx.doi.org/10.1371/journal.pone.0134367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230266	Green Published, gold			2022-12-27	WOS:000358838400110
J	Fehervari, TD; Okazaki, Y; Sawai, H; Yagi, T				Fehervari, Tams David; Okazaki, Yuka; Sawai, Hajime; Yagi, Tetsuya			In Vivo Voltage-Sensitive Dye Study of Lateral Spreading of Cortical Activity in Mouse Primary Visual Cortex Induced by a Current Impulse	PLOS ONE			English	Article							HORIZONTAL CONNECTIONS; SPATIOTEMPORAL DYNAMICS; INTRINSIC CONNECTIONS; RECEPTIVE-FIELDS; SYNAPTIC CONNECTIONS; AXONAL PROJECTIONS; STRIATE CORTEX; NEURONS; EXCITATION; RESPONSES	In the mammalian primary visual cortex (V1), lateral spreading of excitatory potentials is believed to be involved in spatial integrative functions, but the underlying cortical mechanism is not well understood. Visually-evoked population-level responses have been shown to propagate beyond the V1 initial activation site in mouse, similar to higher mammals. Visually- evoked responses are, however, affected by neuronal circuits prior to V1 (retina, LGN), making the separate analysis of V1 difficult. Intracortical stimulation eliminates these initial processing steps. We used in vivo RH1691 voltage-sensitive dye (VSD) imaging and intracortical microstimulation in adult C57BL/6 mice to elucidate the spatiotemporal properties of population-level signal spreading in V1 cortical circuits. The evoked response was qualitatively similar to that measured in single-cell electrophysiological experiments in rodents: a fast transient fluorescence peak followed by a fast and a slow decrease or hyperpolarization, similar to EPSP and fast and slow IPSPs in single cells. The early cortical response expanded at speeds commensurate with long horizontal projections (at 5% of the peak maximum, 0.08-0.15 m/s) however, the bulk of the VSD signal propagated slowly (at half-peak maximum, 0.05-0.08 m/s) suggesting an important role of regenerative multisynaptic transmission through short horizontal connections in V1 spatial integrative functions. We also found a tendency for a widespread and fast cortical response suppression in V1, which was eliminated by GABAA-antagonists gabazine and bicuculline methiodide. Our results help understand the neuronal circuitry involved in lateral spreading in V1.	[Fehervari, Tams David; Okazaki, Yuka; Yagi, Tetsuya] Osaka Univ, Grad Sch Engn, Div Elect Elect & Informat Engn, Suita, Osaka, Japan; [Okazaki, Yuka] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka, Japan; [Sawai, Hajime] Osaka Univ, Grad Sch Med, Div Med, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Yagi, T (corresponding author), Osaka Univ, Grad Sch Engn, Div Elect Elect & Informat Engn, Suita, Osaka, Japan.	yagi@eei.eng.osaka-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) project "Creating Hybrid Organs of the Future" at Osaka University; MEXT [21700332]; Japan Society for the Promotion of Science [19206041]	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) project "Creating Hybrid Organs of the Future" at Osaka University; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, http://www.mext.go.jp/english/) project "Creating Hybrid Organs of the Future" at Osaka University, a Grant-in-Aid for Young Scientists (B) (21700332) from MEXT to YO and a Grant-in-Aid for Scientific Research (A) (19206041) from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/) to TY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed B, 2008, CEREB CORTEX, V18, P2796, DOI 10.1093/cercor/bhn038; Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; BISHOP PO, 1971, J PHYSIOL-LONDON, V219, P625, DOI 10.1113/jphysiol.1971.sp009681; Bosking WH, 1997, J NEUROSCI, V17, P2112; BURKHALTER A, 1989, J COMP NEUROL, V279, P171, DOI 10.1002/cne.902790202; BURKHALTER A, 1990, J COMP NEUROL, V302, P920, DOI 10.1002/cne.903020417; Chavane F, 2000, J PHYSIOL-PARIS, V94, P333, DOI 10.1016/S0928-4257(00)01096-2; Chavane F, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00004; Contreras D, 2001, J NEUROSCI, V21, P9403, DOI 10.1523/JNEUROSCI.21-23-09403.2001; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; Devonshire IM, 2010, EUR J NEUROSCI, V32, P786, DOI 10.1111/j.1460-9568.2010.07322.x; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; Fehervari T, 2011, PROGRAM NO 37806; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Fukuda M, 1998, NEUROSCI RES, V31, P9, DOI 10.1016/S0168-0102(98)00018-2; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; GRINVALD A, 1994, J NEUROSCI, V14, P2545; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Ichinose T, 1996, NEUROSCIENCE, V73, P25, DOI 10.1016/0306-4522(96)00026-7; Jancke D, 2004, NATURE, V428, P423, DOI 10.1038/nature02396; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Lippert MT, 2007, J NEUROPHYSIOL, V98, P502, DOI 10.1152/jn.01169.2006; MacLean JN, 2006, NAT METHODS, V3, P129, DOI 10.1038/NMETH849; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; MCDONALD CT, 1993, J NEUROSCI, V13, P768; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; Mohajerani MH, 2013, NAT NEUROSCI, V16, P1426, DOI 10.1038/nn.3499; Mohajerani MH, 2010, J NEUROSCI, V30, P3745, DOI 10.1523/JNEUROSCI.6437-09.2010; Muller L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4675; MURAKOSHI T, 1993, NEUROSCI LETT, V163, P211, DOI 10.1016/0304-3940(93)90385-X; MURAKOSHI T, 1995, VISION RES, V35, P25, DOI 10.1016/0042-6989(94)E0056-Q; NELSON DA, 1995, NEURON, V15, P23, DOI 10.1016/0896-6273(95)90061-6; Olivas ND, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00070; ORBACH HS, 1993, EXP BRAIN RES, V94, P371, DOI 10.1007/BF00230197; Osanai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013738; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Pisauro MA, 2013, J NEUROSCI, V33, P18343, DOI 10.1523/JNEUROSCI.2130-13.2013; Polack PO, 2012, J NEUROSCI, V32, P11120, DOI 10.1523/JNEUROSCI.6304-11.2012; Roland PE, 2006, P NATL ACAD SCI USA, V103, P12586, DOI 10.1073/pnas.0604925103; Rubino D, 2006, NAT NEUROSCI, V9, P1549, DOI 10.1038/nn1802; SCHARFMAN HE, 1988, SYNAPSE, V2, P619, DOI 10.1002/syn.890020607; Schuett S, 2002, J NEUROSCI, V22, P6549; Shao ZW, 1996, J NEUROSCI, V16, P7353; Shao ZW, 1999, J NEUROPHYSIOL, V81, P1014, DOI 10.1152/jn.1999.81.3.1014; Sharon D, 2007, CEREB CORTEX, V17, P2866, DOI 10.1093/cercor/bhm019; Sit YF, 2009, NEURON, V64, P943, DOI 10.1016/j.neuron.2009.08.041; TANIFUJI M, 1994, SCIENCE, V266, P1057, DOI 10.1126/science.7973662; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; Tucker TR, 2003, J NEUROPHYSIOL, V89, P488, DOI 10.1152/jn.00869.2001; Vaiceliunaite A, 2013, J NEUROPHYSIOL, V110, P964, DOI 10.1152/jn.00138.2013; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; WELIKY M, 1994, J NEUROSCI, V14, P7291; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; Xu WF, 2007, NEURON, V55, P119, DOI 10.1016/j.neuron.2007.06.016; YOSHIMURA Y, 1994, J NEUROPHYSIOL, V71, P1638, DOI 10.1152/jn.1994.71.5.1638; Yuste R, 1997, CEREB CORTEX, V7, P546, DOI 10.1093/cercor/7.6.546	66	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133853	10.1371/journal.pone.0133853	http://dx.doi.org/10.1371/journal.pone.0133853			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230520	Green Submitted, gold, Green Published			2022-12-27	WOS:000358838400059
J	Lis, CG; Patel, K; Gupta, D				Lis, Christopher G.; Patel, Kamal; Gupta, Digant			The Relationship between Patient Satisfaction with Service Quality and Survival in Non-Small Cell Lung Cancer - Is Self-Rated Health a Potential Confounder?	PLOS ONE			English	Article							ADVANCED COLORECTAL-CANCER; OF-LIFE PARAMETERS; BREAST-CANCER; PROGNOSTIC-FACTORS; EORTC QLQ-C30; ONCOLOGY; CARE; DETERMINANTS; ASSOCIATION; PREDICTOR	Background/Aims Previously we reported that higher patient satisfaction (PS) with service quality is associated with favorable survival outcomes in a variety of cancers. However, we cautioned the readers that patients with greater satisfaction might be the ones with better self-rated health (SRH), a well-established prognosticator of cancer survival. In other words, SRH could potentially confound the PS and survival relationship. We investigated this hypothesis in non-small cell lung cancer (NSCLC). Methods 778 NSCLC patients (327 males and 451 females; mean age 58.8 years) treated at 4 Cancer Treatment Centers of America hospitals between July 2011 and March 2013. PS was measured on a 7-point scale ranging from "completely dissatisfied" to "completely satisfied". SRH was measured on a 7-point scale ranging from "very poor" to "excellent". Both were dichotomized into 2 categories: top box response (7) versus all others (1-6). Patient survival was the primary end point. Cox regression was used to evaluate the association between PS and survival controlling for covariates. Results 74, 70, 232 and 391 patients had stage I, II, III and IV disease respectively. 631 (81.1%) patients were "completely satisfied". 184 (23.7%) patients had "excellent" SRH. There was a weak but significant correlation between overall PS and SRH (Kendall's tau b = 0.19; p<0.001). On univariate analysis, "completely satisfied" patients had a significantly lower risk of mortality (HR = 0.75; 95% CI: 0.57 to 0.99; p = 0.04). Similarly, patients with "excellent" SRH had a significantly lower risk of mortality (HR = 0.61; 95% CI: 0.46 to 0.81; p = 0.001). On multivariate analysis controlling for stage at diagnosis, treatment history and gender, SRH was found to be a significant predictor of survival (HR = 0.67; 95% CI: 0.50 to 0.89; p = 0.007) while PS was not (HR = 0.86; 95% CI: 0.64 to 1.2; p = 0.32). Among the individual PS items, the only significant independent predictor of survival was "teams communicating with each other concerning your medical condition and treatment" (HR = 0.59; 95% CI: 0.36 to 0.94; p = 0.03). Conclusion SRH appears to confound the PS-survival relationship in NSCLC. SRH should be used as a control/stratification variable in analyses involving PS as a predictor of clinical cancer outcomes.	[Lis, Christopher G.; Patel, Kamal; Gupta, Digant] Canc Treatment Ctr Amer, Schaumburg, IL 60173 USA		Gupta, D (corresponding author), Canc Treatment Ctr Amer, 500 Remington Rd, Schaumburg, IL 60173 USA.	digant.gupta@ctca-hope.com	GUPTA, DIGANT/ABA-9729-2020	GUPTA, DIGANT/0000-0002-1963-8886				Akin S, 2010, EUR J ONCOL NURS, V14, P400, DOI 10.1016/j.ejon.2010.01.003; Besley D., 2004, REGRESSION DIAGNOSTI; Bredart A, 2003, PSYCHO-ONCOLOGY, V12, P68, DOI 10.1002/pon.620; Bredart A, 2001, ONCOLOGY-BASEL, V61, P120, DOI 10.1159/000055362; Cleary PD, 1999, QUAL HEALTH CARE, V8, P212, DOI 10.1136/qshc.8.4.212; Coates A, 1997, EUR J CANCER, V33, P1025, DOI 10.1016/S0959-8049(97)00049-X; Collette L, 2004, J CLIN ONCOL, V22, P3877, DOI 10.1200/JCO.2004.07.089; Dancey J, 1997, QUAL LIFE RES, V6, P151; Dharma-Wardene M, 2004, QUAL LIFE RES, V13, P1209, DOI 10.1023/B:QURE.0000037481.36604.eb; Efficace F, 2004, J CLIN ONCOL, V22, P3381, DOI 10.1200/JCO.2004.02.060; Fang FM, 2004, INT J RADIAT ONCOL, V58, P1394, DOI 10.1016/j.ijrobp.2003.09.100; Fielding R, 2007, EUR J CANCER, V43, P1723, DOI 10.1016/j.ejca.2007.05.002; Gupta D, 2012, J HEALTHC QUAL, P10; Gupta D, 2013, INT J QUAL HLTH CARE; Gupta D, 2013, SUPPORT CARE CANC; Gupta D, 2007, SUPPORT CARE CANCER, V15, P387, DOI 10.1007/s00520-006-0165-z; Gupta D, 2006, J GASTROINTEST CANC, V37, P65, DOI 10.1007/s12029-007-0001-9; Halyard Michele Y, 2008, J Support Oncol, V6, P221; Arraras JI, 2013, PSYCHO-ONCOLOGY, V22, P2454, DOI 10.1002/pon.3307; Iskandarsyah A, 2013, SUPPORT CARE CANCER, V21, P2999, DOI 10.1007/s00520-013-1877-5; Kleeberg UR, 2005, SUPPORT CARE CANCER, V13, P303, DOI 10.1007/s00520-004-0727-x; Langendijk H, 2000, RADIOTHER ONCOL, V55, P19, DOI 10.1016/S0167-8140(00)00158-4; Lis CG, 2006, SUPPORT CARE CANCER, V14, P1104, DOI 10.1007/s00520-006-0100-3; Lis CG, 2006, J GASTROINTEST CANC, V37, P35, DOI 10.1385/IJGC:37:1:35; Lis CG, 2009, PATIENT PREFER ADHER, V3, P287; Lis CG, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-190; Loblaw DA, 1999, J CLIN ONCOL, V17, P1931, DOI 10.1200/JCO.1999.17.6.1931; Maisey NR, 2002, EUR J CANCER, V38, P1351, DOI 10.1016/S0959-8049(02)00098-9; Mathieson CM, 1996, CAN FAM PHYSICIAN, V42, P1712; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Pita-Fernandez S, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-117; Roychowdhury DF, 2003, J CLIN ONCOL, V21, P673, DOI 10.1200/JCO.2003.04.166; Sixma Herman J., 1998, Health Expect, V1, P82, DOI 10.1046/j.1369-6513.1998.00004.x; Wong WS, 2008, MED CARE, V46, P293, DOI 10.1097/MLR.0b013e31815b9785; Wong WS, 2009, MED CARE, V47, P875, DOI 10.1097/MLR.0b013e3181a393cf	35	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134617	10.1371/journal.pone.0134617	http://dx.doi.org/10.1371/journal.pone.0134617			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230934	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400140
J	Roy, S; Banerjee, V; Das, KP				Roy, Sujit; Banerjee, Victor; Das, Kali Pada			Understanding the Physical and Molecular Basis of Stability of Arabidopsis DNA Pol lambda under UV-B and High NaCl Stress	PLOS ONE			English	Article							POLYMERASE-LAMBDA; ESCHERICHIA-COLI; PROLINE RESIDUES; ATPOL-LAMBDA; X-FAMILY; PROTEINS; REPAIR; SALT; BYPASS; DAMAGE	Here, we have investigated the physical and molecular basis of stability of Arabidopsis DNA Pol lambda, the sole X family DNA polymerase member in plant genome, under UV-B and salinity stress in connection with the function of the N-terminal BRCT (breast cancer-associated C terminus) domain and Ser-Pro rich region in the regulation of the overall structure of this protein. Tryptophan fluorescence studies, fluorescence quenching and Bis-ANS binding experiments using purified recombinant full length Pol lambda and its N-terminal deletion forms have revealed UV-B induced conformational change in BRCT domain deficient Pol lambda. On the other hand, the highly conserved C-terminal catalytic core PolX domain maintained its tertiary folds under similar condition. Circular dichroism (CD) and fourier transform infrared (FT-IR) spectral studies have indicated appreciable change in the secondary structural elements in UV-B exposed BRCT domain deficient Pol lambda. Increased thermodynamic stability of the C-terminal catalytic core domain suggested destabilizing effect of the N-terminal SerPro rich region on the protein structure. Urea-induced equilibrium unfolding studies have revealed increased stability of Pol lambda and its N-terminal deletion mutants at high NaCl concentration. In vivo aggregation studies using transient expression systems in Arabidopsis and tobacco indicated possible aggregation of Pol lambda lacking the BRCT domain. Immunoprecipitation assays revealed interaction of Pol lambda with the eukaryotic molecular chaperone HSP90, suggesting the possibility of regulation of Pol lambda stability by HSP90 in plant cell. Overall, our results have provided one of the first comprehensive information on the biophysical characteristics of Pol lambda and indicated the importance of both BRCT and Ser-Pro rich modules in regulating the stability of this protein under genotoxic stress in plants.	[Roy, Sujit; Banerjee, Victor; Das, Kali Pada] Bose Inst, Dept Chem, Prot Chem Lab, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute	Roy, S (corresponding author), Univ Burdwan, UGC Ctr Adv Studies, Dept Bot, Burdwan 713104, W Bengal, India.	sujitroy2006@gmail.com	Banerjee, Victor/N-8427-2014; BANERJEE, VICTOR/J-9581-2019	Banerjee, Victor/0000-0002-3906-3362; BANERJEE, VICTOR/0000-0002-3906-3362	Council of Scientific and Industrial Research (CSIR), Govt. of India [13(8611-A)/2013-Pool)]; Bose Institute; Council of Scientific and Industrial Research, Govt. of India	Council of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); Bose Institute(Department of Science & Technology (India)); Council of Scientific and Industrial Research, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the research grant from the Council of Scientific and Industrial Research (CSIR) Pool Scientist's Scheme (Ref. No. 13(8611-A)/2013-Pool), Govt. of India to SR and funding from Bose Institute to KPD. VB was supported by doctoral fellowship from the Council of Scientific and Industrial Research, Govt. of India.	Albani JR, 2004, STRUCTURE AND DYNAMI; Amoroso A, 2011, PLANT CELL, V23, P806, DOI 10.1105/tpc.110.081455; Banerjee V, 2014, LANGMUIR, V30, P4775, DOI 10.1021/la5007007; Banerjee V, 2013, COLLOID SURFACE B, V111, P71, DOI 10.1016/j.colsurfb.2013.04.052; Banerjee V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072318; Biswas A, 2004, J BIOL CHEM, V279, P42648, DOI 10.1074/jbc.M404444200; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Braithwaite EK, 2005, J BIOL CHEM, V280, P31641, DOI 10.1074/jbc.C500256200; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Choudhury SR, 2012, J BIOL CHEM, V287, P17870, DOI 10.1074/jbc.M112.353219; Crespan E, 2007, NUCLEIC ACIDS RES, V35, P5173, DOI 10.1093/nar/gkm568; Das KP, 1996, J BIOL CHEM, V271, P10449, DOI 10.1074/jbc.271.18.10449; Dastidar KG, 2006, PLANT PHYSIOL, V140, P1279, DOI 10.1104/pp.105.075150; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Fersht A, 1999, STRUCTURE AND MECHAN; Forsberg J, 1998, PLANT SCI, V131, P65, DOI 10.1016/S0168-9452(97)00242-2; Garcia-Diaz M, 2009, NAT STRUCT MOL BIOL, V16, P967, DOI 10.1038/nsmb.1654; Hollosy F, 2002, MICRON, V33, P179, DOI 10.1016/S0968-4328(01)00011-7; JAENICKE R, 1991, EUR J BIOCHEM, V202, P715, DOI 10.1111/j.1432-1033.1991.tb16426.x; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Kim J, 2010, PLANT PHYSIOL, V154, P611, DOI 10.1104/pp.110.162271; Kunkel TA, 2004, DNA REPAIR AND REPLI; Lakowicz JR, 1991, TOPICS IN FLUORESCEN, V1; Layton JC, 2005, J BACTERIOL, V187, P449, DOI 10.1128/JB.187.2.449-457.2005; Lee JW, 2004, J BIOL CHEM, V279, P805, DOI 10.1074/jbc.M307913200; LEVITT M, 1981, J MOL BIOL, V145, P251, DOI 10.1016/0022-2836(81)90342-9; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; Makhatadze GI, 1998, PROTEIN SCI, V7, P689, DOI 10.1002/pro.5560070318; McIntyre J, 2006, MUTAT RES-FUND MOL M, V593, P153, DOI 10.1016/j.mrfmmm.2005.07.003; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; Navratilova B, 2008, PLANT CELL TISS ORG, V94, P313, DOI 10.1007/s11240-008-9416-7; Nelson ED, 1998, P NATL ACAD SCI USA, V95, P10682, DOI 10.1073/pnas.95.18.10682; Nomura M, 2005, BIOCHEM BIOPH RES CO, V335, P900, DOI 10.1016/j.bbrc.2005.07.160; Pozo FM, 2011, MOL CELL BIOL, V31, P3396, DOI 10.1128/MCB.05117-11; Pradeep L, 2002, J MOL BIOL, V324, P331, DOI 10.1016/S0022-2836(02)01068-9; Ramadan K, 2004, NAT REV MOL CELL BIO, V5, P1038, DOI 10.1038/nrm1530; Ray S, 2014, PROTEIN J, V33, P143, DOI 10.1007/s10930-014-9546-1; Roy S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00487; Roy S, 2013, PLANT PHYSIOL, V162, P1195, DOI 10.1104/pp.113.219022; Roy S, 2011, PLANT CELL PHYSIOL, V52, P448, DOI 10.1093/pcp/pcr002; Sakurai K, 2001, PROTEIN SCI, V10, P2325, DOI 10.1110/ps.17001; SALVUCCI ME, 1987, PLANT PHYSIOL, V85, P66, DOI 10.1104/pp.85.1.66; Sekimoto T, 2010, MOL CELL, V37, P79, DOI 10.1016/j.molcel.2009.12.015; Sergeev YV, 2005, INVEST OPHTH VIS SCI, V46, P3263, DOI 10.1167/iovs.05-0112; Sharma KK, 1998, J BIOL CHEM, V273, P8965, DOI 10.1074/jbc.273.15.8965; Shimazaki N, 2002, GENES CELLS, V7, P639, DOI 10.1046/j.1365-2443.2002.00547.x; Sreerama N, 1999, PROTEIN SCI, V8, P370; Stecklein SR, 2012, P NATL ACAD SCI USA, V109, P13650, DOI 10.1073/pnas.1203326109; Taldone T, 2009, BIOORGAN MED CHEM, V17, P2225, DOI 10.1016/j.bmc.2008.10.087; Uchiyama Y, 2004, EUR J BIOCHEM, V271, P2799, DOI 10.1111/j.1432-1033.2004.04214.x; Wen W-S, 2010, MOL VIS, V16, P2777; Wimmer U, 2008, EMBO REP, V9, P1027, DOI 10.1038/embor.2008.148; Xia Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01560; Zucca E, 2013, NUCLEIC ACIDS RES, V41, P229, DOI 10.1093/nar/gks1016	56	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133843	10.1371/journal.pone.0133843	http://dx.doi.org/10.1371/journal.pone.0133843			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230318	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400056
J	Su, Z; Robinson, A; Hu, L; Klein, JD; Hassounah, F; Li, M; Wang, HD; Cai, H; Wang, XNH				Su, Zhen; Robinson, Alayna; Hu, Li; Klein, Janet D.; Hassounah, Faten; Li, Min; Wang, Haidong; Cai, Hui; Wang, Xiaonan H.			Acupuncture plus Low-Frequency Electrical Stimulation (Acu-LFES) Attenuates Diabetic Myopathy by Enhancing Muscle Regeneration	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; PROTEIN-DEGRADATION; PROTEOLYSIS; ACTIVATION; EXERCISE; PATHWAY; ATROPHY; DYSFUNCTION; EXPRESSION; INHIBITOR	Mortality and morbidity are increased in patients with muscle atrophy resulting from catabolic diseases such as diabetes. At present there is no pharmacological treatment that successfully reverses muscle wasting from catabolic conditions. We hypothesized that acupuncture plus low frequency electric stimulation (Acu-LFES) would mimic the impact of exercise and prevent diabetes-induced muscle loss. Streptozotocin (STZ) was used to induce diabetes in mice. The mice were then treated with Acu-LFES for 15 minutes daily for 14 days. Acupuncture points were selected according to the WHO Standard Acupuncture Nomenclature guide. The needles were connected to an SDZ-II electronic acupuncture device delivering pulses at 20Hz and 1mA. Acu-LFES prevented soleus and EDL muscle weight loss and increased hind-limb muscle grip function in diabetic mice. Muscle regeneration capacity was significantly increased by Acu-LFES. The expression of Pax7, MyoD, myogenin and embryo myosin heavy chain (eMyHC) was significantly decreased in diabetic muscle vs. control muscle. The suppressed levels in diabetic muscle were reversed by Acu-LFES. The IGF-1 signaling pathway was also upregulated by Acu-LFES. Phosphorylation of Akt, mTOR and p70S6K were downregulated by diabetes leading to a decline in muscle mass, however, Acu-LFES countered the diabetes-induced decline. In addition, microRNA-1 and -206 were increased by Acu-LFES after 24 days of treatment. We conclude that Acu-LFES is effective in counteracting diabetes-induced skeletal muscle atrophy by increasing IGF-1 and its stimulation of muscle regeneration.	[Su, Zhen] Wenzhou Med Univ, Affiliated Hosp 1, Dept Nephrol, Wenzhou, Zhejiang, Peoples R China; [Hu, Li] Shanghai Univ Tradit Chinese Med, Coll Acumox & Tuina, Acumox & Tuina Res Sect, Shanghai, Peoples R China; [Su, Zhen; Robinson, Alayna; Hu, Li; Klein, Janet D.; Hassounah, Faten; Li, Min; Wang, Haidong; Cai, Hui; Wang, Xiaonan H.] Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA	Wenzhou Medical University; Shanghai University of Traditional Chinese Medicine; Emory University	Wang, XNH (corresponding author), Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA.	xwang03@emory.edu			NIAMS [R01 AR060268]; National Natural Science Foundation of China [30871179]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060268] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	NIAMS R01 AR060268 to XW (PI), National Natural Science Foundation of China (30871179) to ZS (PI), and Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents to ZS (PI).	Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Butterfield GE, 1997, AM J PHYSIOL-ENDOC M, V272, pE94, DOI 10.1152/ajpendo.1997.272.1.E94; Caron AZ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-185; Chen Y, 2008, KIDNEY INT, V73, P848, DOI 10.1038/sj.ki.5002801; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; D'Souza DM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00379; Eddins MJ, 2011, CELL BIOCHEM BIOPHYS, V60, P113, DOI 10.1007/s12013-011-9175-7; Ernst G, 2003, COMPLEMENT THER MED, V11, P93, DOI 10.1016/S0965-2299(03)00004-9; Gagan J, 2012, J BIOL CHEM, V287, P40360, DOI 10.1074/jbc.M112.378414; Goljanek-Whysall K, 2012, J CELL SCI, V125, P3590, DOI 10.1242/jcs.101758; Grefte S, 2007, STEM CELLS DEV, V16, P857, DOI 10.1089/scd.2007.0058; Griffiths RD, 1996, NUTRITION, V12, P456, DOI 10.1016/S0899-9007(96)00141-4; Hu JP, 2008, ENDOCRINOLOGY, V149, P5384, DOI 10.1210/en.2008-0132; Hu JP, 2010, J AM SOC NEPHROL, V21, P1174, DOI 10.1681/ASN.2009101011; Hu L, 2015, J AM SOC NEPHROL, V26, P626, DOI 10.1681/ASN.2014020144; Hu ZY, 2014, AGING-US, V6, P160, DOI 10.18632/aging.100643; Hua YN, 2012, J CELL MOL MED, V16, P83, DOI 10.1111/j.1582-4934.2011.01307.x; Jamart C, 2011, MUSCLE NERVE, V43, P708, DOI 10.1002/mus.21949; Kopple JD, 2007, J AM SOC NEPHROL, V18, P2975, DOI 10.1681/ASN.2006070794; Lam DW, 2012, CURR OPIN ENDOCRINOL, V19, P93, DOI 10.1097/MED.0b013e328350583a; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Lim S, 2010, EVID-BASED COMPL ALT, V7, P167, DOI 10.1093/ecam/nep006; Lin RT, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/371475; Liu N, 2012, J CLIN INVEST, V122, P2054, DOI 10.1172/JCI62656; Macdonald JH, 2007, NEPHRON CLIN PRACT, V106, P125, DOI 10.1159/000103000; MacPherson H, 2001, BMJ-BRIT MED J, V323, P486, DOI 10.1136/bmj.323.7311.486; Majchrzak KM, 2008, NEPHROL DIAL TRANSPL, V23, P1362, DOI 10.1093/ndt/gfm773; Man KM, 2011, EUR J ANAESTH, V28, P420, DOI 10.1097/EJA.0b013e32833fad52; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; Onda A, 2011, BIOCHEM BIOPH RES CO, V410, P434, DOI 10.1016/j.bbrc.2011.05.152; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; Takaoka Y, 2007, PHYSIOL GENOMICS, V30, P102, DOI 10.1152/physiolgenomics.00057.2006; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; Wang XH, 2007, GENE THER, V14, P711, DOI 10.1038/sj.gt.3302927; Wang XN, 2006, ENDOCRINOLOGY, V147, P4160, DOI 10.1210/en.2006-0251; Wang XNH, 2014, NAT REV NEPHROL, V10, P504, DOI 10.1038/nrneph.2014.112; Wang XNH, 2013, INT J BIOCHEM CELL B, V45, P2230, DOI 10.1016/j.biocel.2013.06.027; Wang XNH, 2013, CURR OPIN CLIN NUTR, V16, P258, DOI 10.1097/MCO.0b013e32835f81b9; Wang XNH, 2009, KIDNEY INT, V76, P751, DOI 10.1038/ki.2009.260; WINDSOR JA, 1988, ANN SURG, V208, P209, DOI 10.1097/00000658-198808000-00013; Zhang LP, 2013, CELL METAB, V18, P368, DOI 10.1016/j.cmet.2013.07.012; Zhang LP, 2011, FASEB J, V25, P1653, DOI 10.1096/fj.10-176917; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571; Zhou Q, 2007, ENDOCRINOLOGY, V148, P5696, DOI 10.1210/en.2007-0183	46	31	35	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134511	10.1371/journal.pone.0134511	http://dx.doi.org/10.1371/journal.pone.0134511			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230945	Green Published, gold			2022-12-27	WOS:000358838400129
J	Sun, H; Yang, ZQ; Lin, KQ; Liu, SY; Huang, K; Wang, XY; Chu, JY; Huang, XQ				Sun, Hao; Yang, Zhaoqing; Lin, Keqin; Liu, Shuyuan; Huang, Kai; Wang, Xiuyun; Chu, Jiayou; Huang, Xiaoqin			The Adaptive Change of HLA-DRB1 Allele Frequencies Caused by Natural Selection in a Mongolian Population That Migrated to the South of China	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; MULTILOCUS GENOTYPE DATA; GENETIC DIVERSITY; DNA POLYMORPHISM; INFERENCE; SOFTWARE; MHC; HISTORY; LOCI	Pathogen-driven balancing selection determines the richness of human leukocyte antigen (HLA) alleles. Changes in the pathogen spectrum may cause corresponding changes in HLA loci. Approximately 700 years ago, a Mongolian population moved from the north of China to the Yunnan region in the south of China. The pathogen spectrum in the south of China differs from that in the north. In this study, changes in the HLA genes in the Yunnan Mongolian population, as well as the underlying mechanism, were investigated. A sequence-based typing method (SBT) was used to genotype HLA-DRB1 in 470 individuals from two Mongolian populations and another five ethnic groups. Meanwhile, 10 autosomal short tandem repeats (STRs) were genotyped to assess the influence of genetic background on HLA-DRB1 frequencies. The frequencies of certain alleles changed significantly in the Mongolian population that migrated to Yunnan. For example, DRB1*12:02:01 increased from 6.1% to 35.4%. STR analysis excluded the possibility of a recent bottleneck and indicated that 50% of the genetic consistency between northern and southern Mongolians; Tajima's D value for HLA-DRB1 exon2 and dN/dS analysis showed that the HLA-DRB1 genes in both Mongolian populations were under balancing selection. However, the sites under natural selection changed. We proposed that the dramatically change of HLA frequencies in southern Mongolian was caused by a combination of inter-population gene flow and natural selection. Certain diseases specific to the south of China, such as malaria, may be the driving force behind the enhanced DRB1*12:02:01 frequency.	[Huang, Xiaoqin] Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R China; Peking Union Med Coll, Kunming 650118, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Huang, XQ (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R China.	Huangxiaoqin@imbcams.com.cn			Fundamental Research Funds for the Central Universities [3332013085, 33320140013]; Chinese National High Technology Research and Development Program [2012AA021802]; Chinese National Natural Science Foundation [31371265]; Peking Union Medical College Youth Fund	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chinese National High Technology Research and Development Program(National High Technology Research and Development Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Peking Union Medical College Youth Fund	This research was funded by Peking Union Medical College Youth Fund & Fundamental Research Funds for the Central Universities (NO. 3332013085, NO. 33320140013), which was received by HS. It was funded in part with Chinese National High Technology Research and Development Program (NO. 2012AA021802) which was received by ZY, and Chinese National Natural Science Foundation (NO. 31371265) which was received by JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2010, MOL ECOL, V19, P3842, DOI 10.1111/j.1365-294X.2010.04772.x; Andres AM, 2001, ENCY LIFE SCI; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Cavalli-Sforza LL, 1998, P NATL ACAD SCI USA, V95, P11501, DOI 10.1073/pnas.95.20.11501; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Cornuet JM, 1996, GENETICS, V144, P2001; Cornuet JM, 2014, BIOINFORMATICS; Cristescu R, 2010, CONSERV GENET, V11, P1043, DOI 10.1007/s10592-009-9949-2; Di D, 2011, AM J PHYS ANTHROPOL, V145, P81, DOI 10.1002/ajpa.21470; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Harris EE, 2006, YEARB PHYS ANTHROPOL, V49, P89, DOI 10.1002/ajpa.20518; Howes RE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-418; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Johnson AH, 2004, INFECT IMMUN, V72, P2762, DOI 10.1128/IAI.72.5.2762-2771.2004; Li T, 2010, TRENDS PARASITOL, V26, P264, DOI 10.1016/j.pt.2010.02.007; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu C, 1995, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V13, P8; Lu L., 2009, J KUNMING MED U, V8, P17; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Park L, 2011, GENET RES, V93, P105, DOI 10.1017/S0016672310000558; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Robert CP, 2011, P NATL ACAD SCI USA, V108, P15112, DOI 10.1073/pnas.1102900108; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sanchez-Mazas A, 2012, PHILOS T R SOC B, V367, P830, DOI 10.1098/rstb.2011.0312; Sayer D, 2001, TISSUE ANTIGENS, V57, P46, DOI 10.1034/j.1399-0039.2001.057001046.x; Shen CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013458; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Sun H, 2013, J HUM GENET, V58, P686, DOI 10.1038/jhg.2013.79; Sun H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060822; TAJIMA F, 1989, GENETICS, V123, P585; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Xu B, 2013, MOL BIOL EVOL, V30, P2723, DOI 10.1093/molbev/mst179; Xu L, 2011, P NATL ACAD SCI USA, V108, P10214, DOI 10.1073/pnas.1019486108; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	44	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134334	10.1371/journal.pone.0134334	http://dx.doi.org/10.1371/journal.pone.0134334			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230582	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400103
J	Yue, CJ; Chen, J; Hou, RR; Liu, J; Li, XP; Gao, ZZ; Liu, C; Wang, DY; Lu, Y; Li, HQ; Hu, YL				Yue, Chanjuan; Chen, Jin; Hou, Ranran; Liu, Jie; Li, Xiuping; Gao, Zhenzhen; Liu, Cui; Wang, Deyun; Lu, Yu; Li, Hongquan; Hu, Yuanliang			Effects of Selenylation Modification on Antioxidative Activities of Schisandra chinensis Polysaccharide	PLOS ONE			English	Article							DETOXIFYING ENZYMES; SELENIUM; OPTIMIZATION; GLYCATION; EXTRACT; GLYCOXIDATION; GENOTOXICITY; ACTIVATION; EXPRESSION; ASSAY	The selenylation modification of Schisandra chinensis polysaccharide (SCP) was conducted by the HNO3-Na2SeO3 method respectively under nine conditions according to L-9(3(4)) orthogonal design. Nine selenizing SCPs, sSCP(1)-sSCP(9), were obtained, and their antioxidant activities were compared. In vitro test, the free radical-scavenging rates of nine sSCPs were determined for DPPH center dot, center dot OH and ABTS(+). sSCP(1) presented the most significant effect, and could inhibit the nonenzymatic protein glycation. In vivo test, 14-day-old chickens were injected respectively with sSCP(1) and SCP, the serum contents of CAT, SOD and MDA were determined. The result showed that as compared with the SCP group, the SOD and CAT activities were significantly or numerically raised and MDA content was significantly or numerically lowered in the sSCP(1) group. These results indicate that selenylation modification can significantly enhance the antioxidant and antiglycative activity of SCP in vitro or in vivo. sSCP(1) possesses the best efficacy and its modification conditions can be as optimal modification conditions that were 200 mg of Na2SeO3 for 500 mg of SCP, reaction temperature of 50 degrees C and reaction time of 6 h.	[Yue, Chanjuan; Hou, Ranran; Liu, Jie; Li, Xiuping; Gao, Zhenzhen; Liu, Cui; Wang, Deyun; Hu, Yuanliang] Nanjing Agr Univ, Coll Vet Med, Inst Tradit Chinese Vet Med, Nanjing 210095, Jiangsu, Peoples R China; [Chen, Jin; Lu, Yu] Jiangsu Acad Agr Sci, Natl Res Ctr Vet Biol Engn & Technol, Nanjing 210014, Jiangsu, Peoples R China; [Li, Hongquan] Shanxi Agr Univ, Coll Anim Sci & Vet Med, Taigu 030801, Shanxi, Peoples R China	Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; Shanxi Agricultural University	Hu, YL (corresponding author), Nanjing Agr Univ, Coll Vet Med, Inst Tradit Chinese Vet Med, Nanjing 210095, Jiangsu, Peoples R China.	ylhu@njau.edu.cn			National Natural Science Foundation of China [31272596]; Special Fund for Agro-scientific Research in the Public Interest [201403051]; Priority Academic Program Development of Jiangsu Higher Education Institutions [09080900101]; Key Scientific and Technological Grant from Shanxi Province [2010311047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Priority Academic Program Development of Jiangsu Higher Education Institutions; Key Scientific and Technological Grant from Shanxi Province	The project was supported by National Natural Science Foundation of China (31272596), Special Fund for Agro-scientific Research in the Public Interest (201403051), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (09080900101), and Key Scientific and Technological Grant from Shanxi Province (2010311047). The authors are grateful to all other staff in the Institute of Traditional Chinese Veterinary Medicine of Nanjing Agricultural University for their assistance in the experiments.	Ahmad S, 2014, GLYCOBIOLOGY, V24, P979, DOI 10.1093/glycob/cwu057; Ahmad S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072128; Ahmad S, 2011, BIOCHEM BIOPH RES CO, V407, P568, DOI 10.1016/j.bbrc.2011.03.064; Arthur JR, 2003, J NUTR, V133, p1457S, DOI 10.1093/jn/133.5.1457S; BAKER JR, 1994, CLIN CHEM, V40, P1950; Chen L, 2005, WORLD J GASTROENTERO, V11, P5795, DOI 10.3748/wjg.v11.i37.5795; Chen SH, 2013, EUR FOOD RES TECHNOL, V237, P691, DOI 10.1007/s00217-013-2044-4; Chen W. J., 2007, FOOD DRUG, V9, P66; Cheng N, 2013, FOOD CHEM TOXICOL, V55, P234, DOI 10.1016/j.fct.2012.11.022; Cui JJ, 2010, J ETHNOPHARMACOL, V132, P512, DOI 10.1016/j.jep.2010.08.052; Fan YP, 2012, INT J BIOL MACROMOL, V51, P1028, DOI 10.1016/j.ijbiomac.2012.08.025; FU MX, 1994, DIABETES, V43, P676, DOI 10.2337/diabetes.43.5.676; GT Ling, 2004, ANTIOXIDANT FOOD HLT, P295; HALLIWELL B, 1994, NUTR REV, V52, P253; HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3; Hancke JL, 1999, FITOTERAPIA, V70, P451, DOI 10.1016/S0367-326X(99)00102-1; Harabawy ASA, 2014, ECOTOX ENVIRON SAFE, V104, P28, DOI 10.1016/j.ecoenv.2014.02.015; Jia SR, 2007, BIOTECHNOL BIOPROC E, V12, P271, DOI 10.1007/BF02931103; Kokubo T, 2011, FOOD CHEM, V129, P92, DOI 10.1016/j.foodchem.2011.04.031; Kong XF, 2004, INT IMMUNOPHARMACOL, V4, P975, DOI 10.1016/j.intimp.2004.03.008; Lee IK, 2006, BIOORG MED CHEM LETT, V16, P2376, DOI 10.1016/j.bmcl.2006.01.121; Lee MS, 2015, FOOD CHEM, V174, P538, DOI 10.1016/j.foodchem.2014.11.090; Li G, 2001, Chinese Patent, Patent No. [CNn21414C, 21414C]; Li HW, 2010, CHINESE J ANAL CHEM, V38, P1256, DOI 10.3724/SP.J.1096.2010.01256; Li Siwei, 2013, Chinese Journal of Applied and Environmental Biology, V19, P980, DOI 10.3724/SP.J.1145.2013.00980; Olabinri B M, 2010, RES J BIOL SCI, V5, P102; Pareek A, 2013, J ETHNOPHARMACOL, V150, P973, DOI 10.1016/j.jep.2013.09.048; Qin T, 2013, CARBOHYD POLYM, V92, P645, DOI 10.1016/j.carbpol.2012.08.097; Qiu SL, 2014, CARBOHYD POLYM, V103, P148, DOI 10.1016/j.carbpol.2013.12.032; Qiu SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086377; Rahbar S, 1999, BIOCHEM BIOPH RES CO, V262, P651, DOI 10.1006/bbrc.1999.1275; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Ren XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087578; Seifried HE, 2007, J NUTR BIOCHEM, V18, P567, DOI 10.1016/j.jnutbio.2006.10.007; Souza BWS, 2012, FOOD HYDROCOLLOID, V27, P287, DOI 10.1016/j.foodhyd.2011.10.005; Sun ZH, 2012, LIVEST SCI, V149, P232, DOI 10.1016/j.livsci.2012.07.014; Veterinary Pharmacopoeia Commission of the People's Republic of China, 2010, VET PHARM PEOPL RE 1, P72; Wang JL, 2012, INT J BIOL MACROMOL, V51, P987, DOI 10.1016/j.ijbiomac.2012.08.011; Wang L, 2011, CARBOHYD POLYM, V86, P1745, DOI 10.1016/j.carbpol.2011.07.007; Wang X, 2012, FOOD CHEM, V130, P821, DOI 10.1016/j.foodchem.2011.07.064; Wang YP, 2014, CARBOHYD POLYM, V111, P324, DOI 10.1016/j.carbpol.2014.03.083; WELLSKNECHT KJ, 1995, BIOCHEMISTRY-US, V34, P3702, DOI 10.1021/bi00011a027; Xu FB, 1994, SELENIUM ITS CHEM BI, P66; Zhao BT, 2013, INT J BIOL MACROMOL, V58, P320, DOI 10.1016/j.ijbiomac.2013.04.059; Zhao T, 2014, CARBOHYD POLYM, V105, P26, DOI 10.1016/j.carbpol.2014.01.059; Zhao T, 2014, CARBOHYD POLYM, V103, P488, DOI 10.1016/j.carbpol.2013.12.058	46	30	32	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134363	10.1371/journal.pone.0134363	http://dx.doi.org/10.1371/journal.pone.0134363			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230941	Green Submitted, gold, Green Published			2022-12-27	WOS:000358838400107
J	Cabasso, O; Pekar, O; Horowitz, M				Cabasso, Or; Pekar, Olga; Horowitz, Mia			SUMOylation of EHD3 Modulates Tubulation of the Endocytic Recycling Compartment	PLOS ONE			English	Article							DOMAIN-CONTAINING PROTEINS; NUCLEAR-PORE COMPLEX; PLASMA-MEMBRANE; FAMILY PROTEINS; MECHANISMS; SPECIFICITY; ENDOSOME; SUMO; INTERACTS; RME-1	Endocytosis defines the entry of molecules or macromolecules through the plasma membrane as well as membrane trafficking in the cell. It depends on a large number of proteins that undergo protein-protein and protein-phospholipid interactions. EH Domain containing (EHDs) proteins formulate a family, whose members participate in different stages of endocytosis. Of the four mammalian EHDs (EHD1-EHD4) EHD1 and EHD3 control traffic to the endocytic recycling compartment (ERC) and from the ERC to the plasma membrane, while EHD2 modulates internalization. Recently, we have shown that EHD2 undergoes SUMOylation, which facilitates its exit from the nucleus, where it serves as a co-repressor. In the present study, we tested whether EHD3 undergoes SUMOylation and what is its role in endocytic recycling. We show, both in-vitro and in cell culture, that EHD3 undergoes SUMOylation. Localization of EHD3 to the tubular structures of the ERC depends on its SUMOylation on lysines 315 and 511. Absence of SUMOylation of EHD3 has no effect on its dimerization, an important factor in membrane localization of EHD3, but has a dominant negative effect on its appearance in tubular ERC structures. Non-SUMOylated EHD3 delays transferrin recycling from the ERC to the cell surface. Our findings indicate that SUMOylation of EHD3 is involved in tubulation of the ERC membranes, which is important for efficient recycling.	[Cabasso, Or; Pekar, Olga; Horowitz, Mia] Tel Aviv Univ, Dept Cell Res & Immunol, Ramat Aviv, Israel	Tel Aviv University	Horowitz, M (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, Ramat Aviv, Israel.	horwitzm@post.tau.ac.il			Jascquline Seroussi Foundation [0604460011]	Jascquline Seroussi Foundation	This work was supported by Jascquline Seroussi Foundation no 0604460011 (Tel Aviv University).	Anckar J, 2007, BIOCHEM SOC T, V35, P1409, DOI 10.1042/BST0351409; Balogh P, 2013, PATHOL ONCOL RES, V19, P141, DOI 10.1007/s12253-012-9595-8; Bar M, 2008, PLANT J, V55, P1025, DOI 10.1111/j.1365-313X.2008.03571.x; Bar M, 2014, PLANT MOL BIOL, V84, P509, DOI 10.1007/s11103-013-0148-7; Benjamin S, 2011, BIOCHEM J, V439, P433, DOI 10.1042/BJ20111010; Blume JJ, 2007, EXP CELL RES, V313, P219, DOI 10.1016/j.yexcr.2006.10.006; Cai BS, 2013, J BIOL CHEM, V288, P30172, DOI 10.1074/jbc.M113.488627; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Confalonieri S, 2002, FEBS LETT, V513, P24, DOI 10.1016/S0014-5793(01)03241-0; Curran J, 2014, CIRC RES, V115, P68, DOI 10.1161/CIRCRESAHA.115.304149; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; de Figueiredo P, 2001, J BIOL CHEM, V276, P47361, DOI 10.1074/jbc.M108508200; DEFIGUEIREDO P, 1995, MOL BIOL CELL, V6, P871, DOI 10.1091/mbc.6.7.871; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; EATON S, 1995, J CELL BIOL, V131, P151, DOI 10.1083/jcb.131.1.151; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Galperin E, 2002, TRAFFIC, V3, P575, DOI 10.1034/j.1600-0854.2002.30807.x; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Gupta GD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100554; Imoto S, 2008, BIOCHEM BIOPH RES CO, V370, P359, DOI 10.1016/j.bbrc.2008.03.116; Ishii K, 2012, J PHARMACOL SCI, V120, P264, DOI 10.1254/jphs.12R12CP; Konopacki FA, 2011, P NATL ACAD SCI USA, V108, P19772, DOI 10.1073/pnas.1111575108; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Lu Q, 2015, NAT CELL BIOL, V17, P228, DOI 10.1038/ncb3109; Ma L, 2014, MOL CELL PROTEOMICS, V13, P1659, DOI 10.1074/mcp.M113.035626; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mintz L, 1999, GENOMICS, V59, P66, DOI 10.1006/geno.1999.5800; Mishra RK, 2004, J BIOL CHEM, V279, P31445, DOI 10.1074/jbc.M402911200; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2011, TRENDS CELL BIOL, V21, P122, DOI 10.1016/j.tcb.2010.10.003; Paoluzi S, 1998, EMBO J, V17, P6541, DOI 10.1093/emboj/17.22.6541; Pekar O, 2012, THESIS; Pekar O, 2012, BIOCHEM J, V444, P383, DOI 10.1042/BJ20111268; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Pohl U, 2000, GENOMICS, V63, P255, DOI 10.1006/geno.1999.6087; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Shah C, 2014, STRUCTURE, V22, P409, DOI 10.1016/j.str.2013.12.015; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Simpson-Lavy KJ, 2013, P NATL ACAD SCI USA, V110, P17432, DOI 10.1073/pnas.1304839110; Smith CA, 2004, MOL BIOL CELL, V15, P3698, DOI 10.1091/mbc.E04-01-0026; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wasik U, 2014, BBA-MOL CELL RES, V1843, P2878, DOI 10.1016/j.bbamcr.2014.07.018; Watts FZ, 2013, CHROMOSOMA, V122, P451, DOI 10.1007/s00412-013-0422-0; Wilkinson Kevin A, 2012, Commun Integr Biol, V5, P223, DOI 10.4161/cib.19195; Wyatt D, 2011, J BIOL CHEM, V286, P3884, DOI 10.1074/jbc.M110.152116	57	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134053	10.1371/journal.pone.0134053	http://dx.doi.org/10.1371/journal.pone.0134053			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226295	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700054
J	Hueging, K; Weller, R; Doepke, M; Vieyres, G; Todt, D; Wolk, B; Vondran, FWR; Geffers, R; Lauber, C; Kaderali, L; Penin, F; Pietschmann, T				Hueging, Kathrin; Weller, Romy; Doepke, Mandy; Vieyres, Gabrielle; Todt, Daniel; Woelk, Benno; Vondran, Florian W. R.; Geffers, Robert; Lauber, Chris; Kaderali, Lars; Penin, Francois; Pietschmann, Thomas			Several Human Liver Cell Expressed Apolipoproteins Complement HCV Virus Production with Varying Efficacy Conferring Differential Specific Infectivity to Released Viruses	PLOS ONE			English	Article							HEPATITIS-C VIRUS; LOW-DENSITY LIPOPROTEINS; SCAVENGER RECEPTOR BI; A-I; CHOLESTEROL TRANSPORT; BINDING-SITES; HDL RECEPTOR; LIFE-CYCLE; SR-BI; ASSOCIATION	Apolipoprotein E (ApoE), an exchangeable apolipoprotein, is necessary for production of infectious Hepatitis C virus (HCV) particles. However, ApoE is not the only liver-expressed apolipoprotein and the role of other apolipoproteins for production of infectious HCV progeny is incompletely defined. Therefore, we quantified mRNA expression of human apolipoproteins in primary human hepatocytes. Subsequently, cDNAs encoding apolipoproteins were expressed in 293T/miR-122 cells to explore if they complement HCV virus production in cells that are non-permissive due to limiting endogenous levels of human apolipoproteins. Primary human hepatocytes expressed high mRNA levels of ApoA1, A2, C1, C3, E, and H. ApoA4, A5, B, D, F, J, L1, L2, L3, L4, L6, M, and O were expressed at intermediate levels, and C2, C4, and L5 were not detected. All members of the ApoA and ApoC family of lipoproteins complemented HCV virus production in HCV transfected 293T/miR-122 cells, albeit with significantly lower efficacy compared with ApoE. In contrast, ApoD expression did not support production of infectious HCV. Specific infectivity of released particles complemented with ApoA family members was significantly lower compared with ApoE. Moreover, the ratio of extracellular to intracellular infectious virus was significantly higher for ApoE compared to ApoA2 and ApoC3. Since apolipoproteins complementing HCV virus production share amphipathic alpha helices as common structural features we altered the two alpha helices of ApoC1. Helix breaking mutations in both ApoC1 helices impaired virus assembly highlighting a critical role of alpha helices in apolipoproteins supporting HCV assembly. In summary, various liver expressed apolipoproteins with amphipathic alpha helices complement HCV virus production in human non liver cells. Differences in the efficiency of virus assembly, the specific infectivity of released particles, and the ratio between extracellular and intracellular infectivity point to distinct characteristics of these apolipoproteins that influence HCV assembly and cell entry. This will guide future research to precisely pinpoint how apolipoproteins function during virus assembly and cell entry.	[Hueging, Kathrin; Weller, Romy; Doepke, Mandy; Vieyres, Gabrielle; Todt, Daniel; Pietschmann, Thomas] TWINCORE, Ctr Expt & Clin Infect Res, Inst Expt Virol, Hannover, Germany; [Woelk, Benno] Hannover Med Sch, Inst Virol, Hannover, Germany; [Vondran, Florian W. R.] Hannover Med Sch, Dept Gen Visceral & Transplant Surg, Hannover, Germany; [Vondran, Florian W. R.] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Hannover, Germany; [Vondran, Florian W. R.; Pietschmann, Thomas] German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Hannover, Germany; [Geffers, Robert] Helmholtz Ctr Infect Res, Res Grp Genome Analyt, Braunschweig, Germany; [Lauber, Chris; Kaderali, Lars] Tech Univ Dresden, Fac Med, Inst Med Informat & Biometry, D-01062 Dresden, Germany; [Penin, Francois] Univ Lyon, Inst Biol & Chim Prot Bases Mol & Struct Syst Inf, CNRS, Labex Ecofect,UMR 5086, Lyon, France	Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Hannover Medical School; Hannover Medical School; German Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Technische Universitat Dresden; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Pietschmann, T (corresponding author), TWINCORE, Ctr Expt & Clin Infect Res, Inst Expt Virol, Hannover, Germany.	thomas.pietschmann@twincore.de	Pietschmann, Thomas/E-9241-2015; Todt, Daniel/W-9362-2019	Pietschmann, Thomas/0000-0001-5138-6239; Todt, Daniel/0000-0002-3564-1014; Pietschmann, Thomas/0000-0001-6789-4422; Kaderali, Lars/0000-0002-2359-2294; Hueging, Kathrin/0000-0002-9850-8640	Deutsche Forschungsgemeinschaft [SFB 900]; Helmholtz Association [SO-024];  [ANR-11-BINF-003]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Association(Helmholtz Association); 	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 900, project A6) and by a grant from the Helmholtz Association (SO-024) to TP. FP is supported by the Mapping project (ANR-11-BINF-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bolanos-Garcia VM, 2003, PROG BIOPHYS MOL BIO, V83, P47, DOI 10.1016/S0079-6107(03)00028-2; Boyer A, 2014, J BIOL CHEM, V289, P18904, DOI 10.1074/jbc.M113.538256; Catanese MT, 2013, P NATL ACAD SCI USA, V110, P9505, DOI 10.1073/pnas.1307527110; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Da Costa D, 2012, J VIROL, V86, P11919, DOI 10.1128/JVI.01066-12; de Beer MC, 2001, J LIPID RES, V42, P309; Fukuhara T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004534; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Gravitz L, 2011, NATURE, V474, pS2, DOI 10.1038/474S2a; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gursky O, 2005, CURR OPIN LIPIDOL, V16, P287, DOI 10.1097/01.mol.0000169348.61191.ac; Hishiki T, 2010, J VIROL, V84, P12048, DOI 10.1128/JVI.01063-10; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Hueging K, 2014, J VIROL, V88, P1433, DOI 10.1128/JVI.01815-13; Jiang JY, 2012, J VIROL, V86, P7256, DOI 10.1128/JVI.07222-11; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Jonas A, 2008, LIPOPROTEIN STRUCTUR, P485; Kleine M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101386; Lee JY, 2014, J VIROL, V88, P12422, DOI 10.1128/JVI.01660-14; LI WH, 1988, J LIPID RES, V29, P245; Liadaki KN, 2000, J BIOL CHEM, V275, P21262, DOI 10.1074/jbc.M002310200; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lund-Katz S, 2010, SUBCELL BIOCHEM, V51, P183, DOI 10.1007/978-90-481-8622-8_7; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAHLEY RW, 1984, J LIPID RES, V25, P1277; Mancone C, 2011, GUT, V60, P378, DOI 10.1136/gut.2010.211292; Menzel N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002829; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Meunier JC, 2008, J VIROL, V82, P9647, DOI 10.1128/JVI.00914-08; Moradpour D, 1996, VIROLOGY, V222, P51, DOI 10.1006/viro.1996.0397; Narbus CM, 2011, J VIROL, V85, P12087, DOI 10.1128/JVI.05843-11; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Reiss S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003359; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Rozek A, 1999, BIOCHEMISTRY-US, V38, P14475, DOI 10.1021/bi982966h; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; Saito H, 2003, J BIOL CHEM, V278, P14782, DOI 10.1074/jbc.M213207200; SEGREST JP, 1992, J LIPID RES, V33, P141; Smith LE, 2013, J LIPID RES, V54, P1939, DOI 10.1194/jlr.M037903; Steinmann E, 2008, J VIROL, V82, P7034, DOI 10.1128/JVI.00118-08; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Thuahnai ST, 2003, J LIPID RES, V44, P1132, DOI 10.1194/jlr.M200429-JLR200; Thi VLD, 2012, J BIOL CHEM, V287, P31242, DOI 10.1074/jbc.M112.365924; Vieyres G, 2013, METHODS, V59, P233, DOI 10.1016/j.ymeth.2012.09.005; Wahid A, 2013, J VIRAL HEPATITIS, V20, P369, DOI 10.1111/jvh.12094; Williams DL, 2000, J BIOL CHEM, V275, P18897, DOI 10.1074/jbc.M002411200; Xu SZ, 1997, J LIPID RES, V38, P1289; Zeisel MB, 2013, CURR TOP MICROBIOL, V369, P87, DOI 10.1007/978-3-642-27340-7_4	55	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134529	10.1371/journal.pone.0134529	http://dx.doi.org/10.1371/journal.pone.0134529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226615	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700107
J	Matsuzaki, J; Suzuki, H; Kobayakawa, M; Inadomi, JM; Takayama, M; Makino, K; Iwao, Y; Sugino, Y; Kanai, T				Matsuzaki, Juntaro; Suzuki, Hidekazu; Kobayakawa, Masao; Inadomi, John M.; Takayama, Michiyo; Makino, Kanako; Iwao, Yasushi; Sugino, Yoshinori; Kanai, Takanori			Association of Visceral Fat Area, Smoking, and Alcohol Consumption with Reflux Esophagitis and Barrett's Esophagus in Japan	PLOS ONE			English	Article							INTERNATIONAL BEACON CONSORTIUM; POOLED ANALYSIS; INCREASED RISK; UNITED-STATES; ADENOCARCINOMA; METAANALYSIS; DIAGNOSIS; OBESITY; DISEASE; TRENDS	Background Central obesity has been suggested as a risk factor for gastroesophageal reflux disease. The aim of this study was to evaluate the association of visceral fat area and other lifestyle factors with reflux esophagitis or Barrett's esophagus in Japanese population. Methods Individuals who received thorough medical examinations including the measurement of visceral fat area by abdominal computed tomography were enrolled. Factors associated with the presence of reflux esophagitis, the severity of reflux esophagitis, or the presence of Barrett's esophagus were determined using multivariable logistic regression models. Results A total of 2608 individuals were eligible for the analyses. Visceral fat area was associated with the presence of reflux esophagitis both in men (odds ratio, 1.21 per 50 cm(2); 95% confident interval, 1.01 to 1.46) and women (odds ratio, 2.31 per 50 cm(2); 95% confident interval, 1.57 to 3.40). Current smoking and serum levels of triglyceride were also associated with the presence of reflux esophagitis in men. However, significant association between visceral fat area and the severity of reflux esophagitis or the presence of Barrett's esophagus was not shown. In men, excessive alcohol consumption on a drinking day, but not the frequency of alcohol drinking, was associated with both the severity of reflux esophagitis (odds ratio, 2.13; 95% confident interval, 1.03 to 4.41) and the presence of Barrett's esophagus (odds ratio, 1.71; 95% confident interval, 1.14 to 2.56). Conclusion Visceral fat area was independently associated with the presence of reflux esophagitis, but not with the presence of Barrett's esophagus. On the other hand, quantity of alcohol consumption could play a role in the development of severe reflux esophagitis and Barrett's esophagus in Japanese population.	[Matsuzaki, Juntaro; Takayama, Michiyo; Makino, Kanako; Iwao, Yasushi; Sugino, Yoshinori] Keio Univ Hosp, Ctr Prevent Med, Tokyo, Japan; [Suzuki, Hidekazu; Kanai, Takanori] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Kobayakawa, Masao] Natl Ctr Global Hlth & Med, Dept Gastroenterol, Tokyo, Japan; [Inadomi, John M.] Univ Washington, Sch Med, Dept Internal Med, Div Gastroenterol, Seattle, WA USA	Keio University; Keio University; National Center for Global Health & Medicine - Japan; University of Washington; University of Washington Seattle	Suzuki, H (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan.	hsuzuki.a6@keio.jp	Matsuzaki, Juntaro/S-4107-2019; 小早川, 雅男/HII-5007-2022; SUZUKI, HIDEKAZU/S-9376-2019; Sato, Yurie/B-2144-2014; Suzuki, Hidekazu/AAO-6330-2020; Suzuki, Hidekazu/J-4396-2013; Inadomi, John/A-6221-2014	Matsuzaki, Juntaro/0000-0002-3204-5049; Suzuki, Hidekazu/0000-0002-8994-6163; Kanai, Takanori/0000-0002-1466-4532; Inadomi, John/0000-0001-6776-8661	Japan Society for the Promotion of Science (JSPS) [26860527, 25293178, 26670065]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1411003]; Takeda Science Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was funded by a Grant-in-Aid for Young Scientists (B) (26860527, to J.M.), a Grant-in-Aid for Scientific Research B (25293178, to H.S.), and a Grant-in-Aid for challenging Exploratory Research (26670065, to H.S.) from the Japan Society for the Promotion of Science (JSPS) (https://www.jsps.go.jp/english/), MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1411003, to H.S.) (http://www.mext.go.jp/english/pressrelease/1317526.htm), and a grant from Takeda Science Foundation (to J.M.) (http://www.takeda-sci.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-56; Akiyama T, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-58; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; Breslow RA, 2008, ALCOHOL CLIN EXP RES, V32, P513, DOI 10.1111/j.1530-0277.2007.00595.x; Conigrave KM, 2001, DIABETES, V50, P2390, DOI 10.2337/diabetes.50.10.2390; El-Serag HB, 2014, GUT, V63, P220, DOI 10.1136/gutjnl-2012-304189; Endlicher E, 2005, ENDOSCOPY, V37, P1131, DOI 10.1055/s-2005-870409; Fernandes ML, 2006, AM J GASTROENTEROL, V101, P1430, DOI 10.1111/j.1572-0241.2006.00570.x; Fitzgerald RC, 2014, GUT, V63, P7, DOI 10.1136/gutjnl-2013-305372; GOEDDE HW, 1992, HUM GENET, V88, P344; Gunji T, 2011, J GASTROENTEROL, V46, P448, DOI 10.1007/s00535-010-0359-5; Hampel H, 2005, ANN INTERN MED, V143, P199, DOI 10.7326/0003-4819-143-3-200508020-00006; Kagemoto K, 2014, GASTROINTEST ENDOSC, V80, P239, DOI 10.1016/j.gie.2014.01.022; Kato M, 2011, J GASTROENTEROL, V46, P1361, DOI 10.1007/s00535-011-0453-3; Kubo A, 2013, GUT, V62, P1684, DOI 10.1136/gutjnl-2012-303753; Lassen A, 2006, AM J GASTROENTEROL, V101, P1193, DOI 10.1111/j.1572-0241.2006.00550.x; Lee HS, 2014, CLIN ENDOSC, V47, P15, DOI 10.5946/ce.2014.47.1.15; Lou ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105612; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Minatsuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069891; Murase K, 2014, SLEEP, V37, P1810, DOI 10.5665/sleep.4176; Nam SY, 2015, J NEUROGASTROENTEROL, V21, P247, DOI 10.5056/jnm14114; Okita K, 2008, J GASTROENTEROL, V43, P928, DOI 10.1007/s00535-008-2261-y; Rubenstein JH, 2014, GUT, V63, P230, DOI 10.1136/gutjnl-2012-304103; Shinkai H, 2014, DIGESTION, V90, P1, DOI 10.1159/000357776; Simard EP, 2012, CA-CANCER J CLIN, V62, P118, DOI 10.3322/caac.20141; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1399, DOI 10.1016/j.cgh.2013.05.009; Thrift AP, 2014, AM J GASTROENTEROL, V109, P1586, DOI 10.1038/ajg.2014.206; Watari J, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-143	29	38	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133865	10.1371/journal.pone.0133865	http://dx.doi.org/10.1371/journal.pone.0133865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225858	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700041
J	Moraes, I; Yuan, ZF; Liu, SC; Souza, GM; Garcia, BA; Casas-Mollano, JA				Moraes, Izabel; Yuan, Zuo-Fei; Liu, Shichong; Souza, Glaucia Mendes; Garcia, Benjamin A.; Armando Casas-Mollano, J.			Analysis of Histones H3 and H4 Reveals Novel and Conserved Post-Translational Modifications in Sugarcane	PLOS ONE			English	Article							MASS-SPECTROMETRY ANALYSIS; MODIFICATION PATTERNS; ARABIDOPSIS; CHROMATIN; GENE; ACETYLATION; VARIANTS; GENOME; PHOSPHORYLATION; IDENTIFICATION	Histones are the main structural components of the nucleosome, hence targets of many regulatory proteins that mediate processes involving changes in chromatin. The functional outcome of many pathways is "written" in the histones in the form of post-translational modifications that determine the final gene expression readout. As a result, modifications, alone or in combination, are important determinants of chromatin states. Histone modifications are accomplished by the addition of different chemical groups such as methyl, acetyl and phosphate. Thus, identifying and characterizing these modifications and the proteins related to them is the initial step to understanding the mechanisms of gene regulation and in the future may even provide tools for breeding programs. Several studies over the past years have contributed to increase our knowledge of epigenetic gene regulation in model organisms like Arabidopsis, yet this field remains relatively unexplored in crops. In this study we identified and initially characterized histones H3 and H4 in the monocot crop sugarcane. We discovered a number of histone genes by searching the sugarcane ESTs database. The proteins encoded correspond to canonical histones, and their variants. We also purified bulk histones and used them to map post-translational modifications in the histones H3 and H4 using mass spectrometry. Several modifications conserved in other plants, and also novel modified residues, were identified. In particular, we report O-acetylation of serine, threonine and tyrosine, a recently identified modification conserved in several eukaryotes. Additionally, the sub-nuclear localization of some well-studied modifications (i.e., H3K4me3, H3K9me2, H3K27me3, H3K9ac, H3T3ph) is described and compared to other plant species. To our knowledge, this is the first report of histones H3 and H4 as well as their post-translational modifications in sugarcane, and will provide a starting point for the study of chromatin regulation in this crop.	[Moraes, Izabel; Souza, Glaucia Mendes; Armando Casas-Mollano, J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Yuan, Zuo-Fei; Liu, Shichong; Garcia, Benjamin A.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Epigenet Program, Philadelphia, PA 19104 USA	Universidade de Sao Paulo; University of Pennsylvania; Pennsylvania Medicine	Casas-Mollano, JA (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	acasasmollano@gmail.com	Yuan, Zuofei/O-3209-2017; Souza, Glaucia/E-6780-2012; Mollano, Juan Armando Casas/G-4065-2012; Moraes, Izabel/R-8959-2017; Moraes, Izabel/H-7125-2013	Yuan, Zuofei/0000-0003-1252-6766; Souza, Glaucia/0000-0001-6903-9913; Mollano, Juan Armando Casas/0000-0001-7246-7142; Moraes, Izabel/0000-0002-5540-3179; Moraes, Izabel/0000-0003-0019-1620	Sao Paulo Research Foundation [FAPESP 2011/50483-2]; National Science Foundation (NSF) Early Faculty CAREER award; FAPESP Post-doctoral fellowship [2013/01484-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110174] Funding Source: NIH RePORTER	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Science Foundation (NSF) Early Faculty CAREER award(National Science Foundation (NSF)); FAPESP Post-doctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Sao Paulo Research Foundation (www.fapesp.br) grant FAPESP 2011/50483-2 to JAC-M. BAG acknowledges funding from the National Science Foundation (NSF) Early Faculty CAREER award. IM is recipient of a FAPESP Post-doctoral fellowship (2013/01484-1).	Alvarez-Venegas Raul, 2010, Arabidopsis Book, V8, pe0128, DOI 10.1199/tab.0128; Bailey AO, 2013, P NATL ACAD SCI USA, V110, P11827, DOI 10.1073/pnas.1300325110; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Berr A, 2010, PLANT PHYSIOL, V154, P1403, DOI 10.1104/pp.110.161497; Boeckmann L, 2013, MOL BIOL CELL, V24, P2034, DOI 10.1091/mbc.E12-12-0893; Bowler C, 2004, PLANT J, V39, P776, DOI 10.1111/j.1365-313X.2004.02169.x; Britton LMP, 2013, EPIGENETICS-US, V8, P1101, DOI 10.4161/epi.26025; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; CHABOUTE ME, 1993, BIOCHIMIE, V75, P523, DOI 10.1016/0300-9084(93)90057-Y; Chen LT, 2010, J EXP BOT, V61, P3345, DOI 10.1093/jxb/erq154; Clayton AL, 2003, FEBS LETT, V546, P51, DOI 10.1016/S0014-5793(03)00451-4; D'Hont A, 2005, CYTOGENET GENOME RES, V109, P27, DOI 10.1159/000082378; D'Hont A, 2001, INTERNATIONAL SOCIETY OF SUGAR CANE TECHNOLOGISTS, VOL II, PROCEEDINGS, P556; de Setta N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-540; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; Elsaesser SJ, 2010, CURR OPIN GENET DEV, V20, P110, DOI 10.1016/j.gde.2010.01.003; Feng SH, 2011, CURR OPIN PLANT BIOL, V14, P179, DOI 10.1016/j.pbi.2010.12.002; Fransz P, 2002, P NATL ACAD SCI USA, V99, P14584, DOI 10.1073/pnas.212325299; Fransz P, 1998, PLANT J, V13, P867, DOI 10.1046/j.1365-313X.1998.00086.x; Fu Y, 2004, BIOINFORMATICS, V20, P1948, DOI 10.1093/bioinformatics/bth186; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; Garsmeur O, 2011, NEW PHYTOL, V189, P629, DOI 10.1111/j.1469-8137.2010.03497.x; Goutte-Gattat D, 2013, P NATL ACAD SCI USA, V110, P8579, DOI 10.1073/pnas.1302955110; Houben A, 2003, PLANT J, V33, P967, DOI 10.1046/j.1365-313X.2003.01681.x; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson L, 2004, NUCLEIC ACIDS RES, V32, P6511, DOI 10.1093/nar/gkh992; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Lee TJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000982; Lin S, 2012, METHOD ENZYMOL, V512, P3, DOI 10.1016/B978-0-12-391940-3.00001-9; Maeshima K, 2014, CHROMOSOMA, V123, P225, DOI 10.1007/s00412-014-0460-2; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Moraes I, 2014, EPIGENETICS IN PLANTS OF AGRONOMIC IMPORTANCE: FUNDAMENTALS AND APPLICATIONS: TRANSCRIPTIONAL REGULATION AND CHROMATIN REMODELLING IN PLANTS, P47, DOI 10.1007/978-3-319-07971-4_4; Nagaki K, 2005, CHROMOSOME RES, V13, P195, DOI 10.1007/s10577-005-0847-2; Okada T, 2005, PLANT J, V44, P557, DOI 10.1111/j.1365-313X.2005.02554.x; Plazas-Mayorca MD, 2009, J PROTEOME RES, V8, P5367, DOI 10.1021/pr900777e; Rossetto D, 2012, EPIGENETICS-US, V7, P1098, DOI 10.4161/epi.21975; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shu H, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r62; Sokol A, 2007, PLANTA, V227, P245, DOI 10.1007/s00425-007-0612-1; Stroud H, 2012, P NATL ACAD SCI USA, V109, P5370, DOI 10.1073/pnas.1203145109; Sui PF, 2013, MOL PLANT, V6, P975, DOI 10.1093/mp/sss152; Sun CH, 2012, PLANT CELL, V24, P3235, DOI 10.1105/tpc.112.101436; Talbert PB, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanurdzic M, 2008, PLOS BIOL, V6, P2880, DOI 10.1371/journal.pbio.0060302; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; To TK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002055; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Vettore AL, 2003, GENOME RES, V13, P2725, DOI 10.1101/gr.1532103; Wang LH, 2007, RAPID COMMUN MASS SP, V21, P2985, DOI 10.1002/rcm.3173; Waterborg JH, 2012, BIOCHEM CELL BIOL, V90, P79, DOI [10.1139/O11-036, 10.1139/o11-036]; Waterborg JH, 2011, BBA-GENE REGUL MECH, V1809, P353, DOI 10.1016/j.bbagrm.2011.02.005; WATERBORG JH, 1987, ARCH BIOCHEM BIOPHYS, V256, P167, DOI 10.1016/0003-9861(87)90435-8; WATERBORG JH, 1995, PLANT PHYSIOL, V109, P393, DOI 10.1104/pp.109.2.393; Wu T, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-98; Xu L, 2008, MOL CELL BIOL, V28, P1348, DOI 10.1128/MCB.01607-07; Yuan ZF, 2015, MOL CELL PROTEOMICS, V14, P1696, DOI 10.1074/mcp.M114.046011; Yuan ZF, 2014, J PROTEOME RES, V13, P4470, DOI 10.1021/pr5008015; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001210; Zhang XL, 2005, PLANT CELL, V17, P572, DOI 10.1105/tpc.104.028522	64	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134586	10.1371/journal.pone.0134586	http://dx.doi.org/10.1371/journal.pone.0134586			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226299	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700114
J	Olsson, M; Tengvall, K; Frankowiack, M; Kierczak, M; Bergvall, K; Axelsson, E; Tintle, L; Marti, E; Roosje, P; Leeb, T; Hedhammar, A; Hammarstrom, L; Lindblad-Toh, K				Olsson, Mia; Tengvall, Katarina; Frankowiack, Marcel; Kierczak, Marcin; Bergvall, Kerstin; Axelsson, Erik; Tintle, Linda; Marti, Eliane; Roosje, Petra; Leeb, Tosso; Hedhammar, Ake; Hammarstrom, Lennart; Lindblad-Toh, Kerstin			Genome-Wide Analyses Suggest Mechanisms Involving Early B-Cell Development in Canine IgA Deficiency	PLOS ONE			English	Article							SERUM IGA; RELATIVE DEFICIENCY; IMMUNOGLOBULIN-A; PROTEIN; SLIT; DOG; POPULATION; GENE; IMMUNODEFICIENCY; ROBO	Immunoglobulin A deficiency (IgAD) is the most common primary immune deficiency disorder in both humans and dogs, characterized by recurrent mucosal tract infections and a predisposition for allergic and other immune mediated diseases. In several dog breeds, low IgA levels have been observed at a high frequency and with a clinical resemblance to human IgAD. In this study, we used genome-wide association studies (GWAS) to identify genomic regions associated with low IgA levels in dogs as a comparative model for human IgAD. We used a novel percentile groups-approach to establish breed-specific cut-offs and to perform analyses in a close to continuous manner. GWAS performed in four breeds prone to low IgA levels (German shepherd, Golden retriever, Labrador retriever and Shar-Pei) identified 35 genomic loci suggestively associated (p < 0.0005) to IgA levels. In German shepherd, three genomic regions (candidate genes include KIRREL3 and SERPINA9) were genome-wide significantly associated (p < 0.0002) with IgA levels. A similar to 20kb long haplotype on CFA28, significantly associated (p = 0.0005) to IgA levels in Shar-Pei, was positioned within the first intron of the gene SLIT1. Both KIRREL3 and SLIT1 are highly expressed in the central nervous system and in bone marrow and are potentially important during B-cell development. SERPINA9 expression is restricted to B-cells and peaks at the time-point when B-cells proliferate into antibody-producing plasma cells. The suggestively associated regions were enriched for genes in Gene Ontology gene sets involving inflammation and early immune cell development.	[Olsson, Mia; Frankowiack, Marcel; Hammarstrom, Lennart] Karolinska Univ Hosp, Karolinska Inst, Div Clin Immunol, Dept Lab Med, Huddinge, Sweden; [Tengvall, Katarina; Kierczak, Marcin; Axelsson, Erik; Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Bergvall, Kerstin; Hedhammar, Ake] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Tintle, Linda] Wurtsboro Vet Clin, Wurtsboro, NY USA; [Marti, Eliane] Univ Bern, Vetsuisse Fac, Div Clin Dermatol, Dept Clin Vet Med, Bern, Switzerland; [Marti, Eliane; Roosje, Petra; Leeb, Tosso] Univ Bern, Vetsuisse Fac, Dermfocus, Bern, Switzerland; [Roosje, Petra] Univ Bern, Vetsuisse Fac, Dept Clin Res & Vet Publ Hlth, Bern, Switzerland; [Leeb, Tosso] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Lindblad-Toh, Kerstin] Broad Inst MIT & Harvard, Cambridge, MA USA	Karolinska Institutet; Karolinska University Hospital; Uppsala University; Swedish University of Agricultural Sciences; University of Bern; University of Bern; University of Bern; University of Bern; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Tengvall, K (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden.	Mia.Olsson@ki.se; Katarina.Tengvall@imbim.uu.se; kersli@broadinstitute.org	Leeb, Tosso/G-3187-2014; Tengvall, Katarina/L-1933-2019	Leeb, Tosso/0000-0003-0553-4880; Hedhammar, Ake/0000-0001-7048-3851; Kierczak, Marcin/0000-0003-2629-5655	Swedish Research Council [521-2012-2826, 521-2011-3515]; Swedish Research Council FORMAS [221-2009-1689]; European Research Council (ERC) [310203]; European Commission, FP7-LUPA [GA-201370]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); European Research Council (ERC)(European Research Council (ERC)European Commission); European Commission, FP7-LUPA(European Commission)	The study has been funded by grants to; KLT the Swedish Research Council, http://www.vr.se/, grant number 521-2012-2826, Swedish Research Council FORMAS, http://www.formas.se/, grant number: 221-2009-1689 and the European Research Council (ERC), http://erc.europa.eu/, starting grant agreement: 310203; LH the Swedish Research Council, http://www.vr.se/, grant number 521-2011-3515; TL the European Commission, http://www.eurolupa.eu/, FP7-LUPA, GA-201370. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Burrows PD, 1997, ADV IMMUNOL, V65, P245, DOI 10.1016/S0065-2776(08)60744-0; Chaumeil J, 2012, CURR OPIN IMMUNOL, V24, P153, DOI 10.1016/j.coi.2012.01.003; CONLEY ME, 1981, NEW ENGL J MED, V305, P495, DOI 10.1056/NEJM198108273050905; DAY MJ, 1988, RES VET SCI, V45, P360, DOI 10.1016/S0034-5288(18)30965-2; Day MJ, 1999, J SMALL ANIM PRACT, V40, P561, DOI 10.1111/j.1748-5827.1999.tb03022.x; Edson MA, 2010, ENDOCRINOLOGY, V151, P358, DOI 10.1210/en.2009-0760; FELSBURG PJ, 1985, CLIN IMMUNOL IMMUNOP, V36, P297, DOI 10.1016/0090-1229(85)90050-9; Ferreira RC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002476; Ferreira RC, 2010, NAT GENET, V42, P777, DOI 10.1038/ng.644; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Frankowiack M, 2013, DEV COMP IMMUNOL, V40, P180, DOI 10.1016/j.dci.2013.01.005; Frazer JK, 2000, EUR J IMMUNOL, V30, P3039, DOI 10.1002/1521-4141(200010)30:10<3039::AID-IMMU3039>3.0.CO;2-H; Gerke P, 2006, J COMP NEUROL, V498, P466, DOI 10.1002/cne.21064; Geutskens SB, 2012, LAB INVEST, V92, P1129, DOI 10.1038/labinvest.2012.81; GLICKMAN LT, 1988, AM J VET RES, V49, P1240; Gonzalez-Quintela A, 2008, CLIN EXP IMMUNOL, V151, P42, DOI 10.1111/j.1365-2249.2007.03545.x; Griot-Wenk ME, 1999, RES VET SCI, V67, P239, DOI 10.1053/rvsc.1999.0314; Guerin A, 2012, AM J MED GENET A, V158A, P2551, DOI 10.1002/ajmg.a.35621; HAMMARSTROM L, 1985, CLIN EXP IMMUNOL, V60, P661; Hammarstrom L, 2000, CLIN EXP IMMUNOL, V120, P225, DOI 10.1046/j.1365-2249.2000.01131.x; HAMMARSTROM L, 1985, LANCET, V1, P778; Harmar AJ, 2009, NUCLEIC ACIDS RES, V37, pD680, DOI 10.1093/nar/gkn728; Hasegawa K, 2004, HUM GENET, V115, P295, DOI 10.1007/s00439-004-1157-z; Heuser M, 2014, HAEMATOLOGICA, V99, pE165, DOI 10.3324/haematol.2013.101642; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jacob CMA, 2008, J CLIN IMMUNOL, V28, pS56, DOI 10.1007/s10875-007-9163-2; Karlsson EK, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r132; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kramer SG, 2001, SCIENCE, V292, P737, DOI 10.1126/science.1058766; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Lequarre AS, 2011, VET J, V189, P155, DOI 10.1016/j.tvjl.2011.06.013; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Littler RM, 2006, VET REC, V158, P334, DOI 10.1136/vr.158.10.334; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MOROFF SD, 1986, VET IMMUNOL IMMUNOP, V13, P181, DOI 10.1016/0165-2427(86)90071-1; NIEHRS C, 1993, CELL, V72, P491, DOI 10.1016/0092-8674(93)90069-3; Olsson M, 2014, VET IMMUNOL IMMUNOP, V160, P255, DOI 10.1016/j.vetimm.2014.05.010; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Prasad A, 2004, J BIOL CHEM, V279, P9115, DOI 10.1074/jbc.M308083200; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Prince JEA, 2013, DEVELOPMENT, V140, P2398, DOI 10.1242/dev.087262; Rabenhorst A, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0423-y; Raychaudhuri S, 2011, BIOINFORMATICS, V27, P1589, DOI 10.1093/bioinformatics/btr185; RIVAS AL, 1995, CLIN IMMUNOL IMMUNOP, V74, P243, DOI 10.1006/clin.1995.1036; SCHREIBER M, 1992, EUR J CLIN CHEM CLIN, V30, P775; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tengvall K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003475; Ueno H, 2003, NAT IMMUNOL, V4, P457, DOI 10.1038/ni916; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Wang N, 2011, MOL MED, V17, P1383, DOI 10.2119/molmed.2011.00195; Wayne RK, 2012, MAMM GENOME, V23, P3, DOI 10.1007/s00335-011-9386-7; Weber-Mzell D, 2004, EUR J CLIN INVEST, V34, P224, DOI 10.1111/j.1365-2362.2004.01311.x; WHITBREAD TJ, 1984, RES VET SCI, V37, P350, DOI 10.1016/S0034-5288(18)31877-0; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; WILLARD MD, 1994, J AM VET MED ASSOC, V204, P1201; Woof JM, 2006, J PATHOL, V208, P270, DOI 10.1002/path.1877; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x	65	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133844	10.1371/journal.pone.0133844	http://dx.doi.org/10.1371/journal.pone.0133844			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225558	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700039
J	Schroeder, LF; Elbireer, A; Jackson, JB; Amukele, TK				Schroeder, Lee F.; Elbireer, Ali; Jackson, J. Brooks; Amukele, Timothy K.			Laboratory Diagnostics Market in East Africa: A Survey of Test Types, Test Availability, and Test Prices in Kampala, Uganda	PLOS ONE			English	Article							SEROLOGICAL TESTS	Background Diagnostic laboratory tests are routinely defined in terms of their sensitivity, specificity, and ease of use. But the actual clinical impact of a diagnostic test also depends on its availability and price. This is especially true in resource-limited settings such as sub-Saharan Africa. We present a first-of-its-kind report of diagnostic test types, availability, and prices in Kampala, Uganda. Methods Test types (identity) and availability were based on menus and volumes obtained from clinical laboratories in late 2011 in Kampala using a standard questionnaire. As a measure of test availability, we used the Availability Index (AI). AI is the combined daily testing volumes of laboratories offering a given test, divided by the combined daily testing volumes of all laboratories in Kampala. Test prices were based on a sampling of prices collected in person and via telephone surveys in 2015. Findings Test volumes and menus were obtained for 95% (907/954) of laboratories in Kampala city. These 907 laboratories offered 100 different test types. The ten most commonly offered tests in decreasing order were Malaria, HCG, HIV serology, Syphilis, Typhoid, Urinalysis, Brucellosis, Stool Analysis, Glucose, and ABO/Rh. In terms of AI, the 100 tests clustered into three groups: high (12 tests), moderate (33 tests), and minimal (55 tests) availability. 50% and 36% of overall availability was provided through private and public laboratories, respectively. Point-of-care laboratories contributed 35% to the AI of high availability tests, but only 6% to the AI of the other tests. The mean price of the most commonly offered test types was $2.62 (range $1.83-$3.46). Interpretation One hundred different laboratory test types were in use in Kampala in late 2011. Both public and private laboratories were critical to test availability. The tests offered in point-of-care laboratories tended to be the most available tests. Prices of the most common tests ranged from $1.83-$3.46.	[Schroeder, Lee F.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Elbireer, Ali; Amukele, Timothy K.] Makerere Univ, Johns Hopkins Univ, Infect Dis Inst, Clin Core Lab, Kampala, Uganda; [Elbireer, Ali] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Jackson, J. Brooks] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Amukele, Timothy K.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	University of Michigan System; University of Michigan; Makerere University; Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University	Schroeder, LF (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	leeschro@med.umich.edu		jackson, brooks/0000-0001-9458-135X; Elbireer, Ali/0000-0002-2513-3497				Amukele TK, 2015, AM J CLIN PATHOL, V143, P50, DOI 10.1309/AJCPCYA54DWZQPQT; [Anonymous], 2011, COMM SER TESTS DIAGN; [Anonymous], 2014, MAL DIAGN TECHN LAND; [Anonymous], 2014, HIV AIDS DIAGN TECHN; Barbiero VK, 2010, FULFILLING PEPFAR MA, P289; Center for Medicare and Medicaid Services, 2013, CLIN LAB FEE SCHED; Denkinger CM, 2015, J INFECT DIS, V211, pS29, DOI 10.1093/infdis/jiu821; Dowdy DW, 2011, PLOS MED, P8, DOI [10.1371/journal.pmed.1001063, DOI 10.1371/JOURNAL.PMED.1001063]; Elbireer AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064661; Ferrante di Ruffano L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e686; Global Burden of Disease Collaborative Network, 2012, GLOBAL BURDEN DIS ST; Hay Burgess Deborah C, 2006, Nature, V444 Suppl 1, P1; International Bank for Reconstruction and Development / World Bank, 2011, HLTH PARTN GOV CAN E; Jaroslawski S, 2012, J EPIDEMIOL GLOB HEA, V2, P39, DOI 10.1016/j.jegh.2011.12.001; Levinson DR, 2013, COMP LAB TEST PAYMEN; Lewin Group, 2008, LAB MED NAT STAT REP; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; Palamountain KM, 2012, J INFECT DIS, V205, pS181, DOI 10.1093/infdis/jis203; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Schroeder LF, 2014, AM J CLIN PATHOL, V141, P791, DOI 10.1309/AJCPQ5KTKAGSSCFN; Steingart KR, 2012, INDIAN J MED RES, V135, P695; Steingart KR, 2011, PLOS MED, V8; Stull TM, 1998, JAMA-J AM MED ASSOC, V279, P463, DOI 10.1001/jama.279.6.463; The Centers for Medicare and Medicaid Services (CMS), 2012, PROV SERV FIL; Uganda Bureau of Statistics (UBOS), 2012, STAT HOUS; UNITAID, 2014, TUB DIAGN TECHN MARK; United Nations, 2012, POL DECL HIGH LEV M, V117; Urdea Mickey, 2006, Nature, V444 Suppl 1, P73, DOI 10.1038/nature05448; USAID. The DHS Program Demographic and Health Surveys, DHS PROGR DEM HLTH S; World Bank, WORLD DEV IND; World Health Organization Regional Office for Africa, 2012, WHO GUID STEPW LAB I	32	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134578	10.1371/journal.pone.0134578	http://dx.doi.org/10.1371/journal.pone.0134578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226183	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700113
J	Zheng, G; Li, YX; Huang, HS; Wang, JH; Hirayama, A; Lin, JX				Zheng, Guian; Li, Yuxin; Huang, Huishan; Wang, Jinghan; Hirayama, Atsushi; Lin, Jinxiu			The Effect of Statin Therapy on Coronary Plaque Composition Using Virtual Histology Intravascular Ultrasound: A Meta-Analysis	PLOS ONE			English	Article							LIPID-LOWERING TREATMENT; C-REACTIVE PROTEIN; ATHEROSCLEROTIC PLAQUE; CLINICAL PRESENTATION; ATORVASTATIN THERAPY; PROGRESSION; ARTERY; CALCIFICATION; REGRESSION; CLASSIFICATION	Objective Previous studies have indicated that statin therapy may promote plaque regression. However, the impact of statin therapy on plaque composition has not been clearly elucidated. We performed a meta-analysis to investigate the effect of statin therapy on coronary plaque composition as assessed by virtual histology intravascular ultrasound (VH-IVUS). Methods Online databases were searched from inception to March 1, 2015. Studies providing VH-IVUS volumetric analyses of coronary plaque composition at baseline and follow-up in patients receiving statin therapy were included. Weighted mean difference (WMD) using a random-effects model was used. Results Ten studies involving 682 patients were included. There was a substantial reduction in fibrous volume between baseline and follow-up (WMD: -2.37 mm(3), 95% confidence interval (CI) -4.01 to -0.74 mm(3), P=0.004), and a significant increase in dense calcium (DC) volume (WMD: 0.89 mm(3), 95% CI 0.70 to 1.08 mm(3), P<0.00001). No significant change was seen in fibro-fatty and necrotic core (NC) volumes. In stratified analyses, the fibrous volume was decreased significantly (WMD: -3.39 mm(3), 95% CI -6.56 to -0.21 mm(3), P=0.04) and the absolute DC volume (WMD: 0.99 mm(3), 95% CI 0.23 to 1.76 mm(3), P=0.01) was increased in the subgroup with >= 12 months follow-up, whereas no significant change was observed in the subgroup with < 12 months follow-up. Similarly, a substantial decrease in fibrous volume (WMD: -2.01 mm(3), 95% CI -3.05 to -0.96 mm(3), P<0.0002) and an increase in DC volume (WMD: 0.90 mm(3), 95% CI 0.70 to 1.10 mm(3), P<0.00001) were observed in the subgroup with high-intensive statin therapy, while the change in fibrous and DC volumes approached statistical significance (P=0.05 and P=0.05, respectively) in the subgroup with low-intensive statin therapy. Conclusions Statin treatment, particularly of high-intensity and long-term duration, induced a marked modification in coronary plaque composition including a decrease in fibrous tissue and an increase in DC.	[Zheng, Guian; Lin, Jinxiu] Fujian Med Univ, Clin Med Coll 1, Fuzhou, Fujian, Peoples R China; [Zheng, Guian] Fujian Med Univ, Dept Cardiol, Zhangzhou Hosp Affiliated, Fuzhou, Fujian, Peoples R China; [Li, Yuxin] Nihon Univ, Sch Med, Dept Adv Cardiovas Imaging Anal, Tokyo, Japan; [Huang, Huishan] Zhangzhou Med Sci Inst, Dept Mol Biol, Zhangzhou, Fujian, Peoples R China; [Wang, Jinghan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol,Zhejiang Inst Hematol, Hangzhou 310003, Zhejiang, Peoples R China; [Hirayama, Atsushi] Nihon Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Lin, Jinxiu] Fujian Med Univ, Dept Cardiol, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China	Fujian Medical University; Fujian Medical University; Nihon University; Zhejiang University; Nihon University; Fujian Medical University	Lin, JX (corresponding author), Fujian Med Univ, Clin Med Coll 1, Fuzhou, Fujian, Peoples R China.	jxlin2014@gmail.com	Li, yuxin/GSD-1668-2022; li, yu/HGL-9518-2022; Li, yu/HHZ-5236-2022; li, Yu/HCI-9086-2022		National Natural Science Foundation of China grants, China [81470305]	National Natural Science Foundation of China grants, China(National Natural Science Foundation of China (NSFC))	This work was totally supported by National Natural Science Foundation of China grants, China(grant number 81470305) [http://www.nsfc.gov.cn/]. The author JW received this funding and the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Beckman JA, 2001, ARTERIOSCL THROM VAS, V21, P1618, DOI 10.1161/hq0901.095554; Bedi U, 2011, J CLIN HYPERTENS, V13, P492, DOI 10.1111/j.1751-7176.2011.00428.x; Egede R, 2013, EUROINTERVENTION, V8, P1182, DOI 10.4244/EIJV8I10A182; Eshtehardi P, 2012, J INVASIVE CARDIOL, V24, P522; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Gao WQ, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-60; Gill EA, 2010, CURR ATHEROSCLER REP, V12, P83, DOI 10.1007/s11883-009-0073-z; Hong MK, 2009, JACC-CARDIOVASC INTE, V2, P679, DOI 10.1016/j.jcin.2009.03.015; Hong YJ, 2012, J CARDIOL, V60, P277, DOI 10.1016/j.jjcc.2012.04.003; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Hutcheson JD, 2014, CURR OPIN LIPIDOL, V25, P327, DOI 10.1097/MOL.0000000000000105; Hwang DS, 2013, YONSEI MED J, V54, P336, DOI 10.3349/ymj.2013.54.2.336; Kaneda H, 2010, AM J CARDIOL, V106, P1735, DOI 10.1016/j.amjcard.2010.08.012; Kataoka Y, 2014, AM J CARDIOL, V114, P549, DOI 10.1016/j.amjcard.2014.05.035; Konig A, 2008, NAT CLIN PRACT CARD, V5, P219, DOI 10.1038/ncpcardio1123; Komukai K, 2014, J AM COLL CARDIOL, V64, P2207, DOI 10.1016/j.jacc.2014.08.045; Kovarnik T, 2012, CIRC J, V76, P176, DOI 10.1253/circj.CJ-11-0730; Lee SWL, 2012, CIRC J, V76, P2662, DOI 10.1253/circj.CJ-12-0325; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Madhavan MV, 2014, J AM COLL CARDIOL, V63, P1703, DOI 10.1016/j.jacc.2014.01.017; Mills EJ, 2011, EUR HEART J, V32, P1409, DOI 10.1093/eurheartj/ehr035; Mintz GS, 2009, CIRC J, V73, P1557, DOI 10.1253/circj.CJ-09-0475; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nasu K, 2009, JACC-CARDIOVASC INTE, V2, P689, DOI 10.1016/j.jcin.2009.04.016; Nicholls SJ, 2011, NEW ENGL J MED, V365, P2078, DOI 10.1056/NEJMoa1110874; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Nozue T, 2014, HEART VESSELS, V29, P456, DOI 10.1007/s00380-013-0387-1; Nozue T, 2014, CORONARY ARTERY DIS, V25, P343, DOI 10.1097/MCA.0000000000000084; Nozue T, 2012, AM HEART J, V163, P191, DOI 10.1016/j.ahj.2011.11.004; Pugliese G, 2015, ATHEROSCLEROSIS, V238, P220, DOI 10.1016/j.atherosclerosis.2014.12.011; Puri R, 2014, EUR HEART J-CARD IMG, V15, P380, DOI 10.1093/ehjci/jet251; Raber L, 2015, EUR HEART J, V36, P490, DOI 10.1093/eurheartj/ehu373; Rodriguez-Granillo GA, 2007, AM J CARDIOL, V99, P5, DOI 10.1016/j.amjcard.2006.07.054; Schmermund A, 2006, CIRCULATION, V113, P427, DOI 10.1161/CIRCULATIONAHA.105.568147; Shanahan CM, 2007, CIRCULATION, V116, P2782, DOI 10.1161/CIRCULATIONAHA.107.749655; Shin ES, 2012, INT J CARDIOVAS IMAG, V28, P1643, DOI 10.1007/s10554-011-9989-9; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Taguchi I, 2013, AM J CARDIOL, V111, P1246, DOI 10.1016/j.amjcard.2013.01.265; Tian JW, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-70; Tomey MI, 2014, J AM COLL CARDIOL, V63, P1604, DOI 10.1016/j.jacc.2014.01.042; Valgimigli M, 2007, J AM COLL CARDIOL, V49, P23, DOI 10.1016/j.jacc.2006.03.073; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Vliegenthart R, 2005, CIRCULATION, V112, P572, DOI 10.1161/CIRCULATIONAHA.104.488916; Wells G.A., NEWCASTLE OTTAWA SCA	46	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133433	10.1371/journal.pone.0133433	http://dx.doi.org/10.1371/journal.pone.0133433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225936	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700022
J	Zhou, H; Jiang, XX				Zhou, Hang; Jiang, Xinxin			Research on Taxiway Path Optimization Based on Conflict Detection	PLOS ONE			English	Article								Taxiway path planning is one of the effective measures to make full use of the airport resources, and the optimized paths can ensure the safety of the aircraft during the sliding process. In this paper, the taxiway path planning based on conflict detection is considered. Specific steps are shown as follows: firstly, make an improvement on A * algorithm, the conflict detection strategy is added to search for the shortest and safe path in the static taxiway network. Then, according to the sliding speed of aircraft, a time table for each node is determined and the safety interval is treated as the constraint to judge whether there is a conflict or not. The intelligent initial path planning model is established based on the results. Finally, make an example in an airport simulation environment, detect and relieve the conflict to ensure the safety. The results indicate that the model established in this paper is effective and feasible. Meanwhile, make comparison with the improved A*algorithm and other intelligent algorithms, conclude that the improved A*algorithm has great advantages. It could not only optimize taxiway path, but also ensure the safety of the sliding process and improve the operational efficiency.	[Zhou, Hang; Jiang, Xinxin] Nanjing Univ Aeronaut & Astronaut, Coll Civil Aviat, Nanjing 210016, Jiangsu, Peoples R China	Nanjing University of Aeronautics & Astronautics	Jiang, XX (corresponding author), Nanjing Univ Aeronaut & Astronaut, Coll Civil Aviat, Nanjing 210016, Jiangsu, Peoples R China.	jiangxinxin958@nuaa.edu.cn			National Natural Science Foundation of China [61262002]; Fundamental Research Funds for the Central Universities [NS2014064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China, NO. 61262002; Fundamental Research Funds for the Central Universities, NO. NS2014064.	Clare G, 2009, PERC AIAA GUID NAV C; Dong Tian-sheng, 2010, Journal of Computer Applications, V30, P482, DOI 10.3724/SP.J.1087.2010.00482; [董莹 Dong Ying], 2011, [交通运输系统工程与信息, Journal of Transporation Systems Engineering & Information Technology], V11, P141; Gao GZ, 2012, SHANDONG TRANSPORTAT, P24; Hesselink H H, 1998, PLANNING AIRCRAFT MO; Li N, 2012, COMPUTER SIMULATION, V29, P88; Liu Zhao-ming, 2008, Journal of East China University of Science and Technology, V34, P392; Marin AG, 2006, ANN OPER RES, V143, P191, DOI 10.1007/s10479-006-7381-2; Poole D L, 2010, ARTIFICIAL INTELLIGE; Smeltink J., 2004, P INFORMS ANN M DENV; Tang Xin-Min, 2010, Systems Engineering and Electronics, V32, P2669, DOI 10.3969/j.issn.1001-506X.2010.12.36; Teixeira R, 1992, THESIS LOUGHBOROUGH; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Wang C, 2012, RES TAXIING ROUTE PL; Xue L, 2012, COMMAND INFORM SYSTE, V3, P59; Yang YT, 2014, OBSTACLE AVOIDANCE A; Zhang Jinhong, 2014, ScientificWorldJournal, V2014, P910421, DOI 10.1155/2014/910421; Zhou Xiaojing, 2011, RES ROUTING GAME MAP; [朱新平 Zhu Xinping], 2013, [西南交通大学学报, Journal of Southwest Jiaotong University], V48, P565	19	7	7	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134522	10.1371/journal.pone.0134522	http://dx.doi.org/10.1371/journal.pone.0134522			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226485	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700106
J	Zhou, W; Wen, JH; Koh, YS; Xiong, QY; Gao, M; Dobbie, G; Alam, S				Zhou, Wei; Wen, Junhao; Koh, Yun Sing; Xiong, Qingyu; Gao, Min; Dobbie, Gillian; Alam, Shafiq			Shilling Attacks Detection in Recommender Systems Based on Target Item Analysis	PLOS ONE			English	Article							OF-THE-ART; TAG	Recommender systems are highly vulnerable to shilling attacks, both by individuals and groups. Attackers who introduce biased ratings in order to affect recommendations, have been shown to negatively affect collaborative filtering (CF) algorithms. Previous research focuses only on the differences between genuine profiles and attack profiles, ignoring the group characteristics in attack profiles. In this paper, we study the use of statistical metrics to detect rating patterns of attackers and group characteristics in attack profiles. Another question is that most existing detecting methods are model specific. Two metrics, Rating Deviation from Mean Agreement (RDMA) and Degree of Similarity with Top Neighbors (DegSim), are used for analyzing rating patterns between malicious profiles and genuine profiles in attack models. Building upon this, we also propose and evaluate a detection structure called RD-TIA for detecting shilling attacks in recommender systems using a statistical approach. In order to detect more complicated attack models, we propose a novel metric called DegSim' based on DegSim. The experimental results show that our detection model based on target item analysis is an effective approach for detecting shilling attacks.	[Zhou, Wei] Chongqing Univ, Coll Comp Sci, Chongqing 630044, Peoples R China; [Wen, Junhao; Xiong, Qingyu; Gao, Min] Chongqing Univ, Sch Software Engn, Chongqing 630044, Peoples R China; [Koh, Yun Sing; Dobbie, Gillian; Alam, Shafiq] Univ Auckland, Dept Comp Sci, Auckland 1, New Zealand	Chongqing University; Chongqing University; University of Auckland	Wen, JH (corresponding author), Chongqing Univ, Sch Software Engn, Chongqing 630044, Peoples R China.	wjhcqu@cqu.edu.cn		Alam, Shafiq/0000-0002-9566-8040; Koh, Yun Sing/0000-0001-7256-4049	National Science Foundations of China [61379158, 71102065]; Ph.D. Programs Foundation of Ministry of Education of China [20120191110028]; Fundamental Research Funds for the Central Universities [CDJZR13 09 551, 106112014CDJZR095502]	National Science Foundations of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The research reported in this paper has been supported by the National Science Foundations of China under grant No.61379158 and No.71102065, and the Ph.D. Programs Foundation of Ministry of Education of China under grant No. 20120191110028, and Projects (No. CDJZR13 09 551) and (No. 106112014CDJZR095502) are supported by the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; Bhaumik Runa, 2006, P 4 WORKSH INT TECHN; Burke R., 2005, 5 IEEE INT C DAT MIN, P4; Burke R., 2006, ACM SIGKDD INT C KNO, P542; Burke R, 2006, 8 IEEE INT C ENT COM, P23; Cao J, 2013, WORLD WIDE WEB, V16, P729, DOI 10.1007/s11280-012-0164-6; Carrer-Neto W, 2012, EXPERT SYST APPL, V39, P10990, DOI 10.1016/j.eswa.2012.03.025; Cheng Z., 2009, RECSYS, P141; Chirita P.A., 2005, P 7 ACM INT WORKSH W, DOI 10.1145/1097047.1097061; Chung CY, 2013, DECIS SUPPORT SYST, V55, P314, DOI 10.1016/j.dss.2013.01.020; Fu L, 2003, LECT NOTES COMPUT SC, V2911, P111; Grcar M, 2006, STUD CLASS DATA ANAL, P251, DOI 10.1007/3-540-34416-0_27; Horng SJ, 2011, EXPERT SYST APPL, V38, P306, DOI 10.1016/j.eswa.2010.06.066; Hurley N., 2009, P 3 ACM C REC SYST, P149; Lam S. K., 2004, P 13 INT C WORLD WID, P393, DOI DOI 10.1145/988672.988726; Li YH, 2012, EXPERT SYST APPL, V39, P424, DOI 10.1016/j.eswa.2011.07.032; Mehta B., 2008, P 31 ANN INT ACM SIG, P75; Mehta B, 2007, RECSYS 07: PROCEEDINGS OF THE 2007 ACM CONFERENCE ON RECOMMENDER SYSTEMS, P49; Mehta B, 2009, USER MODEL USER-ADAP, V19, P65, DOI 10.1007/s11257-008-9050-4; Mobasher B, 2007, ACM T INTERNET TECHN, V7, DOI 10.1145/1278366.1278372; Wang G, 2010, EXPERT SYST APPL, V37, P6225, DOI 10.1016/j.eswa.2010.02.102; Williams Chad, 2006, TECHNICAL REPORT; Williams CA, 2007, SERV ORIENTED COMPUT, V1, P157, DOI 10.1007/s11761-007-0013-0; Wu JJ, 2010, DATA MIN KNOWL DISC, V20, P191, DOI 10.1007/s10618-009-0146-1; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2; Wu Z., 2012, P 18 INT C KNOWLEDGE, P985, DOI 10.1145/2339530.2339684; Zhang S., 2006, Proceedings of the Twenty-Ninth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P517, DOI 10.1145/1148170.1148259; Zhang S., 2006, P 12 ACM SIGKDD INT, P809; Zhang ZK, 2011, J COMPUT SCI TECH-CH, V26, P767, DOI 10.1007/s11390-011-0176-1; Zheng N, 2011, EXPERT SYST APPL, V38, P4575, DOI 10.1016/j.eswa.2010.09.131; Zhou T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020648	31	20	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0130968	10.1371/journal.pone.0130968	http://dx.doi.org/10.1371/journal.pone.0130968			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222882	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800010
J	Dai, N; Hu, J; Liu, H				Dai, Ning; Hu, Jian; Liu, Hao			3D Simulation Modeling of the Tooth Wear Process	PLOS ONE			English	Article							INTERPOLATION; EROSION	Severe tooth wear is the most common non-caries dental disease, and it can seriously affect oral health. Studying the tooth wear process is time-consuming and difficult, and technological tools are frequently lacking. This paper presents a novel method of digital simulation modeling that represents a new way to study tooth wear. First, a feature extraction algorithm is used to obtain anatomical feature points of the tooth without attrition. Second, after the alignment of non-attrition areas, the initial homogeneous surface is generated by means of the RBF (Radial Basic Function) implicit surface and then deformed to the final homogeneous by the contraction and bounding algorithm. Finally, the method of bilinear interpolation based on Laplacian coordinates between tooth with attrition and without attrition is used to inversely reconstruct the sequence of changes of the 3D tooth morphology during gradual tooth wear process. This method can also be used to generate a process simulation of nonlinear tooth wear by means of fitting an attrition curve to the statistical data of attrition index in a certain region. The effectiveness and efficiency of the attrition simulation algorithm are verified through experimental simulation.	[Dai, Ning; Liu, Hao] Nanjing Univ Aeronaut & Astronaut, Coll Mech & Elect Engn, Nanjing, Jiangsu, Peoples R China; [Hu, Jian] Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China	Nanjing University of Aeronautics & Astronautics; Nanjing Medical University	Dai, N (corresponding author), Nanjing Univ Aeronaut & Astronaut, Coll Mech & Elect Engn, Nanjing, Jiangsu, Peoples R China.	dai_ning@nuaa.edu.cn			National Natural Science Foundation of China [51205192]; National High Technology Research and Development Program of China [SS2013AA040801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This study was supported by the National Natural Science Foundation of China (51205192) and the National High Technology Research and Development Program of China (SS2013AA040801). The funders supported the authors in study design, data collection and analysis.	Alexa M, 2003, VISUAL COMPUT, V19, P105, DOI 10.1007/s00371-002-0180-0; Athanasiadis T, 2012, COMPUT AIDED GEOM D, V29, P2, DOI 10.1016/j.cagd.2011.09.004; Benazzi S, 2011, AM J PHYS ANTHROPOL, V144, P309, DOI 10.1002/ajpa.21413; Carr JC, 2001, COMP GRAPH, P67, DOI 10.1145/383259.383266; DeLong R, 2006, DENT MATER, V22, P702, DOI 10.1016/j.dental.2006.02.003; Donald AS, 2000, J PROSTHET DENT, V83, P76; Dong XL, 2007, J 4 MIL MED U, V28, P550; Evans AR, 2005, BIOL J LINN SOC, V85, P81, DOI 10.1111/j.1095-8312.2005.00474.x; Fan WM, 2000, OPERATIVE DENT ENDOD; Garland M., 1997, COMPUTER GRAPHICS, V31, P209, DOI DOI 10.1145/258734258849; Hove LH, 2013, EUR ARCH PAEDIATR DE, V14, P29, DOI 10.1007/s40368-012-0004-5; Kanai T, 1998, VISUAL COMPUT, V14, P166, DOI 10.1007/s003710050132; Lee CH, 2005, P ACM SIGGRAPH, P659; Lerios A., 1995, SIGGRAPH, V1995, P449; Mitchell HL, 2004, MED BIOL ENG COMPUT, V42, P100, DOI 10.1007/BF02351017; Mitchell HL, 2003, MED BIOL ENG COMPUT, V41, P464, DOI 10.1007/BF02348090; Parent RE, 1992, VISUALIZATION COMPUT, V3, P219; Penny FB, 2008, CLIN ORAL INVESTI S1, V12, P15; Rodriguez JM, 2012, DENT MATER, V28, P245, DOI 10.1016/j.dental.2011.10.002; SCHROEDER WJ, 1992, COMP GRAPH, V26, P65, DOI 10.1145/142920.134010; SMITH BGN, 1984, BRIT DENT J, V156, P435, DOI 10.1038/sj.bdj.4805394; [宋西平 SONG Xiping], 2008, [复合材料学报, Acta Materiae Compositae Sinica], V25, P93; TEAFORD MF, 1991, J DENT RES, V70, P204, DOI 10.1177/00220345910700030901; Toledo S., 2003, TAUCS LIB SPARSE LIN; Yan HB, 2004, COMPUT ANIMAT VIRT W, V15, P443, DOI 10.1002/cav.48; Yip KH, 2006, TOOTH EROSION PREVEN; Zhang J, 2004, TRIBOLOGY, V24, P471; Zhao Wei, 2002, Zhonghua Kou Qiang Yi Xue Za Zhi, V37, P219; Zou LF, 2009, WEAR, V266, P605, DOI 10.1016/j.wear.2008.04.062	29	2	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134807	10.1371/journal.pone.0134807	http://dx.doi.org/10.1371/journal.pone.0134807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241942	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942700069
J	Hanno-Iijima, Y; Tanaka, M; Iijima, T				Hanno-Iijima, Yoko; Tanaka, Masami; Iijima, Takatoshi			Activity-Dependent Bidirectional Regulation of GAD Expression in a Homeostatic Fashion Is Mediated by BDNF-Dependent and Independent Pathways	PLOS ONE			English	Article							MESSENGER-RNA; NEUROTROPHIC FACTOR; VESICULAR GLUTAMATE; QUANTAL AMPLITUDE; BRAIN; TRANSCRIPTION; DISTINCT; NEURONS; TRKB	Homeostatic synaptic plasticity, or synaptic scaling, is a mechanism that tunes neuronal transmission to compensate for prolonged, excessive changes in neuronal activity. Both excitatory and inhibitory neurons undergo homeostatic changes based on synaptic transmission strength, which could effectively contribute to a fine-tuning of circuit activity. However, gene regulation that underlies homeostatic synaptic plasticity in GABAergic (GABA, gamma aminobutyric) neurons is still poorly understood. The present study demonstrated activity-dependent dynamic scaling in which NMDA-R (N-methyl-D-aspartic acid receptor) activity regulated the expression of GABA synthetic enzymes: glutamic acid decarboxylase 65 and 67 (GAD65 and GAD67). Results revealed that activity-regulated BDNF (brain-derived neurotrophic factor) release is necessary, but not sufficient, for activity-dependent up-scaling of these GAD isoforms. Bidirectional forms of activity-dependent GAD expression require both BDNF-dependent and BDNF-independent pathways, both triggered by NMDA-R activity. Additional results indicated that these two GAD genes differ in their responsiveness to chronic changes in neuronal activity, which could be partially caused by differential dependence on BDNF. In parallel to activity-dependent bidirectional scaling in GAD expression, the present study further observed that a chronic change in neuronal activity leads to an alteration in neurotransmitter release from GABAergic neurons in a homeostatic, bidirectional fashion. Therefore, the differential expression of GAD65 and 67 during prolonged changes in neuronal activity may be implicated in some aspects of bidirectional homeostatic plasticity within mature GABAergic presynapses.	[Hanno-Iijima, Yoko; Tanaka, Masami; Iijima, Takatoshi] Tokai Univ, Inst Innovat Sci & Technol, Div Med, Hiratsuka, Kanagawa 25912, Japan; [Hanno-Iijima, Yoko; Tanaka, Masami; Iijima, Takatoshi] Tokai Univ, Sch Med, Hiratsuka, Kanagawa 25912, Japan	Tokai University; Tokai University	Iijima, T (corresponding author), Tokai Univ, Inst Innovat Sci & Technol, Div Med, Hiratsuka, Kanagawa 25912, Japan.	takatoshi.iijima@tokai-u.jp			Innovative Academic Promotional System in Private Schools Capable of Reproducing First-Rate Researchers under Improvement of Independent Research Environment for Young Researchers Program"; Mitsubishi Foundation; Yamada Science Foundation; Takeda Science Foundation	Innovative Academic Promotional System in Private Schools Capable of Reproducing First-Rate Researchers under Improvement of Independent Research Environment for Young Researchers Program"; Mitsubishi Foundation; Yamada Science Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Innovative Academic Promotional System in Private Schools Capable of Reproducing First-Rate Researchers under Improvement of Independent Research Environment for Young Researchers Program" organized by the Ministry of Education, Culture, Sports, Science and Technology (JST) (to Tokai Univ. IIST), the Mitsubishi Foundation (Mitsubishi zaidan) (T.I.), Yamada Science Foundation (T.I.) and Takeda Science Foundation (T.I.).	Baroncelli L, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/286073; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; Cellerino A, 1996, EUR J NEUROSCI, V8, P1190, DOI 10.1111/j.1460-9568.1996.tb01287.x; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; Dieni S, 2012, J CELL BIOL, V196, P775, DOI 10.1083/jcb.201201038; Erickson JD, 2006, NEUROCHEM INT, V48, P643, DOI 10.1016/j.neuint.2005.12.029; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; Fukuchi M, 2015, J BIOL CHEM, V290, P6825, DOI 10.1074/jbc.M114.617258; Gorba T, 1999, EUR J NEUROSCI, V11, P1179, DOI 10.1046/j.1460-9568.1999.00551.x; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Lau CG, 2012, J NEUROSCI, V32, P8521, DOI 10.1523/JNEUROSCI.1245-12.2012; Leslie KR, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0005.2001; Matsumoto T, 2006, MOL CELL NEUROSCI, V31, P70, DOI 10.1016/j.mcn.2005.09.002; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Pan ZZZ, 2012, TRANSCR-AUSTIN, V3, P68, DOI 10.4161/trns.19511; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Sanchez-Huertas C, 2011, CEREB CORTEX, V21, P777, DOI 10.1093/cercor/bhq150; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; Swanwick CC, 2006, MOL CELL NEUROSCI, V31, P481, DOI 10.1016/j.mcn.2005.11.002; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Wang G, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/825364; ZAFRA F, 1992, J NEUROSCI, V12, P4793; Zhang Z, 2011, NAT MED, V17, P1448, DOI 10.1038/nm.2442	30	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134296	10.1371/journal.pone.0134296	http://dx.doi.org/10.1371/journal.pone.0134296			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241953	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700037
J	Shao, GF; Li, TJ; Zuo, WD; Wu, SX; Liu, TD				Shao, Guifang; Li, Tiejun; Zuo, Wangda; Wu, Shunxiang; Liu, Tundong			A Combinational Clustering Based Method for cDNA Microarray Image Segmentation	PLOS ONE			English	Article							SPOT SEGMENTATION; MODEL	Microarray technology plays an important role in drawing useful biological conclusions by analyzing thousands of gene expressions simultaneously. Especially, image analysis is a key step in microarray analysis and its accuracy strongly depends on segmentation. The pioneering works of clustering based segmentation have shown that k-means clustering algorithm and moving k-means clustering algorithm are two commonly used methods in microarray image processing. However, they usually face unsatisfactory results because the real microarray image contains noise, artifacts and spots that vary in size, shape and contrast. To improve the segmentation accuracy, in this article we present a combination clustering based segmentation approach that may be more reliable and able to segment spots automatically. First, this new method starts with a very simple but effective contrast enhancement operation to improve the image quality. Then, an automatic gridding based on the maximum between-class variance is applied to separate the spots into independent areas. Next, among each spot region, the moving k-means clustering is first conducted to separate the spot from background and then the k-means clustering algorithms are combined for those spots failing to obtain the entire boundary. Finally, a refinement step is used to replace the false segmentation and the inseparable ones of missing spots. In addition, quantitative comparisons between the improved method and the other four segmentation algorithms-edge detection, thresholding, k-means clustering and moving k-means clustering-are carried out on cDNA microarray images from six different data sets. Experiments on six different data sets, 1) Stanford Microarray Database (SMD), 2) Gene Expression Omnibus (GEO), 3) Baylor College of Medicine (BCM), 4) Swiss Institute of Bioinformatics (SIB), 5) Joe DeRisi's individual tiff files (DeRisi), and 6) University of California, San Francisco (UCSF), indicate that the improved approach is more robust and sensitive to weak spots. More importantly, it can obtain higher segmentation accuracy in the presence of noise, artifacts and weakly expressed spots compared with the other four methods.	[Shao, Guifang; Wu, Shunxiang; Liu, Tundong] Xiamen Univ, Dept Automat, Xiamen, Peoples R China; [Li, Tiejun] Jimei Univ, Informat Engn Coll, Xiamen, Peoples R China; [Zuo, Wangda] Univ Miami, Dept Civil Architectural & Environm Engn, Coral Gables, FL 33124 USA	Xiamen University; Jimei University; University of Miami	Shao, GF (corresponding author), Xiamen Univ, Dept Automat, Xiamen, Peoples R China.	gfshao@xmu.edu.cn		shao, guifang/0000-0001-6189-2207; Zuo, Wangda/0000-0003-2102-5592	National Natural Science Foundation of China [61403318]; Natural Science Foundation of Fujian Province of China [2013J01255]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	This work was supported by the National Natural Science Foundation of China, grant no. 61403318 (http://www.nsfc.gov.cn/), and the Natural Science Foundation of Fujian Province of China, grant no. 2013J01255 (http://xmgl.fjkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo Jesus, 2008, Image Analysis & Stereology, V27, P107, DOI 10.5566/ias.v27.p107-124; Athanasiadis E, 2011, COMPUT METH PROG BIO, V104, P307, DOI 10.1016/j.cmpb.2011.03.007; Athanasiadis EI, 2009, IEEE T INF TECHNOL B, V13, P1068, DOI 10.1109/TITB.2009.2032332; Bajcsy P, 2005, P IEEE CS C COMP VIS, P147; Bajcsy P, 2006, EURASIP J APPL SIG P, DOI 10.1155/ASP/2006/80163; Barrera J, 2002, REAL TIME IMAGING, V8, P491; Blekas K, 2005, IEEE T MED IMAGING, V24, P901, DOI 10.1109/TMI.2005.848358; Demirkaya O, 2003, P ANN INT IEEE EMBS, V25, P674, DOI 10.1109/IEMBS.2003.1279852; Elbs M, 2007, ANAL BIOANAL CHEM, V387, P2017, DOI 10.1007/s00216-006-1098-6; Farouk RM, 2014, INT J ARTIFICIAL INT, V5, P21; Giannakeas N, 2013, COMPUT BIOL MED, V43, P705, DOI 10.1016/j.compbiomed.2013.03.003; Giannakeas N, 2008, IEEE ENG MED BIO, P875, DOI 10.1109/IEMBS.2008.4649293; Giannakeas N, 2009, COMPUT MED IMAG GRAP, V33, P40, DOI 10.1016/j.compmedimag.2008.10.003; Harikiran J, 2014, J THEORETICAL APPL I, V65, P235; Harikiran J, 2012, INT J COMPUTER SCI I, V9, P316; Ho J, 2008, IEEE T MED IMAGING, V27, P847, DOI 10.1109/TMI.2008.915697; Kadam AB, 2012, ADV COMPUT RES, V4, P130; Katsigiannis S, 2013, 13 IEEE INT C BIOINF, P1; Kavitha MG, 2013, INT J SCI ENG RES, V4, P46; Kim JH, 2001, EXP MOL MED, V33, P83, DOI 10.1038/emm.2001.15; Larese MG, 2013, PATTERN ANAL APPL, V16, P307, DOI 10.1007/s10044-011-0234-x; Li QH, 2005, BIOINFORMATICS, V21, P2875, DOI 10.1093/bioinformatics/bti447; Liew AWC, 2003, PATTERN RECOGN, V36, P1251, DOI 10.1016/S0031-3203(02)00170-X; Lukac R, 2006, INT J IMAG SYST TECH, V16, P51, DOI 10.1002/ima.20067; Maguluri LP, 2013, INT J EMERGING SCI E, V1, P27; Manjunath SS, 2013, INT J INNOVATIVE TEC, V2, P189; Mouysset S, 2012, ADV INTEL SOFT COMPU, V154, P1; Ng MK, 2002, PATTERN RECOGN, V35, P2783, DOI 10.1016/S0031-3203(02)00021-3; Ni SH, 2009, ROM J INF SCI TECH, V12, P249; Raghavarao S, 2011, GLOBAL J COMPUTER SC, V11, P31; Rajkumar P, 2013, INT J COMPUTER SCI E, V5, P528; Rueda L, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-113; Shao GF, 2013, IEEE ACM T COMPUT BI, V10, P181, DOI 10.1109/TCBB.2012.130; Sreedevi A, 2013, INT J SIGNAL IMAGE P, V4, P83; Tian MX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067014; Uslan V, 2010, IEEE ENG MED BIO, P1828, DOI 10.1109/IEMBS.2010.5626430; Wang XH, 2003, IEEE T NANOBIOSCI, V2, P184, DOI 10.1109/TNB.2003.816225; Wang ZD, 2014, NEUROCOMPUTING, V142, P408, DOI 10.1016/j.neucom.2014.03.052; Wang ZD, 2013, COMPUT METH PROG BIO, V111, P189, DOI 10.1016/j.cmpb.2013.03.013; Wu H, 2003, P 1 AS PAC BIOINF C, V19, P111; Yeganeh SH, 2008, INT C COMP ELEC ENG, P619, DOI 10.1109/ICCEE.2008.92; Zacharia E, 2011, EVOLUTIONARY ALGORITHMS, P459; Zacharia E, 2010, IEEE T NANOBIOSCI, V9, P181, DOI 10.1109/TNB.2010.2050900	43	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133025	10.1371/journal.pone.0133025	http://dx.doi.org/10.1371/journal.pone.0133025			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241767	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942700010
J	Takashima, M; Manabe, R; Iwasaki, W; Ohyama, A; Ohkuma, M; Sugita, T				Takashima, Masako; Manabe, Ri-ichiroh; Iwasaki, Wataru; Ohyama, Akira; Ohkuma, Moriya; Sugita, Takashi			Selection of Orthologous Genes for Construction of a Highly Resolved Phylogenetic Tree and Clarification of the Phylogeny of Trichosporonales Species	PLOS ONE			English	Article							CELL-WALL POLYSACCHARIDE; OLEAGINOUS YEASTS; BASIDIOMYCETOUS YEAST; SP-NOV.; RECLASSIFICATION; CLASSIFICATION; SUBSTITUTIONS; EVOLUTION; CURVATUS; FUNGI	The order Trichosporonales (Tremellomycotina, Basidiomycota) includes various species that have clinical, agricultural and biotechnological value. Thus, understanding why and how evolutionary diversification occurred within this order is extremely important. This study clarified the phylogenetic relationships among Tricosporonales species. To select genes suitable for phylogenetic analysis, we determined the draft genomes of 17 Trichosporonales species and extracted 30 protein-coding DNA sequences (CDSs) from genomic data. The CDS regions of Trichosporon asahii and T. faecale were identified by referring to mRNA sequence data since the intron positions of the respective genes differed from those of Cryptococcus neoformans (outgroup) and are not conserved within this order. A multiple alignment of the respective gene was first constructed using the CDSs of T. asahii, T. faecale and C. neoformans, and those of other species were added and aligned based on codons. The phylogenetic trees were constructed based on each gene and a concatenated alignment. Resolution of the maximum-likelihood trees estimated from the concatenated dataset based on both nucleotide (72,531) and amino acid (24,173) sequences were greater than in previous reports. In addition, we found that several genes, such as phosphatidylinositol 3-kinase TOR1 and glutamate synthase (NADH), had good resolution in this group (even when used alone). Our study proposes a set of genes suitable for constructing a phylogenetic tree with high resolution to examine evolutionary diversification in Trichosporonales. These can also be used for epidemiological and biogeographical studies, and may also serve as the basis for a comprehensive reclassification of pleomorphic fungi.	[Takashima, Masako; Ohkuma, Moriya] RIKEN BioResource Ctr, Japan Collect Microorganisms, Tsukuba, Ibaraki 3050074, Japan; [Manabe, Ri-ichiroh] RIKEN Ctr Life Sci Technol, Div Genom Technol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Iwasaki, Wataru] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130032, Japan; [Ohyama, Akira] In Silico Biol Inc, SOHO Stn 706, Planning, Naka Ku, Yokohama, Kanagawa 2310023, Japan; [Sugita, Takashi] Meiji Pharmaceut Univ, Dept Microbiol, Tokyo 2048588, Japan	RIKEN; RIKEN; University of Tokyo; Meiji Pharmaceutical University	Takashima, M (corresponding author), RIKEN BioResource Ctr, Japan Collect Microorganisms, Tsukuba, Ibaraki 3050074, Japan.	masako@jcm.riken.jp	Ohkuma, Moriya/A-8100-2011; Iwasaki, Wataru/O-4917-2014; Takashima, Masako/N-7959-2015	Iwasaki, Wataru/0000-0002-9169-9245; 	Institute of Fermentation, Osaka; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Innovative Technology (the Cell Innovation Program) from MEXT, Japan	Institute of Fermentation, Osaka; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Innovative Technology (the Cell Innovation Program) from MEXT, Japan	This study was supported primarily by a grant from the Institute of Fermentation, Osaka, awarded to MT. RM was supported by a research grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) to the RIKEN Center for Life Science Technologies (the RIKEN Omics Science Center ceased to exist on 1 April 2013 owing to the reorganization of RIKEN) and by a grant of the Innovative Cell Biology by Innovative Technology (the Cell Innovation Program) from MEXT, Japan to Yoshihide Hayashizaki. In silico biology, inc. provided support in the form of salaries for author AO but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.'	Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Boekhout T, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1623, DOI 10.1016/B978-0-444-52149-1.00137-3; Colombo AL, 2011, CLIN MICROBIOL REV, V24, P682, DOI 10.1128/CMR.00003-11; Daniel HM, 2014, ANTON LEEUW INT J G, V106, P67, DOI 10.1007/s10482-014-0170-z; Fell JW, 2000, INT J SYST EVOL MICR, V50, P1351, DOI 10.1099/00207713-50-3-1351; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Findley K, 2009, EUKARYOT CELL, V8, P353, DOI 10.1128/EC.00373-08; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Fonseca A, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1661, DOI 10.1016/B978-0-444-52149-1.00138-5; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guerreiro MA, 2013, EUKARYOT CELL, V12, P746, DOI 10.1128/EC.00065-13; Gujjari P, 2011, MYCOLOGIA, V103, P1110, DOI 10.3852/10-403; HASSAN M, 1995, PROCESS BIOCHEM, V30, P629, DOI 10.1016/0032-9592(94)00061-L; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Ichikawa T, 2001, EUR J BIOCHEM, V268, P5098, DOI 10.1046/j.0014-2956.2001.02438.x; Ichikawa T, 2001, CARBOHYD RES, V330, P495, DOI 10.1016/S0008-6215(00)00325-6; Ikeda R, 1996, MICROBIOL IMMUNOL, V40, P813, DOI 10.1111/j.1348-0421.1996.tb01146.x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kawaji H, 2014, GENOME RES, V24, P708, DOI 10.1101/gr.156232.113; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koufopanou V, 2013, FEMS YEAST RES, V13, P574, DOI 10.1111/1567-1364.12059; Kuramae EE, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-134; Kuramae EE, 2006, FEMS YEAST RES, V6, P1213, DOI 10.1111/j.1567-1364.2006.00119.x; Kurtzman CP, 2013, FEMS YEAST RES, V13, P23, DOI 10.1111/1567-1364.12006; Matheny PB, 2007, MOL PHYLOGENET EVOL, V43, P430, DOI 10.1016/j.ympev.2006.08.024; Millanes AM, 2011, MOL PHYLOGENET EVOL, V61, P12, DOI 10.1016/j.ympev.2011.05.014; Molnar O, 2004, SYST APPL MICROBIOL, V27, P661, DOI 10.1078/0723202042369947; MOORE RT, 1980, BOT MAR, V23, P361; Nagy LG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5471; Okoli I, 2007, FEMS YEAST RES, V7, P339, DOI 10.1111/j.1567-1364.2006.00164.x; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Sampaio JP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1485, DOI 10.1016/B978-0-444-52149-1.00120-8; Schulze I, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0024-0; Shertz CA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-510; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Sugita T, 2005, APPL ENVIRON MICROB, V71, P7626, DOI 10.1128/AEM.71.11.7626-7629.2005; Sugita T, 2000, MICROBIOL IMMUNOL, V44, P455, DOI 10.1111/j.1348-0421.2000.tb02520.x; Sugita Takashi, 1998, Mycoscience, V39, P7, DOI 10.1007/BF02461572; Sugita T, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P2015, DOI 10.1016/B978-0-444-52149-1.00161-0; Takashima M, 2001, INT J SYST EVOL MICR, V51, P2199, DOI 10.1099/00207713-51-6-2199; Takashima M., 1999, MICROBIOL CULT COLL, V15, P35; Takashima Masako, 2000, Mycoscience, V41, P357, DOI 10.1007/BF02463949; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanimura A, 2014, BIORESOURCE TECHNOL, V153, P230, DOI 10.1016/j.biortech.2013.11.086; Wang H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-195; Weiss M, 2014, SYSTEMATICS EVOLUTIO, VVII, P331, DOI DOI 10.1007/978-3-642-55318-9_12	47	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0131217	10.1371/journal.pone.0131217	http://dx.doi.org/10.1371/journal.pone.0131217			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241762	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942700002
J	Zhu, MK; Chen, GP; Dong, TT; Wang, LL; Zhang, JL; Zhao, ZP; Hu, ZL				Zhu, Mingku; Chen, Guoping; Dong, Tingting; Wang, Lingling; Zhang, Jianling; Zhao, Zhiping; Hu, Zongli			SlDEAD31, a Putative DEAD-Box RNA Helicase Gene, Regulates Salt and Drought Tolerance and Stress-Related Genes in Tomato	PLOS ONE			English	Article							TIME RT-PCR; ABIOTIC STRESS; OXIDATIVE STRESS; TRANSCRIPTION FACTORS; MOLECULAR-CLONING; SALINITY STRESS; ARABIDOPSIS; RESPONSES; FAMILY; PROTEIN	The DEAD-box RNA helicases are involved in almost every aspect of RNA metabolism, associated with diverse cellular functions including plant growth and development, and their importance in response to biotic and abiotic stresses is only beginning to emerge. However, none of DEAD-box genes was well characterized in tomato so far. In this study, we reported on the identification and characterization of two putative DEAD-box RNA helicase genes, SlDEAD30 and SlDEAD31 from tomato, which were classified into stress-related DEAD-box proteins by phylogenetic analysis. Expression analysis indicated that SlDEAD30 was highly expressed in roots and mature leaves, while SlDEAD31 was constantly expressed in various tissues. Furthermore, the expression of both genes was induced mainly in roots under NaCl stress, and SlDEAD31 mRNA was also increased by heat, cold, and dehydration. In stress assays, transgenic tomato plants overexpressing SlDEAD31 exhibited dramatically enhanced salt tolerance and slightly improved drought resistance, which were simultaneously demonstrated by significantly enhanced expression of multiple biotic and abiotic stress-related genes, higher survival rate, relative water content (RWC) and chlorophyll content, and lower water loss rate and malondialdehyde (MDA) production compared to wild-type plants. Collectively, these results provide a preliminary characterization of SlDEAD30 and SlDEAD31 genes in tomato, and suggest that stress-responsive SlDEAD31 is essential for salt and drought tolerance and stress-related gene regulation in plants.	[Zhu, Mingku; Chen, Guoping; Dong, Tingting; Wang, Lingling; Zhang, Jianling; Zhao, Zhiping; Hu, Zongli] Chongqing Univ, Bioengn Coll, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 400044, Peoples R China	Chongqing University	Hu, ZL (corresponding author), Chongqing Univ, Bioengn Coll, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 400044, Peoples R China.	huzongli71@163.com	朱, 明库/ABD-8211-2021		National Natural Science Foundation of China [31171968]; Natural Science Foundation of Chongqing of China [CSTC2013jcyjA0001]; Fundamental Research Funds for the Central Universities [106112015CDJZR235504]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing of China(Natural Science Foundation of Chongqing); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (31171968), the Natural Science Foundation of Chongqing of China (CSTC2013jcyjA0001), and the Fundamental Research Funds for the Central Universities (No. 106112015CDJZR235504). ZH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin M, 2012, MOL BREEDING, V30, P345, DOI 10.1007/s11032-011-9625-3; AN G, 1987, METHOD ENZYMOL, V153, P292; Bernadac A, NATO SCI SERIES, V3492003, P118; Boudet N, 2001, GENOME RES, V11, P2101, DOI 10.1101/gr.200801; Bussink HJ, 2001, EUR J BIOCHEM, V268, P15, DOI 10.1046/j.1432-1327.2001.01774.x; Chung E, 2009, GENE, V443, P91, DOI 10.1016/j.gene.2009.05.005; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Dhanda SS, 1998, EUPHYTICA, V104, P39, DOI 10.1023/A:1018644113378; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Foolad MR, 2007, ADV MOL BREEDING DRO, P669, DOI DOI 10.1007/978-1-4020-5578-2-27; Gong ZZ, 2005, PLANT CELL, V17, P256, DOI 10.1105/tpc.104.027557; Gong ZZ, 2002, P NATL ACAD SCI USA, V99, P11507, DOI 10.1073/pnas.172399299; Guan QM, 2013, PLANT CELL, V25, P342, DOI 10.1105/tpc.112.108340; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Kant P, 2007, PLANT PHYSIOL, V145, P814, DOI 10.1104/pp.107.099895; Kazan K, 2003, TRENDS PLANT SCI, V8, P468, DOI 10.1016/j.tplants.2003.09.001; Kim JS, 2008, PLANT CELL PHYSIOL, V49, P1563, DOI 10.1093/pcp/pcn125; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Lee KH, 2013, PLANT J, V73, P720, DOI 10.1111/tpj.12055; Li DY, 2008, J EXP BOT, V59, P2133, DOI 10.1093/jxb/ern072; Lim CJ, 2010, BIOCHEM BIOPH RES CO, V399, P750, DOI 10.1016/j.bbrc.2010.08.016; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Linder P, 2009, TRENDS PLANT SCI, V14, P344, DOI 10.1016/j.tplants.2009.03.007; Liu HH, 2008, J EXP BOT, V59, P633, DOI 10.1093/jxb/erm355; Liu M, 2010, J INTEGR PLANT BIOL, V52, P817, DOI 10.1111/j.1744-7909.2010.00972.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu C, 2013, AFR J BIOTECHNOL, V9, P6294; Macovei A, 2012, PLANT SIGNAL BEHAV, V7, P1138, DOI [10.4161/psb.21343, 10.4161/psb.21586]; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Najami N, 2008, MOL GENET GENOMICS, V279, P171, DOI 10.1007/s00438-007-0305-2; Nakamura T, 2004, PLANT SCI, V167, P63, DOI 10.1016/j.plantsci.2004.03.001; Nemati SH., 2011, J BIOL ENV SCI, V5, P159, DOI DOI 10.1007/S12298-011-0097-Z; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Owttrim GW, 2006, NUCLEIC ACIDS RES, V34, P3220, DOI 10.1093/nar/gkl408; Pan Y, 2012, PLANT CELL REP, V31, P349, DOI 10.1007/s00299-011-1170-3; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schutzendubel A, 2002, J EXP BOT, V53, P1351, DOI 10.1093/jexbot/53.372.1351; Spooner DM, 2005, TAXON, V54, P43, DOI 10.2307/25065301; Tang YM, 2012, PHYSIOL PLANTARUM, V144, P210, DOI 10.1111/j.1399-3054.2011.01539.x; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tripurani SK, 2011, PLANT MOL BIOL REP, V29, P761, DOI 10.1007/s11105-010-0282-1; Tuteja N, 2003, J EXP BOT, V54, P2201, DOI 10.1093/jxb/erg246; Tuteja N, 2009, MUTAT RES-REV MUTAT, V681, P134, DOI 10.1016/j.mrrev.2008.06.004; Umate P, 2010, PLANT MOL BIOL, V73, P449, DOI 10.1007/s11103-010-9632-5; Vashisht AA, 2006, J PHOTOCH PHOTOBIO B, V84, P150, DOI 10.1016/j.jphotobiol.2006.02.010; Wang YC, 2000, PLANT CELL, V12, P2129, DOI 10.1105/tpc.12.11.2129; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Western TL, 2002, DEVELOPMENT, V129, P1569; Xu RR, 2013, GENE, V513, P128, DOI 10.1016/j.gene.2012.10.053; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yoine M, 2006, PLANT CELL PHYSIOL, V47, P572, DOI 10.1093/pcp/pcj035; Zhang CJ, 2011, PLANT CELL REP, V30, P389, DOI 10.1007/s00299-010-0939-0; Zhang WW, 2014, PLANT SOIL, V381, P143, DOI 10.1007/s11104-014-2120-y; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	59	25	30	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133849	10.1371/journal.pone.0133849	http://dx.doi.org/10.1371/journal.pone.0133849			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241658	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700025
J	Fang, CL; Ma, HT; Wang, J				Fang, Chuanglin; Ma, Haitao; Wang, Jing			A Regional Categorization for "New-Type Urbanization" in China	PLOS ONE			English	Article							RURAL INCOME DISPARITY; SUSTAINABLE URBANIZATION; PERI-URBANIZATION; FOOD SECURITY; LAND-USE; URBAN; AREA	Regional differences in the character of urbanization in China are substantial. The promotion of what has been termed "new-type urbanization" cannot, as a result of these regional differences, be expected to follow a universal approach-rather, such a development must objectively adhere to locational and category-specific principles and adopt differentiated urbanization development models. Regional categorization is often used in geography, but is rarely deployed in research addressing human and social problems relating to urbanization. In March 2014, China published the National New-type Urbanization Plan (2014-2020), which calls for the scientific and reasonable planning of "new-type urbanization," and appropriate regional categorizations are urgently needed in order to guide this reform. Responding to this challenge, this research engaged in the design of a "dominantly quantitative analysis, qualitatively supplemented" method in order to divide China into 5 main regions and 47 sub-regions in terms of new-type urbanization. The paper discusses the features and key problems of each region. This study introduces a new method for regional categorization, thereby remedying the lack of regional categorization in relation to "new-type urbanization" in China, and ultimately promoting the development of regional categorization in the humanities as a valuable reference for healthy and sustainable Chinese urbanization.	[Fang, Chuanglin; Ma, Haitao] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Fang, Chuanglin; Ma, Haitao] Chinese Acad Sci, Key Lab Reg Sustainable Dev Modeling, Beijing, Peoples R China; [Wang, Jing] Beijing Acad Social Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; Beijing Academy of Social Sciences	Ma, HT (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	maht@igsnrr.ac.cn			National Natural Science Foundation of China [41371177, 71433008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant no 41371177, 71433008; http://www.nsfc.gov.cn/). The funder contributed to study design.	Bai XM, 2014, NATURE, V509, P158, DOI 10.1038/509158a; Cao HH, 2010, REG STUD, V44, P965, DOI 10.1080/00343400903401550; Cao SX, 2014, LAND USE POLICY, V39, P412, DOI 10.1016/j.landusepol.2013.12.004; Chan KW, 2014, EURASIAN GEOGR ECON, V55, P1, DOI 10.1080/15387216.2014.925410; Chen Q, 2014, CHINA ECON REV, V30, P485, DOI 10.1016/j.chieco.2014.07.005; Chen WY, 2015, APPL GEOGR, V58, P32, DOI 10.1016/j.apgeog.2015.01.007; Christiansen F, 2009, J AGRAR CHANGE, V9, P548, DOI 10.1111/j.1471-0366.2009.00231.x; Deng XZ, 2014, ENVIRONMENT, V56, P12, DOI 10.1080/00139157.2014.901836; Fan WQ, 2014, ADV MATER RES-SWITZ, V919-921, P1577, DOI 10.4028/www.scientific.net/AMR.919-921.1577; [方创琳 FANG ChuangLin], 2011, [地理科学, Scientia Geographica Sinica], V31, P1025; Fang CL, 2011, REPORT CHINESE URBAN; Huo YJ, 2013, APPL MECH MATER, V409-410, P908, DOI 10.4028/www.scientific.net/AMM.409-410.908; Li JD, 2014, SUSTAINABILITY-BASEL, V6, P4042, DOI 10.3390/su6074042; Li YC, 2014, HABITAT INT, V42, P76, DOI 10.1016/j.habitatint.2013.10.009; Lian HP, 2014, WORLD DEV, V61, P1, DOI 10.1016/j.worlddev.2014.03.026; Lin GCS, 2014, ENVIRON PLANN A, V46, P1814, DOI 10.1068/a130016p; Lin XQ, 2015, J GEOGR SCI, V25, P545, DOI 10.1007/s11442-015-1186-7; Liu R, 2012, ENVIRON PLANN A, V44, P1219, DOI 10.1068/a44294; Liu SW, 2014, HABITAT INT, V42, P103, DOI 10.1016/j.habitatint.2013.11.003; Long HL, 2014, HABITAT INT, V44, P536, DOI 10.1016/j.habitatint.2014.10.011; Magdoff F, 2012, MON REV, V64, P1; News B, 2013, SEATTLE TIMES; Ong LH, 2014, CHINA QUART, V217, P162, DOI 10.1017/S0305741014000010; PETERSEN E, 2010, J URBAN AFF, V32, P517; Qian JX, 2012, HABITAT INT, V36, P152, DOI 10.1016/j.habitatint.2011.06.012; Shen LY, 2014, HABITAT INT, V44, P111, DOI 10.1016/j.habitatint.2014.05.009; Sun PJ, 2013, CHINESE GEOGR SCI, V23, P729, DOI 10.1007/s11769-013-0634-5; Wang FL, 2015, CHINESE GEOGR SCI, V25, P98, DOI 10.1007/s11769-014-0713-2; Wei YD, 2014, STOCH ENV RES RISK A, V28, P757, DOI 10.1007/s00477-013-0840-9; Wei YD, 2014, STOCH ENV RES RISK A, V28, P755, DOI 10.1007/s00477-013-0820-0; Wu FL, 2009, J REGIONAL SCI, V49, P232, DOI 10.1111/j.1467-9787.2008.00604_13.x; Yang XJ, 2013, SCIENCE, V342, P310, DOI 10.1126/science.342.6156.310-a; Yeung YM, 2009, CHINA REV, V9, P193; Young D, 1998, URBAN STUD, V35, P1439, DOI 10.1080/0042098984222; Yu ATW, 2014, HABITAT INT, V44, P177, DOI 10.1016/j.habitatint.2014.06.007; Yu TL, 2014, RUSS J ECOL+, V45, P399, DOI 10.1134/S1067413614050154; Zhang KH, 2002, URBAN STUD, V39, P2301, DOI 10.1080/0042098022000033881; Zhang QF, 2011, ECOL ECON, V70, P1051, DOI 10.1016/j.ecolecon.2011.01.016; Zhang XJ, 2008, P SOC PHOTO-OPT INST, P7083; Zhao PJ, 2013, CITIES, V30, P68, DOI 10.1016/j.cities.2011.12.008; Zhu JM, 2014, URBAN STUD, V51, P1120, DOI 10.1177/0042098013499083; Zhu L, 2011, CHINA WORLD ECON, V19, P40, DOI 10.1111/j.1749-124X.2011.01234.x	42	25	34	11	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134253	10.1371/journal.pone.0134253	http://dx.doi.org/10.1371/journal.pone.0134253			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1UY	26237405	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942400020
J	Malathy, EM; Muthuswamy, V				Malathy, E. M.; Muthuswamy, Vijayalakshmi			Knapsack - TOPSIS Technique for Vertical Handover in Heterogeneous Wireless Network	PLOS ONE			English	Article							DECISION ALGORITHM; AUTHENTICATION SCHEME; QUALITY; SERVICE; ENVIRONMENT	In a heterogeneous wireless network, handover techniques are designed to facilitate anywhere/anytime service continuity for mobile users. Consistent best-possible access to a network with widely varying network characteristics requires seamless mobility management techniques. Hence, the vertical handover process imposes important technical challenges. Handover decisions are triggered for continuous connectivity of mobile terminals. However, bad network selection and overload conditions in the chosen network can cause fallout in the form of handover failure. In order to maintain the required Quality of Service during the handover process, decision algorithms should incorporate intelligent techniques. In this paper, a new and efficient vertical handover mechanism is implemented using a dynamic programming method from the operation research discipline. This dynamic programming approach, which is integrated with the Technique to Order Preference by Similarity to Ideal Solution (TOPSIS) method, provides the mobile user with the best handover decisions. Moreover, in this proposed handover algorithm a deterministic approach which divides the network into zones is incorporated into the network server in order to derive an optimal solution. The study revealed that this method is found to achieve better performance and QoS support to users and greatly reduce the handover failures when compared to the traditional TOPSIS method. The decision arrived at the zone gateway using this operational research analytical method (known as the dynamic programming knapsack approach together with Technique to Order Preference by Similarity to Ideal Solution) yields remarkably better results in terms of the network performance measures such as throughput and delay.	[Malathy, E. M.; Muthuswamy, Vijayalakshmi] Anna Univ, Coll Engn, Dept Informat Sci & Technol, Madras 600025, Tamil Nadu, India	Anna University; Anna University Chennai	Malathy, EM (corresponding author), Anna Univ, Coll Engn, Dept Informat Sci & Technol, Madras 600025, Tamil Nadu, India.	malathyem@ssn.edu.in	E.M, Malathy/ABC-4943-2021; Muthuswamy, Vijayalakshmi/S-7222-2019	Muthuswamy, Vijayalakshmi/0000-0003-4748-990X				Alam N., 2012, 19 INT C TEL ICT 23, P1; Bellavista P, 2010, IEEE COMMUN MAG, V48, P114, DOI 10.1109/MCOM.2010.5439084; Bessie Malila, 2013, IEEE C EUR ITS TEL I, P266; Bhosale S, 2014, KSII T INTERNET INF, V8, P35, DOI 10.3837/tiis.2014.01.003; Busanelli S., 2011, INT J ENERGY INFORM, V2, P75; Fu AM, 2014, KSII T INTERNET INF, V8, P3250, DOI 10.3837/tiis.2014.09.017; Ghahfarokhi BS, 2011, WIREL COMMUN MOB COM, V11, P723, DOI 10.1002/wcm.854; Huang KL, 2013, WIRELESS PERS COMMUN, V71, P555, DOI 10.1007/s11277-012-0828-7; Jakimoski K., 2012, IEEE INT J ADV SCI T, V49, P1; Kantubukta V, 2013, IET NETW, V2, P103, DOI 10.1049/iet-net.2012.0183; Kassar M, 2008, COMPUT COMMUN, V31, P2607, DOI 10.1016/j.comcom.2008.01.044; Khattab O., 2013, INT J COMPUTER NETWO, V5, P53, DOI DOI 10.5121/IJCNC.2013.5304; Kumar R, 2010, INT J NEXT GENERATIO, V2, P80, DOI DOI 10.5121/IJNGN.2010.2308; Maaloul Sassi, 2012, INT J COMPUTER APPL, V47, P6, DOI [10.5120/7302-0498, DOI 10.5120/7302-0498]; Mahmood A., 2013, ASIAN J APPL SCI, V1, P229; Omar Khattab, 2013, INT J FUTURE GENERAT, V6; SAATY TL, 1990, EUR J OPER RES, V48, P9, DOI 10.1016/0377-2217(90)90057-I; Savitha K., 2010, J COMPUTER APPL JCA, V3, P12; Singhrova A, 2012, IET COMMUN, V6, P211, DOI 10.1049/iet-com.2010.0820; Song QY, 2005, IEEE WIREL COMMUN, V12, P42; Stevens N E, 2010, IEEE T VEH TECHNOL, V59, P431, DOI [10.1109/TVT.2009.2032235, DOI 10.1109/TVT.2009.2032235]; Stevens-Navarro E, 2008, INT J FUTUR GENER CO, V1, P51; Vasu K, 2012, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2012-322; Vladimir Lavrukhin, IEEE 13 INT C ITS TE, P266	24	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134232	10.1371/journal.pone.0134232	http://dx.doi.org/10.1371/journal.pone.0134232			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237221	gold, Green Submitted, Green Published			2022-12-27	WOS:000358942400018
J	Abbott, MJ; Roth, TM; Ho, L; Wang, LP; O'Carroll, D; Nissenson, RA				Abbott, Marcia J.; Roth, Theresa M.; Ho, Linh; Wang, Liping; O'Carroll, Dylan; Nissenson, Robert A.			Negative Skeletal Effects of Locally Produced Adiponectin	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE MASS; INSULIN SENSITIVITY; ADIPOSE-TISSUE; PPAR-GAMMA; OSTEOBLAST DIFFERENTIATION; ADIPOCYTE DIFFERENTIATION; CIRCULATING ADIPONECTIN; SUPPRESSING OSTEOCLAST; MARROW FAT	Epidemiological studies show that high circulating levels of adiponectin are associated with low bone mineral density. The effect of adiponectin on skeletal homeostasis, on osteoblasts in particular, remains controversial. We investigated this issue using mice with adipocyte-specific over-expression of adiponectin (AdTg). MicroCT and histomorphometric analysis revealed decreases (15%) in fractional bone volume in AdTg mice at the proximal tibia with no changes at the distal femur. Cortical bone thickness at mid-shafts of the tibia and at the tibiofibular junction was reduced (3-4%) in AdTg mice. Dynamic histomorphometry at the proximal tibia in AdTg mice revealed inhibition of bone formation. AdTg mice had increased numbers of adipocytes in close proximity to trabecular bone in the tibia, associated with increased adiponectin levels in tibial marrow. Treatment of BMSCs with adiponectin after initiation of osteoblastic differentiation resulted in reduced mineralized colony formation and reduced expression of mRNA of osteoblastic genes, osterix (70%), Runx2 (52%), alkaline phosphatase (72%), Col1 (74%), and osteocalcin (81%). Adiponectin treatment of differentiating osteoblasts increased expression of the osteoblast genes PPAR gamma (32%) and C/ebp alpha (55%) and increased adipocyte colony formation. These data suggest a model in which locally produced adiponectin plays a negative role in regulating skeletal homeostasis through inhibition of bone formation and by promoting an adipogenic phenotype.	[Abbott, Marcia J.; Roth, Theresa M.; Ho, Linh; Wang, Liping; O'Carroll, Dylan; Nissenson, Robert A.] Univ Calif San Francisco, VA Med Ctr, Endocrine Res Unit, San Francisco, CA 94143 USA; [Abbott, Marcia J.; Roth, Theresa M.; Ho, Linh; Wang, Liping; O'Carroll, Dylan; Nissenson, Robert A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Abbott, Marcia J.; Roth, Theresa M.; Ho, Linh; Wang, Liping; O'Carroll, Dylan; Nissenson, Robert A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Abbott, Marcia J.] Chapman Univ, Crean Coll Hlth & Behav Sci, Dept Hlth Sci & Kinesiol, Orange, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Chapman University System; Chapman University	Nissenson, RA (corresponding author), Univ Calif San Francisco, VA Med Ctr, Endocrine Res Unit, San Francisco, CA 94143 USA.	Robert.Nissenson@ucsf.edu		Ho, Linh/0000-0001-9252-8539	Department of Veterans Affairs (Merit Review grant) [1I01BX001496]	Department of Veterans Affairs (Merit Review grant)(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs (Merit Review grant 1I01BX001496), to RAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Barbour KE, 2011, J BONE MINER RES, V26, P1568, DOI 10.1002/jbmr.361; Berner HS, 2004, BONE, V35, P842, DOI 10.1016/j.bone.2004.06.008; Cawthorn WP, 2014, CELL METAB, V20, P368, DOI 10.1016/j.cmet.2014.06.003; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; Ealey KN, 2008, EXP BIOL MED, V233, P1546, DOI 10.3181/0806-RM-192; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; Gimble JM, 2012, CLIN BIOCHEM, V45, P874, DOI 10.1016/j.clinbiochem.2012.03.006; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Huang JC, 2004, J BONE MINER RES, V19, P235, DOI 10.1359/JBMR.0301226; Jurimae J, 2007, AM J PHYSIOL-ENDOC M, V293, pE42, DOI 10.1152/ajpendo.00610.2006; Kajimura D, 2013, CELL METAB, V17, P901, DOI 10.1016/j.cmet.2013.04.009; Kao R, 2012, ENDOCRINE, V42, P622, DOI 10.1007/s12020-012-9717-9; Kao RS, 2013, BONE, V55, P277, DOI 10.1016/j.bone.2013.04.001; Krings A, 2012, BONE, V50, P546, DOI 10.1016/j.bone.2011.06.016; Lecka-Czernik Beata, 2010, Curr Osteoporos Rep, V8, P84, DOI 10.1007/s11914-010-0016-1; Lee HW, 2009, STEM CELLS, V27, P2254, DOI 10.1002/stem.144; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Lin YY, 2014, BONE, V64, P147, DOI 10.1016/j.bone.2014.03.051; Liu LF, 2010, J CELL PHYSIOL, V225, P837, DOI 10.1002/jcp.22291; Luo E, 2012, ACTA BIOMATER, V8, P734, DOI 10.1016/j.actbio.2011.10.029; Millard SM, 2011, J BONE MINER RES, V26, P822, DOI 10.1002/jbmr.273; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Naot D, 2012, ENDOCRINOLOGY, V153, P2076, DOI 10.1210/en.2011-2004; Napoli N, 2010, BONE, V47, P1001, DOI 10.1016/j.bone.2010.08.010; Oshima K, 2005, BIOCHEM BIOPH RES CO, V331, P520, DOI 10.1016/j.bbrc.2005.03.210; Peng J, 2008, ENDOCRINOLOGY, V149, P1329, DOI 10.1210/en.2007-0235; Reid IR, 2010, ARCH BIOCHEM BIOPHYS, V503, P20, DOI 10.1016/j.abb.2010.06.027; Ritchie IRW, 2011, AM J PHYSIOL-REG I, V300, pR492, DOI 10.1152/ajpregu.00602.2010; Rosen CJ, 2009, CRIT REV EUKAR GENE, V19, P109, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.20; Sadie-Van Gijsen H, 2013, CELL MOL LIFE SCI, V70, P2331, DOI 10.1007/s00018-012-1211-2; Shafiei MS, 2011, AM J PATHOL, V178, P2690, DOI 10.1016/j.ajpath.2011.02.035; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Turner JJO, 2009, SCAND J IMMUNOL, V69, P329, DOI 10.1111/j.1365-3083.2008.02224.x; Wang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068497; Wattanachanya L, 2013, ENDOCRINOLOGY, V154, P2069, DOI 10.1210/en.2012-2034; Williams GA, 2009, ENDOCRINOLOGY, V150, P3603, DOI 10.1210/en.2008-1639; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Wren TAL, 2011, J CLIN ENDOCR METAB, V96, P782, DOI 10.1210/jc.2010-1922; Wu YW, 2014, AM J PHYSIOL-ENDOC M, V306, pE1418, DOI 10.1152/ajpendo.00048.2014; Yamauchi T, 2014, BEST PRACT RES CL EN, V28, P15, DOI 10.1016/j.beem.2013.09.003; Zaidi M, 2012, ENDOCRINOLOGY, V153, P2070, DOI 10.1210/en.2012-1022	43	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134290	10.1371/journal.pone.0134290	http://dx.doi.org/10.1371/journal.pone.0134290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230337	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400100
J	Koenigs, A; Zipfel, PF; Kraiczy, P				Koenigs, Arno; Zipfel, Peter F.; Kraiczy, Peter			Translation Elongation Factor Tuf of Acinetobacter baumannii Is a Plasminogen-Binding Protein	PLOS ONE			English	Article							FACTOR EF-TU; IMMUNE EVASION; FACTOR-H; PSEUDOMONAS-AERUGINOSA; LEGIONELLA-PNEUMOPHILA; BORRELIA-BURGDORFERI; SURFACE PROTEIN; BACTERIAL; COMPLEMENT; ACTIVATION	Acinetobacter baumannii is an important nosocomial pathogen, causing a variety of opportunistic infections of the skin, soft tissues and wounds, urinary tract infections, secondary meningitis, pneumonia and bacteremia. Over 63% of A. baumannii infections occurring in the United States are caused by multidrug resistant isolates, and pan-resistant isolates have begun to emerge that are resistant to all clinically relevant antibiotics. The complement system represents the first line of defense against invading pathogens. However, many A. baumannii isolates, especially those causing severe bacteremia are resistant to complement- mediated killing, though the underlying mechanisms remain poorly understood. Here we show for the first time that A. baumannii binds host-derived plasminogen and we identify the translation elongation factor Tuf as a moonlighting plasminogen-binding protein that is exposed on the outer surface of A. baumannii. Binding of plasminogen to Tuf is at least partly dependent on lysine residues and ionic interactions. Plasminogen, once bound to Tuf can be converted to active plasmin and proteolytically degrade fibrinogen as well as the key complement component C3b. Thus, Tuf acts as a multifunctional protein that may contribute to virulence of A. baumannii by aiding in dissemination and evasion of the complement system.	[Koenigs, Arno; Kraiczy, Peter] Univ Hosp, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Zipfel, Peter F.] Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany; [Zipfel, Peter F.] Univ Jena, Jena, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Kraiczy, P (corresponding author), Univ Hosp, Inst Med Microbiol & Infect Control, Frankfurt, Germany.	Kraiczy@em.uni-frankfurt.de						Antunes LCS, 2014, PATHOG DIS, V71, P292, DOI 10.1111/2049-632X.12125; Baensch M, 1998, MICROBIOL-UK, V144, P2241, DOI 10.1099/00221287-144-8-2241; Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Barthel D, 2012, J BIOL CHEM, V287, P18831, DOI 10.1074/jbc.M111.323287; Barthel D, 2012, J IMMUNOL, V188, P379, DOI 10.4049/jimmunol.1101927; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BHAKDI S, 1991, IMMUNOL TODAY, V12, P318, DOI 10.1016/0167-5699(91)90007-G; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; Candela M, 2010, MICROBIOL-SGM, V156, P1609, DOI 10.1099/mic.0.038307-0; Cateau E, 2014, J HOSP INFECT, V87, P131, DOI 10.1016/j.jhin.2014.05.001; Cateau E, 2011, FEMS MICROBIOL LETT, V319, P19, DOI 10.1111/j.1574-6968.2011.02261.x; CDC U, 2013, ANTIBIOTIC RESISTANC; Chapman MR, 2010, MBIO, V1, DOI [10.1128/mBio.00131-10, DOI 10.1128/MBI0.00131-10]; COLEMAN JL, 1995, INFECT IMMUN, V63, P2478, DOI 10.1128/IAI.63.7.2478-2484.1995; Copley SD, 2012, BIOESSAYS, V34, P578, DOI 10.1002/bies.201100191; Coulon C, 2010, J CLIN MICROBIOL, V48, P2689, DOI 10.1128/JCM.00309-10; Dallo SF, 2012, THESCIENTIFICWORLDJO, V2012, DOI DOI 10.1100/2012/128705; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Falagas ME, 2007, CRIT CARE, V11, DOI 10.1186/cc5911; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Floden AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027502; Fulde M, 2011, BIOCHEM J, V434, P523, DOI 10.1042/BJ20101121; Gottig S, 2014, J ANTIMICROB CHEMOTH, V69, P2578, DOI 10.1093/jac/dku170; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; Grundy JE, 2007, THROMB HAEMOSTASIS, V97, P38, DOI 10.1160/TH06-08-0476; Hallstrom T, 2012, J IMMUNOL, V189, P4939, DOI 10.4049/jimmunol.1200386; Heffron SE, 2006, ACTA CRYSTALLOGR D, V62, P433, DOI 10.1107/S0907444906004021; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Joly-Guillou ML, 2005, CLIN MICROBIOL INFEC, V11, P868, DOI 10.1111/j.1469-0691.2005.01227.x; Kim SW, 2009, FEMS MICROBIOL LETT, V301, P224, DOI 10.1111/j.1574-6968.2009.01820.x; King LB, 2013, J INFECT DIS, V207, P1128, DOI 10.1093/infdis/jis939; King LB, 2009, FEMS IMMUNOL MED MIC, V55, P414, DOI 10.1111/j.1574-695X.2009.00538.x; Klos A, 2009, MOL IMMUNOL; Koenigs A, 2013, J BIOL CHEM, V288, P25229, DOI 10.1074/jbc.M112.413872; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; KUUSELA P, 1990, EUR J BIOCHEM, V193, P759, DOI 10.1111/j.1432-1033.1990.tb19397.x; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; LIJNEN HR, 1995, BAILLIERE CLIN HAEM, V8, P277, DOI 10.1016/S0950-3536(05)80268-9; LIJNEN HR, 1994, EUR J BIOCHEM, V224, P143, DOI 10.1111/j.1432-1033.1994.tb20005.x; MAYER M, 1990, CLIN BIOCHEM, V23, P197, DOI 10.1016/0009-9120(90)90601-P; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; Mohan S, 2014, MOL IMMUNOL, V62, P249, DOI 10.1016/j.molimm.2014.06.029; Muller-Eberhard HJ, 1985, J INVEST DERMATOL S, V85, p47s; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Poltermann S, 2007, J BIOL CHEM, V282, P37537, DOI 10.1074/jbc.M707280200; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; Premkumar L, 2014, J BIOL CHEM, V289, P19869, DOI 10.1074/jbc.M114.571737; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; RINGNER M, 1994, FEMS IMMUNOL MED MIC, V9, P29, DOI 10.1016/0928-8244(94)00012-3; ROWBOTHAM TJ, 1983, J CLIN PATHOL, V36, P978, DOI 10.1136/jcp.36.9.978; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Soufo HJD, 2010, P NATL ACAD SCI USA, V107, P3163, DOI 10.1073/pnas.0911979107; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Tilley D, 2014, FEMS MICROBIOL LETT, V356, P53, DOI 10.1111/1574-6968.12496; Towner KJ, 2009, J HOSP INFECT, V73, P355, DOI 10.1016/j.jhin.2009.03.032; ULLBERG M, 1990, INFECT IMMUN, V58, P21, DOI 10.1128/IAI.58.1.21-25.1990; ULLBERG M, 1989, APMIS, V97, P996, DOI 10.1111/j.1699-0463.1989.tb00508.x; URANO T, 1987, P NATL ACAD SCI USA, V84, P4031, DOI 10.1073/pnas.84.12.4031; Verma A, 2010, INFECT IMMUN, V78, P2053, DOI 10.1128/IAI.01282-09; Vieira ML, 2011, MICROB PATHOGENESIS, V51, P360, DOI 10.1016/j.micpath.2011.06.008; Vieira ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011259; Vranckx L, 2007, MICROBIOL-SGM, V153, P3757, DOI 10.1099/mic.0.2007/010116-0; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; WEBER S, 1995, J BACTERIOL, V177, P11, DOI 10.1128/jb.177.1.11-19.1995; Wolff DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081818; WU HL, 1990, J BIOL CHEM, V265, P19658; Xolalpa W, 2007, PROTEOMICS, V7, P3332, DOI 10.1002/pmic.200600876; Young KC, 1998, J BIOL CHEM, V273, P3110, DOI 10.1074/jbc.273.5.3110	69	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134418	10.1371/journal.pone.0134418	http://dx.doi.org/10.1371/journal.pone.0134418			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230848	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400117
J	Biros, E; Moran, CS; Norman, PE; Hankey, GJ; Yeap, BB; Almeida, OP; Flicker, L; White, R; Jones, R; Golledge, J				Biros, Erik; Moran, Corey S.; Norman, Paul E.; Hankey, Graeme J.; Yeap, Bu B.; Almeida, Osvaldo P.; Flicker, Leon; White, Richard; Jones, Rhondda; Golledge, Jonathan			Association between the Advanced Glycosylation End Product-Specific Receptor Gene and Cardiovascular Death in Older Men	PLOS ONE			English	Article							INHIBITS MACROPHAGE ACTIVITY; ABDOMINAL AORTIC-ANEURYSM; SPLICE VARIANTS; CAROTID PLAQUE; RAGE GENE; INFLAMMATION; HMGB1; BINDING; HEALTH; ALPHA(V)BETA(3)-INTEGRIN	Advanced glycosylation end product-specific receptor (AGER) signaling has been implicated in atherosclerosis. The aim of this study was to evaluate whether a common genetic variation in the AGER gene is associated with cardiovascular (CV) death. We included 1304 older men who were genotyped for rs1035798: C>T, which is a single nucleotide polymorphism (SNP) mapped to the third intron of AGER. Cox proportional hazard analysis was used to estimate the association of rs1035798: C>T with CV death. In addition we analyzed total RNA extracted from carotid atherosclerosis biopsies of 18 patients that did or did not have recent symptoms of cerebral embolization by quantitative real-time reverse transcription PCR (qRT-PCR). The minor T-allele of rs1035798: C>T was found to be associated with CV death under dominant (HR = 1.43, 95% CI: 1.01-2.02, P = 0.04) and recessive (HR = 2.05, 95% CI: 1.11-3.81, P = 0.02) models of inheritance even after adjustment for traditional cardiovascular risk factors. No association was found between rs1035798: C>T and non-CV death. qRT-PCR results suggested that median relative expression of AGER isoform 1 and isoform 6 transcripts were approximately 6-(P = 0.01) and 2-fold (P = 0.02) greater, respectively, within carotid biopsies of symptomatic compared to asymptomatic patients. These data suggest that the minor (T) allele of rs1035798: C>T represents an independent susceptibility factor for CV death. The expression of AGER isoforms is different in atheroma from patients with recent symptoms. Further studies are needed to investigate if rs1035798: C>T influences the alternative splicing of AGER.	[Biros, Erik; Moran, Corey S.; Jones, Rhondda; Golledge, Jonathan] James Cook Univ, Coll Med & Dent, Queensland Res Ctr Peripheral Vasc Dis, Townsville, Qld 4811, Australia; [Norman, Paul E.] Univ Western Australia, Sch Surg, Perth, WA 6009, Australia; [Hankey, Graeme J.; Yeap, Bu B.; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Hankey, Graeme J.] Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA, Australia; [Yeap, Bu B.] Fremantle Hosp, Dept Endocrinol, Perth, WA, Australia; [Yeap, Bu B.] Fiona Stanley Hosp, Dept Endocrinol, Perth, WA, Australia; [Almeida, Osvaldo P.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Almeida, Osvaldo P.; Flicker, Leon] Med Res Ctr, WA Ctr Hlth & Ageing, Perth, WA, Australia; [Almeida, Osvaldo P.] Royal Perth Hosp, Dept Psychiat, Perth, WA 6001, Australia; [Flicker, Leon] Royal Perth Hosp, Dept Geriatr Med, Perth, WA 6001, Australia; [White, Richard] Townsville Hosp, Dept Neurol, Townsville, Qld, Australia; [Golledge, Jonathan] Townsville Hosp, Dept Vasc & Endovasc Surg, Townsville, Qld, Australia	James Cook University; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; Royal Perth Hospital; University of Western Australia	Golledge, J (corresponding author), James Cook Univ, Coll Med & Dent, Queensland Res Ctr Peripheral Vasc Dis, Townsville, Qld 4811, Australia.	jonathan.golledge@jcu.edu.au	Flicker, Leon/AAE-1530-2022; Hankey, Graeme J/H-4968-2014; golledge, jonathan/I-2371-2013; Almeida, Osvaldo P./A-4925-2008; Jones, Rhondda/E-4853-2013	Flicker, Leon/0000-0002-3650-0475; Hankey, Graeme J/0000-0002-6044-7328; Almeida, Osvaldo P./0000-0002-8689-6199; golledge, jonathan/0000-0002-5779-8848; Jones, Rhondda/0000-0002-1031-2863	Townsville Private Practice Trust Fund, Australia [RG04213]; National Health and Medical Research Council [1022752, 1021416, 1020955, 1003707, 1000967]; National Heart Foundation of Australia; Queensland Government; National Health and Medical Research Council, Australia [1019921]; Health and Medical Research Office, Queensland Government	Townsville Private Practice Trust Fund, Australia; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Queensland Government; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Health and Medical Research Office, Queensland Government	The Townsville Private Practice Trust Fund (http://www.health.qld.gov.au/; RG04213), Australia, The National Health and Medical Research Council (http://www.nhmrc.gov.au/; 1022752, 1021416, 1020955, 1003707 and 1000967), The National Heart Foundation of Australia (http://www.heartfoundation.org.au/), and The Queensland Government supported this work. JG holds a Practitioner Fellowship from the National Health and Medical Research Council, Australia (1019921), and a Senior Clinical Research Fellowship from the Health and Medical Research Office, Queensland Government.	Barr ELM, 2009, INTERN MED J, V39, P49, DOI 10.1111/j.1445-5994.2008.01864.x; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bierhaus A, 2006, CURR OPIN INVEST DR, V7, P985; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Caillier SJ, 2008, J IMMUNOL, V181, P5473, DOI 10.4049/jimmunol.181.8.5473; Cipollone F, 2003, CIRCULATION, V108, P1070, DOI 10.1161/01.CIR.0000086014.80477.0D; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friggeri A, 2010, AM J PHYSIOL-CELL PH, V299, pC1267, DOI 10.1152/ajpcell.00152.2010; Goiledge J, 2008, EUR J VASC ENDOVASC, V35, P2, DOI 10.1016/j.ejvs.2007.09.004; Golledge J, 2000, STROKE, V31, P774, DOI 10.1161/01.STR.31.3.774; Golledge J, 2014, J NUTR HEALTH AGING; Golledge J, 2007, CIRCULATION, V116, P2275, DOI 10.1161/CIRCULATIONAHA.107.717926; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; Herisson F, 2011, ATHEROSCLEROSIS, V216, P348, DOI 10.1016/j.atherosclerosis.2011.02.004; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Hull J, 2007, PLOS GENET, V3, P1009, DOI 10.1371/journal.pgen.0030099; Hunter GC, 1999, J VASC SURG, V30, P36, DOI 10.1016/S0741-5214(99)70174-6; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; Li SSY, 2003, BIOSTATISTICS, V4, P513, DOI 10.1093/biostatistics/4.4.513; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; Mendis S., 2011, GLOB ATL CARD DIS PR; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Najafi AH, 2013, DIS MODEL MECH, V6, P323, DOI 10.1242/dmm.009977; Norman PE, 2009, INT J EPIDEMIOL, V38, P48, DOI 10.1093/ije/dyn041; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; Norton K., 2000, ANTHROPOMETRICA, V2, P27; Olsson S, 2013, EUR J NEUROL, V20, P991, DOI 10.1111/ene.12041; Organization WH, 2016, GLOBAL STATUS REPORT; Pisetsky DS, 2010, AM J PHYSIOL-CELL PH, V299, pC1253, DOI 10.1152/ajpcell.00397.2010; Rossi A, 2006, INT J CARDIOL, V111, P263, DOI 10.1016/j.ijcard.2005.08.030; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schlueter C, 2003, BBA-GENE STRUCT EXPR, V1630, P1, DOI 10.1016/j.bbaexp.2003.08.008; Shaikh S, 2012, EUR J VASC ENDOVASC, V44, P491, DOI 10.1016/j.ejvs.2012.08.005; Silvestre-Roig C, 2014, CIRC RES, V114, P214, DOI 10.1161/CIRCRESAHA.114.302355; Tedgui A, 2005, VASC MED, V10, P45, DOI 10.1191/1358863x05vm589ra; VanderWeele TJ, 2011, BIOMETRICS, V67, P1406, DOI 10.1111/j.1541-0420.2011.01619.x; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050790; Yan SF, 2009, ANN MED, V41, P408, DOI 10.1080/07853890902806576; Yeramian A, 2006, EUR J IMMUNOL, V36, P1516, DOI 10.1002/eji.200535694; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236	49	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134475	10.1371/journal.pone.0134475	http://dx.doi.org/10.1371/journal.pone.0134475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226616	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000358837700097
J	Gonzalez-Tokman, D; Martinez-Garza, C				Gonzalez-Tokman, Daniel; Martinez-Garza, Cristina			Effect of Ecological Restoration on Body Condition of a Predator	PLOS ONE			English	Article							ORB-WEAVING SPIDER; NEPHILA-CLAVIPES; CONSERVATION PHYSIOLOGY; MATING SUCCESS; HABITAT; TERRITORIAL; PREY; SIZE; DRAGONFLIES; NUTRITION	Ecological restoration attempts to recover the structure and function of ecosystems that have been degraded by human activities. A crucial test of ecosystem recovery would be to determine whether individuals in restored environments are as healthy as those in conserved environments. However, the impact of restoration on physiology of terrestrial animals has never been tested. Here, we evaluated the effect of two restoration methods on body condition measured as body size, body mass, lipid and muscle content of the spider Nephila clavipes in a tropical dry forest that has suffered chronic disturbance due to cattle grazing. We used experimental plots that had been excluded from disturbance by cattle grazing during eight years. Plots were either planted with native trees (i.e. maximal intervention), or only excluded from disturbance (i.e. minimal intervention), and were compared with control conserved (remnants of original forest) and disturbed plots (where cattle is allowed to graze). We predicted (1) better body condition in spiders of conserved and restored sites, compared to disturbed sites, and (2) better body condition in plots with maximal intervention than in plots with minimal intervention. The first prediction was not supported in males or females, and the second prediction was only supported in females: body dry mass was higher in planted than in conserved plots for spiders of both sexes and also higher that in disturbed plots for males, suggesting that plantings are providing more resources. We discuss how different life histories and environmental pressures, such as food availability, parasitism, and competition for resources can explain our contrasting findings in male and female spiders. By studying animal physiology in restoration experiments it is possible to understand the mechanistic basis of ecological and evolutionary processes that determine success of ecological restoration.	[Gonzalez-Tokman, Daniel; Martinez-Garza, Cristina] Univ Autonoma Estado Morelos, Ctr Invest Biodiversidad & Conservac, Cuernavaca, Morelos, Mexico; [Gonzalez-Tokman, Daniel] Consejo Nacl Ciencia & Technol, Catedras CONACYT, Mexico City, DF, Mexico	Universidad Autonoma del Estado de Morelos	Gonzalez-Tokman, D (corresponding author), Inst Ecol, AC Carretera Antigua Coatepec 351, Xalapa 91070, Veracruz, Mexico.	daniel.gt@inecol.mx	Martínez-Garza, Cristina/K-4519-2019; Martínez-Garza, Cristina/H-8956-2019; Gonzalez-Tokman, Daniel/Q-6833-2018	Martínez-Garza, Cristina/0000-0002-9310-564X; Gonzalez-Tokman, Daniel/0000-0001-7251-5773				Adams SM, 2005, HYDROBIOLOGIA, V542, P77, DOI 10.1007/s10750-004-3951-y; Bandi C, 2001, TRENDS PARASITOL, V17, P88, DOI 10.1016/S1471-4922(00)01812-2; Block WA, 2001, RESTOR ECOL, V9, P293, DOI 10.1046/j.1526-100x.2001.009003293.x; Carrasco-Carballido V., 2011, MEM C COL REST EC 2, P297; CHRISTENSON TE, 1979, BEHAV ECOL SOCIOBIOL, V5, P87, DOI 10.1007/BF00302697; COHN J, 1987, J ARACHNOL, V15, P185; Cooke SJ, 2008, BIOSCIENCE, V58, P957, DOI 10.1641/B581009; Cooke SJ, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot001; Crawley M.J., 2007, R BOOK; de la O-Toris J, 2012, BOT SCI, V90, P469, DOI 10.17129/botsci.475; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Devoto M, 2012, ECOL LETT, V15, P319, DOI 10.1111/j.1461-0248.2012.01740.x; Dorado O, 2005, PROGRAMA CONSERVACIO; ELGAR MA, 1991, EVOLUTION, V45, P444, DOI 10.1111/j.1558-5646.1991.tb04419.x; Gonzalez-Tokman D, 2011, ANIM BEHAV, V81, P1185, DOI 10.1016/j.anbehav.2011.02.027; Gonzalez-Tokman DM, 2013, FUNCT ECOL, V27, P739, DOI 10.1111/1365-2435.12072; Jimenez-Cortes JG, 2012, J INSECT PHYSIOL, V58, P318, DOI 10.1016/j.jinsphys.2011.11.004; Heiling AM, 1998, J ARACHNOL, V26, P91; HIGGINS L, 1993, J ARACHNOL, V21, P107; HIGGINS LE, 1992, ANIM BEHAV, V44, P485, DOI 10.1016/0003-3472(92)90058-H; HIGGINS LE, 1987, J ARACHNOL, V15, P401; Homyack JA, 2010, WILDLIFE RES, V37, P332, DOI 10.1071/WR08093; Howe HF, 2014, BOT SCI, V92, P459; HUEY RB, 1991, AM NAT, V137, pS91, DOI 10.1086/285141; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Jensen K, 2010, J INSECT PHYSIOL, V56, P1095, DOI 10.1016/j.jinsphys.2010.03.001; Jespersen LB, 2003, FUNCT ECOL, V17, P737, DOI 10.1111/j.1365-2435.2003.00788.x; Jones HP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005653; Juan-Baeza I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128583; Labocha MK, 2014, OIKOS, V123, P111, DOI 10.1111/j.1600-0706.2013.00755.x; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Lee KP, PHYSL ENTOMOLOGY, V29, P108; Longcore T, 2003, RESTOR ECOL, V11, P397, DOI 10.1046/j.1526-100X.2003.rec0221.x; Marden JH, 2004, ANIM BEHAV, V68, P857, DOI 10.1016/j.anbehav.2003.09.019; MARDEN JH, 1989, PHYSIOL ZOOL, V62, P505, DOI 10.1086/physzool.62.2.30156182; Martinez-Garza C, 2011, FOREST ECOL MANAG, V262, P2207, DOI 10.1016/j.foreco.2011.08.013; Martinez-Perez A, 2014, EFECTO TRATAMIENTOS; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; Mayntz D, 2001, OECOLOGIA, V127, P207, DOI 10.1007/s004420000591; McIver J, 2001, FOREST ECOL MANAG, V153, P15, DOI 10.1016/S0378-1127(01)00451-0; MCLACHLAN AD, 1984, ANNU REV BIOPHYS BIO, V13, P167; Meraz LC, 2012, J ETHOL, V30, P93, DOI 10.1007/s10164-011-0300-2; Miller LA, 2001, BIOSCIENCE, V51, P570, DOI 10.1641/0006-3568(2001)051[0570:HSIDAA]2.0.CO;2; MOORE CW, 1977, AM MIDL NAT, V98, P95, DOI 10.2307/2424717; Moya-Larano J, 2008, J ANIM ECOL, V77, P1099, DOI 10.1111/j.1365-2656.2008.01433.x; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Pekar S, 2010, ANIM BEHAV, V79, P1301, DOI 10.1016/j.anbehav.2010.03.002; R Development Core Team, 2014, R LANG ENV STAT COMP; Raubenheimer D, 2007, ECOLOGY, V88, P2598, DOI 10.1890/07-0012.1; Raubenheimer D, 2012, PHILOS T R SOC B, V367, P1628, DOI 10.1098/rstb.2012.0007; Razeng E, 2014, J AVIAN BIOL, V45, P1, DOI DOI 10.1111/JAY.00475; Richmond CE, 2005, ECOL MODEL, V188, P279, DOI 10.1016/j.ecolmodel.2005.03.002; Robinson M. H., 1976, SMITHSON CONTRIB ZOO, V218, P1; Shackelford N, 2013, RESTOR ECOL, V21, P297, DOI 10.1111/rec.12012; Simpson SJ, 2015, ANNU REV ENTOMOL, V60, P293, DOI 10.1146/annurev-ento-010814-020917; Stevenson RD, 2006, INTEGR COMP BIOL, V46, P1169, DOI 10.1093/icb/icl052; Stevenson RD, 2006, INTEGR COMP BIOL, V46, P1088, DOI 10.1093/icb/icl053; Stockwell Craig A., 2006, P113; Suding KN, 2011, ANNU REV ECOL EVOL S, V42, P465, DOI 10.1146/annurev-ecolsys-102710-145115; Toft Soren, 2013, P373; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; Warbrick-Smith J, 2006, P NATL ACAD SCI USA, V103, P14045, DOI 10.1073/pnas.0605225103; Weinstein MP, 2009, ESTUAR COAST, V32, P1011, DOI 10.1007/s12237-009-9185-5; Wikelski Martin, 2001, Trends in Ecology and Evolution, V16, P479, DOI 10.1016/S0169-5347(01)02279-0; Wilder SM, 2011, ADV INSECT PHYSIOL, V40, P87, DOI 10.1016/B978-0-12-387668-3.00002-7; Wilder SM, 2010, OIKOS, V119, P350, DOI 10.1111/j.1600-0706.2009.17819.x; Wilder SM, 2010, OECOLOGIA, V162, P617, DOI 10.1007/s00442-009-1518-3; Young TP, 2005, ECOL LETT, V8, P662, DOI 10.1111/j.1461-0248.2005.00764.x; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zedier I. B., 2006, FDN RESTORATION ECOL; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zuur Alain F., 2009, P1	72	6	6	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133551	10.1371/journal.pone.0133551	http://dx.doi.org/10.1371/journal.pone.0133551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226363	Green Submitted, gold, Green Published			2022-12-27	WOS:000358837700025
J	Heer, K; Kalko, EKV; Albrecht, L; Garcia-Villacorta, R; Staeps, FC; Herre, EA; Dick, CW				Heer, Katrin; Kalko, Elisabeth K. V.; Albrecht, Larissa; Garcia-Villacorta, Roosevelt; Staeps, Felix C.; Allen Herre, Edward; Dick, Christopher W.			Spatial Scales of Genetic Structure in Free-Standing and Strangler Figs (Ficus, Moraceae) Inhabiting Neotropical Forests	PLOS ONE			English	Article							RAIN-FOREST; FRUIT CHARACTERISTICS; TREE; SOFTWARE; BAT; PHYLOGEOGRAPHY; POPULATIONS; DISPERSAL; INSIPIDA; ECOLOGY	Wind-borne pollinating wasps (Agaonidae) can transport fig (Ficus sp., Moraceae) pollen over enormous distances (> 100 km). Because of their extensive breeding areas, Neotropical figs are expected to exhibit weak patterns of genetic structure at local and regional scales. We evaluated genetic structure at the regional to continental scale (Panama, Costa Rica, and Peru) for the free-standing fig species Ficus insipida. Genetic differentiation was detected only at distances > 300 km (Jost's D-est = 0.68 +/- 0.07 & F-ST = 0.30 +/- 0.03 between Mesoamerican and Amazonian sites) and evidence for phylogeographic structure (R-ST>>permuted R-ST) was only significant in comparisons between Central and South America. Further, we assessed local scale spatial genetic structure (SGS, d <= 8 km) in Panama and developed an agent-based model parameterized with data from F. insipida to estimate minimum pollination distances, which determine the contribution of pollen dispersal on SGS. The local scale data for F. insipida was compared to SGS data collected for an additional free-standing fig, F. yoponensis (subgenus Pharmacosycea), and two species of strangler figs, F. citrifolia and F. obtusifolia (subgenus Urostigma) sampled in Panama. All four species displayed significant SGS (mean Sp = 0.014 +/- 0.012). Model simulations indicated that most pollination events likely occur at distances > > 1 km, largely ruling out spatially limited pollen dispersal as the determinant of SGS in F. insipida and, by extension, the other fig species. Our results are consistent with the view that Ficus develops fine-scale SGS primarily as a result of localized seed dispersal and/or clumped seedling establishment despite extensive long-distance pollen dispersal. We discuss several ecological and life history factors that could have species-or subgenus-specific impacts on the genetic structure of Neotropical figs.	[Heer, Katrin] Univ Marburg, Fac Biol, Conservat Biol, D-35043 Marburg, Germany; [Heer, Katrin] Univ Marburg, Fac Biol, Dept Ecol, D-35043 Marburg, Germany; [Heer, Katrin; Kalko, Elisabeth K. V.; Albrecht, Larissa] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Kalko, Elisabeth K. V.; Allen Herre, Edward] Smithsonian Trop Res Inst, Balboa, Panama; [Garcia-Villacorta, Roosevelt] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh EH9 3JH, Midlothian, Scotland; [Dick, Christopher W.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Philipps University Marburg; Philipps University Marburg; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Edinburgh; University of Michigan System; University of Michigan	Heer, K (corresponding author), Univ Marburg, Fac Biol, Conservat Biol, Karl von Frisch Str 8, D-35043 Marburg, Germany.	katrin.heer@uni-marburg.de	Heer, Katrin/C-6725-2018	Heer, Katrin/0000-0002-1036-599X	German National Merit Foundation (Studienstiftung des Deutschen Volkes); NSF [DEB 0640379]	German National Merit Foundation (Studienstiftung des Deutschen Volkes); NSF(National Science Foundation (NSF))	The project was funded by a scholarship from the German National Merit Foundation (Studienstiftung des Deutschen Volkes) to KH and NSF funding (DEB 0640379) to CWD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, P NATL ACAD SCI USA, V106, P20342, DOI 10.1073/pnas.0902213106; [Anonymous], 2014, R LANG ENV STAT COMP; Banack SA, 2002, BIOTROPICA, V34, P232, DOI 10.1111/j.1744-7429.2002.tb00534.x; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P399, DOI 10.1146/annurev.es.21.110190.002151; BERG CC, 1989, EXPERIENTIA, V45, P605, DOI 10.1007/BF01975677; Born C, 2008, P ROY SOC B-BIOL SCI, V275, P2171, DOI 10.1098/rspb.2008.0446; Campana MG, 2011, MOL ECOL RESOUR, V11, P349, DOI 10.1111/j.1755-0998.2010.02917.x; Cavers S, 2005, HEREDITY, V95, P281, DOI 10.1038/sj.hdy.6800709; Cavers S, 2013, J BIOGEOGR, V40, P615, DOI 10.1111/jbi.12097; Chen Y, 2011, BIOCHEM SYST ECOL, V39, P441, DOI 10.1016/j.bse.2011.06.006; Compton SG, 2000, BIOTROPICA, V32, P515, DOI 10.1111/j.1744-7429.2000.tb00497.x; Crozier YC, 2007, MOL ECOL NOTES, V7, P57, DOI 10.1111/j.1471-8286.2006.01523.x; Cruaud A, 2012, SYST BIOL, V61, P1029, DOI 10.1093/sysbio/sys068; Dev SA, 2011, BIOTROPICA, V43, P309, DOI 10.1111/j.1744-7429.2010.00704.x; Dick C. W., 2008, Tropical Plant Biology, V1, P20, DOI 10.1007/s12042-007-9006-6; Dick CW, 2008, EVOLUTION, V62, P2760, DOI 10.1111/j.1558-5646.2008.00506.x; Dick CW, 2013, ECOL EVOL, V3, P162, DOI 10.1002/ece3.441; Doyle J. J., 1987, PHYTOCHEM B, P11; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Foster RB, 1982, ECOLOGY TROPICAL FOR, P67; Giannini NP, 2004, OIKOS, V105, P209, DOI 10.1111/j.0030-1299.2004.12690.x; Graffelman J, 2009, GUIDE SCATTERPLOT BI; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Hardy OJ, 2006, MOL ECOL, V15, P559, DOI 10.1111/j.1365-294X.2005.02785.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Harrison RD, 2005, BIOSCIENCE, V55, P1053, DOI 10.1641/0006-3568(2005)055[1053:FATDOT]2.0.CO;2; Harrison RD, 2006, J TROP ECOL, V22, P631, DOI 10.1017/S0266467406003488; Heer K, 2012, AM J BOT, V99, pE330, DOI 10.3732/ajb.1200032; Heer K, 2010, OECOLOGIA, V163, P425, DOI 10.1007/s00442-010-1600-x; Herre EA, 2008, ANNU REV ECOL EVOL S, V39, P439, DOI 10.1146/annurev.ecolsys.37.091305.110232; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Coronado ENH, 2014, J BIOGEOGR, V41, P1697, DOI 10.1111/jbi.12326; Jackson AP, 2008, SYMBIOSIS, V45, P57; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jump AS, 2012, HEREDITY, V108, P633, DOI 10.1038/hdy.2012.1; Kalko EKV, 1996, J BIOGEOGR, V23, P565, DOI 10.1111/j.1365-2699.1996.tb00018.x; Korine C, 2000, OECOLOGIA, V123, P560, DOI 10.1007/PL00008861; LASKA M, 1990, Z SAUGETIERKD, V55, P49; Lemon J., 2006, R R NEWS; Lewin-Koh N.J., 2011, MAPTOOLS TOOLS READI; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Machado CA, 2005, P NATL ACAD SCI USA, V102, P6558, DOI 10.1073/pnas.0501840102; MILTON K, 1991, J ECOL, V79, P1, DOI 10.2307/2260781; MILTON K, 1982, ECOLOGY, V63, P752, DOI 10.2307/1936796; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; MORRISON DW, 1980, J MAMMAL, V61, P20, DOI 10.2307/1379953; MORRISON DW, 1978, ECOLOGY, V59, P716, DOI 10.2307/1938775; MORRISON DW, 1978, J MAMMAL, V59, P622, DOI 10.2307/1380242; Nason JD, 1998, NATURE, V391, P685, DOI 10.1038/35607; Nazareno AG, 2013, ECOL EVOL, V3, P3495, DOI 10.1002/ece3.739; Pardini EA, 2008, MOL ECOL, V17, P2865, DOI 10.1111/j.1365-294X.2008.03807.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pebesma E.J., 2005, R NEWS, V5; Pritchard JK, 2000, GENETICS, V155, P945; Renoult JP, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-248; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rymer PD, 2013, J BIOGEOGR, V40, P693, DOI 10.1111/j.1365-2699.2012.02727.x; Saeki I, 2011, J BIOGEOGR, V38, P992, DOI 10.1111/j.1365-2699.2010.02462.x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Scotti-Saintagne C, 2013, J BIOGEOGR, V40, P707, DOI 10.1111/j.1365-2699.2012.02797.x; Serio-Silva JC, 2002, ORYX, V36, P266, DOI 10.1017/S0030605302000480; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; Terborgh J, 1997, J TROP ECOL, V13, P833, DOI 10.1017/S0266467400011020; Thornton IWB, 1996, J BIOGEOGR, V23, P577, DOI 10.1111/j.1365-2699.1996.tb00019.x; VALDEYRON G, 1985, GENETIC DIFFERENTIAT, P383; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vanderhoff Elizabeth Natasha, 2009, Biota Neotrop., V9, P419, DOI 10.1590/S1676-06032009000300039; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Vignes H, 2006, MOL ECOL NOTES, V6, P792, DOI 10.1111/j.1471-8286.2006.01347.x; Wang R, 2009, POPUL ECOL, V51, P307, DOI 10.1007/s10144-008-0126-0; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wendeln MC, 2000, BIOTROPICA, V32, P489, DOI 10.1111/j.1744-7429.2000.tb00495.x; WINDSOR DM, 1989, EXPERIENTIA, V45, P647, DOI 10.1007/BF01975681; Wright S, 1943, GENETICS, V28, P114; Yu H, 2010, MOL ECOL, V19, P4441, DOI 10.1111/j.1365-294X.2010.04777.x	78	10	11	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133581	10.1371/journal.pone.0133581	http://dx.doi.org/10.1371/journal.pone.0133581			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226482	Green Submitted, gold, Green Published			2022-12-27	WOS:000358837700026
J	Jo, DH; Park, SW; Cho, CS; Powner, MB; Kim, JH; Fruttiger, M; Kim, JH				Jo, Dong Hyun; Park, Sung Wook; Cho, Chang Sik; Powner, Michael B.; Kim, Jin Hyoung; Fruttiger, Marcus; Kim, Jeong Hun			Intravitreally Injected Anti-VEGF Antibody Reduces Brown Fat in Neonatal Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BEVACIZUMAB AVASTIN; ADIPOSE-TISSUE; RETINOPATHY; ANGIOGENESIS; SAFETY; NEOVASCULARIZATION; PHARMACOKINETICS; ENERGY	Anti-vascular endothelial growth factor (VEGF) agents are the mainstay treatment for various angiogenesis-related retinal diseases. Currently, bevacizumab, a recombinant humanized anti-VEGF antibody, is trailed in retinopathy of prematurity, a vasoproliferative retinal disorder in premature infants. However, the risks of systemic complications after intravitreal injection of anti-VEGF antibody in infants are not well understood. In this study, we show that intravitreally injected anti-VEGF antibody is transported into the systemic circulation into the periphery where it reduces brown fat in neonatal C57BL/6 mice. A considerable amount of anti-VEGF antibody was detected in serum after intravitreal injection. Furthermore, in interscapular brown adipose tissue, we found lipid droplet accumulation, decreased VEGF levels, loss of vascular network, and decreased expression of mitochondria-related genes, Ppargc1a and Ucp1, all of which are characteristics of "whitening" of brown fat. With increasing age and body weight, brown fat restored its morphology and vascularity. Our results show that there is a transient, but significant impact of intravitreally administered anti-VEGF antibody on brown adipose tissue in neonatal mice. We suggest that more attention should be focused on the metabolic and developmental significance of brown adipose tissue in bevacizumab treated retinopathy of prematurity infants.	[Jo, Dong Hyun; Park, Sung Wook; Cho, Chang Sik; Kim, Jin Hyoung; Kim, Jeong Hun] Seoul Natl Univ Hosp, Clin Res Inst, Fight Angiogenesis Related Blindness FARB Lab, Seoul 110744, South Korea; [Jo, Dong Hyun; Park, Sung Wook; Cho, Chang Sik; Kim, Jeong Hun] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Powner, Michael B.; Fruttiger, Marcus] UCL, UCL Inst Ophthalmol, London, England; [Kim, Jeong Hun] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); University of London; University College London; Seoul National University (SNU)	Kim, JH (corresponding author), Seoul Natl Univ Hosp, Clin Res Inst, Fight Angiogenesis Related Blindness FARB Lab, Seoul 110744, South Korea.; Kim, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.; Kim, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	steph25@snu.ac.kr	Jo, Dong Hyun/D-5962-2012; Park, Sung Wook/D-5541-2012; Powner, Michael/CAG-7455-2022	Jo, Dong Hyun/0000-0002-6320-6829; Park, Sung Wook/0000-0001-8151-6663; Kim, Jeong Hun/0000-0003-2957-1766; Fruttiger, Marcus/0000-0002-6962-5485; Powner, Michael/0000-0003-4913-1004	Bio-Signal Analysis Technology Innovation Program of NRF [20090090895]; pioneer Research Program of NRF [2012-0009544]; MD-PhD program of KRIBB [700-2015-2018]; Seoul National University Research Grant [800-20140542]; Seoul National University Hospital Research Grant [03-2014-0260]	Bio-Signal Analysis Technology Innovation Program of NRF; pioneer Research Program of NRF; MD-PhD program of KRIBB; Seoul National University Research Grant; Seoul National University Hospital Research Grant	This study was supported by the Bio-Signal Analysis Technology Innovation Program (20090090895) of NRF, the pioneer Research Program (2012-0009544) of NRF, the MD-PhD program of KRIBB (700-2015-2018), the Seoul National University Research Grant (800-20140542) and the Seoul National University Hospital Research Grant (03-2014-0260).	Avery RL, 2006, OPHTHALMOLOGY, V113, P1695, DOI 10.1016/j.ophtha.2006.05.064; Avery RL, 2012, J AAPOS, V16, P2, DOI 10.1016/j.jaapos.2011.11.002; Bagchi M, 2013, FASEB J, V27, P3257, DOI 10.1096/fj.12-221812; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Cypess AM, 2014, CELL METAB, V20, P408, DOI 10.1016/j.cmet.2014.07.025; Elias I, 2012, DIABETES, V61, P1801, DOI 10.2337/db11-0832; Gordon MS, 2001, J CLIN ONCOL, V19, P843, DOI 10.1200/JCO.2001.19.3.843; Hard AL, 2011, ACTA PAEDIATR, V100, P1523, DOI 10.1111/j.1651-2227.2011.02445.x; Hellstrom A, 2013, LANCET, V382, P1445, DOI 10.1016/S0140-6736(13)60178-6; Jo DH, 2014, ARCH PHARM RES, V37, P285, DOI 10.1007/s12272-013-0324-y; Kim H, 2009, MOL VIS, V15; Kim JH, 2008, J CELL MOL MED, V12, P2407, DOI 10.1111/j.1582-4934.2008.00243.x; Kim LA, 2012, AM J PATHOL, V181, P376, DOI 10.1016/j.ajpath.2012.06.006; Lee BJ, 2012, EYE, V26, P903, DOI 10.1038/eye.2012.111; Lepore D, 2014, OPHTHALMOLOGY, V121, P2212, DOI 10.1016/j.ophtha.2014.05.015; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Mintz-Hittner HA, 2010, J AAPOS, V14, P2, DOI 10.1016/j.jaapos.2009.12.002; Miyake T, 2010, INVEST OPHTH VIS SCI, V51, P1606, DOI 10.1167/iovs.09-4140; Powner MB, 2014, INVEST OPHTH VIS SCI, V55, P1607, DOI 10.1167/iovs.13-12574; Qian J, 2011, RETINA-J RET VIT DIS, V31, P161, DOI 10.1097/IAE.0b013e3181e46ad8; Sato T, 2012, AM J OPHTHALMOL, V153, P327, DOI 10.1016/j.ajo.2011.07.005; Shimizu I, 2014, J CLIN INVEST, V124, P2099, DOI 10.1172/JCI71643; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stefanini MO, 2010, CANCER RES, V70, P9886, DOI 10.1158/0008-5472.CAN-10-1419; Sun K, 2014, MOL METAB, V3, P474, DOI 10.1016/j.molmet.2014.03.010; Sung HK, 2013, CELL METAB, V17, P61, DOI 10.1016/j.cmet.2012.12.010; Tolentino M, 2011, SURV OPHTHALMOL, V56, P95, DOI 10.1016/j.survophthal.2010.08.006; van Wijngaarden P, 2005, JAMA-J AM MED ASSOC, V293, P1509, DOI 10.1001/jama.293.12.1509; Wu WC, 2010, INVEST OPHTH VIS SCI, V51, P3701, DOI 10.1167/iovs.09-4425; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009	33	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134308	10.1371/journal.pone.0134308	http://dx.doi.org/10.1371/journal.pone.0134308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226015	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000358837700072
J	Li, GG; Wulan, H; Song, ZC; Paik, PA; Tsao, ML; Goodman, GM; MacEachern, PT; Downey, RS; Jankowska, AJ; Rabinowitz, YM; Learch, TB; Song, DZ; Yuan, JJ; Zheng, SH; Zheng, ZD				Li, Guanggang; Wulan, Hasi; Song, Zongchang; Paik, Paul A.; Tsao, Ming L.; Goodman, Gary M.; MacEachern, Paul T.; Downey, Robert S.; Jankowska, Anna J.; Rabinowitz, Yaron M.; Learch, Thomas B.; Song, David Z.; Yuan, Ji J.; Zheng, Shihang; Zheng, Zhendong			RETRACTED: Regulatory B Cell Function Is Suppressed by Smoking and Obesity in H-pylori-Infected Subjects and Is Correlated with Elevated Risk of Gastric Cancer (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							INFLAMMATION; INITIATION; CYTOKINES; RESPONSES; IMMUNITY	Helicobacter pylori infection occurs in more than half of the world's population and is the main cause for gastric cancer. A series of lifestyle and nutritional factors, such as tobacco smoking and obesity, have been found to elevate the risk for cancer development. In this study, we sought to determine the immunological aspects during H. pylori infection and gastric cancer development. We found that B cells from H. pylori-infected patients presented altered composition and function compared to uninfected patients. IL-10-expressing CD24(+)CD38(+) B cells were upregulated in H. pylori-infected patients, contained potent regulatory activity in inhibiting T cell pro-inflammatory cytokine secretion, and responded directly to H. pylori antigen stimulation. Interestingly, in H. pylori-infected smoking subjects and obese subjects, the number of IL-10(+) B cells and CD24(+)CD38(+) B cells were reduced compared to H. pylori-infected asymptomatic subjects. Regulatory functions mediated by CD24(+)CD38(+) B cells were also impaired. In addition, gastric cancer positive patients had reduced IL-10-producing B cell frequencies after H. pylori-stimulation. Altogether, these data suggest that in H. pylori-infection, CD24(+)CD38(+) B cell is upregulated and plays a role in suppressing pro-inflammatory responses, possibly through IL-10 production, a feature that was not observed in smoking and obese patients.	[Li, Guanggang] Beijing Mil Command, Gen Hosp, Affiliated Bayi Brain Hosp, Beijing 100700, Peoples R China; [Wulan, Hasi] Peoples Liberat Army Gen Hosp, Dept Plast & Reconstruct Surg, Beijing 100853, Peoples R China; [Song, Zongchang] 155th Cent Hosp PLA, Dept Oncol, Kaifeng 475003, Peoples R China; [Paik, Paul A.; Tsao, Ming L.; Goodman, Gary M.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [MacEachern, Paul T.; Downey, Robert S.; Jankowska, Anna J.; Rabinowitz, Yaron M.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA; [Learch, Thomas B.] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA; [Song, David Z.; Yuan, Ji J.] Univ British Columbia, Univ Hosp, Vancouver, BC V5Z 1M9, Canada; [Zheng, Shihang] China Med Univ, Shengjing Hosp, Dept Gastroenterol, Shenyang 110022, Peoples R China; [Zheng, Zhendong] Second Mil Med Univ, Changzheng Hosp, Dept Med Oncol, Shanghai 200070, Peoples R China; [Zheng, Zhendong] Shenyang Mil Area Command, Gen Hosp, Dept Oncol, Shenyang 110840, Peoples R China	Seventh Medical Center of Chinese PLA General Hospital; Chinese People's Liberation Army General Hospital; Roswell Park Cancer Institute; Georgetown University; University System of Maryland; University of Maryland Baltimore; University of British Columbia; China Medical University; Naval Medical University	Learch, TB (corresponding author), Univ Maryland, Med Ctr, Baltimore, MD 21201 USA.	learchtb@medscientist.org; song@olc.ubc.ca; yuan@olc.ubc.ca; drzhendongzheng@126.com						Albuquerque A, 2014, VIRCHOWS ARCH, V465, P643, DOI 10.1007/s00428-014-1659-6; Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Candando KM, 2014, IMMUNOL REV, V259, P259, DOI 10.1111/imr.12176; Carcas Lauren Peirce, 2014, J Carcinog, V13, P14, DOI 10.4103/1477-3163.146506; Das A, 2012, J IMMUNOL, V189, P3925, DOI 10.4049/jimmunol.1103139; Ding Q, 2011, J CLIN INVEST, V121, P3645, DOI 10.1172/JCI46274; Epplein M, 2013, CANCER CAUSE CONTROL, V24, P2245, DOI 10.1007/s10552-013-0284-z; Gray BM, 2013, INFECT IMMUN, V81, P740, DOI 10.1128/IAI.01269-12; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Kabisch R, 2014, PLOS ONE, P9; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Kopitar AN, 2007, J INFECTION, V54, P257, DOI 10.1016/j.jinf.2006.05.009; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089236; Lund FE, 2008, CURR OPIN IMMUNOL, V20, P332, DOI 10.1016/j.coi.2008.03.003; Malfertheiner P, 2014, CURR OPIN GASTROEN, V30, P589, DOI 10.1097/MOG.0000000000000128; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Moir S, 2010, BLOOD, V116, P5571, DOI 10.1182/blood-2010-05-285528; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Oshima H, 2014, ONCOGENE, V33, P3820, DOI 10.1038/onc.2013.356; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Palanichamy A, 2009, J IMMUNOL, V182, P5982, DOI 10.4049/jimmunol.0801859; Pourhoseingholi Mohamad Amin, 2015, Gastroenterol Hepatol Bed Bench, V8, P19; Qadri Qurteeba, 2014, J Gastrointest Cancer, V45, P126, DOI 10.1007/s12029-014-9583-1; Rhee KH, 2014, YONSEI MED J, V55, P1453, DOI 10.3349/ymj.2014.55.6.1453; Rosser EC, 2014, MOL IMMUNOL, V62, P296, DOI 10.1016/j.molimm.2014.01.014; Shiomi S, 2008, HELICOBACTER, V13, P518, DOI 10.1111/j.1523-5378.2008.00629.x; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; Xiao S, 2012, P NATL ACAD SCI USA, V109, P12105, DOI 10.1073/pnas.1120914109; Yamaoka Y, 2014, FUTURE ONCOL, V10, P1487, DOI [10.2217/fon.14.29, 10.2217/FON.14.29]; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270	34	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134591	10.1371/journal.pone.0134591	http://dx.doi.org/10.1371/journal.pone.0134591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226399	gold, Green Published, Green Submitted			2022-12-27	WOS:000358837700115
J	Lovato, TL; Sensibaugh, CA; Swingle, KL; Martinez, MM; Cripps, RM				Lovato, TyAnna L.; Sensibaugh, Cheryl A.; Swingle, Kirstie L.; Martinez, Melody M.; Cripps, Richard M.			The Drosophila Transcription Factors Tinman and Pannier Activate and Collaborate with Myocyte Enhancer Factor-2 to Promote Heart Cell Fate	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; GENE-EXPRESSION; HUMAN FIBROBLASTS; NKX2.5 MUTATIONS; CARDIAL CELLS; RAT HEARTS; LAME DUCK; CARDIOMYOCYTES; DISEASE; TARGET	Expression of the MADS domain transcription factor Myocyte Enhancer Factor 2 (MEF2) is regulated by numerous and overlapping enhancers which tightly control its transcription in the mesoderm. To understand how Mef2 expression is controlled in the heart, we identified a late stage Mef2 cardiac enhancer that is active in all heart cells beginning at stage 14 of embryonic development. This enhancer is regulated by the NK-homeodomain transcription factor Tinman, and the GATA transcription factor Pannier through both direct and indirect interactions with the enhancer. Since Tinman, Pannier and MEF2 are evolutionarily conserved from Drosophila to vertebrates, and since their vertebrate homologs can convert mouse fibroblast cells to cardiomyocytes in different activator cocktails, we tested whether over-expression of these three factors in vivo could ectopically activate known cardiac marker genes. We found that mesodermal over-expression of Tinman and Pannier resulted in approximately 20% of embryos with ectopic Hand and Sulphonylurea receptor (Sur) expression. By adding MEF2 alongside Tinman and Pannier, a dramatic expansion in the expression of Hand and Sur was observed in almost all embryos analyzed. Two additional cardiac markers were also expanded in their expression. Our results demonstrate the ability to initiate ectopic cardiac fate in vivo by the combination of only three members of the conserved Drosophila cardiac transcription network, and provide an opportunity for this genetic model system to be used to dissect the mechanisms of cardiac specification.	[Lovato, TyAnna L.; Sensibaugh, Cheryl A.; Swingle, Kirstie L.; Martinez, Melody M.; Cripps, Richard M.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Cripps, RM (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	rcripps@unm.edu	Avila, Melody/W-7725-2019	Avila, Melody/0000-0001-8416-603X	National Institutes of Health [R01 GM061738, R25 GM060201, P20 GM103452]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103452, P30GM110907, R01GM061738, R25GM060201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R01 GM061738 awarded by the National Institutes of Health, RMC R25 GM060201 awarded by the National Institutes of Health, KLS, MMM P20 GM103452 awarded by the National Institutes of Health, provided resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka T, 2006, P NATL ACAD SCI USA, V103, P11999, DOI 10.1073/pnas.0603098103; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BODMER R, 1993, DEVELOPMENT, V118, P719; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Brown S, 2003, DEVELOPMENT, V130, P3077, DOI 10.1242/dev.00535; Busser BW, 2012, P NATL ACAD SCI USA, V109, P20768, DOI 10.1073/pnas.1210415109; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Christianson A., 2006, GLOBAL REPORT BIRTH; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Cripps RM, 1999, DEV BIOL, V215, P420, DOI 10.1006/dbio.1999.9446; Duan H, 2001, DEVELOPMENT, V128, P4489; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Elliott DA, 2003, J AM COLL CARDIOL, V41, P2072, DOI 10.1016/S0735-1097(03)00420-0; Fernandes S, 2010, J MOL CELL CARDIOL, V49, P941, DOI 10.1016/j.yjmcc.2010.09.008; Fu JD, 2013, STEM CELL REP, V1, P235, DOI 10.1016/j.stemcr.2013.07.005; Gajewski K, 2000, GENESIS, V28, P36, DOI 10.1002/1526-968X(200009)28:1<36::AID-GENE50>3.0.CO;2-4; Gajewski K, 1997, EMBO J, V16, P515, DOI 10.1093/emboj/16.3.515; Gajewski K, 1998, DEV GENES EVOL, V208, P382, DOI 10.1007/s004270050194; Gajewski K, 2001, DEV BIOL, V233, P425, DOI 10.1006/dbio.2001.0220; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gilboa SM, 2010, CIRCULATION, V122, P2254, DOI 10.1161/CIRCULATIONAHA.110.947002; Goldmuntz E, 2001, CIRCULATION, V104, P2565, DOI 10.1161/hc4601.098427; Gonzalez P, 2006, J MED GENET, V43, P167, DOI 10.1136/jmg.2005.035071; Gunthorpe D, 1999, DEV BIOL, V215, P130, DOI 10.1006/dbio.1999.9449; Gutierrez-Roelens Ilse, 2002, Hum Mutat, V20, P75, DOI 10.1002/humu.9041; Han Z, 2005, DEVELOPMENT, V132, P3525, DOI 10.1242/dev.01899; Hendren JD, 2007, MECH DEVELOP, V124, P416, DOI 10.1016/j.mod.2007.03.002; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Ifkovits JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089678; Jin H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003195; Klinedinst SL, 2003, DEVELOPMENT, V130, P3027, DOI 10.1242/dev.00517; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Leal SM, 2009, DEV BIOL, V325, P138, DOI 10.1016/j.ydbio.2008.10.006; Lecuyer Eric, 2008, V420, P289, DOI 10.1007/978-1-59745-583-1_18; Lee Y, 1998, MOL CELL BIOL, V18, P3120, DOI 10.1128/MCB.18.6.3120; Li T, 2007, J MOL BIOL, V370, P976, DOI 10.1016/j.jmb.2007.05.033; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Lockwood WK, 2002, MECH DEVELOP, V114, P13, DOI 10.1016/S0925-4773(02)00044-8; Maass M, 2010, EUROPEAN HEART J, V34; McElhinney DB, 2003, J AM COLL CARDIOL, V42, P1650, DOI 10.1016/j.jacc.2003.05.004; Molina MR, 2001, MECH DEVELOP, V109, P51, DOI 10.1016/S0925-4773(01)00509-3; Nam YJ, 2013, P NATL ACAD SCI USA, V110, P5588, DOI 10.1073/pnas.1301019110; Nguyen HT, 1998, DEV BIOL, V204, P550, DOI 10.1006/dbio.1998.9081; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Ponzielli R, 2002, DEVELOPMENT, V129, P4509; RAMAIN P, 1993, DEVELOPMENT, V119, P1277; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ryan KM, 2007, DEV BIOL, V302, P694, DOI 10.1016/j.ydbio.2006.10.025; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Shiojima I, 1999, J BIOL CHEM, V274, P8231, DOI 10.1074/jbc.274.12.8231; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Thummel CS, 1992, DROS INF SERV, V71, P150; Watakabe A, 2010, METHODS, V52, P367, DOI 10.1016/j.ymeth.2010.07.003; Yu T, 2013, CIRC J, V77, P1297, DOI 10.1253/circj.CJ-12-0977; Zhang SX, 2001, MECH DEVELOP, V101, P35, DOI 10.1016/S0925-4773(00)00549-9	60	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0132965	10.1371/journal.pone.0132965	http://dx.doi.org/10.1371/journal.pone.0132965			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225919	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700012
J	Borrell, F; Junno, A; Barcelo, JA				Borrell, Ferran; Junno, Aripekka; Anton Barcelo, Joan			Synchronous Environmental and Cultural Change in the Emergence of Agricultural Economies 10,000 Years Ago in the Levant	PLOS ONE			English	Article							EASTERN MEDITERRANEAN REGION; EARLY HOLOCENE CLIMATE; GLACIAL-INTERGLACIAL TRANSITION; STABLE-ISOTOPE RECORDS; CORE AREA HYPOTHESIS; NEAR-EAST; SOREQ CAVE; CAL BC; DOMESTICATION; CULTIVATION	The commonly held belief that the emergence and establishment of farming communities in the Levant was a smooth socio-economic continuum during the Pre-Pottery Neolithic (ca. 12,000-9,000 cal BP) with only rare minor disruptions is challenged by recently obtained evidence from this region. Using a database of archaeological radiocarbon dates and diagnostic material culture records from a series of key sites in the northern Levant we show that the hitherto apparent long-term continuity interpreted as the origins and consolidation of agricultural systems was not linear and uninterrupted. A major cultural discontinuity is observed in the archaeological record around 10,000 cal BP in synchrony with a Holocene Rapid Climate Change (RCC), a short period of climatic instability recorded in the Northern Hemisphere. This study demonstrates the interconnectedness of the first agricultural economies and the ecosystems they inhabited, and emphasizes the complex nature of human responses to environmental change during the Neolithic period in the Levant. Moreover, it provides a new environmental-cultural scenario that needs to be incorporated in the models reconstructing both the establishment of agricultural economy in southwestern Asia and the impact of environmental changes on human populations.	[Borrell, Ferran] Ctr Rech Francais Jerusalem CRFJ CNRS, Jerusalem, Israel; [Junno, Aripekka] Univ Helsinki, Dept Philosophy Hist Culture & Art Studies, Helsinki, Finland; [Anton Barcelo, Joan] Univ Autonoma Barcelona, Dept Prehist, E-08193 Barcelona, Spain	University of Helsinki; Autonomous University of Barcelona	Borrell, F (corresponding author), Ctr Rech Francais Jerusalem CRFJ CNRS, Jerusalem, Israel.	silmarils1000@hotmail.com	Barcelo, Juan/L-2626-2014	Barcelo, Juan/0000-0002-1580-471X	Spanish Ministry of Science and Innovation [HAR2012-31036, CSD2010-00034]; Bettencourt-Schueller Foundation	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Bettencourt-Schueller Foundation	Funding for this research was provided by the Spanish Ministry of Science and Innovation (Grant HAR2012-31036 and Project CSD2010-00034 "Social and environmental transitions: Simulating the past to understand human behavior", see: http://www.simulpast.es) to J.A. Barcelo. F. Borrell was supported by a Bettencourt-Schueller Foundation postdoctoral grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbes F, 2003, 1150 BAR; Abbo S, 2014, TRENDS PLANT SCI, V19, P351, DOI 10.1016/j.tplants.2013.12.002; Abbo S, 2010, CRIT REV PLANT SCI, V29, P317, DOI 10.1080/07352689.2010.502823; Alley RB, 2005, QUATERNARY SCI REV, V24, P1123, DOI 10.1016/j.quascirev.2004.12.004; Almogi-Labin A, 2009, QUATERNARY SCI REV, V28, P2882, DOI 10.1016/j.quascirev.2009.07.017; Asouti E, 2013, CURR ANTHROPOL, V54, P299, DOI 10.1086/670679; Atakuman C, 2014, J WORLD PREHIST, V27, P1, DOI 10.1007/s10963-014-9070-4; Bar-Matthews M, 1999, EARTH PLANET SC LETT, V166, P85, DOI 10.1016/S0012-821X(98)00275-1; Bar-Matthews M, 2003, GEOCHIM COSMOCHIM AC, V67, P3181, DOI 10.1016/S0016-7037(02)01031-1; Bar-Yosef O., 2014, SETTLEMENT SURVEY ST, P159; Bar-Yosef O., 1989, BRIT ARCHAEOLOGICAL, V508, P59; Bar-Yosef O., 2001, ORIGIN HUMAN SOCIAL, P1, DOI DOI 10.1186/2045-3701-4-49; Bar-Yosef O, 2003, EXAMINING FARMING LA, P113; Bar-Yosef O, 2011, CURR ANTHROPOL, V52, pS175, DOI 10.1086/659784; BarMatthews M, 1997, QUATERNARY RES, V47, P155, DOI 10.1006/qres.1997.1883; Barzilai O, 2010, 2180 BAR; Belfer-Cohen A, 2011, CURR ANTHROPOL, V52, pS209, DOI 10.1086/658861; Berger JF, 2009, QUATERN INT, V200, P31, DOI 10.1016/j.quaint.2008.05.013; Bjorck S, 2001, GEOLOGY, V29, P1107, DOI 10.1130/0091-7613(2001)029<1107:HRAOAE>2.0.CO;2; Blockley SPE, 2011, QUATERNARY SCI REV, V30, P98, DOI 10.1016/j.quascirev.2010.09.021; Boch R, 2009, QUATERNARY SCI REV, V28, P2527, DOI 10.1016/j.quascirev.2009.05.015; BocquetAppel JP, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P1, DOI 10.1007/978-1-4020-8539-0; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; Borrell F, 2013, STONE TOOLS TRANSITI, P247; Borrell F, 2011, PALEORIENT, V37, P35; Borrell F, 2014, CAMB ARCHAEOL J, V24, P215, DOI 10.1017/S0959774314000456; Borrell F, 2011, J FIELD ARCHAEOL, V36, P132, DOI 10.1179/009346911X12991472411240; Brayshaw DJ, 2011, HOLOCENE, V21, P15, DOI 10.1177/0959683610377528; Cai BG, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL030986; Cauvin J., 1994, NAISSANCE DIVINITES; Clare L, 2010, DOC PRAEHIST, V37, P283, DOI 10.4312/dp.37.24; Fujii S, 1986, B ANCIENT ORIENT MUS, V8, P25; Fuller DQ, 2011, WORLD ARCHAEOL, V43, P628, DOI 10.1080/00438243.2011.624747; Gebel H.G.K., 2004, NEOLITHICS, V1, P28; Goodfriend GA, 1999, QUATERNARY SCI REV, V18, P501, DOI 10.1016/S0277-3791(98)00092-4; Gopher A, 2013, TEL AVIV, V40, P187, DOI 10.1179/033443513X13753505864377; Goring-Morris AN., 2009, TRANSITIONS PREHISTO, P185; Heun M, 2012, J EXP BOT, V63, P4333, DOI 10.1093/jxb/ers162; Hillman G, 2001, HOLOCENE, V11, P383, DOI 10.1191/095968301678302823; Jones MD, 2008, QUATERN INT, V181, P32, DOI 10.1016/j.quaint.2007.01.012; Jones MD, 2007, QUATERNARY RES, V67, P463, DOI 10.1016/j.yqres.2007.01.004; Kuijt I, 2000, J ANTHROPOL ARCHAEOL, V19, P75, DOI 10.1006/jaar.1999.0352; Lev-Yadun S, 2000, SCIENCE, V288, P1602, DOI 10.1126/science.288.5471.1602; Mayewski PA, 2004, QUATERNARY RES, V62, P243, DOI 10.1016/j.yqres.2004.07.001; Mayewski PA, 1997, J GEOPHYS RES-OCEANS, V102, P26345, DOI 10.1029/96JC03365; McLaren SJ, 2004, PALAEOGEOGR PALAEOCL, V205, P131, DOI 10.1016/j.palaeo.2003.12.006; Migowski C, 2006, QUATERNARY RES, V66, P421, DOI 10.1016/j.yqres.2006.06.010; Nishiaki Y, 2000, 840 BAR; Pustovoytov K, 2007, QUATERNARY RES, V67, P315, DOI 10.1016/j.yqres.2007.01.002; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rasmussen SO, 2007, QUATERNARY SCI REV, V26, P1907, DOI 10.1016/j.quascirev.2007.06.015; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Riehl S, 2013, SCIENCE, V341, P65, DOI 10.1126/science.1236743; Roberts N, 2008, QUATERNARY SCI REV, V27, P2426, DOI 10.1016/j.quascirev.2008.09.005; Roberts N, 2001, HOLOCENE, V11, P721, DOI 10.1191/09596830195744; Robinson SA, 2006, QUATERNARY SCI REV, V25, P1517, DOI 10.1016/j.quascirev.2006.02.006; Rohling EJ, 2005, NATURE, V434, P975, DOI 10.1038/nature03421; Rollefson GO, 2001, ARCHAEOLOGY JORDAN, P67; Rossignol-Strick M, 1999, QUATERNARY SCI REV, V18, P515, DOI 10.1016/S0277-3791(98)00093-6; Simmons AH, 2007, NEOLITHIC REVOLUTION; Staubwasser M, 2006, QUATERNARY RES, V66, P372, DOI 10.1016/j.yqres.2006.09.001; Stordeur D, 2010, DEV PRESTATE COMMUNI, P123; Teller JT, 2004, GEOL SOC AM BULL, V116, P729, DOI 10.1130/B25316.1; Turner R, 2010, J QUATERNARY SCI, V25, P371, DOI 10.1002/jqs.1332; Vigne JD, 2011, CURR ANTHROPOL, V52, pS255, DOI 10.1086/659306; Watkins T, 2010, ANTIQUITY, V84, P621, DOI 10.1017/S0003598X00100122; Weiss E, 2006, SCIENCE, V312, P1608, DOI 10.1126/science.1127235; WEISS H, 1993, SCIENCE, V261, P995, DOI 10.1126/science.261.5124.995; Weninger B, 2007, CALPAL 2007 COLOGNE; Weninger B, 2006, QUATERNARY RES, V66, P401, DOI 10.1016/j.yqres.2006.06.009; Weninger B, 2009, DOC PRAEHIST, V36, P7, DOI 10.4312/dp.36.2; Willcox G, 2005, VEG HIST ARCHAEOBOT, V14, P534, DOI 10.1007/s00334-005-0075-x; Willcox G, 2013, SCIENCE, V341, P39, DOI 10.1126/science.1240496; Willcox G, 2012, ANTIQUITY, V86, P99, DOI 10.1017/S0003598X00062487; Willcox G, 2009, HOLOCENE, V19, P151, DOI 10.1177/0959683608098961; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zeder MA, 2009, J ARCHAEOL RES, V17, P1, DOI 10.1007/s10814-008-9025-3	77	31	31	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134810	10.1371/journal.pone.0134810	http://dx.doi.org/10.1371/journal.pone.0134810			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CO1VB	26241310	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942700071
J	Kanaya, G; Suzuki, T; Kikuchi, E				Kanaya, Gen; Suzuki, Takao; Kikuchi, Eisuke			Impacts of the 2011 Tsunami on Sediment Characteristics and Macrozoobenthic Assemblages in a Shallow Eutrophic Lagoon, Sendai Bay, Japan	PLOS ONE			English	Article							ORGANIC ENRICHMENT; MARINE-SEDIMENTS; GAMO LAGOON; RECOVERY; RECOLONIZATION; COMMUNITIES	A huge tsunami is one of the greatest disturbance events in coastal benthic communities, although the ecological consequences are not fully understood. Here we examined the tsunami-induced changes in the sediment environment and macrozoobenthic assemblage in a eutrophic brackish lagoon in eastern Japan. The 7.2-m-high tsunami completely replaced muddy sediment with drifting sea sand throughout the lagoon, leading to the drastic changes in quantity and quality of sedimental organic matters, sulfide contents, and sediment redox condition. Intensive physical stress devastated the benthic community, but the disappearance of sulfidic muddy bottoms significantly improved the habitat quality for macrozoobenthos. The re-established macrozoobenthic community after 5 months was characterized by (1) a 2-fold higher total density, but sharp declines in species richness, diversity, and evenness; (2) an increased density of opportunistic taxa (e.g., polychaete Pseudopolydora spp. and amphipod Monocorophium uenoi) in newly created sandy bottoms; and (3) disappearance of several dominant taxa including bivalves and chironomid larvae. These findings indicate that the sensitivity and recovery potential of macrozoobenthos were highly taxa-specific, which was closely related to the taxa's ecological characteristics, including tolerance to physical disturbance, life-history traits, and life form. Our data revealed the rapid recolonization of opportunistic macrozoobenthos after a huge tsunami, which would contribute to the functional recovery of estuarine soft-bottom habitats shortly after a disturbance event.	[Kanaya, Gen] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Kanaya, Gen; Kikuchi, Eisuke] Tohoku Univ, Grad Sch Sci, Inst Biol, Sendai, Miyagi 9808578, Japan; [Suzuki, Takao] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808578, Japan; [Kikuchi, Eisuke] Miyagi Univ Educ, EEC, Sendai, Miyagi 9800845, Japan	National Institute for Environmental Studies - Japan; Tohoku University; Tohoku University; Miyagi University Education	Kanaya, G (corresponding author), Natl Inst Environm Studies, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	gen@nies.go.jp			National Institute for Environmental Studies (NIES); Ministry of Education, Culture, Sports, Science and Technology, Japan	National Institute for Environmental Studies (NIES); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was financially supported by the research fund from National Institute for Environmental Studies (NIES) and by the fund, Tohoku Ecosystem-Associated Marine Science (TEAMS), from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikins S, 2002, MAR ECOL PROG SER, V245, P171, DOI 10.3354/meps245171; Beukema JJ, 1999, J SEA RES, V42, P235, DOI 10.1016/S1385-1101(99)00027-1; Cardoso PG, 2008, ESTUAR COAST SHELF S, V76, P553, DOI 10.1016/j.ecss.2007.07.026; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Council for the Promotion of Nature Restoration in Gamo Tidal Flat, 2008, TOT PLAN NAT REST GA; Gorley C.K., 2006, GETTING STARTED PRIM; GRASSLE JF, 1974, J MAR RES, V32, P253; Hargrave BT, 2008, MAR POLLUT BULL, V56, P810, DOI 10.1016/j.marpolbul.2008.02.006; Ito Kinuko, 2001, Japanese Journal of Benthology, V56, P9; Jaramillo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035348; Kahoku Shimpo, 2013, WATASHI GA MITA OTSU; Kanaya G, 2005, MAR ECOL PROG SER, V299, P67, DOI 10.3354/meps299067; Kanaya G., 2014, GLOB ENVIRON RES, V18, P35; Kanaya G., 2011, CHIKYU KANKYO, V16, P33; Kanaya G, 2007, MAR ECOL PROG SER, V345, P117, DOI 10.3354/meps07025; Kanaya G, 2014, MAR ENVIRON RES, V95, P81, DOI 10.1016/j.marenvres.2013.12.014; Kanaya Gen, 2012, Japanese Journal of Benthology, V67, P20; Kanaya G, 2011, ESTUAR COAST SHELF S, V92, P169, DOI 10.1016/j.ecss.2010.12.029; Kikuchi E, 2006, LIMNOLOGY, V7, P103, DOI 10.1007/s10201-006-0169-x; Kurihara Y, 2001, REPORT FUNDAMENTAL I; Levin LA, 2001, ECOSYSTEMS, V4, P430, DOI 10.1007/s10021-001-0021-4; Lomovasky BJ, 2011, J SEA RES, V65, P205, DOI 10.1016/j.seares.2010.10.002; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Miura O, 2012, J MOLLUS STUD, V78, P377, DOI 10.1093/mollus/eys025; Noda A, 2007, SEDIMENT GEOL, V200, P314, DOI 10.1016/j.sedgeo.2007.01.010; Norio O, 2011, INT J DISAST RISK SC, V2, P34, DOI 10.1007/s13753-011-0004-9; Sawai Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053692; Seike K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065417; Suzuki T., 2011, J JAPAN SOC WATER EN, V34, P395; Szczucinski W, 2012, SEDIMENT GEOL, V282, P40, DOI 10.1016/j.sedgeo.2012.07.019; Thrush SF, 1996, ECOLOGY, V77, P2472, DOI 10.2307/2265747; Thrush SF, 2006, ECOSYSTEMS, V9, P1029, DOI 10.1007/s10021-005-0068-8; Tomiyama T, 2010, MAR ECOL PROG SER, V406, P185, DOI 10.3354/meps08530; Urabe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062779; Van Colen C, 2008, MAR ECOL PROG SER, V372, P31, DOI 10.3354/meps07640; Widdicombe S, 2001, LIMNOL OCEANOGR, V46, P1720, DOI 10.4319/lo.2001.46.7.1720	36	37	40	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0135125	10.1371/journal.pone.0135125	http://dx.doi.org/10.1371/journal.pone.0135125			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241654	Green Submitted, gold, Green Published			2022-12-27	WOS:000358942700097
J	Mehra, M; Gangwar, I; Shankar, R				Mehra, Mrigaya; Gangwar, Indu; Shankar, Ravi			A Deluge of Complex Repeats: The Solanum Genome	PLOS ONE			English	Article								Repetitive elements have lately emerged as key components of genome, performing varieties of roles. It has now become necessary to have an account of repeats for every genome to understand its dynamics and state. Recently, genomes of two major Solanaceae species, Solanum tuberosum and Solanum lycopersicum, were sequenced. These species are important crops having high commercial significance as well as value as model species. However, there is a reasonable gap in information about repetitive elements and their possible roles in genome regulation for these species. The present study was aimed at detailed identification and characterization of complex repetitive elements in these genomes, along with study of their possible functional associations as well as to assess possible transcriptionally active repetitive elements. In this study, it was found that similar to 50-60% of genomes of S. tuberosum and S. lycopersicum were composed of repetitive elements. It was also found that complex repetitive elements were associated with >95% of genes in both species. These two genomes are mostly composed of LTR retrotransposons. Two novel repeat families very similar to LTR/ERV1 and LINE/RTE-BovB have been reported for the first time. Active existence of complex repeats was estimated by measuring their transcriptional abundance using Next Generation Sequencing read data and Microarray platforms. A reasonable amount of regulatory components like transcription factor binding sites and miRNAs appear to be under the influence of these complex repetitive elements in these species, while several genes appeared to possess exonized repeats.	[Mehra, Mrigaya; Gangwar, Indu; Shankar, Ravi] CSIR Inst Himalayan Bioresource Technol CSIR IHBT, Div Biotechnol, Studio Computat Biol & Bioinformat, Palampur 176061, Himachal Prades, India; [Mehra, Mrigaya; Gangwar, Indu; Shankar, Ravi] Acad Sci & Innovat Res, Madras, Tamil Nadu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT); Academy of Scientific & Innovative Research (AcSIR)	Shankar, R (corresponding author), CSIR Inst Himalayan Bioresource Technol CSIR IHBT, Div Biotechnol, Studio Computat Biol & Bioinformat, Palampur 176061, Himachal Prades, India.	ravish@ihbt.res.in			SERB (Science and Engineering Research Board) [SR/FT/LS-97/2010]; CSIR;  [BSC-118]	SERB (Science and Engineering Research Board); CSIR(Council of Scientific & Industrial Research (CSIR) - India); 	This study was funded by SERB (Science and Engineering Research Board) young scientist fast track grant award (SR/FT/LS-97/2010) to Ravi Shankar and BSC-118. MM and IG are thankful to CSIR for their SRFship. IHBT communication number for this MS is 3876. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119	1	11	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133962	10.1371/journal.pone.0133962	http://dx.doi.org/10.1371/journal.pone.0133962			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241045	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700030
J	Wu, L; He, Y; Jiang, B; Sun, DL; Wang, JH; Liu, M; Yang, SS; Wang, YY				Wu, Lei; He, Yao; Jiang, Bin; Sun, Dongling; Wang, Jianhua; Liu, Miao; Yang, Shanshan; Wang, Yiyan			Trends in Prevalence, Awareness, Treatment and Control of Hypertension during 2001-2010 in an Urban Elderly Population of China	PLOS ONE			English	Article							JOINT NATIONAL COMMITTEE; BLOOD-PRESSURE; RISK-FACTORS; US ADULTS; 33 COMMUNITIES; PREHYPERTENSION; DISEASE; HEALTH; OLDER	Objective As the most important risk factors of cardiovascular disease, pre-hypertension and hypertension are important public health challenges. Few studies have focused on the trends of pre-hypertension and hypertension specifically for the aging population in China. Given the anticipated growth of the elderly population in China, there is an urgent need to document the conditions of pre-hypertension and hypertension in this aging population. Methods We conducted two cross-sectional surveys of Chinese adults aged >= 60 years in 2001 and 2010. A total of 2,272 (943 males, 1,329 females) and 2,074 (839 males, 1,235 females) participants were included in the two surveys, respectively. Results The age-and sex-standardized prevalence of hypertension significantly increased from 60.1% to 65.2% from the 2001 to the 2010 survey. Among the participants with hypertension, the awareness, treatment and control of hypertension all significantly increased from 69.8% to 74.5%, 50.3% to 63.7%, and 15.3% to 30.3%, respectively, from 2001 to 2010. A logistic regression showed that a higher education level, a higher BMI, a family history of hypertension and doctor-diagnosed cardiovascular disease were significantly associated with hypertension awareness and treatment. Conclusion Hypertension prevalence increased rapidly between the years surveyed. Although the awareness, treatment and control of hypertension improved significantly, the values of these variables remained low. More attention should be given to the elderly because the population is aging worldwide, and urgent action, optimal treatment approaches and proper public health strategies must be taken to prevent and manage hypertension.	[Wu, Lei; He, Yao; Wang, Jianhua; Liu, Miao; Yang, Shanshan; Wang, Yiyan] Chinese Peoples Liberat Army Gen Hosp, Dept Epidemiol, Inst Geriatr, Beijing, Peoples R China; [Wu, Lei; He, Yao; Wang, Jianhua; Liu, Miao; Yang, Shanshan; Wang, Yiyan] Chinese Peoples Liberat Army Gen Hosp, Beijing Key Lab Aging & Geriatr, Beijing, Peoples R China; [He, Yao] Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Beijing, Peoples R China; [Jiang, Bin] Chinese Peoples Liberat Army Gen Hosp, Dept Acupuncture, Beijing, Peoples R China; [Sun, Dongling] Capital Med Univ, Dept Neuroepidemiol, Beijing Neurosurg Inst, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Beijing Neurosurgical Institute; Capital Medical University	He, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Epidemiol, Inst Geriatr, Beijing, Peoples R China.	yhe301@x263.net	刘, 淼/X-1216-2019	He, Yao/0000-0001-6205-7895; Liu, Miao/0000-0002-7975-6702	National Natural Science Foundation of China [81373080]; Ministry of Science and Technology of China [2013CB530800]; Research Foundation by the Ministry of Health of PLA China [13CXZ029]; Beijing Municipal Science and Technology Commission [D121100004912003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Research Foundation by the Ministry of Health of PLA China; Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	This study was supported by research grants from the National Natural Science Foundation of China, 81373080; Ministry of Science and Technology of China, 2013CB530800; Research Foundation by the Ministry of Health of PLA China, 13CXZ029 and the Beijing Municipal Science and Technology Commission, D121100004912003.	Agyemang C, 2006, J HUM HYPERTENS, V20, P874, DOI 10.1038/sj.jhh.1002073; Agyemang C, 2006, J HUM HYPERTENS, V20, P67, DOI 10.1038/sj.jhh.1001923; Anderson G, 2004, PUBLIC HEALTH REP, V119, P263, DOI 10.1016/j.phr.2004.04.005; [Anonymous], 2008, WHO REP 2008 PRIM HL; [Anonymous], 1999, WHO REP 1999 MAK DIF; Bromfield SG, 2014, J CLIN HYPERTENS, V16, P270, DOI 10.1111/jch.12281; Cai L, 2011, PUBLIC HEALTH REP, V126, P420; Cai L, 2012, CLIN EXP HYPERTENS, V34, P45, DOI 10.3109/10641963.2011.618206; Chen R, 2003, J HUM HYPERTENS, V17, P751, DOI 10.1038/sj.jhh.1001612; Chiu YH, 2006, J HYPERTENS, V24, P821, DOI 10.1097/01.hjh.0000222750.82820.19; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026; He Y, 2006, J AM COLL CARDIOL, V47, P1588, DOI 10.1016/j.jacc.2005.11.074; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Joshi V, 2007, ASIA-PAC J PUBLIC HE, V19, P3, DOI 10.1177/10105395070190020201; Ke L, 2015, AM J HYPERTENS, V28, P159, DOI 10.1093/ajh/hpu121; Li H, 2010, J HYPERTENS, V28, P432, DOI 10.1097/HJH.0b013e328334b39e; Ma WJ, 2012, AM J HYPERTENS, V25, P590, DOI 10.1038/ajh.2012.11; Meng XJ, 2011, J HYPERTENS, V29, P1303, DOI 10.1097/HJH.0b013e328347f79e; Ostchega Y, 2007, J AM GERIATR SOC, V55, P1056, DOI 10.1111/j.1532-5415.2007.01215.x; Parekh AK, 2011, PUBLIC HEALTH REP, V126, P460, DOI 10.1177/003335491112600403; People's republic of China ministry of health disease control division, 2003, OV OB PREV CONTR GUI; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Quasem I, 2001, B WORLD HEALTH ORGAN, V79, P490; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Sheng CS, 2013, HYPERTENS RES, V36, P824, DOI 10.1038/hr.2013.57; Smith JP, 2014, J ECON AGEING, V4, P37, DOI 10.1016/j.jeoa.2014.08.006; Staessen JA, 2000, LANCET, V355, P865, DOI 10.1016/S0140-6736(99)07330-4; Sur ZQ, 2007, CLIN CARDIOL, V30, P183, DOI 10.1002/clc.20073; Tian S, 2011, HYPERTENS RES, V34, P1087, DOI 10.1038/hr.2011.99; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062469; Wang J, 2014, J HUM HYPERTENS, V28, P25, DOI 10.1038/jhh.2013.44; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; Wu Y, 2009, J HYPERTENS, V27, P190, DOI 10.1097/HJH.0b013e328317c8c3; Xi B, 2012, INT J CARDIOL, V158, P326, DOI 10.1016/j.ijcard.2012.04.140; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang GH, 2010, BIOMED ENVIRON SCI, V23, P422, DOI 10.1016/S0895-3988(11)60002-0; Zhao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061779; Zhao Y, 2012, J CLIN HYPERTENS, V14, P637, DOI 10.1111/j.1751-7176.2012.00670.x	42	48	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0132814	10.1371/journal.pone.0132814	http://dx.doi.org/10.1371/journal.pone.0132814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1VB	26241049	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700006
J	Jurak, E; Patyshakuliyeva, A; de Vries, RP; Gruppen, H; Kabel, MA				Jurak, Edita; Patyshakuliyeva, Aleksandrina; de Vries, Ronald P.; Gruppen, Harry; Kabel, Mirjam A.			Compost Grown Agaricus bisporus Lacks the Ability to Degrade and Consume Highly Substituted Xylan Fragments	PLOS ONE			English	Article							WHEAT-FLOUR ARABINOXYLAN; H-1-NMR SPECTROSCOPY; ASPERGILLUS-AWAMORI; ENZYME-ACTIVITIES; BUTTON MUSHROOM; MODE; OLIGOSACCHARIDES; PURIFICATION	The fungus Agaricus bisporus is commercially grown for the production of edible mushrooms. This cultivation occurs on compost, but not all of this substrate is consumed by the fungus. To determine why certain fractions remain unused, carbohydrate degrading enzymes, water-extracted from mushroom-grown compost at different stages of mycelium growth and fruiting body formation, were analyzed for their ability to degrade a range of polysaccharides. Mainly endo-xylanase, endo-glucanase, beta-xylosidase and beta-glucanase activities were determined in the compost extracts obtained during mushroom growth. Interestingly, arabinofuranosidase activity able to remove arabinosyl residues from doubly substituted xylose residues and a-glucuronidase activity were not detected in the compost enzyme extracts. This correlates with the observed accumulation of arabinosyl and glucuronic acid substituents on the xylan backbone in the compost towards the end of the cultivation. Hence, it was concluded that compost grown A. bisporus lacks the ability to degrade and consume highly substituted xylan fragments.	[Jurak, Edita; Gruppen, Harry; Kabel, Mirjam A.] Wageningen Univ, Food Chem Lab, NL-6708 WG Wageningen, Netherlands; [Patyshakuliyeva, Aleksandrina; de Vries, Ronald P.] Univ Utrecht, Fungal Physiol, CBS KNAW Fungal Biodivers Ctr, NL-3584 CT Utrecht, Netherlands; [Patyshakuliyeva, Aleksandrina; de Vries, Ronald P.] Univ Utrecht, Fungal Mol Physiol, NL-3584 CT Utrecht, Netherlands	Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); Utrecht University; Utrecht University	Kabel, MA (corresponding author), Wageningen Univ, Food Chem Lab, Bornse Weilanden 9, NL-6708 WG Wageningen, Netherlands.	mirjam.kabel@wur.nl	de Vries, Ronald P./F-8125-2011; Jurak, Edita/AAM-2163-2020; Kabel, Mirjam/M-1051-2016	de Vries, Ronald P./0000-0002-4363-1123; Kabel, Mirjam/0000-0002-2787-7852; Jurak, Edita/0000-0003-4253-4556	Technology Foundation STW [11108]; applied science division of NWO; technology programme of the Ministry of Economic Affairs (The Netherlands); CNC Grondstoffen B.V.; Walkro International	Technology Foundation STW(Technologiestichting STW); applied science division of NWO(Netherlands Organization for Scientific Research (NWO)); technology programme of the Ministry of Economic Affairs (The Netherlands); CNC Grondstoffen B.V.; Walkro International	This research was supported and approved by the Technology Foundation STW (11108), applied science division of NWO and the technology programme of the Ministry of Economic Affairs (The Netherlands) and by CNC Grondstoffen B.V. and Walkro International. CNC provided the compost samples used in this research.	BONNEN AM, 1994, APPL ENVIRON MICROB, V60, P960, DOI 10.1128/AEM.60.3.960-965.1994; Broek L. A. M. van den, 2005, Applied Microbiology and Biotechnology, V67, P641, DOI 10.1007/s00253-004-1850-9; CLAYDON N, 1988, T BRIT MYCOL SOC, V90, P85, DOI 10.1016/S0007-1536(88)80183-9; Daas PJH, 1999, CARBOHYD RES, V318, P135, DOI 10.1016/S0008-6215(99)00093-2; de Vries RP, 1999, APPL ENVIRON MICROB, V65, P2453; Gerrits J, 1968, MUSHROOM SCI, V7, P1; GRUPPEN H, 1992, CARBOHYD RES, V233, P45, DOI 10.1016/S0008-6215(00)90919-4; HAYES WA, 1969, ANN APPL BIOL, V64, P177, DOI 10.1111/j.1744-7348.1969.tb02867.x; IIYAMA K, 1994, APPL ENVIRON MICROB, V60, P1538, DOI 10.1128/AEM.60.5.1538-1546.1994; Jurak E, ACCUMULATION R UNPUB; Jurak E, 2014, CARBOHYD POLYM, V101, P281, DOI 10.1016/j.carbpol.2013.09.050; Kabel MA, 2006, BIOTECHNOL BIOENG, V93, P56, DOI 10.1002/bit.20685; KORMELINK FJM, 1993, CARBOHYD RES, V249, P355, DOI 10.1016/0008-6215(93)84100-K; KORMELINK FJM, 1993, CARBOHYD RES, V249, P369, DOI 10.1016/0008-6215(93)84101-B; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; McCleary BV, 1993, US Patent, Patent No. [US 5250306 A, 5250306]; Morin E, 2012, P NATL ACAD SCI USA, V109, P17501, DOI 10.1073/pnas.1206847109; Patyshakuliyeva A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-663; PULS J, 1987, ENZYME MICROB TECH, V9, P83, DOI 10.1016/0141-0229(87)90147-5; Savoie JM, 1998, MYCOL RES, V102, P1113, DOI 10.1017/S0953756298006121; Schols HA, CARBOHYDR RES, V206, P117; Singh A, 2003, J CHEM TECHNOL BIOT, V78, P743, DOI 10.1002/jctb.852; Sorensen HR, 2006, APPL MICROBIOL BIOT, V73, P850, DOI 10.1007/s00253-006-0543-y; Van Laere KMJ, 1999, APPL MICROBIOL BIOT, V51, P606, DOI 10.1007/s002530051439; WOOD DA, 1977, ARCH MICROBIOL, V114, P161, DOI 10.1007/BF00410778; WOOD DA, 1980, J GEN MICROBIOL, V117, P327	26	15	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134169	10.1371/journal.pone.0134169	http://dx.doi.org/10.1371/journal.pone.0134169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237450	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942400016
J	Chung, W; Kim, R				Chung, Woojin; Kim, Roeul			Are Married Men Healthier than Single Women? A Gender Comparison of the Health Effects of Marriage and Marital Satisfaction in East Asia	PLOS ONE			English	Article							SELF-RATED HEALTH; SOUTH-KOREA; SON PREFERENCE; LONG-TERM; MORTALITY; SELECTION; QUALITY; JAPAN; DEPRESSION; CHINESE	Background Although Asian societies are remarkably different from Western societies in terms of sociocultural characteristics, little is known about the gender differences in the health effects of marriage and marital satisfaction in Asian countries. Methodology/Principal Findings Using a randomly sampled dataset from the 2006 East Asian Social Survey comprising 8528 individuals from China, Japan, Taiwan, and South Korea, this study performs analyses using a multivariate logistic regression model to predict the probability for a man or a woman to report poor health. Our results differ quite significantly from those of most studies focusing on Western countries. Considering marital satisfaction, there may be no health benefits from marriage for a specific gender in a given country, because the health loss associated with a dissatisfied marriage usually supersedes the health benefits from marriage. Moreover, women may reap greater health benefits from marriage than men. Additionally, those most likely to report poor health are found to be married and dissatisfied men or women, rather than never-married individuals. Conclusion/Significance The present study argues the need to design and carry out a gender-and country-specific social health policy approach to target individuals suffering from poor health, thereby reducing the gender differences in health status.	[Chung, Woojin] Yonsei Univ, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Seoul 120749, South Korea; [Chung, Woojin] Yonsei Univ, Inst Hlth Serv Res, Seoul 120749, South Korea; [Kim, Roeul] Korea Hlth Promot Fdn, Natl Tobacco Control Ctr, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Yonsei University; Yonsei University Health System; Yonsei University	Kim, R (corresponding author), Korea Hlth Promot Fdn, Natl Tobacco Control Ctr, Seoul, South Korea.	sunset0822@hotmail.com		Kim, Roeul/0000-0003-4663-4490; chung, woojin/0000-0003-2090-4851				Academy of East Asian Studies, 2006, EAST ASIAN SOCIAL SU; Benyamini Y, 2000, PSYCHOSOM MED, V62, P354, DOI 10.1097/00006842-200005000-00009; Cheung YB, 1998, PUBLIC HEALTH, V112, P113; Chung WJ, 2007, POPUL DEV REV, V33, P757, DOI 10.1111/j.1728-4457.2007.00196.x; Chung W, 2011, APPL ECON, V43, P3365, DOI 10.1080/00036841003636284; Das Gupta M, 2003, J DEV STUD, V40, P153, DOI 10.1080/00220380412331293807; Eaker ED, 2007, PSYCHOSOM MED, V69, P509, DOI 10.1097/PSY.0b013e3180f62357; Ferree MM, 2010, J MARRIAGE FAM, V72, P420, DOI 10.1111/j.1741-3737.2010.00711.x; Gallin R S, 1994, J Cross Cult Gerontol, V9, P127, DOI 10.1007/BF00972145; GOLDMAN N, 1993, DEMOGRAPHY, V30, P189, DOI 10.2307/2061837; GOVE WR, 1973, AM J SOCIOL, V78, P812, DOI 10.1086/225404; Han KT, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0109-0; Hanibuchi T, 2012, EUR J PUBLIC HEALTH, V22, P47, DOI 10.1093/eurpub/ckq174; Hawkins DN, 2005, SOC FORCES, V84, P451, DOI 10.1353/sof.2005.0103; Holt-Lunstad J, 2008, ANN BEHAV MED, V35, P239, DOI 10.1007/s12160-008-9018-y; Idler E, 2004, J HEALTH SOC BEHAV, V45, P336, DOI 10.1177/002214650404500307; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Ikeda A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-73; Jang SN, 2009, SOC SCI MED, V69, P1608, DOI 10.1016/j.socscimed.2009.09.007; Kazer MW, 2011, J CANCER SURVIV, V5, P132, DOI 10.1007/s11764-010-0157-3; KiecoltGlaser JK, 1996, J CONSULT CLIN PSYCH, V64, P324, DOI 10.1037/0022-006X.64.2.324; Kimmel PL, 2000, J AM SOC NEPHROL, V11, P1518, DOI 10.1681/ASN.V1181518; Kung WW, 2003, JOURNAL OF COMPARATI, V35, P33; Law RW, 2009, J AGING HEALTH, V21, P803, DOI 10.1177/0898264309338300; Lee DTS, 2004, BRIT J PSYCHIAT, V184, P34, DOI 10.1192/bjp.184.1.34; LEVENSON RW, 1993, PSYCHOL AGING, V8, P301, DOI 10.1037/0882-7974.8.2.301; LILLARD LA, 1995, AM J SOCIOL, V100, P1131, DOI 10.1086/230634; Lindstrom M, 2009, HEALTH POLICY, V93, P172, DOI 10.1016/j.healthpol.2009.05.010; Midlarsky E, 2006, ANN NY ACAD SCI, V1087, P279, DOI 10.1196/annals.1385.003; MORGAN SP, 1983, AM SOCIOL REV, V48, P269, DOI 10.2307/2095111; Murray JE, 2000, DEMOGRAPHY, V37, P511, DOI 10.1353/dem.2000.0010; NOLENHOEKSEMA S, 1987, PSYCHOL BULL, V101, P259, DOI 10.1037//0033-2909.101.2.259; OECD, 2014, AVERAGE ANNUAL HOURS; Park J, 2009, IND HEALTH, V47, P50, DOI 10.2486/indhealth.47.50; Patten SB, 2006, CAN J PSYCHIAT, V51, P84, DOI 10.1177/070674370605100204; Pimentel EF, 2000, J MARRIAGE FAM, V62, P32, DOI 10.1111/j.1741-3737.2000.00032.x; Proulx CM, 2013, J FAM PSYCHOL, V27, P194, DOI 10.1037/a0031877; Raymo JM, 2005, AM SOCIOL REV, V70, P801, DOI 10.1177/000312240507000504; Sakauchi F, 2007, ASIAN PAC J CANCER P, V8, P123; SHEK DTL, 1995, SEX ROLES, V32, P699, DOI 10.1007/BF01560185; Shirahase S, 2003, WIVES ECONOMIC CONTR; Siu BWM, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-22; St John PD, 2009, CAN J PSYCHIAT, V54, P487, DOI 10.1177/070674370905400710; Svedberg P, 2006, EUR J EPIDEMIOL, V21, P767, DOI 10.1007/s10654-006-9064-3; Troxel WM, 2005, ARCH INTERN MED, V165, P1022, DOI 10.1001/archinte.165.9.1022; Tsuya NorikoO., 2000, REV POPULATION SOCIA, V9, P195; Umberson D, 1996, AM SOCIOL REV, V61, P837, DOI 10.2307/2096456; UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S; Waldron I, 1996, SOC SCI MED, V43, P113, DOI 10.1016/0277-9536(95)00347-9; Wickrama KAS, 2001, J MARRIAGE FAM, V63, P527, DOI 10.1111/j.1741-3737.2001.00527.x; Williams K, 2003, J HEALTH SOC BEHAV, V44, P470, DOI 10.2307/1519794; World Bank, 2014, LABOR FORCE PARTICIP; XU XH, 1990, J MARRIAGE FAM, V52, P709; Yodanis C, 2005, GENDER SOC, V19, P644, DOI 10.1177/0891243205278166	54	7	8	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134260	10.1371/journal.pone.0134260	http://dx.doi.org/10.1371/journal.pone.0134260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230841	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400095
J	Esteban-Tejeda, L; Prado, C; Cabal, B; Sanz, J; Torrecillas, R; Moya, JS				Esteban-Tejeda, Leticia; Prado, Catuxa; Cabal, Belen; Sanz, Jesus; Torrecillas, Ramon; Moya, Jose Serafin			Antibacterial and Antifungal Activity of ZnO Containing Glasses	PLOS ONE			English	Article							ZINC-OXIDE; IN-VITRO; NANOPARTICLES; TOXICITY; COATINGS; CORROSION; PAINTS; COPPER	A new family of non-toxic biocides based on low melting point (1250 degrees C) transparent glasses with high content of ZnO (15-40wt%) belonging to the miscibility region of the B2O3-SiO2-Na2O-ZnO system has been developed. These glasses have shown an excellent biocide activity (logarithmic reduction > 3) against Gram-(E. coli), Gram+ (S. aureus) and yeast (C. krusei); they are chemically stable in different media (distilled water, sea-like water, LB and DMEN media) as well as biocompatible. The cytotoxicity was evaluated by the Neutral Red Uptake using NIH-3T3 (mouse embryonic fibroblast cells) and the cell viability was >80%. These new glasses can be considered in several and important applications in the field of inorganic non-toxic biocide agents such as medical implants, surgical equipment, protective apparels in hospitals, water purifications systems, food packaging, food storages or textiles.	[Esteban-Tejeda, Leticia; Sanz, Jesus; Moya, Jose Serafin] CSIC, Mat Sci Inst Madrid ICMM, Dept Biomat & Bioinspired Mat, Spanish Natl Res Council, E-28049 Madrid, Spain; [Prado, Catuxa; Cabal, Belen; Torrecillas, Ramon] Univ Oviedo, Spanish Natl Res Council, Nanomat & Nanotechnol Res Ctr, CINN CSIC UNIOVI PA,Principado Asturias, El Entrego 33940, Asturias, Spain; [Torrecillas, Ramon] Moscow State Univ Technol STANKIN, Moscow 101472, Russia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion en Nanomateriales y Nanotecnologia (CINN); Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA; University of Oviedo; Moscow State Technology University Stankin	Esteban-Tejeda, L (corresponding author), CSIC, Mat Sci Inst Madrid ICMM, Dept Biomat & Bioinspired Mat, Spanish Natl Res Council, Plaza Murillo 2, E-28049 Madrid, Spain.	lesteban@icmm.csic.es	Cabal, Belén/G-2694-2019; Torrecillas, Ramón/G-7851-2011	Cabal, Belén/0000-0002-4102-3810; Torrecillas, Ramón/0000-0003-3856-0217; Prado, Catuxa/0000-0002-6630-4395	Consejo Superior de Investigaciones Cientificas (CSIC) [201360E012]; Spanish Ministry of Science and Innovation [MAT2012-38645]; JAE-Doc program (CSIC)	Consejo Superior de Investigaciones Cientificas (CSIC); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); JAE-Doc program (CSIC)	This study has been supported by Consejo Superior de Investigaciones Cientificas (CSIC) project reference number 201360E012 and by the Spanish Ministry of Science and Innovation MAT2012-38645. C. Prado and B. Cabal acknowledge financial support from JAE-Doc program (CSIC, cofounded by FSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, 109935 ISO; [Anonymous], 2004, 20645 ISO; Bai Y, 2014, ENV SCI TECHNOL; Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Boch P, 2007, CERAMIC MATERIALS: PROCESSES, PROPERTIES AND APPLICATIONS, P1, DOI 10.1002/9780470612415; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; Byrne RS, 2002, INT J PHARM, V246, P61, DOI 10.1016/S0378-5173(02)00357-5; Cabal B, 2014, NEW BIOCOMPATIBLE AN, V4, DOI [10.1038/srep05440, DOI 10.1038/SREP05440]; Cates S, 2014, ENVIRON SCI TECHNOL, V48; Commission, 2011, TE COMB ANT RES NEWD; Cook J, 1996, BIOL CONTROL, V7, P333, DOI 10.1006/bcon.1996.0102; Cosgrove SE, 2006, CLIN INFECT DIS, V42, pS82, DOI 10.1086/499406; DOE US, 2001, DESIGN CONSTRUCTION; Drewello R, 1997, APPL MICROBIOL BIOT, V47, P337, DOI 10.1007/s002530050937; Ehrt D, 2013, PHYS CHEM GLASSES-B, V54, P65; Engelhardt G, 1987, HIGH RESOLUTION SOLI; ENNAS G, 1990, J NON-CRYST SOLIDS, V125, P181, DOI 10.1016/0022-3093(90)90337-L; Esteban-Tejeda L, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1447-2; Esteban-Tejeda L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033135; Estes DM, 2010, EXPERT REV ANTI-INFE, V8, P325, DOI [10.1586/eri.10.4, 10.1586/ERI.10.4]; Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x; Green JBD, 2011, BIOINTERPHASES, V6, pMR13, DOI 10.1116/1.3645195; Hanagata N, 2011, ACS NANO, V5, P9326, DOI 10.1021/nn202966t; Hanley C, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/29/295103; Horie M, 2012, CHEM RES TOXICOL, V25, P605, DOI 10.1021/tx200470e; Hu S, 2009, J MATER SCI-MATER M, V20, P281, DOI 10.1007/s10856-008-3564-5; Jantzen CM, 1993, CHARACTERIZATION DEF; Kogel J.E., 2006, IND MINERALS ROCKS C; Konstantinou IK, 2004, ENVIRON INT, V30, P235, DOI 10.1016/S0160-4120(03)00176-4; Le Y, 2010, MATER CHEM PHYS, V120, P351, DOI 10.1016/j.matchemphys.2009.11.020; LES A, 1984, WATER AIR SOIL POLL, V23, P129, DOI 10.1007/BF00206971; Levy SB, 2001, EMERG INFECT DIS, V7, P512, DOI 10.3201/eid0707.017705; Li JH, 2012, TOXICOL RES-UK, V1, P137, DOI 10.1039/c2tx20016c; Li M, 2011, ENVIRON SCI TECHNOL, V45, P1977, DOI 10.1021/es102624t; Li MH, 2011, ENVIRON SCI TECHNOL, V45, P755, DOI 10.1021/es102266g; Lusvardi G, 2002, J PHYS CHEM B, V106, P9753, DOI 10.1021/jp020321s; Materials ASfTa, 1997, C128997 ASTM; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Moya JS, 2011, J AM CERAM SOC, V94, P2067, DOI 10.1111/j.1551-2916.2011.04399.x; Moya JS, 2011, ADV ENG MATER, V13, pB256, DOI 10.1002/adem.201080133; Navarro JMF, 1991, CONSEJO SUPERIOR INV, P144; Nriagu J., 2007, ZINC TOXICITY HUMANS, P1; Owen D, 1981, J AM CERAM SOC; Padmavathy N, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/3/035004; Raghupathi KR, 2011, LANGMUIR, V27, P4020, DOI 10.1021/la104825u; Rawat J, 2010, MATER SCI FORUM, V657, P75, DOI 10.4028/www.scientific.net/MSF.657.75; Reddy KM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2742324; Rogalsky S, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40050; Savvova OV, 2012, GLASS CERAM+, V69, P20, DOI 10.1007/s10717-012-9407-3; SCHOLES S, 1975, J NON-CRYST SOLIDS, V19, P167, DOI 10.1016/0022-3093(75)90082-4; Shannon MA, 2008, NATURE, V452, P301, DOI 10.1038/nature06599; Simoncic B, 2010, TEXT RES J, V80, P1721, DOI 10.1177/0040517510363193; Spencer CG, 2009, ANGLE ORTHOD, V79, P317, DOI 10.2319/011408-19.1; van der Zande M, 2012, ACS NANO, V6, P7427, DOI 10.1021/nn302649p; Wang X, 2009, ADV MATER RES-SWITZ, V79-82, P2091, DOI 10.4028/www.scientific.net/AMR.79-82.2091; Xie YP, 2011, APPL ENVIRON MICROB, V77, P2325, DOI 10.1128/AEM.02149-10; Yebra DM, 2006, PROG ORG COAT, V56, P327, DOI 10.1016/j.porgcoat.2006.06.007	58	34	34	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132709	10.1371/journal.pone.0132709	http://dx.doi.org/10.1371/journal.pone.0132709			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230940	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400019
J	Gargano, EM; Allegretta, G; Perspicace, E; Carotti, A; Van Koppen, C; Frotscher, M; Marchais-Oberwinkler, S; Hartmann, RW				Gargano, Emanuele M.; Allegretta, Giuseppe; Perspicace, Enrico; Carotti, Angelo; Van Koppen, Chris; Frotscher, Martin; Marchais-Oberwinkler, Sandrine; Hartmann, Rolf W.			17 beta-Hydroxysteroid Dehydrogenase Type 2 Inhibition: Discovery of Selective and Metabolically Stable Compounds Inhibiting Both the Human Enzyme and Its Murine Ortholog	PLOS ONE			English	Article							17-BETA-HYDROXY STEROID DEHYDROGENASE; 4,5-DISUBSTITUTED CIS-PYRROLIDINONES; II 17-BETA-HYDROXYSTEROID-DEHYDROGENASE; BIOLOGICAL EVALUATION; NONSTEROIDAL INHIBITORS; DRUG DISCOVERY; OSTEOPOROSIS; POTENT; DERIVATIVES; IDENTIFICATION	Design and synthesis of a new class of inhibitors for the treatment of osteoporosis and its comparative h17 beta-HSD2 and m17 beta-HSD2 SAR study are described. 17a is the first compound to show strong inhibition of both h17 beta-HSD2 and m17 beta-HSD2, intracellular activity, metabolic stability, selectivity toward h17 beta-HSD1, m17 beta-HSD1 and estrogen receptors a and beta as well as appropriate physicochemical properties for oral bioavailability. These properties make it eligible for pre-clinical animal studies, prior to human studies.	[Gargano, Emanuele M.; Perspicace, Enrico; Frotscher, Martin; Marchais-Oberwinkler, Sandrine; Hartmann, Rolf W.] Univ Saarland, Pharmaceut & Med Chem, D-66123 Saarbrucken, Germany; [Allegretta, Giuseppe; Marchais-Oberwinkler, Sandrine; Hartmann, Rolf W.] Helmholtz Inst Pharmaceut Res Saarland, Saarbrucken, Germany; [Carotti, Angelo] Univ Bari, Dipartimento Farmacochim, Bari, Italy; [Van Koppen, Chris] ElexoPharm GmbH, Saarbrucken, Germany	Saarland University; Helmholtz Association; Helmholtz-Center for Infection Research; Universita degli Studi di Bari Aldo Moro	Marchais-Oberwinkler, S (corresponding author), Univ Saarland, Pharmaceut & Med Chem, D-66123 Saarbrucken, Germany.	s.marchais@mx.uni-saarland.de; rolf.hartmann@helmoltz-hzi.de		gargano, emanuele/0000-0001-8277-6248	Deutsche Forschungsgemeinschaft (DFG) [HA1315/12-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors acknowledge the Deutsche Forschungsgemeinschaft (DFG) for financial support (Grants HA1315/12-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Elexopharm GmbH had no financial interest in this collaboration.	Bey E, 2008, BIOORGAN MED CHEM, V16, P6423, DOI 10.1016/j.bmc.2008.04.073; Bydal P, 2004, STEROIDS, V69, P325, DOI 10.1016/j.steroids.2004.03.002; Day JM, 2006, MOL CELL ENDOCRINOL, V248, P246, DOI 10.1016/j.mce.2006.01.011; Di L, 2003, J BIOMOL SCREEN, V8, P453, DOI 10.1177/1087057103255988; Dong Y, 1998, J BONE MINER RES, V13, P1539, DOI 10.1359/jbmr.1998.13.10.1539; Gargano EM, 2014, EUR J MED CHEM, V87, P203, DOI 10.1016/j.ejmech.2014.09.061; Gunn D, 2005, BIOORG MED CHEM LETT, V15, P3053, DOI 10.1016/j.bmcl.2005.04.025; Hui JPM, 2012, RAPID COMMUN MASS SP, V26, P345, DOI 10.1002/rcm.5336; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Kruchten P, 2009, MOL CELL ENDOCRINOL, V301, P154, DOI 10.1016/j.mce.2008.09.035; LIN SX, 1992, J BIOL CHEM, V267, P16182; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Marchais-Oberwinkler S, 2008, J MED CHEM, V51, P4685, DOI 10.1021/jm800367k; Marchais-Oberwinkler S, 2013, J MED CHEM, V56, P167, DOI 10.1021/jm3014053; Marchais-Oberwinkler S, 2011, J MED CHEM, V54, P534, DOI 10.1021/jm1009082; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Moreno-Farre J., 2007, AUSTR ASIAN J CANC, V6, P55; Perspicace E, 2013, EUR J MED CHEM, V69, P201, DOI 10.1016/j.ejmech.2013.08.026; Poirier D, 2001, MOL CELL ENDOCRINOL, V171, P119, DOI 10.1016/S0303-7207(00)00427-5; PURANEN TJ, 1994, BIOCHEM J, V304, P289, DOI 10.1042/bj3040289; Reinwald S, 2008, J BONE MINER RES, V23, P1353, DOI 10.1359/JBMR.080516; Sam K M, 1998, Drug Des Discov, V15, P157; SAM KM, 1995, J MED CHEM, V38, P4518, DOI 10.1021/jm00022a018; Tremblay MR, 2001, STEROIDS, V66, P821, DOI 10.1016/S0039-128X(01)00116-7; Turner A. Simon, 2001, European Cells & Materials, V1, P66; U. S. Environmental Protection Agency, 2015, PROT IN VITR ESTR RE; Vanderschueren D, 2008, CURR OPIN ENDOCRINOL, V15, P250, DOI 10.1097/MED.0b013e3282fe6ca9; Wetzel M, 2012, EUR J MED CHEM, V47, P1, DOI 10.1016/j.ejmech.2011.09.004; Wetzel M, 2011, J MED CHEM, V54, P7547, DOI 10.1021/jm2008453; Wood J, 2006, BIOORG MED CHEM LETT, V16, P4965, DOI 10.1016/j.bmcl.2006.06.041; WU L, 1993, J BIOL CHEM, V268, P12964; Xu KY, 2011, EUR J MED CHEM, V46, P5978, DOI 10.1016/j.ejmech.2011.10.010; Xu KY, 2011, LETT DRUG DES DISCOV, V8, P406, DOI 10.2174/157018011795514230; ZHU DW, 1993, J MOL BIOL, V234, P242, DOI 10.1006/jmbi.1993.1578	35	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134754	10.1371/journal.pone.0134754	http://dx.doi.org/10.1371/journal.pone.0134754			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230928	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400162
J	Gazy, I; Zeevi, DA; Renbaum, P; Zeligson, S; Eini, L; Bashari, D; Smith, Y; Lahad, A; Goldberg, M; Ginsberg, D; Levy-Lahad, E				Gazy, Inbal; Zeevi, David A.; Renbaum, Paul; Zeligson, Sharon; Eini, Lital; Bashari, Dana; Smith, Yoav; Lahad, Amnon; Goldberg, Michal; Ginsberg, Doron; Levy-Lahad, Ephrat			TODRA, a IncRNA at the RAD51 Locus, Is Oppositely Regulated to RAD51, and Enhances RAD51-Dependent DSB (Double Strand Break) Repair	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; DNA-REPAIR; HOMOLOGOUS RECOMBINATION; TRANSCRIPTIONAL REGULATION; NONCODING RNA; C-ABL; EXPRESSION; LONG; BRCA1; E2F	Expression of RAD51, a crucial player in homologous recombination (HR) and DNA double-strand break (DSB) repair, is dysregulated in human tumors, and can contribute to genomic instability and tumor progression. To further understand RAD51 regulation we functionally characterized a long non-coding (lnc) RNA, dubbed TODRA (Transcribed in the Opposite Direction of RAD51), transcribed 69bp upstream to RAD51, in the opposite direction. We demonstrate that TODRA is an expressed transcript and that the RAD51 promoter region is bidirectional, supporting TODRA expression (7-fold higher than RAD51 in this assay, p = 0.003). TODRA overexpression in HeLa cells induced expression of TPIP, a member of the TPTE family which includes PTEN. Similar to PTEN, we found that TPIP co-activates E2F1 induction of RAD51. Analysis of E2F1's effect on the bidirectional promoter showed that E2F1 binding to the same site that promotes RAD51 expression, results in downregulation of TODRA. Moreover, TODRA overexpression induces HR in a RAD51-dependent DSB repair assay, and increases formation of DNA damage-induced RAD51-positive foci. Importantly, gene expression in breast tumors supports our finding that E2F1 oppositely regulates RAD51 and TODRA: increased RAD51 expression, which is associated with an aggressive tumor phenotype (e.g. negative correlation with positive ER (r = -0.22, p = 0.02) and positive PR status (r = -0.27, p<0.001); positive correlation with ki67 status (r = 0.36, p = 0.005) and HER2 amplification (r = 0.41, p = 0.001)), correlates as expected with lower TODRA and higher E2F1 expression. However, although E2F1 induction resulted in TPIP downregulation in cell lines, we find that TPIP expression in tumors is not reduced despite higher E2F1 expression, perhaps contributing to increased RAD51 expression. Our results identify TPIP as a novel E2F1 co-activator, suggest a similar role for other TPTEs, and indicate that the TODRA lncRNA affects RAD51 dysregulation and RAD51-dependent DSB repair in malignancy. Importantly, gene expression in breast tumors supports our finding that E2F1 oppositely regulates RAD51 and TODRA: increased RAD51 expression, which is associated with an aggressive tumor phenotype (e.g. negative correlation with positive ER (r = -0.22, p = 0.02) and positive PR status (r = -0.27, p<0.001); positive correlation with ki67 status (r = 0.36, p = 0.005) and HER2 amplification (r = 0.41, p = 0.001)), correlates as expected with lower TODRA and higher E2F1 expression. However, although E2F1 induction resulted in TPIP downregulation in cell lines, we find that TPIP expression in tumors is not reduced despite higher E2F1 expression, perhaps contributing to increased RAD51 expression. Our results identify TPIP as a novel E2F1 co-activator, suggest a similar role for other TPTEs, and indicate that the TODRA lncRNA affects RAD51 dysregulation and RAD51-dependent DSB repair in malignancy.	[Gazy, Inbal; Levy-Lahad, Ephrat] Hebrew Univ Jerusalem, Sch Med, Human Genet, IL-91010 Jerusalem, Israel; [Gazy, Inbal; Zeevi, David A.; Renbaum, Paul; Zeligson, Sharon; Levy-Lahad, Ephrat] Shaare Zedek Med Ctr, Inst Med Genet, Jerusalem, Israel; [Eini, Lital; Goldberg, Michal] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, Jerusalem, Israel; [Bashari, Dana; Ginsberg, Doron] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Smith, Yoav] Hebrew Univ Jerusalem, Sch Med, Genom Data Anal Unit, IL-91010 Jerusalem, Israel; [Lahad, Amnon] Hebrew Univ Jerusalem, Sch Med, Dept Family Med, IL-91010 Jerusalem, Israel; [Lahad, Amnon] Clalit Hlth Serv, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Bar Ilan University; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Clalit Health Services	Levy-Lahad, E (corresponding author), Hebrew Univ Jerusalem, Sch Med, Human Genet, IL-91010 Jerusalem, Israel.	lahad@szmc.org.il	Levy-Lahad, Ephrat/F-2186-2018	Levy-Lahad, Ephrat/0000-0002-2637-1921; ginsberg, doron/0000-0002-1257-4920; Gazy, Inbal/0000-0003-3944-6977; Goldberg, Michal/0000-0001-9397-2383	New York Breast Cancer Research Foundation; Israel Science Foundation [635/06, 648/13]	New York Breast Cancer Research Foundation; Israel Science Foundation(Israel Science Foundation)	This work was supported by the New York Breast Cancer Research Foundation (IG, ELL), the Israel Science Foundation (Grant Number: 635/06 to DG; 648/13 to MG), and a gift of Ellie and David Werber (IG, ELL). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Berkovich E, 2003, ONCOGENE, V22, P161, DOI 10.1038/sj.onc.1206144; Bindra RS, 2007, ONCOGENE, V26, P2048, DOI 10.1038/sj.onc.1210001; Bindra RS, 2005, CANCER RES, V65, P11597, DOI 10.1158/0008-5472.CAN-05-2119; Cam H, 2003, CANCER CELL, V3, P311, DOI 10.1016/S1535-6108(03)00080-1; Carninci P, 2009, NATURE, V457, P974, DOI 10.1038/457974b; Chaussepied M, 2004, MOL CELL, V16, P831, DOI 10.1016/j.molcel.2004.11.003; Chen G, 1999, J BIOL CHEM, V274, P12748, DOI 10.1074/jbc.274.18.12748; Chia J, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.59; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Flygare J, 2001, EXP CELL RES, V268, P61, DOI 10.1006/excr.2001.5265; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Hegan DC, 2010, P NATL ACAD SCI USA, V107, P2201, DOI 10.1073/pnas.0904783107; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Iwanaga R, 2004, ONCOGENE, V23, P8581, DOI 10.1038/sj.onc.1207976; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kasparek TR, 2011, SEMIN CELL DEV BIOL, V22, P886, DOI 10.1016/j.semcdb.2011.10.007; Lee BK, 2011, NUCLEIC ACIDS RES, V39, P3558, DOI 10.1093/nar/gkq1313; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Lin JM, 2007, GENOME RES, V17, P818, DOI 10.1101/gr.5623407; Lipovich L, 2010, BBA-GENE REGUL MECH, V1799, P597, DOI 10.1016/j.bbagrm.2010.10.001; Maacke H, 2000, ONCOGENE, V19, P2791, DOI 10.1038/sj.onc.1203578; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mitra A, 2009, HISTOPATHOLOGY, V55, P696, DOI 10.1111/j.1365-2559.2009.03448.x; Muggerud AA, 2010, MOL ONCOL, V4, P357, DOI 10.1016/j.molonc.2010.06.007; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Perez DS, 2008, HUM MOL GENET, V17, P642, DOI 10.1093/hmg/ddm336; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shahar OD, 2012, ONCOGENE, V31, P3495, DOI 10.1038/onc.2011.516; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Shimizu H, 2009, BIOCHEM BIOPH RES CO, V382, P286, DOI 10.1016/j.bbrc.2009.03.020; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Suen TC, 2005, BBA-GENE STRUCT EXPR, V1728, P126, DOI 10.1016/j.bbaexp.2005.01.014; Suen TC, 1999, J BIOL CHEM, V274, P31297, DOI 10.1074/jbc.274.44.31297; Suwaki N, 2011, SEMIN CELL DEV BIOL, V22, P898, DOI 10.1016/j.semcdb.2011.07.019; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Tapparel C, 2003, GENE, V323, P189, DOI 10.1016/j.gene.2003.09.038; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Viera A, 2009, J CELL SCI, V122, P2149, DOI 10.1242/jcs.046706; Walker SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Wickramasinghe VO, 2013, MOL CELL, V51, P737, DOI 10.1016/j.molcel.2013.08.031; Xu CF, 1997, J BIOL CHEM, V272, P20994, DOI 10.1074/jbc.272.34.20994; Ying L, 2013, MOL BIOSYST, V9, P407, DOI 10.1039/c2mb25386k; Yoshikawa K, 2000, INT J CANCER, V88, P28, DOI 10.1002/1097-0215(20001001)88:1<28::AID-IJC5>3.0.CO;2-4; Yuan ZM, 1998, J BIOL CHEM, V273, P3799, DOI 10.1074/jbc.273.7.3799; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	64	28	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134120	10.1371/journal.pone.0134120	http://dx.doi.org/10.1371/journal.pone.0134120			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230935	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400074
J	Ghosh, T; Basu, U				Ghosh, Trinath; Basu, Utpal			Cis-Acting Sequence Elements and Upstream Open Reading Frame in Mouse Utrophin-A 5 '-UTR Repress Cap-Dependent Translation	PLOS ONE			English	Article							DYSTROPHIN-RELATED PROTEIN; DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE FIBERS; ENCEPHALOMYOCARDITIS VIRUS-RNA; THERAPEUTIC UP-REGULATION; RIBOSOME ENTRY SITE; MDX MICE; RICH ELEMENT; EXPRESSION; ACTIVATION	Utrophin, the autosomal homologue of dystrophin can functionally compensate for dystrophin deficiency. Utrophin upregulation could therefore be a therapeutic strategy in Duchenne Muscular Dystrophy (DMD) that arises from mutation in dystrophin gene. In contrast to its transcriptional regulation, mechanisms operating at post-transcriptional level of utrophin expression have not been well documented. Although utrophin-A 5'-UTR has been reported with internal ribosome entry site (IRES), its inhibitory effect on translation is also evident. In the present study we therefore aimed to compare relative contribution of cap-independent and cap-dependent translation with mouse utrophin-A 5'-UTR through m7G-capped and A-capped mRNA transfection based reporter assay. Our results demonstrate that cap-independent translation with utrophin-A 5'-UTR is not as strong as viral IRES. However, cap-independent mode has significant contribution as cap-dependent translation is severely repressed with utrophin-A 5'-UTR. We further identified two sequence elements and one upstream open reading frame in utrophin-A 5'-UTR responsible for repression. The repressor elements in utrophin-A 5'-UTR may be targeted for utrophin upregulation.	[Ghosh, Trinath; Basu, Utpal] Univ Kalyani, Dept Mol Biol & Biotechnol, Kalyani 741235, W Bengal, India	Kalyani University	Basu, U (corresponding author), Univ Kalyani, Dept Mol Biol & Biotechnol, Kalyani 741235, W Bengal, India.	utpal@klyuniv.ac.in		Basu, Utpal/0000-0002-8063-3777	Department of Science and Technology, Govt. of India [SR/FT/LS-121/2008]; Council for Scientific and Indistrial Research [09/106(0122)/2010-EMR-I]	Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); Council for Scientific and Indistrial Research	Department of Science and Technology, Govt. of India sanction no. SR/FT/LS-121/2008 Dt. 7 Sept, 2009 to UB. Council for Scientific and Indistrial Research sanction no. 09/106(0122)/2010-EMR-I to TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirouche A, 2014, NUCLEIC ACIDS RES, V42, P3982, DOI 10.1093/nar/gkt1350; Amirouche A, 2013, HUM MOL GENET, V22, P3093, DOI 10.1093/hmg/ddt165; Andreev DE, 2012, FEBS LETT, V586, P4139, DOI 10.1016/j.febslet.2012.10.010; Andreev DE, 2009, NUCLEIC ACIDS RES, V37, P6135, DOI 10.1093/nar/gkp665; Babendure JR, 2006, RNA, V12, P851, DOI 10.1261/rna.2309906; Basu U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029376; BEWICK GS, 1992, NEUROREPORT, V3, P857, DOI 10.1097/00001756-199210000-00009; Burton EA, 1999, P NATL ACAD SCI USA, V96, P14025, DOI 10.1073/pnas.96.24.14025; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Cerletti M, 2003, GENE THER, V10, P750, DOI 10.1038/sj.gt.3301941; Chakkalakal JV, 2008, NUCLEIC ACIDS RES, V36, P826, DOI 10.1093/nar/gkm1107; Deconinck N, 1997, NAT MED, V3, P1216, DOI 10.1038/nm1197-1216; Dennis CL, 1996, NUCLEIC ACIDS RES, V24, P1646, DOI 10.1093/nar/24.9.1646; Di Certo MG, 2010, HUM MOL GENET, V19, P752, DOI 10.1093/hmg/ddp539; EVSTAFIEVA AG, 1991, NUCLEIC ACIDS RES, V19, P665, DOI 10.1093/nar/19.3.665; HELLIWELL TR, 1992, NEUROMUSCULAR DISORD, V2, P177, DOI 10.1016/0960-8966(92)90004-P; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson RJ, 2013, COLD SPRING HARBOR P, V5; KARPATI G, 1993, J NEUROPATH EXP NEUR, V52, P119, DOI 10.1097/00005072-199303000-00004; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; KHURANA TS, 1990, J BIOL CHEM, V265, P16717; Khurana TS, 1999, MOL BIOL CELL, V10, P2075, DOI 10.1091/mbc.10.6.2075; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Kolupaeva VG, 1998, J BIOL CHEM, V273, P18599, DOI 10.1074/jbc.273.29.18599; Kozak M, 2005, NUCLEIC ACIDS RES, V33, P6593, DOI 10.1093/nar/gki958; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; Michel AM, 2014, NUCLEIC ACIDS RES, V42, pD859, DOI 10.1093/nar/gkt1035; Miura P, 2005, J BIOL CHEM, V280, P32997, DOI 10.1074/jbc.M503994200; Miura P, 2010, HUM MOL GENET, V19, P1211, DOI 10.1093/hmg/ddp591; Miura P, 2009, HUM MOL GENET, V18, P4640, DOI 10.1093/hmg/ddp431; Miura P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002309; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; Perkins KJ, 2001, NUCLEIC ACIDS RES, V29, P4843, DOI 10.1093/nar/29.23.4843; Sonnemann KJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000083; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Tinsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019189; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134809	10.1371/journal.pone.0134809	http://dx.doi.org/10.1371/journal.pone.0134809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230628	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400170
J	Liu, CJ; Wu, YW; Ko, KY; Chen, YC; Cheng, MF; Yen, RF; Tzen, KY				Liu, Chia-Ju; Wu, Yen-Wen; Ko, Kuan-Yin; Chen, Yi-Chieh; Cheng, Mei-Fang; Yen, Ruoh-Fang; Tzen, Kai-Yuan			Incremental Diagnostic Performance of Combined Parameters in the Detection of Severe Coronary Artery Disease Using Exercise Gated Myocardial Perfusion Imaging	PLOS ONE			English	Article							TRANSIENT ISCHEMIC DILATION; HEART-RATE RECOVERY; VENTRICULAR EJECTION FRACTION; PROGNOSTIC VALUE; TREADMILL EXERCISE; NORMAL LIMITS; COMPUTED-TOMOGRAPHY; NUCLEAR CARDIOLOGY; PULMONARY UPTAKE; CAVITY DILATION	Purpose Myocardial perfusion imaging (MPI) using gated single-photon emission tomography (gSPECT) may underestimate the severity of coronary artery disease (CAD). This study aimed to evaluate the significance of combined parameters derived from gSPECT, as well as treadmill stress test parameters, in the detection of severe CAD. Methods A total of 211 consecutive patients referred for exercise MPI between June 2011 and June 2013 (who received invasive coronary angiography within six months after MPI) were retrospectively reviewed. Exercise MPI was performed with Bruce protocol and Tl-201 injected at peak exercise. Gated SPECT was performed using a cadmium-zinc-telluride camera and processed by QPS/QGS software. Perfusion defect abnormalities such as sum stress score (SSS); sum difference score, algorithm-derived total perfusion deficits, transient ischemic dilatation ratios of end-diastolic volumes and end-systolic volumes, post-stress changes in ejection fraction, and lung/heart ratio (LHR) were calculated. Treadmill parameters, including ST depression (STD) at the 1st and 3rd minutes of recovery stage (1'STD and 3'STD), maximal STD corrected by heart rate increment (ST/HR), heart rate decline in 1st and 3rd minutes of recovery stage, recovery heart rate ratio (HR ratio), systolic and mean blood pressure ratios (SBP ratio and MAP ratio) during recovery phase were recorded. Diagnostic performances of these parameters were analyzed with receiver operating characteristic (ROC) analysis and logistic regression for detection of left main (>= 50%) or 3-vessel disease (all >= 70% luminal stenosis) on invasive angiography. Results Among various MPI and treadmill parameters used for detection of severe CAD, SSS and ST/HR had the highest AUC (0.78, 0.73, p = NS) and best cut-off values (SSS > 6, ST/HR > 17.39 10(-2)mV/bpm), respectively. By univariate logistic regression, all parameters except 1'HRR, 3'HRR, SBP and MAP ratios increased the odds ratio of severe CAD. Only increased L/H ratio, 3'STD, and HR ratio remained significant after multivariate regression. The predicted values of combined MPI and treadmill parameters (LHR, 3'STD, and HR ratio) gave the best ROC (AUC: 0.91) than any individual parameter or parameter combination. Conclusions Of all treadmill and gSPECT parameters, the combination of MPI and treadmill parameters can offer better diagnostic performance for severe CAD.	[Liu, Chia-Ju; Wu, Yen-Wen; Ko, Kuan-Yin; Chen, Yi-Chieh; Cheng, Mei-Fang; Yen, Ruoh-Fang; Tzen, Kai-Yuan] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan; [Wu, Yen-Wen] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Dept Nucl Med, New Taipei City, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Cardiovasc Med Ctr, Div Cardiol, New Taipei City, Taiwan; [Wu, Yen-Wen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University	Wu, YW (corresponding author), Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan.	wuyw0502@gmail.com	CHENG, MEIFANG/AAV-8665-2021; Liu, Chia-Ju/AAX-8643-2021	CHENG, MEIFANG/0000-0002-9359-0606; Liu, Chia-Ju/0000-0003-1641-5617; YEN, RUOH-FANG/0000-0003-1648-6482; WU, YEN-WEN/0000-0003-1520-1166; TZEN, KAI-YUAN/0000-0002-5657-8579	Ministry of Science and Technology of Taiwan [MOST 100-2314-B-002-158, 101-2314-B-418-012-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	YWW. Grants MOST 100-2314-B-002-158 and 101-2314-B-418-012-MY3 from the Ministry of Science and Technology of Taiwan (http://www.most.gov.tw/mp.aspx?mp=7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababneh AA, 2000, J NUCL CARDIOL, V7, P661, DOI 10.1067/mnc.2000.109861; Abidov A, 2004, J NUCL MED, V45, P1999; Abidov A, 2003, J AM COLL CARDIOL, V42, P1818, DOI 10.1016/j.jacc.2003.07.010; Afonso L, 2009, CLIN CARDIOL, V32, P658, DOI [10.1002/clc.20534, 10.1002/clc.20659]; Allison TG, 1999, AM J CARDIOL, V83, P371, DOI 10.1016/S0002-9149(98)00871-6; Borges-Neto S, 2000, RADIOLOGY, V215, P529, DOI 10.1148/radiology.215.2.r00ma13529; Buechel RR, 2010, EUR J NUCL MED MOL I, V37, P773, DOI 10.1007/s00259-009-1375-7; Cheng VY, 2011, CIRCULATION, V124, P2424, DOI 10.1161/CIRCULATIONAHA.111.039255; Chien CL, 2011, OBESITY FACTS, V4, P372, DOI 10.1159/000333439; Chowdhury FU, 2014, EUR HEART J-CARD IMG, V15, P275, DOI 10.1093/ehjci/jet149; Cole CR, 2000, ANN INTERN MED, V132, P552, DOI 10.7326/0003-4819-132-7-200004040-00007; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; De Winter O, 2005, J NUCL CARDIOL, V12, P662, DOI 10.1016/j.nuclcard.2005.08.002; Dona M, 2011, EUR J NUCL MED MOL I, V38, P485, DOI 10.1007/s00259-010-1643-6; Emmett L, 2005, J NUCL MED, V46, P1596; Germano G, 2007, J NUCL CARDIOL, V14, P433, DOI 10.1016/j.nuclcard.2007.06.008; GILL JB, 1987, NEW ENGL J MED, V317, P1485, DOI 10.1056/NEJM198712103172401; Hamasaki S, 1998, AM J CARDIOL, V81, P1100, DOI 10.1016/S0002-9149(98)00124-6; Hansen CL, 1999, J AM COLL CARDIOL, V33, P1323, DOI 10.1016/S0735-1097(98)00699-8; Hansen CL, 2002, J NUCL CARDIOL, V9, P47, DOI 10.1067/mnc.2002.118695; HASHIMOTO M, 1993, J AM COLL CARDIOL, V22, P659, DOI 10.1016/0735-1097(93)90173-X; Heston TF, 2005, J NUCL MED, V46, P1990; Higgins JP, 2007, EUR J NUCL MED MOL I, V34, P584, DOI 10.1007/s00259-006-0293-1; Hsu BL, 2014, EUR J NUCL MED MOL I, V41, P2294, DOI 10.1007/s00259-014-2881-9; Hsu JC, 2007, INT J CARDIOL, V119, P274, DOI 10.1016/j.ijcard.2006.07.160; Hsu PY, 2015, ACTA CARDIO IN PRESS; Kaminek M, 2002, CLIN NUCL MED, V27, P255, DOI 10.1097/00003072-200204000-00004; Kinoshita N, 2002, CLIN NUCL MED, V27, P34, DOI 10.1097/00003072-200201000-00008; Ko CL, 2015, J NUCL CARDIOL, V22, P308, DOI 10.1007/s12350-014-9963-8; Liu CJ, 2015, ANN NUCL MED; Mang CL, 2008, AM J CARDIOL, V102, P518, DOI 10.1016/j.amjcard.2008.04.027; Mazzanti M, 1996, J AM COLL CARDIOL, V27, P1612, DOI 10.1016/0735-1097(96)00052-6; McHam SA, 1999, J AM COLL CARDIOL, V34, P754, DOI 10.1016/S0735-1097(99)00269-7; Nakajima K, 2007, EUR J NUCL MED MOL I, V34, P1088, DOI 10.1007/s00259-006-0321-1; Nakajima K, 2010, ANN NUCL MED, V24, P125, DOI 10.1007/s12149-009-0337-2; Nishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392; Petretta M, 2013, J NUCL CARDIOL, V20, P45, DOI 10.1007/s12350-012-9642-6; Romanens M, 2001, EUR J NUCL MED, V28, P907, DOI 10.1007/s002590100532; Ronan G, 2014, J NUCL CARDIOL, V21, P192, DOI 10.1007/s12350-013-9841-9; Rywik TM, 1998, CIRCULATION, V97, P2117, DOI 10.1161/01.CIR.97.21.2117; Schindler TH, 2014, SEMIN NUCL MED, V44, P274, DOI 10.1053/j.semnuclmed.2014.04.002; Schultz MG, 2013, AM J HYPERTENS, V26, P357, DOI 10.1093/ajh/hps053; Sharir T, 1999, CIRCULATION, V100, P1035, DOI 10.1161/01.CIR.100.10.1035; Songy B, 2011, CLIN NUCL MED, V36, P776, DOI 10.1097/RLU.0b013e31821a294e; Takahashi Y, 2013, ANN NUCL MED, V27, P11, DOI 10.1007/s12149-012-0653-9; Tanaka H, 2013, CIRC J, V77, P1009, DOI 10.1253/circj.CJ-12-1093; Vivekananthan DP, 2003, J AM COLL CARDIOL, V42, P831, DOI 10.1016/S0735-1097(03)00833-7; Wang SY, 2011, NUCL MED COMMUN, V32, P113, DOI 10.1097/MNM.0b013e3283422838; Watanabe J, 2001, CIRCULATION, V104, P1911, DOI 10.1161/circ.104.16.1911; WEISS AT, 1987, J AM COLL CARDIOL, V9, P752; Wu YW, 2010, J NUCL MED, V51, P906, DOI 10.2967/jnumed.109.073833; Xu Y, 2012, J NUCL CARDIOL, V19, P465, DOI 10.1007/s12350-012-9527-8; Zaman MU, 2011, ANN NUCL MED, V25, P566, DOI 10.1007/s12149-011-0500-4; Zimarino M, 2013, INT J CARDIOL, V168, P1274, DOI 10.1016/j.ijcard.2012.12.007	54	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134485	10.1371/journal.pone.0134485	http://dx.doi.org/10.1371/journal.pone.0134485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230651	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400126
J	Obokata, M; Negishi, K; Ohyama, Y; Okada, H; Imai, K; Kurabayashi, M				Obokata, Masaru; Negishi, Kazuaki; Ohyama, Yoshiaki; Okada, Haruka; Imai, Kunihiko; Kurabayashi, Masahiko			A Risk Score with Additional Four Independent Factors to Predict the Incidence and Recovery from Metabolic Syndrome: Development and Validation in Large Japanese Cohorts	PLOS ONE			English	Article							CARDIOVASCULAR RISK; US ADULTS; URIC-ACID; HEALTH; PREVALENCE; HEART; ASSOCIATION; CHOLESTEROL; DIAGNOSIS; CRITERIA	Background Although many risk factors for Metabolic syndrome (MetS) have been reported, there is no clinical score that predicts its incidence. The purposes of this study were to create and validate a risk score for predicting both incidence and recovery from MetS in a large cohort. Methods Subjects without MetS at enrollment (n = 13,634) were randomly divided into 2 groups and followed to record incidence of MetS. We also examined recovery from it in rest 2,743 individuals with prevalent MetS. Results During median follow-up of 3.0 years, 878 subjects in the derivation and 757 in validation cohorts developed MetS. Multiple logistic regression analysis identified 12 independent variables from the derivation cohort and initial score for subsequent MetS was created, which showed good discrimination both in the derivation (c-statistics 0.82) and validation cohorts (0.83). The predictability of the initial score for recovery from MetS was tested in the 2,743 MetS population (906 subjects recovered from MetS), where nine variables (including age, sex, gamma-glutamyl transpeptidase, uric acid and five MetS diagnostic criteria constituents.) remained significant. Then, the final score was created using the nine variables. This score significantly predicted both the recovery from MetS (c-statistics 0.70, p<0.001, 78% sensitivity and 54% specificity) and incident MetS (c-statistics 0.80) with an incremental discriminative ability over the model derived from five factors used in the diagnosis of MetS (continuous net reclassification improvement: 0.35, p < 0.001 and integrated discrimination improvement: 0.01, p<0.001). Conclusions We identified four additional independent risk factors associated with subsequent MetS, developed and validated a risk score to predict both incident and recovery from MetS.	[Obokata, Masaru; Negishi, Kazuaki; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gunma, Japan; [Ohyama, Yoshiaki] Gunma Univ, Grad Sch Med, Clin Invest & Res Unit, Maebashi, Gunma, Japan; [Okada, Haruka; Imai, Kunihiko] Gunma Chuo Hosp, Japan Community Healthcare Org, Maebashi, Gunma, Japan; [Negishi, Kazuaki] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia	Gunma University; Gunma University; University of Tasmania; Menzies Institute for Medical Research	Negishi, K (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Maebashi, Gunma, Japan.	kazz.negishi@nifty.com	Negishi, Kazuaki/J-7242-2014	Negishi, Kazuaki/0000-0002-9086-2565; Obokata, Masaru/0000-0002-5473-0688	Select Foundation	Select Foundation	The authors received no specific funding for this work. Kazuaki Negishi, MD, PhD, is supported by an award from the Select Foundation, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 2014, CIRCULATION, DOI DOI 10.1161/01.cir.0000441139.02102.80; Baldwin W, 2011, DIABETES, V60, P1258, DOI 10.2337/db10-0916; Boudreau DM, 2009, METAB SYNDR RELAT D, V7, P305, DOI 10.1089/met.2008.0070; Carnethon MR, 2004, DIABETES CARE, V27, P2707, DOI 10.2337/diacare.27.11.2707; Carr DB, 2004, DIABETES, V53, P2087, DOI 10.2337/diabetes.53.8.2087; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Doi Y, 2009, STROKE, V40, P1187, DOI 10.1161/STROKEAHA.108.531319; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Kerner A, 2005, ARTERIOSCL THROM VAS, V25, P193, DOI 10.1161/01.ATV.0000148324.63685.6a; Kim MK, 2013, ENDOCR J, V60, P321, DOI 10.1507/endocrj.EJ12-0331; Koskinen J, 2010, CIRCULATION, V121, P392, DOI 10.1161/CIRCULATIONAHA.109.894584; Kunutsor SK, 2015, INT J CLIN PRACT, V69, P136, DOI 10.1111/ijcp.12507; Lewis SJ, 2008, INT J CLIN PRACT, V62, P1168, DOI 10.1111/j.1742-1241.2008.01770.x; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Magnussen CG, 2012, J AM COLL CARDIOL, V60, P1631, DOI 10.1016/j.jacc.2012.05.056; Misra R, 2010, J DIABETES COMPLICAT, V24, P145, DOI 10.1016/j.jdiacomp.2009.01.003; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Oda E, 2013, INTERNAL MED, V52, P2707, DOI 10.2169/internalmedicine.52.0696; Palaniappan L, 2004, DIABETES CARE, V27, P788, DOI 10.2337/diacare.27.3.788; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Population Reference Bureau, 2013, WORLD POPULATION DAT; Pradhan AD, 2014, CLIN CHEM, V60, P44, DOI 10.1373/clinchem.2013.202549; Ryu S, 2007, ANN EPIDEMIOL, V17, P245, DOI 10.1016/j.annepidem.2006.10.001; Sheu WHH, 2006, DIABETES RES CLIN PR, V74, P162, DOI 10.1016/j.diabres.2006.03.011; Sui XM, 2008, METABOLISM, V57, P845, DOI 10.1016/j.metabol.2008.01.030; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; World Health Organization, 1997, PREVENTING MANAGING; Yang T, 2012, ATHEROSCLEROSIS, V220, P525, DOI 10.1016/j.atherosclerosis.2011.11.014; Yoshiike N, 1998, INT J OBESITY, V22, P684, DOI 10.1038/sj.ijo.0800651; Zamboni M, 1997, AM J CLIN NUTR, V66, P111, DOI 10.1093/ajcn/66.1.111	37	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133884	10.1371/journal.pone.0133884	http://dx.doi.org/10.1371/journal.pone.0133884			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230621	gold, Green Submitted, Green Published			2022-12-27	WOS:000358838400060
J	Petto, C; Gabel, G; Pfannkuche, H				Petto, Carola; Gaebel, Gotthold; Pfannkuche, Helga			Architecture and Chemical Coding of the Inner and Outer Submucous Plexus in the Colon of Piglets	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; VASOACTIVE-INTESTINAL-PEPTIDE; SLOW-TRANSIT CONSTIPATION; PORCINE SMALL-INTESTINE; NITRIC-OXIDE SYNTHASE; PIG SMALL-INTESTINE; MUCOSA IN-VITRO; SUBSTANCE-P; SMOOTH-MUSCLE; DISTAL COLON	In the porcine colon, the submucous plexus is divided into an inner submucous plexus (ISP) on the epithelial side and an outer submucous plexus (OSP) on the circular muscle side. Although both plexuses are probably involved in the regulation of epithelial functions, they might differ in function and neurochemical coding according to their localization. Therefore, we examined expression and co-localization of different neurotransmitters and neuronal markers in both plexuses as well as in neuronal fibres. Immunohistochemical staining was performed on wholemount preparations of ISP and OSP and on cryostat sections. Antibodies against choline acetyltransferase (ChAT), substance P (SP), somatostatin (SOM), neuropeptide Y (NPY), vasoactive intestinal peptide (VIP), neuronal nitric oxide synthase (nNOS) and the pan-neuronal markers Hu C/D and neuron specific enolase (NSE) were used. The ISP contained 1,380 +/- 131 ganglia per cm(2) and 122 +/- 12 neurons per ganglion. In contrast, the OSP showed a wider meshwork (215 +/- 33 ganglia per cm(2)) and smaller ganglia (57 +/- 3 neurons per ganglion). In the ISP, 42% of all neurons expressed ChAT. About 66% of ChAT-positive neurons co-localized SP. A small number of ISP neurons expressed SOM. Chemical coding in the OSP was more complex. Besides the ChAT/+/- SP subpopulation (32% of all neurons), a nNOS-immunoreactive population (31%) was detected. Most nitrergic neurons were only immunoreactive for nNOS; 10% co-localized with VIP. A small subpopulation of OSP neurons was immunoreactive for ChAT/nNOS/+/- VIP. All types of neurotransmitters found in the ISP or OSP were also detected in neuronal fibres within the mucosa. We suppose that the cholinergic population in the ISP is involved in the control of epithelial functions. Regarding neurochemical coding, the OSP shares some similarities with the myenteric plexus. Because of its location and neurochemical characteristics, the OSP may be involved in controlling both the mucosa and circular muscle.	[Petto, Carola; Gaebel, Gotthold; Pfannkuche, Helga] Univ Leipzig, Fac Vet Med, Inst Vet Physiol, D-04109 Leipzig, Germany	Leipzig University	Pfannkuche, H (corresponding author), Univ Leipzig, Fac Vet Med, Inst Vet Physiol, D-04109 Leipzig, Germany.	pfannku@rz.uni-leipzig.de			German Research Foundation (DFG) [PF 403/5-1, PF 403/5-2]; Akademie fur Tiergesundheit; H. Wilhelm Schaumann Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); Akademie fur Tiergesundheit; H. Wilhelm Schaumann Foundation	HP received funding from the German Research Foundation (DFG)(http://www.dfg.de/index.jsp)(PF 403/5-1 and PF 403/5-2) and the 'Akademie fur Tiergesundheit' (http://www.aft-online.net/). CP received a grant from the H. Wilhelm Schaumann Foundation (http://www.schaumann-stiftung.de/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdu F, 2002, AM J PHYSIOL-GASTR L, V282, pG624, DOI 10.1152/ajpgi.00354.2001; Anlauf M, 2003, J COMP NEUROL, V459, P90, DOI 10.1002/cne.10599; Balemba OB, 2001, INT J PARASITOL, V31, P1503, DOI 10.1016/S0020-7519(01)00273-9; BARAMI K, 1995, J NEUROBIOL, V28, P82, DOI 10.1002/neu.480280108; BARBIERS M, 1995, HISTOCHEM CELL BIOL, V103, P115, DOI 10.1007/BF01454008; BARBIERS M, 1993, HISTOCHEMISTRY, V100, P27, DOI 10.1007/BF00268875; Beck M, 2009, CELL TISSUE RES, V338, P37, DOI 10.1007/s00441-009-0852-4; Beuscher N, 2014, HISTOCHEM CELL BIOL, V141, P393, DOI 10.1007/s00418-013-1163-0; Beyer J, 2013, HISTOCHEM CELL BIOL, V140, P157, DOI 10.1007/s00418-013-1078-9; Blumenthal JAS, 1998, CAN J PHYSIOL PHARM, V76, P169; Brehmer A, 2004, J CHEM NEUROANAT, V27, P33, DOI 10.1016/j.jchemneu.2003.09.002; Brookes SJH, 2001, ANAT RECORD, V262, P58; BROWN DR, 1990, PEPTIDES, V11, P497, DOI 10.1016/0196-9781(90)90049-B; Brown DR, 1997, COMP BIOCHEM PHYS A, V118, P309, DOI 10.1016/S0300-9629(96)00311-8; Brown DR, 2004, NEUROGASTROENT MOTIL, V16, P50, DOI 10.1111/j.1743-3150.2004.00475.x; BROWN DR, 1992, J PHARMACOL EXP THER, V261, P1206; BROWN DR, 1990, J PHARMACOL EXP THER, V252, P126; CHANDAN R, 1991, J PHARMACOL EXP THER, V257, P908; Coerdt W, 2004, VIRCHOWS ARCH, V444, P239, DOI 10.1007/s00428-003-0951-7; da Silveira ABM, 2007, DIGEST DIS SCI, V52, P2877, DOI 10.1007/s10620-006-9680-5; Di Giancamillo A, 2010, NEUROGASTROENT MOTIL, V22, pe271, DOI 10.1111/j.1365-2982.2010.01529.x; DOMOTO T, 1990, GASTROENTEROLOGY, V98, P819, DOI 10.1016/0016-5085(90)90003-J; FERRAR JA, 1990, EUR J PHARMACOL, V184, P295, DOI 10.1016/0014-2999(90)90621-C; Frieling T, 1999, N-S ARCH PHARMACOL, V359, P71, DOI 10.1007/PL00005327; Frieling T, 2000, ANN NY ACAD SCI, V915, P98; Furness JB, 2000, J AUTONOM NERV SYST, V81, P87, DOI 10.1016/S0165-1838(00)00127-2; FURNESS JB, 1990, ARCH HISTOL CYTOL, V53, P129, DOI 10.1679/aohc.53.129; FURNESS JB, 1995, GASTROENTEROLOGY, V108, P554, DOI 10.1016/0016-5085(95)90086-1; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Gonkowski Slawomir, 2003, Folia Morphol (Warsz), V62, P455; Gonzalez LM, 2015, TRANSL RES, V166, P12, DOI 10.1016/j.trsl.2015.01.004; HARLING H, 1991, REGUL PEPTIDES, V34, P251, DOI 10.1016/0167-0115(91)90183-H; Hens J, 2000, J COMP NEUROL, V421, P429; Hens J, 2002, HISTOCHEM CELL BIOL, V117, P481, DOI 10.1007/s00418-002-0406-2; Hetz S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00276; HOYLE CHV, 1989, J ANAT, V166, P7; Kapp S, 2006, CELLS TISSUES ORGANS, V184, P31, DOI 10.1159/000096949; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; Kustermann A, 2011, ANAT REC, V294, P858, DOI 10.1002/ar.21365; KUWAHARA A, 1990, J PHARMACOL EXP THER, V252, P1; Lalles JP, 2007, P NUTR SOC, V66, P260, DOI 10.1017/S0029665107005484; Leonhard-Marek S, 2009, J COMP PHYSIOL B, V179, P883, DOI 10.1007/s00360-009-0371-3; Li MKK, 1996, DIGEST DIS SCI, V41, P2440, DOI 10.1007/BF02100140; Low MJ, 2004, BEST PRACT RES CL EN, V18, P607, DOI 10.1016/j.beem.2004.08.005; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V293, pG413, DOI 10.1152/ajpgi.00304.2006; Montedonico S, 2006, J PEDIATR SURG, V41, P1029, DOI 10.1016/j.jpedsurg.2005.12.063; PARSONS AM, 1992, J PHARMACOL EXP THER, V261, P1213; Pfannkuche H, 2011, J ANIM PHYSL ANIM NU; Pidsudko Z, 2008, J COMP PATHOL, V138, P23, DOI 10.1016/j.jcpa.2007.09.003; Porter AJ, 1999, J GASTROEN HEPATOL, V14, P1180, DOI 10.1046/j.1440-1746.1999.02026.x; Priem EKV, 2011, EUR J PHARMACOL, V667, P365, DOI 10.1016/j.ejphar.2011.06.021; RANGACHARI PK, 1990, J PHARMACOL EXP THER, V254, P1076; Riegler M, 1999, AM J PHYSIOL-GASTR L, V276, pG1473, DOI 10.1152/ajpgi.1999.276.6.G1473; Riegler M, 1999, SCAND J GASTROENTERO, V34, P1203, DOI 10.1080/003655299750024715; ROWAN AM, 1994, BRIT J NUTR, V71, P29, DOI 10.1079/BJN19940108; SANDERS KM, 1986, J PHYSIOL-LONDON, V380, P293, DOI 10.1113/jphysiol.1986.sp016286; Scalera G, 1998, PEPTIDES, V19, P991, DOI 10.1016/S0196-9781(98)00053-9; SCHEMANN M, 1993, AM J PHYSIOL, V265, pG1005, DOI 10.1152/ajpgi.1993.265.5.G1005; Skobowiat C, 2010, J VET MED SCI, V72, P1269, DOI 10.1292/jvms.10-0081; TIMMERMANS JP, 1990, CELL TISSUE RES, V260, P367, DOI 10.1007/BF00318639; Timmermans JP, 2001, ANAT REC, V262, P71, DOI 10.1002/1097-0185(20010101)262:1<71::AID-AR1012>3.0.CO;2-A; Timmermans JP, 1997, COMP BIOCHEM PHYS A, V118, P331, DOI 10.1016/S0300-9629(96)00314-3; Wattchow D, 2008, NEUROGASTROENT MOTIL, V20, P1298, DOI 10.1111/j.1365-2982.2008.01165.x; Wedel T, 1999, ANN ANAT, V181, P327, DOI 10.1016/S0940-9602(99)80122-8; Wedel T, 2002, DIS COLON RECTUM, V45, P54, DOI 10.1007/s10350-004-6114-3; Wester T, 1998, J PEDIATR SURG, V33, P619, DOI 10.1016/S0022-3468(98)90328-1; Wojtkiewicz J, 2011, J MOL NEUROSCI; Wood J., 1994, PHYSL ENTERIC NERVOU	68	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133350	10.1371/journal.pone.0133350	http://dx.doi.org/10.1371/journal.pone.0133350			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230272	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400033
J	de Hair, MJH; Leclerc, P; Newsum, EC; Maijer, KI; van de Sande, MGH; Ramwadhdoebe, TH; van Schaardenburg, D; van Baarsen, LGM; Korotkova, M; Gerlag, DM; Tak, PP; Jakobsson, PJ				de Hair, Maria J. H.; Leclerc, Patrick; Newsum, Elize C.; Maijer, Karen I.; van de Sande, Marleen G. H.; Ramwadhdoebe, Tamara H.; van Schaardenburg, Dirkjan; van Baarsen, Lisa G. M.; Korotkova, Marina; Gerlag, Danielle M.; Tak, Paul-Peter; Jakobsson, Per-Johan			Expression of Prostaglandin E-2 Enzymes in the Synovium of Arthralgia Patients at Risk of Developing Rheumatoid Arthritis and in Early Arthritis Patients	PLOS ONE			English	Article							E SYNTHASE; PROINFLAMMATORY CYTOKINES; CELL INFILTRATE; IMAGE-ANALYSIS; TISSUE; PAIN; CYCLOOXYGENASE-2; JOINT; QUANTIFICATION; GENERATION	Objective Arthralgia may precede the development of synovial inflammation in autoantibody-positive individuals at risk of developing rheumatoid arthritis (RA). A major pathway involved in pain is the prostaglandin (PG) E-2 pathway. We investigated this pathway in the synovium of individuals with RA-specific autoantibodies and in early arthritis patients. Methods Nineteen autoantibody-positive individuals (IgM-rheumatoid factor and/or anti-cyclic citrullinated peptide antibodies) with arthralgia (n=15) and/or a positive family history of RA (n=8), who had been prospectively followed for at least 2 years, were included. In addition, we included early arthritis patients (disease-modifying antirheumatic drug naive) who after 2 years follow up fulfilled classification criteria for RA (n=63), spondyloarthritis (SpA; n=14), or had unclassified arthritis (UA; n=27). In all subjects we assessed pain and performed synovial biopsy sampling by mini-arthroscopy at baseline. Tissue sections were examined by immunohistochemistry to detect and quantify PGE(2) pathway enzymes expression levels (mPGES-1; COX-1 and -2; 15-PGDH). Results In both study groups synovial expression of PGE(2) enzymes was not clearly related to pain sensation. Expression levels at baseline were not associated with the development of arthritis after follow up (6 out of 19 autoantibody-positive individuals). However, in early SpA patients the expression levels of mPGES-1 and COX-1 were significantly increased compared to RA and UA patients. Conclusion Pain in autoantibody-positive individuals without synovial inflammation who are at risk of developing RA and in early arthritis patients may be regulated by pathways other than the PGE(2) pathway or originate at sites other than the synovium. In contrast, in SpA, the PGE2 pathway may be inherently linked to the pathophysiology/etiology of the disease.	[de Hair, Maria J. H.; Newsum, Elize C.; Maijer, Karen I.; van de Sande, Marleen G. H.; Ramwadhdoebe, Tamara H.; van Baarsen, Lisa G. M.; Gerlag, Danielle M.; Tak, Paul-Peter] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Leclerc, Patrick; Korotkova, Marina; Jakobsson, Per-Johan] Karolinska Inst, Dept Med, Rheumatol Res Unit, Stockholm, Sweden; [Ramwadhdoebe, Tamara H.; van Baarsen, Lisa G. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [van Schaardenburg, Dirkjan] Reade, Dept Rheumatol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Karolinska Institutet; University of Amsterdam; Academic Medical Center Amsterdam	Tak, PP (corresponding author), GlaxoSmithKline, Stevenage, Herts, England.	paul-peter.x.tak@gsk.com	van Baarsen, Lisa G/N-3646-2015; Jakobsson, Per-Johan/ABC-5594-2021	van Baarsen, Lisa G/0000-0003-3346-8921; 	Dutch Arthritis Foundation [6-1-303]; Swedish Research Council; Swedish Rheumatism Association; King Gustaf V 80 years Foundation; Karolinska Institutet Foundation; Marianne and Marcus Wallenberg foundation	Dutch Arthritis Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; King Gustaf V 80 years Foundation; Karolinska Institutet Foundation(Karolinska Institutet); Marianne and Marcus Wallenberg foundation	This study was financially supported by the Dutch Arthritis Foundation (grant 6-1-303), the Swedish Research Council; the Swedish Rheumatism Association; the King Gustaf V 80 years Foundation; the Karolinska Institutet Foundation and the Marianne and Marcus Wallenberg foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO K, 1991, J RHEUMATOL, V18, P1282; Bos WH, 2010, ANN RHEUM DIS, V69, P490, DOI 10.1136/ard.2008.105759; Braun J, 2011, ANN RHEUM DIS, V70, P896, DOI 10.1136/ard.2011.151027; Chen M, 2008, ARTHRITIS RHEUM, V58, P1354, DOI 10.1002/art.23453; de Hair MJH, 2014, ARTHRITIS RHEUMATOL, V66, P513, DOI 10.1002/art.38273; de Hair MJH, 2011, J RHEUMATOL, V38, P2068, DOI 10.3899/jrheum.110426; Dolhain RJEM, 1998, BRIT J RHEUMATOL, V37, P324; DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218, DOI 10.1002/art.1780341003; Gerlag DM, 2012, ANN RHEUM DIS, V71, P638, DOI 10.1136/annrheumdis-2011-200990; Gerlag DM, 2009, BEST PRACT RES CL RH, V23, P221, DOI 10.1016/j.berh.2009.01.006; Gheorghe KR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016378; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; Ito S, 2001, NEUROSCI RES, V41, P299, DOI 10.1016/S0168-0102(01)00289-9; Korotkova M, 2014, NAT REV RHEUMATOL, V10, P229, DOI 10.1038/nrrheum.2014.1; Kraan MC, 2000, RHEUMATOLOGY, V39, P43, DOI 10.1093/rheumatology/39.1.43; MAPP PI, 1995, ANN RHEUM DIS, V54, P398, DOI 10.1136/ard.54.5.398; Murphey LJ, 2004, ANAL BIOCHEM, V334, P266, DOI 10.1016/j.ab.2004.08.019; Myers LK, 2000, ARTHRITIS RHEUM-US, V43, P2687, DOI 10.1002/1529-0131(200012)43:12<2687::AID-ANR8>3.0.CO;2-9; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Pulichino AM, 2006, J PHARMACOL EXP THER, V319, P1043, DOI 10.1124/jpet.106.110387; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Schaible HG, 2010, ANN NY ACAD SCI, V1193, P60, DOI 10.1111/j.1749-6632.2009.05301.x; Schaible HG, 2004, LANGENBECK ARCH SURG, V389, P237, DOI 10.1007/s00423-004-0468-9; Schett G, 2010, BEST PRACT RES CL RH, V24, P363, DOI 10.1016/j.berh.2010.01.005; Siegle I, 1998, ARTHRITIS RHEUM-US, V41, P122, DOI 10.1002/1529-0131(199801)41:1<122::AID-ART15>3.3.CO;2-#; Sieper J, 2012, NAT REV RHEUMATOL, V8, P280, DOI 10.1038/nrrheum.2012.40; Stichtenoth DO, 2001, J IMMUNOL, V167, P469, DOI 10.4049/jimmunol.167.1.469; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Thoren S, 2000, EUR J BIOCHEM, V267, P6428, DOI 10.1046/j.1432-1327.2000.01735.x; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; ULFGREN AK, 1995, ANN RHEUM DIS, V54, P654, DOI 10.1136/ard.54.8.654; van de Sande MGH, 2011, ANN RHEUM DIS, V70, P772, DOI 10.1136/ard.2010.139527; van de Sande MGH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036668; van de Sande MGH, 2011, ANN RHEUM DIS, V70, P423, DOI 10.1136/ard.2010.139550; van der Hall Pascal O., 2007, V135, P121; Visser H, 2002, ARTHRITIS RHEUM, V46, P357, DOI 10.1002/art.10117; Westman M, 2004, ARTHRITIS RHEUM-US, V50, P1774, DOI 10.1002/art.20286	38	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133669	10.1371/journal.pone.0133669	http://dx.doi.org/10.1371/journal.pone.0133669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225917	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700032
J	Jiang, Y; Wan, LP; Qin, YW; Wang, XR; Yan, SK; Xie, KC; Wang, C				Jiang, Ying; Wan, Liping; Qin, Youwen; Wang, Xiaorui; Yan, Shike; Xie, Kuangcheng; Wang, Chun			Donor Chimerism of B Cells and Nature Killer Cells Provides Useful Information to Predict Hematologic Relapse following Allogeneic Hematopoietic Stem Cell Transplantation	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; MYELOGENOUS LEUKEMIA; PEDIATRIC-PATIENTS; ENGRAFTMENT; KINETICS; MALIGNANCIES; SURVIVAL; MARROW	In this study we investigated the correlation between donor chimerism status and disease relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT). The chimerism of Fluorescence-activated cell sorter (FACS) sorted CD3+T lymphocytes of 153 cases, CD56+CD16+NK lymphocytes of 153 cases and CD19+B lymphocytes of 31 cases with acute B lymphoblastic leukemia (B-ALL) was analyzed post-transplant utilizing polymerase chain reaction amplification of short tandem repeats (PCR-STR). A total of 33 patients (33/153, 21.6%) had recurrent disease. The positive predictive values of declining donor chimerism for hematologic and isolated extramedullary relapse were 58.8% and 10% (P=0.018, Chi-Square). The positive predictive values of declining donor chimerism in BMB, BMT, BMNK and PBB for hematologic relapse were 11.6%, 0%, 0% and 0% under close monitoring in patients with B-ALL. Only the donor chimerism in BMB significantly decreased in the group with hematologic relapse as compared with the group without hematologic relapse (P=0.00, Independent-samples T test) in patients with B-ALL. The median drop of donor chimerism in PBT, BMT, PBNK and BMNK were 0%, 0%, 5.9% and 2.8% one or two weeks prior to hematologic relapse in patients with non-B-ALL. The donor chimerism in PBNK significantly decreased prior to hematologic relapse in the group with hematologic relapse as compared with the group without hematologic relapse (P=0.022, Independent-samples T test). These data suggest donor chimerism of BMB can be used to predict the occurrence of hematologic relapse in patients with B-ALL. Donor chimerism decrease in PBNK was associated with a somewhat increased risk of hematologic relapse in patients with non-B-ALL. Therefore, our results reveal a more effective path to individually predict for hematologic relapse by dynamic monitoring different cell lineages in different disease.	[Jiang, Ying; Wan, Liping; Qin, Youwen; Wang, Xiaorui; Yan, Shike; Wang, Chun] Shanghai Jiao Tong Univ, Coll Med, Shanghai Peoples Hosp 1, Dept Hematol, Shanghai 200030, Peoples R China; [Xie, Kuangcheng] Shanghai Jiao Tong Univ, Coll Med, Shanghai Peoples Hosp 1, Dept Cent Lab, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, C (corresponding author), Shanghai Jiao Tong Univ, Coll Med, Shanghai Peoples Hosp 1, Dept Hematol, Shanghai 200030, Peoples R China.	wangchun2@medmail.com.cn		Wan, Liping/0000-0001-6868-0258	Shanghai Science and Technology Committee Grant [044119632]	Shanghai Science and Technology Committee Grant	This study supported by Shanghai Science and Technology Committee Grant (rant numbers 044119632; http://www.stcsm.gov.cn/) (to CW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antin JH, 2001, BIOL BLOOD MARROW TR, V7, P473, DOI 10.1053/bbmt.2001.v7.pm11669214; Bader P, 2000, BRIT J HAEMATOL, V108, P761, DOI 10.1046/j.1365-2141.2000.01927.x; Bader P, 2004, J CLIN ONCOL, V22, P1696, DOI 10.1200/JCO.2004.05.198; Baron F, 2004, BLOOD, V104, P2254, DOI 10.1182/blood-2004-04-1506; Bornhauser M, 2009, HAEMATOL-HEMATOL J, V94, P1613, DOI 10.3324/haematol.2009.007765; Chiorean EG, 2004, BIOL BLOOD MARROW TR, V10, P171, DOI 10.1016/j.bbmt.2003.10.004; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Czekalska Sylwia, 2010, Przegl Lek, V67, P1282; Dubovsky J, 1999, LEUKEMIA, V13, P2060, DOI 10.1038/sj.leu.2401603; George Nahas, 2013, BLOOD, V122, P4545; Horky O, 2011, INT J LAB HEMATOL, V33, P57, DOI 10.1111/j.1751-553X.2010.01249.x; Jiang Ying, 2008, Zhonghua Xue Ye Xue Za Zhi, V29, P667; Kristt D, 2007, BONE MARROW TRANSPL, V39, P255, DOI 10.1038/sj.bmt.1705576; Kumar L, 2007, NATL MED J INDIA, V20, P128; Lange T, 2011, LEUKEMIA, V25, P498, DOI 10.1038/leu.2010.283; Lion T, 2001, LEUKEMIA, V15, P307, DOI 10.1038/sj.leu.2402017; Lion Thomas, 2007, Methods Mol Med, V134, P197; Machaczka M, 2012, LEUKEMIA LYMPHOMA, V53, P1699, DOI 10.3109/10428194.2012.666661; Maeng H, 2004, YONSEI MED J, V45, P330, DOI 10.3349/ymj.2004.45.2.330; Maris MB, 2003, BLOOD, V102, P2021, DOI 10.1182/blood-2003-02-0482; Mollet I, 2012, PATHOL BIOL, V60, P106, DOI 10.1016/j.patbio.2010.07.001; Nikolousis E, 2013, LEUKEMIA RES, V37, P561, DOI 10.1016/j.leukres.2013.01.010; Nollet F, 2001, BONE MARROW TRANSPL, V28, P511, DOI 10.1038/sj.bmt.1703162; Ohashi H, 2005, AM J HEMATOL, V79, P142, DOI 10.1002/ajh.20333; Oran B, 2011, CURR OPIN HEMATOL, V18, P388, DOI 10.1097/MOH.0b013e32834b6158; Passweg JR, 2012, BONE MARROW TRANSPL, V47, P906, DOI 10.1038/bmt.2012.66; Peterlin P, 2015, BIOL BLOOD MARROW TR, V21, P180, DOI 10.1016/j.bbmt.2014.08.018; Qin XY, 2012, CHINESE MED J-PEKING, V125, P1952, DOI 10.3760/cma.j.issn.0366-6999.2012.11.021; Rauwerdink CA, 2012, EXP MOL PATHOL, V93, P339, DOI 10.1016/j.yexmp.2012.07.003; Reshef R, 2014, BIOL BLOOD MARROW TR, V20, P1758, DOI 10.1016/j.bbmt.2014.07.003; Sufliarska S, 2007, NEOPLASMA, V54, P424; Wan Li-ping, 2006, Zhonghua Nei Ke Za Zhi, V45, P485	32	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133671	10.1371/journal.pone.0133671	http://dx.doi.org/10.1371/journal.pone.0133671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226104	gold, Green Published, Green Submitted			2022-12-27	WOS:000358837700033
J	Lal, S; Kersch, C; Beeson, KA; Wu, YJ; Muldoon, LL; Neuwelt, EA				Lal, Sangeet; Kersch, Cymon; Beeson, Kathleen A.; Wu, Y. Jeffrey; Muldoon, Leslie L.; Neuwelt, Edward A.			Interactions between alpha v-Integrin and HER2 and Their Role in the Invasive Phenotype of Breast Cancer Cells In Vitro and in Rat Brain	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; PROSTATE-CANCER; PHASE-II; METASTASIS; GROWTH; INTETUMUMAB; ACTIVATION; SURVIVAL; KINASE; ALPHA-V-BETA-3	Background We tested the hypothesis that alpha v-integrin and the human epidermal growth factor receptor type 2 (HER2) interact with each other in brain trophic metastatic breast cancer cells and influence their invasive phenotype. Methods Clones of MDA-MB231BR human breast cancer cells with stable knock down of av-integrin in combination with high or low levels of HER2 were created. The interactions of these two proteins and their combined effect on cell migration and invasion were investigated in vitro and in vivo. Results Knockdown of alpha v-integrin in MDA-MB231BR clones altered the actin cytoskeleton and cell morphology. HER2 co-precipitated with alpha v-integrin in three breast cancer cell lines in vitro, suggesting they complex in cells. Knockdown of alpha v-integrin altered HER2 localization from its normal membrane position to a predominantly lysosomal localization. When alpha v-integrin expression was decreased by 69-93% in HER2-expressing cells, cellular motility was significantly reduced. Deficiency of both alpha v-integrin and HER2 decreased cellular migration and invasion by almost 90% compared to cells expressing both proteins (P<0.01). After intracerebral inoculation, cells expressing high levels of both alpha v-integrin and HER2 showed a diffusely infiltrative tumor phenotype, while cells deficient in alpha v-integrin and/or HER2 showed a compact tumor growth phenotype. In the alpha v-integrin positive/HER2 positive tumors, infiltrative growth was 57.2 +/- 19% of tumor volume, compared to only 5.8 +/- 6.1% infiltration in the double deficient tumor cells. Conclusions alpha v-integrin interacts with HER2 in breast cancer cells and may regulate HER2 localization. The combined impacts of alpha v-integrin and HER2 influence the invasive phenotype of breast cancer cells. Targeting alpha v-integrin in HER2-positive breast cancer may slow growth and decrease infiltration in the normal brain.	[Lal, Sangeet; Kersch, Cymon; Beeson, Kathleen A.; Wu, Y. Jeffrey; Muldoon, Leslie L.; Neuwelt, Edward A.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Muldoon, Leslie L.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Neuwelt, Edward A.] Oregon Hlth & Sci Univ, Dept Neurosurg, Portland, OR 97201 USA; [Neuwelt, Edward A.] Vet Adm Med Ctr EAN, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Neuwelt, EA (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA.	neuwelte@ohsu.edu	Davis, William E/P-1888-2016		National Institutes of Health National Cancer Institute grant [CA137488]; National Institute of Neurological Diseases and Stroke grant [NS44687]; Veterans Administration Merit Review grant; Department of Defense grant [W81XWH]; Walter S. and Lucienne Driskill Foundation;  [PS0NSO61800]; NATIONAL CANCER INSTITUTE [R01CA137488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044687, R37NS044687] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Diseases and Stroke grant; Veterans Administration Merit Review grant(US Department of Veterans Affairs); Department of Defense grant(United States Department of Defense); Walter S. and Lucienne Driskill Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health National Cancer Institute grant CA137488; National Institute of Neurological Diseases and Stroke grant NS44687; a Veterans Administration Merit Review grant; a Department of Defense grant W81XWH; and the Walter S. and Lucienne Driskill Foundation, all to Edward A. Neuwelt. Immunofluorescence was performed at the OHSU Neuroscience Imaging Center core, supported by grant PS0NSO61800 (PI: Sue Aicher).	Alghisi GC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004449; Arjonen A, 2012, TRAFFIC, V13, P610, DOI 10.1111/j.1600-0854.2012.01327.x; Beasley KD, 2011, NEUROSURG CLIN N AM, V22, P7, DOI 10.1016/j.nec.2010.08.009; Bertelsen V, 2014, MEMBRANES, V4, P424, DOI 10.3390/membranes4030424; Brufsky AM, 2011, CLIN CANCER RES, V17, P4834, DOI 10.1158/1078-0432.CCR-10-2962; De Franceschi N, 2015, J CELL SCI, V128, P839, DOI 10.1242/jcs.161653; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dittrich A, 2014, J MAMMARY GLAND BIOL, P1; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Gupta P, 2014, ONCOTARGET, V5, P1812, DOI 10.18632/oncotarget.1743; Heidenreich A, 2013, ANN ONCOL, V24, P329, DOI 10.1093/annonc/mds505; Kim KB, 2012, MELANOMA RES, V22, P294, DOI 10.1097/CMR.0b013e32835312e4; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Lorger M, 2009, P NATL ACAD SCI USA, V106, P10666, DOI 10.1073/pnas.0903035106; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Moore KM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju169; Ning SC, 2010, CANCER RES, V70, P7591, DOI 10.1158/0008-5472.CAN-10-1639; Novitskaya V, 2014, ONCOGENE, V33, P2779, DOI 10.1038/onc.2013.231; O'Day S, 2011, BRIT J CANCER, V105, P346, DOI 10.1038/bjc.2011.183; Owonikoko TK, 2014, NAT REV CLIN ONCOL, V11, P203, DOI 10.1038/nrclinonc.2014.25; Palmieri D, 2007, CANCER RES, V67, P4190, DOI 10.1158/0008-5472.CAN-06-3316; Patil A, 2015, CANCER LETT, V358, P93, DOI 10.1016/j.canlet.2014.12.026; Puhalla S, 2015, NEURO-ONCOLOGY, V17, P639, DOI 10.1093/neuonc/nov023; Sato T, 2003, HEPATO-GASTROENTEROL, V50, P27; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Soung YH, 2010, BMB REP, V43, P311, DOI 10.5483/BMBRep.2010.43.5.311; van den Hoogen C, 2011, AM J PATHOL, V179, P2559, DOI 10.1016/j.ajpath.2011.07.011; Vogetseder A, 2013, INT J CANCER, V133, P2362, DOI 10.1002/ijc.28267; von Schlippe M, 2000, J CELL SCI, V113, P425; Wang HY, 2014, J BIOL CHEM, V289, P30318, DOI 10.1074/jbc.M114.586438; Wang SE, 2009, CANCER RES, V69, P475, DOI 10.1158/0008-5472.CAN-08-2649; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Wickstrom SA, 2011, TRENDS CELL BIOL, V21, P266, DOI 10.1016/j.tcb.2011.02.003; Wu YJ, 2012, J NEURO-ONCOL, V110, P27, DOI 10.1007/s11060-012-0942-0	37	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0131842	10.1371/journal.pone.0131842	http://dx.doi.org/10.1371/journal.pone.0131842			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222911	Green Published, Green Submitted, gold			2022-12-27	WOS:000358836800020
J	Lewis, JR; Lim, WH; Ueland, T; Wong, G; Zhu, K; Lim, EM; Bollerslev, J; Prince, RL				Lewis, Joshua R.; Lim, Wai H.; Ueland, Thor; Wong, Germaine; Zhu, Kun; Lim, Ee M.; Bollerslev, Jens; Prince, Richard L.			Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women	PLOS ONE			English	Article							ATHEROSCLEROTIC VASCULAR-DISEASE; CORONARY-ARTERY CALCIFICATION; GLOMERULAR-FILTRATION-RATE; SMOOTH-MUSCLE-CELLS; SERUM OSTEOPROTEGERIN; PLASMA OSTEOPROTEGERIN; GENE POLYMORPHISMS; CALCIUM; EVENTS; 5-YEAR	Background Data on the predictive role of estimated glomerular filtration rate (eGFR) and osteoprotegerin (OPG) for cardiovascular (CVD) and all-cause mortality risk have been presented by our group and others. We now present data on the interactions between OPG with stage I to III chronic kidney disease (CKD) for all-cause and CVD mortality. Methods and Results The setting was a 15-year study of 1,292 women over 70 years of age initially randomized to a 5-year controlled trial of 1.2 g of calcium daily. Serum OPG and creatinine levels with complete mortality records obtained from the Western Australian Data Linkage System were available. Interactions were detected between OPG levels and eGFR for both CVD and all-cause mortality (P < 0.05). Compared to participants with eGFR >= 60ml/min/1.73m(2) and low OPG, participants with eGFR of < 60ml/min/1.73m(2) and elevated OPG had a 61% and 75% increased risk of all-cause and CVD mortality respectively (multivariate-adjusted HR, 1.61; 95% CI, 1.27-2.05; P < 0.001 and HR, 1.75; 95% CI, 1.22-2.55; P = 0.003). This relationship with mortality was independent of decline in renal function (P < 0.05). Specific causes of death in individuals with elevated OPG and stage III CKD highlighted an excess of coronary heart disease, renal failure and chronic obstructive pulmonary disease deaths (P < 0.05). Conclusion The association between elevated OPG levels with CVD and all-cause mortality was more evident in elderly women with poorer renal function. Assessment of OPG in the context of renal function may be important in studies investigating its relationship with all-cause and CVD mortality.	[Lewis, Joshua R.; Lim, Wai H.; Zhu, Kun; Prince, Richard L.] Univ Western Australia, Sch Med & Pharmacol, Sir Charles Gairdner Hosp Unit, Perth, WA 6009, Australia; [Lewis, Joshua R.; Zhu, Kun; Lim, Ee M.; Prince, Richard L.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Perth, WA, Australia; [Lim, Wai H.] Sir Charles Gairdner Hosp, Dept Renal Med, Perth, WA, Australia; [Ueland, Thor] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway; [Wong, Germaine] Univ Sydney, Sydney Med Sch, Sch Publ Hlth, Ctr Kidney Res,Childrens Hosp Westmead, Sydney, NSW 2006, Australia; [Lim, Ee M.] Sir Charles Gairdner Hosp, PathWest, Perth, WA, Australia; [Bollerslev, Jens] Oslo Univ Hosp, Rikshosp, Dept Endocrinol, Sect Specialised Endocrinol, Oslo, Norway; [Bollerslev, Jens] Univ Oslo, Oslo, Norway	University of Western Australia; University of Western Australia; University of Western Australia; University of Oslo; National Hospital Norway; University of Sydney; University of Western Australia; University of Oslo; National Hospital Norway; University of Oslo	Lewis, JR (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Sir Charles Gairdner Hosp Unit, Perth, WA 6009, Australia.	joshua.lewis@uwa.edu.au	lewis, josh/GZG-7164-2022	Wong, Germaine/0000-0001-8422-7269	Kidney Health Australia [S07 10]; Healthway Health Promotion Foundation of Western Australia; Sir Charles Gairdner Hospital Research Advisory Committee Grant; National Health and Medical Research Council of Australia [254627, 303169, 572604]; Raine Medical Research Foundation Priming Grant	Kidney Health Australia; Healthway Health Promotion Foundation of Western Australia; Sir Charles Gairdner Hospital Research Advisory Committee Grant; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Raine Medical Research Foundation Priming Grant	The study was supported by Kidney Health Australia grant S07 10, Healthway Health Promotion Foundation of Western Australia, Sir Charles Gairdner Hospital Research Advisory Committee Grant and by project grants 254627, 303169 and 572604 from the National Health and Medical Research Council of Australia. The salary of Dr. Lewis is supported by a Raine Medical Research Foundation Priming Grant. None of the funding agencies had any role in the conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.	Abedin M, 2007, AM J CARDIOL, V99, P513, DOI 10.1016/j.amjcard.2006.08.064; Anand DV, 2006, J AM COLL CARDIOL, V47, P1850, DOI 10.1016/j.jacc.2005.12.054; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Britt H, 1997, Health Inf Manag, V27, P171; Chino T, 2009, J LEUKOCYTE BIOL, V86, P933, DOI 10.1189/jlb.0708419; Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560; Corallini F, 2009, EUR J HISTOCHEM, V53, P19; Eagan TML, 2010, EUR RESPIR J, V35, P540, DOI 10.1183/09031936.00088209; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hjelmesaeth J, 2006, J AM SOC NEPHROL, V17, P1746, DOI 10.1681/ASN.2005121368; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Jono S, 2002, CIRCULATION, V106, P1192, DOI 10.1161/01.CIR.0000031524.49139.29; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewis JR, 2014, AM J NEPHROL, V39, P66, DOI 10.1159/000357787; Lewis JR, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-58; Lim WH, 2013, QJM-INT J MED, V106, P443, DOI 10.1093/qjmed/hct043; Mikami S, 2008, HYPERTENS RES, V31, P1163, DOI 10.1291/hypres.31.1163; Montanez-Barragan A, 2014, J NEPHROL, V27, P607, DOI 10.1007/s40620-014-0092-x; Morena M, 2006, J AM SOC NEPHROL, V17, P262, DOI 10.1681/ASN.2005030260; Morony S, 2008, CIRCULATION, V117, P411, DOI 10.1161/CIRCULATIONAHA.107.707380; Olesen P, 2005, DIABETOLOGIA, V48, P561, DOI 10.1007/s00125-004-1652-8; Omland T, 2008, J AM COLL CARDIOL, V51, P627, DOI 10.1016/j.jacc.2007.09.058; Prince RL, 2006, ARCH INTERN MED, V166, P869, DOI 10.1001/archinte.166.8.869; Sato T, 2001, AM J KIDNEY DIS, V38, pS175, DOI 10.1053/ajkd.2001.27437; Shin JY, 2006, DIABETES CARE, V29, P1664, DOI 10.2337/dc06-0631; Shlipak MG, 2009, J AM SOC NEPHROL, V20, P2625, DOI 10.1681/ASN.2009050546; Sigrist MK, 2009, NEPHROL DIAL TRANSPL, V24, P3157, DOI 10.1093/ndt/gfp253; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Svensson M, 2012, NEPHROL DIAL TRANSPL, V27, P2571, DOI 10.1093/ndt/gfr694; Ueland T, 2007, BONE, V40, P175, DOI 10.1016/j.bone.2006.06.022; Ueland T, 2011, J INTERN MED, V270, P452, DOI 10.1111/j.1365-2796.2011.02393.x; Ueland T, 2001, EUR J ENDOCRINOL, V145, P685, DOI 10.1530/eje.0.1450685; Ueland T, 2009, CLIN ENDOCRINOL, V71, P828, DOI 10.1111/j.1365-2265.2009.03605.x; WHO (World Health Organization), 1977, MAN INT STAT CLASS D; World Health Organization, 1992, INT STAT CLASS DIS R	35	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134266	10.1371/journal.pone.0134266	http://dx.doi.org/10.1371/journal.pone.0134266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222774	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800119
J	Barrios, C; Beaumont, M; Pallister, T; Villar, J; Goodrich, JK; Clark, A; Pascual, J; Ley, RE; Spector, TD; Bell, JT; Menni, C				Barrios, Clara; Beaumont, Michelle; Pallister, Tess; Villar, Judith; Goodrich, Julia K.; Clark, Andrew; Pascual, Julio; Ley, Ruth E.; Spector, Tim D.; Bell, Jordana T.; Menni, Cristina			Gut-Microbiota-Metabolite Axis in Early Renal Function Decline	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; P-CRESYL SULFATE; INDOXYL SULFATE; UREMIC SOLUTES; INTESTINAL MICROBIOTA; CKD; PATTERNS; COHORT; FLORA; RISK	Introduction Several circulating metabolites derived from bacterial protein fermentation have been found to be inversely associated with renal function but the timing and disease severity is unclear. The aim of this study is to explore the relationship between indoxyl-sulfate, p-cresyl-sulfate, phenylacetylglutamine and gut-microbial profiles in early renal function decline. Results Indoxyl-sulfate (Beta(SE) = -2.74(0.24); P = 8.8x10(-29)), p-cresyl-sulfate (-1.99(0.24), P = 4.6x10(-16)), and phenylacetylglutamine(-2.73 (0.25), P = 1.2x10(-25)) were inversely associated with eGFR in a large population base cohort (TwinsUK, n = 4439) with minimal renal function decline. In a sub-sample of 855 individuals, we analysed metabolite associations with 16S gut microbiome profiles (909 profiles, QIIME 1.7.0). Three Operational Taxonomic Units (OTUs) were significantly associated with indoxyl-sulfate and 52 with phenylacetylglutamine after multiple testing; while one OTU was nominally associated with p-cresyl sulfate. All 56 microbial members belong to the order Clostridiales and are represented by anaerobic Gram-positive families Christensenellaceae, Ruminococcaceae and Lachnospiraceae. Within these, three microbes were also associated with eGFR. Conclusions Our data suggest that indoxyl-sulfate, p-cresyl-sulfate and phenylacetylglutamine are early markers of renal function decline. Changes in the intestinal flora associated with these metabolites are detectable in early kidney disease. Future efforts should dissect this relationship to improve early diagnostics and therapeutics strategies.	[Barrios, Clara; Beaumont, Michelle; Pallister, Tess; Spector, Tim D.; Bell, Jordana T.; Menni, Cristina] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Barrios, Clara; Pascual, Julio] Hosp del Mar, Dept Nephrol, Inst Mar Invest Med, Barcelona, Spain; [Villar, Judith] Hosp del Mar, Dept Infect Dis, Inst Mar Invest Med, Barcelona, Spain; [Goodrich, Julia K.; Clark, Andrew; Ley, Ruth E.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA	University of London; King's College London; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Cornell University	Barrios, C (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England.	CBarrios@parcdesalutmar.cat; cristina.menni@kcl.ac.uk	Ley, Ruth E/M-8542-2014; Goodrich, Julia/ABD-8368-2021; Bell, Jordana/AAH-7312-2019; Barrios, Clara/AAF-6865-2021	Ley, Ruth E/0000-0002-9087-1672; Bell, Jordana/0000-0002-3858-5986; Beaumont, Michelle/0000-0002-3227-380X; Menni, Cristina/0000-0001-9790-0571	Wellcome Trust; European Community; National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London; Cornell Centre for Comparative Population Genomics; ERC Advanced Principal Investigator award; Spanish Society of Nephrology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007617] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London; Cornell Centre for Comparative Population Genomics; ERC Advanced Principal Investigator award(European Research Council (ERC)); Spanish Society of Nephrology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	TwinsUK was funded by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). The study also receives support from the National Institute for Health Research (NIHR) Clinical Research Facility at Guy's & St Thomas' NHS Foundation Trust and NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust, the King's College London, the Cornell Centre for Comparative Population Genomics. Tim Spector is the holder of an ERC Advanced Principal Investigator award. Clara Barrios is supported by a grant from the Spanish Society of Nephrology.	Anders HJ, 2013, KIDNEY INT, V83, P1010, DOI 10.1038/ki.2012.440; Angelakis E, 2013, LANCET INFECT DIS, V13, P889, DOI 10.1016/S1473-3099(13)70179-8; Aronov PA, 2011, J AM SOC NEPHROL, V22, P1769, DOI 10.1681/ASN.2010121220; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cruickshank-Quinn CI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101855; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Festi D, 2014, WORLD J GASTROENTERO, V20, P16079, DOI 10.3748/wjg.v20.i43.16079; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Han JL, 2014, WORLD J GASTROENTERO, V20, P17737, DOI 10.3748/wjg.v20.i47.17737; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Kang SM, 2011, CLIN BIOCHEM, V44, P293, DOI 10.1016/j.clinbiochem.2010.11.010; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin CJ, 2011, J CLIN LAB ANAL, V25, P191, DOI 10.1002/jcla.20456; Meijers BKI, 2008, AM J KIDNEY DIS, V51, P839, DOI 10.1053/j.ajkd.2007.12.035; Meijers BKI, 2010, CLIN J AM SOC NEPHRO, V5, P1182, DOI 10.2215/CJN.07971109; Menni C, 2015, J HYPERTENS, V33, P791, DOI 10.1097/HJH.0000000000000467; Menni C, 2013, INT J EPIDEMIOL, V42, P1111, DOI 10.1093/ije/dyt094; Menni C, 2013, METABOLOMICS, V9, P506, DOI 10.1007/s11306-012-0469-6; Meyer TW, 2012, KIDNEY INT, V81, P949, DOI 10.1038/ki.2011.504; Moayyeri A, 2013, INT J EPIDEMIOL, V42, P76, DOI 10.1093/ije/dyr207; Monleon D, 2009, NMR BIOMED, V22, P342, DOI 10.1002/nbm.1345; Niewczas MA, 2014, KIDNEY INT, V85, P1214, DOI 10.1038/ki.2013.497; Niwa T, 2010, J RENAL NUTR, V20, pS2, DOI 10.1053/j.jrn.2010.05.002; Poesen R, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-87; Poesen R, 2013, CLIN J AM SOC NEPHRO, V8, P1508, DOI 10.2215/CJN.00300113; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Ramezani A, 2014, J AM SOC NEPHROL, V25, P657, DOI 10.1681/ASN.2013080905; Ranganathan N, 2009, CURR MED RES OPIN, V25, P1919, DOI 10.1185/03007990903069249; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Teucher B, 2007, TWIN RES HUM GENET, V10, P734, DOI 10.1375/twin.10.5.734; Tumur Z, 2010, AM J NEPHROL, V31, P435, DOI 10.1159/000299798; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Vaziri ND, 2012, CURR OPIN NEPHROL HY, V21, P587, DOI 10.1097/MNH.0b013e328358c8d5; Viaene L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079682; Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14; Wu IW, 2011, NEPHROL DIAL TRANSPL, V26, P938, DOI 10.1093/ndt/gfq580	38	88	96	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134311	10.1371/journal.pone.0134311	http://dx.doi.org/10.1371/journal.pone.0134311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241311	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700039
J	Claudino, MA; Leiria, LOS; da Silva, FH; Alexandre, EC; Renno, A; Monica, FZ; de Nucci, G; Fertrin, KY; Antunes, E; Costa, FF; Franco-Penteado, CF				Claudino, Mario Angelo; Silveira Leiria, Luiz Osorio; da Silva, Fabio Henrique; Alexandre, Eduardo Costa; Renno, Andre; Monica, Fabiola Zakia; de Nucci, Gilberto; Fertrin, Kleber Yotsumoto; Antunes, Edson; Costa, Fernando Ferreira; Franco-Penteado, Carla Fernanda			Urinary Bladder Dysfunction in Transgenic Sickle Cell Disease Mice	PLOS ONE			English	Article							NOCTURNAL ENURESIS; CONTRACTION; DETRUSOR; CHILDREN; TRACT; OUTCOMES; CA2+; PATHOPHYSIOLOGY; COMPLICATIONS; ACETYLCHOLINE	Background Urological complications associated with sickle cell disease (SCD), include nocturia, enuresis, urinary infections and urinary incontinence. However, scientific evidence to ascertain the underlying cause of the lower urinary tract symptoms in SCD is lacking. Objective Thus, the aim of this study was to evaluate urinary function, in vivo and ex vivo, in the Berkeley SCD murine model (SS). Methods Urine output was measured in metabolic cage for both wild type and SS mice (25-30 g). Bladder strips and urethra rings were dissected free and mounted in organ baths. In isolated detrusor smooth muscle (DSM), relaxant response to mirabegron and isoproterenol (1 nM-10 mu M) and contractile response to (carbachol (CCh; 1 nM-100 mu M), KCl (1 mM-300mM), CaCl2 (1 mu M-100mM), alpha,beta-methylene ATP (1, 3 and 10 mu M) and electrical field stimulation (EFS; 1-32 Hz) were measured. Phenylephrine (Phe; 10nM-100 mu M) was used to evaluate the contraction mechanism in the urethra rings. Cystometry and histomorphometry were also performed in the urinary bladder. Results SS mice present a reduced urine output and incapacity to produce typical bladder contractions and bladder emptying (ex vivo), compared to control animals. In DSM, relaxation in response to a selective beta 3-adrenergic agonist (mirabegron) and to a non-selective beta-adrenergic (isoproterenol) agonist were lower in SS mice. Additionally, carbachol, alpha,beta-methylene ATP, KCl, extracellular Ca2+ and electrical-field stimulation promoted smaller bladder contractions in SS group. Urethra contraction induced by phenylephrine was markedly reduced in SS mice. Histological analyses of SS mice bladder revealed severe structural abnormalities, such as reductions in detrusor thickness and bladder volume, and cell infiltration. Conclusions Taken together, our data demonstrate, for the first time, that SS mice display features of urinary bladder dysfunction, leading to impairment in urinary continence, which may have an important role in the pathogenesis of the enuresis and infections observed the SCD patients.	[Claudino, Mario Angelo; Silveira Leiria, Luiz Osorio; Alexandre, Eduardo Costa; Renno, Andre; Monica, Fabiola Zakia; de Nucci, Gilberto; Antunes, Edson] Univ Estadual Campinas, Dept Pharmacol, Campinas, SP, Brazil; [da Silva, Fabio Henrique; Costa, Fernando Ferreira; Franco-Penteado, Carla Fernanda] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil; [Fertrin, Kleber Yotsumoto] Univ Estadual Campinas, Fac Med Sci, Dept Clin Pathol, Campinas, SP, Brazil; [Claudino, Mario Angelo] Univ Sao Francisco, Sch Med, Lab Multidisciplinary Res, BR-12900000 Braganca Paulista, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Sao Francisco	Franco-Penteado, CF (corresponding author), Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil.	carlapenteado@gmail.com	Monica, Fabiola Zakia/B-4191-2013; Alexandre, Eduardo/D-3797-2013; Costa, Fernando F/D-1566-2012; De Nucci, Gilberto/J-5990-2012; Claudino, Mário A/D-5367-2014; Silva, Fábio/D-5412-2013; De Nucci, Gilberto/ABB-7380-2021; Fertrin, Kleber/M-4175-2013; ANTUNES, EDSON/F-6731-2012	Monica, Fabiola Zakia/0000-0002-8449-6677; Alexandre, Eduardo/0000-0002-9482-6799; Costa, Fernando F/0000-0002-4632-572X; De Nucci, Gilberto/0000-0002-4346-7941; Silva, Fábio/0000-0003-3374-5570; De Nucci, Gilberto/0000-0002-4346-7941; Fertrin, Kleber/0000-0003-2637-3297; Claudino, Mario Angelo/0000-0002-3590-9607; ANTUNES, EDSON/0000-0003-2201-8247	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/57441-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [481761/2008-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grants from the Brazilian funding bodies: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br), Grant number: 2008/57441-0 FFC, and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br), Grant number: 481761/2008-0 CFFP.	Abrams P, 2006, UROLOGY, V68, P17, DOI 10.1016/j.urology.2006.05.044; Andersson KE, 2004, PHARMACOL REV, V56, P581, DOI 10.1124/pr.56.4.4; Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Anele UA, 2016, NEUROUROL URODYNAM, V35, P642, DOI 10.1002/nau.22777; Ataga KI, 2000, AM J HEMATOL, V63, P205, DOI 10.1002/(SICI)1096-8652(200004)63:4<205::AID-AJH8>3.3.CO;2-#; BAILL IC, 1990, INT J GYNECOL OBSTET, V33, P19, DOI 10.1016/0020-7292(90)90649-6; Barakat LP, 2001, J DEV BEHAV PEDIATR, V22, P300, DOI 10.1097/00004703-200110000-00004; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Burnstock G, 2011, BJU INT, V107, P192, DOI 10.1111/j.1464-410X.2010.09926.x; Chapple CR, 2015, EUR UROL, V68, P351, DOI 10.1016/j.eururo.2015.02.030; Claudino MA, 2012, ANEMIA, V2012, DOI 10.1155/2012/723520; Claudino MA, 2009, J SEX MED, V6, P2187, DOI 10.1111/j.1743-6109.2009.01337.x; Conran N, 2009, HEMOGLOBIN, V33, P1, DOI 10.1080/03630260802625709; Field JJ, 2008, UROLOGY, V72, P81, DOI 10.1016/j.urology.2008.02.006; FIGUEROA TE, 1995, J UROLOGY, V153, P1987, DOI 10.1016/S0022-5347(01)67386-5; Ford Anthony P D W, 2011, Handb Exp Pharmacol, P485, DOI 10.1007/978-3-642-16499-6_22; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; Frazier EP, 2008, N-S ARCH PHARMACOL, V377, P449, DOI 10.1007/s00210-007-0208-0; Hagglof B, 1997, SCAND J UROL NEPHROL, V31, P79; Hamdi IM, 2002, SAUDI MED J, V23, P1455; Hsu L, 2006, BLOOD, V107, P3414, DOI 10.1182/blood-2005-11-4500; Igawa Y, 2004, J UROLOGY, V172, P2460, DOI 10.1097/01.ju.0000138054.77785.4a; Jans SMPJ, 2010, INT J CLIN PRACT, V64, P1688, DOI 10.1111/j.1742-1241.2010.02451.x; Kato GJ, 2008, JAMA-J AM MED ASSOC, V300, P2638, DOI 10.1001/jama.2008.598; Kennedy C, 2007, J NEUROSCI, V27, P845, DOI 10.1523/JNEUROSCI.3115-06.2007; Kumar V, 2004, J UROLOGY, V172, P744, DOI 10.1097/01.ju.0000131244.67160.f4ABSTRACT; Leiria LOS, 2011, BRIT J PHARMACOL, V163, P1276, DOI 10.1111/j.1476-5381.2011.01311.x; Masters JG, 1999, BRIT J PHARMACOL, V127, P996, DOI 10.1038/sj.bjp.0702640; Matsui M, 2000, P NATL ACAD SCI USA, V97, P9579, DOI 10.1073/pnas.97.17.9579; Michel MC, 2006, BRIT J PHARMACOL, V147, pS88, DOI 10.1038/sj.bjp.0706619; MILLER JM, 1983, SOUTHERN MED J, V76, P962, DOI 10.1097/00007611-198308000-00004; Nath KA, 2015, NAT REV NEPHROL, V11, P161, DOI 10.1038/nrneph.2015.8; Nomiya M, 2015, INT J UROL, V22, P40, DOI 10.1111/iju.12652; Osman NI, 2014, EUR UROL, V65, P389, DOI 10.1016/j.eururo.2013.10.015; Pastore LM, 1999, EPIDEMIOLOGY, V10, P282, DOI 10.1097/00001648-199905000-00016; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Pinna C, 2006, LIFE SCI, V79, P1301, DOI 10.1016/j.lfs.2006.03.035; Portocarrero ML, 2012, J UROLOGY, V187, P1037, DOI 10.1016/j.juro.2011.10.171; READETT DRJ, 1990, ARCH DIS CHILD, V65, P615, DOI 10.1136/adc.65.6.615; Silva IV, 2015, EUR J HAEMATOL, V94, P157, DOI 10.1111/ejh.12411; Steinberg MH, 1999, NEW ENGL J MED, V340, P1021, DOI 10.1056/NEJM199904013401307; TARRY WF, 1987, J UROLOGY, V138, P592, DOI 10.1016/S0022-5347(17)43267-8; Tita ATN, 2007, OBSTET GYNECOL, V110, P1113, DOI 10.1097/01.AOG.0000285995.41769.83; UCHIDA W, 1994, N-S ARCH PHARMACOL, V350, P398; Wegener JW, 2004, FASEB J, V18, P1159, DOI 10.1096/fj.04-1516fje; Wuest M, 2007, EUR J PHARMACOL, V565, P180, DOI 10.1016/j.ejphar.2007.02.046; Yamaguchi O, 2014, NEUROUROL URODYNAM, V33, P54, DOI 10.1002/nau.22517; ZARKOWSKY HS, 1986, J PEDIATR-US, V109, P579, DOI 10.1016/S0022-3476(86)80216-5	48	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133996	10.1371/journal.pone.0133996	http://dx.doi.org/10.1371/journal.pone.0133996			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241312	gold, Green Published, Green Submitted			2022-12-27	WOS:000358942700031
J	Djulbegovic, M; Beckstead, J; Elqayam, S; Reljic, T; Kumar, A; Paidas, C; Djulbegovic, B				Djulbegovic, Mia; Beckstead, Jason; Elqayam, Shira; Reljic, Tea; Kumar, Ambuj; Paidas, Charles; Djulbegovic, Benjamin			Thinking Styles and Regret in Physicians	PLOS ONE			English	Article							DECISION CURVE ANALYSIS; DUAL-PROCESS THEORIES; INDIVIDUAL-DIFFERENCES; ANTICIPATED REGRET; COGNITION; RATIONALITY; DEBATE; BELIEF; TESTS; BIAS	Background Decision-making relies on both analytical and emotional thinking. Cognitive reasoning styles (e.g. maximizing and satisficing tendencies) heavily influence analytical processes, while affective processes are often dependent on regret. The relationship between regret and cognitive reasoning styles has not been well studied in physicians, and is the focus of this paper. Methods A regret questionnaire and 6 scales measuring individual differences in cognitive styles (maximizing-satisficing tendencies; analytical vs. intuitive reasoning; need for cognition; intolerance toward ambiguity; objectivism; and cognitive reflection) were administered through a web-based survey to physicians of the University of South Florida. Bonferroni's adjustment was applied to the overall correlation analysis. The correlation analysis was also performed without Bonferroni's correction, given the strong theoretical rationale indicating the need for a separate hypothesis. We also conducted a multivariate regression analysis to identify the unique influence of predictors on regret. Results 165 trainees and 56 attending physicians (age range 25 to 69) participated in the survey. After bivariate analysis we found that maximizing tendency positively correlated with regret with respect to both decision difficulty (r=0.673; p<0.001) and alternate search strategy (r=0.239; p=0.002). When Bonferroni's correction was not applied, we also found a negative relationship between satisficing tendency and regret (r=-0.156; p=0.021). In trainees, but not faculty, regret negatively correlated with rational-analytical thinking (r=-0.422; p<0.001), need for cognition (r=-0.340; p<0.001), and objectivism (r=-0.309; p=0.003) and positively correlated with ambiguity intolerance (r=0.285; p=0.012). However, after conducting a multivariate regression analysis, we found that regret was positively associated with maximizing only with respect to decision difficulty (r=0.791;p<0.001), while it was negatively associated with satisficing (r=-0.257; p=0.020) and objectivism (r=-0.267; p=0.034). We found no statistically significant relationship between regret and overall accuracy on conditional inferential tasks. Conclusion Regret in physicians is strongly associated with their tendency to maximize; i.e. the tendency to consider more choices among abundant options leads to more regret. However, physicians who exhibit satisficing tendency - the inclination to accept a "good enough" solution - feel less regret. Our observation that objectivism is a negative predictor of regret indicates that the tendency to seek and use empirical data in decision-making leads to less regret. Therefore, promotion of evidence-based reasoning may lead to lower regret.	[Djulbegovic, Mia; Reljic, Tea; Kumar, Ambuj; Paidas, Charles; Djulbegovic, Benjamin] Univ S Florida, Morsani Coll Med, Tampa, FL 33612 USA; [Reljic, Tea; Kumar, Ambuj; Djulbegovic, Benjamin] Univ S Florida, Program Comparat Effectiveness Res, Tampa, FL 33612 USA; [Kumar, Ambuj; Djulbegovic, Benjamin] Univ S Florida, Dept Med, Div Evidence Based Med, Tampa, FL 33612 USA; [Beckstead, Jason] Univ S Florida, Coll Nursing, Tampa, FL 33612 USA; [Elqayam, Shira] De Montfort Univ, Sch Appl Social Sci, Leicester LE1 9BH, Leics, England; [Djulbegovic, Benjamin] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Hematol & Hlth Outcomes Res, Tampa, FL 33612 USA; [Paidas, Charles; Djulbegovic, Benjamin] Tampa Gen Hosp, Tampa, FL 33606 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; De Montfort University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Tampa General Hospital	Djulbegovic, M (corresponding author), Univ S Florida, 12901 Bruce B Downs Blvd,MDC27, Tampa, FL 33612 USA.	mia.djulbeg@gmail.com	Reljic, Tea/I-7578-2013; Djulbegovic, Benjamin/I-3661-2012; Kumar, Ambuj/I-4940-2012; Elqayam, Shira/L-1551-2019; KUMAR, ASHOK/AAF-4055-2021; Kumar, Ambuj/U-5268-2019; Reljic, Tea/N-2758-2019	Reljic, Tea/0000-0003-2029-6753; Djulbegovic, Benjamin/0000-0003-0671-1447; KUMAR, ASHOK/0000-0002-9244-0622; Reljic, Tea/0000-0003-2029-6753; Paidas, Charles/0000-0001-9991-9604	University of South Florida Graduate Medical Education	University of South Florida Graduate Medical Education	Financial support for this study was provided in full by support from University of South Florida Graduate Medical Education (Dr. Charles Paidas). The funding agreement ensured the authors' independence in designing the study, interpreting the data, and writing and publishing the report.	Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Brandstatter E, 2006, PSYCHOL REV, V113, P409, DOI 10.1037/0033-295X.113.2.409; Budner S, 1962, J PERSONALITY; CACIOPPO JT, 1984, J PERS ASSESS, V48, P306, DOI 10.1207/s15327752jpa4803_13; Colombo B, 2010, TRENDS AND PROSPECTS IN METACOGNITION RESEARCH, P445, DOI 10.1007/978-1-4419-6546-2_20; Djulbegovic B, 2014, MED DECIS MAKING, V34, P627, DOI 10.1177/0272989X14525855; Djulbegovic B, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-94; Evans J. S. B., 2007, HYPOTHETICAL THINKIN; Evans JST, 2006, PSYCHON B REV, V13, P378, DOI 10.3758/BF03193858; Evans JST, 2013, PERSPECT PSYCHOL SCI, V8, P223, DOI 10.1177/1745691612460685; Evans JSBT, 2011, DEV REV, V31, P86, DOI 10.1016/j.dr.2011.07.007; Evans JST, 2010, Q J EXP PSYCHOL, V63, P892, DOI 10.1080/17470210903111821; Evans JSBT, 2005, THINK REASONING, V11, P382, DOI 10.1080/13546780542000005; EVANS JST, 1983, MEM COGNITION, V11, P295, DOI 10.3758/BF03196976; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Gigerenzer G, 2009, TOP COGN SCI, V1, P107, DOI 10.1111/j.1756-8765.2008.01006.x; Kozhevnikov M, 2014, PSYCHOL SCI PUBL INT, V15, P3, DOI 10.1177/1529100614525555; Kruglanski AW, 2011, PSYCHOL REV, V118, P97, DOI 10.1037/a0020762; LEARY MR, 1986, J PERS ASSESS, V50, P32, DOI 10.1207/s15327752jpa5001_5; Nenkov GY, 2008, JUDGM DECIS MAK, V3, P371; Pacini R, 1999, J PERS SOC PSYCHOL, V76, P972, DOI 10.1037/0022-3514.76.6.972; Pieters R, 2007, J CONSUM PSYCHOL, V17, P29, DOI 10.1207/s15327663jcp1701_6; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sandberg T, 2008, BRIT J SOC PSYCHOL, V47, P589, DOI 10.1348/014466607X258704; Schwartz B, 2002, J PERS SOC PSYCHOL, V83, P1178, DOI 10.1037//0022-3514.83.5.1178; Simon H, 1957, MODELS MAN SOCIAL RA; Sinsky CA, 2013, JAMA INTERN MED, V173, P1733, DOI 10.1001/jamainternmed.2013.9257; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Sorum PC, 2004, MED DECIS MAKING, V24, P149, DOI 10.1177/0272989X04263163; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Stanovich KE, 2013, THINK REASONING, V19, P1, DOI 10.1080/13546783.2012.713178; Toplak ME, 2014, DEV PSYCHOL, V50, P1037, DOI 10.1037/a0034910; Tsalatsanis A., 2014, 36 ANN M SOC MED DEC; Tsalatsanis A, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-77; Tsalatsanis A, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-51; Turner BM, 2012, JUDGM DECIS MAK, V7, P48; Zeelenberg M, 2007, J CONSUM PSYCHOL, V17, P3, DOI 10.1207/s15327663jcp1701_3	38	21	22	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134038	10.1371/journal.pone.0134038	http://dx.doi.org/10.1371/journal.pone.0134038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1VB	26241650	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700033
J	Schmid, MK; Reich, O; Faes, L; Boehni, SC; Bittner, M; Howell, JP; Thiel, MA; Signorell, A; Bachmann, LM				Schmid, Martin K.; Reich, Oliver; Faes, Livia; Boehni, Sophie C.; Bittner, Mario; Howell, Jeremy P.; Thiel, Michael A.; Signorell, Andri; Bachmann, Lucas M.			Comparison of Outcomes and Costs of Ranibizumab and Aflibercept Treatment in Real-Life	PLOS ONE			English	Article							MACULAR DEGENERATION; BEVACIZUMAB; EFFICACY; SAFETY	Background Treatment efficacy and costs of anti-VEGF drugs have not been studied in clinical routine. Objective To compare treatment costs and clinical outcomes of the medications when adjusting for patients' characteristics and clinical status. Design Comparative study. Setting The largest public ophthalmologic clinic in Switzerland. Patients Health care claims data of patients with age-related macular degeneration, diabetic macula edema and retinal vein occlusion were matched to clinical and outcome data. Measurements Patients' underlying condition, gender, age, visual acuity and retinal thickness at baseline and after completing the loading phase, the total number of injections per treatment, the visual outcome and vital status was secured. Results We included 315 patients (19595 claims) with a follow-up time of 1 to 99 months (mean 32.7, SD 25.8) covering the years 2006-2014. Mean age was 78 years (SD 9.3) and 200 (63.5%) were female. At baseline, the mean number of letters was 55.6 (SD 16.3) and the central retinal thickness was 400.1 mu m (SD 110.1). Patients received a mean number of 15.1 injections (SD 13.7; range 1 to 85). Compared to AMD, adjusted cost per month were significantly higher (+2174.88 CHF, 95% CI: 1094.50-3255.27; p<0.001) for patients with DME, while cost per month for RVO were slightly but not significantly higher. (+284.71 CHF, 95% CI: -866.73-1436.15; p = 0.627). Conclusions Patients with DME are almost twice as expensive as AMD and RVO patients. Cost excess occurs with non-ophthalmologic interventions. The currently licensed anti-VEGF medications did not differ in costs, injection frequency and clinical outcomes. Linking health care claims to clinical data is a useful tool to examine routine clinical care.	[Schmid, Martin K.; Faes, Livia; Boehni, Sophie C.; Bittner, Mario; Howell, Jeremy P.; Thiel, Michael A.] Cantonal Hosp Lucerne, Eye Clin, Luzern, Switzerland; [Reich, Oliver; Signorell, Andri] Helsana Grp, Dept Hlth Sci, Zurich, Switzerland; [Bachmann, Lucas M.] Medignit Inc Res Consultants, Zurich, Switzerland	Lucerne Cantonal Hospital	Bachmann, LM (corresponding author), Medignit Inc Res Consultants, Zurich, Switzerland.	bachmann@medignition.ch		, Lucas/0000-0002-9868-154X	Novartis Pharma Schweiz AG, Switzerland	Novartis Pharma Schweiz AG, Switzerland	An unrestricted educational grant was awarded to Oliver Reich (OR) and Andri Signorell (AS) by Novartis Pharma Schweiz AG, Switzerland. The funder had no role in study design; collection, analysis, and interpretation of data; writing of the paper; or in the decision to submit the paper for publication. Lucas Bachmann (LB) is an employee of medignition Inc. OR and AS are employees of the Helsana Health Insurance Company. These funders provided support in the form of salaries but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	[Anonymous], 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Black N, 1996, BRIT MED J, V312, P1215; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Holz FG, 2011, OPHTHALMOLOGY, V118, P663, DOI 10.1016/j.ophtha.2010.12.019; Johnston SS, 2013, ADV THER, V30, P1111, DOI 10.1007/s12325-013-0078-4; Mitchell P, 2011, CURR MED RES OPIN, V27, P1465, DOI 10.1185/03007995.2011.585394; Raftery J, 2007, BRIT J OPHTHALMOL, V91, P1244, DOI 10.1136/bjo.2007.116616; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schmid MK, 2015, BRIT J OPHTHALMOL, V99, P141, DOI 10.1136/bjophthalmol-2014-305149; Schmidt-Erfurth U, 2014, OPHTHALMOLOGY, V121, P193, DOI 10.1016/j.ophtha.2013.08.011; Vedula SS, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005139.pub2	12	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0135050	10.1371/journal.pone.0135050	http://dx.doi.org/10.1371/journal.pone.0135050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241852	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942700091
J	Gremmel, T; Frelinger, AL; Michelson, AD				Gremmel, Thomas; Frelinger, Andrew L., III; Michelson, Alan D.			Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ELEVATION MYOCARDIAL-INFARCTION; LOW-DOSE ASPIRIN; CARDIOVASCULAR-DISEASE; PLATELET ACTIVATION; PLASMA-LEVELS; P-SELECTIN; CLOPIDOGREL; RISK; EVENTS	Plasma soluble CD40 ligand (sCD40L) is mainly generated by cleavage of CD40L from the surface of activated platelets, and therefore considered a platelet activation marker. Although the predictive value of sCD40L for ischemic events has been demonstrated in patients with acute coronary syndromes (ACS), studies on the association of sCD40L with cardiovascular outcomes in lower risk populations yielded heterogeneous results. We therefore sought to investigate factors influencing sCD40L levels, and the predictive value of sCD40L for long-term ischemic events in unselected, aspirin-treated patients undergoing cardiac catheterization. sCD40L was determined by a commercially available enzyme-linked immunosorbent assay in 682 consecutive patients undergoing cardiac catheterization. Two-year follow-up data were obtained from 562 patients. Dual antiplatelet therapy with aspirin and clopidogrel was associated with significantly lower levels of sCD40L and lower platelet surface expressions of P-selectin and activated GPIIb/IIIa compared to aspirin monotherapy (all p <= 0.01). Hypertension was linked to lower plasma concentrations of sCD40L, whereas female sex, increasing high-sensitivity C-reactive protein, and hematocrit were associated with higher sCD40L concentrations (all p<0.05). sCD40L levels were similar in patients without and with the primary endpoint in the overall study population (p = 0.4). Likewise, sCD40L levels did not differ significantly between patients without and with the secondary endpoints (both p >= 0.4). Similar results were obtained when only patients with angiographically-proven coronary artery disease (n = 459), stent implantation (n = 205) or ACS (n = 125) were analyzed. The adjustment for differences in patient characteristics by multivariate regression analyses did not change the results. ROC curve analyses did not reveal cut-off values for sCD40L for the prediction of the primary or secondary endpoints. In conclusion, plasma sCD40L levels are reduced by antiplatelet therapy with clopidogrel, but not associated with long-term ischemic outcomes in unselected consecutive aspirin-treated patients undergoing cardiac catheterization.	[Gremmel, Thomas; Frelinger, Andrew L., III; Michelson, Alan D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Platelet Res Studies,Div Hematol Oncol,Boston, Boston, MA 02115 USA; [Gremmel, Thomas] Med Univ Vienna, Dept Internal Med 2, Vienna, Austria	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Medical University of Vienna	Gremmel, T (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Platelet Res Studies,Div Hematol Oncol,Boston, 44 Binney St, Boston, MA 02115 USA.	thomas.gremmel@childrens.harvard.edu	Michelson, Alan/ABE-8487-2021	Michelson, Alan/0000-0002-1746-4819; Gremmel, Thomas/0000-0001-9554-7292	Bristol-Myers Squibb; GLSynthesis; Lilly/Daiichi Sankyo; Pfizer	Bristol-Myers Squibb(Bristol-Myers Squibb); GLSynthesis; Lilly/Daiichi Sankyo(Daiichi Sankyo Company LimitedEli Lilly); Pfizer(Pfizer)	Alan D. Michelson has received grant support from Bristol-Myers Squibb, GLSynthesis, Lilly/Daiichi Sankyo and Pfizer, and served on data monitoring committees of Lilly/Daiichi Sankyo clinical trials. Andrew L. Frelinger has received grant support from Bristol-Myers Squibb, GLSynthesis, Lilly/Daiichi Sankyo and Pfizer. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; Azar RR, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.10.021; Blann AD, 2005, THROMB HAEMOSTASIS, V93, P578, DOI 10.1160/TH04-09-0586; de Lemos JA, 2005, ARTERIOSCL THROM VAS, V25, P2192, DOI 10.1161/01.ATV.0000182904.08513.60; Dominguez-Rodriguez A, 2007, THROMB RES, V121, P293, DOI 10.1016/j.thromres.2007.04.007; Frelinger AL, 2006, CIRCULATION, V113, P2888, DOI 10.1161/CIRCULATIONAHA.105.596627; Furman MI, 2005, J THROMB HAEMOST, V3, P312, DOI 10.1111/j.1538-7836.2005.01124.x; Furman MI, 2004, J AM COLL CARDIOL, V43, P2319, DOI 10.1016/j.jacc.2003.12.055; Garlichs CD, 2003, STROKE, V34, P1412, DOI 10.1161/01.STR.0000074032.64049.47; GRAF D, 1995, EUR J IMMUNOL, V25, P1749, DOI 10.1002/eji.1830250639; Gremmel T, 2014, ATHEROSCLEROSIS, V237, P692, DOI 10.1016/j.atherosclerosis.2014.10.095; Heeschen C, 2003, NEW ENGL J MED, V348, P1104, DOI 10.1056/NEJMoa022600; Heitzer T, 2006, ARTERIOSCL THROM VAS, V26, P1648, DOI 10.1161/01.ATV.0000225288.74170.dc; Henn V, 2001, BLOOD, V98, P1047, DOI 10.1182/blood.V98.4.1047; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Hristov M, 2010, CIRCULATION, V121, P315, DOI 10.1161/CIRCULATIONAHA.109.862771; Jefferis BJ, 2011, J THROMB HAEMOST, V9, P1452, DOI 10.1111/j.1538-7836.2011.04415.x; Lim HS, 2004, CIRCULATION, V109, P2524, DOI 10.1161/01.CIR.0000129773.70647.94; Linden MD, 2007, J THROMB HAEMOST, V5, P761, DOI 10.1111/j.1538-7836.2007.02462.x; Ludwiczek O, 2003, INT J COLORECTAL DIS, V18, P142, DOI 10.1007/s00384-002-0425-4; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Morrow DA, 2008, EUR HEART J, V29, P1096, DOI 10.1093/eurheartj/ehn071; Nannizzi-Alaimo L, 2002, CIRCULATION, V105, P2849, DOI 10.1161/01.CIR.0000019068.32280.B3; Pusuroglu H, 2014, CORONARY ARTERY DIS, V25, P558, DOI 10.1097/MCA.0000000000000142; Rondina MT, 2008, CARDIOLOGY, V109, P196, DOI 10.1159/000106683; Rosiak M, 2013, CARDIOL J, V20, P545, DOI 10.5603/CJ.2013.0045; Rosin C, 2006, PLATELETS, V17, P61, DOI 10.1080/09537100500227021; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Santilli F, 2009, J AM COLL CARDIOL, V53, P667, DOI 10.1016/j.jacc.2008.10.047; Schernthaner GH, 2006, EUR J CLIN INVEST, V36, P395, DOI 10.1111/j.1365-2362.2006.01649.x; Schonbeck U, 2001, CIRCULATION, V104, P2266, DOI 10.1161/hc4401.099447; Stout RD, 1996, IMMUNOL TODAY, V17, P487, DOI 10.1016/0167-5699(96)10060-I; Tanne D, 2006, INT J CARDIOL, V107, P322, DOI 10.1016/j.ijcard.2005.03.051; Undas A, 2009, KARDIOL POL, V67, P591; Valdes V, 2015, J THROMB THROMBOLYS, V40, P83, DOI 10.1007/s11239-015-1179-5; Varo N, 2003, CIRCULATION, V108, P1049, DOI 10.1161/01.CIR.0000088521.04017.13; Varo N, 2003, CIRCULATION, V107, P2664, DOI 10.1161/01.CIR.0000074043.46437.44; Varo N, 2006, CLIN SCI, V111, P341, DOI 10.1042/CS20060047; Wenzel F, 2008, CLIN HEMORHEOL MICRO, V39, P417, DOI 10.3233/CH-2008-1112; Wiley JA, 1997, J IMMUNOL, V158, P2932; Wykrzykowska JJ, 2009, J THROMB THROMBOLYS, V28, P410, DOI 10.1007/s11239-009-0354-y; Yip HK, 2006, AM J CARDIOL, V97, P192, DOI 10.1016/j.amjcard.2005.08.023	42	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134599	10.1371/journal.pone.0134599	http://dx.doi.org/10.1371/journal.pone.0134599			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237513	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942400030
J	Diedrichsen, J; Zotow, E				Diedrichsen, Joern; Zotow, Ewa			Surface-Based Display of Volume-Averaged Cerebellar Imaging Data	PLOS ONE			English	Article							INTRINSIC FUNCTIONAL CONNECTIVITY; HUMAN CONNECTOME PROJECT; HUMAN CEREBRAL-CORTEX; CORTICAL SURFACE; ORGANIZATION; ATLAS; FMRI; REGISTRATION; SEGMENTATION; LOCALIZATION	The paper presents a flat representation of the human cerebellum, useful for visualizing functional imaging data after volume-based normalization and averaging across subjects. Instead of reconstructing individual cerebellar surfaces, the method uses a white-and grey-matter surface defined on volume-averaged anatomical data. Functional data can be projected along the lines of corresponding vertices on the two surfaces. The flat representation is optimized to yield a roughly proportional relationship between the surface area of the 2D-representation and the volume of the underlying cerebellar grey matter. The map allows users to visualize the activation state of the complete cerebellar grey matter in one concise view, equally revealing both the anterior-posterior (lobular) and medial-lateral organization. As examples, published data on resting-state networks and task-related activity are presented on the flatmap. The software and maps are freely available and compatible with most major neuroimaging packages.	[Diedrichsen, Joern; Zotow, Ewa] UCL, Inst Cognit Neurosci, London, England	University of London; University College London	Diedrichsen, J (corresponding author), UCL, Inst Cognit Neurosci, London, England.	j.diedrichsen@ucl.ac.uk	Diedrichsen, Jörn/AAQ-2242-2020; Diedrichsen, Jörn/A-7789-2010	Diedrichsen, Jörn/0000-0003-0264-8532; Diedrichsen, Jörn/0000-0003-0264-8532	Wellcome Trust [094874/Z/10/Z]; James S. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); James S. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research was funded by the Wellcome Trust (094874/Z/10/Z) and by a Understanding Human Cognition Scholar award from the James S. McDonnell Foundation (see: https://www.jsmf.org/programs/uhc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen BB, 2003, J COMP NEUROL, V466, P356, DOI 10.1002/cne.10884; ANDERSSON G, 1978, EXP BRAIN RES, V32, P565; Andersson JL, 2008, FNIRT FMRIBS NONLINE; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Balsters JH, 2010, NEUROIMAGE, V49, P2045, DOI 10.1016/j.neuroimage.2009.10.045; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; BRAITENBERG V, 1958, J COMP NEUROL, V109, P1, DOI 10.1002/cne.901090102; Buckner RL, 2013, NEURON, V80, P807, DOI 10.1016/j.neuron.2013.10.044; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; De Zeeuw CI, 1998, TRENDS NEUROSCI, V21, P391, DOI 10.1016/S0166-2236(98)01310-1; Diedrichsen J, 2011, NEUROIMAGE, V54, P1786, DOI 10.1016/j.neuroimage.2010.10.035; Diedrichsen J, 2015, CEREBELLAR TOOLBOX S, DOI DOI 10.6084/M9.FIGSHARE.1485637; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Diedrichsen J, 2006, NEUROIMAGE, V33, P127, DOI 10.1016/j.neuroimage.2006.05.056; Friston K, 1999, J STAT PARAMETER MAP; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Glickstein M, 2011, CORTEX, V47, P59, DOI 10.1016/j.cortex.2009.09.001; Grodd W, 2001, HUM BRAIN MAPP, V13, P55, DOI 10.1002/hbm.1025; Jansen J, 1972, HUMAN CEREBEL LUM CE; KH E, 2014, HUM BRAIN MAPP, V35, P593, DOI [10.1002/hbm.22194, DOI 10.1002/HBM.22194]; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; LARSELL O, 1958, Arch Sci Biol (Bologna), V42, P90; Lee Gregory P, 2004, Cogn Behav Neurol, V17, P9, DOI 10.1097/00146965-200403000-00002; Liotti M, 2000, BIOL PSYCHIAT, V48, P30, DOI 10.1016/S0006-3223(00)00874-X; McDermott KB, 2003, NEUROPSYCHOLOGIA, V41, P293, DOI 10.1016/S0028-3932(02)00162-8; Oosterhof NN, 2011, NEUROIMAGE, V56, P593, DOI 10.1016/j.neuroimage.2010.04.270; Pelphrey KA, 2014, NEURAL CORRELATES AN, DOI [10.1093/cercor/bhu146, DOI 10.1093/CERC0R/BHU146]; Salmi J, 2010, J COGNITIVE NEUROSCI, V22, P2663, DOI 10.1162/jocn.2009.21382; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Schraa-Tam CKL, 2012, CEREBELLUM, V11, P233, DOI 10.1007/s12311-011-0301-2; Sereno MI, 2014, ANN M SOC NEUROSCIEN; Shaikh AG, 2011, J NEUROPHYSIOL, V105, P3034, DOI 10.1152/jn.00721.2010; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Sugihara I, 2004, J NEUROSCI, V24, P8771, DOI 10.1523/JNEUROSCI.1961-04.2004; Sultan Fahad, 1993, Journal fuer Hirnforschung, V34, P79; Timmann D, 2009, NEUROSCIENCE, V162, P836, DOI 10.1016/j.neuroscience.2009.01.040; Tucholka A, 2012, NEUROIMAGE, V63, P1443, DOI 10.1016/j.neuroimage.2012.06.019; Tukey JW, 1977, EXPLORATORY DATA ANA; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2004, NEUROIMAGE, V23, pS97, DOI 10.1016/j.neuroimage.2004.07.024; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; Van Overwalle F, 2014, NEUROIMAGE, V86, P554, DOI 10.1016/j.neuroimage.2013.09.033; Voogd J., 2004, HUMAN NERVOUS SYSTEM, P321, DOI [10.1016/B978-012547626-3/50012-0, DOI 10.1016/B978-012547626-3/50012-0]; Wiestler T, 2011, J NEUROPHYSIOL, V105, P3042, DOI 10.1152/jn.00106.2011; WORSLEY KJ, 1996, HUM BRAIN MAPP, V12, P900, DOI DOI 10.1038/JCBFM.1992.127; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	55	128	127	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133402	10.1371/journal.pone.0133402	http://dx.doi.org/10.1371/journal.pone.0133402			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230510	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400036
J	Heim, O; Treitler, JT; Tschapka, M; Knornschild, M; Jung, K				Heim, Olga; Treitler, Julia T.; Tschapka, Marco; Knoernschild, Mirjam; Jung, Kirsten			The Importance of Landscape Elements for Bat Activity and Species Richness in Agricultural Areas	PLOS ONE			English	Article							FORAGING HABITAT; SCATTERED TREES; BIODIVERSITY; INTENSIFICATION; ECHOLOCATION; CONSEQUENCES; INSECT; IDENTIFICATION; CONNECTIVITY; VARIABILITY	Landscape heterogeneity is regarded as a key factor for maintaining biodiversity and ecosystem function in production landscapes. We investigated whether grassland sites at close vicinity to forested areas are more frequently used by bats. Considering that bats are important consumers of herbivorous insects, including agricultural pest, this is important for sustainable land management. Bat activity and species richness were assessed using repeated monitoring from May to September in 2010 with acoustic monitoring surveys on 50 grassland sites in the Biosphere Reserve Schorfheide-Chorin (North-East Germany). Using spatial analysis (GIS), we measured the closest distance of each grassland site to potentially connecting landscape elements (e.g., trees, linear vegetation, groves, running and standing water). In addition, we assessed the distance to and the percent land cover of forest remnants and urban areas in a 200 m buffer around the recording sites to address differences in the local landscape setting. Species richness and bat activity increased significantly with higher forest land cover in the 200 m buffer and at smaller distance to forested areas. Moreover, species richness increased in proximity to tree groves. Larger amount of forest land cover and smaller distance to forest also resulted in a higher activity of bats on grassland sites in the beginning of the year during May, June and July. Landscape elements near grassland sites also influenced species composition of bats and species richness of functional groups (open, edge and narrow space foragers). Our results highlight the importance of forested areas, and suggest that agricultural grasslands that are closer to forest remnants might be better buffered against outbreaks of agricultural pest insects due to higher species richness and higher bat activity. Furthermore, our data reveals that even for highly mobile species such as bats, a very dense network of connecting elements within the landscape is beneficial to promote activity in open areas and thus assure vital ecosystem function in agricultural landscapes.	[Heim, Olga; Treitler, Julia T.; Tschapka, Marco; Knoernschild, Mirjam; Jung, Kirsten] Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, D-89069 Ulm, Germany; [Tschapka, Marco; Knoernschild, Mirjam] Smithsonian Trop Res Inst, Balboa, Panama	Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute	Jung, K (corresponding author), Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, D-89069 Ulm, Germany.	kirsten.jung@uni-ulm.de	Heim, Olga/T-9756-2019	Heim, Olga/0000-0002-6664-7793; Knornschild, Mirjam/0000-0003-0448-9600	German Science Foundation [KA 1241/19-1]	German Science Foundation(German Research Foundation (DFG))	This work has been funded by the German Science Foundation (http://www.dfg.de), Priority Program 1374 (KA 1241/19-1) to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2004, ANNU REV ENV RESOUR, V29, P261, DOI 10.1146/annurev.energy.29.062403.102142; Baguette M, 2013, BIOL REV, V88, P310, DOI 10.1111/brv.12000; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barto EK, 2010, SOIL BIOL BIOCHEM, V42, P2316, DOI 10.1016/j.soilbio.2010.09.008; Bates D, 2003, R LANG ENV STAT COMP; Benton TG, 2002, J APPL ECOL, V39, P673, DOI 10.1046/j.1365-2664.2002.00745.x; Boatman ND, 2004, IBIS, V146, P131, DOI 10.1111/j.1474-919X.2004.00347.x; Bohm SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017857; Boughey KL, 2011, BIOL CONSERV, V144, P1790, DOI 10.1016/j.biocon.2011.02.017; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Ellenberg H, 1996, VEGETATION MITTELEUR; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Ewers RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058093; Fischer J, 2006, FRONT ECOL ENVIRON, V4, P80, DOI 10.1890/1540-9295(2006)004[0080:BEFART]2.0.CO;2; Fischer J, 2010, BIOL CONSERV, V143, P1564, DOI 10.1016/j.biocon.2010.03.030; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Fischer M, 2010, LONG-TERM ECOLOGICAL RESEARCH: BETWEEN THEORY AND APPLICATION, P429, DOI 10.1007/978-90-481-8782-9_29; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; FORMAN RTT, 1984, ENVIRON MANAGE, V8, P495, DOI 10.1007/BF01871575; Frey-Ehrenbold A, 2013, J APPL ECOL, V50, P252, DOI 10.1111/1365-2664.12034; Fuentes-Montemayor E, 2011, BIOL CONSERV, V144, P2233, DOI 10.1016/j.biocon.2011.05.015; Getzin S, 2012, METHODS ECOL EVOL, V3, P397, DOI 10.1111/j.2041-210X.2011.00158.x; Hayes JP, 1997, J MAMMAL, V78, P514, DOI 10.2307/1382902; Hendrickx F, 2007, J APPL ECOL, V44, P340, DOI 10.1111/j.1365-2664.2006.01270.x; Kalda O, 2015, AGR ECOSYST ENVIRON, V199, P105, DOI 10.1016/j.agee.2014.08.028; Kalda R, 2015, BIODIVERS CONSERV, V24, P337, DOI 10.1007/s10531-014-0811-6; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lumsden LF, 2005, BIOL CONSERV, V122, P205, DOI 10.1016/j.biocon.2004.07.006; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Marshall EJR, 2002, AGR ECOSYST ENVIRON, V89, P5, DOI 10.1016/S0167-8809(01)00315-2; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; MILLER LA, 1981, J COMP PHYSIOL, V142, P67, DOI 10.1007/BF00605477; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; Obrist MK, 2004, MAMMALIA, V68, P307, DOI 10.1515/mamm.2004.030; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Parsons S, 2000, J EXP BIOL, V203, P2641; Pfalzer G, 2003, J ZOOL, V261, P21, DOI 10.1017/S0952836903003935; Rich TCG, 1996, BIOL CONSERV, V75, P217, DOI 10.1016/0006-3207(95)00077-1; Rosenberg DK, 1997, BIOSCIENCE, V47, P677, DOI 10.2307/1313208; Russo D, 2002, J ZOOL, V258, P91, DOI 10.1017/S0952836902001231; Russo D, 2003, ECOGRAPHY, V26, P197, DOI 10.1034/j.1600-0587.2003.03422.x; Rydell J, 1996, OIKOS, V76, P243, DOI 10.2307/3546196; RYDELL J, 1990, ETHOLOGY, V85, P103; Saab V, 1999, ECOL APPL, V9, P135, DOI 10.1890/1051-0761(1999)009[0135:IOSSTH]2.0.CO;2; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Siriwardena GM, 1998, J APPL ECOL, V35, P24, DOI 10.1046/j.1365-2664.1998.00275.x; Skiba R, 2003, EUROPAISCHE FLEDERMA, V1; Stoate C, 2001, J ENVIRON MANAGE, V63, P337, DOI 10.1006/jema.2001.0473; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Williams P, 2004, BIOL CONSERV, V115, P329, DOI 10.1016/S0006-3207(03)00153-8	56	47	49	1	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134443	10.1371/journal.pone.0134443	http://dx.doi.org/10.1371/journal.pone.0134443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26231029	gold, Green Submitted, Green Published			2022-12-27	WOS:000358838400119
J	Hu, HJ; Park, SG; Jang, HB; Choi, MG; Park, KH; Kang, JH; Park, SI; Lee, HJ; Cho, SH				Hu, Hae-Jin; Park, Sin-Gi; Jang, Han Byul; Choi, Min-Gyu; Park, Kyung-Hee; Kang, Jae Heon; Park, Sang Ick; Lee, Hye-Ja; Cho, Seung-Hak			Obesity Alters the Microbial Community Profile in Korean Adolescents	PLOS ONE			English	Article							GUT MICROBIOME; DNA EXTRACTION; CHILDREN; BACTERIAL; IMPACT; AGE	Obesity is an increasing public health concern worldwide. According to the latest Organization for Economic Co-operation and Development (OECD) report (2014), the incidence of child obesity in Korea has exceeded the OECD average. To better understand and control this condition, the present study examined the composition of the gut microbial community in normal and obese adolescents. Fecal samples were collected from 67 obese (body mass index [BMI] >= 30 kg/m(2), or >= 99th BMI percentile) and 67 normal (BMI < 25 kg/m(2) or < 85th BMI percentile) Korean adolescents aged 13-16 years and subjected to 16S rRNA gene sequencing. Analysis of bacterial composition according to taxonomic rank (genus, family, and phylum) revealed marked differences in the Bacteroides and Prevotella populations in normal and obese samples (p < 0.005) at the genus and family levels; however, there was no difference in the Firmicutes-to-Bacteroidetes (F/B) ratio between normal and obese adolescents samples at the phylum level (F/B normal = 0.50 +/- 0.53; F/B obese = 0.56 +/- 0.86; p = 0.384). Statistical analysis revealed a significant association between the compositions of several bacterial taxa and child obesity. Among these, Bacteroides and Prevotella showed the most significant association with BMI (p < 0.0001 and 0.0001, respectively). We also found that the composition of Bacteroides was negatively associated with triglycerides (TG), total cholesterol, and high-sensitive C-reactive protein (hs-crp) (p = 0.0049, 0.0023, and 0.0038, respectively) levels, whereas that of Prevotella was positively associated with TG and hs-crp levels (p = 0.0394 and 0.0150, respectively). We then applied the association rule mining algorithm to generate "rules" to identify the association between the populations of multiple bacterial taxa and obesity; these rules were able to discriminate obese from normal states. Therefore, the present study describes a systemic approach to identify the association between bacterial populations in the gut and childhood obesity.	[Cho, Seung-Hak] Korea Natl Inst Hlth, Div Enter Dis, Cheongju, Chungcheongbuk, South Korea; [Jang, Han Byul; Park, Sang Ick; Lee, Hye-Ja] Korea Natl Inst Hlth, Ctr Biomed Sci, Cheongju, Chungcheongbuk, South Korea; [Hu, Hae-Jin; Park, Sin-Gi] TheragenEtex Bio Inst Inc, Suwon, South Korea; [Choi, Min-Gyu] Hallym Univ, Sacred Heart Hosp, Dept Family Med, Seoul, South Korea; [Park, Kyung-Hee] Hallym Univ, Sacred Heart Hosp, Dept Family Med, Anyang, Gyeonggi Do, South Korea; [Kang, Jae Heon] Inje Univ, Coll Med, Seoul Paik Hosp, Dept Family Med,Obes Res Inst, Seoul, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Hallym University; Hallym University; Inje University	Lee, HJ (corresponding author), Korea Natl Inst Hlth, Ctr Biomed Sci, Cheongju, Chungcheongbuk, South Korea.	hyejalee@yahoo.co.kr; skcho38@korea.kr	Park, Kyung Hee/AAU-7867-2020	Park, Kyung Hee/0000-0001-9806-0076	Korea National Institute of Health [KNIH4800-4845-300, KNIH4800-4845-302]; Korean Children & Adolescent Study [KoCAS2013-64001-00]; TheragenEtex Bio Institute Inc	Korea National Institute of Health; Korean Children & Adolescent Study; TheragenEtex Bio Institute Inc	This study was funded by the following grants: KNIH4800-4845-300, http://www.nih.go.kr/NIH/eng/main.jsp, Korea National Institute of Health, SHC KNIH4800-4845-302, http://www.nih.go.kr/NIH/eng/main.jsp, Korea National Institute of Health, HJL KoCAS2013-64001-00, Korean Children & Adolescent Study, SIP. Bioinformatics analyses were performed by TheragenEtex Bio Institute Inc. Additionally, TheragenEtex Bio Institute Inc provided support in the form of salaries for authors Hae-Jin Hu and Sin-Gi Park, but did not have any additional role in the study design, data collection and analysis (other than already disclosed), decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agans R, 2011, FEMS MICROBIOL ECOL, V77, P404, DOI 10.1111/j.1574-6941.2011.01120.x; Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bervoets L, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-10; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Bouchard C, 2008, OBESITY, V16, pS5, DOI 10.1038/oby.2008.528; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Chiu CM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/906168; Chun J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-101; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Durban A., 2013, METAGENOMICS, V2, P235722, DOI [10.4303/mg/235722, DOI 10.4303/MG/235722]; Ferrer M, 2013, ENVIRON MICROBIOL, V15, P211, DOI 10.1111/j.1462-2920.2012.02845.x; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hur M, 2011, APPL ENVIRON MICROB, V77, P7611, DOI 10.1128/AEM.06102-11; Karlsson CLJ, 2012, OBESITY, V20, P2257, DOI 10.1038/oby.2012.110; Kim BS, 2012, ANAEROBE, V18, P310, DOI 10.1016/j.anaerobe.2012.01.003; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lim MY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07348; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Marti A, 2008, P NUTR SOC, V67, P1, DOI 10.1017/S002966510800596X; McOrist AL, 2002, J MICROBIOL METH, V50, P131, DOI 10.1016/S0167-7012(02)00018-0; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Nam YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022109; Nechvatal JM, 2008, J MICROBIOL METH, V72, P124, DOI 10.1016/j.mimet.2007.11.007; Qi L, 2008, NUTR REV, V66, P684, DOI 10.1111/j.1753-4887.2008.00128.x; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Tims S, 2013, ISME J, V7, P707, DOI 10.1038/ismej.2012.146; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yin XX, 2003, SIAM PROC S, P331; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	41	75	79	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134333	10.1371/journal.pone.0134333	http://dx.doi.org/10.1371/journal.pone.0134333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230509	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400102
J	Ivers, KM; Sredar, N; Patel, NB; Rajagopalan, L; Queener, HM; Twa, MD; Harwerth, RS; Porter, J				Ivers, Kevin M.; Sredar, Nripun; Patel, Nimesh B.; Rajagopalan, Lakshmi; Queener, Hope M.; Twa, Michael D.; Harwerth, Ronald S.; Porter, Jason			In Vivo Changes in Lamina Cribrosa Microarchitecture and Optic Nerve Head Structure in Early Experimental Glaucoma	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE ELEVATION; OPEN-ANGLE GLAUCOMA; SCANNING LASER OPHTHALMOSCOPY; AXONAL-TRANSPORT BLOCKADE; FIBER LAYER THICKNESS; COHERENCE TOMOGRAPHY; CONNECTIVE-TISSUE; MONKEY EYES; DAMAGE; DEFORMATION	The lamina cribrosa likely plays an important role in retinal ganglion cell axon injury in glaucoma. We sought to (1) better understand optic nerve head (ONH) structure and anterior lamina cribrosa surface (ALCS) microarchitecture between fellow eyes of living, normal non-human primates and (2) characterize the time-course of in vivo structural changes in the ONH, ALCS microarchitecture, and retinal nerve fiber layer thickness (RNFLT) in non-human primate eyes with early experimental glaucoma (EG). Spectral domain optical coherence tomography (SDOCT) images of the ONH were acquired cross-sectionally in six bilaterally normal rhesus monkeys, and before and approximately every two weeks after inducing unilateral EG in seven rhesus monkeys. ONH parameters and RNFLT were quantified from segmented SDOCT images. Mean ALCS pore area, elongation and nearest neighbor distance (NND) were quantified globally, in sectors and regionally from adaptive optics scanning laser ophthalmoscope images. In bilaterally normal monkeys, ONH parameters were similar between fellow eyes with few inter-eye differences in ALCS pore parameters. In EG monkeys, an increase in mean ALCS Depth (ALCSD) was the first structural change measured in 6 of 7 EG eyes. A decrease in mean minimum rim width (MRW) simultaneously accompanied this early change in 4 of 6 EG eyes and was the first structural change in the 7th EG eye. Mean ALCS pore parameters were among the first or second changes measured in 4 EG eyes. Mean ALCS pore area and NND increased in superotemporal and temporal sectors and in central and peripheral regions at the first time-point of change in ALCS pore geometry. RNFLT and/or mean ALCS radius of curvature were typically the last parameters to initially change. Survival analyses found mean ALCSD was the only parameter to significantly show an initial change prior to the first measured loss in RNFLT across EG eyes.	[Ivers, Kevin M.; Patel, Nimesh B.; Rajagopalan, Lakshmi; Queener, Hope M.; Harwerth, Ronald S.; Porter, Jason] Univ Houston, Coll Optometry, Houston, TX 77204 USA; [Sredar, Nripun] Univ Houston, Dept Comp Sci, Houston, TX 77204 USA; [Twa, Michael D.] Univ Alabama Birmingham, Sch Optometry, Birmingham, AL 35294 USA	University of Houston System; University of Houston; University of Houston System; University of Houston; University of Alabama System; University of Alabama Birmingham	Porter, J (corresponding author), Univ Houston, Coll Optometry, Houston, TX 77204 USA.	jporter@central.uh.edu	Twa, Michael/I-3131-2019; Sredar, Nripun/Q-3714-2019	Twa, Michael/0000-0003-4544-5153; Sredar, Nripun/0000-0002-9567-9815; Patel, Nimesh/0000-0002-1772-2611	National Institutes of Health [R01 EY021783, R01 EY001139, K23 EY021761, P30 EY007551]; NATIONAL EYE INSTITUTE [R01EY001139, R01EY022362, R01EY021783, K23EY021761, P30EY007551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Institutes of Health R01 EY021783 (JP); National Institutes of Health R01 EY001139 (RH); National Institutes of Health K23 EY021761 (NP); National Institutes of Health P30 EY007551 (Laura Frishman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2012, INVEST OPHTH VIS SCI, V53, P4111, DOI 10.1167/iovs.11-7536; ANDERSON DR, 1969, ARCH OPHTHALMOL-CHIC, V82, P800; ANDERSON DR, 1974, INVEST OPHTH VISUAL, V13, P771; Bellezza AJ, 2000, INVEST OPHTH VIS SCI, V41, P2991; Bellezza AJ, 2003, INVEST OPHTH VIS SCI, V44, P623, DOI 10.1167/iovs.01-1282; Burgoyne CF, 2004, INVEST OPHTH VIS SCI, V45, P4388, DOI 10.1167/iovs.04-0022; Chauhan BC, 2013, OPHTHALMOLOGY, V120, P535, DOI 10.1016/j.ophtha.2012.09.055; Cull GA, 2012, INVEST OPHTH VIS SCI, V53, P7766, DOI 10.1167/iovs.12-10752; DANDONA L, 1990, ARCH OPHTHALMOL-CHIC, V108, P393, DOI 10.1001/archopht.1990.01070050091039; Demsar J, 2013, J MACH LEARN RES, V14, P2349; Downs JC, 2008, OPTOMETRY VISION SCI, V85, P425, DOI 10.1097/OPX.0b013e31817841cb; Downs JC, 2011, EXP EYE RES, V93, P133, DOI 10.1016/j.exer.2010.08.004; Downs JC, 2001, INVEST OPHTH VIS SCI, V42, P3202; Fontana L, 1998, CURR EYE RES, V17, P363, DOI 10.1080/02713689808951216; Fortune B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077831; Fortune B, 2013, INVEST OPHTH VIS SCI, V54, P5653, DOI 10.1167/iovs.13-12219; Frishman LJ, 1996, INVEST OPHTH VIS SCI, V37, P125; Furlanetto RL, 2013, INVEST OPHTH VIS SCI, V54, P4836, DOI 10.1167/iovs.12-11530; GAASTERLAND D, 1974, INVEST OPHTH VISUAL, V13, P455; Harwerth RS, 1997, J GLAUCOMA, V6, P390; He L, 2014, INVEST OPHTH VIS SCI, V55, P574, DOI 10.1167/iovs.13-13245; Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8; Inoue R, 2009, OPHTHALMOLOGY, V116, P214, DOI 10.1016/j.ophtha.2008.09.008; Ivers KM, 2011, INVEST OPHTH VIS SCI, V52, P5473, DOI 10.1167/iovs.11-7347; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; Lee EJ, 2012, INVEST OPHTH VIS SCI, V53, P198, DOI 10.1167/iovs.11-7848; Li CH, 2010, OPT EXPRESS, V18, P16671, DOI 10.1364/OE.18.016671; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Nadler Z, 2013, BIOMED OPT EXPRESS, V4, P2596, DOI 10.1364/BOE.4.002596; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Patel NB, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14191; PEDERSON JE, 1984, ARCH OPHTHALMOL-CHIC, V102, P1689, DOI 10.1001/archopht.1984.01040031373030; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P137; QUIGLEY HA, 1983, INVEST OPHTH VIS SCI, V24, P1305; QUIGLEY HA, 1976, INVEST OPHTH VISUAL, V15, P606; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; QUIGLEY HA, 1977, INVEST OPHTH VIS SCI, V16, P640; Roberts MD, 2010, INVEST OPHTH VIS SCI, V51, P295, DOI 10.1167/iovs.09-4016; Roberts MD, 2009, INVEST OPHTH VIS SCI, V50, P681, DOI 10.1167/iovs.08-1792; Sigal IA, 2004, INVEST OPHTH VIS SCI, V45, P4378, DOI 10.1167/iovs.04-0133; Sredar N, 2013, BIOMED OPT EXPRESS, V4, P1153, DOI 10.1364/BOE.4.001153; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P9431, DOI 10.1167/iovs.11-7922; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P1206, DOI 10.1167/iovs.10-5599; Tezel G, 2004, BRIT J OPHTHALMOL, V88, P251, DOI 10.1136/bjo.2003.019281; Vilupuru AS, 2007, J OPT SOC AM A, V24, P1417, DOI 10.1364/JOSAA.24.001417; Wang B, 2013, INVEST OPHTH VIS SCI, V54, P8270, DOI 10.1167/iovs.13-13109; Yang H, 2011, INVEST OPHTH VIS SCI, V53, P394; Yang HL, 2007, INVEST OPHTH VIS SCI, V48, P4597, DOI 10.1167/iovs.07-0349; Yang HL, 2011, INVEST OPHTH VIS SCI, V52, P345, DOI 10.1167/iovs.09-5122	51	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134223	10.1371/journal.pone.0134223	http://dx.doi.org/10.1371/journal.pone.0134223			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230993	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400086
J	Lin, ZJ; Zhao, ZH; Xu, HH; Zhang, X; Wang, TT; Kan, HD; Norback, D				Lin, Zhijing; Zhao, Zhuohui; Xu, Huihui; Zhang, Xin; Wang, Tingting; Kan, Haidong; Norback, Dan			Home Dampness Signs in Association with Asthma and Allergic Diseases in 4618 Preschool Children in Urumqi, China-The Influence of Ventilation/Cleaning Habits	PLOS ONE			English	Article							RESPIRATORY SYMPTOMS; HOUSING CHARACTERISTICS; ENVIRONMENTAL-FACTORS; CHILDHOOD ASTHMA; EARLY-LIFE; HEALTH; PREVALENCE; BUILDINGS; MOLDS; SCHOOLCHILDREN	There is an increasing prevalence of childhood asthma and allergic diseases in mainland of China. Few studies investigated the indoor dampness, ventilation and cleaning habits and their interrelationship with childhood asthma and allergic diseases. A large-scale cross-sectional study was performed in preschool children in Urumqi, China. Questionnaire was used to collect information on children's health, home dampness and ventilation/cleaning (V/C) habits. Multiple logistic regressions were applied to analyze the associations between childhood asthma/allergic diseases and each sign of home dampness, dampness levels, each V/C habit and total V/C scores. The associations between dampness and health were further performed by strata analyses in two groups with low and high V/C scores. Totally 4618 (81.7%) of 5650 children returned the questionnaire. Reports on home dampness were most common for water condensation on windows (20.8%) followed by damp beddings (18.0%). The most common ventilation measure was the use of exhaust fan in bathroom (59.3%), followed by daily home cleaning (48.3%), frequently putting beddings to sunshine (29.9%) and frequently opening windows in winter (8.4%). There were positive associations between the 6 signs of home dampness and children's health particularly the symptoms last 12 months. By comparing with the reference dampness level (dampness scored 0), both the low dampness (scored 1 similar to 2) level and the high dampness level (scored 3 similar to 6) showed significantly increasing associations with childhood symptoms. There were crude negative associations between V/C habits and childhood health but not significant adjusting for home dampness levels. The risks of home dampness on children's health were lower in the group with higher V/C score but the differences were not statistically significant. Home dampness is a potential risk factor for childhood asthma and allergic symptoms in preschool children in Urumqi, China. No significant effects were observed for ordinary home ventilation and cleaning habits in reducing the risks of home dampness on childhood asthma and allergic diseases in Urumqi, China.	[Lin, Zhijing; Zhao, Zhuohui; Kan, Haidong] Fudan Univ, Dept Environm Hlth, Sch Publ Hlth, Key Lab Publ Hlth Safety,Minist Educ, Shanghai 200032, Peoples R China; [Xu, Huihui] Shanghai Municipal Ctr Dis Control & Prevent, Dept Environm Hlth, Shanghai 200032, Peoples R China; [Zhang, Xin] Shanxi Univ, Inst Environm Sci, Taiyuan 030006, Peoples R China; [Wang, Tingting] Xinjiang Med Univ, Sch Publ Hlth, Dept Maternal Child & Adolescent Hlth, Urumqi, Peoples R China; [Norback, Dan] Uppsala Univ, Dept Med Sci Occupat & Environm Med, SE-751 Uppsala, Sweden	Fudan University; Shanghai Center for Disease Control & Prevention; Shanxi University; Xinjiang Medical University; Uppsala University	Zhao, ZH (corresponding author), Fudan Univ, Dept Environm Hlth, Sch Publ Hlth, Key Lab Publ Hlth Safety,Minist Educ, Shanghai 200032, Peoples R China.	zhzhao@fudan.edu.cn	wang, tingting/AAK-2640-2020; Kan, Haidong/AGU-0328-2022	Norback, Dan/0000-0002-5174-6668				Aberg N, 1996, ALLERGY, V51, P232, DOI 10.1111/j.1398-9995.1996.tb04598.x; Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C; [Anonymous], 2009, WHO GUID IND AIR QUA; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Asher MI, 1998, EUR RESPIR J, V12, P315; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bornehag CG, 2005, INDOOR AIR, V15, P48, DOI 10.1111/j.1600-0668.2005.00306.x; Bornehag CG, 2001, INDOOR AIR, V11, P72; Bornehag CG, 2004, INDOOR AIR, V14, P59, DOI 10.1111/j.1600-0668.2004.00274.x; Braun FC, 2004, EUR J RESP, V23, P407; BRUNEKREEF B, 1989, AM REV RESPIR DIS, V140, P1363, DOI 10.1164/ajrccm/140.5.1363; Butler Sarnia, 2003, N Z Med J, V116, pU494; Chang P, 1954, COLLECTED SCI PAPERS, P273; Chen Yu-zhi, 2004, Zhonghua Jiehe He Huxi Zazhi, V27, P112; Claeson AS, 2007, J ENVIRON MONITOR, V9, P240, DOI 10.1039/b614766f; DALES RE, 1991, AM J EPIDEMIOL, V134, P196, DOI 10.1093/oxfordjournals.aje.a116072; Dong GH, 2008, RESPIRATION, V76, P82, DOI 10.1159/000121370; Dong GH, 2008, INT J ENVIRON HEAL R, V18, P267, DOI 10.1080/09603120701842864; Dong GH, 2008, REV EPIDEMIOL SANTE, V56, P97, DOI 10.1016/j.respe.2007.12.002; Engvall K, 2001, INT J TUBERC LUNG D, V5, P468; Gunnbjornsdottir MI, 2006, THORAX, V61, P221, DOI 10.1136/thx.2005.057430; Hsu NY, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/158248; Hu Y, 2014, INDOOR AIR, V24, P450, DOI 10.1111/ina.12104; Karvonen AM, 2009, PEDIATRICS, V124, pE329, DOI 10.1542/peds.2008-1590; Lee IS, 2003, YONSEI MED J, V44, P313, DOI 10.3349/ymj.2003.44.2.313; Leech JA, 2002, J EXPO ANAL ENV EPID, V12, P427, DOI 10.1038/sj.jea.7500244; Leung R, 1997, EUR RESPIR J, V10, P354, DOI 10.1183/09031936.97.10020354; Li XF, 2013, HV AC, V43, P46; Mudarri D, 2007, INDOOR AIR, V17, P226, DOI 10.1111/j.1600-0668.2007.00474.x; National Bureau of Statistics-People's Republic of China, 2011, CHIN STAT YB 2010 20; National Cooperative Group on Childhood Asthma, 2013, Zhonghua Er Ke Za Zhi, V51, P729; Naydenov K, 2008, PEDIAT ALLERG IMM-UK, V19, P702, DOI 10.1111/j.1399-3038.2008.00721.x; Pirhonen I, 1996, EUR RESPIR J, V9, P2618, DOI 10.1183/09031936.96.09122618; PLATT SD, 1989, BRIT MED J, V298, P1673, DOI 10.1136/bmj.298.6689.1673; Sauni R, 2013, EVID BASED CHILD HLT, V8, P994; Sun Y, 2011, INDOOR AIR, V21, P277, DOI 10.1111/j.1600-0668.2010.00699.x; Sun YX, 2011, SCI TOTAL ENVIRON, V409, P4229, DOI 10.1016/j.scitotenv.2011.07.011; Tham KW, 2007, PEDIAT ALLERG IMM-UK, V18, P418, DOI 10.1111/j.1399-3038.2007.00544.x; VERHOEFF AP, 1995, AM J EPIDEMIOL, V141, P103, DOI 10.1093/oxfordjournals.aje.a117398; Wang H, 2013, CHINESE SCI BULL, V58, P4259, DOI 10.1007/s11434-013-5774-6; Wang Hong-yu, 2006, Zhonghua Er Ke Za Zhi, V44, P41; Wang TT, 2013, CHINESE SCI BULL, V58, P4237, DOI 10.1007/s11434-013-5727-0; Yang CY, 1997, PEDIATR PULM, V24, P73, DOI 10.1002/(SICI)1099-0496(199708)24:2<73::AID-PPUL1>3.0.CO;2-J; Zhang M, 2013, CHINESE SCI BULL, V58, P4223, DOI 10.1007/s11434-013-5687-4; Zhang YP, 2013, CHINESE SCI BULL, V58, P4182, DOI 10.1007/s11434-013-5914-z; Zhang YP, 2013, ENVIRON HEALTH PERSP, V121, P751, DOI 10.1289/ehp.1205983; Zhao ZH, 2013, CHINESE SCI BULL, V58, P4245, DOI 10.1007/s11434-013-5705-6	47	14	14	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134359	10.1371/journal.pone.0134359	http://dx.doi.org/10.1371/journal.pone.0134359			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230849	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400106
J	Loffler, A; Luck, T; Then, FS; Sikorski, C; Kovacs, P; Bottcher, Y; Breitfeld, J; Tonjes, A; Horstmann, A; Loffler, M; Engel, C; Thiery, J; Villringer, A; Stumvoll, M; Riedel-Heller, SG				Loeffler, Antje; Luck, Tobias; Then, Francisca S.; Sikorski, Claudia; Kovacs, Peter; Boettcher, Yvonne; Breitfeld, Jana; Toenjes, Anke; Horstmann, Annette; Loeffler, Markus; Engel, Christoph; Thiery, Joachim; Villringer, Arno; Stumvoll, Michael; Riedel-Heller, Steffi G.			Eating Behaviour in the General Population: An Analysis of the Factor Structure of the German Version of the Three-Factor-Eating-Questionnaire (TFEQ) and Its Association with the Body Mass Index	PLOS ONE			English	Article							DIETARY RESTRAINT; QUESTIONNAIRE	The Three-Factor-Eating-Questionnaire (TFEQ) is an established instrument to assess eating behaviour. Analysis of the TFEQ-factor structure was based on selected, convenient and clinical samples so far. Aims of this study were (I) to analyse the factor structure of the German version of the TFEQ and (II)-based on the refined factor structure-to examine the association between eating behaviour and the body mass index (BMI) in a general population sample of 3,144 middle-aged and older participants (40-79 years) of the ongoing population based cohort study of the Leipzig Research Center for Civilization Diseases (LIFE Health Study). The factor structure was examined in a split-half analysis with both explorative and confirmatory factor analysis. Associations between TFEQ-scores and BMI values were tested with multiple regression analyses controlled for age, gender, and education. We found a three factor solution for the TFEQ with an 'uncontrolled eating', a 'cognitive restraint' and an 'emotional eating' domain including 29 of the original 51 TFEQ-items. Scores of the 'uncontrolled eating domain' showed the strongest correlation with BMI values (partial r = 0.26). Subjects with scores above the median in both 'uncontrolled eating' and 'emotional eating' showed the highest BMI values (mean = 29.41 kg/m(2)), subjects with scores below the median in all three domains showed the lowest BMI values (mean = 25.68 kg/m(2); F = 72.074, p<0.001). Our findings suggest that the TFEQ is suitable to identify subjects with specific patterns of eating behaviour that are associated with higher BMI values. Such information may help health care professionals to develop and implement more tailored interventions for overweight and obese individuals.	[Loeffler, Antje; Luck, Tobias; Then, Francisca S.; Sikorski, Claudia; Riedel-Heller, Steffi G.] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth ISAP, D-04109 Leipzig, Germany; [Loeffler, Antje; Luck, Tobias; Then, Francisca S.] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany; [Sikorski, Claudia; Kovacs, Peter; Boettcher, Yvonne; Breitfeld, Jana; Horstmann, Annette; Stumvoll, Michael] Univ Leipzig, IFB AdiposityDis, Med Ctr, D-04109 Leipzig, Germany; [Toenjes, Anke; Stumvoll, Michael] Univ Leipzig, Dept Med, Div Endocrinol & Nephrol, D-04109 Leipzig, Germany; [Horstmann, Annette; Villringer, Arno] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Loeffler, Markus; Engel, Christoph] Univ Leipzig, IMISE, D-04109 Leipzig, Germany; [Thiery, Joachim] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04109 Leipzig, Germany; [Villringer, Arno] Univ Leipzig, Day Clin Cognit Neurol, D-04109 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Max Planck Society; Leipzig University; Leipzig University; Leipzig University	Loffler, A (corresponding author), Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth ISAP, D-04109 Leipzig, Germany.	antje.loeffler@medizin.uni-leipzig.de	Horstmann, Annette/C-9083-2011; Rodriguez, Francisca/AAD-6803-2019; Riedel-Heller, Steffi/ABG-1537-2021; Rodriguez, Francisca S./N-4360-2018; Stumvoll, Michael/ABE-1121-2021	Horstmann, Annette/0000-0001-6184-8484; Rodriguez, Francisca/0000-0003-2919-5510; Rodriguez, Francisca S./0000-0003-2919-5510; Stumvoll, Michael/0000-0001-6225-8240; Kovacs, Peter/0000-0002-0290-5423; Luck, Tobias/0000-0001-7551-4397; Engel, Christoph/0000-0002-7247-282X; Villringer, Arno/0000-0003-2604-2404	LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig; Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF, Germany) [FKZ: 01EO1001]; European Union; European Regional Development Fund (ERDF); Free State of Saxony; German Research Council [DFG - SFB 1052, SPP 1629 TO 718/2-1]; German Diabetes Association	LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig; Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF, Germany)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony; German Research Council(German Research Foundation (DFG)); German Diabetes Association	This publication was supported by LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig, and the Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF, Germany, FKZ: 01EO1001). LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF), and by means of the Free State of Saxony within the framework of the excellence initiative. A. T. was supported by grants from the German Research Council (DFG - SFB 1052 "Obesity mechanisms"; and SPP 1629 TO 718/2-1) and from the German Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brauns H, 1999, ZUMA NACHRICHTEN, V23, P7; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dietrich A, 2014, FRONT PSYCHOL, V5, DOI [10.3389/fpsyg.2014.00079, 10.3389/fpsyg.2014.01073]; Effertz T, 2013, KOSTEN ADIPOSITAS DE; French SA, 2012, APPETITE, V59, P541, DOI 10.1016/j.appet.2012.07.001; GANLEY RM, 1988, INT J EAT DISORDER, V7, P635, DOI 10.1002/1098-108X(198809)7:5<635::AID-EAT2260070507>3.0.CO;2-K; Geliebter Allan, 2003, Eat Behav, V3, P341, DOI 10.1016/S1471-0153(02)00100-9; Hautzinger M, 2012, ALLGEMEINE DEPRESSIO, V2nd; Horstmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074362; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; HYLAND ME, 1989, CURR PSYCHOL RES REV, V8, P228, DOI 10.1007/BF02686751; Johnson F, 2012, INT J OBESITY, V36, P665, DOI 10.1038/ijo.2011.156; Karlsson J, 2000, INT J OBESITY, V24, P1715, DOI 10.1038/sj.ijo.0801442; Koenders PG, 2011, J OCCUP ENVIRON MED, V53, P1287, DOI 10.1097/JOM.0b013e31823078a2; Mazzeo SE, 2003, INT J EAT DISORDER, V34, P255, DOI 10.1002/eat.10180; Mensink GBM, 2013, BUNDESGESUNDHEITSBLA, V56, P786, DOI 10.1007/s00103-012-1656-3; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Renner B, 2012, APPETITE, V59, P117, DOI 10.1016/j.appet.2012.04.004; Stein J, 2014, PSYCHIAT PRAX, V41, P135, DOI 10.1055/s-0033-1343176; Stewart TM, 2002, APPETITE, V38, P39, DOI 10.1006/appe.2001.0445; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Timko C Alix, 2005, Eat Behav, V6, P119, DOI 10.1016/j.eatbeh.2004.09.002; Westenh&ouml;fer J, 1989, VERL FUR PSYCHOLOGIE; Westenhoefer J, 1999, INT J EAT DISORDER, V26, P53, DOI 10.1002/(SICI)1098-108X(199907)26:1&lt;53::AID-EAT7&gt;3.0.CO;2-N	25	46	49	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133977	10.1371/journal.pone.0133977	http://dx.doi.org/10.1371/journal.pone.0133977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230264	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400066
J	Schupbach, J; Niederhauser, C; Yerly, S; Regenass, S; Gorgievski, M; Aubert, V; Ciardo, D; Klimkait, T; Dollenmaier, G; Andreutti, C; Martinetti, G; Brandenberger, M; Gebhardt, MD				Schuepbach, Joerg; Niederhauser, Christoph; Yerly, Sabine; Regenass, Stephan; Gorgievski, Meri; Aubert, Vincent; Ciardo, Diana; Klimkait, Thomas; Dollenmaier, Guenter; Andreutti, Corinne; Martinetti, Gladys; Brandenberger, Marcel; Gebhardt, Martin D.			Decreasing Proportion of Recent Infections among Newly Diagnosed HIV-1 Cases in Switzerland, 2008 to 2013 Based on Line-Immunoassay-Based Algorithms	PLOS ONE			English	Article							UNITED-STATES; SPECIFICITY; ANTIBODIES; ASSAYS; GAG; PERFORMANCE; HEMOPHILIA; DIVERSITY; DYNAMICS; MARKER	Background HIV surveillance requires monitoring of new HIV diagnoses and differentiation of incident and older infections. In 2008, Switzerland implemented a system for monitoring incident HIV infections based on the results of a line immunoassay (Inno-Lia) mandatorily conducted for HIV confirmation and type differentiation (HIV-1, HIV-2) of all newly diagnosed patients. Based on this system, we assessed the proportion of incident HIV infection among newly diagnosed cases in Switzerland during 2008-2013. Methods and Results Inno-Lia antibody reaction patterns recorded in anonymous HIV notifications to the federal health authority were classified by 10 published algorithms into incident (up to 12 months) or older infections. Utilizing these data, annual incident infection estimates were obtained in two ways, (i) based on the diagnostic performance of the algorithms and utilizing the relationship 'incident = true incident + false incident', (ii) based on the window-periods of the algorithms and utilizing the relationship 'Prevalence = Incidence x Duration'. From 20082013, 3'851 HIV notifications were received. Adult HIV-1 infections amounted to 3'809 cases, and 3'636 of them (95.5%) contained Inno-Lia data. Incident infection totals calculated were similar for the performance-and window-based methods, amounting on average to 1'755 (95% confidence interval, 1588-1923) and 1'790 cases (95% CI, 1679-1900),respectively. More than half of these were among men who had sex with men. Both methods showed a continuous decline of annual incident infections 2008-2013, totaling -59.5% and -50.2%, respectively. The decline of incident infections continued even in 2012, when a 15% increase in HIV notifications had been observed. This increase was entirely due to older infections. Overall declines 2008-2013 were of similar extent among the major transmission groups. Conclusions Inno-Lia based incident HIV-1 infection surveillance proved useful and reliable. It represents a free, additional public health benefit of the use of this relatively costly test for HIV confirmation and type differentiation.	[Schuepbach, Joerg] Univ Zurich, Inst Med Virol, Swiss Natl Ctr Retroviruses, CH-8057 Zurich, Switzerland; [Niederhauser, Christoph] Swiss Red Cross Berne, Blood Transfus Serv, Bern, Switzerland; [Yerly, Sabine] Univ Hosp Geneva, Virol Lab, CH-14 Geneva, Switzerland; [Regenass, Stephan] Univ Hosp, Clin Immunol, Zurich, Switzerland; [Gorgievski, Meri] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Aubert, Vincent] Univ Hosp Ctr, Univ Hosp, Serv Immunol & Allergy, Lausanne, Switzerland; [Ciardo, Diana] Inst Dr Viollier AG, Basel, Switzerland; [Klimkait, Thomas] Univ Basel, Inst Med Microbiol, Basel, Switzerland; [Dollenmaier, Guenter] Zentrum Labormed St Gallen, St Gallen, Switzerland; [Andreutti, Corinne] Clin Source, Lab, Lausanne, Switzerland; [Martinetti, Gladys] Ente Osped Cantonale, Microbiol Serv, Bellinzona, Switzerland; [Brandenberger, Marcel] Lab Synlab Luzern, Luzern, Switzerland; [Gebhardt, Martin D.] Swiss Fed Off Publ Hlth, CH-3003 Bern, Switzerland	University of Zurich; University of Geneva; University of Zurich; University Zurich Hospital; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel	Schupbach, J (corresponding author), Univ Zurich, Inst Med Virol, Swiss Natl Ctr Retroviruses, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	schupbach.jorg@virology.uzh.ch	Schüpbach, Jörg/G-4209-2016	Schüpbach, Jörg/0000-0002-8074-5891; Klimkait, Thomas/0000-0003-4945-6511	Swiss Federal Office of Public Health (SFOPH) [07.005822, 09.001294, 10.001983, 11.005726]; Labor Synlab Luzern; Institut Dr. Viollier AG; Clinique de la Source	Swiss Federal Office of Public Health (SFOPH); Labor Synlab Luzern; Institut Dr. Viollier AG; Clinique de la Source	This study was financed by contracts 07.005822, 09.001294, 10.001983 and 11.005726 with the Swiss Federal Office of Public Health (SFOPH); see: http://www.bag.admin.ch/org/index.html?lang = en. Even though one of the authors (MDG) is an employee of the SFOPH, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Institut Dr. Viollier AG, Clinique de la Source, and Labor Synlab Luzern provided support in the form of salaries for authors DC, CA & MB respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aghaizu A, 2014, EUROSURVEILLANCE, V19; [Anonymous], 2013, MONITORING RECENTLY; [Anonymous], 2013, SHCS REPORT; [Anonymous], 2010, NATL PROGRAMME HIV S; [Anonymous], 2014, SERVICES DOHAH; [Anonymous], 2006, SCHWEIZERISCHE HIV T, P1022; [Anonymous], 2014, BAG B, P351; [Anonymous], 2014, HIV AIDS ESTIMATES 2; Binley JM, 1997, J VIROL, V71, P2799, DOI 10.1128/JVI.71.4.2799-2809.1997; CHARGELEGUE D, 1993, CLIN EXP IMMUNOL, V93, P331, DOI 10.1111/j.1365-2249.1993.tb08181.x; CHARGELEGUE D, 1993, AIDS, V7, pS87, DOI 10.1097/00002030-199311002-00017; Chavez P, 2011, J CLIN VIROL, V52, pS51, DOI 10.1016/j.jcv.2011.09.010; Curtis KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077765; Curtis KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064201; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Eshleman SH, 2013, J INFECT DIS, V207, P223, DOI 10.1093/infdis/jis658; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Goubar A, 2008, J R STAT SOC A STAT, V171, P541, DOI 10.1111/j.1467-985X.2007.00537.x; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hallett TB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005720; Hladik W, 2012, AIDS RES HUM RETROV, V28, P95, DOI [10.1089/aid.2010.0347, 10.1089/AID.2010.0347]; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Kassanjee R, 2014, AIDS, V28, P2439, DOI 10.1097/QAD.0000000000000429; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; Laeyendecker O, 2008, JAIDS-J ACQ IMM DEF, V48, P211, DOI 10.1097/QAI.0b013e3181743980; Laeyendecker O, 2012, AIDS RES HUM RETROV, V28, P1177, DOI 10.1089/aid.2011.0341; Laeyendecker O, 2013, J INFECT DIS, V207, P232, DOI 10.1093/infdis/jis659; LANGE JMA, 1988, ANN MED INTERNE, V139, P80; Le Vu S, 2008, EURO SURVEILL, P13; Le Vu S, 2010, LANCET INFECT DIS, V10, P682, DOI 10.1016/S1473-3099(10)70167-5; Lindback S, 2000, AIDS, V14, P2283, DOI 10.1097/00002030-200010200-00009; Malm K, 2009, TRANSFUSION MED, V19, P78, DOI 10.1111/j.1365-3148.2009.00907.x; Marinda ET, 2010, JAIDS-J ACQ IMM DEF, V53, P496, DOI 10.1097/QAI.0b013e3181b61938; Miller WC, 2013, LANCET INFECT DIS, V13, P459, DOI 10.1016/S1473-3099(12)70314-6; Ministerial Council on Education Employment Training and Youth Affairs, 2009, MCEETYA 4 YEAR PLAN; Murphy G, 2008, EURO SURVEILL, V13; Park SY, 2011, AIDS, V25, pF13, DOI 10.1097/QAD.0b013e328349f089; POLLET DE, 1991, CLIN CHEM, V37, P1700; Ragonnet-Cronin M, 2012, J INFECT DIS, V206, P756, DOI 10.1093/infdis/jis411; Remis RS, 2009, AIDS, V23, P493, DOI 10.1097/QAD.0b013e328323ad5f; Schupbach J, 2007, PLOS MED, V4, P1921, DOI 10.1371/journal.pmed.0040343; Schupbach J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071662; Schupbach J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-88; Schupbach J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-254; SCHUPBACH J, 1985, NEW ENGL J MED, V312, P265, DOI 10.1056/NEJM198501313120502; UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, 2011, USE ASS REC INF EST, P1; WALTHER L, 1995, CLIN DIAGN VIROL, V4, P67, DOI 10.1016/0928-0197(94)00057-2; Welte A, 2010, EUROSURVEILLANCE, V15, P18	50	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0131828	10.1371/journal.pone.0131828	http://dx.doi.org/10.1371/journal.pone.0131828			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230082	gold, Green Published, Green Accepted			2022-12-27	WOS:000358838400010
J	Silvy, F; Bertin, D; Bardin, N; Auger, I; Guzian, MC; Mattei, JP; Guis, S; Roudier, J; Balandraud, N				Silvy, Florent; Bertin, Daniel; Bardin, Nathalie; Auger, Isabelle; Guzian, Marie-Caroline; Mattei, Jean-Pierre; Guis, Sandrine; Roudier, Jean; Balandraud, Nathalie			Antinuclear Antibodies in Patients with Psoriatic Arthritis Treated or Not with Biologics	PLOS ONE			English	Article							CITRULLINATED PEPTIDE ANTIBODIES; RHEUMATOID-ARTHRITIS; CLASSIFICATION CRITERIA; AUTOANTIBODY INDUCTION; CASPAR CRITERIA; INFLIXIMAB; SPONDYLOARTHRITIS; AUTOIMMUNITY	Background With the emergence of biotherapies, accurate diagnosis in early arthritis is needed. At this time, there is no biological marker of psoriatic arthritis. Objective To test whether antinuclear antibodies (ANA) can be used as a diagnostic tool in psoriatic arthritis (PsA), we evaluated the prevalence of ANA in biologic-naive PsA patients and in healthy blood donors. Methods 232 patients from the Rheumatology department, St Marguerite's Hospital, Marseilles, who fulfilled the CASPAR criteria for PsA, underwent clinical and laboratory investigations. Antinuclear antibodies (ANA), anti-extractable nuclear antigen antibodies (ENA), rheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA) were assayed. Ninety-one healthy blood donors were also tested. Results Detection of ANA by indirect immunofluorescence was significantly more frequent in sera from PsA patients than those from controls at serum dilution of 1: 100 (57% compared with 40%, Odds Ratio (OR) 1.98 (1.2-3.4) p<0.02) and 1: 160 (52% compared with 24%, OR 3,7 (1.9-7.2) p<0.001). No patients had lupus specific autoantibodies, 15% had RF (34/232), and 1.7% had ACPA (4/232). Conclusions Detection of ANA was more frequent in sera from PsA patients than in those from healthy controls. This suggests that ANA could be a diagnosis orientation tool in PsA. Nevertheless, the specificity of these antibodies still remains to be investigated.	[Silvy, Florent; Guzian, Marie-Caroline; Mattei, Jean-Pierre; Guis, Sandrine; Roudier, Jean; Balandraud, Nathalie] AP HM, IML, Rheumatol 1, F-13009 Marseille, France; [Bertin, Daniel; Bardin, Nathalie] Hop Conception, AP HM, Immunol Lab, Pole Biol, F-13005 Marseille, France; [Bardin, Nathalie] Aix Marseille Univ, INSERM UMRs 1076, UFR Pharm, F-13005 Marseille, France; [Auger, Isabelle; Roudier, Jean; Balandraud, Nathalie] Aix Marseille Univ, INSERM UMRs 1097, Immunogenet Lab, F-13288 Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Balandraud, N (corresponding author), AP HM, IML, Rheumatol 1, 270 Blvd St Marguerite, F-13009 Marseille, France.	nathalie.balandraud@ap-hm.fr	AUGER, ISABELLE/P-6294-2016; Balandraud, Nathalie/ABD-6012-2020; Bardin, Nathalie/AAL-3663-2020; roudier, jean/A-8654-2011	AUGER, ISABELLE/0000-0002-1414-8095; Balandraud, Nathalie/0000-0002-3839-0185; Bardin, Nathalie/0000-0003-3680-082X; roudier, jean/0000-0001-5435-8567				Bacquet-Deschryver H, 2008, J CLIN IMMUNOL, V28, P445, DOI 10.1007/s10875-008-9214-3; Bogliolo L, 2005, J RHEUMATOL, V32, P511; Brito FD, 2014, REV BRAS REUMATOL, V54, P13, DOI [10.1016/j.rbre.2014.02.001, 10.1016/j.rbr.2014.01.002]; Candia L, 2006, JCR-J CLIN RHEUMATOL, V12, P226, DOI 10.1097/rhu.0000242779.73390.51; Caspi D, 2006, ARTHRIT RHEUM-ARTHR, V55, P53, DOI 10.1002/art.21691; Chandran V, 2012, NAT REV RHEUMATOL, V8, P503, DOI 10.1038/nrrheum.2012.121; Chimenti MS, 2014, DRUG DEVELOP RES, V75, pS61, DOI 10.1002/ddr.21198; Dalmady S, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/474028; Feletar M, 2004, ANN RHEUM DIS, V63, P156, DOI 10.1136/ard.2003.006775; Hoffmann JHO, 2011, BRIT J DERMATOL, V165, P1355, DOI 10.1111/j.1365-2133.2011.10555.x; Inanc N, 2007, CLIN RHEUMATOL, V26, P17, DOI 10.1007/s10067-006-0214-5; Johnson SR, 2005, ANN RHEUM DIS, V64, P770, DOI 10.1136/ard.2004.031286; Li QZ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3271; Lora V, 2013, IMMUNOL RES, V56, P382, DOI 10.1007/s12026-013-8410-2; Maejima H, 2010, J DERMATOL, V37, P339, DOI 10.1111/j.1346-8138.2010.00814.x; Marchesoni A, 2006, J RHEUMATOL, V33, P435; Meroni PL, 2010, ANN RHEUM DIS, V69, P1420, DOI 10.1136/ard.2009.127100; Ouedraogo DD, 2007, CLIN EXP RHEUMATOL, V25, P930; Poulalhon N, 2007, BRIT J DERMATOL, V156, P329, DOI 10.1111/j.1365-2133.2006.07639.x; Saraceno R, 2013, J AM ACAD DERMATOL, V69, P314, DOI 10.1016/j.jaad.2013.03.020; Saraceno R, 2012, J AM ACAD DERMATOL, V66, pE180, DOI 10.1016/j.jaad.2011.06.008; Sellam J, 2005, JOINT BONE SPINE, V72, P48, DOI 10.1016/j.jbspin.2004.03.003; Shibata S, 2009, J DERMATOL SCI, V53, P34, DOI 10.1016/j.jdermsci.2008.06.008; Sonnichsen N, 1966, Dtsch Gesundheitsw, V21, P973; Tillett W, 2012, J RHEUMATOL, V39, P154, DOI 10.3899/jrheum.110845; Alonso JCT, 2010, REUMATOL CLIN, V6, P18, DOI 10.1016/j.reuma.2009.12.002; Vander Cruyssen B, 2005, ANN RHEUM DIS, V64, P1145, DOI 10.1136/ard.2004.032177; Viana VST, 2010, REV BRAS REUMATOL, V50, P230, DOI 10.1590/S0482-50042010000300003; Zeidler H, 2011, ANN RHEUM DIS, V70, P1, DOI 10.1136/ard.2010.135889	29	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134218	10.1371/journal.pone.0134218	http://dx.doi.org/10.1371/journal.pone.0134218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230924	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400085
J	Whittington, J; Sawaya, MA				Whittington, Jesse; Sawaya, Michael A.			A Comparison of Grizzly Bear Demographic Parameters Estimated from Non-Spatial and Spatial Open Population Capture-Recapture Models	PLOS ONE			English	Article							GLACIER NATIONAL-PARK; URSUS-ARCTOS; DENSITY-ESTIMATION; SURVIVAL; BLACK; SIZE; CONNECTIVITY; INFORMATION; ABUNDANCE; INFERENCE	Capture-recapture studies are frequently used to monitor the status and trends of wildlife populations. Detection histories from individual animals are used to estimate probability of detection and abundance or density. The accuracy of abundance and density estimates depends on the ability to model factors affecting detection probability. Non-spatial capture-recapture models have recently evolved into spatial capture-recapture models that directly include the effect of distances between an animal's home range centre and trap locations on detection probability. Most studies comparing non-spatial and spatial capture-recapture biases focussed on single year models and no studies have compared the accuracy of demographic parameter estimates from open population models. We applied open population non-spatial and spatial capture-recapture models to three years of grizzly bear DNA-based data from Banff National Park and simulated data sets. The two models produced similar estimates of grizzly bear apparent survival, per capita recruitment, and population growth rates but the spatial capture-recapture models had better fit. Simulations showed that spatial capture-recapture models produced more accurate parameter estimates with better credible interval coverage than non-spatial capture-recapture models. Non-spatial capture-recapture models produced negatively biased estimates of apparent survival and positively biased estimates of per capita recruitment. The spatial capture-recapture grizzly bear population growth rates and 95% highest posterior density averaged across the three years were 0.925 (0.786-1.071) for females, 0.844 (0.703-0.975) for males, and 0.882 (0.779-0.981) for females and males combined. The non-spatial capture-recapture population growth rates were 0.894 (0.758-1.024) for females, 0.825 (0.700-0.948) for males, and 0.863 (0.771-0.957) for both sexes. The combination of low densities, low reproductive rates, and predominantly negative population growth rates suggest that Banff National Park's population of grizzly bears requires continued conservation-oriented management actions.	[Whittington, Jesse] Banff Natl Pk Resource Conservat, Pk Canada, Banff, AB, Canada; [Sawaya, Michael A.] Sinopah Wildlife Res Assoc, Missoula, MT USA		Whittington, J (corresponding author), Banff Natl Pk Resource Conservat, Pk Canada, Banff, AB, Canada.	jesse.whittington@pc.gc.ca		Whittington, Jesse/0000-0002-4129-7491	Parks Canada; Western Transportation Institute at Montana State University; Woodcock Foundation; Henry P. Kendall Foundation; Wilburforce Foundation; National Fish and Wildlife Foundation; Alberta Conservation Association; Calgary Foundation; Mountain Equipment Cooperative	Parks Canada; Western Transportation Institute at Montana State University; Woodcock Foundation; Henry P. Kendall Foundation; Wilburforce Foundation; National Fish and Wildlife Foundation; Alberta Conservation Association; Calgary Foundation; Mountain Equipment Cooperative	Funding for this project was provided by Parks Canada, the Western Transportation Institute at Montana State University, the Woodcock Foundation, the Henry P. Kendall Foundation, and the Wilburforce Foundation. Additional support was provided by the National Fish and Wildlife Foundation, Alberta Conservation Association, Calgary Foundation, and the Mountain Equipment Cooperative.	Augustine BC, 2014, METHODS ECOL EVOL, V5, P1154, DOI 10.1111/2041-210X.12289; Blanc L, 2013, J WILDLIFE MANAGE, V77, P372, DOI 10.1002/jwmg.453; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Boulanger J, 2001, CAN J ZOOL, V79, P642, DOI 10.1139/cjz-79-4-642; Boulanger J, 2008, ECOL APPL, V18, P577, DOI 10.1890/06-1941.1; Boulanger J, 2013, WILDLIFE BIOL, V19, P274, DOI 10.2981/12-088; Canada Parks, 2010, BANFF NAT PARK CAN M; Chandler RB, 2013, ANN APPL STAT, V7, P936, DOI 10.1214/12-AOAS610; Clevenger AP, 2010, ECOL SOC, V15; Efford MG, 2014, ECOLOGY, V95, P1341, DOI 10.1890/13-1497.1; Efford MG, 2013, METHODS ECOL EVOL, V4, P629, DOI 10.1111/2041-210X.12049; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; Efford MG, 2011, ECOLOGY, V92, P2202, DOI 10.1890/11-0332.1; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Festa- Bianchet M., 2010, STATUS GRIZZLY BEAR; Gardner B, 2013, METHODS ECOLOGY EVOL; Gardner B, 2010, ECOLOGY, V91, P3376, DOI 10.1890/09-0804.1; Gardner B, 2010, J WILDLIFE MANAGE, V74, P318, DOI 10.2193/2009-101; Gardner B, 2009, ECOLOGY, V90, P1106, DOI 10.1890/07-2112.1; Garshelis DL, 2005, J WILDLIFE MANAGE, V69, P277, DOI 10.2193/0022-541X(2005)069<0277:GBDIAA>2.0.CO;2; Gerber B., 2011, POPULATION ECOLOGY, V54, P1; Gerber BD, 2015, ECOL APPL, V25, P695, DOI 10.1890/14-0960.1; Gibeau ML, 2002, BIOL CONSERV, V103, P227, DOI 10.1016/S0006-3207(01)00131-8; Graves TA, 2011, ANIM CONSERV, V14, P652, DOI 10.1111/j.1469-1795.2011.00471.x; Graves TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049410; Herrero S., 2005, BIOL DEMOGRAPHY ECOL; Holland W. D., 1983, ECOLOGICAL BIOPHYSIC; Howe EJ, 2013, POPULATION ECOLOGY, P1; Ivan JS, 2013, ECOLOGY, V94, P817, DOI 10.1890/12-0102.1; Ivan JS, 2013, ECOLOGY, V94, P809, DOI 10.1890/12-0101.1; Johnson CJ, 2004, J WILDLIFE MANAGE, V68, P966, DOI 10.2193/0022-541X(2004)068[0966:MSAOTA]2.0.CO;2; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Kellner K, 2015, JAGSUI WRAPPER RJAGS; Kendall KC, 2008, J WILDLIFE MANAGE, V72, P1693, DOI 10.2193/2008-007; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kruschke J. K, 2010, DOING BAYESIAN DATA; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Mowat G, 2005, WILDLIFE BIOL, V11, P31, DOI 10.2981/0909-6396(2005)11[31:GUAABB]2.0.CO;2; Mowat G, 2000, J WILDLIFE MANAGE, V64, P183, DOI 10.2307/3802989; Nielsen SE, 2004, BIOL CONSERV, V120, P101, DOI 10.1016/j.biocon.2004.02.020; Plummer M., 2003, P 3 INT WORKSH DISTR; Proctor MF, 2012, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.6; R Development Core Team, 2015, LANG ENV STAT COMP; Raabe J., 2013, CANADIAN J FISHERIES, V130, P120; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Royle JA, 2007, J COMPUT GRAPH STAT, V16, P67, DOI 10.1198/106186007X181425; Royle JA, 2013, METHODS ECOL EVOL, V4, P520, DOI 10.1111/2041-210X.12039; Royle JA, 2013, ECOLOGY, V94, P287, DOI 10.1890/12-0413.1; Royle JA, 2011, J WILDLIFE MANAGE, V75, P604, DOI 10.1002/jwmg.79; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Sawaya MA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.1705; Sawaya MA, 2013, CONSERV BIOL, V27, P721, DOI 10.1111/cobi.12075; Sawaya MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034777; Schaub M, 2014, METHODS ECOL EVOL, V5, P1316, DOI 10.1111/2041-210X.12134; Schwartz CC, 2012, WILDLIFE BIOL, V18, P246, DOI 10.2981/11-060; Schwartz CC, 2010, J WILDLIFE MANAGE, V74, P654, DOI 10.2193/2009-206; SEBER GAF, 1965, BIOMETRIKA, V52, P249; Sharma RK, 2010, ANIM CONSERV, V13, P94, DOI 10.1111/j.1469-1795.2009.00305.x; Sollmann R, 2013, J APPL ECOL, V50, P961, DOI 10.1111/1365-2664.12098; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Stetz JB, 2014, WILDLIFE SOC B, V38, P60, DOI 10.1002/wsb.356; Stetz JB, 2010, J WILDLIFE MANAGE, V74, P860, DOI 10.2193/2008-435; Sutherland C, 2015, METHODS ECOL EVOL, V6, P169, DOI 10.1111/2041-210X.12316; Woods JG, 1999, WILDLIFE SOC B, V27, P616	65	34	34	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134446	10.1371/journal.pone.0134446	http://dx.doi.org/10.1371/journal.pone.0134446			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230262	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400121
J	Pfaff, A; Robalino, J; Herrera, D; Sandoval, C				Pfaff, Alexander; Robalino, Juan; Herrera, Diego; Sandoval, Catalina			Protected Areas' Impacts on Brazilian Amazon Deforestation: Examining Conservation - Development Interactions to Inform Planning	PLOS ONE			English	Article							RESERVE SELECTION; CONSERVING BIODIVERSITY; FOREST LOSS; LOCATION; PARKS; NETWORKS; PRESSURE; COVER; BIRDS	Protected areas are the leading forest conservation policy for species and ecoservices goals and they may feature in climate policy if countries with tropical forest rely on familiar tools. For Brazil's Legal Amazon, we estimate the average impact of protection upon deforestation and show how protected areas' forest impacts vary significantly with development pressure. We use matching, i.e., comparisons that are apples-to-apples in observed land characteristics, to address the fact that protected areas (PAs) tend to be located on lands facing less pressure. Correcting for that location bias lowers our estimates of PAs' forest impacts by roughly half. Further, it reveals significant variation in PA impacts along development-related dimensions: for example, the PAs that are closer to roads and the PAs closer to cities have higher impact. Planners have multiple conservation and development goals, and are constrained by cost, yet still conservation planning should reflect what our results imply about future impacts of PAs.	[Pfaff, Alexander; Herrera, Diego] Duke Univ, Durham, NC 27708 USA; [Robalino, Juan; Sandoval, Catalina] Ctr Agron Trop Invest & Ensenanza, Turrialba, Costa Rica; [Robalino, Juan] Univ Gothenburg, Environm Dev Initiat EfD, Gothenburg, Sweden	Duke University; CATIE - Centro Agronomico Tropical de Investigacion y Ensenanza; University of Gothenburg	Pfaff, A (corresponding author), Duke Univ, Durham, NC 27708 USA.	alex.pfaff@duke.edu		Robalino, Juan/0000-0003-1450-7382	World Bank; Interamerican Development Bank; Inter-American Institute for Global Change Research; Tinker Foundation; NASA LBA (Walker Reis project); Swedish International Development Cooperation Agency (Sida) through the Environment for Development Initiative (EfD)	World Bank(The World Bank India); Interamerican Development Bank; Inter-American Institute for Global Change Research; Tinker Foundation; NASA LBA (Walker Reis project); Swedish International Development Cooperation Agency (Sida) through the Environment for Development Initiative (EfD)	For financial support for various efforts that contributed to this paper we thank many funders: the World Bank, Interamerican Development Bank, Inter-American Institute for Global Change Research, the Tinker Foundation, NASA LBA (Walker & Reis project) and Swedish International Development Cooperation Agency (Sida) through the Environment for Development Initiative (EfD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Camm JD, 2002, OPER RES, V50, P946, DOI 10.1287/opre.50.6.946.351; Campbell A., 2008, BIODIVERSITY, V9, P117, DOI [10.1080/14888386.2008.9712916, DOI 10.1080/14888386.2008.9712916]; Carr DL, 2006, J LAT AM GEOGR, V5, P97, DOI 10.1353/lag.2006.0002; Church RL, 1996, BIOL CONSERV, V76, P105, DOI 10.1016/0006-3207(95)00102-6; COCKS KD, 1989, BIOL CONSERV, V49, P113, DOI 10.1016/0006-3207(89)90083-9; Csuti B, 1997, BIOL CONSERV, V80, P83, DOI 10.1016/S0006-3207(96)00068-7; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; DELGADO C, 2008, NASA LBA C AM PERSP; FEARNSIDE PM, 1995, CONSERV BIOL, V9, P1134, DOI 10.1046/j.1523-1739.1995.9051127.x-i1; Fuller DO, 2004, CONSERV BIOL, V18, P249, DOI 10.1111/j.1523-1739.2004.00018.x; Gaveau DLA, 2007, BIOL CONSERV, V134, P495, DOI 10.1016/j.biocon.2006.08.035; GEHLBACH F R, 1975, Biological Conservation, V8, P79, DOI 10.1016/0006-3207(75)90033-6; HUNTER ML, 1993, CONSERV BIOL, V7, P420, DOI 10.1046/j.1523-1739.1993.07020420.x; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Joppa L, 2010, ANN NY ACAD SCI, V1185, P135, DOI 10.1111/j.1749-6632.2009.05162.x; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; KIRKPATRICK JB, 1983, BIOL CONSERV, V25, P127, DOI 10.1016/0006-3207(83)90056-3; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Mena CF, 2006, WORLD DEV, V34, P1831, DOI 10.1016/j.worlddev.2006.02.009; Messina JP, 2006, APPL GEOGR, V26, P113, DOI 10.1016/j.apgeog.2005.11.003; Nagendra H, 2008, AMBIO, V37, P330, DOI 10.1579/06-R-184.1; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Nolte C, 2013, P NATL ACAD SCI USA, V110, P4956, DOI 10.1073/pnas.1214786110; Oliveira PJC, 2007, SCIENCE, V317, P1233, DOI 10.1126/science.1146324; Pearce D, 2005, WORLD ECON, V6, P57; Pfaff A, 2015, CAN ROAD LOCAT UNPUB; Pfaff A, 2014, WORLD DEV, V55, P7, DOI 10.1016/j.worlddev.2013.01.011; Pfaff A, 2012, OXFORD REV ECON POL, V28, P164, DOI 10.1093/oxrep/grs012; Pfaff A, 2009, BE J ECON ANAL POLI, V9, DOI 10.2202/1935-1682.1990; Pfaff ASP, 2004, RESOUR ENERGY ECON, V26, P237, DOI 10.1016/j.reseneeco.2003.11.009; Polasky S, 2000, BIOL CONSERV, V94, P1, DOI 10.1016/S0006-3207(99)00171-8; Powell GVN, 2000, BIOL CONSERV, V93, P35, DOI 10.1016/S0006-3207(99)00115-9; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sader SA, 2001, INT J REMOTE SENS, V22, P1937, DOI 10.1080/01431160152043649; SAETERSDAL M, 1993, BIOL CONSERV, V66, P131, DOI 10.1016/0006-3207(93)90144-P; Sanchez-Azofeifa GA, 1999, CONSERV BIOL, V13, P407, DOI 10.1046/j.1523-1739.1999.013002407.x; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; TUBBS C R, 1971, Biological Conservation, V3, P169, DOI 10.1016/0006-3207(71)90159-5; WILLIAMS G, 1980, BIOL CONSERV, V18, P93, DOI 10.1016/0006-3207(80)90074-9	46	87	88	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0129460	10.1371/journal.pone.0129460	http://dx.doi.org/10.1371/journal.pone.0129460			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225922	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700002
J	Song, YC; Sanganahalli, BG; Hyder, F; Lin, WC; Riera, JJ				Song, Yinchen; Sanganahalli, Basavaraju G.; Hyder, Fahmeed; Lin, Wei-Chiang; Riera, Jorge J.			Distributions of Irritative Zones Are Related to Individual Alterations of Resting-State Networks in Focal Epilepsy	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; TONIC-CLONIC SEIZURES; CORTICAL DYSPLASIA; FUNCTIONAL CONNECTIVITY; GRANGER CAUSALITY; BOLD-FMRI; EEG-FMRI; RAT MODEL; DISCHARGES; SPIKE	Alterations in the connectivity patterns of the fMRI-based resting-state networks (RSNs) have been reported in several types of epilepsies. Evidence pointed out these alterations might be associated with the genesis and propagation of interictal epileptiform discharges (IEDs). IEDs also evoke blood-oxygen-level dependent (BOLD) responses, which have been used to delineate irritative zones during preoperative work-up. Therefore, one may expect a relationship between the topology of the IED-evoked BOLD response network and the altered spatial patterns of the RSNs. In this study, we used EEG recordings and fMRI data obtained simultaneously from a chronic model of focal epilepsy in Wistar rats to verify our hypothesis. We found that IED-evoked BOLD response networks comprise both cortical and subcortical structures with a rat-dependent topology. In all rats, IEDs evoke both activation and deactivation types of BOLD responses. Using a Granger causality method, we found that in many cases areas with BOLD deactivation have directed influences on areas with activation (p<0.05). We were able to predict topological properties (i.e., focal/diffused, unilateral/bilateral) of the IED-evoked BOLD response network by performing hierarchical clustering analysis on major spatial features of the RSNs. All these results suggest that IEDs and disruptions in the RSNs found previously in humans may be different manifestations of the same transient events, probably reflecting altered consciousness. In our opinion, the shutdown of specific nodes of the default mode network may cause uncontrollable excitability in other functionally connected brain areas. We conclude that IED-evoked BOLD responses (i.e., activation and deactivation) and alterations of RSNs are intrinsically related, and speculate that an understanding of their interplay is necessary to discriminate focal epileptogenesis and network propagation phenomena across different brain modules via hub-based connectivity.	[Song, Yinchen; Lin, Wei-Chiang; Riera, Jorge J.] Florida Int Univ, Dept Biomed Engn, Miami, FL 33199 USA; [Sanganahalli, Basavaraju G.; Hyder, Fahmeed] Yale Univ, Magnet Resonance Res Ctr, New Haven, CT USA	State University System of Florida; Florida International University; Yale University	Riera, JJ (corresponding author), Florida Int Univ, Dept Biomed Engn, Miami, FL 33199 USA.	jrieradi@fiu.edu	Riera, J/ABB-8551-2020; Song, Yinchen/K-5874-2019; Sanganahalli, Basavaraju G/C-3296-2008	Riera, J/0000-0001-8530-8431; Sanganahalli, Basavaraju G/0000-0002-0851-6621; Song, Yinchen/0000-0001-5820-0353	Florida International University start-up package	Florida International University start-up package	This work was supported by Florida International University start-up package to JJR.	Aghakhani Y, 2004, BRAIN, V127, P1127, DOI 10.1093/brain/awh136; Airaksinen AM, 2012, EPILEPSIA, V53, P1245, DOI 10.1111/j.1528-1167.2012.03539.x; Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Alonso-Nanclares L, 2005, BRAIN, V128, P158, DOI 10.1093/brain/awh331; Bae J, 2015, JOVE-J VIS EXP, DOI 10.3791/52700; Battaglia G, 2013, EPILEPSIA, V54, P33, DOI 10.1111/epi.12272; Bergstrom RA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01483; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Blumcke I, 2009, EPILEPTIC DISORD, V11, P181, DOI 10.1684/epd.2009.0261; Caballero-Gaudes C, 2013, NEUROIMAGE, V68, P248, DOI 10.1016/j.neuroimage.2012.12.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cepeda C, 2003, J NEUROSCI RES, V72, P472, DOI 10.1002/jnr.10604; Charara A, 2013, 29 SO BIOM ENG C; Chowdhury FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110136; Colacitti C, 1999, J NEUROPATH EXP NEUR, V58, P92, DOI 10.1097/00005072-199901000-00010; Colciaghi F, 2011, BRAIN, V134, P2828, DOI 10.1093/brain/awr045; Colombo N, 2003, AM J NEURORADIOL, V24, P724; Cui ZG, 2011, J CLIN NEUROSCI, V18, P404, DOI 10.1016/j.jocn.2010.05.035; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; DeSalvo MN, 2010, NEUROIMAGE, V50, P902, DOI 10.1016/j.neuroimage.2010.01.006; Englot DJ, 2008, J NEUROSCI, V28, P9066, DOI 10.1523/JNEUROSCI.2014-08.2008; Englot DJ, 2009, J NEUROSCI, V29, P13006, DOI 10.1523/JNEUROSCI.3846-09.2009; Fahoum F, 2012, EPILEPSIA, V53, P1618, DOI 10.1111/j.1528-1167.2012.03533.x; Fauser S, 2006, BRAIN, V129, P1907, DOI 10.1093/brain/awl133; Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; Gotman J, 2008, EPILEPSIA, V49, P42, DOI 10.1111/j.1528-1167.2008.01509.x; Grouiller F, 2011, BRAIN, V134, P2867, DOI 10.1093/brain/awr156; Hamandi K, 2008, NEUROIMAGE, V39, P608, DOI 10.1016/j.neuroimage.2007.07.009; Jacobs J, 2007, EPILEPSIA, V48, P2068, DOI 10.1111/j.1528-1167.2007.01192.x; Ji GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063183; Jonckers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018876; Kabat J, 2012, POL J RADIOL, V77, P35, DOI 10.12659/PJR.882968; Keogh BP, 2005, EPILEPSY RES, V66, P75, DOI 10.1016/j.eplepsyres.2005.07.008; Kobayashi E, 2006, EPILEPSIA, V47, P343, DOI 10.1111/j.1528-1167.2006.00427.x; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Lerner JT, 2009, EPILEPSIA, V50, P1310, DOI 10.1111/j.1528-1167.2008.01998.x; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Lin JJ, 2007, CEREB CORTEX, V17, P2007, DOI 10.1093/cercor/bhl109; Lu HB, 2012, P NATL ACAD SCI USA, V109, P3979, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Lui S, 2008, J MAGN RESON IMAGING, V27, P1214, DOI 10.1002/jmri.21370; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; Luo C, 2010, EPILEPSY RES, V91, P133, DOI 10.1016/j.eplepsyres.2010.07.003; Luo Q, 2013, NEUROIMAGE, V79, P241, DOI 10.1016/j.neuroimage.2013.04.091; Marin-Padilla M, 2003, J NEUROPATH EXP NEUR, V62, P1129, DOI 10.1093/jnen/62.11.1129; Mishra AM, 2011, J NEUROSCI, V31, P15053, DOI 10.1523/JNEUROSCI.0101-11.2011; Moeller F, 2013, EPILEPSIA, V54, pE103, DOI 10.1111/epi.12243; Murta T, 2012, NEUROIMAGE, V62, P1634, DOI 10.1016/j.neuroimage.2012.05.053; Ndode-Ekane XE, 2010, NEUROSCIENCE, V166, P312, DOI 10.1016/j.neuroscience.2009.12.002; Nersesyan H, 2004, J CEREBR BLOOD F MET, V24, P589, DOI 10.1097/01.WCB.0000117688.98763.23; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pedreira C, 2014, NEUROIMAGE, V99, P461, DOI 10.1016/j.neuroimage.2014.05.009; Pittau F, 2012, NEUROLOGY, V78, P1479, DOI 10.1212/WNL.0b013e3182553bf7; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Roebroeck A, 2011, NEUROIMAGE, V58, P296, DOI 10.1016/j.neuroimage.2009.09.036; Schmidt H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003947; Schridde U, 2008, CEREB CORTEX, V18, P1814, DOI 10.1093/cercor/bhm208; Seth AK, 2013, NEUROIMAGE, V65, P540, DOI 10.1016/j.neuroimage.2012.09.049; Song J, 2015, BRAIN CONNECT, V5, P276, DOI 10.1089/brain.2014.0308; Song Y, 2015, IEEE T BIOMEDICAL EN; Spreafico R, 2010, ACTA NEUROPATHOL, V120, P359, DOI 10.1007/s00401-010-0714-x; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Szaflarski JP, 2010, EPILEPSY BEHAV, V18, P404, DOI 10.1016/j.yebeh.2010.05.009; Tenney JR, 2004, EPILEPSIA, V45, P576, DOI 10.1111/j.0013-9580.2004.39303.x; Terry JR, 2012, EPILEPSIA, V53, pe166, DOI 10.1111/j.1528-1167.2012.03560.x; Thornton R, 2011, ANN NEUROL, V70, P822, DOI 10.1002/ana.22535; Valdes-Hernandez PA, 2011, FRONTIERS NEUROINFOR, V5; van den Heuvel MP, 2016, BRAIN STRUCT FUNCT, V221, P1719, DOI 10.1007/s00429-015-0999-6; van Diessen E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114606; van Luijtelaar G, 2013, NEUROBIOL DIS, V60, P126, DOI 10.1016/j.nbd.2013.08.013; van Meer MPA, 2012, J NEUROSCI, V32, P4495, DOI 10.1523/JNEUROSCI.3662-11.2012; Vulliemoz S, 2009, NEUROIMAGE, V46, P834, DOI 10.1016/j.neuroimage.2009.01.070; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223; Zhang ZQ, 2009, J NEUROL, V256, P1705, DOI 10.1007/s00415-009-5187-2; Zhang ZQ, 2009, NEUROSCI LETT, V458, P97, DOI 10.1016/j.neulet.2009.04.040	84	13	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134352	10.1371/journal.pone.0134352	http://dx.doi.org/10.1371/journal.pone.0134352			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226628	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700077
J	Trombetta, B; D'Atanasio, E; Massaia, A; Myres, NM; Scozzari, R; Cruciani, F; Novelletto, A				Trombetta, Beniamino; D'Atanasio, Eugenia; Massaia, Andrea; Myres, Natalie M.; Scozzari, Rosaria; Cruciani, Fulvio; Novelletto, Andrea			Regional Differences in the Accumulation of SNPs on the Male-Specific Portion of the Human Y Chromosome Replicate Autosomal Patterns: Implications for Genetic Dating	PLOS ONE			English	Article							MUTATION-RATE; SEQUENCE; CONVERSION; HISTORY; RATES; TIME; AGE	Factors affecting the rate and pattern of the mutational process are being identified for human autosomes, but the same relationships for the male specific portion of the Y chromosome (MSY) are not established. We considered 3,390 mutations occurring in 19 sequence bins identified by sequencing 1.5 Mb of the MSY from each of 104 present-day chromosomes. The occurrence of mutations was not proportional to the amount of sequenced bases in each bin, with a 2-fold variation. The regression of the number of mutations per unit sequence against a number of indicators of the genomic features of each bin, revealed the same fundamental patterns as in the autosomes. By considering the sequences of the same region from two precisely dated ancient specimens, we obtained a calibrated region-specific substitution rate of 0.716 x 10(-9)/site/year. Despite its lack of recombination and other peculiar features, the MSY then resembles the autosomes in displaying a marked regional heterogeneity of the mutation rate. An immediate implication is that a given figure for the substitution rate only makes sense if bound to a specific DNA region. By strictly applying this principle we obtained an unbiased estimate of the antiquity of lineages relevant to the genetic history of the human Y chromosome. In particular, the two deepest nodes of the tree highlight the survival, in Central-Western Africa, of lineages whose coalescence (291 ky, 95% C.I. 253-343) predates the emergence of anatomically modern features in the fossil record.	[Trombetta, Beniamino; D'Atanasio, Eugenia; Massaia, Andrea; Scozzari, Rosaria; Cruciani, Fulvio] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol C Darwin, I-00185 Rome, Italy; [Myres, Natalie M.] AncestryDNA, Provo, UT USA; [Cruciani, Fulvio] CNR, Ist Biol & Patol Mol, Rome, Italy; [Novelletto, Andrea] Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); University of Rome Tor Vergata	Cruciani, F (corresponding author), Univ Roma La Sapienza, Dipartimento Biol & Biotecnol C Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	fulvio.cruciani@uniroma1.it; novelletto@bio.uniroma2.it	D'ATANASIO, EUGENIA/AAX-8157-2020	D'ATANASIO, EUGENIA/0000-0002-4965-246X; Trombetta, Beniamino/0000-0001-8245-9437; Novelletto, Andrea/0000-0002-1146-7680; Cruciani, Fulvio/0000-0002-6900-024X	Italian Ministry of Education [2012JA4BTY_004, 2012JA4BTY_003]; Sapienza University of Rome [C26A13S9AR]; AncestryDNA	Italian Ministry of Education; Sapienza University of Rome; AncestryDNA	This work was supported by the Italian Ministry of Education (http://www.istruzione.it), Progetti PRIN (grant numbers 2012JA4BTY_004 to F.C. and 2012JA4BTY_003 to A. N.) and by Sapienza University of Rome (http://www.uniroma1.it) (grant number C26A13S9AR to F.C). AncestryDNA provided support in the form of salaries for author N.M.M., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Batini C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8152; Boone JL, 2002, WORLD ARCHAEOL, V34, P6, DOI 10.1080/00438240220134232; Cruciani F, 2010, AM J HUM GENET, V86, P495, DOI 10.1016/j.ajhg.2010.01.033; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Elango N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000015; Elhaik E, 2014, EUR J HUM GENET, V1-6; Elhaik E, 2015, EUR J HUM GENET, V23, P567, DOI 10.1038/ejhg.2014.227; Francalacci P, 2013, SCIENCE, V341, P565, DOI 10.1126/science.1237947; Francioli LC, 2015, NAT GENET; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Hallast P, 2015, MOL BIOL EVOL, V32, P661, DOI 10.1093/molbev/msu327; Hamilton MJ, 2009, P NATL ACAD SCI USA, V106, P12255, DOI 10.1073/pnas.0905708106; Helgason A, 2015, NAT GENET; Hellmann I, 2005, GENOME RES, V15, P1222, DOI 10.1101/gr.3461105; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Hodgkinson A, 2009, PLOS BIOL, V7, P226, DOI 10.1371/journal.pbio.1000027; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Karmin M, 2015, GENOME RES, V25, P459, DOI 10.1101/gr.186684.114; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Lippold Sebastian, 2014, Investig Genet, V5, P13, DOI 10.1186/2041-2223-5-13; Makova KD, 2015, NAT REV GENET, V16, P213, DOI 10.1038/nrg3890; Mendez FL, 2013, AM J HUM GENET, V92, P454, DOI 10.1016/j.ajhg.2013.02.002; Mendez FL, 2014, EUR J HUM GENET; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Montano V, 2011, MOL ECOL, V20, P2693, DOI 10.1111/j.1365-294X.2011.05130.x; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Niederstatter H, 2013, FORENSIC SCI INT-GEN, V7, P593, DOI 10.1016/j.fsigen.2013.05.010; O'Fallon B, 2013, GENETICS, V194, P485, DOI 10.1534/genetics.113.152074; Poznik GD, 2013, SCIENCE, V341, P562, DOI 10.1126/science.1237619; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Rito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080031; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rosser ZH, 2009, AM J HUM GENET, V85, P130, DOI 10.1016/j.ajhg.2009.06.009; Rowley-Conwy P, 2011, CURR ANTHROPOL, V52, pS431, DOI 10.1086/658368; Rozen S, 2009, AM J HUM GENET, V85, P923, DOI 10.1016/j.ajhg.2009.11.011; Sayres MAW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004064; Schaibley VM, 2013, GENOME RES, V23, P1974, DOI 10.1101/gr.154971.113; Scozzari R, 2014, GENOME RES, V24, P535, DOI 10.1101/gr.160788.113; Segurel L, 2014, ANNU REV GENOM HUM G, V15, P47, DOI 10.1146/annurev-genom-031714-125740; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trombetta B, 2015, GENOME BIOL EVOL; Trombetta B, 2014, MOL BIOL EVOL, V31, P2108, DOI 10.1093/molbev/msu155; Trombetta B, 2010, MOL BIOL EVOL, V27, P714, DOI 10.1093/molbev/msp231; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2015, EUR J HUM GENET, V23, P124, DOI 10.1038/ejhg.2014.50; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; van Oven M, 2014, HUM MUTAT, V35, P187, DOI 10.1002/humu.22468; Wang CC, 2015, INVESTIG GENET, V6, DOI [10.1186/s13323-015-0025-z, 10.1186/2041-2223-5-12]; Weddington N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-530; Wei W, 2013, GENOME RES, V23, P388, DOI 10.1101/gr.143198.112; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; Zhivotovsky LA, 2006, MOL BIOL EVOL, V23, P2268, DOI 10.1093/molbev/msl105	65	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134646	10.1371/journal.pone.0134646	http://dx.doi.org/10.1371/journal.pone.0134646			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226630	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700127
J	Zhang, P; Ha, T; Larouche, M; Swanson, D; Goldowitz, D				Zhang, Peter; Ha, Thomas; Larouche, Matt; Swanson, Douglas; Goldowitz, Dan			Kruppel-Like Factor 4 Regulates Granule Cell Pax6 Expression and Cell Proliferation in Early Cerebellar Development	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GOBLET CELLS; KLF4; TRANSCRIPTION; CANCER; MOUSE; GENE; ROLES; MATH1; KRUPPEL-LIKE-FACTOR-4	Kruppel-like factor 4 (Klf4) is a transcription factor that regulates many important cellular processes in stem cell biology, cancer, and development. We used histological and molecular methods to study the expression of Klf4 in embryonic development of the normal and Klf4 knockout cerebellum. We find that Klf4 is expressed strongly in early granule cell progenitor development but tails-off considerably by the end of embryonic development. Klf4 is also co-expressed with Pax6 in these cells. In the Klf4-null mouse, which is perinatal lethal, Klf4 positively regulates Pax6 expression and regulates the proliferation of neuronal progenitors in the rhombic lip, external granular layer and the neuroepithelium. This paper is the first to describe a role for Klf4 in the cerebellum and provides insight into this gene's function in neuronal development.	[Zhang, Peter; Ha, Thomas; Larouche, Matt; Swanson, Douglas; Goldowitz, Dan] Univ British Columbia, Dept Med Genet, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada	Child & Family Research Institute; University of British Columbia	Goldowitz, D (corresponding author), Univ British Columbia, Dept Med Genet, Child & Family Res Inst, Ctr Mol Med & Therapeut, 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	dang@cmmt.ubc.ca		Goldowitz, Daniel/0000-0003-4756-4017	National Institutes of Health; Natural Sciences and Engineering Research Council of Canada; NeuroDevNet; University of British Columbia	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NeuroDevNet; University of British Columbia	We thank A. Poon, J. Yeung, J. Cairns, S. Tremblay, J. Wilking for support and suggestions on experimental design and manuscript preparation. We thank F. Lucero Villegas for animal management. We thank D. Rains and J. Boyle for technical support. We thank National Institutes of Health, Natural Sciences and Engineering Research Council of Canada, NeuroDevNet and University of British Columbia for funding.	Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Ha T, 2015, DEV BIOL, V397, P18, DOI 10.1016/j.ydbio.2014.09.032; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Huang CC, 2005, CANCER BIOL THER, V4, P1401, DOI 10.4161/cbt.4.12.2355; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Katz JP, 2002, DEVELOPMENT, V129, P2619; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Nakahara Y, NEOPLASIA NEW YORK N, V12, P20; Palin K, 2006, NAT PROTOC, V1, P368, DOI 10.1038/nprot.2006.56; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; PIERCE E T, 1975, Brain Research, V95, P503, DOI 10.1016/0006-8993(75)90124-9; Qin S, 2012, MOL CELL BIOL, V32, P4297, DOI 10.1128/MCB.00838-12; Qin S, 2011, P NATL ACAD SCI USA, V108, P21117, DOI 10.1073/pnas.1112351109; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Seto Y, 2014, NATURE COMMUNICATION, V5; Swamynathan SK, 2008, INVEST OPHTH VIS SCI, V49, P3360, DOI 10.1167/iovs.08-1811; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Swanson DJ, 2005, DEV BRAIN RES, V160, P176, DOI 10.1016/j.devbrainres.2005.09.005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Yamanaka S, 2008, CELL PROLIFERAT, V41, P51, DOI 10.1111/j.1365-2184.2008.00493.x; Yamasaki T, 2001, DEVELOPMENT, V128, P3133; Yang YZ, 2005, CANCER BIOL THER, V4, P1216, DOI 10.4161/cbt.4.11.2090; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006	36	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134390	10.1371/journal.pone.0134390	http://dx.doi.org/10.1371/journal.pone.0134390			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226504	gold, Green Published, Green Submitted			2022-12-27	WOS:000358837700086
J	Rabelo, ALA; Keller, VN; Pilati, R; Wicherts, JM				Rabelo, Andre L. A.; Keller, Victor N.; Pilati, Ronaldo; Wicherts, Jelte M.			No Effect of Weight on Judgments of Importance in the Moral Domain and Evidence of Publication Bias from a Meta-Analysis	PLOS ONE			English	Article							DISGUST; RECOMMENDATIONS; EMBODIMENT; PERCEPTION	In different cultures, people use the concept of weight to refer to important matters. Recent studies in grounded cognition suggested that experiences of weight affect unrelated judgments of importance in metaphor-congruent ways. Theories in grounded cognition and prime-to-behavior effects state that sensations of weight activate concepts of importance, which may affect morality-related variables that are influenced by judgments of importance. The present research aimed to test the effect of carrying a heavy (or light) clipboard on the perceived importance of helping and on the judged severity of moral transgressions. After finding no significant effects in two experiments, a third study explored whether these results were due to a specific lack of effect of weight on morality-related variables or to the concept of importance not being grounded in sensations of weight in Brazilian samples. Specifically, in Study 3 we attempted to replicate two seminal studies but found no significant effects. Together with evidence of publication bias in a meta-analysis of published studies, the current results suggest that the concept of importance may not be as universally grounded in sensations of weight as previously assumed. We discuss the implications of these results for grounded cognition theories and methodological and statistical aspects of priming studies.	[Rabelo, Andre L. A.; Keller, Victor N.; Pilati, Ronaldo] Univ Brasilia, Dept Work & Social Psychol, Brasilia, DF, Brazil; [Wicherts, Jelte M.] Tilburg Univ, Dept Methodol & Stat, NL-5000 LE Tilburg, Netherlands	Universidade de Brasilia; Tilburg University	Rabelo, ALA (corresponding author), Univ Brasilia, Dept Work & Social Psychol, Brasilia, DF, Brazil.	andreluiz.arabelo@gmail.com	Wicherts, Jelte M./A-2664-2008; Pilati, Ronaldo/O-7435-2019	Wicherts, Jelte M./0000-0003-2415-2933; Pilati, Ronaldo/0000-0003-2982-5033	National Council of Technological and Scientific Development (CNPq) of Brazil	National Council of Technological and Scientific Development (CNPq) of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by the National Council of Technological and Scientific Development (CNPq) of Brazil. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JM, 2010, SCIENCE, V328, P1712, DOI 10.1126/science.1189993; Alban MW, 2013, J EXP PSYCHOL LEARN, V39, P1628, DOI 10.1037/a0032420; American Psychological Association, 2012, GUID ETH COND BEH PR; Asendorpf JB, 2013, EUR J PERSONALITY, V27, P108, DOI 10.1002/per.1919; Bakker M, 2012, PERSPECT PSYCHOL SCI, V7, P543, DOI 10.1177/1745691612459060; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Champely S., 2012, PWR BASIC FUNCTIONS; Chandler JJ, 2012, J EXP SOC PSYCHOL, V48, P948, DOI 10.1016/j.jesp.2012.03.003; Eskine KJ, 2011, PSYCHOL SCI, V22, P295, DOI 10.1177/0956797611398497; Fanelli D, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001563; Francis G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114255; Funder DC, 2014, PERS SOC PSYCHOL REV, V18, P3, DOI 10.1177/1088868313507536; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Hafner M, 2013, EXP PSYCHOL, V60, P1; Hambleton R.K., 2011, CROSS CULTURAL RES M, P46, DOI DOI 10.1017/CBO9780511779381.004; IJzerman H, 2013, SOC SCI RES NETW; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jostmann NB, 2009, PSYCHOL SCI, V20, P1169, DOI 10.1111/j.1467-9280.2009.02426.x; Kaspar K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078307; Kaspar K, 2013, J NONVERBAL BEHAV, V37, P165, DOI 10.1007/s10919-013-0154-0; Koole SL, 2012, PERSPECT PSYCHOL SCI, V7, P608, DOI 10.1177/1745691612462586; Kouchaki M, 2014, J EXP PSYCHOL GEN, V143, P414, DOI 10.1037/a0031769; Lakens D, 2014, SOC COGNITION, V32, P168, DOI 10.1521/soco.2014.32.supp.168; Landau MJ, 2010, PSYCHOL BULL, V136, P1045, DOI 10.1037/a0020970; Leung AKY, 2011, SOC PERSONAL PSYCHOL, V5, P591, DOI 10.1111/j.1751-9004.2011.00373.x; Loersch C, 2014, SOC COGNITION, V32, P137, DOI 10.1521/soco.2014.32.supp.137; Loersch C, 2011, PERSPECT PSYCHOL SCI, V6, P234, DOI 10.1177/1745691611406921; Maglio SJ, 2012, J EXP PSYCHOL GEN, V141, P211, DOI 10.1037/a0024520; Niedenthal PM, 2005, PERS SOC PSYCHOL REV, V9, P184, DOI 10.1207/s15327957pspr0903_1; Pilati Ronaldo, 2008, Estud. psicol. (Natal), V13, P213, DOI 10.1590/S1413-294X2008000300004; R Core Team, 2012, R LANG ENV STAT COMP; Rabelo ALA, 2012, PSICO PUCRS ONLINE, V43, P163; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Schnall S, 2008, PERS SOC PSYCHOL B, V34, P1096, DOI 10.1177/0146167208317771; Shalev I, 2011, PERSPECT PSYCHOL SCI, V6, P488, DOI 10.1177/1745691611416993; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; van Assen MALM, 2015, PSYCHOL METHODS, V20, P293, DOI 10.1037/met0000025; Vandekerckhove J, 2013, J MATH PSYCHOL, V57, P170, DOI 10.1016/j.jmp.2013.03.007; WEINER B, 1980, J EDUC PSYCHOL, V72, P676, DOI 10.1037/0022-0663.72.5.676; Wheatley T, 2005, PSYCHOL SCI, V16, P780, DOI 10.1111/j.1467-9280.2005.01614.x; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Zhang M, 2012, J CONSUM RES, V38, P1063, DOI 10.1086/661768	43	18	19	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134808	10.1371/journal.pone.0134808	http://dx.doi.org/10.1371/journal.pone.0134808			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1VB	26241042	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700070
J	Holm, LS; Thulstrup, PW; Kasimova, MR; van de Weert, M				Holm, Louise Stenstrup; Thulstrup, Peter W.; Kasimova, Marina R.; van de Weert, Marco			Preferential Interactions and the Effect of Protein PEGylation	PLOS ONE			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; ULTRAVIOLET CIRCULAR-DICHROISM; INCREASED THERMAL-STABILITY; GUANIDINE HYDROCHLORIDE; POLYETHYLENE-GLYCOL; THERAPEUTIC PROTEINS; SECONDARY-STRUCTURE; PHYSICAL STABILITY; NATIVE-STATE; HEN LYSOZYME	Background PEGylation is a strategy used by the pharmaceutical industry to prolong systemic circulation of protein drugs, whereas formulation excipients are used for stabilization of proteins during storage. Here we investigate the role of PEGylation in protein stabilization by formulation excipients that preferentially interact with the protein. Methodology/Principal Findings The model protein hen egg white lysozyme was doubly PEGylated on two lysines with 5 kDa linear PEGs (mPEG-succinimidyl valerate, MW 5000) and studied in the absence and presence of preferentially excluded sucrose and preferentially bound guanine hydrochloride. Structural characterization by far-and near-UV circular dichroism spectroscopy was supplemented by investigation of protein thermal stability with the use of differential scanning calorimetry, far and near-UV circular dichroism and fluorescence spectroscopy. It was found that PEGylated lysozyme was stabilized by the preferentially excluded excipient and destabilized by the preferentially bound excipient in a similar manner as lysozyme. However, compared to lysozyme in all cases the melting transition was lower by up to a few degrees and the calorimetric melting enthalpy was decreased to half the value for PEGylated lysozyme. The ratio between calorimetric and van't Hoff enthalpy suggests that our PEGylated lysozyme is a dimer. Conclusion/Significance The PEGylated model protein displayed similar stability responses to the addition of preferentially active excipients. This suggests that formulation principles using preferentially interacting excipients are similar for PEGylated and non-PEGylated proteins.	[Holm, Louise Stenstrup; Kasimova, Marina R.; van de Weert, Marco] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Copenhagen, Denmark; [Thulstrup, Peter W.] Univ Copenhagen, Dept Chem, Dept Chem, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Holm, LS (corresponding author), Novo Nordisk AS, CMC Supply, Biopharm Formulat Dev, DK-2820 Gentofte, Denmark.	LouiseSHolm@gmail.com	Thulstrup, Peter Waaben/C-5598-2013; Thulstrup, Peter Waaben/V-6371-2019; van de Weert, Marco/AGR-7726-2022	Thulstrup, Peter Waaben/0000-0002-9241-4352; Thulstrup, Peter Waaben/0000-0002-9241-4352; van de Weert, Marco/0000-0002-8530-6441	Advanced Technology Foundation; Ministry of Science, Technology and Innovation; Apotekerfonden; Drug Research Academy; Danish Agency for Science, Technology and Innovation	Advanced Technology Foundation; Ministry of Science, Technology and Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Apotekerfonden; Drug Research Academy; Danish Agency for Science, Technology and Innovation	Funding was kindly provided by the Advanced Technology Foundation and the Ministry of Science, Technology and Innovation for the NanoDSC instrument, by Apotekerfonden af 1991 for the Fluorolog, by the Drug Research Academy for the purchase of the NanoDrop 2000c and the Danish Agency for Science, Technology and Innovation for a PhD mobility stipend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author MRK is currently employed by Symphogen A/S, however, the work performed in connection with the article itself commenced prior to MRK's employment with Symphogen A/S and was then completed outside of her regular working hours at Symphogen A/S. MRK asked and received permission from Symphogen A/S to work on this paper. Symphogen A/S did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD F, 1982, J BIOL CHEM, V257, P2935; AHMAD F, 1992, BIOCHEM J, V287, P481, DOI 10.1042/bj2870481; Alconcel SNS, 2011, POLYM CHEM-UK, V2, P1442, DOI 10.1039/c1py00034a; Arakawa T, 2001, BIOSCI BIOTECH BIOCH, V65, P1321, DOI 10.1271/bbb.65.1321; ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6536, DOI 10.1021/bi00268a033; ARAKAWA T, 1985, BIOCHEMISTRY-US, V24, P6756, DOI 10.1021/bi00345a005; AUNE KC, 1969, BIOCHEMISTRY-US, V8, P4579, DOI 10.1021/bi00839a052; BACK JF, 1979, BIOCHEMISTRY-US, V18, P5191, DOI 10.1021/bi00590a025; Bailon P, 2001, BIOCONJUGATE CHEM, V12, P195, DOI 10.1021/bc000082g; Blumlein A, 2013, BBA-PROTEINS PROTEOM, V1834, P2064, DOI 10.1016/j.bbapap.2013.06.001; Cueto M, 2003, INT J PHARM, V252, P159, DOI 10.1016/S0378-5173(02)00627-0; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Ferreira M, 1997, J THERM ANAL, V48, P683, DOI 10.1007/bf01979514; Fishburn CS, 2008, J PHARM SCI-US, V97, P4167, DOI 10.1002/jps.21278; FORMOSO C, 1975, J BIOL CHEM, V250, P3738; Furness EL, 1998, BIOMATERIALS, V19, P1361, DOI 10.1016/S0142-9612(98)00007-6; GEKKO K, 1983, J BIOCHEM-TOKYO, V94, P199, DOI 10.1093/oxfordjournals.jbchem.a134330; GOUX WJ, 1980, BIOPOLYMERS, V19, P2191, DOI 10.1002/bip.1980.360191205; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; GRIKO YV, 1995, J MOL BIOL, V252, P447, DOI 10.1006/jmbi.1995.0510; Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005; Hawe A, 2012, J PHARM SCI-US, V101, P895, DOI 10.1002/jps.22812; Heller MC, 1999, J PHARM SCI, V88, P58, DOI 10.1021/js980257j; Hinds K, 2000, BIOCONJUGATE CHEM, V11, P195, DOI 10.1021/bc9901189; Holm LS, 2014, J PHARM SCI-US, V103, P3043, DOI 10.1002/jps.24094; IMOTO T, 1972, P NATL ACAD SCI USA, V69, P1151, DOI 10.1073/pnas.69.5.1151; ITZHAKI LS, 1994, BIOCHEMISTRY-US, V33, P5212, DOI 10.1021/bi00183a026; Ivens IA, 2013, HAEMOPHILIA, V19, P11, DOI 10.1111/j.1365-2516.2012.02931.x; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kendrick BS, 1997, P NATL ACAD SCI USA, V94, P11917, DOI 10.1073/pnas.94.22.11917; Kim YS, 2003, PROTEIN SCI, V12, P1252, DOI 10.1110/ps.0242603; Kurtin WE, 2002, BIOCHEM MOL BIOL EDU, V30, P244, DOI 10.1002/bmb.2002.494030040083; Laurents DV, 1997, BIOCHEMISTRY-US, V36, P1496, DOI 10.1021/bi962198z; Lee H, 2003, J PHARM SCI-US, V92, P97, DOI 10.1002/jps.10270; LEE JC, 1981, J BIOL CHEM, V256, P7193; LEE JC, 1981, J BIOL CHEM, V256, P625; Liu W, 2005, BIOTECHNOL BIOENG, V90, P482, DOI 10.1002/bit.20442; Liu YF, 1996, BIOCHEMISTRY-US, V35, P3059, DOI 10.1021/bi952198j; MAKHATADZE GI, 1992, J MOL BIOL, V226, P491, DOI 10.1016/0022-2836(92)90963-K; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; Matsuo K, 2009, PROTEINS, V77, P191, DOI 10.1002/prot.22430; Mosharraf M, 2007, INT J PHARMACEUT, V336, P215, DOI 10.1016/j.ijpharm.2006.11.064; Nodake Y, 2000, BIOSCI BIOTECH BIOCH, V64, P767, DOI 10.1271/bbb.64.767; Nozaki Y, 1972, Methods Enzymol, V26, P43; Ohtake S, 2011, ADV DRUG DELIVER REV, V63, P1053, DOI 10.1016/j.addr.2011.06.011; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Palm T, 2011, PHARM DEV TECHNOL, V16, P441, DOI 10.3109/10837450.2010.535830; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pasut G, 2007, PROG POLYM SCI, V32, P933, DOI 10.1016/j.progpolymsci.2007.05.008; Pasut G, 2006, ADV POLYM SCI, V192, P95, DOI 10.1007/12_022; Pedotti R, 2001, NAT IMMUNOL, V2, P216, DOI 10.1038/85266; Pfister D, 2014, J CONTROL RELEASE, V180, P134, DOI 10.1016/j.jconrel.2014.02.002; Pinholt C, 2011, EUR J PHARM BIOPHARM, V77, P139, DOI 10.1016/j.ejpb.2010.11.001; Plesner B, 2011, EUR J PHARM BIOPHARM, V79, P399, DOI 10.1016/j.ejpb.2011.05.003; PRIVALOV G, 1995, ANAL BIOCHEM, V232, P79, DOI 10.1006/abio.1995.9957; Rajan RS, 2006, PROTEIN SCI, V15, P1063, DOI 10.1110/ps.052004006; Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4; Schwalbe H, 2001, PROTEIN SCI, V10, P677, DOI 10.1110/ps.43301; Stigsnaes P, 2007, INT J PHARMACEUT, V330, P89, DOI 10.1016/j.ijpharm.2006.09.002; SUCKAU D, 1992, P NATL ACAD SCI USA, V89, P5630, DOI 10.1073/pnas.89.12.5630; TANFORD C, 1970, BIOCHEMISTRY-US, V9, P206, DOI 10.1021/bi00804a003; TANFORD C, 1973, J MOL BIOL, V73, P185, DOI 10.1016/0022-2836(73)90322-7; TANFORD C, 1966, J MOL BIOL, V15, P489, DOI 10.1016/S0022-2836(66)80123-7; Tattini V, 2005, INT J PHARMACEUT, V304, P124, DOI 10.1016/j.ijpharm.2005.08.006; Tuesca AD, 2009, PHARM RES-DORDR, V26, P727, DOI 10.1007/s11095-008-9816-8; van de Weert M, 2004, PHARM RES-DORDR, V21, P2354, DOI 10.1007/s11095-004-7689-z; Wei W, 1999, INT J PHARMACEUT, V185, P129, DOI 10.1016/S0378-5173(99)00152-0; Wu FG, 2011, PHYS CHEM CHEM PHYS, V13, P3429, DOI 10.1039/c0cp01184c; YUNUS WMB, 1988, APPL OPTICS, V27, P3341, DOI 10.1364/AO.27.003341; Zielenkiewicz W, 2006, J THERM ANAL CALORIM, V83, P587, DOI 10.1007/s10973-005-7417-x	71	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133584	10.1371/journal.pone.0133584	http://dx.doi.org/10.1371/journal.pone.0133584			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230338	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400045
J	Protogerou, AD; Fransen, J; Zampeli, E; Argyris, AA; Aissopou, E; Arida, A; Konstantonis, GD; Tentolouris, N; Makrilakis, K; Psichogiou, M; Daikos, G; Kitas, GD; Sfikakis, PP				Protogerou, Athanasios D.; Fransen, Jaap; Zampeli, Evangelia; Argyris, Antonis A.; Aissopou, Evagelia; Arida, Aikaterini; Konstantonis, George D.; Tentolouris, Nikos; Makrilakis, Konstantinos; Psichogiou, Mina; Daikos, George; Kitas, George D.; Sfikakis, Petros P.			The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CARDIOVASCULAR-DISEASE; CAROTID ATHEROSCLEROSIS; FOLLOW-UP; HIV-INFECTION; ARTERIES; PLAQUES; ASSOCIATION; EVENTS; RECOMMENDATIONS	Background Presence of femoral atheromatic plaques, an emerging cardiovascular disease (CVD) biomarker additional to carotid plaques, is poorly investigated in conditions associating with accelerated atherosclerosis such as Rheumatoid Arthritis (RA), Human Immunodeficiency Virus (HIV) infection and Type 2 Diabetes Mellitus (T2DM). Objective/Methods To assess the frequency of femoral/carotid subclinical atheromatosis phenotypes in RA, HIV and T2DM and search for each disease-specific probability of either femoral and/or carotid subclinical atheromatosis, we examined by ultrasound a single-center cohort of CVD-free individuals comprised of consecutive non-diabetic patients with RA (n=226) and HIV (n=133), T2DM patients (n=109) and non-diabetic individuals with suspected/known hypertension (n=494) who served as reference group. Results Subclinical atheromatosis -defined as local plaque presence in at least on arterial bed was diagnosed in 50% of the overall population. Among them, femoral plaques only were found in 25% of either RA or HIV patients, as well as in 16% of T2DM patients and 35% of reference subjects. After adjusting for all classical CVD risk factors, RA and HIV patients had comparable probability to reference group of having femoral plaques, but higher probability (1.75; 1.17-2.63 (odds ratio; 95% confidence intervals), 2.04; 1.14-3.64, respectively) of having carotid plaques, whereas T2DM patients had higher probability to have femoral and carotid plaques, albeit, due to their pronounced dyslipidemic profile. Conclusion RA and HIV accelerate predominantly carotid than femoral. A "two windows" carotid/femoral, rather than carotid alone ultrasound, screening improves substantially subclinical atheromatosis detection in patients at high CVD risk.	[Protogerou, Athanasios D.; Zampeli, Evangelia; Argyris, Antonis A.; Aissopou, Evagelia; Arida, Aikaterini; Konstantonis, George D.; Tentolouris, Nikos; Makrilakis, Konstantinos; Psichogiou, Mina; Daikos, George; Sfikakis, Petros P.] Laikon Gen Hosp, Dept Propaedeut & Internal Med 1, Athens, Greece; [Protogerou, Athanasios D.; Zampeli, Evangelia; Arida, Aikaterini; Konstantonis, George D.; Sfikakis, Petros P.] Natl & Kapodistrian Univ Athens, Sch Med, Joint Acad Rheumatol Program, Athens 11528, Greece; [Fransen, Jaap] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, Nijmegen, Netherlands; [Kitas, George D.] Dudley Grp NHS Fdn Trust, Dept Rheumatol, Dudley, England; [Kitas, George D.] Univ Manchester, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England	Laiko General Hospital; Athens Medical School; National & Kapodistrian University of Athens; Radboud University Nijmegen; University of Manchester	Protogerou, AD (corresponding author), Laikon Gen Hosp, Dept Propaedeut & Internal Med 1, Athens, Greece.	aprotog@med.uoa.gr	Daikos, George L./ABD-8378-2021; Fransen, J./L-4310-2015; Makrilakis, Konstantinos/AAG-4487-2020; Sfikakis, Petros/AAD-7289-2019; Kitas, George/AAO-6396-2020; Protogerou, Athanassios/AAD-7210-2019; Argyris, Antonios/ABI-8234-2020; TENTOLOURIS, NIKOLAOS/AAH-6231-2019	Makrilakis, Konstantinos/0000-0002-4160-0577; Argyris, Antonios/0000-0002-8906-6959; TENTOLOURIS, NIKOLAOS/0000-0003-0615-2534; Protogerou, Athanase/0000-0002-3825-532X; KITAS, GEORGE/0000-0002-0828-6176; Zampeli, Evangelia/0000-0002-3668-4454	ELKE grant, Athens University Medical School [097]	ELKE grant, Athens University Medical School	Supported by ELKE grant 097, Athens University Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other source of funding exists.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Arts EEA, 2015, ANN RHEUM DIS, V74, P668, DOI 10.1136/annrheumdis-2013-204024; Belcaro G, 2001, ATHEROSCLEROSIS, V156, P379, DOI 10.1016/S0021-9150(00)00665-1; Bianda N, 2012, EUR HEART J, V33, P230, DOI 10.1093/eurheartj/ehr332; Currier JS, 2014, ANN INTERN MED, V160, P509, DOI 10.7326/M14-0378; Dalager S, 2008, J VASC SURG, V47, P296, DOI 10.1016/j.jvs.2007.10.037; Dalager S, 2007, STROKE, V38, P2698, DOI 10.1161/STROKEAHA.107.486480; del Rincon I, 2003, ARTHRITIS RHEUM, V48, P1833, DOI 10.1002/art.11078; Depairon M, 2001, AIDS, V15, P329, DOI 10.1097/00002030-200102160-00005; European Centre for Diseases Prevention and Control, 2010, EVIDENCE SYNTHESIS F; Evans MR, 2011, ARTHRITIS RHEUM-US, V63, P1211, DOI 10.1002/art.30265; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Frerix M, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4489; Friis-Moller N, 2010, EUR J CARDIOV PREV R, V17, P491, DOI 10.1097/HJR.0b013e328336a150; Fukudome Y, 1997, Hypertens Res, V20, P175, DOI 10.1291/hypres.20.175; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Griffin M, 2009, VASC MED, V14, P227, DOI 10.1177/1358863X08101542; Held C, 2001, EUR HEART J, V22, P62, DOI 10.1053/euhj.1999.2006; Herisson F, 2011, ATHEROSCLEROSIS, V216, P348, DOI 10.1016/j.atherosclerosis.2011.02.004; Hulsen E, 2009, HEART, V95, P1826, DOI [10.1136/hrt.2009.177774, DOI 10.1136/HRT.2009.177774]; Jonsson SW, 2001, J RHEUMATOL, V28, P2597; Kawai VK1, 2014, ARTHRITIS RHEUMATOL; Khoury Z, 1997, AM J CARDIOL, V80, P1429, DOI 10.1016/S0002-9149(97)00701-7; Kitas GD, 2011, ANN RHEUM DIS, V70, P8, DOI 10.1136/ard.2010.142133; Kranjec I, 2011, J CARDIOVASC MED, V12, P297, DOI 10.2459/JCM.0b013e328343e962; Lamina C, 2006, EUR HEART J, V27, P2580, DOI 10.1093/eurheartj/ehl228; Langlois MR, 2008, ARTERIOSCL THROM VAS, V28, P1563, DOI 10.1161/ATVBAHA.108.167346; Maeno T, 2002, DIABETES, V51, P1523, DOI 10.2337/diabetes.51.5.1523; Maher E, 2012, J BIOMECH, V45, P1393, DOI 10.1016/j.jbiomech.2012.02.026; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Mangili A, 2011, ATHEROSCLEROSIS, V214, P468, DOI 10.1016/j.atherosclerosis.2010.11.013; Nolting PRWD, 2003, ARCH INTERN MED, V163, P1837, DOI 10.1001/archinte.163.15.1837; Panayiotou AG, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-44; Pasterkamp G, 1999, ARTERIOSCL THROM VAS, V19, P54, DOI 10.1161/01.ATV.19.1.54; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Post WS, 2014, ANN INTERN MED, V160, P458, DOI 10.7326/M13-1754; Protogerou AD, 2014, J AM COLL CARDIOL, V63, P1748, DOI 10.1016/j.jacc.2014.01.044; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Roman MJ, 2006, VASC MED, V11, P201, DOI 10.1177/1358863x06070511; Roman MJ, 2012, HYPERTENSION, V59, P29, DOI 10.1161/HYPERTENSIONAHA.111.181925; Roman MJ, 2006, ANN INTERN MED, V144, P249, DOI 10.7326/0003-4819-144-4-200602210-00006; Ryd&eacute;n L, 2014, EUR HEART J; Safar ME, 2006, HDB HYPERTENSION, V23; SALONEN JT, 1994, J INTERN MED, V236, P561, DOI 10.1111/j.1365-2796.1994.tb00846.x; SALONEN R, 1995, CIRCULATION, V92, P1758, DOI 10.1161/01.CIR.92.7.1758; Sass C, 1998, J HYPERTENS, V16, P1593, DOI 10.1097/00004872-199816110-00005; Schmidt C, 2005, ATHEROSCLEROSIS, V181, P125, DOI 10.1016/j.atherosclerosis.2004.12.034; Scuteri A, 2009, NUTR METAB CARDIOVAS, V19, P532, DOI 10.1016/j.numecd.2008.11.004; Shaikh S, 2012, EUR J VASC ENDOVASC, V44, P491, DOI 10.1016/j.ejvs.2012.08.005; Stamatelopoulos KS, 2010, ATHEROSCLEROSIS, V212, P305, DOI 10.1016/j.atherosclerosis.2010.05.007; Stamatelopoulos KS, 2009, ARTERIOSCL THROM VAS, V29, P1702, DOI 10.1161/ATVBAHA.109.190108; Tyrrell PN, 2010, ARTERIOSCL THROM VAS, V30, P1014, DOI 10.1161/ATVBAHA.109.198424; van Sloten TT, 2014, J AM COLL CARDIOL, V63, P1739, DOI 10.1016/j.jacc.2013.12.041; Weir-McCall JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099190; Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955; Zannad F, 2012, EUR J PREV CARDIOL, V19, P1454, DOI 10.1177/1741826711424873	59	21	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132307	10.1371/journal.pone.0132307	http://dx.doi.org/10.1371/journal.pone.0132307			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230728	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400017
J	Schai-Braun, SC; Reichlin, TS; Ruf, T; Klansek, E; Tataruch, F; Arnold, W; Hacklander, K				Schai-Braun, Stephanie C.; Reichlin, Thomas S.; Ruf, Thomas; Klansek, Erich; Tataruch, Frieda; Arnold, Walter; Hacklaender, Klaus			The European Hare (Lepus europaeus): A Picky Herbivore Searching for Plant Parts Rich in Fat	PLOS ONE			English	Article							ACID-COMPOSITION; BROWN HARES; HABITAT SELECTION; FARMLAND; ADAPTATION; DEMOGRAPHY; ABUNDANCE; QUALITY; PALLAS; IMPACT	European hares of both sexes rely on fat reserves, particularly during the reproduc-tive season. Therefore, hares should select dietary plants rich in fat and energy. However, hares also require essential polyunsaturated fatty acids (PUFA) such as linoleic acid (LA) and alpha-linolenic acid (ALA) to reproduce and survive. Although hares are able to absorb PUFA selectively in their gastrointestinal tract, it is unknown whether this mechanism is sufficient to guarantee PUFA supply. Thus, diet selection may involve a trade-off between a preference for energy versus a preference for crucial nutrients, namely PUFA. We compared plant and nutrient availability and use by hares in an arable landscape in Austria over three years. We found that European hares selected their diet for high energy content (crude fat and crude protein), and avoided crude fibre. There was no evidence of a preference for plants rich in LA and ALA. We conclude that fat is the limiting resource for this herbivorous mammal, whereas levels of LA and ALA in forage are sufficiently high to meet daily requirements, especially since their uptake is enhanced by physiological mechanisms. Animals selected several plant taxa all year round, and preferences did not simply correlate with crude fat content. Hence, European hares might not only select for plant taxa rich in fat, but also for high-fat parts of preferred plant taxa. As hares preferred weeds/grasses and various crop types while avoiding cereals, we suggest that promoting heterogeneous habitats with high crop diversity and set-asides may help stop the decline of European hares throughout Europe.	[Schai-Braun, Stephanie C.; Hacklaender, Klaus] Univ Nat Resources & Life Sci, Inst Wildlife Biol & Game Management, Dept Integrat Biol & Biodivers Res, Vienna, Austria; [Reichlin, Thomas S.] Univ Bern, Vetsuisse Fac, Div Anim Welf, Bern, Switzerland; [Ruf, Thomas; Klansek, Erich; Tataruch, Frieda; Arnold, Walter] Univ Vet Med, Res Inst Wildlife Ecol, Dept Integrat Biol & Evolut, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Bern; University of Veterinary Medicine Vienna	Schai-Braun, SC (corresponding author), Univ Nat Resources & Life Sci, Inst Wildlife Biol & Game Management, Dept Integrat Biol & Biodivers Res, Vienna, Austria.	stephanie.schai-braun@boku.ac.at	Schai-Braun, Stéphanie/Z-2789-2019; Schai-Braun, Stéphanie/AAW-4182-2020; Arnold, Walter/C-3394-2013; Hackländer, Klaus/ABC-4327-2020	Schai-Braun, Stéphanie/0000-0001-8124-9139; Arnold, Walter/0000-0001-6785-5685; Hacklander, Klaus/0000-0002-6774-435X; Ruf, Thomas/0000-0002-9235-7079	Deutsche Wildtier Stiftung; Hunting Societies of Austria; Verein Grunes Keuz	Deutsche Wildtier Stiftung; Hunting Societies of Austria; Verein Grunes Keuz	The study was funded by the Deutsche Wildtier Stiftung, the Hunting Societies of Austria, and the Verein Grunes Keuz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2000, AM J PHYSIOL-ENDOC M, V279, pE744, DOI 10.1152/ajpendo.2000.279.4.E744; [Anonymous], 1993, INTRO BOOTSTRAP; Ayre KJ, 1996, J APPL PHYSIOL, V80, P464, DOI 10.1152/jappl.1996.80.2.464; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barton K., 2013, MUMIN MULTIMODEL INF; Bro E, 2004, J APPL ECOL, V41, P846, DOI 10.1111/j.0021-8901.2004.00939.x; Chapuis JL, 1990, MAMM BIOL, V55, P176; CHESSON J, 1983, ECOLOGY, V64, P1297, DOI 10.2307/1937838; Chiari M, 2014, EUR J WILDLIFE RES, V60, P891, DOI 10.1007/s10344-014-0856-6; Clapham WM, 2005, J AGR FOOD CHEM, V53, P10068, DOI 10.1021/jf0517039; Dixon Philip M., 1993, P290; Faraway J.J., 2016, EXTENDING LINEAR MOD, DOI [10.1201/9781315382722, DOI 10.1201/9781315382722]; Flux J, 1976, NZ J SCI, V102, P357; Fromm M, 2012, EUR FOOD RES TECHNOL, V234, P1033, DOI 10.1007/s00217-012-1709-8; FRYLESTAM B, 1986, MAMMAL REV, V16, P157, DOI 10.1111/j.1365-2907.1986.tb00037.x; Gorski J, 1999, EUR J APPL PHYSIOL O, V79, P421, DOI 10.1007/s004210050532; Hacklander K, 2011, MAMM BIOL, V76, P662, DOI 10.1016/j.mambio.2011.05.001; Hacklander K, 2002, J COMP PHYSIOL B, V172, P183, DOI 10.1007/s00360-001-0243-y; Hacklander K, 2002, PHYSIOL BIOCHEM ZOOL, V75, P19, DOI 10.1086/324770; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Helge JW, 2001, J APPL PHYSIOL, V90, P670, DOI 10.1063/1.1380406; HOMOLKA M, 1987, FOLIA ZOOL, V36, P103; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jennings N, 2006, WILDLIFE BIOL, V12, P179, DOI 10.2981/0909-6396(2006)12[179:VIDCAD]2.0.CO;2; Krebs CJ., 1989, ECOLOGICAL METHODOLO, P392; Kronfeld N, 1996, J MAMMAL, V77, P171, DOI 10.2307/1382718; Langbein J, 1999, MAMMAL REV, V29, P93, DOI 10.1046/j.1365-2907.1999.00040.x; MANLY BFJ, 1972, AM NAT, V106, P719, DOI 10.1086/282808; Meichtry-Stier KS, 2014, AGR ECOSYST ENVIRON, V189, P101, DOI 10.1016/j.agee.2014.02.038; Mir PS, 2006, CAN J ANIM SCI, V86, P279, DOI 10.4141/A05-050; MONAGHAN P, 1985, ANIM BEHAV, V33, P993, DOI 10.1016/S0003-3472(85)80033-6; PALMQUIST DL, 1980, J DAIRY SCI, V63, P1, DOI 10.3168/jds.S0022-0302(80)82881-5; Petrovan SO, 2013, ANIM CONSERV, V16, P344, DOI 10.1111/acv.12002; Pierce BJ, 2014, INTEGR COMP BIOL, V54, P903, DOI 10.1093/icb/icu098; Popescu FD, 2011, J COMP PHYSIOL B, V181, P681, DOI 10.1007/s00360-011-0559-1; R Development Core Team, 2012, R LANG ENV STAT COMP; Raczynski J., 1964, Acta Theriologica, V9, P305; Reichlin T, 2006, EUR J WILDLIFE RES, V52, P109, DOI 10.1007/s10344-005-0013-3; Ruf T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000065; Sahoo A, 2010, GRASSL SCI, V56, P116, DOI 10.1111/j.1744-697X.2010.00183.x; Schai-Braun SC, 2014, ACTA THERIOL, V59, P277, DOI 10.1007/s13364-013-0162-9; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Smith RK, 2005, ACTA THERIOL, V50, P391, DOI 10.1007/BF03192634; Smith RK, 2005, MAMMAL REV, V35, P1, DOI 10.1111/j.1365-2907.2005.00057.x; Smith RK, 2004, J APPL ECOL, V41, P1092, DOI 10.1111/j.0021-8901.2004.00976.x; SUCHENTRUNK F, 1991, Z SAUGETIERKD, V56, P365; TAPPER SC, 1986, J APPL ECOL, V23, P39, DOI 10.2307/2403079; Tufarelli V, 2010, ANIMAL, V4, P763, DOI 10.1017/S1751731109991741; Valencak TG, 2009, J EXP BIOL, V212, P231, DOI 10.1242/jeb.022640; Valencak TG, 2009, J COMP PHYSIOL B, V179, P933, DOI 10.1007/s00360-009-0376-y; Valencak TG, 2003, J COMP PHYSIOL B, V173, P695, DOI 10.1007/s00360-003-0382-4; Z&ouml;rner E, 1996, DER FELDHASE	52	48	48	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134278	10.1371/journal.pone.0134278	http://dx.doi.org/10.1371/journal.pone.0134278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230115	Green Submitted, gold, Green Published			2022-12-27	WOS:000358838400098
J	Su, CY; Liu, YP; Yang, CJ; Lin, YF; Chiou, J; Chi, LH; Lee, JJ; Wu, ATH; Lu, PJ; Huang, MS; Hsiao, M				Su, Chia-Yi; Liu, Yu-Peng; Yang, Chih-Jen; Lin, Yuan-Feng; Chiou, Jean; Chi, Li-Hsing; Lee, Jih-Jong; Wu, Alex T. H.; Lu, Pei-Jung; Huang, Ming-Shyan; Hsiao, Michael			Plasminogen Activator Inhibitor-2 Plays a Leading Prognostic Role among Protease Families in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							UROKINASE RECEPTOR; MATRIX METALLOPROTEINASES; EXPRESSION; METASTASIS; SERPINB2; MARKER; SYSTEM; TYPE-1; FIBROBLASTS; SURVIVAL	Background In lung cancer, uPA, its receptor (uPAR), and the inhibitors PAI-1 and PAI-2 of the plasminogen activator family interact with MMP-2 and MMP-9 of the MMP family to promote cancer progression. However, it remains undetermined which of these markers plays the most important role and may be the most useful indicator to stratify the patients by risk. Methods We determined the individual prognostic value of these 6 markers by analyzing a derivation cohort with 98 non-small cell lung cancer patients by immunohistochemical staining. The correlation between the IHC expression levels of these markers and disease prognosis was investigated, and an immunohistochemical panel for prognostic prediction was subsequently generated through prognostic model analysis. The value of the immunohistochemical panel was then verified by a validation cohort with 91 lung cancer patients. Results In derivation cohort, PAI-2 is the most powerful prognostic factor (HR = 2.30; P = 0.001), followed by MMP-9 (HR = 2.09; P = 0.019) according to multivariate analysis. When combining PAI-2 and MMP-9, the most unfavorable prognostic group (low PAI-2 and high MMP-9 IHC expression levels) showed a 6.40-fold increased risk of a poor prognosis compared to the most favorable prognostic group (high PAI-2 and low MMP-9 IHC expression levels). PAI-2 and MMP-9 IHC panel could more precisely identify high risk patients in both derivation and validation cohort. Conclusions We revealed PAI-2 as the most powerful prognostic marker among PA and MMP protease family even after considering their close relationships with each other. By utilizing a combination of PAI-2 and MMP-9, more precise prognostic information than merely using pathological stage alone can be obtained for lung cancer patients.	[Su, Chia-Yi; Chiou, Jean; Hsiao, Michael] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Liu, Yu-Peng] Kaohsiung Med Univ, Dept Genome Med, Kaohsiung, Taiwan; [Yang, Chih-Jen; Huang, Ming-Shyan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Lin, Yuan-Feng] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chiou, Jean] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Chiou, Jean; Chi, Li-Hsing; Wu, Alex T. H.] Acad Sinica, Taichung, Taiwan; [Chi, Li-Hsing; Wu, Alex T. H.] Taipei Med Univ, PhD Program Translat Med, Taipei, Taiwan; [Lee, Jih-Jong] Natl Taiwan Univ, Sch Vet Med, Inst Vet Clin Sci, Taipei 10764, Taiwan; [Lu, Pei-Jung] Natl Cheng Kung Univ, Inst Clin Med, Tainan 70101, Taiwan	Academia Sinica - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Taipei Medical University; China Medical University Taiwan; Academia Sinica - Taiwan; Taipei Medical University; National Taiwan University; National Cheng Kung University	Huang, MS (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan.	shyang@kmu.edu.tw; mhsiao@gate.sinica.edu.tw	Su, Chia-Yi/L-5378-2016; Hsiao, Michael/U-6238-2019; Chiou, Jean/G-8255-2014; Chi, Tex/I-9129-2012	Su, Chia-Yi/0000-0002-9483-4510; Hsiao, Michael/0000-0001-8529-9213; Chiou, Jean/0000-0001-6926-0159; Chi, Tex/0000-0002-4476-2600; LEE, JIH-JONG/0000-0002-4424-730X				Ali HR, 2012, BRIT J CANCER, V106, P1798, DOI 10.1038/bjc.2012.167; Allen BJ, 2003, BRIT J CANCER, V88, P944, DOI 10.1038/sj.bjc.6600838; Annabi B, 2005, CLIN EXP METASTAS, V22, P429, DOI 10.1007/s10585-005-2669-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chambers SK, 1997, INT J CANCER, V74, P571, DOI 10.1002/(SICI)1097-0215(19971219)74:6<571::AID-IJC2>3.3.CO;2-Z; Cochran BJ, 2011, J BIOL CHEM, V286, P24467, DOI 10.1074/jbc.M111.225706; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cox G, 2001, THORAX, V56, P561, DOI 10.1136/thorax.56.7.561; Cox G, 1999, THORAX, V54, P169, DOI 10.1136/thx.54.2.169; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Di Y, 2010, FEBS LETT, V584, P3469, DOI 10.1016/j.febslet.2010.07.005; Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559; Duggan C, 1997, BRIT J CANCER, V76, P622, DOI 10.1038/bjc.1997.435; GANESH S, 1994, CANCER RES, V54, P4065; He Y, 2007, CLIN CANCER RES, V13, P3115, DOI 10.1158/1078-0432.CCR-06-2088; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Higgins KA, 2012, J THORAC ONCOL, V7, P1141, DOI 10.1097/JTO.0b013e3182519a42; Hung JJ, 2009, THORAX, V64, P1082, DOI 10.1136/thx.2009.115691; Ishikawa S, 2004, CLIN CANCER RES, V10, P6579, DOI 10.1158/1078-0432.CCR-04-0272; Johnson DH, 2014, J CLIN ONCOL, V32, P973, DOI 10.1200/JCO.2013.53.1228; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Medcalf RL, 2005, FEBS J, V272, P4858, DOI 10.1111/j.1742-4658.2005.04879.x; MUELLER BM, 1995, P NATL ACAD SCI USA, V92, P205, DOI 10.1073/pnas.92.1.205; Nordengren J, 2002, INT J CANCER, V97, P379, DOI 10.1002/ijc.1611; Offersen BV, 2007, LUNG CANCER, V56, P43, DOI 10.1016/j.lungcan.2006.11.018; OKA T, 1991, CANCER RES, V51, P3522; Pavey S J, 1996, Boll Soc Ital Biol Sper, V72, P331; PEDERSEN H, 1994, CANCER RES, V54, P120; PEDERSEN H, 1994, CANCER RES, V54, P4671; Peng WJ, 2012, CLIN CHIM ACTA, V413, P1121, DOI 10.1016/j.cca.2012.03.012; Praus M, 1999, GENE THER, V6, P227, DOI 10.1038/sj.gt.3300802; Qian QA, 2010, CANCER INVEST, V28, P661, DOI 10.3109/07357901003735634; Robbie LA, 2000, BRIT J HAEMATOL, V109, P342, DOI 10.1046/j.1365-2141.2000.02057.x; Robert C, 1999, CLIN CANCER RES, V5, P2094; Salden M, 2000, ANN ONCOL, V11, P327, DOI 10.1023/A:1008312801800; SCHERRER A, 1991, LEUKEMIA, V5, P479; Schroder WA, 2014, CANCER MED-US, V3, P500, DOI 10.1002/cam4.229; Shao WL, 2011, J SURG ONCOL, V104, P841, DOI 10.1002/jso.22001; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Stewart CE, 2013, LUNG, V191, P215, DOI 10.1007/s00408-013-9450-z; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; Volm M, 1999, ONCOL REP, V6, P611; Werle B, 2004, ANTICANCER RES, V24, P4147; Xu DM, 2010, CANCER RES, V70, P6988, DOI 10.1158/0008-5472.CAN-10-0242; Yoshino H, 1998, BRIT J CANCER, V78, P833, DOI 10.1038/bjc.1998.588	46	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133411	10.1371/journal.pone.0133411	http://dx.doi.org/10.1371/journal.pone.0133411			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230665	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400038
J	Curie, A; Yang, K; Kirsch, I; Gollub, RL; Portes, VD; Kaptchuk, TJ; Jensen, KB				Curie, Aurore; Yang, Kathy; Kirsch, Irving; Gollub, Randy L.; Portes, Vincent des; Kaptchuk, Ted J.; Jensen, Karin B.			Placebo Responses in Genetically Determined Intellectual Disability: A Meta-Analysis	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; DOWN-SYNDROME; DOUBLE-BLIND; CONTROLLED-TRIAL; ALZHEIMERS-DISEASE; CLINICAL-TRIALS; FOLINIC ACID; YOUNG MALES; CHILDREN; DONEPEZIL	Background Genetically determined Intellectual Disability (ID) is an intractable condition that involves severe impairment of mental abilities such as learning, reasoning and predicting the future. As of today, little is known about the placebo response in patients with ID. Objective To determine if placebo response exists in patients with genetically determined ID. Data sources and Study selection We searched Medline/PubMed, EMBASE, CENTRAL and PsycINFO to find all placebo-controlled double-blind randomized clinical trials (RCTs) in patients with genetically determined ID, published up to April 2013, focusing on core ID symptoms. Data extraction and synthesis Two investigators extracted outcome data independently. Main outcomes and measures Bias-corrected standardized mean difference (Hedge's g) was computed for each outcome measure, using the Comprehensive Meta-Analysis software. A priori defined patient subgroups were analyzed using a mixed-effect model. The relationship between pre-defined continuous variable moderators (age, IQ, year of publication and trial duration) and effect size was analyzed using meta-regression Results Twenty-two placebo-controlled double-blind RCTs met the inclusion criteria (n = 721, mean age = 17.1 years, 62% men, mean trial duration = 35 weeks). There was a significant overall placebo response from pre- to post-treatment in patients with ID (g = 0.468, p = 0.002), both for "subjective outcomes" (a third-person's evaluation of the patient) (g = 0.563, p = 0.022) and "objective outcomes" (direct evaluation of the patient's abilities) (g = 0.434, p = 0.036). Individuals with higher IQ had higher response to placebo (p = 0.02) and no placebo response was observed in ID patients with comorbid dementia. A significant effect of age (p = 0.02) was found, indicating higher placebo responses in treatment of younger patients. Conclusions and relevance Results suggest that patients with genetically determined ID improve in the placebo arm of RCTs. Several mechanisms may contribute to placebo effects in ID, including expectancy, implicit learning and "placebo-by-proxy" induced by clinicians/family members. As the condition is refractory, there is little risk that improvements are explained by spontaneous remission. While new avenues for treatment of genetically determined ID are emerging, our results demonstrate how contextual factors can affect clinical outcomes and emphasize the importance of being vigilant on the role of placebos when testing novel treatments in ID.	[Curie, Aurore; Yang, Kathy; Gollub, Randy L.; Jensen, Karin B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat,Martinos Ctr Biomed Imaging, Boston, MA 02138 USA; [Curie, Aurore; Portes, Vincent des] CNRS, Inst Cognit Sci, L2C2, UMR5304, Bron, France; [Curie, Aurore; Portes, Vincent des] Hosp Civils Lyon, Hop Femmes Meres Enfants, Ctr Reference Deficiences Intellectuelles Causes, Bron, France; [Curie, Aurore; Portes, Vincent des] Univ Lyon 1, F-69365 Lyon, France; [Curie, Aurore] INSERM, EPICIME CIC1407, F-69500 Bron, France; [Kirsch, Irving; Kaptchuk, Ted J.; Jensen, Karin B.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Program Placebo Studies, Boston, MA USA; [Kirsch, Irving] Univ Plymouth, Sch Psychol, Plymouth PL4 8AA, Devon, England; [Jensen, Karin B.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Harvard University; Harvard Medical School; Massachusetts General Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Plymouth; Karolinska Institutet	Curie, A (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat,Martinos Ctr Biomed Imaging, Boston, MA 02138 USA.	aurorecurie@yahoo.fr	Kirsch, Irving/P-9316-2019	Gollub, Randy L./0000-0002-9434-4044; Curie, Aurore/0000-0001-7823-290X; Jensen, Karin/0000-0003-2521-3160	COFAS Marie Curie Postdoc Program; Swedish Society for Medical Research; Jerome Lejeune's Foundation; Xtraordinaire Association; Foundation for Science and Therapeutic Encounter; NIH/NCCIH [K24 AT004095, R01AT005280]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT005280] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT004095] Funding Source: NIH RePORTER	COFAS Marie Curie Postdoc Program; Swedish Society for Medical Research; Jerome Lejeune's Foundation; Xtraordinaire Association; Foundation for Science and Therapeutic Encounter; NIH/NCCIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by the COFAS Marie Curie Postdoc Program (KBJ), Swedish Society for Medical Research (KBJ), Jerome Lejeune's Foundation (Postdoctoral Fellowship AC), Xtraordinaire Association (Postdoctoral Fellowship AC), Foundation for Science and Therapeutic Encounter (TJK), K24 AT004095 (from NIH/NCCIH) (TJK), R01AT005280 (from NIH/NCCIH) (RG/TJK).	Allan LG, 2002, EVAL HEALTH PROF, V25, P410, DOI 10.1177/0163278702238054; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Benedetti F, 2006, PAIN, V121, P133, DOI 10.1016/j.pain.2005.12.016; Benedetti F, 2004, NAT NEUROSCI, V7, P587, DOI 10.1038/nn1250; BENNETT FC, 1983, PEDIATRICS, V72, P707; Berry-Kravis E, 2006, J CHILD ADOL PSYCHOP, V16, P525, DOI 10.1089/cap.2006.16.525; Berry-Kravis E, 2013, J DEV BEHAV PEDIATR, V34, P508, DOI 10.1097/DBP.0b013e31829d1f20; Berry-Kravis EM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004214; Bingel U, 2006, PAIN, V120, P8, DOI 10.1016/j.pain.2005.08.027; Blehaut H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008394; Boada R, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.66; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Buchel C, 2014, NEURON, V81, P1223, DOI 10.1016/j.neuron.2014.02.042; Colloca L, 2008, PAIN, V136, P211, DOI 10.1016/j.pain.2008.02.006; Conzemius MG, 2012, JAVMA-J AM VET MED A, V241, P1314, DOI 10.2460/javma.241.10.1314; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; des Portes V, 2013, HAND CLINIC, V111, P297, DOI 10.1016/B978-0-444-52891-9.00035-X; Eippert F, 2009, SCIENCE, V326, P404, DOI 10.1126/science.1180142; Eippert F, 2009, NEURON, V63, P533, DOI 10.1016/j.neuron.2009.07.014; El-Chammas K, 2013, JAMA PEDIATR, V167, P250, DOI 10.1001/jamapediatrics.2013.508; Ellis JM, 2008, BMJ-BRIT MED J, V336, P594, DOI 10.1136/bmj.39465.544028.AE; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; Faria V, 2014, J PEDIATR-US, V165, P659, DOI 10.1016/j.jpeds.2014.06.040; Finestack LH, 2009, TOP LANG DISORD, V29, P133, DOI 10.1097/TLD.0b013e3181a72016; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Frankland PW, 2004, MOL PSYCHIATR, V9, P417, DOI 10.1038/sj.mp.4001432; Fulda S, 2008, BRAIN, V131, P902, DOI 10.1093/brain/awm244; Furmark T, 2008, J NEUROSCI, V28, P13066, DOI 10.1523/JNEUROSCI.2534-08.2008; Grelotti DJ, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4345; Grieco J, 2015, AM J MED GENET C, V169, P135, DOI 10.1002/ajmg.c.31439; Hagerman R, 2012, RESULTS PROBL CELL D, V54, P297, DOI 10.1007/978-3-642-21649-7_17; HAGERMAN RJ, 1986, AM J MED GENET, V23, P241, DOI 10.1002/ajmg.1320230119; Hagerman RJ, 2002, CURR OPIN GENET DEV, V12, P278, DOI 10.1016/S0959-437X(02)00299-X; Hanney M, 2012, LANCET, V379, P528, DOI 10.1016/S0140-6736(11)61676-0; Haqq AM, 2003, J CLIN ENDOCR METAB, V88, P2206, DOI 10.1210/jc.2002-021536; Hessl D, 2009, AM J MED GENET B, V150B, P545, DOI 10.1002/ajmg.b.30858; Hooper SR, 2008, NEUROPSYCHOLOGY, V22, P36, DOI 10.1037/0894-4105.22.1.36; Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708; Jensen KB, 2015, CEREB CORTEX, V25, P3903, DOI 10.1093/cercor/bhu275; Jensen KB, 2012, P NATL ACAD SCI USA, V109, P15959, DOI 10.1073/pnas.1202056109; Johnson N, 2003, AM J MENT RETARD, V108, P367, DOI 10.1352/0895-8017(2003)108<367:EODOCF>2.0.CO;2; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; Kasari C, 2003, J CHILD PSYCHOL PSYC, V44, P424, DOI 10.1111/1469-7610.00132; Khan A, 2008, J PSYCHIATR RES, V42, P791, DOI 10.1016/j.jpsychires.2007.10.004; Kishnani PS, 2010, AM J MED GENET A, V152A, P3028, DOI 10.1002/ajmg.a.33730; Kishnani PS, 2009, AM J MED GENET A, V149A, P1641, DOI 10.1002/ajmg.a.32953; Klinger R, 2007, PAIN, V128, P31, DOI 10.1016/j.pain.2006.08.025; Kondoh T, 2011, INT J PSYCHIAT MED, V41, P71, DOI 10.2190/PM.41.1.g; Leigh MJS, 2013, J DEV BEHAV PEDIATR, V34, P147, DOI 10.1097/DBP.0b013e318287cd17; Leuchter AF, 2002, AM J PSYCHIAT, V159, P122, DOI 10.1176/appi.ajp.159.1.122; Lightbody AA, 2009, DEV DISABIL RES REV, V15, P343, DOI 10.1002/ddrr.77; Lott IT, 2010, LANCET NEUROL, V9, P623, DOI 10.1016/S1474-4422(10)70112-5; Matre D, 2006, J NEUROSCI, V26, P559, DOI 10.1523/JNEUROSCI.4218-05.2006; Patel SM, 2005, NEUROGASTROENT MOTIL, V17, P332, DOI 10.1111/j.1365-2982.2005.00650.x; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Petrovic P, 2005, NEURON, V46, P957, DOI 10.1016/j.neuron.2005.05.023; Picker JD, 2013, ANN NEUROL, V74, P382, DOI 10.1002/ana.24002; Prasher VP, 2002, INT J GERIATR PSYCH, V17, P270, DOI 10.1002/gps.587; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; PUESCHEL SM, 1980, AM J DIS CHILD, V134, P838, DOI 10.1001/archpedi.1980.02130210022007; Rana JS, 2005, AM J CARDIOL, V95, P1456, DOI 10.1016/j.amjcard.2005.02.013; Rheims S, 2008, PLOS MED, V5, P1223, DOI 10.1371/journal.pmed.0050166; Rief W, 2009, J AFFECT DISORDERS, V118, P1, DOI 10.1016/j.jad.2009.01.029; Rothner AD, 2006, HEADACHE, V46, P101, DOI 10.1111/j.1526-4610.2006.00313.x; Rutherford BR, 2014, JAMA PSYCHIAT, V71, P1409, DOI 10.1001/jamapsychiatry.2014.1319; Sahu JK, 2013, J CHILD NEUROL, V28, P570, DOI 10.1177/0883073812449381; Sandler AD, 2000, J DEV BEHAV PEDIATR, V21, P347, DOI 10.1097/00004703-200010000-00005; Sauro MD, 2005, J PSYCHOSOM RES, V58, P115, DOI 10.1016/j.jpsychores.2004.07.001; SELIKOWITZ M, 1990, ARCH DIS CHILD, V65, P112, DOI 10.1136/adc.65.1.112; SMITH GF, 1984, J PEDIATR-US, V105, P228, DOI 10.1016/S0022-3476(84)80118-3; Talbot WA, 2013, EQUINE VET J, V45, P293, DOI 10.1111/j.2042-3306.2012.00618.x; Teipel SJ, 2006, BEHAV GENET, V36, P405, DOI 10.1007/s10519-006-9047-x; Torrioli MG, 2008, AM J MED GENET A, V146A, P803, DOI 10.1002/ajmg.a.32268; van Trotsenburg ASP, 2005, J CLIN ENDOCR METAB, V90, P3304, DOI 10.1210/jc.2005-0130; Vicari S, 2013, PSYCHIAT GENET, V23, P95, DOI 10.1097/YPG.0b013e32835fe426; Waber RL, 2008, JAMA-J AM MED ASSOC, V299, P1016, DOI 10.1001/jama.299.9.1016; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Walach HaM C., 1999, IS PLACEBO EFFECT DE, P321; WEATHERS C, 1983, AM J MENT DEF, V88, P214; Weimer K, 2013, PEDIATR RES, V74, P96, DOI 10.1038/pr.2013.66; Whalley B, 2013, J BEHAV MED, V36, P341, DOI 10.1007/s10865-012-9429-x; Williams KW, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003495.pub2; Zhang W, 2008, ANN RHEUM DIS, V67, P1716, DOI 10.1136/ard.2008.092015; Zubieta JK, 2005, J NEUROSCI, V25, P7754, DOI 10.1523/JNEUROSCI.0439-05.2005	84	32	32	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133316	10.1371/journal.pone.0133316	http://dx.doi.org/10.1371/journal.pone.0133316			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226597	Green Published, gold			2022-12-27	WOS:000358837700017
J	Garcia-Cobos, S; Kock, R; Mellmann, A; Frenzel, J; Friedrich, AW; Rossen, JWA				Garcia-Cobos, Silvia; Koeck, Robin; Mellmann, Alexander; Frenzel, Julia; Friedrich, Alexander W.; Rossen, John W. A.			Molecular Typing of Enterobacteriaceae from Pig Holdings in North-Western Germany Reveals Extended-Spectrum and AmpC beta-Lactamases Producing but no Carbapenem Resistant Ones	PLOS ONE			English	Article							FOOD-PRODUCING ANIMALS; RETAIL CHICKEN MEAT; ESCHERICHIA-COLI; PUBLIC-HEALTH; COMPANION ANIMALS; RISK-FACTORS; ANTIBIOTIC-RESISTANCE; CTX-M; PLASMIDS; HUMANS	The increase of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) in humans and in food-producing animals is of public health concern. The latter could contribute to spreading of these bacteria or their resistance genes to humans. Several studies have reported the isolation of third generation cephalosporin resistant bacteria in livestock animals. However, the number of samples and the methodology used differ considerably between studies limiting comparability and prevalence assessment. In the present study, a total of 564 manure and dust samples were collected from 47 pig farms in Northern Germany and analysed to determine the prevalence of ESBL-E. Molecular typing and characterization of resistance genes was performed for all ESBL-E isolates. ESBL-E isolates were found in 55.3% of the farms. ESBL-Escherichia coli was found in 18.8% of the samples, ESBL-Klebsiella pneumoniae in 0.35%. The most prevalent ESBL genes among E. coli were CTX-M-1 like (68.9%), CTX-M-15 like (16%) and CTX-M-9 group (14.2%). In 20% of the latter two, also the OXA-1 like gene was found resulting in a combination of genes typical for isolates from humans. Genetic relation was found between isolates not only from the same, but also from different farms, with multilocus sequence type (ST) 10 being predominant among the E. coli isolates. In conclusion, we showed possible spread of ESBL-E between farms and the presence of resistance genes and STs previously shown to be associated with human isolates. Follow-up studies are required to monitor the extent and pathways of ESBL-E transmission between farms, animals and humans.	[Garcia-Cobos, Silvia; Frenzel, Julia; Friedrich, Alexander W.; Rossen, John W. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Koeck, Robin] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [Mellmann, Alexander] Univ Hosp Munster, Inst Hyg, Munster, Germany	University of Groningen; University of Munster; University of Munster	Rossen, JWA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.	j.rossen@umcg.nl	Köck, Robin/AAC-1552-2019; Rossen, John W/G-7564-2011; GARCÍA-COBOS, SILVIA/A-7087-2017; Friedrich, Alex/ABG-9823-2020	Rossen, John W/0000-0002-7167-8623; GARCÍA-COBOS, SILVIA/0000-0002-1417-5691; Mellmann, Alexander/0000-0002-0649-5185	European Union [III-2-03_025, III-1-02_073]	European Union(European Commission)	This work was supported by the SafeGuard (grant III-2-03_025) and EurSafety Health-net (grant III-1-02_073) projects within the INTERREG IVa program of the European Union.	Bae IK, 2014, DIAGN MICR INFEC DIS, V79, P373, DOI 10.1016/j.diagmicrobio.2014.03.007; Bielaszewska M, 2007, APPL ENVIRON MICROB, V73, P3144, DOI 10.1128/AEM.02937-06; Bolton DJ, 2013, INT J FOOD MICROBIOL, V160, P298, DOI 10.1016/j.ijfoodmicro.2012.11.001; Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Campos CB, 2014, INT J MED MICROBIOL, V304, P678, DOI 10.1016/j.ijmm.2014.04.012; Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x; Cuzon G, 2012, J ANTIMICROB CHEMOTH, V67, P1865, DOI 10.1093/jac/dks156; de Been M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004776; Deplano A, 2011, J CLIN MICROBIOL, V49, P3616, DOI 10.1128/JCM.00528-11; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Escudero E, 2010, RES VET SCI, V88, P83, DOI 10.1016/j.rvsc.2009.05.021; EUCAST, CLIN BREAKP TABL V 5; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Friese A, 2013, BERL MUNCH TIERARZTL, V126, P175, DOI 10.2376/0005-9366-126-175; Goering RV, 2013, EURO SURVEILL, V18; Goncalves A, 2010, FOODBORNE PATHOG DIS, V7, P1569, DOI 10.1089/fpd.2010.0598; Guerra B, 2014, VET MICROBIOL, V171, P290, DOI 10.1016/j.vetmic.2014.02.001; Hansen KH, 2013, APPL ENVIRON MICROB, V79, P794, DOI 10.1128/AEM.02399-12; Hering J, 2014, PREV VET MED, V116, P129, DOI 10.1016/j.prevetmed.2014.06.014; Horton RA, 2011, APPL ENVIRON MICROB, V77, P3715, DOI 10.1128/AEM.02831-10; Huijbers PMC, 2013, CLIN MICROBIOL INFEC, V19, pE256, DOI 10.1111/1469-0691.12150; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Kluytmans-van den Bergh MFQ, 2015, J CLIN MICROBIOL, DOI [10.1128/JCM.01251-15, DOI 10.1128/JCM.01251-15]; Kola A, 2012, J ANTIMICROB CHEMOTH, V67, P2631, DOI 10.1093/jac/dks295; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Liebana E, 2013, CLIN INFECT DIS, V56, P1030, DOI 10.1093/cid/cis1043; Literak I, 2013, MICROB DRUG RESIST, V19, P57, DOI 10.1089/mdr.2012.0124; Machado E, 2008, J ANTIMICROB CHEMOTH, V62, P296, DOI 10.1093/jac/dkn179; Meyer E, 2012, INFECTION, V40, P685, DOI 10.1007/s15010-012-0324-8; Moodley A, 2009, ANTIMICROB AGENTS CH, V53, P1709, DOI 10.1128/AAC.01014-08; Ojer-Usoz E, 2013, MEAT SCI, V93, P316, DOI 10.1016/j.meatsci.2012.09.009; Ortega A, 2012, ANTIMICROB AGENTS CH, V56, P3576, DOI 10.1128/AAC.06393-11; Oteo J, 2009, INT J ANTIMICROB AG, V34, P173, DOI 10.1016/j.ijantimicag.2009.03.006; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Randall LP, 2014, J ANTIMICROB CHEMOTH, V69, P2947, DOI 10.1093/jac/dku258; Rayamajhi N, 2008, INT J FOOD MICROBIOL, V124, P183, DOI 10.1016/j.ijfoodmicro.2008.03.009; Reuland EA, 2014, EUR J CLIN MICROBIOL, V33, P1843, DOI 10.1007/s10096-014-2142-7; Rodrigues C, 2013, J ANTIMICROB CHEMOTH, V68, P2245, DOI 10.1093/jac/dkt187; Schink AK, 2013, J ANTIMICROB CHEMOTH, V68, P1741, DOI 10.1093/jac/dkt123; Seiffert SN, 2013, DRUG RESIST UPDATE, V16, P22, DOI 10.1016/j.drup.2012.12.001; Shahada F, 2011, ANTIMICROB AGENTS CH, V55, P4114, DOI 10.1128/AAC.00560-11; Shaheen BW, 2011, ANTIMICROB AGENTS CH, V55, P5666, DOI 10.1128/AAC.00656-11; Smet A, 2010, FEMS MICROBIOL REV, V34, P295, DOI 10.1111/j.1574-6976.2009.00198.x; Strauss LM, 2015, J ANTIMICROB CHEMOTH, V70, P710, DOI 10.1093/jac/dku450; Stuart JC, 2012, INT J FOOD MICROBIOL, V154, P212, DOI 10.1016/j.ijfoodmicro.2011.12.034; Thai TH, 2012, J FOOD PROTECT, V75, P1709, DOI 10.4315/0362-028X.12-101; Valentin L, 2014, INT J MED MICROBIOL, V304, P805, DOI 10.1016/j.ijmm.2014.07.015; Valenza G, 2014, ANTIMICROB AGENTS CH, V58, P1228, DOI 10.1128/AAC.01993-13; von Salviati C, 2015, VET MICROBIOL, V175, P77, DOI 10.1016/j.vetmic.2014.10.010; Wang J, 2014, J ANTIMICROB CHEMOTH, V69, P2658, DOI 10.1093/jac/dku206; Wang J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00188; Wu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075392	52	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134533	10.1371/journal.pone.0134533	http://dx.doi.org/10.1371/journal.pone.0134533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225428	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700108
J	Lahmann, C; Kramer, HB; Ashcroft, FM				Lahmann, Carolina; Kramer, Holger B.; Ashcroft, Frances M.			Systemic Administration of Glibenclamide Fails to Achieve Therapeutic Levels in the Brain and Cerebrospinal Fluid of Rodents	PLOS ONE			English	Article							K-ATP CHANNEL; DRUG-METABOLIZING-ENZYMES; CANCER RESISTANCE PROTEIN; PANCREATIC BETA-CELLS; DEND SYNDROME; ACTIVATING MUTATIONS; DEVELOPMENTAL DELAY; ORAL SULFONYLUREAS; SUBUNIT KIR6.2; P-GLYCOPROTEIN	Activating mutations in the Kir6.2 (KCNJ11) subunit of the ATP-sensitive potassium channel cause neonatal diabetes (ND). Patients with severe mutations also suffer from neurological complications. Glibenclamide blocks the open KATP channels and is the treatment of choice for ND. However, although glibenclamide successfully restores normoglycaemia, it has a far more limited effect on the neurological problems. To assess the extent to which glibenclamide crosses the blood-brain barrier (BBB) in vivo, we quantified glibenclamide concentrations in plasma, cerebrospinal fluid (CSF), and brain tissue of rats, control mice, and mice expressing a human neonatal diabetes mutation (Kir6.2-V59M) selectively in neurones (nV59M mice). As only small sample volumes can be obtained from rodents, we developed a highly sensitive method of analysis, using liquid chromatography tandem mass spectrometry acquisition with pseudo-selected reaction monitoring, achieving a quantification limit of 10ng/ml (20nM) glibenclamide in a 30 mu l sample. Glibenclamide was not detectable in the CSF or brain of rats after implantation with subcutaneous glibenclamide pellets, despite high plasma concentrations. Further, one hour after a suprapharmacological glibenclamide dose was administered directly into the lateral ventricle of the brain, the plasma concentration was twice that of the CSF. This suggests the drug is rapidly exported from the CSF. Elacridar, an inhibitor of P-glycoprotein and breast cancer resistance protein (major multidrug resistance transporters at the BBB), did not affect glibenclamide levels in CSF and brain tissue. We also identified a reduced sensitivity to volatile anaesthetics in nV59M mice and showed this was not reversed by systemic delivery of glibenclamide. Our results therefore suggest that little glibenclamide reaches the central nervous system when given systemically, that glibenclamide is rapidly removed across the BBB when given intracranioventricularly, and that any glibenclamide that does enter (and is below our detection limit) is insufficient to influence neuronal function as assessed by anaesthesia sensitivity.	[Ashcroft, Frances M.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; Univ Oxford, OXION, Oxford, England	University of Oxford; University of Oxford	Ashcroft, FM (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	frances.ashcroft@dpag.ox.ac.uk	Kramer, Holger/AAL-4433-2020	Kramer, Holger/0000-0002-6400-0945	Wellcome Trust [084655/Z/08/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by Wellcome Trust grant to OXION (084655/Z/08/Z) to CL HBK FMA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 1999, CANCER RES, V59, P4237; Anderson GD, 2005, J WOMENS HEALTH, V14, P19, DOI 10.1089/jwh.2005.14.19; Battaglia D, 2012, PEDIATR DIABETES, V13, P656, DOI 10.1111/j.1399-5448.2012.00874.x; Bauer M, 2013, J NUCL MED, V54, P1181, DOI 10.2967/jnumed.112.118232; Bessadok A, 2011, J BIOL CHEM, V286, P3552, DOI 10.1074/jbc.M110.155200; Clark RH, 2010, SCIENCE, V329, P458, DOI 10.1126/science.1186146; Della Manna T, 2008, ARQ BRAS ENDOCRINOL, V52, P1350, DOI 10.1590/S0004-27302008000800024; Do TM, 2012, J ALZHEIMERS DIS, V30, P155, DOI 10.3233/JAD-2012-112189; Edghill EL, 2010, REV ENDOCR METAB DIS, V11, P193, DOI 10.1007/s11154-010-9149-x; Fendler W, 2013, DIABETES CARE, V36, P2311, DOI 10.2337/dc12-2166; Gedeon C, 2006, PLACENTA, V27, P1096, DOI 10.1016/j.placenta.2005.11.012; Girard CA, 2009, J CLIN INVEST, V119, P80, DOI 10.1172/JCI35772; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Golstein PE, 1999, PFLUG ARCH EUR J PHY, V437, P652, DOI 10.1007/s004240050829; Gribble FM, 2003, DIABETOLOGIA, V46, P875, DOI 10.1007/s00125-003-1143-3; Gurgel LC, 2007, DIABETES CARE, V30, P108, DOI DOI 10.2337/DC07-1196; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; HENQUIN JC, 1992, DIABETOLOGIA, V35, P907, DOI 10.1007/BF00401417; Hopfgartner G, 2003, MASS SPECTROM REV, V22, P195, DOI 10.1002/mas.10050; Itoh S, 2013, J PEDIATR ENDOCR MET, V26, P143, DOI 10.1515/jpem-2012-0236; Karibe T, 2015, PHARM RES-DORDR, V32, P1634, DOI 10.1007/s11095-014-1563-4; Karschin C, 1997, FEBS LETT, V401, P59, DOI 10.1016/S0014-5793(96)01438-X; Koster JC, 2008, BIOPHYS J, V95, P4689, DOI 10.1529/biophysj.108.138685; Masia R, 2007, DIABETES, V56, P328, DOI 10.2337/db06-1275; Mlynarski WC, 2007, NAT CLIN PRACT NEURO, V3, P640, DOI 10.1038/ncpneuro0640; MOURRE C, 1990, BRAIN RES, V519, P29, DOI 10.1016/0006-8993(90)90057-I; Myngheer N, 2014, DIABETES CARE, V37, P3333, DOI 10.2337/dc14-1247; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; PEARSON JG, 1985, AM J MED, V79, P67, DOI 10.1016/S0002-9343(85)80010-3; Proks P, 2013, DIABETES, V62, P3909, DOI 10.2337/db13-0531; Rafiq M, 2008, DIABETES CARE, V31, P204, DOI 10.2337/dc07-1785; Remedi MS, 2008, PLOS MED, V5, P1473, DOI 10.1371/journal.pmed.0050206; Sapunar Damir, 2012, J Pain Res, V5, P31, DOI 10.2147/JPR.S26603; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Shawahna R, 2011, MOL PHARMACEUT, V8, P1332, DOI 10.1021/mp200129p; Shimomura K, 2007, NEUROLOGY, V69, P1342, DOI 10.1212/01.wnl.0000268488.51776.53; Slingerland AS, 2008, DIABETIC MED, V25, P277, DOI 10.1111/j.1464-5491.2007.02373.x; Slingerland AS, 2006, DIABETOLOGIA, V49, P2559, DOI 10.1007/s00125-006-0407-0; Takanaga H, 1998, J PHARM PHARMACOL, V50, P1027, DOI 10.1111/j.2042-7158.1998.tb06918.x; Tournier N, 2013, AAPS J, V15, P1082, DOI 10.1208/s12248-013-9514-2; Ward KW, 2004, J PHARMACOL EXP THER, V310, P703, DOI 10.1124/jpet.104.068288; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Yao XQ, 1996, J CLIN INVEST, V97, P2525, DOI 10.1172/JCI118700; Zwaveling-Soonawala N, 2011, DIABETOLOGIA, V54, P469, DOI 10.1007/s00125-010-1981-8	44	53	54	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134476	10.1371/journal.pone.0134476	http://dx.doi.org/10.1371/journal.pone.0134476			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225433	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700098
J	Li, Q; Yang, F; Liu, R; Luo, L; Yang, YL; Zhang, L; Liu, H; Zhang, W; Fan, ZX; Yang, ZQ; Cui, LW; He, YS				Li, Qing; Yang, Fang; Liu, Rong; Luo, Lan; Yang, Yuling; Zhang, Lu; Liu, Huaie; Zhang, Wen; Fan, Zhixiang; Yang, Zhaoqing; Cui, Liwang; He, Yongshu			Prevalence and Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency at the China-Myanmar Border	PLOS ONE			English	Article							G6PD DEFICIENCY; PLASMODIUM-FALCIPARUM; CAMBODIAN POPULATION; COMMON VARIANT; ORANG ASLI; MUTATIONS; MALARIA; THAILAND; SPREAD; 871G-GREATER-THAN-A	Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked hereditary disease that predisposes red blood cells to oxidative damage. G6PD deficiency is particularly prevalent in historically malaria-endemic areas. Use of primaquine for malaria treatment may result in severe hemolysis in G6PD deficient patients. In this study, we systematically evaluated the prevalence of G6PD deficiency in the Kachin (Jingpo) ethnic group along the China-Myanmar border and determined the underlying G6PD genotypes. We surveyed G6PD deficiency in 1770 adult individuals (671 males and 1099 females) of the Kachin ethnicity using a G6PD fluorescent spot test. The overall prevalence of G6PD deficiency in the study population was 29.6% (523/1770), among which 27.9% and 30.6% were males and females, respectively. From these G6PD deficient samples, 198 unrelated individuals (147 females and 51 males) were selected for genotyping at 11 known G6PD single nucleotide polymorphisms (SNPs) in Southeast Asia (ten in exons and one in intron 11) using a multiplex SNaPshot assay. Mutations with known association to a deficient phenotype were detected in 43.9% (87/198) of cases, intronic and synonymous mutations were detected alone in 34.8% (69/198) cases and no mutation were found in 21.2% (42/198) cases. Five non-synonymous mutations, Mahidol 487G>A, Kaiping 1388G>A, Canton 1376G>T, Chinese 4 392G>T, and Viangchan 871G>A were detected. Of the 87 cases with known deficient mutations, the Mahidol variant was the most common (89.7%; 78/87), followed by the Kaiping (8.0%; 7/87) and the Viangchan (2.2%; 2/87) variants. The Canton and Chinese 4 variants were found in 1.1% of these 87 cases. Among them, two females carried the Mahidol/Viangchan and Mahidol/Kaiping double mutations, respectively. Interestingly, the silent SNPs 1311C>T and IVS11nt93T>C both occurred in the same 95 subjects with frequencies at 56.4% and 23.5% in tested females and males, respectively (P<0.05). It is noteworthy that 24 subjects carrying the Mahidol mutation and two carrying the Kaiping mutation also carried the 1311C>T/IVS11nt93T>C SNPs. Further studies are needed to determine the enzyme levels of the G6PD deficient people and presence of additional G6PD mutations in the study population.	[Li, Qing; Yang, Fang; Luo, Lan; Yang, Yuling; Zhang, Lu; Zhang, Wen; Fan, Zhixiang; He, Yongshu] Kunming Med Univ, Dept Cell Biol & Med Genet, Kunming, Yunnan, Peoples R China; [Liu, Rong; Liu, Huaie] Kunming Med Univ, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Yang, Zhaoqing] Kunming Med Univ, Dept Pathogen Biol & Immunol, Kunming, Yunnan, Peoples R China; [Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Kunming Medical University; Kunming Medical University; Kunming Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cui, LW (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	luc2@psu.edu; yongshuhe@hotmail.com			National Natural Science Foundation of China [31260264]; High Talents introduction project of Yunnan province [2013HA026]; National Institute of Allergy and Infectious Diseases, National Institutes of Health [NIH U19AI089672]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089672] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Talents introduction project of Yunnan province; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Natural Science Foundation of China (# 31260264), High Talents introduction project of Yunnan province (# 2013HA026), and the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH U19AI089672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVING A S, 1960, Bull World Health Organ, V22, P621; Amini F, 2011, INTERN MED J, V41, P351, DOI 10.1111/j.1445-5994.2011.02456.x; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Ashley EA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-418; Baird JK, 2011, CLIN INFECT DIS, V52, P621, DOI 10.1093/cid/ciq258; Bancone G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116063; BEUTLER E, 1968, BLOOD, V32, P816, DOI 10.1182/blood.V32.5.816.816; Beutler E, 1996, BLOOD REV, V10, P45, DOI 10.1016/S0268-960X(96)90019-3; BEUTLER E, 1990, AM J HUM GENET, V47, P1008; Charoenkwan P, 2014, SE ASIAN J TROP MED, V45, P187; CHEN EY, 1991, GENOMICS, V10, P792, DOI 10.1016/0888-7543(91)90465-Q; Cui LW, 2012, ACTA TROP, V121, P227, DOI 10.1016/j.actatropica.2011.02.016; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; Gomez-Manzo S, 2014, INT J MOL SCI, V15, P21179, DOI 10.3390/ijms151121179; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Howes RE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-418; Howes RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001339; Huang YX, 2008, MOL GENET METAB, V93, P44, DOI 10.1016/j.ymgme.2007.08.122; Jiang WY, 2006, HUM GENET, V119, P463, DOI 10.1007/s00439-005-0126-5; KURDIHAIDAR B, 1990, AM J HUM GENET, V47, P1013; Laosombat V, 2005, BLOOD CELL MOL DIS, V34, P191, DOI 10.1016/j.bcmd.2004.11.001; Li NN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-361; Lin M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123991; Louicharoen C, 2005, J HUM GENET, V50, P448, DOI 10.1007/s10038-005-0276-2; Louicharoen C, 2009, SCIENCE, V326, P1546, DOI 10.1126/science.1178849; Matsuoka H, 2005, J HUM GENET, V50, P468, DOI 10.1007/s10038-005-0279-z; Matsuoka H, 2004, J HUM GENET, V49, P544, DOI 10.1007/s10038-004-0187-7; Minucci A, 2012, BLOOD CELL MOL DIS, V48, P154, DOI 10.1016/j.bcmd.2012.01.001; Moiz B, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-41; Monteiro WM, 2014, MEM I OSWALDO CRUZ, V109, P553, DOI 10.1590/0074-0276140123; Nantakomol D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-289; Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005; Nuchprayoon I, 2008, J HUM GENET, V53, P48, DOI 10.1007/s10038-007-0217-3; PANICH V, 1972, Journal of the Medical Association of Thailand, V55, P576; Phompradit P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-368; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Summerer M, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-17; Tanphaichitr V S, 1995, Southeast Asian J Trop Med Public Health, V26 Suppl 1, P137; Taylor W, 2012, SE ASIAN J TROP MED, V44, P231; Tun KM, 2015, LANCET INFECT DIS, V15, P415, DOI 10.1016/S1473-3099(15)70032-0; Wang JC, 2008, ACTA MED OKAYAMA, V62, P327; White NJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-418; Yang YF, 2007, SCI CHINA SER C, V50, P479, DOI 10.1007/s11427-007-0072-7; Yang Z, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P259; Yu Guo-long, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P448; Yu Guo-long, 2004, Zhonghua Xue Ye Xue Za Zhi, V25, P610; Zhang L, 2015, INT J LAB H IN PRESS	47	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134593	10.1371/journal.pone.0134593	http://dx.doi.org/10.1371/journal.pone.0134593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226515	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700116
J	Miftahussurur, M; Sharma, RP; Shrestha, PK; Suzuki, R; Uchida, T; Yamaoka, Y				Miftahussurur, Muhammad; Sharma, Rabi Prakash; Shrestha, Pradeep Krishna; Suzuki, Rumiko; Uchida, Tomohisa; Yamaoka, Yoshio			Molecular Epidemiology of Helicobacter pylori Infection in Nepal: Specific Ancestor Root	PLOS ONE			English	Article							CYTOTOXIN PRODUCTION; VIRULENCE FACTORS; CAGA; PREVALENCE; GENOTYPES; VACA; ASSOCIATION; MECHANISMS; DIVERSITY; DISEASE	Prevalence of Helicobacter pylori infection in Nepal, a low-risk country for gastric cancer, is debatable. To our knowledge, no studies have examined H. pylori virulence factors in Nepal. We determined the prevalence of H. pylori infection by using three different tests, and the genotypes of virulence factors were determined by PCR followed by sequencing. Multilocus sequence typing was used to analyze the population structure of the Nepalese strains. The prevalence of H. pylori infection in dyspeptic patients was 38.4% (56/146), and was significantly related with source of drinking water. In total, 51 strains were isolated and all were cagA-positive. Western-type-cagA (94.1%), cagA pre-EPIYA type with no deletion (92.2%), vacA s1a (74.5%), and m1c (54.9%) were the predominant genotypes. Antral mucosal atrophy levels were significantly higher in patients infected with vacA s1 than in those infected with s2 genotypes (P = 0.03). Several Nepalese strains were H. pylori recombinants with genetic features of South Asian and East Asian genotypes. These included all East-Asian-type-cagA strains, with significantly lesser activity and inflammation in the corpus than the strains of the specific South Asian genotype (P = 0.03 and P = 0.005, respectively). Although the population structure confirmed that most Nepalese strains belonged to the hpAsia2 population, some strains shared hpEurope- and Nepalese-specific components. Nepalese patients infected with strains belonging to hpEurope showed higher inflammation in the antrum than strains from the Nepalese specific population (P = 0.05). These results support that ancestor roots of Kathmandu's people not only connected with India alone.	[Miftahussurur, Muhammad; Suzuki, Rumiko; Yamaoka, Yoshio] Oita Univ, Dept Environm & Prevent Med, Fac Med, Yufu City, Oita, Japan; [Miftahussurur, Muhammad] Airlangga Univ, Fac Med, Dept Internal Med, Gastroenterohepatol Div, Surabaya, Indonesia; [Miftahussurur, Muhammad] Airlangga Univ, Inst Trop Dis, Surabaya, Indonesia; [Sharma, Rabi Prakash; Shrestha, Pradeep Krishna] Tribhuvan Univ Teaching Hosp, Dept Gastroenterol, Kathmandu, Nepal; [Uchida, Tomohisa] Oita Univ, Dept Mol Pathol, Fac Med, Yufu City, Oita, Japan; [Yamaoka, Yoshio] Baylor Coll Med, Dept Med Gastroenterol, Houston, TX 77030 USA; [Yamaoka, Yoshio] Michael E DeBakey VA Med Ctr, Houston, TX USA	Oita University; Airlangga University; Airlangga University; Tribhuvan University; Institute of Medicine (IoM) - Nepal; Oita University; Baylor College of Medicine; Baylor College of Medicine	Yamaoka, Y (corresponding author), Oita Univ, Dept Environm & Prevent Med, Fac Med, Yufu City, Oita, Japan.	yyamaoka@oita-u.ac.jp	Miftahussurur, Muhammad/AAB-6151-2021	Miftahussurur, Muhammad/0000-0003-1415-6033; Yamaoka, Yoshio/0000-0002-1222-5819	National Institutes of Health [DK62813]; Ministry of Education, Culture, Sports, Science, and Technology(MEXT) of Japan [24406015, 24659200, 25293104, 26640114, 15H02657]; Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits; Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST); Japanese Government (Monbukagakusho: MEXT) Scholarship Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062813] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26440198] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology(MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST); Japanese Government (Monbukagakusho: MEXT) Scholarship Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the National Institutes of Health (DK62813) and the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology(MEXT) of Japan (24406015, 24659200, 25293104, 26640114 and 15H02657) (YY). It was also supported by the Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits (YY), the Strategic Funds for the Promotion of Science and Technology from Japan Science and Technology Agency (JST) (YY). MM is a PhD student supported by The Japanese Government (Monbukagakusho: MEXT) Scholarship Program for 2012.	ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Bornschein J, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-10; Chomvarin C, 2008, INT J INFECT DIS, V12, P30, DOI 10.1016/j.ijid.2007.03.012; Devi SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-184; Dhakhwa R, 2012, J Nepal Health Res Counc, V10, P57; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Dube C., 2009, Reviews on Environmental Health, V24, P1; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Gayden T, 2013, AM J PHYS ANTHROPOL, V151, P169, DOI 10.1002/ajpa.22240; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Kraft C, 2005, INT J MED MICROBIOL, V295, P299, DOI 10.1016/j.ijmm.2005.06.002; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Lee YY, 2012, HELICOBACTER, V17, P54, DOI 10.1111/j.1523-5378.2011.00917.x; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Makaju R K, 2005, Kathmandu Univ Med J (KUMJ), V3, P355; Matsuhisa T, 2007, Kathmandu Univ Med J (KUMJ), V5, P295; Matsunari O, 2012, J CLIN MICROBIOL, V50, P876, DOI 10.1128/JCM.05562-11; Miftahussurur M, 2015, EPIDEMIOL INFECT, V143, P986, DOI 10.1017/S095026881400154X; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Mukhopadhyay AK, 2000, J BACTERIOL, V182, P3219, DOI 10.1128/JB.182.11.3219-3227.2000; Rahman M, 2003, J CLIN MICROBIOL, V41, P2008, DOI 10.1128/JCM.41.5.2008-2014.2003; Rugge M, 2007, GUT, V56, P631, DOI 10.1136/gut.2006.106666; Salaun L, 2004, MICROBIOL-SGM, V150, P817, DOI 10.1099/mic.0.26993-0; Saribasak H, 2004, J CLIN MICROBIOL, V42, P1648, DOI 10.1128/JCM.42.4.1648-1651.2004; Sherpa Tshering W, 2012, N Z Med J, V125, P30; Shrestha Roshana, 2014, J Family Med Prim Care, V3, P154, DOI 10.4103/2249-4863.137663; Shrestha S, 2012, Nepal Med Coll J, V14, P229; Sodhi JS, 2013, J GASTROEN HEPATOL, V28, P808, DOI 10.1111/jgh.12178; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suerbaum S, 1999, TRENDS MICROBIOL, V7, P182, DOI 10.1016/S0966-842X(99)01505-X; Suzuki H, 2009, GASTRIC CANCER, V12, P79, DOI 10.1007/s10120-009-0507-x; Suzuki R, 2012, INFECT GENET EVOL, V12, P203, DOI 10.1016/j.meegid.2011.12.002; Thapa R, 2013, J NEPAL MED ASSOC, V52, P354; Uchida T, 2007, CANCER SCI, V98, P521, DOI 10.1111/j.1349-7006.2007.00415.x; Uchida T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-175; Vilaichone RK, 2013, WORLD J GASTROENTERO, V19, P2806, DOI 10.3748/wjg.v19.i18.2806; Vilaichone RK, 2004, HELICOBACTER, V9, P453, DOI 10.1111/j.1083-4389.2004.00260.x; Wirth T, 2004, P NATL ACAD SCI USA, V101, P4746, DOI 10.1073/pnas.0306629101; Yamaoka Y, 1999, GASTROENTEROLOGY, V117, P342, DOI 10.1053/gast.1999.0029900342; Yamaoka Y, 1998, HELICOBACTER, V3, P241, DOI 10.1046/j.1523-5378.1998.08056.x; Yamaoka Y, 2002, FEBS LETT, V517, P180, DOI 10.1016/S0014-5793(02)02617-0; Yamaoka Y, 2009, CLIN MICROBIOL INFEC, V15, P829, DOI 10.1111/j.1469-0691.2009.02967.x; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154; Yamaoka Y, 2008, INTERNAL MED, V47, P1077, DOI 10.2169/internalmedicine.47.0975; Yamazaki S, 2005, J CLIN MICROBIOL, V43, P3906, DOI 10.1128/JCM.43.8.3906-3916.2005	48	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134216	10.1371/journal.pone.0134216	http://dx.doi.org/10.1371/journal.pone.0134216			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226153	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000358837700063
J	Shim, WH; Kim, HS; Choi, CG; Kim, SJ				Shim, Woo Hyun; Kim, Ho Sung; Choi, Choong-Gon; Kim, Sang Joon			Comparison of Apparent Diffusion Coefficient and Intravoxel Incoherent Motion for Differentiating among Glioblastoma, Metastasis, and Lymphoma Focusing on Diffusion-Related Parameter	PLOS ONE			English	Article							NERVOUS-SYSTEM LYMPHOMA; BRAIN-TUMORS; PERFUSION; EXPERIENCE; UTILITY; LESIONS; LIVER	Background and Purpose Brain tumor cellularity has been assessed by using apparent diffusion coefficient (ADC). However, the ADC value might be influenced by both perfusion and true molecular diffusion, and the perfusion effect on ADC can limit the reliability of ADC in the characterization of tumor cellularity, especially, in hypervascular brain tumors. In contrast, the IVIM technique estimates parameter values for diffusion and perfusion effects separately. The purpose of our study was to compare ADC and IVIM for differentiating among glioblastoma, metastatic tumor, and primary CNS lymphoma (PCNSL) focusing on diffusion-related parameter. Materials and Methods We retrospectively reviewed the data of 128 patients with pathologically confirmed glioblastoma (n = 55), metastasis (n = 31), and PCNSL (n = 42) prior to any treatment. Two neuroradiologists independently calculated the maximum IVIM-f (f(max)) and minimum IVIM-D (D-min) by using 16 different b-values with a bi-exponential fitting of diffusion signal decay, minimum ADC (ADC(min)) by using 0 and 1000 b-values with a mono-exponential fitting and maximum normalized cerebral blood volume (nCBV(max)). The differences in f(max), D-min, nCBV(max), and ADC(min) among the three tumor pathologies were determined by one-way ANOVA with multiple comparisons. The f(max) and D-min were correlated to the corresponding nCBV and ADC using partial correlation analysis, respectively. Results Using a mono-exponential fitting of diffusion signal decay, the mean ADC(min) was significantly lower in PCNSL than in glioblastoma and metastasis. However, using a bi-exponential fitting, the mean D-min did not significantly differ in the three groups. The mean f(max) significantly increased in the glioblastomas (reader 1, 0.103; reader 2, 0.109) and the metastasis (reader 1, 0.105; reader 2, 0.107), compared to the primary CNS lymphomas (reader 1, 0.025; reader 2, 0.023) (P < .001 for each). The correlation between f(max) and the corresponding nCBV was highest in glioblastoma group, and the correlation between D-min and the corresponding ADC was highest in primary CNS lymphomas group. Conclusion Unlike ADC value derived from a mono-exponential fitting of diffusion signal, diffusion-related parametric value derived from a bi-exponential fitting with separation of perfusion effect doesn't differ among glioblastoma, metastasis, and PCNSL.	[Kim, Ho Sung] Univ Ulsan, Coll Med, Dept Radiol, Asan Med Ctr, Seoul, South Korea; Univ Ulsan, Asan Med Ctr, Coll Med, Res Inst Radiol, Seoul, South Korea	University of Ulsan; University of Ulsan; Asan Medical Center	Kim, HS (corresponding author), Univ Ulsan, Coll Med, Dept Radiol, Asan Med Ctr, Seoul, South Korea.	radhskim@gmail.com						Andreou A, 2013, EUR RADIOL, V23, P428, DOI 10.1007/s00330-012-2604-1; Bisdas S, 2013, NEURORADIOLOGY, V55, P1189, DOI 10.1007/s00234-013-1229-7; Federau C, 2012, RADIOLOGY, V265, P874, DOI 10.1148/radiol.12120584; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Hakyemez B, 2006, J MAGN RESON IMAGING, V24, P817, DOI 10.1002/jmri.20707; Kim DY, 2014, AM J NEURORADIOL, V35, P2082, DOI 10.3174/ajnr.A3995; Kim HS, 2014, AM J NEURORADIOL, V35, P490, DOI 10.3174/ajnr.A3719; Koeller KK, 1997, RADIOGRAPHICS, V17, P1497, DOI 10.1148/radiographics.17.6.9397461; Le Bihan D, 2008, RADIOLOGY, V249, P748, DOI 10.1148/radiol.2493081301; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lee IH, 2010, EUR J RADIOL, V76, P48, DOI 10.1016/j.ejrad.2009.05.013; Lemke A, 2011, MAGN RESON IMAGING, V29, P766, DOI 10.1016/j.mri.2011.03.004; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Sigmund EE, 2011, MAGN RESON MED, V65, P1437, DOI 10.1002/mrm.22740; Suh CH, 2014, RADIOLOGY, V272, P504, DOI 10.1148/radiol.14131895; Sundgren PC, 2006, MAGN RESON IMAGING, V24, P1131, DOI 10.1016/j.mri.2006.07.008; Toh CH, 2008, AM J NEURORADIOL, V29, P471, DOI 10.3174/ajnr.A0872; Weber MA, 2006, NEUROLOGY, V66, P1899, DOI 10.1212/01.wnl.0000219767.49705.9c; Yamasaki F, 2005, RADIOLOGY, V235, P985, DOI 10.1148/radiol.2353031338	19	30	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134761	10.1371/journal.pone.0134761	http://dx.doi.org/10.1371/journal.pone.0134761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225937	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700132
J	Sinnett, PM; Carr, B; Cook, G; Mucklerath, H; Varney, L; Weiher, M; Yerokhin, V; Vassar, M				Sinnett, Philip Marcus; Carr, Branden; Cook, Gregory; Mucklerath, Halie; Varney, Laura; Weiher, Matt; Yerokhin, Vadim; Vassar, Matt			Systematic Reviewers in Clinical Neurology Do Not Routinely Search Clinical Trials Registries	PLOS ONE			English	Article							PUBLICATION BIAS	We examined the use of clinical trials registries in published systematic reviews and meta-analyses from clinical neurology. A review of publications between January 1, 2008 and December 31, 2014 from five neuroscience journals (Annals of Neurology, Brain, Lancet Neurology, Neurology, and The Neuroscientist) was performed to identify eligible systematic reviews. The systematic reviews comprising the final sample were independently appraised to determine if clinical trials registries had been included as part of the search process. Studies acknowledging the use of a trials registry were further examined to determine whether trial data had been incorporated into the analysis. The initial search yielded 194 studies, of which 78 systematic reviews met the selection criteria. Of those, five acknowledged the use of a specific clinical trials registry: four reviewed unpublished trial data and two incorporated unpublished trial data into their results. Based on our sample of systematic reviews, there was no increase in the use of trials registries in systematic review searches over time. Few systematic reviews published in clinical neurology journals included data from relevant clinical trials registries.	[Sinnett, Philip Marcus; Carr, Branden; Cook, Gregory; Mucklerath, Halie; Varney, Laura; Weiher, Matt; Yerokhin, Vadim; Vassar, Matt] Oklahoma State Univ, Ctr Hlth Sci, Tulsa, OK 74106 USA	Oklahoma State University System; Oklahoma State University Center for Health Sciences	Vassar, M (corresponding author), Oklahoma State Univ, Ctr Hlth Sci, Tulsa, OK 74106 USA.	matt.vassar@okstate.edu	Yerokhin, Vadim/O-7068-2018; Vassar, Matt/AAD-5385-2020	Yerokhin, Vadim/0000-0002-7976-0736; Vassar, Ben Matthew/0000-0003-2859-6152				Clinicialtrials.gov, TRENDS CHARTS MAPS; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Hart B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7202; Jones CW, 2014, SYST REV, V3, DOI 10.1186/2046-4053-3-126; Liebeskind DS, 2006, NEUROLOGY, V67, P973, DOI 10.1212/01.wnl.0000237331.16541.ac; Liu Shimin, 2009, J Exp Stroke Transl Med, V2, P16; Montori VM, 2005, BMJ-BRIT MED J, V330, P68, DOI 10.1136/bmj.38336.804167.47; Schroll JB, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2231; WHO, INT CLIN TRIALS REG; World Health Organization, WHO STAT PUBL DISCL	12	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134596	10.1371/journal.pone.0134596	http://dx.doi.org/10.1371/journal.pone.0134596			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225564	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700119
J	Regan, T; Levesque, JV; Lambert, SD; Kelly, B				Regan, Tim; Levesque, Janelle V.; Lambert, Sylvie D.; Kelly, Brian			A Qualitative Investigation of Health Care Professionals', Patients' and Partners' Views on Psychosocial Issues and Related Interventions for Couples Coping with Cancer	PLOS ONE			English	Article							COMMUNICATION-SKILLS; PROSTATE-CANCER; BREAST-CANCER; OF-LIFE; PSYCHOLOGICAL DISTRESS; INFORMAL CARERS; ONCOLOGY; NEEDS; PERCEPTIONS; WOMEN	Introduction There is growing evidence that cancer affects couples as an interdependent system and that couple-based psychosocial interventions are efficacious in reducing distress and improving coping skills. However, adoption of a couples-focused approach into cancer care is limited. Previous research has shown that patients and partners hold differing views from health care professionals (HCPs) regarding their psychosocial needs, and HCPs from different disciplines also hold divergent views regarding couples' psychosocial needs. This study aimed to explore the perspectives of HCPs and couples on the provision of couple-focused psychosocial care in routine cancer services. Methods A qualitative study using semi-structured interviews was undertaken with 20 HCPs (medical oncologists, nurses, psycho-oncology professionals) and 20 couples where one member had been diagnosed with cancer (breast, prostate, head/neck, bowel, multiple myeloma). Interviews were analysed using the framework approach. Results Three core themes were identified: "How Do Couples Cope with Cancer?" emphasised the positive and negative coping strategies used by couples, and highlighted that partners perceived a lack of engagement by HCPs. "What Is Couple-focused Psychosocial Care for People with Cancer?" described varying perspectives regarding the value of couple-focused psychosocial care and variation in the types of support couples need among HCPs and couples. Whereas most couples did not perceive a need for specialist couple-focused support and interventions, most HCPs felt couple-focused psychosocial care was necessary. "How Can Couple-Focused Psychosocial Care be Improved?" described couples' view of a need for better provision of information, and the importance of their relationship with oncology clinicians. HCPs identified a lack of confidence in responding to the emotional needs of couples, and barriers to providing psychosocial care, including challenges identifying distress (through screening) and referring distressed individuals/couples for specialist assessment. Conclusions The three core themes revealed discrepancies about couple-focused psychosocial care between HCPs and couples, and HCPs from different professional backgrounds, and several barriers to the provision of psychosocial care for couples. Despite HCPs and couples acknowledging that a couple-focused approach to psycho-social support was potentially beneficial, the majority of couples did not feel they needed specific couple-focused interventions. These issues and recommendations for future research are discussed.	[Regan, Tim] Univ Newcastle, Sch Med & Publ Hlth, Fac Hlth, Hlth Behav Res Grp, Newcastle, NSW 2300, Australia; [Levesque, Janelle V.] Univ New S Wales, Ingham Inst Appl Med Res, South Western Sydney Clin Sch,UNSW Med, Ctr Oncol Educ & Res Translat CONCERT Psychooncol, Sydney, NSW, Australia; [Lambert, Sylvie D.] McGill Univ, Ingram Sch Nursing, Montreal, PQ, Canada; [Regan, Tim; Kelly, Brian] Univ Newcastle, Fac Hlth & Med, Sch Med & Publ Hlth, Ctr Translat Neurosci & Mental Hlth, Newcastle, NSW 2300, Australia	University of Newcastle; Ingham Institute for Applied Medical Research; University of New South Wales Sydney; McGill University; University of Newcastle	Regan, T (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Fac Hlth, Hlth Behav Res Grp, Newcastle, NSW 2300, Australia.	timothy.regan@newcastle.edu.au	Lambert, Sylvie/AAB-2890-2019; Kelly, Brian/G-7755-2013	Lambert, Sylvie/0000-0002-9202-9251; Kelly, Brian/0000-0003-4460-1134	Department of Innovation, Industry, Science, and Research from the Australian government	Department of Innovation, Industry, Science, and Research from the Australian government	Acknowledgement is extended to the Department of Innovation, Industry, Science, and Research from the Australian government for funding Tim Regan's Australian Postgraduate Award (APA) scholarship.	Adams E, 2012, SUPPORT CARE CANCER, V20, P2785, DOI 10.1007/s00520-012-1400-4; Arno PS, 1999, HLTH AFFAIRS, V18; Badr H, 2013, PSYCHO-ONCOLOGY, V22, P1688, DOI 10.1002/pon.3200; Baravelli C, 2009, J CANCER SURVIV, V3, P99, DOI 10.1007/s11764-009-0086-1; Barth J, 2011, ANN ONCOL, V22, P1030, DOI 10.1093/annonc/mdq441; Botti M, 2006, CANCER NURS, V29, P309, DOI 10.1097/00002820-200607000-00010; Broom A, 2009, HEALTH, V13, P317, DOI 10.1177/1363459308101806; Bultz BD, 2011, PSYCHO-ONCOLOGY, V20, P463, DOI 10.1002/pon.1932; Bylund CL, 2010, PSYCHO-ONCOLOGY, V19, P583, DOI 10.1002/pon.1585; Carlson LE, 2012, J CLIN ONCOL, V30, P1160, DOI 10.1200/JCO.2011.39.5509; Carnevale Franco A, 2002, Can J Nurs Res, V34, P121; Chiovitti RF, 2003, J ADV NURS, V44, P427, DOI 10.1046/j.0309-2402.2003.02822.x; Christensen A, 1988, PERSPECTIVES MARITAL, P30; Couper J, 2006, PSYCHO-ONCOLOGY, V15; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; COYNE JC, 1991, J PERS SOC PSYCHOL, V61, P404, DOI 10.1037/0022-3514.61.3.404; Dilworth S, 2014, PSYCHO ONCOLGY; Dumont S, 2006, J PALLIAT MED, V9, P912, DOI 10.1089/jpm.2006.9.912; Dzidowska M, 2010, ASIA-PAC J CLIN ONCO, V6, P165, DOI 10.1111/j.1743-7563.2010.01318.x; Evertsen JM, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-19; Faller H, 2013, J CLIN ONCOL, V31, P782, DOI 10.1200/JCO.2011.40.8922; Fallowfield L, 1999, EUR J CANCER, V35, P1592, DOI 10.1016/S0959-8049(99)00212-9; Fallowfield L, 1998, J CLIN ONCOL, V16, P1961, DOI 10.1200/JCO.1998.16.5.1961; Fann JR, 2012, J CLIN ONCOL, V30, P1178, DOI 10.1200/JCO.2011.39.7398; Feltwell AK, 2004, PATIENT EDUC COUNS, V54, P179, DOI 10.1016/S0738-3991(03)00212-X; Forsythe LP, 2012, J CLIN ONCOL, V30, P2897, DOI 10.1200/JCO.2011.39.9832; Forsythe LP, 2013, J CLIN ONCOLOGY, V31; Given B, 2009, FAMILY CARE DURING C; Holland JC, 2013, J NATL COMPR CANC NE, V11, P190, DOI 10.6004/jnccn.2013.0027; Hopkinson JB, 2012, J PAIN SYMPTOM MANAG, V43, P111, DOI 10.1016/j.jpainsymman.2011.03.013; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine (US) Committee on Psychosocial Services to Cancer Patients/Families in a Community Setting, 2008, CANC CARE WHOLE PATI; Ito T, 2011, PSYCHO-ONCOLOGY, V20, P647, DOI 10.1002/pon.1945; Jacobs JR, 2002, J CANCER EDUC, V17, P33; Johnston BM, 2012, SUPPORT CARE CANCER, V20, P1619, DOI 10.1007/s00520-011-1252-3; Kissane DW, 2012, J CLIN ONCOL, V30, P1242, DOI 10.1200/JCO.2011.39.6184; Lambert SD, 2013, SUPPORT CARE CANCER, V21, P3451, DOI 10.1007/s00520-013-1914-4; Lambert SD, 2012, BMJ SUPPORT PALLIAT, V2, P224, DOI 10.1136/bmjspcare-2012-000226; Lambert SD, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-119; Lambert SD, 2013, SUPPORT CARE CANCER, V21, P75, DOI 10.1007/s00520-012-1495-7; LERMAN C, 1993, CANCER, V72, P2612, DOI 10.1002/1097-0142(19931101)72:9<2612::AID-CNCR2820720916>3.0.CO;2-F; Lethborg CE, 2003, SOC WORK HEALTH CARE, V37, P63, DOI 10.1300/J010v37n01_04; Lindau ST, 2011, PSYCHO-ONCOLOGY, V20, P179, DOI 10.1002/pon.1787; Mackenzie L.J., 2012, BMJ OPEN, V2, DOI [10.1136/bmjopen-2012-001265, DOI 10.1136/BMJ0PEN-2012-001265]; Manne SL, 2006, PSYCHO-ONCOL, V15, P234, DOI 10.1002/pon.941; Manne SL, 2005, J CONSULT CLIN PSYCH, V73, P634, DOI 10.1037/0022-006X.73.4.634; McIlfatrick S, 2007, J ADV NURS, V57, P77, DOI 10.1111/j.1365-2648.2006.04062.x; Merluzzi TV, 1997, PSYCHO-ONCOLOGY, V6, P197, DOI 10.1002/(SICI)1099-1611(199709)6:3<197::AID-PON270>3.0.CO;2-S; MEYER TJ, 1995, HEALTH PSYCHOL, V14, P101, DOI 10.1037/0278-6133.14.2.101; Mitchell A, 2008, PSYCHO-ONCOL, V17, P226, DOI 10.1002/pon.1228; Morrison-Beedy D, 2001, APPL NURS RES, V14, P48, DOI 10.1053/apnr.2001.21081; Mystakidou K, 2007, CANCER NURS, V30, P412, DOI 10.1097/01.NCC.0000290807.84076.73; National Comprehensive Cancer Network, 2010, DISTRESS MANAGEMENT, V10; NBC Centre, 2003, CLINICAL PRACTICE GU; Northouse LL, 2013, PSYCHO-ONCOLOGY, V22, P555, DOI 10.1002/pon.3036; Northouse LL, 2010, CA-CANCER J CLIN, V60, P317, DOI 10.3322/caac.20081; Pincus HA, 2009, J CLIN ONCOL, V27, P661, DOI 10.1200/JCO.2008.19.7780; Pitceathly C, 2003, EUR J CANCER, V39, P1517, DOI 10.1016/S0959-8049(03)00309-5; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Razavi D, 2003, J CLIN ONCOL, V21, P3141, DOI 10.1200/JCO.2003.08.031; Regan T, 2013, PSYCHO-ONCOLOGY, DOI [10.1002/pon.3342, DOI 10.1002/P0N.3342]; Regan TW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-279; Regan TW, 2014, PATIENT ED COUNSELIN; Riege AM, 2003, INT J-TORONTO, V6, P75, DOI [10.1108/13522750310470055, DOI 10.1108/13522750310470055]; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Royak-Schaler R, 2006, ONCOL NURS FORUM, V33, P753, DOI 10.1188/06.ONF.753-760; SANDELOWSKI M, 1986, ADV NURS SCI, V8, P27, DOI 10.1097/00012272-198604000-00005; Savarkar V.D, 2007, ESSENTIALS HINDUTVA; Segrin C, 2007, PSYCHO-ONCOLOGY, V16, P634, DOI 10.1002/pon.1111; Segrin C, 2012, HEALTH PSYCHOL, V31, P70, DOI 10.1037/a0025394; Sheard T, 1999, BRIT J CANCER, V80, P1770, DOI 10.1038/sj.bjc.6690596; Sinfield P, 2008, PATIENT EDUC COUNS, V73, P91, DOI 10.1016/j.pec.2008.05.001; Steginga SK, 2008, PSYCHO-ONCOLOGY, V17, P997, DOI 10.1002/pon.1317; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Stenberg U, 2010, PSYCHO-ONCOLOGY, V19, P1013, DOI 10.1002/pon.1670; Streubert Speziale H., 2003, QUALITATIVE RES NURS, V3rd; Surbone A, 2010, SUPPORT CARE CANCER, V18, P255, DOI 10.1007/s00520-009-0693-4; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Traa MJ, 2014, SUPPORT CARE CANCER, V22, P763, DOI 10.1007/s00520-013-2032-z; Turner J, 2007, PSYCHO-ONCOL, V16, P149, DOI 10.1002/pon.1106; Uitterhoeve RJ, 2010, EUR J CANCER CARE, V19, P442, DOI 10.1111/j.1365-2354.2009.01082.x; Ussher JM, 2009, HEALTH PSYCHOL REV, V3, P85, DOI 10.1080/17437190903033401; van der Meulen N, 2008, PSYCHO-ONCOLOGY, V17, P857, DOI 10.1002/pon.1290; Wessels H, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-198; Western Australia Department of Health, 2008, PSYCHO ONCOLOGY MODE; Zeliadt SB, 2011, BJU INT, V108, P851, DOI [10.1111/j.1464-410X.2010.09945,10540.x, 10.1111/j.1464-410X.2010.09945.x]; Zwahlen D, 2011, PSYCHO-ONCOLOGY, V20, P394, DOI 10.1002/pon.1744	87	11	11	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133837	10.1371/journal.pone.0133837	http://dx.doi.org/10.1371/journal.pone.0133837			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JM	26222890	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800070
J	Choi, J; Chung, H; Lee, GW; Koh, SK; Chae, SK; Lee, YH				Choi, Jaehyuk; Chung, Hyunjung; Lee, Gir-Won; Koh, Sun-Ki; Chae, Suhn-Kee; Lee, Yong-Hwan			Genome-Wide Analysis of Hypoxia-Responsive Genes in the Rice Blast Fungus, Magnaporthe oryzae	PLOS ONE			English	Article							TRANSCRIPTIONAL RESPONSE; CRYPTOCOCCUS-NEOFORMANS; LOW-OXYGEN; RNA-SEQ; PATHOGENICITY; GRISEA; INFECTION; METABOLISM; EXPRESSION; VIRULENCE	Rice blast fungus, Magnaporthe oryzae, is the most destructive pathogen in the rice-growing area. This fungus has a biotrophic phase early in infection and later switches to a necrotrophic lifestyle. During the biotrophic phase, the fungus competes with its host for nutrients and oxygen. Continuous uptake of oxygen is essential for successful establishment of blast disease of this pathogen. Here, we report transcriptional responses of the fungus to oxygen limitation. Transcriptome analysis using RNA-Seq identified that 1,047 genes were up-regulated in response to hypoxia. Those genes are involved in mycelial development, sterol biosynthesis, and metal ion transport based on hierarchical GO terms, and are well-conserved among three fungal species. In addition, null mutants of two hypoxia-responsive genes were generated and their roles in fungal development and pathogenicity tested. The mutant for the sterol regulatory element-binding protein gene, MoSRE1, exhibited increased sensitivity to a hypoxia-mimicking agent, increased conidiation, and delayed invasive growth within host cells, which is suggestive of important roles in fungal development. However, such defects did not cause any significant decrease in disease severity. The other null mutant, for the alcohol dehydrogenase gene MoADH1, showed no defect in the hypoxia-mimicking condition (using cobalt chloride) and fungal development. Taken together, this comprehensive transcriptional profiling in response to a hypoxic condition with experimental validations would provide new insights into fungal development and pathogenicity in plant pathogenic fungi.	[Choi, Jaehyuk] Incheon Natl Univ, Coll Life Sci & Bioengn, Div Life Sci, Inchon 406772, South Korea; [Chung, Hyunjung; Lee, Yong-Hwan] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Lee, Gir-Won; Lee, Yong-Hwan] Seoul Natl Univ, Fungal Bioinformat Lab, Seoul 151921, South Korea; [Koh, Sun-Ki; Chae, Suhn-Kee] Paichai Univ, Dept Biochem, Taejon 302735, South Korea; [Lee, Yong-Hwan] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul 151921, South Korea; [Lee, Yong-Hwan] Seoul Natl Univ, Ctr Fungal Genet Resources, Seoul 151921, South Korea; [Lee, Yong-Hwan] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul 151921, South Korea; [Lee, Yong-Hwan] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea	Incheon National University; Seoul National University (SNU); Seoul National University (SNU); Pai Chai University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, YH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea.	yonglee@snu.ac.kr		Lee, Gil-Won/0000-0002-1621-1713; Chae, Suhn-Kee/0000-0003-2164-1053	National Research Foundation of Korea - Korean government [2014R1A2A1A10051434, 2013-010928]; Rural Development Administration, Republic of Korea [PJ011154]	National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by National Research Foundation of Korea grants funded by the Korean government (2014R1A2A1A10051434 and 2013-010928), and the Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ011154) Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Barker BM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-62; Blatzer M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002374; Camilo CM, 2010, EUKARYOT CELL, V9, P915, DOI 10.1128/EC.00047-10; Chang YC, 2007, MOL MICROBIOL, V64, P614, DOI 10.1111/j.1365-2958.2007.05676.x; Chi MH, 2009, PLANT PATHOLOGY J, V25, P108, DOI 10.5423/PPJ.2009.25.1.108; Choi J, 2007, MOL MICROBIOL, V66, P371, DOI 10.1111/j.1365-2958.2007.05918.x; Choi J, 2013, NUCLEIC ACIDS RES, V41, pD714, DOI 10.1093/nar/gks1163; Choi J, 2009, FUNGAL GENET BIOL, V46, P243, DOI 10.1016/j.fgb.2008.11.010; Chun CD, 2007, PLOS PATHOG, V3, P225, DOI 10.1371/journal.ppat.0030022; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Ernst JF, 2009, CELL MICROBIOL, V11, P183, DOI 10.1111/j.1462-5822.2008.01259.x; Geigenberger P, 2003, CURR OPIN PLANT BIOL, V6, P247, DOI 10.1016/S1369-5266(03)00038-4; Grahl N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002145; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Igwe EI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-408; JACOBSON MD, 1995, NATURE, V374, P814, DOI 10.1038/374814a0; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; Khang CH, 2010, PLANT CELL, V22, P1388, DOI 10.1105/tpc.109.069666; Khush GS, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P1, DOI 10.1007/978-1-4020-9500-9_1; Koga H, 2004, PHYSIOL MOL PLANT P, V64, P67, DOI 10.1016/j.pmpp.2004.07.002; Lau GW, 1998, FUNGAL GENET BIOL, V24, P228, DOI 10.1006/fgbi.1998.1053; Lee H, 2007, MOL MICROBIOL, V65, P1018, DOI 10.1111/j.1365-2958.2007.05844.x; Masuo S, 2010, MOL GENET GENOMICS, V284, P415, DOI 10.1007/s00438-010-0576-x; MCCLUNG CR, 1989, NATURE, V339, P558, DOI 10.1038/339558a0; Mosquera G, 2009, PLANT CELL, V21, P1273, DOI 10.1105/tpc.107.055228; Ober ES, 1996, J EXP BOT, V47, P447, DOI 10.1093/jxb/47.3.447; PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0; Park J, 2014, PLANT PATHOLOGY J, V30, P136, DOI 10.5423/PPJ.OA.02.2014.0018; Park J, 2013, EUKARYOT CELL, V12, P1547, DOI 10.1128/EC.00234-13; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Rijnders JGHM, 2000, NEW PHYTOL, V147, P497, DOI 10.1046/j.1469-8137.2000.00727.x; Rolletschek H, 2002, J EXP BOT, V53, P1099, DOI 10.1093/jexbot/53.371.1099; Sambrook J., 2001, MOL CLONING LAB MANU; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Setiadi ER, 2006, J MOL BIOL, V361, P399, DOI 10.1016/j.jmb.2006.06.040; Talbot NJ, 1996, PLANT CELL, V8, P985, DOI 10.1105/tpc.8.6.985; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; VALENT B, 1991, GENETICS, V127, P87; van Dongen JT, 2003, PLANT PHYSIOL, V131, P1529, DOI 10.1104/pp.102.017202; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; Yi M, 2009, PLANT CELL, V21, P681, DOI 10.1105/tpc.107.055988; Zitomer RS, 1997, KIDNEY INT, V51, P507, DOI 10.1038/ki.1997.71	49	9	10	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134939	10.1371/journal.pone.0134939	http://dx.doi.org/10.1371/journal.pone.0134939			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241858	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942700083
J	Fusaro, M; Carbonare, LD; Dusso, A; Arcidiacono, MV; Valenti, MT; Aghi, A; Pasho, S; Gallieni, M				Fusaro, Maria; Carbonare, Luca Dalle; Dusso, Adriana; Vittoria Arcidiacono, Maria; Valenti, Maria Teresa; Aghi, Andrea; Pasho, Sabina; Gallieni, Maurizio			Differential Effects of Dabigatran and Warfarin on Bone Volume and Structure in Rats with Normal Renal Function	PLOS ONE			English	Article							LONG-TERM WARFARIN; VITAMIN-K; VASCULAR CALCIFICATIONS; VERTEBRAL FRACTURES; ORAL ANTICOAGULANTS; MENAQUINONE-4 VITAMIN-K-2; PHYLLOQUINONE VITAMIN-K-1; OSTEOPOROTIC FRACTURE; ELDERLY-PATIENTS; LUMBAR VERTEBRA	Background Warfarin, a widely used anticoagulant, is a vitamin K antagonist impairing the activity of vitamin K-dependent Bone Gla Protein (BGP or Osteocalcin) and Matrix Gla Protein (MGP). Because dabigatran, a new anticoagulant, has no effect on vitamin K metabolism, the aim of this study was to compare the impact of warfarin and dabigatran administration on bone structure and vascular calcification. Methods Rats with normal renal function received for 6 weeks warfarin, dabigatran or placebo. Bone was evaluated immuno-histochemically and hystomorphometrically after double labelling with declomycin and calcein. Aorta and iliac arteries were examined histologically. Results Histomorphometric analysis of femur and vertebrae showed significantly decreased bone volume and increased trabecular separation in rats treated with warfarin. Vertebra analysis showed that the trabecular number was higher in dabigatran treated rats. Osteoblast activity and resorption parameters were similar among groups, except for maximum erosion depth, which was higher in warfarin treated rats, suggesting a higher osteoclastic activity. Therefore, warfarin treatment was also associated with higher bone formation rate/bone surface and activation frequency. Warfarin treatment may cause an increased bone turnover characterized by increased remodelling cycles, with stronger osteoclast activity compared to the other groups. There were no differences among experimental groups in calcium deposition either in aortic or iliac arteries. Conclusions These findings suggest for the first time that dabigatran has a better bone safety profile than warfarin, as warfarin treatment affects bone by reducing trabecular size and structure, increasing turnover and reducing mineralization. These differences could potentially result in a lower incidence of fractures in dabigatran treated patients.	[Fusaro, Maria] Natl Res Council CNR, Neurosci Inst, Padua, Italy; [Carbonare, Luca Dalle; Valenti, Maria Teresa] Univ Verona, Dept Med, Sect Internal Med D, I-37100 Verona, Italy; [Dusso, Adriana; Vittoria Arcidiacono, Maria] IRB Lleida Lleida Inst Biomed Res, Div Expt Nephrol, Lleida, Spain; [Aghi, Andrea] Univ Padua, Nephrol Unit, Padua, Italy; [Pasho, Sabina; Gallieni, Maurizio] Univ Milan, Nephrol & Dialysis Unit, Osped San Carlo Borromeo, Milan, Italy; [Pasho, Sabina; Gallieni, Maurizio] Univ Milan, Dept Clin & Biomed Sci Luigi Sacco, Milan, Italy	University of Verona; Institut de Recerca Biomedica - IRB Lleida; University of Padua; San Carlo Borromeo Hospital; University of Milan; University of Milan; Luigi Sacco Hospital	Fusaro, M (corresponding author), Natl Res Council CNR, Neurosci Inst, Padua, Italy.	dante.lucia@libero.it	Arcidiacono, Maria Vittoria/G-5827-2016; fusaro, maria/R-3386-2016; Dusso, Adriana S/E-8617-2011; Gallieni, Maurizio/H-2895-2019; Fusaro, Maria/AAY-7487-2020; Valenti, Maria Teresa/F-4712-2011; Carbonare, Luca Dalle/E-5720-2011; Fusaro, Maria/AAA-5509-2019; Arcidiacono, Maria Vittoria/F-9180-2010	Arcidiacono, Maria Vittoria/0000-0002-4209-6245; fusaro, maria/0000-0001-9478-4851; Gallieni, Maurizio/0000-0002-2011-2160; Fusaro, Maria/0000-0001-9478-4851; Arcidiacono, Maria Vittoria/0000-0002-4209-6245; Dalle Carbonare, Luca/0000-0003-3263-6671	Boehringer-Ingelheim Pharma, Germany (manufacturer of Dabigatran)	Boehringer-Ingelheim Pharma, Germany (manufacturer of Dabigatran)	This study was supported by a grant form Boehringer-Ingelheim Pharma, Germany (manufacturer of Dabigatran). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amizuka N, 2009, J ELECTRON MICROSC, V58, P55, DOI 10.1093/jmicro/dfp008; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Azuma K, 2015, J BONE MINER RES, V30, P1245, DOI 10.1002/jbmr.2463; Binkley N, 2007, J BONE MINER RES, V22, P695, DOI 10.1359/JBMR.070208; Caraballo PJ, 1999, ARCH INTERN MED, V159, P1750, DOI 10.1001/archinte.159.15.1750; Caraballo PJ, 1999, OSTEOPOROSIS INT, V9, P441, DOI 10.1007/s001980050169; Carbonare LD, 2005, MICRON, V36, P609, DOI 10.1016/j.micron.2005.07.007; Cheung AM, 2008, PLOS MED, V5, P1461, DOI 10.1371/journal.pmed.0050196; Danziger J, 2008, CLIN J AM SOC NEPHRO, V3, P1504, DOI 10.2215/CJN.00770208; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Eastell R, 2006, NAT CLIN PRACT ENDOC, V2, P484, DOI 10.1038/ncpendmet0274; Fusaro M, 2015, CURR VASC PHARMACOL, V13, P248, DOI 10.2174/15701611113119990146; Fusaro M, 2012, J BONE MINER RES, V27, P2271, DOI 10.1002/jbmr.1677; Fusaro M, 2011, CURR VASC PHARMACOL, V9, P763, DOI 10.2174/157016111797484134; Gage BF, 2006, ARCH INTERN MED, V166, P241, DOI 10.1001/archinte.166.2.241; Haffa A, 2000, J BONE MINER RES, V15, P872, DOI 10.1359/jbmr.2000.15.5.872; Hirota Y, 2013, J BIOL CHEM, V288, P33071, DOI 10.1074/jbc.M113.477356; Ichikawa T, 2006, J BIOL CHEM, V281, P16927, DOI 10.1074/jbc.M600896200; Jamal SA, 1998, ANN INTERN MED, V128, P829, DOI 10.7326/0003-4819-128-10-199805150-00006; KIMMEL DB, 1991, CELL MATER, P11; Kruger T, 2013, ARTERIOSCL THROM VAS, V33, P2618, DOI 10.1161/ATVBAHA.113.302244; Lanham-New SA, 2008, P NUTR SOC, V67, P163, DOI 10.1017/S0029665108007003; LIAN JB, 1984, J CLIN INVEST, V73, P1223, DOI 10.1172/JCI111308; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Mamdani M, 2003, PHARMACOTHERAPY, V23, P1, DOI 10.1592/phco.23.1.1.31922; McCabe KM, 2013, KIDNEY INT, V83, P835, DOI 10.1038/ki.2012.477; MELLISH RWE, 1991, J BONE MINER RES, V6, P689; MENON RK, 1987, J CLIN ENDOCR METAB, V64, P59, DOI 10.1210/jcem-64-1-59; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; Okano T, 2008, J BIOL CHEM, V283, P11270, DOI 10.1074/jbc.M702971200; PETTIFOR JM, 1975, J PEDIATR-US, V86, P459; PHILIP WJU, 1995, QJM-INT J MED, V88, P635; PRICE PA, 1987, THROMB RES, V46, P121, DOI 10.1016/0049-3848(87)90212-X; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400; Schurgers LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043229; SERRE CM, 1995, J BONE MINER RES, V10, P1158; Stangier J, 2009, CLIN APPL THROMB-HEM, V15, p9S, DOI 10.1177/1076029609343004; Stangier J, 2012, BLOOD COAGUL FIBRIN, V23, P138, DOI 10.1097/MBC.0b013e32834f1b0c; Sugiyama T, 2007, J ENDOCRINOL, V194, P213, DOI 10.1677/JOE-07-0119; Thijssen HHW, 2006, BRIT J NUTR, V95, P260, DOI 10.1079/BJN20051630; Thijssen HHW, 1996, J NUTR, V126, P537, DOI 10.1093/jn/126.2.537; Torbergsen AC, 2015, CLIN NUTR, V34, P101, DOI 10.1016/j.clnu.2014.01.016; VESTERBY A, 1989, BONE, V10, P7, DOI 10.1016/8756-3282(89)90140-3; Weber P, 2001, NUTRITION, V17, P880, DOI 10.1016/S0899-9007(01)00709-2; WEINSTEIN RS, 1994, J BONE MINER RES, V9, P1797	46	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133847	10.1371/journal.pone.0133847	http://dx.doi.org/10.1371/journal.pone.0133847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241483	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942700024
J	Hayrapetyan, H; Tempelaars, M; Groot, MN; Abee, T				Hayrapetyan, Hasmik; Tempelaars, Marcel; Groot, Masja Nierop; Abee, Tjakko			Bacillus cereus ATCC 14579 RpoN (Sigma 54) Is a Pleiotropic Regulator of Growth, Carbohydrate Metabolism, Motility, Biofilm Formation and Toxin Production	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; SIGMA(54)-DEPENDENT GENES; TRANSCRIPTIONAL ACTIVATOR; PTS PERMEASE; EXPRESSION; SUBTILIS; BEHAVIOR; THURINGIENSIS; TYPHIMURIUM; SENSITIVITY	Sigma 54 is a transcriptional regulator predicted to play a role in physical interaction of bacteria with their environment, including virulence and biofilm formation. In order to study the role of Sigma 54 in Bacillus cereus, a comparative transcriptome and phenotypic study was performed using B. cereus ATCC 14579 WT, a markerless rpoN deletion mutant, and its complemented strain. The mutant was impaired in many different cellular functions including low temperature and anaerobic growth, carbohydrate metabolism, sporulation and toxin production. Additionally, the mutant showed lack of motility and biofilm formation at air-liquid interphase, and this correlated with absence of flagella, as flagella staining showed only WT and complemented strain to be highly flagellated. Comparative transcriptome analysis of cells harvested at selected time points during growth in aerated and static conditions in BHI revealed large differences in gene expression associated with loss of phenotypes, including significant down regulation of genes in the mutant encoding enzymes involved in degradation of branched chain amino acids, carbohydrate transport and metabolism, flagella synthesis and virulence factors. Our study provides evidence for a pleiotropic role of Sigma 54 in B. cereus supporting its adaptive response and survival in a range of conditions and environments.	[Hayrapetyan, Hasmik; Tempelaars, Marcel; Abee, Tjakko] Wageningen Univ, Food Microbiol Lab, NL-6708 WG Wageningen, Netherlands; [Hayrapetyan, Hasmik; Tempelaars, Marcel; Groot, Masja Nierop; Abee, Tjakko] TIFN, NL-6709 PA Wageningen, Netherlands; [Groot, Masja Nierop] Wageningen UR, Food & Biobased Res, NL-6708 WG Wageningen, Netherlands	Wageningen University & Research; Top Institute Food & Nutrition; Wageningen University & Research	Abee, T (corresponding author), Wageningen Univ, Food Microbiol Lab, Bornse Weilanden 9, NL-6708 WG Wageningen, Netherlands.	tjakko.abee@wur.nl	Tempelaars, Marcel/C-5077-2008	Tempelaars, Marcel/0000-0003-0635-5606	TI Food and Nutrition	TI Food and Nutrition	The project is funded by TI Food and Nutrition, a public-private partnership on precompetitive research in food and nutrition. The public partners are responsible for the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The private partners have contributed to the project through regular discussion.	Ali NO, 2001, J BACTERIOL, V183, P2497; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Arous S, 2004, MICROBIOL-SGM, V150, P1581, DOI 10.1099/mic.0.26860-0; Arsene F, 2000, INT J FOOD MICROBIOL, V55, P3, DOI 10.1016/S0168-1605(00)00206-3; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Blom EJ, 2007, BIOINFORMATICS, V23, P1161, DOI 10.1093/bioinformatics/btl658; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Castelijn GAA, 2013, VET MICROBIOL, V161, P305, DOI 10.1016/j.vetmic.2012.07.047; Ceuppens S, 2013, FEMS MICROBIOL ECOL, V84, P433, DOI 10.1111/1574-6941.12110; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; Dalet K, 2001, MICROBIOL-SGM, V147, P3263, DOI 10.1099/00221287-147-12-3263; Debarbouille M, 1999, J BACTERIOL, V181, P2059, DOI 10.1128/JB.181.7.2059-2066.1999; DEBARBOUILLE M, 1991, P NATL ACAD SCI USA, V88, P9092, DOI 10.1073/pnas.88.20.9092; Doan T, 2003, MOL MICROBIOL, V47, P1709, DOI 10.1046/j.1365-2958.2003.03404.x; Dong T, 2011, MOL MICROBIOL, V79, P375, DOI 10.1111/j.1365-2958.2010.07449.x; Francke C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-385; Gao T, 2015, MICROBIOLOGYOPEN; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Guinebretiere MH, 2008, ENVIRON MICROBIOL, V10, P851, DOI 10.1111/j.1462-2920.2007.01495.x; Hao B, 2013, APPL MICROBIOL BIOT, V97, P2575, DOI 10.1007/s00253-012-4372-x; HARSHEY RM, 1994, P NATL ACAD SCI USA, V91, P8631, DOI 10.1073/pnas.91.18.8631; Hayrapetyan H, 2015, INT J FOOD MICROBIOL, V200, P72, DOI 10.1016/j.ijfoodmicro.2015.02.005; Hechard Y, 2001, MICROBIOL-SGM, V147, P1575, DOI 10.1099/00221287-147-6-1575; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Houry A, 2010, MICROBIOL-SGM, V156, P1009, DOI 10.1099/mic.0.034827-0; Hsueh YH, 2007, APPL ENVIRON MICROB, V73, P7225, DOI 10.1128/AEM.00690-07; Hwang JK, 2010, J ANIM VET ADV, V9, P3034; Hwang S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-207; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Iyer VS, 2012, J BACTERIOL, V194, P368, DOI 10.1128/JB.06046-11; JONES DHA, 1994, MICROBIOL-SGM, V140, P1035, DOI 10.1099/13500872-140-5-1035; Jones J, 2007, ENVIRON MICROBIOL, V9, P3046, DOI 10.1111/j.1462-2920.2007.01416.x; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Lindback T, 2012, ENVIRON MICROBIOL, V14, P2233, DOI 10.1111/j.1462-2920.2012.02766.x; Mattila M, 2012, FOOD MICROBIOL, V32, P152, DOI 10.1016/j.fm.2012.05.005; MERRICK MJ, 1993, MOL MICROBIOL, V10, P903, DOI 10.1111/j.1365-2958.1993.tb00961.x; Mols M, 2013, J APPL MICROBIOL, V115, P689, DOI 10.1111/jam.12278; Mols M, 2011, ENVIRON MICROBIOL, V13, P2835, DOI 10.1111/j.1462-2920.2011.02490.x; Nakano MM, 1996, J BACTERIOL, V178, P3796, DOI 10.1128/jb.178.13.3796-3802.1996; Okada Y, 2006, FEMS MICROBIOL LETT, V263, P54, DOI 10.1111/j.1574-6968.2006.00405.x; Peng Q, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00407; Peng Q, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0306-3; Pfluger-Grau K, 2010, TRENDS MICROBIOL, V18, P205, DOI 10.1016/j.tim.2010.02.003; Reitzer L, 2001, MICROBIOL MOL BIOL R, V65, P422, DOI 10.1128/MMBR.65.3.422-444.2001; Rosenfeld E, 2005, CAN J MICROBIOL, V51, P149, DOI [10.1139/w04-132, 10.1139/W04-132]; Saldias MS, 2008, INFECT IMMUN, V76, P1059, DOI 10.1128/IAI.01167-07; Salvetti S, 2007, MICROBIOL-SGM, V153, P2541, DOI 10.1099/mic.0.2006/005553-0; Sana TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076030; Song FP, 2012, FASEB J, V26, P3336, DOI 10.1096/fj.11-197681; Stevens MJA, 2010, MICROBIOL-SGM, V156, P695, DOI 10.1099/mic.0.034165-0; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; van der Voort M, 2009, J APPL MICROBIOL, V107, P795, DOI 10.1111/j.1365-2672.2009.04252.x; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; Wiegeshoff F, 2006, J BACTERIOL, V188, P3130, DOI 10.1128/JB.188.8.3130-3133.2006; Wijman JGE, 2007, APPL ENVIRON MICROB, V73, P1481, DOI 10.1128/AEM.01781-06; Wolfe AJ, 2004, APPL ENVIRON MICROB, V70, P2520, DOI 10.1128/AEM.70.4.2520-2524.2004; Xu YB, 2014, FEMS MICROBIOL LETT, V354, P142, DOI 10.1111/1574-6968.12438; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang Z, 2014, J BACTERIOL, V196, P2934, DOI 10.1128/JB.01675-14; Zhu L, 2010, J BACTERIOL, V192, P346, DOI 10.1128/JB.01038-09	62	34	37	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134872	10.1371/journal.pone.0134872	http://dx.doi.org/10.1371/journal.pone.0134872			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241851	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942700075
J	Huang, HS; Ma, MC				Huang, Ho-Shiang; Ma, Ming-Chieh			High Sodium-Induced Oxidative Stress and Poor Anticrystallization Defense Aggravate Calcium Oxalate Crystal Formation in Rat Hyperoxaluric Kidneys	PLOS ONE			English	Article							RENAL EPITHELIAL-CELLS; TAMM-HORSFALL PROTEIN; STONE FORMATION; MESSENGER-RNA; NADPH OXIDASE; FREE-RADICALS; SALT INTAKE; EXPRESSION; OSTEOPONTIN; INJURY	Enhanced sodium excretion is associated with intrarenal oxidative stress. The present study evaluated whether oxidative stress caused by high sodium (HS) may be involved in calcium oxalate crystal formation. Male rats were fed a sodium-depleted diet. Normal-sodium and HS diets were achieved by providing drinking water containing 0.3% and 3% NaCl, respectively. Rats were fed a sodium-depleted diet with 5% hydroxyl-L-proline (HP) for 7 and 42 days to induce hyperoxaluria and/or calcium oxalate deposition. Compared to normal sodium, HS slightly increased calcium excretion despite diuresis; however, the result did not reach statistical significance. HS did not affect the hyperoxaluria, hypocalciuria or supersaturation caused by HP; however, it increased calcium oxalate crystal deposition soon after 7 days of co-treatment. Massive calcium oxalate formation and calcium crystal excretion in HS+HP rats were seen after 42 days of treatment. HP-mediated hypocitraturia was further exacerbated by HS. Moreover, HS aggravated HP-induced renal injury and tubular damage via increased apoptosis and oxidative stress. Increased urinary malondialdehyde excretion, in situ superoxide production, NAD(P)H oxidase and xanthine oxidase expression and activity, and decreased antioxidant enzyme expression or activity in the HS+HP kidney indicated exaggerated oxidative stress. Interestingly, this redox imbalance was associated with reduced renal osteopontin and Tamm-Horsfall protein expression (via increased excretion) and sodium-dependent dicarboxylate cotransporter NaDC-1 upregulation. Collectively, our results demonstrate that a HS diet induces massive crystal formation in the hyperoxaluric kidney; this is not due to increased urinary calcium excretion but is related to oxidative injury and loss of anticrystallization defense.	[Huang, Ho-Shiang] Natl Cheng Kung Univ Hosp, Dept Urol, Tainan 70428, Taiwan; [Ma, Ming-Chieh] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; Fu Jen Catholic University	Ma, MC (corresponding author), Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan.	med0041@mail.fju.edu.tw			Ministry of Science and Technology [NSC102-2314-B-006-080, NSC101-2314-B-030-002-MY3]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported financially by grants from the Ministry of Science and Technology NSC102-2314-B-006-080 to Huang HS and NSC101-2314-B-030-002-MY3 to Ma MC.	Aruga S, 2000, KIDNEY INT, V58, P206, DOI 10.1046/j.1523-1755.2000.00155.x; Bushinsky DA, 2002, KIDNEY INT, V61, P975, DOI 10.1046/j.1523-1755.2002.00190.x; Cha JH, 2000, YONSEI MED J, V41, P128, DOI 10.3349/ymj.2000.41.1.128; Chuaypen N, 2013, ASIAN BIOMED, V7, P571, DOI 10.5372/1905-7415.0704.214; DINICOLANTONIO R, 1990, HYPERTENSION, V15, P177, DOI 10.1161/01.HYP.15.2.177; Dobrian AD, 2003, AM J PHYSIOL-RENAL, V285, pF619, DOI 10.1152/ajprenal.00388.2002; El-Achkar TM, 2008, AM J PHYSIOL-RENAL, V295, pF534, DOI 10.1152/ajprenal.00083.2008; HAMM LL, 1990, KIDNEY INT, V38, P728, DOI 10.1038/ki.1990.265; Huang HS, 2006, KIDNEY INT, V70, P699, DOI 10.1038/sj.ki.5001651; Huang HS, 2008, AM J PHYSIOL-RENAL, V295, pF388, DOI 10.1152/ajprenal.00405.2007; Huang HS, 2003, NEUROUROL URODYNAM, V22, P176, DOI 10.1002/nau.10055; Huang HS, 2002, J UROLOGY, V167, P2584, DOI 10.1016/S0022-5347(05)65042-2; Huang S, 2009, AM J PHYSIOL-RENAL, V296, pF34, DOI 10.1152/ajprenal.90309.2008; Iguchi S, 2004, NEPHRON EXP NEPHROL, V97, P96, DOI 10.1159/000078643; Johnson RJ, 1999, HYPERTENSION, V34, P151, DOI 10.1161/01.HYP.34.1.151; Khan SR, 2006, KIDNEY INT, V70, P914, DOI 10.1038/sj.ki.5001699; Khan SR, 2013, J UROLOGY, V189, P803, DOI 10.1016/j.juro.2012.05.078; Khan SR, 2011, NEPHROL DIAL TRANSPL, V26, P1778, DOI 10.1093/ndt/gfq692; Kitiyakara C, 2003, J AM SOC NEPHROL, V14, P2775, DOI 10.1097/01.ASN.0000092145.90389.65; Ma MC, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0480-y; Mo L, 2004, KIDNEY INT, V66, P1159, DOI 10.1111/j.1523-1755.2004.00867.x; Mohamaden WI, 2014, J BASIC APPL ZOOL, DOI [10.1016/j.jobaz.2014.03.002, DOI 10.1016/J.JOBAZ.2014.03.002]; Nouvenne A, 2008, CLIN CASES MINER BON, V5, P135; Pan WL, 2012, AM J PHYSIOL-RENAL, V302, pF943, DOI 10.1152/ajprenal.00504.2010; Peng PH, 2009, J NEUROCHEM, V108, P741, DOI 10.1111/j.1471-4159.2008.05807.x; SAKHAEE K, 1993, J UROLOGY, V150, P310, DOI 10.1016/S0022-5347(17)35468-X; Scheid C, 1996, KIDNEY INT, V49, P413, DOI 10.1038/ki.1996.60; Ticinesi A, 2014, NEPHROL DIAL TRANSPL; Tiselius HG, 2003, UROL RES, V31, P410, DOI 10.1007/s00240-003-0363-9; Torffvit O, 2004, NEPHRON PHYSIOL, V97, pp31, DOI [DOI 10.1159/000077600, 10.1159/000077600]; Tsuji H, 2007, INT J UROL, V14, P630, DOI 10.1111/j.1442-2042.2007.01783.x; Umekawa T, 2002, KIDNEY INT, V61, P105, DOI 10.1046/j.1523-1755.2002.00106.x; Wesson JA, 2003, J AM SOC NEPHROL, V14, P139, DOI 10.1097/01.ASN.0000040593.93815.9D; Yatabe MS, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-160; Zacchia M, 2010, J NEPHROL, V23, pS49	35	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134764	10.1371/journal.pone.0134764	http://dx.doi.org/10.1371/journal.pone.0134764			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241473	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700064
J	Kim, YB; Lee, SH; Kang, SJ; Choi, MJ; Lee, J; Kim, CH				Kim, Young Bin; Lee, Sang Hyeok; Kang, Shin Jin; Choi, Myung Jin; Lee, Jung; Kim, Chang Hun			Virtual World Currency Value Fluctuation Prediction System Based on User Sentiment Analysis	PLOS ONE			English	Article							BEHAVIORS; NETWORKS	In this paper, we present a method for predicting the value of virtual currencies used in virtual gaming environments that support multiple users, such as massively multiplayer online role-playing games (MMORPGs). Predicting virtual currency values in a virtual gaming environment has rarely been explored; it is difficult to apply real-world methods for predicting fluctuating currency values or shares to the virtual gaming world on account of differences in domains between the two worlds. To address this issue, we herein predict virtual currency value fluctuations by collecting user opinion data from a virtual community and analyzing user sentiments or emotions from the opinion data. The proposed method is straightforward and applicable to predicting virtual currencies as well as to gaming environments, including MMORPGs. We test the proposed method using large-scale MMORPGs and demonstrate that virtual currencies can be effectively and efficiently predicted with it.	[Kim, Young Bin] Korea Univ, Interdisciplinary Program Visual Informat Proc, Seoul, South Korea; [Lee, Sang Hyeok; Choi, Myung Jin; Lee, Jung; Kim, Chang Hun] Korea Univ, Dept Comp & Radio Commun Engn, Seoul, South Korea; [Kang, Shin Jin] Hongik Univ, Sch Games, Seoul, South Korea	Korea University; Korea University; Hongik University	Kim, CH (corresponding author), Korea Univ, Dept Comp & Radio Commun Engn, Seoul, South Korea.	chkim@korea.ac.kr		Kim, YoungBin/0000-0002-2114-0120	National Research Foundation of Korea (NRF) - Ministry of Education, Science, ICT and future Planning [NRF-2012R1A1A1012895, NRF-2013R1A1A2011602, NRF-2014R1A2A2A01007143]	National Research Foundation of Korea (NRF) - Ministry of Education, Science, ICT and future Planning(National Research Foundation of Korea)	This research was supported by a Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, ICT and future Planning (NRF-2012R1A1A1012895, NRF-2013R1A1A2011602, NRF-2014R1A2A2A01007143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal Apoorv, 2011, SENTIMENT ANAL TWITT; Alm Cecilia, 2005, EMOTIONS TEXT MACHIN; Annett M, 2008, LECT NOTES ARTIF INT, V5032, P25; [Anonymous], 2006, COMP MMOG CURR PRIC; Baccianella S, 2010, LREC 2010 - SEVENTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION; Bainbridge WS, 2007, SCIENCE, V317, P472, DOI 10.1126/science.1146930; Bifet A, 2010, DS 10 P 13 INT DISC; Bitcoin Forum, 2006, SIMPL MACH; Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; Bordino I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040014; Boyd DM, 2007, J COMPUT-MEDIAT COMM, V13, P210, DOI 10.1111/j.1083-6101.2007.00393.x; Bravo-Marquez F, 2013, P 2 INT WORKSH ISS S, P1, DOI DOI 10.1145/2502069.2502071; Cambria E, 2013, COMP INT HUM LIK INT; Cambria E, 2013, BIOL INSPIR COGN ARC, V4, P41, DOI 10.1016/j.bica.2013.02.003; Catanese S. A., 2011, P WIMS 11 MAY 2011, P1; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chang PC, 2008, P 3 WORKSH STAT MACH, P224; Cheng Tao, 2014, PLoS One, V9, pe97807, DOI 10.1371/journal.pone.0097807; Cheong F, 2011, P 15 PAC AS C INF SY; Cohen-Charash Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072031; Corominas-Murtra B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112606; Ediger D, 2010, PAR PROC ICPP 2010 3; Fuchs B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103503; Gargiulo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048916; Granger C.W., 2000, Q REV ECON FINANC, V40, P337, DOI DOI 10.1016/S1062-9769(00)00042-9; Guerrero Razuri JF, IBERAMIA 2014 IB AM, P613; Holland LHM, 2006, MAKING REAL MONEY VI; Jiang ZQ, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/48007; Kimoto T, 1990, STOCK MARK PRED SYST; Klein D, 2003, P 41 ANN M ASS COMP, V1; Klenner M., 2008, P S AFF LANG HUM MAC, P60; Klimek P, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/6/063008; Knoke D., 2008, SOCIAL NETWORK ANAL, DOI 10.4135/9781412985864; Kollar P, 2014, WORLD WARCRAFT HITS; Kondor D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086197; Kosminsky E., 2009, J VIRTUAL WORLDS RES, V2; Kouloumpis E., 2011, P INT AAAI C WEBL SO, P538; Lahmiri S., 2011, INT J COMPUTER APPL, V29, P24; Lehdonvirta V, 2009, ELECTRON COMMER RES, V9, P97, DOI 10.1007/s10660-009-9028-2; Linden T., 2010, 2009 END YEAR 2 LIFE; MacInnes I, 2005, DIG GAM RES ASS C; McCord M., 2011, Autonomic and Trusted Computing. Proceedings 8th International Conference (ATC 2011), P175, DOI 10.1007/978-3-642-23496-5_13; Messinger PR, 2009, DECIS SUPPORT SYST, V47, P204, DOI 10.1016/j.dss.2009.02.014; Mohammad SM, 2013, COMPUT INTELL-US, V29, P436, DOI 10.1111/j.1467-8640.2012.00460.x; Monroe W, 2014, P 52 ANN M ASS COMP, V2; O'Reilly T., 2007, COMMUNICATIONS STRAT, V65, P17, DOI DOI 10.1109/KIMAS.2003.1245106; Pak A, 2010, P 7 C INT RES EV LRE; Papagiannidis S, 2008, TECHNOL FORECAST SOC, V75, P610, DOI 10.1016/j.techfore.2007.04.007; Plutchik R, 2001, AM SCI, V89, P344, DOI 10.1511/2001.28.739; Russell M. A., 2013, MINING SOCIAL WEB DA; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Scarle S, 2012, ELECTRON COMMER RES, V12, P379, DOI 10.1007/s10660-012-9098-4; Schumaker RP, 2009, ACM T INFORM SYST, V27, DOI 10.1145/1462198.1462204; Shin DH, 2008, INTERACT COMPUT, V20, P433, DOI 10.1016/j.intcom.2008.04.001; Song J, 2011, RECENT ADV INTRUSION; STIGLER GJ, 1957, J POLIT ECON, V65, P1, DOI 10.1086/257878; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; Szell M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01214; Szell M, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500646; Szell M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00457; Szell M, 2010, SOC NETWORKS, V32, P313, DOI 10.1016/j.socnet.2010.06.001; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; Thelwall M, 2012, J AM SOC INF SCI TEC, V63, P163, DOI 10.1002/asi.21662; Thomas K., 2011, P 2011 ACM SIGCOMM C, P243, DOI [10.1145/2068816.2068840, DOI 10.1145/2068816.2068840]; Thurner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029796; Toutanova K, 2003, HLT-NAACL 2003: HUMAN LANGUAGE TECHNOLOGY CONFERENCE OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE MAIN CONFERENCE, P252, DOI 10.3115/1073445.1073478; Tseng H, 2005, P 4 AIGHAN WORKSH CH; Wang Alex Hai, 2010, P 2010 INT C IEEE; Wang Q-H, 2010, SYST SCI HICSS 2010; Wang QH, 2013, INFORM SYST FRONT, V15, P481, DOI 10.1007/s10796-011-9339-4; Wohn DY, 2014, P 32 ANN ACM C HUM F; Xie WJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05244; Yang HQ, 2002, LECT NOTES COMPUT SC, V2412, P391; Yardi S, 2010, 1 MONDAY, V15, DOI [10.5210/fm.v15i1.2793, DOI 10.5210/FM.V15I1.2793]; Yong Sauk Hau, 2011, Computers in Human Behavior, V27, P956, DOI 10.1016/j.chb.2010.11.022; Yue Guo, 2007, Data Base for Advances in Information Systems, V38, P69, DOI 10.1145/1314234.1314247; Zhang YD, 2009, EXPERT SYST APPL, V36, P8849, DOI 10.1016/j.eswa.2008.11.028	77	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0132944	10.1371/journal.pone.0132944	http://dx.doi.org/10.1371/journal.pone.0132944			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1VB	26241496	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942700008
J	Rey, MD; Calderon, MC; Rodrigo, MJ; Zacarias, L; Alos, E; Prieto, P				Rey, Maria-Dolores; Calderon, Maria-Carmen; Jesus Rodrigo, Maria; Zacarias, Lorenzo; Alos, Enriqueta; Prieto, Pilar			Novel Bread Wheat Lines Enriched in Carotenoids Carrying Hordeum chilense Chromosome Arms in the ph1b Background	PLOS ONE			English	Article							YELLOW PIGMENT CONTENT; IN-SITU HYBRIDIZATION; GENETIC-CONTROL; DURUM-WHEAT; IDENTIFICATION; FRUIT; LOCUS; BIOSYNTHESIS; VULGARE; BARLEY	The use of crop wild relative species to improve major crops performance is well established. Hordeum chilense has a high potential as a genetic donor to increase the carotenoid content of wheat. Crosses between the 7H(ch) H. chilense substitution lines in wheat and the wheat pairing homoeologous1b (ph1b) mutant allowed the development of wheat-H. chilense translocation lines for both 7H(ch)alpha and 7H(ch)beta chromosome arms in the wheat background. These translocation lines were characterized by in situ hybridization and using molecular markers. In addition, reverse phase chromatography (HPLC) analysis was carried out to evaluate the carotenoid content and both 7H(ch)alpha.7AL and 7AS.7H(ch)beta disomic translocation lines. The carotenoid content in 7H(ch)alpha.7AL and 7AS.7H(ch)beta disomic translocation lines was higher than the wheat-7H(ch) addition line and double amount of carotenoids than the wheat itself. A proteomic analysis confirmed that the presence of chromosome 7H(ch) introgressions in wheat scarcely altered the proteomic profile of the wheat flour. The Psy1 (Phytoene Synthase1) gene, which is the first committed step in the carotenoid biosynthetic pathway, was also cytogenetically mapped on the 7H(ch)alpha chromosome arm. These new wheat-H. chilense translocation lines can be used as a powerful tool in wheat breeding programs to enrich the diet in bioactive compounds.	[Rey, Maria-Dolores; Calderon, Maria-Carmen; Alos, Enriqueta; Prieto, Pilar] CSIC, Inst Agr Sostenible, Dept Mejora Genet Vegetal, Cordoba, Spain; [Jesus Rodrigo, Maria; Zacarias, Lorenzo] CSIC, Inst Agroquim & Tecnol Alimentos, E-46010 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Prieto, P (corresponding author), CSIC, Inst Agr Sostenible, Dept Mejora Genet Vegetal, Cordoba, Spain.	pilar.prieto@ias.csic.es	Alos, Enriqueta/E-7674-2012; Rodrigo, Maria J/H-7720-2012; Rey, María-Dolores/I-3931-2018; Prieto, Pilar/N-6394-2014; ZACARIAS, LORENZO/W-2510-2018	Alos, Enriqueta/0000-0003-2878-2617; Rodrigo, Maria J/0000-0003-2668-0684; Rey, María-Dolores/0000-0002-6967-8536; Prieto, Pilar/0000-0002-8160-808X; ZACARIAS, LORENZO/0000-0003-3982-8860	ERC [243118]	ERC(European Research Council (ERC)European Commission)	This work was supported by the ERC Starting Grant 243118 (http://www.ias.csic.es/ercstg-superwheatcrops/).	Altenbach Susan B, 2011, BMC Res Notes, V4, P242, DOI 10.1186/1756-0500-4-242; Alvarez JB, 1998, PLANT BREEDING, V117, P287, DOI 10.1111/j.1439-0523.1998.tb01942.x; Atienza SG, 2007, AUST J AGR RES, V58, P767, DOI 10.1071/AR06338; Atienza SG, 2004, PLANT BREEDING, V123, P303, DOI 10.1111/j.1439-0523.2004.00918.x; Britton G., 1998, CAROTENOIDS BIOSYNTH, V3, P384; CABRERA A, 1995, GENOME, V38, P435, DOI 10.1139/g95-057; Carmona L, 2012, POSTHARVEST BIOL TEC, V74, P108, DOI 10.1016/j.postharvbio.2012.06.021; Carvalho Luiz Joaquim Castelo Branco, 2012, Open Biochem J, V6, P116, DOI 10.2174/1874091X01206010116; Collado-Romero M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00356; De Angelis M, 2008, J AGR FOOD CHEM, V56, P8619, DOI 10.1021/jf8008876; Calderon MD, 2012, PLANT BREEDING, V131, P733, DOI 10.1111/j.1439-0523.2012.02010.x; Dinesh Yadav, 2011, Asian Journal of Biotechnology, V3, P1, DOI 10.3923/ajbkr.2011.1.21; Farre G, 2010, PLANT SCI, V179, P28, DOI 10.1016/j.plantsci.2010.03.009; Fosrter BP, 1990, HEREDITY, V65, P99; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; Fung PK, 2010, CHEM BIODIVERS, V7, P1098, DOI 10.1002/cbdv.200900313; Greer E, 2012, PLANT CELL, V24, P152, DOI 10.1105/tpc.111.094771; Griffiths S, 2006, NATURE, V439, P749, DOI 10.1038/nature04434; Hagras AAA, 2005, GENES GENET SYST, V80, P147, DOI 10.1266/ggs.80.147; Halvorsen BL, 2002, J NUTR, V132, P461, DOI 10.1093/jn/132.3.461; Hentschel V, 2002, J AGR FOOD CHEM, V50, P6663, DOI 10.1021/jf025701p; Hernandez P, 2001, THEOR APPL GENET, V102, P1259, DOI 10.1007/s001220000514; Islam A. K. M. R., 1988, Proceedings of the seventh international wheat genetics symposium, held at Cambridge, UK, 13-19 July 1988., P309; Islam A.K.M.R., 1978, 5 INT WHEAT GENETICS, P365; ISLAM AKMR, 1981, HEREDITY, V46, P161, DOI 10.1038/hdy.1981.24; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; KANEKO S, 1995, BIOSCI BIOTECH BIOCH, V59, P1; Karlova R, 2011, PLANT CELL, V23, P923, DOI 10.1105/tpc.110.081273; Lado J, 2015, PHYSL PLANTARUM; Larre C, 2011, J PROTEOMICS, V74, P1279, DOI 10.1016/j.jprot.2011.03.014; LEPAGE M, 1968, CEREAL CHEM, V45, P600; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Martin A, 2005, CYTOGENET GENOME RES, V109, P378, DOI 10.1159/000082423; Martin A, 1998, TRITICEAE III, P377; May T, 2000, PLANT CELL, V12, P53, DOI 10.1105/tpc.12.1.53; Miller T.E., 1982, INDUCED VARIABILITY, P79; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nadolska-Orczyk A, 2009, J APPL GENET, V50, P185, DOI 10.1007/BF03195672; Neta-Sharir I, 2005, PLANT CELL, V17, P1829, DOI 10.1105/tpc.105.031914; OKAMOTO M., 1957, Wheat Information Service, pp; Pedersen C, 1996, GENOME, V39, P93, DOI 10.1139/g96-013; Pedersen C, 1997, GENOME, V40, P589, DOI 10.1139/g97-077; Prieto P, 2004, HEREDITAS, V141, P122, DOI 10.1111/j.1601-5223.2004.01825.x; Prieto P, 2001, HEREDITAS, V135, P171, DOI 10.1111/j.1601-5223.2001.t01-1-00171.x; Rayburn A. L., 1986, PLANT MOL BIOL REP, V4, P102, DOI [10.1007/BF02732107, DOI 10.1007/BF02732107, /10.1007/BF02732107]; Rey MD, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00160; Rey MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107714; RILEY R, 1958, NATURE, V182, P713, DOI 10.1038/182713a0; RILEY RALPH, 1960, HEREDITY, V15, P407, DOI 10.1038/hdy.1960.106; Roder MS, 1998, GENETICS, V149, P2007; Rodrigo MJ, 2004, J AGR FOOD CHEM, V52, P6724, DOI 10.1021/jf049607f; Rodrigo MJ, 2003, J EXP BOT, V54, P727, DOI 10.1093/jxb/erg083; Rodriguez-Suarez C, 2012, THEOR APPL GENET, V124, P713, DOI 10.1007/s00122-011-1741-2; Rodriguez-Suarez C, 2010, CROP PASTURE SCI, V61, P743, DOI 10.1071/CP10025; Rodriguez-Suarez C, 2014, PLANT MOL BIOL, V84, P659, DOI 10.1007/s11103-013-0160-y; Rodriguez-Suarez C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-200; Rouseff R, 1996, J AGR FOOD CHEM, V44, P2176, DOI 10.1021/jf950631q; Rubiales D, 2000, EUPHYTICA, V115, P221, DOI 10.1023/A:1004097830103; SCHWARZACHER T, 1989, ANN BOT-LONDON, V64, P315, DOI 10.1093/oxfordjournals.aob.a087847; Sears E. R., 1981, Wheat science - today and tomorrow., P75; Sears E. R., 1958, Proceedings of the X International Congress of Genetics, McGill University, Montreal, Canada, August 20-27, 1958., V2, P258; SEARS ER, 1977, CAN J GENET CYTOL, V19, P585, DOI 10.1139/g77-063; SEARS ER, 1976, ANNU REV GENET, V10, P31, DOI 10.1146/annurev.ge.10.120176.000335; SEARS ER, 1972, CAN J GENET CYTOL, V14, P736; Tasleem-Tahir A, 2011, PROTEOMICS, V11, P371, DOI 10.1002/pmic.201000333; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; vanGijlswijk RPM, 1997, J HISTOCHEM CYTOCHEM, V45, P375, DOI 10.1177/002215549704500305; Wang XW, 2002, CROP SCI, V42, P1365, DOI 10.2135/cropsci2002.1365; Yousafzai FK, 2010, FUNCT INTEGR GENOMIC, V10, P147, DOI 10.1007/s10142-010-0171-6; Zhang CY, 2011, CROP SCI, V51, P1580, DOI 10.2135/cropsci2010.12.0689	70	14	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134598	10.1371/journal.pone.0134598	http://dx.doi.org/10.1371/journal.pone.0134598			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241856	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700051
J	Piguet, V; D'Incau, S; Besson, M; Desmeules, J; Cedraschi, C				Piguet, Valerie; D'Incau, Stephanie; Besson, Marie; Desmeules, Jules; Cedraschi, Christine			Prescribing Generic Medication in Chronic Musculoskeletal Pain Patients: An Issue of Representations, Trust, and Experience in a Swiss Cohort	PLOS ONE			English	Article							QUALITATIVE RESEARCH; HEALTH-CARE; DRUG SUBSTITUTION; SATURATION; MEDICINES; PHARMACY; POLICIES; VIEWS; NEED	Objective Parallel to an ever stronger advocacy for the use of generics, various sources of information report concerns regarding substitution. The literature indicates that information regarding substitution is not univocal. The aim of this qualitative study was to explore patients' representations regarding generics in patients suffering from non-specific disabling chronic musculoskeletal pain, as these patients are confronted with the issue of the prescription and/or substitution of original formulations with generics. Methods Qualitative methods were selected because the aim was to access the range of patients' representations and to consider their conceptions. Standardized face-to-face semi-structured interviews were used, and transcripts were submitted to content analysis. Results Patients' representations suggest that they might be confident in taking a generic medication: when he/she has an understanding of generics as resulting from a development process that has become part of the public domain; the generic medication is prescribed by the physician; each prescription is discussed, i.e., the patient is prescribed the generic version of a given medication and not a generic medication. Discussion Economic arguments are not sufficient to justify substitution, and may even raise issues calling upon cognitive dissonance. Even in non-life-threatening diseases, negative cues require attention and need be de-emphasized - in particular lower price as an indication of lower quality, and generic status as contradictory with advocating individualization of medication.	[Piguet, Valerie; Besson, Marie; Desmeules, Jules; Cedraschi, Christine] Univ Hosp Geneva, Ctr Multidisciplinary Pain, Div Clin Pharmacol & Toxicol, Geneva, Switzerland; [Piguet, Valerie; Besson, Marie; Desmeules, Jules; Cedraschi, Christine] Univ Geneva, Geneva, Switzerland; [D'Incau, Stephanie] Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland; [Cedraschi, Christine] Univ Hosp Geneva, Div Gen Med Rehabil, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva	Piguet, V (corresponding author), Univ Hosp Geneva, Ctr Multidisciplinary Pain, Div Clin Pharmacol & Toxicol, Geneva, Switzerland.	Valerie.Piguet@hcuge.ch	Besson, Marie/AAG-3253-2019					Al Ameri MN, 2011, TRANSPL INT, V24, P770, DOI 10.1111/j.1432-2277.2011.01268.x; Andersson K, 2005, PHARMACOEPIDEM DR S, V14, P341, DOI 10.1002/pds.1055; Babar ZUD, 2014, HEALTH POLICY, V117, P285, DOI 10.1016/j.healthpol.2014.06.004; Barbour RS, 2003, J EVAL CLIN PRACT, V9, P179, DOI 10.1046/j.1365-2753.2003.00371.x; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Barry CA, 1999, QUAL HEALTH RES, V9, P26, DOI 10.1177/104973299129121677; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Daly J, 2007, J CLIN EPIDEMIOL, V60, P43, DOI 10.1016/j.jclinepi.2006.03.014; Daubresse M, 2013, MED CARE, V51, P870, DOI 10.1097/MLR.0b013e3182a95d86; Decollogny A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-17; Dylst P, 2013, EXPERT REV PHARM OUT, V13, P59, DOI [10.1586/ERP.12.83, 10.1586/erp.12.83]; Ess SM, 2003, PHARMACOECONOMICS, V21, P89, DOI 10.2165/00019053-200321020-00002; Fairman KA, 2008, J MANAGE CARE PHARM, V14, P387, DOI 10.18553/jmcp.2008.14.4.387; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Gaskell G., 2000, QUALITATIVE RES TEXT, P38, DOI DOI 10.4135/9781849209731; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; Glaser B, 1996, DISCOVERY GROUNDED T; Guba E., 2005, SAGE HDB QUALITATIVE, V3rd, P191; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hakonsen H, 2009, CURR MED RES OPIN, V25, P2515, DOI 10.1185/03007990903192223; Hassali Mohamed A A, 2009, Int J Pharm Pract, V17, P79; Heikkila Reeta, 2011, BMC Clin Pharmacol, V11, P20, DOI 10.1186/1472-6904-11-20; Himmel W, 2005, INT J CLIN PHARM TH, V43, P472; Kaplan WA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074399; Kjoenniksen I, 2006, PHARM WORLD SCI, V28, P284, DOI 10.1007/s11096-006-9043-5; KUZEL AJ, 1992, RES METH PR, V3, P31; LEVENTHAL H, 1992, COGNITIVE THER RES, V16, P143, DOI 10.1007/BF01173486; Leventhal H., 2003, SELF REGULATION HLTH, P138; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Lionberger R, 2013, CLIN PHARMACOL THER, V94, P438, DOI 10.1038/clpt.2013.104; Mays N, 1996, QUALITATIVE RES HLTH; Mody GM, 2012, BEST PRACT RES CL RH, V26, P237, DOI 10.1016/j.berh.2012.03.002; Morse J. M., 2002, INT J QUAL METHODS, P13, DOI 10.1177/160940690200100202; Nelson AE, 2014, SEMIN ARTHRITIS RHEU, V43, P701, DOI 10.1016/j.semarthrit.2013.11.012; O'Reilly M, 2013, QUAL RES, V13, P190, DOI 10.1177/1468794112446106; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Sander JW, 2010, EXPERT REV NEUROTHER, V10, P1887, DOI [10.1586/ern.10.163, 10.1586/ERN.10.163]; Sarradon-Eck A, 2007, REV EPIDEMIOL SANTE, V55, P179, DOI 10.1016/j.respe.2007.01.026; Schwartz N., 1992, CONTEXT EFFECTS SOCI; Shah RR, 2012, BRIT J CLIN PHARMACO, V74, P698, DOI 10.1111/j.1365-2125.2012.04328.x; Shrank WH, 2007, J GEN INTERN MED, V22, P1298, DOI 10.1007/s11606-007-0284-3; Shrank WH, 2010, HEALTH AFFAIR, V29, P1383, DOI 10.1377/hlthaff.2009.0424; Shrank WH, 2009, HEALTH AFFAIR, V28, P546, DOI 10.1377/hlthaff.28.2.546; Shrank WH, 2009, MED CARE, V47, P319, DOI 10.1097/MLR.0b013e31818af850; Simoens Steven, 2008, Expert Rev Clin Pharmacol, V1, P497, DOI 10.1586/17512433.1.4.497; Stone J, 2010, FRONT SOC PSYCHOL, P313; Strauss A., 1990, BASICS QUALITATIVE R; Turk DC, 2011, LANCET, V377, P2226, DOI 10.1016/S0140-6736(11)60402-9; Waber RL, 2008, JAMA-J AM MED ASSOC, V299, P1016, DOI 10.1001/jama.299.9.1016; Wicklund R.A., 2013, PERSPECTIVES COGNITI; Yu Y, 2013, CLIN PHARMACOL THER, V94, P519, DOI 10.1038/clpt.2013.108	53	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134661	10.1371/journal.pone.0134661	http://dx.doi.org/10.1371/journal.pone.0134661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1UY	26237036	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942400031
J	Rajasingh, S; Thangavel, J; Czirok, A; Samanta, S; Roby, KF; Dawn, B; Rajasingh, J				Rajasingh, Sheeja; Thangavel, Jayakumar; Czirok, Andras; Samanta, Saheli; Roby, Katherine F.; Dawn, Buddhadeb; Rajasingh, Johnson			Generation of Functional Cardiomyocytes from Efficiently Generated Human iPSCs and a Novel Method of Measuring Contractility	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; ACUTE MYOCARDIAL-INFARCTION; CONVECTIVE TISSUE MOVEMENTS; PROGENITOR CELLS; DIRECTED DIFFERENTIATION; THERAPY; DISEASE; TRANSPLANTATION; REGENERATION; INDUCTION	Human induced pluripotent stem cells (iPSCs) derived cardiomyocytes (iCMCs) would provide an unlimited cell source for regenerative medicine and drug discoveries. The objective of our study is to generate functional cardiomyocytes from human iPSCs and to develop a novel method of measuring contractility of CMCs. In a series of experiments, adult human skin fibroblasts (HSF) and human umbilical vein endothelial cells (HUVECs) were treated with a combination of pluripotent gene DNA and mRNA under specific conditions. The iPSC colonies were identified and differentiated into various cell lineages, including CMCs. The contractile activity of CMCs was measured by a novel method of frame-by-frame cross correlation (particle image velocimetry-PIV) analysis. Our treatment regimen transformed 4% of HSFs into iPSC colonies at passage 0, a significantly improved efficiency compared with use of either DNA or mRNA alone. The iPSCs were capable of differentiating both in vitro and in vivo into endodermal, ectodermal and mesodermal cells, including CMCs with >88% of cells being positive for troponin T (CTT) and Gata4 by flow cytometry. We report a highly efficient combination of DNA and mRNA to generate iPSCs and functional iCMCs from adult human cells. We also report a novel approach to measure contractility of iCMCs.	[Rajasingh, Sheeja; Thangavel, Jayakumar; Samanta, Saheli; Dawn, Buddhadeb; Rajasingh, Johnson] Univ Kansas, Med Ctr, Dept Internal Med, Cardiovasc Res Inst,Div Cardiovasc Dis, Kansas City, KS 66103 USA; [Czirok, Andras; Roby, Katherine F.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Rajasingh, Johnson] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Rajasingh, J (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, Cardiovasc Res Inst,Div Cardiovasc Dis, Kansas City, KS 66103 USA.	rjohnson9@kumc.edu	Rajasingh, Johnson/AAT-1985-2021	Rajasingh, Johnson/0000-0002-6172-4083	American Heart Association Grant - Jon Holden DeHaan Foundation [10SDG2630181]; National Institutes of Health [R21HL97349, R01GM102801, R01HL117730]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097349, R01HL117730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103326, R01GM102801] Funding Source: NIH RePORTER	American Heart Association Grant - Jon Holden DeHaan Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by American Heart Association Grant - Jon Holden DeHaan Foundation 10SDG2630181 and National Institutes of Health grants R21HL97349 (to JR), R01GM102801 (to AC) and R01HL117730 (to BD).	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Aleksandrova A, 2012, DEV BIOL, V363, P348, DOI 10.1016/j.ydbio.2011.12.036; [Anonymous], 2011, GUIDE FOR THE CARE A; Assmus B, 2010, CIRC-HEART FAIL, V3, P89, DOI 10.1161/CIRCHEARTFAILURE.108.843243; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Choi SH, 2012, CIRC J, V76, P1307, DOI 10.1253/circj.CJ-11-1479; D'Amario D, 2011, CIRC RES, V108, P857, DOI 10.1161/CIRCRESAHA.111.241380; Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102; Dimmeler S, 2008, CIRC RES, V102, P1319, DOI 10.1161/CIRCRESAHA.108.175943; Frati C, 2011, CURR PHARM DESIGN, V17, P3252; Hussein SMI, 2012, CURR OPIN GENET DEV, V22, P435, DOI 10.1016/j.gde.2012.08.007; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Kim C, 2010, STEM CELLS DEV, V19, P783, DOI 10.1089/scd.2009.0349; Leistner DM, 2011, CLIN RES CARDIOL, V100, P925, DOI 10.1007/s00392-011-0327-y; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Losordo DW, 2004, CIRCULATION, V109, P2487, DOI 10.1161/01.CIR.0000128595.79378.FA; Losordo DW, 2012, CIRC CARDIOVASC INTE; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Lundy SD, 2013, STEM CELLS DEV, V22, P1991, DOI 10.1089/scd.2012.0490; Narsinh K, 2011, CIRC RES, V108, P1146, DOI 10.1161/CIRCRESAHA.111.240374; Narsinh KH, 2011, NAT PROTOC, V6, P78, DOI 10.1038/nprot.2010.173; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Pal D., 2012, NAT MED; Rajasingh J, 2008, CIRC RES, V102, pE107, DOI 10.1161/CIRCRESAHA.108.176115; Rajasingh J, 2007, CIRC RES, V101, P910, DOI 10.1161/CIRCRESAHA.107.156786; Rajasingh J, 2012, PROG MOL BIOL TRANSL, V111, P51, DOI [10.1016/B978-0-12-398459-3.00003-4, 10.1016/B978-0-12-358459-3.00003-4]; Rajasingh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022550; Sampsell-Barron Tori, 2013, Methods Mol Biol, V1001, P81, DOI 10.1007/978-1-62703-363-3_8; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schlaeger TM, 2015, NAT BIOTECHNOL, V33, P58, DOI 10.1038/nbt.3070; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Taapken SM, 2011, NAT BIOTECHNOL, V29, P313, DOI 10.1038/nbt.1835; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008067; Thangavel J, 2014, AM J PATHOL, V184, P2237, DOI 10.1016/j.ajpath.2014.05.008; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1; Xu XQ, 2009, STEM CELLS, V27, P2163, DOI 10.1002/stem.166; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Zamir EA, 2006, P NATL ACAD SCI USA, V103, P19806, DOI 10.1073/pnas.0606100103; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	47	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134093	10.1371/journal.pone.0134093	http://dx.doi.org/10.1371/journal.pone.0134093			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237415	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942400014
J	Adhikari, D; Tiwary, R; Barik, SK				Adhikari, Dibyendu; Tiwary, Raghuvar; Barik, Saroj Kanta			Modelling Hotspots for Invasive Alien Plants in India	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; CLIMATE-CHANGE; POTENTIAL DISTRIBUTION; BIODIVERSITY HOTSPOTS; BIOLOGICAL INVASIONS; NATURAL-SELECTION; RAPID EVOLUTION; HOT-SPOTS; DIVERSITY; RANGE	Identification of invasion hotspots that support multiple invasive alien species (IAS) is a prerequisite for control and management of invasion. However, till recently it remained a methodological challenge to precisely determine such invasive hotspots. We identified the hotspots of alien species invasion in India through Ecological Niche Modelling (ENM) using species occurrence data from the Global Biodiversity Information Facility (GBIF). The predicted area of invasion for selected species were classified into 4 categories based on number of model agreements for a region i.e. high, medium, low and very low. About 49% of the total geographical area of India was predicted to be prone to invasion at moderate to high levels of climatic suitability. The intersection of anthropogenic biomes and ecoregions with the regions of 'high' climatic suitability was classified as hotspot of alien plant invasion. Nineteen of 47 ecoregions of India, harboured such hotspots. Most ecologically sensitive regions of India, including the 'biodiversity hotspots' and coastal regions coincide with invasion hotspots, indicating their vulnerability to alien plant invasion. Besides demonstrating the usefulness of ENM and open source data for IAS management, the present study provides a knowledge base for guiding the formulation of an effective policy and management strategy for controlling the invasive alien species.	[Adhikari, Dibyendu; Tiwary, Raghuvar; Barik, Saroj Kanta] North Eastern Hill Univ, Dept Bot, Shillong 793022, Meghalaya, India	North Eastern Hill University	Barik, SK (corresponding author), North Eastern Hill Univ, Dept Bot, Shillong 793022, Meghalaya, India.	sarojkbarik@gmail.com	Adhikari, Dibyendu/GPW-8128-2022; BARIK, SAROJ KANTA/ADR-1820-2022	Adhikari, Dibyendu/0000-0002-5057-0541; BARIK, SAROJ KANTA/0000-0002-1795-9539				Adhikari D, 2012, ECOL ENG, V40, P37, DOI 10.1016/j.ecoleng.2011.12.004; Ali Rauf, 2006, Journal of the Bombay Natural History Society, V103, P349; Allouche O, 2008, J APPL ECOL, V45, P599, DOI 10.1111/j.1365-2664.2007.01445.x; Annapurna C, 2003, WEED RES, V43, P190, DOI 10.1046/j.1365-3180.2003.00332.x; [Anonymous], 2011, INDIA STATE OF FORES; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Barik SK, 2012, CABI INVASIVE SER, P77, DOI 10.1079/9781845939076.0077; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Bellard C, 2014, GLOBAL ECOL BIOGEOGR, V23, P1376, DOI 10.1111/geb.12228; Bhatt J, 2011, INVASIVE ALIEN PLANT, V1; Biswas SR, 2007, FOREST ECOL MANAG, V245, P1, DOI 10.1016/j.foreco.2007.02.011; Catford JA, 2011, J APPL ECOL, V48, P432, DOI 10.1111/j.1365-2664.2010.01945.x; Colautti RI, 2015, MOL ECOL, V24, P1999, DOI 10.1111/mec.13162; Curnutt JL, 2000, BIOL CONSERV, V94, P341, DOI 10.1016/S0006-3207(99)00186-X; Dawson W, 2012, NEW PHYTOL, V194, P859, DOI 10.1111/j.1469-8137.2012.04104.x; Denslow JS, 2003, ANN MO BOT GARD, V90, P119, DOI 10.2307/3298531; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Dullinger S, 2009, BIOL INVASIONS, V11, P2401, DOI 10.1007/s10530-009-9424-5; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ellis E. C., 2008, ANTHROPOGENIC BIOMES; Escalante Tania, 2013, TIP Revista Especializada en Ciencias Quimico-Biologicas, V16, P5; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; GOPINATHAN MC, 1982, NEW PHYTOL, V91, P531, DOI 10.1111/j.1469-8137.1982.tb03331.x; GRACE J, 1987, NEW PHYTOL, V106, P113; Gravuer K, 2008, P NATL ACAD SCI USA, V105, P6344, DOI 10.1073/pnas.0712026105; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Hijmans R.J., 2001, MANUAL; Hooker JD, 1882, THE FLORA OF BRITISH, VIII; Hooker JD, 1872, THE FLORA OF BRITISH, VI; Hooker JD, 1885, THE FLORA OF BRITISH, VIV; Hooker JD, 1885, THE FLORA OF BRITISH, VV; Hooker JD, 1879, THE FLORA OF BRITISH, VII; Hooker JD, 1894, THE FLORA OF BRITISH, VVI; Hufbauer RA, 2012, EVOL APPL, V5, P89, DOI 10.1111/j.1752-4571.2011.00211.x; Hulme Philip E., 2007, V25, P56; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jaryan V, 2013, NATL ACAD SCI LETT, V36, P85, DOI 10.1007/s40009-012-0103-1; Jha CS, 2000, CURR SCI INDIA, V79, P231; Jimenez-Valverde Alberto, 2009, Biodiversity Informatics, V6, P28; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Khuroo AA, 2012, BIOL INVASIONS, V14, P99, DOI 10.1007/s10530-011-9981-2; Khuroo AA, 2007, BIOL INVASIONS, V9, P269, DOI 10.1007/s10530-006-9032-6; King JR, 2008, P NATL ACAD SCI USA, V105, P20339, DOI 10.1073/pnas.0809423105; Lekevicius Edmundas, 2009, Ekologija, V55, P165; Leu M, 2008, ECOL APPL, V18, P1119, DOI 10.1890/07-0480.1; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Lin W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001208; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Luoto M, 2007, GLOBAL ECOL BIOGEOGR, V16, P34, DOI 10.1111/j.1466-8238.2006.00262.x; Mack RN, 2001, BIOSCIENCE, V51, P95, DOI 10.1641/0006-3568(2001)051[0095:HAGPDG]2.0.CO;2; MAHESHWA.JK, 1965, NATURE, V206, P1270, DOI 10.1038/2061270a0; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; McNeely JA, 2001, THE GREAT RESHUFFLIN; Merila J, 2014, EVOL APPL, V7, P1, DOI 10.1111/eva.12137; Mesgaran MB, 2014, DIVERS DISTRIB, V20, P1147, DOI 10.1111/ddi.12209; Mittermeier R.A., 2011, BIODIVERSITY HOTSPOT, V1st ed., P3; Moles AT, 2008, J ECOL, V96, P13, DOI 10.1111/j.1365-2745.2007.01332.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Negi PS, 2007, CURR SCI INDIA, V92, P968; O'Donnell J, 2012, GLOBAL CHANGE BIOL, V18, P617, DOI 10.1111/j.1365-2486.2011.02537.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; PANETTA FD, 1991, WEED RES, V31, P273, DOI 10.1111/j.1365-3180.1991.tb01767.x; Parepa M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2632; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peh KSH, 2010, BIODIVERS CONSERV, V19, P1083, DOI 10.1007/s10531-009-9755-7; Peterson A. T, 2011, ECOLOGICAL NICHES GE, DOI 10.23943/princeton/9780691136868.001.0001; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pysek P, 2003, CONSERV BIOL, V17, P1414, DOI 10.1046/j.1523-1739.2003.02248.x; Rasingam L, 2009, BIODIVERS CONSERV, V18, P1045, DOI 10.1007/s10531-008-9496-z; Reddy CS, 2009, BANGL J PLANT TAXON, V16, P29; Reddy CS, 2008, LIFE SCI J, V5, P84; Reshi Z. A., 2012, Proceedings of the National Academy of Sciences India. Section B, Biological Sciences, V82, P305; Rius M, 2014, TRENDS ECOL EVOL, V29, P233, DOI 10.1016/j.tree.2014.02.003; Roura-Pascual N, 2011, P NATL ACAD SCI USA, V108, P220, DOI 10.1073/pnas.1011723108; Sanders NJ, 2003, P NATL ACAD SCI USA, V100, P2474, DOI 10.1073/pnas.0437913100; Schmitt CB, 2009, BIOL CONSERV, V142, P2122, DOI 10.1016/j.biocon.2009.04.012; SCOTT JK, 1993, J BIOGEOGR, V20, P87, DOI 10.2307/2845742; Sekar K. C., 2012, American Journal of Plant Sciences, V3, P177, DOI 10.4236/ajps.2012.32021; Shah MA, 2012, J PLANT ECOL-UK, V5, P167, DOI 10.1093/jpe/rtr021; Sharma GP, 2005, CURR SCI INDIA, V88, P726; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Sloan S, 2014, BIOL CONSERV, V177, P12, DOI 10.1016/j.biocon.2014.05.027; Stadler J, 2000, ECOGRAPHY, V23, P169, DOI 10.1111/j.1600-0587.2000.tb00272.x; Stohlgren TJ, 1999, ECOL MONOGR, V69, P25, DOI 10.1890/0012-9615(1999)069[0025:EPSIHS]2.0.CO;2; Strauss SY, 2014, OIKOS, V123, P257, DOI 10.1111/j.1600-0706.2013.01093.x; Thuiller W, 2006, GLOBAL CHANGE BIOL, V12, P424, DOI 10.1111/j.1365-2486.2006.01115.x; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Thuiller Wilfried, 2007, V193, P197; Tilman D, 2001, P NATL ACAD SCI USA, V98, P5433, DOI 10.1073/pnas.091093198; Vaclavik T, 2012, DIVERS DISTRIB, V18, P73, DOI 10.1111/j.1472-4642.2011.00854.x; Vandepitte K, 2014, MOL ECOL, V23, P2157, DOI 10.1111/mec.12683; Vicente J, 2010, ECOGRAPHY, V33, P1081, DOI 10.1111/j.1600-0587.2010.6380.x; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; Wilson JRU, 2007, DIVERS DISTRIB, V13, P11, DOI 10.1111/j.1366-9516.2006.00302.x; Woodward FI, 1987, CLIMATE AND PLANT DI; Yang XQ, 2013, ECOL ENG, V51, P83, DOI 10.1016/j.ecoleng.2012.12.004; Zenni RD, 2014, ECOL LETT, V17, P727, DOI 10.1111/ele.12278	113	60	63	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134665	10.1371/journal.pone.0134665	http://dx.doi.org/10.1371/journal.pone.0134665			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230513	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400146
J	Agudelo-Gomez, D; Pineda-Sierra, S; Ceron-Munoz, MF				Agudelo-Gomez, Divier; Pineda-Sierra, Sebastian; Fernando Ceron-Munoz, Mario			Genetic Evaluation of Dual-Purpose Buffaloes (Bubalus bubalis) in Colombia Using Principal Component Analysis	PLOS ONE			English	Article							FACTOR-ANALYTIC MODELS; DAY MILK-YIELD; BREEDING VALUES; GROWTH TRAITS; PARAMETERS	Genealogy and productive information of 48621 dual-purpose buffaloes born in Colombia between years 1996 and 2014 was used. The following traits were assessed using one-trait models: milk yield at 270 days (MY270), age at first calving (AFC), weaning weight (WW), and weights at the following ages: first year (W12), 18 months (W18), and 2 years (W24). Direct additive genetic and residual random effects were included in all the traits. Maternal permanent environmental and maternal additive genetic effects were included for WW and W12. The fixed effects were: contemporary group (for all traits), sex (for WW, W12, W18, and W24), parity (for WW, W12, and MY270). Age was included as covariate for WW, W12, W18 and W24. Principal component analysis (PCA) was conducted using the genetic values of 133 breeding males whose breeding-value reliability was higher than 50% for all the traits in order to define the number of principal components (PC) which would explain most of the variation. The highest heritabilities were for W18 and MY270, and the lowest for AFC; with 0.53, 0.23, and 0.17, respectively. The first three PCs represented 66% of the total variance. Correlation of the first PC with meat production traits was higher than 0.73, and it was -0.38 with AFC. Correlations of the second PC with maternal genetic component traits for WW and W12 were above 0.75. The third PC had 0.84 correlation with MY270. PCA is an alternative approach for analyzing traits in dual-purpose buffaloes and reduces the dimension of the traits.	[Agudelo-Gomez, Divier] Corp Univ Lasallista, Fac Ciencias Adm & Agr, Grp Invest Sobre Prod Desarrollo & Transformac Ag, Caldas Antioquia, Colombia; [Agudelo-Gomez, Divier; Pineda-Sierra, Sebastian; Fernando Ceron-Munoz, Mario] Univ Antioquia, Fac Ciencias Agr, Grp Invest Genet Mejoramiento & Modelac Anim GaMM, Medellin, Colombia	Universidad de Antioquia	Agudelo-Gomez, D (corresponding author), Corp Univ Lasallista, Fac Ciencias Adm & Agr, Grp Invest Sobre Prod Desarrollo & Transformac Ag, Caldas Antioquia, Colombia.	diagudelo@lasallistadocentes.edu.co	Cerón-Muñoz, Mario Fernando/AAD-9778-2020; Agudelo Gomez, Divier Antonio/O-9733-2016	Cerón-Muñoz, Mario Fernando/0000-0002-7233-6625; Agudelo Gomez, Divier Antonio/0000-0001-6184-335X	Comite para el desarrollo de la investigacion, CODI, Universidad de Antioquia	Comite para el desarrollo de la investigacion, CODI, Universidad de Antioquia	The authors received funding for this work from Comite para el desarrollo de la investigacion, CODI, Universidad de Antioquia.	[Anonymous], 2014, R LANG ENV STAT COMP; Aspilcueta-Borquis RR, 2010, GENET MOL RES, V9, P1636, DOI 10.4238/vol9-3gmr846; Bignardi AB, 2014, LIVEST SCI, V162, P50, DOI 10.1016/j.livsci.2014.01.031; Bignardi AB, 2012, J DAIRY SCI, V95, P2157, DOI 10.3168/jds.2011-4494; Boldman K.G., 1995, MANUAL USE MTDFREML; Boligon AA, 2013, LIVEST SCI, V152, P135, DOI 10.1016/j.livsci.2013.01.005; Bolívar Vergara Diana María, 2010, Rev. Fac. Nac. Agron. Medellín, V63, P5587; Vergara DMB, 2012, REV COLOMB CIENC PEC, V25, P202; Buzanskas ME, 2013, REPROD FERT DEVELOP, V25, P775, DOI 10.1071/RD12132; de Albuquerque LG, 2001, J ANIM BREED GENET, V118, P83, DOI 10.1046/j.1439-0388.2001.00279.x; Dias LT, 2004, REV BRAS ZOOTECN, V33, P97, DOI 10.1590/S1516-35982004000100013; FEDEGAN, 2006, PLAN ESTR GAN COL 20, P296; Holdridge L, 1996, SKELETAL NUCL MED, P225; Hurtado-Lugo N., 2006, Livestock Research for Rural Development, V18, P39; Husson F., 2014, R PACKAGE VERSION, V1, P102; ICAR, 2012, INT AGR REC REC PRAC, P580; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kirkpatrick M, 2004, GENETICS, V168, P2295, DOI 10.1534/genetics.104.029181; Malhado CHM, 2007, ITAL J ANIM SCI, V6, P325; Malhado CHM, 2013, REV BRAS ZOOTECN, V42, P565, DOI 10.1590/S1516-35982013000800005; Meyer K, 2007, J ANIM BREED GENET, V124, P50, DOI 10.1111/j.1439-0388.2007.00637.x; Meyer K, 2005, ANIM SCI, V81, P337, DOI 10.1079/ASC50850337; Oliveira DP, 2014, 10 WORLD C GEN APPL, P3; Rencher AC, 2002, METHODS MULTIVARIATE, DOI [10.1002/0471271357, DOI 10.1002/0471271357]; Rosati A, 2002, LIVEST PROD SCI, V74, P185, DOI 10.1016/S0301-6226(01)00293-7; Savegnago RP, 2011, POULTRY SCI, V90, P2174, DOI 10.3382/ps.2011-01474; Seno LO, 2010, LIVEST RES RURAL DEV, P22; Tonhati H, 2008, GENET MOL BIOL, V31, P674, DOI 10.1590/S1415-47572008000400012; Val JE, 2008, ARQ BRAS MED VET ZOO, V60, P705, DOI 10.1590/S0102-09352008000300027; Wichern DW, 1992, APPL MULTIVARIATE ST, P442; WILLHAM RL, 1972, J ANIM SCI, V35, P1288	31	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132811	10.1371/journal.pone.0132811	http://dx.doi.org/10.1371/journal.pone.0132811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230093	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400021
J	Bildosola, I; Rio-Belver, R; Cilleruelo, E; Garechana, G				Bildosola, Inaki; Rio-Belver, Rosa; Cilleruelo, Ernesto; Garechana, Gaizka			Design and Implementation of a Cloud Computing Adoption Decision Tool: Generating a Cloud Road	PLOS ONE			English	Article								Migrating to cloud computing is one of the current enterprise challenges. This technology provides a new paradigm based on "on-demand payment" for information and communication technologies. In this sense, the small and medium enterprise is supposed to be the most interested, since initial investments are avoided and the technology allows gradual implementation. However, even if the characteristics and capacities have been widely discussed, entry into the cloud is still lacking in terms of practical, real frameworks. This paper aims at filling this gap, presenting a real tool already implemented and tested, which can be used as a cloud computing adoption decision tool. This tool uses diagnosis based on specific questions to gather the required information and subsequently provide the user with valuable information to deploy the business within the cloud, specifically in the form of Software as a Service (SaaS) solutions. This information allows the decision makers to generate their particular Cloud Road. A pilot study has been carried out with enterprises at a local level with a two-fold objective: to ascertain the degree of knowledge on cloud computing and to identify the most interesting business areas and their related tools for this technology. As expected, the results show high interest and low knowledge on this subject and the tool presented aims to readdress this mismatch, insofar as possible.	[Bildosola, Inaki; Cilleruelo, Ernesto] Univ Basque Country UPV EHU, Fac Engn Bilbao ETSI Bilbao, Ind Org & Management Engn Dept, Foresight Technol & Management FTM Grp, Basque Country, Spain; [Rio-Belver, Rosa] Univ Basque Country UPV EHU, Univ Coll Engn Vitoria Gasteiz, Ind Org & Management Engn Dept, Foresight Technol & Management FTM Grp, Basque Country, Spain; [Garechana, Gaizka] Univ Basque Country UPV EHU, Escuela Univ Estudios Empresariales Bilbao, Ind Org & Management Engn Dept, Foresight Technol & Management FTM Grp, Basque Country, Spain	University of Basque Country; University of Basque Country; University of Basque Country	Bildosola, I (corresponding author), Univ Basque Country UPV EHU, Fac Engn Bilbao ETSI Bilbao, Ind Org & Management Engn Dept, Foresight Technol & Management FTM Grp, Basque Country, Spain.	inaki.bildosola@ehu.es	Rio-Belver, Rosa M/C-9742-2009; Cilleruelo, Ernesto/L-4774-2017; Garechana, Gaizka/ABG-9948-2020	Rio-Belver, Rosa M/0000-0002-4244-9098; Cilleruelo, Ernesto/0000-0002-4184-6462; Garechana, Gaizka/0000-0002-1913-3239; Bildosola, Inaki/0000-0002-4964-9762	program INNPACTO; Project: Plataforma Inteligente de Gestion Empresarial Basada en Cloud Computing y la WEB 2.0 [IPT2011-1805-430000]; Ministerio de Economia y Competitividad	program INNPACTO; Project: Plataforma Inteligente de Gestion Empresarial Basada en Cloud Computing y la WEB 2.0; Ministerio de Economia y Competitividad(Spanish Government)	This work is funded by the program INNPACTO 2011; Project: (2011-2013) Plataforma Inteligente de Gestion Empresarial Basada en Cloud Computing y la WEB 2.0; Project Reference: IPT2011-1805-430000. The Financing Entity was: Ministerio de Economia y Competitividad http://www.mineco.gob.es/portal/site/mineco/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CLOUD COMPUTINGS ROL; Bildosola I, 2015, ENHANCING SYNERGIES, P371; CB Consulting, 2012, CLOUD COMP SIT ESP; CB Consulting, 2012, CLOUD COMP VIRT ESP; Chang V, 2013, INT J INFORM MANAGE, V33, P524, DOI 10.1016/j.ijinfomgt.2013.01.005; Cisco, 2013, WHIT PAP CISC GLOB C; Gartner, 2012, GARTN SAYS WORLDW SO; Gens F, 2012, IDC PREDICTIONS 2013; Gerhardter A, 2013, FLEXIBILITY IMPROVED, P171; Ghag SS, 2008, FINANCIAL IMPLICATIO; Grossman Robert L., 2009, IT Professional, V11, P23, DOI 10.1109/MITP.2009.40; Hinchcliffe D, 2009, WHAT DOES CLOUD COMP; Iyer EK, 2013, NAT C BUS AN BUS INT; Khajeh-Hosseini A, 2012, SOFTWARE PRACT EXPER, V42, P447, DOI 10.1002/spe.1072; Kloch C, 2011, WIRELESS PERS COMMUN, V58, P17, DOI 10.1007/s11277-011-0286-7; Marston S, 2011, DECIS SUPPORT SYST, V51, P176, DOI 10.1016/j.dss.2010.12.006; Mell P., 2011, NIST DEFINITION CLOU; Menzel M, 2013, SOFTWARE PRACT EXPER, V43, P1283, DOI 10.1002/spe.1110; Merz S, 2012, MARKET ANAL STAT; Miller H. Gilbert, 2009, IT Professional, V11, P57, DOI 10.1109/MITP.2009.117; Misra SC, 2011, MATH COMPUT MODEL, V53, P504, DOI 10.1016/j.mcm.2010.03.037; Morgan L, 2013, P 21 EUR C INF SYST; Porter M.E., 1980, U ILLINOIS URBANA CH; PORTER ME, 1990, HARVARD BUS REV, V68, P73; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Raihana G. F. H., 2012, INT J COMPUTER SCI I, V2, P76; Rosenberg D, 2012, COST CLOUD ADOPTION; SaaS Directory, 2014, ONL SOFTW APPL; Shimba F, 2010, THESIS DUBLIN I TECH; Sultan N, 2010, INT J INFORM MANAGE, V30, P109, DOI 10.1016/j.ijinfomgt.2009.09.004; Sultan NA, 2011, INT J INFORM MANAGE, V31, P272, DOI 10.1016/j.ijinfomgt.2010.08.001; Talukder AK, 2010, COMPUT COMMUN NETW S, P343, DOI 10.1007/978-1-84996-241-4_20; Udo GG, 2000, IND MANAGE DATA SYST, V100, P421, DOI 10.1108/02635570010358348; Urue&ntilde;a A, 2012, CLOUD COMPUTING RET; Wang HY, 2012, INFORM TECHNOL MANAG, V13, P445, DOI 10.1007/s10799-012-0139-4; Wang JJ, 2007, COMPUT OPER RES, V34, P3691, DOI 10.1016/j.cor.2006.01.017; Wu Y, 2013, J SUPPLY CHAIN MANAG, V49, P25, DOI 10.1111/j.1745-493x.2012.03287.x; Zabalza-Vivanco J, 2012, 16 C, P637; Zabalza-Vivanco J, 2013, P 7 INT C IND ENG IN, P137; Zhang LJL, 2012, IEEE T SERV COMPUT, V4, P067	40	10	10	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134563	10.1371/journal.pone.0134563	http://dx.doi.org/10.1371/journal.pone.0134563			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230400	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400134
J	Zhang, JJ; Tian, JJ; Wei, SS; Duan, SB; Wang, HM; Chen, YZ; Ding, SH; Zhang, C; Meng, QL; Li, Y				Zhang, Jin-ju; Tian, Jing-jing; Wei, Shuang-shi; Duan, Sheng-bao; Wang, Hong-mei; Chen, Ye-zhou; Ding, Shao-hua; Zhang, Chun; Meng, Qing-lin; Li, Yong			An Internal Reference Control Duplex Real-Time Polymerase Chain Reaction Assay for Detecting Bacterial Contamination in Blood Products	PLOS ONE			English	Article							PCR ASSAY; PLATELET; TRANSFUSION; COMPONENTS	Real-time polymerase chain reaction (RT-PCR) enables effective and sensitive screening for infectious risk in the field of blood safety. However, when using RT-PCR to detect bacterial contamination, several intractable points must be considered, one of which is the lack of appropriate quality control. In this study, we developed a simplified RT-PCR assay in which the same primer set and two distinct probes were used to detect both, an internal reference control and the target in a reaction. The copy number of the internal reference control represents the positive detection limit of the assay; therefore, when the threshold-cycle value of the target is less than or equal to that of the internal reference control, the result obtained for the target can be considered to be a true positive. When human gDNA was spiked with Escherichia coli gDNA and the detection limit for the internal reference control was set to five copies, the measured detection limit for E. coli gDNA was two copies. The internal reference control duplex RT-PCR assay showed high efficiency (0.91-1.02), high linearity (R-2 > 0.99), and good reproducibility in intra-and inter-assay comparisons. Lastly, when human platelet-rich plasma samples were spiked with E. coli or other bacterial species, all species were detected efficiently, and the results of a two-sample pooled t test showed that the limit of detection for E. coli was 1 cfu/mL. Here, we present a synthetic internal reference control molecule and a new statistical method for improving the reliability of RT-PCR assays when screening for bacterial contamination in blood products.	[Zhang, Jin-ju; Tian, Jing-jing; Wei, Shuang-shi; Duan, Sheng-bao; Wang, Hong-mei; Chen, Ye-zhou; Ding, Shao-hua; Zhang, Chun; Meng, Qing-lin; Li, Yong] Chinese Acad Sci, Key Lab Biomed Diagnost, Suzhou Inst Biomed Engn & Technol, Suzhou, Jiangsu, Peoples R China	Chinese Academy of Sciences; Suzhou Institute of Biomedical Engineering & Technology, CAS	Meng, QL (corresponding author), Chinese Acad Sci, Key Lab Biomed Diagnost, Suzhou Inst Biomed Engn & Technol, Suzhou, Jiangsu, Peoples R China.	mengql@sibet.ac.cn		Meng, Qinglin/0000-0002-1885-1183	Suzhou Municipal Science and Technology Project research fund [ZXY201422]; Natural Science Foundation for Young Scientists of Jiangsu Province [BK20130343]	Suzhou Municipal Science and Technology Project research fund; Natural Science Foundation for Young Scientists of Jiangsu Province	This work was supported by the Suzhou Municipal Science and Technology Project research fund (grant ZXY201422) (http://kjxm.szkj.gov.cn/) and the Natural Science Foundation for Young Scientists of Jiangsu Province (Grant BK20130343) (http://www.jskjjh.gov.cn/13kjskj2/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Al-Soud W, 2005, FEMS IMMUNOL MED MIC, V44, P177, DOI 10.1016/j.femsim.2004.12.004; Benjamin RJ, 2007, TRANSFUSION, V47, P1381, DOI 10.1111/j.1537-2995.2007.01326.x; Brecher ME, 2005, CLIN MICROBIOL REV, V18, P195, DOI 10.1128/CMR.18.1.195-204.2005; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; Dreier J, 2004, J CLIN MICROBIOL, V42, P4759, DOI 10.1128/JCM.42.10.4759-4764.2004; Dreier J, 2007, TRANSFUS MED REV, V21, P237, DOI 10.1016/j.tmrv.2007.03.006; Dunbar NM, 2013, TRANSFUSION, V53, P2307, DOI 10.1111/trf.12083; Jenkins C, 2011, TRANSFUSION, V51, P2555, DOI 10.1111/j.1537-2995.2011.03187.x; Mohammadi T, 2003, J CLIN MICROBIOL, V41, P4796, DOI 10.1128/JCM.41.10.4796-4798.2003; Mohammadi T, 2005, TRANSFUSION, V45, P731, DOI 10.1111/j.1537-2995.2005.04258.x; Patel P, 2012, TRANSFUSION, V52, P1423, DOI 10.1111/j.1537-2995.2011.03484.x; Pietersz RNI, 2007, VOX SANG, V93, P260, DOI 10.1111/j.1423-0410.2007.00967.x; Rood IGH, 2008, J MICROBIOL METH, V75, P64, DOI 10.1016/j.mimet.2008.05.007; Rood IGH, 2011, TRANSFUSION, V51, P2006, DOI 10.1111/j.1537-2995.2011.03090.x; Rood IGH, 2010, TRANSFUSION, V50, P1352, DOI 10.1111/j.1537-2995.2009.02580.x; Roth WK, 2000, VOX SANG, V78, P257; [Standards Program Committee American Association of Blood Banks], 2004, STANDARDS BLOOD BANK; Stocher M, 2004, J CLIN VIROL, V29, P171, DOI 10.1016/S1386-6532(03)00121-5; Stormer M, 2007, CLIN CHEM, V53, P104, DOI 10.1373/clinchem.2006.070987	19	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134743	10.1371/journal.pone.0134743	http://dx.doi.org/10.1371/journal.pone.0134743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230627	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400159
J	Chen, P; Hu, YF; Wang, L; Xiao, WF; Bao, XY; Pan, C; Yi, HS; Chen, XY; Pan, MH; Lu, C				Chen, Peng; Hu, Yan-Fen; Wang, La; Xiao, Wen-Fu; Bao, Xi-Yan; Pan, Chun; Yi, Hua-Shan; Chen, Xiang-Yun; Pan, Min-Hui; Lu, Cheng			Mitochondrial Apoptotic Pathway Is Activated by H2O2-Mediated Oxidative Stress in BmN-SWU1 Cells from Bombyx mori Ovary	PLOS ONE			English	Article							CYTOCHROME-C; ENDONUCLEASE-G; OXYGEN; SILKWORM; RELEASE; AUTOPHAGY	Apoptosis is a known regulator of morphogenetic events. In mammals, the critical role of oxidative stress-induced apoptosis has been well-studied; however, in insects the role of oxidative stress in apoptosis is not clear. In a previous study, we showed that apoptosis-related genes are present in the silkworm Bombyx mori, an important lepidopteran insect model. In this study, we evaluated the effect of H2O2-induced oxidative stress on apoptosis, reactive oxygen species (ROS) levels, mitochondrial response, cytochrome c release and apoptosis-related gene expression in the BmN-SWU1 cell line from B. mori ovaries. Our results showed that BmN-SWU1 cells exposed to H2O2 showed cell protuberances, cytoplasmic condensation, apoptotic bodies, DNA ladder formation and caspase activities indicating apoptosis. H2O2-induced apoptosis also increased intracellular ROS level, changed mitochondrial distribution, reduced mitochondrial membrane potential and increased the release of cytochrome c from mitochondria. Furthermore, western blot analysis revealed a significant increase in p53 and cytochrome c expression, and a decrease in Bcl-2 expression compared to the controls. Moreover, quantitative real-time PCR (qRT-PCR) showed an increase in the transcript levels of BmICE, Bmapaf-1 and BmEndoG by 439.5%, 423.9% and 42.2%, respectively, after treatment with 1 mu M H2O2 for 24 h. However, the transcript levels of Bmbuffy declined by 41.4% after 24 h of exposure to 1 mu M H2O2. These results show that H2O2 treatment induced apoptosis in BmN-SWU1 cells via the mitochondrial apoptotic pathway. Further, it appears that oxidative stress induced by H2O2 activates both caspase-dependent and caspase-independent mitochondrial apoptotic pathways in silkworm cells. Taken together, these findings improve our knowledge of apoptosis in silkworm and the apoptotic pathways in insects.	[Chen, Peng; Hu, Yan-Fen; Wang, La; Xiao, Wen-Fu; Bao, Xi-Yan; Pan, Chun; Yi, Hua-Shan; Chen, Xiang-Yun; Pan, Min-Hui; Lu, Cheng] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China; [Chen, Peng; Pan, Min-Hui; Lu, Cheng] Southwest Univ, Key Lab Sericulture Funct Genom & Biotechnol, Minist Agr, Chongqing 400716, Peoples R China	Southwest University - China; Ministry of Agriculture & Rural Affairs; Southwest University - China	Pan, MH (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China.	pmh047@126.com; lucheng@swu.edu.cn	Huashan, Yi/ABD-6113-2021		Hi-Tech Research and Development 863 Program of China [2013AA102507]; National Natural Science Foundation of China [31172269, 31272505, 31472152]	Hi-Tech Research and Development 863 Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Hi-Tech Research and Development 863 Program of China (No. 2013AA102507) and National Natural Science Foundation of China (Nos. 31172269, 31272505, and 31472152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KM, 1999, MED HYPOTHESES, V52, P451, DOI 10.1054/mehy.1997.0521; Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; Bryant B, 2009, INSECT MOL BIOL, V18, P341, DOI 10.1111/j.1365-2583.2009.00878.x; Casares C, 2012, EUR ARCH OTO-RHINO-L, V269, P2455, DOI 10.1007/s00405-012-2029-0; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Curtin JF, 2002, J IMMUNOL METHODS, V265, P49, DOI 10.1016/S0022-1759(02)00070-4; Dorstyn L, 2002, J CELL BIOL, V156, P1089, DOI 10.1083/jcb.200111107; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Franzetti E, 2012, APOPTOSIS, V17, P305, DOI 10.1007/s10495-011-0675-0; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Grutter MG, 2000, CURR OPIN STRUC BIOL, V10, P649, DOI 10.1016/S0959-440X(00)00146-9; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li QR, 2010, CAN J ZOOL, V88, P1169, DOI 10.1139/Z10-083; Liu KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040877; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Pan C, 2014, BIOCHEM BIOPH RES CO, V447, P237, DOI 10.1016/j.bbrc.2014.03.093; Pan MH, 2010, TISSUE CELL, V42, P42, DOI 10.1016/j.tice.2009.07.002; Poli G, 2004, CURR MED CHEM, V11, P1163, DOI 10.2174/0929867043365323; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Scarlett JL, 2000, FEBS LETT, V475, P267, DOI 10.1016/S0014-5793(00)01681-1; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Siu PM, 2009, LIFE SCI, V84, P468, DOI 10.1016/j.lfs.2009.01.014; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Suganuma I, 2011, INSECT BIOCHEM MOLEC, V41, P909, DOI 10.1016/j.ibmb.2011.08.005; Tian L, 2012, ARCH INSECT BIOCHEM, V79, P207, DOI 10.1002/arch.20457; van Loo G, 2001, CELL DEATH DIFFER, V8, P1136, DOI 10.1038/sj.cdd.4400944; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zamzami N, 1996, J EXP MED, V183, P1533, DOI 10.1084/jem.183.4.1533; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zhang JY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-611; Zhou DH, 2014, ADV CANCER RES, V122, P1, DOI 10.1016/B978-0-12-420117-0.00001-3; Zmasek CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008649	42	27	30	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134694	10.1371/journal.pone.0134694	http://dx.doi.org/10.1371/journal.pone.0134694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225758	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700130
J	Li, XJ; Wu, J; Han, J; Hu, YF; Mi, KX				Li, Xiaojing; Wu, Jun; Han, Jiao; Hu, Yongfei; Mi, Kaixia			Distinct Responses of Mycobacterium smegmatis to Exposure to Low and High Levels of Hydrogen Peroxide	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEIN-KINASE; REACTIVE OXYGEN; STATIONARY-PHASE; SIGMA-FACTOR; DNA-DAMAGE; TUBERCULOSIS; ADAPTATION; RESISTANCE; MUTAGENESIS	Hydrogen peroxide (H2O2) is a natural oxidant produced by aerobic organisms and gives rise to oxidative damage, including DNA mutations, protein inactivation and lipid damage. The genus Mycobacterium utilizes redox sensors and H2O2 scavenging enzymes for the detoxification of H2O2. To date, the precise response to oxidative stress has not been fully elucidated. Here, we compared the effects of different levels of H2O2 on transcription in M. smegmatis using RNA-sequencing. A 0.2 mM H2O2 treatment had little effect on the growth and viability of M. smegmatis whereas 7 mM H2O2 was lethal. Analysis of global transcription showed that 0.2 mM H2O2 induced relatively few changes in gene expression, whereas a large proportion of the mycobacterial genome was found to be differentially expressed after treatment with 7 mM H2O2. Genes differentially expressed following treatment with 0.2 mM H2O2 included those coding for proteins involved in glycolysis-gluconeogenesis and fatty acid metabolism pathways, and expression of most genes encoding ribosomal proteins was lower following treatment with 7 mM H2O2. Our analysis shows that M. smegmatis utilizes the sigma factor MSMEG_5214 in response to 0.2 mM H2O2, and the RpoE1 sigma factors MSMEG_0573 and MSMEG_0574 in response to 7 mM H2O2. In addition, different transcriptional regulators responded to different levels of H2O2: MSMEG_1919 was induced by 0.2 mM H2O2, while high-level induction of DevR occurred in response to 7 mM H2O2. We detected the induction of different detoxifying enzymes, including genes encoding KatG, AhpD, TrxB and Trx, at different levels of H2O2 and the detoxifying enzymes were expressed at different levels of H2O2. In conclusion, our study reveals the changes in transcription that are induced in response to different levels of H2O2 in M. smegmatis.	[Li, Xiaojing; Wu, Jun; Han, Jiao; Hu, Yongfei; Mi, Kaixia] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Li, Xiaojing; Wu, Jun; Hu, Yongfei; Mi, Kaixia] Beijing Key Lab Microbial Drug Resistance & Resis, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS	Mi, KX (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.	mik@im.ac.cn		hu, yong fei/0000-0002-2158-6018	National Basic Research Program of China [2012CB518700, 2014CB744400]; Key Program of the Chinese Academy of Sciences [KJZD-EW-L02]	National Basic Research Program of China(National Basic Research Program of China); Key Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Basic Research Program of China (2012CB518700 and 2014CB744400) and the Key Program of the Chinese Academy of Sciences (KJZD-EW-L02).	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bhat SA, 2012, FREE RADICAL BIO MED, V53, P1625, DOI 10.1016/j.freeradbiomed.2012.08.008; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Cirillo SLG, 2009, INFECT IMMUN, V77, P2557, DOI 10.1128/IAI.01481-08; Colangeli R, 2009, P NATL ACAD SCI USA, V106, P4414, DOI 10.1073/pnas.0810126106; DeMaio J, 1996, P NATL ACAD SCI USA, V93, P2790, DOI 10.1073/pnas.93.7.2790; Durbach SI, 1997, MOL MICROBIOL, V26, P643, DOI 10.1046/j.1365-2958.1997.5731934.x; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Grant CM, 2011, ANTIOXID REDOX SIGN, V15, P191, DOI 10.1089/ars.2010.3699; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Hu YM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005150; Humpel A, 2010, J BACTERIOL, V192, P2491, DOI 10.1128/JB.00035-10; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kapopoulou A, 2011, TUBERCULOSIS, V91, P8, DOI 10.1016/j.tube.2010.09.006; KNOX R, 1956, AM REV TUBERC PULM, V73, P726; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li XJ, 2014, PROTEIN CELL, V5, P182, DOI 10.1007/s13238-014-0024-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malhotra V, 2012, J BACTERIOL, V194, P4184, DOI 10.1128/JB.00585-12; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Papavinasasundaram KG, 2001, MICROBIOL-SGM, V147, P3271, DOI 10.1099/00221287-147-12-3271; Park ST, 2008, P NATL ACAD SCI USA, V105, P13105, DOI 10.1073/pnas.0801143105; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Saint-Joanis B, 1999, BIOCHEM J, V338, P753, DOI 10.1042/0264-6021:3380753; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Stallings CL, 2009, CELL, V138, P146, DOI 10.1016/j.cell.2009.04.041; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Venugopal A, 2011, CELL HOST MICROBE, V9, P21, DOI 10.1016/j.chom.2010.12.004; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Warner DF, 2010, P NATL ACAD SCI USA, V107, P13093, DOI 10.1073/pnas.1002614107; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833; Zahrt TC, 2001, MOL MICROBIOL, V39, P1174, DOI 10.1046/j.1365-2958.2001.02321.x; Zahrt TC, 2002, ANTIOXID REDOX SIGN, V4, P141, DOI 10.1089/152308602753625924	43	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134595	10.1371/journal.pone.0134595	http://dx.doi.org/10.1371/journal.pone.0134595			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225431	Green Submitted, gold, Green Published			2022-12-27	WOS:000358837700118
J	Stucht, D; Danishad, KA; Schulze, P; Godenschweger, F; Zaitsev, M; Speck, O				Stucht, Daniel; Danishad, K. Appu; Schulze, Peter; Godenschweger, Frank; Zaitsev, Maxim; Speck, Oliver			Highest Resolution In Vivo Human Brain MRI Using Prospective Motion Correction	PLOS ONE			English	Article							HEAD MOTION; ARTIFACTS	High field MRI systems, such as 7 Tesla (T) scanners, can deliver higher signal to noise ratio (SNR) than lower field scanners and thus allow for the acquisition of data with higher spatial resolution, which is often demanded by users in the fields of clinical and neuroscientific imaging. However, high resolution scans may require long acquisition times, which in turn increase the discomfort for the subject and the risk of subject motion. Even with a cooperative and trained subject, involuntary motion due to heartbeat, swallowing, respiration and changes in muscle tone can cause image artifacts that reduce the effective resolution. In addition, scanning with higher resolution leads to increased sensitivity to even very small movements. Prospective motion correction (PMC) at 3T and 7T has proven to increase image quality in case of subject motion. Although the application of prospective motion correction is becoming more popular, previous articles focused on proof of concept studies and technical descriptions, whereas this paper briefly describes the technical aspects of the optical tracking system, marker fixation and cross calibration and focuses on the application of PMC to very high resolution imaging without intentional motion. In this study we acquired in vivo MR images at 7T using prospective motion correction during long acquisitions. As a result, we present images among the highest, if not the highest resolution of in vivo human brain MRI ever acquired.	[Stucht, Daniel; Danishad, K. Appu; Schulze, Peter; Godenschweger, Frank; Speck, Oliver] Otto Von Guericke Univ, Biomed Magnet Resonance, Magdeburg, Germany; [Stucht, Daniel] Otto Von Guericke Univ, Inst Biometry & Med Informat, Magdeburg, Germany; [Zaitsev, Maxim] Univ Med Ctr Freiburg, Dept Radiol, Freiburg, Germany; [Speck, Oliver] Ctr Behav Brain Sci, Magdeburg, Germany; [Speck, Oliver] Leibniz Inst Neurobiol, Magdeburg, Germany; [Schulze, Peter; Speck, Oliver] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany	Otto von Guericke University; Otto von Guericke University; University of Freiburg; Leibniz Institut fur Neurobiologie (LIN); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Stucht, D (corresponding author), Otto Von Guericke Univ, Biomed Magnet Resonance, Magdeburg, Germany.	daniel.stucht@ovgu.de	Zaitsev, Maxim/F-1173-2010; Speck, Oliver/F-1406-2013	Zaitsev, Maxim/0000-0001-7530-1228; Speck, Oliver/0000-0002-6019-5597	Federal Ministry of Education and Research within the Forschungscampus STIMULATE [13GW0095A]; National Institutes of Health [BRP 2R01 DA021146]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021146] Funding Source: NIH RePORTER	Federal Ministry of Education and Research within the Forschungscampus STIMULATE; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work of this paper is partly funded by the Federal Ministry of Education and Research within the Forschungscampus STIMULATE under grant number "13GW0095A" and was also supported by the National Institutes of Health (BRP 2R01 DA021146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Shigaki BC, 2011, J MAGN RESON IMAGING, V33, P498, DOI 10.1002/jmri.22467; Armstrong BSR, 2010, ISMRM WORKSHOP SERIE; ArmstrongB SR, 2010, ISMRM WORKSHOP SERIE; AXEL L, 1986, RADIOLOGY, V160, P795, DOI 10.1148/radiology.160.3.3737920; Budde J, 2014, NEUROIMAGE, V86, P592, DOI 10.1016/j.neuroimage.2013.08.013; Christoforidis GA, 2012, RADIOLOGY, V264, P210, DOI 10.1148/radiol.12110799; Clarke TA, 1998, PHOTOGRAMM REC, V16, P51, DOI 10.1111/0031-868X.00113; EHMAN RL, 1984, AM J ROENTGENOL, V143, P1175, DOI 10.2214/ajr.143.6.1175; FLETCHER BD, 1984, RADIOLOGY, V150, P137, DOI 10.1148/radiology.150.1.6689753; Forstmann BU, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.50; Ge Y, 2008, ARCH NEUROL-CHICAGO, V65, P812, DOI 10.1001/archneur.65.6.812; Hanke M, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.3; Herbst M, 2013, P 21 SCI M INT SOC M, P3766; Herbst M, 2014, MAGN RESON MED, V71, P182, DOI 10.1002/mrm.24645; Kadashevich I, 2011, MAGMA S1, V24, P266; Keuken MC, 2013, J NEUROSCI, V33, P4896, DOI 10.1523/JNEUROSCI.3241-12.2013; Kirov II, 2013, SCHIZOPHR RES, V147, P362, DOI 10.1016/j.schres.2013.04.020; LANZER P, 1984, RADIOLOGY, V150, P121, DOI 10.1148/radiology.150.1.6227934; Lee CC, 1998, MAGN RESON MED, V39, P234, DOI 10.1002/mrm.1910390210; Lusebrink F, 2013, NEUROIMAGE, V70, P122, DOI 10.1016/j.neuroimage.2012.12.016; Maclaren J, 2013, MAGN RESON MED, V69, P621, DOI 10.1002/mrm.24314; Maclaren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048088; Maclaren J, 2010, MAGN RESON MED, V63, P162, DOI 10.1002/mrm.22191; Ooi MB, 2011, MAGN RESON MED, V66, P73, DOI 10.1002/mrm.22780; Ooi MB, 2009, MAGN RESON MED, V62, P943, DOI 10.1002/mrm.22082; Pipe JG, 1999, MAGNET RESON MED, V42, P963, DOI 10.1002/(SICI)1522-2594(199911)42:5<963::AID-MRM17>3.0.CO;2-L; Pohmann R, 2016, MAGN RESON MED, V75, P801, DOI 10.1002/mrm.25677; Qin L, 2009, MAGN RESON MED, V62, P924, DOI 10.1002/mrm.22076; Reuter M, 2015, NEUROIMAGE, V107, P107, DOI 10.1016/j.neuroimage.2014.12.006; RUNGE VM, 1984, RADIOLOGY, V151, P521, DOI 10.1148/radiology.151.2.6709928; SCHULTZ CL, 1984, RADIOLOGY, V152, P117, DOI 10.1148/radiology.152.1.6729101; Stamm AC, 2013, MAGN RESON IMAGING, V31, P545, DOI 10.1016/j.mri.2012.10.023; Stucht D, 2012, BILDVERARBEITUNG MED, P27; Stucht D, 2012, MED IMAGE UNDERSTAND, P223; Versluis MJ, 2012, MAGN RESON MED, V68, P1836, DOI 10.1002/mrm.24202; Versluis MJ, 2010, NEUROIMAGE, V51, P1082, DOI 10.1016/j.neuroimage.2010.03.048; Ward HA, 2000, MAGNET RESON MED, V43, P459, DOI 10.1002/(SICI)1522-2594(200003)43:3<459::AID-MRM19>3.0.CO;2-1; WOOD ML, 1985, MED PHYS, V12, P143, DOI 10.1118/1.595782; Wrede KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106697; Yang S., 2011, P 28 ANN SCI M EUR S, P490; Yang S, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00031; Zaitsev M, 2006, NEUROIMAGE, V31, P1038, DOI 10.1016/j.neuroimage.2006.01.039; Zaitsev M., 2015, J MAGN RESON IMAGING	43	94	94	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133921	10.1371/journal.pone.0133921	http://dx.doi.org/10.1371/journal.pone.0133921			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226146	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700043
J	Wijtzes, AI; Jansen, W; Jaddoe, VWV; Franco, OH; Hofman, A; van Lenthe, FJ; Raat, H				Wijtzes, Anne I.; Jansen, Wilma; Jaddoe, Vincent W. V.; Franco, Oscar H.; Hofman, Albert; van Lenthe, Frank J.; Raat, Hein			Social Inequalities in Young Children's Meal Skipping Behaviors: The Generation R Study	PLOS ONE			English	Article							BODY-MASS INDEX; BREAKFAST CONSUMPTION; WEIGHT STATUS; SOCIOECONOMIC POSITION; RISK-FACTORS; ADOLESCENTS; OVERWEIGHT; PATTERNS; HEALTH; INCOME	Background Regular meal consumption is considered an important aspect of a healthy diet. While ample evidence shows social inequalities in breakfast skipping among adolescents, little is known about social inequalities in breakfast skipping and skipping of other meals among young school-aged children. Such information is crucial in targeting interventions aimed to promote a healthy diet in children. Methods We examined data from 4704 ethnically diverse children participating in the Generation R Study, a population-based prospective cohort study in Rotterdam, the Netherlands. Information on family socioeconomic position (SEP), ethnic background, and meal skipping behaviors was assessed by parent-reported questionnaire when the child was 6 years old. Multiple logistic regression analyses were performed to assess the associations of family SEP (educational level, household income, employment status, family composition) and ethnic background with meal skipping behaviors, using high SEP children and native Dutch children as reference groups. Results Meal skipping prevalence ranged from 3% (dinner) to 11% (lunch). The prevalence of meal skipping was higher among low SEP children and ethnic minority children. Maternal educational level was independently associated with breakfast skipping ([low maternal educational level] OR: 2.21; 95% CI: 1.24,3.94). Paternal educational level was independently associated with lunch skipping ([low paternal educational level] OR: 1.53; 95% CI: 1.06,2.20) and dinner skipping ([mid-high paternal educational level] OR: 0.39; 95% CI: 0.20,0.76). Household income was independently associated with breakfast skipping ([low income] OR: 2.43, 95% CI: 1.40,4.22) and dinner skipping ([low income] OR: 2.44; 95% CI: 1.22,4.91). In general, ethnicminority children were more likely to skip breakfast, lunch, and dinner compared with native Dutch children. Adjustment for family SEP attenuated the associations of ethnicminority background with meal skipping behaviors considerably. Conclusion Low SEP children and ethnic minority children are at an increased risk of breakfast, lunch, and dinner skipping compared with high SEP children and native Dutch children, respectively. Given these inequalities, interventions aimed to promote regular meal consumption, breakfast consumption in particular, should target children from low socioeconomic groups and ethnic minority children. More qualitative research to investigate the pathways underlying social inequalities in children's meal skipping behaviors is warranted.	[Wijtzes, Anne I.; Jaddoe, Vincent W. V.; Hofman, Albert] Erasmus MC, Generat Study Grp R, Rotterdam, Netherlands; [Wijtzes, Anne I.; Jansen, Wilma; van Lenthe, Frank J.; Raat, Hein] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Jansen, Wilma] Dept Social Dev, Rotterdam, Netherlands; [Jaddoe, Vincent W. V.] Erasmus MC, Dept Pediat, Rotterdam, Netherlands; [Franco, Oscar H.; Hofman, Albert] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Wijtzes, AI (corresponding author), Erasmus MC, Generat Study Grp R, Rotterdam, Netherlands.	a.wijtzes@erasmusmc.nl	Jansen, Wilma/ABD-5066-2020; Franco, Óscar H/ABE-2305-2020	Jansen, Wilma/0000-0002-4453-9054; Franco, Óscar H/0000-0002-4606-4929	Erasmus Medical Center, Rotterdam; Netherlands Organization for Health Research and Development (ZonMw); ZonMw [102047]; Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; AXA; Erasmus University Rotterdam	Erasmus Medical Center, Rotterdam; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); ZonMw(Netherlands Organization for Health Research and Development); Nestle Nutrition (Nestec Ltd.)(Nestle SA); Metagenics Inc.; AXA; Erasmus University Rotterdam	The Generation R Study is made possible by financial support from Erasmus Medical Center, Rotterdam, Erasmus University Rotterdam, and the Netherlands Organization for Health Research and Development (ZonMw). The present study was supported by an additional grant from ZonMw (grant No 102047). O.H. Franco works in ErasmusAGE, a center for aging research across the life course funded by Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; and AXA. These funding sources had no involvement in study design; collection, analysis, and interpretation of data; writing of the report; and in the decision to submit this article for publication.	Albertson AM, 2007, OBESITY, V15, P2282, DOI 10.1038/oby.2007.271; Bjelland M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-793; Braveman P, 2001, PUBLIC HEALTH REP, V116, P449, DOI 10.1093/phr/116.5.449; Brug J, 2012, PEDIATR OBES, V7, P399, DOI 10.1111/j.2047-6310.2012.00067.x; Brugman E, 1998, EUR J PUBLIC HEALTH, V8, P325, DOI 10.1093/eurpub/8.4.325; Brussaard J H, 2001, Public Health Nutr, V4, P659; Crawford PB, 2004, J AM DIET ASSOC, V104, P387, DOI 10.1016/j.jada.2003.12.018; Deshmukh-Taskar PR, 2010, J AM DIET ASSOC, V110, P869, DOI 10.1016/j.jada.2010.03.023; Dubois L, 2009, PUBLIC HEALTH NUTR, V12, P19, DOI 10.1017/S1368980008001894; Dubois L, 2006, PUBLIC HEALTH NUTR, V9, P436, DOI 10.1079/PHN2005867; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1; Koletzko B, 2010, CRIT REV FOOD SCI, V50, P100, DOI 10.1080/10408390903467431; Lahelma E, 2004, J EPIDEMIOL COMMUN H, V58, P327, DOI 10.1136/jech.2003.011148; Lehto R, 2011, PUBLIC HEALTH NUTR, V14, P1245, DOI 10.1017/S1368980010003034; Levin KA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-228; Levin KA, 2012, APPETITE, V59, P63, DOI 10.1016/j.appet.2012.03.016; Lien L, 2007, PUBLIC HEALTH NUTR, V10, P422, DOI 10.1017/S1368980007258550; Manios Y, 2015, PUBLIC HEALTH NUTR, V18, P774, DOI 10.1017/S1368980014001219; Matthys C, 2003, EUR J CLIN NUTR, V57, P366, DOI 10.1038/sj.ejcn.1601533; Merten MJ, 2009, J AM DIET ASSOC, V109, P1384, DOI 10.1016/j.jada.2009.05.008; Moreno LA, 2007, CURR OPIN CLIN NUTR, V10, P336, DOI 10.1097/MCO.0b013e3280a94f59; Nielsen A, 2014, APPETITE, V78, P122, DOI 10.1016/j.appet.2014.03.018; Pearson N, 2012, BRIT J NUTR, V108, P932, DOI 10.1017/S000711451100612X; Pearson N, 2011, PREV MED, V53, P268, DOI 10.1016/j.ypmed.2011.07.014; Pearson N, 2009, APPETITE, V52, P1, DOI 10.1016/j.appet.2008.08.006; Rampersaud GC, 2005, J AM DIET ASSOC, V105, P743, DOI 10.1016/j.jada.2005.02.007; Sausenthaler S, 2007, PUBLIC HEALTH NUTR, V10, P24, DOI 10.1017/S1368980007193940; Siega-Riz AM, 1998, AM J CLIN NUTR, V67, p748S, DOI 10.1093/ajcn/67.4.748S; Slusser W, 2011, PUBLIC HEALTH NUTR, V14, P1833, DOI 10.1017/S1368980011000620; Smith GD, 2000, AM J PUBLIC HEALTH, V90, P1694, DOI 10.2105/AJPH.90.11.1694; Statistics Netherlands, 2004, STAND OND 2003; Statistics Netherlands, 2010, JAARR INT 2010; Stea TH, 2014, PUBLIC HEALTH NUTR, P1; Stronks K, 1997, INT J EPIDEMIOL, V26, P592, DOI 10.1093/ije/26.3.592; Szajewska H, 2010, CRIT REV FOOD SCI, V50, P113, DOI 10.1080/10408390903467514; Thibault H, 2013, PUBLIC HEALTH NUTR, V16, P193, DOI 10.1017/S136898001200359X; Thivel D, 2015, J DEV BEHAV PEDIATR, V36, P158, DOI 10.1097/DBP.0000000000000131; Timlin MT, 2008, PEDIATRICS, V121, pE638, DOI 10.1542/peds.2007-1035; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; Utter J, 2007, J AM DIET ASSOC, V107, P570, DOI 10.1016/j.jada.2007.01.010; Veldhuis L, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-74; Vik FN, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-58; Vossenaar M, 2009, PUBLIC HEALTH NUTR, V12, P1330, DOI 10.1017/S136898000800400X; Zarnowiecki D, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-44	46	23	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134487	10.1371/journal.pone.0134487	http://dx.doi.org/10.1371/journal.pone.0134487			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JT	26225757	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700100
J	Zhen, XM; Wu, BL; Wang, J; Lu, CL; Gao, HF; Qiao, J				Zhen, Xiumei; Wu, Bailin; Wang, Jian; Lu, Cuiling; Gao, Huafang; Qiao, Jie			Increased Incidence of Mitochondrial Cytochrome C Oxidase 1 Gene Mutations in Patients with Primary Ovarian Insufficiency	PLOS ONE			English	Article							IN-VITRO; DYSFUNCTION; REPRODUCTION; MECHANISMS; INHIBITOR; SEQUENCES; FAILURE; STRESS; POOL	Primary ovarian insufficiency (POI), also known as premature ovarian failure (POF), is defined as more than six months of cessation of menses before the age of 40 years, with two serum follicle stimulating hormone (FSH) levels (at least 1 month apart) falling in the menopause range. The cause of POI remains undetermined in the majority of cases, although some studies have reported increased levels of reactive oxygen species (ROS) in idiopathic POF. The role of mitochondrial DNA in the pathogenesis of POI has not been studied extensively. This aim of this study was to uncover underlying mitochondrial genetic defects in patients with POI. The entire region of the mitochondrial genome was amplified in subjects with idiopathic POI (n=63) and age-matched healthy female controls (n=63) using nine pair sets of primers, followed by screening of the mitochondrial genome using an Illumina MiSeq. We identified a total of 96 non-synonymous mitochondrial variations in POI patients and 93 non-synonymous variations in control subjects. Of these, 21 (9 in POI and 12 in control) non-synonymous variations had not been reported previously. Eight mitochondrial cytochrome coxidase 1 (MT-CO1) missense variants were identified in POI patients, whereas only four missense mutations were observed in controls. A high incidence of MT-CO1 missense variants were identified in POI patients compared with controls, and the difference between the groups was statistically significant (13/63 vs. 5/63, p=0.042). Our results show that patients with primary ovarian insufficiency exhibit an increased incidence of mitochondrial cytochrome c oxidase 1 gene mutations, suggesting that MT-CO1 gene mutation may be causal in POI.	[Zhen, Xiumei; Lu, Cuiling; Qiao, Jie] Peking Univ, Hosp 3, Dept Obstet & Gynecol, Ctr Reprod Med, Beijing 100191, Peoples R China; [Zhen, Xiumei; Wu, Bailin; Wang, Jian; Gao, Huafang] Harvard Univ, Sch Med, Boston Childrens Hosp, Genet Diag Lab Med, Boston, MA 02115 USA; [Gao, Huafang] Natl Res Inst Hlth & Family Planning, Human Genet Resource Ctr, Beijing 100081, Peoples R China; [Wang, Jian] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai 200127, Peoples R China	Peking University; Harvard University; Boston Children's Hospital; Harvard Medical School; Shanghai Jiao Tong University	Gao, HF (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Genet Diag Lab Med, Boston, MA 02115 USA.	2548621608@qq.com; jie.qiao@263.net	Lu, Cuiling/C-2347-2015	Lu, Cuiling/0000-0001-6944-9760; Qiao, Jie/0000-0003-2126-1376	Scientific Research Foundation for the returned overseas, Peking University Third Hospital [Y-70538-02]; National Natural Science Foundation of China [81300456]	Scientific Research Foundation for the returned overseas, Peking University Third Hospital; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Project sponsored by the Scientific Research Foundation for the returned overseas, Peking University Third Hospital (Y-70538-02) and National Natural Science Foundation of China (81300456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Beck-Peccoz P, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-9; Bentov Y, 2013, FERTIL STERIL, V99, P18, DOI 10.1016/j.fertnstert.2012.11.031; Bentov Y, 2011, J ASSIST REPROD GEN, V28, P773, DOI 10.1007/s10815-011-9588-7; Bentov Y, 2010, FERTIL STERIL, V93, P272, DOI 10.1016/j.fertnstert.2009.07.988; Chen Z, 2015, J BIOL CHEM; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Fujii J, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-43; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Mancuso C, 2007, FRONT BIOSCI-LANDMRK, V12, P1107, DOI 10.2741/2130; May-Panloup P, 2005, HUM REPROD, V20, P593, DOI 10.1093/humrep/deh667; May-Panloup P, 2004, M S-MED SCI, V20, P779, DOI 10.1051/medsci/2004208-9779; Novin Marefat Ghaffari, 2015, Iranian Biomedical Journal, V19, P23, DOI 10.6091/ibj.1400.2015; Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076; Ramos A, 2009, ELECTROPHORESIS, V30, P1587, DOI 10.1002/elps.200800601; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Rzheshevsky AV, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1056, DOI 10.1134/S0006297914100071; Sedensky MM, 2006, EXP GERONTOL, V41, P237, DOI 10.1016/j.exger.2006.01.004; Slotkin EK, 2015, MOL CANCER THER, V14, P395, DOI 10.1158/1535-7163.MCT-14-0711; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Thouas GA, 2004, BIOL REPROD, V71, P1936, DOI 10.1095/biolreprod.104.033589; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Venkatesh S, 2010, ARCH GYNECOL OBSTET, V282, P313, DOI 10.1007/s00404-010-1444-y; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Zhang HY, 2015, APOPTOSIS, V20, P50, DOI 10.1007/s10495-014-1066-0	27	16	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0132610	10.1371/journal.pone.0132610	http://dx.doi.org/10.1371/journal.pone.0132610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225554	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700009
J	Liu, L; Tan, QH; Hu, B; Wu, H; Wang, CH; Liu, R; Tang, CW				Liu, Ling; Tan, Qinghua; Hu, Bin; Wu, Hao; Wang, Chunhui; Liu, Rui; Tang, Chengwei			Somatostatin Improved B Cells Mature in Macaques during Intestinal Ischemia-Reperfusion	PLOS ONE			English	Article							INJURY; LIPOPOLYSACCHARIDE; GUT; INFLAMMATION; CYTOKINE; ANTIBODY; IMMUNITY; PATHWAY; ROLES	Aims Intestinal ischemia-reperfusion has been taken as an important pathophysiological process for multiple organ dysfunctions in critical patients. Recent studies reported that dual expression programs of the B cells receptors and Toll-like receptors on B-lymphocytes permit these ubiquitous cells to integrate both adaptive and innate immune functions. Our previous studies found that somatostatin inhibited the intestinal inflammatory injury after ischemia-reperfusion in macaques. However, the changes of B cells and the effects of somatostatin on B cells after intestinal ischemia-reperfusion were unclear. Methods 15 macaques were divided into control, intestinal ischemia-reperfusion and somatostatin pretreatment groups. Immunohistochemistry was performed to identify the distributions of adaptive and innate immunity markers in the iliac mucosa. Hmy2.cir B lymphoblastoid cell line was cultured in vitro study. Enzyme-linked immunosorbent assay was used to measure IgM, IL-6 and SIgA, and the expressions of B cells transcription factors, PAX-5 and BLIMP-1, were detected by Western blotting. Results B2 lymphocytes in normal Peyer's patches were presented the phenotype of PAX-5(+)CD20(+)CD5(-). Ischemia-reperfusion increased the numbers and sizes of Peyer's patches but with PAX-5(+)CD20(-)CD5(-) B cells, an unmatured set of B cells. Somatostatin partly kept the phenotype of mature B cells during ischemia-reperfusion. The innate immunity of B cells was inhibited whereas the adaptive immunity was increased in the intestinal mucosa in the somatostatin group, compared to the ischemia-reperfusion group. In vitro, somatostatin significantly inhibited IL-6 and promoted IgM by increasing the expression of both PAX-5 and BLIMP-1 in the proinflammatory condition. Conclusion Intestinal ischemia-reperfusion resulted in the proliferation of unmatured B cells which were involved in the augmentation of innate immunity. Somatostatin, with a bi-directional regulation function on innate as well as adaptive immunity of B cells, greatly improved B cells mature in macaques during ischemia-reperfusion. Preventive supplements of somatostatin may greatly limit intestinal injury and bacterial translocation during ischemia-reperfusion.	[Liu, Ling; Tan, Qinghua; Hu, Bin; Wu, Hao; Wang, Chunhui; Tang, Chengwei] Sichuan Univ, West China Hosp, Dept Gastroenterol, Chengdu 610064, Peoples R China; [Liu, Rui] Sichuan Univ, West China Hosp, Div Peptides Related Human Dis, Key Lab Biotherapy Human Dis,Minist Educ, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Tang, CW (corresponding author), Sichuan Univ, West China Hosp, Dept Gastroenterol, Chengdu 610064, Peoples R China.	shcqcdmed@163.com		Liu, Ling/0000-0001-6413-708X	Natural Science Fund of China [30330270]	Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	Key Grant 30330270 of Natural Science Fund of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlawat S, 2014, MICROSC MICROANAL, V20, P198, DOI 10.1017/S1431927613013640; AMERICAN GASTROENTEROLOGICAL ASSOCIATION MEDICAL POSITION STATEMENT, 2000, GASTROENTEROLOGY, V118, P951, DOI DOI 10.1016/S0016-5085(00)70182-X; Brandtzaeg P, 1999, IMMUNOL REV, V171, P45, DOI 10.1111/j.1600-065X.1999.tb01342.x; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Desouki MM, 2010, CLIN MED RES, V8, P84, DOI 10.3121/cmr.2010.891; Grootjans J, 2010, AM J PATHOL, V176, P2283, DOI 10.2353/ajpath.2010.091069; Guo Mei-Mei, 2005, Shengli Xuebao, V57, P719; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; HARDY RR, 1994, IMMUNOL REV, V137, P91, DOI 10.1111/j.1600-065X.1994.tb00660.x; Lenaerts K, 2013, CURR OPIN ORGAN TRAN, V18, P298, DOI 10.1097/MOT.0b013e32835ef1eb; Lichtenauer-Kaligis EGR, 2004, EUR J ENDOCRINOL, V150, P565, DOI 10.1530/eje.0.1500565; Linfert Douglas, 2009, Transplant Rev (Orlando), V23, P1, DOI 10.1016/j.trre.2008.08.003; Liu BS, 2014, EUR J IMMUNOL, V44, P2121, DOI 10.1002/eji.201344341; Liu L, 2014, DIGEST DIS SCI, V59, P2423, DOI 10.1007/s10620-014-3177-4; Mann MK, 2012, AUTOIMMUNITY, V45, P388, DOI 10.3109/08916934.2012.665523; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Parekh VV, 2003, J IMMUNOL, V170, P5897, DOI 10.4049/jimmunol.170.12.5897; Puleo F, 2011, SEMIN RESP CRIT CARE, V32, P626, DOI 10.1055/s-0031-1287871; Raman VS, 2000, J IMMUNOL, V165, P6809, DOI 10.4049/jimmunol.165.12.6809; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Rosskopf D, 2003, AM J PHYSIOL-CELL PH, V284, pC179, DOI 10.1152/ajpcell.00160.2001; Rotstein O D, 2000, Surg Infect (Larchmt), V1, P217, DOI 10.1089/109629600750018141; SCICCHITANO R, 1987, Brain Behavior and Immunity, V1, P173, DOI 10.1016/0889-1591(87)90019-5; STANISZ AM, 1986, J IMMUNOL, V136, P152; TARLINTON D, 1994, IMMUNOL REV, V137, P203, DOI 10.1111/j.1600-065X.1994.tb00666.x; Tian J, 2001, J IMMUNOL, V167, P1081, DOI 10.4049/jimmunol.167.2.1081; Vadasz Z, 2013, FEBS LETT, V587, P2074, DOI 10.1016/j.febslet.2013.05.023; Wesemann DR, 2013, NATURE, V501, DOI 10.1038/nature12496; Wu H, 2009, J GASTROINTEST SURG, V13, P983, DOI 10.1007/s11605-009-0816-8; Xu H, 2008, IMMUNOLOGY, V125, P218, DOI 10.1111/j.1365-2567.2008.02832.x; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270; Yang H, 2013, NEUROPEPTIDES, V47, P237, DOI 10.1016/j.npep.2013.04.003; Zhang M, 2004, P NATL ACAD SCI USA, V101, P3886, DOI 10.1073/pnas.0400347101; Zinkernagel RM, 2003, ANNU REV IMMUNOL, V21, P515, DOI 10.1146/annurev.immunol.21.120601.141045	36	9	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133692	10.1371/journal.pone.0133692	http://dx.doi.org/10.1371/journal.pone.0133692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222793	Green Submitted, Green Published, gold			2022-12-27	WOS:000358836800060
J	Virk, N; Li, DY; Tian, LM; Huang, L; Hong, YB; Li, XH; Zhang, YF; Liu, B; Zhang, HJ; Song, FM				Virk, Nasar; Li, Dayong; Tian, Limei; Huang, Lei; Hong, Yongbo; Li, Xiaohui; Zhang, Yafen; Liu, Bo; Zhang, Huijuan; Song, Fengming			Arabidopsis Raf-Like Mitogen-Activated Protein Kinase Kinase Kinase Gene Raf43 Is Required for Tolerance to Multiple Abiotic Stresses	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; INNATE IMMUNITY; ABSCISIC-ACID; MAPKK KINASE; STOMATAL DEVELOPMENT; FUNCTIONAL-ANALYSIS; DISEASE RESISTANCE; POSITIVE REGULATOR; DROUGHT RESISTANCE; SIGNALING NETWORKS	Mitogen-activated protein kinase (MAPK) cascades are critical signaling modules that mediate the transduction of extracellular stimuli into intracellular response. A relatively large number of MAPKKKs have been identified in a variety of plant genomes but only a few of them have been studied for their biological function. In the present study, we identified an Arabidopsis Raf-like MAPKKK gene Raf43 and studied its function in biotic and abiotic stress response using a T-DNA insertion mutant raf43-1 and two Raf43-overexpressing lines Raf43-OE#1 and Raf43-OE#13. Expression of Raf43 was induced by multiple abiotic and biotic stresses including treatments with drought, mannitol and oxidative stress or defense signaling molecule salicylic acid and infection with necrotrophic fungal pathogen Botrytis cinerea. Seed germination and seedling root growth of raf43-1 were significantly inhibited on MS medium containing mannitol, NaCl, H2O2 or methyl viologen (MV) while seed germination and seedling root growth of the Raf43-OE#1 and Raf43-OE#13 lines was similar to wild type Col-0 under the above stress conditions. Soil-grown raf43-1 plants exhibited reduced tolerance to MV, drought and salt stress. Abscisic acid inhibited significantly seed germination and seedling root growth of the raf43-1 line but had no effect on the two Raf43-overexpressing lines. Expression of stress-responsive RD17 and DREB2A genes was significantly down-regulated in raf43-1 plants. However, the raf43-1 and Raf43-overexpressing plants showed similar disease phenotype to the wild type plants after infection with B. cinerea or Pseudomonas syringae pv. tomato DC3000. Our results demonstrate that Raf43, encoding for a Raf-like MAPKKK, is required for tolerance to multiple abiotic stresses in Arabidopsis.	[Virk, Nasar; Li, Dayong; Tian, Limei; Huang, Lei; Hong, Yongbo; Li, Xiaohui; Zhang, Yafen; Liu, Bo; Zhang, Huijuan; Song, Fengming] Zhejiang Univ, Inst Biotechnol, Natl Key Lab Rice Biol, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Zhang, HJ (corresponding author), Zhejiang Univ, Inst Biotechnol, Natl Key Lab Rice Biol, Hangzhou 310058, Zhejiang, Peoples R China.	zhanghj82@zju.edu.cn			National High-Tech R D Program [2012AA101505]; National Transgenic Major Project of China [2011ZX08009-003-001]; National Natural Science Foundation [31272028]; Research Fund for the Doctoral Program of Higher Education of China [20120101110070]	National High-Tech R D Program(National High Technology Research and Development Program of China); National Transgenic Major Project of China; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National High-Tech R & D Program (No. 2012AA101505), the National Transgenic Major Project of China (No. 2011ZX08009-003-001), the National Natural Science Foundation (No. 31272028) and the Research Fund for the Doctoral Program of Higher Education of China (20120101110070).	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Brunaud V, 2002, EMBO REP, V3, P1152, DOI 10.1093/embo-reports/kvf237; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; del Pozo O, 2004, EMBO J, V23, P3072, DOI 10.1038/sj.emboj.7600283; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Faulkner C, 2012, CURR OPIN PLANT BIOL, V15, P699, DOI 10.1016/j.pbi.2012.08.009; Frye CA, 2001, P NATL ACAD SCI USA, V98, P373, DOI 10.1073/pnas.011405198; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Furuya T, 2013, J PLANT RES, V126, P833, DOI 10.1007/s10265-013-0576-0; Gao L, 2008, PLANT MOL BIOL, V67, P125, DOI 10.1007/s11103-008-9306-8; Gao MH, 2008, CELL RES, V18, P1190, DOI 10.1038/cr.2008.300; Gao ZY, 2003, J BIOL CHEM, V278, P34725, DOI 10.1074/jbc.M305548200; Gibson SI, 2001, BIOCHEM BIOPH RES CO, V280, P196, DOI 10.1006/bbrc.2000.4062; GILMOUR SJ, 1992, PLANT MOL BIOL, V18, P13, DOI 10.1007/BF00018452; Gonzalez-Guzman M, 2002, PLANT CELL, V14, P1833, DOI 10.1105/tpc.002477; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Hashimoto M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-103; Huang YD, 2014, PLANT J, V77, P577, DOI 10.1111/tpj.12404; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ichimura K, 2006, J BIOL CHEM, V281, P36969, DOI 10.1074/jbc.M605319200; Iuchi S, 2000, PLANT PHYSIOL, V123, P553, DOI 10.1104/pp.123.2.553; Jin HL, 2002, DEV CELL, V3, P291, DOI 10.1016/S1534-5807(02)00205-8; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; King SRF, 2014, PLANT CELL, V26, P1345, DOI 10.1105/tpc.113.120055; Kong Q, 2012, PLANT CELL, V24, P2225, DOI 10.1105/tpc.112.097253; Kong XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057714; Krysan PJ, 2002, PLANT CELL, V14, P1109, DOI 10.1105/tpc.001164; Li XH, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-166; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; Mehrotra R, 2014, J PLANT PHYSIOL, V171, P486, DOI 10.1016/j.jplph.2013.12.007; Melech-Bonfil S, 2010, PLANT J, V64, P379, DOI 10.1111/j.1365-313X.2010.04333.x; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Menges M, 2008, NEW PHYTOL, V179, P643, DOI 10.1111/j.1469-8137.2008.02552.x; Miao Y, 2007, PLANT MOL BIOL, V65, P63, DOI 10.1007/s11103-007-9198-z; Nakagami H, 2004, J BIOL CHEM, V279, P26959, DOI 10.1074/jbc.M312662200; Nakagami H, 2006, J BIOL CHEM, V281, P38697, DOI 10.1074/jbc.M605293200; Ning J, 2011, PLANT CELL, V23, P4334, DOI 10.1105/tpc.111.093419; Ning J, 2010, PLANT PHYSIOL, V152, P876, DOI 10.1104/pp.109.149856; Oh CS, 2010, PLANT CELL, V22, P260, DOI 10.1105/tpc.109.070664; Osakabe Y, 2013, J EXP BOT, V64, P445, DOI 10.1093/jxb/ers354; Rao KP, 2010, DNA RES, V17, P139, DOI 10.1093/dnares/dsq011; Rasmussen MW, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00169; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Rook F, 2001, PLANT J, V26, P421, DOI 10.1046/j.1365-313X.2001.2641043.x; Sasayama D, 2011, PLANT BIOTECHNOL-NAR, V28, P463, DOI 10.5511/plantbiotechnology.11.1027a; SCHONFELD MA, 1988, CROP SCI, V28, P526, DOI 10.2135/cropsci1988.0011183X002800030021x; Shen XL, 2011, PLANT CELL ENVIRON, V34, P179, DOI 10.1111/j.1365-3040.2010.02219.x; Shitamichi N, 2013, PLANT BIOTECHNOL-NAR, V30, P111, DOI 10.5511/plantbiotechnology.13.0108a; Shou HX, 2004, J EXP BOT, V55, P1013, DOI 10.1093/jxb/erh129; Shou HX, 2004, P NATL ACAD SCI USA, V101, P3298, DOI 10.1073/pnas.0308095100; Sinha AK, 2011, PLANT SIGNAL BEHAV, V6, P196, DOI 10.4161/psb.6.2.14701; Soyano T, 2003, GENE DEV, V17, P1055, DOI 10.1101/gad.1071103; Suarez-Rodriguez MC, 2007, PLANT PHYSIOL, V143, P661, DOI 10.1104/pp.106.091389; Sun Y, 2014, J EXP BOT, V65, P2171, DOI 10.1093/jxb/eru092; Suzuki N, 2014, NEW PHYTOL, V203, P32, DOI 10.1111/nph.12797; Tang DZ, 2002, PLANT J, V32, P975, DOI 10.1046/j.1365-313X.2002.01482.x; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103032; Yin ZJ, 2013, INT J MOL SCI, V14, P18740, DOI 10.3390/ijms140918740; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543; Zhao CZ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004389	68	20	24	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133975	10.1371/journal.pone.0133975	http://dx.doi.org/10.1371/journal.pone.0133975			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222830	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800090
J	Cervero-Arago, S; Rodriguez-Martinez, S; Puertas-Bennasar, A; Araujo, RM				Cervero-Arago, Silvia; Rodriguez-Martinez, Sarah; Puertas-Bennasar, Antoni; Araujo, Rosa M.			Effect of Common Drinking Water Disinfectants, Chlorine and Heat, on Free Legionella and Amoebae-Associated Legionella	PLOS ONE			English	Article							HARTMANNELLA-VERMIFORMIS; PNEUMOPHILA; RESISTANCE; SYSTEMS; SUSCEPTIBILITY; INACTIVATION; BIOFILMS; BACTERIA; MODEL	Chlorine and thermal treatments are the most commonly used procedures to control and prevent Legionella proliferation in drinking water systems of large buildings. However, cases of legionellosis still occur in facilities with treated water. The purpose of this work was to model the effect of temperature and free chlorine applied in similar exposure conditions as in drinking water systems on five Legionella spp. strains and two amoebal strains of the genera Acanthamoeba. Inactivation models obtained were used to determine the effectiveness of the treatments applied which resulted more effective against Legionella than Acanthamoeba, especially those in cystic stages. Furthermore, to determine the influence of the relationship between L. pneumophila and Acanthamoeba spp. on the treatment effectiveness, inactivation models of the bacteria-associated amoeba were also constructed and compared to the models obtained for the free living bacteria state. The Legionella-amoeba association did not change the inactivation models, but it reduced the effectiveness of the treatments applied. Remarkably, at the lowest free chlorine concentration, 0.5 mg L-1, as well as at the lowest temperatures, 50 degrees C and 55 degrees C, the influence of the Legionella-amoeba associate state was the strongest in reducing the effectiveness of the treatments compared to the free Legionella state. Therefore, the association established between L. pneumophila and amoebae in the water systems indicate an increased health risk in proximal areas of the system (close to the tap) where lower free chlorine concentrations and lower temperatures are commonly observed.	[Cervero-Arago, Silvia; Rodriguez-Martinez, Sarah; Puertas-Bennasar, Antoni; Araujo, Rosa M.] Univ Barcelona, Fac Biol, Dept Microbiol, Ave Diagonal 643, E-08028 Barcelona, Spain; [Cervero-Arago, Silvia] Med Univ Vienna, Inst Hyg & Appl Immunol, Water Hyg, A-1090 Vienna, Austria; [Rodriguez-Martinez, Sarah] Univ Haifa, Fac Nat Sci, Dept Biol & Environm, IL-36006 Oranim, Tivon, Israel	University of Barcelona; Medical University of Vienna; University of Haifa	Araujo, RM (corresponding author), Univ Barcelona, Fac Biol, Dept Microbiol, Ave Diagonal 643, E-08028 Barcelona, Spain.	raraujo@ub.edu	Cervero-Aragó, Sílvia/AAA-5349-2020; Araujo, Rosa/D-4407-2014	Cervero-Aragó, Sílvia/0000-0002-3224-2317; Araujo, Rosa/0000-0002-1980-6501	Spanish Ministry of Education and Science [CGL2008-01393/BOS]; Austrian Bundesministerium fur Wissenschaft und Forschung HSRSM [LE103HS001]	Spanish Ministry of Education and Science(Spanish Government); Austrian Bundesministerium fur Wissenschaft und Forschung HSRSM	This study was supported by the Spanish Ministry of Education and Science (CGL2008-01393/BOS). The work of SCA, SRM, APB and RMA was funded by the same project. SCA was granted by the Austrian Bundesministerium fur Wissenschaft und Forschung HSRSM Projekt LE103HS001 as a member of the Interuniversity Cooperation Centre for Water & Health (www.waterandhealth.at) during the analysis and the writing of the manuscript.	Abu Kwaik Y, 1998, B I PASTEUR, V96, P237; Alleron L, 2008, CURR MICROBIOL, V57, P497, DOI 10.1007/s00284-008-9275-9; Bargellini A, 2011, WATER RES, V45, P2315, DOI 10.1016/j.watres.2011.01.009; Bartram Jamie, 2007, P1; Buse HY, 2012, WATER RES, V46, P921, DOI 10.1016/j.watres.2011.12.022; Cervero-Arago S, 2014, J APPL MICROBIOL, V116, P728, DOI 10.1111/jam.12379; Cervero-Arago S, 2014, WATER RES, V67, P299, DOI 10.1016/j.watres.2014.09.023; CHANG SL, 1978, APPL ENVIRON MICROB, V35, P368, DOI 10.1128/AEM.35.2.368-375.1978; Coulon C, 2010, J CLIN MICROBIOL, V48, P2689, DOI 10.1128/JCM.00309-10; Deborde M, 2008, WATER RES, V42, P13, DOI 10.1016/j.watres.2007.07.025; Donlan RM, 2005, BIOFOULING, V21, P1, DOI 10.1080/08927010500044286; Dupuy M, 2011, WATER RES, V45, P1087, DOI 10.1016/j.watres.2010.10.025; Dusserre E, 2008, APPL ENVIRON MICROB, V74, P4817, DOI 10.1128/AEM.02899-07; EC, 1998, OFF J EUR COMMUNITIE, P41; Graham FF, 2012, EPIDEMIOL INFECT, V140, P1481, DOI 10.1017/S0950268811000975; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Grimm D, 1998, APPL ENVIRON MICROB, V64, P2686; International Organization for Standardization, 2005, 81992005 ISO; KUCHTA JM, 1983, APPL ENVIRON MICROB, V46, P1134, DOI 10.1128/AEM.46.5.1134-1139.1983; Kuiper MW, 2004, APPL ENVIRON MICROB, V70, P6826, DOI 10.1128/AEM.70.11.6826-6833.2004; Kusnetsov J, 2003, APMIS, V111, P546, DOI 10.1034/j.1600-0463.2003.1110503.x; Lau HY, 2009, J APPL MICROBIOL, V107, P368, DOI 10.1111/j.1365-2672.2009.04208.x; Lau R, 2013, J ENVIRON HEALTH, V75, P82; LECHEVALLIER MW, 1988, APPL ENVIRON MICROB, V54, P2492, DOI 10.1128/AEM.54.10.2492-2499.1988; Lin YE, 2011, CURR OPIN INFECT DIS, V24, P350, DOI 10.1097/QCO.0b013e3283486c6e; Lorenzo-Morales J, 2013, TRENDS PARASITOL, V29, P181, DOI 10.1016/j.pt.2013.01.006; Loret J. F., 2005, Journal of Water and Health, V3, P423; Mouchtouri V, 2007, AM J INFECT CONTROL, V35, P623, DOI 10.1016/j.ajic.2007.01.002; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Saint CP, 1999, J MICROBIOL METH, V37, P245, DOI 10.1016/S0167-7012(99)00070-6; Schmitz-Esser S, 2008, APPL ENVIRON MICROB, V74, P5822, DOI 10.1128/AEM.01093-08; Schoen ME, 2011, WATER RES, V45, P5826, DOI 10.1016/j.watres.2011.08.031; Serrano-Suarez A, 2013, ENVIRON SCI POLLUT R, V20, P5534, DOI 10.1007/s11356-013-1557-5; Siddiqui R, 2008, J MED MICROBIOL, V57, P428, DOI 10.1099/jmm.0.47694-0; Spinks AT, 2006, WATER RES, V40, P1326, DOI 10.1016/j.watres.2006.01.032; Storey MV, 2004, SCAND J INFECT DIS, V36, P656, DOI 10.1080/00365540410020785; STOUT JE, 1986, APPL ENVIRON MICROB, V52, P396, DOI 10.1128/AEM.52.2.396-399.1986; Szewzyk U, 2000, ANNU REV MICROBIOL, V54, P81, DOI 10.1146/annurev.micro.54.1.81; Taylor M, 2009, MICROB ECOL, V58, P538, DOI 10.1007/s00248-009-9514-z; Garcia MT, 2007, ENVIRON MICROBIOL, V9, P1267, DOI 10.1111/j.1462-2920.2007.01245.x; Thomas V, 2004, J APPL MICROBIOL, V97, P950, DOI 10.1111/j.1365-2672.2004.02391.x; Thurston-Enriquez JA, 2003, APPL ENVIRON MICROB, V69, P3979, DOI 10.1128/AEM.69.7.3979-3985.2003; Velonakis EN, 2010, CLIN MICROBIOL INFEC, V16, P763, DOI 10.1111/j.1469-0691.2009.02957.x; WHO, 2008, GUID DRINK WAT QUAL; WHO, 2014, WAT SAF DISTR SYST	45	71	73	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134726	10.1371/journal.pone.0134726	http://dx.doi.org/10.1371/journal.pone.0134726			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241039	Green Submitted, gold, Green Published			2022-12-27	WOS:000358942700062
J	Lee, SH; Jin, KS; Bang, OY; Kim, BJ; Park, SJ; Lee, NH; Yoo, KH; Koo, HH; Sung, KW				Lee, Soo Hyun; Jin, Kyung Sil; Bang, Oh Young; Kim, Byoung Joon; Park, Soo Jin; Lee, Na Hee; Yoo, Keon Hee; Koo, Hong Hoe; Sung, Ki Woong			Differential Migration of Mesenchymal Stem Cells to Ischemic Regions after Middle Cerebral Artery Occlusion in Rats	PLOS ONE			English	Article							MARROW STROMAL CELLS; FUNCTIONAL RECOVERY; THERAPEUTIC BENEFIT; STROKE; TRANSPLANTATION; BRAIN; MODEL; MICE; EXPRESSION; VECTOR	To evaluate the optimal timing of mesenchymal stem cell (MSC) transplantation following stroke, rats were transplanted with MSCs at 1 (D1), 4 (D4), and 7 days (D7) after middle cerebral artery occlusion (MCAo). Rats in the D1 group showed a better functional recovery than those in the D4 or D7 groups after MCAo. MSCs preferentially migrated to the cortex in the D1 group, while the MSCs in the D4 or D7 groups preferentially migrated to the striatum. Interestingly, the level of monocyte chemotactic protein-1 (MCP-1) in the cortex was highest at 1 day after MCAo, while the level of stromal cell-derived factor-1 (SDF-1) in the striatum was lowest at 1 day after MCAo and then increased over time. The pattern of MCP-1 and SDF-1 level changes according to the time after MCAo was consistent with in vivo and in vitro migration patterns of MSCs. The results suggest that an earlier MSC transplantation is associated with a better functional recovery after stroke, which could be explained by the preferential migration of MSCs to the cortex in the early transplantation group. The time-dependent differential expression of MCP-1 and SDF-1 between ischemic regions seemed to mediate the differential migration of MSCs. Highest level of MCP-1 at one day of stroke may induce preferential migration of MSCs to the cortex, then better functional improvement.	[Lee, Soo Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea; [Jin, Kyung Sil; Park, Soo Jin; Lee, Na Hee; Yoo, Keon Hee; Koo, Hong Hoe; Sung, Ki Woong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea; [Bang, Oh Young; Kim, Byoung Joon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea	Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Sung, KW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea.	kwsped@skku.edu			Samsung Biomedical Research Institute [SBRI C-B11-131]; IN-SUNG Foundation for Medical Research [CB08051]	Samsung Biomedical Research Institute(Samsung); IN-SUNG Foundation for Medical Research	This study was supported by grants from the Samsung Biomedical Research Institute (SBRI C-B11-131) and the IN-SUNG Foundation for Medical Research (CB08051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Boltze J, 2012, CELL TRANSPLANT, V21, P1199, DOI 10.3727/096368911X589609; Borlongan CV, 2004, BRAIN RES, V1010, P108, DOI 10.1016/j.brainres.2004.02.072; CHEN H, 1992, J CEREBR BLOOD F MET, V12, P621, DOI 10.1038/jcbfm.1992.86; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen LW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007119; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Honma T, 2006, EXP NEUROL, V199, P56, DOI 10.1016/j.expneurol.2005.05.004; Honmou O, 2011, BRAIN, V134, P1790, DOI 10.1093/brain/awr063; Ikeda N, 2005, STROKE, V36, P2725, DOI 10.1161/01.STR.0000190006.88896.d3; Ishizaka S, 2013, STROKE, V44, P720, DOI 10.1161/STROKEAHA.112.677328; Le Blanc K, 2008, LANCET, V372, P716; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lee SH, 2013, BONE MARROW TRANSPLA; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Liu H, 2006, BRAIN, V129, P2734, DOI 10.1093/brain/awl207; Newman MB, 2005, STEM CELLS DEV, V14, P576, DOI 10.1089/scd.2005.14.576; Okumura N, 1996, BLOOD, V87, P4100, DOI 10.1182/blood.V87.10.4100.bloodjournal87104100; Rosenblum S, 2012, STROKE, V43, P1624, DOI 10.1161/STROKEAHA.111.637884; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Siegel G, 2009, TRANSPLANTATION, V87, pS45, DOI 10.1097/TP.0b013e3181a285b0; Stumm RK, 2002, J NEUROSCI, V22, P5865; Toyoshima A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127302; Wang L, 2002, EXP HEMATOL, V30, P831, DOI 10.1016/S0301-472X(02)00829-9; Wang LQ, 2014, CNS NEUROSCI THER, V20, P317, DOI 10.1111/cns.12216; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Zhao MZ, 2006, J CEREBR BLOOD F MET, V26, P1176, DOI 10.1038/sj.jcbfm.9600273	34	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134920	10.1371/journal.pone.0134920	http://dx.doi.org/10.1371/journal.pone.0134920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241653	gold, Green Published, Green Submitted			2022-12-27	WOS:000358942700081
J	OuYang, FQ; Mao, JF; Wang, JH; Zhang, SG; Li, Y				OuYang, Fangqun; Mao, Jian-Feng; Wang, Junhui; Zhang, Shougong; Li, Yue			Transcriptome Analysis Reveals that Red and Blue Light Regulate Growth and Phytohormone Metabolism in Norway Spruce [Picea abies (L.) Karst.]	PLOS ONE			English	Article							APICAL BUD FORMATION; GENE-EXPRESSION; PHOTOPERIODIC CONTROL; ABSCISIC-ACID; PHYTOCHROME-B; FAR-RED; ARABIDOPSIS; QUALITY; AUXIN; DORMANCY	The mechanisms by which different light spectra regulate plant shoot elongation vary, and phytohormones respond differently to such spectrum-associated regulatory effects. Light supplementation can effectively control seedling growth in Norway spruce. However, knowledge of the effective spectrum for promoting growth and phytohormone metabolism in this species is lacking. In this study, 3-year-old Norway spruce clones were illuminated for 12 h after sunset under blue or red light-emitting diode (LED) light for 90 d, and stem increments and other growth traits were determined. Endogenous hormone levels and transcriptome differences in the current needles were assessed to identify genes related to the red and blue light regulatory responses. The results showed that the stem increment and gibberellin (GA) levels of the seedlings illuminated by red light were 8.6% and 29.0% higher, respectively, than those of the seedlings illuminated by blue light. The indoleacetic acid (IAA) level of the seedlings illuminated by red light was 54.6% lower than that of the seedlings illuminated by blue light, and there were no significant differences in abscisic acid (ABA) or zeatin riboside [ZR] between the two groups of seedlings. The transcriptome results revealed 58,736,166 and 60,555,192 clean reads for the blue-light-and red-light-illuminated samples, respectively. Illumina sequencing revealed 21,923 unigenes, and 2744 (approximately 93.8%) out of 2926 differentially expressed genes (DEGs) were found to be upregulated under blue light. The main KEGG classifications of the DEGs were metabolic pathway (29%), biosynthesis of secondary metabolites (20.49%) and hormone signal transduction (8.39%). With regard to hormone signal transduction, AUXIN-RESISTANT1 (AUX1), AUX/IAA genes, auxin-inducible genes, and early auxin-responsive genes [(auxin response factor (ARF) and small auxin-up RNA (SAUR)] were all upregulated under blue light compared with red light, which might have yielded the higher IAA level. DELLA and phytochrome-interacting factor 3 (PIF3), involved in negative GA signaling, were also upregulated under blue light, which may be related to the lower GA level. Light quality also affects endogenous hormones by influencing secondary metabolism. Blue light promoted phenylpropanoid biosynthesis, phenylalanine metabolism, flavonoid biosynthesis and flavone and flavonol biosynthesis, accompanied by upregulation of most of the genes in their pathways. In conclusion, red light may promote stem growth by regulating biosynthesis of GAs, and blue light may promote flavonoid, lignin, phenylpropanoid and some hormones (such as jasmonic acid) which were related to plant defense in Norway spruce, which might reduce the primary metabolites available for plant growth.	[OuYang, Fangqun; Wang, Junhui; Zhang, Shougong] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing 100091, Peoples R China; [OuYang, Fangqun; Mao, Jian-Feng; Li, Yue] Beijing Forestry Univ, Coll Biol Sci & Technol, Key Lab Genet & Breeding Forest Trees & Ornamenta, Natl Engn Lab Forest Tree Breeding,Minist Educ, Beijing 100083, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Beijing Forestry University	Wang, JH (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing 100091, Peoples R China.	wangjh808@sina.com; liyue@bjfu.edu.cn	Mao, Jian-Feng/V-9251-2019	Mao, Jian-Feng/0000-0001-9735-8516	Twelfth Five-Year Plan for Science & Technology Support of China [2012BAD01B01]	Twelfth Five-Year Plan for Science & Technology Support of China	This study was supported by a grant from Twelfth Five-Year Plan for Science & Technology Support of China (2012BAD01B01).	AKSENOVA NP, 1994, J PLANT GROWTH REGUL, V13, P143, DOI 10.1007/BF00196378; Awada MA, 2001, SCI HORTIC-AMSTERDAM, V88, P289, DOI 10.1016/S0304-4238(00)00215-6; Beel B, 2012, PLANT CELL, V24, P2992, DOI 10.1105/tpc.112.098947; BEHRINGER FJ, 1992, PLANTA, V188, P85, DOI [10.1007/BF01160716, 10.1007/BF00198943]; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Castillon A, 2007, TRENDS PLANT SCI, V12, P514, DOI 10.1016/j.tplants.2007.10.001; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; CLINE MG, 1994, PHYSIOL PLANTARUM, V90, P230, DOI 10.1034/j.1399-3054.1994.900133.x; Colon-Carmona A, 2000, PLANT PHYSIOL, V124, P1728, DOI 10.1104/pp.124.4.1728; COSGROVE DJ, 1981, PLANT PHYSIOL, V67, P584, DOI 10.1104/pp.67.3.584; de Lucas M, 2014, NEW PHYTOL, V202, P1126, DOI 10.1111/nph.12725; Deng YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039704; El Kayal W, 2011, PLANT CELL ENVIRON, V34, P480, DOI 10.1111/j.1365-3040.2010.02257.x; Fankhauser C, 1997, ANNU REV CELL DEV BI, V13, P203, DOI 10.1146/annurev.cellbio.13.1.203; FERNBACH E, 1990, PLANTA, V180, P212, DOI 10.1007/BF00193998; Gaba V, 1983, THE CONTROL OF CELL, P358; Gebauer R, 2012, TREES-STRUCT FUNCT, V26, P1079, DOI 10.1007/s00468-012-0684-9; Gubler F, 2008, PLANT PHYSIOL, V147, P886, DOI 10.1104/pp.107.115469; Horvath DP, 2003, TRENDS PLANT SCI, V8, P534, DOI 10.1016/j.tplants.2003.09.013; Jenkins GI, 2001, NEW PHYTOL, V151, P121, DOI 10.1046/j.1469-8137.2001.00151.x; JUNTTILA O, 1988, PHYSIOL PLANTARUM, V74, P371, DOI 10.1111/j.1399-3054.1988.tb00645.x; Kasahara M, 2004, PLANT PHYSIOL, V135, P1388, DOI 10.1104/pp.104.042705; Keuskamp DH, 2011, PLANT J, V67, P208, DOI 10.1111/j.1365-313X.2011.04597.x; Kircher S, 2002, PLANT CELL, V14, P1541, DOI 10.1105/tpc.001156; Kurepin LV, 2007, PLANT CELL ENVIRON, V30, P147, DOI 10.1111/j.1365-3040.2006.01612.x; Kurepin LV, 2012, BOTANY, V90, P237, DOI [10.1139/B11-108, 10.1139/b11-108]; Lau OS, 2010, CURR OPIN PLANT BIOL, V13, P571, DOI 10.1016/j.pbi.2010.07.001; Lee H, 2008, PLANT MOL BIOL, V67, P659, DOI 10.1007/s11103-008-9345-1; Li CY, 2003, PHYSIOL PLANTARUM, V117, P206, DOI 10.1034/j.1399-3054.2003.00002.x; Lu Na, 2012, Environmental Control in Biology, V50, P63; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Molmann JA, 2006, PLANT CELL ENVIRON, V29, P166, DOI 10.1111/j.1365-3040.2005.01408.x; Mortensen L. M., 1988, New Forests, V2, P281; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Olsen JE, 1997, PLANT J, V12, P1339, DOI 10.1046/j.1365-313x.1997.12061339.x; Olsen JE, 1997, PLANT CELL PHYSIOL, V38, P536, DOI 10.1093/oxfordjournals.pcp.a029202; Olsen JE, 2010, PLANT MOL BIOL, V73, P37, DOI 10.1007/s11103-010-9620-9; Pierik R, 2009, PLANT SIGNAL BEHAV, V4, P755, DOI [10.4161/psb.4.8.9179, 10.1104/pp.108.13349]; Quail PH, 2002, CURR OPIN CELL BIOL, V14, P180, DOI 10.1016/S0955-0674(02)00309-5; Ralph S, 2006, PLANT MOL BIOL, V60, P21, DOI 10.1007/s11103-005-2226-y; Reddy SK, 2014, PLANT PHYSIOL, V164, P1542, DOI 10.1104/pp.113.234021; Reddy SK, 2013, PLANT PHYSIOL, V163, P1047, DOI 10.1104/pp.113.221895; Ruttink T, 2007, PLANT CELL, V19, P2370, DOI 10.1105/tpc.107.052811; Sellaro R, 2009, CURR BIOL, V19, P1216, DOI 10.1016/j.cub.2009.05.062; Sellin A, 2011, PLANT CELL ENVIRON, V34, P1079, DOI 10.1111/j.1365-3040.2011.02306.x; Seo J-K, 2014, SCI REPORTS, P4; Son KH, 2013, HORTSCIENCE, V48, P988; Sun TP, 2010, PLANT PHYSIOL, V154, P567, DOI 10.1104/pp.110.161554; Tanaka Y, 2004, BIOSCI BIOTECH BIOCH, V68, P462, DOI 10.1271/bbb.68.462; Wang WJ, 2013, PLANTA, V237, P1123, DOI 10.1007/s00425-012-1831-7; Wang YS, 2012, SCI HORTIC-AMSTERDAM, V133, P72, DOI 10.1016/j.scienta.2011.10.017; WEILER EW, 1981, PLANTA, V153, P561, DOI 10.1007/BF00385542; Yadav V, 2005, PLANT CELL, V17, P1953, DOI 10.1105/tpc.105.032060; Yakovlev IA, 2006, TREE GENET GENOMES, V2, P39, DOI 10.1007/s11295-005-0031-z; Yamada H, 2001, PLANT CELL PHYSIOL, V42, P1017, DOI 10.1093/pcp/pce127; Yu SM, 2013, J APPL MICROBIOL, V115, P509, DOI 10.1111/jam.12252; Zhang ZL, 2014, MOL PLANT, V7, P1429, DOI 10.1093/mp/ssu058; Zhong SW, 2012, CURR BIOL, V22, P1530, DOI 10.1016/j.cub.2012.06.039; Zhou XY, 2013, MOL PLANT, V6, P887, DOI 10.1093/mp/sss123	61	57	57	4	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0127896	10.1371/journal.pone.0127896	http://dx.doi.org/10.1371/journal.pone.0127896			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237749	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942400002
J	Birlanga, V; Villanova, J; Cano, A; Cano, EA; Acosta, M; Perez-Perez, JM				Birlanga, Virginia; Villanova, Joan; Cano, Antonio; Cano, Emilio A.; Acosta, Manuel; Manuel Perez-Perez, Jose			Quantitative Analysis of Adventitious Root Growth Phenotypes in Carnation Stem Cuttings	PLOS ONE			English	Article							COLD-STORAGE PERIOD; WATER-USE; TRAITS; TRANSPORT; RESPONSES; DROUGHT; REGIONS; LEVEL; LEAF	Carnation is one of the most important species on the worldwide market of cut flowers. Commercial carnation cultivars are vegetatively propagated from terminal stem cuttings that undergo a rooting and acclimation process. For some of the new cultivars that are being developed by ornamental breeders, poor adventitious root (AR) formation limits its commercial scaling-up, due to a significant increase in the production costs. We have initiated a genetical-genomics approach to determine the molecular basis of the differences found between carnation cultivars during adventitious rooting. The detailed characterization of AR formation in several carnation cultivars differing in their rooting losses has been performed (i) during commercial production at a breeders' rooting station and (ii) on a defined media in a controlled environment. Our study reveals the phenotypic signatures that distinguishes the bad-rooting cultivars and provides the appropriate set-up for the molecular identification of the genes involved in AR development in this species.	[Birlanga, Virginia; Villanova, Joan; Manuel Perez-Perez, Jose] Univ Miguel Hernandez, Inst Bioingn, Elche, Spain; [Cano, Antonio; Acosta, Manuel] Univ Murcia, Dept Biol Vegetal Fisiol Vegetal, Murcia, Spain; [Cano, Emilio A.] Barberet & Blanc SA, Dept Res & Dev, Puerto Lumbreras, Spain	Universidad Miguel Hernandez de Elche; University of Murcia	Perez-Perez, JM (corresponding author), Univ Miguel Hernandez, Inst Bioingn, Elche, Spain.	jmperez@umh.es	Cano, Antonio/B-8723-2008; Acosta, Manuel/A-2127-2008; Perez-Perez, Jose Manuel/B-4247-2011	Cano, Antonio/0000-0001-8555-5053; Acosta, Manuel/0000-0003-0611-6672; Perez-Perez, Jose Manuel/0000-0003-2848-4919	Ministerio de Economia y Competitividad (MINECO) of Spain [AGL2012-33610]; Center for the Development of Industrial Technology [CARNOMICS E! 6384]	Ministerio de Economia y Competitividad (MINECO) of Spain; Center for the Development of Industrial Technology	Funding was provided by Ministerio de Economia y Competitividad (MINECO) of Spain (http://www.mineco.gob.es/), grant no. AGL2012-33610; Center for the Development of Industrial Technology (https://www.cdti.es/), grant no. CARNOMICS E! 6384. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agull&oacute;-Ant&oacute;n MA, 2011, WHAT MAKES DIFFERENC; Ahkami AH, 2013, PLANTA, V238, P499, DOI 10.1007/s00425-013-1907-z; Agullo-Anton MA, 2013, PLANT SCI, V201, P1, DOI 10.1016/j.plantsci.2012.11.006; Agullo-Anton MA, 2014, PHYSIOL PLANTARUM, V150, P446, DOI 10.1111/ppl.12114; Bai CH, 2013, J EXP BOT, V64, P1745, DOI 10.1093/jxb/ert041; Fang SQ, 2013, P NATL ACAD SCI USA, V110, P2670, DOI 10.1073/pnas.1222821110; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Galkovskyi T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-116; Garrido G, 2003, BIOL PLANTARUM, V47, P481, DOI 10.1023/B:BIOP.0000041050.41513.da; Garrido G, 1996, SCI HORTIC-AMSTERDAM, V65, P73, DOI 10.1016/0304-4238(95)00860-8; Garrido G, 1998, SCI HORTIC-AMSTERDAM, V74, P219, DOI 10.1016/S0304-4238(98)00078-8; Garrido G, 2002, PHYSIOL PLANTARUM, V114, P303, DOI 10.1034/j.1399-3054.2002.1140217.x; Guerrero JR, 1999, J PLANT GROWTH REGUL, V18, P183, DOI 10.1007/PL00007068; Kirkegaard JA, 2007, AUST J AGR RES, V58, P303, DOI 10.1071/AR06285; Lampinen BD, 2004, J HORTIC SCI BIOTECH, V79, P638, DOI 10.1080/14620316.2004.11511819; Lopez-Iglesias B, 2014, ACTA OECOL, V56, P10, DOI 10.1016/j.actao.2014.01.003; Lynch JP, 2015, J EXP BOT, V66, P2199, DOI 10.1093/jxb/eru508; Perez-Perez JM, 2011, PLANT CELL ENVIRON, V34, P2200, DOI 10.1111/j.1365-3040.2011.02415.x; Massey F. J., 1951, J AM STAT ASS, V46; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Richards RA, 2010, FUNCT PLANT BIOL, V37, P85, DOI 10.1071/FP09219; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheela V, 2008, FLOWERS TRADE; Topp CN, 2013, P NATL ACAD SCI USA, V110, pE1695, DOI 10.1073/pnas.1304354110; Valladares F, 2006, PLANT BIOLOGY, V8, P688, DOI 10.1055/s-2006-924107; Vegh KR, 2013, BIOLOGIA, V68, P1123, DOI 10.2478/s11756-013-0258-3; Villacorta C, 2015, GENE EXPRESSION PROF; Wojciechowski K, 2015, PHYS CHEM CHEM PHYS, V17, P1106, DOI 10.1039/c4cp03835e; Zurek PR, 2015, PLANT PHYSIOL, V167, P1487, DOI 10.1104/pp.114.251751	30	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133123	10.1371/journal.pone.0133123	http://dx.doi.org/10.1371/journal.pone.0133123			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230608	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400026
J	Gomes, TN; Hedeker, D; dos Santos, FK; Pereira, S; Katzmarzyk, PT; Maia, JAR				Gomes, Thayse Natacha; Hedeker, Donald; dos Santos, Fernanda Karina; Pereira, Sara; Katzmarzyk, Peter T.; Maia, Jose A. R.			Why Are Children Different in Their Daily Sedentariness? An Approach Based on the Mixed-Effects Location Scale Model	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PRESCHOOL-CHILDREN; SEX-DIFFERENCES; BEHAVIOR; ADOLESCENTS; TIME; PATTERNS; YOUTH; SCHOOL; MATURATION	This study aimed to investigate the between-and within-individual variability in sedentary time over seven days, using a mixed-effects location scale model. The sample comprised 686 Portuguese children (381 girls) aged 9-11 years, from 23 schools. Sedentary time was estimated by the Actigraph GT3X+ accelerometer, which was used 24 hours/day for 7 consecutive days; height, sitting height, and weight were measured, BMI was computed (WHO cut-points were used to classify subjects as normal weight or overweight/obese), and maturity offset was estimated. Information regarding the home environment was obtained by questionnaire. Results revealed that (i) children were more sedentary on Friday, but less so on Saturday and Sunday (compared to Monday), with significant variation between-and within-subjects (between-subject variance=0.800, within-subject variance=1.793, intra-subject correlation=0.308); (ii) there is a sex effect on sedentariness, with boys being less sedentary than girls (p<0.001), and the between-subject variance was 1.48 times larger for boys than girls; (iii) in terms of the within-subject variance, or erraticism, Tuesday, Wednesday and Friday have similar erraticism levels as Monday (Thursday has less, while Saturday and Sunday have more); in addition, girls (variance ratio=0.632, p<0.001), overweight/obese children (variance ratio=0.861, p=0.019), and those later mature (variance ratio=0.849, p=0.013) have less erraticism than their counterparts; (iv) the within-subject variance varied significantly across subjects (scale std dev=0.342 +/- 0.037, p<0.001); and (v) in the fixed part of the model, only biological maturation was positively related to sedentariness. This study demonstrated that there is significant between-and within-subject variability in sedentariness across a whole week. This implies that a focus on intra-individual variability, instead of only on mean values, would provide relevant information towards a more complete map of children's sedentary behaviour, which can be helpful when developing more efficient strategies to reduce sedentariness.	[Gomes, Thayse Natacha; Pereira, Sara; Maia, Jose A. R.] Univ Porto, Fac Sport, Kinanthropometry Lab, Ctr Res Educ Innovat & Intervent Sport CIFI2D, P-4100 Oporto, Portugal; [Hedeker, Donald] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA; [dos Santos, Fernanda Karina] Univ Fed Pernambuco, CAV, Dept Phys Educ & Sports Sci, Vitoria De Santo Antao, Pernambuco, Brazil; [Katzmarzyk, Peter T.] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA	Universidade do Porto; University of Chicago; Universidade Federal de Pernambuco; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Gomes, TN (corresponding author), Univ Porto, Fac Sport, Kinanthropometry Lab, Ctr Res Educ Innovat & Intervent Sport CIFI2D, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	thayse_natacha@hotmail.com	Katzmarzyk, Peter T/N-1974-2017; Hedeker, Donald/R-7055-2019; Pereira, Sara/V-1516-2019; Gomes, Thayse Natacha Queiroz Ferreira/AAL-5002-2020	Katzmarzyk, Peter T/0000-0002-9280-6022; Pereira, Sara/0000-0002-4661-3879; Queiroz Ferreira Gomes, Thayse Natacha/0000-0003-4991-1238	Coca-Cola Company	Coca-Cola Company	ISCOLE was funded by The Coca-Cola Company. The funder had no role in the study design, data collection and analysis, decision to publish or preparation of this manuscript.	Atkin AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067627; Barreira TV, 2014, MED SCI SPO IN PRESS; Biddle S., 2010, SEDENTARY BEHAV OBES; Biddle SJH, 2009, PREV MED, V48, P151, DOI 10.1016/j.ypmed.2008.10.025; Blatchford P, 2003, BRIT J DEV PSYCHOL, V21, P481, DOI 10.1348/026151003322535183; Brodersen NH, 2005, ANN BEHAV MED, V29, P2, DOI 10.1207/s15324796abm2901_2; Carson V, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-173; Cumming SP, 2008, J ADOLESCENT HEALTH, V42, P480, DOI 10.1016/j.jadohealth.2007.10.005; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; EPSTEIN S, 1979, J PERS SOC PSYCHOL, V37, P1097, DOI 10.1037/0022-3514.37.7.1097; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Funda&ccedil;&atilde;o Francisco Manuel dos Santos, 2013, PORDATA; Gomes TN, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-890; Gomes TN, 2014, J SCHOOL HEALTH, V84, P668, DOI 10.1111/josh.12193; Gorely T, 2007, J BEHAV MED, V30, P521, DOI 10.1007/s10865-007-9126-3; Hamaker EL, 2014, HDB RES ETHODS STUDY, P43; Harrington DM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-120; Hedeker D, 2008, BIOMETRICS, V64, P627, DOI 10.1111/j.1541-0420.2007.00924.x; Hedeker D, 2012, STAT MED, V31, P3328, DOI 10.1002/sim.5338; Brodersen NH, 2007, BRIT J SPORT MED, V41, P140, DOI 10.1136/bjsm.2006.031138; Hertzog C, 2003, PSYCHOL AGING, V18, P639, DOI 10.1037/0882-7974.18.4.639; Hinkley T, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-66; Katzmarzyk PT, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-900; Leatherdale ST, 2010, PREV CHRONIC DIS, V7; Rodrigues AMM, 2010, PEDIATR EXERC SCI, V22, P442, DOI 10.1123/pes.22.3.442; Marques A, 2014, AM J HUM BIOL; Marshall SJ, 2002, PEDIATR EXERC SCI, V14, P401, DOI 10.1123/pes.14.4.401; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Nilsson A, 2009, SCAND J MED SCI SPOR, V19, P10, DOI 10.1111/j.1600-0838.2007.00762.x; Pate RR, 2011, BRIT J SPORT MED, V45, P906, DOI 10.1136/bjsports-2011-090192; Reis HT, 2014, HANDBOOK OF RESEARCH METHODS IN SOCIAL AND PERSONALITY PSYCHOLOGY, SECOND EDITION, P1; Ridgers ND, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056838; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sardinha LB, 2011, INT J PEDIATR OBES, V6, pE124, DOI 10.3109/17477166.2010.490263; Sherar LB, 2007, MED SCI SPORT EXER, V39, P830, DOI 10.1249/mss.0b013e3180335c3c; Steele RM, 2008, J APPL PHYSIOL, V105, P342, DOI 10.1152/japplphysiol.00072.2008; Steele RM, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-88; Stone Arthur S., 1994, Annals of Behavioral Medicine, V16, P199; Telford RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-81; Thompson AM, 2003, MED SCI SPORT EXER, V35, P1684, DOI 10.1249/01.MSS.0000089244.44914.1F; Tudor-Locke Catrine, 2014, Appl Physiol Nutr Metab, V39, P53, DOI 10.1139/apnm-2013-0173; Uijtdewilligen L, 2011, BRIT J SPORT MED, V45, P896, DOI 10.1136/bjsports-2011-090197; Van Cauwenberghe E, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-138; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Verloigne M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-34; Vicente-Rodriguez G, 2008, NUTRITION, V24, P654, DOI 10.1016/j.nut.2008.03.011; Zabinski MF, 2007, HEALTH PSYCHOL, V26, P113, DOI 10.1037/0278-6133.26.1.113	48	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132192	10.1371/journal.pone.0132192	http://dx.doi.org/10.1371/journal.pone.0132192			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230652	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400016
J	Kim, S; Yoon, Y; Choi, KH				Kim, Sejeong; Yoon, Yohan; Choi, Kyoung-Hee			Pseudomonas aeruginosa DesB Promotes Staphylococcus aureus Growth Inhibition in Coculture by Controlling the Synthesis of HAQs	PLOS ONE			English	Article							SMALL-COLONY VARIANTS; GENE; EXPRESSION; RESISTANCE; MEXT; REGULATOR; BIOSYNTHESIS; VIRULENCE; PATHWAYS; PROTEASE	Pseudomonas aeruginosa is a pathogen that can cause serious infections and usually coexists with other pathogens, such as Staphylococcus aureus. Virulence factors are important for maintaining a presence of the organisms in these multispecies environments, and DesB plays an important role in P. aeruginosa virulence. Therefore, we investigated the effect of DesB on S. aureus reduction under competitive situation. Liquid cultures of P. aeruginosa wild type (WT) and its desB mutant were spotted on agar plates containing S. aureus, and the size of the clear zones was compared. In addition, interbacterial competition between P. aeruginosa and S. aureus was observed over time during planktonic coculture. The transcriptional profiles of the WT and desB mutant were compared by qRT-PCR and microarray to determine the role of DesB in S. aureus reduction at the molecular level. As a result, the clear zone was smaller for the desB mutant than for P. aeruginosa PAO1 (WT), and in planktonic coculture, the number of S. aureus cells was reduced in the desB mutant. qRT-PCR and microarray revealed that the expression of MvfR-controlled pqsA-E and phnAB operons was significantly decreased, but the mexEF-oprN operon was highly expressed. The results indicate that intracellular levels of 4-hydroxy-2-heptylquinoline (HHQ), a ligand of MvfR, are reduced due to MexEF-OprN-mediated efflux in desB mutant, resulting in the decrease of MvfR binding to pqsA-E promoter and the reduction of 4-hydroxy-2-alkylquinolines (HAQs) synthesis. Overexpression of mexEF-oprN operon in desB mutant was phenotypically confirmed by observing significantly increased resistance to chloramphenicol. In conclusion, these results suggest that DesB plays a role in the inhibition of S. aureus growth by controlling HAQ synthesis.	[Kim, Sejeong; Yoon, Yohan] Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Choi, Kyoung-Hee] Wonkwang Univ, Dept Oral Microbiol, Coll Dent, Iksan, South Korea	Sookmyung Women's University; Wonkwang University	Yoon, Y (corresponding author), Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea.	yyoon@sookmyung.ac.kr; kheechoi@wku.ac.kr		Kim, Sejeong/0000-0001-9741-8056	Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Science, ICT & Future Planning [NRF-2014R1A1A3051383]	Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2014R1A1A3051383).	Baldan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089614; Barequet IS, 2004, ANTIMICROB AGENTS CH, V48, P1681, DOI 10.1128/AAC.48.5.1681-1687.2004; Beaume M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00321; Biswas L, 2009, APPL ENVIRON MICROB, V75, P6910, DOI 10.1128/AEM.01211-09; BRITO N, 1989, RES MICROBIOL, V140, P125, DOI 10.1016/0923-2508(89)90046-6; BYNG GS, 1979, J BACTERIOL, V138, P846, DOI 10.1128/JB.138.3.846-852.1979; Chen AI, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004480; Coleman JP, 2008, J BACTERIOL, V190, P1247, DOI 10.1128/JB.01140-07; DeLeon S, 2014, INFECT IMMUN, V82, P4718, DOI 10.1128/IAI.02198-14; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Diggle SP, 2007, CHEM BIOL, V14, P87, DOI 10.1016/j.chembiol.2006.11.014; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Fargier E, 2012, J BACTERIOL, V194, P3502, DOI 10.1128/JB.06632-11; Fetar H, 2011, ANTIMICROB AGENTS CH, V55, P508, DOI 10.1128/AAC.00830-10; FUKUDA H, 1990, ANTIMICROB AGENTS CH, V34, P1757, DOI 10.1128/AAC.34.9.1757; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; GAMBELLO MJ, 1993, INFECT IMMUN, V61, P1180, DOI 10.1128/IAI.61.4.1180-1184.1993; Haba E, 2003, BIOTECHNOL BIOENG, V81, P316, DOI 10.1002/bit.10474; HAYS EE, 1945, J BIOL CHEM, V159, P725; Hoang TT, 1997, J BACTERIOL, V179, P5326, DOI 10.1128/jb.179.17.5326-5332.1997; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; KESSLER E, 1993, J BIOL CHEM, V268, P7503; Kohler T, 1999, J BACTERIOL, V181, P6300; Kohler T, 2001, J BACTERIOL, V183, P5213, DOI 10.1128/JB.183.18.5213-5222.2001; Korgaonkar A, 2013, P NATL ACAD SCI USA, V110, P1059, DOI 10.1073/pnas.1214550110; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Lamarche MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024310; MACHAN ZA, 1992, J ANTIMICROB CHEMOTH, V30, P615, DOI 10.1093/jac/30.5.615; Maseda H, 2000, FEMS MICROBIOL LETT, V192, P107, DOI 10.1016/S0378-1097(00)00419-5; Mashburn LM, 2005, J BACTERIOL, V187, P554, DOI 10.1128/JB.187.2.554-566.2005; McKnight SL, 2000, J BACTERIOL, V182, P2702, DOI 10.1128/JB.182.10.2702-2708.2000; Mitchell G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-33; MORSE SA, 1980, ANTIMICROB AGENTS CH, V18, P416, DOI 10.1128/AAC.18.3.416; Nair N, 2014, INFECT IMMUN, V82, P2162, DOI 10.1128/IAI.00059-14; Olivares J, 2012, ENVIRON MICROBIOL, V14, P1968, DOI 10.1111/j.1462-2920.2012.02727.x; Pastar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056846; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Prithiviraj B, 2005, INFECT IMMUN, V73, P5319, DOI 10.1128/IAI.73.9.5319-5328.2005; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Rosenbluth DB, 2004, CHEST, V126, P412, DOI 10.1378/chest.126.2.412; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sage AE, 1997, J BACTERIOL, V179, P4874, DOI 10.1128/jb.179.15.4874-4881.1997; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Schweizer HP, 2011, ARCH MICROBIOL, V193, P227, DOI 10.1007/s00203-010-0665-6; Sobel ML, 2005, J BACTERIOL, V187, P1246, DOI 10.1128/JB.187.4.1246-1253.2005; Tian ZX, 2009, NUCLEIC ACIDS RES, V37, P7546, DOI 10.1093/nar/gkp828; Van Delden C, 1998, EMERG INFECT DIS, V4, P551, DOI 10.3201/eid0404.980405; Wade DS, 2005, J BACTERIOL, V187, P4372, DOI 10.1128/JB.187.13.4372-4380.2005; Xiao GP, 2006, MOL MICROBIOL, V62, P1689, DOI 10.1111/j.1365-2958.2006.05462.x; Zhu K, 2006, MOL MICROBIOL, V60, P260, DOI 10.1111/j.1365-2958.2006.05088.x	53	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134624	10.1371/journal.pone.0134624	http://dx.doi.org/10.1371/journal.pone.0134624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230088	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400142
J	Leber, A; Viladomiu, M; Hontecillas, R; Abedi, V; Philipson, C; Hoops, S; Howard, B; Bassaganya-Riera, J				Leber, Andrew; Viladomiu, Monica; Hontecillas, Raquel; Abedi, Vida; Philipson, Casandra; Hoops, Stefan; Howard, Brad; Bassaganya-Riera, Josep			Systems Modeling of Interactions between Mucosal Immunity and the Gut Microbiome during Clostridium difficile Infection	PLOS ONE			English	Article							TOXIN-A; CELLS; INFLAMMATION; COLITIS	Clostridium difficile infections are associated with the use of broad-spectrum antibiotics and result in an exuberant inflammatory response, leading to nosocomial diarrhea, colitis and even death. To better understand the dynamics of mucosal immunity during C. difficile infection from initiation through expansion to resolution, we built a computational model of the mucosal immune response to the bacterium. The model was calibrated using data from a mouse model of C. difficile infection. The model demonstrates a crucial role of T helper 17 (Th17) effector responses in the colonic lamina propria and luminal commensal bacteria populations in the clearance of C. difficile and colonic pathology, whereas regulatory T (Treg) cells responses are associated with the recovery phase. In addition, the production of anti-microbial peptides by inflamed epithelial cells and activated neutrophils in response to C. difficile infection inhibit the re-growth of beneficial commensal bacterial species. Computational simulations suggest that the removal of neutrophil and epithelial cell derived anti-microbial inhibitions, separately and together, on commensal bacterial regrowth promote recovery and minimize colonic inflammatory pathology. Simulation results predict a decrease in colonic inflammatory markers, such as neutrophilic influx and Th17 cells in the colonic lamina propria, and length of infection with accelerated commensal bacteria regrowth through altered anti-microbial inhibition. Computational modeling provides novel insights on the therapeutic value of repopulating the colonic microbiome and inducing regulatory mucosal immune responses during C. difficile infection. Thus, modeling mucosal immunity-gut microbiota interactions has the potential to guide the development of targeted fecal transplantation therapies in the context of precision medicine interventions.	[Leber, Andrew; Viladomiu, Monica; Hontecillas, Raquel; Abedi, Vida; Philipson, Casandra; Hoops, Stefan; Bassaganya-Riera, Josep] Virginia Tech, Ctr Modeling Immun Enter Pathogens, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Leber, Andrew; Viladomiu, Monica; Hontecillas, Raquel; Abedi, Vida; Philipson, Casandra; Hoops, Stefan; Howard, Brad; Bassaganya-Riera, Josep] Virginia Tech, Nutr Immunol & Mol Med Lab, Virginia Bioinformat Inst, Www Nimml Org, Blacksburg, VA USA; [Howard, Brad] Virginia Tech, Dept Biol Sci, Virginia Bioinformat Inst, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Bassaganya-Riera, J (corresponding author), Virginia Tech, Ctr Modeling Immun Enter Pathogens, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	jbassaga@vt.edu	Viladomiu, Monica/GNM-6447-2022; Philipson, Casandra/AAY-5746-2021	Abedi, Vida/0000-0001-7689-933X	National Institute of Allergy and Infectious Diseases [HHSN272201000056C]; Nutritional Immunology and Molecular Medicine Laboratory	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Nutritional Immunology and Molecular Medicine Laboratory	This work was supported in part by National Institute of Allergy and Infectious Diseases Contract No. HHSN272201000056C to JB-R and funds from the Nutritional Immunology and Molecular Medicine Laboratory (www.nimml.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausiello CM, 2006, MICROBES INFECT, V8, P2640, DOI 10.1016/j.micinf.2006.07.009; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Beard DA, 2014, PLOS COMPUTATIONAL B, V10, DOI [10.1371/journal.pcbi.1003509, DOI 10.1371/J0URNAL.PCBI.1003509]; Blake KM, 2004, CLIN EXP IMMUNOL, V136, P262, DOI 10.1111/j.1365-2249.2004.02429.x; Bobak DA, 2010, CURRENT INFECTIOUS D, V13, P21; Brazil JC, 2010, J IMMUNOL, V185, P7026, DOI 10.4049/jimmunol.1001293; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Buffie CG, 2012, INFECT IMMUN, V80, P62, DOI 10.1128/IAI.05496-11; Carbo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073365; Carbo A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003027; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; Foglia G, 2012, VACCINE, V30, P4307, DOI 10.1016/j.vaccine.2012.01.056; Gasch M, 2014, MEDIATORS OF INFLAMM, V2014, P1; Hall AJ, 2012, CLIN INFECT DIS, V55, P216, DOI 10.1093/cid/cis386; HECHT G, 1988, J CLIN INVEST, V82, P1516, DOI 10.1172/JCI113760; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hussack G, 2011, J BIOL CHEM, V286, P8961, DOI 10.1074/jbc.M110.198754; Iapichino G, 2008, J MED MICROBIOL, V57, P1007, DOI 10.1099/jmm.0.47387-0; Ishida Y, 2004, J IMMUNOL, V172, P3018, DOI 10.4049/jimmunol.172.5.3018; Jafari NV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069846; Jarchum I, 2012, INFECT IMMUN, V80, P2989, DOI 10.1128/IAI.00448-12; Kasendra M, 2014, J INFECT DIS, V209, P1095, DOI 10.1093/infdis/jit617; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lo Vecchio A, 2012, CURR OPIN GASTROEN, V28, P1, DOI 10.1097/MOG.0b013e32834bc9a9; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Mahida YR, 1996, GUT, V38, P337, DOI 10.1136/gut.38.3.337; Marteau PR, 2001, AM J CLIN NUTR, V73, p430S, DOI 10.1093/ajcn/73.2.430s; Mathew S, 2014, J THEOR BIOL, V358, P132, DOI 10.1016/j.jtbi.2014.05.036; McDermott AJ, 2015, IMMUNOLOGY, V144, P704, DOI 10.1111/imm.12425; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; McLoughlin RM, 2011, J ALLERGY CLIN IMMUN, V127, P1097, DOI 10.1016/j.jaci.2011.02.012; Mei YG, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S12-S2; Miao HY, 2010, J VIROL, V84, P6687, DOI 10.1128/JVI.00266-10; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Pothoulakis C, 2001, AM J PHYSIOL-GASTR L, V280, pG178, DOI 10.1152/ajpgi.2001.280.2.G178; Prado-Montes de Oca E, 2010, INT J BIOCHEM CELL B, V42, P800, DOI 10.1016/j.biocel.2010.01.021; Rao K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092578; Rao K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058265; RIEGLER M, 1995, J CLIN INVEST, V95, P2004, DOI 10.1172/JCI117885; Schlackow I, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001279; Scott KP, 2015, MICROBIAL ECOLOGY IN, V26; See I, 2014, CLIN INFECT DIS, V58, P1394, DOI 10.1093/cid/ciu125; Shapira Y, 2010, J AUTOIMMUN, V34, pJ168, DOI 10.1016/j.jaut.2009.11.018; Smyth DJ, 2011, DIABETES, V60, P3081, DOI 10.2337/db11-0638; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Sorg JA, 2009, J BACTERIOL, V191, P1115, DOI 10.1128/JB.01260-08; Stagg AJ, 2003, GUT, V52, P1522, DOI 10.1136/gut.52.10.1522; Swale A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106118; Terrier MCZ, 2014, WORLD J GASTROENTERO, V20, P7416, DOI 10.3748/wjg.v20.i23.7416; Viladomiu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047525; Weingarden AR, 2014, AM J PHYSIOL-GASTR L, V306, pG310, DOI 10.1152/ajpgi.00282.2013; Wendelsdorf K, 2010, J THEOR BIOL, V264, P1225, DOI 10.1016/j.jtbi.2010.03.027	59	20	26	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134849	10.1371/journal.pone.0134849	http://dx.doi.org/10.1371/journal.pone.0134849			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230099	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400175
J	Lutzenberger, M; Burwinkel, M; Riemer, C; Bode, V; Baier, M				Lutzenberger, Manuel; Burwinkel, Michael; Riemer, Constanze; Bode, Victoria; Baier, Michael			Ablation of CCAAT/Enhancer-Binding Protein Delta (C/EBPD): Increased Plaque Burden in a Murine Alzheimer's Disease Model	PLOS ONE			English	Article							COMPLEMENT COMPONENT C3; GENE-EXPRESSION; AMYLOID PLAQUES; IN-VITRO; A-BETA; ACTIVATION; ASTROCYTES; INFLAMMATION; NEURODEGENERATION; QUANTIFICATION	Alzheimer's disease (AD) and prion diseases carry a significant inflammatory component. The astrocytic overexpression of CCAAT/enhancer-binding protein delta (C/EBPD) in prion-and AD-affected brain tissue prompted us to study the role of this transcription factor in murine model systems of these diseases. Ablation of C/EBPD had neither in the AD model (APP/PS1 double transgenic mice) nor in the prion model (scrapie-infected C57BL/6 mice) an influence on overt clinical symptoms. Moreover, the absence of C/EBPD did not affect the extent of the disease-related gliosis. However, C/EBPD-deficient APP/PS1 double transgenic mice displayed significantly increased amyloid beta (Abeta) plaque burdens while amyloid precursor protein (APP) expression and expression of genes involved in beta amyloid transport and turnover remained unchanged. Gene expression analysis in mixed glia cultures demonstrated a strong dependency of complement component C3 on the presence of C/EBPD. Accordingly, C3 mRNA levels were significantly lower in brain tissue of C/EBPD-deficient mice. Vice versa, C3 expression in U-373 MG cells increased upon transfection with a C/EBPD expression vector. Taken together, our data indicate that a C/EBPD-deficiency leads to increased Abeta plaque burden in AD model mice. Furthermore, as shown in vivo and in vitro, C/EBPD is an important driver of the expression of acute phase response genes like C3 in the amyloid-affected CNS.	[Lutzenberger, Manuel; Burwinkel, Michael; Riemer, Constanze; Bode, Victoria; Baier, Michael] Robert Koch Inst, Ctr Biol Threats & Special Pathogens ZBS6, Res Grp Proteinopathies Neurodegenerat Dis, Berlin, Germany	Robert Koch Institute	Burwinkel, M (corresponding author), Robert Koch Inst, Ctr Biol Threats & Special Pathogens ZBS6, Res Grp Proteinopathies Neurodegenerat Dis, Berlin, Germany.	burwinkelm@rki.de		Burwinkel, Michael/0000-0003-4811-7323	Germany Federal Ministry of Health [IIA5-2512NIK004//321-4471-02]; Robert Koch-Institut	Germany Federal Ministry of Health; Robert Koch-Institut	This work was funded in part by the Germany Federal Ministry of Health (grant IIA5-2512NIK004//321-4471-02) and Robert Koch-Institut.	Arguello AA, 2013, J NEUROSCI, V33, P3646, DOI 10.1523/JNEUROSCI.1635-12.2013; Balamurugan K, 2013, INT J BIOL SCI, V9, P917, DOI 10.7150/ijbs.7224; Balamurugan K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2677; Bruder C, 2004, MOL IMMUNOL, V40, P949, DOI 10.1016/j.molimm.2003.10.016; Burwinkel M, 2004, EMBO REP, V5, P527, DOI 10.1038/sj.embor.7400125; Cardinaux JR, 1996, J NEUROSCI, V16, P919; Cardinaux JR, 2000, GLIA, V29, P91, DOI 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.0.CO;2-I; Chang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045378; Chauhan NB, 2004, J NEUROSCI RES, V78, P732, DOI 10.1002/jnr.20298; Chen XQ, 2012, J IMMUNOL, V189, P347, DOI 10.4049/jimmunol.1103715; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Eikelenboom P, 1996, NEUROBIOL AGING, V17, P673; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Floden AM, 2007, J NEUROSCI METH, V164, P218, DOI 10.1016/j.jneumeth.2007.04.018; Fu HJ, 2012, GLIA, V60, P993, DOI 10.1002/glia.22331; Gomez-Nicola D, 2013, J NEUROSCI, V33, P2481, DOI 10.1523/JNEUROSCI.4440-12.2013; Hasebe R, 2012, VIROLOGY, V423, P205, DOI 10.1016/j.virol.2011.11.017; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Ko CY, 2015, NEUROBIOL AGING, V36, P1356, DOI 10.1016/j.neurobiolaging.2014.11.020; Ko CY, 2014, NEUROBIOL AGING, V35, P24, DOI 10.1016/j.neurobiolaging.2013.07.021; Ko CY, 2012, NEUROBIOL AGING, V33, DOI [10.1016/j.neurobiolaging.2010.09.017, DOI 10.1016/J.NEUR0BI0LAGING.2010.09.017]; Li RN, 2004, NEUROBIOL AGING, V25, P991, DOI 10.1016/j.neurobiolaging.2003.10.016; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu YW, 2007, CELL MOL LIFE SCI, V64, P3282, DOI 10.1007/s00018-007-7375-5; Lv Y, 2015, MOL NEUROBIOL, V52, P1165, DOI 10.1007/s12035-014-8915-2; Mabbott NA, 2001, NAT MED, V7, P485, DOI 10.1038/86562; Maier M, 2008, J NEUROSCI, V28, P6333, DOI 10.1523/JNEUROSCI.0829-08.2008; Maranto J, 2011, J CELL BIOCHEM, V112, P1168, DOI 10.1002/jcb.23032; Michel B, 2013, INT IMMUNOL, V25, P697, DOI 10.1093/intimm/dxt034; Moore F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031062; Morrison JP, 2009, TOXICOL PATHOL, V37, P502, DOI 10.1177/0192623309335631; Paxinos G, 2002, MOUSE BRAIN STEREOTA, V1st; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Riemer C, 2004, BIOCHEM BIOPH RES CO, V323, P556, DOI 10.1016/j.bbrc.2004.08.124; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sedo A, 2001, EUR J HISTOCHEM, V45, P57; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Stoltzner SE, 2000, AM J PATHOL, V156, P489, DOI 10.1016/S0002-9440(10)64753-0; Sun Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-76; Svotelis A, 2005, BIOCHEM BIOPH RES CO, V328, P461, DOI 10.1016/j.bbrc.2005.01.002; Valente T, 2013, NEUROBIOL AGING, V34, P2110, DOI 10.1016/j.neurobiolaging.2013.02.007; Veerhuis R, 1999, EXP NEUROL, V160, P289, DOI 10.1006/exnr.1999.7199; Villalba M, 2012, MED MICROBIOL IMMUN, V201, P371, DOI 10.1007/s00430-012-0247-0; Wang SM, 2015, MOL NEUROBIOL, V51, P370, DOI 10.1007/s12035-014-8714-9; Wilcock DM, 2006, NAT PROTOC, V1, P1591, DOI 10.1038/nprot.2006.277; Wyss-Coray T, 2002, P NATL ACAD SCI USA, V99, P10837, DOI 10.1073/pnas.162350199; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yan CG, 2012, J BIOL CHEM, V287, P3217, DOI 10.1074/jbc.M111.280834; Yasojima K, 1999, AM J PATHOL, V154, P927, DOI 10.1016/S0002-9440(10)65340-0	52	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134228	10.1371/journal.pone.0134228	http://dx.doi.org/10.1371/journal.pone.0134228			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230261	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400088
J	Martinez, AA; Zaldivar, Y; Arteaga, G; de Castillo, Z; Ortiz, A; Mendoza, Y; Castillero, O; Castillo, JA; Cristina, J; Pascale, JM				Martinez, Alexander A.; Zaldivar, Yamitzel; Arteaga, Griselda; de Castillo, Zoila; Ortiz, Alma; Mendoza, Yaxelis; Castillero, Omar; Castillo, Juan A.; Cristina, Juan; Pascale, Juan M.			Phylogenetic Analysis of Hepatitis B Virus Genotypes Circulating in Different Risk Groups of Panama, Evidence of the Introduction of Genotype A2 in the Country	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCES; INFECTION; MUTATIONS; TIME	The Hepatitis B Virus (HBV) can cause acute or chronic infection it is also associated with the development of liver cancer, thousands of new infections occur on a yearly basis, and many of these cases are located in certain areas of the Caribbean and Latin America. In these areas, the HBV prevalence is still high which makes this virus a serious public health concern to the entire region. Studies performed in Panama suggest a complex pattern in the distribution of HBV among the country's different risk groups. We use phylogenetic analysis in order to determine which HBV genotypes were circulating in these specific groups; for this we used a fragment of the PreS2/2 region of the HBV genome. Subsequently whole HBV genome sequences were used for Bayesian analysis of phylodynamics and phylogeography. Two main genotypes were found: genotype A (54.5%) and genotype F (45.5%). There was a difference in the distribution of genotypes according to risk groups: 72.9% of high risk groups were associated to genotype A, and 55.0% of samples of genotype F were associated to the low risk group (p<0.002). The Bayesian analysis of phylogeny-traits association revealed a statistically significant geographical association (p<0.0001) with both genotypes and different regions of the country. The Bayesian time of most recent common ancestor analysis (tMRCA) revealed a recent tMRCA for genotype A2 circulating in Panama (1997, 95% HPD: 1986-2005), when it is compared with Panamanian genotype F1c sequences (1930, 95% HPD: 1810 - 2005). These results suggest a possible change in the distribution of HBV genotypes in Panama and Latin America as a whole. They also serve to encourage the implementation of vaccination programs in high-risk groups, in order to prevent an increase in the number of new HBV cases in Latin America and worldwide.	[Martinez, Alexander A.; Zaldivar, Yamitzel; Arteaga, Griselda; Ortiz, Alma; Mendoza, Yaxelis; Castillero, Omar; Castillo, Juan A.; Pascale, Juan M.] Gorgas Mem Inst Hlth Studies, Dept Genom & Prote, Panama City, Panama; [Martinez, Alexander A.; Mendoza, Yaxelis] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur City, Andhra Pradesh, India; [Martinez, Alexander A.; Mendoza, Yaxelis] INDICASAT AIP, City of Knowledge, Panama; [de Castillo, Zoila] Complejo Hosp Dr Arnulfo Arias Madrid, Caja de Seguro Social, Nucle Acid Test Unit, Panama City, Panama; [Arteaga, Griselda; Pascale, Juan M.] Univ Panama, Sch Med, Dept Microbiol, Panama City, Panama; [Cristina, Juan] Univ Republica, Fac Ciencias, Ctr Invest Nucl, Lab Virol Mol, Montevideo, Uruguay	Instituto Conmemorativo Gorgas de Estudios de la Salud; Acharya Nagarjuna University; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); Universidad de Panama; Universidad de la Republica, Uruguay	Pascale, JM (corresponding author), Gorgas Mem Inst Hlth Studies, Dept Genom & Prote, Panama City, Panama.	jpascale@gorgas.gob.pa	Martínez, Alexander/HHC-2101-2022; Martinez Caballero, Alexander Augusto/F-9601-2012	Martinez Caballero, Alexander Augusto/0000-0002-7816-3040	Secretaria Nacional de Ciencia y Tecnologia (SENACYT) [FID09-050]	Secretaria Nacional de Ciencia y Tecnologia (SENACYT)	This study was supported by GRANT FID09-050, Secretaria Nacional de Ciencia y Tecnologia (SENACYT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mora MVA, 2011, INFECT GENET EVOL, V11, P103, DOI 10.1016/j.meegid.2010.10.003; Alvarado-Esquivel C, 2006, WORLD J GASTROENTERO, V12, P6540, DOI 10.3748/wjg.v12.i40.6540; Alvarado-Mora MV, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-244; Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642; ArauzRuiz P, 1997, J INFECT DIS, V176, P851, DOI 10.1086/516507; ArauzRuiz P, 1997, J MED VIROL, V51, P305, DOI 10.1002/(SICI)1096-9071(199704)51:4&lt;305::AID-JMV8&gt;3.0.CO;2-9; Bini EJ, 2010, HEPATOLOGY, V51, P759, DOI 10.1002/hep.23461; Bouckaert R, 2013, ANTIVIR THER, V18, P497, DOI 10.3851/IMP2656; Campos RH, 2006, J CLIN VIROL SUPPL 2, V34, pS8; Carobene M, 2014, J MED VIROL, V86, P64, DOI 10.1002/jmv.23805; Chow EPF, PLOS ONE, V9, DOI [10.1371/journal.pone.0089959, DOI 10.1371/J0URNAL.P0NE.0089959]; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fujisaki S, 2011, J CLIN MICROBIOL, V49, P1017, DOI 10.1128/JCM.02149-10; Ghany MG, 2015, CLIN GASTROENTEROL H, V13, P183, DOI 10.1016/j.cgh.2014.06.028; Grabarczyk P, 2010, J VIRAL HEPATITIS, V17, P444, DOI 10.1111/j.1365-2893.2009.01192.x; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; GUNTHER S, 1995, J VIROL, V69, P5437; Hakre S, J URBAN HEAL SPRINGE, V91, P793; Hakre S, 2013, SEX TRANSM INFECT, V89, P156, DOI 10.1136/sextrans-2012-050557; HOLMES EC, 1995, J INFECT DIS, V171, P45, DOI 10.1093/infdis/171.1.45; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Koibuchi T, 2001, J MED VIROL, V64, P435, DOI 10.1002/jmv.1069; Kojima Y, 2013, EPIDEMIOL INFECT, V141, P2410, DOI 10.1017/S0950268812003123; Kowdley KV, 2012, HEPATOLOGY, V56, P422, DOI 10.1002/hep.24804; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Kramvis A, 2013, ANTIVIR THER, V18, P513, DOI 10.3851/IMP2657; Kurbanov F, 2010, HEPATOL RES, V40, P14, DOI 10.1111/j.1872-034X.2009.00601.x; Lama JR, 2010, AM J TROP MED HYG, V83, P194, DOI 10.4269/ajtmh.2010.10-0003; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Liu SJ, 2009, JNCI-J NATL CANCER I, V101, P1066, DOI 10.1093/jnci/djp180; Garcia-Montalvo BM, 2011, ANN HEPATOL, V10, P133; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martinez AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103545; McCullough D., PATH BETWEEN THE SEA, P1870; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Paraskevis D, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-57; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Pollack H, 2006, MMWR-MORBID MORTAL W, V55, P505; Price H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049314; Ramachandran S, 2014, J VIROL, V88, P13971, DOI 10.1128/JVI.01594-14; Roman S, 2010, J MED VIROL, V82, P1527, DOI 10.1002/jmv.21846; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; Sakurai M, 2004, WORLD J GASTROENTERO, V10, P2218; Sanchez LV, 2007, INTERVIROLOGY, V50, P9, DOI 10.1159/000096307; Santos AO, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-315; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka Y, 2006, J HEPATOL, V45, P646, DOI 10.1016/j.jhep.2006.06.018; Torres C, 2011, MOL PHYLOGENET EVOL, V59, P114, DOI 10.1016/j.ympev.2011.01.010; van der Kuyl AC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-540; van Houdt R, 2012, J HEPATOL, V57, P529, DOI 10.1016/j.jhep.2012.04.030; Venegas M, 2011, J MED VIROL, V83, P1530, DOI 10.1002/jmv.22129	56	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134850	10.1371/journal.pone.0134850	http://dx.doi.org/10.1371/journal.pone.0134850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230260	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400176
J	Mullette-Gillman, OA; Leong, RLF; Kurnianingsih, YA				Mullette-Gillman, O'Dhaniel A.; Leong, Ruth L. F.; Kurnianingsih, Yoanna A.			Cognitive Fatigue Destabilizes Economic Decision Making Preferences and Strategies	PLOS ONE			English	Article							MENTAL FATIGUE; SLEEP-DEPRIVATION; WORKING-MEMORY; ATTENTION; RISK; SELF; UNCERTAINTY; PERFORMANCE; AVERSION; JUDGMENT	Objective It is common for individuals to engage in taxing cognitive activity for prolonged periods of time, resulting in cognitive fatigue that has the potential to produce significant effects in behaviour and decision making. We sought to examine whether cognitive fatigue modulates economic decision making. Methods We employed a between-subject manipulation design, inducing fatigue through 60 to 90 minutes of taxing cognitive engagement against a control group that watched relaxing videos for a matched period of time. Both before and after the manipulation, participants engaged in two economic decision making tasks (one for gains and one for losses). The analyses focused on two areas of economic decision making-preferences and choice strategies. Uncertainty preferences (risk and ambiguity) were quantified as premium values, defined as the degree and direction in which participants alter the valuation of the gamble in comparison to the certain option. The strategies that each participant engaged in were quantified through a choice strategy metric, which contrasts the degree to which choice behaviour relies upon available satisficing or maximizing information. We separately examined these metrics for alterations within both the gains and losses domains, through the two choice tasks. Results The fatigue manipulation resulted in significantly greater levels of reported subjective fatigue, with correspondingly higher levels of reported effort during the cognitively taxing activity. Cognitive fatigue did not alter uncertainty preferences (risk or ambiguity) or informational strategies, in either the gains or losses domains. Rather, cognitive fatigue resulted in greater test-retest variability across most of our economic measures. These results indicate that cognitive fatigue destabilizes economic decision making, resulting in inconsistent preferences and informational strategies that may significantly reduce decision quality.	[Mullette-Gillman, O'Dhaniel A.; Leong, Ruth L. F.; Kurnianingsih, Yoanna A.] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore; [Mullette-Gillman, O'Dhaniel A.; Leong, Ruth L. F.] Duke NUS Grad Med Sch, Neurosci & Behav Disorders Program, Ctr Cognit Neurosci, Singapore, Singapore; [Mullette-Gillman, O'Dhaniel A.] SINAPSE Inst Cognit Sci & Neurotechnol, Singapore, Singapore	National University of Singapore; National University of Singapore	Mullette-Gillman, OA (corresponding author), Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore.	odubik@gmail.com	Mullette-Gillman, O'Dhaniel/B-8707-2012; Kurnianingsih, Yoanna/GQZ-3248-2022; Leong, Ruth/AGW-5987-2022	Mullette-Gillman, O'Dhaniel/0000-0002-5585-2978; Kurnianingsih, Yoanna/0000-0002-3610-2522; 	National University of Singapore [R-581-000-123-133, R-581-000-133-112]	National University of Singapore(National University of Singapore)	This project was funded National University of Singapore grants R-581-000-123-133 and R-581-000-133-112.	Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bailey A, 2007, MULT SCLER J, V13, P73, DOI 10.1177/1352458506071162; Bartlett FC, 1943, PROC R SOC SER B-BIO, V131, P247, DOI 10.1098/rspb.1943.0006; Baumeister RF, 2002, J CONSUM RES, V28, P670, DOI 10.1086/338209; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Boksem MAS, 2006, BIOL PSYCHOL, V72, P123, DOI 10.1016/j.biopsycho.2005.08.007; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; BOWMAN EH, 1963, MANAGE SCI, V9, P310, DOI 10.1287/mnsc.9.2.310; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CAMERER C, 1992, J RISK UNCERTAINTY, V5, P325, DOI 10.1007/BF00122575; Carod-Artal F. J., 2013, BURNOUT SYNDROME INT, P15; Chee MWL, 2006, NEUROIMAGE, V31, P419, DOI 10.1016/j.neuroimage.2005.12.001; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Dobryakova E, 2013, J INT NEUROPSYCH SOC, V19, P849, DOI 10.1017/S1355617713000684; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; Fellows LK, 2007, CEREB CORTEX, V17, P2669, DOI 10.1093/cercor/bhl176; Habeck C, 2004, COGNITIVE BRAIN RES, V18, P306, DOI 10.1016/j.cogbrainres.2003.10.019; Henri-Bhargava A, 2012, NEUROPSYCHOLOGIA, V50, P1536, DOI 10.1016/j.neuropsychologia.2012.03.006; Hockey G. R. J., 2011, COGNITIVE FATIGUE MU, P167, DOI [10.1037/12343-008, DOI 10.1037/12343-008]; Hockey GRJ, 2000, COGNITION EMOTION, V14, P823, DOI 10.1080/02699930050156654; Hockey GRJ, 1997, BIOL PSYCHOL, V45, P73; HOGARTH RM, 1981, MANAGE SCI, V27, P93, DOI 10.1287/mnsc.27.1.93; Holding D, 1983, STRESS FATIGUE HUMAN; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Job V, 2013, P NATL ACAD SCI USA, V110, P14837, DOI 10.1073/pnas.1313475110; Karelaia N, 2008, PSYCHOL BULL, V134, P404, DOI 10.1037/0033-2909.134.3.404; Kleiner M, 2007, PERCEPTION, V36, P14; Knight Frank H, 1921, RISK UNCERTAINTY AND; Kurnianingsih YA, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00280; Levy DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053978; Lim J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009087; Linder JA, 2014, JAMA INTERN MED, V174, P2029, DOI 10.1001/jamainternmed.2014.5225; Lorist MM, 2000, PSYCHOPHYSIOLOGY, V37, P614, DOI 10.1111/1469-8986.3750614; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Massar SA, 2010, PSYCHOPHYSIOLOGY, V47, P1119, DOI 10.1111/j.1469-8986.2010.01028.x; Meijman T, 2000, ERGONOMICS AND SAFETY FOR GLOBAL BUSINESS QUALITY AND PRODUCTIVITY, P45; Pardini M, 2010, BEHAV NEUROSCI, V124, P329, DOI 10.1037/a0019585; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Sanders A.F., 1998, ELEMENTS HUMAN PERFO, DOI 10.4324/9780203774250; Shigihara Y., 2013, NEUROL PSYCHIAT BRAI, V19, P5, DOI [10.1016/j.npbr.2012.07.002, DOI 10.1016/J.NPBR.2012.07.002]; Stanton SJ, 2011, PSYCHOL SCI, V22, P447, DOI 10.1177/0956797611401752; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; van der Linden D, 2003, ACTA PSYCHOL, V113, P45, DOI 10.1016/S0001-6918(02)00150-6; van der Linden D, 2006, PSYCHOL RES-PSYCH FO, V70, P395, DOI 10.1007/s00426-005-0228-7; Xu XM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109950; Zijlstra F. R. H., 1993, EFFICIENCY WORK BEHA	49	18	18	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132022	10.1371/journal.pone.0132022	http://dx.doi.org/10.1371/journal.pone.0132022			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230404	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400013
J	Nishikawa, Y; Okuzaki, D; Fukushima, K; Mukai, S; Ohno, S; Ozaki, Y; Yabuta, N; Nojima, H				Nishikawa, Yukihiro; Okuzaki, Daisuke; Fukushima, Kohshiro; Mukai, Satomi; Ohno, Shouichi; Ozaki, Yuki; Yabuta, Norikazu; Nojima, Hiroshi			Withaferin A Induces Cell Death Selectively in Androgen-Independent Prostate Cancer Cells but Not in Normal Fibroblast Cells	PLOS ONE			English	Article							STEM-LIKE CELLS; DOWN-REGULATION; STEROIDAL LACTONE; INDUCED APOPTOSIS; GROWTH ARREST; C-FOS; AUTOPHAGY; ENRICHMENT; CULTURE; AGENT	Withaferin A (WA), a major bioactive component of the Indian herb Withania somnifera, induces cell death (apoptosis/necrosis) in multiple types of tumor cells, but the molecular mechanism underlying this cytotoxicity remains elusive. We report here that 2 mu M WA induced cell death selectively in androgen-insensitive PC-3 and DU-145 prostate adenocarcinoma cells, whereas its toxicity was less severe in androgen-sensitive LNCaP prostate adenocarcinoma cells and normal human fibroblasts (TIG-1 and KD). WA also killed PC-3 cells in spheroid-forming medium. DNA microarray analysis revealed that WA significantly increased mRNA levels of c-Fos and 11 heat-shock proteins (HSPs) in PC-3 and DU-145, but not in LNCaP and TIG-1. Western analysis revealed increased expression of c-Fos and reduced expression of the anti-apoptotic protein c-FLIP(L). Expression of HSPs such as HSPA6 and Hsp70 was conspicuously elevated; however, because siRNA-mediated depletion of HSF-1, an HSP-inducing transcription factor, reduced PC-3 cell viability, it is likely that these heat-shock genes were involved in protecting against cell death. Moreover, WA induced generation of reactive oxygen species (ROS) in PC-3 and DU-145, but not in normal fibroblasts. Immunocytochemistry and immuno-electron microscopy revealed that WA disrupted the vimentin cytoskeleton, possibly inducing the ROS generation, c-Fos expression and c-FLIP(L) suppression. These observations suggest that multiple events followed by disruption of the vimentin cytoskeleton play pivotal roles in WA-mediated cell death.	[Nishikawa, Yukihiro; Okuzaki, Daisuke; Fukushima, Kohshiro; Mukai, Satomi; Ohno, Shouichi; Ozaki, Yuki; Yabuta, Norikazu; Nojima, Hiroshi] Osaka Univ, Dept Mol Genet, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Okuzaki, Daisuke; Nojima, Hiroshi] Osaka Univ, DNA Chip Dev Ctr Infect Dis, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Nojima, H (corresponding author), Osaka Univ, Dept Mol Genet, Microbial Dis Res Inst, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	snj-0212@biken.osaka-u.ac.jp	Okuzaki, Daisuke/AAN-5641-2020	Okuzaki, Daisuke/0000-0002-4552-783X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [15101006, 20370081, 23370086, 21651085, 22570185]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research S (No. 15101006), Scientific Research B (No. 20370081 and 23370086) and Exploratory Research (No. 21651085) to H.N. and Scientific Research C (No. 22570185) to N.Y. from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http://www.mext.go.jp/english/).	Abdullah LN, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-3; [Anonymous], MOL CELL BIOL, V16, P211; Antony ML, 2014, J BIOL CHEM, V289, P1852, DOI 10.1074/jbc.M113.496844; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bargagna-Mohan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063881; Cereda V, 2014, EXPERT OPIN INV DRUG, V23, P469, DOI 10.1517/13543784.2014.885950; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031864; Choi MJ, 2011, TOXICOL IN VITRO, V25, P692, DOI 10.1016/j.tiv.2011.01.010; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Falsey RR, 2006, NAT CHEM BIOL, V2, P33, DOI 10.1038/nchembio755; Fan XL, 2012, UROL ONCOL-SEMIN ORI, V30, P314, DOI 10.1016/j.urolonc.2010.03.019; French LE, 1999, NAT MED, V5, P146, DOI 10.1038/5505; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Geary LA, 2014, MOL CANCER RES, V12, P607, DOI 10.1158/1541-7786.MCR-13-0469; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Hahm ER, 2013, CURR CANCER DRUG TAR, V13, P640, DOI 10.2174/15680096113139990039; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Khan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050547; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lazaro-Dieguez F, 2008, J CELL SCI, V121, P1415, DOI 10.1242/jcs.017665; Lee J., 2013, MOL CARCINOG; Liu BQ, 2013, AUTOPHAGY, V9, P905, DOI 10.4161/auto.24292; Luo Y, 2014, ONCOL REP, V31, P874, DOI 10.3892/or.2013.2905; Mayola E, 2011, APOPTOSIS, V16, P1014, DOI 10.1007/s10495-011-0625-x; Munagala R, 2011, CARCINOGENESIS, V32, P1697, DOI 10.1093/carcin/bgr192; Nagalingam A, 2014, CANCER RES, V74, P2617, DOI 10.1158/0008-5472.CAN-13-2081; Ouyang DY, 2013, AUTOPHAGY, V9, P20, DOI 10.4161/auto.22397; Ozorowski G, 2012, BIOL CHEM, V393, P1151, DOI 10.1515/hsz-2012-0184; Roy RV, 2013, J NAT PROD, V76, P1909, DOI 10.1021/np400441f; Sheng X, 2013, ONCOL LETT, V5, P787, DOI 10.3892/ol.2012.1090; Shi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051076; Silginer M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.543; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Wang L, 2013, INT J BIOL SCI, V9, P472, DOI 10.7150/ijbs.5855; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Yang ES, 2011, CHEM-BIOL INTERACT, V190, P9, DOI 10.1016/j.cbi.2011.01.015; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017; Zhang K, 2014, PROSTATE, V74, P381, DOI 10.1002/pros.22759; Zhang XP, 2007, CANCER RES, V67, P9425, DOI 10.1158/0008-5472.CAN-07-1310; Zhang X, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-84	43	38	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134137	10.1371/journal.pone.0134137	http://dx.doi.org/10.1371/journal.pone.0134137			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230090	Green Submitted, gold, Green Published			2022-12-27	WOS:000358838400076
J	Nuccitelli, R; Berridge, JC; Mallon, Z; Kreis, M; Athos, B; Nuccitelli, P				Nuccitelli, Richard; Berridge, Jon Casey; Mallon, Zachary; Kreis, Mark; Athos, Brian; Nuccitelli, Pamela			Nanoelectroablation of Murine Tumors Triggers a CD8-Dependent Inhibition of Secondary Tumor Growth	PLOS ONE			English	Article							PULSED ELECTRIC-FIELDS; IMMUNOGENIC CELL-DEATH; HEPATOCELLULAR-CARCINOMA; CALRETICULIN EXPOSURE; IMMUNE-RESPONSE; THERAPY; ABLATION; STIMULATION; CLEARANCE; MELANOMAS	We have used both a rat orthotopic hepatocellular carcinoma model and a mouse allograft tumor model to study liver tumor ablation with nanosecond pulsed electric fields (nsPEF). We confirm that nsPEF treatment triggers apoptosis in rat liver tumor cells as indicated by the appearance of cleaved caspase 3 and 9 within two hours after treatment. Furthermore we provide evidence that nsPEF treatment leads to the translocation of calreticulin (CRT) to the cell surface which is considered a damage-associated molecular pattern indicative of immunogenic cell death. We provide direct evidence that nanoelectroablation triggers a CD8-dependent inhibition of secondary tumor growth by comparing the growth rate of secondary orthotopic liver tumors in nsPEF-treated rats with that in nsPEF-treated rats depleted of CD8(+) cytotoxic T-cells. The growth of these secondary tumors was severely inhibited as compared to tumor growth in CD8-depleated rats, with their average size only 3% of the primary tumor size after the same one-week growth period. In contrast, when we depleted CD8(+) T-cells the second tumor grew more robustly, reaching 54% of the size of the first tumor. In addition, we demonstrate with immunohistochemistry that CD8(+) T-cells are highly enriched in the secondary tumors exhibiting slow growth. We also showed that vaccinating mice with nsPEF-treated isogenic tumor cells stimulates an immune response that inhibits the growth of secondary tumors in a CD8(+)-dependent manner. We conclude that nanoelectroablation triggers the production of CD8(+) cytotoxic T-cells resulting in the inhibition of secondary tumor growth.	[Nuccitelli, Richard; Berridge, Jon Casey; Mallon, Zachary; Kreis, Mark; Athos, Brian; Nuccitelli, Pamela] BioElectroMed Corp, Burlingame, CA 94010 USA		Nuccitelli, R (corresponding author), BioElectroMed Corp, Burlingame, CA 94010 USA.	rich@bioelectromed.com			NIH [R44CA150484]; BioElectroMed Corp; NATIONAL CANCER INSTITUTE [R44CA150484] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BioElectroMed Corp; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All work was sponsored by the NIH grant No:R44CA150484. BioElectroMed Corp provided support in the form of salaries for authors RM, JCB, ZM, MK, BA, and PN but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre FM, 2010, BIOELECTROCHEMISTRY, V79, P95, DOI 10.1016/j.bioelechem.2009.12.007; Calvet CY, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28131; Chen R, 2014, EUR J CANCER, V50, P2705, DOI 10.1016/j.ejca.2014.07.006; Chen X, 2012, TECHNOL CANCER RES T, V11, P83, DOI 10.7785/tcrt.2012.500237; Chen XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086421; Fitzmorris P, 2014, J CANC RES CLIN ONCO; GABRIEL B, 1994, EUR J BIOCHEM, V223, P25, DOI 10.1111/j.1432-1033.1994.tb18962.x; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Garg AD, 2012, CANCER IMMUNOL IMMUN, V61, P215, DOI 10.1007/s00262-011-1184-2; Golden EB, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28518; Krysko DV, 2006, APOPTOSIS, V11, P1709, DOI 10.1007/s10495-006-9527-8; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Kudo M, 2011, ONCOLOGY-BASEL, V81, P1, DOI 10.1159/000333252; Fernandez ML, 2012, BIOCHEM BIOPH RES CO, V423, P325, DOI 10.1016/j.bbrc.2012.05.122; Long G, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2113183; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Nuccitelli R, 2013, BIOCHEM BIOPH RES CO, V435, P580, DOI 10.1016/j.bbrc.2013.05.014; Nuccitelli R, 2013, INT J CANCER, V132, P1933, DOI 10.1002/ijc.27860; Nuccitelli R, 2012, PIGM CELL MELANOMA R, V25, P618, DOI 10.1111/j.1755-148X.2012.01027.x; Nuccitelli R, 2012, BIOCHEM BIOPH RES CO, V424, P446, DOI 10.1016/j.bbrc.2012.06.129; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Pakhomova ON, 2012, ARCH BIOCHEM BIOPHYS, V527, P55, DOI 10.1016/j.abb.2012.08.004; Panzarini E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105778; Scheffer SR, 2003, INT J CANCER, V103, P205, DOI 10.1002/ijc.10777; Schoenbach KH., 2010, ADV ELECTROPORATION, P19; Son RS, 2014, J MEMBR BIOL; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140; White JA, 2004, J BIOL CHEM, V279, P22964, DOI 10.1074/jbc.M311135200; Wu S, 2013, CANC LETT, V10; Yin SY, 2014, CANCER LETT, V346, P285, DOI 10.1016/j.canlet.2014.01.009; Yu Z, 2014, ONCOTARGET, V5, P6526, DOI 10.18632/oncotarget.2310	31	59	64	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134364	10.1371/journal.pone.0134364	http://dx.doi.org/10.1371/journal.pone.0134364			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26231031	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400108
J	Omondi, D; Masiga, DK; Ajamma, YU; Fielding, BC; Njoroge, L; Villinger, J				Omondi, David; Masiga, Daniel K.; Ajamma, Yvonne Ukamaka; Fielding, Burtram C.; Njoroge, Laban; Villinger, Jandouwe			Unraveling Host-Vector-Arbovirus Interactions by Two-Gene High Resolution Melting Mosquito Bloodmeal Analysis in a Kenyan Wildlife-Livestock Interface	PLOS ONE			English	Article							WEST NILE VIRUS; MALARIA VECTOR; CULEX-QUINQUEFASCIATUS; FEEDING-BEHAVIOR; MEAL SOURCES; IDENTIFICATION; TRANSMISSION; DIPTERA; FLAVIVIRUSES; ALPHAVIRUSES	The blood-feeding patterns of mosquitoes are directly linked to the spread of pathogens that they transmit. Efficient identification of arthropod vector bloodmeal hosts can identify the diversity of vertebrate species potentially involved in disease transmission cycles. While molecular bloodmeal analyses rely on sequencing of cytochrome b (cyt b) or cytochrome oxidase 1 gene PCR products, recently developed bloodmeal host identification based on high resolution melting (HRM) analyses of cyt b PCR products is more cost-effective. To resolve the diverse vertebrate hosts that mosquitoes may potentially feed on in sub-Saharan Africa, we utilized HRM profiles of both cyt b and 16S ribosomal RNA genes. Among 445 blood-fed Aedeomyia, Aedes, Anopheles, Culex, Mansonia, and Mimomyia mosquitoes from Kenya's Lake Victoria and Lake Baringo regions where many mosquito-transmitted pathogens are endemic, we identified 33 bloodmeal hosts including humans, eight domestic animal species, six peridomestic animal species and 18 wildlife species. This resolution of vertebrate host species was only possible by comparing profiles of both cyt b and 16S markers, as melting profiles of some pairs of species were similar for either marker but not both. We identified mixed bloodmeals in a Culex pipiens from Mbita that had fed on a goat and a human and in two Mansonia africana mosquitoes from Baringo that each had fed on a rodent (Arvicanthis niloticus) in addition to a human or baboon. We further detected Sindbis and Bunyamwera viruses in blood-fed mosquito homogenates by Vero cell culture and RTPCR in Culex, Aedeomyia, Anopheles and Mansonia mosquitoes from Baringo that had fed on humans and livestock. The observed mosquito feeding on both arbovirus amplifying hosts (including sheep and goats) and possible arbovirus reservoirs (birds, porcupine, baboons, rodents) informs arbovirus disease epidemiology and vector control strategies.	[Omondi, David; Masiga, Daniel K.; Ajamma, Yvonne Ukamaka; Villinger, Jandouwe] Int Ctr Insect Physiol & Ecol, Martin Luscher Emerging Infect Dis ML EID, Nairobi, Kenya; [Omondi, David; Fielding, Burtram C.] Univ Western Cape, Dept Med Biosci, Mol Biol & Virol Lab, ZA-7535 Bellville, South Africa; [Omondi, David] Egerton Univ, Biochem & Mol Biol Dept, Egerton 20115, Kenya; [Njoroge, Laban] Natl Museums Kenya, Dept Zool, Invertebrates Zool Sect, Nairobi, Kenya	International Centre of Insect Physiology & Ecology (ICIPE); University of the Western Cape; Egerton University	Villinger, J (corresponding author), Int Ctr Insect Physiol & Ecol, Martin Luscher Emerging Infect Dis ML EID, POB 30772-00100, Nairobi, Kenya.	jandouwe@icipe.org	Villinger, Jandouwe/ABH-2172-2020; Fielding, Burtram/S-3240-2019; Omondi, David/ABA-9172-2020	Villinger, Jandouwe/0000-0002-5097-6605; Fielding, Burtram/0000-0002-1873-3363; Ajamma, Yvonne/0000-0002-2523-4992; Omondi, David/0000-0002-8735-5255; Masiga, Daniel/0000-0001-7513-0887	Swedish International Development Cooperation Agency (SIDA) from Training Health Researchers into Vocational Excellence (THRiVE) in East Africa - Wellcome Trust [087540]	Swedish International Development Cooperation Agency (SIDA) from Training Health Researchers into Vocational Excellence (THRiVE) in East Africa - Wellcome Trust	This study was mainly funded by the Swedish International Development Cooperation Agency (SIDA) (awarded to JV, DKM, and DOO) supplemented by funds from Training Health Researchers into Vocational Excellence (THRiVE) in East Africa (grant number 087540) funded by Wellcome Trust (awarded to JV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092; BEIER JC, 1990, J AM MOSQUITO CONTR, V6, P207; Boakye DA, 1999, MED VET ENTOMOL, V13, P282, DOI 10.1046/j.1365-2915.1999.00193.x; Conlon JM, 2014, PHARMACEUTICALS, V7, P58, DOI 10.3390/ph7010058; Crabtree M, 2009, J MED ENTOMOL, V46, P961, DOI 10.1603/033.046.0431; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; Edwards FW, 1941, MOSQUITOES ETHIOPIAN; Eshoo MW, 2007, VIROLOGY, V368, P286, DOI 10.1016/j.virol.2007.06.016; Fornadel CM, 2011, VECTOR-BORNE ZOONOT, V11, P1173, DOI 10.1089/vbz.2010.0082; Fornadel CM, 2010, AM J TROP MED HYG, V83, P848, DOI 10.4269/ajtmh.2010.10-0242; Garcia-Rejon JE, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.3201; Gerrard SR, 2004, J VIROL, V78, P8922, DOI 10.1128/JVI.78.16.8922-8926.2004; Greenberg JA, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.7501; Greenberg JA, 2012, J VECTOR ECOL, V37, P83, DOI 10.1111/j.1948-7134.2012.00203.x; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022574; Kipanga PN, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-429; KONISHI E, 1989, J MED ENTOMOL, V26, P535, DOI 10.1093/jmedent/26.6.535; LaBeaud AD, 2011, EMERG INFECT DIS, V17, P233, DOI 10.3201/eid1702.091666; Lambert AJ, 2009, J CLIN MICROBIOL, V47, P2398, DOI 10.1128/JCM.00182-09; Lewis A., 1989, BIRD ATLAS KENYA; Lutomiah J, 2014, VECTOR-BORNE ZOONOT, V14, P656, DOI 10.1089/vbz.2013.1564; Lutomiah J, 2013, J VECTOR ECOL, V38, P134, DOI 10.1111/j.1948-7134.2013.12019.x; Lwande OW, 2013, VECTOR-BORNE ZOONOT, V13, P637, DOI 10.1089/vbz.2012.1190; Mala AO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-121; Mease LE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-371; Metzker ML, 2005, GENOME RES, V15, P1767, DOI 10.1101/gr.3770505; Minakawa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032725; Mukabana WR, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-9; Muturi CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017284; Mwangangi JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-13; Nichol ST, 2001, BUNYAVIRUSES, P24; O'Guinn ML, 2002, J MED ENTOMOL, V39, P806, DOI 10.1603/0022-2585-39.5.806; Ochieng C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-140; Odhiambo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105446; Okiro Emelda A, 2009, BMC Med, V7, P75, DOI 10.1186/1741-7015-7-75; Opiyo P, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-48; Pena VH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001530; Rappole JH, 2000, EMERG INFECT DIS, V6, P319, DOI 10.3201/eid0604.000401; Rappole JH, 2003, J APPL MICROBIOL, V94, p47S; Simpson JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007861; Tabue RN, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-262; Vazquez A, 2012, VECTOR-BORNE ZOONOT, V12, P223, DOI 10.1089/vbz.2011.0687; Williams CR, 2006, BIOL LETT-UK, V2, P242, DOI 10.1098/rsbl.2006.0448; Worrall E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-338; Yanase T, 2006, ARCH VIROL, V151, P2253, DOI 10.1007/s00705-006-0808-x; Zirkel F, 2011, MBIO, V2, DOI 10.1128/mBio.00077-11	48	32	33	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134375	10.1371/journal.pone.0134375	http://dx.doi.org/10.1371/journal.pone.0134375			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230507	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400113
J	Charpentier, C; Le, MP; Joly, V; Visseaux, B; Lariven, S; Phung, B; Yeni, P; Yazdanpanah, Y; Descamps, D; Peytavin, G; Landman, R				Charpentier, Charlotte; Le, Minh Patrick; Joly, Veronique; Visseaux, Benoit; Lariven, Sylvie; Phung, Bao; Yeni, Patrick; Yazdanpanah, Yazdan; Descamps, Diane; Peytavin, Gilles; Landman, Roland			Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up	PLOS ONE			English	Article							SINGLE-TABLET REGIMEN; DISOPROXIL FUMARATE; RILPIVIRINE; EMTRICITABINE; RPV/TDF/FTC; TENOFOVIR	Objective To assess, in a clinical cohort, the efficacy of switching treatment in virologically-suppressed patients to tenofovir/emtricitabine/rilpivirine as a single-tablet regimen (STR) using the PCR signal of the viral load (VL) assay and plasma drug determination (C24h). Patients and methods An observational single-centre study enrolling patients with VL<50 copies/mL initiating rilpivirine-based STR. C24h and VL were performed until W48 and W96 of STR, respectively. PCRneg was defined as an undetected PCR signal. Medians (IQR) were presented. Results 116 patients were enrolled. At STR baseline, time since first antiretroviral therapy and time of virological suppression were 6 years (2-9) and 17 months (7-43), respectively. Before STR initiation, patients were receiving protease inhibitors and non-nucleoside reverse transcriptase inhibitors-based regimen in 44% and 47% of cases, respectively. Historical genotype showed virus resistant to one drug of the STR in 6 patients (5%). At W96, 17 (15%) discontinued STR due to adverse events. The proportion of patients maintaining VL < 50 copies/mL on treatment was 98%, 99%, 100%, 100%, 100% and 100% at W12, W24, W36, W48, W72 and W96, respectively. Among them, 70%, 66%, 68%, 59%, 74%, 68% and 60% were PCRneg at baseline, W12, W24, W36, W48, W72 and W96, respectively. Median rilpivirine C24h was 91 ng/mL (57-141, n = 285), with 91% of rilpivirine C24h > 50 ng/mL, the target effective concentration. Conclusions In this clinical cohort of virologically-suppressed patients switching to a new STR, most subjects had adequate rilpivirine C24h and displayed a high level of virological suppression with no residual viremia until W96.	[Charpentier, Charlotte; Joly, Veronique; Visseaux, Benoit; Yeni, Patrick; Yazdanpanah, Yazdan; Descamps, Diane; Peytavin, Gilles; Landman, Roland] Univ Paris Diderot, Sorbonne Paris Cite, IAME, UMR 1137, F-75018 Paris, France; [Charpentier, Charlotte; Joly, Veronique; Visseaux, Benoit; Yeni, Patrick; Yazdanpanah, Yazdan; Descamps, Diane; Peytavin, Gilles; Landman, Roland] INSERM, IAME, UMR 1137, F-75018 Paris, France; [Charpentier, Charlotte; Visseaux, Benoit; Descamps, Diane] Hop Bichat Claude Bernard, AP HP, Lab Virol, F-75018 Paris, France; [Le, Minh Patrick; Peytavin, Gilles] Hop Bichat Claude Bernard, AP HP, Lab Pharmacol, F-75018 Paris, France; [Joly, Veronique; Lariven, Sylvie; Phung, Bao; Yeni, Patrick; Yazdanpanah, Yazdan; Landman, Roland] Hop Bichat Claude Bernard, AP HP, Serv Malad Infect & Tropicales, F-75018 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Charpentier, C (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, IAME, UMR 1137, F-75018 Paris, France.	charlotte.charpentier@aphp.fr	LE, Minh P/K-3072-2019		French National Agency for Research on AIDS and Viral Hepatitis (ANRS)	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR))	The research leading to these results has received funding from the French National Agency for Research on AIDS and Viral Hepatitis (ANRS).	Allavena C, 2014, J ANTIMICROB CHEMOTH, V69, P2804, DOI 10.1093/jac/dku187; Amiel C, 2014, J ANTIMICROB CHEMOTH, V69, P3335, DOI 10.1093/jac/dku294; Brochot A, 2011, 13 EUR AIDS CLIN SOC; Gantner P, 2015, HIV MED, V16, P132, DOI 10.1111/hiv.12183; Jung BH, 2007, BIOMED CHROMATOGR, V21, P1095, DOI 10.1002/bmc.865; Nguyen LBL, 2014, AIDS, V28, P1995, DOI 10.1097/QAD.0000000000000387; Mills AM, 2013, HIV CLIN TRIALS, V14, P216, DOI 10.1310/hct1405-216; Palella FJ, 2014, AIDS, V28, P335, DOI 10.1097/QAD.0000000000000087; Reigadas S, 2014, ANTIVIR THER, V19, pA122	9	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134430	10.1371/journal.pone.0134430	http://dx.doi.org/10.1371/journal.pone.0134430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226257	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700094
J	He, YY; Liu, Z; Shi, JM; Wang, YS; Zhang, JM; Liu, JY				He, Yunyue; Liu, Zhong; Shi, Jianmai; Wang, Yishan; Zhang, Jiaming; Liu, Jinyuan			K-Shortest-Path-Based Evacuation Routing with Police Resource Allocation in City Transportation Networks	PLOS ONE			English	Article							OR/MS RESEARCH; ALGORITHM; DESIGN; URBAN; MODEL	Emergency evacuation aims to transport people from dangerous places to safe shelters as quickly as possible. Police play an important role in the evacuation process, as they can handle traffic accidents immediately and help people move smoothly on roads. This paper investigates an evacuation routing problem that involves police resource allocation. We propose a novel k-th-shortest-path-based technique that uses explicit congestion control to optimize evacuation routing and police resource allocation. A nonlinear mixed-integer programming model is presented to formulate the problem. The model's objective is to minimize the overall evacuation clearance time. Two algorithms are given to solve the problem. The first one linearizes the original model and solves the linearized problem with CPLEX. The second one is a heuristic algorithm that uses a police resource utilization efficiency index to directly solve the original model. This police resource utilization efficiency index significantly aids in the evaluation of road links from an evacuation throughput perspective. The proposed algorithms are tested with a number of examples based on real data from cities of different sizes. The computational results show that the police resource utilization efficiency index is very helpful in finding near-optimal solutions. Additionally, comparing the performance of the heuristic algorithm and the linearization method by using randomly generated examples indicates that the efficiency of the heuristic algorithm is superior.	[He, Yunyue; Liu, Zhong; Shi, Jianmai; Zhang, Jiaming] Natl Univ Def Technol, Sci & Technol Informat Syst Engn Lab, Changsha, Hunan, Peoples R China; [Wang, Yishan] Beijing Special Engn Design & Res Inst, Beijing, Peoples R China; [Liu, Jinyuan] Natl Univ Def Technol, Dept Management, Changsha, Hunan, Peoples R China	National University of Defense Technology - China; National University of Defense Technology - China	He, YY (corresponding author), Natl Univ Def Technol, Sci & Technol Informat Syst Engn Lab, Changsha, Hunan, Peoples R China.	heyunyue09@163.com	Zhang, Jiaming/GSD-8224-2022; Wang, Yixuan/GZK-6559-2022; wang, yi/GVT-8516-2022; wang, yixuan/GXW-2866-2022; Wang, Yijun/GXW-1763-2022		National Natural Science Foundation of China [71201169, 71471174]; Research Project of Hunan [YB2013B011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Project of Hunan	This work was supported by National Natural Science Foundation of China project with no. 71201169, and Research Project of Hunan with no. YB2013B011. We received fund from National Natural Science Foundation of China project with no. 71471174. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aty MA, 2000, ACCIDENT ANAL PREV, V32, P633, DOI 10.1016/S0001-4575(99)00094-9; Aljazzar H, 2011, ARTIF INTELL, V175, P2129, DOI 10.1016/j.artint.2011.07.003; Altay N, 2006, EUR J OPER RES, V175, P475, DOI 10.1016/j.ejor.2005.05.016; Parejo JA, 2012, SOFT COMPUT, V16, P527, DOI 10.1007/s00500-011-0754-8; Brinkhoff T, 2002, GEOINFORMATICA, V6, P153, DOI 10.1023/A:1015231126594; Campos VBG DSP, 1999, P 5 INT C URB TRANSP, P555; CHALMET LG, 1982, MANAGE SCI, V28, P86, DOI 10.1287/mnsc.28.1.86; Cova TJ, 2003, TRANSPORT RES A-POL, V37, P579, DOI 10.1016/S0965-8564(03)00007-7; Cova TJ, 2002, ENVIRON PLANN A, V34, P2211, DOI 10.1068/a34251; Daganzo CF, 2011, TRANSPORT RES B-METH, V45, P1424, DOI 10.1016/j.trb.2011.05.015; Dantzig G. B., 1963, LINEAR PROGRAMMING E; dos Santos DS, 2012, APPL SOFT COMPUT, V12, P2123, DOI 10.1016/j.asoc.2012.03.016; Dotson L.J., 2005, IDENTIFICATION ANAL; Eppstein D., 1997, FINDING K SHORTEST P; Galindo G, 2013, EUR J OPER RES, V230, P201, DOI 10.1016/j.ejor.2013.01.039; GIULIANO G, 1989, TRANSPORT RES A-POL, V23, P387, DOI 10.1016/0191-2607(89)90086-1; Goerlandt F, 2011, RELIAB ENG SYST SAFE, V96, P91, DOI 10.1016/j.ress.2010.09.003; Government H., 2014, EV SHELT GUID; Han Chuan-feng, 2009, Proceedings of the 2009 Fifth International Conference on Natural Computation (ICNC 2009), P259, DOI 10.1109/ICNC.2009.333; Helbing D, 2005, TRANSPORT SCI, V39, P1, DOI 10.1287/trsc.1040.0108; Hobeika AG, 1998, IEEE T ENG MANAGE, V45, P192, DOI 10.1109/17.669768; IFRC, 2010, WORLD DIS REP 2010; Jennings C., 1994, EVACUATION FIRES, V4, P289; Kerbache L, 2000, EUR J OPER RES, V121, P105, DOI 10.1016/S0377-2217(99)00018-1; Kim SH, 2008, IEEE T KNOWL DATA EN, V20, P1115, DOI 10.1109/TKDE.2007.190722; Lindell MK, 2008, TRANSPORT RES A-POL, V42, P140, DOI 10.1016/j.tra.2007.06.014; Lindell MK, 2007, J URBAN PLAN DEV, V133, P18, DOI 10.1061/(ASCE)0733-9488(2007)133:1(18); McPhail C, 1991, ISSUES NURSING HOME, V9, P247; Mert A, 2010, 24 MIN EURO C CONT O, P23; Molina D, 2011, SOFT COMPUT, V15, P2201, DOI 10.1007/s00500-010-0647-2; Nurre SG, 2012, EUR J OPER RES, V223, P794, DOI 10.1016/j.ejor.2012.07.010; Petty KF, 1996, TRANSPORT RES C-EMER, V4, P71, DOI 10.1016/0968-090X(96)00001-0; Poch M, 1996, J TRANSP ENG-ASCE, V122, P105, DOI 10.1061/(ASCE)0733-947X(1996)122:2(105); Police MSU, 2014, EV EM; Program PE, 2009, EV OP GUID; SHERALI HD, 1991, TRANSPORT RES B-METH, V25, P439, DOI 10.1016/0191-2615(91)90037-J; Stepanov A, 2009, EUR J OPER RES, V198, P435, DOI 10.1016/j.ejor.2008.08.025; TWEEDIE SW, 1986, SOC SCI J, V23, P189, DOI 10.1016/0362-3319(86)90035-2; Yamada T, 1996, INT J SYST SCI, V27, P931, DOI 10.1080/00207729608929296; Yan S, 2009, COMPUT OPER RES, V36, P2049, DOI 10.1016/j.cor.2008.07.002; YEN JY, 1971, MANAGE SCI, V17, P712, DOI 10.1287/mnsc.17.11.712	42	8	8	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0131962	10.1371/journal.pone.0131962	http://dx.doi.org/10.1371/journal.pone.0131962			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226109	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700003
J	Inshaw, J; Leen, C; Fisher, M; Gilson, R; Hawkins, D; Collins, S; Fox, J; McLean, K; Fidler, S; Phillips, A; Lattimore, S; Babiker, A; Porter, K				Inshaw, Jamie; Leen, Clifford; Fisher, Martin; Gilson, Richard; Hawkins, David; Collins, Simon; Fox, Julie; McLean, Ken; Fidler, Sarah; Phillips, Andrew; Lattimore, Sam; Babiker, Abdel; Porter, Kholoud		UK HIV Seroconverters Cohort	The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; COINFECTION; EPIDEMIOLOGY; INDIVIDUALS; PREVALENCE; ACCELERATE; OUTCOMES; ENGLAND	Introduction The effect of HCV infection on HIV disease progression remains unclear; the effect of HCV infection duration on HIV disease progression is unknown. Methods We used data from a cohort of HIV seroconverters to investigate the effect of HCV infection duration on time from HIV seroconversion to CD4 <350cells/mm(3), AIDS or death, censoring at the earlier of cART initiation or last clinic visit, adjusting for confounders and splitting data into follow up periods from HIV seroconversion (<2, 2-4 and >4 years). We additionally compared CD4 cell decline following HCV infection to that of mono-infected individuals with similar HIV infection duration by fitting a random effects model. In a separate analysis, we used linear mixed models to we examine the effect of HCV infection and its duration on CD4 increase over 48 weeks following cART. Results Of 1655 individuals, 97 (5.9%) were HCV co-infected. HCV<1 year was associated with a higher risk of endpoint in each follow-up period from HIV seroconversion (HR [95% CI] 2.58 [1.51, 4.41], p = 0.001; 3.80 [1.20, 12.03], p = 0.023; 2.03 [0.88, 4.71], p = 0.098 for <2, 2-4 and >4 years respectively), compared to mono-infected individuals. However, we found no evidence of an association for those with HCV>2 years (all p>0.89). Individuals experienced a somewhat greater decrease in CD4 count following HCV infection lasting 13 months, relative to individuals with HIV alone, (estimate = -3.33, 95% CI [-7.29, 0.63] cells/mm(3) per month, p = 0.099). Of 1502 initiating cART, 106 (7.1%) were HCV co-infected, with no evidence of HCV duration at cART being associated with immunological response (p = 0.45). Conclusions The impact of HCV co-infection on HIV disease progression appears to be restricted to the first year after HCV infection.	[Inshaw, Jamie; Babiker, Abdel; Porter, Kholoud] UCL, MRC, Clin Trials Unit, London, England; [Leen, Clifford] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; [Fisher, Martin] Brighton & Sussex Univ NHS Trust, Brighton, E Sussex, England; [Gilson, Richard; Phillips, Andrew] UCL, Dept Infect & Populat Hlth, London, England; [Hawkins, David] Chelsea & Westminster Hosp, London, England; [Collins, Simon] HIV I Base, London, England; [Fox, Julie] Kings Coll London, Guys & St Thomas NHS Trust, London WC2R 2LS, England; [McLean, Ken] Charing Cross Hosp, London, England; [Fidler, Sarah] Imperial Coll NHS Trust, London, England; [Lattimore, Sam] Publ Hlth England, London, England	Medical Research Council Clinical Trials Unit; University of London; University College London; University of Edinburgh; University of London; University College London; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Imperial College London; Public Health England	Inshaw, J (corresponding author), UCL, MRC, Clin Trials Unit, London, England.	j.inshaw@ucl.ac.uk	Collins, Simon/AAB-5123-2022; Phillips, Andrew N/B-4427-2008	Phillips, Andrew N/0000-0003-2384-4807; Fidler, Sarah/0000-0003-1676-7583; fox, Julie/0000-0002-0583-8019; Inshaw, Jamie/0000-0002-7003-8966; delpech, valerie/0000-0002-9952-8109; Collins, Simon/0000-0002-3537-2432; Porter, Kholoud/0000-0002-9226-6206; Leen, Clifford/0000-0001-8439-7719	UK Medical Research Council; Medical Research Council [MC_UU_12023/15, MR/L00528X/1, MC_UU_12023/23, MC_U122886352, MC_UU_12023/16] Funding Source: researchfish; MRC [MC_UU_12023/15, MC_UU_12023/16, MC_U122886352, MR/L00528X/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; [Anonymous], 2003, BRIT HIV ASS BHIVA G; BERAL V, 1996, EPIDEMIOL INFECT, V117, P305; Brant LJ, 2007, EPIDEMIOL INFECT, V135, P417, DOI 10.1017/S0950268806006832; Chen TY, 2009, CLIN INFECT DIS, V49, P1605, DOI 10.1086/644771; DORRUCCI M, 1995, J INFECT DIS, V172, P1503, DOI 10.1093/infdis/172.6.1503; FEENEY C, 1995, CRIT CARE MED, V23, P1680, DOI 10.1097/00003246-199510000-00012; GORHAM ED, 1993, ARCH INTERN MED, V153, P869, DOI 10.1001/archinte.153.7.869; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Harris RJ, 2014, J HEPATOL, V61, P530, DOI 10.1016/j.jhep.2014.05.008; Haydon GH, 1998, EUR J GASTROEN HEPAT, V10, P485, DOI 10.1097/00042737-199806000-00009; Hung CC, 2005, INT J STD AIDS, V16, P42, DOI 10.1258/0956462052932629; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Klein MB, 2003, JAIDS-J ACQ IMM DEF, V33, P365, DOI 10.1097/00126334-200307010-00011; Laskus T, 2000, J INFECT DIS, V181, P442, DOI 10.1086/315283; Miller MF, 2005, CLIN INFECT DIS, V41, P713, DOI 10.1086/432618; Mocroft A, 2006, SCAND J INFECT DIS, V38, P1092, DOI 10.1080/00365540600786515; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Piroth L, 1998, AIDS, V12, P381, DOI 10.1097/00002030-199804000-00006; Raunch A, 2005, J ACQ IMMUN DEF SYND, V38, P238; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Slavenburg S, 2009, ANTIVIR THER, V14, P1139, DOI 10.3851/IMP1464; Stebbing J, 2005, CLIN INFECT DIS, V41, P906, DOI 10.1086/432885; Sulkowski M, 2002, J AM MED ASS, V288; Sulkowski MS, 2000, CLIN INFECT DIS, V30, pS77, DOI 10.1086/313842; Sullivan PS, 2006, AIDS, V20, P1171, DOI 10.1097/01.aids.0000226958.87471.48; Turner J, 2010, J VIRAL HEPATITIS, V17, P569, DOI 10.1111/j.1365-2893.2009.01215.x; van de Laar T., 2009, GASTROENTEROLOGY, V136, P1609, DOI DOI 10.1053/J.GASTR0.2009.02.006; van der Helm J, 2013, GASTROENTEROLOGY, V144, P751, DOI 10.1053/j.gastro.2012.12.026; van der Helm JJ, 2011, AIDS, V25, P1083, DOI 10.1097/QAD.0b013e3283471cce; VENTO S, 1993, LANCET, V341, P958, DOI 10.1016/0140-6736(93)91248-K	31	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0132772	10.1371/journal.pone.0132772	http://dx.doi.org/10.1371/journal.pone.0132772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225723	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700010
J	Jiang, WX; Wei, WJ; Gaertig, MA; Li, SH; Li, XJ				Jiang, Wenxiao; Wei, Wenjie; Gaertig, Marta A.; Li, Shihua; Li, Xiao-Jiang			Therapeutic Effect of Berberine on Huntington's Disease Transgenic Mouse Model	PLOS ONE			English	Article							RAT MODEL; COPTIDIS-RHIZOMA; CELL-DEATH; PROTEIN; PATHOGENESIS; EXPRESSION; CANCER; NEUROPROTECTION; ACCUMULATION; IMPAIRMENT	Huntington disease (HD) represents a family of neurodegenerative diseases that are caused by misfolded proteins. The misfolded proteins accumulate in the affected brain regions in an age-dependent manner to cause late-onset neurodegeneration. Transgenic mouse models expressing the HD protein, huntingtin, have been widely used to identify therapeutics that may retard disease progression. Here we report that Berberine (BBR), an organic small molecule isolated from plants, has protective effects on transgenic HD (N171-82Q) mice. We found that BBR can reduce the accumulation of mutant huntingtin in cultured cells. More importantly, when given orally, BBR could effectively alleviate motor dysfunction and prolong the survival of transgenic N171-82Q HD mice. We found that BBR could promote the degradation of mutant huntingtin by enhancing autophagic function. Since BBR is an orally-taken drug that has been safely used to treat a number of diseases, our findings suggest that BBR can be tested on different HD animal models and HD patients to further evaluate its therapeutic effects.	[Jiang, Wenxiao; Wei, Wenjie; Gaertig, Marta A.; Li, Shihua; Li, Xiao-Jiang] Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA 30322 USA; [Wei, Wenjie] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Neurol, Tongji Med Coll, Wuhan 430032, Peoples R China; [Jiang, Wenxiao] Emory Univ, Grad Program Microbiol & Mol Genet, Atlanta, GA 30322 USA	Emory University; Huazhong University of Science & Technology; Emory University	Li, XJ (corresponding author), Emory Univ, Dept Human Genet, Sch Med, 615 Michael St, Atlanta, GA 30322 USA.	xli2@emory.edu			National Institutes of Health [NS036232, NS041669, AG019206]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041669, R01NS036232, R01NS045016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031153, R01AG019206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health (NS036232, NS041669 and AG019206).	Asai M, 2007, BIOCHEM BIOPH RES CO, V352, P498, DOI 10.1016/j.bbrc.2006.11.043; Chen JH, 2012, INT IMMUNOPHARMACOL, V12, P94, DOI 10.1016/j.intimp.2011.10.019; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Dong H, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/591654; Dragunow M, 2004, FRONT BIOSCI, V9, P100, DOI 10.2741/1197; Dudek NL, 2010, BRAIN PATHOL, V20, P176, DOI 10.1111/j.1750-3639.2008.00258.x; Durairajan SSK, 2012, NEUROBIOL AGING, V33, P2903, DOI 10.1016/j.neurobiolaging.2012.02.016; Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hayashi K, 2007, BIOORG MED CHEM LETT, V17, P1562, DOI 10.1016/j.bmcl.2006.12.085; Ho DJ, 2010, EXP NEUROL, V225, P74, DOI 10.1016/j.expneurol.2010.05.006; Iizuka N, 2000, CANCER LETT, V148, P19, DOI 10.1016/S0304-3835(99)00264-5; Ji HF, 2011, MOLECULES, V16, P6732, DOI 10.3390/molecules16086732; Jiang Q, 2011, MOL CELL ENDOCRINOL, V331, P34, DOI 10.1016/j.mce.2010.07.023; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Kim M, 2014, INT NEUROUROL J, V18, P115, DOI 10.5213/inj.2014.18.3.115; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; KURTH JH, 1993, ANN NEUROL, V33, P368, DOI 10.1002/ana.410330406; Kwon IH, 2010, NEUROSCI LETT, V486, P29, DOI 10.1016/j.neulet.2010.09.038; Lan JR, 2015, J ETHNOPHARMACOL, V161, P69, DOI 10.1016/j.jep.2014.09.049; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Li X, 2010, HUM MOL GENET, V19, P2445, DOI 10.1093/hmg/ddq127; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Lu SS, 2009, J ENDOCRINOL, V200, P159, DOI 10.1677/JOE-08-0419; Margolis RL, 2014, J HUNTINGTONS DIS, V3, P137, DOI 10.3233/JHD-140107; Munoz-Sanjuan I, 2011, J CLIN INVEST, V121, P476, DOI 10.1172/JCI45364; Panahi N, 2013, ARCH MED SCI, V9, P146, DOI 10.5114/aoms.2013.33354; Peng PL, 2008, INT J RADIAT ONCOL, V70, P529, DOI 10.1016/j.ijrobp.2007.08.034; Perry T, 2007, EXP NEUROL, V203, P293, DOI 10.1016/j.expneurol.2006.09.028; Poon LH, 2010, ANN PHARMACOTHER, V44, P1080, DOI 10.1345/aph.1M582; Qiu ZH, 2006, J BIOL CHEM, V281, P16672, DOI 10.1074/jbc.M511648200; Quintanilla RA, 2008, J BIOL CHEM, V283, P25628, DOI 10.1074/jbc.M804291200; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Shin KS, 2013, ARCH PHARM RES, V36, P759, DOI 10.1007/s12272-013-0051-4; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Squitieri F, 2006, MECH AGEING DEV, V127, P208, DOI 10.1016/j.mad.2005.09.012; Takase Hideki, 1993, Folia Pharmacologica Japonica, V102, P101; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; Wang CE, 2008, J CELL BIOL, V181, P803, DOI 10.1083/jcb.200710158; Wang N, 2010, J CELL BIOCHEM, V111, P1426, DOI 10.1002/jcb.22869; Wang XL, 2005, AM J CHINESE MED, V33, P935, DOI 10.1142/S0192415X05003557; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Yang L, 2002, NEUROSCI RES, V42, P261, DOI 10.1016/S0168-0102(02)00005-6; Yu YL, 2010, BIOCHEM PHARMACOL, V79, P1000, DOI 10.1016/j.bcp.2009.11.017; Zhang H, 2010, METABOLISM, V59, P285, DOI 10.1016/j.metabol.2009.07.029; Zhang XL, 2012, BRAIN RES, V1459, P61, DOI 10.1016/j.brainres.2012.03.065; Zhu FQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-78	51	102	105	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134142	10.1371/journal.pone.0134142	http://dx.doi.org/10.1371/journal.pone.0134142			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225560	gold, Green Published, Green Submitted			2022-12-27	WOS:000358837700059
J	Nicholls, SG; Hayes, TP; Brehaut, JC; McDonald, M; Weijer, C; Saginur, R; Fergusson, D				Nicholls, Stuart G.; Hayes, Tavis P.; Brehaut, Jamie C.; McDonald, Michael; Weijer, Charles; Saginur, Raphael; Fergusson, Dean			A Scoping Review of Empirical Research Relating to Quality and Effectiveness of Research Ethics Review	PLOS ONE			English	Review							LOCAL RESEARCH; COMMITTEE MEMBERS; HOSPITAL ETHICS; BOARDS; IRBS; PARTICIPATION; COMMUNICATION; PERFORMANCE; OVERSIGHT; PROTOCOLS	Background To date there is no established consensus of assessment criteria for evaluating research ethics review. Methods We conducted a scoping review of empirical research assessing ethics review processes in order to identify common elements assessed, research foci, and research gaps to aid in the development of assessment criteria. Electronic searches of Ovid Medline, PsychInfo, and the Cochrane DSR, ACP Journal Club, DARE, CCTR, CMR, HTA, and NHSEED, were conducted. After de-duplication, 4234 titles and abstracts were reviewed. Altogether 4036 articles were excluded following screening of titles, abstracts and full text. A total of 198 articles included for final data extraction. Results Few studies originated from outside North America and Europe. No study reported using an underlying theory or framework of quality/effectiveness to guide study design or analyses. We did not identify any studies that had involved a controlled trial - randomised or otherwise of ethics review procedures or processes. Studies varied substantially with respect to outcomes assessed, although tended to focus on structure and timeliness of ethics review. Discussion Our findings indicate a lack of consensus on appropriate assessment criteria, exemplified by the varied study outcomes identified, but also a fragmented body of research. To date research has been largely quantitative, with little attention given to stakeholder experiences, and is largely cross sectional. A lack of longitudinal research to date precludes analyses of change or assessment of quality improvement in ethics review.	[Nicholls, Stuart G.; Brehaut, Jamie C.; Fergusson, Dean] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Hayes, Tavis P.; Brehaut, Jamie C.; Saginur, Raphael; Fergusson, Dean] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [McDonald, Michael] Univ British Columbia, W Maurice Young Ctr Appl Eth, Vancouver, BC V5Z 1M9, Canada; [Weijer, Charles] Univ Western Ontario, Rotman Inst Philosophy, London, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of British Columbia; Western University (University of Western Ontario)	Nicholls, SG (corresponding author), Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada.	snicholl@uottawa.ca	Weijer, Charles/ABC-5433-2020; Nicholls, Stuart G./I-9160-2019	Weijer, Charles/0000-0002-5510-1074; Nicholls, Stuart G./0000-0003-0485-9069; Fergusson, Dean/0000-0002-3389-2485	Canadian Institutes of Health Research Planning Grant [MPE-126678]	Canadian Institutes of Health Research Planning Grant	This study was funded by a Canadian Institutes of Health Research Planning Grant #MPE-126678. No funders were involved in the design or conduct of the review.	Abbott L, 2011, J EMPIR RES HUM RES, V6, P3, DOI 10.1525/jer.2011.6.1.3; Allen HJ, 1998, GENET TEST, V2, P329, DOI 10.1089/gte.1998.2.329; ALLEN P, 1983, J MED ETHICS, V9, P61, DOI 10.1136/jme.9.2.61; ALLEN PA, 1982, LANCET, V1, P1233; Anderson JA, 2011, HLTH LAW REV, V19, P12; Angell E, 2006, J MED ETHICS, V32, P662, DOI 10.1136/jme.2005.014159; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Association for the Accreditation of Human Research Protection Programs, 2009, AAHRPP ACCR STAND; Ateudjieu J, 2010, DEV WORLD BIOETH, V10, P88, DOI 10.1111/j.1471-8847.2009.00266.x; Banos JE, 2010, CROAT MED J, V51, P552, DOI 10.3325/cmj.2010.51.552; Beagan Brenda, 2005, Health Law Rev, V13, P62; Berry J, 1997, J MED ETHICS, V23, P379, DOI 10.1136/jme.23.6.379; Borovecki A, 2005, BMJ-BRIT MED J, V331, P227, DOI 10.1136/bmj.331.7510.227; Brahme Radhika, 2009, Indian J Med Ethics, V6, P78; Bruni RA, 2008, CAN MED ASSOC J, V179, P15, DOI 10.1503/cmaj.071656; Byrne MM, 2006, ACAD MED, V81, P708, DOI 10.1097/00001888-200608000-00006; Carline JD, 2007, ACAD MED, V82, pS57, DOI 10.1097/ACM.0b013e31813e66d4; Chaudhry SH, 2013, CLIN TRIALS, V10, P257, DOI 10.1177/1740774513475530; Dal-Re R, 1999, J MED ETHICS, V25, P268, DOI 10.1136/jme.25.3.268; Davies H, 2009, J MED ETHICS, V35, P382, DOI 10.1136/jme.2008.027722; de Jong JP, 2010, J CLIN EPIDEMIOL, V63, P1342, DOI 10.1016/j.jclinepi.2010.01.018; De Vries R, 2004, ETHICS BEHAV, V14, P351, DOI 10.1207/s15327019eb1404_6; DENHAM MJ, 1979, BRIT MED J, V2, P1042, DOI 10.1136/bmj.2.6197.1042; Driscoll A, 2008, J CLIN NURS, V17, P2212, DOI 10.1111/j.1365-2702.2007.02219.x; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Emanuel EJ, 2004, ANN INTERN MED, V141, P282, DOI 10.7326/0003-4819-141-4-200408170-00008; Feldman JA, 2009, J EMPIR RES HUM RES, V4, P63, DOI 10.1525/jer.2009.4.1.63; Fitzgerald Maureen H, 2006, Account Res, V13, P47, DOI 10.1080/08989620600588944; FOSTER CG, 1995, J MED ETHICS, V21, P214, DOI 10.1136/jme.21.4.214; Geisser ME, 2011, J EMPIR RES HUM RES, V6, P21, DOI 10.1525/jer.2011.6.1.21; Heimer CA, 2010, ANNU REV LAW SOC SCI, V6, P601, DOI 10.1146/annurev.lawsocsci.093008.131454; Howe A, 2009, PRIM HEALTH CARE RES, V11, P17; Jamrozik K., 2004, BMJ-BRIT MED J, V329, P236; Joffe S, 2001, J NATL CANCER I, V93, P139, DOI 10.1093/jnci/93.2.139; Joffe S, 2012, J LAW MED ETHICS, V40, P922, DOI 10.1111/j.1748-720X.2012.00721.x; Karunaratne AS, 2006, INTERN MED J, V36, P86, DOI 10.1111/j.1445-5994.2006.01016.x; Kass Nancy, 2003, IRB, V25, P1, DOI 10.2307/3563634; Kassam-Adams N, 2002, GEN HOSP PSYCHIAT, V24, P336, DOI 10.1016/S0163-8343(02)00200-1; Keith-Spiegel P, 2006, J EMPIR RES HUM RES, V1, P67, DOI 10.1525/jer.2006.1.1.67; Kent G, 1997, J MED ETHICS, V23, P186, DOI 10.1136/jme.23.3.186; Klitzman R., 2011, PLOS ONE, V6; Klitzman R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022796; Klitzman RL, 2012, DEV WORLD BIOETH, V12, P63, DOI 10.1111/j.1471-8847.2012.00324.x; Larson E, 2004, J NURS SCHOLARSHIP, V36, P260, DOI 10.1111/j.1547-5069.2004.04047.x; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Lidz CW, 2012, ACAD MED, V87, P969, DOI 10.1097/ACM.0b013e3182575e2e; Lynoe N, 1999, SCAND J PUBLIC HEALT, V27, P152, DOI 10.1177/14034948990270020401; Marteau T M, 2001, Health Expect, V4, P99, DOI 10.1046/j.1369-6513.2001.00140.x; Maskell NA, 2003, QJM-INT J MED, V96, P305, DOI 10.1093/qjmed/hcg042; McDonald M, 2011, HLTH LAW REV, V19, P36; McDonald M, 2009, J ACAD ETHICS, V7, P1, DOI 10.1007/s10805-009-9082-3; McGrath MM, 2009, AM J PUBLIC HEALTH, V99, P1510, DOI 10.2105/AJPH.2008.149310; McKenzie JE, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-28; Mosconi P, 2006, EUR J CANCER PREV, V15, P91, DOI 10.1097/01.cej.0000195705.82374.bc; Nelson K, 2002, MED CARE, V40, P283, DOI 10.1097/00005650-200204000-00004; Norton Karleen, 2008, IRB, V30, P10; Redman BK, 2006, J MED ETHICS, V32, P153, DOI 10.1136/jme.2005.012567; Reeser JC, 2008, J EMPIR RES HUM RES, V3, P25, DOI 10.1525/jer.2008.3.1.25; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sarpel Umut, 2013, Med Educ Online, V18, P1, DOI 10.3402/meo.v18i0.19524; Schrag Z., 2012, RES ETHICS, V7, P120; Silberman G, 2011, MILBANK Q, V89, P599, DOI 10.1111/j.1468-0009.2011.00644.x; Simek J, 2010, J MED ETHICS, V36, P548, DOI 10.1136/jme.2009.034298; Skrutkowski Myrian, 1998, IRB, V20, P1, DOI 10.2307/3564412; Sleem H, 2010, J EMPIR RES HUM RES, V5, P85, DOI 10.1525/jer.2010.5.3.85; Strauss A. L., 1996, QUALITATIVE ANAL SOC; Taylor HA, 2008, CLIN TRIALS, V5, P277, DOI 10.1177/1740774508091262; Tsan Min-Fu, 2013, IRB, V35, P10; Tsan Min-Fu, 2010, IRB, V32, P16; Valdez-Martinez E, 2006, DEV WORLD BIOETH, V6, P95, DOI 10.1111/j.1471-8847.2006.00144.x; Wagner TH, 2004, MED CARE, V42, P817, DOI 10.1097/01.mlr.0000132395.32967.d4; Wichman Alison, 2006, IRB, V28, P7; Wu MH, 2011, J MED ETHICS, V37, P493, DOI 10.1136/jme.2010.038836; Wynn LL, 2011, J POLICY HIST, V23, P94, DOI 10.1017/S0898030610000333	74	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133639	10.1371/journal.pone.0133639	http://dx.doi.org/10.1371/journal.pone.0133639			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JT	26225553	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700029
J	Tomlin, D				Tomlin, Damon			Rational Constraints and the Evolution of Fairness in the Ultimatum Game	PLOS ONE			English	Article							STAKES; EXPECTATIONS; PREFERENCES; INFORMATION; PUNISHMENT; ANONYMITY	Behavior in the Ultimatum Game has been well-studied experimentally, and provides a marked contrast between the theoretical model of a self-interested economic agent and that of an actual human concerned with social norms such as fairness. How did such norms evolve, when punishing unfair behavior can be costly to the punishing agent? The work described here simulated a series of Ultimatum Games, in which populations of agents earned resources based on their preferences for proposing and accepting (or rejecting) offers of various sizes. Two different systems governing the acceptance or rejection of offers were implemented. Under one system, the probability that an agent accepted an offer of a given size was independent of the probabilities of accepting the other possible offers. Under the other system, a simple, ordinal constraint was placed on the acceptance probabilities such that a given offer was at least as likely to be accepted as a smaller offer. For simulations under either system, agents' preferences and their corresponding behavior evolved over multiple generations. Populations without the ordinal constraint came to emulate maximizing economic agents, while populations with the constraint came to resemble the behavior of human players.	Univ Colorado, Dept Psychol, Colorado Springs, CO 80933 USA	University of Colorado System; University of Colorado at Colorado Springs	Tomlin, D (corresponding author), Univ Colorado, Dept Psychol, Colorado Springs, CO 80933 USA.	dtomlin@uccs.edu						Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; BOLTON GE, 1995, GAME ECON BEHAV, V10, P95, DOI 10.1006/game.1995.1026; Brosnan SF, 2013, P NATL ACAD SCI USA, V110, P10416, DOI 10.1073/pnas.1301194110; CAMERER C, 1995, J ECON PERSPECT, V9, P209, DOI 10.1257/jep.9.2.209; Camerer C, 2003, BEHAV GAME THEORY; Camerer C., 2004, FDN HUMAN SOCIALITY, P55, DOI DOI 10.1093/0199262055.003.0003; Cameron LA, 1999, ECON INQ, V37, P47, DOI 10.1111/j.1465-7295.1999.tb01415.x; Croson RTA, 1996, J ECON BEHAV ORGAN, V30, P197, DOI 10.1016/S0167-2681(96)00857-8; Eckel CC, 2001, ECON INQ, V39, P171, DOI 10.1093/ei/39.2.171; Ewens W.J., 2004, MATH POPULATION GENE; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fischbacher U, 2009, J ECON BEHAV ORGAN, V72, P527, DOI 10.1016/j.jebo.2009.05.021; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; GALE J, 1995, GAME ECON BEHAV, V8, P56, DOI 10.1016/S0899-8256(05)80017-X; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Harrison GW, 1996, INT J GAME THEORY, V25, P303, DOI 10.1007/BF02425260; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Hoffman E, 1996, INT J GAME THEORY, V25, P289, DOI 10.1007/BF02425259; HOFFMAN E, 1994, GAME ECON BEHAV, V7, P346, DOI 10.1006/game.1994.1056; Huck S, 1999, GAME ECON BEHAV, V28, P13, DOI 10.1006/game.1998.0691; Iranzo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043781; Jensen K, 2007, SCIENCE, V318, P107, DOI 10.1126/science.1145850; Kagel JH, 1996, GAME ECON BEHAV, V13, P100, DOI 10.1006/game.1996.0026; Kahneman D., 1986, J BUS, V59, P285, DOI DOI 10.1086/296367; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Kravitz D.A., 1992, J SOCIO-ECON, V21, P65, DOI DOI 10.1016/1053-5357(92)90026-4; Larrick RP, 1997, J PERS SOC PSYCHOL, V72, P810, DOI 10.1037/0022-3514.72.4.810; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; OCHS J, 1989, AM ECON REV, V79, P355; Oosterbeek H, 2004, EXP ECON, V7, P171, DOI 10.1023/B:EXEC.0000026978.14316.74; Page KM, 2000, P ROY SOC B-BIOL SCI, V267, P2177, DOI 10.1098/rspb.2000.1266; Page KM, 2001, J THEOR BIOL, V209, P173, DOI 10.1006/jtbi.2000.2251; PRASNIKAR V, 1992, Q J ECON, V107, P865, DOI 10.2307/2118366; RABIN M, 1993, AM ECON REV, V83, P1281; Rand DG, 2013, P NATL ACAD SCI USA, V110, P2581, DOI 10.1073/pnas.1214167110; ROTH AE, 1991, AM ECON REV, V81, P1068; Sanfey A.G., 2009, MIND SOC, V8, P93, DOI [10.1007/s11299-009-0053-6, DOI 10.1007/S11299-009-0053-6]; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schotter A, 1996, J ECON BEHAV ORGAN, V31, P37, DOI 10.1016/S0167-2681(96)00863-3; Slonim R, 1998, ECONOMETRICA, V66, P569, DOI 10.2307/2998575; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; WEG E, 1993, J ECON PSYCHOL, V14, P17, DOI 10.1016/0167-4870(93)90038-M	43	2	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134636	10.1371/journal.pone.0134636	http://dx.doi.org/10.1371/journal.pone.0134636			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JT	26226512	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700126
J	Kan, CW; Au, CH				Kan, Chi-wai; Au, Chui-ha			In-Vitro Analysis of the Effect of Constructional Parameters and Dye Class on the UV Protection Property of Cotton Knitted Fabrics	PLOS ONE			English	Article							RING-SPUN YARNS; ULTRAVIOLET PROTECTION; WOVEN FABRICS; UNCONVENTIONAL SYSTEMS; SUMMER FABRICS; SKIN-CANCER; FIBER-TYPE; RADIATION; TRANSMISSION; COLOR	Cotton knitted fabrics were manufactured with different yarn types (conventional ring spun yarn and torque-free ring spun yarn) with different fibre types (combed cotton and combed Supima cotton) and yarn fineness (Ne30 and Ne40). These fabrics were then dyed with three types of dye (reactive, direct and sulphur dye) with three dye concentrations (0.1%, 1.0% and 5.0% on-weight of fabric (owf)) in three colours (red, yellow and blue). This study examined the impact of constructional parameters and dyeing on ultraviolet (UV) protection properties of cotton knitted fabric. In-vitro test with spectrophotometer was used for evaluating the UV protection property of dyed cotton knitted fabrics. Among the six parameters investigated, fineness of yarn and dye concentration were the most significant factors affecting UPF while the color effect is the least significant. Experimental results revealed that the UPF value of dyed fabrics made from combed cotton is generally higher than the combed Supima cotton since combed cotton is composed of shorter fibres which facilitate the blocking or absorption of UV radiation. Second, fabrics made with twist yarn (i.e. ring spun yarn) have higher UPF value than the corresponding ESTex one (i.e. torque-free yarn) in general since fabrics made with ring spun yarn tend to shrink during wet processing and so it is more compact. Third, the UPF value of fabrics made with 30Ne yarn was higher than the 40Ne one since it is thicker and has lower fabric porosity. Fourth, fabrics dyed with lower concentration of dye gave the lowest UPF. Fifth, the sulphur dyed samples performed worse than the reactive and direct dyed samples in terms of UV protection property. Sixth, there is no significant difference in UPF for red, yellow and blue coloured fabrics. Seventh, this study also demonstrated that lightness of fabric is negatively related to UV protection property.	[Kan, Chi-wai; Au, Chui-ha] Hong Kong Polytech Univ, Inst Text & Clothing, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Kan, CW (corresponding author), Hong Kong Polytech Univ, Inst Text & Clothing, Kowloon, Hong Kong, Peoples R China.	tccwk@polyu.edu.hk		Kan, Chi-wai/0000-0002-7668-2410	Hong Kong Polytechnic University	Hong Kong Polytechnic University(Hong Kong Polytechnic University)	The authors received financial support from the Hong Kong Polytechnic University for this work.	Algaba I, 2004, AATCC REV, V4, P26; Algaba I, 2007, TEXT RES J, V77, P826, DOI 10.1177/0040517507080670; Algaba IM, 2008, FIBRES TEXT EAST EUR, V16, P85; Bajaj P, 2000, INDIAN J FIBRE TEXT, V25, P315; Capjack L., 1994, FAM CONSUM SCI RES J, V23, P198; Crews P.C., 1999, TEXT CHEM COLOR, V31, P17, DOI DOI 10.3403/00776353; Davis S, 1997, INT J DERMATOL, V36, P374, DOI 10.1046/j.1365-4362.1997.00046.x; Dimitrovski K, 2010, TEXT RES J, V80, P1027, DOI 10.1177/0040517509352527; Dubrovski PD, 2009, TEXT RES J, V79, P351, DOI 10.1177/0040517508090490; Gambichler T, 2002, PHOTODERMATOL PHOTO, V18, P29, DOI 10.1034/j.1600-0781.2002.180105.x; Hoffmann K, 2000, J AM ACAD DERMATOL, V43, P1009, DOI 10.1067/mjd.2000.107959; Hoffmann K, 2001, ARCH DERMATOL, V137, P1089; Kan CW, 2014, SCI WORLD J, DOI 10.1155/2014/506049; Kan CW, 2014, CARBOHYD POLYM, V101, P451, DOI 10.1016/j.carbpol.2013.09.044; Kan CW, 2013, MATERIALS, V6, P4985, DOI 10.3390/ma6114985; Kursun S, 2010, TEXT RES J, V80, P1811, DOI 10.1177/0040517510369401; Lau YM, 1997, TEXT RES J, V67, P815, DOI 10.1177/004051759706701106; Narayanan DL, 2010, INT J DERMATOL, V49, P978, DOI 10.1111/j.1365-4632.2010.04474.x; Paul R, 2010, TEXT RES J, V80, P454, DOI 10.1177/0040517509342316; Riva A, 2006, J TEXT I, V97, P349, DOI 10.1533/joti.2005.0162; Saladi RN, 2005, DRUG TODAY, V41, P37, DOI 10.1358/dot.2005.41.1.875777; Sarkar AK, 2007, PHOTODERMATOL PHOTO, V23, P191, DOI 10.1111/j.1600-0781.2007.00306.x; Srinivasan M, 2000, TEXT CHEM COLOR AM D, V32, P36; Stankovic SB, 2009, TEXT RES J, V79, P1034, DOI 10.1177/0040517508102016; Takuya T, 2010, RES J TEXTILE APPARE, V14, P9, DOI DOI 10.1108/RJTA-14-02-2010-B002; Tao XM, 1997, TEXT RES J, V67, P739, DOI 10.1177/004051759706701006; Urbas R, 2011, TEXT RES J, V81, P1916, DOI 10.1177/0040517511413326; Wan ML, 2010, COLOR TECHNOL, V126, P18, DOI 10.1111/j.1478-4408.2010.00222.x; Wilson CA, 2006, TEXT RES J, V76, P216, DOI 10.1177/0040517506060907; Wilson CA, 2008, TEXT RES J, V78, P95, DOI 10.1177/0040517508089660; World Health Organization, ULTR RAD HLTH; Xin JH, 2004, TEXT RES J, V74, P97, DOI 10.1177/004051750407400202; Yang K, 2007, TEXT RES J, V77, P675, DOI 10.1177/0040517507080545; Zhang YH, 2015, J TEXT I, V106, P648, DOI 10.1080/00405000.2014.933514; Zhou Y, 1998, TEXT CHEM COLOR, V30, P19	35	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133416	10.1371/journal.pone.0133416	http://dx.doi.org/10.1371/journal.pone.0133416			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222792	Green Submitted, gold, Green Published			2022-12-27	WOS:000358836800050
J	Dyson, ZA; Tucci, J; Seviour, RJ; Petrovski, S				Dyson, Zoe A.; Tucci, Joseph; Seviour, Robert J.; Petrovski, Steve			Lysis to Kill: Evaluation of the Lytic Abilities, and Genomics of Nine Bacteriophages Infective for Gordonia spp. and Their Potential Use in Activated Sludge Foam Biocontrol	PLOS ONE			English	Article							RHODOCOCCUS; DNA; SEQUENCE; GENES; GENUS; PREDICTION	Nine bacteriophages (phages) infective for members of the genus Gordonia were isolated from wastewater and other natural water environments using standard enrichment techniques. The majority were broad host range phages targeting more than one Gordonia species. When their genomes were sequenced, they all emerged as double stranded DNA Siphoviridae phages, ranging from 17,562 to 103,424 bp in size, and containing between 27 and 127 genes, many of which were detailed for the first time. Many of these phage genomes diverged from the expected modular genome architecture of other characterized Siphoviridae phages and contained unusual lysis gene arrangements. Whole genome sequencing also revealed that infection with lytic phages does not appear to prevent spontaneous prophage induction in Gordonia malaquae lysogen strain BEN700. TEM sample preparation techniques were developed to view both attachment and replication stages of phage infection.	[Dyson, Zoe A.; Tucci, Joseph] La Trobe Inst Mol Sci, Bundoora, Vic, Australia; [Seviour, Robert J.; Petrovski, Steve] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia	La Trobe University	Petrovski, S (corresponding author), La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia.	steve.petrovski@latrobe.edu.au	Dyson, Zoe Anne/AAW-4294-2021	Dyson, Zoe Anne/0000-0002-8887-3492; seviour, robert/0000-0002-1366-0484; Petrovski, Steve/0000-0002-6304-6853	La Trobe University	La Trobe University	This work was supported by La Trobe University.	Ali Y, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00098; Arenskotter M, 2004, APPL ENVIRON MICROB, V70, P3195, DOI 10.1128/AEM.70.6.3195-3204.2004; Bajpai R, 2012, J VIROL, V86, P9552, DOI 10.1128/JVI.01529-12; Catalano CE, 2000, CELL MOL LIFE SCI, V57, P128, DOI 10.1007/s000180050503; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; de los Reyes FL, 2010, MICROBIAL ECOLOGY OF ACTIVATED SLUDGE, P215; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Drzyzga O, 2012, CRIT REV MICROBIOL, V38, P300, DOI 10.3109/1040841X.2012.668134; El Tahir Y, 2001, INT J MED MICROBIOL, V291, P209, DOI 10.1078/1438-4221-00119; Fujisawa H, 1997, GENES CELLS, V2, P537, DOI 10.1046/j.1365-2443.1997.1450343.x; Goodfellow M, 2012, BERGEYS MANUAL SYSTE, P419; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Hatfull GF, 2008, CURR OPIN MICROBIOL, V11, P447, DOI 10.1016/j.mib.2008.09.004; HENTHORN KS, 1995, J BACTERIOL, V177, P3185, DOI 10.1128/jb.177.11.3185-3190.1995; KLATTE S, 1994, INT J SYST BACTERIOL, V44, P769, DOI 10.1099/00207713-44-4-769; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; LECHEVALIER MP, 1974, INT J SYST BACTERIOL, V24, P278, DOI 10.1099/00207713-24-2-278; Lesnik EA, 2001, NUCLEIC ACIDS RES, V29, P3583, DOI 10.1093/nar/29.17.3583; Markine-Goriaynoff N, 2004, J GEN VIROL, V85, P2741, DOI 10.1099/vir.0.80320-0; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Payne K, 2009, MOL MICROBIOL, V73, P367, DOI 10.1111/j.1365-2958.2009.06775.x; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Petrovski S, 2014, ARCH VIROL, V159, P167, DOI 10.1007/s00705-013-1799-z; Petrovski S, 2013, VIRUS GENES, V46, P588, DOI 10.1007/s11262-013-0887-1; Petrovski S, 2013, ARCH VIROL, V158, P601, DOI 10.1007/s00705-012-1530-5; Petrovski S, 2012, APPL ENVIRON MICROB, V78, P42, DOI 10.1128/AEM.05584-11; Petrovski S, 2012, J VIROL, V86, P358, DOI 10.1128/JVI.05460-11; Petrovski S, 2011, APPL ENVIRON MICROB, V77, P7864, DOI 10.1128/AEM.05692-11; Petrovski S, 2011, APPL ENVIRON MICROB, V77, P3923, DOI 10.1128/AEM.00025-11; Petrovski S, 2011, WATER RES, V45, P2146, DOI 10.1016/j.watres.2010.12.026; Petrovski S, 2011, APPL ENVIRON MICROB, V77, P1389, DOI 10.1128/AEM.01938-10; Pope WH, 2014, J VIROL, V88, P2461, DOI 10.1128/JVI.03363-13; Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; SODDELL JA, 1990, J APPL BACTERIOL, V69, P145, DOI 10.1111/j.1365-2672.1990.tb01506.x; Soddell JA., 1999, MICROBIOLOGY ACTIVAT; Summer EJ, 2011, APPL ENVIRON MICROB, V77, P669, DOI 10.1128/AEM.01952-10; Tamaki H, 2012, ENVIRON MICROBIOL, V14, P441, DOI 10.1111/j.1462-2920.2011.02630.x; Thomas JA, 2002, WATER SCI TECHNOL, V46, P511, DOI 10.2166/wst.2002.0527; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Xu J, 2004, MOL CELL, V16, P11, DOI 10.1016/j.molcel.2004.09.006	43	30	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134512	10.1371/journal.pone.0134512	http://dx.doi.org/10.1371/journal.pone.0134512			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241321	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942700047
J	Lo Gullo, A; Mandraffino, G; Bagnato, G; Aragona, CO; Imbalzano, E; D'Ascola, A; Rotondo, F; Cinquegrani, A; Mormina, E; Saitta, C; Versace, AG; Sardo, MA; Lo Gullo, R; Loddo, S; Saitta, A				Lo Gullo, Alberto; Mandraffino, Giuseppe; Bagnato, Gianluca; Aragona, Caterina Oriana; Imbalzano, Egidio; D'Ascola, Angela; Rotondo, Francesco; Cinquegrani, Antonella; Mormina, Enricomaria; Saitta, Carlo; Versace, Antonio Giovanni; Sardo, Maria Adriana; Lo Gullo, Renato; Loddo, Saverio; Saitta, Antonino			Vitamin D Status in Rheumatoid Arthritis: Inflammation, Arterial Stiffness and Circulating Progenitor Cell Number	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; C-REACTIVE PROTEIN; CARDIOVASCULAR RISK; ENDOTHELIAL DYSFUNCTION; CD34(+) CELLS; D DEFICIENCY; VASCULAR FUNCTION; DISEASE-ACTIVITY; STEM-CELLS; SUPPLEMENTATION	Background and Aims Suboptimal vitamin D status was recently acknowledged as an independent predictor of cardiovascular diseases and all-cause mortality in several clinical settings, and its serum levels are commonly reduced in Rheumatoid Arthritis (RA). Patients affected by RA present accelerated atherosclerosis and increased cardiovascular morbidity and mortality with respect to the general population. In RA, it has been reported an impairment of the number and the activity of circulating proangiogenic haematopoietic cells (PHCs), including CD34+, that may play a role in endothelial homeostasis. The purpose of the study is to investigate the association between vitamin D levels and PHCs, inflammatory markers, and arterial stiffening in patients with RA. Methods and Results CD34+ cells were isolated from 27 RA patients and 41 controls. Vitamin D levels, C-reactive protein (CRP), fibrinogen, pulse wave velocity (PWV), and carotid intima-media thickness (cIMT) were also evaluated. CD34+ count and vitamin D levels were lower in RA patients as compared to controls, while fibrinogen, CRP, PWV and cIMT were higher in RA patients. CD34+ cell number appeared to be associated with vitamin D levels, and negatively correlated to fibrinogen and early atherosclerosis markers (PWV and cIMT); vitamin D levels appear also to be inversely associated to fibrinogen. Conclusions RA patients with moderate disease activity presented with low vitamin D levels, low CD34+ cell count, increased PWV and cIMT; we found that vitamin D deficiency is associated to CD34+ cell reduction in peripheral blood, and with fibrinogen levels. This suggests that vitamin D might contribute to endothelial homeostasis in patients with RA.	[Lo Gullo, Alberto; Mandraffino, Giuseppe; Bagnato, Gianluca; Aragona, Caterina Oriana; Imbalzano, Egidio; Saitta, Carlo; Versace, Antonio Giovanni; Sardo, Maria Adriana; Lo Gullo, Renato; Saitta, Antonino] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [D'Ascola, Angela; Loddo, Saverio] Univ Messina, Dept Biochem Physiol & Nutr Sci, Messina, Italy; [Rotondo, Francesco] Univ Messina, Dept Gen Surg & Oncol, Messina, Italy; [Cinquegrani, Antonella; Mormina, Enricomaria] Univ Messina, Dept Biomed Sci & Morphol & Funct Images, Messina, Italy	University of Messina; University of Messina; University of Messina; University of Messina	Mandraffino, G (corresponding author), Univ Messina, Dept Clin & Expt Med, Messina, Italy.	gmandraffino@unime.it	Mormina, Enricomaria/K-4664-2016; Gullo, Alberto Lo/AAC-2766-2019; Bagnato, Gianluca/D-5742-2018; Saitta, Carlo/A-1747-2015; Imbalzano, Egidio/A-2063-2015; Mandraffino, Giuseppe/K-4346-2018; Aragona, Oriana/AAN-1310-2020; Loddo, Saverio/I-7397-2012	Mormina, Enricomaria/0000-0003-2716-5772; Bagnato, Gianluca/0000-0002-7594-8520; Imbalzano, Egidio/0000-0003-2656-5467; Mandraffino, Giuseppe/0000-0003-0272-2237; Aragona, Oriana/0000-0002-1314-6602; Sardo, Maria Adriana/0000-0003-2872-2542; Loddo, Saverio/0000-0002-3338-9599; Versace, Antonio Giovanni/0000-0001-5021-1365; Lo Gullo, Alberto/0000-0003-4383-0314; d'ascola, angela/0000-0001-7530-1316; Saitta, Antonino/0000-0002-2577-5676	University of Messina (PRA-Progetto di Ricerca di Ateneo - University of Messina) [J41J1000013005]	University of Messina (PRA-Progetto di Ricerca di Ateneo - University of Messina)	This work was supported by a grant from the University of Messina (PRA-Progetto di Ricerca di Ateneo - J41J1000013005 - University of Messina).	Amer M, 2012, AM J CARDIOL, V109, P226, DOI 10.1016/j.amjcard.2011.08.032; Andress DL, 2006, KIDNEY INT, V69, P33, DOI 10.1038/sj.ki.5000045; Antico A, 2012, AUTOIMMUN REV, V12, P127, DOI 10.1016/j.autrev.2012.07.007; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barnett D, 1999, CLIN LAB HAEMATOL, V21, P301, DOI 10.1046/j.1365-2257.1999.00253.x; Beveridge LA, 2015, JAMA INTERN MED, V175, P745, DOI 10.1001/jamainternmed.2015.0237; Bickford PC, 2006, STEM CELLS DEV, V15, P118, DOI 10.1089/scd.2006.15.118; Bjelakovic G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub3; Chao H, 2010, MICROVASC RES, V79, P169, DOI 10.1016/j.mvr.2010.02.003; Choy E, 2014, RHEUMATOLOGY, V53, P2143, DOI 10.1093/rheumatology/keu224; Cianciolo G, 2011, BLOOD PURIFICAT, V32, P161, DOI 10.1159/000325459; Dalbeni A, 2014, NUTR METAB CARDIOVAS, V24, P861, DOI 10.1016/j.numecd.2014.02.015; de Boer HC, 2011, ARTERIOSCL THROM VAS, V31, P408, DOI 10.1161/ATVBAHA.110.216879; Di Stefano R, 2013, INTERN EMERG MED, V8, pS47, DOI 10.1007/s11739-013-0915-0; Fadini GP, 2006, EUR HEART J, V27, P2247, DOI 10.1093/eurheartj/ehl198; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Grundmann M, 2012, AM J PHYSIOL-CELL PH, V303, pC954, DOI 10.1152/ajpcell.00030.2012; Haque UJ, 2012, ARTHRIT CARE RES, V64, P1497, DOI 10.1002/acr.21715; Herbrig K, 2006, ANN RHEUM DIS, V65, P157, DOI 10.1136/ard.2005.035378; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hong Q, 2014, RHEUMATOLOGY, V53, P1994, DOI 10.1093/rheumatology/keu173; Hur J, 2007, CIRCULATION, V116, P1671, DOI 10.1161/CIRCULATIONAHA.107.694778; Jablonski KL, 2011, HYPERTENSION, V57, P63, DOI 10.1161/HYPERTENSIONAHA.110.160929; Ku IA, 2009, CIRC J, V73, P977, DOI 10.1253/circj.CJ-09-0274; Lavie CJ, 2011, J AM COLL CARDIOL, V58, P1547, DOI 10.1016/j.jacc.2011.07.008; Lee JH, 2013, ARTERIOSCL THROM VAS, V33, P1622, DOI 10.1161/ATVBAHA.112.301052; Liew JY, 2015, NUTR METAB CARDIOVAS, V25, P274, DOI 10.1016/j.numecd.2014.12.005; Lo Gullo A, 2014, CLIN EXP RHEUMATOL, V32, P922; Lo Gullo A, 2014, SCAND J RHEUMATOL, V43, P184, DOI 10.3109/03009742.2013.836564; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Mandraffino G, 2012, EXP GERONTOL, V47, P394, DOI 10.1016/j.exger.2012.03.007; Mandraffino G, 2011, HYPERTENS RES, V34, P876, DOI 10.1038/hr.2011.56; Martini G, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0555-9; Meune C, 2009, RHEUMATOLOGY, V48, P1309, DOI 10.1093/rheumatology/kep252; Myasoedova E, 2016, ANN RHEUM DIS, V75, P560, DOI 10.1136/annrheumdis-2014-206411; Park YJ, 2014, ARTHRITIS RHEUMATOL, V66, P1450, DOI 10.1002/art.38352; Pesarin F, 2010, PERMUTATION TESTS FO; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; Ponda MP, 2012, CIRCULATION, V126, P270, DOI 10.1161/CIRCULATIONAHA.111.077875; Ranganathan P, 2013, J RHEUMATOL, V40, P1529, DOI 10.3899/jrheum.130012; Reid D, 2011, AM J CLIN NUTR, V93, P1006, DOI 10.3945/ajcn.110.008490; Richardson MR, 2011, J MOL CELL CARDIOL, V50, P266, DOI 10.1016/j.yjmcc.2010.07.009; Rigato M, 2015, J CLIN ENDOCR METAB, V100, P2666, DOI 10.1210/jc.2015-1687; Rodriguez-Carrio J, 2015, ANN RHEUM DIS, V74, P921, DOI 10.1136/annrheumdis-2013-204250; Rodriguez-Carrio J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086069; Ross AC, 2011, J AM DIET ASSOC, V111, P524, DOI 10.1016/j.jada.2011.01.004; Rossini M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3195; Seida JC, 2014, J CLIN ENDOCR METAB, V99, P3551, DOI 10.1210/jc.2014-2136; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; Silva MC, 2015, NUTR RES, V35, P91, DOI 10.1016/j.nutres.2014.12.008; Steinmetz M, 2010, HYPERTENSION, V55, P593, DOI 10.1161/HYPERTENSIONAHA.109.134213; Uberti F, 2014, J CLIN ENDOCR METAB, V99, P1367, DOI 10.1210/jc.2013-2103; Verma S, 2004, CIRCULATION, V109, P2058, DOI 10.1161/01.CIR.0000127577.63323.24; Yoder MC, 2013, J MOL MED, V91, P285, DOI 10.1007/s00109-013-1002-8	55	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134602	10.1371/journal.pone.0134602	http://dx.doi.org/10.1371/journal.pone.0134602			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241902	gold, Green Published, Green Submitted			2022-12-27	WOS:000358942700052
J	Siristatidis, C; Sergentanis, TN; Vogiatzi, P; Kanavidis, P; Chrelias, C; Papantoniou, N; Psaltopoulou, T				Siristatidis, Charalampos; Sergentanis, Theodoros N.; Vogiatzi, Paraskevi; Kanavidis, Prodromos; Chrelias, Charalampos; Papantoniou, Nikolaos; Psaltopoulou, Theodora			In Vitro Maturation in Women with vs. without Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							OOCYTE MATURATION; MATURED OOCYTES; SYNDROME PCOS; FERTILIZATION; INFERTILITY; CYCLES; IMPACT; IVM	Objective To evaluate in vitro maturation (IVM) in sub-fertile women with polycystic ovarian syndrome (PCOS) undergoing in vitro fertilisation (IVF), by comparing outcomes with a control group of non-PCOS. Study design A search strategy was developed for PubMed and studies reporting rates of the following outcomes (live birth; clinical pregnancy; implantation; cycle cancellation; oocyte maturation; oocyte fertilization; miscarriage) between patients with PCOS, PCO and controls undergoing IVM were deemed eligible. The review was conducted in accordance to the PRISMA guidelines and included studies quality was assessed through the Newcastle-Ottawa Quality scale. ORs with their corresponding 95% CIs were calculated for the main analysis and subgroup analyses were performed for PCOS cases vs. controls and PCOS vs. PCO cases. Alternative analyses were performed for live birth and clinical pregnancy, based on cycles and on women. Subgroup analyses for FSH stimulation, hCG priming and type of procedure (IVF/ICSI) were undertaken for all meta-analyses encompassing at least four study arms. Random effects models were used to calculate pooled effect estimates. Results Eleven studies were identified. A total of 268 PCOS patients (328 cycles), 100 PCO patients (110 cycles) and 440 controls (480 cycles) were included in the meta-analysis. A borderline trend towards higher birth rates among PCOS patients emerged (pooled OR = 1.74, 95% CI: 0.99-3.04) mainly reflected at the subgroup analysis vs. controls. Clinical pregnancy (pooled OR = 2.37, 95% CI: 1.53-3.68) and implantation rates (pooled OR = 1.73, 95% CI: 1.06-2.81) were higher, while cancellation rates lower (pooled OR = 0.18, 95% CI: 0.06-0.47) among PCOS vs. non-PCOS subjects; maturation and miscarriage rates did not differ between groups, while a borderline trend towards lower fertilization rates among PCOS patients was observed. Conclusion The present meta-analysis provides preliminary evidence on the effectiveness of IVM as a treatment option when offered in sub-fertile PCOS women, as the latter present at least as high outcome rates as those in non-PCOS.	[Siristatidis, Charalampos; Vogiatzi, Paraskevi] Univ Athens, Dept Obstet & Gynecol 3, Assisted Reprod Unit, Athens, Greece; [Sergentanis, Theodoros N.; Kanavidis, Prodromos; Psaltopoulou, Theodora] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Chrelias, Charalampos; Papantoniou, Nikolaos] Univ Athens, Dept Obstet & Gynecol 3, Athens, Greece	National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens	Siristatidis, C (corresponding author), Univ Athens, Dept Obstet & Gynecol 3, Assisted Reprod Unit, Athens, Greece.	harrysiri@yahoo.gr	Siristatidis, Charalambos/AAD-6990-2019; Psaltopoulou, Theodora/AAA-6878-2020; Vogiatzi, Paraskevi/AAH-4494-2021; Sergentanis, Theodoros N./AAD-8303-2019	Siristatidis, Charalambos/0000-0003-0850-6623; Psaltopoulou, Theodora/0000-0002-1404-9716; Sergentanis, Theodoros N./0000-0002-9355-5528; Vogiatzi, Paraskevi/0000-0001-9971-1619; Kanavidis, Prodromos/0000-0002-2819-472X	NIMH NIH HHS [R01 MH08632] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Azziz R, 2005, J CLIN ENDOCR METAB, V90, P4650, DOI 10.1210/jc.2005-0628; Baird DT, 2012, HUM REPROD UPDATE, V18, P586, DOI 10.1093/humupd/dms019; Barnes FL, 1996, FERTIL STERIL, V65, P1151, DOI 10.1016/S0015-0282(16)58330-7; Buckett WM, 2008, FERTIL STERIL, V110, P885; Cha KY, 2005, FERTIL STERIL, V83, P1461, DOI 10.1016/j.fertnstert.2004.11.044; Cha KY, 1998, HUM REPROD UPDATE, V4, P103, DOI 10.1093/humupd/4.2.103; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chian RC, 1999, NEW ENGL J MED, V341, P1624, DOI 10.1056/NEJM199911183412118; Child TJ, 2002, OBSTET GYNECOL, V100, P665, DOI 10.1016/S0029-7844(02)02193-2; Child TJ, 2001, FERTIL STERIL, V76, P936, DOI 10.1016/S0015-0282(01)02853-9; De Vos M, 2011, FERTIL STERIL, V96, P860, DOI 10.1016/j.fertnstert.2011.07.1108; de Ziegler D, 2012, FERTIL STERIL, V98, P290, DOI 10.1016/j.fertnstert.2012.06.043; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; EDWARDS RG, 1965, NATURE, V208, P349, DOI 10.1038/208349a0; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fauser BCJM, 2012, FERTIL STERIL, V97, P28, DOI 10.1016/j.fertnstert.2011.09.024; Grynberg M, 2013, FERTIL STERIL, V99, P1182, DOI 10.1016/j.fertnstert.2013.01.090; Heijnen EMEW, 2006, HUM REPROD UPDATE, V12, P13, DOI 10.1093/humupd/dmi036; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Junk SM, 2012, FERTIL STERIL, V98, P888, DOI 10.1016/j.fertnstert.2012.06.055; Kedem A, 2013, GYNECOL ENDOCRINOL, V29, P651, DOI 10.3109/09513590.2013.798279; Le Du A, 2005, HUM REPROD, V20, P420, DOI 10.1093/humrep/deh603; Lindenberg S, 2013, FERTIL STERIL, V99, P1170, DOI 10.1016/j.fertnstert.2013.02.007; Mikkelsen AL, 2001, HUM REPROD, V16, P1714, DOI 10.1093/humrep/16.8.1714; Mills EJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2914; Qiao J, 2011, HUM REPROD UPDATE, V17, P17, DOI 10.1093/humupd/dmq032; Shu-Chi M, 2006, EARLY HUM DEV, V82, P677, DOI 10.1016/j.earlhumdev.2006.01.012; Siristatidis C, 2012, AM J OBSTET GYNECOL, V207, pE12, DOI 10.1016/j.ajog.2012.04.005; Siristatidis CS, 2013, COCHRANE DB SYST REV, V8; Soderstrom-Anttila V, 2005, HUM REPROD, V20, P1534, DOI 10.1093/humrep/deh768; Son WY, 2008, REPROD BIOMED ONLINE, V17, P59, DOI 10.1016/S1472-6483(10)60294-5; Son WY, 2010, HUM REPROD UPDATE, V16, P675, DOI 10.1093/humupd/dmq014; Son WY, 2005, HUM REPROD, V20, P3204, DOI 10.1093/humrep/dei195; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Tarlatzis BC, 2008, HUM REPROD, V23, P462, DOI 10.1093/humrep/dem426; TROUNSON A, 1994, FERTIL STERIL, V62, P353; Vieira RC, 2011, J ASSIST REPROD GEN, V28, P15, DOI 10.1007/s10815-010-9475-7; Wells G.A., NEWCASTLE OTTAWA SCA; Zhao Jun-Zhao, 2009, Zhonghua Fu Chan Ke Za Zhi, V44, P409; Zhao Jun-zhao, 2006, Zhonghua Fu Chan Ke Za Zhi, V41, P173	40	40	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134696	10.1371/journal.pone.0134696	http://dx.doi.org/10.1371/journal.pone.0134696			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241855	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942700059
J	Chennu, A; Volkenborn, N; de Beer, D; Wethey, DS; Woodin, SA; Polerecky, L				Chennu, Arjun; Volkenborn, Nils; de Beer, Dirk; Wethey, David S.; Woodin, Sarah A.; Polerecky, Lubos			Effects of Bioadvection by Arenicola marina on Microphytobenthos in Permeable Sediments	PLOS ONE			English	Article							PORE-WATER EXCHANGE; ORGANIC-MATTER; ANAEROBIC DECOMPOSITION; MICROSCALE DISTRIBUTION; INTERTIDAL SEDIMENTS; HYDRAULIC ACTIVITIES; BURROW VENTILATION; SANDY SEDIMENTS; ECOLOGICAL ROLE; SECRET GARDEN	We used hyperspectral imaging to study short-term effects of bioturbation by lugworms (Arenicola marina) on the surficial biomass of microphytobenthos (MPB) in permeable marine sediments. Within days to weeks after the addition of a lugworm to a homogenized and recomposed sediment, the average surficial MPB biomass and its spatial heterogeneity were, respectively, 150-250% and 280% higher than in sediments without lugworms. The surficial sediment area impacted by a single medium-sized lugworm (similar to 4 g wet weight) over this time-scale was at least 340 cm(2). While sediment reworking was the primary cause of the increased spatial heterogeneity, experiments with lugworm-mimics together with modeling showed that bioadvective porewater transport from depth to the sediment surface, as induced by the lugworm ventilating its burrow, was the main cause of the increased surficial MPB biomass. Although direct measurements of nutrient fluxes are lacking, our present data show that enhanced advective supply of nutrients from deeper sediment layers induced by faunal ventilation is an important mechanism that fuels high primary productivity at the surface of permeable sediments even though these systems are generally characterized by low standing stocks of nutrients and organic material.	[Chennu, Arjun; de Beer, Dirk; Polerecky, Lubos] Max Planck Inst Marine Microbiol, Bremen, Germany; [Volkenborn, Nils; Wethey, David S.; Woodin, Sarah A.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	Max Planck Society; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Chennu, A (corresponding author), Max Planck Inst Marine Microbiol, Bremen, Germany.	achennu@mpi-bremen.de	Chennu, Arjun/AAV-8003-2021; de Beer, Dirk/L-4840-2013; Wethey, David S/K-8063-2014; Woodin, Sarah A/K-8481-2014; Polerecky, Lubos/E-1134-2014	Chennu, Arjun/0000-0002-0389-5589; de Beer, Dirk/0000-0001-5274-1781; Wethey, David S/0000-0002-2549-1606; Woodin, Sarah A/0000-0001-5615-2212; Polerecky, Lubos/0000-0003-4425-585X	Marie Curie Initial Training Network "SENSEnet" [237868]; National Science Foundation [OCE0928002, OCE1129401]; NASA [NNX11AP77G]; Max Planck Society of Germany; Directorate For Geosciences [1129401] Funding Source: National Science Foundation	Marie Curie Initial Training Network "SENSEnet"; National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Max Planck Society of Germany(Max Planck Society); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for this work was provided by the Marie Curie Initial Training Network "SENSEnet" (grant number: 237868), the National Science Foundation (OCE0928002, OCE1129401), NASA (NNX11AP77G) and the Max Planck Society of Germany.	Andresen M, 2002, OPHELIA, V56, P179, DOI 10.1080/00785236.2002.10409498; Banta GT, 1999, AQUAT MICROB ECOL, V19, P189, DOI 10.3354/ame019189; Berner R.A., 1980, EARLY DIAGENESIS THE; BEUKEMA JJ, 1979, NETH J SEA RES, V13, P331, DOI 10.1016/0077-7579(79)90010-3; BLACKBURN TH, 1983, LIMNOL OCEANOGR, V28, P477, DOI 10.4319/lo.1983.28.3.0477; Boudreau B.P., 2001, BENTHIC BOUNDARY LAY; Brito A, 2009, ESTUAR COAST SHELF S, V83, P67, DOI 10.1016/j.ecss.2009.03.023; BROTAS V, 1995, HYDROBIOLOGIA, V300, P93, DOI 10.1007/BF00024451; Cahoon LB, 1999, OCEANOGR MAR BIOL, V37, P47; Chennu A, 2013, LIMNOL OCEANOGR-METH, V11, P511, DOI 10.4319/lom.2013.11.511; de Beer D, 2005, LIMNOL OCEANOGR, V50, P113, DOI 10.4319/lo.2005.50.1.0113; de Beer D, 2002, ACS SYM SER, P227; Donadi S, 2013, ECOSYSTEMS, V16, P1325, DOI 10.1007/s10021-013-9686-8; Herman PMJ, 2000, MAR ECOL PROG SER, V204, P79, DOI 10.3354/meps204079; Hulthe G, 1998, GEOCHIM COSMOCHIM AC, V62, P1319, DOI 10.1016/S0016-7037(98)00044-1; HYLLEBERG J, 1975, Ophelia, V14, P113; Koh CH, 2007, ESTUAR COAST SHELF S, V72, P42, DOI 10.1016/j.ecss.2006.10.005; KRAGER CD, 1993, LIMNOL OCEANOGR, V38, P509; Kristensen E, 2000, HYDROBIOLOGIA, V426, P1, DOI 10.1023/A:1003980226194; KRISTENSEN E, 1985, J COASTAL RES, V1, P109; Kristensen E, 1995, LIMNOL OCEANOGR, V40, P1430, DOI 10.4319/lo.1995.40.8.1430; Kristensen E, 2001, Geochem Trans, V2, P92, DOI 10.1186/1467-4866-2-92; Lorenzen J, 1998, APPL ENVIRON MICROB, V64, P3264; MacIntyre HL, 1996, ESTUARIES, V19, P186, DOI 10.2307/1352224; Malcolm S. J., 1997, BIOGEOCHEMISTRY INTE, P84, DOI [10.1017/CBO9780511524905.006, DOI 10.1017/CBO9780511524905.006]; Matsui GY, 2011, LIMNOL OCEANOGR-METH, V9, P84, DOI 10.4319/lom.2011.9.84; Meysman FJR, 2005, MAR ECOL PROG SER, V303, P195, DOI 10.3354/meps303195; Meysman FJR, 2006, LIMNOL OCEANOGR, V51, P142, DOI 10.4319/lo.2006.51.1.0142; Miller DC, 1996, ESTUARIES, V19, P202, DOI 10.2307/1352225; Na T, 2008, J MAR RES, V66, P691, DOI 10.1357/002224008787536826; Precht E, 2004, LIMNOL OCEANOGR, V49, P693, DOI 10.4319/lo.2004.49.3.0693; Precht E, 2003, LIMNOL OCEANOGR, V48, P1674, DOI 10.4319/lo.2003.48.4.1674; Rao AMF, 2014, ESTUAR COAST SHELF S, V148, P36, DOI 10.1016/j.ecss.2014.06.006; Reise K., 1985, TIDAL FLAT ECOLOGY E; Riisgard HU, 1998, VIE MILIEU, V48, P243; Riisgard HU, 1996, MAR ECOL PROG SER, V138, P149, DOI 10.3354/meps138149; Stal LJ, 2010, ECOL ENG, V36, P236, DOI 10.1016/j.ecoleng.2008.12.032; SUN MY, 1993, GEOCHIM COSMOCHIM AC, V57, P147; Thornton DCO, 1999, MAR ECOL PROG SER, V184, P11, DOI 10.3354/meps184011; Timmermann K, 2003, VIE MILIEU, V53, P187; Timmermann K, 2006, J MAR RES, V64, P915, DOI 10.1357/002224006779698378; Volkenborn N, 2007, LIMNOL OCEANOGR, V52, P1898, DOI 10.4319/lo.2007.52.5.1898; Volkenborn N, 2007, ESTUAR COAST SHELF S, V74, P331, DOI 10.1016/j.ecss.2007.05.001; Volkenborn N, 2006, J EXP MAR BIOL ECOL, V330, P169, DOI 10.1016/j.jembe.2005.12.025; Volkenborn N, 2010, LIMNOL OCEANOGR, V55, P1231, DOI 10.4319/lo.2010.55.3.1231; Wells G, 1966, J SEA RES, V3, P294; Wethey DS, 2008, J MAR RES, V66, P255, DOI 10.1357/002224008785837121; Woodin SA, 2010, INTEGR COMP BIOL, V50, P176, DOI 10.1093/icb/icq031	48	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134236	10.1371/journal.pone.0134236	http://dx.doi.org/10.1371/journal.pone.0134236			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230398	Green Published, gold			2022-12-27	WOS:000358838400090
J	Ennequin, G; Boisseau, N; Caillaud, K; Chavanelle, V; Etienne, M; Li, XY; Sirvent, P				Ennequin, Gael; Boisseau, Nathalie; Caillaud, Kevin; Chavanelle, Vivien; Etienne, Monique; Li, Xinyan; Sirvent, Pascal			Neuregulin 1 Improves Glucose Tolerance in db/db Mice	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; INSULIN ACTION; MUSCLE-CELLS; CARDIAC DEVELOPMENT; SKELETAL-MUSCLE; GENE-EXPRESSION; FACTOR FKHR; HEREGULIN; ERBB3; LIVER	In vitro experiments using rodent skeletal muscle cells suggest that neuregulin 1 (NRG1) is involved in glucose metabolism regulation, although no study has evaluated the role of NRG1 in systemic glucose homeostasis. The purpose of this study was to investigate the effect of chronic and acute NRG1 treatment on glucose homeostasis in db/db mice. To this aim, glucose tolerance tests were performed in 8-week-old male db/db mice after treatment with NRG1 (50 mu g.kg(-1)) or saline 3 times per week for 8 weeks. In other experiments, glucose tolerance and pyruvate tolerance tests were performed in db/db mice 15 minutes after a single NRG1 (50 mu g.kg(-1)) or saline injection. Liver, adipose tissue, hypothalamus and skeletal muscle were also collected 30 minutes after acute NRG1 (50 mu g.kg(-1)) or saline treatment, and the phosphorylation status of the ERBB receptors, AKT (on Ser473) and FOXO1 (on Ser256) was assessed by western blotting. Chronic treatment (8 weeks) with NRG1 improved glucose tolerance in db/db mice. Acute treatment also lowered glycemia and insulinemia during glucose or pyruvate tolerance tests. NRG1 acute injection induced activation of ERBB3 receptors and phosphorylation of AKT and FOXO1 only in liver. Altogether, this study shows that acute and chronic NRG1 treatments improve glucose tolerance in db/db mice. This effect could be mediated through inhibition of hepatic gluconeogenesis.	[Ennequin, Gael; Boisseau, Nathalie; Caillaud, Kevin; Chavanelle, Vivien; Etienne, Monique; Sirvent, Pascal] Univ Clermont Ferrand, Univ Clermont Auvergne, Lab Adaptat Metab Exercice Condit Physiol & Patho, EA 3533, F-63171 Aubiere, France; [Ennequin, Gael; Boisseau, Nathalie; Caillaud, Kevin; Chavanelle, Vivien; Etienne, Monique; Sirvent, Pascal] CRNH Auvergne, F-63001 Clermont Ferrand, France; [Li, Xinyan] Zensun Sci & Tech Ltd, Shanghai, Peoples R China	Universite Clermont Auvergne (UCA)	Sirvent, P (corresponding author), Univ Clermont Ferrand, Univ Clermont Auvergne, Lab Adaptat Metab Exercice Condit Physiol & Patho, EA 3533, BP 80026, F-63171 Aubiere, France.	pascal.sirvent@univ-bpclermont.fr		CAILLAUD, Kevin/0000-0003-3139-9475	Zensun Sci Tech Ltd.	Zensun Sci Tech Ltd.	The authors received no specific funding for this work. Zensun Sci & Tech Ltd. provided support in the form of salary for author (XL), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Barnett AH, 2013, CURR MED RES OPIN, V29, P1503, DOI 10.1185/03007995.2013.834250; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Britsch S, 2007, ADV ANAT EMBRYOL CEL, V190, P1; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Camprecios G, 2011, J CELL PHYSIOL, V226, P450, DOI 10.1002/jcp.22354; Canto C, 2004, J BIOL CHEM, V279, P12260, DOI 10.1074/jbc.M308554200; Canto C, 2007, DIABETES, V56, P2185, DOI 10.2337/db06-1726; Canto C, 2006, J BIOL CHEM, V281, P21690, DOI 10.1074/jbc.M600475200; CARRAWAY KL, 1994, J BIOL CHEM, V269, P14303; Carver RS, 1996, J BIOL CHEM, V271, P13491, DOI 10.1074/jbc.271.23.13491; Carver RS, 2002, GASTROENTEROLOGY, V123, P2017, DOI 10.1053/gast.2002.37060; Carver RS, 1997, ENDOCRINOLOGY, V138, P5195, DOI 10.1210/en.138.12.5195; Cherrington AD, 2007, BIOCHEM SOC T, V35, P1171, DOI 10.1042/BST0351171; Cote GM, 2005, EXP CELL RES, V311, P135, DOI 10.1016/j.yexcr.2005.08.017; Ennequin G, 2015, DIABETES METAB, V41, P168, DOI 10.1016/j.diabet.2014.12.002; Ennequin G, 2015, J PHYSIOL-LONDON, V593, P2665, DOI 10.1113/JP270026; Erickson SL, 1997, DEVELOPMENT, V124, P4999; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gross DN, 2009, CURR DIABETES REP, V9, P208, DOI 10.1007/s11892-009-0034-5; Guma A, 2010, AM J PHYSIOL-ENDOC M, V298, pE742, DOI 10.1152/ajpendo.00541.2009; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Huang YZ, 2002, INT J DEV NEUROSCI, V20, P173, DOI 10.1016/S0736-5748(02)00011-4; Krag TOB, 2004, P NATL ACAD SCI USA, V101, P13856, DOI 10.1073/pnas.0405972101; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; Liu XF, 2006, J AM COLL CARDIOL, V48, P1438, DOI 10.1016/j.jacc.2006.05.057; Mei L, 2014, NEURON, V83, P27, DOI 10.1016/j.neuron.2014.06.007; Meyer D, 1997, DEVELOPMENT, V124, P3575; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Miller TA, 2009, BIOCHEM BIOPH RES CO, V379, P32, DOI 10.1016/j.bbrc.2008.11.150; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Odiete O, 2012, CIRC RES, V111, P1376, DOI 10.1161/CIRCRESAHA.112.267286; Oh KJ, 2013, BMB REP, V46, P567, DOI 10.5483/BMBRep.2013.46.12.248; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; SHERWIN RS, 1980, DIABETES CARE, V3, P261, DOI 10.2337/diacare.3.2.261; South JCM, 2013, ENDOCRINOLOGY, V154, P2385, DOI 10.1210/en.2012-2133; Suarez E, 2001, J BIOL CHEM, V276, P18257, DOI 10.1074/jbc.M008100200; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tappy L, 2001, CURR OPIN CLIN NUTR, V4, P273, DOI 10.1097/00075197-200107000-00005; Tran L, 2015, ANN PHARMACOTHER, V49, P540, DOI 10.1177/1060028014558289; TZAHAR E, 1994, J BIOL CHEM, V269, P25226; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Verspohl EJ, 2012, PHARMACOL REV, V64, P188, DOI 10.1124/pr.110.003319; Wallia A, 2014, JAMA-J AM MED ASSOC, V311, P2315, DOI 10.1001/jama.2014.5951; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Wu XD, 2012, ARTERIOSCL THROM VAS, V32, P1236, DOI 10.1161/ATVBAHA.111.244525; Yanai H, 2015, WORLD J DIABETES, V6, P30, DOI 10.4239/wjd.v6.i1.30; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; ZHU XJ, 1995, EMBO J, V14, P5842, DOI 10.1002/j.1460-2075.1995.tb00272.x	51	27	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0130568	10.1371/journal.pone.0130568	http://dx.doi.org/10.1371/journal.pone.0130568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230680	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400006
J	Hatt, L; Aagaard, MM; Graakjaer, J; Bach, C; Sommer, S; Agerholm, IE; Kolvraa, S; Bojesen, A				Hatt, Lotte; Aagaard, Mads M.; Graakjaer, Jesper; Bach, Cathrine; Sommer, Steffen; Agerholm, Inge E.; Kolvraa, Steen; Bojesen, Anders			Microarray-Based Analysis of Methylation Status of CpGs in Placental DNA and Maternal Blood DNA - Potential New Epigenetic Biomarkers for Cell Free Fetal DNA-Based Diagnosis	PLOS ONE			English	Article							CIRCULATION; TRISOMY-21	Epigenetic markers for cell free fetal DNA in the maternal blood circulation are highly interesting in the field of non-invasive prenatal testing since such markers will offer a possibility to quantify the amount of fetal DNA derived from different chromosomes in a maternal blood sample. The aim of the present study was to define new fetal specific epigenetic markers present in placental DNA that can be utilized in non-invasive prenatal diagnosis. We have conducted a high-resolution methylation specific beadchip microarray study assessing more than 450.000 CpG sites. We have analyzed the DNA methylation profiles of 10 maternal blood samples and compared them to 12 1st trimesters chorionic samples from normal placentas, identifying a number of CpG sites that are differentially methylated in maternal blood cells compared to chorionic tissue. To strengthen the utility of these differentially methylated CpG sites to be used with methyl-sensitive restriction enzymes (MSRE) in PCR-based NIPD, we furthermore refined the list of selected sites, containing a restriction sites for one of 16 different methylation-sensitive restriction enzymes. We present a list of markers on chromosomes 13, 18 and 21 with a potential for aneuploidy testing as well as a list of markers for regions harboring sub-microscopic deletion- or duplication syndromes.	[Hatt, Lotte; Aagaard, Mads M.; Graakjaer, Jesper; Kolvraa, Steen; Bojesen, Anders] Vejle Hosp, Dept Clin Genet, DK-7100 Vejle, Denmark; [Hatt, Lotte; Bach, Cathrine; Sommer, Steffen; Agerholm, Inge E.] Horsens Hosp, Dept Gynecol & Obstet, DK-8700 Horsens, Denmark; [Hatt, Lotte; Kolvraa, Steen; Bojesen, Anders] Univ Southern Denmark, Inst Reg Hlth Res, DK-5000 Odense, Denmark	University of Southern Denmark; Lillebaelt Hospital; Aarhus University; University of Southern Denmark	Hatt, L (corresponding author), Vejle Hosp, Dept Clin Genet, DK-7100 Vejle, Denmark.	lotte@hatt.nu		Bojesen, Anders Miki/0000-0003-4030-0019	University of Southern Denmark; Jorgen Werner Schous Fond; Det Videnskabelige Fond ved Horsens Sygehus; Familien Hede-Nielsens Fond; Aase og Ejner Danielsens Fond	University of Southern Denmark; Jorgen Werner Schous Fond; Det Videnskabelige Fond ved Horsens Sygehus; Familien Hede-Nielsens Fond; Aase og Ejner Danielsens Fond	Funding was provided by the University of Southern Denmark(LH), Jorgen Werner Schous Fond (AB), Det Videnskabelige Fond ved Horsens Sygehus(SS), Familien Hede-Nielsens Fond(LH), and Aase og Ejner Danielsens Fond(LH). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, PHEATMAP PRETTY HEAT; Bianchi DW, 2002, PRENATAL DIAG, V22, P609, DOI 10.1002/pd.347; Bunce K, 2012, PRENATAL DIAG, V32, P542, DOI 10.1002/pd.3853; Chu TJ, 2009, PRENATAL DIAG, V29, P1020, DOI 10.1002/pd.2335; Dan S, 2012, PRENATAL DIAG, V32, P1225, DOI 10.1002/pd.4002; Guetta E, 2003, BLOOD CELL MOL DIS, V30, P13, DOI 10.1016/S1079-9796(03)00008-1; Hatt L, 2014, FETAL DIAGN THER, V35, P218, DOI 10.1159/000356073; Kin TS, 2007, BIOINFORMATICS, V23, P2945, DOI 10.1093/bioinformatics/btm455; Krabchi K, 2001, CLIN GENET, V60, P145, DOI 10.1034/j.1399-0004.2001.600209.x; Lapaire O, 2007, PLACENTA, V28, P1, DOI 10.1016/j.placenta.2006.02.004; Lim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027709; Lo YM, 1997, LANCET, V350, P485, DOI DOI 10.1016/S0140-6736(97)02174-0; Mersy E, 2013, HUM REPROD UPDATE, V19, P318, DOI 10.1093/humupd/dmt001; Ou XL, 2014, TRANSFUSION, V54, P2523, DOI 10.1111/trf.12659; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Petersen OB, 2014, ULTRASOUND OBST GYN, V43, P265, DOI 10.1002/uog.13270; R Core Team, 2013, LANG ENV STAT COMP; Tong YK, 2010, CLIN CHEM, V56, P90, DOI 10.1373/clinchem.2009.134114; Tsaliki E, 2012, PRENATAL DIAG, V32, P996, DOI 10.1002/pd.3947; Xiang YQ, 2014, MOL HUM REPROD, V20, P875, DOI 10.1093/molehr/gau048	20	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0128918	10.1371/journal.pone.0128918	http://dx.doi.org/10.1371/journal.pone.0128918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230497	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400003
J	Rapacz, M; Sasal, M; Kalaji, HM; Cielniak, JK				Rapacz, Marcin; Sasal, Monika; Kalaji, Hazem M.; Cielniak, Janusz Ko			Is the OJIP Test a Reliable Indicator of Winter Hardiness and Freezing Tolerance of Common Wheat and Triticale under Variable Winter Environments?	PLOS ONE			English	Article							VIVO CHLOROPHYLL FLUORESCENCE; LOW-TEMPERATURE; COLD-ACCLIMATION; FROST TOLERANCE; PHOTOSYSTEM-II; SURVIVAL; STRESS; EFFICIENCY; PLANTS; PHOTOINHIBITION	OJIP analysis, which explores changes in photosystem II (PSII) photochemical performance, has been used as a measure of plant susceptibility to stress. However, in the case of freezing tolerance and winter hardiness, which are highly environmentally variable, the use of this method can give ambiguous results depending on the species as well as the sampling year and time. To clarify this issue, we performed chlorophyll fluorescence measurements over three subsequent winters (2010/11, 2011/12 and 2012/13) on 220 accessions of common winter wheat and 139 accessions of winter triticale. After freezing, leaves were collected from cold-acclimated plants in the laboratory and field-grown plants. Observations of field survival in seven locations across Poland and measurements of freezing tolerance of the studied plants were also recorded. Our results confirm that the OJIP test is a reliable indicator of winter hardiness and freezing tolerance of common wheat and triticale under unstable winter environments. Regardless of species, the testing conditions giving the most reliable results were identical, and the reliability of the test could be easily checked by analysis of some relationships between OJIP-test parameters. We also found that triticale is more winter hardy and freezing tolerant than wheat. In addition, the two species were characterized by different patterns of photosynthetic apparatus acclimation to cold.	[Rapacz, Marcin; Sasal, Monika; Cielniak, Janusz Ko] Agr Univ Krakow, Fac Agr & Econ, Dept Plant Physiol, Krakow, Poland; [Kalaji, Hazem M.] Warsaw Univ Life Sci, Dept Plant Physiol, Fac Agr & Biol, Warsaw, Poland	Agricultural University Krakow; Warsaw University of Life Sciences	Rapacz, M (corresponding author), Agr Univ Krakow, Fac Agr & Econ, Dept Plant Physiol, Krakow, Poland.	rrrapacz@cyf-kr.edu.pl	Rapacz, Marcin/T-8263-2017; Kalaji, Mohamed Hazem/E-8086-2012	Rapacz, Marcin/0000-0003-1071-1159; Kalaji, Mohamed Hazem/0000-0002-3833-4917	Ministry of Agriculture and Rural Development (Poland) [HOR hn 801-19/11, HOR hn 801-21/11, HOR hn 801-18/12, HOR hn 801-19/12, HOR hn 801-7/13, HOR hn 801-8/13, HOR hn 801-10/14]; University of Agriculture in Poland [DS 3113]	Ministry of Agriculture and Rural Development (Poland); University of Agriculture in Poland	This work was supported by Ministry of Agriculture and Rural Development (Poland) - Grant No. HOR hn 801-19/11, 21/11, 18/12, 19/12, 7/13, 8/13, 10/14. http://www.minrol.gov.pl/eng; and University of Agriculture in Poland (DS 3113). http://www.ur.krakow.pl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Badeck FW, 2015, AGRONOMY-BASEL, V5, P71, DOI 10.3390/agronomy5010071; Borawska-Jarmulowicz B, 2014, PLANT SOIL ENVIRON, V60, P177, DOI 10.17221/57/2014-PSE; Borawska-Jarmulowicz B, 2014, RUSS J PLANT PHYSL+, V61, P281, DOI 10.1134/S1021443714030029; CHERNEV P, 2006, ECOL ENG ENV PROTECT, V5, P19; Crosatti C, 2013, PHYSIOL PLANTARUM, V147, P55, DOI 10.1111/j.1399-3054.2012.01689.x; Gusta LV, 2013, PHYSIOL PLANTARUM, V147, P4, DOI 10.1111/j.1399-3054.2012.01611.x; Gusta LV, 2001, CAN J PLANT SCI, V81, P241, DOI 10.4141/P00-068; HOMMO LM, 1994, PLANT BREEDING, V112, P285, DOI 10.1111/j.1439-0523.1994.tb00686.x; Huner NPA, 2013, BOTANY, V91, P127, DOI 10.1139/cjb-2012-0174; Humphreys MW, 2007, EUPHYTICA, V158, P337, DOI 10.1007/s10681-006-9240-2; HUNER NPA, 1993, PHOTOSYNTH RES, V37, P19, DOI 10.1007/BF02185436; Kalaji HM, 2014, PLANT PHYSIOL BIOCH, V81, P16, DOI 10.1016/j.plaphy.2014.03.029; Kalaji HM, 2012, J PHOTOCH PHOTOBIO B, V112, P1, DOI 10.1016/j.jphotobiol.2012.03.009; Kalaji HM, 2011, OMICS, V15, P925, DOI 10.1089/omi.2011.0070; Kalaji HM, 2011, ENVIRON EXP BOT, V73, P64, DOI 10.1016/j.envexpbot.2010.10.009; LIMIN AE, 1985, CAN J PLANT SCI, V65, P487, DOI 10.4141/cjps85-070; Mishra A, 2011, PLANT SIGNAL BEHAV, V6, P301, DOI 10.4161/psb.6.2.15278; Neuner G, 1999, J APPL BOT-ANGEW BOT, V73, P50; Prasil IT, 2007, FIELD CROP RES, V102, P1, DOI 10.1016/j.fcr.2006.12.012; Rapacz M, 2008, J AGRON CROP SCI, V194, P61, DOI 10.1111/j.1439-037X.2007.00292.x; Rapacz M, 2007, PHOTOSYNTHETICA, V45, P409, DOI 10.1007/s11099-007-0069-2; Rapacz M, 2004, NEW PHYTOL, V162, P105, DOI 10.1111/j.1469-8137.2004.01024.x; Rapacz M, 2011, J AGRON CROP SCI, V197, P378, DOI 10.1111/j.1439-037X.2011.00472.x; Rapacz M, 2010, J AGRON CROP SCI, V196, P9, DOI 10.1111/j.1439-037X.2009.00389.x; Rapacz M, 2009, PLANT BREEDING, V128, P227, DOI 10.1111/j.1439-0523.2008.01566.x; Rapacz M, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1907-7; Rapacz M, 2014, PLANT SCI, V225, P34, DOI 10.1016/j.plantsci.2014.05.009; Rizza F, 2001, PLANT BREEDING, V120, P389, DOI 10.1046/j.1439-0523.2001.00635.x; Sandve SR, 2011, PLANT SCI, V180, P69, DOI 10.1016/j.plantsci.2010.07.011; Soja G, 1998, PHYSIOL PLANTARUM, V104, P639, DOI 10.1034/j.1399-3054.1998.1040417.x; STEPONKUS PL, 1984, ANNU REV PLANT PHYS, V35, P543, DOI 10.1146/annurev.pp.35.060184.002551; Strasser R.J., 2000, PROBING PHOTOSYNTHES, P445; Strasser RJ, 2004, ADV PHOTO RESPIRAT, V19, P321; STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x; Taulavuori K, 2000, J PLANT PHYSIOL, V157, P227, DOI 10.1016/S0176-1617(00)80195-9; Yan K, 2013, IND CROP PROD, V50, P809, DOI 10.1016/j.indcrop.2013.08.012; Yan K, 2013, ACTA PHYSIOL PLANT, V35, P2867, DOI 10.1007/s11738-013-1325-7; Yan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062100; Zurek G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091475	40	40	40	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134820	10.1371/journal.pone.0134820	http://dx.doi.org/10.1371/journal.pone.0134820			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230839	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400172
J	Romsang, A; Duang-nkern, J; Wirathorn, W; Vattanaviboon, P; Mongkolsuk, S				Romsang, Adisak; Duang-nkern, Jintana; Wirathorn, Wilaiwan; Vattanaviboon, Paiboon; Mongkolsuk, Skorn			Pseudomonas aeruginosa IscR-Regulated Ferredoxin NADP(+) Reductase Gene (fprB) Functions in Iron-Sulfur Cluster Biogenesis and Multiple Stress Response	PLOS ONE			English	Article							ESCHERICHIA-COLI; DEPENDENT REGULATION; OXIDATIVE STRESS; SUCCINATE-DEHYDROGENASE; SUPEROXIDE STRESS; SOXRS RESPONSE; EXPRESSION; BINDING; 4FE-4S; SUSCEPTIBILITY	P. aeruginosa (PAO1) has two putative genes encoding ferredoxin NADP(+) reductases, denoted fprA and fprB. Here, the regulation of fprB expression and the protein's physiological roles in [4Fe-4S] cluster biogenesis and stress protection are characterized. The fprB mutant has defects in [4Fe-4S] cluster biogenesis, as shown by reduced activities of [4Fe-4S] cluster-containing enzymes. Inactivation of the gene resulted in increased sensitivity to oxidative, thiol, osmotic and metal stresses compared with the PAO1 wild type. The increased sensitivity could be partially or completely suppressed by high expression of genes from the isc operon, which are involved in [Fe-S] cluster biogenesis, indicating that stress sensitivity in the fprB mutant is partially caused by a reduction in levels of [4Fe-4S] clusters. The pattern and regulation of fprB expression are in agreement with the gene physiological roles; fprB expression was highly induced by redox cycling drugs and diamide and was moderately induced by peroxides, an iron chelator and salt stress. The stress-induced expression of fprB was abolished by a deletion of the iscR gene. An IscR DNA-binding site close to fprB promoter elements was identified and confirmed by specific binding of purified IscR. Analysis of the regulation of fprB expression supports the role of IscR in directly regulating fprB transcription as a transcription activator. The combination of IscRr-egulated expression of fprB and the fprB roles in response to multiple stressors emphasizes the importance of [Fe-S] cluster homeostasis in both gene regulation and stress protection.	[Romsang, Adisak; Wirathorn, Wilaiwan; Mongkolsuk, Skorn] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand; [Duang-nkern, Jintana; Vattanaviboon, Paiboon; Mongkolsuk, Skorn] Chulabhorn Res Inst, Biotechnol Lab, Bangkok, Thailand; [Vattanaviboon, Paiboon; Mongkolsuk, Skorn] Mahidol Univ, Fac Sci, Ctr Excellence Emerging Bacterial Infect, Bangkok 10400, Thailand; [Vattanaviboon, Paiboon] Chulabhorn Grad Inst, Program Appl Biol Sci Environm Hlth, Bangkok, Thailand; [Mongkolsuk, Skorn] Minist Educ, Ctr Excellence Environm Hlth & Toxicol EHT, Bangkok, Thailand	Mahidol University; Chulabhorn Research Institute; Mahidol University; Chulabhorn Graduate Institute	Mongkolsuk, S (corresponding author), Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand.	skorn.mon@mahidol.ac.th	Vattanaviboon, Paiboon/V-1380-2019; Romsang, Adisak/K-2630-2019; Romsang, Adisak/H-7142-2014	Romsang, Adisak/0000-0002-5339-5443; Romsang, Adisak/0000-0002-5339-5443	Center of Excellence on Environmental Health and Toxicology, Ministry of Education, Thailand; Chulabhorn Research Institute; Royal Golden Jubilee Ph.D. Program from Thailand Research Fund [PHD/0294/2550]; Royal Golden Jubilee Ph.D. Program from Mahidol University [PHD/0294/2550]	Center of Excellence on Environmental Health and Toxicology, Ministry of Education, Thailand; Chulabhorn Research Institute; Royal Golden Jubilee Ph.D. Program from Thailand Research Fund; Royal Golden Jubilee Ph.D. Program from Mahidol University	This work was supported by grants from the Center of Excellence on Environmental Health and Toxicology, Ministry of Education, Thailand (http://www.etm.sc.mahidol.ac.th/index.asp), the Chulabhorn Research Institute (http://www.cri.or.th/en/index.php) and by the Royal Golden Jubilee Ph.D. Program (PHD/0294/2550) from the joint funding of Thailand Research Fund and Mahidol University (http://rgj.trf.or.th/eng/rgje11.asp). Parts of this work are from A.R. dissertation submitted for a Ph.D. degree from Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Arai H, 1997, MOL MICROBIOL, V25, P1141, DOI 10.1046/j.1365-2958.1997.5431906.x; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; BIANCHI V, 1995, J BACTERIOL, V177, P4528, DOI 10.1128/jb.177.15.4528-4531.1995; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Carrillo N, 2003, EUR J BIOCHEM, V270, P1900, DOI 10.1046/j.1432-1033.2003.03566.x; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; Daung-nkern J, 2010, J ANTIMICROB CHEMOTH, V65, P1831, DOI 10.1093/jac/dkq194; Eiamphungporn W, 2006, J BACTERIOL, V188, P8669, DOI 10.1128/JB.00856-06; EnosBerlage JL, 1997, J BACTERIOL, V179, P3989, DOI 10.1128/jb.179.12.3989-3996.1997; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Giro M, 2006, MICROBIOL-SGM, V152, P1119, DOI 10.1099/mic.0.28612-0; Hassett DJ, 1996, J BACTERIOL, V178, P3996, DOI 10.1128/jb.178.14.3996-4003.1996; Jang SJ, 2010, MOL MICROBIOL, V78, P1448, DOI 10.1111/j.1365-2958.2010.07418.x; JOHNSON MK, 1985, J BIOL CHEM, V260, P7368; Jouanneau Y, 1998, EUR J BIOCHEM, V251, P54, DOI 10.1046/j.1432-1327.1998.2510054.x; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; Kobayashi K, 2004, J BIOCHEM, V136, P607, DOI 10.1093/jb/mvh168; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Krapp AR, 2002, J BACTERIOL, V184, P1474, DOI 10.1128/JB.184.5.1474-1480.2002; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Tondo ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027124; Lee, 2007, J MICROBIOL BIOTECHN, V17, P1504; Lee Y, 2006, BIOCHEM BIOPH RES CO, V339, P1246, DOI 10.1016/j.bbrc.2005.11.135; Lewis TA, 2013, J BACTERIOL, V195, P3876, DOI 10.1128/JB.00528-13; Loprasert S, 2003, ARCH MICROBIOL, V180, P498, DOI 10.1007/s00203-003-0621-9; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Mahavihakanont A, 2012, J BACTERIOL, V194, P209, DOI 10.1128/JB.05603-11; Medina M, 2008, PROTEINS, V72, P848, DOI 10.1002/prot.21979; Membrillo-Hernandez J, 1999, J BIOL CHEM, V274, P748, DOI 10.1074/jbc.274.2.748; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Nesbit AD, 2009, J MOL BIOL, V387, P28, DOI 10.1016/j.jmb.2009.01.055; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Palma M, 2005, INFECT IMMUN, V73, P2958, DOI 10.1128/IAI.73.5.2958-2966.2005; Park W, 2006, BIOCHEM BIOPH RES CO, V341, P51, DOI 10.1016/j.bbrc.2005.12.142; Prasad GS, 1998, PROTEIN SCI, V7, P2541, DOI 10.1002/pro.5560071207; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Rajagopalan S, 2013, NAT STRUCT MOL BIOL, V20, P740, DOI 10.1038/nsmb.2568; Ranquet C, 2007, J BIOL CHEM, V282, P30442, DOI 10.1074/jbc.M702519200; ROBBINS AH, 1989, P NATL ACAD SCI USA, V86, P3639, DOI 10.1073/pnas.86.10.3639; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Romsang A, 2015, INT J ANTIMICROB AG, V45, P314, DOI 10.1016/j.ijantimicag.2014.10.024; Romsang A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086763; Romsang A, 2013, J BACTERIOL, V195, P3299, DOI 10.1128/JB.00167-13; Sambrook J., 2001, MOL CLONING LAB MANU; Schreiber K, 2007, J BACTERIOL, V189, P4310, DOI 10.1128/JB.00240-07; Shin M, 2004, PHOTOSYNTH RES, V80, P307, DOI 10.1023/B:PRES.0000030456.96329.f9; Somprasong N, 2012, J BACTERIOL, V194, P3904, DOI 10.1128/JB.00347-12; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Takeda K, 2010, BIOMETALS, V23, P727, DOI 10.1007/s10534-010-9339-8; Thorgersen MP, 2009, MICROBIOL-SGM, V155, P295, DOI 10.1099/mic.0.020727-0; Wang A, 2007, BIOCHEMISTRY-US, V46, P12198, DOI 10.1021/bi7013135; Weeratunga SK, 2009, BIOCHEMISTRY-US, V48, P7420, DOI 10.1021/bi900561a; Xu FF, 2012, APPL ENVIRON MICROB, V78, P3614, DOI 10.1128/AEM.07368-11; Yan R, 2015, BBA-PROTEINS PROTEOM, V1854, P1113, DOI 10.1016/j.bbapap.2015.02.002; Yao HL, 2011, BIOCHEMISTRY-US, V50, P5236, DOI 10.1021/bi2004119; Yeom J, 2010, J BIOL CHEM, V285, P22689, DOI 10.1074/jbc.M110.127456; Yeom J, 2009, J BACTERIOL, V191, P1472, DOI 10.1128/JB.01473-08; Yeom S, 2010, MICROBIOL-SGM, V156, P1487, DOI 10.1099/mic.0.034181-0	60	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134374	10.1371/journal.pone.0134374	http://dx.doi.org/10.1371/journal.pone.0134374			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230408	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400112
J	Wagner, CS; Horlings, E; Whetsell, TA; Mattsson, P; Nordqvist, K				Wagner, Caroline S.; Horlings, Edwin; Whetsell, Travis A.; Mattsson, Pauline; Nordqvist, Katarina			Do Nobel Laureates Create Prize-Winning Networks? An Analysis of Collaborative Research in Physiology or Medicine	PLOS ONE			English	Article							AGE; DYNAMICS; PATTERNS	Nobel Laureates in Physiology or Medicine who received the Prize between 1969 and 2011 are compared to a matched group of scientists to examine productivity, impact, coauthorship and international collaboration patterns embedded within research networks. After matching for research domain, h-index, and year of first of publication, we compare bibliometric statistics and network measures. We find that the Laureates produce fewer papers but with higher average citations. The Laureates also produce more sole-authored papers both before and after winning the Prize. The Laureates have a lower number of coauthors across their entire careers than the matched group, but are equally collaborative on average. Further, we find no differences in international collaboration patterns. The Laureates coauthor network reveals significant differences from the non-Laureate network. Laureates are more likely to build bridges across a network when measuring by average degree, density, modularity, and communities. Both the Laureate and non- Laureate networks have "small world" properties, but the Laureates appear to exploit "structural holes" by reaching across the network in a brokerage style that may add social capital to the network. The dynamic may be making the network itself highly attractive and selective. These findings suggest new insights into the role "star scientists" in social networks and the production of scientific discoveries.	[Wagner, Caroline S.; Whetsell, Travis A.] Ohio State Univ, John Glenn Coll Publ Affairs, Battelle Ctr Sci & Technol Policy, Columbus, OH 43210 USA; [Horlings, Edwin] Rathenau Inst, The Hague, Netherlands; [Mattsson, Pauline] Karolinska Inst, Dept Learning Informat Management & Eth LIME, S-17177 Stockholm, Sweden; [Nordqvist, Katarina] Nobel Museum, S-10316 Stockholm, Sweden	University System of Ohio; Ohio State University; Royal Netherlands Academy of Arts & Sciences; Rathenau Institute (KNAW); Karolinska Institutet	Wagner, CS (corresponding author), Ohio State Univ, John Glenn Coll Publ Affairs, Battelle Ctr Sci & Technol Policy, Columbus, OH 43210 USA.	wagner.911@osu.edu	Wagner, Caroline S/A-7170-2012; Nordqvist, Katarina/B-7964-2016	Wagner, Caroline S/0000-0002-1724-8489; Nordqvist, Katarina/0000-0001-9561-5590	Battelle Center for Science and Technology Policy; Swedish Research Council [B0210101]	Battelle Center for Science and Technology Policy; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding was provided by the Battelle Center for Science and Technology Policy. Katarina Nordqvist and Pauline Mattsson acknowledge support from the Swedish Research Council (grant B0210101).	Azoulay P, 2014, MANAGE SCI, V60, P92, DOI 10.1287/mnsc.2013.1755; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bornholdt S, 2013, ARXIV13017471V1; Boyack KW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018029; Burt RS, 2000, RES ORGAN BEHAV, V22, P345, DOI 10.1016/S0191-3085(00)22009-1; BURT RS, 1980, ANNU REV SOCIOL, V6, P79, DOI 10.1146/annurev.so.06.080180.000455; De Nooy W., 2011, EXPLORATORY SOCIAL N, V27; Doran KB, 2013, NAT BUR EC RES; Galenson DW, 2005, NAT BUR EC RES; GARFIELD E, 1992, THEOR MED, V13, P117, DOI 10.1007/BF02163625; Garfield E, 1968, P 135 M AAAS DALL TX; Gingras Y, 2010, SCIENTOMETRICS, V82, P401, DOI 10.1007/s11192-009-0035-9; Gurney T, 2012, SCIENTOMETRICS, V91, P435, DOI 10.1007/s11192-011-0589-1; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hollingsworth J. R., 2013, EXCEPTIONAL CREATIVI, P25; Horlings E, 2013, SCIENTOMETRICS, V94, P1137, DOI 10.1007/s11192-012-0789-3; Jacomy M., 2009, P INT AAAI C WEBL SO; Jones BF, 2011, P NATL ACAD SCI USA, V108, P18910, DOI 10.1073/pnas.1102895108; MANNICHE E, 1957, BEHAV SCI, V2, P301; Monge P. R., 2003, THEORIES COMMUNICATI, DOI 10.1093/oso/9780195160369.001.0001; PRICE DJD, 1966, AM PSYCHOL, V21, P1011; Sher IH, 1965, P C SPONS OFF NAV RE, P135; Somers A., 2009, SCI ASSESSMENT INTEG; STEPHAN PE, 1993, SCIENTOMETRICS, V28, P387, DOI 10.1007/BF02026517; Wagner CS, 2005, RES POLICY, V34, P1608, DOI 10.1016/j.respol.2005.08.002; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Whitley R, 1984, INTELLECTUAL SOCIAL; Wren JD, 2007, EMBO REP, V8, P988, DOI 10.1038/sj.embor.7401095; Zucker LG, 1996, P NATL ACAD SCI USA, V93, P12709, DOI 10.1073/pnas.93.23.12709; ZUCKERMAN H, 1967, AM SOCIOL REV, V32, P391, DOI 10.2307/2091086	30	34	35	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134164	10.1371/journal.pone.0134164	http://dx.doi.org/10.1371/journal.pone.0134164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230622	Green Published, gold			2022-12-27	WOS:000358838400082
J	Butler, BE; Hall, AJ; Lomber, SG				Butler, Blake E.; Hall, Amee J.; Lomber, Stephen G.			High-Field Functional Imaging of Pitch Processing in Auditory Cortex of the Cat	PLOS ONE			English	Article							BOLD SIGNAL CHANGES; SOUND LOCALIZATION; POSTERIOR FIELD; TONOTOPIC MAPS; REPRESENTATION; ORGANIZATION; PERIODICITY; PERCEPTION; RESPONSES; NOISE	The perception of pitch is a widely studied and hotly debated topic in human hearing. Many of these studies combine functional imaging techniques with stimuli designed to disambiguate the percept of pitch from frequency information present in the stimulus. While useful in identifying potential "pitch centres" in cortex, the existence of truly pitch-responsive neurons requires single neuron-level measures that can only be undertaken in animal models. While a number of animals have been shown to be sensitive to pitch, few studies have addressed the location of cortical generators of pitch percepts in non-human models. The current study uses high-field functional magnetic resonance imaging (fMRI) of the feline brain in an attempt to identify regions of cortex that show increased activity in response to pitch-evoking stimuli. Cats were presented with iterated rippled noise (IRN) stimuli, narrowband noise stimuli with the same spectral profile but no perceivable pitch, and a processed IRN stimulus in which phase components were randomized to preserve slowly changing modulations in the absence of pitch (IRNo). Pitch-related activity was not observed to occur in either primary auditory cortex (A1) or the anterior auditory field (AAF) which comprise the core auditory cortex in cats. Rather, cortical areas surrounding the posterior ectosylvian sulcus responded preferentially to the IRN stimulus when compared to narrowband noise, with group analyses revealing bilateral activity centred in the posterior auditory field (PAF). This study demonstrates that fMRI is useful for identifying pitch-related processing in cat cortex, and identifies cortical areas that warrant further investigation. Moreover, we have taken the first steps in identifying a useful animal model for the study of pitch perception.	[Butler, Blake E.; Lomber, Stephen G.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Butler, Blake E.; Lomber, Stephen G.] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Hall, Amee J.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; [Lomber, Stephen G.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Lomber, Stephen G.] Univ Western Ontario, Natl Ctr Audiol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Butler, BE (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.	bbutler9@uwo.ca	Lomber, Stephen/B-6820-2015	Lomber, Stephen/0000-0002-3001-7909	Natural Sciences and Engineering Research Council; Canadian Institutes for Health Research; Canada Foundation for Innovation	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	Funding for this project was provided by the Natural Sciences and Engineering Research Council, the Canadian Institutes for Health Research, and the Canada Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker D, 2012, CEREB CORTEX, V22, P745, DOI 10.1093/cercor/bhr065; Barker D, 2011, NEUROREPORT, V22, P111, DOI 10.1097/WNR.0b013e328342ba30; Belin P, 1999, NEUROIMAGE, V10, P417, DOI 10.1006/nimg.1999.0480; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Brown TA, 2013, NEUROIMAGE, V64, P458, DOI 10.1016/j.neuroimage.2012.09.034; Butler BE, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00180; CHUNG DY, 1976, PERCEPT PSYCHOPHYS, V20, P433, DOI 10.3758/BF03208278; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; DYSON DH, 1988, CAN J VET RES, V52, P419; Fishman YI, 1998, BRAIN RES, V786, P18, DOI 10.1016/S0006-8993(97)01423-6; Griffiths TD, 2001, NAT NEUROSCI, V4, P633, DOI 10.1038/88459; Hall AJ, 2014, J NEUROSCI METH, V224, P96, DOI 10.1016/j.jneumeth.2013.12.012; Hall DA, 2005, J NEUROPHYSIOL, V94, P3181, DOI 10.1152/jn.00271.2005; Hall DA, 2007, NEUROREPORT, V18, P323, DOI 10.1097/WNR.0b013e32802b70ce; Hall DA, 2009, CEREB CORTEX, V19, P576, DOI 10.1093/cercor/bhn108; Harrington IA, 2008, HEARING RES, V240, P22, DOI 10.1016/j.heares.2008.02.004; HEFFNER H, 1976, J ACOUST SOC AM, V59, P915, DOI 10.1121/1.380951; Heil P, 1998, CEREB CORTEX, V8, P125, DOI 10.1093/cercor/8.2.125; HU XP, 1994, MAGN RESON MED, V31, P495, DOI 10.1002/mrm.1910310505; IMIG TJ, 1980, J COMP NEUROL, V192, P293, DOI 10.1002/cne.901920208; Kastrup A, 2008, NEUROIMAGE, V41, P1364, DOI 10.1016/j.neuroimage.2008.03.049; Klassen LM, 2004, MAGN RESON MED, V51, P881, DOI 10.1002/mrm.20094; Langers D, 2014, INT C AUD CORT MAGD; Langner G, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.027.2009; Lee CC, 2011, HEARING RES, V274, P85, DOI 10.1016/j.heares.2010.05.008; Loftus WC, 2001, J NEUROPHYSIOL, V86, P475, DOI 10.1152/jn.2001.86.1.475; Malhotra S, 2007, J NEUROPHYSIOL, V97, P26, DOI 10.1152/jn.00720.2006; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; Olfert ED, 1993, GUIDE CARE USE EXPT, V1; Oxenham AJ, 2012, J NEUROSCI, V32, P13335, DOI 10.1523/JNEUROSCI.3815-12.2012; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Patterson RD, 1996, J ACOUST SOC AM, V100, P3286, DOI 10.1121/1.417212; Penagos H, 2004, J NEUROSCI, V24, P6810, DOI 10.1523/JNEUROSCI.0383-04.2004; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; PHILLIPS DP, 1984, J NEUROPHYSIOL, V51, P147, DOI 10.1152/jn.1984.51.1.147; Puschmann S, 2010, NEUROIMAGE, V49, P1641, DOI 10.1016/j.neuroimage.2009.09.045; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; Schafer K, 2012, NEUROIMAGE, V59, P3119, DOI 10.1016/j.neuroimage.2011.11.085; Schulze H, 2002, EUR J NEUROSCI, V15, P1077, DOI 10.1046/j.1460-9568.2002.01935.x; Stecker GC, 2003, BIOL CYBERN, V89, P341, DOI 10.1007/s00422-003-0439-1; Tian B, 1998, J NEUROPHYSIOL, V79, P2629, DOI 10.1152/jn.1998.79.5.2629	42	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134362	10.1371/journal.pone.0134362	http://dx.doi.org/10.1371/journal.pone.0134362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225563	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700079
J	Chen, C; Cai, JJ; Zhang, S; Gan, L; Dong, YL; Zhu, T; Ma, G; Li, T; Zhang, XY; Li, Q; Cheng, X; Wu, CM; Yang, J; Zuo, YX; Liu, J				Chen, Chan; Cai, Jingjing; Zhang, Shu; Gan, Lu; Dong, Yuanlin; Zhu, Tao; Ma, Gang; Li, Tao; Zhang, Xiyang; Li, Qian; Cheng, Xu; Wu, Chaomeng; Yang, Jing; Zuo, Yunxia; Liu, Jin			Protective Effect of RNase on Unilateral Nephrectomy-Induced Postoperative Cognitive Dysfunction in Aged Mice	PLOS ONE			English	Article							EXTRACELLULAR RNA; SURGERY; DECLINE; RESPONSES; DELIRIUM; BRAIN; DRUGS	Postoperative cognitive dysfunction (POCD) is a common complication after surgery, especially for elderly patients. Administration of RNase has been reported to exhibit neuroprotective effects in acute stroke. However, the potential role of RNase on POCD is unknown. Therefore, we sought to investigate whether RNase treatment could mitigate unilateral nephrectomy induced-cognitive deficit in aged mice. In the present study, twelve-month-old mice were administered RNase or an equal amount of normal saline perioperatively. All mice underwent Morris Water Maze (MWM) training 3 times per day for 7 days to acclimatize them to the water maze before surgical operation, and testing on days 1, 3 and 7 after surgery. We found that perioperative administration of RNase: 1) attenuated unilateral nephrectomy-induced cognitive impairment at day 3 after surgery; 2) reduced the hippocampal cytokines mRNA production and serum cytokines protein production at day 1 and day 7 (for MCP-1) after surgery, and; 3) inhibited hippocampal apoptosis as indicated by cleaved caspase-3 western blot and TUNEL staining at day 1 after surgery. In addition, a trend decrease of total serum RNA levels was detected in the RNase treated group after surgery compared with the untreated group. Further, our protocol of RNase administration had no impact on the arterial blood gas analysis right after surgery, kidney function and mortality rate at the observed days postoperatively. In conclusion, perioperative RNase treatment attenuated unilateral nephrectomy-induced cognitive impairment in aged mice.	[Chen, Chan; Cai, Jingjing; Gan, Lu; Zhu, Tao; Ma, Gang; Li, Tao; Zhang, Xiyang; Li, Qian; Cheng, Xu; Wu, Chaomeng; Yang, Jing; Zuo, Yunxia; Liu, Jin] Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu 610064, Sichuan, Peoples R China; [Chen, Chan; Cai, Jingjing; Gan, Lu; Zhu, Tao; Ma, Gang; Li, Tao; Zhang, Xiyang; Li, Qian; Cheng, Xu; Wu, Chaomeng; Yang, Jing; Zuo, Yunxia; Liu, Jin] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Shu] Sichuan Univ, West China Hosp, Dept Emergency Med, Chengdu 610064, Sichuan, Peoples R China; [Dong, Yuanlin] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Geriatr Anesthesia Res Unit, Boston, MA 02114 USA; [Dong, Yuanlin] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Sichuan University; Sichuan University; Sichuan University; Harvard University; Massachusetts General Hospital; Harvard University	Li, T (corresponding author), Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu 610064, Sichuan, Peoples R China.	xwtao_zhu@yahoo.com	Li, Tao/ADA-1377-2022	Dong, Yuanlin/0000-0002-4760-0519; Chen, Chan/0000-0001-5823-8247; Liu, Jin/0000-0002-2026-2513	China Medical Board [0082827601157]; Science and Technology Pillar Program of Sichuan Province Research Grant [2014sz0056]	China Medical Board; Science and Technology Pillar Program of Sichuan Province Research Grant	This work was financially supported by Distinguished Professorships Awards (no. 0082827601157, to JL) from the China Medical Board (URLs: http://www.chinamedicalboard.org/active_grants), and the Science and Technology Pillar Program of Sichuan Province Research Grant (no. 2014sz0056, to CC) (URLs: http://xmgl.scst.gov.cn/index.html).	Ballard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037410; BAYNES JW, 1976, J BIOL CHEM, V251, P6016; Cao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051431; Chen C, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000683; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Cunningham C, 2012, J NEUROIMMUNE PHARM, V7, P60, DOI 10.1007/s11481-011-9312-5; Deiner S, 2009, Br J Anaesth, V103 Suppl 1, pi41, DOI 10.1093/bja/aep291; Evered L, 2011, ANESTH ANALG, V112, P1179, DOI 10.1213/ANE.0b013e318215217e; Field R, 2010, BRAIN BEHAV IMMUN, V24, P996, DOI 10.1016/j.bbi.2010.04.004; Fischer S, 2007, BLOOD, V110, P2457, DOI 10.1182/blood-2006-08-040691; He HJ, 2012, CNS NEUROSCI THER, V18, P994, DOI 10.1111/cns.12018; Kong FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061385; Lee DC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-56; Li YC, 2012, ACTA ANAESTH SCAND, V56, P595, DOI 10.1111/j.1399-6576.2011.02616.x; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Rosczyk HA, 2008, EXP GERONTOL, V43, P840, DOI 10.1016/j.exger.2008.06.004; Rudolph JL, 2008, J GERONTOL A-BIOL, V63, P184, DOI 10.1093/gerona/63.2.184; Rybak SM, 2009, CURR PHARM DESIGN, V15, P2665, DOI 10.2174/138161209788923921; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Simsekyilmaz S, 2014, CIRCULATION, V129, P598, DOI 10.1161/CIRCULATIONAHA.113.002562; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Vizcaychipi MP, 2014, ANN SURG, V259, P1235, DOI 10.1097/SLA.0000000000000257; Vlisides P, 2014, J ANESTH PERIOPER ME, V1, P60; Walberer M, 2009, CURR NEUROVASC RES, V6, P12, DOI 10.2174/156720209787466037; Wan YJ, 2010, CRIT CARE MED, V38, P2190, DOI 10.1097/CCM.0b013e3181f17bcb	28	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134307	10.1371/journal.pone.0134307	http://dx.doi.org/10.1371/journal.pone.0134307			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225860	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700071
J	Hu, ZL; Holzschuh, J; Driever, W				Hu, Zhilian; Holzschuh, Jochen; Driever, Wolfgang			Loss of DDB1 Leads to Transcriptional p53 Pathway Activation in Proliferating Cells, Cell Cycle Deregulation, and Apoptosis in Zebrafish Embryos	PLOS ONE			English	Article							DNA-BINDING PROTEIN-1; NUCLEOTIDE EXCISION-REPAIR; UBIQUITIN LIGASE; DAMAGED DNA; GENOME STABILITY; S-PHASE; XERODERMA-PIGMENTOSUM; DANIO-RERIO; GENES DDB1; DEGRADATION	DNA damage-binding protein 1 (DDB1) is a large subunit of the heterodimeric DDB complex that recognizes DNA lesions and initiates the nucleotide excision repair process. DDB1 is also a component of the CUL4 E3 ligase complex involved in a broad spectrum of cellular processes by targeted ubiquitination of key regulators. Functions of DDB1 in development have been addressed in several model organisms, however, are not fully understood so far. Here we report an ENU induced mutant ddb1 allele (ddb1(m863)) identified in zebrafish (Danio rerio), and analyze its effects on development. Zebrafish ddb1 is expressed broadly, both maternally and zygotically, with enhanced expression in proliferation zones. The (ddb1(m863) mutant allele affects the splice acceptor site of exon 20, causing a splicing defect that results in truncation of the 1140 amino acid protein after residue 800, lacking part of the beta-propeller domain BPC and the C-terminal helical domain CTD. ddb1(m863) zygotic mutant embryos have a pleiotropic phenotype, including smaller and abnormally shaped brain, head skeleton, eyes, jaw, and branchial arches, as well as reduced dopaminergic neuron groups. However, early forming tissues develop normally in zygotic ddb1(m863) mutant embryos, which may be due to maternal rescue. In ddb1(m863) mutant embryos, pcna-expressing proliferating cell populations were reduced, concurrent with increased apoptosis. We also observed a concomitant strong up-regulation of transcripts of the tumor suppressor p53 (tp53) and the cell cycle inhibitor cdkn1a (p21a/b(CIP1/WAF1)) in proliferating tissues. In addition, transcription of cyclin genes ccna2 and ccnd1 was deregulated in ddb1(m863) mutants. Reduction of p53 activity by anti-sense morpholinos alleviated the apoptotic phenotype in ddb1(m863) mutants. These results imply that Ddb1 may be involved in maintaining proper cell cycle progression and viability of dividing cells during development through transcriptional mechanisms regulating genes involved in cell cycle control and cell survival.	[Hu, Zhilian; Holzschuh, Jochen; Driever, Wolfgang] Univ Freiburg, Inst Biol 1, Dev Biol, Fac Biol, D-79104 Freiburg, Germany; [Hu, Zhilian] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Driever, Wolfgang] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Michigan System; University of Michigan; University of Freiburg	Driever, W (corresponding author), Univ Freiburg, Inst Biol 1, Dev Biol, Fac Biol, Hauptstr 1, D-79104 Freiburg, Germany.	driever@biologie.uni-freiburg.de	HU, ZHILIANN/AIF-3594-2022	Driever, Wolfgang/0000-0002-9551-9141; HU, ZHILIAN/0000-0002-1632-6318	LGFG (State of Baden-Wurttemberg); EC; Excellence Initiative of the German Federal Government [DFG BIOSS - EXC 294]; German Research Foundation (DFG); Albert Ludwigs University Freiburg; Excellence Initiative of the German State Government [DFG BIOSS - EXC 294]	LGFG (State of Baden-Wurttemberg); EC(European CommissionEuropean Commission Joint Research Centre); Excellence Initiative of the German Federal Government; German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg; Excellence Initiative of the German State Government	This work was supported by a fellowship of the LGFG (State of Baden-Wurttemberg; www.mwk.baden-wuerttemberg.de) (ZH), by the EC programs EU-FP6 IP ZF-MODELS and EU-FP7 IP ZF-HEALTH (www.http://ec.europa.eu/research/), and the Excellence Initiative of the German Federal and State Governments (DFG BIOSS - EXC 294; www.dfg.de). The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2011, CELL CYCLE, V10, P241, DOI 10.4161/cc.10.2.14530; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Banks D, 2006, CELL CYCLE, V5, P1719, DOI 10.4161/cc.5.15.3150; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bernhardt A, 2006, PLANT J, V47, P591, DOI 10.1111/j.1365-313X.2006.02810.x; Bernhardt A, 2010, PLANTA, V232, P555, DOI 10.1007/s00425-010-1195-9; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Bevilacqua MA, 2005, J BIOL CHEM, V280, P31809, DOI 10.1074/jbc.M414677200; Bondar T, 2006, MOL CELL BIOL, V26, P2531, DOI 10.1128/MCB.26.7.2531-2539.2006; Bondar T, 2004, J BIOL CHEM, V279, P9937, DOI 10.1074/jbc.M312570200; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Cang Y, 2007, P NATL ACAD SCI USA, V104, P2733, DOI 10.1073/pnas.0611311104; Cang Y, 2006, CELL, V127, P929, DOI 10.1016/j.cell.2006.09.045; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Cheng R, 1997, MOL MAR BIOL BIOTECH, V6, P88; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; Cid E, 2002, CELL TISSUE RES, V308, P47, DOI 10.1007/s00441-002-0529-8; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Desdouets C, 1996, FEBS LETT, V385, P34, DOI 10.1016/0014-5793(96)00330-4; DUALAN R, 1995, GENOMICS, V29, P62, DOI 10.1006/geno.1995.1215; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Fukumoto Y, 2008, MOL CELL BIOL, V28, P6746, DOI 10.1128/MCB.00757-08; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Guo ZY, 2009, BBA-GENE REGUL MECH, V1789, P758, DOI 10.1016/j.bbagrm.2009.09.011; Harashima H, 2013, TRENDS CELL BIOL, V23, P345, DOI 10.1016/j.tcb.2013.03.002; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hauptmann G, 2000, METH MOL B, V137, P139; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Holmberg C, 2005, GENE DEV, V19, P853, DOI 10.1101/gad.329905; Hotton SK, 2008, ANNU REV PLANT BIOL, V59, P467, DOI 10.1146/annurev.arplant.58.032806.104011; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Hurley PJ, 2007, CELL CYCLE, V6, P414, DOI 10.4161/cc.6.4.3886; Hyun DH, 2010, NEUROSCI LETT, V477, P115, DOI 10.1016/j.neulet.2010.04.045; Iovine B, 2011, INT J BIOCHEM CELL B, V43, P1664, DOI 10.1016/j.biocel.2011.09.001; Iovine B, 2011, BIOCHIMIE, V93, P867, DOI 10.1016/j.biochi.2010.12.017; Iovine B, 2009, BIOCHIMIE, V91, P364, DOI 10.1016/j.biochi.2008.10.017; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jin SK, 2001, J CELL SCI, V114, P4139; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; Kim SH, 2008, MOL CELL, V32, P757, DOI 10.1016/j.molcel.2008.11.016; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lee Kyu-Sung, 1992, Yonsei Medical Journal, V33, P265; Li JY, 2006, CANCER RES, V66, P8590, DOI 10.1158/0008-5472.CAN-06-1115; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Lv XB, 2010, J BIOL CHEM, V285, P18234, DOI 10.1074/jbc.M109.094144; Masai I, 2005, DEVELOPMENT, V132, P1539, DOI 10.1242/dev.01714; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Nichols AF, 2003, NUCLEIC ACIDS RES, V31, P562, DOI 10.1093/nar/gkg152; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Rao KS, 2007, NAT CLIN PRACT NEURO, V3, P162, DOI 10.1038/ncpneuro0448; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rogers N, 2010, NEUROPATH APPL NEURO, V36, P113, DOI [10.1111/j.1365-2990.2009.01063.x, 10.1111/j.1365-2990.2010.01063.x]; Ryu S, 2005, P NATL ACAD SCI USA, V102, P18467, DOI 10.1073/pnas.0506187102; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Shibutani ST, 2008, DEV CELL, V15, P890, DOI 10.1016/j.devcel.2008.10.003; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shimanouchi K, 2006, J BIOCHEM, V139, P51, DOI 10.1093/jb/mvj006; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Soria G, 2010, DNA REPAIR, V9, P358, DOI 10.1016/j.dnarep.2009.12.003; Sugasawa K, 2009, MOL CELL, V36, P642, DOI 10.1016/j.molcel.2009.09.035; Sugiyama M, 2009, P NATL ACAD SCI USA, V106, P20812, DOI 10.1073/pnas.0906464106; Takata K, 2004, GENETICS, V168, P855, DOI 10.1534/genetics.103.025965; Takata K, 2004, BIOCHEM BIOPH RES CO, V323, P1024, DOI 10.1016/j.bbrc.2004.08.182; Takata K, 2002, NUCLEIC ACIDS RES, V30, P3795, DOI 10.1093/nar/gkf490; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Vejrup-Hansen R, 2014, J CELL SCI, V127, P2460, DOI 10.1242/jcs.139816; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wakasugi M, 2007, BIOCHEM BIOPH RES CO, V364, P771, DOI 10.1016/j.bbrc.2007.10.063; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Yamaji S, 2010, P NATL ACAD SCI USA, V107, P22237, DOI 10.1073/pnas.1015793108; ZHANG Y, 2008, EURASIP J ADV SIG PR, V2008, P1, DOI DOI 10.1155/2008/529480; Zhao XH, 2015, HUM MOL GENET, V24, P853, DOI 10.1093/hmg/ddu503; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010; Zolezzi F, 2002, J BIOL CHEM, V277, P41183, DOI 10.1074/jbc.M207890200	92	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134299	10.1371/journal.pone.0134299	http://dx.doi.org/10.1371/journal.pone.0134299			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225764	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700070
J	Galbavy, W; Kaczocha, M; Puopolo, M; Liu, LX; Rebecchi, MJ				Galbavy, William; Kaczocha, Martin; Puopolo, Michelino; Liu, Lixin; Rebecchi, Mario J.			Neuroimmune and Neuropathic Responses of Spinal Cord and Dorsal Root Ganglia in Middle Age	PLOS ONE			English	Article							PERIPHERAL-NERVE INJURY; SATELLITE GLIAL-CELLS; CHRONIC CONSTRICTION; SCIATIC-NERVE; CHRONIC PAIN; MECHANICAL ALLODYNIA; ALZHEIMERS-DISEASE; IMMUNE-SYSTEM; NITRIC-OXIDE; MOUSE MODEL	Prior studies of aging and neuropathic injury have focused on senescent animals compared to young adults, while changes in middle age, particularly in the dorsal root ganglia (DRG), have remained largely unexplored. 14 neuroimmune mRNA markers, previously associated with peripheral nerve injury, were measured in multiplex assays of lumbar spinal cord (LSC), and DRG from young and middle-aged (3, 17 month) naive rats, or from rats subjected to chronic constriction injury (CCI) of the sciatic nerve (after 7 days), or from aged-matched sham controls. Results showed that CD2, CD3e, CD68, CD45, TNF-alpha, IL6, CCL2, ATF3 and TGF beta 1 mRNA levels were substantially elevated in LSC from naive middle-aged animals compared to young adults. Similarly, LSC samples from older sham animals showed increased levels of T-cell and microglial/macrophage markers. CCI induced further increases in CCL2, and IL6, and elevated ATF3 mRNA levels in LSC of young and middle-aged adults. Immunofluorescence images of dorsal horn microglia from middle-aged naive or sham rats were typically hypertrophic with mostly thickened, de-ramified processes, similar to microglia following CCI. Unlike the spinal cord, marker expression profiles in naive DRG were unchanged across age (except increased ATF3); whereas, levels of GFAP protein, localized to satellite glia, were highly elevated in middle age, but independent of nerve injury. Most neuroimmune markers were elevated in DRG following CCI in young adults, yet middle-aged animals showed little response to injury. No age-related changes in nociception (heat, cold, mechanical) were observed in naive adults, or at days 3 or 7 post-CCI. The patterns of marker expression and microglial morphologies in healthy middle age are consistent with development of a para-inflammatory state involving microglial activation and T-cell marker elevation in the dorsal horn, and neuronal stress and satellite cell activation in the DRG. These changes, however, did not affect the establishment of neuropathic pain.	[Galbavy, William; Kaczocha, Martin; Puopolo, Michelino; Liu, Lixin; Rebecchi, Mario J.] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Rebecchi, MJ (corresponding author), SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA.	Mario.Rebecchi@stonybrookmedicine.edu		Kaczocha, Martin/0000-0002-2527-1398; Galbavy, William/0000-0003-0948-9538	Department of Anesthesiology, Stony Brook University School of Medicine; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035949] Funding Source: NIH RePORTER	Department of Anesthesiology, Stony Brook University School of Medicine; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was entirely supported by internal funds of the Department of Anesthesiology, Stony Brook University School of Medicine.	Barrientos RM, 2009, BRAIN BEHAV IMMUN, V23, P450, DOI 10.1016/j.bbi.2009.01.016; Beggs S, 2012, NAT NEUROSCI, V15, P1068, DOI 10.1038/nn.3155; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Calvo M, 2012, LANCET NEUROL, V11, P629, DOI 10.1016/S1474-4422(12)70134-5; Cao L, 2008, EUR J IMMUNOL, V38, P448, DOI 10.1002/eji.200737485; Chung JY, 2010, NEUROCHEM RES, V35, P620, DOI 10.1007/s11064-009-0108-4; CHUNG JM, 1995, NEUROSCI LETT, V183, P54, DOI 10.1016/0304-3940(94)11113-W; Chung YH, 2005, J MOL HISTOL, V36, P325, DOI 10.1007/s10735-005-9001-x; Conde JR, 2006, NEUROBIOL AGING, V27, P1451, DOI 10.1016/j.neurobiolaging.2005.07.012; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Crisp T, 2006, BEHAV BRAIN RES, V166, P159, DOI 10.1016/j.bbr.2005.07.006; Crisp T, 2003, NEUROSCI LETT, V339, P103, DOI 10.1016/S0304-3940(03)00009-0; Di Ieva A, 2014, NEUROSCIENTIST, V20, P403, DOI 10.1177/1073858413513927; Dominguez E, 2010, J NEUROSCI, V30, P5754, DOI 10.1523/JNEUROSCI.5007-09.2010; Eggen BJL, 2013, J NEUROIMMUNE PHARM, V8, P807, DOI 10.1007/s11481-013-9490-4; Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014; Franceschi C, 2001, AGING-CLIN EXP RES, V13, P163, DOI 10.1007/BF03351475; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Gao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062456; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Gemechu JM, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00038; Giunta B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-51; Godbout JP, 2006, NEUROL CLIN, V24, P521, DOI 10.1016/j.ncl.2006.03.010; Gomez-Nicola D, 2008, J NEUROCHEM, V107, P1741, DOI 10.1111/j.1471-4159.2008.05746.x; Grace PM, 2014, NAT REV IMMUNOL, V14, P217, DOI 10.1038/nri3621; Grace PM, 2011, BRAIN BEHAV IMMUN, V25, P1322, DOI 10.1016/j.bbi.2011.04.003; Grace PM, 2011, BRAIN BEHAV IMMUN, V25, P503, DOI 10.1016/j.bbi.2010.11.018; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hoozemans JJM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-171; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Hu P, 2002, NEUROSCIENCE, V112, P23, DOI 10.1016/S0306-4522(02)00065-9; Hu P, 2007, BRAIN BEHAV IMMUN, V21, P599, DOI 10.1016/j.bbi.2006.10.013; Huang CY, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-7; Huang LYM, 2013, GLIA, V61, P1571, DOI 10.1002/glia.22541; Inoue K, 2009, GLIA, V57, P1469, DOI 10.1002/glia.20871; Iwata K, 2004, J OROFAC PAIN, V18, P293; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Johannes CB, 2010, J PAIN, V11, P1230, DOI 10.1016/j.jpain.2010.07.002; Jurgens HA, 2012, EXP NEUROL, V233, P40, DOI 10.1016/j.expneurol.2010.11.014; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Khalil Z, 2001, FREE RADICAL BIO MED, V31, P430, DOI 10.1016/S0891-5849(01)00597-4; KIM YI, 1995, NEUROSCI LETT, V199, P158, DOI 10.1016/0304-3940(95)12038-6; Kullberg S, 2001, BRAIN RES, V899, P169, DOI 10.1016/S0006-8993(01)02222-3; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Latremoliere A, 2008, J NEUROSCI, V28, P8489, DOI 10.1523/JNEUROSCI.2552-08.2008; Leboeuf-Yde C, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-39; Lee WH, 2010, NEUROSCI LETT, V476, P89, DOI 10.1016/j.neulet.2010.04.009; Leite-Almeida H, 2009, PAIN, V144, P57, DOI 10.1016/j.pain.2009.02.024; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; Li K, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/901420; Loram LC, 2009, J NEUROSCI, V29, P14015, DOI 10.1523/JNEUROSCI.3447-09.2009; Lovell JA, 2000, PHARMACOL BIOCHEM BE, V66, P873, DOI 10.1016/S0091-3057(00)00285-9; Mika J, 2008, PAIN, V138, P587, DOI 10.1016/j.pain.2008.02.015; Mika J, 2013, EUR J PHARMACOL, V716, P106, DOI 10.1016/j.ejphar.2013.01.072; Mika J, 2009, EUR J PHARMACOL, V623, P65, DOI 10.1016/j.ejphar.2009.09.030; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; Nakayamada S, 2012, CURR OPIN IMMUNOL, V24, P297, DOI 10.1016/j.coi.2012.01.014; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Novak JC, 1999, BRAIN RES, V833, P308, DOI 10.1016/S0006-8993(99)01522-X; Oakley R, 2014, AGING DIS, V5, P114, DOI 10.14336/AD.2014.0500114; Ohara PT, 2009, NEUROSCIENTIST, V15, P450, DOI 10.1177/1073858409336094; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pickering G, 2006, EUR J PAIN, V10, P749, DOI 10.1016/j.ejpain.2005.12.002; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Ramer MS, 1998, J COMP NEUROL, V394, P38; Rustoen T, 2005, CLIN J PAIN, V21, P513, DOI 10.1097/01.ajp.0000146217.31780.ef; Sacerdote P, 2008, NEUROSCI LETT, V436, P210, DOI 10.1016/j.neulet.2008.03.023; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Sansoni P, 2008, EXP GERONTOL, V43, P61, DOI 10.1016/j.exger.2007.06.008; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Sieber MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026288; Sierra A, 2007, GLIA, V55, P412, DOI 10.1002/glia.20468; Sparkman NL, 2008, NEUROIMMUNOMODULAT, V15, P323, DOI 10.1159/000156474; Stichel CC, 2007, NEUROBIOL AGING, V28, P1507, DOI 10.1016/j.neurobiolaging.2006.07.022; Streit WJ, 2010, AGING DIS, V1, P254; Stuesse SL, 2001, EXP BRAIN RES, V137, P219, DOI 10.1007/s002210000630; Stuesse SL, 2000, NEUROSCI LETT, V287, P121, DOI 10.1016/S0304-3940(00)01142-3; Sweitzer SM, 2002, PAIN, V100, P163, DOI 10.1016/S0304-3959(02)00257-9; Takeda M, 2009, NEUROSCI BIOBEHAV R, V33, P784, DOI 10.1016/j.neubiorev.2008.12.005; Tsuda M, 2009, P NATL ACAD SCI USA, V106, P8032, DOI 10.1073/pnas.0810420106; von Bernhardi R, 2010, J NEUROCHEM, V112, P1099, DOI 10.1111/j.1471-4159.2009.06537.x; Wong WT, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00022; Xie W, 2009, NEUROSCIENCE, V160, P847, DOI 10.1016/j.neuroscience.2009.03.016; Yezierski RP, 2010, J GERONTOL A-BIOL, V65, P353, DOI 10.1093/gerona/glq024; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043	89	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134394	10.1371/journal.pone.0134394	http://dx.doi.org/10.1371/journal.pone.0134394			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241743	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700042
J	Gignoux-Wolfsohn, SA; Vollmer, SV				Gignoux-Wolfsohn, Sarah A.; Vollmer, Steven V.			Identification of Candidate Coral Pathogens on White Band Disease-Infected Staghorn Coral	PLOS ONE			English	Article							PLAGUE-LIKE DISEASE; BACTERIAL COMMUNITIES; REEF CORAL; HEALTHY; DIVERSITY; DYNAMICS; SEAWATER; ECOLOGY; SHIFTS; AGENT	Bacterial diseases affecting scleractinian corals pose an enormous threat to the health of coral reefs, yet we still have a limited understanding of the bacteria associated with coral diseases. White band disease is a bacterial disease that affects the two Caribbean acroporid corals, the staghorn coral Acropora cervicornis and the elkhorn coral A. palmate. Species of Vibrio and Rickettsia have both been identified as putative WBD pathogens. Here we used Illumina 16S rRNA gene sequencing to profile the bacterial communities associated with healthy and diseased A. cervicornis collected from four field sites during two different years. We also exposed corals in tanks to diseased and healthy (control) homogenates to reduce some of the natural variation of field-collected coral bacterial communities. Using a combination of multivariate analyses, we identified community-level changes between diseased and healthy corals in both the field-collected and tank-exposed datasets. We then identified changes in the abundances of individual operational taxonomic units (OTUs) between diseased and healthy corals. By comparing the diseased and healthy-associated bacteria in field-collected and tank-exposed corals, we were able to identify 16 healthy-associated OTUs and 106 consistently disease-associated OTUs, which are good candidates for putative WBD pathogens. A large percentage of these disease-associated OTUs belonged to the order Flavobacteriales. In addition, two of the putative pathogens identified here belong to orders previously suggested as WBD pathogens: Vibronales and Rickettsiales.	[Gignoux-Wolfsohn, Sarah A.; Vollmer, Steven V.] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA	Northeastern University	Gignoux-Wolfsohn, SA (corresponding author), Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA.	gignoux-wolfsohn.s@husky.neu.edu		Gignoux-Wolfsohn, Sarah/0000-0002-9037-1088	National Science Foundation [OCE 0751666]	National Science Foundation(National Science Foundation (NSF))	Supported by National Science Foundation grant to SVV (OCE 0751666).	Allers E, 2008, APPL ENVIRON MICROB, V74, P3274, DOI 10.1128/AEM.01870-07; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2014, ENDANGERED THREATENE; Apprill A, 2013, ENVIRON MICROBIOL, V15, P2063, DOI 10.1111/1462-2920.12107; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Barneah O, 2007, ENVIRON MICROBIOL, V9, P1995, DOI 10.1111/j.1462-2920.2007.01315.x; Barriuso J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-473; Bayer T, 2013, APPL ENV MICROBIOLOG, V79; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Bullock GL, 1986, COLUMNARIS DIS FISHE, P129; Burge CA, 2014, ANNU REV MAR SCI, V6, P249, DOI 10.1146/annurev-marine-010213-135029; Butler SM, 2005, NAT REV MICROBIOL, V3, P611, DOI 10.1038/nrmicro1207; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cardenas A, 2012, ISME J, V6, P502, DOI 10.1038/ismej.2011.123; Casas V, 2004, ENVIRON MICROBIOL, V6, P1137, DOI 10.1111/j.1462-2920.2004.00647.x; Ceh J, 2013, MICROB ECOL, V65, P227, DOI 10.1007/s00248-012-0105-z; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; Chow J, 2011, CURR OPIN IMMUNOL, V23, P473, DOI 10.1016/j.coi.2011.07.010; Closek CJ, 2014, ISME J, V8, P2411, DOI 10.1038/ismej.2014.85; Cook GM, 2013, CORAL REEFS, V32, P375, DOI 10.1007/s00338-012-0989-6; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Croquer A, 2013, ENV MICROBIOL REP, V5, P90, DOI 10.1111/j.1758-2229.2012.00397.x; Davis HS, 1922, NEW BACTERIAL DIS FR; de Castro AP, 2010, MICROB ECOL, V59, P658, DOI 10.1007/s00248-010-9646-1; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Frias-Lopez J, 2004, APPL ENVIRON MICROB, V70, P5955, DOI 10.1128/AEM.70.10.5955-5962.2004; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Friedman CS, 2000, INT J SYST EVOL MICR, V50, P847, DOI 10.1099/00207713-50-2-847; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Garcia GD, 2013, MICROB ECOL, V65, P1076, DOI 10.1007/s00248-012-0161-4; Gignoux-Wolfsohn SA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00804; Gil-Agudelo D. L, 2006, Rev. biol. trop, V54, P59; GLADFELTER WB, 1982, B MAR SCI, V32, P639; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Goreau TJ, 1998, REV BIOL TROP, V46, P157; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Jari Oksanen F.G.B, 2013, VEGAN COMMUNITY ECOL; Jensen S, 2010, FEMS MICROBIOL ECOL, V74, P523, DOI 10.1111/j.1574-6941.2010.00981.x; Jones RJ, 2004, MAR ECOL PROG SER, V281, P63, DOI 10.3354/meps281063; Kimes NE, 2013, ENVIRON MICROBIOL, V15, P2082, DOI 10.1111/1462-2920.12130; Kline DI, 2011, SCI REP-UK, V1, DOI 10.1038/srep00007; Kvennefors ECE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010401; Lee MD, 2006, AVIAN DIS, V50, P1, DOI 10.1637/7474-111605R.1; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Lesser MP, 2014, FEMS MICROBIOL ECOL, V88, P457, DOI 10.1111/1574-6941.12311; Littman RA, 2009, FEMS MICROBIOL ECOL, V68, P152, DOI 10.1111/j.1574-6941.2009.00666.x; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mason OU, 2012, ISME J, V6, P1715, DOI 10.1038/ismej.2012.59; Moreno Y, 2003, APPL ENVIRON MICROB, V69, P1181, DOI 10.1128/AEM.69.2.1181-1186.2003; Morrow KM, 2012, APPL ENVIRON MICROB, V78, P6438, DOI 10.1128/AEM.01162-12; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; PETERS EC, 1983, J INVERTEBR PATHOL, V41, P394, DOI 10.1016/0022-2011(83)90260-4; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Richardson LL, 1998, TRENDS ECOLOGY EVOLU, V13; Ritchie KB, 1998, REV BIOL TROP, V46, P199; Ritchie KB, 1995, MOL MAR BIOL BIOTECH, V4, P345; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Roder C, 2014, MOL ECOL, V23, P965, DOI 10.1111/mec.12638; Roder C, 2014, ISME J, V8, P31, DOI 10.1038/ismej.2013.127; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Sato Y, 2010, ISME J, V4, P203, DOI 10.1038/ismej.2009.103; Sekar R, 2006, APPL ENVIRON MICROB, V72, P5963, DOI 10.1128/AEM.00843-06; Sere MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083746; Sharp KH, 2012, ISME J, V6, P790, DOI 10.1038/ismej.2011.144; Starliper CE, 2011, J ADV RES, V2, P97, DOI 10.1016/j.jare.2010.04.001; Stoddard R, 2005, EMERGING INFECT DIS, V11; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Sweet MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0094; Sweet M, 2012, ENVIRON MICROBIOL, V14, P2184, DOI 10.1111/j.1462-2920.2012.02746.x; Thompson FL, 2006, INT J SYST EVOL MICR, V56, P365, DOI 10.1099/ijs.0.63800-0; Tiirola M, 2002, DIS AQUAT ORGAN, V51, P93, DOI 10.3354/dao051093; Vollmer SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003718; Walker DH., 1996, MED MICROBIOLOGY, V4th; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zwart MP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002122	84	44	44	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134416	10.1371/journal.pone.0134416	http://dx.doi.org/10.1371/journal.pone.0134416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241853	gold, Green Published, Green Submitted			2022-12-27	WOS:000358942700043
J	Lee, MY; Park, C; Berent, RM; Park, PJ; Fuchs, R; Syn, H; Chin, A; Townsend, J; Benson, CC; Redelman, D; Shen, TW; Park, JK; Miano, JM; Sanders, KM; Ro, S				Lee, Moon Young; Park, Chanjae; Berent, Robyn M.; Park, Paul J.; Fuchs, Robert; Syn, Hannah; Chin, Albert; Townsend, Jared; Benson, Craig C.; Redelman, Doug; Shen, Tsai-wei; Park, Jong Kun; Miano, Joseph M.; Sanders, Kenton M.; Ro, Seungil			Smooth Muscle Cell Genome Browser: Enabling the Identification of Novel Serum Response Factor Target Genes	PLOS ONE			English	Article							PHENOTYPIC DIVERSITY; CARDIAC MYOCYTES; SKELETAL-MUSCLE; MECHANISMS; EXPRESSION; CA2+; JUNCTOPHILIN-2; TRANSPORTERS; PLASTICITY; INTESTINE	Genome-scale expression data on the absolute numbers of gene isoforms offers essential clues in cellular functions and biological processes. Smooth muscle cells (SMCs) perform a unique contractile function through expression of specific genes controlled by serum response factor (SRF), a transcription factor that binds to DNA sites known as the CArG boxes. To identify SRF-regulated genes specifically expressed in SMCs, we isolated SMC populations from mouse small intestine and colon, obtained their transcriptomes, and constructed an interactive SMC genome and CArGome browser. To our knowledge, this is the first online resource that provides a comprehensive library of all genetic transcripts expressed in primary SMCs. The browser also serves as the first genome-wide map of SRF binding sites. The browser analysis revealed novel SMC-specific transcriptional variants and SRF target genes, which provided new and unique insights into the cellular and biological functions of the cells in gastrointestinal (GI) physiology. The SRF target genes in SMCs, which were discovered in silico, were confirmed by proteomic analysis of SMC-specific Srf knockout mice. Our genome browser offers a new perspective into the alternative expression of genes in the context of SRF binding sites in SMCs and provides a valuable reference for future functional studies.	[Lee, Moon Young; Park, Chanjae; Berent, Robyn M.; Park, Paul J.; Fuchs, Robert; Syn, Hannah; Chin, Albert; Townsend, Jared; Redelman, Doug; Sanders, Kenton M.; Ro, Seungil] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA; [Lee, Moon Young] Wonkwang Univ, Dept Physiol, Wonkwang Digest Dis Res Inst, Iksan, Jeollabuk Do, South Korea; [Lee, Moon Young] Wonkwang Univ, Sch Med, Inst Wonkwang Med Sci, Iksan, Jeollabuk Do, South Korea; [Benson, Craig C.; Miano, Joseph M.] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY USA; [Shen, Tsai-wei] LC Sci, Houston, TX USA; [Park, Jong Kun] Wonkwang Univ, Div Biol Sci, Iksan, Jeollabuk Do, South Korea	Nevada System of Higher Education (NSHE); University of Nevada Reno; Wonkwang University; Wonkwang University; University of Rochester; Wonkwang University	Ro, S (corresponding author), Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA.	sro@medicine.nevada.edu	Chin, Albert/AAM-4155-2020; Miano, Joseph/L-5634-2018	Chin, Albert/0000-0001-6790-2437; Park, Jong Kun/0000-0003-3342-3088; Ro, Seungil/0000-0003-0861-8334; Miano, Joseph/0000-0001-7522-3207	National Institutes of Health [R21DK092667, R01DK094886, P20 RR018751, HL117907]; National Institutes of Health (AHA GIA); SoongSan Fellowship in WonKwang University; LC Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018751] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK041315, R01DK094886] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (AHA GIA); SoongSan Fellowship in WonKwang University; LC Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grants (R21DK092667 and R01DK094886 to S. Ro, P20 RR018751 to K.M. Sanders and S. Ro, and HL117907 and AHA GIA to J.M. Miano) and SoongSan Fellowship in WonKwang University 2013 (to M. Lee). LC Sciences provided support in the form of a salary for author T. Shen, but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beavers DL, 2013, J AM COLL CARDIOL, V62, P2010, DOI 10.1016/j.jacc.2013.06.052; Benson CC, 2011, PHYSIOL GENOMICS, V43, P1038, DOI 10.1152/physiolgenomics.00098.2011; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; Bitar KN, 2014, GASTROENTEROLOGY, V146, P1614, DOI 10.1053/j.gastro.2014.03.044; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Chen J, 2008, NEUROGASTROENT MOTIL, V20, P829, DOI 10.1111/j.1365-2982.2008.01149.x; Fisher SA, 2010, PHYSIOL GENOMICS, V42A, P169, DOI 10.1152/physiolgenomics.00111.2010; Floyd R, 2007, CELL CALCIUM, V42, P467, DOI 10.1016/j.ceca.2007.05.011; Garbino A, 2009, PHYSIOL GENOMICS, V37, P175, DOI 10.1152/physiolgenomics.00017.2009; Golini L, 2011, J BIOL CHEM, V286, P43717, DOI 10.1074/jbc.M111.292755; Halayko AJ, 2001, J APPL PHYSIOL, V90, P358, DOI 10.1152/jappl.2001.90.1.358; Ilagan RM, 2011, J CELL PHYSIOL, V226, P2702, DOI 10.1002/jcp.22622; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Miano JM, 2010, LAB INVEST, V90, P1274, DOI 10.1038/labinvest.2010.104; MURER H, 1983, J EXP BIOL, V106, P163; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park C, 2011, GASTROENTEROLOGY, V141, P164, DOI 10.1053/j.gastro.2011.03.058; Park C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018628; Perez CF, 2005, AM J PHYSIOL-CELL PH, V288, pC640, DOI 10.1152/ajpcell.00407.2004; Ro S, 2010, GASTROENTEROLOGY, V138, P1068, DOI 10.1053/j.gastro.2009.11.007; Sanders KM, 2012, NAT REV GASTRO HEPAT, V9, P633, DOI 10.1038/nrgastro.2012.168; SHIMIZU RT, 1995, J BIOL CHEM, V270, P7631, DOI 10.1074/jbc.270.13.7631; Shimoda LA, 2010, ADV EXP MED BIOL, V661, P221, DOI 10.1007/978-1-60761-500-2_14; Spencer JA, 1999, ONCOGENE, V18, P7319, DOI 10.1038/sj.onc.1203121; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Takeshima H, 1998, EMBO J, V17, P3309, DOI 10.1093/emboj/17.12.3309; Takeshima H, 2002, FRONT BIOSCI-LANDMRK, V7, pD1642, DOI 10.2741/takeshim; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Woo JS, 2009, MOL CELL BIOCHEM, V328, P25, DOI 10.1007/s11010-009-0070-0; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002	41	37	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133751	10.1371/journal.pone.0133751	http://dx.doi.org/10.1371/journal.pone.0133751			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241044	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700022
J	Thomsen, LB; Burkhart, A; Moos, T				Thomsen, Louiza Bohn; Burkhart, Annette; Moos, Torben			A Triple Culture Model of the Blood-Brain Barrier Using Porcine Brain Endothelial cells, Astrocytes and Pericytes	PLOS ONE			English	Article							IN-VITRO MODEL; DRUG TRANSPORT; FUNCTIONAL-CHARACTERIZATION; PERMEABILITY; VIVO; ESTABLISHMENT; INTEGRITY; SYSTEM	In vitro blood-brain barrier (BBB) models based on primary brain endothelial cells (BECs) cultured as monoculture or in co-culture with primary astrocytes and pericytes are useful for studying many properties of the BBB. The BECs retain their expression of tight junction proteins and efflux transporters leading to high trans-endothelial electric resistance (TEER) and low passive paracellular permeability. The BECs, astrocytes and pericytes are often isolated from small rodents. Larger species as cows and pigs however, reveal a higher yield, are readily available and have a closer resemblance to humans, which make them favorable high-throughput sources for cellular isolation. The aim of the present study has been to determine if the preferable combination of purely porcine cells isolated from the 6 months old domestic pigs, i.e. porcine brain endothelial cells (PBECs) in co-culture with porcine astrocytes and pericytes, would compare with PBECs co-cultured with astrocytes and pericytes isolated from newborn rats with respect to TEER value and low passive permeability. The astrocytes and pericytes were grown both as contact and non-contact co-cultures as well as in triple culture to examine their effects on the PBECs for barrier formation as revealed by TEER, passive permeability, and expression patterns of tight junction proteins, efflux transporters and the transferrin receptor. This syngenic porcine in vitro BBB model is comparable to triple cultures using PBECs, rat astrocytes and rat pericytes with respect to TEER formation, low passive permeability, and expression of hallmark proteins signifying the brain endothelium (tight junction proteins claudin 5 and occludin, the efflux transporters P-glycoprotein (PgP) and breast cancer related protein (BCRP), and the transferrin receptor).	[Thomsen, Louiza Bohn; Burkhart, Annette; Moos, Torben] Aalborg Univ, Dept Hlth Sci & Technol, Neurobiol Lab, Aalborg, Denmark	Aalborg University	Thomsen, LB (corresponding author), Aalborg Univ, Dept Hlth Sci & Technol, Neurobiol Lab, Aalborg, Denmark.	lbt@hst.aau.dk		Thomsen, Louiza Bohn/0000-0002-3144-7150; Larsen, Annette Burkhart/0000-0003-2086-4693; Moos, Torben/0000-0001-9989-0207	Obel Family Foundation; Obel.com; A.P. Moeller Foundation "Fonden til Laegevidenskabens Fremme", apmollerfonde.dk	Obel Family Foundation; Obel.com; A.P. Moeller Foundation "Fonden til Laegevidenskabens Fremme", apmollerfonde.dk	This work was partly supported by the Obel Family Foundation, Obel.com and the A.P. Moeller Foundation "Fonden til Laegevidenskabens Fremme", apmollerfonde.dk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; BAUER HC, 1993, DEV BRAIN RES, V75, P269, DOI 10.1016/0165-3806(93)90031-5; BOWMAN PD, 1983, ANN NEUROL, V14, P396, DOI 10.1002/ana.410140403; BRIGHTMA.MW, 1969, J CELL BIOL, V40, P648, DOI 10.1083/jcb.40.3.648; Calabria AR, 2006, J NEUROCHEM, V97, P922, DOI 10.1111/j.1471-4159.2006.03793.x; Cantrill CA, 2012, BRAIN RES, V1479, P17, DOI 10.1016/j.brainres.2012.08.031; Correale J, 2009, NEUROCHEM RES, V34, P2067, DOI 10.1007/s11064-009-0081-y; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Franke H, 2000, BRAIN RES PROTOC, V5, P248, DOI 10.1016/S1385-299X(00)00020-9; Gad S. C., 2008, PRECLINICAL DEV HDB; Gaillard PJ, 2001, EUR J PHARM SCI, V12, P215, DOI 10.1016/S0928-0987(00)00123-8; Gaillard PJ, 2000, EUR J PHARM SCI, V12, P95, DOI 10.1016/S0928-0987(00)00152-4; Hoheisel D, 1998, BIOCHEM BIOPH RES CO, V244, P312, DOI 10.1006/bbrc.1997.8051; Krueger M, 2010, GLIA, V58, P1, DOI 10.1002/glia.20898; Lamszus K, 1999, J NEUROSCI RES, V55, P370, DOI 10.1002/(SICI)1097-4547(19990201)55:3<370::AID-JNR12>3.0.CO;2-U; Lichota J, 2010, J NEUROCHEM, V113, P1, DOI [10.1111/j.1471-4159.2009.06544, 10.1111/j.1471-4159.2009.06544.x]; Malina KCK, 2009, BRAIN RES, V1284, P12, DOI 10.1016/j.brainres.2009.05.072; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Nakhlband A, 2011, BIOIMPACTS, V1, P153, DOI 10.5681/bi.2011.021; Patabendige A, 2013, BRAIN RES, V1521, P1, DOI 10.1016/j.brainres.2012.06.057; Patabendige A, 2013, BRAIN RES, V1521, P16, DOI 10.1016/j.brainres.2013.04.006; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725; Skinner RA, 2009, BRIT J PHARMACOL, V156, P1115, DOI 10.1111/j.1476-5381.2008.00129.x; Smith M, 2007, J DRUG TARGET, V15, P253, DOI 10.1080/10611860701288539; Thanabalasundaram G, 2011, INT J BIOCHEM CELL B, V43, P1284, DOI 10.1016/j.biocel.2011.05.002; Tigges U, 2012, MICROVASC RES, V84, P74, DOI 10.1016/j.mvr.2012.03.008; Wuest DM, 2013, J NEUROSCI METH, V212, P211, DOI 10.1016/j.jneumeth.2012.10.016; Zhang Y, 2006, DRUG METAB DISPOS, V34, P1935, DOI 10.1124/dmd.105.006437	34	86	91	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134765	10.1371/journal.pone.0134765	http://dx.doi.org/10.1371/journal.pone.0134765			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241648	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942700065
J	Li, WS; Wang, Y; Zhang, Q; Tang, LL; Liu, XP; Dai, YH; Xiao, L; Huang, SG; Chen, L; Guo, ZM; Lu, J; Yuan, K				Li, Wanshuai; Wang, Yong; Zhang, Qi; Tang, Lili; Liu, Xiaoping; Dai, Yunhua; Xiao, Liang; Huang, Shuguang; Chen, Lu; Guo, Zhongmin; Lu, Jim; Yuan, Kai			MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer	PLOS ONE			English	Article							DOWN-REGULATION; MIR-150; SERUM; PROLIFERATION; EXPRESSIONS; STATISTICS; PLASMA	Background Non-small cell lung cancer (NSCLC) is a leading cause of cancer death worldwide. Early diagnosis is essential for improvements of prognosis and survival of the patients. Currently, there is no effective biomarker available in clinical settings for early detection of lung cancer. Altered expressions in many cancer types including NSCLC and stable existence in plasma make microRNAs (miRNAs) a group of potentially useful biomarkers for clinical assessments of patients with NSCLC. Objectives To evaluate the potential values of miRNAs as blood-based biomarkers for early diagnosis and prognosis in NSCLC patients. Methods Peripheral blood samples from healthy volunteers and early-staged NSCLC patients before and after surgery were collected, and plasma was separated. Expression of ten miRNAs in the plasma and tumor sections of the patients was detected by quantitative real-time polymerase chain reaction. Results MiRNA (miR)-486 and miR-150 were found to significantly distinguish lung cancer patients from healthy volunteers. Area under curve of miR-486 and miR-150 were 0.926 (sensitivity, 0.909; specificity, 0.818) and 0.752 (sensitivity, 0.818; specificity, 0.818), respectively. In response to therapy, patients with down-regulated miR-486 expression showed prolonged recurrence-free survival than those with un-reduced miR-486 expression (median, unreached vs. 19 months; hazard ratio, 0.1053; 95% confidence interval, 0.01045 to 1.060; P=0.056). Conclusions The results suggest that miR-486 and miR-150 could be potential blood-based biomarkers for early diagnosis of NSCLC. Monitoring change of miR-486 expression in plasma might be an effective and non-invasive method for recurrence prediction of early-staged NSCLC patients.	[Wang, Yong; Yuan, Kai] 2 Peoples Hosp Changzhou, Dept Cardiothorac Surg, Changzhou 213004, Jiangsu, Peoples R China; [Li, Wanshuai; Zhang, Qi; Tang, Lili; Liu, Xiaoping; Dai, Yunhua; Xiao, Liang; Huang, Shuguang; Chen, Lu; Guo, Zhongmin; Lu, Jim] Changzhou GoPath Diagnost Lab Co Ltd, Changzhou 213164, Jiangsu, Peoples R China; [Lu, Jim] GoPath Labs LLC, Buffalo Grove, IL 60089 USA		Lu, J (corresponding author), Changzhou GoPath Diagnost Lab Co Ltd, 801 Changwuzhong Rd, Changzhou 213164, Jiangsu, Peoples R China.	JLu@gopathlabs.com; yuankai1978@163.com	Li, Wanshuai/F-6092-2014	Li, Wanshuai/0000-0002-5361-4319	Changzhou Science and Technology Support Program [CE20125002]	Changzhou Science and Technology Support Program	This work was supported by Changzhou Science and Technology Support Program (No. CE20125002).	Auperin A, 2010, J CLIN ONCOL, V28, P2181, DOI 10.1200/JCO.2009.26.2543; Aushev VN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078649; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Ebrahimi F, 2014, EXP MOL PATHOL, V96, P98, DOI 10.1016/j.yexmp.2013.12.004; Gu XY, 2014, TUMOR BIOL, V35, P5287, DOI 10.1007/s13277-014-1688-4; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Jiang M, 2013, MOL CELL BIOCHEM, V383, P67, DOI 10.1007/s11010-013-1755-y; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lee HY, 2015, MOL MED REP, V11, P2034, DOI 10.3892/mmr.2014.2890; Li ZH, 2013, J INT MED RES, V41, P1437, DOI 10.1177/0300060513497560; Mozzoni P, 2013, BIOMARKERS, V18, P679, DOI 10.3109/1354750X.2013.845610; Peng Y, 2013, P NATL ACAD SCI USA, V110, P15043, DOI 10.1073/pnas.1307107110; Shao YJ, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/626185; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Solomides CC, 2012, ACTA CYTOL, V56, P645, DOI 10.1159/000343473; Song HT, 2014, J PSYCHIATR RES, V54, P134, DOI 10.1016/j.jpsychires.2014.03.008; Tafsiri E, 2015, TUMOR BIOL, V36, P1603, DOI 10.1007/s13277-014-2755-6; Tio TL, 1996, GASTROINTEST ENDOSC, V43, pS19; Wang DT, 2013, ONCOL REP, V30, P492, DOI 10.3892/or.2013.2453; Wang J, 2014, ONCOGENE, V33, P1181, DOI 10.1038/onc.2013.42; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Wang Y, 2011, NAT NANOTECHNOL, V6, P668, DOI [10.1038/NNANO.2011.147, 10.1038/nnano.2011.147]; Wink KCJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00292; Zeng XL, 2013, CHINESE MED J-PEKING, V126, P4510, DOI 10.3760/cma.j.issn.0366-6999.20122931; Zhang N, 2013, FEBS LETT, V587, P2346, DOI 10.1016/j.febslet.2013.05.059	25	54	54	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134220	10.1371/journal.pone.0134220	http://dx.doi.org/10.1371/journal.pone.0134220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237047	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942400017
J	Carias, C; Reed, C; Kim, IK; Foppa, IM; Biggerstaff, M; Meltzer, MI; Finelli, L; Swerdlow, DL				Carias, Cristina; Reed, Carrie; Kim, Inkyu K.; Foppa, Ivo M.; Biggerstaff, Matthew; Meltzer, Martin I.; Finelli, Lyn; Swerdlow, David L.			Net Costs Due to Seasonal Influenza Vaccination - United States, 2005-2009	PLOS ONE			English	Article							HEALTHY WORKING ADULTS; PANDEMIC INFLUENZA; HOSPITALIZATION; IMPACT; AGE; IMMUNIZATION; CHILDREN; DISEASE; BURDEN; RISK	Background Seasonal influenza causes considerable morbidity and mortality across all age groups, and influenza vaccination was recommended in 2010 for all persons aged 6 months and above. We estimated the averted costs due to influenza vaccination, taking into account the seasonal economic burden of the disease. Methods We used recently published values for averted outcomes due to influenza vaccination for influenza seasons 2005-06, 2006-07, 2007-08, and 2008-09, and age cohorts 6 months-4 years, 5-19 years, 20-64 years, and 65 years and above. Costs were calculated according to a payer and societal perspective (in 2009 US$), and took into account medical costs and productivity losses. Results When taking into account direct medical costs (payer perspective), influenza vaccination was cost saving only for the older age group (65 >=) in seasons 2005-06 and 2007-08. Using the same perspective, influenza vaccination resulted in total costs of $US 1.7 billion (95% CI: $US 0.3-4.0 billion) in 2006-07 and $US 1.8 billion (95% CI: $US 0.1-4.1 billion) in 2008-09. When taking into account a societal perspective (and including the averted lost earnings due to premature death) averted deaths in the older age group influenced the results, resulting in cost savings for all ages combined in season 07-08. Discussion Influenza vaccination was cost saving in the older age group (65 >=) when taking into account productivity losses and, in some seasons, when taking into account medical costs only. Averted costs vary significantly per season; however, in seasons where the averted burden of deaths is high in the older age group, averted productivity losses due to premature death tilt overall seasonal results towards savings. Indirect vaccination effects and the possibility of diminished case severity due to influenza vaccination were not considered, thus the averted burden due to influenza vaccine may be even greater than reported.	[Carias, Cristina; Swerdlow, David L.] Ctr Dis Control & Prevent, Off Sci & Integrated Programs, Atlanta, GA 30322 USA; [Carias, Cristina] IHRC INC, Atlanta, GA USA; [Reed, Carrie; Kim, Inkyu K.; Foppa, Ivo M.; Biggerstaff, Matthew; Finelli, Lyn] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Kim, Inkyu K.; Foppa, Ivo M.] Battelle Mem Inst, Atlanta, GA USA; [Meltzer, Martin I.] Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Carias, C (corresponding author), Ctr Dis Control & Prevent, Off Sci & Integrated Programs, Atlanta, GA 30322 USA.	vnn9@cdc.gov	Foppa, Ivo/I-8694-2016; Finelli, Lyn/AAK-2360-2020; Meltzer, Martin/AAT-3235-2021	Foppa, Ivo/0000-0002-3933-8565; Meltzer, Martin/0000-0002-7250-0472; Biggerstaff, Matthew/0000-0001-5108-8311	IHRC.INC; Battelle Memorial Institute	IHRC.INC; Battelle Memorial Institute	IHRC.INC provided support in the form of salaries for authors CC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Battelle Memorial Institute provided support in the form of salaries for authors IKK and IMF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; Beyer WEP, 2013, VACCINE, V31, P6030, DOI 10.1016/j.vaccine.2013.09.063; [Bureau of Labor Statistics United States Department of Labor], 2014, LAB FORC STAT CURR P; [Bureau of Labor Statistics United States Department of Labor], OCC LAB STAT MAY 200; [Bureau of Labor Statistics United States Department of Labor], 2013, AM TIME USE SURVEY; Centers for Disease Control and Prevention, FLU VACC COV HIGH RI; Coleman MS, 2005, VACCINE, V23, P915, DOI 10.1016/j.vaccine.2004.07.028; Fairbrother G, 2010, VACCINE, V28, P4913, DOI 10.1016/j.vaccine.2010.05.036; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Foppa IM, 2015, VACCINE INPRESS; Haddix AC, 2003, PREVENTION EFFECTIVE; Hall JL, 2005, J PEDIATR-US, V147, P807, DOI 10.1016/j.jpeds.2005.06.031; Kennedy Erin D., 2011, Morbidity and Mortality Weekly Report, V60, P781; Keren R, 2006, PEDIATRICS, V118, pE1321, DOI 10.1542/peds.2006-0598; Kostova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066312; Lehmann HC, 2010, LANCET INFECT DIS, V10, P643, DOI 10.1016/S1473-3099(10)70140-7; McLean HQ, 2014, VACCINE, V32, P453, DOI 10.1016/j.vaccine.2013.11.060; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mullooly JP, 2007, VACCINE, V25, P846, DOI 10.1016/j.vaccine.2006.09.041; Newall AT, 2009, PHARMACOECONOMICS, V27, P439, DOI 10.2165/00019053-200927060-00001; Nichol KL, 1996, ARCH INTERN MED, V156, P1546, DOI 10.1001/archinte.156.14.1546; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; Postma MJ, 2002, DRUGS, V62, P1013, DOI 10.2165/00003495-200262070-00003; Prosser LA, 2008, PHARMACOECONOMICS, V26, P163, DOI 10.2165/00019053-200826020-00006; Prosser LA, 2006, EMERG INFECT DIS, V12, P1548, DOI 10.3201/eid1210.051015; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Thompson M. G., 2010, MMWR-MORBID MORTAL W, V59, P1057; Zimmerman RK, 2010, VACCINE, V28, P6470, DOI 10.1016/j.vaccine.2010.07.037	30	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132922	10.1371/journal.pone.0132922	http://dx.doi.org/10.1371/journal.pone.0132922			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230271	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400022
J	Edwards, AE; Fitzgerald, SM; Parrish, JK; Klavitter, JL; Romano, MD				Edwards, Ann E.; Fitzgerald, Shannon M.; Parrish, Julia K.; Klavitter, John L.; Romano, Marc D.			Foraging Strategies of Laysan Albatross Inferred from Stable Isotopes: Implications for Association with Fisheries	PLOS ONE			English	Article							BLACK-BROWED ALBATROSS; NORTH PACIFIC-OCEAN; TROPHIC RELATIONSHIPS; SOUTHERN-OCEAN; ENVIRONMENTAL VARIABILITY; PROVISIONING BEHAVIOR; COMMERCIAL FISHERIES; BREEDING PERFORMANCE; LONGLINE FISHERIES; ANTHROPOGENIC CO2	Fatal entanglement in fishing gear is the leading cause of population decline for albatross globally, a consequence of attraction to bait and fishery discards of commercial fishing operations. We investigated foraging strategies of Laysan albatross (Phoebastria immutabilis), as inferred from nitrogen and carbon isotope values of primary feathers, to determine breeding-related, seasonal, and historic factors that may affect the likelihood of association with Alaskan or Hawaiian longline fisheries. Feather samples were collected from live birds monitored for breeding status and breeding success on Midway Atoll in the northwestern Hawaiian Islands, birds salvaged as fisheries-bycatch, and birds added to museum collections before 1924. During the chick-rearing season (sampled April-May), means and variances of stable isotope values of birds with the highest, most consistent reproductive success were distinct from less productive conspecifics and completely different from birds caught in Hawaiian or Alaskan longline fisheries, suggesting birds with higher multi-annual reproductive success were less likely to associate with these fisheries. Contemporary birds with the highest reproductive success had mean values most similar to historic birds. Values of colony-bound, courting prebreeders were similar to active breeders but distinct from prebreeders caught in Alaskan longline fisheries. During the breeding season, delta N-15 values were highly variable for both contemporary and historic birds. Although some historic birds exhibited extremely low d15N values unmatched by contemporary birds (< 11.2%), others had values as high as the highest fishery-associated contemporary birds. During the non-breeding season (sampled July-September), isotopic variability coalesced into a more narrow set of values for both contemporary and historic birds. Our results suggest that foraging strategies of Laysan albatross are a complex function of season, breeding status, and multi-annual breeding success, factors that likely affect the probability of association with fisheries.	[Edwards, Ann E.; Fitzgerald, Shannon M.] Alaska Fisheries Sci Ctr, Natl Ocean & Atmospher Adm, Seattle, WA 98195 USA; [Edwards, Ann E.; Parrish, Julia K.] Univ Washington, Sch Aquat & Fisheries Sci, Seattle, WA 98195 USA; [Klavitter, John L.] US Fish & Wildlife Serv, Midway Atoll Natl Wildlife Refuge, Papah Naumoku Kea Marine Natl Monument, Falls Church, VA USA; [Romano, Marc D.] US Fish & Wildlife Serv, Migratory Birds & Habitat Programs, Portland, OR USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service	Edwards, AE (corresponding author), Alaska Fisheries Sci Ctr, Natl Ocean & Atmospher Adm, Seattle, WA 98195 USA.	aee@uw.edu			NOAA National Seabird Grant	NOAA National Seabird Grant	This research was initiated while AEE held a National Research Council Postdoctoral Fellowship Award at NOAA's Alaska Fisheries Science Center. Funding for feather shipment and stable isotope analysis came from an NOAA National Seabird Grant to SMF and AEE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views presented are those of the authors, and do not necessarily represent those of the funders.	Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Annett CA, 1999, ECOLOGY, V80, P288, DOI 10.1890/0012-9658(1999)080[0288:LTROIW]2.0.CO;2; Arata JA, 2009, US GEOLOGICAL SURVEY; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Ayers JM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005596; Barbraud C, 2005, ECOLOGY, V86, P682, DOI 10.1890/04-0075; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Becker BH, 2006, CONSERV BIOL, V20, P470, DOI 10.1111/j.1523-1739.2006.00379.x; Bisson JR, 2008, THESIS U HAWAII; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bograd SJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020637; Bond AL, 2010, WATERBIRDS, V33, P50, DOI 10.1675/063.033.0106; Bridge ES, 2011, CONDOR, V113, P1, DOI 10.1525/cond.2011.100228; Bugoni L, 2010, J EXP MAR BIOL ECOL, V391, P190, DOI 10.1016/j.jembe.2010.06.027; Bunce A, 2005, J ZOOL, V266, P163, DOI 10.1017/S0952836905006734; Cam E, 2000, J ANIM ECOL, V69, P380, DOI 10.1046/j.1365-2656.2000.00400.x; Cherel Y, 2005, OECOLOGIA, V145, P533, DOI 10.1007/s00442-005-0156-7; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Chouvelon T, 2012, PROG OCEANOGR, V101, P92, DOI 10.1016/j.pocean.2012.01.004; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; CURIO E, 1983, IBIS, V125, P400, DOI 10.1111/j.1474-919X.1983.tb03130.x; Dietrich KS, 2009, BIOL CONSERV, V142, P2642, DOI 10.1016/j.biocon.2009.06.013; Edwards AE, 2005, CONDOR, V107, P835, DOI 10.1650/7533.1; Edwards AE, 2008, J AVIAN BIOL, V39, P144, DOI 10.1111/j.2007.0908-8857.04139.x; Fernandez P, 2001, J ZOOL, V254, P391, DOI 10.1017/S0952836901000899; Fischer KN, 2009, BIOL CONSERV, V142, P751, DOI 10.1016/j.biocon.2008.12.007; FISHER HI, 1967, IBIS, V109, P373, DOI 10.1111/j.1474-919X.1967.tb04011.x; FISHER HI, 1976, WILSON BULL, V88, P121; Fisher HI, 1969, MICRONESICA, V5, P173; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Furness RW, 2006, ARDEA, V94, P631; Garthe S, 1996, MAR ECOL PROG SER, V136, P1, DOI 10.3354/meps136001; Gould P, 1997, CAN J ZOOL, V75, P549, DOI 10.1139/z97-068; Gould P, 2000, WATERBIRDS, V23, P165; Gremillet D, 2008, P R SOC B, V275, P1149, DOI 10.1098/rspb.2007.1763; Gruber N, 1999, GLOBAL BIOGEOCHEM CY, V13, P307, DOI 10.1029/1999GB900019; HARRISON CS, 1983, WILDLIFE MONOGR, P1; Hazen EL, 2013, NAT CLIM CHANGE, V3, P234, DOI 10.1038/NCLIMATE1686; Hilton GM, 2006, GLOBAL CHANGE BIOL, V12, P611, DOI 10.1111/j.1365-2486.2006.01130.x; HOBSON KA, 1994, J ANIM ECOL, V63, P786, DOI 10.2307/5256; Huang HW, 2011, ANIM CONSERV, V14, P562, DOI 10.1111/j.1469-1795.2011.00462.x; Hyrenbach KD, 2002, MAR ECOL PROG SER, V233, P283, DOI 10.3354/meps233283; Ichii T, 2004, FISH OCEANOGR, V13, P295, DOI 10.1111/j.1365-2419.2004.00293.x; Jaeger A, 2010, RAPID COMMUN MASS SP, V24, P3456, DOI 10.1002/rcm.4792; Jaeger A, 2010, MAR ECOL PROG SER, V401, P269, DOI 10.3354/meps08380; Jouventin P, 2002, P ROY SOC B-BIOL SCI, V269, P1955, DOI 10.1098/rspb.2002.2080; Kappes MA, 2010, PROG OCEANOGR, V86, P246, DOI 10.1016/j.pocean.2010.04.012; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kitaysky AS, 2000, J ANIM ECOL, V69, P248, DOI 10.1046/j.1365-2656.2000.00392.x; LANGSTON NE, 1995, CONDOR, V97, P1, DOI 10.2307/1368978; Larson KW, 2009, J ORNITHOL, V150, P709, DOI 10.1007/s10336-009-0408-0; Mariano-Jelicich R, 2014, MAR BIOL, V161, P119, DOI 10.1007/s00227-013-2320-7; McNeil BI, 2001, GLOBAL BIOGEOCHEM CY, V15, P597, DOI 10.1029/2000GB001352; Morrison KW, 2014, MAR BIOL, V161, P2243, DOI 10.1007/s00227-014-2502-y; MULLIN MM, 1984, LIMNOL OCEANOGR, V29, P1267, DOI 10.4319/lo.1984.29.6.1267; Naughton MB, 2007, CONSERVATION ACTION; Nevoux M, 2007, J ANIM ECOL, V76, P159, DOI 10.1111/j.1365-2656.2006.01191.x; Niel C, 2005, CONSERV BIOL, V19, P826, DOI 10.1111/j.1523-1739.2005.00310.x; Oppel S, 2008, MAR ECOL PROG SER, V373, P149, DOI 10.3354/meps07744; Patrick SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087269; Phillips RA, 2006, BIOL CONSERV, V129, P336, DOI 10.1016/j.biocon.2005.10.046; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Pinaud D, 2005, MAR ECOL PROG SER, V298, P295, DOI 10.3354/meps298295; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; Pitman Robert L., 2004, Marine Ornithology, V32, P159; Polovina JJ, 2011, ICES J MAR SCI, V68, P986, DOI 10.1093/icesjms/fsq198; PRINCE PA, 1993, IBIS, V135, P121, DOI 10.1111/j.1474-919X.1993.tb02823.x; Quay P, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001817; Quillfeldt P, 2005, MAR ECOL PROG SER, V295, P295, DOI 10.3354/meps295295; Quillfeldt P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1157, DOI 10.1007/s00265-010-0931-2; Quillfeldt P, 2008, MAR ECOL PROG SER, V373, P137, DOI 10.3354/meps07751; Ramos R, 2009, OECOLOGIA, V160, P97, DOI 10.1007/s00442-008-1273-x; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Rohwer S, 2011, CONDOR, V113, P61, DOI 10.1525/cond.2011.100092; Rohwer Sievert, 2006, Western Birds, V37, P245; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Suryan RM, 2007, BIOL CONSERV, V137, P450, DOI 10.1016/j.biocon.2007.03.015; Suryan RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004016; Sydeman WJ, 1997, CONDOR, V99, P327, DOI 10.2307/1369938; Tanaka H, 2008, MAR BIOL, V154, P557, DOI 10.1007/s00227-008-0949-4; USFWS, 2012, BIOL OP US FISH WILD; WARHAM J, 1990, PETRELS THEIR ECOLOG; WEIMERSKIRCH H, 1992, OIKOS, V64, P464, DOI 10.2307/3545162; Weimerskirch H, 2000, POLAR BIOL, V23, P733, DOI 10.1007/s003000000144; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Wu JP, 1997, DEEP-SEA RES PT I, V44, P287, DOI 10.1016/S0967-0637(96)00099-4; Xavier JC, 2007, J ZOOL, V271, P408, DOI 10.1111/j.1469-7998.2006.00224.x; Young LC, 2010, J ZOOL, V281, P232, DOI 10.1111/j.1469-7998.2010.00698.x; Young LC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007623	90	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133471	10.1371/journal.pone.0133471	http://dx.doi.org/10.1371/journal.pone.0133471			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230731	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400039
J	Macinko, J; Mullachery, P; Silver, D; Jimenez, G; Neto, OLM				Macinko, James; Mullachery, Pricila; Silver, Diana; Jimenez, Geronimo; Morais Neto, Otaliba Libanio			Patterns of Alcohol Consumption and Related Behaviors in Brazil: Evidence from the 2013 National Health Survey (PNS 2013)	PLOS ONE			English	Article							TRAFFIC ACCIDENTS; SOCIAL INEQUALITIES; DRINKING; MORTALITY; GENDER; PREVALENCE; CULTURE; TRENDS; STATE; CARE	This study uses data from a nationally representative household survey (the 2013 National Health Survey, n = 62,986) to describe patterns of alcohol consumption and related behaviors among Brazilian adults. Analyses include descriptive and multivariable Poisson regression for self-reports in the past 30 days of: drinking any alcohol, binge drinking, binge drinking 4 or more times, and driving after drinking (DD); as well as age of alcohol consumption initiation. Results show that current drinking prevalence was 26%, with an average age of initiation of 18.7 years. Binge drinking was reported by 51% of drinkers, 43% of whom reported binge drinking 4 or more times. Drinking and driving was reported by nearly one quarter of those who drive a car/motorcycle. Current drinking was more likely among males, ages 25-34, single, urban, and those with more education. Binge drinking was more likely among males, older age groups, and people who started drinking before 18. Drinking and driving was higher among males, those with more education, and rural residents. Those who binge-drink were nearly 70% more likely to report DD. All behaviors varied significantly among Brazilian states. Given their potential health consequences, the levels of injurious alcohol behaviors observed here warrant increased attention from Brazilian policymakers and civil society.	[Macinko, James] Univ Calif Los Angeles, Dept Hlth Policy & Management, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA; [Macinko, James] Univ Calif Los Angeles, Dept Community Hlth Sci, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Mullachery, Pricila; Silver, Diana; Jimenez, Geronimo] NYU, Dept Nutr Food Studies & Publ Hlth, New York, NY USA; [Morais Neto, Otaliba Libanio] Univ Fed Goias, Inst Patol Trop & Saude Publ, Setor Univ, BR-74605050 Goiania, Go, Brazil	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; New York University; Universidade Federal de Goias	Macinko, J (corresponding author), Univ Calif Los Angeles, Dept Hlth Policy & Management, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA.	jmacinko@ucla.edu	Jimenez, Geronimo/J-4131-2019	Jimenez, Geronimo/0000-0002-1304-426X; Mullachery, Pricila H./0000-0003-4758-3875; Macinko, James/0000-0001-8055-5441	Brazilian Ministry of Health	Brazilian Ministry of Health	The survey data used in this study was financed by the Brazilian Ministry of Health. The current study received no funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida N, 2005, SOC PSYCH PSYCH EPID, V40, P214, DOI 10.1007/s00127-005-0883-4; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; [Anonymous], NAT HIGHW TRAFF SAF; Bacchieri G, 2011, REV SAUDE PUBL, V45, P949, DOI 10.1590/S0034-89102011005000069; Bandi P, 2015, INJURY EPID IN PRESS; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bloomfield K, 2006, ALCOHOL ALCOHOLISM, V41, pI3, DOI 10.1093/alcalc/agl070; Bloomfield K, 2006, ALCOHOL ALCOHOLISM, V41, pI26, DOI 10.1093/alcalc/agl073; Bloomfield Kim, 2000, Subst Abus, V21, P223, DOI 10.1023/A:1007849106375; Campos VR, 2013, CAD SAUDE PUBLICA, V29, P51, DOI 10.1590/S0102-311X2013000100007; Chandran A, 2012, TRAFFIC INJ PREV, V13, P11, DOI 10.1080/15389588.2011.633289; Chiappetta V, DRUG ALCOHOL DEPENDE, V141, P138; da Costa JSD, 2004, REV SAUDE PUBL, V38, P284, DOI 10.1590/S0034-89102004000200019; Dawson DA, 2015, DRUG ALCOHOL DEPEN, V148, P56, DOI 10.1016/j.drugalcdep.2014.12.016; De Boni R, 2012, REV BRAS PSIQUIATR, V34, P306, DOI 10.1016/j.rbp.2012.02.003; Neto OLD, 2012, CIENC SAUDE COLETIVA, V17, P2223; European Comission, 2014, ROAD SAF ALC MOB TRA; Gawryszewski VP, 2014, ADDICTION, V109, P570, DOI 10.1111/add.12418; Grittner U, 2013, EUR J PUBLIC HEALTH, V23, P332, DOI 10.1093/eurpub/cks044; Grittner U, 2012, ALCOHOL ALCOHOLISM, V47, P597, DOI 10.1093/alcalc/ags040; Halme JT, 2008, ALCOHOL CLIN EXP RES, V32, P1615, DOI 10.1111/j.1530-0277.2008.00740.x; Jomar RT, 2014, CIENC SAUDE COLETIVA, V19, P27, DOI 10.1590/1413-81232014191.2009; Karriker-Jaffe KJ, 2013, AM J PUBLIC HEALTH, V103, P649, DOI 10.2105/AJPH.2012.300882; Laranjeira R, 2014, THE SECOND BRAZILIAN; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Malta DC, 2014, REV SAUDE PUBL, V48, P692, DOI 10.1590/S0034-8910.2014048005633; McKee M, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0074-8; Ministerio da Saude SVS, 2011, SIST INF MORT SIM; Pechansky F, 2009, REV BRAS PSIQUIATR, V31, P125, DOI 10.1590/S1516-44462009000200008; Plunk AD, 2014, ALCOHOL CLIN EXP RES, V38, P471, DOI 10.1111/acer.12250; Reichenheim ME, 2011, LANCET, V377, P1962, DOI 10.1016/S0140-6736(11)60053-6; Roswall Nina, 2015, J Prev Med Public Health, V48, P1, DOI 10.3961/jpmph.14.052; Saldanha RF, 2014, CIENC SAUDE COLETIVA, V19, P3925, DOI 10.1590/1413-81232014199.12892013; Saloner B, 2013, HEALTH AFFAIR, V32, P135, DOI 10.1377/hlthaff.2011.0983; Sanchez ZM, 2013, J PEDIATR-US, V163, P363, DOI 10.1016/j.jpeds.2013.01.029; Sanchez ZM, 2013, DRUG ALCOHOL DEPEN, V127, P87, DOI 10.1016/j.drugalcdep.2012.06.018; Modelli Manoel Eugenio dos Santos, 2008, Rev. Saúde Pública, V42, P350, DOI 10.1590/S0034-89102008005000012; Shield KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051923; Sousa T, INJURY, V44, pS11; Szwarcwald CL, 2014, CIENC SAUDE COLETIVA, V19, P333, DOI 10.1590/1413-81232014192.14072012; Theall KP, 2011, ALCOHOL CLIN EXP RES, V35, P996, DOI 10.1111/j.1530-0277.2010.01430.x; van Oers JAM, 1999, ALCOHOL ALCOHOLISM, V34, P78, DOI 10.1093/alcalc/34.1.78; Whiteford HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116820; Wolle CC, 2011, REV BRAS PSIQUIATR, V33, P367, DOI 10.1590/S1516-44462011000400010	44	31	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134153	10.1371/journal.pone.0134153	http://dx.doi.org/10.1371/journal.pone.0134153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230389	gold, Green Published			2022-12-27	WOS:000358838400079
J	Peng, J; Wheeler, K; Shi, JX; Groner, JI; Haley, KJ; Xiang, HY				Peng, Jin; Wheeler, Krista; Shi, Junxin; Groner, Jonathan Ira; Haley, Kathryn Jo; Xiang, Huiyun			Trauma with Injury Severity Score of 75: Are These Unsurvivable Injuries?	PLOS ONE			English	Article							MORTALITY; TRIAGE; CARE	Trauma patients with an ISS=75 have been deliberately excluded from some trauma studies because they were assumed to have "unsurvivable injuries." This study aimed to assess the true mortality among patients with an ISS=75, and to examine the characteristics and primary diagnoses of these patients. Retrospective review of the 2006-2010 U.S. Nationwide Emergency Department Sample (NEDS) generated 2,815 patients with an ISS=75 for analysis, representing an estimated 13,569 patients in the country. Dispositions from the emergency department and hospital for these patients were tabulated by trauma center level. Survivors and non-survivors were compared using Pearson's chi-square test. Primary diagnosis codes of these patients were tabulated by mortality status. Overall, about 48.6% of patients with an ISS=75 were discharged alive, 25.8% died and 25.6% had unknown mortality status. The mortality risks of these patients did not vary significantly across different levels of trauma centers (15.6% vs. 13.0%, P = 0.16). Non-survivors were more likely than survivors to: be male (81.2% vs. 74.4%, P < 0.0001), be over 65 years (20.3% vs. 10.2%, P < 0.0001), be uninsured (33.8% vs. 19.1%), have at least one chronic condition (58.0% vs. 43.7%, P < 0.0001), sustain life-threatening injuries (79.2% vs. 49.4%, P<0.0001), sustain penetrating injuries (42.0% vs. 25.9%, P<0.0001), and have injuries caused by motor vehicle crashes (32.9% vs. 21.1%, P<0.0001) or firearms (21.9% vs. 4.4%, P<0.0001). The most frequent diagnosis code was 862.8 (injury to multiple and unspecified intrathoracic organs, without mention of open wound into cavity). Our results revealed that at least half of patients with an ISS=75 survived, demonstrating that the rationale for excluding patients with an ISS=75 from analysis is not always justified. To avoid bias and inaccurate results, trauma researchers should examine the mortality status of patients with an ISS= 75 before exclusion, and explicitly describe their method of generating ISS scores.	[Peng, Jin; Wheeler, Krista; Shi, Junxin; Groner, Jonathan Ira; Xiang, Huiyun] Nationwide Childrens Hosp, Res Inst, Ctr Pediat Trauma Res, Columbus, OH 43205 USA; [Peng, Jin; Xiang, Huiyun] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA; [Groner, Jonathan Ira; Xiang, Huiyun] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Groner, Jonathan Ira; Haley, Kathryn Jo] Nationwide Childrens Hosp, Trauma Program, Dept Pediat Surg, Columbus, OH USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Xiang, HY (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Pediat Trauma Res, Columbus, OH 43205 USA.	huiyun.xiang@nationwidechildrens.org	Groner, Jonathan/E-3156-2011		Agency for Healthcare Research and Quality [1R03-HS022277]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R03HS022277] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study was funded by a research grant from the Agency for Healthcare Research and Quality (http://www.ahrq.gov/ PI: Dr. Huiyun Xiang, Grant # 1R03-HS022277). The views expressed here are solely the responsibility of the authors and do not necessarily reflect the official views of the funding agencies. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Charles A, 2007, AM SURGEON, V73, P1; Clark D, 2010, STAT SOFTWARE COMPON; Di Bartolomeo S, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-17; Greene NH, 2015, INJ PREV; Heffernan DS, 2012, CRIT CARE, V16, DOI 10.1186/cc11157; MacLeod JBA., 2003, EUR J TRAUMA, V29, P392, DOI [10.1007/s00068-003-1277-5, DOI 10.1007/s00068-003-1277-5]; Meredith JW, 2002, J TRAUMA, V53, P621, DOI 10.1097/00005373-200210000-00001; Miller Matthew L, 2008, Ann Adv Automot Med, V52, P101; Mohan D, 2014, MED DECIS MAKING, V34, P242, DOI 10.1177/0272989X13508007; Mohan D, 2011, ARCH SURG-CHICAGO, V146, P786, DOI 10.1001/archsurg.2011.43; Murad MK, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-13; Murad MK, 2010, PREHOSP DISASTER MED, V25, P533, DOI 10.1017/S1049023X00008724; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; Petrucelli E, 1981, ACCID ANALPREV, V12, P29; Pruitt Z, 2013, AM J MANAG CARE, V19, P917; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Thomas A, 2008, ABBREVIATED INJURY S; Xiang HY, 2014, AM J EMERG MED, V32, P997, DOI 10.1016/j.ajem.2014.05.038	19	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134821	10.1371/journal.pone.0134821	http://dx.doi.org/10.1371/journal.pone.0134821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230931	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400173
J	Perrot, N; Baudrit, C; Brousset, JM; Abbal, P; Guillemin, H; Perret, B; Goulet, E; Guerin, L; Barbeau, G; Picque, D				Perrot, Nathalie; Baudrit, Cedric; Brousset, Jean Marie; Abbal, Philippe; Guillemin, Herve; Perret, Bruno; Goulet, Etienne; Guerin, Laurence; Barbeau, Gerard; Picque, Daniel			A Decision Support System Coupling Fuzzy Logic and Probabilistic Graphical Approaches for the Agri-Food Industry: Prediction of Grape Berry Maturity	PLOS ONE			English	Article							OF-THE-ART; MANAGEMENT ZONES; QUALITY-CONTROL	Agri-food is one of the most important sectors of the industry and a major contributor to the global warming potential in Europe. Sustainability issues pose a huge challenge for this sector. In this context, a big issue is to be able to predict the multiscale dynamics of those systems using computing science. A robust predictive mathematical tool is implemented for this sector and applied to the wine industry being easily able to be generalized to other applications. Grape berry maturation relies on complex and coupled physicochemical and biochemical reactions which are climate dependent. Moreover one experiment represents one year and the climate variability could not be covered exclusively by the experiments. Consequently, harvest mostly relies on expert predictions. A big challenge for the wine industry is nevertheless to be able to anticipate the reactions for sustainability purposes. We propose to implement a decision support system so called FGRAPEDBN able to (1) capitalize the heterogeneous fragmented knowledge available including data and expertise and (2) predict the sugar (resp. the acidity) concentrations with a relevant RMSE of 7 g/l (resp. 0.44 g/l and 0.11 g/kg). FGRAPEDBN is based on a coupling between a probabilistic graphical approach and a fuzzy expert system.	[Perrot, Nathalie] INRA, Unite Genie & Microbiol Proc Alimentaires, F-78850 Thiverval Grignon, France; [Baudrit, Cedric; Brousset, Jean Marie; Guillemin, Herve; Perret, Bruno; Picque, Daniel] INRA, Inst Mecan & Ingn, Talence, France; [Abbal, Philippe] INRA, Unite Sci CEnol, F-34060 Montpellier, France; [Goulet, Etienne; Guerin, Laurence] Inst Francais Vigne & Vin, Unite VINs Innovat Itineraires TERroirs & Acteurs, Amboise, France; [Barbeau, Gerard] INRA, Unite Vigne & Vin, Beaucouze, France; [Goulet, Etienne] InterLoire, Tours, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE; INRAE	Baudrit, C (corresponding author), INRA, Inst Mecan & Ingn, Talence, France.	cedric.baudrit@u-bordeaux.fr		Abbal, Philippe/0000-0003-0672-9196; Perrot, Nathalie Mejean/0000-0003-3795-0838	INTERLOIRE	INTERLOIRE	This work is a result of phd thesis funded by INTERLOIRE. The funder "InterLoire" participated to the definition of the study, the collect of data and result analysis. Etienne Goulet (co-author of paper) is the technical director of the French organisation "InterLoire".	Barbeau G., 2003, J INT SCI VIGNE VIN, V37, P199; Baudrit C, 2013, J FOOD ENG, V115, P1, DOI 10.1016/j.jfoodeng.2012.09.012; Cayla L., 2002, REV FR OENOL, V193, P10; Champagnol F., 1984, ELEMENTS PHYSL VIGNE; Coombe B. G., 2000, Australian Journal of Grape and Wine Research, V6, P131, DOI 10.1111/j.1755-0238.2000.tb00171.x; Coulon-Leroy C, 2013, COMPUT ELECTRON AGR, V99, P135, DOI 10.1016/j.compag.2013.09.010; Fragoulis G, 2009, J ENVIRON QUAL, V38, P826, DOI 10.2134/jeq2008.0182; Geiger D, 1997, ANN STAT, V25, P1344; Gil Y., BIOSYSTEMS ENG, V100, P184; Heckerman D., 1999, LEARNING GRAPHICAL M, P301; Huglin P., 1978, CR HEBD ACAD SCI, V64, P1117, DOI DOI 10.4236/OJOG.2018.813145; Jensen Finn V., 2010, BAYESIAN NETWORKS DE; Jiang YZ, 2015, IEEE T CYBERNETICS, V45, P548, DOI 10.1109/TCYB.2014.2330844; Juang CF, 2002, IEEE T FUZZY SYST, V10, P155, DOI 10.1109/91.995118; Kobayashi H, 2011, J JPN SOC HORTIC SCI, V80, P255, DOI 10.2503/jjshs1.80.255; Lawrence N, 2005, J MACH LEARN RES, V6, P1783; Lehmann RJ, 2012, COMPUT ELECTRON AGR, V89, P158, DOI 10.1016/j.compag.2012.09.005; MCLACHLAN GJ, 2004, ANAL MICROARRAY GENE; Morari F, 2009, COMPUT ELECTRON AGR, V68, P97, DOI 10.1016/j.compag.2009.05.003; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Perez-Magarino S, 2006, FOOD CHEM, V96, P197, DOI 10.1016/j.foodchem.2005.02.021; Perrot N, 2004, J FOOD ENG, V64, P321, DOI 10.1016/j.jfoodeng.2003.10.019; Perrot N, 2000, J FOOD PROCESS ENG, V23, P249, DOI 10.1111/j.1745-4530.2000.tb00515.x; Perrot N, 2006, FUZZY SET SYST, V157, P1145, DOI 10.1016/j.fss.2005.12.013; Perrot N, 2013, WOODHEAD PUBL FOOD S, P200, DOI 10.1533/9780857095763.1.200; Perrot N, 2011, TRENDS FOOD SCI TECH, V22, P304, DOI 10.1016/j.tifs.2011.03.008; Prade Henri, 1980, FUZZY SETS SYSTEMS T, V144; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Riou C., 1994, DETERMINISME CLIMATI; Tagarakis A, 2013, PRECIS AGRIC, V14, P18, DOI 10.1007/s11119-012-9275-4; Urretavizcaya I., 2014, PRECIS AGRIC, V14, P18; van Leeuwen C, 2004, AM J ENOL VITICULT, V55, P207; van Mil HGJ, 2014, TRENDS FOOD SCI TECH, V40, P20, DOI 10.1016/j.tifs.2014.07.005; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	35	13	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134373	10.1371/journal.pone.0134373	http://dx.doi.org/10.1371/journal.pone.0134373			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230334	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400111
J	Thorley, C				Thorley, Craig			Blame Conformity: Innocent Bystanders Can Be Blamed for a Crime as a Result of Misinformation from a Young, but Not Elderly, Adult Co-Witness	PLOS ONE			English	Article							MEMORY CONFORMITY; SOCIAL CONTAGION; UNCONSCIOUS TRANSFERENCE; UNANSWERABLE QUESTIONS; EYEWITNESS; ACCURACY; PERCEPTIONS; INFORMATION; CHILDRENS; TALK	This study examined whether or not exposing an eyewitness to a co-witness statement that incorrectly blames an innocent bystander for a crime can increase the likelihood of the eyewitness subsequently blaming the innocent bystander for the crime. It also examined whether or not the perceived age of the co-witness influences this effect. Participant eyewitnesses first watched a video of a crime featuring a perpetrator and an innocent bystander. They then read one of six bogus co-witness statements about the crime. All were presented as having been written by a female co-witness and they differed in terms of her age (young adult or elderly) and who she blamed for the crime (the perpetrator, the innocent bystander, or nobody). One week later the participants were asked who committed the crime. When the young adult co-witness had blamed the innocent bystander just over 40% of participants subsequently did the same. Few participants (less than 8%) in the other conditions subsequently blamed the innocent bystander. The elderly co-witness was also rated as less credible, less competent, and less accurate than the younger co-witness suggesting eyewitnesses were less likely to be influenced by her incorrect statement as they perceived her to be a less reliable source of information. The applied implications of these findings are discussed.	Univ Liverpool, Dept Psychol Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Thorley, C (corresponding author), Univ Liverpool, Dept Psychol Sci, Liverpool L69 3BX, Merseyside, England.	craig.thorley@liverpool.ac.uk	Thorley, Craig/AAZ-7907-2020	Thorley, Craig/0000-0002-3207-435X				Andrews JJ, 2014, APPL COGNITIVE PSYCH, V28, P505, DOI 10.1002/acp.3024; Betz AL, 1996, SOC COGNITION, V14, P113, DOI 10.1521/soco.1996.14.2.113; Borchard E. M., 1932, CONVICTING THE INNOC; Brimacombe CAE, 2003, LAW HUMAN BEHAV, V27, P507, DOI 10.1023/A:1025486006769; BUCKHOUT R, 1974, SCI AM, V231, P23, DOI 10.1038/scientificamerican1274-23; Crombag H, 2005, THE POPULAR POLICEMA; Davis D., 2007, HDB EYEWITNESS PSYCH, V1, P195; Davis SD, 2013, PSYCHON B REV, V20, P760, DOI 10.3758/s13423-013-0392-5; Fradella H, 2011, AMERICA S COURTS AND; Gabbert F, 2004, LEGAL CRIMINOL PSYCH, V9, P215, DOI 10.1348/1355325041719428; Gabbert F, 2012, COURT REV, P36; Gabbert F, 2007, ACTA PSYCHOL, V124, P319, DOI 10.1016/j.actpsy.2006.03.009; Garrett B, 2011, CONVICTING THE INNOC; Garven S, 2000, J APPL PSYCHOL, V85, P38, DOI 10.1037/0021-9010.85.1.38; Greene E, 1980, LAW HUMAN BEHAV, V4, P323, DOI [DOI 10.1007/BF01040624, 10.1007/BF01040624]; Kelley CM, 2003, J MEM LANG, V48, P704, DOI 10.1016/S0749-596X(02)00504-1; Kennedy KM, 2009, EXP AGING RES, V35, P268, DOI 10.1080/03610730902720638; Koriat A, 1996, PSYCHOL REV, V103, P490, DOI 10.1037/0033-295X.103.3.490; KORIAT A, 1994, J EXP PSYCHOL GEN, V123, P297, DOI 10.1037/0096-3445.123.3.297; Lampinen JM, 2012, THE PSYCHOLOGY OF EY; Loftus, 1976, LAW PSYCHOL REV, V2, P93; LUUS CAE, 1994, J APPL PSYCHOL, V79, P714, DOI 10.1037/0021-9010.79.5.714; Meade ML, 2002, MEM COGNITION, V30, P995, DOI 10.3758/BF03194318; Mehta CR, 2011, IBM SPSS EXACT TESTS; MILLER DG, 1976, B PSYCHONOMIC SOC, V7, P9, DOI 10.3758/BF03337105; Ministry of Justice (United Kingdom), 2011, ACHIEVING BEST EVIDE; National Institute of Justice, 1999, EYEWITNESS EVIDENCE; National Institute of Justice, 2002, EYEWITNESS EVIDENCE; Paterson HM, 2006, APPL COGNITIVE PSYCH, V20, P1083, DOI 10.1002/acp.1261; Paterson HM, 2009, PSYCHIAT PSYCHOL LAW, V16, pS112, DOI 10.1080/13218710802620380; Paterson HM, 2006, PSYCHOL CRIME LAW, V12, P181, DOI 10.1080/10683160512331316334; Petterson B, 2012, PSYCHIAT PSYCHOL LAW, V19, P735, DOI 10.1080/13218719.2011.615821; Porter C, 2007, THE CONVICTION OF TH; READ JD, 1990, APPL COGNITIVE PSYCH, V4, P3, DOI 10.1002/acp.2350040103; Roebers CM, 2002, J COGN DEV, V3, P415, DOI 10.1207/S15327647JCD3,4-03; Roediger HL, 2001, PSYCHON B REV, V8, P365, DOI 10.3758/BF03196174; ROSS DF, 1990, LAW HUMAN BEHAV, V14, P5, DOI 10.1007/BF01055786; ROSS DF, 1994, J APPL PSYCHOL, V79, P918, DOI 10.1037/0021-9010.79.6.918; RYAN EB, 1993, J GERONTOL, V48, pP199, DOI 10.1093/geronj/48.4.P199; RYAN EB, 1992, J GERONTOL, V47, pP41, DOI 10.1093/geronj/47.1.P41; Scoboria A, 2008, J EXP PSYCHOL-APPL, V14, P255, DOI 10.1037/1076-898X.14.3.255; See STK, 2001, PSYCHOL AGING, V16, P346; Shaw JS, 1997, LAW HUMAN BEHAV, V21, P503, DOI 10.1023/A:1024875723399; Skagerberg EM, 2008, PSYCHOL CRIME LAW, V14, P513, DOI 10.1080/10683160801948980; The Innocence Project, 2010, 250 EXONERATED TOO M; Thorley C, 2013, PSYCHOL CRIME LAW, V19, P565, DOI 10.1080/1068316X.2011.648637; Thorley C, 2013, APPL COGNITIVE PSYCH, V27, P291, DOI 10.1002/acp.2906; Williams GL, 1963, PROOF OF GUILT A STU, V3rd; Williamson P, 2013, BEHAV SCI LAW, V31, P607, DOI 10.1002/bsl.2094; Wright DB, 2009, CURR DIR PSYCHOL SCI, V18, P174, DOI 10.1111/j.1467-8721.2009.01631.x; Wright DB, 2000, BRIT J PSYCHOL, V91, P189, DOI 10.1348/000712600161781; Wright DB, 1999, HDB APPL COGNITION, P789; Zaragoza M. S., 2007, DO JUSTICE LET SKY F, P35	53	14	14	6	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134739	10.1371/journal.pone.0134739	http://dx.doi.org/10.1371/journal.pone.0134739			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230523	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000358838400158
J	Waechter, S; Sutterlin, B; Siegrist, M				Waechter, Signe; Suetterlin, Bernadette; Siegrist, Michael			Desired and Undesired Effects of Energy Labels-An Eye-Tracking Study	PLOS ONE			English	Article							CARBON EMISSIONS; DECISION-MAKING; NUTRITION LABEL; ECO-LABELS; CONSUMPTION; INFORMATION; EFFICIENCY; MOVEMENTS; CHOICE; POLICY	Saving energy is an important pillar for the mitigation of climate change. Electric devices (e.g., freezer and television) are an important player in the residential sector in the final demand for energy. Consumers' purchase decisions are therefore crucial to successfully reach the energy-efficiency goals. Putting energy labels on products is often considered an adequate way of empowering consumers to make informed purchase decisions. Consequently, this approach should contribute to reducing overall energy consumption. The effectiveness of its measurement depends on consumers' use and interpretation of the information provided. Despite advances in energy efficiency and a mandatory labeling policy, final energy consumption per capita is in many countries still increasing. This paper provides a systematic analysis of consumers' reactions to one of the most widely used ecolabels, the European Union (EU) energy label, by using eye-tracking methodology as an objective measurement. The study's results partially support the EU's mandatory policy, showing that the energy label triggers attention toward energy information in general. However, the energy label's effect on consumers' actual product choices seems to be rather low. The study's results show that the currently used presentation format on the label is insufficient. The findings suggest that it does not facilitate the integration of energy-related information. Furthermore, the current format can attract consumers to focus more on energy-efficiency information, leading them to disregard information about actual energy consumption. As a result, the final energy consumption may increase because excellent ratings on energy efficiency (e.g., A(++)) do not automatically imply little consumption. Finally, implications for policymakers and suggestions for further research are discussed.	[Waechter, Signe; Suetterlin, Bernadette; Siegrist, Michael] ETH, IED, Consumer Behav, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Waechter, S (corresponding author), ETH, IED, Consumer Behav, Zurich, Switzerland.	siwaechter@ethz.ch	Sütterlin, Bernadette/S-3265-2016; Siegrist, Michael/A-1032-2008	Sütterlin, Bernadette/0000-0001-9749-6660; Siegrist, Michael/0000-0002-6139-7190	Swiss Federal Office of Energy; Energy-Economy-Society research project	Swiss Federal Office of Energy; Energy-Economy-Society research project	This work was funded by the Swiss Federal Office of Energy and it is part of the Energy-Economy-Society research project (http://www.bfe.admin.ch/forschungewg/index.html?lang = en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[AFD OECD/IEA], 2008, PROM EN EFF INV CAS; Allcott H, 2013, ENERGY EFFICIENCY: TOWARDS THE END OF DEMAND GROWTH, P133, DOI 10.1016/B978-0-12-397879-0.00005-0; ANDERSON CD, 1982, J CONSUM RES, V9, P163, DOI 10.1086/208909; [Anonymous], 1992, OFFIC J EUR COMMUNIT; [Anonymous], 2012, OFFIC J EUR UNION; [Anonymous], 2010, OFFIC J EUR UNION; Ares G, 2013, J SENS STUD, V28, P138, DOI 10.1111/joss.12031; Ashby NJS, 2015, JUDGM DECIS MAK, V10, P172; Ashby NJS, 2012, JUDGM DECIS MAK, V7, P254; Attari SZ, 2010, P NATL ACAD SCI USA, V107, P16054, DOI 10.1073/pnas.1001509107; Ball D.A., 1992, J CONSUM PSYCHOL, V1, P155, DOI [10.1016/S1057-7408(08)80055-1, DOI 10.1016/S1057-7408(08)80055-1]; BFE, 2013, SWISS EN STAT 2012; Boardman B, 2004, ENVIRON SCI POLICY, V7, P165, DOI 10.1016/j.envsci.2004.03.002; Bradu C, 2014, J BUS ETHICS, V124, P283, DOI 10.1007/s10551-013-1872-2; Buckley R, 2014, J CLEAN PROD, DOI [http://dx.doi.org/10.1016/j.jclepro.2014.08.067, DOI 10.1016/J.JCLEPR0.2014.08.067]; Davis LW, 2008, RAND J ECON, V39, P530, DOI 10.1111/j.0741-6261.2008.00026.x; de Almeida A, 2011, ENERG BUILDINGS, V43, P1884, DOI 10.1016/j.enbuild.2011.03.027; Dendler L, 2014, J CLEAN PROD, V63, P74, DOI 10.1016/j.jclepro.2013.04.037; Djamasbi S, 2012, 18 AM C INF SYST AMC; Duchowski A, 2007, VISUAL ATTENTION EYE, P3; Duchowski A, 2007, EYE TRACKING METHODO, P137, DOI [10.1007/978-1-84628-609-4_12, DOI 10.1007/978-1-84628-609-4_12]; Egan C, 2000, INTERIM FINDINGS EVA; Eidgen&ouml;ssisches Departement f&uuml;r Umwelt V Energie und Kommunikation (UVEK), 2013, EN STRAT 2050; Eurostat, 2012, EN TRANSP ENV IND; Field A., 2013, DISCOVERING STAT USI; Galarraga Gallastegui I., 2002, European Environment, V12, P316, DOI 10.1002/eet.304; Gegenfurtner A, 2011, EDUC PSYCHOL REV, V23, P523, DOI 10.1007/s10648-011-9174-7; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; Gillingham K., 2013, BRIDGING ENERGY EFFI; Glockner A, 2011, J BEHAV DECIS MAKING, V24, P71, DOI 10.1002/bdm.684; Goldberg JH, 1999, INT J IND ERGONOM, V24, P631, DOI 10.1016/S0169-8141(98)00068-7; Graham DJ, 2012, FOOD POLICY, V37, P378, DOI 10.1016/j.foodpol.2012.03.004; Heinzle S, 2009, CONSUMER SURVEY NEW; Heinzle SL, 2012, J CONSUM POLICY, V35, P43, DOI 10.1007/s10603-012-9189-6; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Herring H, 2006, ENERGY, V31, P10, DOI 10.1016/j.energy.2004.04.055; Holmqvist K., 2011, EYE TRACKING COMPREH; Horstmann N, 2009, JUDGM DECIS MAK, V4, P335; IEA, 2009, GADG GIG; IEA & OECD, 2003, COOL APPL POL STRAT; International Risk Governance Council, 2013, REB EFF IMPL CONS BE; JAFFE AB, 1994, ENERG POLICY, V22, P804, DOI 10.1016/0301-4215(94)90138-4; JUST MA, 1976, COGNITIVE PSYCHOL, V8, P441, DOI 10.1016/0010-0285(76)90015-3; Kahneman D., 2011, THINKING FAST SLOW; Kralik JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046240; Le Meur O, 2009, IM PROC ICIP 2009 16; MCNEILL DL, 1979, J CONSUM RES, V6, P1, DOI 10.1086/208743; Merritt AC, 2010, SOC PERSONAL PSYCHOL, V4, P344, DOI 10.1111/j.1751-9004.2010.00263.x; Molenbroek E, 2013, EVALUATION ENERGY LA; Molenbroek E, 2014, ENERC32012523 EC; OECD/IEA, 2013, EN POL HIGHL; Orquin JL, 2013, ACTA PSYCHOL, V144, P190, DOI 10.1016/j.actpsy.2013.06.003; Otto S, 2014, EUR PSYCHOL, V19, P96, DOI 10.1027/1016-9040/a000182; Pedersen E.R., 2006, BUSINESS STRATEGY EN, V15, P15, DOI DOI 10.1002/BSE.434; Pieters RGM, 1996, ADV CONSUM RES, V23, P242; Poole A, 2005, BCS CONF SERIES, P363, DOI 10.1007/1-84628-062-1_23; Prognos, 2012, EN SWITZ UNT 2050; Sammer K., 2006, BUSINESS STRATEGY EN, V15, P185, DOI [10.1002/bse.522, DOI 10.1002/BSE.522]; Schulte-Mecklenbeck M, 2013, APPETITE, V71, P242, DOI 10.1016/j.appet.2013.08.008; Shen J, 2009, J ENVIRON MANAGE, V90, P3561, DOI 10.1016/j.jenvman.2009.06.010; Shi SW, 2013, MANAGE SCI, V59, P1009, DOI 10.1287/mnsc.1120.1625; SHIPPEE G, 1980, ENVIRON MANAGE, V4, P297, DOI 10.1007/BF01869423; Siegrist M, 2015, FOOD QUAL PREFER, V39, P183, DOI 10.1016/j.foodqual.2014.07.010; Slovic P, 2007, EUR J OPER RES, V177, P1333, DOI 10.1016/j.ejor.2005.04.006; Sorqvist P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080719; Soytas U, 2007, ECOL ECON, V62, P482, DOI 10.1016/j.ecolecon.2006.07.009; Stawreberg L, 2011, J CLEAN PROD, V19, P1300, DOI 10.1016/j.jclepro.2011.03.016; Stuttgen P, 2012, MARKET SCI, V31, P878, DOI 10.1287/mksc.1120.0732; Sutterlin B, 2014, J ENVIRON PSYCHOL, V40, P259, DOI 10.1016/j.jenvp.2014.07.005; Tatler BW, 2010, I-PERCEPTION, V1, P7, DOI 10.1068/i0382; Teisl MF, 2008, J ECON PSYCHOL, V29, P140, DOI 10.1016/j.joep.2007.04.002; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; Thogersen J, 2003, J ENVIRON PSYCHOL, V23, P225, DOI 10.1016/S0272-4944(03)00018-5; Tiefenbeck V, 2013, ENERG POLICY, V57, P160, DOI 10.1016/j.enpol.2013.01.021; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; UNEMA P, 1990, VISUAL SEARCH, P193; van Amstel M, 2008, J CLEAN PROD, V16, P263, DOI 10.1016/j.jclepro.2006.07.039; Velichkovsky B.M., 2002, TRANSPORT RES F, V5, P145, DOI [10.1016/S1369-8478(02)00013-X, DOI 10.1016/S1369-8478(02)00013-X]; Waechter S, 2015, J CLEAN PROD, V93, P193, DOI 10.1016/j.jclepro.2015.01.011; Walton KC, 2014, ENRGY PROCED, V57, P826, DOI 10.1016/j.egypro.2014.10.291; Ward DO, 2011, ENERG POLICY, V39, P1450, DOI 10.1016/j.enpol.2010.12.017; Weber EU, 2009, ANNU REV PSYCHOL, V60, P53, DOI 10.1146/annurev.psych.60.110707.163633; Wiel S, 2003, ENERG POLICY, V31, P1403, DOI 10.1016/S0301-4215(02)00199-4; Wiel S, 2000, ENVIRON SCI POLICY, V3, P7, DOI [http://dx.doi.org/10.1016/S1462-9011(00)00014-9, DOI 10.1016/S1462-9011(00)00014-9]; Wilson C, 2007, ANNU REV ENV RESOUR, V32, P169, DOI 10.1146/annurev.energy.32.053006.141137; Zhang XP, 2009, ECOL ECON, V68, P2706, DOI 10.1016/j.ecolecon.2009.05.011	87	32	33	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134132	10.1371/journal.pone.0134132	http://dx.doi.org/10.1371/journal.pone.0134132			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26231028	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400075
J	Wright, NE; Strong, JA; Gilbart, ER; Shollenbarger, SG; Lisdahl, KM				Wright, Natasha E.; Strong, Judith A.; Gilbart, Erika R.; Shollenbarger, Skyler G.; Lisdahl, Krista M.			5-HTTLPR Genotype Moderates the Effects of Past Ecstasy Use on Verbal Memory Performance in Adolescent and Emerging Adults: A Pilot Study	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; MDMA ECSTASY; CANNABIS USE; NEUROPSYCHOLOGICAL EVIDENCE; HIPPOCAMPAL DYSFUNCTION; COGNITIVE FUNCTION; POSITRON EMISSION; POLYMORPHISMS; MOOD; ASSOCIATION	Objective Ecstasy use is associated with memory deficits. Serotonin transporter gene (5-HTTLPR) polymorphisms have been linked with memory function in healthy samples. The present pilot study investigated the influence of 5-HTTLPR polymorphisms on memory performance in ecstasy users, marijuana-using controls, and non-drug-using controls, after a minimum of 7 days of abstinence. Method Data were collected from 116 young adults (18-25 years-old), including 45 controls, 42 marijuana users, and 29 ecstasy users, and were balanced for 5-HTTLPR genotype. Participants were abstinent seven days prior to completing memory testing. Three MANCOVAs and one ANCOVA were run to examine whether drug group, 5-HTTLPR genotype, and their interactions predicted verbal and visual memory after controlling for gender, past year alcohol use, other drug use, and nicotine cotinine levels. Results MANCOVA and ANCOVA analysis revealed a significant interaction between drug group and genotype (p = .03) such that ecstasy users with the L/L genotype performed significantly worse on CVLT-2 total recall (p = .05), short (p = .008) and long delay free recall (p = .01), and recognition (p = .006), with the reverse pattern found in controls. Ecstasy did not significantly predict visual memory. 5-HTTLPR genotype significantly predicted memory for faces (p = .02); short allele carriers performed better than those with L/L genotype. Conclusions 5-HTTLPR genotype moderated the effects of ecstasy on verbal memory, with L/L carriers performing worse compared to controls. Future research should continue to examine individual differences in ecstasy's impact on neurocognitive performance as well as relationships with neuronal structure. Additional screening and prevention efforts focused on adolescents and emerging adults are necessary to prevent ecstasy consumption.	[Wright, Natasha E.; Gilbart, Erika R.; Shollenbarger, Skyler G.; Lisdahl, Krista M.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA; [Strong, Judith A.] Univ Cincinnati, Dept Anesthesiol, Cincinnati, OH USA	University of Wisconsin System; University of Wisconsin Milwaukee; University System of Ohio; University of Cincinnati	Lisdahl, KM (corresponding author), Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA.	krista.medina@gmail.com	Lisdahl, Krista/P-8470-2019	Lisdahl, Krista/0000-0001-9515-1335; Strong, Judith/0000-0001-9363-0551; Wade, Natasha/0000-0002-9629-2305	National Institute on Drug Abuse [R03 DA027457]; University of Cincinnati Center for Environmental Genetics Pilot Program [P30 ES06096]; National Institute of Drug Abuse [R01 DA030354]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030354, R03DA027457] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); University of Cincinnati Center for Environmental Genetics Pilot Program; National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was funded by the National Institute on Drug Abuse (R03 DA027457; PI: KML) and the University of Cincinnati Center for Environmental Genetics Pilot Program (P30 ES06096; PI: KML). KML was also funded by the National Institute of Drug Abuse (R01 DA030354) during manuscript preparation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DE, 2012, J COGNITIVE NEUROSCI, V24, P1069, DOI 10.1162/jocn_a_00207; Ando RD, 2010, BEHAV BRAIN RES, V207, P280, DOI 10.1016/j.bbr.2009.10.011; Bava S, 2010, NEUROPSYCHOL REV, V20, P398, DOI 10.1007/s11065-010-9146-6; Lopez-Rodriguez AB, 2014, BRIT J PHARMACOL, V171, P1435, DOI 10.1111/bph.12519; Bolla KI, 1998, NEUROLOGY, V51, P1532, DOI 10.1212/WNL.51.6.1532; Buchert R, 2004, AM J PSYCHIAT, V161, P1181, DOI 10.1176/appi.ajp.161.7.1181; Croft RJ, 2001, PSYCHOPHARMACOLOGY, V153, P373, DOI 10.1007/s002130000591; Curran HV, 1997, ADDICTION, V92, P821, DOI 10.1111/j.1360-0443.1997.tb02951.x; Cuyas E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027206; De Pradier M, 2010, EUR PSYCHIAT, V25, P323, DOI 10.1016/j.eurpsy.2009.10.002; Delis DC, 2000, MANUAL CALIFORNIA VE; Fagundo AB, 2010, J PSYCHOPHARMACOL, V24, P1381, DOI 10.1177/0269881109354926; FISCHER C, 1995, J NEUROSCI, V15, P5476; Fox HC, 2002, PSYCHOPHARMACOLOGY, V162, P203, DOI 10.1007/s00213-002-1071-9; Frodl T, 2008, MOL PSYCHIATR, V13, P1093, DOI 10.1038/mp.2008.62; Gilbertson R, 2011, J CLIN EXP NEUROPSYC, V33, P609, DOI 10.1080/13803395.2010.543887; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gonzalez R, 2012, J CLIN EXP NEUROPSYC, V34, P962, DOI 10.1080/13803395.2012.703642; Goodwin RS, 2008, J ANAL TOXICOL, V32, P562, DOI 10.1093/jat/32.8.562; Gouzoulis-Mayfrank E, 2003, PROG NEURO-PSYCHOPH, V27, P819, DOI 10.1016/S0278-5846(03)00114-3; Haenisch B, 2013, J AFFECT DISORDERS, V146, P438, DOI 10.1016/j.jad.2012.08.001; Hall MH, 2010, HARVARD REV PSYCHIAT, V18, P67, DOI 10.3109/10673220903523532; Halpern JH, 2011, ADDICTION, V106, P777, DOI 10.1111/j.1360-0443.2010.03252.x; Hanson KL, 2010, J CLIN EXP NEUROPSYC, V32, P337, DOI 10.1080/13803390903042361; Hart AB, 2013, NEUROPSYCHOPHARMACOL, V38, P802, DOI 10.1038/npp.2012.245; Harvey MA, 2007, DRUG ALCOHOL REV, V26, P309, DOI 10.1080/09595230701247772; Hatzidimitriou G, 1999, J NEUROSCI, V19, P5096; Jacobsen LK, 2004, PSYCHOPHARMACOLOGY, V173, P383, DOI 10.1007/s00213-003-1679-4; Jager G, 2007, PSYCHOPHARMACOLOGY, V193, P403, DOI 10.1007/s00213-007-0792-1; Johnston L. D., 2012, MONITORING FUTURE NA, VI; Kaiser R, 2002, CLIN BIOCHEM, V35, P49, DOI 10.1016/S0009-9120(02)00273-4; Kalechstein AD, 2007, PSYCHOPHARMACOLOGY, V189, P531, DOI 10.1007/s00213-006-0601-2; Kish SJ, 2010, BRAIN, V133, P1779, DOI 10.1093/brain/awq103; Lamers CTJ, 2006, J PSYCHOPHARMACOL, V20, P302, DOI 10.1177/0269881106059495; Lasky-Su JA, 2005, AM J MED GENET B, V133B, P110, DOI 10.1016/j.ajmg.b.30104; Laucht M, 2009, INT J NEUROPSYCHOPH, V12, P737, DOI 10.1017/S1461145708009875; Laws KR, 2007, HUM PSYCHOPHARM CLIN, V22, P381, DOI 10.1002/hup.857; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 1998, BIOL PSYCHIAT, V44, P179, DOI 10.1016/S0006-3223(98)00121-8; Lisdahl KL, 2012, J INT NEUROPSYCH SOC, V18, P876; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Martin-Santos R, 2010, ADDICT BIOL, V15, P15, DOI 10.1111/j.1369-1600.2009.00180.x; Martins SS, 2005, EXP CLIN PSYCHOPHARM, V13, P244, DOI 10.1037/1064-1297.13.3.244; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; McCann UD, 1998, LANCET, V352, P1433, DOI 10.1016/S0140-6736(98)04329-3; Medina KL, 2005, J INT NEUROPSYCH SOC, V11, P753, DOI 10.1017/S1355617705050915; Medina KL, 2007, J INT NEUROPSYCH SOC, V13, P807, DOI 10.1017/S1355617707071032; Meyers J. E., 1995, REY COMPLEX FIGURE T; Morgan MJ, 2002, PSYCHOPHARMACOLOGY, V159, P294, DOI 10.1007/s002130100907; Noskova T, 2008, PRONEUROPSYCHOPHARMA, V32, P1745; Pardo-Lozano R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047599; Parrott AC, 2001, HUM PSYCHOPHARM CLIN, V16, P557, DOI 10.1002/hup.351; Parrott AC, 1998, J PSYCHOPHARMACOL, V12, P79, DOI 10.1177/026988119801200110; Parrott AC, 2004, PSYCHOPHARMACOLOGY, V173, P234, DOI 10.1007/s00213-003-1712-7; Perrine SA, 2010, NEUROTOXICOLOGY, V31, P654, DOI 10.1016/j.neuro.2010.08.005; Price JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115645; Price JS, 2013, BEHAV BRAIN RES, V242, P158, DOI 10.1016/j.bbr.2012.11.013; Quednow BB, 2006, J PSYCHOPHARMACOL, V20, P373, DOI 10.1177/0269881106061200; Reneman L, 2000, PSYCHOPHARMACOLOGY, V148, P322, DOI 10.1007/s002130050057; Reneman L, 2001, LANCET, V358, P1864, DOI 10.1016/S0140-6736(01)06888-X; Rodgers J, 2003, J PSYCHOPHARMACOL, V17, P389, DOI 10.1177/0269881103174016; Roiser JP, 2006, PSYCHOPHARMACOLOGY, V188, P213, DOI 10.1007/s00213-006-0495-z; RUDNICK G, 1992, P NATL ACAD SCI USA, V89, P1817, DOI 10.1073/pnas.89.5.1817; Semple DM, 1999, BRIT J PSYCHIAT, V175, P63, DOI 10.1192/bjp.175.1.63; SHARKEY J, 1991, PSYCHOPHARMACOLOGY, V105, P113, DOI 10.1007/BF02316872; Sobell L. C, 1992, MEASURING ALCOHOL CO; Sprague JE, 1993, PHYSIOL BEHAV, V79, P1281; Starr LR, 2014, DEV PSYCHOPATHOL, V26, P1241, DOI 10.1017/S0954579414000996; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Tait RJ, 2011, ADDICTION, V106, P2195, DOI 10.1111/j.1360-0443.2011.03574.x; Takagi M, 2011, DRUG ALCOHOL REV, V30, P629, DOI 10.1111/j.1465-3362.2010.00256.x; Tanner-Smith EE, 2006, DRUG ALCOHOL DEPEN, V83, P247, DOI 10.1016/j.drugalcdep.2005.11.016; Taurah L, 2014, PSYCHOPHARMACOLOGY, V231, P737, DOI 10.1007/s00213-013-3288-1; Taylor WD, 2005, ARCH GEN PSYCHIAT, V62, P537, DOI 10.1001/archpsyc.62.5.537; Thompson RD, 2010, ALCOHOL, V44, P401, DOI 10.1016/j.alcohol.2010.05.008; Urban NBL, 2012, NEUROPSYCHOPHARMACOL, V37, P1465, DOI 10.1038/npp.2011.332; Verbaten MN, 2003, HUM PSYCHOPHARM, V167, P85; Verdejo-Garcia A, 2013, NEUROPSYCHOPHARMACOL, V38, P1598, DOI 10.1038/npp.2013.59; Verrico CD, 2007, PSYCHOPHARMACOLOGY, V189, P489, DOI 10.1007/s00213-005-0174-5; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Williams RB, 2003, NEUROPSYCHOPHARMACOL, V28, P533, DOI 10.1038/sj.npp.1300054; Winward JL, 2014, J INT NEUROPSYCH SOC, V20, P784, DOI 10.1017/S1355617714000666; Wu P, 2010, DRUG ALCOHOL DEPEN, V112, P33, DOI 10.1016/j.drugalcdep.2010.05.006; Yubero-Lahoz S, 2014, EUROPEAN J PHARM, V674, P337; Zakzanis KK, 2007, HUM PSYCHOPHARM CLIN, V22, P427, DOI 10.1002/hup.873; Zhang XL, 2015, EXP THER MED, V9, P245, DOI 10.3892/etm.2014.2043	86	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134708	10.1371/journal.pone.0134708	http://dx.doi.org/10.1371/journal.pone.0134708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26231032	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400152
J	Yong, HS; Song, SL; Eamsobhana, P; Goh, SY; Lim, PE; Chow, WL; Chan, KG; Abrahams-Sandi, E				Yong, Hoi-Sen; Song, Sze-Looi; Eamsobhana, Praphathip; Goh, Share-Yuan; Lim, Phaik-Eem; Chow, Wan-Loo; Chan, Kok-Gan; Abrahams-Sandi, Elizabeth			Mitochondrial Genome Supports Sibling Species of Angiostrongylus costaricensis (Nematoda: Angiostrongylidae)	PLOS ONE			English	Article							PHYLOGEOGRAPHY; REDESCRIPTION; ENVIRONMENT; CONGENERS; VASORUM; MODEL	Angiostrongylus costaricensis is a zoonotic parasitic nematode that causes abdominal or intestinal angiostrongyliasis in humans. It is endemic to the Americas. Although the mitochondrial genome of the Brazil taxon has been published, there is no available mitochondrial genome data on the Costa Rica taxon. We report here the complete mitochondrial genome of the Costa Rica taxon and its genetic differentiation from the Brazil taxon. The whole mitochondrial genome was obtained from next-generation sequencing of genomic DNA. It had a total length of 13,652 bp, comprising 36 genes (12 protein-coding genes-PCGs, 2 rRNA and 22 tRNA genes) and a control region (A + T rich non-coding region). It is longer than that of the Brazil taxon (13,585 bp). The larger mitogenome size of the Costa Rica taxon is due to the size of the control region as the Brazil taxon has a shorter length (265 bp) than the Costa Rica taxon (318 bp). The size of 6 PCGs and the start codon for ATP6, CYTB and NAD5 genes are different between the Costa Rica and Brazil taxa. Additionally, the two taxa differ in the stop codon of 6 PCGs. Molecular phylogeny based on 12 PCGs was concordant with two rRNA, 22 tRNA and 36 mitochondrial genes. The two taxa have a genetic distance of p = 16.2% based on 12 PCGs, p = 15.3% based on 36 mitochondrial genes, p = 13.1% based on 2 rRNA genes and p = 10.7% based on 22 tRNA genes, indicating status of sibling species. The Costa Rica and Brazil taxa of A. costaricensis are proposed to be accorded specific status as members of a species complex.	[Yong, Hoi-Sen; Goh, Share-Yuan; Lim, Phaik-Eem; Chan, Kok-Gan] Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia; [Yong, Hoi-Sen; Song, Sze-Looi; Goh, Share-Yuan] Univ Malaya, Chancellery High Impact Res, Kuala Lumpur, Malaysia; [Eamsobhana, Praphathip] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Parasitol, Bangkok 10700, Thailand; [Lim, Phaik-Eem] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Chow, Wan-Loo] Sci Vis Sdn Bhd, Shah Alam 40170, Selangor Darul, Malaysia; [Abrahams-Sandi, Elizabeth] Univ Costa Rica, Dept Parasitol, San Pedro, Costa Rica	Universiti Malaya; Universiti Malaya; Mahidol University; Universiti Malaya; Universidad Costa Rica	Yong, HS (corresponding author), Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia.	yong@um.edu.my; praphathip.eam@mahidol.ac.th; phaikeem@um.edu.my	Song, Sze-Looi/E-7939-2015; LIM, Phaik Eem/B-5331-2010; Yong, Hoi Sen/C-1548-2010; Chan, Kok Gan/B-8347-2010; song, sl/GRS-1884-2022; Eamsobhana, Praphathip/H-3343-2012	LIM, Phaik Eem/0000-0001-9186-1487; Yong, Hoi Sen/0000-0002-9832-8826; Chan, Kok Gan/0000-0002-1883-1115; 	MoHE-HIR Grant [H-50001-00-A000025]; University of Malaya [H-5620009]	MoHE-HIR Grant; University of Malaya(Universiti Malaya)	This study was funded in part by MoHE-HIR Grant (H-50001-00-A000025) and the University of Malaya (H-5620009).	Akaike H., 1973, 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson R. C., 2000, Nematode parasites of vertebrates: their development and transmission., DOI 10.1079/9780851994215.0000; Andrews S., 2010, FASTQC QUALITY CONTR; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Derycke S, 2008, MOL ECOL, V17, P3306, DOI 10.1111/j.1365-294X.2008.03846.x; Eamsobhana P, 2010, ACTA TROP, V116, P152, DOI 10.1016/j.actatropica.2010.07.005; Eamsobhana P, 2010, EXP PARASITOL, V126, P564, DOI 10.1016/j.exppara.2010.06.001; Eamsobhna P., 2010, ANGIOSTRONGYLUS ANGI, P41; Gasser RB, 2012, INFECT GENET EVOL, V12, P1884, DOI 10.1016/j.meegid.2012.07.022; Graeff-Teixeira C, 2009, CLIN MICROBIOL REV, V22, P322, DOI 10.1128/CMR.00044-08; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hu M, 2006, TRENDS PARASITOL, V22, P78, DOI 10.1016/j.pt.2005.12.003; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Humphreys-Pereira DA, 2014, MOL BIOCHEM PARASIT, V194, P20, DOI 10.1016/j.molbiopara.2014.04.003; Hyman BC, 2011, GENETICA, V139, P611, DOI 10.1007/s10709-010-9531-3; Jabbar A, 2013, GENE, V516, P294, DOI 10.1016/j.gene.2012.10.072; Jefferies R, 2009, PARASITOLOGY, V136, P107, DOI 10.1017/S0031182008005258; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kramer MH, 1998, CLIN INFECT DIS, V26, P365, DOI 10.1086/516325; Lagisz M, 2013, J EVOLUTION BIOL, V26, P683, DOI 10.1111/jeb.12068; Lv Shan, 2014, Zhongguo Xuexichongbing Fangzhi Zazhi, V26, P175; Lv S, 2012, PARASITOL RES, V111, P115, DOI 10.1007/s00436-011-2807-4; Maldonado A, 2012, ZOONOSIS, P303, DOI DOI 10.5572/2125; McNulty SN, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-145; MORERA P., 1971, Revista de Biologia Tropicale, V18, P173; MORERA P, 1973, AM J TROP MED HYG, V22, P613, DOI 10.4269/ajtmh.1973.22.613; Mota EM, 2005, MEM I OSWALDO CRUZ, V100, P407, DOI 10.1590/S0074-02762005000400012; Mota EM, 1995, MEM I OSWALDO CRUZ, V90, P707, DOI 10.1590/S0074-02761995000600010; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Park JK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-392; Rambaut A, FIGTREE VERSION 1 4; RODRIGUEZ Rubens, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P55, DOI 10.1590/S0036-46652002000100010; Romero-Alegria A., 2014, ADV INFECT DIS, V04, P36, DOI [10.4236/aid.2014.41007, DOI 10.4236/AID.2014.41007]; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Spratt DM, 2015, INT J PARASITOL-PAR, V4, P178, DOI 10.1016/j.ijppaw.2015.02.006; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Yong HS, 2015, ACTA TROP, V148, P66, DOI 10.1016/j.actatropica.2015.04.020	41	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134581	10.1371/journal.pone.0134581	http://dx.doi.org/10.1371/journal.pone.0134581			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230642	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400137
J	Mentek, M; Truffer, F; Chiquet, C; Godin-Ribuot, D; Amoos, S; Loeuillet, C; Bernabei, M; Geiser, M				Mentek, Marielle; Truffer, Frederic; Chiquet, Christophe; Godin-Ribuot, Diane; Amoos, Serge; Loeuillet, Corinne; Bernabei, Mario; Geiser, Martial			Compact Laser Doppler Flowmeter (LDF) Fundus Camera for the Assessment of Retinal Blood Perfusion in Small Animals	PLOS ONE			English	Article							OPTIC-NERVE HEAD; INTRAOCULAR-PRESSURE; RAT RETINA; FLOW; MICROVASCULATURE; CAT; ISCHEMIA; GRADIENT; VELOCITY; VOLUME	Purpose Noninvasive techniques for ocular blood perfusion assessment are of crucial importance for exploring microvascular alterations related to systemic and ocular diseases. However, few techniques adapted to rodents are available and most are invasive or not specifically focused on the optic nerve head (ONH), choroid or retinal circulation. Here we present the results obtained with a new rodent-adapted compact fundus camera based on laser Doppler flowmetry (LDF). Methods A confocal miniature flowmeter was fixed to a specially designed 3D rotating mechanical arm and adjusted on a rodent stereotaxic table in order to accurately point the laser beam at the retinal region of interest. The linearity of the LDF measurements was assessed using a rotating Teflon wheel and a flow of microspheres in a glass capillary. In vivo reproducibility was assessed in Wistar rats with repeated measurements (inter-session and inter-day) of retinal arteries and ONH blood velocity in six and ten rats, respectively. These parameters were also recorded during an acute intraocular pressure increase to 150 mmHg and after heart arrest (n = 5 rats). Results The perfusion measurements showed perfect linearity between LDF velocity and Teflon wheel or microsphere speed. Intraclass correlation coefficients for retinal arteries and ONH velocity (0.82 and 0.86, respectively) indicated strong inter-session repeatability and stability. Inter-day reproducibility was good (0.79 and 0.7, respectively). Upon ocular blood flow cessation, the retinal artery velocity signal substantially decreased, whereas the ONH signal did not significantly vary, suggesting that it could mostly be attributed to tissue light scattering. Conclusion We have demonstrated that, while not adapted for ONH blood perfusion assessment, this device allows pertinent, stable and repeatable measurements of retinal blood perfusion in rats.	[Mentek, Marielle; Chiquet, Christophe; Godin-Ribuot, Diane; Loeuillet, Corinne] Grenoble Alpes Univ, Lab HP2, F-38000 Grenoble, France; [Mentek, Marielle; Chiquet, Christophe; Godin-Ribuot, Diane; Loeuillet, Corinne] INSERM, Lab U1042, F-38000 Grenoble, France; [Truffer, Frederic; Amoos, Serge; Bernabei, Mario; Geiser, Martial] Univ Appl Sci & Arts Western Switzerland, Inst Syst Engn, Sion, Switzerland; [Chiquet, Christophe] Grenoble Alpes Univ, Grenoble Univ Hosp, Dept Ophthalmol, F-38000 Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Geiser, M (corresponding author), Univ Appl Sci & Arts Western Switzerland, Inst Syst Engn, Sion, Switzerland.	martial.geiser@hevs.ch	Godin-Ribuot, Diane/B-6945-2014; Chiquet, Christophe/M-7426-2014; loeuillet, corinne/M-6504-2014	Godin-Ribuot, Diane/0000-0001-7589-932X; Chiquet, Christophe/0000-0002-7601-4885; Geiser, Martial Henri/0000-0002-1017-2872; loeuillet, corinne/0000-0001-6474-4453	Retina France; Fondation de France, bourse Berthe Fouassier; PHC Germaine de Stael [26419NE, 777772H]	Retina France; Fondation de France, bourse Berthe Fouassier; PHC Germaine de Stael	Funding provided by Retina France 2012 (CC) http://www.retina.fr/retinaDrupal/content/projets-et-bourses-finances-en-2012, Fondation de France, bourse Berthe Fouassier (MM) http://www.fondationdefrance.org/La-Fondation-de-France/Fonds-et-fondations-sous-egide/Toutes-lesfondations/Berthe-Fouassier and PHC Germaine de Stael 2012, projet no 26419NE (CC, MHG), PHC Germaine de Stael 2013, projet no 777772H (CC, MHG) http://www.campusfrance.org/fr/stael. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHUTTO IA, 1995, OPHTHALMIC RES, V27, P249, DOI 10.1159/000267734; Bui BV, 2005, INVEST OPHTH VIS SCI, V46, P202, DOI 10.1167/iovs.04-0421; CAMPBELL MCW, 1981, VISION RES, V21, P1129, DOI 10.1016/0042-6989(81)90016-X; Cheng HY, 2007, OPT LETT, V32, P2188, DOI 10.1364/OL.32.002188; Chiquet C, 2014, INVEST OPHTH VIS SCI, V55, P485, DOI 10.1167/iovs.13-12975; Choi W, 2012, BIOMED OPT EXPRESS, V3, P1047, DOI 10.1364/BOE.3.001047; FITZGERALD MEC, 1990, INVEST OPHTH VIS SCI, V31, P2483; Fredriksson I, 2009, MICROVASC RES, V78, P4, DOI 10.1016/j.mvr.2009.02.008; GEIJER C, 1979, INVEST OPHTH VIS SCI, V18, P1030; Geiser MH, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.127001; Geiser MH, 1999, J BIOMED OPT, V4, P459, DOI 10.1117/1.429960; HEIKE M, 1991, INVEST OPHTH VIS SCI, V32, P73; Hetu S, 2013, CURR EYE RES, V38, P158, DOI 10.3109/02713683.2012.723296; KIEL JW, 1992, INVEST OPHTH VIS SCI, V33, P2399; Li YX, 2008, NEUROIMAGE, V39, P1744, DOI 10.1016/j.neuroimage.2007.10.030; Lorentz K, 2008, ADV EXP MED BIOL, V614, P253, DOI 10.1007/978-0-387-74911-2_29; Mohammed AA, 2012, ANIM SCI PAP REP, V30, P285; Morrison JC, 1999, INVEST OPHTH VIS SCI, V40, P1702; Ninomiya H, 2001, VET OPHTHALMOL, V4, P55, DOI 10.1046/j.1463-5224.2001.00143.x; OBrien C, 1997, BRIT J OPHTHALMOL, V81, P68, DOI 10.1136/bjo.81.1.68; Pannarale L, 1996, J ANAT, V188, P693; Petrig BL, 1999, AM J OPHTHALMOL, V127, P413, DOI 10.1016/S0002-9394(98)00437-1; Pouliot M, 2009, EXP EYE RES, V89, P960, DOI 10.1016/j.exer.2009.08.005; R Core Team, 2021, R LANGUAGE ENV STAT; RAPP LM, 1990, INVEST OPHTH VIS SCI, V31, P1186; Reiner A, 2010, EXP EYE RES, V90, P734, DOI 10.1016/j.exer.2010.03.006; RIVA C, 1972, INVEST OPHTH VISUAL, V11, P936; Riva CE, 1996, MICROVASC RES, V52, P258, DOI 10.1006/mvre.1996.0063; RIVA CE, 1990, MICROVASC RES, V40, P36, DOI 10.1016/0026-2862(90)90005-C; RIVA CE, 1994, INVEST OPHTH VIS SCI, V35, P608; Riva CE, 2010, ACTA OPHTHALMOL, V88, P622, DOI 10.1111/j.1755-3768.2009.01621.x; SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002; SHONAT RD, 1992, INVEST OPHTH VIS SCI, V33, P3174; SOSSI N, 1983, ARCH OPHTHALMOL-CHIC, V101, P98, DOI 10.1001/archopht.1983.01040010100018; Strohmaier C, 2011, EXP EYE RES, V92, P545, DOI 10.1016/j.exer.2011.03.014; Sugiyama K, 1999, INVEST OPHTH VIS SCI, V40, P3084; Tsujikawa A, 2000, JPN J OPHTHALMOL, V44, P257, DOI 10.1016/S0021-5155(99)00226-9; Wang L, 2007, EXP EYE RES, V84, P108, DOI 10.1016/j.exer.2006.09.005; Zhi ZW, 2012, BIOMED OPT EXPRESS, V3, P2220, DOI 10.1364/BOE.3.002220; Zhi ZW, 2011, BIOMED OPT EXPRESS, V2, P579, DOI 10.1364/BOE.2.000579	40	3	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134378	10.1371/journal.pone.0134378	http://dx.doi.org/10.1371/journal.pone.0134378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226150	gold, Green Published, Green Submitted			2022-12-27	WOS:000358837700083
J	Musser, JMB; Heatley, JJ; Koinis, AV; Suchodolski, PF; Guo, JH; Escandon, P; Tizard, IR				Musser, Jeffrey M. B.; Heatley, J. Jill; Koinis, Anastasia V.; Suchodolski, Paulette F.; Guo, Jianhua; Escandon, Paulina; Tizard, Ian R.			Ribavirin Inhibits Parrot Bornavirus 4 Replication in Cell Culture	PLOS ONE			English	Article							PROVENTRICULAR DILATATION DISEASE; COCKATIELS NYMPHICUS-HOLLANDICUS; AVIAN BORNAVIRUS; ANTIVIRAL ACTIVITY; VIRUS-REPLICATION; PSITTACINE BIRDS; MECHANISM; INFECTION; IDENTIFICATION; INTERFERON	Parrot bornavirus 4 is an etiological agent of proventricular dilatation disease, a fatal neurologic and gastrointestinal disease of psittacines and other birds. We tested the ability of ribavirin, an antiviral nucleoside analog with antiviral activity against a range of RNA and DNA viruses, to inhibit parrot bornavirus 4 replication in duck embryonic fibroblast cells. Two analytical methods that evaluate different products of viral replication, indirect immunocytochemistry for viral specific nucleoprotein and qRT-PCR for viral specific phosphoprotein gene mRNA, were used. Ribavirin at concentrations between 2.5 and 25 mu g/mL inhibited parrot bornavirus 4 replication, decreasing viral mRNA and viral protein load, in infected duck embryonic fibroblast cells. The addition of guanosine diminished the antiviral activity of ribavirin suggesting that one possible mechanism of action against parrot bornavirus 4 may likely be through inosine monophosphate dehydrogenase inhibition. This study demonstrates parrot bornavirus 4 susceptibility to ribavirin in cell culture.	[Musser, Jeffrey M. B.; Heatley, J. Jill; Suchodolski, Paulette F.; Guo, Jianhua; Tizard, Ian R.] Texas A&M Univ, Coll Vet Med, Schubot Exot Bird Hlth Ctr, College Stn, TX 77843 USA; [Musser, Jeffrey M. B.; Guo, Jianhua; Escandon, Paulina; Tizard, Ian R.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Heatley, J. Jill] Texas A&M Univ, Coll Vet Med, Dept Small Anim Clin Sci, Zool Med, College Stn, TX 77843 USA; [Koinis, Anastasia V.] Texas A&M Univ, Coll Vet Med, Morris Anim Fdn Vet Student Scholar, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Musser, JMB (corresponding author), Texas A&M Univ, Coll Vet Med, Schubot Exot Bird Hlth Ctr, College Stn, TX 77843 USA.	jmusser@cvm.tamu.edu	Heatley, J Jill/AAI-1838-2020	Heatley, J Jill/0000-0001-7715-7784	Schubot Exotic Bird Health Center; Morris Animal Foundation Veterinary Student Scholar	Schubot Exotic Bird Health Center; Morris Animal Foundation Veterinary Student Scholar	This work was supported by Schubot Exotic Bird Health Center (JMBM, JJH) and Morris Animal Foundation Veterinary Student Scholar (AVK).	BAYLOR NW, 1992, J INFECT DIS, V165, P433, DOI 10.1093/infdis/165.3.433; Borden KLB, 2010, LEUKEMIA LYMPHOMA, V51, P1805, DOI 10.3109/10428194.2010.496506; CARBONE KM, 1993, J VIROL, V67, P1453, DOI 10.1128/JVI.67.3.1453-1460.1993; Charlier CM, 2013, J VIROL, V87, P12339, DOI 10.1128/JVI.01127-13; Chen LL, 2011, ANTIVIR RES, V91, P314, DOI 10.1016/j.antiviral.2011.07.008; Crotty S, 2002, J MOL MED, V80, P86, DOI 10.1007/s00109-001-0308-0; DAHLHAUSEN R, 2002, P ANN C ASS AV VET, P9; DELATORRE JC, 1987, J VIROL, V61, P233, DOI 10.1128/JVI.61.1.233-235.1987; Dixit NM, 2006, CELL MOL LIFE SCI, V63, P832, DOI 10.1007/s00018-005-5455-y; Dou J, 2011, ARCH VIROL, V156, P793, DOI 10.1007/s00705-011-0917-z; Evers DL, 2005, ANTIVIR RES, V68, P124, DOI 10.1016/j.antiviral.2005.08.002; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; GIROND S, 1991, RES VIROLOGY, V142, P261, DOI 10.1016/0923-2516(91)90011-Q; GonzalezDunia D, 1997, J VIROL, V71, P3208, DOI 10.1128/JVI.71.4.3208-3218.1997; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; Gray P, 2010, EMERG INFECT DIS, V16, P473, DOI 10.3201/eid1603.091257; Guo J, 2012, VET MED-RES REP, V3, P49, DOI 10.2147/VMRR.S33353; Honkavuori KS, 2008, EMERG INFECT DIS, V14, P1883, DOI 10.3201/eid1412.080984; Hoppes S, 2013, J EXOT PET MED, V22, P275, DOI 10.1053/j.jepm.2013.08.014; Hoppes Sharman M., 2013, Veterinary Clinics of North America Exotic Animal Practice, V16, P339, DOI 10.1016/j.cvex.2013.01.004; Hui CK, 2003, J INFECT DIS, V187, P1071, DOI 10.1086/368217; Jordan I, 1999, J VIROL, V73, P7903, DOI 10.1128/JVI.73.9.7903-7906.1999; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; KNIGHT V, 1981, ANTIMICROB AGENTS CH, V20, P477, DOI 10.1128/AAC.20.4.477; Kuhn JH, 2015, ARCH VIROL, V160, P621, DOI 10.1007/s00705-014-2276-z; Lanford RE, 2003, J VIROL, V77, P1092, DOI 10.1128/JVI.77.2.1092-1104.2003; Li BQ, 2000, BIOCHEM BIOPH RES CO, V276, P534, DOI 10.1006/bbrc.2000.3485; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marroqui L, 2007, VET MICROBIOL, V122, P52, DOI 10.1016/j.vetmic.2007.01.002; Martin P, 2008, J GASTROEN HEPATOL, V23, P844, DOI 10.1111/j.1440-1746.2008.05398.x; MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104; Mirhosseini N, 2011, J AVIAN MED SURG, V25, P199, DOI 10.1647/2010-030.1; Mizutani T, 1998, ARCH VIROL, V143, P2039, DOI 10.1007/s007050050440; Mori K, 2011, VIRUS RES, V157, P61, DOI 10.1016/j.virusres.2011.02.005; MULLER WEG, 1977, BIOCHEM PHARMACOL, V26, P1071, DOI 10.1016/0006-2952(77)90246-5; Nedorost N, 2012, AVIAN DIS, V56, P414, DOI 10.1637/10026-112911-ResNote.1; Olschlager S, 2011, ANTIVIR RES, V91, P89, DOI 10.1016/j.antiviral.2011.05.006; Ouyang N, 2009, AVIAN PATHOL, V38, P393, DOI 10.1080/03079450903191036; Paeshuyse J, 2011, CURR OPIN VIROL, V1, P590, DOI 10.1016/j.coviro.2011.10.030; Payne S, 2011, AVIAN PATHOL, V40, P15, DOI 10.1080/03079457.2010.536978; Payne S, 2011, J VIROL, V85, P12053, DOI 10.1128/JVI.05700-11; Piepenbring AK, 2012, EMERG INFECT DIS, V18, P234, DOI 10.3201/eid1802.111525; POVEY RC, 1978, AM J VET RES, V39, P175; Reuter A, 2010, VIRUSES-BASEL, V2, P927, DOI 10.3390/v2040927; Rinder M, 2009, J VIROL, V83, P5401, DOI 10.1128/JVI.00133-09; Rivas-Aravena A, 2011, J VIROL, V85, P8037, DOI 10.1128/JVI.00533-11; Rotman Y, 2014, GUT, V63, P161, DOI 10.1136/gutjnl-2012-303852; Rubbenstroth D, 2012, VET MICROBIOL, V161, P36, DOI 10.1016/j.vetmic.2012.07.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705; Staeheli P, 2010, J VIROL, V84, P6269, DOI 10.1128/JVI.02567-09; Stitz L, 2002, FRONT BIOSCI, V7, pD541, DOI 10.2741/stitz; Thomas Emmanuel, 2012, Antiviral Chemistry & Chemotherapy, V23, P1, DOI 10.3851/IMP2125; Zhou SF, 2003, VIROLOGY, V310, P333, DOI 10.1016/S0042-6822(03)00152-1; Zhou Y, 2008, ANTIMICROB AGENTS CH, V52, P110, DOI 10.1128/AAC.00863-07	56	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134080	10.1371/journal.pone.0134080	http://dx.doi.org/10.1371/journal.pone.0134080			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222794	Green Published, gold, Green Submitted			2022-12-27	WOS:000358836800100
J	Hong, JK; Cho, JC				Hong, Jin-Kyung; Cho, Jae-Chang			Environmental Variables Shaping the Ecological Niche of Thaumarchaeota in Soil: Direct and Indirect Causal Effects	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; NET NITROGEN MINERALIZATION; GENOME SEQUENCE; MESOPHILIC CRENARCHAEOTA; NITRIFYING ARCHAEA; TOTAL SULFUR; BACTERIA; OXIDATION; ABUNDANCE; NITRIFICATION	To find environmental variables (EVs) shaping the ecological niche of the archaeal phylum Thaumarchaeota in terrestrial environments, we determined the abundance of Thaumarchaeota in various soil samples using real-time PCR targeting thaumarchaeotal 16S rRNA gene sequences. We employed our previously developed primer, THAUM-494, which had greater coverage for Thaumarchaeota and lower tolerance to nonthaumarchaeotal taxa than previous Thaumarchaeota-directed primers. The relative abundance estimates (RVs) of Thaumarchaeota (R-THAUM), Archaea (R-ARCH), and Bacteria (R-BACT) were subjected to a series of statistical analyses. Redundancy analysis (RDA) showed a significant (p < 0.05) canonical relationship between RVs and EVs. Negative causal relationships between RTHAUM and nutrient level-related EVs were observed in an RDA biplot. These negative relationships were further confirmed by correlation and regression analyses. Total nitrogen content (TN) appeared to be the EV that affected RTHAUM most strongly, and total carbon content (TC), which reflected the content of organic matter (OM), appeared to be the EV that affected it least. However, in the path analysis, a path model indicated that TN might be a mediator EV that could be controlled directly by the OM. Additionally, another path model implied that water content (WC) might also indirectly affect RTHAUM by controlling ammonium nitrogen (NH4+-N) level through ammonification. Thus, although most directly affected by NH4+-N, RTHAUM could be ultimately determined by OM content, suggesting that Thaumarchaeota could prefer low-OM or low-WC conditions, because either of these EVs could subsequently result in low levels of NH4+-N in soil.	[Cho, Jae-Chang] Hankuk Univ Foreign Studies, Inst Environm Sci, Yongin, South Korea; Hankuk Univ Foreign Studies, Dept Environm Sci, Yongin, South Korea	Hankuk University Foreign Studies; Hankuk University Foreign Studies	Cho, JC (corresponding author), Hankuk Univ Foreign Studies, Inst Environm Sci, Yongin, South Korea.	chojc@hufs.ac.kr			NRF [NRF-2012R1A1A2004270]; HUFS; GRRC [GRRC-HUFS-2014-B02]; KEITI (GAIA) [20130005501]	NRF; HUFS; GRRC; KEITI (GAIA)	This work was supported by a research grant from the NRF (Grant No. NRF-2012R1A1A2004270) and by a HUFS 2014 research grant. JKH was supported in part by GRRC (Program No. GRRC-HUFS-2014-B02) and KEITI (GAIA project no. 20130005501).	Agehara S, 2005, SOIL SCI SOC AM J, V69, P1844, DOI 10.2136/sssaj2004.0361; Agogue H, 2008, NATURE, V456, P788, DOI 10.1038/nature07535; [Anonymous], 1982, CHEM MICROBIOLOGY PR; Auguet JC, 2012, ISME J, V6, P1786, DOI 10.1038/ismej.2012.33; Beman JM, 2006, APPL ENVIRON MICROB, V72, P7767, DOI 10.1128/AEM.00946-06; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; BOWMAN RA, 1988, SOIL SCI SOC AM J, V52, P1301, DOI 10.2136/sssaj1988.03615995005200050016x; BREMNER J. M., 1965, SOIL SCI SOC AMER PROC, V29, P504; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Casamayor EO, 2002, ENVIRON MICROBIOL, V4, P338, DOI 10.1046/j.1462-2920.2002.00297.x; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Di HJ, 2009, NAT GEOSCI, V2, P621, DOI 10.1038/NGEO613; Di HJ, 2010, FEMS MICROBIOL ECOL, V72, P386, DOI 10.1111/j.1574-6941.2010.00861.x; Dodsworth JA, 2011, METHOD ENZYMOL, V486, P171, DOI [10.1016/S0076-6879(11)86008-8, 10.1016/B978-0-12-381294-0.00008-0]; Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x; FRANKENBERGER WT, 1990, J CHROMATOGR, V504, P211, DOI 10.1016/S0021-9673(01)89529-7; Geets J, 2006, FEMS MICROBIOL ECOL, V58, P1, DOI 10.1111/j.1574-6941.2006.00170.x; Glass JB, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00061; Godfrey LV, 2011, METHOD ENZYMOL, V486, P483, DOI [10.1016/S0076-6879(11)86022-2, 10.1016/B978-0-12-381294-0.00022-5]; GONCALVES JLM, 1994, SOIL BIOL BIOCHEM, V26, P1557, DOI 10.1016/0038-0717(94)90098-1; Grant WD, 2004, PHILOS T R SOC B, V359, P1249, DOI 10.1098/rstb.2004.1502; Grant WD, 2004, SOIL SCI SOC AM J, V359, P1266; Gubry-Rangin C, 2011, P NATL ACAD SCI USA, V108, P21206, DOI 10.1073/pnas.1109000108; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; HERN JA, 1983, TALANTA, V30, P677, DOI 10.1016/0039-9140(83)80155-6; Herndl GJ, 2005, APPL ENVIRON MICROB, V71, P2303, DOI 10.1128/AEM.71.5.2303-2309.2005; HILL MO, 1980, VEGETATIO, V42, P47, DOI 10.1007/BF00048870; Hofferle S, 2010, FEMS MICROBIOL ECOL, V74, P302, DOI 10.1111/j.1574-6941.2010.00961.x; Hollibaugh JT, 2011, ISME J, V5, P866, DOI 10.1038/ismej.2010.172; Hong JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096197; Ingalls AE, 2006, P NATL ACAD SCI USA, V103, P6442, DOI 10.1073/pnas.0510157103; Isobe K, 2012, FEMS MICROBIOL ECOL, V80, P193, DOI 10.1111/j.1574-6941.2011.01294.x; Ivanov K, 2010, ICP DETERMINATION PH; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; Jung MY, 2011, APPL ENVIRON MICROB, V77, P8635, DOI 10.1128/AEM.05787-11; Kim BK, 2011, J BACTERIOL, V193, P5539, DOI 10.1128/JB.05717-11; Koch AL, 2001, BIOESSAYS, V23, P657, DOI 10.1002/bies.1091; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Lebedeva EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080835; Lehtovirta LE, 2009, FEMS MICROBIOL ECOL, V70, P367, DOI 10.1111/j.1574-6941.2009.00748.x; Lehtovirta-Morley LE, 2011, P NATL ACAD SCI USA, V108, P15892, DOI 10.1073/pnas.1107196108; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Loy A, 2002, APPL ENVIRON MICROB, V68, P5064, DOI 10.1128/AEM.68.10.5064-5081.2002; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Martin-Cuadrado AB, 2008, ISME J, V2, P865, DOI 10.1038/ismej.2008.40; Mosier AC, 2012, J BACTERIOL, V194, P2121, DOI 10.1128/JB.00013-12; Mosier AC, 2012, J BACTERIOL, V194, P2119, DOI 10.1128/JB.00007-12; MYERS RJK, 1982, CAN J SOIL SCI, V62, P111, DOI 10.4141/cjss82-013; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; NOVOZAMSKY I, 1986, COMMUN SOIL SCI PLAN, V17, P1147, DOI 10.1080/00103628609367780; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Ouverney CC, 2000, APPL ENVIRON MICROB, V66, P4829, DOI 10.1128/AEM.66.11.4829-4833.2000; Park BJ, 2010, APPL ENVIRON MICROB, V76, P7575, DOI 10.1128/AEM.01478-10; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Pratscher J, 2011, P NATL ACAD SCI USA, V108, P4170, DOI 10.1073/pnas.1010981108; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Reigstad LJ, 2008, FEMS MICROBIOL ECOL, V64, P167, DOI 10.1111/j.1574-6941.2008.00466.x; Schauss K, 2009, ENVIRON MICROBIOL, V11, P446, DOI 10.1111/j.1462-2920.2008.01783.x; Schmidt TM, 1998, BACTERIAL GENOMES, P221; Schulten HR, 1997, BIOL FERT SOILS, V26, P1, DOI 10.1007/s003740050335; Sikora FJ, 2005, COMMUN SOIL SCI PLAN, V36, P875, DOI 10.1081/CSS-200049468; Spang A, 2012, ENVIRON MICROBIOL, V14, P3122, DOI 10.1111/j.1462-2920.2012.02893.x; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Stahl D.A., 1991, NUCL ACID TECHNIQUES, P205; STANFORD G, 1974, SOIL SCI SOC AM J, V38, P103, DOI 10.2136/sssaj1974.03615995003800010032x; STEHR G, 1995, FEMS MICROBIOL ECOL, V17, P177, DOI 10.1016/0168-6496(95)00022-3; Stopnisek N, 2010, APPL ENVIRON MICROB, V76, P7626, DOI 10.1128/AEM.00595-10; SUWA Y, 1994, WATER RES, V28, P1523, DOI 10.1016/0043-1354(94)90218-6; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Tully BJ, 2012, ENVIRON MICROBIOL, V14, P254, DOI 10.1111/j.1462-2920.2011.02628.x; VANDENWOLLENBERG AL, 1977, PSYCHOMETRIKA, V42, P207, DOI 10.1007/BF02294050; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Verhamme DT, 2011, ISME J, V5, P1067, DOI 10.1038/ismej.2010.191; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Weber EB, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv001; Wessen E, 2010, APPL SOIL ECOL, V45, P193, DOI 10.1016/j.apsoil.2010.04.003; Wright S, 1920, J AGRIC RES, V20, P0557; Wright S., 1971, CAUSAL MODELS SOCIAL, P39; Yao HY, 2013, ENVIRON MICROBIOL, V15, P2545, DOI 10.1111/1462-2920.12141; Yao H, 2011, APPL ENVIRON MICROB, V77, P4618, DOI 10.1128/AEM.00136-11; Zhalnina K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00210; Zhang LM, 2012, ISME J, V6, P1032, DOI 10.1038/ismej.2011.168; Zhang LM, 2010, P NATL ACAD SCI USA, V107, P17240, DOI 10.1073/pnas.1004947107	95	12	15	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133763	10.1371/journal.pone.0133763	http://dx.doi.org/10.1371/journal.pone.0133763			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241328	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942700023
J	van den Berg, MM; Madi, HH; Khader, A; Hababeh, M; Zeidan, W; Wesley, H; Abd El-Kader, M; Maqadma, M; Seita, A				van den Berg, Maartje M.; Madi, Haifa H.; Khader, Ali; Hababeh, Majed; Zeidan, Wafa'a; Wesley, Hannah; Abd El-Kader, Mariam; Maqadma, Mohamed; Seita, Akihiro			Increasing Neonatal Mortality among Palestine Refugees in the Gaza Strip	PLOS ONE			English	Article							INFANT-MORTALITY; CHILDHOOD MORTALITY; METAANALYSIS; COUNTRIES; DEATHS; HEALTH	Background The United Nations Relief and Works Agency for Palestine refugees in the Near East (UNRWA) has periodically estimated infant mortality rates among Palestine refugees in Gaza. These surveys have recorded a decline from 127 per 1000 live births in 1960 to 20.2 in 2008. Methods We used the same preceding-birth technique as in previous surveys. All multiparous mothers who came to the 22 UNRWA health centres to register their last-born child for immunization were asked if their preceding child was alive or dead. We based our target sample size on the infant mortality rate in 2008 and included 3128 mothers from August until October 2013. We used multiple logistic regression analyses to identify predictors of infant mortality. Findings Infant mortality in 2013 was 22.4 per 1000 live births compared with 20.2 in 2008 (p = 0.61), and this change reflected a statistically significant increase in neonatal mortality (from 12.0 to 20.3 per 1000 live births, p = 0.01). The main causes of the 65 infant deaths were preterm birth (n = 25, 39%), congenital anomalies (n = 19, 29%), and infections (n = 12, 19%). Risk factors for infant death were preterm birth (OR 9.88, 3.98-24.85), consanguinity (2.41, 1.35-4.30) and high-risk pregnancies (3.09, 1.46-6.53). Conclusion For the first time in five decades, mortality rates have increased among Palestine refugee newborns in Gaza. The possible causes of this trend may include inadequate neonatal care. We will estimate infant and neonatal mortality rates again in 2015 to see if this trend continues and, if so, to assess how it can be reversed.	[van den Berg, Maartje M.; Khader, Ali; Hababeh, Majed; Zeidan, Wafa'a; Wesley, Hannah; Seita, Akihiro] United Nations Relief & Works Agcy Palestine Refu, Dept Hlth, Amman, Jordan; [Madi, Haifa H.] WHO, Reg Off Eastern Mediterranean, Cairo, Egypt; [Abd El-Kader, Mariam; Maqadma, Mohamed] UNRWA, Field Off Gaza, Dept Hlth, Gaza City, Israel	Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization	van den Berg, MM (corresponding author), United Nations Relief & Works Agcy Palestine Refu, Dept Hlth, Amman, Jordan.	m.berg@unrwa.org			United Nations Relief and Works Agency of Palestine refugees in the Near East (UNRWA)	United Nations Relief and Works Agency of Palestine refugees in the Near East (UNRWA)	The funding of this research was provided by the United Nations Relief and Works Agency of Palestine refugees in the Near East (UNRWA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminu M, 2014, BJOG-INT J OBSTET GY, V121, P141, DOI 10.1111/1471-0528.12995; [Anonymous], 2012, UNICEF LEV TRENDS CH; [Anonymous], 2013, UNRWA ANN REP 2012; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Brass W, 1984, ASIAN PACIFIC CENSUS, V11; Brockerhoff M, 2000, B WORLD HEALTH ORGAN, V78, P30; De-Regil LM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007950.pub2; Giacaman R, 2009, LANCET, V373, P837, DOI 10.1016/S0140-6736(09)60107-0; Gilbert M., 2014, BRIEF REPORT UNRWA G; Hauck FR, 2011, PEDIATRICS, V128, P103, DOI 10.1542/peds.2010-3000; HILL AG, 1990, POP STUD-J DEMOG, V44, P317, DOI 10.1080/0032472031000144616; HILL K, 1991, POPUL INDEX, V57, P368, DOI 10.2307/3643873; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Khan J, 2015, MATERN CHILD HLTH J, V19, P468, DOI 10.1007/s10995-014-1526-8; Kozuki N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S3; Lassi ZS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub2; Madi H., 2000, LANCET, V2000, P356; Massad S, 2012, UN POPULATION FUND U; Massad S, 2009, INT C POP DEV 15; PCBS UNICEF UNFPA, 2014, MULT IND CLUST SURV; Rahim HFA, 2009, LANCET, V373, P967, DOI 10.1016/S0140-6736(09)60108-2; Reidpath DD, 2003, J EPIDEMIOL COMMUN H, V57, P344, DOI 10.1136/jech.57.5.344; Riccardo F, 2011, B WORLD HEALTH ORGAN, V89, P304, DOI 10.2471/BLT.10.082743; Roberts D, 2013, COCHRANE DB SYST REV; Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003; Tsui AO, 2010, EPIDEMIOL REV, V32, P152, DOI 10.1093/epirev/mxq012; UNRWA, 2013, GAZ 2020 UNRW OP RES; UNRWA Health Program, 2009, UNRWA INF MORT SURV; Wagstaff A, 2000, B WORLD HEALTH ORGAN, V78, P19; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; World Health Organization, 2011, WORLD HLTH STAT 2011; World Health Organization, 2009, ASS SAF QUAL HOSP CA	32	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0135092	10.1371/journal.pone.0135092	http://dx.doi.org/10.1371/journal.pone.0135092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1VB	26241479	Green Published, gold			2022-12-27	WOS:000358942700096
J	O'Hurley, G; Busch, C; Fagerberg, L; Hallstrom, BM; Stadler, C; Tolf, A; Lundberg, E; Schwenk, JM; Jirstrom, K; Bjartell, A; Gallagher, WM; Uhlen, M; Ponten, F				O'Hurley, Gillian; Busch, Christer; Fagerberg, Linn; Hallstrom, Bjorn M.; Stadler, Charlotte; Tolf, Anna; Lundberg, Emma; Schwenk, Jochen M.; Jirstrom, Karin; Bjartell, Anders; Gallagher, William M.; Uhlen, Mathias; Ponten, Fredrik			Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate Cancer	PLOS ONE			English	Article							BIOMARKER DISCOVERY; EXPRESSION; ANTIGEN; ATLAS; LOCALIZATION; KALLIKREINS; ROLES	To better understand prostate function and disease, it is important to define and explore the molecular constituents that signify the prostate gland. The aim of this study was to define the prostate specific transcriptome and proteome, in comparison to 26 other human tissues. Deep sequencing of mRNA (RNA-seq) and immunohistochemistry-based protein profiling were combined to identify prostate specific gene expression patterns and to explore tissue biomarkers for potential clinical use in prostate cancer diagnostics. We identified 203 genes with elevated expression in the prostate, 22 of which showed more than five-fold higher expression levels compared to all other tissue types. In addition to previously well-known proteins we identified two poorly characterized proteins, TMEM79 and ACOXL, with potential to differentiate between benign and cancerous prostatic glands in tissue biopsies. In conclusion, we have applied a genome-wide analysis to identify the prostate specific proteome using transcriptomics and antibody-based protein profiling to identify genes with elevated expression in the prostate. Our data provides a starting point for further functional studies to explore the molecular repertoire of normal and diseased prostate including potential prostate cancer markers such as TMEM79 and ACOXL.	[O'Hurley, Gillian; Busch, Christer; Tolf, Anna; Ponten, Fredrik] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [O'Hurley, Gillian; Gallagher, William M.] Univ Coll Dublin, UCD Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 4, Ireland; [O'Hurley, Gillian] OncoMark Ltd, NovaUCD, Dublin 4, Ireland; [Fagerberg, Linn; Hallstrom, Bjorn M.; Stadler, Charlotte; Schwenk, Jochen M.; Uhlen, Mathias] KTH Royal Inst Technol, Sci Life Lab, Stockholm, Sweden; [Jirstrom, Karin] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund Oncol & Pathol, Lund, Sweden; [Bjartell, Anders] Lund Univ, Dept Clin Sci, Div Urol Canc, Skane Univ Hosp Malmo, Malmo, Sweden	Uppsala University; University College Dublin; Royal Institute of Technology; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Ponten, F (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden.	fredrik.ponten@igp.uu.se	Uhlen, Mathias/B-3262-2016; Schwenk, Jochen/AAS-4164-2021; Schwenk, Jochen M/F-1730-2010; Uhlen, Mathias/AAV-8746-2021; Lundberg, Emma S K/F-3891-2010	Uhlen, Mathias/0000-0002-4858-8056; Schwenk, Jochen/0000-0001-8141-8449; Schwenk, Jochen M/0000-0001-8141-8449; Kaller Lundberg, Emma/0000-0001-7034-0850; Fagerberg, Linn/0000-0003-0198-7137; Gallagher, William/0000-0002-4307-5999	Knut and Alice Wallenberg Foundation; Swedish Cancer Foundation; Marie Curie Industry-Academia Partnerships and Pathways program, FAST-PATH [285910]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Cancer Foundation; Marie Curie Industry-Academia Partnerships and Pathways program, FAST-PATH	Funding was provided by the Knut and Alice Wallenberg Foundation and the Swedish Cancer Foundation and by the Marie Curie Industry-Academia Partnerships and Pathways program, FAST-PATH (No. 285910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. OncoMark Ltd provided support in the form of salaries for author GOH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bangma CH, 2012, CRIT REV ONCOL HEMAT, V83, P235, DOI 10.1016/j.critrevonc.2011.10.003; Borgono CA, 2004, MOL CANCER RES, V2, P257; Brawer MK, 1998, UROLOGY, V52, P372, DOI 10.1016/S0090-4295(98)00241-6; Carter HB, 2011, BJU INT, V108, P1684, DOI [10.1111/j.1464-410X.2011.10489.x, 10.1111/j.1464-410X.2010.10489.x]; Carter HB, 2004, JNCI-J NATL CANCER I, V96, P557, DOI 10.1093/jnci/djh111; Danielsson F, 2013, P NATL ACAD SCI USA, V110, P6853, DOI 10.1073/pnas.1216436110; Duijvesz D, 2011, EUR UROL, V59, P823, DOI 10.1016/j.eururo.2010.12.031; Etzioni R, 2002, J NATL CANCER I, V94, P981; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fiorentino M, 2010, UROL CLIN N AM, V37, P131, DOI 10.1016/j.ucl.2009.11.006; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Gunia S, 2009, VIRCHOWS ARCH, V454, P573, DOI 10.1007/s00428-009-0759-1; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; HENTTU P, 1994, ANN MED, V26, P157, DOI 10.3109/07853899409147884; Hong MG, 2013, HUM MUTAT, V34, P515, DOI 10.1002/humu.22267; Issaq HJ, 2011, ELECTROPHORESIS, V32, P967, DOI 10.1002/elps.201000588; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5; Kong HY, 2013, BIOMOL THER, V21, P10, DOI 10.4062/biomolther.2012.095; Kristiansen G, 2012, HISTOPATHOLOGY, V60, P125, DOI 10.1111/j.1365-2559.2011.04083.x; LILJA H, 1985, J CLIN INVEST, V76, P1899, DOI 10.1172/JCI112185; Makarov DV, 2009, ANNU REV MED, V60, P139, DOI 10.1146/annurev.med.60.042307.110714; Ng DP, 2012, BBA-BIOMEMBRANES, V1818, P1115, DOI 10.1016/j.bbamem.2011.07.046; Ploussard G, 2010, NAT REV UROL, V7, P101, DOI 10.1038/nrurol.2009.261; Ponten F, 2011, J INTERN MED, V270, P428, DOI 10.1111/j.1365-2796.2011.02427.x; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; RCoreTeam, 2013, R A LANGUAGE AND ENV; Schaefer A, 2010, UROL ONCOL-SEMIN ORI, V28, P4, DOI 10.1016/j.urolonc.2008.10.021; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stadler C, 2012, J PROTEOMICS, V75, P2236, DOI 10.1016/j.jprot.2012.01.030; Stadler C, 2010, J PROTEOMICS, V73, P1067, DOI 10.1016/j.jprot.2009.10.012; Tassidis H, 2013, TUMOR BIOL, V34, P637, DOI 10.1007/s13277-012-0590-1; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069744	37	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0133449	10.1371/journal.pone.0133449	http://dx.doi.org/10.1371/journal.pone.0133449			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237329	gold, Green Published, Green Submitted			2022-12-27	WOS:000358942400012
J	Badria, FA; Ibrahim, AS; Badria, AF; Elmarakby, AA				Badria, Farid A.; Ibrahim, Ahmed S.; Badria, Adel F.; Elmarakby, Ahmed A.			Curcumin Attenuates Iron Accumulation and Oxidative Stress in the Liver and Spleen of Chronic Iron-Overloaded Rats	PLOS ONE			English	Article							LIPID-PEROXIDATION; TOXICITY; SUPPLEMENTATION; CHELATION; ACID	Objectives Iron overload is now recognized as a health problem in industrialized countries, as excessive iron is highly toxic for liver and spleen. The potential use of curcumin as an iron chelator has not been clearly identified experimentally in iron overload condition. Here, we evaluate the efficacy of curcumin to alleviate iron overload-induced hepatic and splenic abnormalities and to gain insight into the underlying mechanisms. Design and Methods Three groups of male adult rats were treated as follows: control rats, rats treated with iron in a drinking water for 2 months followed by either vehicle or curcumin treatment for 2 more months. Thereafter, we studied the effects of curcumin on iron overload-induced lipid peroxidation and anti-oxidant depletion. Results Treatment of iron-overloaded rats with curcumin resulted in marked decreases in iron accumulation within liver and spleen. Iron-overloaded rats had significant increases in malonyl-dialdehyde (MDA), a marker of lipid peroxidation and nitric oxide (NO) in liver and spleen when compared to control group. The effects of iron overload on lipid peroxidation and NO levels were significantly reduced by the intervention treatment with curcumin (P < 0.05). Furthermore, the endogenous anti-oxidant activities/levels in liver and spleen were also significantly decreased in chronic iron overload and administration of curcumin restored the decrease in the hepatic and splenic antioxidant activities/levels. Conclusion Our study suggests that curcumin may represent a new horizon in managing iron overload-induced toxicity as well as in pathological diseases characterized by hepatic iron accumulation such as thalassemia, sickle cell anemia, and myelodysplastic syndromes possibly via iron chelation, reduced oxidative stress derived lipid peroxidation and improving the body endogenous antioxidant defense mechanism.	[Badria, Farid A.] Mansoura Univ, Fac Pharm, Dept Pharmacognosy, Mansoura 35516, Egypt; [Ibrahim, Ahmed S.] Mansoura Univ, Fac Pharm, Dept Biochem & Clin Biochem, Mansoura 35516, Egypt; [Badria, Adel F.] Univ Alexandria, Med Technol Ctr, Alexandria 21526, Egypt; [Badria, Adel F.] Univ Patras, Dept Mech & Aeronaut Engn, Patras 26500, Greece; [Elmarakby, Ahmed A.] Georgia Regents Univ, Dept Oral Biol, Augusta, GA USA	Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Alexandria University; University of Patras; University System of Georgia; Augusta University	Badria, FA (corresponding author), Mansoura Univ, Fac Pharm, Dept Pharmacognosy, Mansoura 35516, Egypt.	faridbadria@yahoo.com	Elmarakby, Ahmed/ABF-5055-2021; Badria, Adel/AFS-8650-2022; Ibrahim, Ahmed/D-5241-2017; Badria, Adel/C-6488-2018	Badria, Adel/0000-0003-4686-603X; Ibrahim, Ahmed/0000-0001-8480-6252; Badria, Adel/0000-0003-4686-603X				Abou-Seif M, 2004, ARAB J LAB MED, V30, P193; Aebi H, 1984, Methods Enzymol, V105, P121; Badria F, 2007, J ENVIRON SCI, V33, P25; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Barbagallo I, 2013, ANTIOXID REDOX SIGN, V18, P507, DOI 10.1089/ars.2011.4360; Baum L, 2004, J ALZHEIMERS DIS, V6, P367; Bernabe-Pineda M, 2004, SPECTROCHIM ACTA A, V60, P1105, DOI 10.1016/S1386-1425(03)00344-5; Beutler E, 1984, MANUAL BIOCH METHODS; BOYETT JD, 1976, CLIN CHIM ACTA, V69, P233, DOI 10.1016/0009-8981(76)90501-5; Burgos-Moron E, 2011, INT J CANCER, V128, P245, DOI 10.1002/ijc.25291; Burgos-Moron E, 2010, INT J CANCER, V126, P1771, DOI 10.1002/ijc.24967; Calabrese V, 2008, MOL NUTR FOOD RES, V52, P1062, DOI 10.1002/mnfr.200700316; CALLENDER ST, 1980, LANCET, V2, P689; Cappellini MD, 2006, BLOOD, V107, P3455, DOI 10.1182/blood-2005-08-3430; Cohen AR, 2003, BLOOD, V102, P1583, DOI 10.1182/blood-2002-10-3280; COOK JD, 1990, AM J CLIN NUTR, V51, P301, DOI 10.1093/ajcn/51.2.301; Eaton JW, 2002, FREE RADICAL BIO MED, V32, P833, DOI 10.1016/S0891-5849(02)00772-4; Epstein J, 2010, BRIT J NUTR, V103, P1545, DOI 10.1017/S0007114509993667; Erdincler DS, 1997, CLIN CHIM ACTA, V265, P77, DOI 10.1016/S0009-8981(97)00106-X; Fleenor BS, 2012, EXP GERONTOL; Galleano M, 1997, TOXICOLOGY, V124, P73, DOI 10.1016/S0300-483X(97)00135-2; GORDEUK VR, 1987, ANNU REV NUTR, V7, P485, DOI 10.1146/annurev.nu.07.070187.002413; HERSHKO C, 1988, CRC CR REV CL LAB SC, V26, P303, DOI 10.3109/10408368809105894; HORTELANO S, 1995, HEPATOLOGY, V21, P776; Jiao Y, 2006, FREE RADICAL BIO MED, V40, P1152, DOI 10.1016/j.freeradbiomed.2005.11.003; Jiao Y, 2009, BLOOD, V113, P462, DOI 10.1182/blood-2008-05-155952; Kohli K., 2005, Indian Journal of Pharmacology, V37, P141; Lefevre G, 1998, ANN BIOL CLIN-PARIS, V56, P305; LEGGETT BA, 1990, CLIN CHEM, V36, P1350; Mancuso C, 2009, CURR DRUG METAB, V10, P579, DOI 10.2174/138920009789375405; Mancuso C, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00086; Mancuso C, 2009, TRENDS PHARMACOL SCI, V30, P333, DOI 10.1016/j.tips.2009.04.004; Martins JM, 2013, REV BRAS HEMATOL HEM, V34, P459; Messner DJ, 2009, LIVER INT, V29, P63, DOI 10.1111/j.1478-3231.2008.01793.x; Miriyala S, 2007, ADV EXP MED BIOL, V595, P359; NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3; Pearse AGE, 1985, THEORETICL APPL ANAL, P183; Qian Jing-jing, 2012, Zhonghua Yi Xue Za Zhi, V92, P1997; RAVINDRANATH V, 1980, TOXICOLOGY, V16, P259, DOI 10.1016/0300-483X(80)90122-5; Reddy ACP, 1996, TOXICOLOGY, V107, P39, DOI 10.1016/0300-483X(95)03199-P; Richardson, 1999, Expert Opin Investig Drugs, V8, P2141, DOI 10.1517/13543784.8.12.2141; Rivera-Espinoza Y, 2009, LIVER INT, V29, P1457, DOI 10.1111/j.1478-3231.2009.02086.x; Soetikno V, 2012, MOL NUTR FOOD RES; SUMMERS MR, 1979, BRIT J HAEMATOL, V42, P547, DOI 10.1111/j.1365-2141.1979.tb01167.x; Swamy AV, 2012, INDIAN J PHARMACOL, V44, P73, DOI 10.4103/0253-7613.91871; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Wang Z, 2015, DRUG DEV IND PHARM, V41, P613, DOI 10.3109/03639045.2014.886697; ZEBROWSKI EJ, 1979, PHARMACOL RES COMMUN, V11, P95, DOI 10.1016/S0031-6989(79)80063-6; Zhang JF, 2014, FOOD CHEM, V145, P57, DOI 10.1016/j.foodchem.2013.08.025; Zhao YL, 2005, EUR J PHARMACOL, V509, P195, DOI 10.1016/j.ejphar.2004.11.060	50	78	83	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134156	10.1371/journal.pone.0134156	http://dx.doi.org/10.1371/journal.pone.0134156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230491	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400080
J	Chen, SC; Hsiao, PJ; Huang, JC; Lin, KD; Hsu, WH; Lee, YL; Lee, MY; Chang, JM; Shin, SJ				Chen, Szu-Chia; Hsiao, Pi-Jung; Huang, Jiun-Chi; Lin, Kun-Der; Hsu, Wei-Hao; Lee, Yu-Li; Lee, Mei-Yueh; Chang, Jer-Ming; Shin, Shyi-Jang			Abnormally Low or High Ankle-Brachial Index Is Associated with Proliferative Diabetic Retinopathy in Type 2 Diabetic Mellitus Patients	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; BLOOD-PRESSURE INDEX; CARDIOVASCULAR-DISEASE; RISK-FACTORS; PREVALENCE; MORTALITY; ATHEROSCLEROSIS; HEART; CREATININE; MARKERS	Although some studies have reported that low ankle-brachial index (ABI) is associated with diabetic retinopathy (DR) in diabetic patients, it remains controversial as to which stage of DR. The aim of this study is to assess whether peripheral artery disease (PAD), indicated by abnormally low or high ABI, is associated with different stages of DR in patients with type 2 diabetes mellitus (DM), and further evaluate the risk factors. A total of 2001 (858 men and 1143 women) patients with type 2 DM who underwent ABI measurement in an outpatient clinic were enrolled. PAD was defined as ABI < 0.9 or >= 1.3 in either leg. DR was classified as non-DR, nonproliferative DR and proliferative DR stages. The clinical data were analyzed and the risk factors for abnormal ABI were determined by multivariate logistic regression analysis. The prevalence of ABI < 0.9 or >= 1.3 was 3.0%. Multivariate forward logistic regression analysis identified proliferative DR (vs. non-DR) was associated with abnormal ABI (odds ratio, 1.718; 95% confidence interval, 1.152 to 2.562; p = 0.008), but nonproliferative DR was not. Furthermore, the presence of coronary artery disease, cerebrovascular disease, declining renal function and patients without diuretics use were associated with abnormal ABI in patients with proliferative DR. Our study in patients of type 2 DM demonstrated that PAD was associated with proliferative DR. We emphasize the recommendation of performing the ABI test in this population at risk.	[Chen, Szu-Chia; Huang, Jiun-Chi; Chang, Jer-Ming] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Hsiao, Pi-Jung; Lin, Kun-Der; Hsu, Wei-Hao; Lee, Yu-Li; Lee, Mei-Yueh; Shin, Shyi-Jang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Kaohsiung, Taiwan; [Chen, Szu-Chia; Huang, Jiun-Chi; Hsu, Wei-Hao; Lee, Mei-Yueh; Chang, Jer-Ming] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Lee, Yu-Li] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Szu-Chia; Huang, Jiun-Chi; Lee, Mei-Yueh] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan; [Chen, Szu-Chia] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan; [Chang, Jer-Ming] Kaohsiung Med Univ, Coll Med, Renal Care, Kaohsiung, Taiwan; [Shin, Shyi-Jang] Kaohsiung Med Univ, Ctr Lipid & Glycomed Res, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University	Lee, MY (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Kaohsiung, Taiwan.	lovellelee@hotmail.com	蘇, 河名/AAE-9843-2019; Huang, Jiun-Chi/AAI-2494-2021	Huang, Jiun-Chi/0000-0002-5897-2860; Hsiao, Pi-Jung/0000-0001-5024-9371				Abbott JD, 2012, AM HEART J, V164, P585, DOI 10.1016/j.ahj.2012.06.017; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Bundo M, 2010, ANN VASC SURG, V24, P985, DOI 10.1016/j.avsg.2010.06.001; Chatziralli Irini P, 2010, BMC Res Notes, V3, P153, DOI 10.1186/1756-0500-3-153; Chen Ai-Hua, 2013, Rev Diabet Stud, V10, P101, DOI 10.1900/RDS.2013.10.101; Chen YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122022; de Kreutzenberg SV, 2011, NUTR METAB CARDIOVAS, V21, P286, DOI 10.1016/j.numecd.2009.10.003; FISHBANE S, 1995, AM J KIDNEY DIS, V25, P34, DOI 10.1016/0272-6386(95)90622-3; Fishbane S, 1996, AM J KIDNEY DIS, V27, P668, DOI 10.1016/S0272-6386(96)90101-8; FOWKES FGR, 1991, INT J EPIDEMIOL, V20, P384, DOI 10.1093/ije/20.2.384; FOWKES FGR, 1992, AM J EPIDEMIOL, V135, P331; Georgieva AM, 2004, ATHEROSCLEROSIS, V175, P345, DOI 10.1016/j.atherosclerosis.2004.04.006; Gregg EW, 2004, DIABETES CARE, V27, P1591, DOI 10.2337/diacare.27.7.1591; Hayashi C, 2004, DIABETES RES CLIN PR, V66, P269, DOI 10.1016/j.diabres.2004.03.013; Juutilainen A, 2007, DIABETES CARE, V30, P292, DOI 10.2337/dc06-1747; Klein R, 2002, BRIT J OPHTHALMOL, V86, P84, DOI 10.1136/bjo.86.1.84; Koba S, 2002, ATHEROSCLEROSIS, V160, P249, DOI 10.1016/S0021-9150(01)00580-9; Kuswardhani R A Tuty, 2010, Acta Med Indones, V42, P94; Leskinen Y, 2002, AM J KIDNEY DIS, V40, P472, DOI 10.1053/ajkd.2002.34885; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2001, AM J KIDNEY DIS, V38, P1398, DOI 10.1053/ajkd.2001.29275; Li X, 2012, J DIABETES, V4, P140, DOI 10.1111/j.1753-0407.2011.00171.x; Li Xiang, 2012, Zhonghua Yi Xue Za Zhi, V92, P236; MacGregor AS, 1999, DIABETES CARE, V22, P453, DOI 10.2337/diacare.22.3.453; Nathan DM, 2007, DIABETIC MED, V24, P137; Newman AB, 1997, J AM GERIATR SOC, V45, P1472, DOI 10.1111/j.1532-5415.1997.tb03198.x; O'Hare AM, 2006, CIRCULATION, V113, P388, DOI 10.1161/CIRCULATIONAHA.105.570903; ORCHARD TJ, 1993, DIABETES CARE, V16, P1199, DOI 10.2337/diacare.16.8.1199; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Shinohara K, 2004, KIDNEY INT, V65, P936, DOI 10.1111/j.1523-1755.2004.00468.x; Sodhi H S, 2007, Kathmandu Univ Med J (KUMJ), V5, P12; STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369; Talayero Beatriz G, 2011, Curr Cardiol Rep, V13, P544, DOI 10.1007/s11886-011-0220-3; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; Tseng Chin-Hsiao, 1994, Journal of the Formosan Medical Association, V93, P842; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Unwin N, 2000, BRIT J SURG, V87, P328, DOI 10.1046/j.1365-2168.2000.01344.x; Vickery S, 2006, NEPHROL DIAL TRANSPL, V21, P2439, DOI 10.1093/ndt/gfl249; Watkins PJ, 2003, BRIT MED J, V326, P924, DOI 10.1136/bmj.326.7395.924; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Yokoyama Hisayo, 2003, J Atheroscler Thromb, V10, P253; Yu JH, 2011, DIABETES METAB J, V35, P543, DOI 10.4093/dmj.2011.35.5.543; Yun Yong Woon, 2011, J Prev Med Public Health, V44, P260, DOI 10.3961/jpmph.2011.44.6.260	43	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134718	10.1371/journal.pone.0134718	http://dx.doi.org/10.1371/journal.pone.0134718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230390	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400156
J	Chen, Y; Du, YW; Li, Y; Wang, XQ; Gao, P; Yang, G; Fang, Y; Meng, Y; Zhao, XJ				Chen, Yan; Du, Yanwei; Li, Yang; Wang, Xiaoqin; Gao, Pin; Yang, Guang; Fang, Yuan; Meng, Yan; Zhao, Xuejian			Panaxadiol Saponin and Dexamethasone Improve Renal Function in Lipopolysaccharide-Induced Mouse Model of Acute Kidney Injury	PLOS ONE			English	Article							NITRIC-OXIDE; SEPSIS; THERAPY	Background Acute kidney injury (AKI) is a serious complication of systemic inflammatory response syndrome (SIRS), which has a high mortality rate. Previous studies showed that panaxadiol saponin (PDS) and Dexamethasone have similar anti-inflammatory properties and protect cardiopulmonary function in lipopolysaccharide (LPS)-induced septic shock rats. In the present study, we investigated whether PDS or Dexamethasone has a similar role in improving kidney function in LPS-induced AKI mice. Methods and Results Mice subjected to LPS (10 mg/kg) treatment exhibited AKI demonstrated by markedly increased blood urea nitrogen and creatinine levels compared with controls (P<0.01). However, PDS and Dexamethasone induce similar reverse effects on renal function, such as reduced serum creatinine and blood urea nitrogen levels compared with the LPS group (P<0.05). PDS decreased the production and release of tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 by inhibiting the NF-kappa B signaling pathway, down-regulating inducible nitric oxide synthase protein expression levels and inhibiting oxidative stress. In most anti-AKI mechanisms, PDS and dexamethasone were similar, but PDS are better at inhibition of TNF production, promote SOD activity and inhibition of IKB phosphorylation. In addition, nuclear glucocorticoid receptor expression was markedly enhanced in PDS and Dexamethasone treatment groups. Further research is required to determine whether PDS can combine with the glucocorticoid receptor to enter the nucleus. Conclusion This study demonstrated that PDS and dexamethasone have similar reverse amelioration for renal functions, and have potential application prospects in the treatment of sepsis-induced AKI.	[Chen, Yan; Du, Yanwei; Li, Yang; Wang, Xiaoqin; Gao, Pin; Yang, Guang; Fang, Yuan; Meng, Yan; Zhao, Xuejian] Jilin Univ, Coll Basic Med, Dept Pathophysiol, Changchun 130023, Peoples R China; [Chen, Yan] Jilin Univ, Hosp 1, Dept Nephropathy, Changchun 130023, Peoples R China	Jilin University; Jilin University	Meng, Y (corresponding author), Jilin Univ, Coll Basic Med, Dept Pathophysiol, Changchun 130023, Peoples R China.	mengyan2@yahoo.com	Meng, Yan/HGC-0394-2022; meng, yan/GSE-2653-2022		National Natural Science Foundation of China [30900518, 81170304, 81370240]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (Nos. 30900518, 81170304, 30900518 and 81370240).	Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Choi HM, 2013, BIOCHEM BIOPH RES CO, V435, P678, DOI 10.1016/j.bbrc.2013.05.042; Chvojka J, 2010, PHYSIOL RES, V59, P859, DOI 10.33549/physiolres.931936; Dixon WG, 2012, ANN RHEUM DIS, V71, P1761, DOI 10.1136/annrheumdis-2012-202021; Doi K, 2009, J CLIN INVEST, V119, P2868, DOI 10.1172/JCI39421; Gupta A, 2007, AM J PHYSIOL-RENAL, V293, pF245, DOI 10.1152/ajprenal.00477.2006; Holthoff JH, 2010, BIOCHEM PHARMACOL, V80, P1260, DOI 10.1016/j.bcp.2010.06.027; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hsing CH, 2011, NEPHROL DIAL TRANSPL, V26, P1162, DOI 10.1093/ndt/gfq572; Kruzel ML, 2010, INNATE IMMUN-LONDON, V16, P67, DOI 10.1177/1753425909105317; Lee YJ, 1997, MOL CELL ENDOCRINOL, V133, P135, DOI 10.1016/S0303-7207(97)00160-3; [李璐 Li Lu], 2005, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V31, P231; Mayeux PR, 2012, PHARMACOL THERAPEUT, V134, P139, DOI 10.1016/j.pharmthera.2012.01.004; Naito M, 2008, J AM SOC NEPHROL, V19, P1321, DOI 10.1681/ASN.2007121368; NOIRI E, 1994, AM J PATHOL, V144, P1159; Sadr-Azodi O, 2013, JAMA INTERN MED, V173, P444, DOI 10.1001/jamainternmed.2013.2737; Sanchez-Nino MD, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/182958; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Venkatachalam MA, 2012, KIDNEY INT, V81, P338, DOI 10.1038/ki.2011.401; Wang W, 2003, AM J PHYSIOL-RENAL, V284, pF532, DOI 10.1152/ajprenal.00323.2002; Wu LP, 2007, J AM SOC NEPHROL, V18, P1807, DOI 10.1681/ASN.2006121402; Wu LP, 2007, J PHARMACOL EXP THER, V320, P1061, DOI 10.1124/jpet.106117184; Xu L, 1990, CHINESE J PATHOPYSIO, V6, P69	24	35	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134653	10.1371/journal.pone.0134653	http://dx.doi.org/10.1371/journal.pone.0134653			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230340	gold, Green Submitted, Green Published			2022-12-27	WOS:000358838400144
J	Montuelle, SJ; Williams, SH				Montuelle, Stephane J.; Williams, Susan H.			In Vivo Measurement of Mesokinesis in Gekko gecko: The Role of Cranial Kinesis during Gape Display, Feeding and Biting	PLOS ONE			English	Article							PREY TRANSPORT KINEMATICS; BITE FORCE; VARANUS-EXANTHEMATICUS; LACERTID LIZARDS; FINITE-ELEMENT; SKULL; PERFORMANCE; EVOLUTION; BIRDS; BIOMECHANICS	Cranial kinesis refers to movements of skeletal sub-units relative to one another at mobile sutures within the skull. The presence and functional significance of cranial kinesis has been investigated in various vertebrates, with much of our understanding coming from comparative studies and manipulation of ligamentous specimens. Drawing on these studies, cranial kinesis in lizards has been modeled as a four-bar linkage system involving streptostyly (rotation of the quadrate), hypokinesis (dorsoventral flexion and extension of the palatomaxillary sub-unit), mesokinesis (dorsoventral flexion and extension of the snout at the fronto-parietal suture) and metakinesis (sliding movements between parietal and supraocciptal bones). In vivo studies, although limited, suggest that cranial kinesis serves an important role during routine behaviors such as feeding. Here, we use X-ray Reconstruction Of Moving Morphology to further quantify mesokinesis in vivo in Gekko gecko during three routine behaviors: gape display, biting and post-ingestion feeding. During gape display, the snout rotates dorsally above rest position, with mesokinesis accounting for a 10% increase in maximum gape over that achieved solely by the depression of the lower jaw. During defensive biting, the snout rotates ventrally below rest position to participate in gape closure. Finally, ventroflexion of the snout also occurs during post-ingestion feeding, accounting for 42% of gape closure during intra-oral transport, 86% during puncture-crushing, and 61% during pharyngeal packing. Mesokinesis thus appears to facilitate prey puncturing by allowing the snout to rotate ventrally so that the upper teeth pierce the prey item, thus limiting the need for large movements of the lower jaw. This is suggested to maintain a firm grip on the prey and reduce the possibility of prey escape. More generally, this study demonstrates that mesokinesis is a key component of defensive biting and gape display behaviors, as well as post-ingestion feeding, all of which are linked to organismal fitness.	[Montuelle, Stephane J.; Williams, Susan H.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University System of Ohio; Ohio University	Montuelle, SJ (corresponding author), Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Irvine Hall 228, Athens, OH 45701 USA.	montuell@ohio.edu		Montuelle, Stephane/0000-0002-8638-9779; Williams, Susan/0000-0003-4167-678X	National Science Foundation [MRI DBI-0922988]; Ohio Board of Regents; Ohio University Office of the Vice President for Research; Ohio University Heritage College of Osteopathic Medicine Research and Scholarly Affairs Committee	National Science Foundation(National Science Foundation (NSF)); Ohio Board of Regents; Ohio University Office of the Vice President for Research; Ohio University Heritage College of Osteopathic Medicine Research and Scholarly Affairs Committee	Funding for this project was provided by the National Science Foundation (MRI DBI-0922988), the Ohio Board of Regents, the Ohio University Office of the Vice President for Research and the Ohio University Heritage College of Osteopathic Medicine Research and Scholarly Affairs Committee (to SHW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PSL, 2010, J MORPHOL, V271, P990, DOI 10.1002/jmor.10850; Anderson RA, 2008, BIOL J LINN SOC, V93, P709, DOI 10.1111/j.1095-8312.2007.00905.x; Aowphol A, 2006, AMPHIBIA-REPTILIA, V27, P491, DOI 10.1163/156853806778877121; Baier DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063982; Bout RG, 2001, COMP BIOCHEM PHYS A, V131, P197, DOI 10.1016/S1095-6433(01)00470-6; Brainerd EL, 2010, J EXP ZOOL PART A, V313A, P262, DOI 10.1002/jez.589; Chai N, 2009, POINT VET, V40, P25; CONDON K, 1987, EXP BIOL, V47, P73; Cooper WJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-24; Cox MJ, 1998, SNAKES OTHER REPTILE; Cundall David, 2000, P293, DOI 10.1016/B978-012632590-4/50010-1; Curtis N, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0442; Dawson MM, 2011, J EXP BIOL, V214, P2036, DOI 10.1242/jeb.047159; Daza JD, 2009, BIOL J LINN SOC, V97, P677, DOI 10.1111/j.1095-8312.2009.01242.x; DECHOW PC, 1983, J BIOMECH, V16, P797, DOI 10.1016/0021-9290(83)90003-9; Elias JA, 2000, J EXP BIOL, V203, P791; Estrella SM, 2007, J EXP BIOL, V210, P3757, DOI 10.1242/jeb.007690; Frazzetta T., 1983, P222; FRAZZETTA TH, 1962, J MORPHOL, V111, P287, DOI 10.1002/jmor.1051110306; Gidmark NJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1181; Gussekloo SWS, 2005, J EXP BIOL, V208, P3409, DOI 10.1242/jeb.01768; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Herrel A, 2000, J EXP BIOL, V203, P1415; Herrel A, 1999, J EXP BIOL, V202, P3687; Herrel A, 2001, CAN J ZOOL, V79, P662, DOI 10.1139/cjz-79-4-662; Herrel A, 1999, J EXP BIOL, V202, P1127; Herrel A, 2007, INTEGR COMP BIOL, V47, P107, DOI 10.1093/icb/icm014; Holliday CM, 2010, ANAT REC, V293, P1350, DOI 10.1002/ar.21180; Iordansky NN, 2011, BIOL BULL+, V38, P868, DOI 10.1134/S1062359011090032; KARDONG K V, 1974, Forma et Functio, V7, P327; Kleinteich T, 2012, J EXP BIOL, V215, P833, DOI 10.1242/jeb.065979; Lee MSY, 1999, NATURE, V400, P655, DOI 10.1038/23236; Lujan NK, 2012, J MORPHOL, V273, P24, DOI 10.1002/jmor.11003; McBrayer LD, 2002, CAN J ZOOL, V80, P882, DOI 10.1139/Z02-068; McBrayer LD, 2002, ZOOLOGY, V105, P71, DOI 10.1078/0944-2006-00047; Metzger K., 2002, TOPICS FUNCTIONAL EC, P15; Mezzasalma M, 2014, ANAT REC, V297, P463, DOI 10.1002/ar.22827; Mitchell M.A., 2009, MANUAL EXOTIC PET PR; Moazen M, 2008, J ANAT, V213, P499, DOI 10.1111/j.1469-7580.2008.00980.x; Moazen M, 2013, ANAT REC, V296, P198, DOI 10.1002/ar.22629; Moazen M, 2009, P NATL ACAD SCI USA, V106, P8273, DOI 10.1073/pnas.0813156106; Moazen M, 2009, P ROY SOC B-BIOL SCI, V276, P39, DOI 10.1098/rspb.2008.0863; Montuelle SJ, 2009, J EXP BIOL, V212, P2501, DOI 10.1242/jeb.026336; O'Reilly James C., 2000, P149, DOI 10.1016/B978-012632590-4/50007-1; PATCHELL FC, 1986, J HERPETOL, V20, P59, DOI 10.2307/1564125; Payne SL, 2011, ANAT REC, V294, P399, DOI 10.1002/ar.21329; RIEPPEL O, 1981, ZOOL J LINN SOC-LOND, V72, P203, DOI 10.1111/j.1096-3642.1981.tb01570.x; Schaerlaeken V, 2008, J EXP BIOL, V211, P3908, DOI 10.1242/jeb.021345; Schwenk Kurt, 2000, P175, DOI 10.1016/B978-012632590-4/50009-5; SMITH KK, 1985, J EXP BIOL, V114, P53; SMITH KK, 1982, J MORPHOL, V173, P137, DOI 10.1002/jmor.1051730203; THROCKMORTON GS, 1981, J EXP ZOOL, V216, P25, DOI 10.1002/jez.1402160105; THROCKMORTON GS, 1976, J MORPHOL, V148, P363, DOI 10.1002/jmor.1051480307; Verwaijen D, 2002, FUNCT ECOL, V16, P842, DOI 10.1046/j.1365-2435.2002.00696.x; Wainwright PC, 2008, J EXP BIOL, V211, P3523, DOI 10.1242/jeb.007187; Williams SH, 2009, J MORPHOL, V270, P1338, DOI 10.1002/jmor.10761	56	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134710	10.1371/journal.pone.0134710	http://dx.doi.org/10.1371/journal.pone.0134710			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230087	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400153
J	Ugorji, CO; Samson, RS; Liechti, MD; Panicker, JN; Miller, DH; Wheeler-Kingshott, CAM; Yiannakas, MC				Ugorji, Chinyere O.; Samson, Rebecca S.; Liechti, Martina D.; Panicker, Jalesh N.; Miller, David H.; Wheeler-Kingshott, Claudia A. M.; Yiannakas, Marios C.			Grey and White Matter Magnetisation Transfer Ratio Measurements in the Lumbosacral Enlargement: A Pilot In Vivo Study at 3T	PLOS ONE			English	Article							SPINAL-CORD-INJURY; MULTIPLE-SCLEROSIS; BLADDER DYSFUNCTION; MRI; SEGMENTATION; REFLEXES; IMPACT; TISSUE; BRAIN	Magnetisation transfer (MT) imaging of the central nervous system has provided further insight into the pathophysiology of neurological disease. However, the use of this method to study the lower spinal cord has been technically challenging, despite the important role of this region, not only for motor control of the lower limbs, but also for the neural control of lower urinary tract, sexual and bowel functions. In this study, the feasibility of obtaining reliable grey matter (GM) and white matter (WM) magnetisation transfer ratio (MTR) measurements within the lumbosacral enlargement (LSE) was investigated in ten healthy volunteers using a clinical 3T MRI system. The mean cross-sectional area of the LSE (LSE-CSA) and the mean GM area (LSE-GM-CSA) were first obtained by means of image segmentation and tissue-specific (i.e. WM and GM) MTR measurements within the LSE were subsequently obtained. The reproducibility of the segmentation method and MTR measurements was assessed from repeated measurements and their % coefficient of variation (%COV). Mean (+/- SD) LSE-CSA across 10 healthy subjects was 59.3 (+/- 8.4) mm(2) and LSE-GM-CSA was 17.0 (+/- 3.1) mm(2). The mean intra-and inter-rater % COV for measuring the LSE-CSA were 0.8% and 2.3%, respectively and for the LSE-GM-CSA were 3.8% and 5.4%, respectively. Mean (+/- SD) WM-MTR was 43.2 (+/- 4.4) and GM-MTR was 40.9 (+/- 4.3). The mean scan-rescan % COV for measuring WM-MTR was 4.6% and for GM-MTR was 3.8%. Using a paired t-test, a statistically significant difference was identified between WM-MTR and GM-MTR in the LSE (p<0.0001). This pilot study has shown that it is possible to obtain reliable tissue-specific MTR measurements within the LSE using a clinical MR system at 3T. The MTR acquisition and analysis protocol presented in this study can be used in future investigations of intrinsic spinal cord diseases that affect the LSE.	[Ugorji, Chinyere O.; Samson, Rebecca S.; Liechti, Martina D.; Miller, David H.; Wheeler-Kingshott, Claudia A. M.; Yiannakas, Marios C.] UCL Inst Neurol, Dept Neuroinflammat, Queen Sq MS Ctr, NMR Res Unit, London, England; [Liechti, Martina D.; Panicker, Jalesh N.] Natl Hosp Neurol & Neurosurg, Dept Uroneurol, London WC1N 3BG, England; [Liechti, Martina D.; Panicker, Jalesh N.] UCL Inst Neurol, London, England	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London	Ugorji, CO (corresponding author), UCL Inst Neurol, Dept Neuroinflammat, Queen Sq MS Ctr, NMR Res Unit, London, England.	c.ugorji@ucl.ac.uk	Wheeler-Kingshott, Claudia A M Gandini/AAH-7480-2019	Wheeler-Kingshott, Claudia A M Gandini/0000-0002-4832-1300; Liechti, Martina/0000-0002-3024-0975; Samson, Rebecca/0000-0002-0197-702X	Multiple Sclerosis Society of Great Britain and Northern Ireland; Department of Health's Comprehensive Biomedical Research Centre at University College Hospitals Trust; National Institute for Health Research [NF-SI-0508-10058] Funding Source: researchfish	Multiple Sclerosis Society of Great Britain and Northern Ireland; Department of Health's Comprehensive Biomedical Research Centre at University College Hospitals Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	This work and the NMR Research Unit are supported by the Multiple Sclerosis Society of Great Britain and Northern Ireland (http://www.mssociety.org.uk/). This work was supported by the Department of Health's Comprehensive Biomedical Research Centre at University College Hospitals Trust The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KD, 2007, SPINAL CORD, V45, P328, DOI 10.1038/sj.sc.3101977; Bot JCJ, 2004, RADIOLOGY, V233, P531, DOI 10.1148/radiol.2332031572; Callaghan MF, 2014, NEUROBIOL AGING, V35, P1862, DOI 10.1016/j.neurobiolaging.2014.02.008; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Craggs MD, 2006, AUTON NEUROSCI-BASIC, V126, P355, DOI 10.1016/j.autneu.2006.03.010; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; DUBOULAY GH, 1966, BRIT J RADIOL, V39, P255, DOI 10.1259/0007-1285-39-460-255; El Mendili MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095516; Fernandez O, 2002, J NEUROL, V249, P1, DOI 10.1007/PL00007835; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; FRALIX TA, 1991, MAGN RESON MED, V18, P214, DOI 10.1002/mrm.1910180122; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Garcia M, 2011, NEURORADIOLOGY, V53, P159, DOI 10.1007/s00234-010-0714-5; Gilmore CP, 2006, BRAIN PATHOL, V16, P202, DOI 10.1111/j.1750-3639.2006.00018.x; GLOVER GH, 1992, MAGNET RESON MED, V28, P275, DOI 10.1002/mrm.1910280209; Gringel T, 2009, J MAGN RESON IMAGING, V29, P1285, DOI 10.1002/jmri.21756; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Hess MJ, 2012, J SPINAL CORD MED, V35, P211, DOI 10.1179/2045772312Y.0000000025; Horsfield MA, 2010, NEUROIMAGE, V50, P446, DOI 10.1016/j.neuroimage.2009.12.121; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; KONNO H, 1986, J NEUROL SCI, V73, P193, DOI 10.1016/0022-510X(86)90130-9; Labauge P, 2009, Int MS J, V16, P47; LANE B, 1974, RADIOLOGY, V110, P579, DOI 10.1148/110.3.579; Malas MA, 2000, SURG RADIOL ANAT, V22, P163, DOI 10.1007/s00276-000-0163-7; McCombe PA, 2009, EXPERT REV NEUROTHER, V9, P331, DOI 10.1586/14737175.9.3.331; MEHTA RC, 1995, AM J NEURORADIOL, V16, P2085; Nout YS, 2006, PROG BRAIN RES, V152, P359, DOI 10.1016/S0079-6123(05)52024-7; Oh J, 2013, MULT SCLER J, V19, P427, DOI 10.1177/1352458512456614; Oh J, 2013, NEUROLOGY, V80, P540, DOI 10.1212/WNL.0b013e31828154c5; Reitz A, 2004, INT J IMPOT RES, V16, P167, DOI 10.1038/sj.ijir.3901193; Sakakibara R, 2000, J NEUROL NEUROSUR PS, V68, P65, DOI 10.1136/jnnp.68.1.65; SAKAKIBARA R, 1993, JPN J PSYCHIAT NEUR, V47, P591; Samson RS, 2013, NMR BIOMED, V26, P1823, DOI 10.1002/nbm.3022; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Sled JG, 2004, MAGNET RESON MED, V51, P299, DOI 10.1002/mrm.10701; TSUKAGOSHI H, 1979, J NEUROL SCI, V41, P287, DOI 10.1016/0022-510X(79)90089-3; Watanabe T, 1998, J UROLOGY, V159, P965, DOI 10.1016/S0022-5347(01)63786-8; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Wu Y, 2010, P INT MAG REASON MED, V18, P4444; Yiannakas MC, 2012, NEUROIMAGE, V63, P1054, DOI 10.1016/j.neuroimage.2012.07.048; Yiannakas MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105544; Zackowski KM, 2009, BRAIN, V132, P1200, DOI 10.1093/brain/awp032	43	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134495	10.1371/journal.pone.0134495	http://dx.doi.org/10.1371/journal.pone.0134495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230729	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400127
J	van Diest, M; Stegenga, J; Wortche, HJ; Roerdink, JBTM; Verkerke, GJ; Lamoth, CJC				van Diest, Mike; Stegenga, Jan; Wortche, Heinrich J.; Roerdink, Jos B. T. M.; Verkerke, Gijsbertus J.; Lamoth, Claudine J. C.			Quantifying Postural Control during Exergaming Using Multivariate Whole-Body Movement Data: A Self-Organizing Maps Approach	PLOS ONE			English	Article							NONLINEAR DYNAMICS; LATERAL STABILITY; MICROSOFT KINECT; BALANCE CONTROL; FALL RISK; VARIABILITY; REHABILITATION; PREDICTORS; ACCURACY; VALIDITY	Background Exergames are becoming an increasingly popular tool for training balance ability, thereby preventing falls in older adults. Automatic, real time, assessment of the user's balance control offers opportunities in terms of providing targeted feedback and dynamically adjusting the gameplay to the individual user, yet algorithms for quantification of balance control remain to be developed. The aim of the present study was to identify movement patterns, and variability therein, of young and older adults playing a custom-made weight-shifting (ice-skating) exergame. Methods Twenty older adults and twenty young adults played a weight-shifting exergame under five conditions of varying complexity, while multi-segmental whole-body movement data were captured using Kinect. Movement coordination patterns expressed during gameplay were identified using Self Organizing Maps (SOM), an artificial neural network, and variability in these patterns was quantified by computing Total Trajectory Variability (TTvar). Additionally a k Nearest Neighbor (kNN) classifier was trained to discriminate between young and older adults based on the SOM features. Results Results showed that TTvar was significantly higher in older adults than in young adults, when playing the exergame under complex task conditions. The kNN classifier showed a classification accuracy of 65.8%. Conclusions Older adults display more variable sway behavior than young adults, when playing the exergame under complex task conditions. The SOM features characterizing movement patterns expressed during exergaming allow for discriminating between young and older adults with limited accuracy. Our findings contribute to the development of algorithms for quantification of balance ability during home-based exergaming for balance training.	[van Diest, Mike; Stegenga, Jan; Wortche, Heinrich J.] INCAS3, Assen, Netherlands; [van Diest, Mike; Lamoth, Claudine J. C.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Roerdink, Jos B. T. M.] Univ Groningen, Johann Bernoulli Inst Math & Comp Sci, Groningen, Netherlands; [Verkerke, Gijsbertus J.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Ctr Rehabil, Groningen, Netherlands; [Verkerke, Gijsbertus J.] Univ Twente, Dept Biomech Engn, NL-7500 AE Enschede, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Twente	van Diest, M (corresponding author), INCAS3, Assen, Netherlands.	mikevandiest@incas3.eu	Roerdink, Jos B.T.M/B-3631-2008; Lamoth, Claudine JC/N-4325-2013	Lamoth, Claudine JC/0000-0002-6495-2823; Verkerke, Bart/0000-0003-3533-2446	INCAS3; research center SPRINT; Province of Drenthe; Municipality of Assen; European Fund for Regional Development; Ministry of Economic Affairs, Peaks in the Delta; Northern Netherlands Provinces Alliance, Course for the North	INCAS3; research center SPRINT; Province of Drenthe; Municipality of Assen; European Fund for Regional Development(European Commission); Ministry of Economic Affairs, Peaks in the Delta; Northern Netherlands Provinces Alliance, Course for the North	This work was supported by INCAS<SUP>3</SUP> and research center SPRINT. INCAS<SUP>3</SUP> is supported by the Province of Drenthe, the Municipality of Assen, the European Fund for Regional Development and the Ministry of Economic Affairs, Peaks in the Delta. This project is financially supported by the Northern Netherlands Provinces Alliance, Course for the North. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baranowski MT, 2013, GAMES HLTH J, V2; Barzilay O, 2013, J ELECTROMYOGR KINES, V23, P182, DOI 10.1016/j.jelekin.2012.09.004; Bauer HU, 1997, NEURAL PROCESS LETT, V5, P193, DOI 10.1023/A:1009646811510; Beauchet O, 2009, GERONTOLOGY, V55, P702, DOI 10.1159/000235905; Betker AL, 2006, ARCH PHYS MED REHAB, V87, P1141, DOI 10.1016/j.apmr.2006.04.010; Buzzi UH, 2003, CLIN BIOMECH, V18, P435, DOI 10.1016/S0268-0033(03)00029-9; Clark RA, 2013, J BIOMECH, V46, P2722, DOI 10.1016/j.jbiomech.2013.08.011; Clark RA, 2012, GAIT POSTURE, V36, P372, DOI 10.1016/j.gaitpost.2012.03.033; de Vries EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098494; Delbaere K, 2010, J AM GERIATR SOC, V58, P1679, DOI 10.1111/j.1532-5415.2010.03017.x; Demura S, 2008, GERIATR GERONTOL INT, V8, P188, DOI 10.1111/j.1447-0594.2008.00469.x; Federolf P, 2013, J BIOMECH, V46, P2626, DOI 10.1016/j.jbiomech.2013.08.008; Fitzgerald D, 2010, J ORTHOP SPORT PHYS, V40, P11, DOI 10.2519/jospt.2010.3121; Fix E., 1951, JOSEPH; Gravelle DC, 2002, NEUROREPORT, V13, P1853, DOI 10.1097/00001756-200210280-00004; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Haykin S, 1999, P842; Hernandez ME, 2012, HUM MOVEMENT SCI, V31, P1213, DOI 10.1016/j.humov.2011.11.002; Hernandez ME, 2012, CLIN BIOMECH, V27, P910, DOI 10.1016/j.clinbiomech.2012.06.007; Hinton GE, 2007, TRENDS COGN SCI, V11, P428, DOI 10.1016/j.tics.2007.09.004; HORAK FB, 1989, NEUROBIOL AGING, V10, P727, DOI 10.1016/0197-4580(89)90010-9; Huang G, 2015, NEURAL NETWORKS, V61, P32, DOI 10.1016/j.neunet.2014.10.001; Kang HG, 2009, J GERONTOL A-BIOL, V64, P1304, DOI 10.1093/gerona/glp113; Khoshelham K, 2012, SENSORS-BASEL, V12, P1437, DOI 10.3390/s120201437; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; Lakany HM, 2000, NEUROCOMPUTING, V35, P27, DOI 10.1016/S0925-2312(00)00316-7; Lamb PF, 2013, HUM MOVEMENT SCI, V33, P54, DOI [10.1016/j.humov.2013.08.005, DOI 10.1016/J.HUM0V.2013.08.005]; Lamoth CJ, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-2; Lamoth CJC, 2012, GAIT POSTURE, V35, P489, DOI 10.1016/j.gaitpost.2011.11.014; Lamoth CJC, 2009, GAIT POSTURE, V29, P546, DOI 10.1016/j.gaitpost.2008.12.006; Laughton CA, 2003, GAIT POSTURE, V18, P101, DOI 10.1016/S0966-6362(02)00200-X; Maillot P, 2012, PSYCHOL AGING, V27, P589, DOI 10.1037/a0026268; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Nishihori T, 2012, AGING CLIN EXP RES, V24, P162, DOI 10.3275/7626; Pollock AS, 2000, CLIN REHABIL, V14, P402, DOI 10.1191/0269215500cr342oa; Rispens SM, 2015, NEUROREHAB NEURAL RE, V29, P54, DOI 10.1177/1545968314532031; Rogers MW, 2003, EXERC SPORT SCI REV, V31, P182, DOI 10.1097/00003677-200310000-00005; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Shotton J, 2011, PROC CVPR IEEE, P1297, DOI 10.1109/CVPR.2011.5995316; Sihvonen SE, 2004, GERONTOLOGY, V50, P87, DOI 10.1159/000075559; Sloot LH, 2011, ANN BIOMED ENG, V39, P1563, DOI 10.1007/s10439-010-0240-y; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Sturnieks DL, 2008, NEUROPHYSIOL CLIN, V38, P467, DOI 10.1016/j.neucli.2008.09.001; van Diest M, 2014, J BIOMECH, V47, P2925, DOI 10.1016/j.jbiomech.2014.07.017; van Diest M, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-101; Van Vliet PM, 2006, DISABIL REHABIL, V28, P831, DOI 10.1080/09638280500534937	48	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134350	10.1371/journal.pone.0134350	http://dx.doi.org/10.1371/journal.pone.0134350			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230655	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400104
J	Vongrad, V; Imig, J; Mohammadi, P; Kishore, S; Jaskiewicz, L; Hall, J; Guenthard, HF; Beerenwinkel, N; Metzner, KJ				Vongrad, Valentina; Imig, Jochen; Mohammadi, Pejman; Kishore, Shivendra; Jaskiewicz, Lukasz; Hall, Jonathan; Guenthard, Huldrych F.; Beerenwinkel, Niko; Metzner, Karin J.			HIV-1 RNAs are Not Part of the Argonaute 2 Associated RNA Interference Pathway in Macrophages	PLOS ONE			English	Article							SMALL NONCODING RNAS; ENCODED MICRORNAS; MONONUCLEAR PHAGOCYTES; HIV-1-INFECTED CELLS; WIDE IDENTIFICATION; SECONDARY STRUCTURE; GENE-EXPRESSION; INFECTED-CELLS; BINDING-SITES; TAR ELEMENT	Background MiRNAs and other small noncoding RNAs (sncRNAs) are key players in post-transcriptional gene regulation. HIV-1 derived small noncoding RNAs (sncRNAs) have been described in HIV-1 infected cells, but their biological functions still remain to be elucidated. Here, we approached the question whether viral sncRNAs may play a role in the RNA interference (RNAi) pathway or whether viral mRNAs are targeted by cellular miRNAs in human monocyte derived macrophages (MDM). Methods The incorporation of viral sncRNAs and/or their target RNAs into RNA-induced silencing complex was investigated using photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) as well as high-throughput sequencing of RNA isolated by cross-linking immunoprecipitation (HITS-CLIP), which capture Argonaute2-bound miRNAs and their target RNAs. HIV-1 infected monocyte-derived macrophages (MDM) were chosen as target cells, as they have previously been shown to express HIV-1 sncRNAs. In addition, we applied small RNA deep sequencing to study differential cellular miRNA expression in HIV-1 infected versus non-infected MDMs. Results and Conclusion PAR-CLIP and HITS-CLIP data demonstrated the absence of HIV-1 RNAs in Ago2-RISC, although the presence of a multitude of HIV-1 sncRNAs in HIV-1 infected MDMs was confirmed by small RNA sequencing. Small RNA sequencing revealed that 1.4% of all sncRNAs were of HIV-1 origin. However, neither HIV-1 derived sncRNAs nor putative HIV-1 target sequences incorporated into Ago2-RISC were identified suggesting that HIV-1 sncRNAs are not involved in the canonical RNAi pathway nor is HIV-1 targeted by this pathway in HIV-1 infected macrophages.	[Vongrad, Valentina; Guenthard, Huldrych F.; Metzner, Karin J.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Vongrad, Valentina; Guenthard, Huldrych F.; Metzner, Karin J.] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Imig, Jochen; Hall, Jonathan] ETH, Inst Pharmaceut Sci, Zurich, Switzerland; [Mohammadi, Pejman; Beerenwinkel, Niko] ETH, Dept Biosyst Sci & Engn, Basel, Switzerland; [Mohammadi, Pejman; Beerenwinkel, Niko] Swiss Inst Bioinformat, Basel, Switzerland; [Kishore, Shivendra; Jaskiewicz, Lukasz] Univ Basel, Computat & Syst Biol, Basel, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; University of Basel	Vongrad, V (corresponding author), Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	valentina.vongrad@usz.ch	gunthard, huldrych f/F-1724-2011; Metzner, Karin J/G-5319-2011; mohammadi, pejman/AAX-6002-2020	gunthard, huldrych f/0000-0002-1142-6723; Metzner, Karin J/0000-0003-4862-1503; mohammadi, pejman/0000-0003-4457-8552; Hall, Jonathan/0000-0003-4160-7135; Imig, Jochen/0000-0003-0385-1081	Swiss National Science Foundation [31003A_112670, 310030_141067]; University of Zurich's clinical research priority program: viral infectious diseases - ZPHI; Swiss National Science Foundation by a joint Sinergia grant [CRSII3_127454]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich's clinical research priority program: viral infectious diseases - ZPHI; Swiss National Science Foundation by a joint Sinergia grant(Swiss National Science Foundation (SNSF))	This study was funded by the Swiss National Science Foundation (grant no. 31003A_112670 and 310030_141067 to KJM and HFG). This project was further supported by the University of Zurich's clinical research priority program: viral infectious diseases - ZPHI (to KJM and HFG). JI was supported by the Swiss National Science Foundation (in part) by a joint Sinergia grant (CRSII3_127454) to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus CF, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-27; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Chable-Bessia C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-26; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Gebetsberger J, 2013, RNA BIOL, V10, P1798, DOI 10.4161/rna.27177; Grey F, 2005, J VIROL, V79, P12095, DOI 10.1128/JVI.79.18.12095-12099.2005; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hafner M, 2012, METHODS, V58, P164, DOI 10.1016/j.ymeth.2012.07.030; Hafner M, 2012, METHODS, V58, P94, DOI 10.1016/j.ymeth.2012.08.006; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Imig J, 2015, NAT CHEM BIOL, V11, P107, DOI [10.1038/NCHEMBIO.1713, 10.1038/nchembio.1713]; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kaul D, 2006, P INDIAN NATL SCI AC, V72; Kaul D, 2009, MOL CELL BIOCHEM, V323, P143, DOI 10.1007/s11010-008-9973-4; Khorshid M, 2011, NUCLEIC ACIDS RES, V39, pD245, DOI 10.1093/nar/gkq940; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kincaid RP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003018; Kincaid RP, 2012, P NATL ACAD SCI USA, V109, P3077, DOI 10.1073/pnas.1116107109; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; KOYANAGI Y, 1988, SCIENCE, V241, P1673, DOI 10.1126/science.3047875; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Loss-Morais G, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-6; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; OBRIEN WA, 1990, NATURE, V348, P69, DOI 10.1038/348069a0; Omoto S, 2005, J GEN VIROL, V86, P751, DOI 10.1099/vir.0.80449-0; Omoto Shinya, 2004, Retrovirology, V1, P44, DOI 10.1186/1742-4690-1-44; Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Pederson T, 2010, RNA, V16, P1865, DOI 10.1261/rna.2266510; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Rusert P, 2005, J VIROL, V79, P8454, DOI 10.1128/JVI.79.13.8454-8469.2005; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Tan J, 2013, TRENDS MICROBIOL, V21, P405, DOI 10.1016/j.tim.2013.05.001; Tan X, 2012, P NATL ACAD SCI USA, V109, P869, DOI 10.1073/pnas.1119873109; Vaz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-288; Wang LF, 2012, CELL MOL IMMUNOL, V9, P103, DOI 10.1038/cmi.2011.43; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Whisnant AW, 2013, MBIO, V4, DOI 10.1128/mBio.00193-13; Xing L, 2007, J VIROL, V81, P9967, DOI 10.1128/JVI.02244-06; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707	58	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0132127	10.1371/journal.pone.0132127	http://dx.doi.org/10.1371/journal.pone.0132127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226348	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000358837700005
J	Borrill, P; Fahy, B; Smith, AM; Uauy, C				Borrill, Philippa; Fahy, Brendan; Smith, Alison M.; Uauy, Cristobal			Wheat Grain Filling Is Limited by Grain Filling Capacity rather than the Duration of Flag Leaf Photosynthesis: A Case Study Using NAM RNAi Plants	PLOS ONE			English	Article							STARCH SYNTHESIS; SPRING WHEAT; STAY-GREEN; YIELD; SENESCENCE; PROTEIN; BARLEY; IDENTIFICATION; TEMPERATURE; EXPRESSION	It has been proposed that delayed leaf senescence can extend grain filling duration and thus increase yields in cereal crops. We found that wheat (Triticum aestivum) NAM RNAi plants with delayed senescence carried out 40% more flag leaf photosynthesis after anthesis than control plants, but had the same rate and duration of starch accumulation during grain filling and the same final grain weight. The additional photosynthate available in NAM RNAi plants was in part stored as fructans in the stems, whereas stem fructans were remobilised during grain filling in control plants. In both genotypes, activity of starch synthase was limiting for starch synthesis in the later stages of grain filling. We suggest that in order to realise the potential yield gains offered by delayed leaf senescence, this trait should be combined with increased grain filling capacity.	[Borrill, Philippa; Fahy, Brendan; Smith, Alison M.; Uauy, Cristobal] John Innes Ctr, Norwich, Norfolk, England; [Uauy, Cristobal] Natl Inst Agr Bot, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Uauy, C (corresponding author), John Innes Ctr, Norwich Res Pk, Norwich, Norfolk, England.	cristobal.uauy@jic.ac.uk	Uauy, Cristobal/T-4382-2019	Uauy, Cristobal/0000-0002-9814-1770; Borrill, Philippa/0000-0002-7623-8256	Biotechnology and Biological Sciences Research Council [BB/K006517/1, BB/J004588/1, BB/J004561/1]; HarvestPlus Challenge Program [6242]; John Innes Foundation; Biotechnology and Biological Sciences Research Council [BB/M014045/1, BBS/E/J/000C0628, BBS/E/J/000CA530] Funding Source: researchfish; BBSRC [BB/K006517/1, BBS/E/J/000C0628, BB/M014045/1, BBS/E/J/000CA530] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); HarvestPlus Challenge Program; John Innes Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk/) (BB/K006517/1, BB/J004588/1, and BB/J004561/1, to BF, AS, and CU), grant 6242 from the HarvestPlus Challenge Program (CU), and a studentship grant from the John Innes Foundation (PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZCONBIETO J, 1983, PLANT PHYSIOL, V73, P681, DOI 10.1104/pp.73.3.681; Beed FD, 2007, J AGR SCI, V145, P63, DOI 10.1017/S0021859606006678; Birecka H., 1963, ACTA SOC BOT POL, V32, P631; Bogard M, 2011, J EXP BOT, V62, P3621, DOI 10.1093/jxb/err061; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; Borrell AK, 2000, CROP SCI, V40, P1037, DOI 10.2135/cropsci2000.4041037x; BUTTROSE MS, 1962, AUST J BIOL SCI, V15, P611, DOI 10.1071/BI9620611; Derkx AP, 2012, J INTEGR PLANT BIOL, V54, P555, DOI 10.1111/j.1744-7909.2012.01144.x; Driever SM, 2014, J EXP BOT, V65, P4959, DOI 10.1093/jxb/eru253; EVANS LT, 1970, AUST J BIOL SCI, V23, P245, DOI 10.1071/BI9700245; Gaju O, 2011, FIELD CROP RES, V123, P139, DOI 10.1016/j.fcr.2011.05.010; Gaju O, 2014, FIELD CROP RES, V155, P213, DOI 10.1016/j.fcr.2013.09.003; Gregersen PL, 2013, PLANT MOL BIOL, V82, P603, DOI 10.1007/s11103-013-0013-8; Guttieri MJ, 2013, PLANT SOIL, V371, P573, DOI 10.1007/s11104-013-1713-1; HARGREAVES JA, 1988, PHYTOCHEMISTRY, V27, P1627, DOI 10.1016/0031-9422(88)80416-3; HAWKER JS, 1993, AUST J PLANT PHYSIOL, V20, P197, DOI 10.1071/PP9930197; Hawkesford MJ, 2013, FOOD ENERGY SECUR, V2, P34, DOI 10.1002/fes3.15; Hurkman WJ, 2003, PLANT SCI, V164, P873, DOI 10.1016/S0168-9452(03)00076-1; JENNER CF, 1994, AUST J PLANT PHYSIOL, V21, P17, DOI 10.1071/PP9940017; KEELING PL, 1993, PLANTA, V191, P342, DOI 10.1007/BF00195691; Kichey T, 2007, FIELD CROP RES, V102, P22, DOI 10.1016/j.fcr.2007.01.002; KING RW, 1967, PLANTA, V77, P261, DOI 10.1007/BF00385296; KRIEDEMANN P, 1966, ANN BOT-LONDON, V30, P349, DOI 10.1093/oxfordjournals.aob.a084081; KUHBAUCH W, 1989, J PLANT PHYSIOL, V134, P243, DOI 10.1016/S0176-1617(89)80063-X; Li ZY, 1999, PLANT PHYSIOL, V120, P1147, DOI 10.1104/pp.120.4.1147; Li ZY, 2000, PLANT PHYSIOL, V123, P613, DOI 10.1104/pp.123.2.613; Lopes MS, 2012, J EXP BOT, V63, P3789, DOI 10.1093/jxb/ers071; Maydup ML, 2010, FIELD CROP RES, V119, P48, DOI 10.1016/j.fcr.2010.06.014; Parrott DL, 2012, J EXP BOT, V63, P1329, DOI 10.1093/jxb/err360; Reynolds MP, 2005, ANN APPL BIOL, V146, P39, DOI 10.1111/j.1744-7348.2005.03100.x; Rosti S, 2006, J EXP BOT, V57, P3619, DOI 10.1093/jxb/erl110; Ruuska SA, 2006, FUNCT PLANT BIOL, V33, P799, DOI 10.1071/FP06062; Sandana PA, 2009, FIELD CROP RES, V114, P233, DOI 10.1016/j.fcr.2009.08.003; SCHNYDER H, 1993, NEW PHYTOL, V123, P233, DOI 10.1111/j.1469-8137.1993.tb03731.x; Serrago RA, 2013, FIELD CROP RES, V150, P42, DOI 10.1016/j.fcr.2013.05.016; Simmonds J, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0191-9; SLAFER GA, 1994, FIELD CROP RES, V37, P39, DOI 10.1016/0378-4290(94)90080-9; Stamova Boryana S, 2009, Int J Plant Genomics, V2009, P407426, DOI 10.1155/2009/407426; STAMP P, 1976, Z PFLANZENZUCHT, V77, P330; STOY V, 1963, PHYSIOL PLANTARUM, V16, P851, DOI 10.1111/j.1399-3054.1963.tb08363.x; Thomas H, 2014, J EXP BOT, V65, P3889, DOI 10.1093/jxb/eru037; Tomlinson K, 2003, ADV BOT RES, V40, P1, DOI 10.1016/S0065-2296(05)40001-4; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Wan YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-121; Wang ZL, 1998, PHOTOSYNTHETICA, V35, P453, DOI 10.1023/A:1006976605148; Waters BM, 2009, J EXP BOT, V60, P4263, DOI 10.1093/jxb/erp257; Weichert N, 2010, PLANT PHYSIOL, V152, P698, DOI 10.1104/pp.109.150854; Yang JC, 2004, PLANT PHYSIOL, V135, P1621, DOI 10.1104/pp.104.041038; Zhang CH, 2010, J CEREAL SCI, V51, P226, DOI 10.1016/j.jcs.2009.12.002	50	44	45	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134947	10.1371/journal.pone.0134947	http://dx.doi.org/10.1371/journal.pone.0134947			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241955	Green Submitted, gold, Green Published			2022-12-27	WOS:000358942700085
J	Hansen, L; Xu, T; Wickham, J; Chen, Y; Hao, DJ; Hanks, LM; Millar, JG; Teale, SA				Hansen, Laura; Xu, Tian; Wickham, Jacob; Chen, Yi; Hao, Dejun; Hanks, Lawrence M.; Millar, Jocelyn G.; Teale, Stephen A.			Identification of a Male-Produced Pheromone Component of the Citrus Longhorned Beetle, Anoplophora chinensis	PLOS ONE			English	Article							SPOTTED LONGICORN BEETLE; GLABRIPENNIS COLEOPTERA CERAMBYCIDAE; CONTACT SEX-PHEROMONE; PLANT VOLATILES; OLFACTORY CUES; MALASIACA; ORIENTATION; ATTRACTION	The Asian wood-boring beetle Anoplophora chinensis (Forster) (Coleoptera: Cerambycidae) is an important pest of hardwood trees in its native range, and has serious potential to invade other areas of the world through worldwide commerce in woody plants and wood products. This species already has been intercepted in North America, and is the subject of ongoing eradication efforts in several countries in Europe. Attractants such as pheromones would be immediately useful as baits in traps for its detection. Because long-range pheromones are frequently conserved among closely related species of cerambycids, we evaluated two components of the volatile pheromone produced by males of the congener A. glabripennis (Motschulsky), 4-(n-heptyloxy)butan-1-ol and 4-(n-heptyloxy) butanal, as potential pheromones of A. chinensis. Both compounds subsequently were detected in headspace volatiles from male A. chinensis, but not in volatiles from females. Only 4-(n-heptyloxy) butanol elicited responses from beetle antennae in coupled gas chromatography-electroantennogram analyses, and this compound attracted adult A. chinensis of both sexes in field bioassays. These data suggest that 4-(n-heptyloxy) butan-1-ol is an important component of the male-produced attractant pheromone of A. chinensis, which should find immediate use in quarantine monitoring for this pest.	[Hansen, Laura; Xu, Tian; Teale, Stephen A.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA; [Wickham, Jacob; Chen, Yi] Chinese Acad Sci, Inst Chem, Key Lab Analyt Chem Living Biosyst, Beijing 100080, Peoples R China; [Hao, Dejun] Nanjing Forestry Univ, Dept Forest Protect, Nanjing, Jiangsu, Peoples R China; [Hanks, Lawrence M.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Millar, Jocelyn G.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Millar, Jocelyn G.] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Chinese Academy of Sciences; Institute of Chemistry, CAS; Nanjing Forestry University; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Riverside; University of California System; University of California Riverside	Teale, SA (corresponding author), SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA.	sateale@esf.edu	Wickham, Jacob/AAC-4553-2019	Wickham, Jacob/0000-0002-6027-0470; Millar, Jocelyn/0000-0001-7639-9001	United States Department of Agriculture, Animal Plant Health Inspection Service [13-8130-1422-CA, 14-8130-1422-CA]; United States National Science Foundation [0904100]; National Natural Science Foundation of China [21050110424]; Chinese Academy of Sciences, Fellowships for Young International Scientists [2010Y1JB1]	United States Department of Agriculture, Animal Plant Health Inspection Service(United States Department of Agriculture (USDA)); United States National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences, Fellowships for Young International Scientists	The authors thank the United States Department of Agriculture, Animal Plant Health Inspection Service for financial support to JGM, LMH and SAT (grant numbers 13-8130-1422-CA and 14-8130-1422-CA). The United States National Science Foundation (grant number 0904100), The National Natural Science Foundation of China (grant number 21050110424) and the Chinese Academy of Sciences, Fellowships for Young International Scientists (grant number 2010Y1JB1) provided financial support to JW.	Allison JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093203; Allison JD, 2012, ENVIRON ENTOMOL, V41, P1587, DOI 10.1603/EN12185; Alvarez G, 2015, J APPL ENTOMOL, V139, P618, DOI 10.1111/jen.12186; Barbour JD, 2011, ANN ENTOMOL SOC AM, V104, P588, DOI 10.1603/AN10182; CABI, 2014, INVASIVE SPECIES COM; Carde RT, 2014, J CHEM ECOL, V40, P519, DOI 10.1007/s10886-014-0465-6; Fukaya M, 2005, APPL ENTOMOL ZOOL, V40, P63, DOI 10.1303/aez.2005.63; Fukaya M, 2004, ENTOMOL EXP APPL, V111, P111, DOI 10.1111/j.0013-8703.2004.00147.x; Fukaya Midori, 2000, Entomological Science, V3, P211; Ginzel MD, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P375, DOI 10.1017/CBO9780511711909.018; Graham EE, 2010, J ECON ENTOMOL, V103, P641, DOI 10.1603/EC10013; Haack RA, 2010, ANNU REV ENTOMOL, V55, P521, DOI 10.1146/annurev-ento-112408-085427; Lingafelter S.W., 2002, REVISION GENUS ANOPL; Macias-Samano JE, 2012, CAN ENTOMOL, V144, P821, DOI 10.4039/tce.2012.77; Mitchell RF, 2011, ENTOMOL EXP APPL, V141, P71, DOI 10.1111/j.1570-7458.2011.01167.x; Nehme ME, 2014, ENVIRON ENTOMOL, V43, P1034, DOI 10.1603/EN14049; Nehme ME, 2010, ENVIRON ENTOMOL, V39, P169, DOI 10.1603/EN09177; Nehme ME, 2009, ENVIRON ENTOMOL, V38, P1745, DOI 10.1603/022.038.0628; Pajares JA, 2013, ENTOMOL EXP APPL, V149, P118, DOI 10.1111/eea.12113; Reddy G. V. P., 2011, Journal of Entomological and Acarological Research, V43, P111; Rhainds M, 2010, ENVIRON ENTOMOL, V39, P1794, DOI 10.1603/EN10164; Skabeikis DD., 2012, THESIS STATE U NEW Y; StatSoft Inc, 2010, STATISTICA DAT AN SO; Teale SA, 2011, J ECON ENTOMOL, V104, P1592, DOI 10.1603/EC11076; Van der Gaag DJ, 2008, PEST RISK ANAL ANOPL; Wickham JD, 2014, J ECON ENTOMOL, V107, P259, DOI 10.1603/EC13333; Wickham JD, 2012, INSECT SCI, V19, P355, DOI 10.1111/j.1744-7917.2012.01504.x; Yasui H, 2003, ENTOMOL EXP APPL, V107, P167, DOI 10.1046/j.1570-7458.2003.00053.x; Yasui H, 2007, TETRAHEDRON LETT, V48, P2395, DOI 10.1016/j.tetlet.2007.01.101; Zhang AJ, 2002, Z NATURFORSCH C, V57, P553	30	17	22	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134358	10.1371/journal.pone.0134358	http://dx.doi.org/10.1371/journal.pone.0134358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241651	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942700041
J	Thien, TDV; Zadra, A; Labelle, MA; Petit, D; Soucy, JP; Montplaisir, J				Thien Thanh Dang-Vu; Zadra, Antonio; Labelle, Marc-Antoine; Petit, Dominique; Soucy, Jean-Paul; Montplaisir, Jacques			Sleep Deprivation Reveals Altered Brain Perfusion Patterns in Somnambulism	PLOS ONE			English	Article							SLOW-WAVE ACTIVITY; CEREBRAL-CORTEX; SLEEPWALKING; TERRORS; PET	Background Despite its high prevalence, relatively little is known about the pathophysiology of somnambulism. Increasing evidence indicates that somnambulism is associated with functional abnormalities during wakefulness and that sleep deprivation constitutes an important drive that facilitates sleepwalking in predisposed patients. Here, we studied the neural mechanisms associated with somnambulism using Single Photon Emission Computed Tomography (SPECT) with Tc-99m-Ethylene Cysteinate Dimer (ECD), during wakefulness and after sleep deprivation. Methods Ten adult sleepwalkers and twelve controls with normal sleep were scanned using Tc-99m-ECD SPECT in morning wakefulness after a full night of sleep. Eight of the sleepwalkers and nine of the controls were also scanned during wakefulness after a night of total sleep deprivation. Between-group comparisons of regional cerebral blood flow (rCBF) were performed to characterize brain activity patterns during wakefulness in sleepwalkers. Results During wakefulness following a night of total sleep deprivation, rCBF was decreased bilaterally in the inferior temporal gyrus in sleepwalkers compared to controls. Conclusions Functional neural abnormalities can be observed during wakefulness in somnambulism, particularly after sleep deprivation and in the inferior temporal cortex. Sleep deprivation thus not only facilitates the occurrence of sleepwalking episodes, but also uncovers patterns of neural dysfunction that characterize sleepwalkers during wakefulness.	[Thien Thanh Dang-Vu; Zadra, Antonio; Petit, Dominique; Montplaisir, Jacques] Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada; [Thien Thanh Dang-Vu] Concordia Univ, Ctr Studies Behav Neurobiol, PERFORM Ctr, Montreal, PQ H3G 1M8, Canada; [Thien Thanh Dang-Vu] Concordia Univ, Dept Exercise Sci, Montreal, PQ, Canada; [Thien Thanh Dang-Vu] Univ Montreal, Ctr Rech, Inst Univ Geriatrie Montreal, Montreal, PQ, Canada; [Thien Thanh Dang-Vu] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada; [Zadra, Antonio; Labelle, Marc-Antoine] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Soucy, Jean-Paul] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Soucy, Jean-Paul] Ctr Hosp Univ Montreal, Dept Nucl Med, Montreal, PQ, Canada; [Montplaisir, Jacques] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Montplaisir, Jacques] Univ Montreal, Canada Res Chair Sleep Med, Montreal, PQ, Canada	Universite de Montreal; Concordia University - Canada; Concordia University - Canada; Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal	Zadra, A (corresponding author), Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada.	antonio.zadra@umontreal.ca; jy.montplaisir@umontreal.ca		Dang Vu, Thien Thanh/0000-0002-7235-2721	Canadian Institutes of Health Research (CIHR) [MOP 97865]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (CIHR grant # MOP 97865). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AASM, 2005, INT CLASS SLEEP DIS; Bassetti C, 2000, LANCET, V356, P484, DOI 10.1016/S0140-6736(00)02561-7; Bell-McGinty S, 2004, CEREB CORTEX, V14, P496, DOI 10.1093/cercor/bhh011; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; BROUGHTON R, 1994, SLEEP, V17, P253; Cistaro A, 2012, EUR J NUCL MED MOL I, V39, P251, DOI 10.1007/s00259-011-1979-6; Dang-Vu TT, 2007, SLEEP MED, V8, P349, DOI 10.1016/j.sleep.2007.03.006; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; Desautels A, 2013, SLEEP MED, V14, P1187, DOI 10.1016/j.sleep.2013.04.029; Espa F, 2000, CLIN NEUROPHYSIOL, V111, P929, DOI 10.1016/S1388-2457(00)00249-2; Jaar O, 2010, SLEEP, V33, P1511, DOI 10.1093/sleep/33.11.1511; Joo EY, 2005, NEUROIMAGE, V28, P410, DOI 10.1016/j.neuroimage.2005.06.019; KAVEY NB, 1993, PSYCHOSOMATICS, V34, P86, DOI 10.1016/S0033-3182(93)71932-5; Labelle MA, 2015, J SLEEP RES IN PRESS; Mazza S, 2006, NEUROLOGY, V67, P1618, DOI 10.1212/01.wnl.0000242879.39415.49; Montplaisir J, 2011, J CLIN SLEEP MED, V7, P219; Ohayon MM, 1999, J CLIN PSYCHIAT, V60, P268, DOI 10.4088/JCP.v60n0413; Oliviero A, 2007, J NEUROL, V254, P1066, DOI 10.1007/s00415-006-0489-0; Oudiette D, 2009, SLEEP, V32, P1621, DOI 10.1093/sleep/32.12.1621; Zadra A, 2004, J SLEEP RES, V13, P279, DOI 10.1111/j.1365-2869.2004.00404.x; Zadra A, 2008, ANN NEUROL, V63, P513, DOI 10.1002/ana.21339; Zadra A, 2013, LANCET NEUROL, V12, P285, DOI 10.1016/S1474-4422(12)70322-8	22	15	15	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133474	10.1371/journal.pone.0133474	http://dx.doi.org/10.1371/journal.pone.0133474			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241047	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700014
J	Haurogne, K; Pavlovic, M; Rogniaux, H; Bach, JM; Lieubeau, B				Haurogne, Karine; Pavlovic, Marija; Rogniaux, Helene; Bach, Jean-Marie; Lieubeau, Blandine			Type 1 Diabetes Prone NOD Mice Have Diminished Cxcr1 mRNA Expression in Polymorphonuclear Neutrophils and CD4+T Lymphocytes	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR1; IL-8 RECEPTOR; INTERLEUKIN-8 RECEPTORS; T-CELLS; DEFICIENCY; PROTEIN; LOCI; BETA; PYELONEPHRITIS; SUSCEPTIBILITY	In humans, CXCR1 and CXCR2 are two homologous proteins that bind ELR+ chemokines. Both receptors play fundamental roles in neutrophil functions such as migration and reactive oxygen species production. Mouse Cxcr1 and Cxcr2 genes are located in an insulin-dependent diabetes genetic susceptibility locus. The non obese diabetic (NOD) mouse is a spontaneous well-described animal model for insulin-dependent type 1 diabetes. In this disease, insulin deficiency results from the destruction of insulin-producing beta cells by auto-reactive T lymphocytes. This slow-progressing disease is dependent on both environmental and genetic factors. Here, we report descriptive data about the Cxcr1 gene in NOD mice. We demonstrate decreased expression of mRNA for Cxcr1 in neutrophils and CD4+ lymphocytes isolated from NOD mice compared to other strains, related to reduced NOD Cxcr1 gene promoter activity. Looking for Cxcr1 protein, we next analyze the membrane proteome of murine neutrophils by mass spectrometry. Although Cxcr2 protein is clearly found in murine neutrophils, we did not find evidence of Cxcr1 peptides using this method. Nevertheless, in view of recently-published experimental data obtained in NOD mice, we argue for possible Cxcr1 involvement in type 1 diabetes pathogenesis.	[Haurogne, Karine; Bach, Jean-Marie; Lieubeau, Blandine] INRA, USC1383, IECM, F-44026 Nantes, France; [Haurogne, Karine; Bach, Jean-Marie; Lieubeau, Blandine] LUNAM Univ, EA4644, Oniris, Nantes, France; [Pavlovic, Marija; Rogniaux, Helene] INRA, UR1268, BIA, BIBS, F-44026 Nantes, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE	Lieubeau, B (corresponding author), INRA, USC1383, IECM, F-44026 Nantes, France.	blandine.lieubeau@oniris-nantes.fr	Bach, Jean-Marie/AAR-1086-2020	Bach, Jean-Marie/0000-0002-5265-8854; Lieubeau, Blandine/0000-0002-1434-1506				Al-Alwan LA, 2013, J IMMUNOL, V191, P2731, DOI 10.4049/jimmunol.1203421; Alyanakian MA, 2006, DIABETES, V55, P179, DOI 10.2337/diabetes.55.1.179; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; [Anonymous], 2009, Q810W6 CXCR1 MOUSE; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Barlic J, 2000, NAT IMMUNOL, V1, P227, DOI 10.1038/79767; Bates RC, 2004, EXP CELL RES, V299, P315, DOI 10.1016/j.yexcr.2004.05.033; Beech JS, 2007, J NEUROIMMUNOL, V184, P198, DOI 10.1016/j.jneuroim.2006.12.015; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bishayi B, 2015, INFLAMMATION, V38, P812, DOI 10.1007/s10753-014-9991-1; Bleijerved OB, 2012, J PROTEOME RES, V11, P5235, DOI 10.1021/pr3004375; Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497; Carlson T, 2008, J EXP MED, V205, P811, DOI 10.1084/jem.20072404; CHUNTHARAPAI A, 1995, J IMMUNOL, V155, P2587; Citro A, 2015, DIABETES, V64, P1329, DOI 10.2337/db14-0443; Clarke C, 2011, HEPATOLOGY, V53, P261, DOI 10.1002/hep.24028; Cooke A, 2004, TRENDS PARASITOL, V20, P316, DOI 10.1016/j.pt.2004.04.010; Diana J, 2014, EMBO MOL MED, V6, P1090, DOI 10.15252/emmm.201404144; Diana J, 2013, NAT MED, V19, P65, DOI 10.1038/nm.3042; Eikawa S, 2010, J IMMUNOL, V185, P6734, DOI 10.4049/jimmunol.1000225; Fan XD, 2007, J BIOL CHEM, V282, P11658, DOI 10.1074/jbc.M607705200; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Frendeus B, 2000, J EXP MED, V192, P881, DOI 10.1084/jem.192.6.881; Fu WX, 2005, CYTOKINE, V31, P9, DOI 10.1016/j.cyto.2005.02.005; Godaly G, 2000, J IMMUNOL, V165, P5287, DOI 10.4049/jimmunol.165.9.5287; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; Hill NJ, 2000, DIABETES, V49, P1744, DOI 10.2337/diabetes.49.10.1744; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Hosking MP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000648; Hulbert EM, 2007, NUCLEIC ACIDS RES, V35, P6338, DOI 10.1093/nar/gkm715; Jacobs JP, 2010, ARTHRITIS RHEUM-US, V62, P1921, DOI 10.1002/art.27470; Jethwaney D, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-12; Jones SA, 1996, P NATL ACAD SCI USA, V93, P6682, DOI 10.1073/pnas.93.13.6682; Kivity S, 2009, TRENDS IMMUNOL, V30, P409, DOI 10.1016/j.it.2009.05.005; LEE J, 1995, J IMMUNOL, V155, P2158; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Lin XT, 2013, J IMMUNOL, V190, P3109, DOI 10.4049/jimmunol.1203422; Liu LP, 2013, GENESIS, V51, P587, DOI 10.1002/dvg.22401; Lominadze G, 2005, MOL CELL PROTEOMICS, V4, P1503, DOI 10.1074/mcp.M500143-MCP200; Ludwig A, 1997, BLOOD, V90, P4588; Lundstedt AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000825; MALO D, 1994, GENOMICS, V23, P51, DOI 10.1006/geno.1994.1458; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Michel MC, 2009, N-S ARCH PHARMACOL, V379, P385, DOI 10.1007/s00210-009-0395-y; Moepps B, 2006, MOL IMMUNOL, V43, P897, DOI 10.1016/j.molimm.2005.06.043; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; PROCHAZKA M, 1992, DIABETES, V41, P98, DOI 10.2337/diabetes.41.1.98; Raine C, 2007, J NEUROIMMUNOL, V186, P199, DOI 10.1016/j.jneuroim.2007.03.018; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Russo RC, 2014, EXPERT REV CLIN IMMU, V10, P593, DOI 10.1586/1744666X.2014.894886; SERREZE DV, 1994, J EXP MED, V180, P1553, DOI 10.1084/jem.180.4.1553; SPRENGER H, 1994, J IMMUNOL, V153, P2524; Steen A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00277; Stemmler S, 2005, GENES IMMUN, V6, P225, DOI 10.1038/sj.gene.6364181; Stillie R, 2009, J LEUKOCYTE BIOL, V86, P529, DOI 10.1189/jlb.0208125; Sturm A, 2005, CYTOKINE, V29, P42, DOI 10.1016/j.cyto.2004.09.007; Svensson M, 2011, KIDNEY INT, V80, P1064, DOI 10.1038/ki.2011.257; Takata H, 2004, J IMMUNOL, V173, P2231, DOI 10.4049/jimmunol.173.4.2231; Takata H, 2012, BLOOD, V119, P1390, DOI 10.1182/blood-2011-03-343251; Tateda K, 2001, INFECT IMMUN, V69, P2017, DOI 10.1128/IAI.69.4.2017-2024.2001; Tomazella GG, 2010, J PROTEOME RES, V9, P2030, DOI 10.1021/pr1000253; Tomazella GG, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-32; Tsai WC, 2000, INFECT IMMUN, V68, P4289, DOI 10.1128/IAI.68.7.4289-4296.2000; Uriarte SM, 2008, J IMMUNOL, V180, P5575, DOI 10.4049/jimmunol.180.8.5575; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wicker LS, 2004, J IMMUNOL, V173, P164, DOI 10.4049/jimmunol.173.1.164; Wilkinson NC, 1999, J BIOL CHEM, V274, P438, DOI 10.1074/jbc.274.1.438; Williams EJ, 2000, J PATHOL, V192, P533; Zaccone P, 2011, SEMIN IMMUNOL, V23, P122, DOI 10.1016/j.smim.2011.01.013; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	72	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134365	10.1371/journal.pone.0134365	http://dx.doi.org/10.1371/journal.pone.0134365			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230114	gold, Green Submitted, Green Published			2022-12-27	WOS:000358838400109
J	Zhang, XB; Du, YP; Wang, LH; Zhou, Q; Huang, XH; Sun, ZG				Zhang, Xuanbo; Du, Yuping; Wang, Lihong; Zhou, Qing; Huang, Xiaohua; Sun, Zhaoguo			Combined Effects of Lanthanum (III) and Acid Rain on Antioxidant Enzyme System in Soybean Roots	PLOS ONE			English	Article							RARE-EARTH-ELEMENTS; ULTRAVIOLET-B RADIATION; STORED POTATO-TUBERS; LIPID-PEROXIDATION; SUPEROXIDE-DISMUTASE; SEED-GERMINATION; OXIDATIVE STRESS; SEEDLINGS; RESPONSES; GROWTH	Rare earth element pollution (REEs) and acid rain (AR) pollution simultaneously occur in many regions, which resulted in a new environmental issue, the combined pollution of REEs and AR. The effects of the combined pollution on the antioxidant enzyme system of plant roots have not been reported. Here, the combined effects of lanthanum ion (La3+), one type of REE, and AR on the antioxidant enzyme system of soybean roots were investigated. In the combined treatment of La3+ (0.08 mM) and AR, the cell membrane permeability and the peroxidation of cell membrane lipid of soybean roots increased, and the superoxide dismutase, catalase, peroxidase and reduced ascorbic acid served as scavengers of reactive oxygen species. In other combined treatments of La3+ (0.40 mM, 1.20 mM) and AR, the membrane permeability, malonyldialdehyde content, superoxide dismutase activity, peroxidase activity and reduced ascorbic acid content increased, while the catalase activity decreased. The increased superoxide dismutase activity, peroxidase activity and reduced ascorbic acid content were inadequate to scavenge the excess hydrogen peroxide and superoxide, leading to the damage of the cell membrane, which was aggravated with the increase in the concentration of La3+ and the level of AR. The deleterious effects of the combined treatment of La3+ and AR were stronger than those of the single treatment of La3+ or AR. Moreover, the activity of antioxidant enzyme system in the combined treatment group was affected directly and indirectly by mineral element content in soybean plants.	[Zhang, Xuanbo; Du, Yuping; Wang, Lihong; Zhou, Qing; Sun, Zhaoguo] Jiangnan Univ, Jiangsu Coorperat Innovat Ctr Water Treatment Tec, State Key Lab Food Sci & Technol, Environm & Civil Engn, Wuxi, Jiangsu, Peoples R China; [Huang, Xiaohua] Nanjing Normal Univ, Coll Chem & Mat Sci, Jiangsu Key Lab Biomed Mat, Jiangsu Collaborat Innovat Ctr Biomed Funct Mat, Nanjing, Jiangsu, Peoples R China	Jiangnan University; Nanjing Normal University	Zhou, Q (corresponding author), Jiangnan Univ, Jiangsu Coorperat Innovat Ctr Water Treatment Tec, State Key Lab Food Sci & Technol, Environm & Civil Engn, Wuxi, Jiangsu, Peoples R China.	qingzhou510@yahoo.com; huangxiaohuanjnu@yahoo.com		Huang, Xiaohua/0000-0003-4150-0477	Natural Science Foundation of China [31170477]; Jiangsu Province [BK2011160]; Research and Innovation Project for Postgraduate of Higher Education Institutions of Jiangsu Province [CXZZ12 0760]; Fundamental Research Funds for the Central Universities [JUDCF 12024]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province; Research and Innovation Project for Postgraduate of Higher Education Institutions of Jiangsu Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported through the Natural Science Foundation of China (31170477), Jiangsu Province (BK2011160), the Research and Innovation Project for Postgraduate of Higher Education Institutions of Jiangsu Province (CXZZ12 0760) and the Fundamental Research Funds for the Central Universities (JUDCF12024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEERS RF, 1952, J BIOL CHEM, V195, P133; Benedet JA, 2008, FOOD CHEM, V107, P165, DOI 10.1016/j.foodchem.2007.07.076; Bernard E, 2015, ECOTOX ENVIRON SAFE, V114, P273, DOI 10.1016/j.ecoenv.2014.04.024; CAMPBELL WJ, 1990, J EXP BOT, V41, P427, DOI 10.1093/jxb/41.4.427; Chen J, 2013, PLANT PHYSIOL BIOCH, V64, P41, DOI 10.1016/j.plaphy.2012.12.012; d'Aquino L, 2009, CHEMOSPHERE, V75, P900, DOI 10.1016/j.chemosphere.2009.01.026; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; Garg N, 2009, PLANT BIOSYST, V143, P81, DOI 10.1080/11263500802633626; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gu ZM, 2001, CHEMOSPHERE, V44, P545, DOI 10.1016/S0045-6535(00)00484-7; HAMMERSCHMIDT R, 1982, PHYSIOL PLANT PATHOL, V20, P73, DOI 10.1016/0048-4059(82)90025-X; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hong FS, 2003, BIOL TRACE ELEM RES, V94, P273, DOI 10.1385/BTER:94:3:273; Hu ZY, 2006, COMMUN SOIL SCI PLAN, V37, P1381, DOI 10.1080/00103620600628680; Hu ZY, 2004, J PLANT NUTR, V27, P183, DOI 10.1081/PLN-120027555; Huang GR, 2013, BIOL TRACE ELEM RES, V151, P105, DOI 10.1007/s12011-012-9528-0; Huang XH, 2006, J RARE EARTH, V24, P248, DOI 10.1016/S1002-0721(06)60103-8; Ippolito MP, 2011, PLANT BIOSYST, V145, P248, DOI 10.1080/11263504.2010.509937; Ippolito MP, 2010, ARCH ENVIRON CON TOX, V58, P42, DOI 10.1007/s00244-009-9340-9; Kobayashi Y, 2007, FUNCT PLANT BIOL, V34, P984, DOI 10.1071/FP07133; [孔然 Kong Ran], 2012, [城市环境与城市生态, Urban Environment and Urban Ecology], V25, P22; Koricheva J, 1997, ENVIRON POLLUT, V95, P249, DOI 10.1016/S0269-7491(96)00071-1; Kovacik J, 2011, ECOTOXICOLOGY, V20, P348, DOI 10.1007/s10646-010-0585-x; KUMAR GNM, 1993, PLANT PHYSIOL, V102, P115, DOI 10.1104/pp.102.1.115; Liu DW, 2012, ENVIRON SCI POLLUT R, V19, P3282, DOI 10.1007/s11356-012-0844-x; Maeda H, 2008, PLANT CELL, V20, P452, DOI 10.1105/tpc.107.054718; Noto LL, 2013, J LUMIN, V140, P14, DOI 10.1016/j.jlumin.2013.02.051; Olmos E, 1996, PLANT SCI, V120, P37, DOI 10.1016/S0168-9452(96)04483-4; Pang X, 2002, CHEMOSPHERE, V47, P1033, DOI 10.1016/S0045-6535(02)00022-X; Peng Q, 2009, BIOL TRACE ELEM RES, V127, P69, DOI 10.1007/s12011-008-8218-4; Rodewald UC, 2007, J SOLID STATE CHEM, V180, P1720, DOI 10.1016/j.jssc.2007.03.007; SHAW RH, 1967, AGRON J, V59, P155, DOI 10.2134/agronj1967.00021962005900020009x; Shi P, 2005, RUSS J PLANT PHYSL+, V52, P294, DOI 10.1007/s11183-005-0044-3; Shi SY, 2005, NITRIC OXIDE-BIOL CH, V13, P1, DOI 10.1016/j.niox.2005.04.006; Singh A, 2008, J ENVIRON BIOL, V29, P15; Smirnoff N, 2005, BIOL SCI SER, P1, DOI 10.1002/9780470988565; SPYCHALLA JP, 1990, PLANT PHYSIOL, V94, P1207, DOI 10.1104/pp.94.3.1207; SPYCHALLA JP, 1990, PLANT PHYSIOL, V94, P1214, DOI 10.1104/pp.94.3.1214; Sulaiman SF, 2011, J FOOD COMPOS ANAL, V24, P1, DOI 10.1016/j.jfca.2010.04.005; Sun ZG, 2013, CHEMOSPHERE, V93, P344, DOI 10.1016/j.chemosphere.2013.04.089; Sun ZG, 2012, ECOTOX ENVIRON SAFE, V79, P62, DOI 10.1016/j.ecoenv.2011.12.004; Tyler G, 2004, PLANT SOIL, V267, P191, DOI 10.1007/s11104-005-4888-2; Wang LH, 2008, CHEMOSPHERE, V73, P314, DOI 10.1016/j.chemosphere.2008.06.004; Wang LH, 2009, BIOL TRACE ELEM RES, V128, P82, DOI 10.1007/s12011-008-8250-4; Wang XQ, 2013, TREES-STRUCT FUNCT, V27, P297, DOI 10.1007/s00468-012-0799-z; Wei ZG, 2001, ENVIRON POLLUT, V114, P345, DOI 10.1016/S0269-7491(00)00240-2; Wen KJ, 2011, CHEMOSPHERE, V84, P601, DOI 10.1016/j.chemosphere.2011.03.054; Wen XJ, 2013, ENVIRON EARTH SCI, V69, P843, DOI 10.1007/s12665-012-1969-4; Wyrwicka A, 2006, ENVIRON EXP BOT, V56, P198, DOI 10.1016/j.envexpbot.2005.02.003; Xie S.Y., 2012, ENV MONITOR FOREWARN, V4, P33; Xu QM, 2011, ECOTOX ENVIRON SAFE, V74, P1693, DOI 10.1016/j.ecoenv.2011.04.005; Yao D, 2013, INT J METALCAST, V7, P49, DOI 10.1007/BF03355544; Yu JQ, 2002, PHOTOSYNTHETICA, V40, P331, DOI 10.1023/A:1022658504882; Zheng HL, 2000, BIOMETALS, V13, P157, DOI 10.1023/A:1009232821175	54	14	16	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134546	10.1371/journal.pone.0134546	http://dx.doi.org/10.1371/journal.pone.0134546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230263	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400132
J	Benhalevy, D; Bochkareva, ES; Biran, I; Bibi, E				Benhalevy, Daniel; Bochkareva, Elena S.; Biran, Ido; Bibi, Eitan			Model Uracil-Rich RNAs and Membrane Protein mRNAs Interact Specifically with Cold Shock Proteins in Escherichia coli	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; CSPA FAMILY; GENE; EXPRESSION; PHASE	Are integral membrane protein-encoding mRNAs (MPRs) different from other mRNAs such as those encoding cytosolic mRNAs (CPRs)? This is implied from the emerging concept that MPRs are specifically recognized and delivered to membrane-bound ribosomes in a translation-independent manner. MPRs might be recognized through uracil-rich segments that encode hydrophobic transmembrane helices. To investigate this hypothesis, we designed DNA sequences encoding model untranslatable transcripts that mimic MPRs or CPRs. By utilizing in vitro-synthesized biotinylated RNAs mixed with Escherichia coli extracts, we identified a highly specific interaction that takes place between transcripts that mimic MPRs and the cold shock proteins CspE and CspC, which are normally expressed under physiological conditions. Co-purification studies with E. coli expressing 6His-tagged CspE or CspC confirmed that the specific interaction occurs in vivo not only with the model uracil-rich untranslatable transcripts but also with endogenous MPRs. Our results suggest that the evolutionarily conserved cold shock proteins may have a role, possibly as promiscuous chaperons, in the biogenesis of MPRs.	[Benhalevy, Daniel; Bochkareva, Elena S.; Biran, Ido; Bibi, Eitan] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Bibi, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	e.bibi@weizmann.ac.il	Benhalevy, Daniel/AGG-5321-2022	Benhalevy, Daniel/0000-0001-6998-1933; Bibi, Eitan/0000-0003-3700-2707	Israel Science Foundation First Award; Minerva Foundation; Federal German Ministry for Education and Research	Israel Science Foundation First Award; Minerva Foundation; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Israel Science Foundation First Award and by the Minerva Foundation with funding from the Federal German Ministry for Education and Research. E.B. holds the Jerome A., Freda, and Edward M. Siegel professorial Chair.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bae WH, 1999, MOL MICROBIOL, V31, P1429, DOI 10.1046/j.1365-2958.1999.01284.x; Bibi E, 2012, TRENDS BIOCHEM SCI, V37, P1, DOI 10.1016/j.tibs.2011.09.004; Bibi E, 2011, BBA-BIOMEMBRANES, V1808, P841, DOI 10.1016/j.bbamem.2010.07.025; Brandi A, 1999, EMBO J, V18, P1653, DOI 10.1093/emboj/18.6.1653; Cui XYA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001336; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gerst JE, 2008, TRENDS CELL BIOL, V18, P68, DOI 10.1016/j.tcb.2007.11.005; GOLDSTEIN J, 1990, P NATL ACAD SCI USA, V87, P283, DOI 10.1073/pnas.87.1.283; Herskovits AA, 2000, MOL MICROBIOL, V38, P927, DOI 10.1046/j.1365-2958.2000.02198.x; Horn G, 2007, CELL MOL LIFE SCI, V64, P1457, DOI 10.1007/s00018-007-6388-4; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jagannathan S, 2014, J BIOL CHEM, V289, P25907, DOI 10.1074/jbc.M114.580688; Jiang WN, 1997, J BIOL CHEM, V272, P196; Jiang WN, 1996, J BACTERIOL, V178, P4919, DOI 10.1128/jb.178.16.4919-4925.1996; JONES PG, 1987, J BACTERIOL, V169, P2092, DOI 10.1128/jb.169.5.2092-2095.1987; JONES PG, 1994, MOL MICROBIOL, V11, P811, DOI 10.1111/j.1365-2958.1994.tb00359.x; Kraut-Cohen J, 2010, TRENDS BIOCH SCI; Kraut-Cohen J, 2013, MOL BIOL CELL, V24, P3069, DOI 10.1091/mbc.E13-01-0038; Lenz G, 2014, J MOL BIOL, V426, P460, DOI 10.1016/j.jmb.2013.10.018; Lipfert J, 2014, ANNU REV BIOCHEM, V83, P813, DOI 10.1146/annurev-biochem-060409-092720; Loya A, 2008, RNA, V14, P1352, DOI 10.1261/rna.867208; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mellin JR, 2014, SCIENCE, V345, P940, DOI 10.1126/science.1255083; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Pesole G, 2001, GENE, V276, P73, DOI 10.1016/S0378-1119(01)00674-6; Phadtare S, 2004, J BACTERIOL, V186, P7007, DOI 10.1128/JB.186.20.7007-7014.2004; Phadtare S, 1999, MOL MICROBIOL, V33, P1004, DOI 10.1046/j.1365-2958.1999.01541.x; Prilusky J, 2009, P NATL ACAD SCI USA, V106, P6662, DOI 10.1073/pnas.0902029106; Pyhtila B, 2008, RNA, V14, P445, DOI 10.1261/rna.721108; Rath D, 2006, J BACTERIOL, V188, P6780, DOI 10.1128/JB.00471-06; Rey S, 2005, NUCLEIC ACIDS RES, V33, pD164, DOI 10.1093/nar/gki027; Serganov A, 2008, CURR OPIN STRUC BIOL, V18, P120, DOI 10.1016/j.sbi.2007.12.006; Shenhar Y, 2012, ENV MICROBIOL REP, V4, P532, DOI 10.1111/j.1758-2229.2012.00358.x; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; TABOR S, 1990, J BIOL CHEM, V265, P8322; Uppal S, 2008, FEMS MICROBIOL LETT, V279, P83, DOI 10.1111/j.1574-6968.2007.01009.x; Xia B, 2002, J BIOL CHEM, V277, P6005, DOI 10.1074/jbc.M109700200; Yamanaka K, 1997, J BACTERIOL, V179, P5126, DOI 10.1128/jb.179.16.5126-5130.1997; Yamanaka K, 2001, MOL MICROBIOL, V39, P1572, DOI 10.1046/j.1365-2958.2001.02345.x; Yosef I, 2010, MBIO, V1, DOI 10.1128/mBio.00020-10; Yosef I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009130	45	13	13	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134413	10.1371/journal.pone.0134413	http://dx.doi.org/10.1371/journal.pone.0134413			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225847	gold, Green Submitted, Green Published			2022-12-27	WOS:000358837700091
J	Covington, MF; Sherman, S; Lewis, D; Lei, H; Krupinski, E; Kuo, PH				Covington, Matthew F.; Sherman, Scott; Lewis, Denise; Lei, Hong; Krupinski, Elizabeth; Kuo, Phillip H.			Patient Survey on Satisfaction and Impact of 123I-Ioflupane Dopamine Transporter Imaging	PLOS ONE			English	Article							PARKINSONS-DISEASE; CLINICAL-DIAGNOSIS; I-123-FP-CIT SPECT; COST-EFFECTIVENESS; FOLLOW-UP; I-123-IOFLUPANE; MANAGEMENT	Patients were surveyed to assess the impact of dopamine transporter imaging on diagnostic confidence, change in treatment plan, effect on medication compliance, and subjective well-being. Surveys were sent to 140 patients who completed dopamine transporter imaging an average of 18 months prior. Sixty-five surveys from patients (46%) were returned. Questions assessed patients' perceived impact of the imaging on their care. Increased diagnostic confidence following imaging was reported by 69% of patients. Changes to treatment plan from imaging were reported by 24% of patients. Overall satisfaction with the study and its impact was reported by 70% of patients. Dopamine transporter imaging increased diagnostic confidence among patients and overall patient satisfaction with the impact of imaging on clinical care was high.	[Covington, Matthew F.; Lewis, Denise; Krupinski, Elizabeth] Univ Arizona, Coll Med, Dept Med Imaging, Tucson, AZ USA; [Sherman, Scott; Lei, Hong] Univ Arizona, Coll Med, Dept Neurol, Tucson, AZ USA; [Kuo, Phillip H.] Univ Arizona, Coll Med, Dept Med Imaging Med & Biomed Engn, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; University of Arizona	Kuo, PH (corresponding author), Univ Arizona, Coll Med, Dept Med Imaging Med & Biomed Engn, Tucson, AZ 85721 USA.	pkuo@radiology.arizona.edu			General Electric Healthcare	General Electric Healthcare(General ElectricGE Healthcare)	Funding for this project was received from General Electric Healthcare. The funder provided support in the form of salaries for authors [PHK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Antonini A, 2008, MOVEMENT DISORD, V23, P2202, DOI 10.1002/mds.22278; Bega D, 2015, NEURODEGENER DIS, V15, P81, DOI 10.1159/000370116; Booij J, 2001, EUR J NUCL MED, V28, P266, DOI 10.1007/s002590000460; Catafau AM, 2004, MOVEMENT DISORD, V19, P1175, DOI 10.1002/mds.20112; Dodel RC, 2003, MOVEMENT DISORD, V18, pS52, DOI 10.1002/mds.10580; Hauser RA, 2012, J NEUROIMAGING, V22, P225, DOI 10.1111/j.1552-6569.2011.00583.x; Isaias IU, 2010, MOVEMENT DISORD, V25, P679, DOI 10.1002/mds.22870; Kuo PH, 2013, J NUCL MED TECHNOL, V41, P26, DOI 10.2967/jnmt.112.114827; Kupsch A, 2013, NEURODEGENER DIS, V11, P22, DOI 10.1159/000337351; Kupsch AR, 2012, J NEUROL NEUROSUR PS, V83, P620, DOI 10.1136/jnnp-2011-301695; Marshall VL, 2009, MOVEMENT DISORD, V24, P500, DOI 10.1002/mds.22108; Schrag A, 2002, J NEUROL NEUROSUR PS, V73, P529, DOI 10.1136/jnnp.73.5.529; Seifert Kimberly D, 2013, Am J Neurodegener Dis, V2, P29; Tolosa E, 2007, MOVEMENT DISORD, V22, P2346, DOI 10.1002/mds.21710; Van Laere K, 2008, EUR J NUCL MED MOL I, V35, P1367, DOI 10.1007/s00259-008-0777-2; Vlaar AM, 2007, BMC NEURO, V1, P7; Vlaar AMM, 2008, EUR NEUROL, V59, P258, DOI 10.1159/000115640	17	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134457	10.1371/journal.pone.0134457	http://dx.doi.org/10.1371/journal.pone.0134457			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226362	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700095
J	Hargreaves, SK; Williams, RJ; Hofmockel, KS				Hargreaves, Sarah K.; Williams, Ryan J.; Hofmockel, Kirsten S.			Environmental Filtering of Microbial Communities in Agricultural Soil Shifts with Crop Growth	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; RHIZOSPHERE MICROBIOME; NITROGEN DEPOSITION; ENZYME-ACTIVITY; DIVERSITY; FERTILIZATION; PRODUCTIVITY; BIOGEOGRAPHY; ECOSYSTEMS; LINKAGES	Plant and soil properties cooperatively structure soil microbial communities, with implications for ecosystem functioning. However, the extent to which each factor contributes to community structuring is not fully understood. To quantify the influence of plants and soil properties on microbial diversity and composition in an agricultural context, we conducted an experiment within a corn-based annual cropping system and a perennial switchgrass cropping system across three topographic positions. We sequenced barcoded 16S ribosomal RNA genes from whole soil three times throughout a single growing season and across two years in July. To target the belowground effects of plants, we also sampled rhizosphere soil in July. We hypothesized that microbial community alpha-diversity and composition (beta-diversity) would be more sensitive to cropping system effects (annual vs. perennial inputs) than edaphic differences among topographic positions, with greater differences occurring in the rhizosphere compared to whole soil. We found that microbial community composition consistently varied with topographic position, and cropping system and the rhizosphere influenced alpha-diversity. In July, cropping system and rhizosphere structured a small but specific group of microbes implying a subset of microbial taxa, rather than broad shifts in community composition, may explain previously observed differences in resource cycling between treatments. Using rank abundance analysis, we detected enrichment of Saprospirales and Actinomycetales, including cellulose and chitin degraders, in the rhizosphere soil and enrichment of Nitrospirales, Syntrophobacterales, and MND1 in the whole soil. Overall, these findings support environmental filtering for the soil microbial community first by soil and second by the rhizosphere. Across cropping systems, plants selected for a general rhizosphere community with evidence for plant-specific effects related to time of sampling.	[Hargreaves, Sarah K.; Williams, Ryan J.; Hofmockel, Kirsten S.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA	Iowa State University	Hofmockel, KS (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	khof@iastate.edu		Hofmockel, Kirsten/0000-0003-1586-2167	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2010-85101-20471]; National Science Foundation Doctoral Dissertation Improve Grant [DEB-1210742]	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; National Science Foundation Doctoral Dissertation Improve Grant	Funding for this research was provided by the Agriculture and Food Research Initiative Competitive Grant No. 2010-85101-20471 from the USDA National Institute of Food and Agriculture (http://www.nifa.usda.gov/) to KSH and a National Science Foundation (http://www.nsf.gov/) Doctoral Dissertation Improve Grant (DEB-1210742) to SKH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson-Teixeira K. J., 2013, Ecosystems, V16, P508, DOI 10.1007/s10021-012-9628-x; Aronesty E., 2013, OPEN BIOINFORMATICS; Bell CW, 2015, SOIL BIOL BIOCHEM, V85, P170, DOI 10.1016/j.soilbio.2015.03.006; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Buckley DH, 2001, MICROB ECOL, V42, P11, DOI 10.1007/s002480000108; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaparro JM, 2014, ISME J, V8, P790, DOI 10.1038/ismej.2013.196; Chaparro JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055731; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; de Vries FT, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00265; de Vries FT, 2012, FRONT ECOL ENVIRON, V10, P425, DOI 10.1890/110162; DeAngelis KM, 2009, ISME J, V3, P168, DOI 10.1038/ismej.2008.103; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Enwall K, 2007, SOIL BIOL BIOCHEM, V39, P106, DOI 10.1016/j.soilbio.2006.06.015; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Franco-Correa M, 2010, APPL SOIL ECOL, V45, P209, DOI 10.1016/j.apsoil.2010.04.007; Garbeva P, 2008, PLANT SOIL, V302, P19, DOI 10.1007/s11104-007-9432-0; Hargreaves SK, 2014, BIOGEOCHEMISTRY, V117, P67, DOI 10.1007/s10533-013-9893-6; Hogberg MN, 2007, OECOLOGIA, V150, P590, DOI 10.1007/s00442-006-0562-5; Houlden A, 2008, FEMS MICROBIOL ECOL, V65, P193, DOI 10.1111/j.1574-6941.2008.00535.x; Hurlbert AH, 2014, ECOL LETT, V17, P401, DOI 10.1111/ele.12240; Jangid K, 2011, SOIL BIOL BIOCHEM, V43, P2184, DOI 10.1016/j.soilbio.2011.06.022; King AJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1055; Kourtev PS, 2002, ECOLOGY, V83, P3152, DOI 10.1890/0012-9658(2002)083[3152:EPSATM]2.0.CO;2; Ladygina N, 2010, SOIL BIOL BIOCHEM, V42, P162, DOI 10.1016/j.soilbio.2009.10.009; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Mao YJ, 2013, ENVIRON MICROBIOL, V15, P928, DOI 10.1111/j.1462-2920.2012.02844.x; Mao YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024750; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Martinez A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00340; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Ofek M, 2014, ENVIRON MICROBIOL, V16, P2157, DOI 10.1111/1462-2920.12228; Ontl TA, 2013, NEW PHYTOL, V199, P727, DOI 10.1111/nph.12302; Palaniyandi SA, 2013, APPL MICROBIOL BIOT, V97, P9621, DOI 10.1007/s00253-013-5206-1; PARKIN TB, 1987, SOIL SCI SOC AM J, V51, P1194, DOI 10.2136/sssaj1987.03615995005100050019x; Paul EA., 2006, SOIL MICROBIOLOGY EC, V3rd; Philippot L, 2009, PLANT SOIL, V321, P61, DOI 10.1007/s11104-008-9796-9; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Rosenzweig N, 2013, CAN J MICROBIOL, V59, P494, DOI 10.1139/cjm-2012-0661; Salles JF, 2004, APPL ENVIRON MICROB, V70, P4012, DOI 10.1128/AEM.70.7.4012-4020.2004; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Somers E, 2004, CRIT REV MICROBIOL, V30, P205, DOI 10.1080/10408410490468786; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Team RC, LANG ENV STAT COMP; Tscherko D, 2004, SOIL BIOL BIOCHEM, V36, P1685, DOI 10.1016/j.soilbio.2004.07.004; Turner TR, 2013, ISME J, V7, P2248, DOI 10.1038/ismej.2013.119; Waldrop MP, 2004, SOIL BIOL BIOCHEM, V36, P1443, DOI 10.1016/j.soilbio.2004.04.023; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wei CZ, 2013, GLOBAL CHANGE BIOL, V19, P3688, DOI 10.1111/gcb.12348; Wessen E, 2011, ISME J, V5, P1213, DOI 10.1038/ismej.2010.206; Wilson DM, 2014, BIOENERG RES, V7, P885, DOI 10.1007/s12155-014-9409-9; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Zhao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085301; Zhao MX, 2014, ISME J, V8, P2045, DOI 10.1038/ismej.2014.46; Ziegler M, 2013, J MICROBIOL METH, V94, P30, DOI 10.1016/j.mimet.2013.04.003	60	45	45	3	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134345	10.1371/journal.pone.0134345	http://dx.doi.org/10.1371/journal.pone.0134345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226508	gold, Green Submitted, Green Published			2022-12-27	WOS:000358837700076
J	Kudo, N; Yokokawa, H; Fukuda, H; Sanada, H; Miwa, Y; Hisaoka, T; Isonuma, H				Kudo, Nagako; Yokokawa, Hirohide; Fukuda, Hiroshi; Sanada, Hironobu; Miwa, Yuichi; Hisaoka, Teruhiko; Isonuma, Hiroshi			Achievement of Target Blood Pressure Levels among Japanese Workers with Hypertension and Healthy Lifestyle Characteristics Associated with Therapeutic Failure	PLOS ONE			English	Article							BODY-MASS INDEX; PRIMARY-CARE PHYSICIANS; US ADULTS; ALCOHOL; SLEEP; HOME	Background Few studies have examined Japanese with regard to the achievement rates for target blood pressure levels, or the relationship between these rates and healthy lifestyle characteristics in patients with hypertension as defined by the newly established hypertension management guidelines (JSH2014). The aim of this study was to elucidate achievement rates and examine healthy lifestyle characteristics associated with achievement status among Japanese. Methods This cross-sectional study, conducted in January-December 2012, examined blood pressure control and healthy lifestyle characteristics in 8,001 Japanese workers with hypertension (mean age, 57.0 years; 78.8% were men) who participated in a workplace health checkup. Data were collected from workplace medical checkup records and participants' self-administered questionnaires. We divided into 5 groups [G1; young, middle-aged, and early-phase elderly patients (65-74 years old) without diabetes mellitus or chronic kidney disease (CKD) (< 140/90 mmHg), G2; late-phase elderly patients (>= 75 years old) without diabetes mellitus or CKD (< 150/90 mmHg), G3; diabetic patients (< 130/80 mmHg), G4; patients with CKD (< 130/80 mmHg), and G5; patients with cerebrovascular and/or coronary artery diseases (< 140/90 mmHg)] according to JSH2014. And then, achievement rates were calculated in each group. Multivariate analysis identified healthy lifestyle characteristics associated with "therapeutic failure" of target blood pressure. Results Target blood pressures were achieved by 60.2% of young, middle-aged, and early-phase elderly patients (G1), 71.4% of late-phase elderly patients (G2), 30.5% of diabetic patients (G3), 33.4% of those with chronic kidney disease (G4), and 66.0% of those with cerebrovascular and/or coronary artery diseases (G5). A body mass index of 18.5-24.9 and non-daily alcohol consumption were protective factors, and adequate sleep was found to contribute to therapeutic success. Discussion We found low achievement rates for treatment goals among patients with chronic kidney disease and diabetes mellitus. Maintaining an ideal body weight and adequate alcohol consumption may help with blood pressure control. Lifestyle modification may be necessary for better management of hypertension.	[Kudo, Nagako; Yokokawa, Hirohide; Fukuda, Hiroshi; Hisaoka, Teruhiko; Isonuma, Hiroshi] Juntendo Univ, Sch Med, Dept Gen Med, Tokyo 113, Japan; [Kudo, Nagako] Tokorozawa Med Clin, Tokorozawa, Saitama, Japan; [Sanada, Hironobu] Fukushima Welf Federat Agr Cooperat, Div Hlth Sci Res, Aizubange Town, Fukushima, Japan; [Sanada, Hironobu] Fukushima Med Univ, Sch Med, Dept Tumor & Host Biosci, Fukushima, Japan; [Miwa, Yuichi] Tokyo Hlth Serv Assoc, Dept Hlth Screening, Tokyo, Japan	Juntendo University; Fukushima Medical University	Yokokawa, H (corresponding author), Juntendo Univ, Sch Med, Dept Gen Med, Tokyo 113, Japan.	hyokoka@juntendo.ac.jp						[Anonymous], ATL HEART STROK RISK; [Anonymous], CARD DIS; Belloc N B, 1972, Prev Med, V1, P409, DOI 10.1016/0091-7435(72)90014-X; Chirinos JA, 2009, ARCH INTERN MED, V169, P580, DOI 10.1001/archinternmed.2008.611; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Droyvold WB, 2005, INT J OBESITY, V29, P650, DOI 10.1038/sj.ijo.0802944; Hobbs FDR, 2002, FAM PRACT, V19, P596, DOI 10.1093/fampra/19.6.596; Hyman DJ, 2000, ARCH INTERN MED, V160, P2281, DOI 10.1001/archinte.160.15.2281; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jee SH, 2001, AM J HEALTH PROMOT, V15, P244, DOI 10.4278/0890-1171-15.4.244; Johansson JK, 2011, J HYPERTENS, V29, P1897, DOI 10.1097/HJH.0b013e32834abccd; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; MARMOT MG, 1994, BRIT MED J, V308, P1263, DOI 10.1136/bmj.308.6939.1263; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Ministry of Health Labour and Welfare & Ministry of Education Culture Sports Science and Technology, 2013, ETH GUID EP STUD; Muntner P, 2007, CIRCULATION, V116, P39; Muntner P, 2010, AM J KIDNEY DIS, V55, P441, DOI 10.1053/j.ajkd.2009.09.014; Nakamura K, 2014, WORLD J CARDIOL, V6, P531, DOI 10.4330/wjc.v6.i7.531; Nakamura K, 2013, J HYPERTENS, V31, P1032, DOI 10.1097/HJH.0b013e32835f5747; Navar-Boggan AM, 2014, JAMA-J AM MED ASSOC, V311, P1424, DOI 10.1001/jama.2014.2531; Obara T, 2006, DIABETES RES CLIN PR, V73, P276, DOI 10.1016/j.diabres.2006.01.015; Ostchega Y, 2007, J AM GERIATR SOC, V55, P1056, DOI 10.1111/j.1532-5415.2007.01215.x; Sforza E, 2014, J CLIN SLEEP MED, V10, P965, DOI 10.5664/jcsm.4026; Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]; Tseng CH, 2007, CIRC J, V71, P1749, DOI 10.1253/circj.71.1749; WARNICK GR, 1990, CLIN CHEM, V36, P15; Wolf AM, 2007, J AM DIET ASSOC, V107, P1365, DOI 10.1016/j.jada.2007.05.015; World Health Organization, GLOB HLTH OBS RAIS B; Yokokawa H, 2011, INTERNAL MED, V50, P1149, DOI 10.2169/internalmedicine.50.4969; Yoshita K, 2005, J HYPERTENS, V23, P1485, DOI 10.1097/01.hjh.0000173394.39197.4e	31	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133641	10.1371/journal.pone.0133641	http://dx.doi.org/10.1371/journal.pone.0133641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225722	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700030
J	Mondesert, O; Frongia, C; Clayton, O; Boizeau, ML; Lobjois, V; Ducommun, B				Mondesert, Odile; Frongia, Celine; Clayton, Olivia; Boizeau, Marie-Laure; Lobjois, Valerie; Ducommun, Bernard			Monitoring the Activation of the DNA Damage Response Pathway in a 3D Spheroid Model	PLOS ONE			English	Article							CELL-CYCLE; ATM KINASE; P53; MDM2; PROLIFERATION; INHIBITION; CHECKPOINT; EXPRESSION; PROTEINS; DYNAMICS	Monitoring the DNA-Damage Response (DDR) activated pathway in multicellular tumor spheroid models is an important challenge as these 3D models have demonstrated their major relevance in pharmacological evaluation. Herein we present DDR-Act-FP, a fluorescent biosensor that allows detection of DDR activation through monitoring of the p21 promoter p53-dependent activation. We show that cells expressing the DDR-Act-FP biosensor efficiently report activation of the DDR pathway after DNA damage and its pharmacological manipulation using ATM kinase inhibitors. We also report the successful use of this assay to screen a small compound library in order to identify activators of the DDR response. Finally, using multicellular spheroids expressing the DDR-Act-FP we demonstrate that DDR activation and its pharmacological manipulation with inhibitory and activatory compounds can be efficiently monitored in live 3D spheroid model. This study paves the way for the development of innovative screening and preclinical evaluation assays.	[Mondesert, Odile; Frongia, Celine; Clayton, Olivia; Boizeau, Marie-Laure; Lobjois, Valerie; Ducommun, Bernard] Univ Toulouse, ITAV USR3505, F-31106 Toulouse, France; [Mondesert, Odile; Frongia, Celine; Clayton, Olivia; Boizeau, Marie-Laure; Lobjois, Valerie; Ducommun, Bernard] CNRS, ITAV USR3505, F-31106 Toulouse, France; [Ducommun, Bernard] CHU Toulouse, F-31059 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU de Toulouse	Lobjois, V (corresponding author), Univ Toulouse, ITAV USR3505, F-31106 Toulouse, France.	valerie.lobjois@itav.fr; bernard.ducommun@itav.fr		Lobjois, Valerie/0000-0003-2428-2084; DUCOMMUN, Bernard/0000-0002-7126-8368	ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante, National Alliance for Life Sciences Health); Fondation pour la Recherche Medicale; Agence Nationale de la Recherche ANR [12-BSV5-0008-01]; Region Midi-Pyrenees	ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante, National Alliance for Life Sciences Health); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche ANR(French National Research Agency (ANR)); Region Midi-Pyrenees(Region OccitanieRegion Provence-Alpes-Cote d'Azur)	This work was financially supported by the Region Midi-Pyrenees, ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante, National Alliance for Life Sciences & Health) within the framework of the Cancer Plan, Fondation pour la Recherche Medicale (Equipe labellisee 2011), and Agence Nationale de la Recherche ANR (12-BSV5-0008-01).	Chehab NH, 2000, GENE DEV, V14, P278; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Curtin NJ, 2013, BRIT J PHARMACOL, V169, P1745, DOI 10.1111/bph.12244; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fedrigo CA, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-156; Giono LE, 2007, MOL CELL BIOL, V27, P4166, DOI 10.1128/MCB.01967-06; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Jeandupeux E, 2015, BIOCHEM BIOPH RES CO, V463, P1141, DOI 10.1016/j.bbrc.2015.06.072; Johnson SA, 2007, DNA REPAIR, V6, P1277, DOI 10.1016/j.dnarep.2007.02.025; Jorand R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035795; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; LaRue KEA, 2004, CANCER RES, V64, P1621, DOI 10.1158/0008-5472.CAN-2902-2; Laurent J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-73; Li Y, 2010, MOL CANCER THER, V9, P113, DOI 10.1158/1535-7163.MCT-08-1189; Lobjois V, 2009, EUR J CANCER, V45, P2402, DOI 10.1016/j.ejca.2009.05.026; Lorenzo C, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-22; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Miwa S, 2013, J CELL BIOCHEM, V114, P2493, DOI 10.1002/jcb.24599; Miwa S, 2013, ANTICANCER RES, V33, P1373; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; Nadkarni A, 2012, J NEURO-ONCOL, V110, P349, DOI 10.1007/s11060-012-0979-0; Olive PL, 2004, CANCER RES, V64, P5363, DOI 10.1158/0008-5472.CAN-04-0729; Rainey MD, 2008, CANCER RES, V68, P7466, DOI 10.1158/0008-5472.CAN-08-0763; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Shibata A, 2010, MOL CELL BIOL, V30, P3371, DOI 10.1128/MCB.01644-09; Tomas M, 2013, J BIOPHOTONICS, V6, P645, DOI 10.1002/jbio.201200170; Uehara F, 2014, J CELL BIOCHEM, V115, P1724, DOI 10.1002/jcb.24837; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002	30	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134411	10.1371/journal.pone.0134411	http://dx.doi.org/10.1371/journal.pone.0134411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225756	Green Submitted, gold, Green Published			2022-12-27	WOS:000358837700090
J	Namachivayam, K; MohanKumar, K; Arbach, D; Jagadeeswaran, R; Jain, SK; Natarajan, V; Mehta, D; Jankov, RP; Maheshwari, A				Namachivayam, Kopperuncholan; MohanKumar, Krishnan; Arbach, Dima; Jagadeeswaran, Ramasamy; Jain, Sunil K.; Natarajan, Viswanathan; Mehta, Dolly; Jankov, Robert P.; Maheshwari, Akhil			All-Trans Retinoic Acid Induces TGF-beta(2) in Intestinal Epithelial Cells via RhoA-and p38 alpha MAPK-Mediated Activation of the Transcription Factor ATF2	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; VITAMIN-A SUPPLEMENTATION; RAR DOUBLE MUTANTS; TRANSFORMING GROWTH-FACTOR-BETA-2; NECROTIZING ENTEROCOLITIS; HUMAN-MILK; TGF-BETA; PANCREATIC ORGANOGENESIS; NEGATIVE FEEDBACK; RESPONSE ELEMENTS	Objective We have shown previously that preterm infants are at risk of necrotizing enterocolitis (NEC), an inflammatory bowel necrosis typically seen in infants born prior to 32 weeks' gestation, because of the developmental deficiency of transforming growth factor (TGF)beta(2) in the intestine. The present study was designed to investigate all-trans retinoic acid (atRA) as an inducer of TGF-beta(2) in intestinal epithelial cells (IECs) and to elucidate the involved signaling mechanisms. Methods AtRA effects on intestinal epithelium were investigated using IEC6 cells. TGF-beta(2) expression was measured using reverse transcriptase-quantitative polymerase chain reaction (RTqPCR) and Western blots. Signaling pathways were investigated using Western blots, transiently- transfected/transduced cells, kinase arrays, chromatin immunoprecipitation, and selective small molecule inhibitors. Results AtRA-treatment of IEC6 cells selectively increased TGF-beta(2) mRNA and protein expression in a time-and dose-dependent fashion, and increased the activity of the TGF-beta(2) promoter. AtRA effects were mediated via RhoA GTPase, Rho-associated, coiled-coil-containing protein kinase 1 (ROCK1), p38 alpha MAPK, and activating transcription factor (ATF)-2. AtRA increased phospho-ATF2 binding to the TGF-beta(2) promoter and increased histone H2B acetylation in the TGF-beta(2) nucleosome, which is typically associated with transcriptional activation. Conclusions AtRA induces TGF-beta(2) expression in IECs via RhoA-and p38 alpha MAPK-mediated activation of the transcription factor ATF2. Further studies are needed to investigate the role of atRA as a protective/therapeutic agent in gut mucosal inflammation.	[Namachivayam, Kopperuncholan; MohanKumar, Krishnan; Arbach, Dima; Jagadeeswaran, Ramasamy; Maheshwari, Akhil] Univ Illinois, Dept Pediat, Chicago, IL 60607 USA; [Namachivayam, Kopperuncholan; MohanKumar, Krishnan; Maheshwari, Akhil] Univ S Florida, Dept Pediat, Morsani Coll Med, Tampa, FL 33620 USA; [Jain, Sunil K.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Natarajan, Viswanathan; Mehta, Dolly; Maheshwari, Akhil] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Jankov, Robert P.] Hosp Sick Children, Res Inst, Physiol & Expt Med Program, Toronto, ON M5G 1X8, Canada; [Jankov, Robert P.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Jankov, Robert P.] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Maheshwari, Akhil] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL USA; [Maheshwari, Akhil] Univ S Florida, Coll Publ Hlth, Dept Community & Family Hlth, Tampa, FL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; State University System of Florida; University of South Florida; University of Texas System; University of Texas Medical Branch Galveston; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Maheshwari, A (corresponding author), Univ Illinois, Dept Pediat, Chicago, IL 60607 USA.	akhilm@health.usf.edu		Ramasamy, Jagadeesh/0000-0002-7906-4239; Namachivayam, Kopperuncholan/0000-0003-3556-8870	National Institutes of Health [R01HD059142]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059142] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health award R01HD059142 (to A.M.).	Alsayed Y, 2001, J BIOL CHEM, V276, P4012, DOI 10.1074/jbc.M007431200; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; BENBROOK DM, 1990, ONCOGENE, V5, P295; Bruhat A, 2007, NUCLEIC ACIDS RES, V35, P1312, DOI 10.1093/nar/gkm038; Cabrera-Valladares G, 1999, ENDOCRINOLOGY, V140, P3091, DOI 10.1210/en.140.7.3091; Chang J, 2006, P NATL ACAD SCI USA, V103, P14495, DOI 10.1073/pnas.0601911103; Colakoglu N, 2004, J MOL HISTOL, V35, P823, DOI 10.1007/s10735-004-1683-y; Colakoglu N, 2005, J MOL HISTOL, V36, P413, DOI 10.1007/s10735-005-9013-6; Fernandez-Calotti P, 2010, J BIOL CHEM, V285, P13589, DOI 10.1074/jbc.M109.055673; Foitzik K, 2005, J INVEST DERMATOL, V124, P1119, DOI 10.1111/j.0022-202X.2005.23686.x; Frost BL, 2014, PEDIAT RES; Ghatpande SK, 2010, DEV GROWTH DIFFER, V52, P433, DOI 10.1111/j.1440-169X.2010.01183.x; GLICK AB, 1989, CELL REGUL, V1, P87, DOI 10.1091/mbc.1.1.87; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Han GR, 1997, J BIOL CHEM, V272, P13711, DOI 10.1074/jbc.272.21.13711; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Hawkes JS, 1999, PEDIATR RES, V46, P194, DOI 10.1203/00006450-199908000-00012; Jakowlew SB, 2000, PEPTIDES, V21, P1831, DOI 10.1016/S0196-9781(00)00344-2; Joshi S, 2007, BBA-MOL BASIS DIS, V1772, P1093, DOI 10.1016/j.bbadis.2007.05.009; Kadison A, 2001, J PEDIATR SURG, V36, P1150, DOI 10.1053/jpsu.2001.25734; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kurien BT, 2006, METHODS, V38, P283, DOI 10.1016/j.ymeth.2005.11.007; Lalevee S, 2011, J BIOL CHEM, V286, P33322, DOI 10.1074/jbc.M111.263681; Lebman DA, 1999, MICROBES INFECT, V1, P1297, DOI 10.1016/S1286-4579(99)00254-3; Lee HY, 1999, MOL CELL BIOL, V19, P1973; Lee MY, 2002, DIABETES, V51, P3400; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Li H, 2001, ARCH BIOCHEM BIOPHYS, V394, P1, DOI 10.1006/abbi.2001.2518; Liu H, 2006, EMBO J, V25, P1058, DOI 10.1038/sj.emboj.7601020; LOHNES D, 1994, DEVELOPMENT, V120, P2723; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; Maheshwari A, 2011, GASTROENTEROLOGY, V140, P242, DOI 10.1053/j.gastro.2010.09.043; Malpel S, 2000, DEVELOPMENT, V127, P3057; Mason K, 2012, ANIM REPROD SCI, V134, P45, DOI 10.1016/j.anireprosci.2012.08.010; Maynard AA, 2010, AM J PHYSIOL-GASTR L, V299, pG614, DOI 10.1152/ajpgi.00076.2010; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Moreira A, 2012, J MATERN-FETAL NEO M, V25, P84, DOI 10.3109/14767058.2011.561893; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Nafday SM, 2002, J PERINAT MED, V30, P121, DOI 10.1515/JPM.2002.014; Namachivayam K, 2012, RETINOIC ACID PROTEC; Namachivayam K, 2013, AM J PHYSIOL-GASTR L, V304, pG1055, DOI 10.1152/ajpgi.00039.2013; Namachivayam K, 2013, AM J PHYSIOL-GASTR L, V304, pG167, DOI 10.1152/ajpgi.00141.2012; Natarajan V, 2001, AM J PHYSIOL-LUNG C, V281, pL435, DOI 10.1152/ajplung.2001.281.2.L435; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nguyen LK, 2012, J R SOC INTERFACE, V9, P1998, DOI 10.1098/rsif.2012.0028; Ozdemir R, 2013, NEONATOLOGY, V104, P22, DOI 10.1159/000350510; Penttila IA, 1998, PEDIATR RES, V44, P524, DOI 10.1203/00006450-199810000-00010; Plateroti M, 1997, J CELL SCI, V110, P1227; Priyamvada S, 2015, J BIOL CHEM; Qi XM, 2007, J BIOL CHEM, V282, P31398, DOI 10.1074/jbc.M703857200; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Rautava S, 2012, J PEDIATR GASTR NUTR, V54, P630, DOI 10.1097/MPG.0b013e31823e7c29; Rautava S, 2011, NEONATOLOGY, V99, P192, DOI 10.1159/000314109; Reeves AA, 2013, BREASTFEED MED, V8, P496, DOI 10.1089/bfm.2013.0017; Rodriguez-Ubreva J, 2014, METHODS MOL BIOL, V1094, P309, DOI 10.1007/978-1-62703-706-8_24; RUDERT F, 1993, J STEROID BIOCHEM, V46, P121, DOI 10.1016/0960-0760(93)90287-7; Sakabe M, 2012, DEVELOPMENT, V139, P385, DOI 10.1242/dev.067058; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Singh B, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-82; Singh US, 2001, EMBO J, V20, P2413, DOI 10.1093/emboj/20.10.2413; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Wardle SP, 2001, ARCH DIS CHILD-FETAL, V84, pF9, DOI 10.1136/fn.84.1.F9; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202; Xia W, 2006, AM J PHYSIOL-REG I, V290, pR501, DOI 10.1152/ajpregu.00472.2005; Xiao K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104589; Yen A, 1998, CANCER RES, V58, P3163; Yuen DE, 2004, PEDIATR RES, V55, P935, DOI 10.1203/01.pdr.0000127023.22960.85	69	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134003	10.1371/journal.pone.0134003	http://dx.doi.org/10.1371/journal.pone.0134003			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225425	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700048
J	Schmidt, A; John, K; Arida, G; Auge, H; Brandl, R; Horgan, FG; Hotes, S; Marquez, L; Radermacher, N; Settele, J; Wolters, V; Schadler, M				Schmidt, Anja; John, Katharina; Arida, Gertrudo; Auge, Harald; Brandl, Roland; Horgan, Finbarr G.; Hotes, Stefan; Marquez, Leonardo; Radermacher, Nico; Settele, Josef; Wolters, Volkmar; Schaedler, Martin			Effects of Residue Management on Decomposition in Irrigated Rice Fields Are Not Related to Changes in the Decomposer Community	PLOS ONE			English	Article							CONTRASTING CHEMICAL-COMPOSITIONS; LEAF-LITTER DECOMPOSITION; HUMID TROPICAL CONDITIONS; PLANT RESIDUES; STRAW INCORPORATION; STREAM DETRITIVORE; SOIL FAUNA; NITROGEN; INVERTEBRATES; DYNAMICS	Decomposers provide an essential ecosystem service that contributes to sustainable production in rice ecosystems by driving the release of nutrients from organic crop residues. During a single rice crop cycle we examined the effects of four different crop residue management practices (rice straw or ash of burned straw scattered on the soil surface or incorporated into the soil) on rice straw decomposition and on the abundance of aquatic and soild-welling invertebrates. Mass loss of rice straw in litterbags of two different mesh sizes that either prevented or allowed access of meso-and macro-invertebrates was used as a proxy for decomposition rates. Invertebrates significantly increased total loss of litter mass by up to 30%. Initially, the contribution of invertebrates to decomposition was significantly smaller in plots with rice straw scattered on the soil surface; however, this effect disappeared later in the season. We found no significant responses in microbial decomposition rates to management practices. The abundance of aquatic fauna was higher in fields with rice straw amendment, whereas the abundance of soil fauna fluctuated considerably. There was a clear separation between the overall invertebrate community structure in response to the ash and straw treatments. However, we found no correlation between litter mass loss and abundances of various lineages of invertebrates. Our results indicate that invertebrates can contribute to soil fertility in irrigated paddy fields by decomposing rice straw, and that their abundance as well as efficiency in decomposition may be promoted by crop residue management practices.	[Schmidt, Anja; Auge, Harald; Settele, Josef; Schaedler, Martin] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [John, Katharina; Wolters, Volkmar] Univ Giessen, Dept Anim Ecol, D-35390 Giessen, Germany; [Arida, Gertrudo; Marquez, Leonardo] Philippine Rice Res Inst, Crop Protect Div, Munoz, Nueva Ecija, Philippines; [Auge, Harald; Settele, Josef; Schaedler, Martin] iDiv German Ctr Integrat Biodivers Res Halle Jena, Leipzig, Germany; [Brandl, Roland; Hotes, Stefan] Univ Marburg, Dept Ecol, Fac Biol, Marburg, Germany; [Horgan, Finbarr G.] Int Rice Res Inst, Manila 1099, Philippines; [Radermacher, Nico] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Justus Liebig University Giessen; Philippine Rice Research Institute; Philipps University Marburg; CGIAR; International Rice Research Institute (IRRI); University of Gottingen	Schmidt, A (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany.	a.schmidt@ufz.de	Schädler, Martin/H-3176-2011; Auge, Harald/D-4802-2015; Settele, Josef/A-6371-2009; Wolters, Volkmar/B-4635-2010; Schmidt, Anja/V-3289-2017; John, Katharina/AAQ-9248-2021	Schädler, Martin/0000-0001-9700-0311; Auge, Harald/0000-0001-7432-8453; Settele, Josef/0000-0002-8624-4983; Wolters, Volkmar/0000-0002-7556-4578; Schmidt, Anja/0000-0001-5339-219X; John, Katharina/0000-0002-7611-822X; Horgan, Finbarr/0000-0003-3796-667X	German Federal Ministry of Education and Research (BMBF) [01LL0917A, 01LL0917L]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study is part of the international project "LEGATO" (Land-use intensity and Ecological Engineering - Assessment Tools for risks and Opportunities in irrigated rice based production systems - www.legato-project.net), funded by the German Federal Ministry of Education and Research (BMBF, 01LL0917A, 01LL0917L), within the BMBF-Funding Measure "Sustainable Land Management" (http://nachhaltiges-landmanagement.de/en/). The study was carried out in cooperation with the "ICON" project (Introducing Non-Flooded Crops in Rice-Dominated Landscapes: Impact on Carbon, Nitrogen and Water Cycles), sub-project 3 (Influence of soil animals on C and N turnover in rice-based cropping systems) within the DFG-Research Unit FOR 1701. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander M., 1977, Introduction to soil microbiology.; ANDERSON JM, 1988, BIOL FERT SOILS, V6, P216, DOI 10.1007/BF00260818; ANDERSON JM, 1994, SOIL RESILIENCE AND SUSTAINABLE LAND USE, P267; Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; Bambaradeniya CNB, 2004, 63 INT WAT MAN I; Beare MH, 1997, APPL SOIL ECOL, V6, P87, DOI 10.1016/S0929-1393(96)00150-3; Bijay-Singh, 2001, NUTR CYCL AGROECOSYS, V59, P227, DOI 10.1023/A:1014410203975; Bird JA, 2001, SOIL SCI SOC AM J, V65, P1143, DOI 10.2136/sssaj2001.6541143x; Bokhorst S, 2013, SOIL BIOL BIOCHEM, V58, P147, DOI 10.1016/j.soilbio.2012.12.001; BOLLEN WB, 1953, J AGR FOOD CHEM, V1, P379, DOI 10.1021/jf60005a004; CANHOTO C, 1995, FRESHWATER BIOL, V34, P209, DOI 10.1111/j.1365-2427.1995.tb00881.x; Chaudhury M, 2005, COMMUN SOIL SCI PLAN, V36, P1141, DOI 10.1081/CSS-200056885; CHRISTENSEN BT, 1985, SOIL BIOL BIOCHEM, V17, P691, DOI 10.1016/0038-0717(85)90047-1; Cobb N.A., 1918, ESTIMATING NEMA POPU; COGLE AL, 1987, AUST J SOIL RES, V25, P481, DOI 10.1071/SR9870481; Cucu MA, 2014, BIOL FERT SOILS, V50, P755, DOI 10.1007/s00374-013-0893-4; da Fonseca JPC, 1998, APPL SOIL ECOL, V9, P105, DOI 10.1016/S0929-1393(98)00062-6; de Vries Franciska T, 2013, Proc Natl Acad Sci U S A, V110, P14296, DOI 10.1073/pnas.1305198110; Dobermann A., 2002, Better Crops International, V16, P7; Dormann C.F., 2011, ANGEW STATISTIK BIOL; Dungait JAJ, 2012, GLOBAL CHANGE BIOL, V18, P1781, DOI 10.1111/j.1365-2486.2012.02665.x; Eagle AJ, 2001, AGRON J, V93, P1346, DOI 10.2134/agronj2001.1346; Eisenhauer N, 2011, OECOLOGIA, V165, P403, DOI 10.1007/s00442-010-1784-0; Fairhurst T., 2007, RICE PRACTICAL GUIDE; Fernando CH, 1980, RICEFIELD ECOSYSTEMS; Ferreira V, 2012, FRESHW SCI, V31, P945, DOI 10.1899/11-062.1; FRIEBE B, 1991, Zeitschrift fuer Kulturtechnik und Landentwicklung, V32, P121; Garcia-Palacios P, 2013, ECOL LETT, V16, P1045, DOI 10.1111/ele.12137; Hagen EM, 2012, OIKOS, V121, P1507, DOI 10.1111/j.1600-0706.2011.19666.x; Heal O. W., 1997, P3; Khandaker AH, 2004, COMMUN SOIL SCI PLAN, V35, P1469, DOI 10.1081/css-120037558; Klotzbucher T, 2015, BASIC APPL ECOLOGY; Kogel-Knabner I, 2010, GEODERMA, V157, P1, DOI 10.1016/j.geoderma.2010.03.009; KOWALENKO CG, 1978, SOIL BIOL BIOCHEM, V10, P417, DOI 10.1016/0038-0717(78)90068-8; Lavelle P., 1994, The biological management of tropical soil fertility., P137; LEKHA A, 1989, P INDIAN AS-ANIM SCI, V98, P275, DOI 10.1007/BF03179409; Leps J., 2003, MULTIVARIATE ANAL EC; Levine JS, 1996, BIOMASS BURNING GLOB; Leyer I., 2007, MULTIVARIATE STAT OK; [李孝勇 Li Xiaoyong], 2003, [安徽农业科学, Journal of anhui agricultural sciences], V31, P870; Liang WJ, 2005, APPL SOIL ECOL, V29, P185, DOI 10.1016/j.apsoil.2004.10.004; Lu YH, 2003, SOIL BIOL BIOCHEM, V35, P1223, DOI 10.1016/S0038-0717(03)00184-6; MACFADYEN A, 1961, J ANIM ECOL, V30, P171, DOI 10.2307/2120; Martinez A, 2014, FEMS MICROBIOL ECOL, V87, P257, DOI 10.1111/1574-6941.12221; Miller, 2000, ACRES US, V30, P20; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Oksanen J., 2007, COMMUN ECOL PACK, P631; Perez J, 2014, MICROB ECOL, V67, P245, DOI 10.1007/s00248-013-0306-0; Powell JR, 2014, PEDOBIOLOGIA, V57, P1, DOI 10.1016/j.pedobi.2014.01.001; Rao C.R., 1964, SANKHYA A, V26, P329, DOI DOI 10.1214/AOMS/1177704248; REDDY MV, 1994, BIOL FERT SOILS, V17, P45, DOI 10.1007/BF00418671; Riutta T, 2012, SOIL BIOL BIOCHEM, V49, P124, DOI 10.1016/j.soilbio.2012.02.028; Saha P.K., 2009, BANGLADESH J AGR RES, V34, P633, DOI [10.3329/bjar.v34i4.5839, DOI 10.3329/BJAR.V34I4.5839]; Samra JS, 2003, ASA SPEC PUBL, V65; Schadler M, 2003, OIKOS, V103, P121, DOI 10.1034/j.1600-0706.2003.12659.x; Schmidt A, 2015, BASIC APPL ECOL, V16, P674, DOI 10.1016/j.baae.2015.01.006; Schneider K, 2011, ECOLOGY, V92, P765, DOI 10.1890/10-0157.1; Schulze ED, 1993, BIOL DIVERSITY ECOSY; Settele J, 2015, BASIC APPL IN PRESS; Singh Y, 2005, ADV AGRON, P85; Swan CM, 2006, OECOLOGIA, V147, P469, DOI 10.1007/s00442-005-0297-8; Thuy NH, 2008, SOIL SCI SOC AM J, V72, P514, DOI 10.2136/sssaj2006.0403; TIAN G, 1995, APPL SOIL ECOL, V2, P25, DOI 10.1016/0929-1393(94)00033-4; TIAN G, 1993, SOIL BIOL BIOCHEM, V25, P731, DOI 10.1016/0038-0717(93)90114-Q; TIAN G, 1992, SOIL BIOL BIOCHEM, V24, P1051, DOI 10.1016/0038-0717(92)90035-V; VANDENWOLLENBERG AL, 1977, PSYCHOMETRIKA, V42, P207, DOI 10.1007/BF02294050; Villegas-Pangga G, 2000, PLANT SOIL, V223, P1, DOI 10.1023/A:1004777911428; Wassmann R, 2000, NUTR CYCL AGROECOSYS, V58, P23, DOI 10.1023/A:1009874014903; Widyastuti R, 2002, ECOLOGY DEV SERIES, V3; Witkamp M, 1976, ROLE TERRESTRIAL AQU, P375; WOLTERS V, 1991, Z PFLANZ BODENKUNDE, V154, P389, DOI 10.1002/jpln.19911540602; Xu YZ, 2010, FIELD CROP RES, V115, P79, DOI 10.1016/j.fcr.2009.10.005; Yadvinder-Singh, 2010, NUTR CYCL AGROECOSYS, V88, P471, DOI 10.1007/s10705-010-9370-8; YEATES GW, 1993, J NEMATOL, V25, P315	74	15	15	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134402	10.1371/journal.pone.0134402	http://dx.doi.org/10.1371/journal.pone.0134402			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225556	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700089
J	Flis, VV; Fankl, A; Ramprecht, C; Zellnig, G; Leitner, E; Hermetter, A; Daum, G				Flis, Vid V.; Fankl, Ariane; Ramprecht, Claudia; Zellnig, Guenther; Leitner, Erich; Hermetter, Albin; Daum, Guenther			Phosphatidylcholine Supply to Peroxisomes of the Yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							SUBCELLULAR MEMBRANES; LIPID-COMPOSITION; ENDOPLASMIC-RETICULUM; DIFFERENT PATHWAYS; PHOSPHATIDYLETHANOLAMINE; PROTEINS; MITOCHONDRIA; TRANSPORT; ASSOCIATION; INHERITANCE	In the yeast Saccharomyces cerevisiae, phosphatidylcholine (PC), the major phospholipid (PL) of all organelle membranes, is synthesized via two different pathways. Methylation of phosphatidylethanolamine (PE) catalyzed by the methyl transferases Cho2p/Pem1p and Opi3p/Pem2p as well as incorporation of choline through the CDP (cytidine diphosphate)choline branch of the Kennedy pathway lead to PC formation. To determine the contribution of these two pathways to the supply of PC to peroxisomes (PX), yeast mutants bearing defects in the two pathways were cultivated under peroxisome inducing conditions, i.e. in the presence of oleic acid, and subjected to biochemical and cell biological analyses. Phenotype studies revealed compromised growth of both the cho20 Delta opi3 Delta (mutations in the methylation pathway) and the cki1 Delta dpl1 Delta eki1 Delta (mutations in the CDP-choline pathway) mutant when grown on oleic acid. Analysis of peroxisomes from the two mutant strains showed that both pathways produce PC for the supply to peroxisomes, although the CDPcholine pathway seemed to contribute with higher efficiency than the methylation pathway. Changes in the peroxisomal lipid pattern of mutants caused by defects in the PC biosynthetic pathways resulted in changes of membrane properties as shown by anisotropy measurements with fluorescent probes. In summary, our data define the origin of peroxisomal PC and demonstrate the importance of PC for peroxisome membrane formation and integrity.	[Flis, Vid V.; Fankl, Ariane; Ramprecht, Claudia; Hermetter, Albin; Daum, Guenther] Graz Univ Technol, NAWI Graz, Inst Biochem, Graz, Austria; [Zellnig, Guenther] Graz Univ, NAWI Graz, Inst Plant Sci, Graz, Austria; [Leitner, Erich] Graz Univ Technol, NAWI Graz, Inst Analyt Chem & Food Technol, Graz, Austria	Graz University of Technology; University of Graz; Graz University of Technology	Daum, G (corresponding author), Graz Univ Technol, NAWI Graz, Inst Biochem, Graz, Austria.	guenther.daum@tugraz.at	Leitner, Erich/AAG-8826-2021	Leitner, Erich/0000-0003-2520-2111	Austria Science Fund	Austria Science Fund(Austrian Science Fund (FWF))	Funding provided by Austria Science Fund.	Andrade-Navarro MA, 2009, CURR OPIN CELL BIOL, V21, P560, DOI 10.1016/j.ceb.2009.04.005; Barton K, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00196; Birner R, 2003, MOL BIOL CELL, V14, P370, DOI 10.1091/mbc.E02-05-0263; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; Camoes F, 2009, J INHERIT METAB DIS, V32, P163, DOI 10.1007/s10545-008-1018-3; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; DAUM G, 1982, J BIOL CHEM, V257, P3028; Dimitrov L, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013243; Fagarasanu M, 2006, BBA-MOL CELL RES, V1763, P1669, DOI 10.1016/j.bbamcr.2006.08.015; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Faust PL, 2014, BIOCHIMIE, V98, P75, DOI 10.1016/j.biochi.2013.10.019; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gurvitz A, 1998, HISTOCHEM CELL BIOL, V110, P15, DOI 10.1007/s004180050260; HAID A, 1983, METHOD ENZYMOL, V96, P192; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Horvath SE, 2011, BBA-MOL CELL BIOL L, V1811, P1030, DOI 10.1016/j.bbalip.2011.08.007; Jourdain I, 2008, TRAFFIC, V9, P353, DOI 10.1111/j.1600-0854.2007.00685.x; Knoblach Barbara, 2013, Commun Integr Biol, V6, pe26901, DOI 10.4161/cib.26901; Kohlwein SD, 2013, GENETICS, V193, P1, DOI 10.1534/genetics.112.143362; Kranenburg M, 2005, J PHYS CHEM B, V109, P6553, DOI 10.1021/jp0457646; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKOWICZ JR, 1982, BIOPHYS CHEM, V16, P117, DOI 10.1016/0301-4622(82)85013-8; Leekumjorn S, 2006, BIOPHYS J, V90, P3951, DOI 10.1529/biophysj.105.076596; Lodhi IJ, 2014, CELL METAB, V19, P380, DOI 10.1016/j.cmet.2014.01.002; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MORRISON WR, 1964, J LIPID RES, V5, P600; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Nussio MR, 2008, BIOINTERPHASES, V3, P96, DOI 10.1116/1.3040158; Perktold A, 2007, FEMS YEAST RES, V7, P629, DOI 10.1111/j.1567-1364.2007.00226.x; Perry RJ, 2009, EUKARYOT CELL, V8, P830, DOI 10.1128/EC.00024-09; Pink DA, 1998, BBA-BIOMEMBRANES, V1368, P289, DOI 10.1016/S0005-2736(97)00196-X; Pitman MC, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1899153; Quail M A, 1996, Methods Mol Biol, V53, P123; Raychaudhuri S, 2008, P NATL ACAD SCI USA, V105, P15785, DOI 10.1073/pnas.0808321105; Rosenberger S, 2009, BBA-MOL CELL BIOL L, V1791, P379, DOI 10.1016/j.bbalip.2009.01.015; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Schrader Michael, 2013, Subcell Biochem, V69, P1, DOI 10.1007/978-94-007-6889-5_1; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; Tuller G, 1999, YEAST, V15, P1555, DOI 10.1002/(SICI)1097-0061(199910)15:14<1555::AID-YEA479>3.0.CO;2-Z; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Voelker DR, 2000, BBA-MOL CELL BIOL L, V1486, P97, DOI 10.1016/S1388-1981(00)00051-2; Voelker DR, 2005, TRENDS BIOCHEM SCI, V30, P396, DOI 10.1016/j.tibs.2005.05.008; Wriessnegger T, 2007, BBA-MOL CELL BIOL L, V1771, P455, DOI 10.1016/j.bbalip.2007.01.004; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	50	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0135084	10.1371/journal.pone.0135084	http://dx.doi.org/10.1371/journal.pone.0135084			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241051	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700094
J	Koppes, E; Himes, KP; Chaillet, JR				Koppes, Erik; Himes, Katherine P.; Chaillet, J. Richard			Partial Loss of Genomic Imprinting Reveals Important Roles for Kcnq1 and Peg10 Imprinted Domains in Placental Development	PLOS ONE			English	Article							BECKWITH-WIEDEMANN; DNA METHYLATION; MOUSE MODEL; MICE LEADS; GENE; GROWTH; DIFFERENTIATION; RETROTRANSPOSON; MAINTENANCE; OVERGROWTH	Mutations in imprinted genes or their imprint control regions (ICRs) produce changes in imprinted gene expression and distinct abnormalities in placental structure, indicating the importance of genomic imprinting to placental development. We have recently shown that a very broad spectrum of placental abnormalities associated with altered imprinted gene expression occurs in the absence of the oocyte-derived DNMT1o cytosine methyltransferase, which normally maintains parent-specific imprinted methylation during preimplantation. The absence of DNMT1o partially reduces inherited imprinted methylation while retaining the genetic integrity of imprinted genes and their ICRs. Using this novel system, we undertook a broad and inclusive approach to identifying key ICRs involved in placental development by correlating loss of imprinted DNA methylation with abnormal placental phenotypes in a mid-gestation window (E12.5-E15.5). To these ends we measured DNA CpG methylation at 15 imprinted gametic differentially methylated domains (gDMDs) that overlap known ICRs using EpiTYPER-mass array technology, and linked these epigenetic measurements to histomorphological defects. Methylation of some imprinted gDMDs, most notably Dlk1, was nearly normal in mid-gestation DNMT1o-deficient placentas, consistent with the notion that cells having lost methylation on these DMDs do not contribute significantly to placental development. Most imprinted gDMDs however showed a wide range of methylation loss among DNMT1o-deficient placentas. Two striking associations were observed. First, loss of DNA methylation at the Peg10 imprinted gDMD associated with decreased embryonic viability and decreased labyrinthine volume. Second, loss of methylation at the Kcnq1 imprinted gDMD was strongly associated with trophoblast giant cell (TGC) expansion. We conclude that the Peg10 and Kcnq1 ICRs are key regulators of mid-gestation placental function.	[Koppes, Erik] Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Program Integrat Mol Biol, Pittsburgh, PA USA; [Himes, Katherine P.; Chaillet, J. Richard] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Chaillet, JR (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA 15260 USA.	Chaillet@pitt.edu		Koppes, Erik/0000-0002-4175-7777	National Institutes of Health USA [P01-HD069316, UL1-RR0241153, UL1-TR000005]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD069316] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by P01-HD069316, UL1-RR0241153, and UL1-TR000005, all from the National Institutes of Health USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero S, 2008, J MED GENET, V45, P193, DOI 10.1136/jmg.2007.053017; Abu-Amero S, 2010, J MED GENET, V47, P150, DOI 10.1136/jmg.2009.071316; Andrews SC, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-53; Arima T, 2006, DEV BIOL, V297, P361, DOI 10.1016/j.ydbio.2006.05.003; Calvello M, 2013, EPIGENETICS-US, V8, P1053, DOI 10.4161/epi.25812; Charalambous M, 2010, DEV BIOL, V337, P1, DOI 10.1016/j.ydbio.2009.10.011; Choufani S, 2011, GENOME RES, V21, P465, DOI 10.1101/gr.111922.110; Choufani S, 2010, AM J MED GENET C, V154C, P343, DOI 10.1002/ajmg.c.30267; Cirio MC, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-9; Cirio MC, 2008, DEV BIOL, V324, P139, DOI 10.1016/j.ydbio.2008.09.015; Coan PM, 2008, J PHYSIOL-LONDON, V586, P5023, DOI 10.1113/jphysiol.2008.157313; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Court F, 2014, GENOME RES, V24, P554, DOI 10.1101/gr.164913.113; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Frank D, 2002, P NATL ACAD SCI USA, V99, P7490, DOI 10.1073/pnas.122039999; Frost JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001015; Fuke T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060105; Green K, 2007, MAMM GENOME, V18, P32, DOI 10.1007/s00335-006-0092-9; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Himes KP, 2015, PLACENTA, V36, P389, DOI 10.1016/j.placenta.2015.01.012; Himes KP, 2013, DEV BIOL, V373, P72, DOI 10.1016/j.ydbio.2012.10.010; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Hu D, 2010, INT J DEV BIOL, V54, P341, DOI 10.1387/ijdb.082768dh; Jacob KJ, 2013, CLIN GENET, V84, P326, DOI 10.1111/cge.12143; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MacDonald WA, 2014, MOL REPROD DEV, V81, P126, DOI 10.1002/mrd.22220; Oh-McGinnis R, 2011, DEV BIOL, V351, P277, DOI 10.1016/j.ydbio.2011.01.008; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Reinhart B, 2006, MOL CELL BIOL, V26, P8347, DOI 10.1128/MCB.00981-06; Salas M, 2004, MECH DEVELOP, V121, P1199, DOI 10.1016/j.mod.2004.05.017; Schulz R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001214; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Smith AC, 2007, PEDIATR RES, V61, p43R, DOI 10.1203/pdr.0b013e3180457660; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; Toppings M, 2008, HUM REPROD, V23, P807, DOI 10.1093/humrep/den009; Tunster SJ, 2010, MOL CELL BIOL, V30, P295, DOI 10.1128/MCB.00662-09; Tunster SJ, 2011, DIS MODEL MECH, V4, P814, DOI 10.1242/dmm.007328; Weksberg R, 2005, AM J MED GENET C, V137C, P12, DOI 10.1002/ajmg.c.30058; Wylie AA, 2003, AM J PATHOL, V162, P321, DOI 10.1016/S0002-9440(10)63823-0	44	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0135202	10.1371/journal.pone.0135202	http://dx.doi.org/10.1371/journal.pone.0135202			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241757	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000358942700098
J	Usenbo, A; Kramer, V; Young, T; Musekiwa, A				Usenbo, Anthony; Kramer, Veronika; Young, Taryn; Musekiwa, Alfred			Prevalence of Arthritis in Africa: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; RHEUMATOID-ARTHRITIS; URBAN-POPULATION; NEGRO; DISORDERS; DISEASE; OSTEOARTHROSIS; EPIDEMIOLOGY; COMMUNITY; HEALTH	Objective In this systematic review, we estimate the prevalence of six types of arthritis in Africa; namely rheumatoid arthritis, osteoarthritis, juvenile arthritis, psoriatic arthritis, gout, and ankylosing spondylitis. Methods We comprehensively searched literature on 31 August 2014 in MEDLINE, EMBASE, Web of Science and the Cochrane Library to identify eligible studies from 1975 up to 31 July 2014. Two review authors independently selected studies, extracted data, and appraised studies. We carried out random effects meta-analysis of prevalence of arthritis and assessed heterogeneity through subgroup analyses. We performed separate analyses for population-and hospital-based studies, as well as rural and urban settings. Main Findings We included 27 cross-sectional studies (20 population-based and 7 hospital-based) from Africa reporting on the prevalence of arthritis. The majority of the studies were from South Africa (44.4%, 12/27). Rheumatoid arthritis in urban settings ranged from 0.1% in Algeria, 0.6% in the DRC, to a meta-analysis overall prevalence of 2.5% in South Africa, and in rural settings ranged from a meta-analysis overall prevalence of 0.07% in South Africa, 0.3% in Egypt, to 0.4% in Lesotho. Osteoarthritis was the most prevalent form of arthritis and in urban settings it was 55.1% in South Africa and in rural settings, all in South Africa, ranged from 29.5%, 29.7%, up to 82.7% among adults aged over 65 years. Other results include highest prevalence of 33.1% for knee osteoarthritis in rural South Africa, 0.1% for ankylosing spondylitis in rural South Africa, 4.4% for psoriatic arthritis in urban South Africa, 0.7% for gout in urban South Africa, and 0.3% for juvenile idiopathic arthritis in urban Egypt. A third of the included studies had a low risk of bias (33.3%, 9/27), 40.8%(11/27) moderate risk, and 25.9% (7/27) had a high risk of bias. Conclusions In this systematic review, we have identified the paucity of latest prevalence data on arthritis in Africa. More studies are needed to address the prevalence and the true burden of this disease in Africa.	[Usenbo, Anthony] Univ Stellenbosch, Community Hlth Div, Fac Med & Hlth Sci, Cape Town, South Africa; [Kramer, Veronika] Univ Liverpool, Liverpool Sch Trop Med, Cochrane Infect Dis Grp, Liverpool L3 5QA, Merseyside, England; [Young, Taryn; Musekiwa, Alfred] Univ Stellenbosch, Fac Med & Hlth Sci, Ctr Evidence Based Hlth Care, Cape Town, South Africa	Stellenbosch University; Liverpool School of Tropical Medicine; University of Liverpool; Stellenbosch University	Musekiwa, A (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Ctr Evidence Based Hlth Care, Cape Town, South Africa.	Alfred.Musekiwa@gmail.com		Musekiwa, Alfred/0000-0001-5880-3680; Young, Taryn/0000-0003-2406-081X				Abdel-Nasser A, 2004, PREVALENCE RHEUMATOI; Abou El-Soud AM, 2013, RHEUMATOL INT, V33, P2315, DOI 10.1007/s00296-013-2707-2; Alamanos Y, 2008, J RHEUMATOL, V35, P1354; Alamanos Y, 2006, SEMIN ARTHRITIS RHEU, V36, P182, DOI 10.1016/j.semarthrit.2006.08.006; AliGombe A, 1996, J RHEUMATOL, V23, P512; Altman D.G., 1991, PRACTICAL STATISTIC; Arend WP, 1997, ARTHRITIS RHEUM, V40, P595, DOI 10.1002/art.1780400402; BEIGHTON P, 1975, ANN RHEUM DIS, V34, P136, DOI 10.1136/ard.34.2.136; BEIGHTON P, 1977, S AFR MED J, V51, P969; Bija MD, 2015, CLIN RHEUMATOL, V34, P1949, DOI 10.1007/s10067-014-2702-3; BRIGHTON SW, 1988, J RHEUMATOL, V15, P405; BRIGHTON SW, 1985, BRIT J RHEUMATOL, V24, P321; Brown MA, 1997, ANN RHEUM DIS, V56, P68, DOI 10.1136/ard.56.1.68; Cameron M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010538; Chopra A, 2008, BEST PRACT RES CL RH, V22, P583, DOI 10.1016/j.berh.2008.07.001; Costenbader KH, 2008, ARCH INTERN MED, V168, P1664, DOI 10.1001/archinte.168.15.1664; Darmawan J, 2007, CLIN RHEUMATOL, V26, P853, DOI 10.1007/s10067-007-0553-x; Dowman Ben, 2012, J Glob Health, V2, P020406, DOI 10.7189/jogh.02.020406; GBD 2001 Country Collaboration, 2013, LANCET, V381, P965, DOI 10.1016/S0140-6736(13)60283-4; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014; Kaddu-Mukasa M, 2011, AFR HEALTH SCI, V11, P24; Malemba JJ, 2012, RHEUMATOLOGY, V51, P1644, DOI 10.1093/rheumatology/kes092; Malinowski KP, 2015, EXPERT REV PHARM OUT, V15, P285, DOI 10.1586/14737167.2015.1001370; MEYERS OL, 1982, S AFR MED J, V62, P403; MEYERS OL, 1977, ANN RHEUM DIS, V36, P62, DOI 10.1136/ard.36.1.62; MOLL J M H, 1973, Seminars in Arthritis and Rheumatism, V3, P55, DOI 10.1016/0049-0172(73)90035-8; MOOLENBURGH JD, 1986, ANN RHEUM DIS, V45, P691, DOI 10.1136/ard.45.8.691; MUIRDEN KD, 1991, J RHEUMATOL, V18, P793; Ouedraogo D D, 2010, Med Trop (Mars), V70, P345; Petty Ross E., 1998, Journal of Rheumatology, V25, P1991; Pfleger B, 2007, CLIN RHEUMATOL, V26, P1217, DOI 10.1007/s10067-007-0645-7; Pienaar E, 2011, HEALTH INFO LIBR J, V28, P210, DOI [10.1111/j.1471-1842.2011.00936.x, 10.1111/J.1471-1842.2011.00936.x]; SILMAN AJ, 1993, J RHEUMATOL, V20, P618; Singwe-Ngandeu M, 2013, CLIN RHEUMATOL, V32, pS136; Singwe-Ngandeu M, 2007, East Afr Med J, V84, P404; Slimani S, 2014, RHEUMATOLOGY, V53, P571, DOI 10.1093/rheumatology/ket446; SOLOMON L, 1986, S AFR MED J, V69, P15; SOLOMON L, 1976, ANN RHEUM DIS, V35, P274, DOI 10.1136/ard.35.3.274; SOLOMON L, 1975, ANN RHEUM DIS, V34, P128, DOI 10.1136/ard.34.2.128; SOLOMON L, 1975, S AFR MED J, V49, P1737; SOLOMON L, 1975, S AFR MED J, V49, P1292; Symmons D, WHO REPORT 2006; Symmons D, GLOBAL BURDEN OSTEOA; Tayel M Y, 1999, J Egypt Public Health Assoc, V74, P529; Thierry S, 2014, JOINT BONE SPINE, V81, P112, DOI 10.1016/j.jbspin.2013.09.003; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; WHO, BURD MUSC COND START; YACH D, 1985, INT J EPIDEMIOL, V14, P276, DOI 10.1093/ije/14.2.276; Zedini Chekib, 2014, Tunis Med, V92, P128	50	66	68	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133858	10.1371/journal.pone.0133858	http://dx.doi.org/10.1371/journal.pone.0133858			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241756	Green Published, gold, Green Accepted			2022-12-27	WOS:000358942700026
J	Allegue, C; Coll, M; Mates, J; Campuzano, O; Iglesias, A; Sobrino, B; Brion, M; Amigo, J; Carracedo, A; Brugada, P; Brugada, J; Brugada, R				Allegue, Catarina; Coll, Monica; Mates, Jesus; Campuzano, Oscar; Iglesias, Anna; Sobrino, Beatriz; Brion, Maria; Amigo, Jorge; Carracedo, Angel; Brugada, Pedro; Brugada, Josep; Brugada, Ramon			Genetic Analysis of Arrhythmogenic Diseases in the Era of NGS: The Complexity of Clinical Decision-Making in Brugada Syndrome	PLOS ONE			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY/DYSPLASIA; SUDDEN CARDIAC DEATH; LONG-QT SYNDROME; COMMON POLYMORPHISM; ANKYRIN-G; MUTATIONS; COMPOUND; PHENOTYPE; NA(V)1.5; NOISE	Background The use of next-generation sequencing enables a rapid analysis of many genes associated with sudden cardiac death in diseases like Brugada Syndrome. Genetic variation is identified and associated with 30-35% of cases of Brugada Syndrome, with nearly 20-25% attributable to variants in SCN5A, meaning many cases remain undiagnosed genetically. To evaluate the role of genetic variants in arrhythmogenic diseases and the utility of next-generation sequencing, we applied this technology to resequence 28 main genes associated with arrhythmogenic disorders. Materials and Methods A cohort of 45 clinically diagnosed Brugada Syndrome patients classified as SCN5A-negative was analyzed using next generation sequencing. Twenty-eight genes were resequenced: AKAP9, ANK2, CACNA1C, CACNB2, CASQ2, CAV3, DSC2, DSG2, DSP, GPD1L, HCN4, JUP, KCNE1, KCNE2, KCNE3, KCNH2, KCNJ2, KCNJ5, KCNQ1, NOS1AP, PKP2, RYR2, SCN1B, SCN3B, SCN4B, SCN5A, SNTA1, and TMEM43. A total of 85 clinically evaluated relatives were also genetically analyzed to ascertain familial segregation. Results and Discussion Twenty-two patients carried 30 rare genetic variants in 12 genes, only 4 of which were previously associated with Brugada Syndrome. Neither insertion/deletion nor copy number variation were detected. We identified genetic variants in novel candidate genes potentially associated to Brugada Syndrome. These include: 4 genetic variations in AKAP9 including a de novo genetic variation in 3 positive cases; 5 genetic variations in ANK2 detected in 4 cases; variations in KCNJ2 together with CASQ2 in 1 case; genetic variations in RYR2, including a de novo genetic variation and desmosomal proteins encoding genes including DSG2, DSP and JUP, detected in 3 of the cases. Larger gene panels or whole exome sequencing should be considered to identify novel genes associated to Brugada Syndrome. However, application of approaches such as whole exome sequencing would difficult the interpretation for clinical purposes due to the large amount of data generated. The identification of these genetic variants opens new perspectives on the implications of genetic background in the arrhythmogenic substrate for research purposes. Conclusions As a paradigm for other arrhythmogenic diseases and for unexplained sudden death, our data show that clinical genetic diagnosis is justified in a family perspective for confirmation of genetic causality. In the era of personalized medicine using high-throughput tools, clinical decision-making is increasingly complex.	[Allegue, Catarina; Coll, Monica; Mates, Jesus; Campuzano, Oscar; Iglesias, Anna; Brugada, Ramon] IdIBGi Univ Girona, Cardiovasc Genet Ctr, Girona, Spain; [Sobrino, Beatriz; Brion, Maria; Amigo, Jorge; Carracedo, Angel] Grp Med Xenom, Inst Invest Sanitaria Santiago de Compostela, Santiago De Compostela, Spain; [Sobrino, Beatriz; Brion, Maria; Amigo, Jorge; Carracedo, Angel] SERGAS, Fundac Publ Galega Med Xenom, Santiago De Compostela, Spain; [Carracedo, Angel] King Abdulaziz Univ, CEGMR, Jeddah 21413, Saudi Arabia; [Brugada, Pedro] UZ Brussel VUB, Heart Rhythm Management Ctr, Brussels, Belgium; [Brugada, Josep] Univ Barcelona, Hosp Clin, Cardiol Unit, Barcelona, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universidade de Santiago de Compostela; King Abdulaziz University; Vrije Universiteit Brussel; University of Barcelona; Hospital Clinic de Barcelona	Brugada, R (corresponding author), IdIBGi Univ Girona, Cardiovasc Genet Ctr, Girona, Spain.	ramon@brugada.org	campuzano, oscar/J-1968-2014; Amigo Lechuga, Jorge/A-4892-2010; Brion, Maria/J-8059-2014; Rey, Beatriz Sobrino/ABB-8518-2020; Carracedo, Angel/D-4257-2012	campuzano, oscar/0000-0001-5298-5276; Amigo Lechuga, Jorge/0000-0002-1362-2605; Brion, Maria/0000-0001-7463-2148; Carracedo, Angel/0000-0003-1085-8986; Sobrino Rey, Beatriz/0000-0002-6605-9377; ALLEGUE TOSCANO, CATARINA/0000-0002-5121-3159	Instituto de Salud Carlos III [FIS-PI11/01826]; Fundacio La Caixa; Centro Nacional de Investigaciones Cardiovasculares [CNIC-03-2008]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacio La Caixa(La Caixa FoundationEuropean Commission); Centro Nacional de Investigaciones Cardiovasculares	This work was supported by CA: Instituto de Salud Carlos III (FIS-PI11/01826); RB: Fundacio La Caixa; and RB: Centro Nacional de Investigaciones Cardiovasculares (CNIC-03-2008).	Agullo-Pascual E, 2014, FEBS LETT, V588, P1322, DOI 10.1016/j.febslet.2014.02.008; Bezzina CR, 2013, NAT GENET, V45, P1044, DOI 10.1038/ng.2712; Brugada R., 1993, GENEREVIEWS; Burashnikov E, 2010, HEART RHYTHM, V7, P1872, DOI 10.1016/j.hrthm.2010.08.026; Campuzano O, 2015, SCI REPORTS IN PRESS, DOI 10.1038; Campuzano O, 2014, INT J LEGAL MED, V128, P599, DOI 10.1007/s00414-014-0966-4; Cerrone M, 2014, CIRCULATION, V129, P1092, DOI 10.1161/CIRCULATIONAHA.113.003077; Chen L, 2007, P NATL ACAD SCI USA, V104, P20990, DOI 10.1073/pnas.0710527105; Cordeiro JM, 2006, CIRCULATION, V114, P2026, DOI 10.1161/CIRCULATIONAHA.106.627489; Crotti L, 2012, J AM COLL CARDIOL, V60, P1410, DOI 10.1016/j.jacc.2012.04.037; Cusdin FS, 2008, TRAFFIC, V9, P17, DOI 10.1111/j.1600-0854.2007.00673.x; Giudicessi JR, 2013, CURR OPIN CARDIOL, V28, P63, DOI 10.1097/HCO.0b013e32835b0a41; Gollob MH, 2011, CAN J CARDIOL, V27, P232, DOI 10.1016/j.cjca.2010.12.078; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Hwang HW, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027995; Itoh H, 2010, HEART RHYTHM, V7, P1411, DOI 10.1016/j.hrthm.2010.06.013; Kapplinger JD, 2011, J AM COLL CARDIOL, V57, P2317, DOI 10.1016/j.jacc.2010.12.036; Kauferstein S, 2011, INT J CARDIOL, V146, P249, DOI 10.1016/j.ijcard.2010.10.062; Kersey PJ, 2012, NUCLEIC ACIDS RES, V40, pD91, DOI 10.1093/nar/gkr895; Kharche S, 2008, PROG BIOPHYS MOL BIO, V98, P186, DOI 10.1016/j.pbiomolbio.2008.10.010; Lizotte E, 2009, J CARDIOVASC ELECTR, V20, P1137, DOI 10.1111/j.1540-8167.2009.01508.x; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Ohno S, 2013, CIRC J, V77, P1534, DOI 10.1253/circj.CJ-12-1446; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014; Probst V, 2009, CIRC-CARDIOVASC GENE, V2, P552, DOI 10.1161/CIRCGENETICS.109.853374; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shy D, 2013, BBA-MOL CELL RES, V1833, P886, DOI 10.1016/j.bbamcr.2012.10.026; Syrris P, 2007, EUR HEART J, V28, P581, DOI 10.1093/eurheartj/hl380; The 1000 Genomes Project Consortium, 2010, NATURE, V467, P1061, DOI [10.1038/nature09534, DOI 10.1038/NATURE09534]; Vernooy K, 2006, HEART RHYTHM, V3, P131, DOI 10.1016/j.hrthm.2005.11.005; Xia M, 2005, BIOCHEM BIOPH RES CO, V332, P1012, DOI 10.1016/j.bbrc.2005.05.054; Xu TH, 2010, J AM COLL CARDIOL, V55, P587, DOI 10.1016/j.jacc.2009.11.020	33	33	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133037	10.1371/journal.pone.0133037	http://dx.doi.org/10.1371/journal.pone.0133037			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230511	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400025
J	Chen, WC; Tseng, CK; Chen, YH; Lin, CK; Hsu, S; Wang, SN; Lee, JC				Chen, Wei-Chun; Tseng, Chin-Kai; Chen, Yen-Hsu; Lin, Chun-Kuang; Hsu, Shihhsien; Wang, Shen-Nien; Lee, Jin-Ching			HCV NS5A Up-Regulates COX-2 Expression via IL-8-Mediated Activation of the ERK/JNK MAPK Pathway	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAYS; GENE-EXPRESSION; PROSTAGLANDIN E-2; RNA REPLICATION; VIRAL-INFECTION; LIVER-CANCER; INTERLEUKIN-8; CYCLOOXYGENASE-2	Chronic hepatitis C virus (HCV) infection leads to intrahepatic inflammation and liver cell injury, which are considered a risk factor for virus-associated hepatitis, cirrhosis, and hepatocellular carcinoma worldwide. Inflammatory cytokines are critical components of the immune system and influence cellular signaling, and genetic imbalances. In this study, we found that cyclooxygenase-2 (COX-2) and interleukin-8 (IL-8) were significantly induced by HCV infection and HCV NS5A expression, and induction of COX-2 correlated with HCV-induced IL-8 production. We also found that the ERK and JNK signaling pathways were involved in the regulation of IL-8-mediated COX-2 induction in response to HCV infection. Using a promoter-linked reporter assay, we identified that the C/EBP regulatory element within the COX-2 promoter was the dominant factor responsible for the induction of COX-2 by HCV. Silencing C/EBP attenuated HCV-induced COX-2 expression. Our results revealed that HCV-induced inflammation promotes viral replication, providing new insights into the involvement of IL-8-mediated COX-2 induction in HCV replication.	[Chen, Wei-Chun; Hsu, Shihhsien] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Tseng, Chin-Kai] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Tseng, Chin-Kai] Natl Cheng Kung Univ, Coll Med, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ, Ctr Dengue Fever Control & Res, Sepsis Res Ctr, Sch Med,Grad Inst Med, Kaohsiung, Taiwan; [Chen, Yen-Hsu] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Coll Biol Sci & Technol, Hsinchu, Taiwan; [Lin, Chun-Kuang] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung 80424, Taiwan; [Wang, Shen-Nien] Kaohsiung Med Univ Hosp, Dept Surg, Div Hepatobiliary Surg, Kaohsiung, Taiwan; [Wang, Shen-Nien] Kaohsiung Med Univ Hosp, Fac Med, Dept Surg, Kaohsiung, Taiwan; [Lee, Jin-Ching] Kaohsiung Med Univ, Coll Life Sci, Dept Biotechnol, Kaohsiung, Taiwan; [Lee, Jin-Ching] Kaohsiung Med Univ, Coll Pharm, Grad Inst Nat Prod, Kaohsiung, Taiwan	Kaohsiung Medical University; National Cheng Kung University; National Cheng Kung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Yang Ming Chiao Tung University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Lee, JC (corresponding author), Kaohsiung Med Univ, Coll Life Sci, Dept Biotechnol, Kaohsiung, Taiwan.	jclee@kmu.edu.tw		Lee, Jin-Ching/0000-0003-0729-9589; Chen, Yen-hsu/0000-0002-8667-4844	Ministry of Science and Techonology of Taiwan [MOST 103-2622-B-037-007-CC3, MOST 103-2314-B-037 -039 -MY3, NSC 101-2311-B-037-002-MY3, NSC 100-2314-B-037 -001 -MY3]; Kaohsiung Medical University [KMU-TP103H12]	Ministry of Science and Techonology of Taiwan; Kaohsiung Medical University	This work was funded by grants from Ministry of Science and Techonology of Taiwan (http://www.most.gov.tw/mp.aspx) (MOST 103-2622-B-037-007-CC3, MOST 103-2314-B-037 -039 -MY3, NSC 101-2311-B-037-002-MY3, and NSC 100-2314-B-037 -001 -MY3) and Kaohsiung Medical University (http://www2.kmu.edu.tw/index.phtml) (KMU-TP103H12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Aghemo A, 2013, SEMIN IMMUNOPATHOL, V35, P111, DOI 10.1007/s00281-012-0330-z; Akiba J, 2001, INT J ONCOL, V18, P257; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Brownell J, 2013, CLIN CANCER RES, V19, P1347, DOI 10.1158/1078-0432.CCR-12-0928; Buck M, 2007, J CLIN GASTROENTEROL, V41, pS295, DOI 10.1097/MCG.0b013e31814927d5; Dessouki O, 2010, BIOCHEM BIOPH RES CO, V393, P331, DOI 10.1016/j.bbrc.2010.02.008; Emmanouil Kochlios PFaPM, 2012, JOURNAL OF MOLECULAR, V1, P40; Gales Dominique, 2013, ISRN Oncol, V2013, P859154, DOI 10.1155/2013/859154; Goel A, 2001, CANCER LETT, V172, P111, DOI 10.1016/S0304-3835(01)00655-3; Han C, 2006, J BIOL CHEM, V281, P24831, DOI 10.1074/jbc.M602201200; Harper KA, 2008, BIOCHEM SOC T, V36, P543, DOI 10.1042/BST0360543; Hashem Ahmed Murad, 2010, INTERNATIONAL JOURNA, V1, P9; Jahan S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-155; Kato Takanobu, 2005, Uirusu, V55, P287, DOI 10.2222/jsv.55.287; Kumar KJS, 2009, PLANTA MED, V75, P494, DOI 10.1055/s-0029-1185309; Lee CM, 2011, ANTIVIR THER, V16, P825, DOI 10.3851/IMP1868; Lee JC, 2011, J VIRAL HEPATITIS, V18, pE315, DOI 10.1111/j.1365-2893.2010.01424.x; Lee JC, 2011, ANTIVIR RES, V89, P35, DOI 10.1016/j.antiviral.2010.11.003; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Lu LL, 2008, VIROLOGY, V371, P61, DOI 10.1016/j.virol.2007.09.025; Lu XL, 2012, MOL MED REP, V5, P637, DOI 10.3892/mmr.2011.702; Markaverich BM, 2007, ENVIRON HEALTH PERSP, V115, P1727, DOI 10.1289/ehp.10659; Moss SF, 2005, NAT CLIN PRACT ONCOL, V2, P90, DOI 10.1038/ncponc0081; Mukaida N, 2000, INT J HEMATOL, V72, P391; Nishimura-Sakurai Y, 2010, J GASTROENTEROL, V45, P523, DOI 10.1007/s00535-009-0162-3; Petta S, 2010, CURR PHARM DESIGN, V16, P741, DOI 10.2174/138161210790883787; Pollicino T, 2013, VIROLOGY, V444, P317, DOI 10.1016/j.virol.2013.06.028; Polyak SJ, 2001, J VIROL, V75, P6095, DOI 10.1128/JVI.75.13.6095-6106.2001; Qadri I, 2012, J BIOL CHEM, V287, P37340, DOI 10.1074/jbc.M112.384743; Reshi Mohammad Latif, 2014, Int J Cell Biol, V2014, P467452, DOI 10.1155/2014/467452; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sertic J, 2007, CLIN CHEM LAB MED, V45, P1347, DOI 10.1515/CCLM.2007.321; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Steer SA, 2003, VIRAL IMMUNOL, V16, P447, DOI 10.1089/088282403771926283; Tang KH, 2012, HEPATOLOGY, V55, P807, DOI 10.1002/hep.24739; Trujillo-Murillo K, 2007, J VIRAL HEPATITIS, V14, P608, DOI 10.1111/j.1365-2893.2006.00837.x; Trujillo-Murillo K, 2008, HEPATOLOGY, V47, P1462, DOI 10.1002/hep.22215; Tveteraas IH, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-72; Vendramini-Costa DB, 2012, CURR PHARM DESIGN, V18, P3831; Waris G, 2005, J VIROL, V79, P9725, DOI 10.1128/JVI.79.15.9725-9734.2005; Wu XZ, 2008, NEOPLASMA, V55, P472; Xi Liang Y-NH, 2010, SIGNIFICANCE OF COX, V18, P3040; Zampino R, 2013, WORLD J HEPATOL, V5, P528, DOI 10.4254/wjh.v5.i10.528; Zhou L, 2013, DIGEST DIS SCI, V58, P1016, DOI 10.1007/s10620-012-2434-7	48	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133264	10.1371/journal.pone.0133264	http://dx.doi.org/10.1371/journal.pone.0133264			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26231035	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400031
J	Retwitzer, MD; Kifer, I; Sengupta, S; Yakhini, Z; Barash, D				Retwitzer, Matan Drory; Kifer, Ilona; Sengupta, Supratim; Yakhini, Zohar; Barash, Danny			An Efficient Minimum Free Energy Structure-Based Search Method for Riboswitch Identification Based on Inverse RNA Folding	PLOS ONE			English	Article							DYNAMIC-PROGRAMMING ALGORITHM; CONTROLS GENE-EXPRESSION; SECONDARY STRUCTURE; LIGAND-BINDING; COMPARATIVE GENOMICS; WEB SERVER; NONCODING RNAS; SEQUENCE; FAMILIES; MOTIFS	Riboswitches are RNA genetic control elements that were originally discovered in bacteria and provide a unique mechanism of gene regulation. They work without the participation of proteins and are believed to represent ancient regulatory systems in the evolutionary time-scale. One of the biggest challenges in riboswitch research is to find additional eukaryotic riboswitches since more than 20 riboswitch classes have been found in prokaryotes but only one class has been found in eukaryotes. Moreover, this single known class of eukaryotic riboswitch, namely the TPP riboswitch class, has been found in bacteria, archaea, fungi and plants but not in animals. The few examples of eukaryotic riboswitches were identified using sequence-based bioinformatics search methods such as a combination of BLAST and pattern matching techniques that incorporate base-pairing considerations. None of these approaches perform energy minimization structure predictions. There is a clear motivation to develop new bioinformatics methods, aside of the ongoing advances in covariance models, that will sample the sequence search space more flexibly using structural guidance while retaining the computational efficiency of sequence-based methods. We present a new energy minimization approach that transforms structure-based search into a sequence-based search, thereby enabling the utilization of well established sequence-based search utilities such as BLAST and FASTA. The transformation to sequence space is obtained by using an extended inverse RNA folding problem solver with sequence and structure constraints, available within RNAfbinv. Examples in applying the new method are presented for the purine and preQ1 riboswitches. The method is described in detail along with its findings in prokaryotes. Potential uses in finding novel eukaryotic riboswitches and optimizing pre-designed synthetic riboswitches based on ligand simulations are discussed. The method components are freely available for use.	[Retwitzer, Matan Drory; Barash, Danny] Ben Gurion Univ Negev, Dept Comp Sci, IL-84105 Beer Sheva, Israel; [Kifer, Ilona; Yakhini, Zohar] Agilent Labs, Tel Aviv, Israel; [Sengupta, Supratim] Indian Inst Sci Educ & Res Kolkata, Dept Phys Sci, Mohanpur 741246, India; [Kifer, Ilona] Microsoft R&D Ctr, Herzliyya, Israel; [Yakhini, Zohar] Technion Israel Inst Technol, Dept Comp Sci, Lab Computat Biol, IL-32000 Haifa, Israel	Ben Gurion University; Agilent Technologies; Indian Institute of Science Education & Research (IISER) - Kolkata; Technion Israel Institute of Technology	Barash, D (corresponding author), Ben Gurion Univ Negev, Dept Comp Sci, IL-84105 Beer Sheva, Israel.	dbarash@cs.bgu.ac.il	Drory Retwitzer, Matan/AAC-4201-2022	Yakhini, Zohar/0000-0002-0420-5412	Agilent Technologies University Relations Grant; ISF within the ISF-UGC joint research program framework [9/14]; Lynn and William Frankel Center for Computer Sciences at Ben-Gurion University	Agilent Technologies University Relations Grant; ISF within the ISF-UGC joint research program framework; Lynn and William Frankel Center for Computer Sciences at Ben-Gurion University	This work was supported by Agilent Technologies University Relations Grant and the ISF within the ISF-UGC joint research program framework (grant No. 9/14). MD was partially supported by the Lynn and William Frankel Center for Computer Sciences at Ben-Gurion University. The funder provided support in the form of salaries for authors [IK,ZY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abreu-Goodger C, 2005, NUCLEIC ACIDS RES, V33, pW690, DOI 10.1093/nar/gki445; Barash D, 2010, RNA BIOL, V7, P90, DOI 10.4161/rna.7.1.10657; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Barrick Jeffrey E., 2009, V540, P1, DOI 10.1007/978-1-59745-558-9_1; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Bengert P, 2004, NUCLEIC ACIDS RES, V32, pW154, DOI 10.1093/nar/gkh352; Bergig Oriel, 2004, In Silico Biology, V4, P593; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Butler EB, 2011, CHEM BIOL, V18, P293, DOI 10.1016/j.chembiol.2011.01.013; Cochrane JC, 2007, CHEM BIOL, V14, P97, DOI 10.1016/j.chembiol.2006.12.005; Cohen Adaya, 2008, In Silico Biology, V8, P105; Cruz JA, 2011, CR BIOL, V334, P671, DOI 10.1016/j.crvi.2011.05.016; Cruz JA, 2011, NAT METHODS, V8, P513, DOI [10.1038/NMETH.1603, 10.1038/nmeth.1603]; Davis JH, 2011, BIOCHEMISTRY-US, V50, P7236, DOI 10.1021/bi200471c; Dotu I, 2013, RNA BIOL, V10, P1842, DOI 10.4161/rna.26994; Eddy SR, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-18; Epshtein V, 2003, P NATL ACAD SCI USA, V100, P5052, DOI 10.1073/pnas.0531307100; Freyhult E, 2007, BIOINFORMATICS, V23, P2054, DOI 10.1093/bioinformatics/btm314; Garcia-Martin JA, 2013, NUCLEIC ACIDS RES, V41, pW465, DOI 10.1093/nar/gkt280; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gelfand MS, 1999, TRENDS GENET, V15, P439, DOI 10.1016/S0168-9525(99)01856-9; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Grundy FJ, 1998, MOL MICROBIOL, V30, P737, DOI 10.1046/j.1365-2958.1998.01105.x; Hammann C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-210; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Holbrook SR, 2005, CURR OPIN STRUC BIOL, V15, P302, DOI 10.1016/j.sbi.2005.04.005; Kazanov MD, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-347; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kim JN, 2008, BIOL CELL, V100, P1, DOI 10.1042/BC20070088; Klein RJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-44; Kwon MY, 2008, RNA, V14, P25, DOI 10.1261/rna.771608; Lescoute A, 2005, CHEM BIOL, V12, P10, DOI 10.1016/j.chembiol.2005.01.002; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Meyer MM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-268; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Nawrocki EP, 2014, METHODS MOL BIOL, V1097, P163, DOI 10.1007/978-1-62703-709-9_9; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Parker BJ, 2011, GENOME RES, V21, P1929, DOI 10.1101/gr.112516.110; Philips A, 2013, RNA, V19, P1605, DOI 10.1261/rna.039834.113; Ritz J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003152; Ruzzo WL, 2014, METHODS MOL BIOL, V1097, P303, DOI 10.1007/978-1-62703-709-9_15; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Shanahan CA, 2011, J AM CHEM SOC, V133, P15578, DOI 10.1021/ja204650q; Shapiro BA, 1988, COMPUT APPL BIOSCI, V27, P5179; Singh P, 2012, EVOL BIOINFORM, V8, P589, DOI 10.4137/EBO.S10048; Singh P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-325; Smith KD, 2012, BIOCHEMISTRY-US, V51, P425, DOI 10.1021/bi2016662; Smith KD, 2011, BIOCHEM SOC T, V39, P647, DOI 10.1042/BST0390647; Smith KD, 2010, BIOCHEMISTRY-US, V49, P7351, DOI 10.1021/bi100671e; Smith KD, 2009, NAT STRUCT MOL BIOL, V16, P1218, DOI 10.1038/nsmb.1702; Sudarsan N, 2003, RNA, V9, P644, DOI 10.1261/rna.5090103; Veksler-Lublinsky I, 2007, J COMPUT BIOL, V14, P908, DOI 10.1089/cmb.2007.0061; Weinberg Z, 2008, RNA, V14, P822, DOI 10.1261/rna.988608; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31; Weinberg Z, 2009, NATURE, V462, P656, DOI 10.1038/nature08586; Weinbrand L, 2013, BIOINFORMATICS, V29, P2938, DOI 10.1093/bioinformatics/btt494; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967; Yao ZZ, 2006, BIOINFORMATICS, V22, P445, DOI 10.1093/bioinformatics/btk008; Zhang SJ, 2006, BIOINFORMATICS, V22, pE557, DOI 10.1093/bioinformatics/btl232; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	73	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134262	10.1371/journal.pone.0134262	http://dx.doi.org/10.1371/journal.pone.0134262			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230932	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400096
J	Santana, GL; Coelho, BM; Borges, G; Viana, MC; Wang, YP; Andrade, LH				Santana, Geilson Lima; Coelho, Bruno Mendonca; Borges, Guilherme; Viana, Maria Carmen; Wang, Yuan Pang; Andrade, Laura Helena			The Influence of Parental Psychopathology on Offspring Suicidal Behavior across the Lifespan	PLOS ONE			English	Article							MENTAL-HEALTH; RISK-FACTORS; FAMILIAL TRANSMISSION; DISORDERS; HISTORY; ADOLESCENTS; IDEATION; ALCOHOL	Suicide tends to occur in families, and parental psychopathology has been linked to offspring suicidal behaviors. This study explores the influence of parental mental disorders across the lifespan. Data are from the Sao Paulo Megacity Mental Health Survey, a cross-sectional household study with a representative sample of the adult population living in the Sao Paulo Metropolitan Area, Brazil (N=2,942). Survival models examined bivariate and multivariate associations between a range of parental disorders and offspring suicidality. After controlling for comorbidity, number of mental disorders and offspring psychopathology, we found that parental psychopathology influences suicidal behaviors throughout most part of the life cycle, from childhood until young adult years. Generalized anxiety disorder (GAD) and antisocial personality were associated with offspring suicidal ideation (OR 1.8 and 1.9, respectively), panic and GAD predicted suicidal attempts (OR 2.3 and 2.7, respectively), and panic was related to the transition from ideation to attempts (OR 2.7). Although noticed in many different stages of the lifespan, this influence is most evident during adolescence. In this period, depression and antisocial personality increased the odds of suicidal ideation (OR 5.1 and 3.2, respectively), and depression, panic disorder, GAD and substance abuse predicted suicidal attempts (OR varying from 1.7 to 3.8). In short, parental disorders characterized by impulsive-aggression and anxiety-agitation were the main predictors of offspring suicidality across the lifespan. This clinically relevant intergenerational transmission of suicide risk was independent of offspring mental disorders, and this underscores the need for a family approach to psychopathology.	[Santana, Geilson Lima; Coelho, Bruno Mendonca; Wang, Yuan Pang; Andrade, Laura Helena] Univ Sao Paulo, Sch Med, Dept & Inst Psychiat, Sect Psychiat Epidemiol LIM 23, Sao Paulo, Brazil; [Borges, Guilherme] Natl Inst Psychiat, Mexico City, DF, Mexico; [Borges, Guilherme] Metropolitan Autonomous Univ, Mexico City, DF, Mexico; [Viana, Maria Carmen] Univ Fed Espirito Santo, Dept Social Med, Vitoria, Brazil; [Viana, Maria Carmen] Univ Fed Espirito Santo, Postgrad Program Publ Hlth, Vitoria, Brazil	Universidade de Sao Paulo; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Universidad Autonoma Metropolitana - Mexico; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo	Andrade, LH (corresponding author), Univ Sao Paulo, Sch Med, Dept & Inst Psychiat, Sect Psychiat Epidemiol LIM 23, Sao Paulo, Brazil.	lhsgandr@usp.br	Santana, Geilson/GLU-9777-2022; Wang, Yuan-Pang/A-4863-2008; farjad, farshad/AGC-9105-2022; Coêlho, Bruno M/C-8964-2011; Andrade, Laura Helena S. G./F-3023-2010	Santana, Geilson/0000-0002-6611-1702; Wang, Yuan-Pang/0000-0001-7076-8312; Coêlho, Bruno M/0000-0002-2513-6153; Andrade, Laura Helena S. G./0000-0002-2362-3521; Borges, Guilherme/0000-0002-3269-0507	FAPESP - State of Sao Paulo Research Foundation; CAPES - Coordination for the Improvement of Higher Education Personnel/Ministry of Education, Brazil	FAPESP - State of Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES - Coordination for the Improvement of Higher Education Personnel/Ministry of Education, Brazil	LHA receveid a grant from FAPESP - State of Sao Paulo Research Foundation; GLS received a grant from CAPES - Coordination for the Improvement of Higher Education Personnel/Ministry of Education, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerbo E, 2002, BMJ-BRIT MED J, V325, P74, DOI 10.1136/bmj.325.7355.74; Andrade LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031879; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; Atwoli L, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-65; Baldessarini RJ, 2004, HARVARD REV PSYCHIAT, V12, P1, DOI 10.1080/10673220490425915; Beautrais AL, 1999, SUICIDE LIFE-THREAT, V29, P37; Borges G, 2013, ARCH SUICIDE RES, V17, P123, DOI 10.1080/13811118.2013.776449; Brent DA, 2003, AM J PSYCHIAT, V160, P1486, DOI 10.1176/appi.ajp.160.8.1486; Brent DA, 2005, AM J MED GENET C, V133C, P13, DOI 10.1002/ajmg.c.30042; Brent DA, 2002, ARCH GEN PSYCHIAT, V59, P801, DOI 10.1001/archpsyc.59.9.801; Brent DA, 1996, ARCH GEN PSYCHIAT, V53, P1145; Brent DA, 2008, PSYCHIAT CLIN N AM, V31, P157, DOI 10.1016/j.psc.2008.02.001; Casey BJ, 2010, DEV PSYCHOBIOL, V52, P225, DOI 10.1002/dev.20447; EFRON B, 1988, J AM STAT ASSOC, V83, P414, DOI 10.2307/2288857; Geulayov G, 2012, PSYCHOL MED, V42, P1567, DOI 10.1017/S0033291711002753; Glowinski AL, 2004, DRUG ALCOHOL DEPEN, V76, pS69, DOI 10.1016/j.drugalcdep.2004.08.008; Goodwin RD, 2004, PSYCHIAT RES, V126, P159, DOI 10.1016/j.psychres.2004.02.010; Gureje O, 2011, MOL PSYCHIATR, V16, P1221, DOI 10.1038/mp.2010.111; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; IBGE, 2001, CENS DEM POP AN 2000; Institute RT. SUDAAN, 2002, SUDAAN PROF SOFTW SU; Katz C, 2011, J CLIN PSYCHIAT, V72, P1628, DOI 10.4088/JCP.10m06186blu; Kendler KS, 1997, BRIT J PSYCHIAT, V170, P541, DOI 10.1192/bjp.170.6.541; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Klimes-Dougan B, 2008, J CLIN PSYCHOL, V64, P531, DOI 10.1002/jclp.20468; Lewinsohn PM, 2005, PSYCHOL MED, V35, P1493, DOI 10.1017/S0033291705005350; McGirr A, 2009, AM J PSYCHIAT, V166, P1124, DOI 10.1176/appi.ajp.2009.08111744; Mittendorfer-Rutz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051585; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; Oladeji BD, 2011, ARCH SUICIDE RES, V15, P372, DOI 10.1080/13811118.2011.616151; Pfeffer CR, 1998, J NERV MENT DIS, V186, P269, DOI 10.1097/00005053-199805000-00002; Qin P, 2002, LANCET, V360, P1126, DOI 10.1016/S0140-6736(02)11197-4; Stenager K, 2008, SOC PSYCH PSYCH EPID, V43, P920, DOI 10.1007/s00127-008-0385-2; Viana MC, 2009, REV BRAS PSIQUIATR, V31, P375, DOI 10.1590/S1516-44462009000400016; Viana MC, 2004, WORLD MENTAL HLTH SU; Vijayakumar Lakshmi, 2004, World Psychiatry, V3, P158; Wasserman D., 2016, SUICIDE UNNECESSARY; Wasserman Danuta, 2005, World Psychiatry, V4, P114; Wolter K. M., 1985, INTRO VARIANCE ESTIM; World Health Organization, SUIC PREV SUPRE; World Health Organization, 2014, PREV SUIC PREV SUIC	43	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134970	10.1371/journal.pone.0134970	http://dx.doi.org/10.1371/journal.pone.0134970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230321	gold, Green Submitted, Green Published			2022-12-27	WOS:000358838400188
J	Zhang, SM; Jejcic, A; Tam, JP; Vahlne, A				Zhang, Si Min; Jejcic, Alenka; Tam, James P.; Vahlne, Anders			Membrane-Active Sequences within gp41 Membrane Proximal External Region (MPER) Modulate MPER-Containing Peptidyl Fusion Inhibitor Activity and the Biosynthesis of HIV-1 Structural Proteins	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 ENVELOPE GLYCOPROTEIN; SECONDARY STRUCTURE ANALYSES; NEUTRALIZING ANTIBODIES; ATOMIC-STRUCTURE; MEDIATED FUSION; LIPID RAFTS; DOMAIN; ENTRY; GAG	The membrane proximal external region (MPER) is a highly conserved membrane-active region located at the juxtamembrane positions within class I viral fusion glycoproteins and essential for membrane fusion events during viral entry. The MPER in the human immunodeficiency virus type I (HIV-1) envelope protein (Env) interacts with the lipid bilayers through a cluster of tryptophan (Trp) residues and a C-terminal cholesterol-interacting motif. The inclusion of the MPER N-terminal sequence contributes to the membrane reactivity and anti-viral efficacy of the first two anti-HIV peptidyl fusion inhibitors T20 and T1249. As a type I transmembrane protein, Env also interacts with the cellular membranes during its biosynthesis and trafficking. Here we investigated the roles of MPER membrane-active sequences during both viral entry and assembly, specifically, their roles in the design of peptidyl fusion inhibitors and the biosynthesis of viral structural proteins. We found that elimination of the membrane-active elements in MPER peptides, namely, penta Trp -> alanine (Ala) substitutions and the disruption of the C-terminal cholesterol-interacting motif through deletion inhibited the anti-viral effect against the pseudotyped HIV-1. Furthermore, as compared to C-terminal dimerization, N-terminal dimerization of MPER peptides and N-terminal extension with five helix-forming residues enhanced their anti-viral efficacy substantially. The secondary structure study revealed that the penta-Trp -> Ala substitutions also increased the helical content in the MPER sequence, which prompted us to study the biological relevance of such mutations in pre-fusion Env. We observed that Ala mutations of Trp664, Trp668 and Trp670 in MPER moderately lowered the intracellular and intraviral contents of Env while significantly elevating the content of another viral structural protein, p55/Gag and its derivative p24/capsid. The data suggest a role of the gp41 MPER in the membrane-reactive events during both viral entry and budding, and provide insights into the future development of anti-viral therapeutics.	[Zhang, Si Min; Vahlne, Anders] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, SE-14186 Stockholm, Sweden; [Zhang, Si Min; Tam, James P.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Jejcic, Alenka] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, B-3000 Louvain, Belgium	Karolinska Institutet; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; KU Leuven	Vahlne, A (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Microbiol, SE-14186 Stockholm, Sweden.	anders.vahlne@ki.se	Tam, James P/A-2176-2011	Tam, James P/0000-0003-4433-198X; Zhang, Si Min/0000-0001-7763-603X	National Research Foundation in Singapore [NRF-CRP8-2011-05]	National Research Foundation in Singapore(National Research Foundation, Singapore)	This work was supported by the Competitive Research Grant by the National Research Foundation in Singapore (NRF-CRP8-2011-05), available at http://www.nrf.gov.sg/about-nrf/programmes/competitive-research-programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Ako-Adjei D, 2005, J VIROL, V79, P13463, DOI 10.1128/JVI.79.21.13463-13472.2005; Apellaniz B, 2014, J VIROL, V88, P13367, DOI 10.1128/JVI.02151-14; Bellamy-Mclntyre AK, 2007, J BIOL CHEM, V282, P23104, DOI 10.1074/jbc.M703485200; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bianchi E, 2005, P NATL ACAD SCI USA, V102, P12903, DOI 10.1073/pnas.0502449102; Borrego P, 2013, AIDS, V27, P1081, DOI 10.1097/QAD.0b013e32835edc1d; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Celigoy J, 2011, PROTEIN SCI, V20, P2125, DOI 10.1002/pro.736; Chan WE, 2006, VIROLOGY, V348, P418, DOI 10.1016/j.virol.2006.01.010; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Choisy M, 2004, J VIROL, V78, P1962, DOI 10.1128/JVI.78.4.1962-1970.2004; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Devito C, 2000, J IMMUNOL METHODS, V238, P69, DOI 10.1016/S0022-1759(00)00141-1; Dimitrov AS, 2005, BIOCHEMISTRY-US, V44, P12471, DOI 10.1021/bi051092d; Epand RF, 2005, BIOCHEMISTRY-US, V44, P5525, DOI 10.1021/bi0500224; Eron JJ, 2004, J INFECT DIS, V189, P1075, DOI 10.1086/381707; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P343, DOI 10.1089/aid.1994.10.343; Golding H, 2002, J VIROL, V76, P6780, DOI 10.1128/JVI.76.13.6780-6790.2002; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Jejcic A, 2009, J VIROL, V83, P10075, DOI 10.1128/JVI.01700-08; Gomara MJ, 2014, CURR MED CHEM, V21, P1188, DOI 10.2174/15672050113109990204; KLATZMANN D, 1986, CR ACAD SCI III-VIE, V303, P343; Kliger Y, 2001, J BIOL CHEM, V276, P1391, DOI 10.1074/jbc.M004113200; LANDOLTMARTICORENA C, 1993, J MOL BIOL, V229, P602, DOI 10.1006/jmbi.1993.1066; Leung K, 2008, CELL HOST MICROBE, V3, P285, DOI 10.1016/j.chom.2008.04.004; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; LI Y, 1994, VIROLOGY, V204, P266, DOI 10.1006/viro.1994.1531; Liao Y, 2015, BIOCHEMISTRY-US, V54, P1819, DOI 10.1021/bi501352u; Ling YB, 2013, BIOORG MED CHEM LETT, V23, P4770, DOI 10.1016/j.bmcl.2013.07.012; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Lopez CS, 2014, VIROLOGY, V462, P126, DOI 10.1016/j.virol.2014.05.019; Lorizate M, 2008, BBA-BIOMEMBRANES, V1778, P1624, DOI 10.1016/j.bbamem.2007.12.018; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Markosyan RM, 2003, MOL BIOL CELL, V14, P926, DOI 10.1091/mbc.E02-09-0573; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; Munoz-Barroso I, 1999, J VIROL, V73, P6089; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Noah E, 2008, BIOCHEMISTRY-US, V47, P6782, DOI 10.1021/bi7023139; Nomura W, 2013, BIOORGAN MED CHEM, V21, P4452, DOI 10.1016/j.bmc.2013.05.060; Nomura W, 2012, CHEMMEDCHEM, V7, P205, DOI 10.1002/cmdc.201100542; Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Reardon PN, 2014, P NATL ACAD SCI USA, V111, P1391, DOI 10.1073/pnas.1309842111; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saez-Cirion A, 2003, BIOPHYS J, V85, P3769, DOI 10.1016/S0006-3495(03)74792-4; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; SCHWARTZ S, 1990, J VIROL, V64, P2519, DOI 10.1128/JVI.64.6.2519-2529.1990; SCHWARTZ S, 1990, J VIROL, V64, P5448, DOI 10.1128/JVI.64.11.5448-5456.1990; Shnaper S, 2004, J BIOL CHEM, V279, P18526, DOI 10.1074/jbc.M304950200; Song HC, 2004, J VIROL, V78, P10328, DOI 10.1128/JVI.78.19.10328-10335.2004; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Suarez T, 2000, FEBS LETT, V477, P145, DOI 10.1016/S0014-5793(00)01785-3; Suarez T, 2000, J VIROL, V74, P8038, DOI 10.1128/JVI.74.17.8038-8047.2000; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Tam JP, 2002, ORG LETT, V4, P4167, DOI 10.1021/ol026932k; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Veiga AS, 2004, J AM CHEM SOC, V126, P14758, DOI 10.1021/ja0459882; Vincent N, 2002, BBA-BIOMEMBRANES, V1567, P157, DOI 10.1016/S0005-2736(02)00611-9; VONHEIJNE G, 1994, ANNU REV BIOPH BIOM, V23, P167; Walmsley S, 2003, J INFECT DIS, V188, P1827, DOI 10.1086/379810; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Xiao JP, 2013, BIOORG MED CHEM LETT, V23, P6046, DOI 10.1016/j.bmcl.2013.09.034; Yang G, 2013, J EXP MED, V210, P241, DOI 10.1084/jem.20121977; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zhang LS, 2013, J PEPT SCI, V19, P491, DOI 10.1002/psc.2526; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	81	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134851	10.1371/journal.pone.0134851	http://dx.doi.org/10.1371/journal.pone.0134851			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230322	gold, Green Published, Green Accepted			2022-12-27	WOS:000358838400177
J	Aouida, M; Eid, A; Ali, Z; Cradick, T; Lee, C; Deshmukh, H; Atef, A; AbuSamra, D; Gadhoum, SZ; Merzaban, J; Bao, G; Mahfouz, M				Aouida, Mustapha; Eid, Ayman; Ali, Zahir; Cradick, Thomas; Lee, Ciaran; Deshmukh, Harshavardhan; Atef, Ahmed; AbuSamra, Dina; Gadhoum, Samah Zeineb; Merzaban, Jasmeen; Bao, Gang; Mahfouz, Magdy			Efficient fdCas9 Synthetic Endonuclease with Improved Specificity for Precise Genome Engineering	PLOS ONE			English	Article							NUCLEASE-INDUCED MUTATIONS; DNA-BINDING SPECIFICITY; DOUBLE-STRAND BREAKS; OFF-TARGET ACTIVITY; CRISPR-CAS SYSTEMS; TAL EFFECTORS; SACCHAROMYCES-CEREVISIAE; SURROGATE REPORTERS; GENE MODIFICATION; HUMAN-CELLS	The Cas9 endonuclease is used for genome editing applications in diverse eukaryotic species. A high frequency of off-target activity has been reported in many cell types, limiting its applications to genome engineering, especially in genomic medicine. Here, we generated a synthetic chimeric protein between the catalytic domain of the FokI endonuclease and the catalytically inactive Cas9 protein (fdCas9). A pair of guide RNAs (gRNAs) that bind to sense and antisense strands with a defined spacer sequence range can be used to form a catalytically active dimeric fdCas9 protein and generate double-strand breaks (DSBs) within the spacer sequence. Our data demonstrate an improved catalytic activity of the fdCas9 endonuclease, with a spacer range of 15-39 nucleotides, on surrogate reporters and genomic targets. Furthermore, we observed no detectable fdCas9 activity at known Cas9 off-target sites. Taken together, our data suggest that the fdCas9 endonuclease variant is a superior platform for genome editing applications in eukaryotic systems including mammalian cells.	[Aouida, Mustapha; Eid, Ayman; Ali, Zahir; Atef, Ahmed; Mahfouz, Magdy] 4700 King Abdullah Univ Sci & Technol, Lab Genome Engn, Div Biol Sci, Thuwal 239556900, Saudi Arabia; [Aouida, Mustapha; Eid, Ayman; Ali, Zahir; Atef, Ahmed; Mahfouz, Magdy] 4700 King Abdullah Univ Sci & Technol, Ctr Desert Agr, Thuwal 239556900, Saudi Arabia; [Cradick, Thomas; Lee, Ciaran; Deshmukh, Harshavardhan; Bao, Gang] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Cradick, Thomas; Lee, Ciaran; Deshmukh, Harshavardhan; Bao, Gang] Emory Univ, Atlanta, GA 30332 USA; [AbuSamra, Dina; Gadhoum, Samah Zeineb; Merzaban, Jasmeen] King Abdullah Univ Sci & Technol, Lab Cell Signaling & Migrat, Div Biol & Environm Sci & Engn, Thuwal 23955, Saudi Arabia	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; University System of Georgia; Georgia Institute of Technology; Emory University; King Abdullah University of Science & Technology	Mahfouz, M (corresponding author), 4700 King Abdullah Univ Sci & Technol, Lab Genome Engn, Div Biol Sci, Thuwal 239556900, Saudi Arabia.	Magdy.mahfouz@kaust.edu.sa	MAHFOUZ, MAGDY/O-1550-2016; Deshmukh, Harshavardhan/AAD-3213-2022; Lee, Ciaran Michael/AAV-4690-2020; atef, ahmed/B-7842-2013; Eid, Ayman Yehia/K-8509-2019; Merzaban, Jasmeen/V-3147-2018; Aouida, Mustapha/AEJ-4513-2022; Cradick, Thomas/ABC-3775-2021	Lee, Ciaran Michael/0000-0002-0789-9149; Eid, Ayman Yehia/0000-0002-9120-9680; Merzaban, Jasmeen/0000-0002-7276-2907; Aouida, Mustapha/0000-0001-7945-5320; Cradick, Thomas/0000-0002-8489-8318; Mahfouz, Magdy M/0000-0002-0616-6365; Ali, Zahir/0000-0002-7814-8908; Atef, Ahmed/0000-0001-7530-2060	King Abdullah University of Science and Technology	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	King Abdullah University of Science and Technology funded this study.	Andreas S, 2002, NUCLEIC ACIDS RES, V30, P2299, DOI 10.1093/nar/30.11.2299; Aouida M, 2015, J BIOSCI BIOENG, V120, P364, DOI 10.1016/j.jbiosc.2015.02.017; Aouida M, 2014, CURR GENET, V60, P61, DOI 10.1007/s00294-013-0412-z; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099314; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deng D, 2012, CELL RES, V22, P1502, DOI 10.1038/cr.2012.127; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fine EJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1326; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim YH, 2014, METHODS, V69, P108, DOI 10.1016/j.ymeth.2014.04.012; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Li LX, 2013, MOL PLANT, V6, P1318, DOI 10.1093/mp/sst006; Li LX, 2012, PLANT MOL BIOL, V78, P407, DOI 10.1007/s11103-012-9875-4; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Mahfouz MM, 2014, PLANT BIOTECHNOL J, V12, P1006, DOI 10.1111/pbi.12256; Mahfouz Magdy M, 2011, GM Crops, V2, P99, DOI 10.4161/gmcr.2.2.17254; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramakrishna S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4378; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	50	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133373	10.1371/journal.pone.0133373	http://dx.doi.org/10.1371/journal.pone.0133373			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225561	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700019
J	Atray, I; Bentur, JS; Nair, S				Atray, Isha; Bentur, Jagadish Sanmallappa; Nair, Suresh			The Asian Rice Gall Midge (Orseolia oryzae) Mitogenome Has Evolved Novel Gene Boundaries and Tandem Repeats That Distinguish Its Biotypes	PLOS ONE			English	Article							MITOCHONDRIAL GENOME; WOOD-MASON; DNA; EVOLUTION; SEQUENCE; REARRANGEMENTS; REVEALS; INSECTA; REGIONS; MODEL	The complete mitochondrial genome of the Asian rice gall midge, Orseolia oryzae (Diptera; Cecidomyiidae) was sequenced, annotated and analysed in the present study. The circular genome is 15,286 bp with 13 protein-coding genes, 22 tRNAs and 2 ribosomal RNA genes, and a 578 bp non-coding control region. All protein coding genes used conventional start codons and terminated with a complete stop codon. The genome presented many unusual features: (1) rearrangement in the order of tRNAs as well as protein coding genes; (2) truncation and unusual secondary structures of tRNAs; (3) presence of two different repeat elements in separate non-coding regions; (4) presence of one pseudo-tRNA gene; (5) inversion of the rRNA genes; (6) higher percentage of non-coding regions when compared with other insect mitogenomes. Rearrangements of the tRNAs and protein coding genes are explained on the basis of tandem duplication and random loss model and why intramito-chondrial recombination is a better model for explaining rearrangements in the O. oryzae mitochondrial genome is discussed. Furthermore, we evaluated the number of iterations of the tandem repeat elements found in the mitogenome. This led to the identification of genetic markers capable of differentiating rice gall midge biotypes and the two Orseolia species investigated.	[Atray, Isha; Nair, Suresh] Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, New Delhi 110067, India; [Bentur, Jagadish Sanmallappa] Directorate Rice Res, Hyderabad, Andhra Pradesh, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Rice Research	Nair, S (corresponding author), Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, New Delhi 110067, India.	suresh@icgeb.res.in			ICGEB; Department of Biotechnology (DBT); Indian Council of Agricultural Research (ICAR), Government of India; DBT; ICAR; University Grants Commission (UGC), Government of India	ICGEB(Department of Biotechnology (DBT) India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Indian Council of Agricultural Research (ICAR), Government of India(Indian Council of Agricultural Research (ICAR)); DBT(Department of Biotechnology (DBT) India); ICAR(Indian Council of Agricultural Research (ICAR)); University Grants Commission (UGC), Government of India(University Grants Commission, India)	Research on rice gall midge and gall midge-rice interaction in SN's laboratory is partially supported by core grants from ICGEB and extramural funding from the Department of Biotechnology (DBT) and the Indian Council of Agricultural Research (ICAR), Government of India. JSB wishes to acknowledge extramural funding from DBT and ICAR. IA thanks the University Grants Commission (UGC), Government of India, for a Senior Research Fellowship.	Agarrwal R, 2014, J INTEGR PLANT BIOL, V56, P837, DOI 10.1111/jipb.12244; Andow DA, 2010, ENTOMOL EXP APPL, V135, P18, DOI 10.1111/j.1570-7458.2010.00973.x; AVISE JC, 1986, PHILOS T ROY SOC B, V312, P325, DOI 10.1098/rstb.1986.0011; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Beckenbach AT, 2009, GENOME BIOL EVOL, V1, P278, DOI 10.1093/gbe/evp027; Behura SK, 2000, MOL GEN GENET, V263, P328, DOI 10.1007/s004380051175; Behura SK, 1999, INSECT MOL BIOL, V8, P391, DOI 10.1046/j.1365-2583.1999.83126.x; Behura SK, 2011, INSECT BIOCHEM MOLEC, V41, P770, DOI 10.1016/j.ibmb.2011.05.006; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bentur J. S., 2004, New approaches to gall midge resistance in rice, Proceedings of the International Workshop, Hyderabad, India, 22-24 November, 1998, P23; Bentur JS, 2011, INT J MOL SCI, V12, P755, DOI 10.3390/ijms12010755; Bernt M, 2007, BIOINFORMATICS, V23, P2957, DOI 10.1093/bioinformatics/btm468; BOYCE TM, 1989, GENETICS, V123, P825; Cameron SL, 2014, SYST ENTOMOL, V39, P400, DOI 10.1111/syen.12071; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Carapelli A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-315; CROZIER RH, 1993, GENETICS, V133, P97; Curole JP, 1999, TRENDS ECOL EVOL, V14, P394, DOI 10.1016/S0169-5347(99)01660-2; DIEHL SR, 1984, ANNU REV ENTOMOL, V29, P471, DOI 10.1146/annurev.en.29.010184.002351; Dowton M, 1999, MOL BIOL EVOL, V16, P298, DOI 10.1093/oxfordjournals.molbev.a026111; Dowton M, 2001, TRENDS ECOL EVOL, V16, P269, DOI 10.1016/S0169-5347(01)02182-6; Dowton M, 2002, INVERTEBR SYST, V16, P345, DOI 10.1071/IS02003; Dowton M, 1999, MOL PHYLOGENET EVOL, V11, P283, DOI 10.1006/mpev.1998.0580; Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821; Keane B, 1999, AM J BOT, V86, P1226, DOI 10.2307/2656770; Khush GS, 1995, HOST PLANT RESISTANC, P240; Komoto N, 2012, GENOME, V55, P222, DOI [10.1139/g2012-007, 10.1139/G2012-007]; Lakshmi P. Vijaya, 2006, International Journal of Tropical Insect Science, V26, P207, DOI 10.1079/IJT2006114; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; RAND DM, 1994, TRENDS ECOL EVOL, V9, P125, DOI 10.1016/0169-5347(94)90176-7; Rawat N, 2013, PLANT PHYSIOL BIOCH, V63, P122, DOI 10.1016/j.plaphy.2012.11.021; Rawat N, 2012, FUNCT INTEGR GENOMIC, V12, P249, DOI 10.1007/s10142-012-0275-2; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Shao R, 2007, PARASITOLOGY, V134, P153, DOI 10.1017/S0031182006001429; Shao R, 2001, MOL BIOL EVOL, V18, P858, DOI 10.1093/oxfordjournals.molbev.a003867; Shao RF, 2003, MOL BIOL EVOL, V20, P362, DOI 10.1093/molbev/msg045; Shao RF, 2001, MOL BIOL EVOL, V18, P1828, DOI 10.1093/oxfordjournals.molbev.a003970; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Sperisen C, 2001, MOL ECOL, V10, P257, DOI 10.1046/j.1365-294X.2001.01180.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thao ML, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-25; Wei SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012708; Yang L, 2014, SCI REP-UK, V4, DOI 10.1038/srep04089; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	47	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134625	10.1371/journal.pone.0134625	http://dx.doi.org/10.1371/journal.pone.0134625			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226163	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700123
J	Capone, F; Guerriero, E; Colonna, G; Maio, P; Mangia, A; Marfella, R; Paolisso, G; Izzo, F; Potenza, N; Tomeo, L; Castello, G; Costantini, S				Capone, Francesca; Guerriero, Eliana; Colonna, Giovanni; Maio, Patrizia; Mangia, Alessandra; Marfella, Raffaele; Paolisso, Giuseppe; Izzo, Francesco; Potenza, Nicoletta; Tomeo, Luigi; Castello, Giuseppe; Costantini, Susan			The Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 Diabetes	PLOS ONE			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTORS; INSULIN-RESISTANCE; HIGH EXPRESSION; DOWN-REGULATION; ADIPOSE-TISSUE; CANCER-CELLS; LIVER; P53; GENE	Understanding the dynamics of the complex interaction network of cytokines, defined as "cytokinome'', can be useful to follow progression and evolution of hepatocellular carcinoma (HCC) from its early stages as well as to define therapeutic strategies. Recently we have evaluated the cytokinome profile in patients with type 2 diabetes (T2D) and/or chronic hepatitis C (CHC) infection and/or cirrhosis suggesting specific markers for the different stages of the diseases. Since T2D has been identified as one of the contributory cause of HCC, in this paper we examined the serum levels of cytokines, growth factors, chemokines, as well as of other cancer and diabetes biomarkers in a discovery cohort of patients with T2D, chronic hepatitis C (CHC) and/or CHC-related HCC comparing them with a healthy control group to define a profile of proteins able to characterize these patients, and to recognize the association between diabetes and HCC. The results have evidenced that the serum levels of some proteins are significantly and differently up-regulated in all the patients but they increased still more when HCC develops on the background of T2D. Our results were verified also using a separate validation cohort. Furthermore, significant correlations between clinical and laboratory data characterizing the various stages of this complex disease, have been found. In overall, our results highlighted that a large and simple omics approach, such as that of the cytokinome analysis, supplemented by common biochemical and clinical data, can give a complete picture able to improve the prognosis of the various stages of the disease progression. We have also demonstrated by means of interactomic analysis that our experimental results correlate positively with the general metabolic picture that is emerging in the literature for this complex multifactorial disease.	[Capone, Francesca; Guerriero, Eliana; Castello, Giuseppe; Costantini, Susan] Fdn G Pascale IRCCS, Ist Nazl Tumori, CROM, Naples, Italy; [Colonna, Giovanni] Univ Naples 2, Ctr Med Informat, SIM AOU, Naples, Italy; [Maio, Patrizia] Azienda Osped Rilievo Nazl San Giuseppe Moscati, Unita Operat Malattie Infett, Avellino, Italy; [Mangia, Alessandra] IRCCS Casa Sollievo Sofferenza, Liver Unit, San Giovanni Rotondo, Italy; [Marfella, Raffaele; Paolisso, Giuseppe] Univ Naples 2, Dept Geriatr & Metab Dis, Naples, Italy; [Izzo, Francesco] Fdn G Pascale IRCCS, Ist Nazl Tumori, Naples, Italy; [Potenza, Nicoletta] Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy; [Tomeo, Luigi] Lab Borriello SAS, Avellino, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale; Universita della Campania Vanvitelli; San Giuseppe Moscati Hospital; IRCCS Casa Sollievo Della Sofferenza; Universita della Campania Vanvitelli; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale; Universita della Campania Vanvitelli	Costantini, S (corresponding author), Fdn G Pascale IRCCS, Ist Nazl Tumori, CROM, Naples, Italy.	s.costantini@istitutotumori.na.it	Colonna, Giovanni/AAY-3568-2021; paolisso, giuseppe/AAP-8516-2020; Costantini, Susan/J-9914-2018; Mangia, A/AAL-5357-2020; Marfella, Raffaele/AAH-2595-2019; Capone, Francesca/AAS-7458-2021; Izzo, Francesco/K-5261-2016	paolisso, giuseppe/0000-0002-2137-455X; Mangia, A/0000-0002-2600-3555; Marfella, Raffaele/0000-0003-3960-9270; Costantini, Susan/0000-0002-7538-4657; Potenza, Nicoletta/0000-0002-9736-792X; Colonna, Giovanni/0000-0002-0473-1455; Capone, Francesca/0000-0002-5402-6228; Izzo, Francesco/0000-0003-3093-5408				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Baffy G, 2012, AM J GASTROENTEROL, V107, P53, DOI 10.1038/ajg.2011.390; Botella LM, 2000, J IMMUNOL, V164, P1372, DOI 10.4049/jimmunol.164.3.1372; Capone F, 2014, WORLD J GASTROENTERO, V20, P9261, DOI 10.3748/wjg.v20.i28.9261; Capone F, 2010, EUR CYTOKINE NETW, V21, P99, DOI 10.1684/ecn.2010.0192; Chiao PJ, 2002, CANCER, V95, P1696, DOI 10.1002/cncr.10829; Classen JB, 2011, J PEDIATR ENDOCR MET, V24, P455, DOI 10.1515/JPEM.2011.023; Costantini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039486; Costantini S, 2010, BIOINFORMATION, V5, P166, DOI 10.6026/97320630005166; Costantini S, 2010, EUR CYTOKINE NETW, V21, P251, DOI 10.1684/ecn.2010.0214; D'Alessio D, 2011, DIABETES OBES METAB, V13, P126, DOI 10.1111/j.1463-1326.2011.01449.x; Duszka K, 2013, MOL ENDOCRINOL, V27, P135, DOI 10.1210/me.2012-1248; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Erickson RL, 2001, J BIOL CHEM, V276, P16348, DOI 10.1074/jbc.M100128200; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Garcia-Tello A, 2014, ACTAS UROL ESP, V38, P506, DOI 10.1016/j.acuro.2014.02.015; Guerriero E, 2013, CYTOKINE, V64, P584, DOI 10.1016/j.cyto.2013.09.002; Herman WH, 2012, DIABETES CARE, V35, P943, DOI 10.2337/dc12-0298; Hiroi M, 2003, J BIOL CHEM, V278, P651, DOI 10.1074/jbc.M204544200; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Hoffmeister A, 2002, J BIOL CHEM, V277, P22314, DOI 10.1074/jbc.M201657200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Katz SC, 2004, J IMMUNOL, V173, P230, DOI 10.4049/jimmunol.173.1.230; Kavandi L, 2012, J CELL BIOCHEM, V113, P3143, DOI 10.1002/jcb.24191; Kojima K, 2011, BLOOD, V118, P4431, DOI 10.1182/blood-2011-02-334136; Li M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-5; Li S, 2011, INFECT GENET EVOL, V11, P2083, DOI 10.1016/j.meegid.2011.09.025; Liu H, 2008, CELL MOL IMMUNOL, V5, P373, DOI 10.1038/cmi.2008.46; Liu Y, 2011, J HUAZHONG U SCI-MED, V31, P365, DOI 10.1007/s11596-011-0382-7; Macis D, 2014, INT J EPIDEMIOL, V43, P1226, DOI 10.1093/ije/dyu088; Manfroid I, 2001, MOL ENDOCRINOL, V15, P625, DOI 10.1210/me.15.4.625; Marra F, 2009, HEPATOLOGY, V50, P957, DOI 10.1002/hep.23046; Mashili F, 2013, DIABETES, V62, P457, DOI 10.2337/db12-0337; McCormick ME, 2011, ARTERIOSCL THROM VAS, V31, P643, DOI 10.1161/ATVBAHA.110.216200; Meng X, 2014, CANC RES; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Montella M, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.12725; Moskovits N, 2006, CANCER RES, V66, P10671, DOI 10.1158/0008-5472.CAN-06-2323; Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5; Otte C, 2004, EXP CLIN ENDOCR DIAB, V112, P10, DOI 10.1055/s-2004-815720; Parasole R, 2001, CLIN CANCER RES, V7, P3504; Pillai S, 2010, CANCER RES, V70, P4931, DOI 10.1158/0008-5472.CAN-10-0501; Robinson SM, 2010, CLIN SCI, V118, P691, DOI 10.1042/CS20090549; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Sherman M, 2010, SEMIN LIVER DIS, V30, P3, DOI 10.1055/s-0030-1247128; Subramaniam A, 2013, BBA-REV CANCER, V1835, P46, DOI 10.1016/j.bbcan.2012.10.002; Tan DY, 2013, CHINESE J PHYSIOL, V56, P282, DOI 10.4077/CJP.2013.BAB139; Vacca M, 2013, MOL CELL ENDOCRINOL, V368, P108, DOI 10.1016/j.mce.2012.06.025; Wojcik EJ, 2006, ONCOGENE, V25, P2773, DOI 10.1038/sj.onc.1209306; Yan WS, 2009, J BIOL CHEM, V284, P12178, DOI 10.1074/jbc.M900994200; Yokomizo C, 2011, CANCER LETT, V310, P140, DOI 10.1016/j.canlet.2011.06.030; Zhang P, 2012, J INT MED RES, V40, P1654, DOI 10.1177/030006051204000504; Zhao T, 2009, BLOOD, V113, P2755, DOI 10.1182/blood-2008-06-161729	54	15	15	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134594	10.1371/journal.pone.0134594	http://dx.doi.org/10.1371/journal.pone.0134594			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226632	Green Submitted, gold, Green Published			2022-12-27	WOS:000358837700117
J	Chen, DN; Song, CG; Yu, KD; Jiang, YZ; Ye, FG; Shao, ZM				Chen, Dan-Na; Song, Chuan-Gui; Yu, Ke-Da; Jiang, Yi-Zhou; Ye, Fu-Gui; Shao, Zhi-Ming			A Prospective Evaluation of the Association between a Single Nucleotide Polymorphism rs3775291 in Toll-Like Receptor 3 and Breast Cancer Relapse	PLOS ONE			English	Article							RISK; HIGHLIGHTS; CONSENSUS; GENES; TLR4	Background Toll-like receptors (TLRs) regulate the balance between the innate and adaptive immune responses. Missense single nucleotide polymorphisms (SNPs) in TLRs might be functional and thus influence the risks of chronic infection and cancer development. Here, we investigated the association of two missense SNPs, rs3775291 (c. 1234G>A) in the TLR3 gene and rs4833095 (c. 743T>C) in the TLR1 gene, with relapse-free survival (RFS) in a cohort of prospectively observed breast cancer patients. Methods In this prospective observational study, rs3775291 in TLR3 and rs4833095 in TLR1 were genotyped in 715 patients with primary breast cancer in a Chinese population. Results Univariate analysis revealed that the patients with the AA genotype of rs3775291 had a shorter RFS compared with those carrying the G allele in the recessive model (P<0.01), but this finding was not observed with the dominant model (P = 0.31). The results remained significant after adjusting for the clinical parameters in the recessive model (HR = 3.53, 95% confidence interval [CI]: 1.98-6.31, P<0.01). Further survival analysis indicated that this SNP was significant in the luminal-B, triple-negative breast cancer (TNBC), and human epidermal growth factor receptor 2-positive (HER2+) patients using the recessive model but that it was not significant in the luminal-A patients. The SNP rs4833095 showed a non-significant tendency toward an increased RFS rate in the patients with the TT genotype. Conclusion Our results suggest that the SNP rs3775291 in TLR3 may influence patient outcome. Further studies with larger sample sizes should be conducted to validate our findings.	[Chen, Dan-Na; Song, Chuan-Gui; Ye, Fu-Gui] Fujian Med Univ, Affiliated Union Hosp, Dept Gen Surg, Fuzhou, Peoples R China; [Chen, Dan-Na; Yu, Ke-Da; Jiang, Yi-Zhou; Shao, Zhi-Ming] Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Dept Breast Surg,Key Lab Breast Canc, Shanghai 200433, Peoples R China	Fujian Medical University; Fudan University	Song, CG (corresponding author), Fujian Med Univ, Affiliated Union Hosp, Dept Gen Surg, Fuzhou, Peoples R China.	songchuangui@yahoo.com; yukeda@163.com	Shao, Zengwu/E-9301-2018; Chen, Dan/GRY-2691-2022	Shao, Zengwu/0000-0003-1616-8118; Chen, Dan/0000-0002-1570-9034	Natural Science Foundation of Fujian, China [2012J01357]; Training Plan of Middle-aged and Young Talents of Fujian Province Health and Family Planning Commission [2014-ZQN-ZD-10]; National Natural Science Foundation of China [81370075, 81001169]; Training Plan of Excellent Talents in Shanghai Municipality Health System; Research and Innovation Project of Shanghai Municipal Education Commission; Shanghai International Science and Technique Cooperation Foundation [12410707700]; International S&T Cooperation Program of China (ISTCP) [09]; Shanghai Committee of Science and Technology Funds [12DZ2260100]	Natural Science Foundation of Fujian, China(Natural Science Foundation of Fujian Province); Training Plan of Middle-aged and Young Talents of Fujian Province Health and Family Planning Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Training Plan of Excellent Talents in Shanghai Municipality Health System; Research and Innovation Project of Shanghai Municipal Education Commission; Shanghai International Science and Technique Cooperation Foundation; International S&T Cooperation Program of China (ISTCP); Shanghai Committee of Science and Technology Funds(Shanghai Science & Technology Committee)	This work was supported by the Natural Science Foundation of Fujian, China (2012J01357) (for CGS); the Training Plan of Middle-aged and Young Talents of Fujian Province Health and Family Planning Commission (2014-ZQN-ZD-10) (for CGS); the National Natural Science Foundation of China (81370075, 81001169); the Training Plan of Excellent Talents in Shanghai Municipality Health System (for KDY.); the Research and Innovation Project of Shanghai Municipal Education Commission (2014, for KDY.); the Shanghai International Science and Technique Cooperation Foundation (12410707700); the International S&T Cooperation Program of China (ISTCP No. 09); and Shanghai Committee of Science and Technology Funds (12DZ2260100). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basith S, 2012, ARCH PHARM RES, V35, P1297, DOI 10.1007/s12272-012-0802-7; Bell PA, 2002, BIOTECHNIQUES, P70; Castro FA, 2011, EUR J CANCER, V47, P1203, DOI 10.1016/j.ejca.2010.12.011; Chang ZL, 2010, INFLAMM RES, V59, P791, DOI 10.1007/s00011-010-0208-2; Chantratita N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083285; Costantini S, 2009, IMMUNOL LETT, V126, P91, DOI 10.1016/j.imlet.2009.08.006; Dai JC, 2012, INT J CANCER, V130, P671, DOI 10.1002/ijc.26067; Goldhirsch A, 1998, J NATL CANCER I, V90, P1601, DOI 10.1093/jnci/90.21.1601; Goldhirsch A, 2005, ANN ONCOL, V16, P1569, DOI 10.1093/annonc/mdi326; Gonzalez-Reyes S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-665; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kidd LCR, 2013, BREAST CANCER-TARGET, V5, P43, DOI 10.2147/BCTT.S29172; Kutikhin Anton G, 2012, Cancer Manag Res, V4, P23, DOI 10.2147/CMAR.S28683; Kutikhin AG, 2011, HUM IMMUNOL, V72, P1095, DOI 10.1016/j.humimm.2011.07.307; McShane LM, 2012, J CLIN ONCOL, V30, P4223, DOI 10.1200/JCO.2012.42.6858; Salaun B, 2011, CANCER RES, V71, P1607, DOI 10.1158/0008-5472.CAN-10-3490; Sato Y, 2009, CANCER MICROENVIRON, V2, pS205, DOI 10.1007/s12307-009-0022-y; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Yang ZL, 2008, NEW ENGL J MED, V359, P1456, DOI 10.1056/NEJMoa0802437; Yin WJ, 2009, BREAST CANCER RES TR, V114, P527, DOI 10.1007/s10549-008-0022-5; Yu KD, 2009, FASEB J, V23, P2274, DOI 10.1096/fj.08-124073; Yu KD, 2009, HUM MOL GENET, V18, P2502, DOI 10.1093/hmg/ddp171; [俞孔坚 YU Kong-jian], 2009, [中国土地科学, China Land Science], V23, P3; Zeljic K, 2014, ORAL DIS, V20, P416, DOI 10.1111/odi.12144; Zhou P, 2011, FASEB J, V25, P3489, DOI 10.1096/fj.11-189258	29	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133184	10.1371/journal.pone.0133184	http://dx.doi.org/10.1371/journal.pone.0133184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226228	Green Submitted, gold, Green Published			2022-12-27	WOS:000358837700014
J	Ding, SM; Li, XK; Wang, N; Cameron, SL; Mao, M; Wang, YY; Xi, YQ; Yang, D				Ding, Shuangmei; Li, Xuankun; Wang, Ning; Cameron, Stephen L.; Mao, Meng; Wang, Yuyu; Xi, Yuqiang; Yang, Ding			The Phylogeny and Evolutionary Timescale of Muscoidea (Diptera: Brachycera: Calyptratae) Inferred from Mitochondrial Genomes	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; DROSOPHILA-YAKUBA; DNA; FLY; ORGANIZATION; POPULATION; FLIES; SYSTEMATICS; SCHIZOPHORA; NUCLEAR	Muscoidea is a significant dipteran clade that includes house flies (Family Muscidae), latrine flies (F. Fannidae), dung flies (F. Scathophagidae) and root maggot flies (F. Anthomyiidae). It is comprised of approximately 7000 described species. The monophyly of the Muscoidea and the precise relationships of muscoids to the closest superfamily the Oestroidea (blow flies, flesh flies etc) are both unresolved. Until now mitochondrial (mt) genomes were available for only two of the four muscoid families precluding a thorough test of phylogenetic relationships using this data source. Here we present the first two mt genomes for the families Fanniidae (Euryomma sp.) (family Fanniidae) and Anthomyiidae (Delia platura (Meigen, 1826)). We also conducted phylogenetic analyses containing of these newly sequenced mt genomes plus 15 other species representative of dipteran diversity to address the internal relationship of Muscoidea and its systematic position. Both maximum-likelihood and Bayesian analyses suggested that Muscoidea was not a monophyletic group with the relationship: (Fanniidae + Muscidae) + ((Anthomyiidae + Scathophagidae) + (Calliphoridae + Sarcophagidae)), supported by the majority of analysed datasets. This also infers that Oestroidea was paraphyletic in the majority of analyses. Divergence time estimation suggested that the earliest split within the Calyptratae, separating (Tachinidae + Oestridae) from the remaining families, occurred in the Early Eocene. The main divergence within the paraphyletic muscoidea grade was between Fanniidae + Muscidae and the lineage ((Anthomyiidae + Scathophagidae) + (Calliphoridae + Sarcophagidae)) which occurred in the Late Eocene.	[Ding, Shuangmei; Li, Xuankun; Wang, Ning; Wang, Yuyu; Xi, Yuqiang; Yang, Ding] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Wang, Ning] Chinese Acad Agr Sci, Inst Grassland Res, Hohhot, Peoples R China; [Cameron, Stephen L.] Queensland Univ Technol, Fac Sci & Engn, Earth Environm & Biol Sci Sch, Brisbane, Qld 4001, Australia; [Mao, Meng] Univ Wollongong, Sch Biol Sci, Ctr Med Biosci, Wollongong, NSW 2522, Australia	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS; Queensland University of Technology (QUT); University of Wollongong	Xi, YQ (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	yuqiangxi2012@126.com; dyangcau@126.com	Cameron, Stephen L/A-3742-2008; Wang, Yuyu/J-3117-2019; Mao, Meng/AAP-9930-2021	Cameron, Stephen L/0000-0002-6694-4130; 	National Natural Science Foundation of China [31320103902]; National "Twelfth Five-Year" Plan for Science and Technology Support [2012BAD19B00]; Australian Research Council Future Fellowship [FT120100746]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "Twelfth Five-Year" Plan for Science and Technology Support; Australian Research Council Future Fellowship(Australian Research Council)	DY was funded by the National Natural Science Foundation of China (31320103902) and the National "Twelfth Five-Year" Plan for Science and Technology Support (2012BAD19B00). SLC was funded by an Australian Research Council Future Fellowship (FT120100746) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; AVISE J, 1994, NATURAL HIST EVOLUTI; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Bae JS, 2004, MOL PHYLOGENET EVOL, V32, P978, DOI 10.1016/j.ympev.2004.03.009; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Beckenbach AT, 2012, GENOME BIOL EVOL, V4, P89, DOI 10.1093/gbe/evr131; Bernasconi MV, 2000, INSECT MOL BIOL, V9, P67, DOI 10.1046/j.1365-2583.2000.00158.x; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Cameron SL, 2014, SYST ENTOMOL, V39, P400, DOI 10.1111/syen.12071; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Caravas J, 2013, SYST ENTOMOL, V38, P93, DOI 10.1111/j.1365-3113.2012.00657.x; Chan YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014419; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; CUMMING JM, 1995, ENTOMOL SCAND, V26, P121; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Griffiths GCD, 1990, QUAEST ENTOMOL, V26, P117; GRIFFITHS GD, 1972, PHYLOGENETIC CLASSIF; Grimaldi David, 2005, pi; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2; Hennig W., 1965, Stuttgarter Beitraege zur Naturkunde, VNr. 141, P1; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Hillis DM., 1996, MOL SYSTEMATICS, V2nd; Igawa T, 2008, GENE, V407, P116, DOI 10.1016/j.gene.2007.10.001; Junqueira ACM, 2004, GENE, V339, P7, DOI 10.1016/j.gene.2004.06.031; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Kutty SN, 2008, SYST ENTOMOL, V35, P614; Kutty SN, 2010, MOL PHYLOGENET EVOL, V49, P639; Lambkin CL, 2013, SYST ENTOMOL, V38, P164, DOI 10.1111/j.1365-3113.2012.00652.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lewis DL, 1995, INSECT MOL BIOL, V4, P263, DOI 10.1111/j.1365-2583.1995.tb00032.x; Li XK, 2014, MITOCHONDRIAL DNA; Li XK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123594; Llopart A, 2014, MOL ECOL, V23, P1124, DOI 10.1111/mec.12678; McAlpine J.F., 1989, Agriculture Canada Monograph, P1397; MICHELSEN V, 1991, SYST ENTOMOL, V16, P85, DOI 10.1111/j.1365-3113.1991.tb00574.x; Moreno M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-127; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; Nardi F, 2010, MOL PHYLOGENET EVOL, V57, P678, DOI 10.1016/j.ympev.2010.08.008; Negrisolo E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-221; Nelson LA, 2012, GENE, V511, P131, DOI 10.1016/j.gene.2012.09.103; Nelson LA, 2011, MITOCHONDR DNA, V22, P197, DOI 10.3109/19401736.2011.632896; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Oliveira MT, 2007, J MOL EVOL, V64, P519, DOI 10.1007/s00239-006-0099-6; Oliveira MT, 2008, MOL PHYLOGENET EVOL, V48, P850, DOI 10.1016/j.ympev.2008.05.022; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Quicke Donald L.J., 1993, PRINCIPLES TECHNIQUE; Rambaut A, 2007, TREE ANNOTATORY1 4 8; Rambaut A., 2007, TRACER V1 4; Richard VJ, 2010, MANUAL CENTRAL AM DI, V2, P1267; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sheffield NC, 2009, SYST BIOL, V58, P381, DOI 10.1093/sysbio/syp037; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; von Tschirnhaus Michael, 2009, Denisia, P171; WADA S, 1991, J NAT HIST, V25, P1531, DOI 10.1080/00222939100770971; Wang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047302; Weigl S, 2010, MED VET ENTOMOL, V24, P329, DOI 10.1111/j.1365-2915.2010.00873.x; Wiegmann BM, 2003, SYST BIOL, V52, P745, DOI [10.1080/10635150390250965, 10.1093/sysbio/52.6.745]; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Winkler IS, 2010, J PALEONTOL, V84, P935, DOI 10.1666/09-163.1; Yang F, 2011, GENE, V485, P7, DOI 10.1016/j.gene.2011.05.030; Yeates DK, 2007, ZOOTAXA, P565, DOI 10.11646/zootaxa.1668.1.27; Yu DJ, 2007, GENE, V396, P66, DOI 10.1016/j.gene.2007.02.023; Zatwarnicki T., 1996, GENUS, V3, P103; Zhao Z, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052044, 10.1371/journal.pone.0061814, 10.1371/journal.pone.0080574]	72	30	31	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134170	10.1371/journal.pone.0134170	http://dx.doi.org/10.1371/journal.pone.0134170			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225760	gold, Green Submitted, Green Published			2022-12-27	WOS:000358837700060
J	Jennings, S; Collingridge, K				Jennings, Simon; Collingridge, Kate			Predicting Consumer Biomass, Size-Structure, Production, Catch Potential, Responses to Fishing and Associated Uncertainties in the World's Marine Ecosystems	PLOS ONE			English	Article							FOOD-WEB; SPECIES ABUNDANCE; CLIMATE-CHANGE; ENERGY-FLOW; FISHERIES; COMMUNITY; MODEL; SCALE; OCEAN; CONSTRAINTS	Existing estimates of fish and consumer biomass in the world's oceans are disparate. This creates uncertainty about the roles of fish and other consumers in biogeochemical cycles and ecosystem processes, the extent of human and environmental impacts and fishery potential. We develop and use a size-based macroecological model to assess the effects of parameter uncertainty on predicted consumer biomass, production and distribution. Resulting uncertainty is large (e.g. median global biomass 4.9 billion tonnes for consumers weighing 1 g to 1000 kg; 50% uncertainty intervals of 2 to 10.4 billion tonnes; 90% uncertainty intervals of 0.3 to 26.1 billion tonnes) and driven primarily by uncertainty in trophic transfer efficiency and its relationship with predator-prey body mass ratios. Even the upper uncertainty intervals for global predictions of consumer biomass demonstrate the remarkable scarcity of marine consumers, with less than one part in 30 million by volume of the global oceans comprising tissue of macroscopic animals. Thus the apparently high densities of marine life seen in surface and coastal waters and frequently visited abundance hotspots will likely give many in society a false impression of the abundance of marine animals. Unexploited baseline biomass predictions from the simple macroecological model were used to calibrate a more complex size-and trait-based model to estimate fisheries yield and impacts. Yields are highly dependent on baseline biomass and fisheries selectivity. Predicted global sustainable fisheries yield increases approximate to 4 fold when smaller individuals (< 20 cm from species of maximum mass < 1kg) are targeted in all oceans, but the predicted yields would rarely be accessible in practice and this fishing strategy leads to the collapse of larger species if fishing mortality rates on different size classes cannot be decoupled. Our analyses show that models with minimal parameter demands that are based on a few established ecological principles can support equitable analysis and comparison of diverse ecosystems. The analyses provide insights into the effects of parameter uncertainty on global biomass and production estimates, which have yet to be achieved with complex models, and will therefore help to highlight priorities for future research and data collection. However, the focus on simple model structures and global processes means that non-phytoplankton primary production and several groups, structures and processes of ecological and conservation interest are not represented. Consequently, our simple models become increasingly less useful than more complex alternatives when addressing questions about food web structure and function, biodiversity, resilience and human impacts at smaller scales and for areas closer to coasts.	[Jennings, Simon; Collingridge, Kate] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft NR33 0HT, Suffolk, England	Centre for Environment Fisheries & Aquaculture Science	Jennings, S (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Lowestoft NR33 0HT, Suffolk, England.	simon.jennings@cefas.co.uk	Jennings, Simon/F-5085-2012	Jennings, Simon/0000-0002-2390-7225	Centre for Environment, Fisheries and Aquaculture Science "Feeding people and conserving biodiversity: options, tradeoffs and consequences" [DP275-2010]; Department of Environment, Food and Rural Affairs "Developing the evidence base to support the integration of fisheries and environmental management" [MF1225]	Centre for Environment, Fisheries and Aquaculture Science "Feeding people and conserving biodiversity: options, tradeoffs and consequences"; Department of Environment, Food and Rural Affairs "Developing the evidence base to support the integration of fisheries and environmental management"	This research was supported by the Centre for Environment, Fisheries and Aquaculture Science DP275-2010 "Feeding people and conserving biodiversity: options, tradeoffs and consequences" and the Department of Environment, Food and Rural Affairs MF1225 "Developing the evidence base to support the integration of fisheries and environmental management". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Andersen KH, 2006, AM NAT, V168, P54, DOI 10.1086/504849; Andersen KH, 2008, P ROYAL SOC B, V276, P109; Barange M, 2014, NAT CLIM CHANGE, V4, P211, DOI [10.1038/NCLIMATE2119, 10.1038/nclimate2119]; Barnes C, 2008, ECOLOGY, V89; Barnes C, 2011, J PLANKTON RES, V33, P13, DOI 10.1093/plankt/fbq088; Barnes C, 2010, ECOLOGY, V91, P222, DOI 10.1890/08-2061.1; Blanchard JL, 2014, J APPL ECOL, V51, P612, DOI 10.1111/1365-2664.12238; Blanchard JL, 2012, PHILOS T R SOC B, V367, P2979, DOI 10.1098/rstb.2012.0231; BODC, 2008, GEBCO DIG ATL; BORGMANN U, 1987, CAN J FISH AQUAT SCI, V44, P136, DOI 10.1139/f87-316; BOUDREAU PR, 1992, CAN J FISH AQUAT SCI, V49, P1528, DOI 10.1139/f92-169; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brown JH, 2003, P NATL ACAD SCI USA, V100, P1467, DOI 10.1073/pnas.0630310100; Calbet A, 2004, LIMNOL OCEANOGR, V49, P51, DOI 10.4319/lo.2004.49.1.0051; Carr ME, 2006, DEEP-SEA RES PT II, V53, P741, DOI 10.1016/j.dsr2.2006.01.028; Chassot E, 2007, MAR ECOL PROG SER, V343, P45, DOI 10.3354/meps06919; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Christensen V, 2015, GLOBAL ECOL BIOGEOGR, V24, P507, DOI 10.1111/geb.12281; Christensen V, 2014, MAR ECOL PROG SER, V512, P155, DOI 10.3354/meps10946; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; Cushing DH, 1975, MARINE ECOLOGY FISHE; Dalzell P, 1996, OCEANOGR MAR BIOL, V34, P395; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Dunne JP, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002390; Eakins B. W., 2010, VOLUMES WORLDS OCEAN; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; Espinoza P, 2008, PROG OCEANOGR, V79, P215, DOI 10.1016/j.pocean.2008.10.022; FAO, 2013, FAO MAJ FISH AR; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ; Friedland KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028945; Fulton EA, 2003, MAR ECOL PROG SER, V253, P1, DOI 10.3354/meps253001; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Gjosaeter J., 1980, REV WORLD RESOURCES; Hall SJ, 2006, CAN J FISH AQUAT SCI, V63, P1344, DOI 10.1139/F06-039; HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395, DOI 10.4319/lo.1994.39.2.0395; Harfoot MBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001841; Hartvig M, 2011, J THEOR BIOL, V272, P113, DOI 10.1016/j.jtbi.2010.12.006; Heymans JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095845; Hill SL, 2007, FISH FISH, V8, P315, DOI 10.1111/j.1467-2979.2007.00257.x; Hussey NE, 2014, ECOL LETT, V17, P239, DOI 10.1111/ele.12226; Irigoien X, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4271; Jennings S, 2004, J ANIM ECOL, V73, P632, DOI 10.1111/j.0021-8790.2004.00839.x; Jennings S, 2003, ECOL LETT, V6, P971, DOI 10.1046/j.1461-0248.2003.00529.x; Jennings S, 2002, MAR ECOL PROG SER, V240, P11, DOI 10.3354/meps240011; Jennings S, 2008, P ROY SOC B-BIOL SCI, V275, P1375, DOI 10.1098/rspb.2008.0192; Jennings S, 2007, J ANIM ECOL, V76, P72, DOI 10.1111/j.1365-2656.2006.01180.x; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; Kelleher K., 2005, FAO FISH TECH PAP, P152, DOI DOI 10.1136/EBMED-2011-0012; Le Quesne WJF, 2012, J APPL ECOL, V49, P20, DOI 10.1111/j.1365-2664.2011.02087.x; Link JS, 2012, PROG OCEANOGR, V102, P102, DOI 10.1016/j.pocean.2012.03.008; Maury O, 2007, PROG OCEANOGR, V74, P479, DOI 10.1016/j.pocean.2007.05.002; Maury O, 2007, PROG OCEANOGR, V74, P500, DOI 10.1016/j.pocean.2007.05.001; Morel A, 2001, J GEOPHYS RES-OCEANS, V106, P7163, DOI 10.1029/2000JC000319; Moreno AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107690; Pope JG, 2006, ICES J MAR SCI, V63, P1029, DOI 10.1016/j.icesjms.2006.04.015; R Core Team, 2021, R LANGUAGE ENV STAT; Reum J, 2015, J ANIMAL EC IN PRESS; Reuman DC, 2014, J ANIM ECOL, V83, P963, DOI 10.1111/1365-2656.12194; Ricard D, 2012, FISH FISH, V13, P380, DOI 10.1111/j.1467-2979.2011.00435.x; Rosenberg A.A., 2014, 1086 FAO, P175; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; SCHAEFER MB, 1965, T AM FISH SOC, V94, P123, DOI 10.1577/1548-8659(1965)94[123:TPHOTS]2.0.CO;2; Schmidtko S, 2013, J GEOPHYS RES-OCEANS, V118, P1658, DOI 10.1002/jgrc.20122; Scott F, 2014, MIZER MULTISPECIES S; Seibel BA, 2007, PHILOS T R SOC B, V362, P2061, DOI 10.1098/rstb.2007.2101; Travers-Trolet M, 2014, AFR J MAR SCI, V36, P11, DOI 10.2989/1814232X.2014.883326; Travers-Trolet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094286; Trebilco R, 2013, TRENDS ECOL EVOL, V28, P423, DOI 10.1016/j.tree.2013.03.008; Tremblay-Boyer L, 2011, MAR ECOL PROG SER, V442, P169, DOI 10.3354/meps09375; University of Rhode Island/NOAA, 2013, LME POL BOUND; Van Pelt TI, 1997, COMP BIOCHEM PHYS A, V118, P1393, DOI 10.1016/S0300-9629(97)00240-5; Venables WN., 2002, MODERN APPL STAT S 4; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Webb TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010223; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WIEBE PH, 1975, FISH B-NOAA, V73, P777; Wilson RW, 2009, SCIENCE, V323, P359, DOI 10.1126/science.1157972; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	80	69	70	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133794	10.1371/journal.pone.0133794	http://dx.doi.org/10.1371/journal.pone.0133794			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226590	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000358837700037
J	Nielsen, TJ; Vestergaard, M; Fenger-Gron, M; Christensen, B; Larsen, KK				Nielsen, Tine Jepsen; Vestergaard, Mogens; Fenger-Gron, Morten; Christensen, Bo; Larsen, Karen Kjaer			Healthcare Contacts after Myocardial Infarction According to Mental Health and Socioeconomic Position: A Population-Based Cohort Study	PLOS ONE			English	Article							CARDIAC REHABILITATION; DEPRESSION SCALE; HOSPITAL ANXIETY; CARDIOVASCULAR EVENTS; COLLABORATIVE CARE; RISK-FACTOR; MORTALITY; ADHERENCE; ATTENDANCE; SURVIVORS	Objective To examine the long-term use of healthcare contacts to general practice (GP) and hospital after a first-time myocardial infarction (MI) according to mental health and socioeconomic position. Methods Population-based cohort study of all patients discharged with first-time MI in the Central Denmark Region in 2009 (n=908) using questionnaires and nationwide registers. We estimated adjusted incidence rates and incidence rate ratios (IRR) for GP and hospital contacts according to depressive and anxiety symptoms, educational level and cohabitation status. Results During the 24-month period after the MI, patients with anxiety symptoms had 24% more GP contacts (adjusted IRR 1.24, 95% confidence interval (CI) 1.12-1.36) than patients with no anxiety symptoms. In contrast, patients with depressive symptoms (1.05, 0.94-1.16) and with short and medium education (<10 years: 0.96, 0.84-1.08; 10-12 years: 0.91, 0.80-1.03) and patients living alone (0.95, 0.87-1.04) had the same number of GP contacts as their counterparts (patients with no depressive symptoms, with long education [> 12 years] and patients living with a partner). During the first 6 months after the MI, patients living alone had 13% fewer hospital contacts (0.87, 0.77-0.99), patients with short education had 16% fewer hospital contacts (< 10 years: 0.84, 0.72-0.98) and patients with anxiety symptoms had 27% fewer hospital contacts (0.73, 0.62-0.86) than their counterparts. In contrast, patients with depressive symptoms (0.92, 0.77-1.10) and medium education (10-12 years: 1.05, 0.91-1.22) had the same number of hospital contacts as their counterparts. Conclusions This study indicates that patients with depressive symptoms, short and medium education and patients living alone have a lower long-term use of healthcare contacts following MI than patients without these risk factors. Patients with depressive symptoms and low socioeconomic position would be expected to have a higher need of healthcare after MI as they have a poorer prognosis.	[Nielsen, Tine Jepsen; Vestergaard, Mogens; Fenger-Gron, Morten; Larsen, Karen Kjaer] Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Mental Hlth Primary Care MEPRICA, Aarhus, Denmark; [Vestergaard, Mogens; Christensen, Bo; Larsen, Karen Kjaer] Aarhus Univ, Dept Publ Hlth, Sect Gen Med Practice, Aarhus, Denmark	Aarhus University; Aarhus University	Nielsen, TJ (corresponding author), Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Mental Hlth Primary Care MEPRICA, Aarhus, Denmark.	tjn@ph.au.dk	Vestergaard, Mogens/M-9333-2014	Vestergaard, Mogens/0000-0001-8830-2174; Fenger-Gron, Morten/0000-0002-6354-5871	Lundbeck Foundation [R155-2012-11280]	Lundbeck Foundation(Lundbeckfonden)	This study has been supported by an unrestricted grant from the Lundbeck Foundation (grant number: R155-2012-11280). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Alter DA, 2004, JAMA-J AM MED ASSOC, V291, P1100, DOI 10.1001/jama.291.9.1100; Andersen JS, 2011, SCAND J PUBLIC HEALT, V39, P34, DOI 10.1177/1403494810394718; Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 1960, BMJ-BRIT MED J, V2, P1665; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Carney RM, 2002, J PSYCHOSOM RES, V53, P897, DOI 10.1016/S0022-3999(02)00311-2; Carstensen B, 2011, SCAND J PUBLIC HEALT, V39, P58, DOI 10.1177/1403494811404278; CASE RB, 1992, JAMA-J AM MED ASSOC, V267, P515, DOI 10.1001/jama.267.4.515; Doyle F, 2012, PSYCHOSOM MED, V74, P711, DOI 10.1097/PSY.0b013e318268978e; Figarska SM, 2012, EUR J EPIDEMIOL, V27, P867, DOI 10.1007/s10654-012-9736-0; Frasure-Smith N, 2003, ARCH GEN PSYCHIAT, V60, P627, DOI 10.1001/archpsyc.60.6.627; Frasure-Smith N, 2008, ARCH GEN PSYCHIAT, V65, P62, DOI 10.1001/archgenpsychiatry.2007.4; Glazer Kelly M, 2002, J Cardiopulm Rehabil, V22, P40, DOI 10.1097/00008483-200201000-00006; Grace SL, 2002, GEN HOSP PSYCHIAT, V24, P127, DOI 10.1016/S0163-8343(02)00179-2; Green P, 2013, AM J CARDIOL, V111, P1264, DOI 10.1016/j.amjcard.2013.01.272; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; Huffman JC, 2010, NEUROPSYCH DIS TREAT, V6, P123; Jackson L, 2005, HEART, V91, P10, DOI 10.1136/hrt.2004.045559; Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005; Johannesdottir Sigrun Alba, 2012, Clin Epidemiol, V4, P303, DOI 10.2147/CLEP.S37587; Johnston M, 2000, J PSYCHOSOM RES, V48, P579, DOI 10.1016/S0022-3999(00)00102-1; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Kim HK, 2010, PSYCHOSOM MED, V72, P80, DOI 10.1097/PSY.0b013e3181c4e3e9; Larsen KK, 2014, PSYCHOSOM MED, V76, P739, DOI 10.1097/PSY.0000000000000115; Larsen KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074393; Larsen KK, 2011, SCAND J PRIM HEALTH, V29, P210, DOI 10.3109/02813432.2011.629147; Larsen KK, 2012, EUR J PREV CARD 0410; Martin CR, 2003, PSYCHIAT RES, V120, P85, DOI 10.1016/S0165-1781(03)00162-8; Mayer O, 2004, J EPIDEMIOL COMMUN H, V58, P47, DOI 10.1136/jech.58.1.47; McKee MM, 2012, J AM BOARD FAM MED, V25, P416, DOI 10.3122/jabfm.2012.04.110282; Meijer A, 2013, BRIT J PSYCHIAT, V203, P90, DOI 10.1192/bjp.bp.112.111195; Meillier LK, 2012, SCAND J PUBLIC HEALT, V40, P286, DOI 10.1177/1403494812443600; Murphy BM, 2013, EUR J PREV CARDIOL, V20, P995, DOI 10.1177/2047487312449593; Mykletun A, 2007, PSYCHOSOM MED, V69, P323, DOI 10.1097/PSY.0b013e31803cb862; Nielsen KM, 2008, EUR J PUBLIC HEALTH, V18, P479, DOI 10.1093/eurpub/ckn060; Nielsen KM, 2013, DAN MED J, V60; Nielsen TJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003045; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pedersen KM, 2012, J AM BOARD FAM MED, V25, pS34, DOI 10.3122/jabfm.2012.02.110216; Rasmussen JN, 2006, J EPIDEMIOL COMMUN H, V60, P351, DOI 10.1136/jech.200X.040972; Richards DA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4913; Statistics Denmark, 1991, IDA INT DAT LAB MARK; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Thombs BD, 2006, J GEN INTERNAL MED, V21; Thombs BD, 2007, PSYCHOSOMATICS, V48, P185, DOI 10.1176/appi.psy.48.3.185; Tonne C, 2005, CIRCULATION, V111, P3063, DOI 10.1161/CIRCULATIONAHA.104.496174; Vestbo J, 1988, AM REV RESP DIS, V137; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	50	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134557	10.1371/journal.pone.0134557	http://dx.doi.org/10.1371/journal.pone.0134557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JT	26225864	gold, Green Submitted, Green Published			2022-12-27	WOS:000358837700111
J	Alonso, TO; Santos, JM; Teran, LO; Hernandez, MB; Broto, JP; de Erausquin, GA				Ortiz Alonso, Tomas; Matias Santos, Juan; Teran, Laura Ortiz; Borrego Hernandez, Mayelin; Poch Broto, Joaquin; de Erausquin, Gabriel Alejandro			Differences in Early Stages of Tactile ERP Temporal Sequence (P100) in Cortical Organization during Passive Tactile Stimulation in Children with Blindness and Controls	PLOS ONE			English	Article							SOMATOSENSORY EVOKED-POTENTIALS; CROSS-MODAL PLASTICITY; MEDIAN NERVE-STIMULATION; SIGHTED INDIVIDUALS; MENTAL-IMAGERY; CORTEX; SHAPE; ATTENTION; RESPONSES; HUMANS	Compared to their seeing counterparts, people with blindness have a greater tactile capacity. Differences in the physiology of object recognition between people with blindness and seeing people have been well documented, but not when tactile stimuli require semantic processing. We used a passive vibrotactile device to focus on the differences in spatial brain processing evaluated with event related potentials (ERP) in children with blindness (n = 12) vs. normally seeing children (n = 12), when learning a simple spatial task (lines with different orientations) or a task involving recognition of letters, to describe the early stages of its temporal sequence (from 80 to 220 msec) and to search for evidence of multi-modal cortical organization. We analysed the P100 of the ERP. Children with blindness showed earlier latencies for cognitive (perceptual) event related potentials, shorter reaction times, and (paradoxically) worse ability to identify the spatial direction of the stimulus. On the other hand, they are equally proficient in recognizing stimuli with semantic content (letters). The last observation is consistent with the role of P100 on somatosensory-based recognition of complex forms. The cortical differences between seeing control and blind groups, during spatial tactile discrimination, are associated with activation in visual pathway (occipital) and task-related association (temporal and frontal) areas. The present results show that early processing of tactile stimulation conveying cross modal information differs in children with blindness or with normal vision.	[Ortiz Alonso, Tomas] Univ Complutense Madrid, Fac Med, Dept Psychiat, Madrid, Spain; [Matias Santos, Juan] Univ Atacama, Dept Psychol, Copiapo, Chile; [Matias Santos, Juan] Fdn J Robert Cade, CONICET, Cordoba, Argentina; [Teran, Laura Ortiz] Harvard Univ, Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr, Boston, MA 02115 USA; [Borrego Hernandez, Mayelin] Ctr Neurociencias Cuba, Havana, Cuba; [Poch Broto, Joaquin] Univ Complutense Madrid, Hosp Clin Univ San Carlos, Dept Ear Nose & Throat ENT, Madrid, Spain; [de Erausquin, Gabriel Alejandro] Univ S Florida, Ctr Neuromodulat, Tampa, FL 33620 USA; [de Erausquin, Gabriel Alejandro] Univ S Florida, Roskamp Lab Brain Dev Modulat & Repair, Dept Psychiat, Tampa, FL USA; [de Erausquin, Gabriel Alejandro] Univ S Florida, Dept Neurol, Tampa, FL 33620 USA; [de Erausquin, Gabriel Alejandro] Univ S Florida, Dept Neurosurg, Tampa, FL USA	Complutense University of Madrid; Universidad de Atacama; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Harvard University; Massachusetts General Hospital; Complutense University of Madrid; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	de Erausquin, GA (corresponding author), Univ S Florida, Ctr Neuromodulat, Tampa, FL 33620 USA.	gdeeraus@health.usf.edu	de Erausquin, Gabriel A./Z-1952-2019	de Erausquin, Gabriel A./0000-0001-6423-4461; ORTIZ ALONSO, TOMAS/0000-0002-0527-5869	Comunidad Autonoma de Madrid/Madrid Regional Government [CAM-4131308]; Fundacion Mutua Madrilena [MM-4131220]; NIMH [7K08MH077220]; Roskamp Endowment at USF; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH077220] Funding Source: NIH RePORTER	Comunidad Autonoma de Madrid/Madrid Regional Government; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Roskamp Endowment at USF; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research has been made possible through grants from the Comunidad Autonoma de Madrid/Madrid Regional Government (grant #CAM-4131308) and the Fundacion Mutua Madrilena (grants #MM-4131220). GdE was funded in part by NIMH 7K08MH077220 and the Roskamp Endowment at USF. GdE is a Stephen and Constance Lieber Investigator and Sidney R. Baer Jr. Investigator. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALLISON T, 1992, ELECTROEN CLIN NEURO, V84, P301, DOI 10.1016/0168-5597(92)90082-M; Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Amedi A, 2010, RESTOR NEUROL NEUROS, V28, P143, DOI [10.3233/RNN-2010-0503, 10.3233/RNN-2010-0497]; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Bjoertomt O, 2009, J NEUROPSYCHOL, V3, P31, DOI 10.1348/174866408X394604; Bolognini N, 2012, CEREB CORTEX, V22, P2055, DOI 10.1093/cercor/bhr283; Bolton DAE, 2011, NEUROPSYCHOLOGIA, V49, P1928, DOI 10.1016/j.neuropsychologia.2011.03.020; Burton H, 2004, HUM BRAIN MAPP, V23, P210, DOI 10.1002/hbm.20064; Burton H, 2010, HUM BRAIN MAPP, V31, P1686, DOI 10.1002/hbm.20966; Carbonell F, 2004, NEUROIMAGE, V22, P268, DOI 10.1016/j.neuroimage.2004.01.020; Cattaneo Z, 2008, NEUROSCI BIOBEHAV R, V32, P1346, DOI 10.1016/j.neubiorev.2008.05.002; Champoux F, 2011, PSYCHOL SCI, V22, P19, DOI 10.1177/0956797610391099; Cohen LG, 1999, ANN NEUROL, V45, P451, DOI 10.1002/1531-8249(199904)45:4<451::AID-ANA6>3.0.CO;2-B; Collignon O, 2006, BRAIN RES, V1075, P175, DOI 10.1016/j.brainres.2005.12.079; Collignon O, 2009, BRAIN TOPOGR, V21, P232, DOI 10.1007/s10548-009-0075-8; Collignon O, 2007, CEREB CORTEX, V17, P457, DOI 10.1093/cercor/bhj162; Cooke SF, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0284; De Volder AG, 2001, NEUROIMAGE, V14, P129, DOI 10.1006/nimg.2001.0782; Deibert E, 1999, NEUROLOGY, V52, P1413, DOI 10.1212/WNL.52.7.1413; DESMEDT JE, 1989, ELECTROEN CLIN NEURO, V74, P321, DOI 10.1016/0168-5597(89)90001-4; DESMEDT JE, 1983, ELECTROEN CLIN NEURO, V56, P272, DOI 10.1016/0013-4694(83)90252-3; Ding SL, 2009, J COMP NEUROL, V514, P595, DOI 10.1002/cne.22053; Foxe JJ, 2005, NEUROREPORT, V16, P419, DOI 10.1097/00001756-200504040-00001; Frot M, 1999, CEREB CORTEX, V9, P854, DOI 10.1093/cercor/9.8.854; Gilley PM, 2008, BRAIN RES, V1239, P56, DOI 10.1016/j.brainres.2008.08.026; Gordon KA., 2011, COCHLEAR IMPLANTS S2, V12, pS8, DOI DOI 10.1179/146701011X13074645127199; Hegner YL, 2010, J NEUROPHYSIOL, V103, P3115, DOI 10.1152/jn.00940.2009; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; Kanno A, 2003, NEUROIMAGE, V18, P169, DOI 10.1006/nimg.2002.1283; Karlen SJ, 2006, NEUROSCIENCE, V142, P843, DOI 10.1016/j.neuroscience.2006.06.055; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Lacey S, 2009, BRAIN TOPOGR, V21, P269, DOI 10.1007/s10548-009-0087-4; Lage-Castellanos A, 2010, STAT MED, V29, P63, DOI 10.1002/sim.3784; Legon W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051177; Lewis LB, 2010, J NEUROPHYSIOL, V104, P2995, DOI 10.1152/jn.00983.2009; Lucan JN, 2010, HUMAN BRAIN MAPPING; Miquee A, 2008, NEUROSCIENCE, V152, P29, DOI 10.1016/j.neuroscience.2007.12.021; MORRONGIELLO BA, 1994, PERCEPTION, V23, P833, DOI 10.1068/p230833; Nihashi T, 2005, CLIN NEUROPHYSIOL, V116, P842, DOI 10.1016/j.clinph.2004.10.011; Norman JF, 2011, ATTEN PERCEPT PSYCHO, V73, P2323, DOI 10.3758/s13414-011-0160-4; Ortiz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023264; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Ponton CW, 1996, NEUROREPORT, V8, P61, DOI 10.1097/00001756-199612200-00013; Sathian K, 2010, RESTOR NEUROL NEUROS, V28, P271, DOI 10.3233/RNN-2010-0534; Sehatpour P, 2008, P NATL ACAD SCI USA, V105, P4399, DOI 10.1073/pnas.0708418105; SHIMIZU Y, 1995, PERCEPT MOTOR SKILL, V80, P1069, DOI 10.2466/pms.1995.80.3c.1069; Stilla R, 2008, HUM BRAIN MAPP, V29, P1123, DOI 10.1002/hbm.20456; Sutherland MT, 2006, NEUROIMAGE, V33, P1042, DOI 10.1016/j.neuroimage.2006.08.015; Trujillo-Barreto NJ, 2004, NEUROIMAGE, V21, P1300, DOI 10.1016/j.neuroimage.2003.11.008; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wimmer VC, 2010, J COMP NEUROL, V518, P4629, DOI 10.1002/cne.22483; Zhang MM, 2004, COGN AFFECT BEHAV NE, V4, P251, DOI 10.3758/CABN.4.2.251	53	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0124527	10.1371/journal.pone.0124527	http://dx.doi.org/10.1371/journal.pone.0124527			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225827	gold, Green Submitted, Green Published			2022-12-27	WOS:000358837700001
J	Andriollo, T; Naciri, Y; Ruedi, M				Andriollo, Tommy; Naciri, Yamama; Ruedi, Manuel			Two Mitochondrial Barcodes for one Biological Species: The Case of European Kuhl's Pipistrelles (Chiroptera)	PLOS ONE			English	Article							BATS MAMMALIA CHIROPTERA; POSTGLACIAL COLONIZATION; MICROSATELLITE LOCI; CRYPTIC DIVERSITY; GENETIC-STRUCTURE; PHYLOGEOGRAPHY; INFERENCE; PATTERNS; VESPERTILIONIDAE; IDENTIFICATION	The Kuhl's pipistrelle (Pipistrellus kuhlii) is a Western Palaearctic species of bat that exhibits several deeply divergent mitochondrial lineages across its range. These lineages could represent cryptic species or merely ancient polymorphism, but no nuclear markers have been studied so far to properly assess the taxonomic status of these lineages. We examined here two lineages occurring in Western Europe, and used both mitochondrial and nuclear markers to measure degrees of genetic isolation between bats carrying them. The sampling focused on an area of strict lineage sympatry in Switzerland but also included bats from further south, in North Africa. All individuals were barcoded for the COI gene to identify their mitochondrial lineages and five highly polymorphic microsatellite loci were used to cluster them according to their nuclear genotypes. Despite this low number of nuclear markers, all North African nuclear genotypes were grouped in a highly distinct subpopulation when compared with European samples sharing the same mitochondrial barcodes. The reverse situation prevailed in Switzerland where bats carrying distinct barcodes had similar nuclear genotypes. There was a weak east/west nuclear structure of populations, but this was independent of mitochondrial lineages as bats carrying either variant were completely admixed. Thus, the divergent mitochondrial barcodes present in Western Europe do not represent cryptic species, but are part of a single biological species. We argue that these distinct barcodes evolved in allopatry and came recently into secondary contact in an area of admixture north of the Alps. Historical records from this area and molecular dating support such a recent bipolar spatial expansion. These results also highlight the need for using appropriate markers before claiming the existence of cryptic species based on highly divergent barcodes.	[Andriollo, Tommy; Ruedi, Manuel] Museum Hist Nat Ville Geneve, CH-1211 Geneva 6, Switzerland; [Andriollo, Tommy; Naciri, Yamama] Univ Geneva, Fac Sci, Biol Sect, CH-1211 Geneva 4, Switzerland; [Naciri, Yamama] Conservatoire & Jardin Bot Ville Geneve, CH-1292 Geneva, Switzerland; [Naciri, Yamama] Univ Geneva, CH-1292 Geneva, Switzerland	University of Geneva; University of Geneva	Andriollo, T (corresponding author), Museum Hist Nat Ville Geneve, BP 6434, CH-1211 Geneva 6, Switzerland.	tommy.andriollo@ville-ge.ch	Naciri, Yamama/ABB-7091-2021; Naciri, Yamama/E-6120-2012	Naciri, Yamama/0000-0001-6784-8565; Naciri, Yamama/0000-0001-6784-8565; Andriollo, Tommy/0000-0003-3922-7475	Societe Academique de Geneve; Ville de Geneve; Swiss Barcode of Life (SwissBOL) initiative	Societe Academique de Geneve; Ville de Geneve; Swiss Barcode of Life (SwissBOL) initiative	This work received financial support from the Societe Academique de Geneve, the Ville de Geneve and the Swiss Barcode of Life (SwissBOL) initiative.	Andriollo T., 2015, THESIS U GENEVA GENE; Arlettaz R., 1989, Rhinolophe, V6, P7; Aulagnier S, 2008, PIPISTRELLUS KUHLII; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barratt EM, 1997, NATURE, V387, P138, DOI 10.1038/387138b0; Benda P, 2008, PIPISTRELLUS DESERTI; Benda P, 2015, MAMMALIA, V79, P419, DOI 10.1515/mammalia-2014-0024; Benda Petr, 2014, Acta Societatis Zoologicae Bohemicae, V78, P1; Benda Petr, 2012, Acta Societatis Zoologicae Bohemicae, V76, P163; Bogdanowicz W., 2004, HDB SAUGETIERE EUROP, P875; Bogdanowicz W, 2015, ZOOL J LINN SOC-LOND, V174, P635, DOI 10.1111/zoj.12248; Boston ESM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2605; Boston ESM, 2014, ACTA CHIROPTEROL, V16, P263, DOI 10.3161/150811014X687233; Bray TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057306; Burland TM, 1998, MOL ECOL, V7, P136; Castella V, 2001, J EVOLUTION BIOL, V14, P708, DOI 10.1046/j.1420-9101.2001.00331.x; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Coraman E, 2013, CONSERV GENET, V14, P1205, DOI 10.1007/s10592-013-0509-4; Daavalos LM, 2014, J MAMMAL, V95, P781, DOI 10.1644/14-MAMM-A-107; Dietz C, 2009, HDB BATS BRITAIN EUR; Dietz C, 2004, ILLUSTRATED IDENTIFI; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evin A, 2011, J ZOOL, V284, P31, DOI 10.1111/j.1469-7998.2010.00778.x; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Flanders J, 2009, MOL ECOL, V18, P306, DOI 10.1111/j.1365-294X.2008.04021.x; Fluxus Technology, 2014, NETW V 4 6 1 2 PHYL; Galimberti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040122; Garcia-Mudarra JL, 2009, BIOL J LINN SOC, V96, P434, DOI 10.1111/j.1095-8312.2008.01128.x; Gebhard J., 1988, Myotis, V26, P173; GeneCodes, 2010, GENECODES SEQ; Goudet J, 2002, FSTAT 2 9 3 2 PROGRA; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Haffner M, 1991, REV SUISSE ZOOL, V98, P702; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ibanez C, 2006, ACTA CHIROPTEROL, V8, P277, DOI 10.3161/1733-5329(2006)8[277:TICTCD]2.0.CO;2; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jesus J, 2013, HYSTRIX, V24, P177, DOI 10.4404/hystrix-24.2-8736; Juste J, 2004, MOL PHYLOGENET EVOL, V31, P1114, DOI 10.1016/j.ympev.2003.10.005; Juste J, 2013, ZOOL SCR, V42, P441, DOI 10.1111/zsc.12020; Keller A., 1988, Rhinolophe, V5, P31; Kruskop SV, 2012, ACTA CHIROPTEROL, V14, P1, DOI 10.3161/150811012X654222; Kuhl H, 1817, DIE DEUTSCHEN FLEDER; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mayer F, 2001, P ROY SOC B-BIOL SCI, V268, P1825, DOI 10.1098/rspb.2001.1744; Mayer F, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-4; MAYR E., 1991, PRINCIPLES SYSTEMATI, V2nd; Mayr E., 1963, ANIMAL SPECIES EVOLU; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pestano J, 2003, MOL PHYLOGENET EVOL, V26, P56, DOI 10.1016/S1055-7903(02)00307-X; Pfenninger M, 2007, MOL ECOL, V16, P1957, DOI 10.1111/j.1365-294X.2006.03136.x; Pritchard JK, 2000, GENETICS, V155, P945; Puechmaille SJ, 2012, MAMM BIOL, V77, P224, DOI 10.1016/j.mambio.2011.11.004; Racey PA, 2007, BIOL J LINN SOC, V90, P539, DOI 10.1111/j.1095-8312.2007.00746.x; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Razgour O, 2013, ECOL LETT, V16, P1258, DOI 10.1111/ele.12158; Rebelo H, 2012, MOL ECOL, V21, P2761, DOI 10.1111/j.1365-294X.2012.05566.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rutishauser MD, 2012, DIVERS DISTRIB, V18, P1107, DOI 10.1111/j.1472-4642.2012.00904.x; Sachanowicz K, 2006, ACTA CHIROPTEROL, V8, P543, DOI 10.3161/1733-5329(2006)8[543:FREOPK]2.0.CO;2; Safner T, 2011, INT J MOL SCI, V12, P865, DOI 10.3390/ijms12020865; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stadelmann B, 2004, J MAMMAL, V85, P133, DOI 10.1644/1545-1542(2004)085<0133:MSOTFB>2.0.CO;2; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turmelle AS, 2011, MOL ECOL, V20, P357, DOI 10.1111/j.1365-294X.2010.04947.x; Veith M, 2011, ACTA CHIROPTEROL, V13, P89, DOI 10.3161/150811011X578642; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Vonhof MJ, 2006, MOL ECOL, V15, P241, DOI 10.1111/j.1365-294X.2005.02801.x; Wei L, 2009, CONSERV GENET, V10, P677, DOI 10.1007/s10592-008-9613-2	81	23	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134881	10.1371/journal.pone.0134881	http://dx.doi.org/10.1371/journal.pone.0134881			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241944	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700077
J	Fu, LY; Zhang, HR; Lu, J; Zang, H; Lou, MH; Wang, GX				Fu, Liyong; Zhang, Huiru; Lu, Jun; Zang, Hao; Lou, Minghua; Wang, Guangxing			Multilevel Nonlinear Mixed-Effect Crown Ratio Models for Individual Trees of Mongolian Oak (Quercus mongolica) in Northeast China	PLOS ONE			English	Article							HEIGHT-DIAMETER MODEL; AREA INCREMENT MODEL; EVEN-AGED STANDS; PONDEROSA PINE; STONE PINE; SCOTS PINE; GROWTH; PREDICTION; ERROR; IMPACT	In this study, an individual tree crown ratio (CR) model was developed with a data set from a total of 3134 Mongolian oak (Quercus mongolica) trees within 112 sample plots allocated in Wangqing Forest Bureau of northeast China. Because of high correlation among the observations taken from the same sampling plots, the random effects at levels of both blocks defined as stands that have different site conditions and plots were taken into account to develop a nested two-level nonlinear mixed-effect model. Various stand and tree characteristics were assessed to explore their contributions to improvement of model prediction. Diameter at breast height, plot dominant tree height and plot dominant tree diameter were found to be significant predictors. Exponential model with plot dominant tree height as a predictor had a stronger ability to account for the heteroskedasticity. When random effects were modeled at block level alone, the correlations among the residuals remained significant. These correlations were successfully reduced when random effects were modeled at both block and plot levels. The random effects from the interaction of blocks and sample plots on tree CR were substantially large. The model that took into account both the block effect and the interaction of blocks and sample plots had higher prediction accuracy than the one with the block effect and population average considered alone. Introducing stand density into the model through dummy variables could further improve its prediction. This implied that the developed method for developing tree CR models of Mongolian oak is promising and can be applied to similar studies for other tree species.	[Fu, Liyong; Zhang, Huiru; Lu, Jun; Zang, Hao; Lou, Minghua] Chinese Acad Forestry, Res Inst Forest Resource Informat Tech, Beijing 100091, Peoples R China; [Wang, Guangxing] Cent South Univ Forestry & Technol, Res Ctr Forestry Remote Sensing & Informat Engn, Changsha 410004, Hunan, Peoples R China; [Wang, Guangxing] So Illinois Univ, Dept Geog & Environm Resources, Carbondale, IL 62901 USA	Chinese Academy of Forestry; Research Institute of Forest Resources Information Technique, CAF; Central South University of Forestry & Technology; Southern Illinois University System; Southern Illinois University	Wang, GX (corresponding author), Cent South Univ Forestry & Technol, Res Ctr Forestry Remote Sensing & Informat Engn, Changsha 410004, Hunan, Peoples R China.	gxwang@siu.edu		zhang, huiru/0000-0003-4415-985X	National Science and Technology Support Project of the Twelfth Five-year Plan of China [2012BAD22B02]; Chinese National Natural Science Foundation [31300534]; Central South University of Forestry and Technology [112-0990]	National Science and Technology Support Project of the Twelfth Five-year Plan of China; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Central South University of Forestry and Technology	The authors acknowledge the National Science and Technology Support Project of the Twelfth Five-year Plan of China (Nos. 2012BAD22B02), the Chinese National Natural Science Foundation (Nos. 31300534), and the Central South University of Forestry and Technology (Nos. 112-0990) for financial support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adame P, 2008, FOREST ECOL MANAG, V256, P88, DOI 10.1016/j.foreco.2008.04.006; Assmann E., 1970, PRINCIPLES FOREST YI; BELLA IE, 1971, FOREST SCI, V17, P364; Bragg Don C., 2001, Northern Journal of Applied Forestry, V18, P22; Calama R, 2005, SILVA FENN, V39, P37, DOI 10.14214/sf.394; Calama R, 2004, CAN J FOREST RES, V34, P150, DOI [10.1139/x03-199, 10.1139/X03-199]; Clutter JL, 1983, TIMBER MANAGEMENT QU; Crecente-Campo F, 2010, FOREST ECOL MANAG, V259, P943, DOI 10.1016/j.foreco.2009.11.036; Davidian M., 1995, NONLINEAR MODELS REP; Du JiShan, 2000, Scientia Silvae Sinicae, V36, P26; Eerikainen K, 2003, FOREST ECOL MANAG, V175, P355, DOI 10.1016/S0378-1127(02)00138-X; F.S. Popoola, 2012, Journal of forest and environmental science, V28, P63; Fang ZX, 2001, FOREST SCI, V47, P287; Fiala ACS, 2006, FOREST ECOL MANAG, V232, P188, DOI 10.1016/j.foreco.2006.05.069; Fox JC, 2001, FOREST ECOL MANAG, V154, P261, DOI 10.1016/S0378-1127(00)00632-0; Fu LY, 2013, FOREST ECOL MANAG, V302, P210, DOI 10.1016/j.foreco.2013.03.036; Fuller W.A., 2009, MEASUREMENT ERROR MO; GERTNER GZ, 1990, CAN J FOREST RES, V20, P800, DOI 10.1139/x90-105; GHOSH S, 1995, FOREST SCI, V41, P235; Gregoire TG, 1995, CAN J FOREST RES, V1, P25, DOI DOI 10.1139/X95-017; Hall DB, 2001, FOREST SCI, V47, P311; Hasenauer H, 1996, FOREST ECOL MANAG, V84, P49, DOI 10.1016/0378-1127(96)03768-1; HENDERSON CR, 1959, BIOMETRICS, V15, P192, DOI 10.2307/2527669; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Huuskonen S, 2007, FOREST ECOL MANAG, V241, P49, DOI 10.1016/j.foreco.2006.12.024; KERSHAW JA, 1990, CAN J FOREST RES, V20, P1690, DOI 10.1139/x90-225; Leites LP, 2009, CAN J FOREST RES, V39, P655, DOI 10.1139/X08-205; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; McGaughey R.J., 1997, P 1997 ACSM ASPRS AN, V4, P248; MCROBERTS RE, 1994, CAN J FOREST RES, V24, P1766, DOI 10.1139/x94-228; Meng SX, 2009, FOREST SCI, V55, P238; Monserud RA, 1996, FOREST ECOL MANAG, V80, P57, DOI 10.1016/0378-1127(95)03638-5; Nanos N, 2004, FOREST ECOL MANAG, V195, P221, DOI 10.1016/j.foreco.2004.02.031; Navratil S., 1997, Proceedings of a commercial thinning workshop, Whitecourt, Alberta, October 17-18, 1996., P29; NICHOLAS NS, 1991, CAN J FOREST RES, V21, P698, DOI 10.1139/x91-095; O'Hara KL, 1999, FOREST ECOL MANAG, V118, P57, DOI 10.1016/S0378-1127(98)00486-1; OMULE SAY, 1980, FOREST CHRON, V56, P222, DOI 10.5558/tfc56222-5; Pinheiro J. C., 1995, J COMPUTATIONAL GRAP, V4, P12, DOI [DOI 10.2307/1390625, 10.1080/10618600.1995.10474663, DOI 10.1080/10618600.1995.10474663]; Pinherio JC., 2000, MIXED EFFECTS MODELS; Raulier F, 2003, FOREST ECOL MANAG, V184, P65, DOI 10.1016/S0378-1127(03)00149-X; Reineke LH, 1933, J AGRIC RES, V46, P0627; Rijal B, 2012, FOREST CHRON, V88, P60, DOI 10.5558/tfc2012-011; Sanchez-Gonzalez M, 2007, INVEST AGRAR-SIST R, V16, P76, DOI 10.5424/srf/2007161-00999; Sharma M, 2009, FOREST SCI, V55, P268; Soares P, 2001, ANN FOREST SCI, V58, P193, DOI 10.1051/forest:2001118; Sonmez T, 2009, AFR J AGR RES, V4, P214; SPRINZ PT, 1987, CAN J FOREST RES, V17, P534, DOI 10.1139/x87-089; Spurr S.H., 1980, FOREST ECOLOGY; Tahvanainen T, 2008, FOREST ECOL MANAG, V255, P455, DOI 10.1016/j.foreco.2007.09.035; Tang S., 1998, J BIOMATH, V13, P161; Tang SZ, 2001, ECOL MODEL, V142, P285, DOI 10.1016/S0304-3800(01)00326-X; Temesgen H, 2008, CAN J FOREST RES, V38, P553, DOI 10.1139/X07-104; Temesgen H, 2005, FOREST CHRON, V81, P133, DOI 10.5558/tfc81133-1; Toney C, 2009, WEST J APPL FOR, V24, P76, DOI 10.1093/wjaf/24.2.76; Uzoh FCC, 2008, FOREST ECOL MANAG, V256, P438, DOI 10.1016/j.foreco.2008.04.046; Uzoh FCC, 2006, FOREST ECOL MANAG, V221, P147, DOI 10.1016/j.foreco.2005.09.012; Venables W., 2013, MODERN APPL STAT S, V53, P86; Vonesh E.F., 1997, LINEAR NONLINEAR MOD; WEST PW, 1984, FOREST ECOL MANAG, V7, P207, DOI 10.1016/0378-1127(84)90068-9; Wykoff W.R., 1982, INT133 USDA; Yang YQ, 2011, CAN J FOREST RES, V41, P1671, DOI [10.1139/x11-071, 10.1139/X11-071]; Yang YQ, 2009, CAN J FOREST RES, V39, P2203, DOI 10.1139/X09-123; Zhao D, 2012, OPEN J FORESTRY, V2, P107	63	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133294	10.1371/journal.pone.0133294	http://dx.doi.org/10.1371/journal.pone.0133294			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241912	gold, Green Submitted, Green Published			2022-12-27	WOS:000358942700012
J	An, DG; Zheng, Q; Luo, QL; Ma, PT; Zhang, HX; Li, LH; Han, FP; Xu, HX; Xu, YF; Zhang, XT; Zhou, YL				An, Diaoguo; Zheng, Qi; Luo, Qiaoling; Ma, Pengtao; Zhang, Hongxia; Li, Lihui; Han, Fangpu; Xu, Hongxing; Xu, Yunfeng; Zhang, Xiaotian; Zhou, Yilin			Molecular Cytogenetic Identification of a New Wheat-Rye 6R Chromosome Disomic Addition Line with Powdery Mildew Resistance	PLOS ONE			English	Article							TRITICUM-AESTIVUM-L.; SECALE-CEREALE; HEXAPLOID WHEAT; GENE; TRANSLOCATIONS; LOCATION; INTROGRESSION; HYBRIDIZATION; SUBSTITUTION; IMPROVEMENT	Rye (Secale cereale L.) possesses many valuable genes that can be used for improving disease resistance, yield and environment adaptation of wheat (Triticum aestivum L.). However, the documented resistance stocks derived from rye is faced severe challenge due to the variation of virulent isolates in the pathogen populations. Therefore, it is necessary to develop desirable germplasm and search for novel resistance gene sources against constantly accumulated variation of the virulent isolates. In the present study, a new wheat-rye line designated as WR49-1 was produced through distant hybridization and chromosome engineering protocols between common wheat cultivar Xiaoyan 6 and rye cultivar German White. Using sequential GISH (genomic in situ hybridization), mc-FISH (multicolor fluorescence in situ hybridization), mc-GISH (multicolor GISH) and EST (expressed sequence tag)-based marker analysis, WR49-1 was proved to be a new wheat-rye 6R disomic addition line. As expected, WR49-1 showed high levels of resistance to wheat powdery mildew (Blumeria graminis f. sp. tritici, Bgt) pathogens prevalent in China at the adult growth stage and 19 of 23 Bgt isolates tested at the seedling stage. According to its reaction pattern to different Bgt isolates, WR49-1 may possess new resistance gene(s) for powdery mildew, which differed from the documented powdery mildew gene, including Pm20 on chromosome arm 6RL of rye. Additionally, WR49-1 was cytologically stable, had improved agronomic characteristics and therefore could serve as an important bridge for wheat breeding and chromosome engineering.	[An, Diaoguo; Luo, Qiaoling; Ma, Pengtao; Zhang, Hongxia; Xu, Hongxing; Xu, Yunfeng; Zhang, Xiaotian] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Shijiazhuang, Peoples R China; [Zheng, Qi; Han, Fangpu] Chinese Acad Sci, State Key Lab Plant Cell & Chromosome Engn, Inst Genet & Dev Biol, Beijing, Peoples R China; [Li, Lihui] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China; [Zhou, Yilin] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	An, DG (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Shijiazhuang, Peoples R China.	dgan@sjziam.ac.cn		Xu, Yunfeng/0000-0001-6669-4349	National Natural Science Foundation of China [(31171550]; National High-Tech Research and Development Program of China [2011AA1001]; National Scientific and Technological Supporting Program of China [2013BAD01B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Scientific and Technological Supporting Program of China	This work was supported by the National Natural Science Foundation of China (31171550) (http://www.nsfc.gov.cn/) to DGA, National High-Tech Research and Development Program of China (2011AA1001) (http://www.863.gov.cn/) to DGA, and National Scientific and Technological Supporting Program of China (2013BAD01B02) (http://www.most.gov.cn/) to DGA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhimova AG, 1999, CHROMOSOME RES, V7, P205, DOI 10.1023/A:1009299300018; An DG, 2003, ACTA AGRO SIN, V6, P955; An DG, 2006, J INTEGR PLANT BIOL, V48, P838, DOI 10.1111/j.1744-7909.2006.00275.x; An DG, 2013, CHROMOSOME RES, V21, P419, DOI 10.1007/s10577-013-9366-8; Cui Lei, 2012, Acta Agronomica Sinica, V38, P1009, DOI 10.3724/SP.J.1006.2012.01009; CURTIS CA, 1993, PLANT BREEDING, V111, P106, DOI 10.1111/j.1439-0523.1993.tb00615.x; Dundas IS, 2001, CROP SCI, V41, P1771, DOI 10.2135/cropsci2001.1771; Endo TR, 2007, CHROMOSOME RES, V15, P67, DOI 10.1007/s10577-006-1100-3; Falke KC, 2009, THEOR APPL GENET, V118, P1225, DOI 10.1007/s00122-009-0976-7; Farshadfar E., 2013, Australian Journal of Crop Science, V7, P130; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; FRIEBE B, 1991, THEOR APPL GENET, V83, P33, DOI 10.1007/BF00229223; Fu SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070483; Fu SL, 2012, J GENET GENOMICS, V39, P103, DOI 10.1016/j.jgg.2011.11.008; Gallego FJ, 1997, THEOR APPL GENET, V95, P393, DOI 10.1007/s001220050575; He ZhongHu, 2011, Scientia Agricultura Sinica, V44, P2193; HEUN M, 1990, PHYTOPATHOLOGY, V80, P1129, DOI 10.1094/Phyto-80-1129; HEUN M, 1990, PHYTOPATHOLOGY, V80, P242, DOI 10.1094/Phyto-80-242; Hsam SLK, 1997, PLANT BREEDING, V116, P119, DOI 10.1111/j.1439-0523.1997.tb02164.x; Hu H, 1990, PLANT CELL ENG BREED; Huang J, 2012, MOL BREEDING, V30, P1737, DOI 10.1007/s11032-012-9757-0; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; Lee TG, 2009, THEOR APPL GENET, V119, P663, DOI 10.1007/s00122-009-1077-3; Li HongJie, 2011, Acta Agronomica Sinica, V37, P943, DOI 10.3724/SP.J.1006.2011.00943; Li ZS, 2008, J GENET GENOMICS, V35, P451, DOI 10.1016/S1673-8527(08)60062-4; Lind V., 1982, Tagungsbericht, Akademie der Landwirtschaftswissenschaften der Deutschen Demokratischen Republik, P509; Lukaszewski A. J., 1988, Proceedings of the seventh international wheat genetics symposium, held at Cambridge, UK, 13-19 July 1988., P363; Ma PT, 2015, THEOR APPL GENET, V128, P613, DOI 10.1007/s00122-015-2457-5; McDonald BA, 2002, EUPHYTICA, V124, P163, DOI 10.1023/A:1015678432355; MILLER TE, 1984, CAN J GENET CYTOL, V26, P578, DOI 10.1139/g84-091; MUKAI Y, 1993, GENOME, V36, P489, DOI 10.1139/g93-067; Pedersen C, 1997, GENOME, V40, P589, DOI 10.1139/g97-077; Rabinovich SV, 1998, EUPHYTICA, V100, P323, DOI 10.1023/A:1018361819215; SHARP PJ, 1988, THEOR APPL GENET, V75, P286, DOI 10.1007/BF00303966; Sheng BQ, 1991, BEIJING AGR SCI, V1, P38; Si Q.M., 1992, ACTA PHYTOPATHOL SIN, V22, P349, DOI [10.13926/j.cnki.apps.1992.04.021, DOI 10.13926/J.CNKI.APPS.1992.04.021]; Szakacs E, 2010, J APPL GENET, V51, P149, DOI 10.1007/BF03195723; Taylor C, 1998, THEOR APPL GENET, V97, P1000, DOI 10.1007/s001220050984; Wan P, 2007, EUPHYTICA, V155, P125, DOI 10.1007/s10681-006-9313-2; Wang CM, 2009, CEREAL RES COMMUN, V37, P13, DOI 10.1556/CRC.37.2009.1.2; Wang CM, 2009, PLANT DIS, V93, P124, DOI 10.1094/PDIS-93-2-0124; Wang D, 2010, EUPHYTICA, V176, P157, DOI 10.1007/s10681-010-0199-7; Xu H, 2012, CYTOGENET GENOME RES, V136, P220, DOI 10.1159/000336478; Zheng Q, 2006, EUPHYTICA, V152, P51, DOI 10.1007/s10681-006-9176-6; Zhong G. C., 2002, WHEAT DISTANT HYBRID; Zhuang QS., 2003, CHINESE WHEAT IMPROV	46	36	36	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134534	10.1371/journal.pone.0134534	http://dx.doi.org/10.1371/journal.pone.0134534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237413	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942400028
J	Evans-Marin, HL; Cao, AT; Yao, SX; Chen, FD; He, C; Liu, H; Wu, W; Gonzalez, MG; Dann, SM; Cong, YZ				Evans-Marin, Heather L.; Cao, Anthony T.; Yao, Suxia; Chen, Feidi; He, Chong; Liu, Han; Wu, Wei; Gonzalez, Maria G.; Dann, Sara M.; Cong, Yingzi			Unexpected Regulatory Role of CCR9 in Regulatory T Cell Development	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CHEMOKINE RECEPTOR; INTESTINAL INFLAMMATION; EXPERIMENTAL COLITIS; CXCL12 SDF-1-ALPHA; CROHNS-DISEASE; INDUCTION; STIMULATION; MECHANISMS	T cells reactive to microbiota regulate the pathogenesis of inflammatory bowel disease (IBD). As T cell trafficking to intestines is regulated through interactions between highly specific chemokine-chemokine receptors, efforts have been made to develop intestine-specific immunosuppression based on blocking these key processes. CCR9, a gut-trophic chemokine receptor expressed by lymphocytes and dendritic cells, has been implicated in the regulation of IBD through mediating recruitment of T cells to inflamed sites. However, the role of CCR9 in inducing and sustaining inflammation in the context of IBD is poorly understood. In this study, we demonstrate that CCR9 deficiency in effector T cells and Tregs does not affect the development of colitis in a microbiota antigen-specific, T cell-mediated model. However, Treg cells express higher levels of CCR9 compared to those in effector T cells. Interestingly, CCR9 inhibits Treg cell development, in that CCR9(-/)-mice demonstrate a high level of Foxp3(+) Tregs, and ligation of CCR9 by its ligand CCL25 inhibits Treg cell differentiation in vitro. Collectively, our data indicate that in addition to acting as a gut-homing molecule, CCR9 signaling shapes immune responses by inhibiting Treg cell development.	[Evans-Marin, Heather L.; Cao, Anthony T.; Yao, Suxia; He, Chong; Liu, Han; Wu, Wei; Cong, Yingzi] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Chen, Feidi; Cong, Yingzi] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [He, Chong; Wu, Wei] Tongji Univ, Dept Gastroenterol, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China; [Liu, Han] Shandong Univ, Dept Gastroenterol, Qilu Hosp, Jinan, Shandong, Peoples R China; [Gonzalez, Maria G.] Univ Texas Med Branch, Sch Med, Galveston, TX 77555 USA; [Dann, Sara M.] Univ Texas Med Branch, Dept Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Tongji University; Shandong University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Cong, YZ (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.	yicong@utmb.edu	Liu, Han/GVT-8296-2022	Dann, Sara/0000-0002-6893-2838; Cong, Yingzi/0000-0003-4167-7395	National Institutes of Health [DK079918, DK098370]; J.W. McLaughlin Predoctoral Fellowship, UTMB; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079918, R01DK098370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J.W. McLaughlin Predoctoral Fellowship, UTMB; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by DK079918 National Institutes of Health (www.nih.gov) and DK098370 National Institutes of Health (www.nih.gov) to YC. HLE is a recipient of the J.W. McLaughlin Predoctoral Fellowship, UTMB.	Baumgart DC, 2009, DTSCH ARZTEBL INT, V106, P123, DOI 10.3238/arztebl.2009.0123; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Cassani B, 2011, GASTROENTEROLOGY, V141, P2109, DOI 10.1053/j.gastro.2011.09.015; Cong Y, GUT MICROBES, V3, P332; Danese S, 2014, GASTROENTEROLOGY, V147, P981, DOI 10.1053/j.gastro.2014.08.044; Eberhardson M, 2013, CLIN IMMUNOL, V149, P73, DOI 10.1016/j.clim.2013.05.021; Evans-Marin Heather L., 2014, Inflammation & Allergy Drug Targets, V13, P65; Feng T, 2011, J IMMUNOL, V186, P6313, DOI 10.4049/jimmunol.1001454; Feng T, 2010, J EXP MED, V207, P1321, DOI 10.1084/jem.20092253; Hart AL, 2010, INFLAMM BOWEL DIS, V16, P1969, DOI 10.1002/ibd.21304; Hosoe N, 2004, AM J PHYSIOL-GASTR L, V286, pG458, DOI 10.1152/ajpgi.00167.2003; Johnson EL, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-15; Karin N, 2010, J LEUKOCYTE BIOL, V88, P463, DOI 10.1189/jlb.0909602; Karlsson F, 2013, INFLAMM BOWEL DIS, V19, P2282, DOI 10.1097/MIB.0b013e31829c32dd; Keshav S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060094; Linton L, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.23; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Monteleone G, 2008, MUCOSAL IMMUNOL, V1, pS50, DOI 10.1038/mi.2008.55; Nanki T, 2000, J IMMUNOL, V164, P5010, DOI 10.4049/jimmunol.164.10.5010; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Ohoka Y, 2011, J IMMUNOL, V186, P733, DOI 10.4049/jimmunol.1000913; Rivera-Nieves J, 2006, GASTROENTEROLOGY, V131, P1518, DOI 10.1053/j.gastro.2006.08.031; Sapir Y, 2010, J IMMUNOL, V185, P2589, DOI 10.4049/jimmunol.1000666; Saruta M, 2007, J IMMUNOL, V178, P3293, DOI 10.4049/jimmunol.178.5.3293; Schmidt A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00051; Shachar I, 2013, J LEUKOCYTE BIOL, V93, P51, DOI 10.1189/jlb.0612293; Shale M, 2013, IMMUNOL REV, V252, P164, DOI 10.1111/imr.12039; Sharma PK, 2010, INT J CANCER, V127, P2020, DOI 10.1002/ijc.25219; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; Villablanca EJ, 2011, GASTROENTEROLOGY, V140, P1776, DOI 10.1053/j.gastro.2011.02.015; Walters MJ, 2010, J PHARMACOL EXP THER, V335, P61, DOI 10.1124/jpet.110.169714; Wermers JD, 2011, GASTROENTEROLOGY, V140, P1526, DOI 10.1053/j.gastro.2011.01.044; Wurbel MA, 2014, INFLAMM BOWEL DIS, V20, P1165, DOI 10.1097/MIB.0000000000000059; Wurbel MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016442; Zohar Y, 2014, J CLIN INVEST, V124, P2009, DOI 10.1172/JCI71951	36	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134100	10.1371/journal.pone.0134100	http://dx.doi.org/10.1371/journal.pone.0134100			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230654	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400071
J	Martinez-Cuenca, MR; Martinez-Alcantara, B; Quinones, A; Ruiz, M; Iglesias, DJ; Primo-Millo, E; Forner-Giner, MA				Martinez-Cuenca, Mary-Rus; Martinez-Alcantara, Belen; Quiones, Ana; Ruiz, Marta; Iglesias, Domingo J.; Primo-Millo, Eduardo; Angeles Forner-Giner, M.			Physiological and Molecular Responses to Excess Boron in Citrus macrophylla W	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; OXIDATIVE STRESS; MESSENGER-RNA; BORIC-ACID; RT-PCR; TOLERANCE; TRANSPORTER; EXPRESSION; TOXICITY; PLANTS	This work provides insight into several mechanisms involved in boron (B) regulation pathway in response to high B conditions in Citrus. The study was carried out in Citrus macrophylla W. (Cm) seedlings cultured "in vitro" in media with 50 or 400 mu M H3BO3 (control, Ct, and B-excess, +B, plants, respectively). Growth parameters, B concentration, leaf chlorophyll (Chl) concentration, the expression of the main putative genes involved in B transport and distribution, and leaf and root proline and malonaldehyde (MDA) concentrations, were assessed. Excess B led to high B concentration in +B plants (3.8- and 1.4-fold in leaves and roots, respectively) when compared with Ct ones. However, a minor effect was recorded in the plant (incipient visual symptoms, less than 27% reduction in root growth and 26% decrease in Chl b concentration). B toxicity down-regulated by half the expression level of putative B transporter genes NIP5 and PIP1. CmBOR1 gene was not repressed in +B plants and B accumulated in the shoots. High B level increased the transcripts of putative gene TIP5, involved in B transport across the tonoplast, by 3.3- and 2.4-fold in leaves and roots, respectively. The activity of V-PPiase proton pump, related with the electrochemical gradient in the vacuole, was also enhanced in +B organs. B toxicity up-regulated putative BOR4 gene (2.1- and 2.7-fold in roots and leaves, respectively), which codifies for an active efflux B transporter. Accordingly, B was located in +B plants preferently in an insoluble form on cell walls. Finally, excess B caused a significant rise in proline concentration (51% and 34% in roots and leaves, respectively), while the MDA level did not exceed 20%. In conclusion, Cm tolerance to a high B level is likely based on the synergism of several specific mechanisms against B toxicity, including: 1/ down-regulation of NIP5 and PIP1 boron transporters; 2/ activation of B efflux from cells due to the up-regulation of putative BOR4 gene; 3/ compartmentation of B in the vacuole through TIP5 transporter activation and the acidification of the organelle; 4/ insolubilisation of B and deposition in cell walls preventing from cytoplasm damage; and, 5/ induction of an efficient antioxidant system through proline accumulation.	[Martinez-Cuenca, Mary-Rus; Martinez-Alcantara, Belen; Quiones, Ana; Iglesias, Domingo J.; Primo-Millo, Eduardo; Angeles Forner-Giner, M.] Valencian Inst Agrarian Res, Dept Citriculture & Vegetal Prod, Valencia, Spain; [Ruiz, Marta] Valencian Inst Agrarian Res, Dept Vegetal Protect & Biotechnol, Valencia, Spain		Martinez-Cuenca, MR (corresponding author), Valencian Inst Agrarian Res, Dept Citriculture & Vegetal Prod, Valencia, Spain.	martinez_mru@gva.es	Iglesias, Domingo J./C-9000-2014; Forner-Giner, Angeles/D-5306-2014; Primo-Millo, Eduardo/D-8584-2014; Quinones, Ana/E-6229-2014; Martinez-Cuenca, Mary-Rus/K-7710-2015	Forner-Giner, Angeles/0000-0003-3237-0893; Primo-Millo, Eduardo/0000-0002-2146-0175; Quinones, Ana/0000-0002-6096-734X; Martinez-Cuenca, Mary-Rus/0000-0002-9017-2951; MARTINEZ ALCANTARA, BELEN/0000-0002-7816-4115; Ruiz, Marta/0000-0002-7818-4327	National Institute of Research and Agrarian and Food Technology [RTA2011-00127]; Valencian Generalitat; FEDER funds	National Institute of Research and Agrarian and Food Technology; Valencian Generalitat; FEDER funds(European Commission)	This work was funded by the National Institute of Research and Agrarian and Food Technology (RTA2011-00127), Valencian Generalitat and FEDER funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JC, 2012, SCI HORTIC-AMSTERDAM, V142, P149, DOI 10.1016/j.scienta.2012.05.013; Atik AE, 2011, TURK J BOT, V35, P379, DOI 10.3906/bot-1007-29; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Canon P, 2013, PHYSIOL PLANTARUM, V149, P329, DOI 10.1111/ppl.12037; Cervilla LM, 2007, ANN BOT-LONDON, V100, P747, DOI 10.1093/aob/mcm156; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; Claussen W, 2005, PLANT SCI, V168, P241, DOI 10.1016/j.plantsci.2004.07.039; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Embleton TW, 1973, CITRUS IND, V3, P145; Eraslan F, 2007, J PLANT NUTR, V30, P981, DOI 10.1080/15226510701373221; Frommer WB, 2002, NATURE, V420, P282, DOI 10.1038/420282a; Gimeno V, 2012, TREES-STRUCT FUNCT, V26, P1513, DOI 10.1007/s00468-012-0724-5; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gunes A, 2006, SCI HORTIC-AMSTERDAM, V110, P279, DOI 10.1016/j.scienta.2006.07.014; Hajiboland R, 2013, ACTA PHYSIOL PLANT, V35, P2373, DOI 10.1007/s11738-013-1272-3; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Hanitzsch M, 2007, MOL MEMBR BIOL, V24, P507, DOI 10.1080/09687680701447393; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hong ZL, 2000, PLANT PHYSIOL, V122, P1129, DOI 10.1104/pp.122.4.1129; Hu HN, 1996, J EXP BOT, V47, P227, DOI 10.1093/jxb/47.2.227; Kato Y, 2009, PLANT CELL PHYSIOL, V50, P58, DOI 10.1093/pcp/pcn168; Kaur S, 2006, FUNCT PLANT BIOL, V33, P973, DOI 10.1071/FP06111; Keles Y, 2004, PLANT SOIL, V265, P345, DOI 10.1007/s11104-005-0646-8; Legua P, 2014, SCI HORTIC-AMSTERDAM, V174, P60, DOI 10.1016/j.scienta.2014.05.004; Liu GD, 2013, PLANT SOIL, V370, P555, DOI 10.1007/s11104-013-1659-3; MAKKEE M, 1985, RECL TRAV CHIM PAY B, V104, P230; Martinez-Alcantara B, 2015, ENVIRON EXP BOT, V111, P52, DOI 10.1016/j.envexpbot.2014.11.002; Martinez-Ballesta MD, 2008, PHYSIOL PLANTARUM, V132, P479, DOI 10.1111/j.1399-3054.2007.01045.x; Mei L, 2011, SCI HORTIC-AMSTERDAM, V129, P426, DOI 10.1016/j.scienta.2011.04.012; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Miwa K, 2007, SCIENCE, V318, P1417, DOI 10.1126/science.1146634; Miwa K, 2006, PLANT J, V46, P1084, DOI 10.1111/j.1365-313X.2006.02763.x; Miwa K, 2010, ANN BOT-LONDON, V105, P1103, DOI 10.1093/aob/mcq044; Molassiotis A, 2006, ENVIRON EXP BOT, V56, P54, DOI 10.1016/j.envexpbot.2005.01.002; MORAN R, 1980, PLANT PHYSIOL, V65, P478, DOI 10.1104/pp.65.3.478; Nakagawa Y, 2007, PLANT CELL, V19, P2624, DOI 10.1105/tpc.106.049015; Nozawa A, 2006, FEMS MICROBIOL LETT, V262, P216, DOI 10.1111/j.1574-6968.2006.00395.x; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; Pandey N, 2013, ACTA PHYSIOL PLANT, V35, P697, DOI 10.1007/s11738-012-1110-z; Pang YQ, 2010, J GENET GENOMICS, V37, P389, DOI 10.1016/S1673-8527(09)60057-6; Papadakis IE, 2004, PLANT SCI, V166, P539, DOI 10.1016/j.plantsci.2003.10.027; Perez-Castro R, 2012, PLANT CELL PHYSIOL, V53, P485, DOI 10.1093/pcp/pcs001; Reid RJ, 2004, PLANT CELL ENVIRON, V27, P1405, DOI 10.1111/j.1365-3040.2004.01243.x; Reid R, 2007, PLANT CELL PHYSIOL, V48, P1673, DOI 10.1093/pcp/pcm159; Rodriguez-Gamir J, 2011, PLANT PHYSIOL BIOCH, V49, P636, DOI 10.1016/j.plaphy.2011.03.003; Schnurbusch T, 2010, PLANT PHYSIOL, V153, P1706, DOI 10.1104/pp.110.158832; Silva P, 2009, PLANT SIGNAL BEHAV, V4, P718, DOI 10.4161/psb.4.8.9236; Stiles AR, 2010, ENVIRON SCI TECHNOL, V44, P7089, DOI 10.1021/es1016334; Sun JH, 2012, MOL BIOL REP, V39, P1963, DOI 10.1007/s11033-011-0930-z; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Tanaka M, 2011, PLANT CELL, V23, P3547, DOI 10.1105/tpc.111.088351; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Yan JW, 2012, MOL BIOL REP, V39, P1831, DOI 10.1007/s11033-011-0925-9; Yang LT, 2012, MOL BIOL REP, V39, P6353, DOI 10.1007/s11033-012-1457-7; Zekri M, 2002, CITRUS IND, V83, P17	57	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134372	10.1371/journal.pone.0134372	http://dx.doi.org/10.1371/journal.pone.0134372			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225859	Green Published, gold			2022-12-27	WOS:000358837700081
J	Rapoport, A; Seale, DA; Colman, AM				Rapoport, Amnon; Seale, Darryl A.; Colman, Andrew M.			Is Tit-for-Tat the Answer? On the Conclusions Drawn from Axelrod's Tournaments	PLOS ONE			English	Article							PRISONERS-DILEMMA GAME; COOPERATION; EVOLUTION; STRATEGIES	Axelrod's celebrated Prisoner's Dilemma computer tournaments, published in the early 1980s, were designed to find effective ways of acting in everyday interactions with the strategic properties of the iterated Prisoner's Dilemma game. The winner of both tournaments was tit-for-tat, a program that cooperates on the first round and then, on every subsequent round, copies the co-player's choice from the previous round. This has been interpreted as evidence that tit-for-tat is an effective general-purpose strategy. By re-analyzing data from the first tournament and some more recent data, we provide new results suggesting that the efficacy of tit-for-tat is contingent on the design of the tournament, the criterion used to determine success, and the particular values chosen for the Prisoner's Dilemma payoff matrix. We argue that this places in doubt the generality of the results and the policy implications drawn from them.	[Rapoport, Amnon] Univ Calif Riverside, Sch Business Adm, Riverside, CA 92521 USA; [Seale, Darryl A.] Univ Nevada, Lee Business Sch, Las Vegas, NV 89154 USA; [Colman, Andrew M.] Univ Leicester, Sch Psychol, Leicester LE1 7RH, Leics, England	University of California System; University of California Riverside; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Leicester	Seale, DA (corresponding author), Univ Nevada, Lee Business Sch, 4505 Maryland Parkway Box 456009, Las Vegas, NV 89154 USA.	darryl.seale@unlv.edu	Colman, Andrew M./A-3322-2008; Colman, Andrew M./CBO-8743-2022	Colman, Andrew M./0000-0003-0499-3479; Colman, Andrew M./0000-0003-0499-3479	Leicester Judgment and Decision Making Endowment Fund [RM43G0176]	Leicester Judgment and Decision Making Endowment Fund	Preparation of this manuscript was supported by Grant RM43G0176 awarded by the Leicester Judgment and Decision Making Endowment Fund to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3193; Anatol R., 1965, PRISONERS DILEMMA ST; AXELROD R, 1980, J CONFLICT RESOLUT, V24, P379, DOI 10.1177/002200278002400301; Axelrod R, 1980, J CONFLICT RESOLUT, V24, P3, DOI 10.1177/002200278002400101; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Axelrod R, 2012, J THEOR BIOL, V299, P21, DOI 10.1016/j.jtbi.2011.04.015; BEER FA, 1986, J CONFLICT RESOLUT, V30, P171, DOI 10.1177/0022002786030001011; BENDOR J, 1991, J CONFLICT RESOLUT, V35, P691, DOI 10.1177/0022002791035004007; BENDOR J, 1993, J CONFLICT RESOLUT, V37, P709, DOI 10.1177/0022002793037004007; Colman AM, 2013, GAME THEORY ITS APPL; Colman AM, 2012, J THEOR BIOL, V299, P162, DOI 10.1016/j.jtbi.2011.05.022; Donninger C, 1986, PARADOXICAL EFFECTS, P123; Hilbe C, 2015, GAME ECON BEHAV, V92, P41, DOI 10.1016/j.geb.2015.05.005; HOFSTADTER DR, 1983, SCI AM, V248, P14; Humble J, 2004, PRISONERS DILEMMA TO; Jurisic M, 2012, P 35 INT CONV INF CO, P1093; Kendall Graham, 2007, ITERATED PRISONERS D; Kretz T, 2011, COMPLEX SYST, V19, P363; Li Y, 2014, PHYSICA A, V403, P284, DOI 10.1016/j.physa.2014.02.051; Luce R. D., 1989, GAMES DECISIONS INTR; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; OSKAMP S, 1971, J CONFLICT RESOLUT, V15, P225, DOI 10.1177/002200277101500207; Phelan S. E., 2005, Computational & Mathematical Organization Theory, V11, P339, DOI 10.1007/s10588-005-5589-3; Press WH, 2012, P NATL ACAD SCI USA, V109, P10409, DOI 10.1073/pnas.1206569109; RAPOPORT A, 1967, PSYCHOL REV, V74, P136, DOI 10.1037/h0024282; RAPOPORT A, 1984, BEHAV BRAIN SCI, V7, P114, DOI 10.1017/S0140525X00026467; SELTEN R, 1984, BEHAV BRAIN SCI, V7, P115, DOI 10.1017/S0140525X00026479; SMITH JM, 1984, BEHAV BRAIN SCI, V7, P95, DOI 10.1017/S0140525X00026327; Zhang JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090288	29	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134128	10.1371/journal.pone.0134128	http://dx.doi.org/10.1371/journal.pone.0134128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225422	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700058
J	Saavedra-Garcia, L; Bernabe-Ortiz, A; Gilman, RH; Diez-Canseco, F; Cardenas, MK; Sacksteder, KA; Miranda, JJ				Saavedra-Garcia, Lorena; Bernabe-Ortiz, Antonio; Gilman, Robert H.; Diez-Canseco, Francisco; Kathia Cardenas, Maria; Sacksteder, Katherine A.; Jaime Miranda, J.			Applying the Triangle Taste Test to Assess Differences between Low Sodium Salts and Common Salt: Evidence from Peru	PLOS ONE			English	Article							BLOOD-PRESSURE; POTASSIUM-CHLORIDE; RANDOMIZED-TRIALS; MORTALITY; REDUCTION; METAANALYSIS; MAGNESIUM; DISEASE; FLAVOR; ADULTS	Background In resourced-constrained settings, daily cooking practices are still the norm. Replacing sodium in regular salt to produce potassium-enriched salts are potential alternative routes to reduce sodium intake, paired with the benefit associated with potassium intake. This change would likely have effects on palatability and taste of prepared foods, yet a threshold to discriminate sensorial changes can be determined. The main goal of this study was to assess if the use of potassium-enriched salt substitutes lead to perceived differences in taste utilizing a sensory discrimination test. Methods and Results A triangle taste test was conducted and participants were offered samples of cooked rice prepared with different salts. The only ingredient that differed in the preparation was the salt used: 100% NaCl (regular salt) and salts where sodium was replaced by 50%, 33% or 25% KCl (potassium-enriched salt). Comparisons were carried out according to the minimum number of correct judgments. A total of 156 subjects, 49% males, mean age 41.0 years (SD +/- 15.5) years, participated in the study. Samples using 25% potassium-enrichment were indistinguishable in terms of taste from regular salt, whereas samples with 33% and 50% potassium-enrichment were distinguishable. Results were consistent when stratified by sex and age. Less than 10% of participants attributed the differences to bitterness or metallic flavor. Conclusions The 25% potassium-enriched salt is indistinguishable from regular salt. These findings suggest a potential to achieve sodium intake reduction strategies in cooking practices by substituting regular salt with potassium-enriched salt without affecting palatability.	[Saavedra-Garcia, Lorena; Bernabe-Ortiz, Antonio; Diez-Canseco, Francisco; Kathia Cardenas, Maria; Jaime Miranda, J.] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Bernabe-Ortiz, Antonio] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Lima, Peru; [Gilman, Robert H.; Sacksteder, Katherine A.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Gilman, Robert H.] Asociac Benef PRISMA, Area Invest & Desarrollo, Lima, Peru; [Jaime Miranda, J.] Univ Peruana Cayetano Heredia, Dept Med, Sch Med, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidad Peruana Cayetano Heredia	Miranda, JJ (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.	Jaime.Miranda@upch.pe	Saavedra-Garcia, Lorena/AAC-4956-2021	Saavedra-Garcia, Lorena/0000-0003-1524-780X; Diez-Canseco, Francisco/0000-0002-7611-8190; CARDENAS, MARIA KATHIA/0000-0002-3173-9284; Miranda, J. Jaime/0000-0002-4738-5468; Bernabe-Ortiz, Antonio/0000-0002-6834-1376	National Heart, Lung, and Blood Institute, National Institutes of Health, United States of America under the Global Alliance for Chronic Diseases programme [1 U01 HL114180-01]; National Heart, Lung, and Blood Institute Global Health Initiative under the contract Global Health Activities in Developing Countries to Combat Non-Communicable Chronic Diseases [268200900033C-1-0-1]; Medical Research Council [MR/K007467/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL114180] Funding Source: NIH RePORTER; MRC [MR/K007467/1] Funding Source: UKRI	National Heart, Lung, and Blood Institute, National Institutes of Health, United States of America under the Global Alliance for Chronic Diseases programme; National Heart, Lung, and Blood Institute Global Health Initiative under the contract Global Health Activities in Developing Countries to Combat Non-Communicable Chronic Diseases; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study is supported by a grant from the National Heart, Lung, and Blood Institute, National Institutes of Health, United States of America (Project 1 U01 HL114180-01) under the Global Alliance for Chronic Diseases programme. All authors and the CRONICAS Center of Excellence in Chronic Diseases are supported by the National Heart, Lung, and Blood Institute Global Health Initiative under the contract Global Health Activities in Developing Countries to Combat Non-Communicable Chronic Diseases (Project Number 268200900033C-1-0-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand SS, 2011, LANCET, V377, P529, DOI 10.1016/S0140-6736(10)62346-X; Armenteros M, 2012, MEAT SCI, V90, P361, DOI 10.1016/j.meatsci.2011.07.023; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bernabe-Ortiz A, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-93; Bi J, 2006, SENSORY DISCRIMINATION TESTS AND MEASUREMENTS: STATISTICAL PRINCIPLES, PROCEDURES AND TABLES, P1; Bobowski N, 2015, CHEMOSENS PERCEPT, V8, P112, DOI 10.1007/s12078-015-9179-6; Braschi A, 2009, INT J FOOD SCI NUTR, V60, P507, DOI 10.1080/09637480701782118; Chang HY, 2006, AM J CLIN NUTR, V83, P1289, DOI 10.1093/ajcn/83.6.1289; Cutler JA, 1997, AM J CLIN NUTR, V65, P643, DOI 10.1093/ajcn/65.2.643S; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; DeSimone JA, 2013, NUTR REV, V71, P52, DOI 10.1111/nure.12006; Dickinson HO, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004641.pub2; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Geleijnse JM, 2007, EUR J EPIDEMIOL, V22, P763, DOI 10.1007/s10654-007-9186-2; Girgis S, 2003, EUR J CLIN NUTR, V57, P616, DOI 10.1038/sj.ejcn.1601583; Graudal NA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004022.pub3; Grummer J, 2013, J DAIRY SCI, V96, P1401, DOI 10.3168/jds.2012-6057; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; Hetherington MM, 1996, NEUROSCI BIOBEHAV R, V20, P113, DOI 10.1016/0149-7634(95)00048-J; Hooper L, 2004, COCHRANE DATABASE SY; Li N, 2009, BRIT J NUTR, V101, P1088, DOI 10.1017/S0007114508042360; Liem DG, 2011, NUTRIENTS, V3, P694, DOI 10.3390/nu3060694; Meilgaard M. C., 2007, SENSORY EVAL TECHN, V4th; Organization WH, 2016, GLOBAL STATUS REPORT; Pretell EA, 2004, THYROID, V14, P590, DOI 10.1089/1050725041692909; Saavedra-Garcia L, 2015, PUBLIC HEALTH NUTR, V19, P1; SALOVAARA H, 1982, CEREAL CHEM, V59, P427; Sarkkinen ES, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-88; Sinopoli DA, 2012, J FOOD SCI, V77, pS319, DOI 10.1111/j.1750-3841.2012.02862.x; Umesawa M, 2008, AM J CLIN NUTR, V88, P195, DOI 10.1093/ajcn/88.1.195; Whelton PK, 1997, JAMA-J AM MED ASSOC, V277, P1624, DOI 10.1001/jama.277.20.1624; World Health Organisation, 2012, GUID SOD INT AD CHIL GUID SOD INT AD CHIL; World Health Organization, 2013, GLOB ACT PLAN PREV C; Yang QH, 2011, ARCH INTERN MED, V171, P1183, DOI 10.1001/archinternmed.2011.257; Zhou B, 2013, J HUM HYPERTENS, V27, P427, DOI 10.1038/jhh.2012.63	35	16	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134700	10.1371/journal.pone.0134700	http://dx.doi.org/10.1371/journal.pone.0134700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225848	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700131
J	Xie, QL; Zhu, Y; Wu, LH; Fu, LL; Xiang, Y				Xie, Qiao-Ling; Zhu, Ying; Wu, Ling-Hong; Fu, Lin-Lin; Xiang, Yan			The Efficacy and Safety of Entecavir and Interferon Combination Therapy for Chronic Hepatitis B Virus Infection: A Meta-Analysis	PLOS ONE			English	Article							LAMIVUDINE TREATMENT; EMPIRICAL-EVIDENCE; MANAGEMENT; ALPHA-2A; QUALITY; TRIALS; GUIDELINES; CIRRHOSIS; OUTCOMES; BIAS	The objective of this study was to evaluate the effectiveness and safety of entecavir (ETV) and interferon (IFN) combination therapy in the treatment of chronic hepatitis B (CHB) mono-infection via a meta-analysis of randomized controlled trials (RCTs). All eligible RCTs evaluating combination therapy for treating CHB were identified from nine electronic databases. A meta-analysis was performed in accordance with the Cochrane Systemic Review handbook. Eleven trials encompassing 1010 participants were included in this meta-analysis. It showed that at 12 and >= 96 weeks of therapy, the combination of ETV and IFN was not better than ETV in improving the undetectable HBV DNA (12 weeks: RR=1.12, 95% CI=0.88-1.42; >= 96 weeks: RR = 0.64, 95% CI=0.21-1.98, respectively) and HBeAg seroconversion rates (12 weeks: RR=1.35, 95% CI=0.60-3.04; >= 96 weeks: RR=1.36, 95% CI=0.75-2.64, respectively). But at 48 weeks of therapy and approximately 2 years of follow up, combination therapy was superior to ETV in improving the undetectable HBV DNA (48 weeks: RR=1.46, 95% CI=1.13-1.90; follow up: RR=2.20, 95% CI=1.26-3.81, respectively) and HBeAg seroconversion rates (48 weeks: RR=1.82, 95% CI=1.44-2.30; follow up: RR=1.92, 95% CI=1.19-3.11, respectively). When compared to IFN group, at 24 and 48 weeks of therapy, combination group showed a greater undetectable HBV DNA (24 weeks: RR=2.14, 95% CI=1.59-2.89; 48 weeks: RR=2.28, 95% CI=1.54-3.37, respectively) and ALT normalization rate (24 weeks: RR=1.56, 95% CI=1.24-1.96; 48 weeks: RR=1.55, 95% CI = 1.16-2.07, respectively). At 48 weeks of therapy, combination group achieved a greater HBeAg seroconversion rate than IFN (48 weeks: RR=1.58, 95% CI=1.24-2.00). No significant differences were observed in the side effects of the three therapies. So we can conclude that ETV and IFN combination therapy is more effective than ETV or IFN monotherapy in CHB treatment. ETV, IFN, and the combination of the two are safe in CHB treatment.	[Xie, Qiao-Ling; Zhu, Ying; Wu, Ling-Hong; Fu, Lin-Lin; Xiang, Yan] Dalian Med Univ, Affiliated Hosp 1, Dept Infect Dis, Dalian, Liaoning, Peoples R China	Dalian Medical University	Zhu, Y (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Infect Dis, Dalian, Liaoning, Peoples R China.	zhuyingsh52@126.com			National Science Foundation of China [81273925]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This article was supported by The National Science Foundation of China, No. 81273925. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boglione L, 2013, J VIRAL HEPATITIS, V20, pe11, DOI 10.1111/jvh.12018; Boni C, 2001, HEPATOLOGY, V33, P963, DOI 10.1053/jhep.2001.23045; Boni C, 1998, J CLIN INVEST, V102, P968, DOI 10.1172/JCI3731; Brouwer WP, 2014, J HEPATOL, P1; Brunetto MR, 2014, INTERVIROLOGY, V57, P163, DOI 10.1159/000360941; Buti M, 2014, LIVER INT, V34, P108, DOI 10.1111/liv.12392; Chen CC, 2012, J VIRAL HEPATITIS, V19, P161, DOI 10.1111/j.1365-2893.2011.01469.x; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; [程永辉 Cheng Yonghui], 2013, [长江科学院院报, Journal of Yangtze River Scientific Research Institute], V30, P42; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Cui J, 2013, CHINESE J PRIM MED P, V20, P2616; Enomoto M, 2013, J GASTROENTEROL, V48, P999, DOI 10.1007/s00535-012-0742-5; Fan H, 2012, CHIN MED SCI, V2, P75; Huang R, 2013, HEPATOL RES, V43, P1040, DOI 10.1111/hepr.12058; Huiguo M, 2012, MORDEN PRACTICE MED, V24, P550; Hynicka LM, 2010, ANN PHARMACOTHER, V44, P1271, DOI 10.1345/aph.1M590; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jin L., 2012, CHIN HEPATOL, V17, P714; Ke WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098865; Keeffe EB, 2007, CLIN GASTROENTEROL H, V5, P890, DOI 10.1016/j.cgh.2007.05.004; Keeffe EB, 2006, CLIN GASTROENTEROL H, V4, P936, DOI 10.1016/j.cgh.2006.05.016; Kim SR, 2011, HEPAT MON, V11, P601, DOI 10.5812/kowsar.1735143X.657; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Kumada H, 2010, HEPATOL RES, V40, P1, DOI 10.1111/j.1872-034X.2009.00633.x; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Lam Yuk-Fai, 2011, Curr Hepat Rep, V10, P235, DOI 10.1007/s11901-011-0109-z; Liaw YF, 2003, J GASTROEN HEPATOL, V18, P239, DOI 10.1046/j.1440-1746.2003.03037.x; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marcellin P, 2015, J HEPATOL, V62, P41, DOI 10.1016/j.jhep.2014.08.021; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Ridruejo E, 2014, J VIRAL HEPATITIS, V21, P590, DOI 10.1111/jvh.12200; ROBINSON WS, 1976, NEW ENGL J MED, V295, P1168, DOI 10.1056/NEJM197611182952105; Safioleas M, 2007, HEPATO-GASTROENTEROL, V54, P545; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sherman M, 2005, GUT, V54, P1521, DOI 10.1136/gut.2005.071332; Shi Y, 2010, HEPATOB PANCREAT DIS, V9, P462; Sohn HR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-439; Tang CM, 2014, WORLD J GASTROENTERO, V20, P6262, DOI 10.3748/wjg.v20.i20.6262; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Xie Q, 2014, CLIN INFECT DIS, V59, P1714, DOI 10.1093/cid/ciu702; Xun W, 2013, CHIN J INFECT DIS, V31, P181; Yu DX., 2010, HEPATOLOGY, V13, P377; Zeng Wen, 2013, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V27, P115	51	13	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0132219	10.1371/journal.pone.0132219	http://dx.doi.org/10.1371/journal.pone.0132219			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226455	Green Submitted, gold, Green Published			2022-12-27	WOS:000358837700006
J	Alabady, MS; Rogers, WL; Malmberg, RL				Alabady, Magdy S.; Rogers, Willie L.; Malmberg, Russell L.			Development of Transcriptomic Markers for Population Analysis Using Restriction Site Associated RNA Sequencing (RARseq)	PLOS ONE			English	Article							TARGET-ENRICHMENT; SNP DISCOVERY; SARRACENIA; PLANT; GENOME	We describe restriction site associated RNA sequencing (RARseq), an RNAseq-based genotype by sequencing (GBS) method. It includes the construction of RNAseq libraries from double stranded cDNA digested with selected restriction enzymes. To test this, we constructed six single-and six-dual-digested RARseq libraries from six F2 pitcher plant individuals and sequenced them on a half of a Miseq run. On average, the de novo approach of population genome analysis detected 544 and 570 RNA SNPs, whereas the reference transcriptome- based approach revealed an average of 1907 and 1876 RNA SNPs per individual, from single-and dual-digested RARseq data, respectively. The average numbers of RNA SNPs and alleles per loci are 1.89 and 2.17, respectively. Our results suggest that the RARseq protocol allows good depth of coverage per loci for detecting RNA SNPs and polymorphic loci for population genomics and mapping analyses. In non-model systems where complete genomes sequences are not always available, RARseq data can be analyzed in reference to the transcriptome. In addition to enriching for functional markers, this method may prove particularly useful in organisms where the genomes are not favorable for DNA GBS.	[Alabady, Magdy S.; Rogers, Willie L.; Malmberg, Russell L.] Univ Georgia, Dept Plant Biol, Athens, GA 30604 USA	University System of Georgia; University of Georgia	Alabady, MS (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30604 USA.	malabady@uga.edu	Alabady, Magdy/AGZ-6286-2022	Alabady, Magdy/0000-0002-1601-682X; Malmberg, Russell/0000-0002-7448-5034				Azevedo H, 2003, PLANT MOL BIOL REP, V21, P333, DOI 10.1007/BF02772582; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barbazuk WB, 2011, METHODS MOL BIOL, V729, P225, DOI 10.1007/978-1-61779-065-2_15; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rogers WL, 2010, CONSERV GENET RESOUR, V2, P75, DOI 10.1007/s12686-009-9165-x; Srivastava A, 2011, DNA RES, V18, P253, DOI 10.1093/dnares/dsr014; Stephens JD, 2015, MOL PHYLOGENET EVOL, V85, P76, DOI 10.1016/j.ympev.2015.01.015; Stumpf MPH, 2004, EUR J HUM GENET, V12, P469, DOI 10.1038/sj.ejhg.5201179; Zhou LC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-703	16	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134855	10.1371/journal.pone.0134855	http://dx.doi.org/10.1371/journal.pone.0134855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241739	gold, Green Submitted, Green Published			2022-12-27	WOS:000358942700074
J	Franklin, C; Cesko, E; Hillen, U; Schilling, B; Brandau, S				Franklin, Cindy; Cesko, Elvir; Hillen, Uwe; Schilling, Bastian; Brandau, Sven			Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease	PLOS ONE			English	Article							CONSENSUS DEVELOPMENT PROJECT; REGULATORY T-CELLS; DENDRITIC CELLS; SUPPRESSOR-CELLS; CLINICAL-TRIALS; L-ARGININE; PHOTOCHEMOTHERAPY; INDUCTION; MONOCYTES; TRANSPLANTATION	Chronic graft-versus-host disease (cGVHD) is a common side effect of allogeneic stem cell transplantation and a major cause of morbidity and mortality in affected patients. Especially skin, eyes and oral mucosa are affected. This can lead to pain and functional impairment. Extracorporeal photopheresis (ECP) is an effective immunomodulatory therapy with minimal side effects but its mode of action is still largely unknown. The objective of the present study was to examine the effects of ECP on neutrophil granulocytes in patients with cGVHD. Analysis of leukocytes from cGVHD patients obtained from the ECP device during treatment showed that neutrophil granulocytes account for the majority of cells treated during ECP. Neutrophils from healthy donors treated in vitro with 8-methoxypsoralen and UVA light as well as neutrophils from buffy coats of patients with cGVHD treated by ECP showed increased apoptosis and decreased half-life. In remaining non-apoptotic cells chemoirradiation resulted in loss of activation markers and reduced effector functions. This was accompanied by an increase in extracellular arginase-1 activity. Additional comparison of neutrophils isolated from blood of cGVHD patients before and 24h after ECP revealed a decreased half-life and reduction of effector functions of post-ECP neutrophils ex vivo. These observations strongly suggest that ECP induces both apoptosis and physiological changes in neutrophils and that these changes also take place in vivo. This study is the first to show that ECP modulates apoptosis and inflammatory activity in neutrophil granulocytes, indicating that neutrophils may significantly contribute to the overall immunomodulatory effects attributed to this treatment.	[Franklin, Cindy; Cesko, Elvir; Hillen, Uwe; Schilling, Bastian] Univ Hosp Essen, Dept Dermatol Venereol & Allergol, Essen, Germany; [Franklin, Cindy; Brandau, Sven] Univ Hosp Essen, Dept Otorhinolaryngol, Div Res, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Franklin, C (corresponding author), Univ Hosp Essen, Dept Dermatol Venereol & Allergol, Essen, Germany.	cindy.franklin@uk-essen.de	Schilling, Bastian/AAY-8646-2020; Franklin, Cindy/AAU-4915-2021	Schilling, Bastian/0000-0001-8859-4103; Franklin, Cindy/0000-0001-9142-5423; Brandau, Sven/0000-0002-2702-4163	MERCUR Foundation [AN-2012-0030]; IFORES-scholarship of the Medical Faculty of the University Duisburg-Essen	MERCUR Foundation; IFORES-scholarship of the Medical Faculty of the University Duisburg-Essen	This work was supported by a grant from the MERCUR Foundation to BS (AN-2012-0030). CF was supported by an IFORES-scholarship of the Medical Faculty of the University Duisburg-Essen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apisarnthanarax N, 2003, BONE MARROW TRANSPL, V31, P459, DOI 10.1038/sj.bmt.1703871; Baird K, 2013, BIOL BLOOD MARROW TR, V19, P632, DOI 10.1016/j.bbmt.2013.01.013; Berger C, 2010, BLOOD, V116, P4838, DOI 10.1182/blood-2009-11-256040; Bladon J, 2006, J DERMATOL SCI, V43, P85, DOI 10.1016/j.jdermsci.2006.05.004; Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212; Brandau S, 2011, J LEUKOCYTE BIOL, V89, P311, DOI 10.1189/jlb.0310162; Couriel D, 2006, BIOL BLOOD MARROW TR, V12, P375, DOI 10.1016/j.bbmt.2006.02.003; Di Renzo M, 2008, CLIN EXP IMMUNOL, V151, P407, DOI 10.1111/j.1365-2249.2007.03577.x; Di Renzo M, 2005, BRIT J DERMATOL, V153, P59, DOI 10.1111/j.1365-2133.2005.06482.x; Dietrich S, 2013, BIOL BLOOD MARROW TR, V19, P22, DOI 10.1016/j.bbmt.2012.09.018; EDELSON R, 1987, NEW ENGL J MED, V316, P297, DOI 10.1056/NEJM198702053160603; EDELSON RL, 1989, YALE J BIOL MED, V62, P565; Edelson RL, 2013, TRANSFUSION APHERESI; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Florek M, 2014, BLOOD, V124, P1832, DOI 10.1182/blood-2014-02-555128; Flowers MED, 2008, BLOOD, V112, P2667, DOI 10.1182/blood-2008-03-141481; Flowers MED, 2011, BLOOD, V117, P3214, DOI 10.1182/blood-2010-08-302109; Gatza E, 2008, BLOOD, V112, P1515, DOI 10.1182/blood-2007-11-125542; Gonzalez AL, 2014, CLIN EXP IMMUNOL, V175, P449, DOI 10.1111/cei.12231; Gorgun G, 2002, BLOOD, V100, P941, DOI 10.1182/blood-2002-01-0068; Greinix Hildegard T., 1998, Blood, V92, P3098; Hasermann P, 2008, DERMATOLOGY, V216, P287, DOI 10.1159/000113941; Hannani D, 2010, TRANSPLANTATION, V89, P492, DOI 10.1097/TP.0b013e3181c6ffd3; Highfill SL, 2010, BLOOD, V116, P5738, DOI 10.1182/blood-2010-06-287839; Just U, 2012, EXP DERMATOL, V21, P443, DOI 10.1111/j.1600-0625.2012.01491.x; Knobler R, 2009, J AM ACAD DERMATOL, V61, P652, DOI 10.1016/j.jaad.2009.02.039; Lamioni A, 2005, TRANSPLANTATION, V79, P846, DOI 10.1097/01.TP.0000157278.02848.C7; Lotze MT, 2007, CLIN IMMUNOL, V124, P1, DOI 10.1016/j.clim.2007.02.006; Maeda A, 2005, J IMMUNOL, V174, P5968, DOI 10.4049/jimmunol.174.10.5968; Maeda A, 2008, J IMMUNOL, V181, P5956, DOI 10.4049/jimmunol.181.9.5956; Marshall SR, 2006, NAT CLIN PRACT ONCOL, V3, P302, DOI 10.1038/ncponc0511; McKenna KE, 2006, BRIT J DERMATOL, V154, P7, DOI 10.1111/j.1365-2133.2005.06857.x; Merlin E, 2011, TRANSPL IMMUNOL, V24, P100, DOI 10.1016/j.trim.2010.10.007; Ochoa JB, 2001, JPEN-PARENTER ENTER, V25, P23, DOI 10.1177/014860710102500123; Rieber N, 2014, BONE MARROW TRANSPL, V49, P545, DOI 10.1038/bmt.2013.236; Rodriguez PC, 2007, BLOOD, V109, P1568, DOI 10.1182/blood-2006-06-031856; Schwab L, 2014, NAT MED, V20, P648, DOI 10.1038/nm.3517; Seaton ED, 2003, BLOOD, V102, P1217, DOI 10.1182/blood-2002-11-3351; Setterblad N, 2008, TRANSFUSION, V48, P169, DOI 10.1111/j.1537-2995.2007.01502.x; Socie G, 1999, NEW ENGL J MED, V341, P14, DOI 10.1056/NEJM199907013410103; SULLIVAN KM, 1992, BONE MARROW TRANSPL, V10, P127; SULLIVAN KM, 1988, BLOOD, V72, P555; SUSSKIND BM, 1987, J IMMUNOL, V139, P905; TRAUTINGER F, 1991, ANN NY ACAD SCI, V636, P383, DOI 10.1111/j.1749-6632.1991.tb33473.x; Trellakis S, 2011, INT J IMMUNOPATH PH, V24, P683, DOI 10.1177/039463201102400314; Wang H, 2014, IMMUNOL REV, V258, P30, DOI 10.1111/imr.12151; Ward DM, 2011, J CLIN APHERESIS, V26, P276, DOI 10.1002/jca.20300; Wolf D, 2012, BLOOD, V119, P16, DOI 10.1182/blood-2011-08-339465; Wolff D, 2011, BIOL BLOOD MARROW TR, V17, P1, DOI 10.1016/j.bbmt.2010.05.011; Worel N, 2002, BONE MARROW TRANSPL, V30, P619, DOI 10.1038/sj.bmt.1703677; Xia CQ, 2009, CURR OPIN ORGAN TRAN, V14, P338, DOI 10.1097/MOT.0b013e32832ce943	51	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134518	10.1371/journal.pone.0134518	http://dx.doi.org/10.1371/journal.pone.0134518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241482	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942700048
J	Sternemalm, J; Geimer, S; Frikstad, KAM; Schink, KO; Stokke, T; Patzke, S				Sternemalm, Johan; Geimer, Stefan; Frikstad, Kari-Anne M.; Schink, Kay O.; Stokke, Trond; Patzke, Sebastian			CSPP-L Associates with the Desmosome of Polarized Epithelial Cells and Is Required for Normal Spheroid Formation	PLOS ONE			English	Article							MICROTUBULE ORGANIZATION; JOUBERT SYNDROME; PRIMARY CILIA; STRUCTURED ILLUMINATION; CENTROSOMAL PROTEIN; ADHERENS JUNCTIONS; ZONULA ADHERENS; DISEASE; MUTATIONS; CANCER	Deleterious mutations of the Centrosome/Spindle Pole associated Protein 1 gene, CSPP1, are causative for Joubert-syndrome and Joubert-related developmental disorders. These disorders are defined by a characteristic mal-development of the brain, but frequently involve renal and hepatic cyst formation. CSPP-L, the large protein isoform of CSPP1 localizes to microtubule ends of the mitotic mid-spindle and the ciliary axoneme, and is required for ciliogenesis. We here report the microtubule independent but Desmoplakin dependent localization of CSPP-L to Desmosomes in apical-basal polarized epithelial cells. Importantly, siRNA conferred depletion of CSPP-L or Desmoplakin promoted multi-lumen spheroid formation in 3D-cultures of non-ciliated human colon carcinoma Caco-2 cells. Multi-lumen spheroids of CSPP1 siRNA transfectants showed disrupted apical cell junction localization of the cytoskeleton organizing RhoGEF ECT2. Our results hence identify a novel, non-ciliary role for CSPP-L in epithelial morphogenesis.	[Sternemalm, Johan; Frikstad, Kari-Anne M.; Stokke, Trond; Patzke, Sebastian] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Radiat Biol,Div Canc Med Surg & Transplantat, Oslo, Norway; [Geimer, Stefan] Univ Bayreuth, Cell Biol Electron Microscopy, Bayreuth, Germany; [Schink, Kay O.] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol,Div Canc Med Surg & Transplant, Oslo, Norway; [Schink, Kay O.] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway	University of Oslo; University of Bayreuth; University of Oslo; University of Oslo	Patzke, S (corresponding author), Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Radiat Biol,Div Canc Med Surg & Transplantat, Oslo, Norway.	sebastip@rr-research.no	Patzke, Sebastian/G-9909-2019	Patzke, Sebastian/0000-0001-6821-197X; Schink, Kay Oliver/0000-0002-5903-4059; Frikstad, Kari-Anne Myrum/0000-0001-9923-3485	Regional Health Authorities of South-Eastern Norway; Norwegian Cancer Society	Regional Health Authorities of South-Eastern Norway; Norwegian Cancer Society(Norwegian Cancer Society)	This project was financially supported through grants from the Regional Health Authorities of South-Eastern Norway (S.P.) and Norwegian Cancer Society (S.P., T.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizu N, 2014, AM J HUM GENET, V94, P80, DOI 10.1016/j.ajhg.2013.11.015; Asiedu M, 2009, MOL BIOL CELL, V20, P1428, DOI 10.1091/mbc.E08-01-0001; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Brooke MA, 2012, J PATHOL, V226, P158, DOI 10.1002/path.3027; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Chausovsky A, 2000, NAT CELL BIOL, V2, P797, DOI 10.1038/35041037; Chidgey M, 2007, BRIT J CANCER, V96, P1783, DOI 10.1038/sj.bjc.6603808; Christensen ST, 2008, CURR TOP DEV BIOL, V85, P261, DOI 10.1016/S0070-2153(08)00810-7; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Donaldson JC, 2000, EXP CELL RES, V256, P168, DOI 10.1006/excr.2000.4822; El-Amraoui A, 2013, PROG MOL BIOL TRANSL, V116, P361, DOI 10.1016/B978-0-12-394311-8.00016-9; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Gheldof A, 2013, PROG MOL BIOL TRANSL, V116, P317, DOI 10.1016/B978-0-12-394311-8.00014-5; Guo J, 2006, MOL BIOL CELL, V17, P680, DOI 10.1091/mbc.E05-04-0360; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hassounah NB, 2012, CLIN CANCER RES, V18, P2429, DOI 10.1158/1078-0432.CCR-11-0755; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Kuehn EW, 2007, CANCER RES, V67, P4537, DOI 10.1158/0008-5472.CAN-07-0391; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Liu XF, 2004, MOL CELL BIOL, V24, P6665, DOI 10.1128/mcb.24.15.6665-6675.2004; Mans DA, 2008, BIOCH BIOPHYS ACTA; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Nekrasova O, 2013, TRENDS CELL BIOL, V23, P537, DOI 10.1016/j.tcb.2013.06.004; Nelson WJ, 2013, PROG MOL BIOL TRANSL, V116, P3, DOI 10.1016/B978-0-12-394311-8.00001-7; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Patel DM, 2014, J CELL BIOL, V206, P779, DOI 10.1083/jcb.201312110; Patzke S, 2005, ONCOGENE, V24, P1159, DOI 10.1038/sj.onc.1208267; Patzke S, 2012, CILIA, V1, P36; Patzke S, 2006, J CELL PHYSIOL, V209, P199, DOI 10.1002/jcp.20725; Patzke S, 2010, MOL BIOL CELL, V21, P2555, DOI 10.1091/mbc.E09-06-0503; Priya R, 2013, DIFFERENTIATION, V86, P133, DOI 10.1016/j.diff.2013.01.002; Ratheesh A, 2012, NAT CELL BIOL, V14, P818, DOI 10.1038/ncb2532; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Romani M, 2013, LANCET NEUROL, V12, P894, DOI 10.1016/S1474-4422(13)70136-4; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Scheffers MS, 2002, HUM MOL GENET, V11, P59, DOI 10.1093/hmg/11.1.59; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Shaheen R, 2014, AM J HUM GENET, V94, P73, DOI 10.1016/j.ajhg.2013.11.010; Silberberg M, 2005, AM J PHYSIOL-RENAL, V288, pF1153, DOI 10.1152/ajprenal.00008.2005; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; Sternemalm J, 2014, BRIT J CANCER, V111, P326, DOI 10.1038/bjc.2014.297; Sumigray Kaelyn D, 2011, Bioarchitecture, V1, P221; Sumigray KD, 2011, J CELL BIOL, V194, P631, DOI 10.1083/jcb.201104009; Thomason HA, 2010, BIOCHEM J, V429, P419, DOI 10.1042/BJ20100567; Toftgard R, 2009, NAT MED, V15, P994, DOI 10.1038/nm0909-994; Tuz K, 2014, AM J HUM GENET, V94, P62, DOI 10.1016/j.ajhg.2013.11.019; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; WACKER IU, 1992, J CELL BIOL, V117, P813, DOI 10.1083/jcb.117.4.813; Waterman-Storer CM, 2000, MOL BIOL CELL, V11, P2471, DOI 10.1091/mbc.11.7.2471; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; Weigel A, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3083439	53	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134789	10.1371/journal.pone.0134789	http://dx.doi.org/10.1371/journal.pone.0134789			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241740	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700066
J	Liu, QG; Wang, ZC; Xu, XM; Zhang, HZ; Li, CH				Liu, Quangang; Wang, Zhanchao; Xu, Xuemei; Zhang, Haizhen; Li, Chenghao			Genome-Wide Analysis of C2H2 Zinc-Finger Family Transcription Factors and Their Responses to Abiotic Stresses in Poplar (Populus trichocarpa)	PLOS ONE			English	Article							PROTEIN GENE; SALT TOLERANCE; COMPREHENSIVE ANALYSIS; SALINITY STRESS; ARABIDOPSIS; DROUGHT; EXPRESSION; RICE; EXPANSION; COLD	Background C2H2 zinc-finger (C2H2-ZF) proteins are a large gene family in plants that participate in various aspects of normal plant growth and development, as well as in biotic and abiotic stress responses. To date, no overall analysis incorporating evolutionary history and expression profiling of the C2H2-ZF gene family in model tree species poplar (Populus trichocarpa) has been reported. Principal Findings Here, we identified 109 full-length C2H2-ZF genes in P. trichocarpa, and classified them into four groups, based on phylogenetic analysis. The 109 C2H2-ZF genes were distributed unequally on 19 P. trichocarpa linkage groups (LGs), with 39 segmental duplication events, indicating that segmental duplication has been important in the expansion of the C2H2-ZF gene family. Promoter cis-element analysis indicated that most of the C2H2-ZF genes contain phytohormone or abiotic stress-related cis-elements. The expression patterns of C2H2-ZF genes, based on heatmap analysis, suggested that C2H2-ZF genes are involved in tissue and organ development, especially root and floral development. Expression analysis based on quantitative real-time reverse transcription polymerase chain reaction indicated that C2H2-ZF genes are significantly involved in drought, heat and salt response, possibly via different mechanisms. Conclusions This study provides a thorough overview of the P. trichocarpa C2H2-ZF gene family and presents a new perspective on the evolution of this gene family. In particular, some C2H2ZF genes may be involved in environmental stress tolerance regulation. PtrZFP2, 19 and 95 showed high expression levels in leaves and/or roots under environmental stresses. Additionally, this study provided a solid foundation for studying the biological roles of C2H2-ZF genes in Populus growth and development. These results form the basis for further investigation of the roles of these candidate genes and for future genetic engineering and gene functional studies in Populus.	[Liu, Quangang; Wang, Zhanchao; Zhang, Haizhen; Li, Chenghao] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Heilongjiang, Peoples R China; [Xu, Xuemei] Lib Northeast Forestry Univ, Harbin, Heilongjiang, Peoples R China	Northeast Forestry University - China	Li, CH (corresponding author), Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Heilongjiang, Peoples R China.	chli0@163.com						Agarwal P, 2007, PLANT MOL BIOL, V65, P467, DOI 10.1007/s11103-007-9199-y; Al-Ghazi Y, 2009, PLANT CELL PHYSIOL, V50, P1364, DOI 10.1093/pcp/pcp084; Bae EK, 2011, GENE, V483, P43, DOI 10.1016/j.gene.2011.05.015; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-26; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Bi HQ, 2014, AGR FOREST METEOROL, V197, P188, DOI 10.1016/j.agrformet.2014.06.006; Bohm S, 1997, NUCLEIC ACIDS RES, V25, P2464, DOI 10.1093/nar/25.12.2464; Caldeira CF, 2014, PLANT PHYSIOL, V164, P1718, DOI 10.1104/pp.113.228379; Chai GH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-253; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087156; Chu YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098334; Chung HR, 2002, EMBO REP, V3, P1158, DOI 10.1093/embo-reports/kvf243; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; Colasanti J, 1998, CELL, V93, P593, DOI 10.1016/S0092-8674(00)81188-5; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Diaz-Martin J, 2005, PLANT PHYSIOL, V139, P1483, DOI 10.1104/pp.105.069963; Dinneny JR, 2006, DEVELOPMENT, V133, P2285, DOI 10.1242/dev.02416; Englbrecht CC, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-39; Feurtado JA, 2011, PLANT CELL, V23, P1772, DOI 10.1105/tpc.111.085134; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gourcilleau D, 2011, DNA RES, V18, P77, DOI 10.1093/dnares/dsr001; Guo YH, 2009, NEW PHYTOL, V183, P62, DOI 10.1111/j.1469-8137.2009.02838.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; He HS, 2012, PLANT CELL REP, V31, P1199, DOI 10.1007/s00299-012-1241-0; Hiratsu K, 2004, BIOCHEM BIOPH RES CO, V321, P172, DOI 10.1016/j.bbrc.2004.06.115; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu B, 2014, BIOINFORMATICS; Hu RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031149; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Hu W, 2006, PLANT J, V45, P399, DOI 10.1111/j.1365-313X.2005.02626.x; Huang F, 2006, MOL BIOL REP, V33, P279, DOI 10.1007/s11033-006-9012-z; Huang J, 2009, BIOCHEM BIOPH RES CO, V389, P556, DOI 10.1016/j.bbrc.2009.09.032; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; Jenkins MJ, 2014, FOREST SCI, V60, P489, DOI 10.5849/forsci.13-017; Joseph MP, 2014, PLANT PHYSIOL, V165, P1203, DOI 10.1104/pp.113.234294; Kam J, 2008, PLANT MOL BIOL, V67, P305, DOI 10.1007/s11103-008-9319-3; Kim SH, 2004, PLANT MOL BIOL, V55, P883, DOI 10.1007/s11103-005-2151-0; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Kubo K, 1998, NUCLEIC ACIDS RES, V26, P608, DOI 10.1093/nar/26.2.608; Kumar R, 2011, MOL GENET GENOMICS, V285, P245, DOI 10.1007/s00438-011-0602-7; Lafarguette F, 2004, NEW PHYTOL, V164, P107, DOI 10.1111/j.1469-8137.2004.01175.x; Lee BM, 2006, J MOL BIOL, V357, P275, DOI 10.1016/j.jmb.2005.12.010; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Li CL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-131; Li SJ, 2010, MOL CELLS, V29, P475, DOI 10.1007/s10059-010-0059-2; Liu QG, 2015, PLANT MOL BIOL REP, V33, P1740, DOI 10.1007/s11105-015-0870-1; Ludwig AA, 2005, P NATL ACAD SCI USA, V102, P10736, DOI 10.1073/pnas.0502954102; Luo X, 2012, PLANTA, V235, P1141, DOI 10.1007/s00425-011-1563-0; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Moore Michael, 2003, Briefings in Functional Genomics & Proteomics, V1, P342, DOI 10.1093/bfgp/1.4.342; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Muthamilarasan M, 2014, FUNCT INTEGR GENOMIC, V14, P531, DOI 10.1007/s10142-014-0383-2; Nakashima K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00170; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Ohlrogge J, 2000, CURR OPIN PLANT BIOL, V3, P224, DOI 10.1016/S1369-5266(00)00068-6; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Sjodin A, 2009, NEW PHYTOL, V182, P1013, DOI 10.1111/j.1469-8137.2009.02807.x; Song YP, 2014, PLANT MOL BIOL, V86, P139, DOI 10.1007/s11103-014-0218-5; Street NR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-589; Sun SJ, 2010, J EXP BOT, V61, P2807, DOI 10.1093/jxb/erq120; Syvertsen JP, 2014, ENVIRON EXP BOT, V103, P128, DOI 10.1016/j.envexpbot.2013.09.015; TAKATSUJI H, 1992, EMBO J, V11, P241, DOI 10.1002/j.1460-2075.1992.tb05047.x; Takatsuji H, 1999, PLANT MOL BIOL, V39, P1073, DOI 10.1023/A:1006184519697; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor G, 2002, ANN BOT-LONDON, V90, P681, DOI 10.1093/aob/mcf255; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian ZD, 2010, PLANT BIOLOGY, V12, P689, DOI 10.1111/j.1438-8677.2009.00276.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wang Z, 2013, GASTROENT RES PRACT, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0055471; Wei Q, 2012, PLANT CELL TISS ORG, V110, P359, DOI 10.1007/s11240-012-0157-2; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Wu CY, 2008, P NATL ACAD SCI USA, V105, P12915, DOI 10.1073/pnas.0806019105; Xu DQ, 2008, FEBS LETT, V582, P1037, DOI 10.1016/j.febslet.2008.02.052; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Zhou ZJ, 2013, NEW PHYTOL, V198, P699, DOI 10.1111/nph.12211	87	69	76	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134753	10.1371/journal.pone.0134753	http://dx.doi.org/10.1371/journal.pone.0134753			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237514	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942400037
J	Norstrom, M; Kristoffersen, AB; Gorlach, FS; Nygard, K; Hopp, P				Norstrom, Madelaine; Kristoffersen, Anja Brathen; Gorlach, Franziska Sophie; Nygard, Karin; Hopp, Petter			An Adjusted Likelihood Ratio Approach Analysing Distribution of Food Products to Assist the Investigation of Foodborne Outbreaks	PLOS ONE			English	Article							HEMOLYTIC-UREMIC-SYNDROME; ESCHERICHIA-COLI; SAFETY	In order to facilitate foodborne outbreak investigations there is a need to improve the methods for identifying the food products that should be sampled for laboratory analysis. The aim of this study was to examine the applicability of a likelihood ratio approach previously developed on simulated data, to real outbreak data. We used human case and food product distribution data from the Norwegian enterohaemorrhagic Escherichia coli outbreak in 2006. The approach was adjusted to include time, space smoothing and to handle missing or misclassified information. The performance of the adjusted likelihood ratio approach on the data originating from the HUS outbreak and control data indicates that the adjusted approach is promising and indicates that the adjusted approach could be a useful tool to assist and facilitate the investigation of food borne outbreaks in the future if good traceability are available and implemented in the distribution chain. However, the approach needs to be further validated on other outbreak data and also including other food products than meat products in order to make a more general conclusion of the applicability of the developed approach.	[Norstrom, Madelaine; Kristoffersen, Anja Brathen; Gorlach, Franziska Sophie; Hopp, Petter] Norwegian Vet Inst, Dept Hlth Surveillance, Oslo, Norway; [Gorlach, Franziska Sophie] Tech Univ Munich, D-80290 Munich, Germany; [Nygard, Karin] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol, Div Infect Dis Control, Oslo, Norway	Norwegian Veterinary Institute; Technical University of Munich; Norwegian Institute of Public Health (NIPH)	Norstrom, M (corresponding author), Norwegian Vet Inst, Dept Hlth Surveillance, Oslo, Norway.	madelaine.norstrom@vetinst.no		Hopp, Petter/0000-0002-8695-0378				[Anonymous], 2006, E COLI O103 UTBRUDDE; Aung MM, 2014, FOOD CONTROL, V39, P172, DOI 10.1016/j.foodcont.2013.11.007; BELL BP, 1994, JAMA-J AM MED ASSOC, V272, P1349, DOI 10.1001/jama.272.17.1349; Beni LH, 2012, SPAT SPATIO-TEMPORAL, V3, P215, DOI 10.1016/j.sste.2012.02.009; Bielaszewska M, 2007, APPL ENVIRON MICROB, V73, P3144, DOI 10.1128/AEM.02937-06; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Doerr D., 2012, P ACM 1 ACM SIGSPATI, P44, DOI [10.1145/2452516.2452525, DOI 10.1145/2452516.2452525]; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; HUFF DL, 1963, LAND ECON, V39, P81, DOI 10.2307/3144521; Kaferstein F, 1999, B WORLD HEALTH ORGAN, V77, P347; KARCH H, 1992, INFECT IMMUN, V60, P3464, DOI 10.1128/IAI.60.8.3464-3467.1992; Kaufman J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003692; KELLO D, 1990, FOOD ADDIT CONTAM, V7, pS5, DOI 10.1080/02652039009373835; Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7; Norstrom M, 2012, ISVEE 13 INT S VET E, P114; R Core Team, 2012, R LANG ENV STAT COMP; Schimmer B, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-41; Sekse C, 2009, INT J FOOD MICROBIOL, V133, P259, DOI 10.1016/j.ijfoodmicro.2009.05.026; Stewart G.F., 1982, INTRO FOOD SCI TECHN; Tirado C, 2001, J INFECTION, V43, P80, DOI 10.1053/jinf.2001.0861; Werber D, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-11; World Health Organization (WHO), 2008, FOODB DIS OUTBR GUID	22	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134344	10.1371/journal.pone.0134344	http://dx.doi.org/10.1371/journal.pone.0134344			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237468	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942400023
J	Roybal, KT; Mace, EM; Mantell, JM; Verkade, P; Orange, JS; Wulfing, C				Roybal, Kole T.; Mace, Emily M.; Mantell, Judith M.; Verkade, Paul; Orange, Jordan S.; Wuelfing, Christoph			Early Signaling in Primary T Cells Activated by Antigen Presenting Cells Is Associated with a Deep and Transient Lamellal Actin Network	PLOS ONE			English	Article							KINASE C-THETA; IMMUNOLOGICAL SYNAPSE; SPATIOTEMPORAL ORGANIZATION; RECEPTOR MICROCLUSTERS; RETROGRADE FLOW; STEM-CELLS; F-ACTIN; CYTOSKELETON; MOLECULES; DYNAMICS	Cellular signaling transduction critically depends on molecular interactions that are in turn governed by dynamic subcellular distributions of the signaling system components. Comprehensive insight into signal transduction requires an understanding of such distributions and cellular structures driving them. To investigate the activation of primary murine T cells by antigen presenting cells (APC) we have imaged more than 60 signaling intermediates during T cell stimulation with microscopy across resolution limits. A substantial number of signaling intermediates associated with a transient, wide, and actin-associated lamellum extending from an interdigitated T cell: APC interface several micrometers into the T cell, as characterized in detail here. By mapping the more than 60 signaling intermediates onto the spatiotemporal features of cell biological structures, the lamellum and other ones previously described, we also define distinct spatial and temporal characteristics of T cell signal initiation, amplification, and core signaling in the activation of primary T cells by APCs. These characteristics differ substantially from ones seen when T cells are activated using common reductionist approaches.	[Roybal, Kole T.; Wuelfing, Christoph] UT Southwestern Med Ctr, Dept Immunol, Dallas, TX 75390 USA; [Mace, Emily M.; Orange, Jordan S.] Univ Penn, Childrens Hosp Philadelphia, Abramson Res Ctr, Philadelphia, PA 19104 USA; [Mantell, Judith M.; Verkade, Paul] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Wuelfing, Christoph] UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX USA; [Wuelfing, Christoph] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Bristol; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Bristol	Wulfing, C (corresponding author), UT Southwestern Med Ctr, Dept Immunol, Dallas, TX 75390 USA.	Christoph.Wuelfing@bristol.co.uk	Verkade, Paul/N-7240-2014	Verkade, Paul/0000-0002-2497-1026; orange, jordan/0000-0001-7117-7725; Wuelfing, Christoph/0000-0002-6156-9861; Mace, Emily/0000-0003-0226-7393	NIH Ruth L. Kirschstein research service award [2T32AI005284-32]; NIH [A1-97981]; NSF [1121793]; Marie Sklodowska-Curie [321554]; BBSRC [BB/L014181/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L014181/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI005284] Funding Source: NIH RePORTER	NIH Ruth L. Kirschstein research service award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Marie Sklodowska-Curie; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a NIH Ruth L. Kirschstein research service award (2T32AI005284-32) to K.R. and NIH (A1-97981), NSF (1121793), and Marie Sklodowska-Curie (321554) funding to C.W.	Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Babich A, 2012, J CELL BIOL, V197, P775, DOI 10.1083/jcb.201201018; Bacac M, 2008, ANNU REV PATHOL-MECH, V3, P221, DOI 10.1146/annurev.pathmechdis.3.121806.151523; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Brown ACN, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001152; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Davis MM, 2003, ANNU REV BIOCHEM, V72, P717, DOI 10.1146/annurev.biochem.72.121801.161625; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Jenkins MR, 2009, IMMUNITY, V31, P621, DOI 10.1016/j.immuni.2009.08.024; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Kumari S, 2015, ELIFE, V4, DOI 10.7554/eLife.04953; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; McDonald Kent L, 2007, Methods Mol Biol, V369, P143; Meyers J, 2006, CURR BIOL, V16, P1685, DOI 10.1016/j.cub.2006.07.056; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Nelson CM, 2012, ANNU REV BIOMED ENG, V14, P129, DOI [10.1146/annurev-bioeng-071811-150043, 10.1146/annurev.bioeng-071811-150043]; Neves SR, 2008, CELL, V133, P666, DOI 10.1016/j.cell.2008.04.025; Paster W, 2013, J IMMUNOL, V190, P3749, DOI 10.4049/jimmunol.1203389; Purtic B, 2005, P NATL ACAD SCI USA, V102, P2904, DOI 10.1073/pnas.0406867102; Rak GD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001151; Rangamani P, 2013, CELL, V154, P1356, DOI 10.1016/j.cell.2013.08.026; Roybal KT, 2013, IMMUNOL REV, V256, P133, DOI 10.1111/imr.12103; Sage PT, 2012, J IMMUNOL, V188, P3686, DOI 10.4049/jimmunol.1102594; Schell MJ, 2001, J BIOL CHEM, V276, P37537, DOI 10.1074/jbc.M104101200; Singleton K, 2006, J IMMUNOL, V177, P4402, DOI 10.4049/jimmunol.177.7.4402; Singleton KL, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001821; Singleton KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000199; Smoligovets AA, 2012, J CELL SCI, V125, P735, DOI 10.1242/jcs.092825; Sun YB, 2012, ANNU REV BIOPHYS, V41, P519, DOI 10.1146/annurev-biophys-042910-155306; Tskvitaria-Fuller I, 2003, J IMMUNOL, V171, P2287, DOI 10.4049/jimmunol.171.5.2287; Ueda H, 2011, P NATL ACAD SCI USA, V108, P17099, DOI 10.1073/pnas.1113703108; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wang YF, 2007, P NATL ACAD SCI USA, V104, P11748, DOI 10.1073/pnas.0700019104; Yi J, 2012, MOL BIOL CELL, V23, P834, DOI 10.1091/mbc.E11-08-0731; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068	40	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0133299	10.1371/journal.pone.0133299	http://dx.doi.org/10.1371/journal.pone.0133299			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237050	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942400010
J	Baras, AS; Gandhi, N; Munari, E; Faraj, S; Shultz, L; Marchionni, L; Schoenberg, M; Hahn, N; Hoque, M; Berman, D; Bivalacqua, TJ; Netto, G				Baras, Alexander S.; Gandhi, Nilay; Munari, Enrico; Faraj, Sheila; Shultz, Luciana; Marchionni, Luigi; Schoenberg, Mark; Hahn, Noah; Hoque, Mohammad; Berman, David; Bivalacqua, Trinity J.; Netto, George			Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma	PLOS ONE			English	Article							BLADDER-CANCER; GENE-EXPRESSION; PREDICTING RESPONSE; RADICAL CYSTECTOMY; COMBINATION; SUBTYPES	Background The 5-year cancer specific survival (CSS) for patients with muscle invasive urothelial carcinoma of the bladder (MIBC) treated with cystectomy alone is approximately 50%. Platinum based neoadjuvant chemotherapy (NAC) plus cystectomy results in a marginal 5-10% increase in 5-year CSS in MIBC. Interestingly, responders to NAC (<ypT2) have a 5-year CSS of 90% which is in stark contrast to the 30-40% CSS for those whose MIBC is resistance to NAC. While the implementation of NAC for MIBC is increasing, it is still not widely utilized due to concerns related to delay of cystectomy, potential side-effects, and inability to predict effectiveness. Recently suggested molecular signatures of chemoresponsiveness, which could prove useful in this setting, would be of considerable utility but are yet to be translated into clinical practice. Methods mRNA expression data from a prior report on a NAC-treated MIBC cohort were re-analyzed in conjunction with the antibody database of the Human Protein Atlas (HPA) to identify candidate protein based biomarkers detectable by immunohistochemistry (IHC). These candidate biomarkers were subsequently tested in tissue microarrays derived from an independent cohort of NAC naive MIBC biopsy specimens from whom the patients were treated with neoadjuvant gemcitabine cisplatin NAC and subsequent cystectomy. The clinical parameters that have been previously associated with NAC response were also examined in our cohort. Results Our analyses of the available mRNA gene expression data in a discovery cohort (n = 33) and the HPA resulted in 8 candidate protein biomarkers. The combination of GDPD3 and SPRED1 resulted in a multivariate classification tree that was significantly associated with NAC response status (Goodman-Kruskal gamma = 0.85 p<0.0001) in our independent NAC treated MIBC cohort. This model was independent of the clinical factors of age and clinical tumor stage, which have been previously associated with NAC response by our group. The combination of both these protein biomarkers detected by IHC in biopsy specimens along with the relevant clinical parameters resulted in a prediction model able to significantly stratify the likelihood of NAC resistance in our cohort (n = 37) into two well separated halves: low-26% n = 19 and high-89% n = 18, Fisher's exact p = 0.0002). Conclusion We illustrate the feasibility of translating a gene expression signature of NAC response from a discovery cohort into immunohistochemical markers readily applicable to MIBC biopsy specimens in our independent cohort. The results from this study are being characterized in additional validation cohorts. Additionally, we anticipate that emerging somatic mutations in MIBC will also be important for NAC response prediction. The relationship of the findings in this study to the current understanding of variant histologic subtypes of MIBC along with the evolving molecular subtypes of MIBC as it relates to NAC response remains to be fully characterized.	[Baras, Alexander S.; Munari, Enrico; Faraj, Sheila; Shultz, Luciana; Netto, George] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Baras, Alexander S.; Gandhi, Nilay; Bivalacqua, Trinity J.; Netto, George] Johns Hopkins Sch Med, Dept Urol, Baltimore, MD USA; [Marchionni, Luigi; Hahn, Noah; Bivalacqua, Trinity J.; Netto, George] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA; [Schoenberg, Mark] Albert Einstein Coll Med, Dept Urol, Bronx, NY 10467 USA; [Hoque, Mohammad] Johns Hopkins Sch Med, Dept Otolaryngol, Baltimore, MD USA; [Berman, David] Queens Univ, Dept Pathol, Kingston, ON K7L 3N6, Canada	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Yeshiva University; Albert Einstein College of Medicine; Johns Hopkins University; Johns Hopkins Medicine; Queens University - Canada	Baras, AS (corresponding author), Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	baras@jhmi.edu; gnetto1@jhmi.edu	Faraj, Sheila F/I-9725-2016; Munari, Enrico/J-7516-2016; berman, david/HIR-4177-2022; Marchionni, Luigi/S-6774-2017	Munari, Enrico/0000-0002-3867-6685; Marchionni, Luigi/0000-0002-7336-8071; Hoque, Mohammad Obaidul/0000-0001-6701-9978; berman, david/0000-0001-5985-3698; Netto, George/0000-0003-3915-9134	Flight Attendant Medical Research Institute; James Buchanan Brady Urological Institute	Flight Attendant Medical Research Institute; James Buchanan Brady Urological Institute	This work was supported by funding provided by the Flight Attendant Medical Research Institute and The James Buchanan Brady Urological Institute.	Advanced Bladder Cancer Overview Collaboration, 2005, COCHRANE DB SYST REV, V18; Amin MB, 2009, MODERN PATHOL, V22, pS96, DOI 10.1038/modpathol.2009.26; Apolo AB, 2014, UROL ONCOL-SEMIN ORI, V32, P637, DOI 10.1016/j.urolonc.2013.12.012; Chang SS, 2003, J UROLOGY, V170, P1085, DOI 10.1097/01.ju.0000086828.26001.ca; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Friedman J., 1998, ANN STAT; Gandhi NM, 2015, UROL ONCOL; George B, 2007, J CLIN ONCOL, V25, P5352, DOI 10.1200/JCO.2006.10.4125; Groenendijk FH, 2015, EUR UROL; Grossman HB, 2003, NEW ENGL J MED, V349, P859, DOI 10.1056/NEJMoa022148; Kato Y, 2011, EXP THER MED, V2, P47, DOI 10.3892/etm.2010.166; KAUFMAN DS, 1993, NEW ENGL J MED, V329, P1377, DOI 10.1056/NEJM199311043291903; Lindgren D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038863; Lindgren D, 2010, CANCER RES, V70, P3463, DOI 10.1158/0008-5472.CAN-09-4213; McConkey DJ, 2010, UROL ONCOL-SEMIN ORI, V28, P429, DOI 10.1016/j.urolonc.2010.04.008; Riester M, 2012, CLIN CANCER RES, V18, P1323, DOI 10.1158/1078-0432.CCR-11-2271; Ross JS, 2013, MOD PATHOL; Sanchez-Ortiz RF, 2003, J UROLOGY, V169, P110, DOI 10.1016/S0022-5347(05)64047-5; Sjodahl G, 2013, AM J PATHOL, V183, P681, DOI 10.1016/j.ajpath.2013.05.013; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Smith SC, 2011, LANCET ONCOL, V12, P137, DOI 10.1016/S1470-2045(10)70296-5; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Takata R, 2005, CLIN CANCER RES, V11, P2625, DOI 10.1158/1078-0432.CCR-04-1988; Takata R, 2010, AKTUEL UROL, V41, pS41, DOI 10.1055/s-0029-1224655; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Van Allen EM, 2014, CANCER DISCOV, V4, P1140, DOI 10.1158/2159-8290.CD-14-0623; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Williams PD, 2009, CANCER RES, V69, P8302, DOI 10.1158/0008-5472.CAN-09-0798; Zaid HB, 2014, UROLOGY, V83, P75, DOI 10.1016/j.urology.2013.07.072	29	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0131245	10.1371/journal.pone.0131245	http://dx.doi.org/10.1371/journal.pone.0131245			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230923	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400008
J	Bettembourg, C; Diot, C; Dameron, O				Bettembourg, Charles; Diot, Christian; Dameron, Olivier			Optimal Threshold Determination for Interpreting Semantic Similarity and Particularity: Application to the Comparison of Gene Sets and Metabolic Pathways Using GO and ChEBI	PLOS ONE			English	Article							ONTOLOGY ANNOTATIONS; DATABASE; EXPRESSION	Background The analysis of gene annotations referencing back to Gene Ontology plays an important role in the interpretation of high-throughput experiments results. This analysis typically involves semantic similarity and particularity measures that quantify the importance of the Gene Ontology annotations. However, there is currently no sound method supporting the interpretation of the similarity and particularity values in order to determine whether two genes are similar or whether one gene has some significant particular function. Interpretation is frequently based either on an implicit threshold, or an arbitrary one (typically 0.5). Here we investigate a method for determining thresholds supporting the interpretation of the results of a semantic comparison. Results We propose a method for determining the optimal similarity threshold by minimizing the proportions of false-positive and false-negative similarity matches. We compared the distributions of the similarity values of pairs of similar genes and pairs of non-similar genes. These comparisons were performed separately for all three branches of the Gene Ontology. In all situations, we found overlap between the similar and the non-similar distributions, indicating that some similar genes had a similarity value lower than the similarity value of some non-similar genes. We then extend this method to the semantic particularity measure and to a similarity measure applied to the ChEBI ontology. Thresholds were evaluated over the whole HomoloGene database. For each group of homologous genes, we computed all the similarity and particularity values between pairs of genes. Finally, we focused on the PPAR multigene family to show that the similarity and particularity patterns obtained with our thresholds were better at discriminating orthologs and paralogs than those obtained using default thresholds. Conclusion We developed a method for determining optimal semantic similarity and particularity thresholds. We applied this method on the GO and ChEBI ontologies. Qualitative analysis using the thresholds on the PPAR multigene family yielded biologically-relevant patterns.	[Bettembourg, Charles; Dameron, Olivier] Univ Rennes 1, Rennes, France; [Bettembourg, Charles; Diot, Christian] INRA, UMR PEGASE 1348, St Gilles, France; [Bettembourg, Charles; Diot, Christian] Agrocampus OUEST, UMR PEGASE 1348, Rennes, France; [Bettembourg, Charles; Dameron, Olivier] IRISA, Rennes, France; [Bettembourg, Charles; Dameron, Olivier] INRIA, Rennes, France	Universite de Rennes; INRAE; Institut Agro; Agrocampus Ouest; Inria	Bettembourg, C (corresponding author), Univ Rennes 1, Rennes, France.	charles.bettembourg@irisa.fr	Diot, Christian/AAE-2514-2020	Diot, Christian/0000-0001-9525-6401; Dameron, Olivier/0000-0001-8959-7189	French ministry of research	French ministry of research(Ministry of Research, FranceEuropean Commission)	CB was supported by a fellowship from the French ministry of research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez MA, 2011, J BIOINF COMPUT BIOL, V9, P681, DOI 10.1142/S0219720011005641; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azuaje F, 2006, PREDICTIVE INTEGRATI; Barriot R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-332; Bettembourg C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086525; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Chen Gang, 2013, Int J Bioinform Res Appl, V9, P173, DOI 10.1504/IJBRA.2013.052448; Cheng Jill, 2004, J Biopharm Stat, V14, P687, DOI 10.1081/BIP-200025659; Couto F.M., 2005, P 14 ACM INT C INF K, P343, DOI DOI 10.1145/1099554.1099658; Couto FM, 2010, PLOS COMPUT BIOL, V6; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Dameron O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075993; Degtyarenko K, 2008, NUCLEIC ACIDS RES, V36, pD344, DOI 10.1093/nar/gkm791; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Diaz-Diaz N, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-360; Gan MX, 2013, SCI WORLD J, DOI 10.1155/2013/793091; Gentleman R., 2014, VISUALIZING AND DIST; Gillis J, 2013, BIOINFORMATICS, V29, P476, DOI 10.1093/bioinformatics/bts727; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiang J, 1997, PROCEEDINGS OF THE I; Jin B, 2010, BIOINFORMATICS, V26, P2445, DOI 10.1093/bioinformatics/btq449; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Li HZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057809, 10.1371/journal.pone.0066745]; Lin D, 1998, P INT C MACH LEARN; Lord P W, 2003, Pac Symp Biocomput, P601; Mazandu Gaston K., 2012, Advances in Bioinformatics, V2012, P975783, DOI 10.1155/2012/975783; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Michalik L, 2002, INT J DEV BIOL, V46, P105; Miller George, 1998, WORDNET ELECT LEXICA; Mistry M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-327; Pesquita C, 2007, P 10 ANN BIOONT M; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; RADA R, 1989, IEEE T SYST MAN CYB, V19, P17, DOI 10.1109/21.24528; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Sevilla JL, 2005, IEEE ACM T COMPUT BI, V2, P330, DOI 10.1109/TCBB.2005.50; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Sheehan B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-468; Staab S, 2002, COLING; Thomas PD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002386; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064	46	7	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133579	10.1371/journal.pone.0133579	http://dx.doi.org/10.1371/journal.pone.0133579			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230274	gold, Green Submitted, Green Published			2022-12-27	WOS:000358838400044
J	Hofmann, WP; Mauss, S; Lutz, T; Schober, A; Boker, K; Moog, G; Baumgarten, A; Pfeiffer-Vornkahl, H; Alshuth, U; Huppe, D; Wedemeyer, H; Manns, MP; Schott, E				Hofmann, Wolf Peter; Mauss, Stefan; Lutz, Thomas; Schober, Andreas; Boeker, Klaus; Moog, Gero; Baumgarten, Axel; Pfeiffer-Vornkahl, Heike; Alshuth, Ulrich; Hueppe, Dietrich; Wedemeyer, Heiner; Manns, Michael P.; Schott, Eckart			Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; PLUS RIBAVIRIN; HCV GENOTYPE-2; PEGYLATED-INTERFERON; TREATMENT DURATION; THERAPY; INFECTION; CIRRHOSIS; TYPE-1	Background and Aims Individualization of treatment with peginterferon alfa and ribavirin in patients with chronic hepatitis C showed benefit in controlled trials and was implemented in treatment guidelines to increase response rates and to reduce side effects and costs. However, it is unknown whether individualization was adopted in routine daily practice and whether it translated into improved outcomes. Methods From a large noninterventional cohort study, clinical and virologic response data of 10,262 HCV patients who received peginterferon alfa-2a and ribavirin between 2003-2007 and 2008-2011 were analyzed. To account for treatment individualization, a matched-pair analysis (2,997 matched pairs) was performed. Variation in treatment duration and dosing of ribavirin were analyzed as indicators for individualization. Results Sustained virological response (SVR) rates were similar between 2003-2007 and 20082011 (62.0% vs. 63.7%). Patients with comorbidities were more abundant in the later period, (44.3% vs. 57.1%). The subsequent matched-pair analysis demonstrated higher SVR rates in the 2008-2011 period (64.3%) than in the 2003-2007 period (61.2%, p=0.008). More patients received abbreviated or extended treatment regimens in the later than the earlier period as an indicator of treatment individualization. To the same end, ribavirin doses were higher in the later period ( 12.6 versus 11.6 mg/kg/day). Factors independently associated with SVR included HCV genotype, low baseline viral load, younger age, route of infection, absence of concomitant diseases, lower APRI score, normal gamma-GT, higher ribavirin doses, no substitution for drug abuse, treatment duration, and treatment in the 2008-2011 period. Conclusions Treatment individualization with peginterferon alfa and ribavirin was implemented in daily routine between 2003-2007 and 2008-2011, SVR rates improved in the same period. These findings may be most relevant in resource-limited settings.	[Mauss, Stefan] Ctr HIV & Hepatogastroenterol, Dusseldorf, Germany; [Lutz, Thomas] Infektiologikum, Frankfurt, Germany; [Baumgarten, Axel] Ctr Infect Dis, Berlin, Germany; [Pfeiffer-Vornkahl, Heike] Inst Clin Res & Stat, Offenbach, Germany; [Alshuth, Ulrich] Roche Pharma AG, Virol, Grenzach Wyhlen, Germany; [Hueppe, Dietrich] Ctr Gastroenterol, Herne, Germany; [Wedemeyer, Heiner; Manns, Michael P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30623 Hannover, Germany; [Schott, Eckart] Charite, Campus Virchow Klinikum, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany	Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schott, E (corresponding author), Charite, Campus Virchow Klinikum, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany.	eckart.schott@charite.de			Roche Pharma AG	Roche Pharma AG(Roche Holding)	This noninterventional study was funded in full according to GPP (Good Pharmacoepidemiology Practice) guideline definition of a sponsor by Roche Pharma AG, Grenzach-Wyhlen, Germany (Pharmacoepidemiology and Drug Safety 2008; 17: 200-208). Roche Pharma AG provided support in the form of salary for author Ulrich Alshuth. The specific roles of this author are articulated in the 'author contributions' section. According to GPP responsibility for scientific integrity is shared by the collaborating institutions in that case the sponsor Roche Pharma AG, the Association of German gastroenterologists in office based practices (bng, Bundesverband niedergelassener Gastroenterologen e. V.) and lead author Prof. Niederau. Analysis of data, decision to publish, and preparation of the manuscript were in the responsiblity of the authors.	Berg T, 2006, GASTROENTEROLOGY, V130, P1086, DOI 10.1053/j.gastro.2006.02.015; Clark PJ, 2011, AM J GASTROENTEROL, V106, P38, DOI 10.1038/ajg.2010.370; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Dalgard O, 2004, HEPATOLOGY, V40, P1260, DOI 10.1002/hep.20467; Drenth JPH, 2013, NEW ENGL J MED, V368, P1931, DOI 10.1056/NEJMe1303818; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Ferenci P, 2008, GASTROENTEROLOGY, V135, P451, DOI 10.1053/j.gastro.2008.04.015; Ferenci P, 2010, GASTROENTEROLOGY, V138, P503, DOI 10.1053/j.gastro.2009.10.058; Forns X, 2014, GASTROENTEROLOGY, V146, P1669, DOI 10.1053/j.gastro.2014.02.051; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gellad ZF, 2012, VALUE HEALTH, V15, P876, DOI 10.1016/j.jval.2012.06.010; Hofmann WP, 2012, DTSCH ARZTEBL INT, V109, P352, DOI 10.3238/arztebl.2012.0352; Hofmann WP, 2011, NAT REV GASTRO HEPAT, V8, P257, DOI 10.1038/nrgastro.2011.49; Hofmann WP, 2006, Z GASTROENTEROL, V44, P25, DOI 10.1055/s-2005-858960; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Jacobson IM, 2007, HEPATOLOGY, V46, P982, DOI 10.1002/hep.21670; Jacobson IM, 2007, HEPATOLOGY, V46, P971, DOI 10.1002/hep.21932; Jayasekera CR, 2014, NEW ENGL J MED, V370, P1869, DOI 10.1056/NEJMp1400160; Jensen DM, 2006, HEPATOLOGY, V43, P954, DOI 10.1002/hep.21159; Kau A, 2008, J HEPATOL, V49, P634, DOI 10.1016/j.jhep.2008.07.013; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Mangia A, 2014, LIVER INT, V34, pE217, DOI 10.1111/liv.12352; Mangia A, 2010, J HEPATOL, V53, P1000, DOI 10.1016/j.jhep.2010.04.042; Manns M, 2011, J HEPATOL, V55, P554, DOI 10.1016/j.jhep.2010.12.024; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marcellin P, 2012, HEPATOLOGY, V56, P2039, DOI 10.1002/hep.25892; Sanchez-Tapias JM, 2006, GASTROENTEROLOGY, V131, P451, DOI 10.1053/j.gastro.2006.05.016; Sarrazin C, 2010, Z GASTROENTEROL, V48, P289, DOI 10.1055/s-0028-1110008; Sarrazin C, 2011, GASTROENTEROLOGY, V141, P1656, DOI 10.1053/j.gastro.2011.07.019; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; von Wagner M, 2005, GASTROENTEROLOGY, V129, P522, DOI 10.1053/j.gastro.2005.05.008; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Zeuzem S, 2006, J HEPATOL, V44, P97, DOI 10.1016/j.jhep.2005.10.003; Zeuzem S, 2004, J HEPATOL, V40, P993, DOI [10.1016/S0168-8278(04)00060-1, 10.1016/j.jhep.2004.02.007]; Zeuzem S, 2010, CURR MED RES OPIN, V26, P1733, DOI 10.1185/03007995.2010.487038	39	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134839	10.1371/journal.pone.0134839	http://dx.doi.org/10.1371/journal.pone.0134839			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230998	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400174
J	Lewinson, RT; Wiley, JP; Humble, RN; Worobets, JT; Stefanyshyn, DJ				Lewinson, Ryan T.; Wiley, J. Preston; Humble, R. Neil; Worobets, Jay T.; Stefanyshyn, Darren J.			Altering Knee Abduction Angular Impulse Using Wedged Insoles for Treatment of Patellofemoral Pain in Runners: A Six-Week Randomized Controlled Trial	PLOS ONE			English	Article							VISUAL ANALOG SCALE; JOINT COORDINATE SYSTEM; FOOT-ORTHOSES; ADDUCTION MOMENT; OSTEOARTHRITIS; KINEMATICS; INJURIES; KINETICS; ORTHOTICS; SEVERITY	Objective Determine if a change in internal knee abduction angular impulse (KAAI) is related to pain reduction for runners with patellofemoral pain (PFP) by comparing lateral and medial wedge insole interventions, and increased KAAI and decreased KAAI groups. Design Randomized controlled clinical trial (ClinicalTrials. gov ID# NCT01332110). Setting Biomechanics laboratory and community. Patients Thirty-six runners with physician-diagnosed PFP enrolled in the trial, and 27 were analyzed. Interventions Runners with PFP were randomly assigned to either an experimental 3 mm lateral wedge or control 6 mm medial wedge group. Participants completed a biomechanical gait analysis to quantify KAAIs with their assigned insole, and then used their assigned insole for six-weeks during their regular runs. Usual pain during running was measured at baseline and at six-week follow-up using a visual analog scale. Statistical tests were performed to identify differences between wedge types, differences between biomechanical response types (i.e. increase or decrease KAAI), as well as predictors of pain reduction. Main Outcome Measures Percent change in KAAI relative to neutral, and % change in pain over six weeks. Results Clinically meaningful reductions in pain (>33%) were measured for both footwear groups; however, no significant differences between footwear groups were found (p = 0.697). When participants were regrouped based on KAAI change (i.e., increase or decrease), again, no significant differences in pain reduction were noted (p = 0.146). Interestingly, when evaluating absolute change in KAAI, a significant relationship between absolute% change in KAAI and % pain reduction was observed (R-2 = 0.21; p = 0.030), after adjusting for baseline pain levels. Conclusion The greater the absolute % change in KAAI during running, the greater the % reduction in pain over six weeks, regardless of wedge type, and whether KAAIs increased or decreased. Lateral and medial wedge insoles were similar in effectiveness for treatment of PFP.	[Lewinson, Ryan T.; Wiley, J. Preston; Worobets, Jay T.; Stefanyshyn, Darren J.] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada; [Lewinson, Ryan T.; Stefanyshyn, Darren J.] Univ Calgary, Schulich Sch Engn, Biomed Engn Program, Calgary, AB, Canada; [Lewinson, Ryan T.; Wiley, J. Preston; Humble, R. Neil] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [Wiley, J. Preston] Univ Calgary, Fac Kinesiol, Sport Med Ctr, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Lewinson, RT (corresponding author), Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada.	lewinson@ucalgary.ca		Stefanyshyn, Darren/0000-0001-7180-360X	Canadian Institutes of Health Research; Natural Sciences & Engineering Research Council of Canada CREATE program; Alberta Innovates [201300001] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences & Engineering Research Council of Canada CREATE program(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates	This study was funded by graduate student awards for RTL from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) and the Natural Sciences & Engineering Research Council of Canada CREATE program (http://www.nserc-crsng.gc.ca/index_eng.asp). The funding agencies played no role in study design or analysis.	Barton CJ, 2010, SPORTS MED, V40, P377, DOI 10.2165/11530780-000000000-00000; Barton CJ, 2009, GAIT POSTURE, V30, P405, DOI 10.1016/j.gaitpost.2009.07.109; Bennell KL, 2011, ANN RHEUM DIS, V70, P1770, DOI 10.1136/ard.2010.147082; Boldt AR, 2013, J APPL BIOMECH, V29, P68, DOI 10.1123/jab.29.1.68; Brechter JH, 2002, MED SCI SPORT EXER, V34, P1582, DOI 10.1249/01.MSS.0000035990.28354.c6; Chapman GJ, OSTEOARTHRI IN PRESS; Clauser C. E., 1969, WEIGHT VOLUME CTR MA, P1; Clement D B, 1981, Phys Sportsmed, V9, P47, DOI 10.1080/00913847.1981.11711077; COLE GK, 1993, J BIOMECH ENG-T ASME, V115, P344, DOI 10.1115/1.2895496; Collins N, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1735; Dempster WT., 1955, 55159 WADC WRIGHT PA; ENG JJ, 1993, PHYS THER, V73, P62, DOI 10.1093/ptj/73.2.62; Fisher DS, 2007, J ORTHOP RES, V25, P540, DOI 10.1002/jor.20157; Fukuchi C, 2012, FOOTWEAR SCI, V4, P207, DOI 10.1080/19424280.2012.683044; Fulkerson JP, 2002, AM J SPORT MED, V30, P447, DOI 10.1177/03635465020300032501; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; Herzog W, 2003, ARTHRIT RHEUM-ARTHR, V49, P239, DOI 10.1002/art.11004; Hinman RS, 2008, ARTHRIT RHEUM-ARTHR, V59, P408, DOI 10.1002/art.23326; Jensen MP, 2003, J PAIN, V4, P407, DOI 10.1016/S1526-5900(03)00716-8; Kelly AM, 2001, EMERG MED J, V18, P205, DOI 10.1136/emj.18.3.205; Lenhart RL, 2014, MED SCI SPORT EXER, V46, P557, DOI 10.1249/MSS.0b013e3182a78c3a; Lewinson RT, 2013, CLIN J SPORT MED, V23, P392, DOI 10.1097/JSM.0b013e31828b0848; Lewinson RT, 2013, P I MECH ENG H, V227, P811, DOI 10.1177/0954411913483431; Lewinson RT, 2013, CLIN J SPORT MED, V23, P208, DOI 10.1097/JSM.0b013e31826b7c83; Lun VMY, 2005, CLIN J SPORT MED, V15, P233; MacLean CL, 2008, CLIN J SPORT MED, V18, P338, DOI 10.1097/MJT.0b013e31815fa75a; MATHESON GO, 1989, MED SCI SPORT EXER, V21, P379; Mundermann A, 2003, CLIN BIOMECH, V18, P254, DOI 10.1016/S0268-0033(02)00186-9; Mundermann A, 2003, MED SCI SPORT EXER, V35, P1710, DOI 10.1249/01.MSS.0000089352.47259.CA; Nigg BM, 2003, MED SCI SPORT EXER, V35, P314, DOI 10.1249/01.MSS.0000048828.02268.79; Nimon G, 1998, J PEDIATR ORTHOPED, V18, P118, DOI 10.1097/00004694-199801000-00021; Park SK, 2011, CLIN BIOMECH, V26, P392, DOI 10.1016/j.clinbiomech.2010.11.015; Radzimski AO, 2012, KNEE, V19, P163, DOI 10.1016/j.knee.2011.05.013; Reeves ND, 2011, NAT REV RHEUMATOL, V7, P113, DOI 10.1038/nrrheum.2010.212; Robertson GE., 2004, RES METHODS BIOMECHA; Sawatsky A, 2012, CLIN BIOMECH, V27, P595, DOI 10.1016/j.clinbiomech.2011.12.011; Schmalz T, 2006, CLIN BIOMECH, V21, P631, DOI 10.1016/j.clinbiomech.2006.02.004; Sharma L, 1998, ARTHRITIS RHEUM, V41, P1233, DOI 10.1002/1529-0131(199807)41:7<1233::AID-ART14>3.0.CO;2-L; Stefanyshyn DJ, 2006, AM J SPORT MED, V34, P1844, DOI 10.1177/0363546506288753; Taunton JE, 2002, BRIT J SPORT MED, V36, P95, DOI 10.1136/bjsm.36.2.95; Thomee R, 1997, PHYS THER, V77, P1690, DOI 10.1093/ptj/77.12.1690; Utting MR, 2005, KNEE, V12, P362, DOI 10.1016/j.knee.2004.12.006; van Gent RN, 2007, BRIT J SPORT MED, V41, P469, DOI 10.1136/bjsm.2006.033548; van Linschoten R, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4074; Winter D., 2009, BIOMECHANICS MOTOR C, V4th	45	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134461	10.1371/journal.pone.0134461	http://dx.doi.org/10.1371/journal.pone.0134461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230399	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400123
J	Ostermann, JK; Reinhold, T; Witt, CM				Ostermann, Julia K.; Reinhold, Thomas; Witt, Claudia M.			Can Additional Homeopathic Treatment Save Costs? A Retrospective Cost-Analysis Based on 44500 Insured Persons	PLOS ONE			English	Article							COHORT	Objectives The aim of this study was to compare the health care costs for patients using additional homeopathic treatment (homeopathy group) with the costs for those receiving usual care (control group). Methods Cost data provided by a large German statutory health insurance company were retrospectively analysed from the societal perspective (primary outcome) and from the statutory health insurance perspective. Patients in both groups were matched using a propensity score matching procedure based on socio-demographic variables as well as costs, number of hospital stays and sick leave days in the previous 12 months. Total cumulative costs over 18 months were compared between the groups with an analysis of covariance (adjusted for baseline costs) across diagnoses and for six specific diagnoses (depression, migraine, allergic rhinitis, asthma, atopic dermatitis, and headache). Results Data from 44,550 patients (67.3% females) were available for analysis. From the societal perspective, total costs after 18 months were higher in the homeopathy group (adj. mean: EUR 7,207.72 [95% CI 7,001.14-7,414.29]) than in the control group (EUR 5,857.56 [5,650.98-6,064.13]; p<0.0001) with the largest differences between groups for productivity loss (homeopathy EUR 3,698.00 [3,586.48-3,809.53] vs. control EUR 3,092.84 [2,981.31-3,204.37]) and outpatient care costs (homeopathy EUR 1,088.25 [1,073.90-1,102.59] vs. control EUR 867.87 [853.52-882.21]). Group differences decreased over time. For all diagnoses, costs were higher in the homeopathy group than in the control group, although this difference was not always statistically significant. Conclusion Compared with usual care, additional homeopathic treatment was associated with significantly higher costs. These analyses did not confirm previously observed cost savings resulting from the use of homeopathy in the health care system.	[Ostermann, Julia K.; Reinhold, Thomas; Witt, Claudia M.] Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, D-10117 Berlin, Germany; [Witt, Claudia M.] Univ Zurich, Inst Complementary & Integrat Med, Zurich, Switzerland; [Witt, Claudia M.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Witt, Claudia M.] Univ Maryland, Sch Med, Ctr Integrat Med, Baltimore, MD 21201 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Zurich; University of Zurich; University Zurich Hospital; University System of Maryland; University of Maryland Baltimore	Ostermann, JK (corresponding author), Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, D-10117 Berlin, Germany.	julia.ostermann@charite.de	Witt, Claudia M./AAX-2370-2021	Witt, Claudia M./0000-0002-5440-7805; Reinhold, Thomas/0000-0001-5169-7029; Ostermann, Julia/0000-0002-0180-8752	statutory health insurance company Techniker Krankenkasse	statutory health insurance company Techniker Krankenkasse	This is an investigator initiated trial that is co-sponsored by the statutory health insurance company Techniker Krankenkasse. The co-sponsor provided data, but was not involved in the main data analysis, data interpretation, writing, or decision to submit the manuscript. All authors had full access to the data and are responsible for the veracity and completeness of the data reported. All authors had full access to the data in the study and take final responsibility to submit for publication.	[Anonymous], 2014, R LANG ENV STAT COMP; AVERILL RF, 1992, HEALTH SERV RES, V27, P587; AVINA RL, 1978, WESTERN J MED, V128, P366; Baars EW, 2014, BMJ OPEN, V4, DOI DOI 10.1136/BMJ0PEN-2014-005332; DZVh&Auml;, 2012, SEL KLASS HOM BET KR; Ernst E, 2002, BRIT J CLIN PHARMACO, V54, P577, DOI 10.1046/j.1365-2125.2002.01699.x; Gesundheitsberichterstattung des Bundes, 2015, ARZT ARZT ZUS WEIT; Institut f&uuml;r Demoskopie, 2014, HOM ARZN 2014 BEK VE; Jain Asha, 2003, Homeopathy, V92, P71, DOI 10.1016/S1475-4916(03)00004-3; Kliems H, 2011, J ALTERN COMPLEM MED, V17, P265, DOI 10.1089/acm.2010.0158; Linde K, 1997, LANCET, V350, P834, DOI 10.1016/S0140-6736(97)02293-9; MADDOX J, 1988, NATURE, V334, P287, DOI 10.1038/334287a0; Marian F, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-52; Moebus S, 2002, FEDERAL HLTH REPORT; Reinhold T, 2010, J PUBLIC HEALTH-HEID, V18, P327, DOI 10.1007/s10389-010-0315-0; Roll S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054973; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Smith K, 2012, BIOETHICS, V26, P398, DOI 10.1111/j.1467-8519.2010.01876.x; Statistisches Bundesamt, 2014, JAHR ARB; Studer HP, 2011, FORSCH KOMPLEMENTMED, V18, P315, DOI 10.1159/000334797; Viksveen P, 2014, EUR J HEALTH ECON, V15, P157, DOI 10.1007/s10198-013-0462-7; Witt C, 2005, COMPLEMENT THER MED, V13, P79, DOI 10.1016/j.ctim.2005.03.005; Witt CM, 2009, DERMATOLOGY, V219, P329, DOI 10.1159/000248854; Witt CM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2158-5-115	24	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134657	10.1371/journal.pone.0134657	http://dx.doi.org/10.1371/journal.pone.0134657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230412	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400145
J	Slattery, ML; Pellatt, DF; Mullany, LE; Wolff, RK				Slattery, Martha L.; Pellatt, Daniel F.; Mullany, Lila E.; Wolff, Roger K.			Differential Gene Expression in Colon Tissue Associated With Diet, Lifestyle, and Related Oxidative Stress	PLOS ONE			English	Article							ALPHA-7 NICOTINIC RECEPTOR; MEDIATED TOBACCO TOXICITY; CIGARETTE-SMOKING; COLORECTAL ADENOMA; ANTIOXIDANT EXPOSURES; CANCER; RISK; ALCOHOL; BALANCE	Several diet and lifestyle factors may impact health by influencing oxidative stress levels. We hypothesize that level of cigarette smoking, alcohol, anti-inflammatory drugs, and diet alter gene expression. We analyzed RNA-seq data from 144 colon cancer patients who had information on recent cigarette smoking, recent alcohol consumption, diet, and recent aspirin/non-steroidal anti-inflammatory use. Using a false discovery rate of 0.1, we evaluated gene differential expression between high and low levels of exposure using DESeq2. Ingenuity Pathway Analysis (IPA) was used to determine networks associated with de-regulated genes in our data. We identified 46 deregulated genes associated with recent cigarette use; these genes enriched causal networks regulated by TEK and MAP2K3. Different differentially expressed genes were associated with type of alcohol intake; five genes were associated with total alcohol, six were associated with beer intake, six were associated with wine intake, and four were associated with liquor consumption. Recent use of aspirin and/or ibuprofen was associated with differential expression of TMC06, ST8SIA4, and STEAP3 while a summary oxidative balance score (OBS) was associated with SYCP3, HDX, and NRG4 (all up-regulated with greater oxidative balance). Of the dietary antioxidants and carotenoids evaluated only intake of beta carotene (1 gene), Lutein/Zeaxanthine (5 genes), and Vitamin E (4 genes) were associated with differential gene expression. There were similarities in biological function of de-regulated genes associated with various dietary and lifestyle factors. Our data support the hypothesis that diet and lifestyle factors associated with oxidative stress can alter gene expression. However genes altered were unique to type of alcohol and type of antioxidant. Because of potential differences in associations observed between platforms these findings need replication in other populations.	[Slattery, Martha L.; Pellatt, Daniel F.; Mullany, Lila E.; Wolff, Roger K.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Slattery, ML (corresponding author), Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84112 USA.	Marty.Slattery@hsc.utah.edu			National Cancer Institute (NCI) [CA48998]; NATIONAL CANCER INSTITUTE [U01CA048998, R01CA048998, R01CA163683] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by National Cancer Institute (NCI) grants CA48998.	Arredondo J, 2008, FASEB J, V22, P1356, DOI 10.1096/fj.07-9965.com; Arredondo J, 2007, LIFE SCI, V80, P2191, DOI 10.1016/j.lfs.2007.01.013; Bai SK, 2005, EXP MOL MED, V37, P323, DOI 10.1038/emm.2005.42; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chao A, 2000, JNCI-J NATL CANCER I, V92, P1888, DOI 10.1093/jnci/92.23.1888; Chavez Jennifier, 2007, Am J Ther, V14, P189; Dorr C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125045; EDWARDS S, 1994, AM J EPIDEMIOL, V140, P1020, DOI 10.1093/oxfordjournals.aje.a117192; Fonseca NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107026; GIOVANNUCCI E, 1994, J NATL CANCER I, V86, P192, DOI 10.1093/jnci/86.3.192; Giovannucci E, 2001, CANCER EPIDEM BIOMAR, V10, P725; GIOVANNUCCI E, 1994, J NATL CANCER I, V86, P183, DOI 10.1093/jnci/86.3.183; Goodman M, 2008, CANCER CAUSE CONTROL, V19, P1051, DOI 10.1007/s10552-008-9169-y; Goodman M, 2010, ANN EPIDEMIOL, V20, P955, DOI 10.1016/j.annepidem.2010.08.011; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071462; He BM, 2013, MOL MED REP, V8, P1683, DOI 10.3892/mmr.2013.1724; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Liu Kiang, 1994, Ethnicity and Disease, V4, P15; Llinas L, 2011, PULM PHARMACOL THER, V24, P32, DOI 10.1016/j.pupt.2010.10.010; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mena S, 2009, MUTAT RES-GEN TOX EN, V674, P36, DOI 10.1016/j.mrgentox.2008.09.017; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Morel Y, 1999, BIOCHEM J, V342, P481, DOI 10.1042/0264-6021:3420481; Mossman BT, 2006, AM J RESP CELL MOL, V34, P666, DOI 10.1165/rcmb.2006-0047SF; Nagamma T, 2012, ASIAN PAC J CANCER P, V13, P3513, DOI 10.7314/APJCP.2012.13.7.3513; Nielsen OH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006210; Ornish D, 2008, P NATL ACAD SCI USA, V105, P8369, DOI 10.1073/pnas.0803080105; Oyesanmi Olu, 2010, Evid Rep Technol Assess (Full Rep), P1; Petersen DR, 2005, ALCOHOL, V35, P243, DOI 10.1016/j.alcohol.2005.03.013; Rafi MM, 2014, J MED FOOD; Samowitz WS, 2001, GASTROENTEROLOGY, V121, P830, DOI 10.1053/gast.2001.27996; Satia-Abouta J, 2003, CANCER EPIDEM BIOMAR, V12, P747; Slattery ML, 2012, MUTAT RES-FUND MOL M, V734, P30, DOI 10.1016/j.mrfmmm.2012.04.002; Slattery ML, 1998, CANCER EPIDEM BIOMAR, V7, P1079; Slattery ML, 2000, J NATL CANCER I, V92, P1831, DOI 10.1093/jnci/92.22.1831; Slattery ML, 1998, NUTR CANCER, V30, P201, DOI 10.1080/01635589809514664; Slattery ML, 2000, AM J CLIN NUTR, V71, P575; Slattery ML, 2000, MUTAT RES-GENOMICS, V432, P7, DOI 10.1016/S1383-5726(99)00010-2; Stone WL, 1997, JNCI-J NATL CANCER I, V89, P1006, DOI 10.1093/jnci/89.14.1006; Talukder MAH, 2011, AM J PHYSIOL-HEART C, V300, pH388, DOI 10.1152/ajpheart.00868.2010	40	22	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134406	10.1371/journal.pone.0134406	http://dx.doi.org/10.1371/journal.pone.0134406			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230583	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400114
J	Tamminen, K; Balboa, D; Toivonen, S; Pakarinen, MP; Wiener, Z; Alitalo, K; Otonkoski, T				Tamminen, Kaisa; Balboa, Diego; Toivonen, Sanna; Pakarinen, Mikko P.; Wiener, Zoltan; Alitalo, Kari; Otonkoski, Timo			Intestinal Commitment and Maturation of Human Pluripotent Stem Cells Is Independent of Exogenous FGF4 and R-spondin1	PLOS ONE			English	Article							EFFICIENT DIFFERENTIATION; IN-VITRO; WNT; EXPRESSION; SIGNALS; COLON; SPECIFICATION; TRANSCRIPTION; INDUCTION; EXPANSION	Wnt/beta-catenin signaling plays a central role in guiding the differentiation of the posterior parts of the primitive gut tube into intestinal structures in vivo and some studies suggest that FGF4 is another crucial factor for intestinal development. The aim of this study was to define the effects of Wnt and FGF4 on intestinal commitment in vitro by establishing conditions for differentiation of human pluripotent stem cells (hPSC) into posterior endoderm (hindgut) and further to self-renewing intestinal-like organoids. The most prominent induction of the well-established intestinal marker gene CDX2 was achieved when hPSC-derived definitive endoderm cells were treated with Wnt agonist molecule CHIR99021 during differentiation to hindgut. FGF4 was found to be dispensable during intestinal commitment, but it had an early role in repressing development towards the hepatic lineage. When hindgut stage cells were further cultured in 3D, they formed self-renewing organoid structures containing all major intestinal cell types even without exogenous R-spondin1 (RSPO1), a crucial factor for the culture of epithelial organoids derived from adult intestine. This may be explained by the presence of a mesenchymal compartment in the hPSC-derived organoids. Addition of WNT3A increased the expression of the Paneth cell marker Lysozyme in hPSC-derived organoid cultures, whereas FGF4 inhibited both the formation and maturation of intestinal-like organoids. Similar hindgut and organoid cultures were established from human induced pluripotent stem cells, implying that this approach can be used to create patient-specific intestinal tissue models for disease modeling in vitro.	[Tamminen, Kaisa; Balboa, Diego; Toivonen, Sanna; Otonkoski, Timo] Univ Helsinki, Mol Neurol, Res Programs Unit, Helsinki, Finland; [Tamminen, Kaisa; Balboa, Diego; Toivonen, Sanna; Otonkoski, Timo] Univ Helsinki, Biomedicum, Stem Cell Ctr, Helsinki, Finland; [Pakarinen, Mikko P.; Otonkoski, Timo] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Pakarinen, Mikko P.; Otonkoski, Timo] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Wiener, Zoltan; Alitalo, Kari] Biomedicum Helsinki, Translat Canc Biol Program, Helsinki, Finland; [Wiener, Zoltan; Alitalo, Kari] Biomedicum Helsinki, Wihuri Res Inst, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Wihuri Research Institute	Otonkoski, T (corresponding author), Univ Helsinki, Mol Neurol, Res Programs Unit, Helsinki, Finland.	timo.otonkoski@helsinki.fi	Alitalo, Kari K/J-5013-2014; Pakarinen, Mikko/AAD-8834-2019	Alitalo, Kari K/0000-0002-7331-0902; Balboa, Diego/0000-0002-4784-5452	Sigrid Juselius Foundation; Academy of Finland [257157]; Novo Nordisk Foundation [10719]; Helsinki University Central Hospital research funds; Novo Nordisk Fonden [NNF13OC0005565, NNF14OC0010719] Funding Source: researchfish	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Helsinki University Central Hospital research funds; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by grants from the Sigrid Juselius Foundation (http://www.sigridjuselius.fi/), the Academy of Finland (Grant number: 257157 http://www.aka.fi/en-GB/A/), The Novo Nordisk Foundation (Grant number: 10719, http://www.novonordiskfonden.dk/en) and the Helsinki University Central Hospital research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu P, 2008, DEV BIOL, V324, P288, DOI 10.1016/j.ydbio.2008.09.027; Barbara PD, 2003, CELL MOL LIFE SCI, V60, P1322, DOI 10.1007/s00018-003-2289-3; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bayha E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005845; Bell SM, 2013, DEV BIOL, V375, P128, DOI 10.1016/j.ydbio.2012.12.010; Cao L, 2011, DIFFERENTIATION, V81, P1, DOI 10.1016/j.diff.2010.09.182; Chan CWM, 2009, P NATL ACAD SCI USA, V106, P1936, DOI 10.1073/pnas.0812904106; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547; Dessimoz J, 2006, MECH DEVELOP, V123, P42, DOI 10.1016/j.mod.2005.10.001; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Fordham RP, 2013, CELL STEM CELL, V13, P734, DOI 10.1016/j.stem.2013.09.015; Forster R, 2014, STEM CELL REP, V2, P838, DOI 10.1016/j.stemcr.2014.05.001; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Grainger S, 2010, DEV BIOL, V339, P155, DOI 10.1016/j.ydbio.2009.12.025; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Hulmi JJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE41, DOI 10.1152/ajpendo.00389.2012; Illig R, 2013, DEV DYNAM, V242, P53, DOI 10.1002/dvdy.23893; Iwao T, 2014, DRUG METAB PHARMACOK, V29, P44, DOI 10.2133/dmpk.DMPK-13-RG-005; JAMES R, 1994, J BIOL CHEM, V269, P15229; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loh KM, 2014, CELL STEM CELL, V14, P237, DOI 10.1016/j.stem.2013.12.007; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; McConnell BB, 2011, GASTROENTEROLOGY, V141, P1302, DOI 10.1053/j.gastro.2011.06.086; McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410; Mikkola M, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0365; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Ogaki S, 2013, STEM CELLS, V31, P1086, DOI 10.1002/stem.1344; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sherwood RI, 2011, MECH DEVELOP, V128, P387, DOI 10.1016/j.mod.2011.07.005; Shibamoto S, 1998, GENES CELLS, V3, P659; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Stringer EJ, 2012, DEVELOPMENT, V139, P465, DOI 10.1242/dev.070722; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toivonen S, 2013, EXP CELL RES, V319, P2535, DOI 10.1016/j.yexcr.2013.07.007; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Watson CL, 2014, NATURE MED; Wells JM, 2014, DEVELOPMENT, V141, P752, DOI 10.1242/dev.097386; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167	50	20	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134551	10.1371/journal.pone.0134551	http://dx.doi.org/10.1371/journal.pone.0134551			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230325	Green Submitted, gold, Green Published			2022-12-27	WOS:000358838400133
J	Yan, CG; Hao, ZG; Zhang, S; Zhang, BH; Zheng, T				Yan, Chenguang; Hao, Zhiguo; Zhang, Song; Zhang, Baohui; Zheng, Tao			Numerical Methods for the Analysis of Power Transformer Tank Deformation and Rupture Due to Internal Arcing Faults	PLOS ONE			English	Article							PREVENTION; SIMULATION; MODEL	Power transformer rupture and fire resulting from an arcing fault inside the tank usually leads to significant security risks and serious economic loss. In order to reveal the essence of tank deformation or explosion, this paper presents a 3-D numerical computational tool to simulate the structural dynamic behavior due to overpressure inside transformer tank. To illustrate the effectiveness of the proposed method, a 17.3MJ and a 6.3MJ arcing fault were simulated on a real full-scale 360MVA/220kV oil-immersed transformer model, respectively. By employing the finite element method, the transformer internal overpressure distribution, wave propagation and von-Mises stress were solved. The numerical results indicate that the increase of pressure and mechanical stress distribution are non-uniform and the stress tends to concentrate on connecting parts of the tank as the fault time evolves. Given this feature, it becomes possible to reduce the risk of transformer tank rupture through limiting the fault energy and enhancing the mechanical strength of the local stress concentrative areas. The theoretical model and numerical simulation method proposed in this paper can be used as a substitute for risky and costly field tests in fault overpressure analysis and tank mitigation design of transformers.	[Yan, Chenguang; Hao, Zhiguo; Zhang, Baohui; Zheng, Tao] Xi An Jiao Tong Univ, State Key Lab Elect Insulat & Power Equipment, Xian 710049, Peoples R China; [Zhang, Song] Alstom Grid, Redmond, WA USA	Xi'an Jiaotong University; Alstom	Zheng, T (corresponding author), Xi An Jiao Tong Univ, State Key Lab Elect Insulat & Power Equipment, Xian 710049, Peoples R China.	tzheng@mail.xjtu.edu.cn			National Natural Science Foundation of China [51277142]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under Project 51277142. Co-author Song Zhang is employed by Alstom Grid, Redmond, WA. Alstom Grid provided support in the form of salary for author SZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Samra N, 2009, IEEE T POWER DELIVER, V24, P1959, DOI 10.1109/TPWRD.2009.2028817; Allaire G, 2002, J COMPUT PHYS, V181, P577, DOI 10.1006/jcph.2002.7143; An JR, 2012, NEW CHINESE FOREIGN; An L, 2012, COMSOL MULTIPHYSICS; BASTARD P, 1994, IEEE T POWER DELIVER, V9, P690, DOI 10.1109/61.296246; Brady R., 2008, 2008 AMSE PRESS VESS, P49; COURANT R, 1967, IBM J RES DEV, V11, P215, DOI 10.1147/rd.112.0215; Dastous J. B., 1991, MSC WORLD US C LOS A; Dastous JB, 2003, IEEE T POWER DELIVER, V18, P120, DOI 10.1109/TPWRD.2002.803713; Dastous JB, 2010, IEEE T POWER DELIVER, V25, P1657, DOI 10.1109/TPWRD.2010.2047277; FOATA M, 1988, IEEE T POWER SYST, V3, P286, DOI 10.1109/59.43213; Foata M, 2010, CIGRE INT C PAR FRAN; Hackl A, 2012, 2012 XXTH INTERNATIONAL CONFERENCE ON ELECTRICAL MACHINES (ICEM), P2358, DOI 10.1109/ICElMach.2012.6350212; Hibbeler RC, 2008, STRUCTURE ANAL; Kezunovic M, 2000, IEEE T POWER DELIVER, V15, P44, DOI 10.1109/61.847227; MAHIEU WR, 1975, IEEE T POWER AP SYST, V94, P1698, DOI 10.1109/T-PAS.1975.32013; Muller S, 2009, PRES VES P, P357; Shang ZQ, 1963, J XIAN JIAOTONG U, P81; Temkin S., 2001, ELEMENTS ACOUSTICS; Wang QP, 1962, ARC THEORY CALCULATI; Wang Zanji, 2000, Automation of Electric Power Systems, V24, P21; Zhang X, 2006, IEEE T POWER DELIVER, V21, P425, DOI 10.1109/TPWRD.2005.852274; Zhao M., 2004, MECH VIBRATION NOISE	23	3	3	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133851	10.1371/journal.pone.0133851	http://dx.doi.org/10.1371/journal.pone.0133851			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230392	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400057
J	Zinellu, A; Sotgia, S; Scanu, B; Forteschi, M; Giordo, R; Cossu, A; Posadino, AM; Carru, C; Pintus, G				Zinellu, Angelo; Sotgia, Salvatore; Scanu, Bastianina; Forteschi, Mauro; Giordo, Roberta; Cossu, Annalisa; Posadino, Anna Maria; Carru, Ciriaco; Pintus, Gianfranco			Human Serum Albumin Increases the Stability of Green Tea Catechins in Aqueous Physiological Conditions	PLOS ONE			English	Article							(-)-EPIGALLOCATECHIN GALLATE; DRUG-BINDING; POLYPHENOLS; RESVERATROL; METABOLITES; MECHANISMS; FLAVONOIDS; INGESTION; EPIMERS; BSA	Epicatechin (EC), epigallocatechin (EGC), epicatechingallate (ECG) and epigallocatechingallate (EGCG) are antioxidants present in the green tea, a widely used beverage whose health benefits are largely recognized. Nevertheless, major physicochemical limitations, such as the high instability of catechins, pose important questions concerning their potential pharmacological use. Recent studies indicate that binding of catechins with plasmatic proteins may modulate their plasma concentration, tissue delivery and biological activity. After 5 minutes of incubation with HSA both ECG and EGCG were fully bound to HSA, while after 48h incubation only 41% of EC and 70% of EGC resulted linked. HSA had a strong stabilizing effect on all catechins, which could be found in solution between 29 and 85% even after 48h of incubation. In the absence of HSA, EGC and EGCG disappeared in less than 24h, while ECG and EC were found after 48h at 5 and 50%, respectively. The stabilizing effect of HSA toward EGCG, obtained in aqueous physiological conditions, resulted stronger in comparison to cysteine and HCl, previously reported to stabilize this polyphenol. Because of the multitude of contradictory data concerning in vivo and in vitro antioxidant-based experimentations, we believe our work may shed some light on this debated field of research.	[Zinellu, Angelo; Sotgia, Salvatore; Scanu, Bastianina; Forteschi, Mauro; Giordo, Roberta; Cossu, Annalisa; Posadino, Anna Maria; Carru, Ciriaco; Pintus, Gianfranco] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Giordo, Roberta; Cossu, Annalisa; Posadino, Anna Maria; Pintus, Gianfranco] Univ Sassari, Lab Cell Signaling & Redox Biol, I-07100 Sassari, Italy; [Carru, Ciriaco] Hosp Univ Sassari AOU, Qual Control Unit, Sassari, Italy	University of Sassari; University of Sassari	Zinellu, A (corresponding author), Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.	azinellu@uniss.it; gpintus@uniss.it	Pintus, Gianfranco/C-2975-2009; Carru, Ciriaco/AAI-9996-2021; Sotgia, Salvatore/T-6598-2019	Pintus, Gianfranco/0000-0002-3031-7733; Carru, Ciriaco/0000-0002-6985-4907; Posadino, Anna Maria/0000-0002-6155-159X; forteschi, mauro/0000-0002-3958-6788; Zinellu, Angelo/0000-0002-8396-0968; Sotgia, Salvatore/0000-0002-3717-3437	Sardinia Region [7-2007, CPR-25920]; Bank of Sardinia Foundation; Sardinia Region P.O.R. SARDEGNA, F.S.E. Human Capital Objective-Line of Activity 1.3.1	Sardinia Region(Regione Sardegna); Bank of Sardinia Foundation; Sardinia Region P.O.R. SARDEGNA, F.S.E. Human Capital Objective-Line of Activity 1.3.1	This research was supported by the Sardinia Region within the framework of the L.R. no 7-2007, call 2010, grant no CPR-25920 (GP) and the Bank of Sardinia Foundation (GP, CC, AZ). RG is a research fellow supported by the Sardinia Region P.O.R. SARDEGNA, F.S.E. 2007-2013-Human Capital Objective-Line of Activity 1.3.1, while AC is supported by fellowships within the L.R. no 7-2007, call 2010, grant no CPR-25920 GP).	Bae MJ, 2009, MOL NUTR FOOD RES, V53, P709, DOI 10.1002/mnfr.200800274; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Cao H, 2013, CURR DRUG METAB, V14, P446, DOI 10.2174/1389200211314040007; Cha MK, 1996, BIOCHEM BIOPH RES CO, V222, P619, DOI 10.1006/bbrc.1996.0793; Chakraborty B, 2009, J LUMIN, V129, P34, DOI 10.1016/j.jlumin.2008.07.012; Chen ML, 2013, J NUTR BIOCHEM, V24, P1823, DOI 10.1016/j.jnutbio.2013.04.003; Chen ZY, 2001, J AGR FOOD CHEM, V49, P477, DOI 10.1021/jf000877h; Crespy V, 2004, J NUTR, V134, p3431S, DOI 10.1093/jn/134.12.3431S; Henning SM, 2008, J NUTR, V138, P1529; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Hossain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018333; Kusuda M, 2006, BIOSCI BIOTECH BIOCH, V70, P152, DOI 10.1271/bbb.70.152; Lambert JD, 2003, J NUTR, V133, P4172, DOI 10.1093/jn/133.12.4172; Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025; Li CA, 2001, CHEM RES TOXICOL, V14, P702, DOI 10.1021/tx0002536; Li N, 2012, J AGR FOOD CHEM, V60, P12531, DOI 10.1021/jf304116s; Liu EH, 2010, MOLECULES, V15, P9092, DOI 10.3390/molecules15129092; Mochizuki M, 2002, BBA-GEN SUBJECTS, V1569, P35, DOI 10.1016/S0304-4165(01)00230-6; Nakayama T, 2002, FOOD SCI TECHNOL RES, V8, P261, DOI 10.3136/fstr.8.261; Narumi K, 2014, J CHROMATOGR B, V945, P147, DOI 10.1016/j.jchromb.2013.11.007; Nozaki A, 2009, CHEM PHARM BULL, V57, P224, DOI 10.1248/cpb.57.224; Pal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043321; Pantusa M, 2014, J AGR FOOD CHEM, V62, P4384, DOI 10.1021/jf405584a; PETERS T, 1995, ALL ALBUMIN BIOCHEM; Sang SM, 2005, J AGR FOOD CHEM, V53, P9478, DOI 10.1021/jf0519055; Scott E, 2012, MOL NUTR FOOD RES, V56, P7, DOI 10.1002/mnfr.201100400; Soares S, 2007, J AGR FOOD CHEM, V55, P6726, DOI 10.1021/jf070905x; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; Su YL, 2003, FOOD CHEM, V83, P189, DOI 10.1016/S0308-8146(03)00062-1; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Trnkova L, 2011, J MOL STRUCT, V985, P243, DOI 10.1016/j.molstruc.2010.11.001; Unno T, 2000, J SCI FOOD AGR, V80, P601, DOI 10.1002/(SICI)1097-0010(200004)80:5&lt;601::AID-JSFA581&gt;3.0.CO;2-O; WANWIMOLRUK S, 1983, MOL PHARMACOL, V24, P458; Xiao JB, 2011, MOL NUTR FOOD RES, V55, P310, DOI 10.1002/mnfr.201000208; Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309; Zinellu A, 2014, J CHROMATOGR A, V1367, P167, DOI 10.1016/j.chroma.2014.09.053	37	21	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134690	10.1371/journal.pone.0134690	http://dx.doi.org/10.1371/journal.pone.0134690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230943	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400151
J	Crona, M; Hofer, A; Astorga-Wells, J; Sjoberg, BM; Tholander, F				Crona, Mikael; Hofer, Anders; Astorga-Wells, Juan; Sjoberg, Britt-Marie; Tholander, Fredrik			Biochemical Characterization of the Split Class II Ribonucleotide Reductase from Pseudomonas aeruginosa	PLOS ONE			English	Article							ESCHERICHIA-COLI; CYSTEINE RESIDUES; IN-VITRO; PROTEINS; HYDROXYUREA; PREDICTION; INHIBITION; EXPRESSION; TASSER; VIVO	The opportunistic pathogen Pseudomonas aeruginosa can grow under both aerobic and anaerobic conditions. Its flexibility with respect to oxygen load is reflected by the fact that its genome encodes all three existing classes of ribonucleotides reductase (RNR): the oxygen-dependent class I RNR, the oxygen-indifferent class II RNR, and the oxygen-sensitive class III RNR. The P. aeruginosa class II RNR is expressed as two separate polypeptides (NrdJa and NrdJb), a unique example of a split RNR enzyme in a free-living organism. A split class II RNR is also found in a few closely related gamma-Proteobacteria. We have characterized the P. aeruginosa class II RNR and show that both subunits are required for formation of a biologically functional enzyme that can sustain vitamin B12-dependent growth. Binding of the B12 coenzyme as well as substrate and allosteric effectors resides in the NrdJa subunit, whereas the NrdJb subunit mediates efficient reductive dithiol exchange during catalysis. A combination of activity assays and activity-independent methods like surface plasmon resonance and gas phase electrophoretic macromolecule analysis suggests that the enzymatically active form of the enzyme is a (NrdJa-NrdJb) 2 homodimer of heterodimers, and a combination of hydrogen-deuterium exchange experiments and molecular modeling suggests a plausible region in NrdJa that interacts with NrdJb. Our detailed characterization of the split NrdJ from P. aeruginosa provides insight into the biochemical function of a unique enzyme known to have central roles in biofilm formation and anaerobic growth.	[Crona, Mikael; Astorga-Wells, Juan; Tholander, Fredrik] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Hofer, Anders] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [Sjoberg, Britt-Marie] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Karolinska Institutet; Umea University; Stockholm University	Tholander, F (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Scheeles Vag 2, SE-17177 Stockholm, Sweden.	fredrik.tholander@ki.se		Crona, Mikael/0000-0002-6420-6097; Hofer, Anders/0000-0003-2890-2957; Sjoberg, Britt-Marie/0000-0001-5953-3360	Swedish Research Council [VR-NT 2012-5262, VR-M 2012-1932, VR-M 2013-2918]; Royal Swedish Academy of Sciences (the Hierta-Retzius foundation); Magnus Bergvall foundation; Carl Trygger foundation; Swedish Cancer Foundation [CAN 2013/643]; NIH [P30DK089507]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Swedish Academy of Sciences (the Hierta-Retzius foundation); Magnus Bergvall foundation; Carl Trygger foundation; Swedish Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Swedish Research Council to FT, AH and BMS (VR-NT 2012-5262 to FT, VR-M 2012-1932 to AH and VR-M 2013-2918 to BMS), the Royal Swedish Academy of Sciences (the Hierta-Retzius foundation) to FT, the Magnus Bergvall foundation to FT, the Carl Trygger foundation to AH and the Swedish Cancer Foundation (CAN 2013/643) to BMS. The authors also acknowledge the NIH grant P30DK089507 for funding the P. aeruginosa PAO1 transposon mutant library, from which strains used in this work was obtained. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERG A, 1989, J BIOL CHEM, V264, P12249; BOOKER S, 1994, BIOCHEMISTRY-US, V33, P12676, DOI 10.1021/bi00208a019; Comuzzi C, 2003, TALANTA, V59, P67, DOI 10.1016/S0039-9140(02)00457-5; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Crona M, 2010, PROTEIN ENG DES SEL, V23, P633, DOI 10.1093/protein/gzq035; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Fontecave M, 2002, PROG NUCLEIC ACID RE, V72, P95, DOI 10.1016/S0079-6603(02)72068-0; Fylstra D, 1998, INTERFACES, V28, P29, DOI 10.1287/inte.28.5.29; Gotoh H, 2008, RES MICROBIOL, V159, P294, DOI 10.1016/j.resmic.2008.02.002; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; Kaufman SL, 1996, ANAL CHEM, V68, P1895, DOI 10.1021/ac951128f; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Krieger E, 2012, METHODS MOL BIOL, V819, P405, DOI 10.1007/978-1-61779-465-0_25; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Larsson KM, 2010, ACS CHEM BIOL, V5, P933, DOI 10.1021/cb1000845; Lee KM, 2012, INFECT IMMUN, V80, P1639, DOI 10.1128/IAI.06161-11; Licht SS, 1999, J AM CHEM SOC, V121, P7463, DOI 10.1021/ja9913840; Lundin Daniel, 2015, Life-Basel, V5, P604, DOI 10.3390/life5010604; Lundin D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-383; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9733, DOI 10.1021/bi00155a029; Mathews CK, 2014, FASEB J, V28, P3832, DOI 10.1096/fj.14-251249; Mera PE, 2010, APPL MICROBIOL BIOT, V88, P41, DOI 10.1007/s00253-010-2773-2; Perez F, 2014, CLIN INFECT DIS, V59, pS335, DOI 10.1093/cid/ciu612; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; ROSENKRANZ HS, 1967, J BACTERIOL, V94, P1025, DOI 10.1128/JB.94.4.1025-1033.1967; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SHEWACH DS, 1992, ANAL BIOCHEM, V206, P178, DOI 10.1016/S0003-2697(05)80030-2; SINHA NK, 1972, J BACTERIOL, V112, P1321, DOI 10.1128/JB.112.3.1321-1334.1972; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; Sjoberg BM, 2011, INFECT IMMUN, V79, P2663, DOI 10.1128/IAI.01212-10; TEIPEL J, 1969, BIOCHEMISTRY-US, V8, P4656, DOI 10.1021/bi00839a064; Thelander L, 1978, Methods Enzymol, V51, P227; Tholander F, 2012, P NATL ACAD SCI USA, V109, P9798, DOI 10.1073/pnas.1113051109; Torrents E, 2005, J BIOL CHEM, V280, P16571, DOI 10.1074/jbc.M501322200; Torrents E, 2006, J BIOL CHEM, V281, P25287, DOI 10.1074/jbc.M601794200; Yoon MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016105; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	43	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134293	10.1371/journal.pone.0134293	http://dx.doi.org/10.1371/journal.pone.0134293			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225432	gold, Green Published, Green Submitted			2022-12-27	WOS:000358837700068
J	Farshbaf, M; Lindberg, MJ; Truong, A; Bevens, Z; Chambers, E; Pournara, A; Wallberg, AE; White, JB				Farshbaf, Mozhgan; Lindberg, Mikael J.; Anh Truong; Bevens, Zachery; Chambers, Elaina; Pournara, Angeliki; Wallberg, Annika E.; White, J. Brandon			Mastermind-Like 1 Is Ubiquitinated: Functional Consequences for Notch Signaling	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR; MAMMALIAN NOTCH; MAML1; ACTIVATION; ACETYLATION; PROTEOLYSIS; RECEPTORS; REGULATOR; TURNOVER; HOMOLOG	Early studies demonstrated the involvement of ubiquitination of the Notch intracellular domain for rapid turnover of the transcriptional complex at Notch target genes. It was shown that this ubiquitination was promoted by the co-activator Mastermind like 1 (MAML1). MAML1 also contains numerous lysine residues that may also be ubiquitinated and necessary for protein regulation. In this study, we show that over-expressed MAML1 is ubiquitinated and identify eight conserved lysine residues which are required for ubiquitination. We also show that p300 stimulates ubiquitination and that Notch inhibits ubiquitination. Furthermore, we show that a mutant MAML1 that has decreased ubiquitination shows increased output from a HES1 reporter gene assay. Therefore, we speculate that ubiquitination of MAML1 might be a mechanism to maintain low levels of the protein until needed for transcriptional activation. In summary, this study identifies that MAML1 is ubiquitinated in the absence of Notch signaling to maintain low levels of MAML1 in the cell. Our data supports the notion that a precise and tight regulation of the Notch pathway is required for this signaling pathway.	[Farshbaf, Mozhgan; Anh Truong; Bevens, Zachery; Chambers, Elaina; White, J. Brandon] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA; [Lindberg, Mikael J.; Pournara, Angeliki; Wallberg, Annika E.] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	California State University System; San Jose State University; Karolinska Institutet	Wallberg, AE (corresponding author), Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.	Annika.Wallberg@ki.se; Brandon.White@sjsu.edu		Lindberg, Mikael/0000-0001-8595-8901; Truong, Anh/0000-0003-1033-1666; White, Joseph/0000-0001-7854-4444	National Science Foundation [1052039, 0923573]; Swedish Research Council; Direct For Biological Sciences [1052039] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation Grants 1052039 and 0923573 to J.B.W. and by grants from the Swedish Research Council to A.E.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrantes ID, 1999, CURR BIOL, V9, P470, DOI 10.1016/S0960-9822(99)80212-7; Bray S, 2010, CURR TOP DEV BIOL, V92, P253, DOI 10.1016/S0070-2153(10)92008-5; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Geng FQ, 2012, ANNU REV BIOCHEM, V81, P177, DOI 10.1146/annurev-biochem-052110-120012; Hansson ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046001; Housden BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003162; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Ribeiro MSJ, 2007, BIOCHEM J, V404, P289, DOI 10.1042/BJ20061900; Kopan R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011213; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li C, 2011, ONCOGENE, V30, P4350, DOI 10.1038/onc.2011.151; Lindberg MJ, 2010, FASEB J, V24, P2396, DOI 10.1096/fj.09-149401; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Popko-Scibor AE, 2011, BIOCHEM BIOPH RES CO, V416, P300, DOI 10.1016/j.bbrc.2011.11.030; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Ribeiro MSJ, 2009, CURR PROTEIN PEPT SC, V10, P570; Ribeiro MSJ, 2009, NUCLEIC ACIDS RES, V37, P6691, DOI 10.1093/nar/gkp724; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; SMOLLER D, 1990, GENE DEV, V4, P1688, DOI 10.1101/gad.4.10.1688; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Wu LZ, 2005, EMBO J, V24, P2391, DOI 10.1038/sj.emboj.7600719; XU T, 1990, GENE DEV, V4, P464, DOI 10.1101/gad.4.3.464; Zhao YT, 2007, J BIOL CHEM, V282, P11969, DOI 10.1074/jbc.M608974200	33	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134013	10.1371/journal.pone.0134013	http://dx.doi.org/10.1371/journal.pone.0134013			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225565	Green Published, gold			2022-12-27	WOS:000358837700049
J	Fiser, Z; Altermatt, F; Zaksek, V; Knapic, T; Fiser, C				Fiser, Ziga; Altermatt, Florian; Zaksek, Valerija; Knapic, Tea; Fiser, Cene			Morphologically Cryptic Amphipod Species Are "Ecological Clones" at Regional but Not at Local Scale: A Case Study of Four Niphargus Species	PLOS ONE			English	Article							PHYLOGENETIC STRUCTURE; NICHE CONSERVATISM; DIVERSITY; COEXISTENCE; WATER; SIMILARITY; CRUSTACEA; HABITAT; DISTRIBUTIONS; PERSPECTIVES	Recent studies indicate that morphologically cryptic species may be ecologically more different than would be predicted from their morphological similarity and phylogenetic relatedness. However, in biodiversity research it often remains unclear whether cryptic species should be treated as ecologically equivalent, or whether detected differences have ecological significance. In this study, we assessed the ecological equivalence of four morphologically cryptic species of the amphipod genus Niphargus. All species live in a small, isolated area on the Istrian Peninsula in the NW Balkans. The distributional ranges of the species are partially overlapping and all species are living in springs. We reconstructed their ecological niches using morphological traits related to feeding, bioclimatic niche envelope and species' preference for epi-hypogean habitats. The ecological meaning of differences in niches was evaluated using distributional data and co-occurrence frequencies. We show that the species comprise two pairs of sister species. All species differ from each other and the degree of differentiation is not related to phylogenetic relatedness. Moreover, low co-occurrence frequencies in sympatric zones imply present or past interspecific competition. This pattern suggests that species are not differentiated enough to reduce interspecific competition, nor ecologically equivalent to co-exist via neutral dynamics. We tentatively conclude that the question of ecological equivalence relates to the scale of the study: at a fine scale, species' differences may influence dynamics in a local community, whereas at the regional level these species likely play roughly similar ecological roles.	[Fiser, Ziga; Zaksek, Valerija; Fiser, Cene] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia; [Altermatt, Florian] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, CH-8600 Dubendorf, Switzerland; [Altermatt, Florian] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Knapic, Tea] Slovenian Museum Nat Hist, Ljubljana, Slovenia	University of Ljubljana; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Zurich	Fiser, Z (corresponding author), Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia.	fiser.ziga@gmail.com		Altermatt, Florian/0000-0002-4831-6958; Fiser, Ziga/0000-0003-4576-5173	Slovenian Research Agency [P1-0184]; Swiss National Science Foundation [31003A_135622, PP00P3_150698]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The project was funded by Slovenian Research Agency, program P1-0184 (to ZF, VK and CF), and by the Swiss National Science Foundation, grants nr. 31003A_135622 and PP00P3_150698 (to FA).	Ashrafi S, 2011, EUR J WILDLIFE RES, V57, P843, DOI 10.1007/s10344-011-0496-z; Baird HP, 2011, MOL ECOL, V20, P3439, DOI 10.1111/j.1365-294X.2011.05173.x; Best RJ, 2013, ECOL LETT, V16, P72, DOI 10.1111/ele.12016; Best RJ, 2014, ECOLOGY, V95, P775, DOI 10.1890/13-0163.1; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cothran RD, 2015, OECOLOGIA, V178, P819, DOI 10.1007/s00442-015-3262-1; Cothran RD, 2013, OIKOS, V122, P1429, DOI 10.1111/j.1600-0706.2013.00294.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Meester N, 2011, MAR BIOL, V158, P2717, DOI 10.1007/s00227-011-1769-5; Derycke S, 2008, MOL ECOL, V17, P3306, DOI 10.1111/j.1365-294X.2008.03846.x; Esselstyn JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021885; Fiser C, 2006, ZOOL ANZ, V245, P77, DOI 10.1016/j.jcz.2006.05.003; Fiser C, 2013, OIKOS, V122, P770, DOI 10.1111/j.1600-0706.2012.20644.x; Fiser C, 2009, ZOOTAXA, P1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaneto D, 2015, MAR BIODIVERS, V45, P433, DOI 10.1007/s12526-015-0319-7; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; Freckler A, 2014, SCI TOTAL ENVIRON, V439, P158; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heibl C, 2013, PHYLOCLIM INTEGRATIN; Hijmans R.J., 2013, DISMO SPECIES DISTRI, V0, P8; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Ingram T, 2009, ECOLOGY, V90, P2444, DOI 10.1890/08-1841.1; Karaman G, 1984, GLAS PRIR MUZ BEOG B, V39, P85; Karaman G.S., 1989, Bioloski Vestnik, V37, P19; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kembel SW, 2009, ECOL LETT, V12, P949, DOI 10.1111/j.1461-0248.2009.01354.x; Knox MA, 2012, MOL ECOL, V21, P4885, DOI 10.1111/j.1365-294X.2012.05729.x; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Lorz AN, 2009, ZOOKEYS, P91, DOI 10.3897/zookeys.18.103; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Lustrik R, 2011, CONTRIB ZOOL, V80, P133, DOI 10.1163/18759866-08002003; MacNeil C, 1997, BIOL REV, V72, P349, DOI 10.1017/S0006323196005038; Meleg IN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076760; Menzel U, 2013, EMT EXACT MULTINOMIA; Mermillod-Blondin F, 2013, J EXP BIOL, V216, P1683, DOI 10.1242/jeb.081232; Nygren A, 2014, ZOOL SCR, V43, P172, DOI 10.1111/zsc.12044; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Pfenninger M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002157; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pipan T, 2011, J NAT HIST, V45, P253, DOI 10.1080/00222933.2010.523797; Rodder D, 2011, GLOBAL ECOL BIOGEOGR, V20, P915, DOI 10.1111/j.1466-8238.2011.00659.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Siepielski AM, 2010, ECOLOGY, V91, P3153, DOI 10.1890/10-0154.1; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith KL, 2011, EVOLUTION, V65, P976, DOI 10.1111/j.1558-5646.2010.01211.x; Soucek DJ, 2013, ECOTOXICOLOGY, V22, P1359, DOI 10.1007/s10646-013-1122-5; Steen DA, 2014, J ANIM ECOL, V83, P286, DOI 10.1111/1365-2656.12121; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TOWNSEND CR, 1994, FRESHWATER BIOL, V31, P265, DOI 10.1111/j.1365-2427.1994.tb01740.x; Trontelj P, 2012, EVOLUTION, V66, P3852, DOI 10.1111/j.1558-5646.2012.01734.x; Trontelj P, 2009, FRESHWATER BIOL, V54, P727, DOI 10.1111/j.1365-2427.2007.01877.x; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2014, TRENDS ECOL EVOL, V29, P572, DOI 10.1016/j.tree.2014.08.003; Wellborn GA, 2004, FRESHWATER BIOL, V49, P1, DOI 10.1046/j.1365-2426.2003.01160.x; Wellborn GA, 2007, OECOLOGIA, V154, P175, DOI 10.1007/s00442-007-0816-x; Westram AM, 2011, INFECT GENET EVOL, V11, P1083, DOI 10.1016/j.meegid.2011.03.024; Wiens JJ, 2008, ECOL LETT, V11, P1004, DOI 10.1111/j.1461-0248.2008.01238.x; Witt JDS, 2006, MOL ECOL, V15, P3073, DOI 10.1111/j.1365-294X.2006.02999.x	67	36	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134384	10.1371/journal.pone.0134384	http://dx.doi.org/10.1371/journal.pone.0134384			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226375	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000358837700085
J	Ho, SMY; Mak, CWY; Yeung, DN; Duan, WJ; Tang, S; Yeung, JC; Ching, RT				Ho, Samuel M. Y.; Mak, Christine W. Y.; Yeung, Dannii; Duan, Wenjie; Tang, Sandy; Yeung, June C.; Ching, Rita			Emotional Valence, Arousal, and Threat Ratings of 160 Chinese Words among Adolescents	PLOS ONE			English	Article							GENERALIZED SOCIAL PHOBIA; AFFECTIVE NORMS; ATTENTIONAL BIAS; ENGLISH; ADAPTATION; ANEW; INTERFERENCE; INDIVIDUALS; DIMENSIONS; DOMINANCE	This study was conducted to provide ratings of valence/pleasantness, arousal/excitement, and threat/potential harm for 160 Chinese words. The emotional valence classification (positive, negative, or neutral) of all of the words corresponded to that of the equivalent English language words. More than 90% of the participants, junior high school students aged between 12 and 17 years, understood the words. The participants were from both mainland China and Hong Kong, thus the words can be applied to adolescents familiar with either simplified (e.g. in mainland China) or traditional Chinese (e.g. in Hong Kong) with a junior secondary school education or higher. We also established eight words with negative valence, high threat, and high arousal ratings to facilitate future research, especially on attentional and memory biases among individuals prone to anxiety. Thus, the new emotional word list provides a useful source of information for affective research in the Chinese language.	[Ho, Samuel M. Y.; Mak, Christine W. Y.; Yeung, Dannii; Duan, Wenjie; Tang, Sandy; Yeung, June C.] City Univ Hong Kong, Dept Appl Social Sci, Psychol Labs, Hong Kong, Hong Kong, Peoples R China; [Ching, Rita] Womens Fdn, Hong Kong, Hong Kong, Peoples R China	City University of Hong Kong	Ho, SMY (corresponding author), City Univ Hong Kong, Dept Appl Social Sci, Psychol Labs, Hong Kong, Hong Kong, Peoples R China.	munyinho@cityu.edu.hk	Duan, Wenjie/C-8722-2016; Yeung, June/M-4688-2015; Yeung, Dannii Y./K-4183-2012; Ho, Samuel M.Y./D-2454-2014	Duan, Wenjie/0000-0002-1251-3685; Yeung, June/0000-0003-1293-8576; Yeung, Dannii Y./0000-0002-0548-0328; Ho, Samuel M.Y./0000-0001-7803-1657	Women's Foundation [CityU, 9231137]	Women's Foundation	This work was supported by The Women's Foundation (http://twfhk.org/) Grant Number: CityU, Project Number: 9231137.	Amir N, 2009, J CONSULT CLIN PSYCH, V77, P961, DOI 10.1037/a0016685; Amir N, 2009, J ABNORM PSYCHOL, V118, P28, DOI 10.1037/a0012589; ASMUNDSON GJG, 1994, J ANXIETY DISORD, V8, P107, DOI 10.1016/0887-6185(94)90009-4; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Bertels J, 2009, PSYCHOL BELG, V49, P19, DOI 10.5334/pb-49-1-19; Bjork R.A., 1972, CODING PROCESS HUM, P217; Bradley M. M., 1999, C1 U FLOR CTR RES PS, V30, P25; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brosan L, 2011, J BEHAV THER EXP PSY, V42, P258, DOI 10.1016/j.jbtep.2010.12.006; Buckley TC, 2000, CLIN PSYCHOL REV, V20, P1041, DOI 10.1016/S0272-7358(99)00030-6; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Duan W, 2012, HONG KONG J MENT HLT, V38, P24; Duan WJ, 2013, RES SOCIAL WORK PRAC, V23, P336, DOI 10.1177/1049731513477214; Duan WJ, 2012, RES SOCIAL WORK PRAC, V22, P680, DOI 10.1177/1049731512450074; Eilola TM, 2010, BEHAV RES METHODS, V42, P134, DOI 10.3758/BRM.42.1.134; Ferre P, 2012, BEHAV RES METHODS, V44, P395, DOI 10.3758/s13428-011-0165-x; Ho S.M.Y., 2010, POSTTRAUMATIC GROWTH, P147; Ho SMY, 2014, ROUTL STUD ETH MORAL, V28, P215; Ho SMY, PSYCHOL ASS IN PRESS; Jones DC, 2005, J YOUTH ADOLESCENCE, V34, P629, DOI 10.1007/s10964-005-8951-3; Kanske P, 2011, BEHAV RES METHODS, V43, P409, DOI 10.3758/s13428-010-0048-6; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; MacLeod C., 1991, HDB BEHAV THERAPY PS, V16, P116; Mathews A, 1998, COGNITIVE THER RES, V22, P539, DOI 10.1023/A:1018738019346; McAdoo HP, 1994, ACTIVITIES ADAPTATIO, V19, P27; McCabe RE, 1999, COGNITIVE THER RES, V23, P21, DOI 10.1023/A:1018706607051; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; McNally R. J., 1989, COGNITION EMOTION, V3, P27, DOI DOI 10.1080/026999389084; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Montefinese M, 2014, BEHAV RES METHODS, V46, P887, DOI 10.3758/s13428-013-0405-3; Moors A, 2013, BEHAV RES METHODS, V45, P169, DOI 10.3758/s13428-012-0243-8; Onraedt T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090632; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Rammstedt B, 2007, EUR J PSYCHOL ASSESS, V23, P32, DOI 10.1027/1015-5759.23.1.32; Redondo J, 2007, BEHAV RES METHODS, V39, P600, DOI 10.3758/BF03193031; Reff RC, 2005, J SOC CLIN PSYCHOL, V24, P638, DOI 10.1521/jscp.2005.24.5.638; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; RUSSELL JA, 1978, J PERS SOC PSYCHOL, V36, P1152, DOI 10.1037/0022-3514.36.10.1152; Schimmack U, 2005, EMOTION, V5, P55, DOI 10.1037/1528-3542.5.1.55; Schmidt NB, 2009, J ABNORM PSYCHOL, V118, P5, DOI 10.1037/a0013643; Siakaluk PD, 2014, COGNITIVE SCI, V38, P1698, DOI 10.1111/cogs.12137; Siegle GJ, 2002, COGNITIVE THER RES, V26, P73, DOI 10.1023/A:1013893705009; Soares AP, 2012, BEHAV RES METHODS, V44, P256, DOI 10.3758/s13428-011-0131-7; Stewart SH, 1998, COGNITION EMOTION, V12, P105, DOI 10.1080/026999398379808; VASEY MW, 1995, J ABNORM CHILD PSYCH, V23, P267, DOI 10.1007/BF01447092; Warriner AB, 2013, BEHAV RES METHODS, V45, P1191, DOI 10.3758/s13428-012-0314-x; Wei WL, 2011, LECT NOTES COMPUT SC, V6975, P121, DOI 10.1007/978-3-642-24571-8_13; Windmann S, 2001, J COGNITIVE NEUROSCI, V13, P577, DOI 10.1162/089892901750363172	50	38	38	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0132294	10.1371/journal.pone.0132294	http://dx.doi.org/10.1371/journal.pone.0132294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JT	26226604	gold, Green Published, Green Submitted			2022-12-27	WOS:000358837700007
J	Vymetalkova, V; Soucek, P; Kunicka, T; Jiraskova, K; Brynychova, V; Pardini, B; Novosadova, V; Polivkova, Z; Kubackova, K; Kozevnikovova, R; Ambrus, M; Vodickova, L; Naccarati, A; Vodicka, P				Vymetalkova, Veronika; Soucek, Pavel; Kunicka, Tereza; Jiraskova, Katerina; Brynychova, Veronika; Pardini, Barbara; Novosadova, Vendula; Polivkova, Zdena; Kubackova, Katerina; Kozevnikovova, Renata; Ambrus, Miloslav; Vodickova, Ludmila; Naccarati, Alessio; Vodicka, Pavel			Genotype and Haplotype Analyses of TP53 Gene in Breast Cancer Patients: Association with Risk and Clinical Outcomes	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; REPAIR PATHWAY GENES; COLORECTAL-CANCER; ADJUVANT THERAPY; ARGININE ALLELE; CELL-LINES; P53; MUTATIONS; SUSCEPTIBILITY; CHEMOTHERAPY	Variations in the TP53 gene have been suggested to play a role in many cancers, including breast. We previously observed an association between TP53 haplotypes based on four polymorphisms (rs17878362, rs1042522, rs12947788, and rs17884306) and the risk of colorectal and pancreatic cancer. Based on these results, in the present study, we have investigated the same polymorphisms and their haplotypes in 705 breast cancer cases and 611 healthy controls in relation to the disease risk, histopathological features of the tumor and clinical outcomes. In comparison to the most common haplotype A(1)-G-C-G, all the other identified haplotypes were globally associated with a significantly decreased breast cancer risk (P = 0.006). In particular, the A(2)-G-C-G haplotype was associated with a marked decreased risk of breast cancer when compared with the common haplotype (P = 0.0001). Moreover, rs1042522 in patients carrying the GC genotype and receiving only the anthracycline-based chemotherapy was associated with both overall and disease-free survival (recessive model for overall survival HR = 0.30 95% CI 0.11-0.80, P = 0.02 and for diseasefree survival HR = 0.42 95% CI 0.21-0.84, P = 0.01). Present results suggest common genetic features in the susceptibility to breast and gastrointestinal cancers in respect to TP53 variations. In fact, similar haplotype distributions were observed for breast, colorectal, and pancreatic patients in associations with cancer risk. Rs1042522 polymorphism (even after applying the Dunn-Bonferroni correction for multiple testing) appears to be an independent prognostic marker in breast cancer patients.	[Vymetalkova, Veronika; Jiraskova, Katerina; Vodickova, Ludmila; Naccarati, Alessio; Vodicka, Pavel] Acad Sci Czech Republ, Inst Expt Med, Prague, Czech Republic; [Vymetalkova, Veronika; Jiraskova, Katerina; Vodickova, Ludmila; Vodicka, Pavel] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic; [Soucek, Pavel; Kunicka, Tereza; Brynychova, Veronika] Natl Inst Publ Hlth, Toxicogen Unit, Prague, Czech Republic; [Pardini, Barbara; Naccarati, Alessio] Human Genet Fdn, Turin, Italy; [Novosadova, Vendula] Acad Sci Czech Republ, Inst Biotechnol, Prague, Czech Republic; [Kubackova, Katerina] Univ Hosp Motol, Dept Oncol, Prague, Czech Republic; [Kozevnikovova, Renata] MEDICON, Dept Oncosurg, Prague, Czech Republic; [Ambrus, Miloslav] Charles Univ Prague, Fac Med 3, Dept Radiotherapy & Oncol, Prague, Czech Republic; [Polivkova, Zdena] Charles Univ Prague, Fac Med 3, Dept Gen Biol & Genet, Prague, Czech Republic; [Kunicka, Tereza; Brynychova, Veronika] Charles Univ Prague, Fac Med 3, Prague, Czech Republic	Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; National Institute of Public Health (SZU) - Czech Republic; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Motol University Hospital; Charles University Prague; Charles University Prague; Charles University Prague	Vymetalkova, V (corresponding author), Acad Sci Czech Republ, Inst Expt Med, Prague, Czech Republic.	vpolakova@biomed.cas.cz	Pardini, Barbara/K-9451-2016; Novosadova, Vendula/AAJ-1449-2021; Jiraskova, Katerina/C-8232-2017; Vymetalkova, Veronika/H-3167-2014; Soucek, Pavel/H-8018-2019; Pardini, Barbara/ABI-2295-2020	Pardini, Barbara/0000-0001-9571-4257; Jiraskova, Katerina/0000-0001-8462-6358; Vymetalkova, Veronika/0000-0001-6870-6788; Soucek, Pavel/0000-0002-4294-6799; Pardini, Barbara/0000-0001-9571-4257; Naccarati, Alessio/0000-0001-5774-0905; Vodicka, Pavel/0000-0003-2376-1243; Brynychova, Veronika/0000-0001-7206-8942	Grant agency of the Czech Republic (GACR) [CZ:GACR:P304/12/1585]; Ministry of Education, Youth and Sport, Czech Republic (First Medical Faculty, Charles University, Prague, Czech Republic) [Prvouk-P27/LF1/1]; Internal Grant Agency Ministry of Health [NT 13424, NT 14055-3]	Grant agency of the Czech Republic (GACR)(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sport, Czech Republic (First Medical Faculty, Charles University, Prague, Czech Republic); Internal Grant Agency Ministry of Health	This work was supported by Grant agency of the Czech Republic (GACR) [CZ:GACR: P304/12/1585] and by Prvouk-P27/LF1/1 from Ministry of Education, Youth and Sport, Czech Republic (First Medical Faculty, Charles University, Prague, Czech Republic as a recipient) and by Internal Grant Agency Ministry of Health: NT 13424 and NT 14055-3.	Allen-Brady K, 2006, CANCER EPIDEM BIOMAR, V15, P1306, DOI 10.1158/1055-9965.EPI-05-0959; Baudis M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-226; Beggs AD, 2009, EUR J HUM GENET, V17, P855, DOI 10.1038/ejhg.2008.235; Bewick MA, 2006, J CLIN ONCOL, V24, P5645, DOI 10.1200/JCO.2006.05.9923; Bisof V, 2012, MED ONCOL, V29, P472, DOI 10.1007/s12032-011-9875-2; Bisof V, 2010, EUR J GYNAECOL ONCOL, V31, P539; Bonafe M, 2003, CLIN CANCER RES, V9, P4860; Budach W, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-267; Cheng HT, 2012, MOL BIOL REP, V39, P9265, DOI 10.1007/s11033-012-1800-z; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Crawford DC, 2005, ANNU REV MED, V56, P303, DOI 10.1146/annurev.med.56.082103.104540; Dahabreh IJ, 2013, AM J EPIDEMIOL, V177, P1317, DOI 10.1093/aje/kws394; Di Leo A, 2007, ANN ONCOL, V18, P997, DOI 10.1093/annonc/mdm075; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Dunning AM, 1999, CANCER EPIDEM BIOMAR, V8, P843; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fagerholm R, 2008, NAT GENET, V40, P844, DOI 10.1038/ng.155; Fernandez-Cuesta L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3179; Gao YX, 2011, HUM PATHOL, V42, P1693, DOI 10.1016/j.humpath.2010.12.027; Geisler S, 2001, CANCER RES, V61, P2505; Gemignani F, 2004, ONCOGENE, V23, P1954, DOI 10.1038/sj.onc.1207305; Ghazani AA, 2007, NEOPLASIA, V9, P511, DOI 10.1593/neo.07301; Goldhirsch A, 2001, J Natl Cancer Inst Monogr, P44; Haiman CA, 2008, HUM MOL GENET, V17, P825, DOI 10.1093/hmg/ddm354; Hubackova M, 2012, INT J CANCER, V130, P338, DOI 10.1002/ijc.26006; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kunicka T, 2014, DRUG METAB REV; Lajin B, 2013, BREAST CANCER RES TR, V138, P611, DOI 10.1007/s10549-013-2467-4; Leroy B, 2014, HUM MUTAT, V35, P756, DOI 10.1002/humu.22556; Lin WY, 2011, J MED GENET, V48, P477, DOI 10.1136/jmedgenet-2011-100018; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; Mangoni M, 2011, INT J RADIAT ONCOL, V81, P52, DOI 10.1016/j.ijrobp.2010.04.023; Naccarati A, 2012, MUTAGENESIS, V27, P211, DOI 10.1093/mutage/ger067; Naccarati A, 2010, CARCINOGENESIS, V31, P666, DOI 10.1093/carcin/bgq032; Naccarati A, 2012, CARCINOGENESIS, V33, P1346, DOI 10.1093/carcin/bgs172; OConnor PM, 1997, CANCER RES, V57, P4285; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Pardini B, 2008, MUTAT RES-FUND MOL M, V638, P146, DOI 10.1016/j.mrfmmm.2007.09.008; Pardini B, 2011, MUTAT RES-GEN TOX EN, V721, P74, DOI 10.1016/j.mrgentox.2010.12.008; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; Polakova V, 2009, HUM MUTAT, V30, P661, DOI 10.1002/humu.20931; Pooley KA, 2008, CANCER EPIDEM BIOMAR, V17, P3482, DOI 10.1158/1055-9965.EPI-08-0594; Rodrigues P, 2013, MOL CELL BIOCHEM, V379, P181, DOI 10.1007/s11010-013-1640-8; Sagne C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.24; Sapkota Y, 2014, CYTOGENET GENOME RES, V144, P77, DOI 10.1159/000369045; Schneider-Stock R, 2004, NEOPLASIA, V6, P529, DOI 10.1593/neo.04178; Sehl ME, 2009, CLIN CANCER RES, V15, P2192, DOI 10.1158/1078-0432.CCR-08-1417; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sullivan A, 2004, ONCOGENE, V23, P3328, DOI 10.1038/sj.onc.1207428; Szkandera J, 2012, MOL GENET GENOMICS, V287, P755, DOI 10.1007/s00438-012-0715-7; Tommiska J, 2005, CLIN CANCER RES, V11, P5098, DOI 10.1158/1078-0432.CCR-05-0173; Toyama T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1682; Trifa F, 2010, CANCER EPIDEMIOL, V34, P184, DOI 10.1016/j.canep.2010.02.007; Vaclavikova R, 2012, CLIN CHEM LAB MED, V50, P1999, DOI 10.1515/cclm-2012-0103; Vymetalkova V, 2014, MUTAGENESIS, V29, P259, DOI 10.1093/mutage/geu014; Wahl AF, 1996, NAT MED, V2, P72, DOI 10.1038/nm0196-72; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Wu DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061662; Xu Y, 2005, CLIN CANCER RES, V11, P7328, DOI 10.1158/1078-0432.CCR-05-0507	62	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134463	10.1371/journal.pone.0134463	http://dx.doi.org/10.1371/journal.pone.0134463			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226484	gold, Green Published			2022-12-27	WOS:000358837700096
J	Wu, MH; Lee, WJ; Hua, KT; Kuo, ML; Lin, MT				Wu, Ming-Hsun; Lee, Wei-Jiunn; Hua, Kuo-Tai; Kuo, Min-Liang; Lin, Ming-Tsan			Macrophage Infiltration Induces Gastric Cancer Invasiveness by Activating the beta-Catenin Pathway	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; REGULATES EXPRESSION; NECROSIS-FACTOR; CELL-MIGRATION; PROGRESSION; INVASION; SURVIVAL; METALLOPROTEINASE; TUMORIGENESIS; METASTASIS	Background Despite evidence that activated macrophages act in an inflammatory microenvironment to promote gastric tumorigenesis via beta-catenin signaling, the effects of beta-catenin signaling on gastric cancer cell metastasis and the relationship of these cells with surrounding tumor associated macrophages have not been directly studied. Methods Immunohistochemical staining was employed to analyze 103 patients. An invasion assay was used to evaluate the relationship between macrophages and gastric cancer cells. beta-catenin gain-of-function and loss-of-function approaches were performed. To assess the beta-catenin regulation mechanism in gastric cancer cells, Western blotting and reverse-transcription polymerase chain reaction were used. Results Increased density of macrophages was associated with advanced stage and poor survival. Gastric cancer cell lines co-cultured with macrophages conditioned medium showed increased nuclear accumulation of beta-catenin and increased invading ability. AKT but not ERK regulated beta-catenin translocation. MMP7 and CD44, both beta-catenin downstream genes, were involved in macrophage-activated gastric cancer cell invasion. Conclusion(s) Collectively, the clinical data suggest that macrophage infiltration is correlated with increased grade and poor prognosis for gastric cancer patients who underwent radical resection. Macrophages may induce invasiveness by activating the beta-catenin pathway.	[Wu, Ming-Hsun; Lin, Ming-Tsan] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Lee, Wei-Jiunn] Taipei Med Univ, Wan Fang Hosp, Dept Med Educ & Res, Taipei, Taiwan; [Hua, Kuo-Tai; Kuo, Min-Liang] Natl Taiwan Univ, Inst Toxicol, Coll Med, Taipei, Taiwan; [Lin, Ming-Tsan] Natl Taiwan Univ, Coll Med, Dept Med Educ & Bioeth, Grad Inst Med Educ & Bioeth, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; National Taiwan University; National Taiwan University	Lin, MT (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan.	larrywu@hotmail.com	wu, larry/AAV-5282-2021	wu, larry/0000-0002-8811-9203; LIN, MING-TSAN/0000-0001-7313-7057; Hua, Kuo-Tai/0000-0002-8468-4977; KUO, MIN-LIANG/0000-0002-7139-0144	National Science Council, Taiwan [NSC 98-2314-B-002-055-MY2]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from National Science Council, Taiwan (NSC 98-2314-B-002-055-MY2).	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Arnott CH, 2002, ONCOGENE, V21, P4728, DOI 10.1038/sj.onc.1205588; Bakker ERM, 2013, CARCINOGENESIS, V34, P2629, DOI 10.1093/carcin/bgt215; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Bremnes RM, 2002, LUNG CANCER, V36, P115, DOI 10.1016/S0169-5002(01)00471-8; Cervenka I, 2011, MOL CELL BIOL, V31, P179, DOI 10.1128/MCB.00550-10; Chen JJW, 2005, J CLIN ONCOL, V23, P953, DOI 10.1200/JCO.2005.12.172; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Correa P, 2003, CANCER EPIDEM BIOMAR, V12, p238S; Crumley ABC, 2011, ANN SURG ONCOL, V18, P2604, DOI 10.1245/s10434-011-1658-7; Dvory-Sobol H, 2007, CANCER-AM CANCER SOC, V109, P188, DOI 10.1002/cncr.22416; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Fernando HC, 2011, EUR J CARDIO-THORAC, V40, P1177, DOI 10.1016/j.ejcts.2011.02.062; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Hayakawa K, 2006, J IMMUNOL, V176, P2529, DOI 10.4049/jimmunol.176.4.2529; Ishigami S, 2003, ANTICANCER RES, V23, P4079; Ivanov DB, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1174, DOI 10.1023/A:1012445316415; Julkunen K, 2003, ANTICANCER RES, V23, P5043; Lin MT, 2007, J BIOL CHEM, V282, P34594, DOI 10.1074/jbc.M706600200; Lowy AM, 2006, CANCER RES, V66, P4734, DOI 10.1158/0008-5472.CAN-05-4268; Mizukami Y, 2008, BRIT J CANCER, V98, P148, DOI 10.1038/sj.bjc.6604149; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Ohno S, 2003, ANTICANCER RES, V23, P5015; Oshima H, 2011, GASTROENTEROLOGY, V140, P596, DOI 10.1053/j.gastro.2010.11.007; Osinsky S, 2011, CLIN TRANSL ONCOL, V13, P133, DOI 10.1007/s12094-011-0630-0; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Taketo MM, 2006, ONCOGENE, V25, P7522, DOI 10.1038/sj.onc.1210058; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tsukamoto T, 2003, CANCER SCI, V94, P1046, DOI 10.1111/j.1349-7006.2003.tb01399.x; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wu MH, 2012, J NUTR BIOCHEM, V23, P1434, DOI 10.1016/j.jnutbio.2011.09.004; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Yamamoto H, 2009, GASTROENTEROLOGY, V137, P242, DOI 10.1053/j.gastro.2009.02.003	37	27	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134122	10.1371/journal.pone.0134122	http://dx.doi.org/10.1371/journal.pone.0134122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226629	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700057
J	Sehgal, M; Gupta, R; Moussa, A; Singh, TR				Sehgal, Manika; Gupta, Rajinder; Moussa, Ahmed; Singh, Tiratha Raj			An Integrative Approach for Mapping Differentially Expressed Genes and Network Components Using Novel Parameters to Elucidate Key Regulatory Genes in Colorectal Cancer	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; COLON-CANCER; TOOL; PATHWAYS; DISEASE; EXPLORATION; MICROARRAYS; RESOURCE; DATABASE; COMPLEX	For examining the intricate biological processes concerned with colorectal cancer (CRC), a systems biology approach integrating several biological components and other influencing factors is essential to understand. We performed a comprehensive system level analysis for CRC which assisted in unravelling crucial network components and many regulatory elements through a coordinated view. Using this integrative approach, the perceptive of complexity hidden in a biological phenomenon is extensively simplified. The microarray analyses facilitated differential expression of 631 significant genes employed in the progression of disease and supplied interesting associated up and down regulated genes like jun, fos and mapk1. The transcriptional regulation of these genes was deliberated widely by examining transcription factors such as hnf4, nr2f1, znf219 and dr1 which directly influence the expression. Further, interactions of these genes/proteins were evaluated and crucial network motifs were detected to associate with the pathophysiology of CRC. The available standard statistical parameters such as z-score, p-value and significance profile were explored for the identification of key signatures from CRC pathway whereas a few novel parameters representing over-represented structures were also designed in the study. The applied approach revealed 5 key genes i.e. kras, araf, pik3r5, ralgds and akt3 via our novel designed parameters illustrating high statistical significance. These novel parameters can assist in scrutinizing candidate markers for diseases having known biological pathways. Further, investigating and targeting these proposed genes for experimental validations, instead being spellbound by the complicated pathway will certainly endow valuable insight in a well-timed systematic understanding of CRC.	[Sehgal, Manika; Gupta, Rajinder; Singh, Tiratha Raj] JUIT, Dept Biotechnol & Bioinformat, Solan 173234, HP, India; [Moussa, Ahmed] Abdelmalek Essaadi Univ, ENSA, LabTIC Lab, Tangier, Morocco	Jaypee University of Information Technology; Abdelmalek Essaadi University of Tetouan	Singh, TR (corresponding author), JUIT, Dept Biotechnol & Bioinformat, Solan 173234, HP, India.	tiratharaj@gmail.com	Gupta, Rajinder/ABC-8188-2020; Moussa, Ahmed/AAI-1351-2020; Singh, Tiratha Raj/AAL-4256-2020	Gupta, Rajinder/0000-0003-3342-2122; of Information Technology, Jaypee University/0000-0003-4907-3764; Moussa, Ahmed/0000-0003-1628-8179; SEHGAL, MANIKA/0000-0003-0255-7219	Science and Engineering Research Board, Department of Science and Technology (DST), India [SR/FT/LS-026/2009]	Science and Engineering Research Board, Department of Science and Technology (DST), India(Department of Science & Technology (India))	This work was supported by the Science and Engineering Research Board, Department of Science and Technology (DST), India, grant number SR/FT/LS-026/2009.	American Cancer Society, 2013, CANCER FACTS FIGURES; Armaghany Tannaz, 2012, Gastrointest Cancer Res, V5, P19; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Astin Margaret, 2011, Br J Gen Pract, V61, pe231, DOI 10.3399/bjgp11X572427; Baglioni S, 2004, AM J MED GENET C, V129C, P35, DOI 10.1002/ajmg.c.30023; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boyle P, 2000, BRIT MED J, V321, P805, DOI 10.1136/bmj.321.7264.805; Burt RW, 2010, J NATL COMPR CANC NE, V8, P8, DOI 10.6004/jnccn.2010.0003; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Covell DG, 2003, MOL CANCER THER, V2, P317; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Ferlay J, 2013, GLOBOCAN 2012; Ferrari P, 2007, INT J CANCER, V121, P2065, DOI 10.1002/ijc.22966; Fransen K, 2004, CARCINOGENESIS, V25, P527, DOI 10.1093/carcin/bgh049; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Gotea V, 2008, NUCLEIC ACIDS RES, V36, pW133, DOI 10.1093/nar/gkn300; Hegde P, 2001, CANCER RES, V61, P7792; Hong Y, 2007, CLIN CANCER RES, V13, P1107, DOI 10.1158/1078-0432.CCR-06-1633; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jawad N, 2011, RECENT RESULTS CANC, V185, P99, DOI 10.1007/978-3-642-03503-6_6; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Joshi-Tope G, 2003, COLD SPRING HARB SYM, V68, P237, DOI 10.1101/sqb.2003.68.237; Kandasamy K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r3; Kashtan N, 2004, BIOINFORMATICS, V20, P1746, DOI 10.1093/bioinformatics/bth163; Lee JW, 2005, APMIS, V113, P54, DOI 10.1111/j.1600-0463.2005.apm1130108.x; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Panigrahi PP, 2013, J THEOR BIOL, V334, P109, DOI 10.1016/j.jtbi.2013.06.013; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Pratap A, 2014, J BIOL SYST, V22, P89, DOI 10.1142/S0218339014500053; Pulido EG, 2011, THE CHALLENGE OF COL; Schreiber F, 2005, BIOINFORMATICS, V21, P3572, DOI 10.1093/bioinformatics/bti556; Sehgal M, 2014, DNA REPAIR, V16, P97, DOI 10.1016/j.dnarep.2014.01.004; Sehgal Manika, 2012, J Nat Sci Biol Med, V3, P139, DOI 10.4103/0976-9668.101887; Sinicrope FA, 2012, CLIN CANCER RES, V18, P1506, DOI 10.1158/1078-0432.CCR-11-1469; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Sui SJH, 2007, NUCLEIC ACIDS RES, V35, pW245, DOI 10.1093/nar/gkm427; Tan WY, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-26; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Watson AJM, 2011, DIGEST DIS, V29, P222, DOI 10.1159/000323926; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Wernicke S, 2006, IEEE ACM T COMPUT BI, V3, P347, DOI 10.1109/TCBB.2006.51; Wheeler JMD, 2000, GUT, V47, P148, DOI 10.1136/gut.47.1.148; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Zang SZ, 2007, J BIOMED INFORM, V40, P552, DOI 10.1016/j.jbi.2007.01.002; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zou TT, 2002, ONCOGENE, V21, P4855, DOI 10.1038/sj.onc.1205613	55	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0133901	10.1371/journal.pone.0133901	http://dx.doi.org/10.1371/journal.pone.0133901			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222778	gold, Green Submitted, Green Published			2022-12-27	WOS:000358836800080
J	Chen, L; Huang, ZC; Yang, B; Cai, B; Su, ZZ; Wang, LL				Chen, Lin; Huang, Zhuochun; Yang, Bin; Cai, Bei; Su, Zhenzhen; Wang, Lanlan			Association of E26 Transformation Specific Sequence 1 Variants with Rheumatoid Arthritis in Chinese Han Population	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TRANSCRIPTION FACTOR ETS1; CELL-DIFFERENTIATION; GENE; SUSCEPTIBILITY; ACTIVATION; EXPRESSION; BINDING; INDUCTION; PROMOTER	Objective E26 transformation specific sequence 1 (ETS-1) belongs to the ETS family of transcription factors that regulate the expression of various immune-related genes. Increasing evidence indicates that ETS-1 could contribute to the pathogenesis of autoimmune disease. Recent research has provided evidence that ETS-1 might correlate with rheumatoid arthritis (RA), but it's not clearly defined. In this study, we aimed to identify whether polymorphisms of ETS-1 play a role in Rheumatoid arthritis (RA) susceptibility and development in Chinese Han population. Methods Four single nucleotide polymorphisms (SNPs) within ETS-1 were selected based on Hap-Map data and previous associated studies. Whole blood and serum samples were obtained from 158 patients with RA and 192 healthy subjects. Genotyping was performed with polymerase chain reaction-high resolution melting (PCR-HRM) assay and the data was analyzed using SPSS17.0. Results A significantly positive correlation was observed between the SNP rs73013527 of ETS-1 and RA susceptibility, DAS28 and CRP (P<0.001, P = 0.001, and P = 0.028, respectively). Carriers of the haplotype CCT or TCT for rs4937333, rs11221332 and rs73013527 were associated with decreased risk of RA as compared to controls. No statistical significant difference was observed in the distribution of rs10893872, rs4937333 and rs11221332 genotypes between RA patients and controls. Conclusions Our data further supports that ETS-1 has a relevant role in the pathogenesis and development of RA. Allele T of rs73013527 plays a protective role in occurrence of RA but a risk factor in the high disease activity. Rs10893872, rs11221332 and rs4937333 are not associated with RA susceptibility and clinical features.	[Chen, Lin; Huang, Zhuochun; Yang, Bin; Cai, Bei; Su, Zhenzhen; Wang, Lanlan] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Peoples R China	Sichuan University	Wang, LL (corresponding author), Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Peoples R China.	WangLanLanhxvip@126.com	Yang, Bin/Q-6463-2019; Yang, Bin/Y-8079-2019	Yang, Bin/0000-0002-0275-3722; Huang, Zhuochun/0000-0002-2957-779X	Natural Science Foundation of China [81202354, 81301496]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China 81202354 to ZCH and the Natural Science Foundation of China 81301496 to BY. (http://npd.nsfc.gov.cn/fundingProjectSearchAction.action) These funders supported our work including study design, data collection and decision to publish.	Babayeva ND, 2010, CELL CYCLE, V9, P3054, DOI 10.4161/cc.9.14.12257; Barton A, 2009, ARTHRIT CARE RES, V61, P1441, DOI 10.1002/art.24672; Biliavska I, 2013, ANN RHEUM DIS, V72, P1335, DOI 10.1136/annrheumdis-2012-201909; Chatzikyriakidou A, 2013, SCAND J RHEUMATOL, V42, P11, DOI 10.3109/03009742.2012.711367; Dang J, 2014, TISSUE ANTIGENS, V83, P401, DOI 10.1111/tan.12349; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fu JY, 2011, HUM MOL GENET, V20, pR206, DOI 10.1093/hmg/ddr386; Garrett-Sinha LA, 2013, CELL MOL LIFE SCI, V70, P3375, DOI 10.1007/s00018-012-1243-7; Gaudreau MC, 2015, CLIN EXP IMMUNOL, V180, P393, DOI 10.1111/cei.12587; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Heo SH, 2014, INT J BIOL SCI, V10, P438, DOI 10.7150/ijbs.8095; Hikami K, 2011, ARTHRITIS RHEUM-US, V63, P755, DOI 10.1002/art.30188; Hughes T, 2012, ANN RHEUM DIS, V71, P694, DOI 10.1136/annrheumdis-2011-200385; John S, 2014, MOL CELL BIOL, V34, P522, DOI 10.1128/MCB.00612-13; Kothari P, 2014, J IMMUNOL, V192, P349, DOI 10.4049/jimmunol.1301906; Maier H, 2003, MOL CELL BIOL, V23, P1946, DOI 10.1128/MCB.23.6.1946-1960.2003; Mouly E, 2010, J EXP MED, V207, P2113, DOI 10.1084/jem.20092153; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Peterson JC, 2012, ANN RHEUM DIS, V71, P635, DOI 10.1136/annrheumdis-2011-200473; Ramirez K, 2012, IMMUNITY, V36, P921, DOI 10.1016/j.immuni.2012.04.006; Redlich K, 2001, ARTHRITIS RHEUM, V44, P266, DOI 10.1002/1529-0131(200102)44:2<266::AID-ANR43>3.3.CO;2-7; Reynolds RJ, 2014, ARTHRITIS RHEUMATOL, V66, P3274, DOI 10.1002/art.38855; Robinson L, 1997, P NATL ACAD SCI USA, V94, P7170, DOI 10.1073/pnas.94.14.7170; Russell L, 2010, CYTOKINE, V51, P217, DOI 10.1016/j.cyto.2010.03.006; Sasaki I, 2014, CURR TOP MICROBIOL, V381, P257, DOI 10.1007/82_2014_378; Shah S, 2013, NAT GENET, V45, P1226, DOI 10.1038/ng.2754; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Song KS, 2012, MUCOSAL IMMUNOL, V5, P207, DOI 10.1038/mi.2011.67; Tobon GJ, 2010, J AUTOIMMUN, V35, P10, DOI 10.1016/j.jaut.2009.12.009; Tsao HW, 2013, P NATL ACAD SCI USA, V110, P15776, DOI 10.1073/pnas.1304343110; Van Beek JP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1890; Viatte S, 2013, NAT REV RHEUMATOL, V9, P141, DOI 10.1038/nrrheum.2012.237; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wei L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091199; Wells G, 2009, ANN RHEUM DIS, V68, P954, DOI 10.1136/ard.2007.084459; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Yarwood A., 2014, RHEUMATOLOGY; Zhang WL, 2013, J BIOL CHEM, V288, P32126, DOI 10.1074/jbc.M113.495218	38	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134875	10.1371/journal.pone.0134875	http://dx.doi.org/10.1371/journal.pone.0134875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241881	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700076
J	Fernandes, FS; Ramalho, FS; Malaquias, JB; Godoy, WAC; Santos, BDB				Fernandes, Francisco S.; Ramalho, Francisco S.; Malaquias, Jose B.; Godoy, Wesley A. C.; Santos, Barbara Davis B.			Interspecific Associations between Cycloneda sanguinea and Two Aphid Species (Aphis gossypii and Hyadaphis foeniculi) in Sole-Crop and Fennel-Cotton Intercropping Systems	PLOS ONE			English	Article								Aphids cause significant damage to crop plants. Studies regarding predator-prey relationships in fennel (Foeniculum vulgare Mill.) and cotton (Gossypium hirsutum L.) crops are important for understanding essential ecological interactions in the context of intercropping and for establishing pest management programs for aphids. This study evaluated the association among Hyadaphis foeniculi (Passerini) (Hemiptera: Aphididae), Aphis gossypii Glover (Hemiptera: Aphididae) and Cycloneda sanguinea (L.) (Coleoptera: Coccinellidae) in cotton with coloured fibres, fennel and cotton intercropped with fennel. Association analysis was used to investigate whether the presence or absence of prey and predator species can indicate possible interactions between aphids and ladybugs. Significant associations among both apterous and alate H. foeniculi and C. sanguinea were observed in both the fennel and fennel-cotton intercropping systems. The similarity analysis showed that the presence of aphids and ladybugs in the same system is significantly dependent on the type of crop. A substantial amount of evidence indicates that the presence of the ladybug C. sanguinea, is associated with apterous or alate A. gossypii and H. foeniculi in fennel-cotton intercropping system. We recommend that future research vising integrated aphid management taking into account these associations for take decisions.	[Fernandes, Francisco S.; Ramalho, Francisco S.; Malaquias, Jose B.; Santos, Barbara Davis B.] Embrapa Algodao, Unidade Controle Biol, Campina Grande, Paraiba, Brazil; [Fernandes, Francisco S.; Godoy, Wesley A. C.] Univ Sao Paulo, ESALQ, Dept Entomol, BR-09500900 Sao Paulo, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo	Ramalho, FS (corresponding author), Embrapa Algodao, Unidade Controle Biol, Campina Grande, Paraiba, Brazil.	ramalhohvv@globo.com	Malaquias, José Bruno B/I-1945-2015; FS, Ramalho/AAC-8058-2019; Godoy, Wesley AC/B-9787-2012; Fernandes, Francisco/E-4608-2016	Malaquias, José Bruno B/0000-0003-3937-9575; Fernandes, Francisco/0000-0002-0592-2536	Financiadora de Estudos e Projetos (FINEP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Support for this research was provided by the Financiadora de Estudos e Projetos (FINEP), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.		0	2	2	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0131449	10.1371/journal.pone.0131449	http://dx.doi.org/10.1371/journal.pone.0131449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241862	gold, Green Published, Green Submitted			2022-12-27	WOS:000358942700003
J	Guedes, CES; Lima, JGB; Helfer, E; Veras, PST; Viallat, A				Guedes, Carlos E. S.; Lima, Jose G. B.; Helfer, Emmanuele; Veras, Patricia S. T.; Viallat, Annie			Encapsulation of Living Leishmania Promastigotes in Artificial Lipid Vacuoles	PLOS ONE			English	Article							PHAGOCYTOSIS; DIFFERENTIATION; MACROPHAGES; PHAGOSOMES; PROTEIN	After phagocytosis by mammalian macrophages, promastigote forms of Leishmania parasites settle inside intracellular parasitophorous vacuoles (PVs) in which they transform into amastigote forms and replicate. Here, using a variant of the 'inverted emulsion' method, we succeeded in encapsulating living L. amazonensis parasites in giant artificial liposomes that serve as model PVs. We were able to control the size of liposomes, the pH and the composition of their internal volume, and the number of internalized parasites per liposome. L. amazonensis promastigotes encapsulated in liposomes filled with RPMI-Dextran solution at pH 7.5 or 6.5 survived up to 96 h at 24 degrees C. At 37 degrees C and pH 5.5, parasites survived 48h. This method paves the way to identifying certain effectors secreted by the parasite and to unraveling specific mechanisms of fusion between the PV and intracellular vesicles of the host cell. This method will also facilitate the study of the temporal evolution of biophysical properties of the PV during its maturation.	[Guedes, Carlos E. S.; Lima, Jose G. B.; Veras, Patricia S. T.] Fiocruz MS, Ctr Pesquisas Goncalo Moniz, Lab Patol & Biointervencao, Salvador, BA, Brazil; [Helfer, Emmanuele; Viallat, Annie] Aix Marseille Univ, CNRS, CINaM UMR 7325, F-13288 Marseille, France	Fundacao Oswaldo Cruz; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Aix-Marseille Universite	Veras, PST (corresponding author), Fiocruz MS, Ctr Pesquisas Goncalo Moniz, Lab Patol & Biointervencao, Rua Waldemar Falcao 121, Salvador, BA, Brazil.	pveras@bahia.fiocruz.br; viallat@cinam.univ-mrs.fr	Veras, Patricia S T Sampaio Tavares/I-9632-2014	Veras, Patricia S T Sampaio Tavares/0000-0001-8308-9263; Helfer, Emmanuele/0000-0001-8123-0964	program Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES) Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil (COFECUB) [Sv 726/11]; CAPES	program Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES) Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil (COFECUB); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the program Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES) Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil (COFECUB) Sv 726/11 and by CAPES.	Abkarian M, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.041906; Abkarian M, 2011, SOFT MATTER, V7, P15; ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; Antoine JC, 1998, TRENDS MICROBIOL, V6, P392, DOI 10.1016/S0966-842X(98)01324-9; Besteiro S, 2007, INT J PARASITOL, V37, P1063, DOI 10.1016/j.ijpara.2007.03.008; Burchmore RJS, 2001, INT J PARASITOL, V31, P1311, DOI 10.1016/S0020-7519(01)00259-4; CHAKRABORTY P, 1994, METHOD CELL BIOL, V45, P261; Dermine JF, 2000, CELL MICROBIOL, V2, P115, DOI 10.1046/j.1462-5822.2000.00037.x; Descoteaux A, 1999, BBA-MOL BASIS DIS, V1455, P341, DOI 10.1016/S0925-4439(99)00065-4; KIERSZENBAUM F, 1974, J IMMUNOL, V112, P1839; Landfear SM, 2011, EUKARYOT CELL, V10, P483, DOI 10.1128/EC.00287-10; MDaA Descoteaux, 1999, ADV CELL MOL BIOL M, V6, P380; NICHOLS BA, 1981, LAB INVEST, V44, P324; Pautot S, 2003, LANGMUIR, V19, P10; Pincet F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.218101; Richmond DL, 2011, P NATL ACAD SCI USA, V108, P9431, DOI 10.1073/pnas.1016410108; Roux A, 2002, P NATL ACAD SCI USA, V99, P5394, DOI 10.1073/pnas.082107299; Shevchuk Olga, 2013, Methods Mol Biol, V983, P419, DOI 10.1007/978-1-62703-302-2_23; Tsigankov P, 2014, MOL CELL PROTEOMICS, V13, P1787, DOI 10.1074/mcp.M114.037705; Vinet Adrien F., 2009, V531, P329, DOI 10.1007/978-1-59745-396-7_20; Yanagisawa M, 2011, J AM CHEM SOC, V133, P11774, DOI 10.1021/ja2040859	21	0	0	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134925	10.1371/journal.pone.0134925	http://dx.doi.org/10.1371/journal.pone.0134925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241746	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942700082
J	van Leent, MWJ; Stevanovic, J; Jansman, FG; Beinema, MJ; Brouwers, JRBJ; Postma, MJ				van Leent, Merlijn W. J.; Stevanovic, Jelena; Jansman, Frank G.; Beinema, Maarten J.; Brouwers, Jacobus R. B. J.; Postma, Maarten J.			Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data	PLOS ONE			English	Article							WARFARIN; THROMBOEMBOLISM; ANTICOAGULATION; RIVAROXABAN; PREVENTION	Background Vitamin-K antagonists (VKAs) present an effective anticoagulant treatment in deep venous thrombosis (DVT). However, the use of VKAs is limited because of the risk of bleeding and the necessity of frequent and long-term laboratory monitoring. Therefore, new oral anticoagulant drugs (NOACs) such as dabigatran, with lower rates of (major) intracranial bleeding compared to VKAs and not requiring monitoring, may be considered. Objectives To estimate resource utilization and costs of patients treated with the VKAs acenocoumarol and phenprocoumon, for the indication DVT. Furthermore, a formal cost-effectiveness analysis of dabigatran compared to VKAs for DVT treatment was performed, using these estimates. Methods A retrospective observational study design in the thrombotic service of a teaching hospital (Deventer, The Netherlands) was applied to estimate real-world resource utilization and costs of VKA monitoring. A pooled analysis of data from RE-COVER and RE-COVER II on DVT was used to reflect the probabilities for events in the cost-effectiveness model. Dutch costs, utilities and specific data on coagulation monitoring levels were incorporated in the model. Next to the base case analysis, univariate probabilistic sensitivity and scenario analyses were performed. Results Real-world resource utilization in the thrombotic service of patients treated with VKA for the indication of DVT consisted of 12.3 measurements of the international normalized ratio (INR), with corresponding INR monitoring costs of (sic)138 for a standardized treatment period of 180 days. In the base case, dabigatran treatment compared to VKAs in a cohort of 1,000 DVT patients resulted in savings of (sic)18,900 (95% uncertainty interval (UI) - 95,832, 151,162) and 41 (95% UI - 18, 97) quality-adjusted life-years (QALYs) gained calculated from societal perspective. The probability that dabigatran is cost-effective at a conservative willingness-to pay threshold of (sic)20,000 per QALY was 99%. Sensitivity and scenario analyses also indicated cost savings or cost-effectiveness below this same threshold. Conclusions Total INR monitoring costs per patient were estimated at minimally (sic)138. Inserting these real-world data into a cost-effectiveness analysis for patients diagnosed with DVT, dabigatran appeared to be a cost-saving alternative to VKAs in the Netherlands in the base case. Cost savings or favorable cost-effectiveness were robust in sensitivity and scenario analyses. Our results warrant confirmation in other settings and locations.	[van Leent, Merlijn W. J.; Stevanovic, Jelena; Brouwers, Jacobus R. B. J.; Postma, Maarten J.] Univ Groningen, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands; [Jansman, Frank G.; Beinema, Maarten J.] Deventer Hosp, Deventer, Netherlands; [Jansman, Frank G.] Univ Groningen, Unit Pharmacotherapy & Pharmaceut Care, Groningen, Netherlands; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Inst Sci Hlth Aging & Hlth caRE SHARE, NL-9713 AV Groningen, Netherlands	University of Groningen; Deventer Hospital; University of Groningen; University of Groningen	Stevanovic, J (corresponding author), Univ Groningen, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands.	j.stevanovic@rug.nl		Postma, Maarten/0000-0002-6306-3653	GSK Zeist NL; Amgen; GSK Bio Brussels; Shire; Pfizer; SPMSD NL; SPMSD Brussels; MSD; Sanofi; Novartis; Novo Nordisk; Jansen; Roche; Preglem; Boehringer Ingelheim; Viiv; Astra Zeneca	GSK Zeist NL; Amgen(Amgen); GSK Bio Brussels; Shire; Pfizer(Pfizer); SPMSD NL; SPMSD Brussels; MSD; Sanofi; Novartis(Novartis); Novo Nordisk(Novo Nordisk); Jansen; Roche(Roche Holding); Preglem; Boehringer Ingelheim(Boehringer Ingelheim); Viiv; Astra Zeneca(AstraZeneca)	Prof Maarten J. Postma received research grants, honoraria and travel stipends from GSK Zeist NL, Amgen, GSK Bio Brussels, Shire, Pfizer, SPMSD NL, SPMSD Brussels, MSD, Sanofi, Novartis, Novo Nordisk, Jansen, Roche, Preglem, Boehringer Ingelheim, Viiv, Astra Zeneca. MWJ van Leent, J. Stevanovic, F. Jansman, MJ Beinema and JRJB Brouwers have declared that no conflicting interest exists.	[Anonymous], 2011, FED NED TROMB FNT WA; [Anonymous], 2012, NEW ANT WELL DOS INT; [Anonymous], 2006, ZOET; [Anonymous], 2012, DROP; [Anonymous], 1998, WET MED WET OND MET; Beinema M, 2008, THROMB HAEMOSTASIS, V100, P1052, DOI 10.1160/TH08-04-0116; Boulanger L, 2006, INT J CLIN PRACT, V60, P258, DOI 10.1111/j.1368-5031.2006.00790.x; Briggs A, 2006, DECISION MODELLING H; Brouwers J, 2013, PATIENT PERSPECTIVE; Brouwers K, 2014, PHARM WEEKBLAD  0214; Charlton B, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4681; De Caterina R, 2013, THROMB HAEMOSTASIS, V109, P569, DOI 10.1160/TH12-10-0772; De Schryver EL, 2012, VITAMIN K ANTAGONIST; Engelfriet PM, VRAAGTEKENS BIJ NIEU; Freeman JV, 2011, ANN INTERN MED, V154, P1, DOI 10.7326/0003-4819-154-1-201101040-00289; Global-rates, 2014, INFL NED; Hakkaart-van Roijen L, 2010, HANDLEIDING KOSTENON; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Lambooij MS., 2010, 260242001 RIVM; Lamers LM, 2006, HEALTH ECON, V15, P1121, DOI 10.1002/hec.1124; Lefebvre Patrick, 2014, J Med Econ, V17, P52, DOI 10.3111/13696998.2013.858634; Locadia M, 2004, THROMB HAEMOSTASIS, V92, P1336, DOI 10.1160/TH04-02-0075; Mavrakanas T, 2011, PHARMACOL THERAPEUT, V130, P46, DOI 10.1016/j.pharmthera.2010.12.007; Moore TJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4517; National Institute for Health and Care Exlelence, DAB ET TREATM SEC PR; Nederlands Huisartsen Genootschap, NHG STAND DIEP VEN T; Nederlands Huisartsen Genootschap, 2013, NHG STAND ATR M79; Nederlandse Zorgautoriteit, 2013, TBCU705302 NED ZORG; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Schulman S, 2013, CIRCULATION; Schulman S, 2014, ESC C BARC AUG 30; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Seaman CD, 2013, THROMB RES, V132, P647, DOI 10.1016/j.thromres.2013.09.015; Shah SV, 2011, CIRCULATION, V123, P2562, DOI 10.1161/CIRCULATIONAHA.110.985655; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Stangier J, 2009, CLIN APPL THROMB-HEM, V15, p9S, DOI 10.1177/1076029609343004; ten Cate-Hoek AJ, 2009, J THROMB HAEMOST, V7, P2042, DOI 10.1111/j.1538-7836.2009.03627.x; Verhoef TI, 2013, PERSONALISED TREATME; World Medical Association, 2013, DECL HELS ETH PRINC; Z-Index, 2014, AP INK PRIJZ	40	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0135054	10.1371/journal.pone.0135054	http://dx.doi.org/10.1371/journal.pone.0135054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241880	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942700092
J	Vicentini, R; Bottcher, A; Brito, MD; dos Santos, AB; Creste, S; de Andrade Landell, MG; Cesarino, I; Mazzafera, P				Vicentini, Renato; Bottcher, Alexandra; Brito, Michael dos Santos; dos Santos, Adriana Brombini; Creste, Silvana; de Andrade Landell, Marcos Guimaraes; Cesarino, Igor; Mazzafera, Paulo			Large-Scale Transcriptome Analysis of Two Sugarcane Genotypes Contrasting for Lignin Content	PLOS ONE			English	Article							CLASS-III PEROXIDASES; CELL-WALL COMPOSITION; COENZYME-A LIGASES; BIOSYNTHESIS PERTURBATIONS; POPULUS-TRICHOCARPA; EXPRESSION ANALYSIS; METABOLIC FLUX; RNA-SEQ; GENE; SORGHUM	Sugarcane is an important crop worldwide for sugar and first generation ethanol production. Recently, the residue of sugarcane mills, named bagasse, has been considered a promising lignocellulosic biomass to produce the second-generation ethanol. Lignin is a major factor limiting the use of bagasse and other plant lignocellulosic materials to produce second-generation ethanol. Lignin biosynthesis pathway is a complex network and changes in the expression of genes of this pathway have in general led to diverse and undesirable impacts on plant structure and physiology. Despite its economic importance, sugarcane genome was still not sequenced. In this study a high-throughput transcriptome evaluation of two sugarcane genotypes contrasting for lignin content was carried out. We generated a set of 85,151 transcripts of sugarcane using RNA-seq and de novo assembling. More than 2,000 transcripts showed differential expression between the genotypes, including several genes involved in the lignin biosynthetic pathway. This information can give valuable knowledge on the lignin biosynthesis and its interactions with other metabolic pathways in the complex sugarcane genome.	[Vicentini, Renato] Univ Estadual Campinas, Ctr Mol Biol & Genet Engn, Syst Biol Lab, Campinas, SP, Brazil; [Bottcher, Alexandra; Brito, Michael dos Santos; dos Santos, Adriana Brombini; Mazzafera, Paulo] Univ Estadual Campinas, Inst Biol, Dept Plant Biol, Campinas, SP, Brazil; [Brito, Michael dos Santos; Creste, Silvana; de Andrade Landell, Marcos Guimaraes] Agron Inst Campinas, Sugarcane Ctr, Ribeirao Preto, SP, Brazil; [Cesarino, Igor] Univ Sao Paulo, Inst Biosci, Dept Bot, Sao Paulo, SP, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Instituto Agronomico de Campinas (IAC); Universidade de Sao Paulo	Vicentini, R (corresponding author), Univ Estadual Campinas, Ctr Mol Biol & Genet Engn, Syst Biol Lab, Campinas, SP, Brazil.	shinapes@unicamp.br	Cesarino, Igor/N-5887-2014; dos Santos Brito, Michael/AAE-2100-2019; Vicentini, Renato/C-5967-2012	Cesarino, Igor/0000-0002-6789-2432; dos Santos Brito, Michael/0000-0003-0990-5626; Creste, Silvana/0000-0002-3315-3332	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [08/58035-6, 08/58031-0]; Brazilian National Council for Scientific and Technological Development	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by grant 08/58035-6 (PM) and 08/58031-0 (RV) from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo). RV and PM thank Brazilian National Council for Scientific and Technological Development for research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda P, 2012, CURR OPIN BIOTECH, V23, P315, DOI 10.1016/j.copbio.2011.10.012; Barros E, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-51; Bonawitz ND, 2013, CURR OPIN BIOTECH, V24, P336, DOI 10.1016/j.copbio.2012.11.004; Bottcher A, 2013, PLANT PHYSIOL, V163, P1539, DOI 10.1104/pp.113.225250; Brito MS, 2015, TROP PLANT BIOL, V8, P19, DOI 10.1007/s12042-015-9147-y; Cardoso-Silva CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088462; Casu RE, 2004, PLANT MOL BIOL, V54, P503, DOI 10.1023/B:PLAN.0000038255.96128.41; Cesarino I, 2013, J EXP BOT, V64, P1769, DOI 10.1093/jxb/ert045; Cesarino I, 2012, BRAZ J BOT, V35, P303, DOI 10.1590/S0100-84042012000400003; Cesarino I, 2013, PLANT PHYSIOL BIOCH, V62, P1, DOI 10.1016/j.plaphy.2012.10.015; Cesarino I, 2012, PLANT PHYSIOL BIOCH, V55, P66, DOI 10.1016/j.plaphy.2012.03.014; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chen HC, 2013, PLANT PHYSIOL, V161, P1501, DOI 10.1104/pp.112.210971; Chi YH, 2011, DNA RES, V18, P1, DOI 10.1093/dnares/dsq031; Cumbie JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025279; Dauwe R, 2007, PLANT J, V52, P263, DOI 10.1111/j.1365-313X.2007.03233.x; de Setta N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-540; Dembele D, 2003, BIOINFORMATICS, V19, P973, DOI 10.1093/bioinformatics/btg119; Dias MOS, 2009, CHEM ENG RES DES, V87, P1206, DOI 10.1016/j.cherd.2009.06.020; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Escamilla-Trevino L, 2014, PLANT MOL BIOL, V84, P565, DOI 10.1007/s11103-013-0152-y; Gray J, 2012, PLANT SCI, V184, P112, DOI 10.1016/j.plantsci.2011.12.008; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Jung JH, 2012, PLANT BIOTECHNOL J, V10, P1067, DOI 10.1111/j.1467-7652.2012.00734.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Labeeuw L, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0052-y; Lan W, 2015, PLANT PHYSIOL, V167, P1284, DOI 10.1104/pp.114.253757; Lee Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002047; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Li X, 2008, PLANT J, V54, P569, DOI 10.1111/j.1365-313X.2008.03457.x; Lin CY, 2015, MOL PLANT, V8, P176, DOI 10.1016/j.molp.2014.12.003; Lu SF, 2013, P NATL ACAD SCI USA, V110, P10848, DOI 10.1073/pnas.1308936110; Manners J. M., 2011, Tropical Plant Biology, V4, P9, DOI 10.1007/s12042-011-9066-5; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Meyer K, 1998, P NATL ACAD SCI USA, V95, P6619, DOI 10.1073/pnas.95.12.6619; Ming R, 1998, GENETICS, V150, P1663; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; O'Hara LE, 2013, MOL PLANT, V6, P261, DOI 10.1093/mp/sss120; Papini-Terzi FS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-120; Papini-Terzi FS, 2005, DNA RES, V12, P27, DOI 10.1093/dnares/12.1.27; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rogers LA, 2005, J EXP BOT, V56, P1651, DOI 10.1093/jxb/eri162; Rohde A, 2004, PLANT CELL, V16, P2749, DOI 10.1105/tpc.104.023705; Ruegger M, 1999, PLANT PHYSIOL, V119, P101, DOI 10.1104/pp.119.1.101; Saballos A, 2009, GENETICS, V181, P783, DOI 10.1534/genetics.108.098996; Sattler SE, 2009, PLANT PHYSIOL, V150, P584, DOI 10.1104/pp.109.136408; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shen H, 2013, PLANT CELL, V25, P4342, DOI 10.1105/tpc.113.118828; Shi R, 2010, PLANT CELL PHYSIOL, V51, P144, DOI 10.1093/pcp/pcp175; Simmons BA, 2010, CURR OPIN PLANT BIOL, V13, P313, DOI 10.1016/j.pbi.2010.03.001; Stabile SS, 2012, GRASS FORAGE SCI, V67, P43, DOI 10.1111/j.1365-2494.2011.00817.x; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Usadel B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-535; Van Acker R, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-46; Vanholme R, 2013, SCIENCE, V341, P1103, DOI 10.1126/science.1241602; Vanholme R, 2012, NEW PHYTOL, V196, P978, DOI 10.1111/j.1469-8137.2012.04337.x; Vanholme R, 2012, PLANT CELL, V24, P3506, DOI 10.1105/tpc.112.102574; Vanholme R, 2010, PLANT J, V64, P885, DOI 10.1111/j.1365-313X.2010.04353.x; VANSOEST PJ, 1967, J ANIM SCI, V26, P119, DOI 10.2527/jas1967.261119x; Vega-Sanchez ME, 2010, CURR OPIN BIOTECH, V21, P218, DOI 10.1016/j.copbio.2010.02.002; Vermerris W, 2011, J INTEGR PLANT BIOL, V53, P105, DOI 10.1111/j.1744-7909.2010.01020.x; Wang JP, 2014, PLANT CELL, V26, P894, DOI 10.1105/tpc.113.120881; Weng JK, 2008, CURR OPIN BIOTECH, V19, P166, DOI 10.1016/j.copbio.2008.02.014; Xu ZY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S3; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yuan JS, 2008, TRENDS PLANT SCI, V13, P421, DOI 10.1016/j.tplants.2008.06.001; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang XB, 2013, PLANT CELL, V25, P4994, DOI 10.1105/tpc.113.119644; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhao XB, 2012, BIOFUEL BIOPROD BIOR, V6, P465, DOI 10.1002/bbb.1331; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhong RQ, 2014, PLANT SCI, V229, P193, DOI 10.1016/j.plantsci.2014.09.009; Zhou JM, 2006, BBA-GEN SUBJECTS, V1760, P1115, DOI 10.1016/j.bbagen.2006.02.008	76	31	31	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134909	10.1371/journal.pone.0134909	http://dx.doi.org/10.1371/journal.pone.0134909			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241317	Green Published, gold			2022-12-27	WOS:000358942700079
J	Austin, KG; Price, LL; McGraw, SM; Lieberman, HR				Austin, Krista G.; Price, Lori Lyn; McGraw, Susan M.; Lieberman, Harris R.			Predictors of Dietary Supplement Use by US Coast Guard Personnel	PLOS ONE			English	Article								Background Personnel in Armed Forces entities such as the US Coast Guard (USCG) engage in strenuous tasks requiring high levels of physiological and psychological fitness. Previous reports have found increased prevalence of dietary supplement (DS) use by military personnel to meet the demands of their occupation. Objective This study assessed DS prevalence and patterns of use in USCG personnel and compared these findings to reports from other Armed Forces personnel. Design Use of DS by USCG personnel (n = 1059) was assessed by survey at USCG installations. Data were weighted by age, sex, and rank to be representative of total USCG demographics. Results Seventy percent of USCG personnel reported using a DS at least 1 time/wk. Thirty-three percent used 1-2 DS >= 1 time/wk, 18% 3-4 DS >= 1 time/wk, and almost 19% >= 5 DS >= 1 time/wk. Average expenditure on DSs by UCSG personnel was $40/mo. More than 47% of USCG personnel used a multivitamin and mineral, 33% consumed protein supplements, 22% used individual vitamins and minerals, 23% reported taking combination products, and 9% consumed herbal supplements. Increased use of DS use was associated with high intensity operational occupations, participating in high volumes of aerobic exercise and strength training. Use of DS was not associated with age, education or body mass index. Conclusion Occupation is an important determinate of DS use. Prevalence of DS use by USCG personnel is greater than reported for other Armed Forces personnel and reflects high levels of participation in aerobic and strength training activities.	[Austin, Krista G.; McGraw, Susan M.; Lieberman, Harris R.] US Army, Mil Nutr Div, Environm Med Res Inst, Natick, MA 01760 USA; [Austin, Krista G.] Oak Ridge Inst Sci & Educ, Belcamp, MD 21017 USA; [Price, Lori Lyn] Tufts Univ, Inst Clin Res & Hlth Policy Studies, Tufts Med Ctr, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA	Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; Tufts Medical Center	Lieberman, HR (corresponding author), US Army, Mil Nutr Div, Environm Med Res Inst, Natick, MA 01760 USA.	harris.r.lieberman.civ@mail.mil			United States Army Medical Research and Material Command (USAMRMC); Department of Defense Center Alliance for Dietary Supplement Research	United States Army Medical Research and Material Command (USAMRMC); Department of Defense Center Alliance for Dietary Supplement Research	This work was supported by the United States Army Medical Research and Material Command (USAMRMC) and the Department of Defense Center Alliance for Dietary Supplement Research.	Austin KG, 2013, INT J SPORT NUTR EXE, V23, P322, DOI 10.1123/ijsnem.23.4.322; Bailey RL, 2011, J NUTR, V141, P261, DOI 10.3945/jn.110.133025; Barlas FM, 2013, 2011 SURVEY HLTH REL; Bray RM, 2006, 2005 SURVEY HLTH REL; Deuster PA, 2003, MIL MED, V168, P57; Dickinson A, 2014, J AM COLL NUTR, V33, P176, DOI 10.1080/07315724.2013.875423; Dickinson A, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-14; Erdman KA, 2006, MED SCI SPORT EXER, V38, P349, DOI 10.1249/01.mss.0000187332.92169.e0; Gahche Jamie, 2011, NCHS Data Brief, P1; Goston JL, 2010, NUTRITION, V26, P604, DOI 10.1016/j.nut.2009.06.021; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Human Performance Resource Center, OPER SUPPL; Jacobson IG, 2012, ANN EPIDEMIOL, V22, P318, DOI 10.1016/j.annepidem.2012.02.017; Knapik JJ, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-143; Lieberman HR, 2010, AM J CLIN NUTR, V92, P985, DOI 10.3945/ajcn.2010.29274; Lyle BJ, 1998, J NUTR, V128, P2355, DOI 10.1093/jn/128.12.2355; Marcus DM, 2012, ARCH INTERN MED, V172, P1035, DOI 10.1001/archinternmed.2012.2687; Maughan RJ, 2007, J SPORT SCI, V25, pS103, DOI 10.1080/02640410701607395; Maughan RJ, 2013, J NUTR, V143, P1843, DOI 10.3945/jn.113.176651; Morrison LJ, 2004, INT J SPORT NUTR EXE, V14, P481, DOI 10.1123/ijsnem.14.4.481; Radimer KL, 2000, J AM DIET ASSOC, V100, P447, DOI 10.1016/S0002-8223(00)00137-1; Stoltzfus RJ, 1998, GUIDELINES USE IRON; Tsitsimpikou C, 2011, INT J SPORT NUTR EXE, V21, P377, DOI 10.1123/ijsnem.21.5.377; U. S. Coast Guard, 2012, COAST GUARD AVIAT ME; U.S. Food and Drug Administration (FDA), STIM POT DANG HLTH; United States Coast Guard, 2014, MISS READ TOD PREP T; United States Coast Guard, 2013, COAST GUARD HLTH PRO; United States Coast Guard, 2012, COAST GUARD WEIGHT B	28	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133006	10.1371/journal.pone.0133006	http://dx.doi.org/10.1371/journal.pone.0133006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230407	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400024
J	Gervasini, G; Garcia-Cerrada, M; Coto, E; Vergara, E; Garcia-Pino, G; Alvarado, R; Fernandez-Cavada, MJ; Suarez-Alvarez, B; Barroso, S; Doblare, E; Diaz-Corte, C; Lopez-Larrea, C; Cubero, JJ				Gervasini, Guillermo; Garcia-Cerrada, Montserrat; Coto, Eliecer; Vergara, Esther; Garcia-Pino, Guadalupe; Alvarado, Raul; Jesus Fernandez-Cavada, Maria; Suarez-Alvarez, Beatriz; Barroso, Sergio; Doblare, Emilio; Diaz-Corte, Carmen; Lopez-Larrea, Carlos; Jose Cubero, Juan			A 3 '-UTR Polymorphism in Soluble Epoxide Hydrolase Gene Is Associated with Acute Rejection in Renal Transplant Recipients	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; CALCINEURIN INHIBITORS; KIDNEY-TRANSPLANTATION; ARACHIDONIC-ACID; PHARMACOKINETICS; PHARMACODYNAMICS; CYTOCHROME-P450; METABOLITES; DYSFUNCTION; EXPRESSION	Background and Purpose Epoxyeicosatrienoic acids (EETs) are arachidonic acid metabolites that play a protective role against damaging processes that may occur after re-oxygenation of the graft. We aimed to investigate whether the presence of functional polymorphisms in the gene encoding soluble epoxy hydrolase (EPHX2), which metabolizes EETs to less active compounds, may play a role in the outcome of renal transplantation. Methods In a group of 259 Caucasian renal transplant recipients and 183 deceased donors, we determined the presence of three common EPHX2 SNPs, namely rs41507953 (K55R), rs751141 (R287Q) and rs1042032 A/G. Associations with parameters of graft function and the incidence of acute rejection were retrospectively investigated throughout the first year after grafting by logistic regression adjusting for clinical and demographic variables. Results Carriers of the rs1042032 GG genotype displayed significantly lower estimated glomerular filtration rate (eGFR) (38.15 +/- 15.57 vs. 45.99 +/- 16.05; p = 0.04) and higher serum creatinine values (1.57 +/- 0.58 vs. 1.30 +/- 0.47 g/dL; p = 0.02) one year after grafting, compared to patients carrying the wildtype A-allele. The same GG genotype was also associated to increased risk of acute rejection. Interestingly, this association was observed for the genotype of both recipients [OR = 6.34 (1.35-29.90); p = 0.015] and donors [OR = 5.53 (1.10-27.80); p=0.042]. A statistical model including both genotypes along with other meaningful demographic and clinical variables resulted in an increased significance for the association with the recipients' genotype [OR=8.28 (1.21-74.27); p=0.031]. Conclusions Our results suggest that genetic variability in the EETs-metabolizing gene, EPHX2, may have a significant impact on the outcome of deceased-donor renal transplantation.	[Gervasini, Guillermo; Garcia-Cerrada, Montserrat] Univ Extremadura, Sch Med, Dept Med & Surg Therapeut, Div Pharmacol, Badajoz, Spain; [Coto, Eliecer] HUCA, Lab Med, Mol Genet, Oviedo, Spain; [Vergara, Esther; Jesus Fernandez-Cavada, Maria; Doblare, Emilio] Infanta Cristina Univ Hosp, Serv Immunol, Badajoz, Spain; [Garcia-Pino, Guadalupe; Alvarado, Raul; Barroso, Sergio; Jose Cubero, Juan] Infanta Cristina Univ Hosp, Serv Nephrol, Badajoz, Spain; [Suarez-Alvarez, Beatriz] Univ Autonoma Madrid, Hlth Res Inst F Jimenez Diaz, Lab Mol Biol Renal Dis, E-28049 Madrid, Spain; [Diaz-Corte, Carmen] HUCA, Serv Nephrol, Oviedo, Spain; [Lopez-Larrea, Carlos] HUCA, Serv Immunol, Oviedo, Spain; [Coto, Eliecer; Diaz-Corte, Carmen; Lopez-Larrea, Carlos] Inst Salud Carlos III, Red Invest Renal, Madrid, Spain	Universidad de Extremadura; Central University Hospital Asturias; Autonomous University of Madrid; Central University Hospital Asturias; Central University Hospital Asturias; Instituto de Salud Carlos III	Gervasini, G (corresponding author), Univ Extremadura, Sch Med, Dept Med & Surg Therapeut, Div Pharmacol, Badajoz, Spain.	ggervasi@unex.es	Gervasini, Guillermo/N-2198-2014; CASTELLANO, EMILIO DOBLARÉ/R-1342-2019	Gervasini, Guillermo/0000-0002-0524-9767; CASTELLANO, EMILIO DOBLARÉ/0000-0002-8330-8566; , Montse/0000-0002-3867-1630; Barroso Hernandez, sergio/0000-0002-0588-2415; Lopez-Larrea, Carlos/0000-0001-9988-1730	Association for the Study and Prevention of Renal Diseases (ASEPER), Badajoz, Spain; Junta de Extremadura, Consejeria de Economia, Comercio e Innovacion, Merida, Spain [GR10022]; RED de Investigacion Renal - REDINREN (Instituto de Salud Carlos III - European FEDER funds)	Association for the Study and Prevention of Renal Diseases (ASEPER), Badajoz, Spain; Junta de Extremadura, Consejeria de Economia, Comercio e Innovacion, Merida, Spain; RED de Investigacion Renal - REDINREN (Instituto de Salud Carlos III - European FEDER funds)	This work has been supported in part by the Association for the Study and Prevention of Renal Diseases (ASEPER), Badajoz, Spain, and by grant GR10022 from Junta de Extremadura, Consejeria de Economia, Comercio e Innovacion, Merida, Spain. Authors EC, CD-C and CL-L are supported by RED de Investigacion Renal - REDINREN (Instituto de Salud Carlos III - European FEDER funds).	Alkayed NJ, 2002, STROKE, V33, P1677, DOI 10.1161/01.STR.0000016332.37292.59; Chen D, 2012, J CLIN PHARMACOL, V52, P319, DOI 10.1177/0091270010397049; Fisslthaler B, 2001, HYPERTENSION, V38, P1427, DOI 10.1161/hy1201.096532; Fornage M, 2005, HUM MOL GENET, V14, P2829, DOI 10.1093/hmg/ddi315; Garcia M, 2013, EUR J CLIN PHARMACOL, V69, P385, DOI 10.1007/s00228-012-1355-x; Gervasini G, 2013, J CLIN PHARMACOL, V53, P427, DOI 10.1002/jcph.15; Gervasini G, 2012, TRANSPL INT, V25, P471, DOI 10.1111/j.1432-2277.2012.01446.x; Gross GJ, 2005, CARDIOVASC RES, V68, P18, DOI 10.1016/j.cardiores.2005.06.007; Imig JD, 2005, AM J PHYSIOL-RENAL, V289, pF496, DOI 10.1152/ajprenal.00350.2004; Joosten SA, 2005, KIDNEY INT, V68, P1, DOI 10.1111/j.1523-1755.2005.00376.x; Lebranchu Y, 2014, TRANSPL INT, V27, P129, DOI 10.1111/tri.12205; Lee CR, 2006, HUM MOL GENET, V15, P1640, DOI 10.1093/hmg/ddl085; Lee CR, 2010, FASEB J, V24, P3770, DOI 10.1096/fj.10-160119; Lee JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037075; Lee JP, 2011, AM J PHYSIOL-RENAL, V300, pF1283, DOI 10.1152/ajprenal.00733.2010; Lee SH, 2008, TRANSPL P, V40, P1353, DOI 10.1016/j.transproceed.2008.03.137; Levey AS, 2000, J AM SOC NEPHROL, V11, p155A; Macphee IAM, 2002, TRANSPLANTATION, V74, P1486, DOI 10.1097/00007890-200212150-00002; Morris STW, 2000, KIDNEY INT, V57, P1100, DOI 10.1046/j.1523-1755.2000.00937.x; Naderi GH, 2009, TRANSPL P, V41, P2772, DOI 10.1016/j.transproceed.2009.07.041; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; PALLER MS, 1994, P NATL ACAD SCI USA, V91, P7002, DOI 10.1073/pnas.91.15.7002; Podolin PL, 2013, PROSTAG OTH LIPID M, V104, P25, DOI 10.1016/j.prostaglandins.2013.02.001; Poge U, 2005, AM J TRANSPLANT, V5, P1306, DOI 10.1111/j.1600-6143.2005.00861.x; Przybyla-Zawislak BD, 2003, MOL PHARMACOL, V64, P482, DOI 10.1124/mol.64.2.482; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Schuck RN, 2013, ATHEROSCLEROSIS, V227, P442, DOI 10.1016/j.atherosclerosis.2013.01.034; Sharma M, 2009, PROSTAG OTH LIPID M, V89, P43, DOI 10.1016/j.prostaglandins.2009.04.004; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Srivastava PK, 2004, ARCH BIOCHEM BIOPHYS, V427, P164, DOI 10.1016/j.abb.2004.05.003; Staatz CE, 2010, CLIN PHARMACOKINET, V49, P207, DOI 10.2165/11317550-000000000-00000; Staatz CE, 2010, CLIN PHARMACOKINET, V49, P141, DOI 10.2165/11317350-000000000-00000; Thervet E, 2003, TRANSPLANTATION, V76, P1233, DOI 10.1097/01.TP.0000090753.99170.89; Yang L, 2015, BRIT J CLIN PHARMACO, V80, P28, DOI 10.1111/bcp.12603; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452	35	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133563	10.1371/journal.pone.0133563	http://dx.doi.org/10.1371/journal.pone.0133563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230946	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400041
J	Ismael-Badarneh, R; Guetta, J; Klorin, G; Berger, G; Abu-Saleh, N; Abassi, Z; Azzam, ZS				Ismael-Badarneh, Reem; Guetta, Julia; Klorin, Geula; Berger, Gidon; Abu-saleh, Niroz; Abassi, Zaid; Azzam, Zaher S.			The Role of Angiotensin II and Cyclic AMP in Alveolar Active Sodium Transport	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; CELLS; EXPRESSION; CLEARANCE; MEMBRANE; LIQUID; LUNG; NA,K-ATPASE	Active alveolar fluid clearance is important in keeping airspaces free of edema. Angiotensin II plays a role in the pathogenesis of hypertension, heart failure and others. However, little is known about its contribution to alveolar fluid clearance. Angiotensin II effects are mediated by two specific receptors; AT1 and AT2. The localization of these two receptors in the lung, specifically in alveolar epithelial cells type II, was recently reported. We hypothesize that Angiotensin II may have a role in the regulation of alveolar fluid clearance. We investigated the effect of Angiotensin II on alveolar fluid clearance in rats using the isolated perfused lung model and isolated rat alveolar epithelial cells. The rate of alveolar fluid clearance in control rats was 8.6% +/- 0.1 clearance of the initial volume and decreased by 22.5%, 28.6%, 41.6%, 48.7% and 39% in rats treated with 10(-10) M, 10(-9) M, 10(-8) M, 10(-7) M or 10(-6) M of Ang II respectively (P < 0.003). The inhibitory effect of Angiotensin II was restored in losartan, an AT1 specific antagonist, pretreated rats, indicating an AT1 mediated effect of Ang II on alveolar fluid clearance. The expression of Na, K-ATPase proteins and cAMP levels in alveolar epithelial cells were down-regulated following the administration of Angiotensin II; suggesting that cAMP may be involved in AngII-induced reduced Na, K-ATPase expression, though the contribution of additional factors could not be excluded. We herein suggest a novel mechanism of clinical relevance by which angiotensin adversely impairs the ability of the lungs to clear edema.	[Guetta, Julia; Klorin, Geula; Berger, Gidon; Azzam, Zaher S.] Rambam Human Hlth Care Campus, Internal Med B, Haifa, Israel; [Ismael-Badarneh, Reem; Berger, Gidon; Abu-saleh, Niroz; Abassi, Zaid; Azzam, Zaher S.] Technion Israel Inst Technol, Dept Physiol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel; [Azzam, Zaher S.] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, IL-31096 Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Azzam, ZS (corresponding author), Rambam Human Hlth Care Campus, Internal Med B, Haifa, Israel.	z_azzam@rambam.health.gov.il	Abu-Saleh, Niroz/AAQ-6396-2021	Abu-Saleh, Niroz/0000-0001-9253-2773; Abassi, Zaid/0000-0002-7272-197X	Israel Foundation (ISF) [625/08]; Office of Chief Scientist [6267-1]; Ministry of Health, Israel Manlam Office, Hedson fund for medical research Science; Technion, The Israel Institute of Technology; Rappaport Family Institute for Research in the Medical Sciences, Technion, Israel Institute of Technology, Haifa	Israel Foundation (ISF); Office of Chief Scientist; Ministry of Health, Israel Manlam Office, Hedson fund for medical research Science; Technion, The Israel Institute of Technology; Rappaport Family Institute for Research in the Medical Sciences, Technion, Israel Institute of Technology, Haifa	This work was supported by Israel Foundation (ISF), Grant No. 625/08; The Office of Chief Scientist (Grant No. 6267-1); Ministry of Health, Israel Manlam Office, Hedson fund for medical research Science, Technion, The Israel Institute of Technology and The Rappaport Family Institute for Research in the Medical Sciences, Technion, Israel Institute of Technology, Haifa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashry O, 2014, RESP PHYSIOL NEUROBI, V195, P37, DOI 10.1016/j.resp.2014.02.001; BERTHIAUME Y, 1988, J APPL PHYSIOL, V65, P585, DOI 10.1152/jappl.1988.65.2.585; Bertorello AM, 1999, AM J PHYSIOL-LUNG C, V276, pL20, DOI 10.1152/ajplung.1999.276.1.L20; Carranza ML, 1998, J PHYSIOL-LONDON, V511, P235, DOI 10.1111/j.1469-7793.1998.235bi.x; Deng J, 2012, RESP PHYSIOL NEUROBI, V181, P53, DOI 10.1016/j.resp.2011.11.009; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; DZAU VJ, 1987, KIDNEY INT, V31, P1402, DOI 10.1038/ki.1987.156; FRANCIS GS, 1984, ANN INTERN MED, V101, P370, DOI 10.7326/0003-4819-101-3-370; HELWIG J Jr, 1956, Annu Rev Med, V7, P141; Jain L, 2001, AM J PHYSIOL-LUNG C, V280, pL646, DOI 10.1152/ajplung.2001.280.4.L646; Klorin G, 2003, ANAL QUANT CYTOL, V25, P297; PACKER M, 1992, LANCET, V340, P92, DOI 10.1016/0140-6736(92)90406-S; PACKER M, 1992, J AM COLL CARDIOL, V20, P248, DOI 10.1016/0735-1097(92)90167-L; Papp M, 2002, AM J PHYSIOL-LUNG C, V282, pL713, DOI 10.1152/ajplung.00103.2001; Ridge KM, 2003, CIRC RES, V92, P453, DOI 10.1161/01.RES.0000059414.10360.F2; Ridge KM, 2002, MOL BIOL CELL, V13, P1381, DOI 10.1091/mbc.01-07-0323; RUTSCHMAN DH, 1993, J APPL PHYSIOL, V75, P1574, DOI 10.1152/jappl.1993.75.4.1574; Saldias FJ, 2001, AM J PHYSIOL-LUNG C, V281, pL591, DOI 10.1152/ajplung.2001.281.3.L591; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4; TAYLOR AE, 1965, CIRC RES, V16, P353, DOI 10.1161/01.RES.16.4.353; Yamamoto T, 2001, KIDNEY INT, V60, P364, DOI 10.1046/j.1523-1755.2001.00808.x; Yun AJ, 2006, MED HYPOTHESES, V66, P776, DOI 10.1016/j.mehy.2005.10.019	22	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134175	10.1371/journal.pone.0134175	http://dx.doi.org/10.1371/journal.pone.0134175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230832	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400084
J	Juuhl-Langseth, M; Hartberg, CB; Holmen, A; Thormodsen, R; Groote, IR; Rimol, LM; Emblem, KE; Agartz, I; Rund, BR				Juuhl-Langseth, Monica; Hartberg, Cecilie B.; Holmen, Aina; Thormodsen, Rune; Groote, Inge R.; Rimol, Lars M.; Emblem, Kyrre E.; Agartz, Ingrid; Rund, Bjorn R.			Impaired Verbal Learning Is Associated with Larger Caudate Volumes in Early Onset Schizophrenia Spectrum Disorders	PLOS ONE			English	Article							CONSENSUS COGNITIVE BATTERY; SUBCORTICAL BRAIN VOLUMES; BASAL GANGLIA; NEUROCOGNITION; MODEL; ANTIPSYCHOTICS; ABNORMALITIES; SEGMENTATION; MORPHOLOGY; SELECTION	Background Both brain structural abnormalities and neurocognitive impairments are core features of schizophrenia. We have previously reported enlargements in subcortical brain structure volumes and impairment of neurocognitive functioning as measured by the MATRICS Cognitive Consensus Battery (MCCB) in early onset schizophrenia spectrum disorders (EOS). To our knowledge, no previous study has investigated whether neurocognitive performance and volumetric abnormalities in subcortical brain structures are related in EOS. Methods Twenty-four patients with EOS and 33 healthy controls (HC) were included in the study. Relationships between the caudate nucleus, the lateral and fourth ventricles volumes and neurocognitive performance were investigated with multivariate linear regression analyses. Intracranial volume, age, antipsychotic medication and IQ were included as independent predictor-variables. Results The caudate volume was negatively correlated with verbal learning performance uniquely in the EOS group (r=-.454, p=.034). There were comparable positive correlations between the lateral ventricular volume and the processing speed, attention and reasoning and problem solving domains for both the EOS patients and the healthy controls. Antipsychotic medication was related to ventricular enlargements, but did not affect the brain structure-function relationship. Conclusion Enlargement of the caudate volume was related to poorer verbal learning performance in patients with EOS. Despite a 32% enlargement of the lateral ventricles in the EOS group, associations to processing speed, attention and reasoning and problem solving were similar for both the EOS and the HC groups.	[Juuhl-Langseth, Monica] Oslo Univ Hosp, Res Unit Child & Adolescent Mental Hlth, Oslo, Norway; [Hartberg, Cecilie B.; Agartz, Ingrid] Univ Oslo, Inst Clin Med, NORMENT, Oslo, Norway; [Hartberg, Cecilie B.; Agartz, Ingrid] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, Oslo, Norway; [Juuhl-Langseth, Monica; Holmen, Aina; Groote, Inge R.; Rund, Bjorn R.] Univ Oslo, Dept Psychol, Oslo, Norway; [Holmen, Aina] Akershus Univ Hosp, Mental Hlth Serv, Lorenskog, Norway; [Thormodsen, Rune; Rund, Bjorn R.] Vestre Viken Hosp Trust, Drammen, Norway; [Rimol, Lars M.] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7034 Trondheim, Norway; [Emblem, Kyrre E.] Oslo Univ Hosp, Intervent Ctr, Oslo, Norway; [Hartberg, Cecilie B.; Agartz, Ingrid] Diakonhjemmet Hosp, Dept Psychiat Res, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU); University of Oslo; Diakonhjemmet Hospital	Juuhl-Langseth, M (corresponding author), Oslo Univ Hosp, Res Unit Child & Adolescent Mental Hlth, Oslo, Norway.	monica.juuhl-langseth@psykologi.uio.no	Emblem, Kyrre E/H-6691-2012	Emblem, Kyrre E/0000-0002-6580-9519; Agartz, Ingrid/0000-0002-9839-5391	South-Eastern Norway Regional Health Authority [2004-259, 2006-186, 2008011, 2009037]; Oslo University Hospital; Research Council of Norway [190311/V50, 167153/V50]	South-Eastern Norway Regional Health Authority; Oslo University Hospital; Research Council of Norway(Research Council of Norway)	South-Eastern Norway Regional Health Authority provided the main financial support to the study to BRR (Grant # 2004-259, 2006-186). In addition, the study was supported by Oslo University Hospital and by grants to IA (Research Council of Norway: Grants # 190311/V50 and 167153/V50 and the South-Eastern Norway Regional Health Authority: Grants # 2008011 and 2009037). http://www.uio.no, http://www.helse-sorost.no, http://www.forskningsradet.no/no/Forsiden/1173185591033. The funder had no involvement in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev YG, 1998, BEHAV BRAIN RES, V97, P159, DOI 10.1016/S0166-4328(98)00037-0; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Amminger GP, 2011, SCHIZOPHR RES, V131, P112, DOI 10.1016/j.schres.2011.06.009; Andreasen NC, 2013, AM J PSYCHIAT, V170, P609, DOI 10.1176/appi.ajp.2013.12050674; Antonova E, 2004, SCHIZOPHR RES, V70, P117, DOI 10.1016/j.schres.2003.12.002; Armenteros JL, 2006, EUR CHILD ADOLES PSY, V15, P141, DOI 10.1007/s00787-005-0515-2; Aron A.R., 2009, COGNITION BASAL GANG; Arsalidou M, 2013, HUM BRAIN MAPP, V34, P3031, DOI 10.1002/hbm.22124; Brandt GN, 2008, WIEN MED WOCHENSCHR, V158, P84, DOI 10.1007/s10354-007-0478-7; Brent BK, 2013, CHILD ADOL PSYCH CL, V22, P689, DOI 10.1016/j.chc.2013.06.003; Brodal P, 2010, THE CENTRAL NERVOUS; Burgaleta M, 2014, HUM BRAIN MAPP, V35, P1957, DOI 10.1002/hbm.22305; Cannon M, 1999, ARCH GEN PSYCHIAT, V56, P457, DOI 10.1001/archpsyc.56.5.457; Crespo-Facorro B, 2007, INT REV PSYCHIATR, V19, P325, DOI 10.1080/09540260701486647; Crespo-Facorro B, 2007, SCHIZOPHR RES, V91, P87, DOI 10.1016/j.schres.2006.12.015; DELISI LE, 1991, BIOL PSYCHIAT, V29, P159, DOI 10.1016/0006-3223(91)90044-M; DEQUARDO JR, 1994, BIOL PSYCHIAT, V35, P517, DOI 10.1016/0006-3223(94)90098-1; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Driver DI, 2013, CHILD ADOL PSYCH CL, V22, P539, DOI 10.1016/j.chc.2013.04.001; Duffau H, 2014, BRAIN LANG, V131, P1, DOI 10.1016/j.bandl.2013.05.011; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Frangou S, 2004, NEUROIMAGE, V23, P800, DOI 10.1016/j.neuroimage.2004.05.027; Frangou S, 2013, CHILD ADOL PSYCH CL, V22, P715, DOI 10.1016/j.chc.2013.04.007; Gogtay N, 2008, SCHIZOPHRENIA BULL, V34, P30, DOI 10.1093/schbul/sbm103; Gogtay N, 2011, SCHIZOPHRENIA BULL, V37, P504, DOI 10.1093/schbul/sbr030; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; Green MF, 2004, SCHIZOPHR RES, V72, P41, DOI 10.1016/j.schres.2004.09.009; Green MF, 2004, SCHIZOPHR RES, V72, P1, DOI 10.1016/j.schres.2004.09.006; Green Michael F, 2014, Schizophr Res Cogn, V1, pe1; Hartberg CB, 2011, PROG NEURO-PSYCHOPH, V35, P1122, DOI 10.1016/j.pnpbp.2011.03.014; Hollis C, 2003, BRIT J PSYCHIAT, V182, P37, DOI 10.1192/bjp.182.1.37; Holmen A, 2012, SCHIZOPHR RES, V142, P177, DOI 10.1016/j.schres.2012.10.006; Holmen A, 2010, SCHIZOPHRENIA BULL, V36, P852, DOI 10.1093/schbul/sbn174; Houthoofd SAMK, 2008, CLIN THER, V30, P1565, DOI 10.1016/j.clinthera.2008.09.014; Juuhl-Langseth M, 2014, SCHIZOPHR RES, V156, P241, DOI 10.1016/j.schres.2014.04.014; Juuhl-Langseth M, 2012, PSYCHIAT RES-NEUROIM, V203, P14, DOI 10.1016/j.pscychresns.2011.10.005; Kahn RS, 2013, JAMA PSYCHIAT, V70, P1107, DOI 10.1001/jamapsychiatry.2013.155; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keefe RSE, 2013, SCHIZOPHRENIA BULL, V39, P417, DOI 10.1093/schbul/sbr153; Keefe RSE, 2011, SCHIZOPHR RES, V125, P161, DOI 10.1016/j.schres.2010.09.015; Koziol L. F., 2009, SUBCORTICAL STRUCTUR; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Kumra S, 2008, SCHIZOPHRENIA BULL, V34, P15, DOI 10.1093/schbul/sbm123; Kyriakopoulos M, 2007, INT REV PSYCHIATR, V19, P315, DOI 10.1080/09540260701486258; Lawyer G, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-31; Lieberman JA, 2005, ARCH GEN PSYCHIAT, V62, P361, DOI 10.1001/archpsyc.62.4.361; MacDonald PA, 2014, BRAIN IMAGING BEHAV, V8, P52, DOI 10.1007/s11682-013-9242-3; Mamah D, 2007, SCHIZOPHR RES, V89, P59, DOI 10.1016/j.schres.2006.08.031; McClure RK, 2008, SCHIZOPHR RES, V98, P29, DOI 10.1016/j.schres.2007.05.012; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Moncrieff J, 2010, PSYCHOL MED, V40, P1409, DOI 10.1017/S0033291709992297; Nesvag R, 2012, SCHIZOPHR RES, V142, P209, DOI 10.1016/j.schres.2012.10.004; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Pedersen G, 2007, COMPR PSYCHIAT, V48, P88, DOI 10.1016/j.comppsych.2006.03.008; Rapoport JL, 2012, MOL PSYCHIATR, V17, P1228, DOI 10.1038/mp.2012.23; Reichenberg Abraham, 2010, Dialogues Clin Neurosci, V12, P383; Rimol LM, 2010, BIOL PSYCHIAT, V68, P41, DOI 10.1016/j.biopsych.2010.03.036; Robles SG, 2005, J NEUROL NEUROSUR PS, V76, P940, DOI 10.1136/jnnp.2004.045948; Rund BR, 2009, NORD J PSYCHIAT, V63, P196, DOI 10.1080/08039480902767286; Sandman CA, 2014, NEUROIMAGE, V99, P93, DOI 10.1016/j.neuroimage.2014.05.020; Scherk H, 2006, CURR OPIN PSYCHIATR, V19, P145, DOI 10.1097/01.yco.0000214339.06507.d8; Schobel SA, 2009, SCHIZOPHR RES, V114, P110, DOI 10.1016/j.schres.2009.07.016; Seger CA, 2008, NEUROSCI BIOBEHAV R, V32, P265, DOI 10.1016/j.neubiorev.2007.07.010; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shenton Martha E, 2010, Dialogues Clin Neurosci, V12, P317; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Thormodsen R, 2013, PSYCHIAT RES-NEUROIM, V214, P190, DOI 10.1016/j.pscychresns.2013.07.003; Tost H, 2010, NEUROSCI BIOBEHAV R, V34, P689, DOI 10.1016/j.neubiorev.2009.06.005; WASI. Wechsler Abbreviated Scale of Intelligence (WASI), 2007, NORWEGIAN MANUAL SUP; Weinberger DR, 2002, ARCH GEN PSYCHIAT, V59, P553, DOI 10.1001/archpsyc.59.6.553; Zipursky RB, 2013, SCHIZOPHRENIA BULL, V39, P1363, DOI 10.1093/schbul/sbs135	73	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0130435	10.1371/journal.pone.0130435	http://dx.doi.org/10.1371/journal.pone.0130435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230626	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400005
J	Li, AHT; McArthur, E; Maclean, J; Isenor, C; Prakash, V; Kim, SJ; Knoll, G; Shah, B; Garg, AX				Li, Alvin Ho-ting; McArthur, Eric; Maclean, Janet; Isenor, Cynthia; Prakash, Versha; Kim, S. Joseph; Knoll, Greg; Shah, Baiju; Garg, Amit X.			Deceased Organ Donation Registration and Familial Consent among Chinese and South Asians in Ontario, Canada	PLOS ONE			English	Article							POPULATION-BASED COHORT; RACIAL-DIFFERENCES; TRANSPLANT DONORS; BRITISH-COLUMBIA; ATTITUDES; CALIFORNIA; RECIPIENTS; KNOWLEDGE; RATES	Objective For various reasons, people of Chinese (China, Hong Kong or Taiwan) and South Asian (Indian subcontinent) ancestry (the two largest ethnic minority groups in Ontario, Canada) may be less likely to register for deceased organ donation than the general public, and their families may be less likely to consent for deceased organ donation at the time of death. Methods We conducted two population-based studies: (1) a cross-sectional study of deceased organ donor registration as of May 2013, and (2) a cohort study of the steps in proceeding with deceased organ donation for patients who died in hospital from October 2008 to December 2012. Results A total of 49 938 of 559 714 Chinese individuals (8.9%) and 47 774 of 374 291 South Asians (12.8%) were registered for deceased organ donation, proportions lower than the general public (2 676 260 of 10 548 249 (25.4%). Among the 168 703 Ontarians who died in a hospital, the families of 33 of 81 Chinese (40.1%; 95% CI: 30.7%-51.6%) and 39 of 72 South Asian individuals (54.2%; 95% CI: 42.7-65.2%) consented for deceased organ donation, proportions lower than the general public (68.3%; 95% CI: 66.4%-70.0%). Conclusions In Ontario, Canada Chinese and South Asian individuals are less likely to register and their families are less likely to consent to deceased organ donation compared to the remaining general public. There is an opportunity to build support for organ and tissue donation in these two large ethnic communities in Canada.	[Li, Alvin Ho-ting; Garg, Amit X.] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada; [McArthur, Eric; Kim, S. Joseph; Shah, Baiju; Garg, Amit X.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Maclean, Janet; Isenor, Cynthia; Prakash, Versha] Trillium Gift Life Network, Toronto, ON, Canada; [Kim, S. Joseph] Univ Toronto, Dept Med, Div Nephrol, Toronto, ON, Canada; [Knoll, Greg] Ottawa Hosp, Div Nephrol, Ottawa, ON, Canada; [Knoll, Greg] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Knoll, Greg] Univ Ottawa, Ottawa, ON, Canada; [Shah, Baiju] Univ Toronto, Dept Med, Toronto, ON, Canada	Western University (University of Western Ontario); University of Toronto; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Toronto	Li, AHT (corresponding author), Western Univ, Dept Epidemiol & Biostat, London, ON, Canada.	Alvin.li@lhsc.on.ca	Garg, Amit X/G-3295-2011	Knoll, Greg/0000-0001-5442-9310; Isenor, Cynthia/0000-0002-4030-0126	Ontario Ministry of Health and Longterm Care; Academic Medical Organization of Southwestern Ontario; Schulich School of Medicine and Dentistry (SSMD), Western University; Lawson Health Research Institute; Canadian Institutes of Health Research; Kidney Foundation of Canada	Ontario Ministry of Health and Longterm Care(Ministry of Health and Long-Term Care, Ontario); Academic Medical Organization of Southwestern Ontario; Schulich School of Medicine and Dentistry (SSMD), Western University; Lawson Health Research Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada	This Institute for Clinical Evaluative Sciences (ICES) project was conducted by the Kidney, Dialysis and Transplantation program at the ICES Western site. ICES is funded by an annual grant from the Ontario Ministry of Health and Longterm Care. Core funding for ICES Western is provided by the Academic Medical Organization of Southwestern Ontario, the Schulich School of Medicine and Dentistry (SSMD), Western University, and the Lawson Health Research Institute. The ICES Kidney, Dialysis and Transplantation receives programmatic operating grant support from the Canadian Institutes of Health Research. Mr. Li was supported by a doctoral scholarship from the Kidney Foundation of Canada and the Canadian Institutes of Health Research. The opinions, results and conclusions are those of the authors and are independent from the funding sources. No endorsement by these organizations is intended or should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsahafi M, 2013, TRANSPLANTATION, V95, pE70, DOI 10.1097/TP.0b013e3182928261; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Brown CVR, 2010, J TRAUMA, V68, P447, DOI 10.1097/TA.0b013e3181caab8f; Chon WJ, 2014, AM J TRANSPLANT, V14, P172, DOI 10.1111/ajt.12519; (CIHI) CI for HI, 2014, 2014 CORR REP TREAT; Deedat S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003453; Goldberg DS, 2013, CRIT CARE MED, V41, P496, DOI 10.1097/CCM.0b013e318271198c; Government of Canada SC, 2011, NAT HOUS SURV PROF P; Irving MJ, 2012, NEPHROL DIAL TRANSPL, V27, P2526, DOI 10.1093/ndt/gfr683; Israel BA, 1998, ANNU REV PUBL HEALTH, V19, P173, DOI 10.1146/annurev.publhealth.19.1.173; Lee E, 2010, CLIN TRANSPLANT, V24, pE223, DOI 10.1111/j.1399-0012.2010.01260.x; Li AHT, 2014, JAMA-J AM MED ASSOC, V312, P291, DOI 10.1001/jama.2014.2934; Li AHT, 2013, PEDIATR TRANSPLANT, V17, P119, DOI 10.1111/petr.12045; Molzahn AE, 2005, QUAL HEALTH RES, V15, P82, DOI 10.1177/1049732304270653; Molzahn AE, 2005, PROG TRANSPLANT ALIS, V15, P233; Morgan M, 2013, ETHNIC HEALTH, V18, P367, DOI 10.1080/13557858.2012.752073; Morgan SE, 2008, HEALTH COMMUN, V23, P23, DOI 10.1080/10410230701805158; Mukerji G, 2013, J MATERN-FETAL NEO M, V26, P279, DOI 10.3109/14767058.2012.735996; Redelmeier DA, 2013, CAN MED ASSOC J, V185, pE337, DOI 10.1503/cmaj.122047; Rosenblum AM, 2012, TRANSPL INT, V25, P801, DOI 10.1111/j.1432-2277.2012.01472.x; Salim A, 2014, JAMA SURG, V149, P899, DOI 10.1001/jamasurg.2014.1014; Salim A, 2014, JAMA SURG, V149, P71, DOI 10.1001/jamasurg.2013.3967; Salim A, 2010, J AM COLL SURGEONS, V211, P596, DOI 10.1016/j.jamcollsurg.2010.06.390; Saub EJ, 1998, J COMMUN HEALTH, V23, P407, DOI 10.1023/A:1018754023705; Shah BR, 2013, DIABETES CARE, V36, P2670, DOI 10.2337/dc12-2105; Shah BR, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-42; Siminoff LA, 2001, JAMA-J AM MED ASSOC, V286, P71, DOI 10.1001/jama.286.1.71; Wilkins R, 2007, STAT CAN; Yeung DF, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-114; Yoshida EM, 1999, TRANSPLANTATION, V67, P1324, DOI 10.1097/00007890-199905270-00006; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	31	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0124321	10.1371/journal.pone.0124321	http://dx.doi.org/10.1371/journal.pone.0124321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230320	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400001
J	Li, CY; Gao, BL; Liu, XW; Fan, QY; Zhang, XJ; Liu, GC; Yang, HQ; Feng, PY; Wang, Y; Song, P				Li, Cai-Ying; Gao, Bu-Lang; Liu, Xiao-Wei; Fan, Qiong-Ying; Zhang, Xue-Jing; Liu, Guo-Chao; Yang, Hai-Qing; Feng, Ping-Yong; Wang, Yong; Song, Peng			Quantitative Evaluation of the Substantially Variable Morphology and Function of the Left Atrial Appendage and Its Relation with Adjacent Structures	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; STROKE PREVENTION; CATHETER ABLATION; FIBRILLATION; RISK; ANATOMY; CLOSURE; EPIDEMIOLOGY; OBLITERATION; PREVALENCE	Objective To investigate quantitatively the morphology, anatomy and function of the left atrial appendage (LAA) and its relation with adjacent structures. Materials and Methods A total of 860 patients (533 men, 62.0%, age 55.9 +/- 10.4 year) who had cardiac multidetector computed tomography angiography from May to October 2012 were enrolled for analysis. Results Seven types and 6 subtypes of LAA morphology were found with Type 2 being the most prevalent. Type 5 was more significantly (P<0.05) present in women (8.0%) than in men (4.2%). LAA orifice was oval in 81.5%, triangular in 7.3%, semicircular in 4%, water drop-like in 3.2%, round in 2.4% and foot-like in 1.6%. The LAA orifice had a significantly greater (P<0.01) major axis in men (24.79 +/- 3.81) than in women (22.68 +/- 4.07). The LAA orifice long axis was significantly (P<0.05) positively correlated with the height, weight and surface area of the patient. The LAA morphology parameters displayed strong positive correlation with the left atrium volume, aortic cross area long axis or LSPV long axis but poor correlation with the height, weight, surface area and vertebral body height of the patients. Four types of LAA ridge were identified: AI, AII, B and C with the distribution of 17.6%, 69.9%, 5.9% and 6.6%, respectively. The LAA had a significantly (P<0.05) greater distance from its orifice to the mitral ring in women than in men. The LAA had two filling and two emptying processes with the greatest volume at 45% phase but the least volume at 5% phase. The LAA maximal, minimal and emptying volumes were all significantly (P<0.05) positively correlated with the body height, weight and surface area, whereas the LAA ejection fraction had an inverse correlation with the LAA minimal volume but no correlation with the maximal volume. Conclusion The LAA has substantially variable morphologies and relation with the adjacent structures, which may be helpful in guiding the LAA trans-catheter occlusion or catheter ablation procedures.	[Li, Cai-Ying; Liu, Xiao-Wei; Yang, Hai-Qing; Feng, Ping-Yong; Wang, Yong; Song, Peng] Hebei Med Univ, Hosp 2, Dept Med Imaging, Shijiazhuang, Hebei Province, Peoples R China; [Gao, Bu-Lang; Fan, Qiong-Ying; Zhang, Xue-Jing; Liu, Guo-Chao] Hebei Med Univ, Shijiazhuang Hosp 1, Dept Med Res, Shijiazhuang, Hebei Province, Peoples R China	Hebei Medical University; Hebei Medical University	Li, CY (corresponding author), Hebei Med Univ, Hosp 2, Dept Med Imaging, Shijiazhuang, Hebei Province, Peoples R China.	licaying63@163.com; browngao@163.com						Al-Saady NM, 1999, HEART, V82, P547, DOI 10.1136/hrt.82.5.547; Anselmino M, 2011, J CARDIOVASC ELECTR, V22, P1, DOI 10.1111/j.1540-8167.2010.01853.x; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Budge LP, 2008, J INTERV CARD ELECTR, V23, P87, DOI 10.1007/s10840-008-9281-7; Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116; Chang SH, 2007, J CARDIOVASC ELECTR, V18, P47, DOI 10.1111/j.1540-8167.2006.00655.x; Chiang CE, 2014, THROMB HAEMOSTASIS, V111, P789, DOI 10.1160/TH13-11-0948; Christiaens L, 2010, INT J CARDIOL, V140, P189, DOI 10.1016/j.ijcard.2008.11.055; Di Biase L, 2010, CIRCULATION, V122, P109, DOI 10.1161/CIRCULATIONAHA.109.928903; ERNST G, 1995, ANAT REC, V242, P553, DOI 10.1002/ar.1092420411; Garcia-Fernandez MA, 2003, J AM COLL CARDIOL, V42, P1253, DOI 10.1016/S0735-1097(03)00954-9; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Gottlieb I, 2008, J CARDIOVASC ELECTR, V19, P247, DOI 10.1111/j.1540-8167.2007.01043.x; GRIMM RA, 1993, J AM COLL CARDIOL, V22, P1359, DOI 10.1016/0735-1097(93)90543-A; Guo Y, 2014, CHEST; Healey JS, 2005, AM HEART J, V150, P288, DOI 10.1016/j.ahj.2004.09.054; Heist EK, 2006, HEART RHYTHM, V3, P1313, DOI 10.1016/j.hrthm.2006.07.022; HONDO T, 1995, JPN HEART J, V36, P225; Jue J, 1993, J Am Soc Echocardiogr, V6, P237; Kamalesh M, 2000, ECHOCARDIOGR-J CARD, V17, P313, DOI 10.1111/j.1540-8175.2000.tb01142.x; Katz ES, 2000, J AM COLL CARDIOL, V36, P468, DOI 10.1016/S0735-1097(00)00765-8; Kerut EK, 2008, ECHOCARDIOGR-J CARD, V25, P669, DOI 10.1111/j.1540-8175.2008.00637.x; Koplay M, 2012, EUR J RADIOL, V81, P1575, DOI 10.1016/j.ejrad.2011.04.060; Lacomis JM, 2007, EUROPACE, V9, P1134, DOI 10.1093/europace/eum227; Leal S, 2012, CURR CARDIOL REV, V8, P37, DOI 10.2174/157340312801215827; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Majeed A, 2001, HEART, V86, P284, DOI 10.1136/heart.86.3.284; Murakoshi N, 2013, CIRC J, V77, P2419, DOI 10.1253/circj.CJ-13-1129; Nguyen-Do Phong, 2004, Ann Thorac Surg, V78, pe26, DOI 10.1016/j.athoracsur.2003.10.117; Odell JA, 1996, ANN THORAC SURG, V61, P565, DOI 10.1016/0003-4975(95)00885-3; Palios John, 2014, Thrombosis, V2014, P832752, DOI 10.1155/2014/832752; Park HC, 2013, INT J CARDIOVAS IMAG, V29, P935, DOI 10.1007/s10554-012-0161-y; Pollick C, 2000, CHEST, V117, P297, DOI 10.1378/chest.117.2.297; Qamruddin Salima, 2010, Expert Rev Cardiovasc Ther, V8, P65, DOI 10.1586/erc.09.161; Sievert H, 2002, CIRCULATION, V105, P1887, DOI 10.1161/01.CIR.0000015698.54752.6D; Su P, 2008, HEART, V94, P1166, DOI 10.1136/hrt.2006.111989; Syed TM, 2007, NAT CLIN PRACT CARD, V4, P428, DOI 10.1038/ncpcardio0933; Veinot JP, 1997, CIRCULATION, V96, P3112, DOI 10.1161/01.CIR.96.9.3112; Vivas D, 2011, CIRC J, V75, P1314, DOI 10.1253/circj.CJ-11-0402; Walker AM, 2008, HEART RHYTHM, V5, P1365, DOI 10.1016/j.hrthm.2008.07.014; Wang Y, 2010, J CARDIOVASC ELECTR, V21, P973, DOI 10.1111/j.1540-8167.2010.01814.x; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wongcharoen W, 2006, J CARDIOVASC ELECTR, V17, P951, DOI 10.1111/j.1540-8167.2006.00549.x; Wu YW, 2008, INT J CARDIOL, V128, P69, DOI 10.1016/j.ijcard.2007.06.017; Zhou ZQ, 2008, J EPIDEMIOL, V18, P209, DOI 10.2188/jea.JE2008021	45	12	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0126818	10.1371/journal.pone.0126818	http://dx.doi.org/10.1371/journal.pone.0126818			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230395	Green Submitted, gold, Green Published			2022-12-27	WOS:000358838400002
J	Makdissy, N; Haddad, K; Mouawad, C; Popa, I; Younsi, M; Valet, P; Brunaud, L; Ziegler, O; Quilliot, D				Makdissy, Nehman; Haddad, Katia; Mouawad, Charbel; Popa, Iuliana; Younsi, Mohamed; Valet, Philippe; Brunaud, Laurent; Ziegler, Olivier; Quilliot, Didier			Regulation of SREBPs by Sphingomyelin in Adipocytes via a Caveolin and Ras-ERK-MAPK-CREB Signaling Pathway	PLOS ONE			English	Article							ELEMENT-BINDING PROTEINS; PPAR-GAMMA; ADIPOSE-TISSUE; NEUTRAL SPHINGOMYELINASE; INSULIN-RESISTANCE; PLASMA-MEMBRANE; IN-VITRO; PHOSPHOLIPID-COMPOSITION; CHOLESTEROL-SYNTHESIS; GENE-EXPRESSION	Sterol response element binding protein (SREBP) is a key transcription factor in insulin and glucose metabolism. We previously demonstrated that elevated levels of membrane sphingomyelin (SM) were related to peroxisome proliferator-activated receptor-gamma (PPAR gamma), which is a known target gene of SREBP-1 in adipocytes. However, the role of SM in SREBP expression in adipocytes remains unknown. In human abdominal adipose tissue from obese women with various concentrations of fasting plasma insulin, SREBP-1 proteins decreased in parallel with increases in membrane SM levels. An inverse correlation was found between the membrane SM content and the levels of SREBP-1c/ERK/Ras/PPAR gamma/CREB proteins. For the first time, we demonstrate the effects of SM and its signaling pathway in 3T3-F442A adipocytes. These cells were enriched or unenriched with SM in a range of concentrations similar to those observed in obese subjects by adding exogenous natural SMs (having different acyl chain lengths) or by inhibiting neutral sphingomyelinase. SM accumulated in caveolae of the plasma membrane within 24 h and then in the intracellular space. SM enrichment decreased SREBP-1 through the inhibition of extracellular signal-regulated protein kinase (ERK) but not JNK or p38 mitogen-activated protein kinase (MAPK). Ras/Raf-1/MEK1/2 and KSR proteins, which are upstream mediators of ERK, were down-regulated, whereas SREBP-2/caveolin and cholesterol were up-regulated. In SM-unmodulated adipocytes treated with DL-1-Phenyl-2-Palmitoylamino-3-morpholino-1-propanol (PPMP), where the ceramide level increased, the expression levels of SREBPs and ERK were modulated in an opposite direction relative to the SM-enriched cells. SM inhibited the insulin-induced expression of SREBP-1. Rosiglitazone, which is an anti-diabetic agent and potent activator of PPAR gamma, reversed the effects of SM on SREBP-1, PPAR gamma and CREB. Taken together, these findings provide novel insights indicating that excess membrane SM might be critical for regulating SREBPs in adipocytes via a MAPK-dependent pathway.	[Makdissy, Nehman; Haddad, Katia; Mouawad, Charbel] Lebanese Univ, Fac Sci 3, Middle East Inst Hlth, Reviva Regenerat Med Ctr, Bsalim, Lebanon; [Makdissy, Nehman; Younsi, Mohamed; Ziegler, Olivier; Quilliot, Didier] Univ Nancy 1, Lab Nutr & Metab Dis, Vandoeuvre Les Nancy, France; [Popa, Iuliana] Univ Lyon 1, Lab Dermatol Res, EA 4169, F-69365 Lyon, France; [Valet, Philippe] Fac Med Toulouse, INSERM, U858, F-31073 Toulouse, France; [Brunaud, Laurent; Ziegler, Olivier; Quilliot, Didier] CHU Nancy, Serv Diabetol Nutr, Nancy, France; [Brunaud, Laurent; Quilliot, Didier] Univ Nancy 1, Fac Med, INSERM 954, Nancy, France	Universite de Lorraine; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine	Makdissy, N (corresponding author), Lebanese Univ, Fac Sci 3, Middle East Inst Hlth, Reviva Regenerat Med Ctr, Bsalim, Lebanon.	n.makdissy@revivamedical.com	Brunaud, Laurent/AAW-9384-2020; Quillot, Didier/ABB-5326-2021; Valet, Philippe/N-7472-2017	Brunaud, Laurent/0000-0001-5182-6660; Valet, Philippe/0000-0001-6520-7393				Airola Michael V, 2013, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-7091-1368-4_3; Ait-Si-Ali S, 1999, BIOCHEM BIOPH RES CO, V262, P157, DOI 10.1006/bbrc.1999.1132; Al-Makdissy N, 2003, CELL SIGNAL, V15, P1019, DOI 10.1016/S0898-6568(03)00070-6; Al-Makdissy N, 2001, FEBS LETT, V493, P75, DOI 10.1016/S0014-5793(01)02278-5; Bist A, 2000, BIOCHEMISTRY-US, V39, P1966, DOI 10.1021/bi991721h; Bodennec J, 2000, J LIPID RES, V41, P1524; Botolin D, 2006, J LIPID RES, V47, P181, DOI 10.1194/jlr.M500365-JLR200; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Catalan V, 2008, CLIN ENDOCRINOL, V68, P213, DOI 10.1111/j.1365-2265.2007.03021.x; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Cutler RG, 2001, MECH AGEING DEV, V122, P895, DOI 10.1016/S0047-6374(01)00246-9; Czarny M, 2003, J BIOL CHEM, V278, P4424, DOI 10.1074/jbc.M210375200; Daviaud D, 2006, FASEB J, V20, P1528, DOI 10.1096/fj.05-5243fje; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Fruhbeck G, 2007, TRENDS ENDOCRIN MET, V18, P177, DOI 10.1016/j.tem.2007.04.001; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; Grigsby RJ, 2001, BIOCHEM BIOPH RES CO, V287, P1121, DOI 10.1006/bbrc.2001.5694; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; Hla T, 2012, CELL METAB, V16, P420, DOI 10.1016/j.cmet.2012.06.017; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Jiang XC, 2000, ARTERIOSCL THROM VAS, V20, P2614, DOI 10.1161/01.ATV.20.12.2614; KEAN EL, 1966, J LIPID RES, V7, P449; KEMPEN HJM, 1991, ARTERIOSCLER THROMB, V11, P146, DOI 10.1161/01.ATV.11.1.146; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kintscher U, 2005, AM J PHYSIOL-ENDOC M, V288, pE287, DOI 10.1152/ajpendo.00440.2004; Kotzka J, 2000, J LIPID RES, V41, P99; Kummerow FA, 2001, J NUTR BIOCHEM, V12, P602, DOI 10.1016/S0955-2863(01)00181-4; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Lawler JF, 1998, J BIOL CHEM, V273, P5053, DOI 10.1074/jbc.273.9.5053; Le Lay S, 2001, J BIOL CHEM, V276, P16904, DOI 10.1074/jbc.M010955200; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Leon NM, 2002, REV INVEST CLIN, V54, P145; Li ZQ, 2011, MOL CELL BIOL, V31, P4205, DOI 10.1128/MCB.05893-11; Liu B, 1997, J BIOL CHEM, V272, P16281, DOI 10.1074/jbc.272.26.16281; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Masson O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007422; Mendez-Gimenez L, 2014, MOL CELL ENDOCRINOL, V397, P78, DOI 10.1016/j.mce.2014.06.017; Muller-Wieland D, 2002, ANN NY ACAD SCI, V967, P19; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Nagao K, 2007, J BIOL CHEM, V282, P14868, DOI 10.1074/jbc.M611230200; NAOI M, 1974, ANAL BIOCHEM, V58, P571, DOI 10.1016/0003-2697(74)90226-7; Ohanian J, 2001, CELL MOL LIFE SCI, V58, P2053, DOI 10.1007/PL00000836; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Oliner JD, 1996, GENE DEV, V10, P2903, DOI 10.1101/gad.10.22.2903; Ortegren U, 2004, EUR J BIOCHEM, V271, P2028, DOI 10.1111/j.1432-1033.2004.04117.x; Park TS, 2004, CIRCULATION, V110, P3465, DOI 10.1161/01.CIR.0000148370.60535.22; Pham NA, 2005, J INHERIT METAB DIS, V28, P991, DOI 10.1007/s10545-005-0117-7; Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808; Popa I, 2010, ARCH DERMATOL RES, V302, P639, DOI 10.1007/s00403-010-1049-0; Prattes S, 2000, J CELL SCI, V113, P2977; Puri V, 2003, J BIOL CHEM, V278, P20961, DOI 10.1074/jbc.M300304200; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; RAINES MA, 1993, J BIOL CHEM, V268, P14572; RESH MD, 1982, J BIOL CHEM, V257, P6978; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; ROSE HG, 1965, J LIPID RES, V6, P428; Roth G, 2000, J BIOL CHEM, V275, P33302, DOI 10.1074/jbc.M005425200; Scheek S, 1997, P NATL ACAD SCI USA, V94, P11179, DOI 10.1073/pnas.94.21.11179; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Subbaiah PV, 2001, MED HYPOTHESES, V57, P135, DOI 10.1054/mehy.2001.1336; Summers SA, 2005, DIABETES, V54, P591, DOI 10.2337/diabetes.54.3.591; Thorn H, 2003, MOL BIOL CELL, V14, P3967, DOI 10.1091/mbc.E03-01-0050; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; Zeghari N, 2000, AM J PHYSIOL-ENDOC M, V279, pE736, DOI 10.1152/ajpendo.2000.279.4.E736; Zeghari N, 2000, INT J OBESITY, V24, P1600, DOI 10.1038/sj.ijo.0801459; Zhang H, 2013, BIOCHEM SOC T, V41, P1078, DOI 10.1042/BST20130042; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X; ZLATKIS A, 1969, ANAL BIOCHEM, V29, P143, DOI 10.1016/0003-2697(69)90017-7	78	19	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133181	10.1371/journal.pone.0133181	http://dx.doi.org/10.1371/journal.pone.0133181			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230734	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400028
J	Mordecai, EA; Hindenlang, M; Mitchell, CE				Mordecai, Erin A.; Hindenlang, Madeleine; Mitchell, Charles E.			Differential Impacts of Virus Diversity on Biomass Production of a Native and an Exotic Grass Host	PLOS ONE			English	Article							PLANT-VIRUS; COINFECTION; BARLEY; INFECTION; APHID; DISEASE	Pathogens are common and diverse in natural communities and have been implicated in the success of host invasions. Yet few studies have experimentally measured how pathogens impact native versus exotic hosts, particularly when individual hosts are simultaneously coinfected by diverse pathogens. To estimate effects of interactions among multiple pathogens within host individuals on both transmission of pathogens and fitness consequences for hosts, we conducted a greenhouse experiment using California grassland species: the native perennial grass Nassella (Stipa) pulchra, the exotic annual grass Bromus hordeaceus, and three virus species, Barley yellow dwarf virus-PAV, Barley yellow dwarf virus-MAV, and Cereal yellow dwarf virus-RPV. In terms of virus transmission, the native host was less susceptible than the exotic host to MAV. Coinfection of PAV and MAV did not occur in any of the 157 co-inoculated native host plants. In the exotic host, PAV infection most strongly reduced root and shoot biomass, and coinfections that included PAV severely reduced biomass. Infection with single or multiple viruses did not affect biomass in the native host. However, in this species the most potentially pathogenic coinfections (PAV + MAV and PAV + MAV + RPV) did not occur. Together, these results suggest that interactions among multiple pathogens can have important consequences for host health, which may not be predictable from interactions between hosts and individual pathogens. This work addresses a key empirical gap in understanding the impact of multiple generalist pathogens on competing host species, with potential implications for population and community dynamics of native and exotic species. It also demonstrates how pathogens with relatively mild impacts independently can more substantially reduce host performance in coinfection.	[Mordecai, Erin A.; Hindenlang, Madeleine; Mitchell, Charles E.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill	Mordecai, EA (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	emordeca@stanford.edu	Mitchell, Charles E/I-3709-2014	Mitchell, Charles E/0000-0002-1633-1993; Mordecai, Erin/0000-0002-4402-5547	National Science Foundation Postdoctoral Research Fellowship in Biology [DBI-1202892]; NSF/NIH joint program in the Ecology and Evolution of Infectious Diseases [DEB-1015909]; Direct For Biological Sciences [1015909] Funding Source: National Science Foundation; Division Of Environmental Biology [1015825] Funding Source: National Science Foundation	National Science Foundation Postdoctoral Research Fellowship in Biology; NSF/NIH joint program in the Ecology and Evolution of Infectious Diseases; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	E.A.M. was supported by a National Science Foundation Postdoctoral Research Fellowship in Biology (DBI-1202892; nsf.gov) and C.E.M. was supported by the NSF/NIH joint program in the Ecology and Evolution of Infectious Diseases (DEB-1015909; nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAPOLA AIE, 1971, VIROLOGY, V46, P127, DOI 10.1016/0042-6822(71)90012-2; ANAGNOSTAKIS SL, 1987, MYCOLOGIA, V79, P23, DOI 10.2307/3807741; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Borer ET, 2007, P NATL ACAD SCI USA, V104, P5473, DOI 10.1073/pnas.0608573104; Comas J, 1995, J PHYTOPATHOL, V143, P609, DOI 10.1111/j.1439-0434.1995.tb00209.x; Comita LS, 2014, J ECOL, V102, P845, DOI 10.1111/1365-2745.12232; Copeland R, 1998, METH MOL B, V81, P455; Cronin JP, 2014, AM NAT, V184, P172, DOI 10.1086/676854; Cronin JP, 2010, ECOL LETT, V13, P1221, DOI 10.1111/j.1461-0248.2010.01513.x; DINOOR A, 1984, ANNU REV PHYTOPATHOL, V22, P443; Esch GW, 2001, PARASITOLOGY, V123, pS57, DOI 10.1017/S0031182001007697; Ezenwa VO, 2011, INTEGR COMP BIOL, V51, P540, DOI 10.1093/icb/icr058; Fitt BDL, 2006, ANNU REV PHYTOPATHOL, V44, P163, DOI 10.1146/annurev.phyto.44.070505.143417; Gilbert GS, 2002, ANNU REV PHYTOPATHOL, V40, P13, DOI 10.1146/annurev.phyto.40.021202.110417; Graham AL, 2005, J INFECT DIS, V191, P410, DOI 10.1086/426871; Graham AL, 2008, P NATL ACAD SCI USA, V105, P566, DOI 10.1073/pnas.0707221105; Graham AL, 2007, TRENDS PARASITOL, V23, P284, DOI 10.1016/j.pt.2007.04.005; Gray S, 2003, ANNU REV PHYTOPATHOL, V41, P539, DOI 10.1146/annurev.phyto.41.012203.105815; Gray SM, 1995, APHID TRANSMISSION B, P259; Hersh MH, 2012, ECOLOGY, V93, P511, DOI 10.1890/11-0598.1; JAROSZ AM, 1995, NEW PHYTOL, V129, P371, DOI 10.1111/j.1469-8137.1995.tb04308.x; Johnson PTJ, 2012, P NATL ACAD SCI USA, V109, P9006, DOI 10.1073/pnas.1201790109; Johnson PTJ, 2011, ECOLOGY, V92, P535, DOI 10.1890/10-0570.1; Lacroix C, 2014, NEW PHYTOL, V204, P424, DOI 10.1111/nph.12909; Malmstrom CM, 2005, NEW PHYTOL, V168, P217, DOI 10.1111/j.1469-8137.2005.01479.x; Meentemeyer R, 2004, FOREST ECOL MANAG, V200, P195, DOI 10.1016/j.foreco.2004.06.021; Miller WA, 1997, ANNU REV PHYTOPATHOL, V35, P167, DOI 10.1146/annurev.phyto.35.1.167; Mordecai EA, 2011, ECOL MONOGR, V81, P429, DOI 10.1890/10-2241.1; Newman CM, 2011, VECTOR-BORNE ZOONOT, V11, P1099, DOI 10.1089/vbz.2010.0144; R Core Team, 2021, R LANGUAGE ENV STAT; ROCHOW WF, 1983, PHYTOPATHOLOGY, V73, P919, DOI 10.1094/Phyto-73-919; ROCHOW WF, 1971, VIROLOGY, V46, P117, DOI 10.1016/0042-6822(71)90011-0; Rua MA, 2013, J ECOL, V101, P1007, DOI 10.1111/1365-2745.12106; Rua MA, 2013, NEW PHYTOL, V199, P541, DOI 10.1111/nph.12273; Seabloom EW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055675; Seabloom EW, 2009, AM NAT, V173, pE79, DOI 10.1086/596529; WEN F, 1991, J GEN VIROL, V72, P791, DOI 10.1099/0022-1317-72-4-791	37	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134355	10.1371/journal.pone.0134355	http://dx.doi.org/10.1371/journal.pone.0134355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230720	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400105
J	Morita, H; Arae, K; Unno, H; Toyama, S; Motomura, K; Matsuda, A; Suto, H; Okumura, K; Sudo, K; Takahashi, T; Saito, H; Matsumoto, K; Nakae, S				Morita, Hideaki; Arae, Ken; Unno, Hirotoshi; Toyama, Sumika; Motomura, Kenichiro; Matsuda, Akio; Suto, Hajime; Okumura, Ko; Sudo, Katsuko; Takahashi, Takao; Saito, Hirohisa; Matsumoto, Kenji; Nakae, Susumu			IL-25 and IL-33 Contribute to Development of Eosinophilic Airway Inflammation in Epicutaneously Antigen-Sensitized Mice	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; T(H)2 CYTOKINE PRODUCTION; CELL-DERIVED TNF; CD4(+) T-CELLS; ALLERGIC SENSITIZATION; BARRIER DYSFUNCTION; ATOPIC-DERMATITIS; ASTHMATIC AIRWAYS; EXPRESSION; RESPONSES	Background IL-25, IL-33 and TSLP are produced predominantly by epithelial cells and are known to induce Th2-type cytokines. Th2-type cytokines are involved not only in host defense against nematodes, but also in the development of Th2-type allergic diseases. TSLP was reported to be crucial for development of allergic airway inflammation in mice after inhalation of allergens to which they had been sensitized epicutaneously (EC) beforehand. However, the roles of IL-25 and IL-33 in the setting remain unclear. Methods Mice deficient in IL-25 and IL-33 were sensitized EC with ovalbumin (OVA) and then challenged intranasally with OVA. Airway inflammation, the number of inflammatory cells in bronchoalveolar lavage fluids (BALFs) and airway hyperresponsiveness (AHR) in the mice were determined, respectively, by histological analysis, with a hemocytometer, and by using plethysmograph chambers with a ventilator. Expression of mRNA in the skin and lungs was determined by quantitative PCR, while the BALF levels of myeloperoxidase (MPO) and eosinophil peroxidase (EPO) and the serum levels of IgE were determined by ELISA. Results Normal OVA-specific Th2- and Th17-cell responses of lymph nodes and spleens were observed in IL-25-deficient (IL-25(-/-)) and IL-33(-/-) mice after EC sensitization with OVA. Nevertheless, the number of eosinophils, but not neutrophils, in the BALFs, and the levels of Th2 cytokines, but not Th17 cytokines, in the lungs were significantly decreased in the IL-25(-/-) and IL-33(-/-) mice pre-sensitized EC with OVA, followed by inhalation of OVA, whereas their levels of AHR and OVA-specific serum IgE were normal. Conclusions Both IL-25 and IL-33 are critical for induction of Th2-type cytokine-mediated allergic airway eosinophilia, but not Th17-type cytokine-mediated airway neutrophilia, at the local sites of lungs in the challenge phase of mice sensitized EC with OVA. They do not affect OVA-specific T-cell induction in the sensitization phase.	[Morita, Hideaki; Takahashi, Takao] Keio Univ, Sch Med, Dept Pediat, Tokyo 1608582, Japan; [Morita, Hideaki; Arae, Ken; Unno, Hirotoshi; Toyama, Sumika; Motomura, Kenichiro; Matsuda, Akio; Saito, Hirohisa; Matsumoto, Kenji; Nakae, Susumu] Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Tokyo 1578535, Japan; [Unno, Hirotoshi] Jikei Univ, Dept Pediat, Sch Med, Tokyo 1058461, Japan; [Arae, Ken] Kyorin Univ, Dept Immunol, Fac Hlth Sci, Tokyo 1928508, Japan; [Suto, Hajime; Okumura, Ko; Nakae, Susumu] Juntendo Univ, Atopy Res Ctr, Sch Med, Tokyo 1138412, Japan; [Sudo, Katsuko] Tokyo Med Univ, Anim Res Ctr, Tokyo 1608402, Japan; [Nakae, Susumu] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Syst Biol, Tokyo 1088639, Japan; [Nakae, Susumu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Saitama 3320012, Japan	Keio University; National Center for Child Health & Development - Japan; Jikei University; Kyorin University; Juntendo University; Tokyo Medical University; University of Tokyo; Japan Science & Technology Agency (JST)	Nakae, S (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Tokyo 1578535, Japan.	snakae@ims.u-tokyo.ac.jp	Morita, Hideaki/ADL-2008-2022; Morita, Hideaki/S-2214-2016	Morita, Hideaki/0000-0003-0928-8322; Saito, Hirohisa/0000-0002-6630-8337	Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST); Program for Improvement of Research Environment for Young Researchers, The Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Health Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan; Banyu Life Science Foundation International; Grants-in-Aid for Scientific Research [15H04866] Funding Source: KAKEN	Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Program for Improvement of Research Environment for Young Researchers, The Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Health Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Banyu Life Science Foundation International(Banyu Life Science Foundation International); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Young Scientists (B) (H.M. and K.A.), a Grant-in-Aid for Scientific Research (B) (H. Saito and K. Matsumoto), Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST) (S.N.) and the Program for Improvement of Research Environment for Young Researchers, The Special Coordination Funds for Promoting Science and Technology (S.N.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, a Health Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan (H. Saito, S.N. and K. Matsumoto), and a grant from Banyu Life Science Foundation International (H.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Chu DK, 2013, J ALLERGY CLIN IMMUN, V131, P187, DOI 10.1016/j.jaci.2012.08.002; Corrigan CJ, 2011, J ALLERGY CLIN IMMUN, V128, P116, DOI 10.1016/j.jaci.2011.03.043; Demehri S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000067; He R, 2007, P NATL ACAD SCI USA, V104, P15817, DOI 10.1073/pnas.0706942104; Hvid M, 2011, J INVEST DERMATOL, V131, P150, DOI 10.1038/jid.2010.277; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Ishii Akina, 2010, Allergology International, V59, P399, DOI 10.2332/allergolint.10-OA-0218; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Kips JC, 2003, EUR RESPIR J, V22, P374, DOI 10.1183/09031936.03.00026403; Kodama M, 2010, INT ARCH ALLERGY IMM, V152, P67, DOI 10.1159/000312128; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Kubo A, 2012, J CLIN INVEST, V122, P440, DOI 10.1172/JCI57416; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Lambrecht BN, 2014, J ALLERGY CLIN IMMUN, V134, P499, DOI 10.1016/j.jaci.2014.06.036; Larson RP, 2010, J IMMUNOL, V184, P2974, DOI 10.4049/jimmunol.0803478; Louten J, 2011, INT IMMUNOL, V23, P307, DOI 10.1093/intimm/dxr006; Luzina IG, 2012, J IMMUNOL, V189, P403, DOI 10.4049/jimmunol.1200259; Morita H, 2012, ALLERGOL INT, V61, P265, DOI 10.2332/allergolint.11-OA-0379; Nakae S, 2007, J ALLERGY CLIN IMMUN, V120, P48, DOI 10.1016/j.jaci.2007.02.046; Nakae S, 2007, BLOOD, V109, P3640, DOI 10.1182/blood-2006-09-046128; Nakae S, 2007, J ALLERGY CLIN IMMUN, V119, P680, DOI 10.1016/j.jaci.2006.11.701; Nakajima S, 2012, J ALLERGY CLIN IMMUN, V129, P1048, DOI 10.1016/j.jaci.2012.01.063; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Oboki Keisuke, 2010, Allergology International, V59, P143, DOI 10.2332/allergolint.10-RAI-0186; Ohno T, 2012, ALLERGY, V67, P1203, DOI 10.1111/all.12004; Omori M, 2007, J IMMUNOL, V178, P1396, DOI 10.4049/jimmunol.178.3.1396; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Rochman I, 2007, J IMMUNOL, V178, P6720, DOI 10.4049/jimmunol.178.11.6720; Savinko T, 2012, J INVEST DERMATOL, V132, P1392, DOI 10.1038/jid.2011.446; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Suzukawa M, 2012, J IMMUNOL, V189, P3641, DOI 10.4049/jimmunol.1200461; Suzuki Yusuke, 2011, Allergology International, V60, P11, DOI 10.2332/allergolint.10-RAI-0281; Talabot-Ayer D, 2014, CYTOKINE, V69, P68, DOI 10.1016/j.cyto.2014.05.007; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Ziegler SF, 2012, J ALLERGY CLIN IMMUN, V130, P845, DOI 10.1016/j.jaci.2012.07.010	40	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134226	10.1371/journal.pone.0134226	http://dx.doi.org/10.1371/journal.pone.0134226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230091	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400087
J	Nurwulan, NR; Jiang, BC; Iridiastadi, H				Nurwulan, Nurul Retno; Jiang, Bernard C.; Iridiastadi, Hardianto			Posture and Texting: Effect on Balance in Young Adults	PLOS ONE			English	Article							MULTIVARIATE MULTISCALE ENTROPY; ATTENTIONAL DEMANDS; PRESSURE SIGNALS; DISTRACTION; PHONE	Using a mobile phone while doing another activity is a common dual-task activity in our daily lives. This study examined the effect of texting on the postural stability of young adults. Twenty college students were asked to perform static and dynamic postural stability tasks. Traditional COP and multivariate multiscale entropy (MMSE) were used to assess the static postural stability and the Star Excursion Balance Test (SEBT) was used to assess the dynamic postural stability. Results showed that (1) texting impaired postural stability, (2) the complexity index did not change much although the task conditions changed, and (3) performing texting is perceived to be more difficult.	[Nurwulan, Nurul Retno; Jiang, Bernard C.] Natl Taiwan Univ & Sci & Technol, Sch Management, Dept Ind Management, Taipei, Taiwan; [Iridiastadi, Hardianto] Inst Teknol Bandung, Fac Ind Technol, Dept Ind Engn, Bandung, Indonesia	National Taiwan University of Science & Technology; Institute Technology of Bandung	Nurwulan, NR (corresponding author), Natl Taiwan Univ & Sci & Technol, Sch Management, Dept Ind Management, Taipei, Taiwan.	nurul.retno@gmail.com	Nurwulan, Nurul Retno/AAE-5713-2020; Nussbaum, Maury A/A-9655-2008	Nurwulan, Nurul Retno/0000-0002-6308-6249; Nussbaum, Maury A/0000-0002-1887-8431	National Science Council (NSC) of Taiwan [NSC 102-2221-E-155-026-MY3]	National Science Council (NSC) of Taiwan(Ministry of Science and Technology, Taiwan)	This study was financially supported by the National Science Council (NSC) of Taiwan (NSC 102-2221-E-155-026-MY3).	Ahmed MU, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061918; [Anonymous], 2011, MATLAB VERS 7 13 0 5; Bungum TJ, 2005, J COMMUN HEALTH, V30, P269, DOI 10.1007/s10900-005-3705-4; Costa M, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/68008; Costa M, 2003, PHYSICA A, V330, P53, DOI 10.1016/j.physa.2003.08.022; Costa M, 2005, PHYS REV LETT, V89; Forgays DK, 2014, COMPUT HUM BEHAV, V31, P314, DOI 10.1016/j.chb.2013.10.053; Gonzales AL, 2014, COMPUT HUM BEHAV, V39, P197, DOI 10.1016/j.chb.2014.07.026; GRANAT MH, 1990, MED BIOL ENG COMPUT, V28, P601, DOI 10.1007/BF02442615; Gribble, 2003, MEAS PHYS ED EXERC S, V7, P89, DOI [10.1207/S15327841MPEE0702_3, DOI 10.1207/S15327841MPEE0702_3]; Gribble PA, 2012, J ATHL TRAINING, V47, P339, DOI 10.4085/1062-6050-47.3.08; Hasan S. S., 1996, GAIT POSTURE, V4, P1; Huang CW, 2013, SENSORS-BASEL, V13, P10151, DOI 10.3390/s130810151; HUFSCHMIDT A, 1980, ARCH PSYCHIAT NERVEN, V228, P135, DOI 10.1007/BF00365601; Jiang BC, 2013, THEOR ISS ERGON SCI, V14, P227, DOI 10.1080/1463922X.2011.617109; Lamberg EM, 2012, GAIT POSTURE, V35, P688, DOI 10.1016/j.gaitpost.2011.12.005; Mackworth NH, 1948, Q J EXP PSYCHOL, V1, P6, DOI 10.1080/17470214808416738; Nasar J, 2008, ACCIDENT ANAL PREV, V40, P69, DOI 10.1016/j.aap.2007.04.005; Neider MB, 2010, ACCIDENT ANAL PREV, V42, P589, DOI 10.1016/j.aap.2009.10.004; Parasuraman R, 1977, VIGILANCE THEORY OPE; Pellecchia GL, 2003, GAIT POSTURE, V18, P29, DOI 10.1016/S0966-6362(02)00138-8; Schabrun SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084312; Schwebel DC, 2012, ACCIDENT ANAL PREV, V45, P266, DOI 10.1016/j.aap.2011.07.011; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; Skierkowski D, 2012, COMPUT HUM BEHAV, V28, P744, DOI 10.1016/j.chb.2011.11.023; Stavrinos D, 2011, J SAFETY RES, V42, P101, DOI 10.1016/j.jsr.2011.01.004; Teasdale N, 2001, GAIT POSTURE, V14, P203, DOI 10.1016/S0966-6362(01)00134-5; Wei Q, 2012, ENTROPY-SWITZ, V14, P2157, DOI 10.3390/e14112157; Yang WH, 2010, THESIS YUAN ZE U CHU	29	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134230	10.1371/journal.pone.0134230	http://dx.doi.org/10.1371/journal.pone.0134230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230323	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400089
J	Yamaguchi, M; Okamoto, K; Kusano, T; Matsuda, Y; Suzuki, G; Fuse, A; Yokota, H				Yamaguchi, Masahiro; Okamoto, Ken; Kusano, Teruo; Matsuda, Yoko; Suzuki, Go; Fuse, Akira; Yokota, Hiroyuki			The Effects of Xanthine Oxidoreductase Inhibitors on Oxidative Stress Markers following Global Brain Ischemia Reperfusion Injury in C57BL/6 Mice	PLOS ONE			English	Article							NF-KAPPA-B; FOCAL CEREBRAL-ISCHEMIA; OXIDASE INHIBITOR; FREE-RADICALS; MOUSE MODEL; ALLOPURINOL; FEBUXOSTAT; EXPRESSION; OXYPURINOL; SCAVENGER	We demonstrated that 3-nitrotyrosine and 4-hydroxy-2-nonenal levels in mouse brain were elevated from 1 h until 8 h after global brain ischemia for 14 min induced with the 3-vessel occlusion model; this result indicates that ischemia reperfusion injury generated oxidative stress. Reactive oxygen species production was observed not only in the hippocampal region, but also in the cortical region. We further evaluated the neuroprotective effect of xanthine oxidoreductase inhibitors in the mouse 3-vessel occlusion model by analyzing changes in the expression of genes regulated by the transcription factor nuclear factor-kappa B (including pro-inflammatory cytokines interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha), matrix metalloproteinase-9 and intercellular adhesion molecules-1). Administration of allopurinol resulted in a statistically significant decrease in IL-1 beta and TNF-alpha mRNA expression, whereas febuxostat had no significant effect on expression of these genes; nevertheless, both inhibitors effectively reduced serum uric acid concentration. It is suggested that the neuroprotective effect of allopurinol is derived not from inhibition of reactive oxygen species production by xanthine oxidoreductase, but rather from a direct free-radical-scavenging effect.	[Yamaguchi, Masahiro; Suzuki, Go; Fuse, Akira; Yokota, Hiroyuki] Nippon Med Sch, Emergency & Crit Care Med, Tokyo 113, Japan; [Okamoto, Ken; Kusano, Teruo] Nippon Med Sch, Biochem & Mol Biol, Tokyo 113, Japan; [Matsuda, Yoko] Tokyo Metropolitan Geriatr Hosp, Tokyo 173, Japan; [Matsuda, Yoko] Inst Gerontol, Dept Pathol, Tokyo, Japan	Nippon Medical School; Nippon Medical School; Tokyo Metropolitan Institute of Gerontology	Okamoto, K (corresponding author), Nippon Med Sch, Biochem & Mol Biol, 1-1-5 Sendagi, Tokyo 113, Japan.	okamoto@nms.ac.jp	Okamoto, Ken/AAC-8604-2020		JSPS KAKENHI Grant [24590393, 15H04702, 23570198]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 24590393, 15H04702 and 23570198. KO received these grants.	Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Arai T, 1998, LIFE SCI, V63, pPL107, DOI 10.1016/S0024-3205(98)00312-9; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Belboul A, 2001, PERFUSION-UK, V16, P59, DOI 10.1177/026765910101600109; BETZ AL, 1991, AM J PHYSIOL, V260, pH563, DOI 10.1152/ajpheart.1991.260.2.H563; Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Cuzzocrea S, 2000, BRAIN RES, V875, P96, DOI 10.1016/S0006-8993(00)02582-8; DAS DK, 1987, BIOCHEM BIOPH RES CO, V148, P314, DOI 10.1016/0006-291X(87)91112-0; ELION GB, 1966, BIOCHEM PHARMACOL, V15, P863, DOI 10.1016/0006-2952(66)90163-8; George Jacob, 2009, Ther Clin Risk Manag, V5, P799; Guan T, 2013, EUR J PHARMACOL, V714, P303, DOI 10.1016/j.ejphar.2013.07.036; Hashiguchi A, 2003, NEUROSCIENCE, V121, P379, DOI 10.1016/S0306-4522(03)00490-1; HOPSON SB, 1995, J NATL MED ASSOC, V87, P480; Ives A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7555; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kristian T, 2013, TRANSL STROKE RES, V4, P343, DOI 10.1007/s12975-012-0236-z; Kushiyama A, 2012, ARTERIOSCL THROM VAS, V32, P291, DOI 10.1161/ATVBAHA.111.234559; Linder N, 1999, LAB INVEST, V79, P967; LINDSAY S, 1991, AM J PHYSIOL, V261, pH2051, DOI 10.1152/ajpheart.1991.261.6.H2051; MALKIEL S, 1993, FREE RADICAL RES COM, V18, P7, DOI 10.3109/10715769309149909; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Mohiuddin I, 2006, J SURG RES, V133, P143, DOI 10.1016/j.jss.2005.10.008; MOORHOUSE PC, 1987, FEBS LETT, V213, P23, DOI 10.1016/0014-5793(87)81458-8; Nishino T, 1997, BIOCHEM SOC T, V25, P783, DOI 10.1042/bst0250783; Niwa M, 2001, NEUROL MED-CHIR, V41, P63, DOI 10.2176/nmc.41.63; Nomura J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04554; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Okamoto K, 2003, J BIOL CHEM, V278, P1848, DOI 10.1074/jbc.M208307200; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; PARKS DA, 1986, ACTA PHYSIOL SCAND, V126, P87; Saban-Ruiz Jose, 2013, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V12, P94; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Soletsky B, 2012, HYPERTENSION, V60, P1148, DOI 10.1161/HYPERTENSIONAHA.112.196980; Suzuki G, 2015, NEUROL MED-CHIR, V55, P77, DOI 10.2176/nmc.oa.2013-0307; Yabuki Y, 2013, NEUROSCIENCE, V250, P394, DOI 10.1016/j.neuroscience.2013.07.017; Yonekura I, 2004, J CEREBR BLOOD F MET, V24, P151, DOI 10.1097/01.WCB.0000096063.84070.C1; Zhu DY, 2002, LIFE SCI, V71, P1985, DOI 10.1016/S0024-3205(02)01970-7	38	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133980	10.1371/journal.pone.0133980	http://dx.doi.org/10.1371/journal.pone.0133980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230326	Green Submitted, gold, Green Published			2022-12-27	WOS:000358838400067
J	Zandkarimi, H; Ebadi, A; Salami, SA; Alizade, H; Baisakh, N				Zandkarimi, Hana; Ebadi, Ali; Salami, Seyed Alireza; Alizade, Houshang; Baisakh, Niranjan			Analyzing the Expression Profile of AREB/ABF and DREB/CBF Genes under Drought and Salinity Stresses in Grape (Vitis vinifera L.)	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATORY NETWORKS; SIGNAL-TRANSDUCTION PATHWAY; ABSCISIC-ACID; LOW-TEMPERATURE; MOLECULAR RESPONSES; SALT STRESS; TOLERANCE; COLD; DEHYDRATION; ARABIDOPSIS	Expression patterns of four candidate AREB/ABF genes and four DREB/CBF genes were evaluated in leaf and root tissues of five grape varieties ('Qalati', 'Kaj Angoor', 'Sabz Angoor', 'Siahe Zarghan', 'Bidane Safid') with differential response to drought stress. Among the AREB/ABF genes, AREB1 and ABF2 showed up-regulation in response to drought stress in leaf and root tissues of all varieties while AREB2 and ABF1 showed down-regulation in both leaf and root tissues of the sensitive variety 'Bidane Sefid' in response to drought and salt stress. Among the DREB/CBF genes, CBF4 was the most responsive to drought stress in both leaf and root tissues. CBF2 and CBF3 showed up-regulation in all varieties in response to drought stress in leaf except in 'Bidane Sefid'. Under salinity stress, AREB2 and ABF2 showed up-regulation in response to the increasing level of salinity in the leaf tissues but in the root tissues ABF2 was up-regulated in response to increasing NaCl concentration while AREB2 was down-regulated. Therefore, it seems AREB2 has tissue-specific response to salinity stress. All CBF genes were up-regulated in response to salinity stress in the leaf and root tissues. Expression data suggested that CBF2 is more responsive to NaCl stress. Among all four promising and stress tolerant varieties 'Siah Zarghan' and 'Kaj Angoor' were more tolerant than 'Qalati' and 'Sabz Angoor' to drought and salinity.	[Zandkarimi, Hana; Ebadi, Ali; Salami, Seyed Alireza; Alizade, Houshang] Univ Tehran, Dept Hort, Fac Agr, Karaj 31587, Iran; [Zandkarimi, Hana; Baisakh, Niranjan] Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA	University of Tehran; Louisiana State University System; Louisiana State University	Ebadi, A (corresponding author), Univ Tehran, Dept Hort, Fac Agr, Karaj 31587, Iran.	aebadi@ut.ac.ir; nbaisakh@agcenter.lsu.edu						Baisakh N, 2008, FUNCT INTEGR GENOMIC, V8, P287, DOI 10.1007/s10142-008-0075-x; Bartels D, 2003, TOP CURR GENET, V4, P9; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bhargava S, 2013, PLANT BREEDING, V132, P21, DOI 10.1111/pbr.12004; Boneh U, 2012, PLANT SCI, V187, P89, DOI 10.1016/j.plantsci.2012.01.015; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Ghaderi N, 2011, J AGR SCI TECH-IRAN, V13, P601; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Haddadinejad M, 2012, IRANIAN JOURNAL OF H, V44, P193; Hong JP, 2005, PLANTA, V220, P875, DOI 10.1007/s00425-004-1412-5; Hossain MA, 2010, J PLANT PHYSIOL, V167, P1512, DOI 10.1016/j.jplph.2010.05.008; Huang XS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-230; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Kang JY, 2002, PLANT CELL, V14, P343, DOI 10.1105/tpc.010362; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kidokoro S, 2015, PLANT J, V81, P505, DOI 10.1111/tpj.12746; Kim S, 2004, PLANT J, V40, P75, DOI 10.1111/j.1365-313X.2004.02192.x; Knight H, 2004, PLANT PHYSIOL, V135, P1710, DOI 10.1104/pp.104.043562; Knight H, 1998, PLANT J, V16, P681, DOI 10.1046/j.1365-313x.1998.00332.x; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Li DF, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-109; Li XY, 2013, INT J MOL SCI, V14, P12827, DOI 10.3390/ijms140612827; Lindemose S, 2013, INT J MOL SCI, V14, P5842, DOI 10.3390/ijms14035842; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; McGovern PE, 2007, ANCIENT WINE THE SEA; Medina J, 1999, PLANT PHYSIOL, V119, P463, DOI 10.1104/pp.119.2.463; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Nakashima K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00170; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Shinozaki K, 1996, CURR OPIN BIOTECH, V7, P161, DOI 10.1016/S0958-1669(96)80007-3; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Skinner JS, 2005, PLANT MOL BIOL, V59, P533, DOI 10.1007/s11103-005-2498-2; Thomashow MF, 1998, PLANT PHYSIOL, V118, P1, DOI 10.1104/pp.118.1.1; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Vanjildorj E, 2005, PLANT CELL TISS ORG, V83, P41, DOI 10.1007/s11240-005-3800-3; Vanjildorj E, 2006, PLANT CELL TISS ORG, V87, P109, DOI 10.1007/s11240-006-9143-x; Xiao H, 2008, PLANT CELL ENVIRON, V31, P1, DOI 10.1111/j.1365-3040.2007.01741.x; Xiao H, 2006, PLANT CELL ENVIRON, V29, P1410, DOI 10.1111/j.1365-3040.2006.01524.x; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhao T, 2014, MOL BIOL REP, V41, P1577, DOI 10.1007/s11033-013-3004-6; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	55	41	49	8	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134288	10.1371/journal.pone.0134288	http://dx.doi.org/10.1371/journal.pone.0134288			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230273	Green Submitted, gold, Green Published			2022-12-27	WOS:000358838400099
J	Ohsawa, Y; Takayama, K; Nishimatsu, S; Okada, T; Fujino, M; Fukai, Y; Murakami, T; Hagiwara, H; Itoh, F; Tsuchida, K; Hayashi, Y; Sunada, Y				Ohsawa, Yutaka; Takayama, Kentaro; Nishimatsu, Shin-ichiro; Okada, Tadashi; Fujino, Masahiro; Fukai, Yuta; Murakami, Tatsufumi; Hagiwara, Hiroki; Itoh, Fumiko; Tsuchida, Kunihiro; Hayashi, Yoshio; Sunada, Yoshihide			The Inhibitory Core of the Myostatin Prodomain: Its Interaction with Both Type I and II Membrane Receptors, and Potential to Treat Muscle Atrophy	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ACTIVIN; IDENTIFICATION; GENE; MICE; RECOGNITION; EXPRESSION; PROPEPTIDE; REVEALS; GDF-8	Myostatin, a muscle-specific transforming growth factor-beta (TGF-beta), negatively regulates skeletal muscle mass. The N-terminal prodomain of myostatin noncovalently binds to and suppresses the C-terminal mature domain (ligand) as an inactive circulating complex. However, which region of the myostatin prodomain is required to inhibit the biological activity of myostatin has remained unknown. We identified a 29-amino acid region that inhibited myostatin-induced transcriptional activity by 79% compared with the full-length prodomain. This inhibitory core resides near the N-terminus of the prodomain and includes an a-helix that is evolutionarily conserved among other TGF-beta family members, but suppresses activation of myostatin and growth and differentiation factor 11 (GDF11) that share identical membrane receptors. Interestingly, the inhibitory core co-localized and co-immunoprecipitated with not only the ligand, but also its type I and type II membrane receptors. Deletion of the inhibitory core in the full-length prodomain removed all capacity for suppression of myostatin. A synthetic peptide corresponding to the inhibitory core (p29) ameliorates impaired myoblast differentiation induced by myostatin and GDF11, but not activin or TGF-beta 1. Moreover, intramuscular injection of p29 alleviated muscle atrophy and decreased the absolute force in caveolin 3-deficient limb-girdle muscular dystrophy 1C model mice. The injection suppressed activation of myostatin signaling and restored the decreased numbers of muscle precursor cells caused by caveolin 3 deficiency. Our findings indicate a novel concept for this newly identified inhibitory core of the prodomain of myostatin: that it not only suppresses the ligand, but also prevents two distinct membrane receptors from binding to the ligand. This study provides a strong rationale for the use of p29 in the amelioration of skeletal muscle atrophy in various clinical settings.	[Ohsawa, Yutaka; Okada, Tadashi; Fujino, Masahiro; Fukai, Yuta; Murakami, Tatsufumi; Sunada, Yoshihide] Kawasaki Med Sch, Dept Neurol, Kurashiki, Okayama 7010192, Japan; [Takayama, Kentaro; Hayashi, Yoshio] Tokyo Univ Pharm & Life Sci, Dept Med Chem, Hachioji, Tokyo 1920392, Japan; [Nishimatsu, Shin-ichiro] Kawasaki Med Sch, Dept Mol & Dev Biol, Kurashiki, Okayama 7010192, Japan; [Okada, Tadashi] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan; [Fujino, Masahiro] Kawasaki Univ Med Welf, Fac Med Profess, Dept Hlth & Sports Sci, Kurashiki, Okayama 7010193, Japan; [Hagiwara, Hiroki] Teikyo Univ Sci, Dept Med Sci, Uenohara, Yamanashi 4090193, Japan; [Itoh, Fumiko] Tokyo Univ Pharm & Life Sci, Lab Cardiovasc Med, Hachioji, Tokyo 1920392, Japan; [Tsuchida, Kunihiro] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Therapies Intractable Dis, Toyoake, Aichi 4701192, Japan	Kawasaki Medical School; Tokyo University of Pharmacy & Life Sciences; Kawasaki Medical School; Obihiro University of Agriculture & Veterinary Medicine; Tokyo University of Pharmacy & Life Sciences; Fujita Health University	Ohsawa, Y (corresponding author), Kawasaki Med Sch, Dept Neurol, Kurashiki, Okayama 7010192, Japan.	yosawa@med.kawasaki-m.ac.jp; ysunada@med.kawasaki-m.ac.jp	Tsuchida, Kunihiro/A-4501-2012	Tsuchida, Kunihiro/0000-0002-3983-5756; Murakami, Tatsufumi/0000-0001-7851-6822; Itoh, Fumiko/0000-0002-6134-5331	Intramural Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry [20B-13, 23-5, 26-8]; Ministry of Health, Labour, and Welfare of Japan [H20-018]; Japan Society for the Promotion of Science [C-20591013, C-21591101, C-23591261, C-24590363, C-24591281, C-26461285]; Adaptable and Seamless Technology Transfer Program Through Target-Driven R&D from the Japan Society and Technology Agency [AS2421276Q]; Kawasaki Medical School [23-T1, 26-T1]	Intramural Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry; Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Adaptable and Seamless Technology Transfer Program Through Target-Driven R&D from the Japan Society and Technology Agency; Kawasaki Medical School	This work was supported by research grants for Intramural Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry (20B-13, 23-5, 26-8); by grants for Comprehensive Research on Disability, Health, and Welfare from the Ministry of Health, Labour, and Welfare of Japan (H20-018); by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (C-20591013, C-21591101, C-23591261, C-24590363, C-24591281, C-26461285); by the Adaptable and Seamless Technology Transfer Program Through Target-Driven R&D from the Japan Society and Technology Agency (AS2421276Q); and by research project grants from Kawasaki Medical School (23-T1, 26-T1). The sponsors played no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Andersson O, 2006, EMBO REP, V7, P831, DOI 10.1038/sj.embor.7400752; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Cerletti M, 2008, COLD SH Q B, V73, P317, DOI 10.1101/sqb.2008.73.054; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Jiang MS, 2004, BIOCHEM BIOPH RES CO, V315, P525, DOI 10.1016/j.bbrc.2004.01.085; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kotzsch A, 2009, EMBO J, V28, P937, DOI 10.1038/emboj.2009.37; Lach-Trifilieff E, 2014, MOL CELL BIOL, V34, P606, DOI 10.1128/MCB.01307-13; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Moustakas A, 2001, J CELL SCI, V114, P4359; Nickel J, 2005, J MOL BIOL, V349, P933, DOI 10.1016/j.jmb.2005.04.015; Oh SP, 2002, GENE DEV, V16, P2749, DOI 10.1101/gad.1021802; Ohsawa Y, 2006, J CLIN INVEST, V116, P2924, DOI 10.1172/JCI28520; Ohsawa Y, 2012, LAB INVEST, V92, P1100, DOI 10.1038/labinvest.2012.78; Partridge T A, 1997, Methods Mol Biol, V75, P131; Radaev S, 2010, J BIOL CHEM, V285, P14806, DOI 10.1074/jbc.M109.079921; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Sunada Y, 2001, HUM MOL GENET, V10, P173, DOI 10.1093/hmg/10.3.173; Takayama K, 2015, J MED CHEM, V58, P1544, DOI 10.1021/jm501170d; Thies RS, 2001, GROWTH FACTORS, V18, P251; Volonte D, 2004, FASEB J, V18, P237, DOI 10.1096/fj.04-2215fje; Walton KL, 2010, J BIOL CHEM, V285, P17029, DOI 10.1074/jbc.M110.110288; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100	33	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133713	10.1371/journal.pone.0133713	http://dx.doi.org/10.1371/journal.pone.0133713			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226340	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700035
J	Vellakkal, S; Patel, V				Vellakkal, Sukumar; Patel, Vikram			Designing Psychological Treatments for Scalability: The PREMIUM Approach	PLOS ONE			English	Article							PRIMARY-CARE; INTERVENTIONS; DEPRESSION; COUNTRIES; PSYCHOTHERAPY; METAANALYSIS; DISORDERS; DRINKING; HARMFUL; ANXIETY	Introduction Lack of access to empirically-supported psychological treatments (EPT) that are contextually appropriate and feasible to deliver by non-specialist health workers (referred to as 'counsellors') are major barrier for the treatment of mental health problems in resource poor countries. To address this barrier, the 'Program for Effective Mental Health Interventions in Under-resourced Health Systems' (PREMIUM) designed a method for the development of EPT for severe depression and harmful drinking. This was implemented over three years in India. This study assessed the relative usefulness and costs of the five 'steps' (Systematic reviews, In-depth interviews, Key informant surveys, Workshops with international experts, and Workshops with local experts) in the first phase of identifying the strategies and theoretical model of the treatment and two 'steps' (Case series with specialists, and Case series and pilot trial with counsellors) in the second phase of enhancing the acceptability and feasibility of its delivery by counsellors in PREMIUM with the aim of arriving at a parsimonious set of steps for future investigators to use for developing scalable EPT. Data and Methods The study used two sources of data: the usefulness ratings by the investigators and the resource utilization. The usefulness of each of the seven steps was assessed through the ratings by the investigators involved in the development of each of the two EPT, viz. Healthy Activity Program for severe depression and Counselling for Alcohol Problems for harmful drinking. Quantitative responses were elicited to rate the utility (usefulness/influence), followed by open-ended questions for explaining the rankings. The resources used by PREMIUM were computed in terms of time (months) and monetary costs. Results The theoretical core of the new treatments were consistent with those of EPT derived from global evidence, viz. Behavioural Activation and Motivational Enhancement for severe depression and harmful drinking respectively, indicating the universal applicability of these theories. All the steps of both phases in PREMIUM contributed to the development of the final EPT. However, if there were significant resource constraints, the steps can be limited to workshops with international and local experts in the first phase, and case series with specialists, and case series and pilot trial with counsellors in the second phase. Conclusions Integrating global evidence with local knowledge and practices are complementary and feasible goals to contribute to the development of contextually appropriate and feasible EPT in resource poor country settings. The emerging EPT share similar theoretical frameworks to those described in the global evidence. The PREMIUM method has relevance for any setting where populations have poor access to EPT as its explicit goal is to develop scalable treatments.	[Vellakkal, Sukumar; Patel, Vikram] Publ Hlth Fdn India, Ctr Control Chron Condit, New Delhi, India; [Patel, Vikram] London Sch Hyg & Trop Med, Ctr Global Mental Hlth, London WC1, England; [Patel, Vikram] Sangath, Bardez, Goa, India	Public Health Foundation of India; University of London; London School of Hygiene & Tropical Medicine	Patel, V (corresponding author), Publ Hlth Fdn India, Ctr Control Chron Condit, New Delhi, India.	vikram.patel@lshtm.ac.uk	Vellakkal, Sukumar/AAD-4893-2020	Vellakkal, Sukumar/0000-0002-0594-1454; Vellakkal, Sukumar/0000-0003-2635-1944	Wellcome Trust [091834/Z/10/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by Wellcome Trust through a Senior Research Fellowship to Vikram Patel (grant 091834/Z/10/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chowdhary N, 2014, PSYCHOL MED, V44, P1131, DOI 10.1017/S0033291713001785; Chowdhary N, 2014, BRIT J PSYC IN PRESS; Chowdhary N, 2014, BEST PRACT RES CL OB, V28, P113, DOI 10.1016/j.bpobgyn.2013.08.013; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Cuijpers P, 2013, WORLD PSYCHIATRY, V12, P137, DOI 10.1002/wps.20038; Cuijpers P, 2008, J CONSULT CLIN PSYCH, V76, P909, DOI 10.1037/a0013075; Government of India, 2014, WHOL PRIC IND DAT; Jordans MJD, 2011, SOC SCI MED, V73, P456, DOI 10.1016/j.socscimed.2011.06.004; Knapp M, 2006, HEALTH POLICY PLANN, V21, P157, DOI 10.1093/heapol/czl003; Kohn R, 2004, B WORLD HEALTH ORGAN, V82, P858; Nadkarni A, 2015, ALCOHOL CLIN EXP RES, V39, P522, DOI 10.1111/acer.12653; Patel V, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-101; Patel V, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001448; Patel V, 2011, BEHAV RES THER, V49, P523, DOI 10.1016/j.brat.2011.06.012; Strauss A., 1998, BASICS QUALITATIVE R; van Ginneken N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009149.pub2; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; World Health Organisation, 2010, MHGAP INT GUID MENT; World Health Organization, 2005, MENT HLTH ATL	20	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134189	10.1371/journal.pone.0134189	http://dx.doi.org/10.1371/journal.pone.0134189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JT	26225853	Green Accepted, Green Published, gold			2022-12-27	WOS:000358837700061
J	Abdai, J; Gergely, A; Petro, E; Topal, J; Miklosi, A				Abdai, Judit; Gergely, Anna; Petro, Eszter; Topal, Jozsef; Miklosi, Adam			An Investigation on Social Representations: Inanimate Agent Can Mislead Dogs (Canis familiaris) in a Food Choice Task	PLOS ONE			English	Article							OWNERS	The nature of mental representation of others plays a crucial role in social interactions. Dogs present an ideal model species for the investigation of such mental representations because they develop social ties with both conspecifics and heterospecifics. Former studies found that dogs' preference for larger food quantity could be reversed by humans who indicate the smaller quantity. The question is whether this social bias is restricted to human partners. We suggest that after a short positive social experience, an unfamiliar moving inanimate agent (UMO) can also change dogs' choice between two food quantities. We tested four groups of dogs with different partners: In the (1) Helper UMO and (2) Helper UMO Control groups the partner was an interactive remote control car that helped the dog to obtain an otherwise unreachable food. In the (3) Non-helper UMO and (4) Human partner groups dogs had restricted interaction with the remote control car and the unfamiliar human partners. In the Human partner, Helper UMO and Helper UMO Control groups the partners were able to revert dogs' choice for the small amount by indicating the small one, but the Non-helper UMO was not. We suggest that dogs are able to generalize their wide range of experiences with humans to another type of agent as well, based on the recognition of similarities in simple behavioural patterns.	[Abdai, Judit; Gergely, Anna; Petro, Eszter; Miklosi, Adam] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Gergely, Anna; Topal, Jozsef] Hungarian Acad Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary; [Miklosi, Adam] MTA ELTE Comparat Ethol Res Grp, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; MTA-ELTE Comparative Ethology Research Group	Abdai, J (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.	abdai.judit@gmail.com	Abdai, Judit/S-6287-2019; Miklosi, Adam/N-5147-2017	Abdai, Judit/0000-0003-1219-2858; Miklosi, Adam/0000-0003-4831-8985	Swiss National Science Foundation (SNSF) Sinergia project SWARMIX [CRSI22 133059]; Hungarian Academy of Sciences [MTA 01 031]; Hungarian Scientific Research Fund [OTKA K 112138]	Swiss National Science Foundation (SNSF) Sinergia project SWARMIX(Swiss National Science Foundation (SNSF)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This research was supported by the Swiss National Science Foundation (SNSF) Sinergia project SWARMIX (project number CRSI22 133059), the Hungarian Academy of Sciences (MTA 01 031) and the Hungarian Scientific Research Fund (OTKA K 112138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnetta B., 2000, ANIMAL COGNITION, V3, P107, DOI [10.1007/s100710000070, DOI 10.1007/S100710000070, DOI 10.1177/0963721416667718]; Gergely A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072727; Beran MJ, 2008, ANIM BEHAV, V75, P1793, DOI 10.1016/j.anbehav.2007.10.035; Hegedus D, 2013, BEHAVIOUR, V150, P427, DOI 10.1163/1568539X-00003060; Kubinyi E, 2007, COMP COGN BEHAV REV, V2, P26; Lakatos G, 2009, ANIM COGN, V12, P621, DOI 10.1007/s10071-009-0221-4; Marshall-Pescini S, 2011, ANIM COGN, V14, P137, DOI 10.1007/s10071-010-0340-y; Marshall-Pescini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035437; Miklosi A, 2013, TRENDS COGN SCI, V17, P287, DOI 10.1016/j.tics.2013.04.005; Milgram NW, 1999, LEARN MEMORY, V6, P54; Pfungst O., 1911, CONTRIBUTION EXPT AN, DOI [10.5962/bhl.title.56164, DOI 10.5962/BHL.TITLE.56164]; Prato-Previde E, 2008, ANIM COGN, V11, P167, DOI 10.1007/s10071-007-0102-7; Schmidjell T, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00558; Topal J, 2005, J CULT EVOL PSYCHOL, V3, P223, DOI DOI 10.1556/JCEP.3.2005.3-4.1; Udell MAR, 2010, BIOL REV, V85, P327, DOI 10.1111/j.1469-185X.2009.00104.x	15	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134575	10.1371/journal.pone.0134575	http://dx.doi.org/10.1371/journal.pone.0134575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241747	gold, Green Published, Green Submitted			2022-12-27	WOS:000358942700050
J	Famlia, C; Dennison, SR; Quintas, A; Phoenix, DA				Famlia, Carlos; Dennison, Sarah R.; Quintas, Alexandre; Phoenix, David A.			Prediction of Peptide and Protein Propensity for Amyloid Formation	PLOS ONE			English	Article							SECONDARY-STRUCTURE; SEQUENCE DETERMINANTS; FEATURE-SELECTION; AGGREGATION; SEGMENTS; FIBRILS; REGIONS; SERVER; MODEL	Understanding which peptides and proteins have the potential to undergo amyloid formation and what driving forces are responsible for amyloid-like fiber formation and stabilization remains limited. This is mainly because proteins that can undergo structural changes, which lead to amyloid formation, are quite diverse and share no obvious sequence or structural homology, despite the structural similarity found in the fibrils. To address these issues, a novel approach based on recursive feature selection and feed-forward neural networks was undertaken to identify key features highly correlated with the self-assembly problem. This approach allowed the identification of seven physicochemical and biochemical properties of the amino acids highly associated with the self-assembly of peptides and proteins into amyloid-like fibrils (normalized frequency of beta-sheet, normalized frequency of beta-sheet from LG, weights for beta-sheet at the window position of 1, isoelectric point, atom-based hydrophobic moment, helix termination parameter at position j+1 and Delta G degrees values for peptides extrapolated in 0 M urea). Moreover, these features enabled the development of a new predictor (available at http://cran.r-project.org/web/packages/appnn/index.html) capable of accurately and reliably predicting the amyloidogenic propensity from the polypeptide sequence alone with a prediction accuracy of 84.9 % against an external validation dataset of sequences with experimental in vitro, evidence of amyloid formation.	[Famlia, Carlos] Univ Cent Lancashire, Sch Forens & Invest Sci, Preston PR1 2HE, Lancs, England; [Famlia, Carlos; Quintas, Alexandre] Inst Super Ciencias Saude Egas Moniz, Ctr Invest Interdisciplinar Egas Moniz, P-2829511 Monte De Caparica, Caparica, Portugal; [Dennison, Sarah R.] Univ Cent Lancashire, UCLan Biomed Res Facil, Res & Innovat Off, Preston PR1 2HE, Lancs, England; [Dennison, Sarah R.; Phoenix, David A.] London S Bank Univ, Sch Appl Sci, London SE1 0AA, England	University of Central Lancashire; Instituto Superior de Ciencias da Saude Egas Moniz; University of Central Lancashire; London South Bank University	Phoenix, DA (corresponding author), London S Bank Univ, Sch Appl Sci, 103 Borough Rd, London SE1 0AA, England.	phoenixd@lsbu.ac.uk	Quintas, Alexandre/J-6436-2012; Familia, Carlos/A-4535-2013	Quintas, Alexandre/0000-0002-5188-0453; Familia, Carlos/0000-0001-5059-2487				ASTBURY WILLIAM THOMAS, 1935, BIOCHEM JOUR, V29, P2351; Baskakov IV, 2005, AMYLOID PROTEINS: THE BETA SHEET CONFORMATION AND DISEASE, VOLS 1 AND 2, P65, DOI 10.1002/9783527619344.ch4; Becker N, 2009, BIOINFORMATICS, V25, P1711, DOI 10.1093/bioinformatics/btp286; Belli M, 2011, EMBO REP, V12, P657, DOI 10.1038/embor.2011.116; Canty A, 2014, BOOT BOOTSTRAP R S P; Cherny I, 2008, ANGEW CHEM INT EDIT, V47, P4062, DOI 10.1002/anie.200703133; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Davison AC, 1997, BOOTSTRAP METHODS TH; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; DePas WH, 2012, RES MICROBIOL, V163, P592, DOI 10.1016/j.resmic.2012.10.009; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Dubay KF, 2004, J MOL BIOL, V341, P1317, DOI 10.1016/j.jmb.2004.06.043; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; Emily M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079722; Eva Z., 2002, EUR J BIOCHEM, V269, P3362, DOI [10.1046/j.1432-1033.2002.03024.x, DOI 10.1046/J.1432-1033.2002.03024.X]; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; FINKELSTEIN AV, 1991, PROTEINS, V10, P287, DOI 10.1002/prot.340100403; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Frousios KK, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-44; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Hamodrakas SJ, 2007, INT J BIOL MACROMOL, V41, P295, DOI 10.1016/j.ijbiomac.2007.03.008; Hamodrakas SJ, 2011, FEBS J, V278, P2428, DOI 10.1111/j.1742-4658.2011.08164.x; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Hothorn T, 2008, J STAT SOFTW, V28, P1; Hu HJ, 2004, IEEE T NANOBIOSCI, V3, P265, DOI 10.1109/TNB.2004.837906; Idicula-Thomas S, 2007, CURR SCI INDIA, V92, P758; Jimenez LO, 1998, IEEE T SYST MAN CY C, V28, P39, DOI 10.1109/5326.661089; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kawashima S, 1999, NUCLEIC ACIDS RES, V27, P368, DOI 10.1093/nar/27.1.368; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Kelly JW, 2003, J CELL BIOL, V161, P461, DOI 10.1083/jcb.200304074; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Mathura VS, 2005, BIOINFORMATION, V1, P2, DOI 10.6026/97320630001002; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Nerelius C, 2010, BIOCHEM BIOPH RES CO, V396, P2, DOI 10.1016/j.bbrc.2010.02.105; Oliveberg M, 2010, NAT METHODS, V7, P187, DOI 10.1038/nmeth0310-187; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; PALAU J, 1982, INT J PEPT PROT RES, V19, P394; Pastor MT, 2005, CURR OPIN STRUC BIOL, V15, P57, DOI 10.1016/j.sbi.2005.01.004; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Python Software Foundation, 2013, PYTH VERS 2 7 5; Qian N, 1988, J MOL BIOL, V202, P865, DOI 10.1016/0022-2836(88)90564-5; Quintas A, 1999, J BIOL CHEM, V274, P32943, DOI 10.1074/jbc.274.46.32943; R Core Team, 2018, R LANG ENV STAT COMP; Rajagopal K, 2004, CURR OPIN STRUC BIOL, V14, P480, DOI 10.1016/j.sbi.2004.06.006; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; SASAGAWA F, 1993, COMPUT APPL BIOSCI, V9, P147; Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; SIPE J, 2005, WILEY VCH VERLAG GMB, P49, DOI DOI 10.1002/9783527619344; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Tartaglia GG, 2005, PREDICTION AGGREGATI, DOI [10.1110/ps.051471205, DOI 10.1110/PS.051471205]; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Teng PK, 2009, PROTEIN ENG DES SEL, V22, P531, DOI 10.1093/protein/gzp037; The MathWorks I, NEUR NETW TOOLB MATL; The MathWorks I, MATLAB 2011; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tian J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S45; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; Ventura S, 2006, TRENDS BIOTECHNOL, V24, P179, DOI 10.1016/j.tibtech.2006.02.007; Walsh I, 2014, NUCLEIC ACIDS RES, V42, pW301, DOI 10.1093/nar/gku399; Yoon S, 2005, PROTEINS, V60, P110, DOI 10.1002/prot.20477; Yoon S, 2004, PROTEIN SCI, V13, P2149, DOI 10.1110/ps.04790604; Zamani M., 2012, Proceedings of the 2012 IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW), P22, DOI 10.1109/BIBMW.2012.6470326; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6	81	28	28	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134679	10.1371/journal.pone.0134679	http://dx.doi.org/10.1371/journal.pone.0134679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241652	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000358942700057
J	Yan, WM; Deng, L; Zhong, YQW; Shangguan, ZP				Yan, Weiming; Deng, Lei; Zhong, Yangquanwei; Shangguan, Zhouping			The Characters of Dry Soil Layer on the Loess Plateau in China and Their Influencing Factors	PLOS ONE			English	Article							FOREST VEGETATION; WATER DEPLETION; DESICCATION; MOISTURE; ALFALFA; PASTURE; REGION; YIELD; MODEL	A dry soil layer (DSL) is a common soil desiccation phenomenon that generally forms at a particular depth in the soil profile because of climatic factors and poor land management, and this phenomenon can influence the water cycle and has been observed on the Loess Plateau of China and other similar regions around the world. Therefore, an investigation of the DSL formation depth (DSLFD), thickness (DSLT) and mean water content (MWDSL) on the Loess Plateau can provide valuable information. This paper synthesized 69 recent publications (1,149 observations of DSLs from 73 sites) that focused on DSLs in this region, and the results indicated that DSLs are significantly affected by climatic and vegetation factors. The mean annual precipitation had a significant positive relationship with DSLFD (p = 0.0003) and MWDSL (p<0.0001) and a negative relationship with DSLT (p = 0.0071). Crops had the lowest DSLT and highest MWDSL values compared with other vegetation types. A significant correlation was observed between the occurrence of DSLs and the years since planting for grasses, shrubs, trees and orchards, and the severity of DSLs increased with increasing planting years and wheat yield. Our results suggest that optimizing land-use management can mitigate DSL formation and development on the Loess Plateau. Understanding the dominant factors affecting DSLs will provide information for use in guidelines for the sustainable development of economies and restoration of natural environments experiencing water deficiencies.	[Yan, Weiming; Deng, Lei; Zhong, Yangquanwei; Shangguan, Zhouping] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Shangguan, ZP (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China.	shangguan@ms.iswc.ac.cn	Yan, Weiming/CAG-9069-2022		National Natural Science Foundation of China [41390463]; National Key Technology RD Program [2015BAC01B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program)	The study was financially supported by the National Natural Science Foundation of China (41390463) and the National Key Technology R&D Program (2015BAC01B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Brown K, 2002, SCIENCE, V297, P926, DOI 10.1126/science.297.5583.926; Cao Yu, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P72; [陈宝群 CHEN Bao-qun], 2009, [地理与地理信息科学, Geography and Geo-information Science], V25, P85; Chen HS, 2008, J HYDROL, V360, P242, DOI 10.1016/j.jhydrol.2008.07.037; Chen HS, 2008, GEODERMA, V143, P91, DOI 10.1016/j.geoderma.2007.10.013; Chen LD, 2007, PROG PHYS GEOG, V31, P389, DOI 10.1177/0309133307081290; Cheng JiMin, 2005, Scientia Silvae Sinicae, V41, P37; Cheng Jimin, 2005, Ying Yong Sheng Tai Xue Bao, V16, P435; Cheng JM, 2002, VEGETATION CONSTRUCT, P101; [程立平 Cheng Liping], 2014, [生态学报, Acta Ecologica Sinica], V34, P1975; Cheng LiPing, 2011, Transactions of the Chinese Society of Agricultural Engineering, V27, P203; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fu BJ, 2003, CATENA, V54, P197, DOI 10.1016/S0341-8162(03)00065-1; Fu M, 2001, ARID ZONE RES, V19, P71; Giorgi F, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024288; Han SF, 1990, B SOIL WATER CONSERV, V10, P36, DOI DOI 10.13961/J.CNKI.ST-BCTB.1990.01.007; [何福红 He Fuhong], 2010, [地理研究, Geographical Research], V29, P1863; Huang M.B., 2001, DILI XUEBAO, V56, P12; Huang MB, 2006, AGR WATER MANAGE, V85, P67, DOI 10.1016/j.agwat.2006.03.009; Kattge J, 2007, PLANT CELL ENVIRON, V30, P1176, DOI 10.1111/j.1365-3040.2007.01690.x; [李军 LI Jun], 2009, [自然资源学报, Journal of Natural Resources], V24, P2124; Li W, 2008, FOREST ECOL MANAG, V255, P2467, DOI 10.1016/j.foreco.2008.01.006; Li Y., 2000, J NAT RESOUR, V16, P427; Li Y.S., 1983, ACTA ECOLOGICA SINIC, V3, P91; Li YS, 2008, AGR ECOSYST ENVIRON, V124, P24, DOI 10.1016/j.agee.2007.08.007; [刘沛松 LIU Peisong], 2011, [河北农业大学学报, Journal of Agricultural University of Hebei], V34, P29; RICHARDS BG, 1983, GEOTECHNIQUE, V33, P127, DOI 10.1680/geot.1983.33.2.127; Robinson N, 2006, PLANT SOIL, V286, P141, DOI 10.1007/s11104-006-9032-4; Shangguan ZP, 2007, INT J SUST DEV WORLD, V14, P299, DOI 10.1080/13504500709469730; Shangguan ZP, 2006, INT J SUST DEV WORLD, V13, P307, DOI 10.1080/13504500609469682; Shi H, 2000, J ARID ENVIRON, V45, P9, DOI 10.1006/jare.1999.0618; Wang GY, 2007, SCIENCE, V318, P1556, DOI 10.1126/science.1147247; Wang L., 2000, J SOIL WATER CONSERV, V14, P87; Wang Li, 2004, Transactions of the Chinese Society of Agricultural Engineering, V20, P27; Wang Li, 2004, Yingyong Shengtai Xuebao, V15, P436; Wang' XL, 2008, AGR WATER MANAGE, V95, P190, DOI 10.1016/j.agwat.2007.10.001; Wang YQ, 2012, SURV GEOPHYS, V33, P311, DOI 10.1007/s10712-011-9154-y; Wang YQ, 2011, AGR FOREST METEOROL, V151, P437, DOI 10.1016/j.agrformet.2010.11.016; Wang YQ, 2010, GEODERMA, V159, P99, DOI 10.1016/j.geoderma.2010.07.001; Wang YQ, 2010, J HYDROL, V381, P9, DOI 10.1016/j.jhydrol.2009.09.042; Wang Z. Q., 2002, J ARID LAND RESOURCE, V16, P53; Wang ZQ, 2009, J GEOGR SCI, V19, P707, DOI 10.1007/s11442-009-0707-7; [薛晓辉 Xue Xiaohui], 2010, [干旱地区农业研究, Agricultural Research in the Arid Areas], V28, P75; Yang WeiXi, 1996, Scientia Silvae Sinicae, V32, P78; Yang WZ, 1999, SCI CHINA SER D, V42, P240, DOI 10.1007/BF02878961; Yang WZ., 2001, J NATURAL RESOURCES, V16, P433, DOI DOI 10.11849/ZRZYXB.2001.05.006; [姚玉璧 Yao Yubi], 2005, [资源科学, Resources Science], V27, P146; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P9892, DOI 10.1073/pnas.1732012100; [张海 Zhang Hai], 2003, [水土保持学报, Journal of Soil and Water Conservation], V17, P162; Zhong YQW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098850; ZHU XA, 1983, GEODERMA, V29, P237, DOI 10.1016/0016-7061(83)90090-3; 韩蕊莲, 1996, 干旱地区农业研究, V14, P104	53	54	61	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134902	10.1371/journal.pone.0134902	http://dx.doi.org/10.1371/journal.pone.0134902			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241046	Green Published, gold, Green Submitted			2022-12-27	WOS:000358942700078
J	Ray, P; Chapman, SC				Ray, Poulomi; Chapman, Susan C.			Cytoskeletal Reorganization Drives Mesenchymal Condensation and Regulates Downstream Molecular Signaling	PLOS ONE			English	Article							CELL-SHAPE CHANGES; RHO-KINASE; EXTRACELLULAR-MATRIX; CARTILAGE FORMATION; ACTIN ORGANIZATION; FOCAL ADHESIONS; TENSILE FORCES; GROWTH-FACTOR; CHICK LIMB; STEM-CELLS	Skeletal condensation occurs when specified mesenchyme cells self-organize over several days to form a distinctive cartilage template. Here, we determine how and when specified mesenchyme cells integrate mechanical and molecular information from their environment, forming cartilage condensations in the pharyngeal arches of chick embryos. By disrupting cytoskeletal reorganization, we demonstrate that dynamic cell shape changes drive condensation and modulate the response of the condensing cells to Fibroblast Growth Factor (FGF), Bone Morphogenetic Protein (BMP) and Transforming Growth Factor beta (TGF-beta) signaling pathways. Rho Kinase (ROCK)-driven actomyosin contractions and Myosin II-generated differential cell cortex tension regulate these cell shape changes. Disruption of the condensation process inhibits the differentiation of the mesenchyme cells into chondrocytes, demonstrating that condensation regulates the fate of the mesenchyme cells. We also find that dorsal and ventral condensations undergo distinct cell shape changes. BMP signaling is instructive for dorsal condensation-specific cell shape changes. Moreover, condensations exhibit ventral characteristics in the absence of BMP signaling, suggesting that in the pharyngeal arches ventral morphology is the ground pattern. Overall, this study characterizes the interplay between cytoskeletal dynamics and molecular signaling in a self-organizing system during tissue morphogenesis.	[Ray, Poulomi; Chapman, Susan C.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA	Clemson University	Chapman, SC (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	schapm2@clemson.edu	Chapman, Susan C/J-2688-2013	Chapman, Susan C/0000-0002-4314-9193	National Institute on Deafness and other Communication Disorders of the National Institutes of Health [R01DC009236]; NIFA (National Institute of Food and Agriculture)/USDA [SC-1700374]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009236] Funding Source: NIH RePORTER	National Institute on Deafness and other Communication Disorders of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIFA (National Institute of Food and Agriculture)/USDA; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research reported in this publication was supported by National Institute on Deafness (http://www.nidcd.nih.gov/) and other Communication Disorders of the National Institutes of Health under award number R01DC009236 to SCC. Technical Contribution No. 6248 of the Clemson University Experiment Station. This material is based upon work supported by the NIFA (National Institute of Food and Agriculture)/USDA, under project number SC-1700374 to SCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Alexander C, 2011, DEVELOPMENT, V138, P5135, DOI 10.1242/dev.067801; Barna M, 2007, DEV CELL, V12, P931, DOI 10.1016/j.devcel.2007.04.016; Boergermann JH, 2010, INT J BIOCHEM CELL B, V42, P1802, DOI 10.1016/j.biocel.2010.07.018; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; Cameron TL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-20; Christley S, 2007, PLOS COMPUT BIOL, V3, P743, DOI 10.1371/journal.pcbi.0030076.eor; COULY GF, 1993, DEVELOPMENT, V117, P409; DANIELS K, 1991, J CELL SCI, V100, P249; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Duprez D, 1996, MECH DEVELOP, V57, P145, DOI 10.1016/0925-4773(96)00540-0; Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308; Ghosh S, 2009, BIOMATERIALS, V30, P6530, DOI 10.1016/j.biomaterials.2009.08.019; GODDETTE DW, 1986, J BIOL CHEM, V261, P5974; Goldmann WH, 2012, CELL BIOL INT, V36, P649, DOI 10.1042/CBI20120184; HALL BK, 1992, ANAT EMBRYOL, V186, P107; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hanein D, 2012, CURR OPIN CELL BIOL, V24, P134, DOI 10.1016/j.ceb.2011.12.001; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Keller B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016421; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kim D, 2009, J CELL BIOCHEM, V107, P622, DOI 10.1002/jcb.22191; Kim MJ, 2012, BIOCHEM BIOPH RES CO, V418, P500, DOI 10.1016/j.bbrc.2012.01.053; Koppen M, 2006, DEVELOPMENT, V133, P2671, DOI 10.1242/dev.02439; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Kumar M, 2012, DEV DYNAM, V241, P1091, DOI 10.1002/dvdy.23768; Lecuit T, 2008, HFSP J, V2, P72, DOI 10.2976/1.2896332; Mammoto T, 2011, DEV CELL, V21, P758, DOI 10.1016/j.devcel.2011.07.006; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Mathieu PS, 2012, TISSUE ENG PART B-RE, V18, P436, DOI [10.1089/ten.teb.2012.0014, 10.1089/ten.TEB.2012.0014]; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McBride SH, 2008, TISSUE ENG PT A, V14, P1573, DOI 10.1089/ten.tea.2008.0113; Merrill AE, 2008, DEVELOPMENT, V135, P1223, DOI 10.1242/dev.015933; Meyer TN, 2006, DIFFERENTIATION, V74, P638, DOI 10.1111/j.1432-0436.2006.00102.x; Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016; Miyajima D, 2012, J BIOL CHEM, V287, P33545, DOI 10.1074/jbc.M111.329938; Osterfield M, 2013, DEV CELL, V24, P400, DOI 10.1016/j.devcel.2013.01.017; Otsu K, 2011, J CELL PHYSIOL, V226, P2527, DOI 10.1002/jcp.22597; Paluch E, 2009, CURR BIOL, V19, pR790, DOI 10.1016/j.cub.2009.07.029; Quinlan R, 2004, DEVELOPMENT, V131, P593, DOI 10.1242/dev.00950; Shimizu H, 2007, DEV GROWTH DIFFER, V49, P449, DOI 10.1111/j.1440-169x.2007.00945.x; Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045; Solnica-Krezel L, 2012, ANNU REV CELL DEV BI, V28, P687, DOI 10.1146/annurev-cellbio-092910-154043; Staines KA, 2012, CELL BIOCHEM FUNCT, V30, P633, DOI 10.1002/cbf.2852; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Wandzioch E, 2009, SCIENCE, V324, P1707, DOI 10.1126/science.1174497; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Warren M, 2009, DEV DYNAM, V238, P944, DOI 10.1002/dvdy.21895; Watanabe T, 2010, CURR OPIN GENET DEV, V20, P443, DOI 10.1016/j.gde.2010.05.004; Wood JL, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-16; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; Woods A, 2006, J BIOL CHEM, V281, P13134, DOI 10.1074/jbc.M509433200; Wu P, 2006, DEV DYNAM, V235, P1400, DOI 10.1002/dvdy.20825; Xu T, 2012, INT J MOL MED, V30, P1119, DOI 10.3892/ijmm.2012.1107; Yan YL, 2002, DEVELOPMENT, V129, P5065; ZANETTI NC, 1984, J CELL BIOL, V99, P115, DOI 10.1083/jcb.99.1.115	61	18	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134702	10.1371/journal.pone.0134702	http://dx.doi.org/10.1371/journal.pone.0134702			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237312	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942400033
J	Brittin, J; Sorensen, D; Trowbridge, M; Lee, KK; Breithecker, D; Frerichs, L; Huang, T				Brittin, Jeri; Sorensen, Dina; Trowbridge, Matthew; Lee, Karen K.; Breithecker, Dieter; Frerichs, Leah; Huang, Terry			Physical Activity Design Guidelines for School Architecture	PLOS ONE			English	Article							BODY-MASS INDEX; ELEMENTARY-SCHOOL; BUILT ENVIRONMENT; ACTIVITY THERMOGENESIS; CHILDHOOD OBESITY; NON-EXERCISE; ACTIVITY INTERVENTIONS; PLAYGROUND MARKINGS; COMMUNITY DESIGN; STAIR USE	Increasing children's physical activity at school is a national focus in the U.S. to address childhood obesity. While research has demonstrated associations between aspects of school environments and students' physical activity, the literature currently lacks a synthesis of evidence to serve as a practical, spatially-organized resource for school designers and decision-makers, as well as to point to pertinent research opportunities. This paper describes the development of a new practical tool: Physical Activity Design Guidelines for School Architecture. Its aims are to provide architects and designers, as well as school planners, educators, and public health professionals, with strategies for making K-12 school environments conducive to healthy physical activity, and to engage scientists in transdisciplinary perspectives toward improved knowledge of the school environment's impact. We used a qualitative review process to develop evidence-based and theory-driven school design guidelines that promote increased physical activity among students. The design guidelines include specific strategies in 10 school design domains. Implementation of the guidelines is expected to enable students to adopt healthier physical activity behaviors. The tool bridges a translational gap between research and environmental design practice, and may contribute to setting new industry and education standards.	[Brittin, Jeri; Frerichs, Leah; Huang, Terry] Univ Nebraska, Med Ctr, Coll Publ Hlth, Dept Hlth Promot Social & Behav Hlth, Omaha, NE 68182 USA; [Sorensen, Dina] VMDO Architects, Charlottesville, VA USA; [Trowbridge, Matthew] Univ Virginia, Sch Med, Dept Emergency Med, Charlottesville, VA 22908 USA; [Lee, Karen K.] New York City Dept Hlth & Mental Hyg, New York, NY USA; [Breithecker, Dieter] Fed Inst Posture & Mobilisat Support, Wiesbaden, Germany; [Frerichs, Leah] Univ N Carolina, Ctr Hlth Equ, Chapel Hill, NC USA; [Huang, Terry] CUNY, Sch Publ Hlth, New York, NY 10021 USA	University of Nebraska System; University of Nebraska Medical Center; University of Virginia; New York City Department of Health & Mental Hygiene; University of North Carolina; University of North Carolina Chapel Hill; City University of New York (CUNY) System	Brittin, J (corresponding author), Univ Nebraska, Med Ctr, Coll Publ Hlth, Dept Hlth Promot Social & Behav Hlth, Omaha, NE 68182 USA.	jeri.brittin@unmc.edu	Brittin, Jeri/P-3780-2019; Lee, Karen/GVT-9602-2022	Brittin, Jeri/0000-0002-1316-6451; Trowbridge, Matthew/0000-0002-8012-1966; Huang, Terry/0000-0001-5544-5187	YOUTH-NEX, the University of Virginia Center to Promote Effective Youth Development; VMDO Architects	YOUTH-NEX, the University of Virginia Center to Promote Effective Youth Development; VMDO Architects	This work was supported by funding from YOUTH-NEX, the University of Virginia Center to Promote Effective Youth Development (MT and TH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. VMDO Architects provided support in the form of a salary for author DS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Unrelated to this project, authors TS and JB have been consultants to VMDO Architects. The specific roles of the authors are articulated in the 'author contributions' section.	Amedeo D.M., 2003, GEOGRAPHY AM DAWN 21, P133; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Anthamatten P, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-27; Ashe M, 2011, PUBLIC HEALTH, V125, P889, DOI 10.1016/j.puhe.2011.04.010; Ashe M, 2007, J LAW MED ETHICS, V35, P138, DOI 10.1111/j.1748-720X.2007.00118.x; Babey SH, 2009, J PUBLIC HEALTH POL, V30, pS203, DOI 10.1057/jphp.2008.61; Bandura A., 1986, SOCIAL FDN THOUGHT A; BARANOWSKI T, 1993, RES Q EXERCISE SPORT, V64, P127, DOI 10.1080/02701367.1993.10608789; Barrett P, 2012, BUILD ENVIRON, V59, P678; Barrett P, 2010, INTELL BUILD INT, V2, P218, DOI 10.3763/inbi.2010.0042; Bauman AE, 2002, AM J PREV MED, V23, P5, DOI 10.1016/S0749-3797(02)00469-5; Bell, 2007, CHILDRENS GEOGRAPHIE, V5, P463, DOI DOI 10.1080/14733280701631965; Benden M.E., 2012, J EXERC PHYSL ONLINE, V15, P9; Benden ME, 2011, AM J PUBLIC HEALTH, V101, P1433, DOI 10.2105/AJPH.2010.300072; Benjamin RM, 2010, PUBLIC HEALTH REP, V125, P514, DOI 10.1177/003335491012500402; Binns HJ, 2009, PEDIATRICS, V123, P1591, DOI 10.1542/peds.2009-0750; Blake JJ, 2012, J PUBLIC HEALTH MAN, V18, P412, DOI 10.1097/PHH.0b013e3182215048; Boarnet MG, 2005, AM J PREV MED, V28, P134, DOI 10.1016/j.amepre.2004.10.026; Boehmer TK, 2008, AM J PREV MED, V34, P333, DOI 10.1016/j.amepre.2008.01.003; Boldemann C, 2006, PREV MED, V42, P301, DOI 10.1016/j.ypmed.2005.12.006; Boutelle KN, 2001, AM J PUBLIC HEALTH, V91, P2004, DOI 10.2105/AJPH.91.12.2004; Braza M, 2004, AM J HEALTH PROMOT, V19, P128, DOI 10.4278/0890-1171-19.2.128; Breithecker D, OPPORTUNITIES IMPROV; Breithecker D, 2008, HALTUNG BEWEGUNG, V3, P5; Breithecker D, 2003, HALTUNG BEWEGUNG, V2, P5; Brink LA, 2010, AM J PUBLIC HEALTH, V100, P1672, DOI 10.2105/AJPH.2009.178939; Buck C, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-65; Budgen Pip, 2007, Health Promot J Austr, V18, P77; Buliung RN, 2009, PREV MED, V48, P507, DOI 10.1016/j.ypmed.2009.03.001; Burke NM, 2009, AM J PREV MED, V37, pS386, DOI 10.1016/j.amepre.2009.09.010; Canter D, 1997, ADV ENV BEH, V4, P109; Cardon G, 2004, PATIENT EDUC COUNS, V54, P133, DOI 10.1016/S0738-3991(03)00215-5; Cardon G, 2009, PREV MED, V48, P335, DOI 10.1016/j.ypmed.2009.02.013; Cardon GM, 2012, HEALTH EDUC RES, V27, P470, DOI 10.1093/her/cys043; Carpet and Rug Institute, 2010, ARCHIT REC, V198, P123; City of New York, 2010, ACT DES GUID PROM PH; Cohen D, 2008, J PHYS ACT HEALTH, V5, P719, DOI 10.1123/jpah.5.5.719; Cohen Deborah A, 2006, J Phys Act Health, V3, pS129, DOI 10.1123/jpah.3.s1.s129; Colabianchi N, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-32; Colabianchi N, 2009, PREV MED, V48, P140, DOI 10.1016/j.ypmed.2008.11.005; [Committee on Physical Activity and Physical Education in the School Environment Institute of Medicine (US)], 2013, ED STUD BODY TAK PHY; Community Preventive Services Task Force, 2018, PHYS ACT ACT TRAV SC; Cradock AL, 2007, AM J PREV MED, V33, P106, DOI 10.1016/j.amepre.2007.04.009; D'Haese S, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-88; Dobbins M, 2013, COCHRANE DATABASE SY, P2; Doggett F, 2010, J ACOUST SOC AM, V127, P1860; Duderstadt KG, 2009, J PEDIATR HEALTH CAR, V23, P269, DOI 10.1016/j.pedhc.2009.04.009; Durant N, 2009, J SCHOOL HEALTH, V79, P153, DOI 10.1111/j.1746-1561.2008.00384.x; Dyment JE, 2008, HEALTH EDUC RES, V23, P952, DOI 10.1093/her/cym059; Egger J., 2009, NYC VITAL SIGNS, V8, P1; Eves FF, 2009, J ENVIRON PSYCHOL, V29, P300, DOI 10.1016/j.jenvp.2008.10.002; Eyler AA, 2008, HEALTH EDUC RES, V23, P963, DOI 10.1093/her/cym061; Farley TA, 2007, AM J PUBLIC HEALTH, V97, P1625, DOI 10.2105/AJPH.2006.092692; Fein AJ, 2004, INT J BEHAV MED, V11, P135, DOI 10.1207/s15327558ijbm1103_2; Fenton M, 2012, CHILD OBES, V8, P44, DOI 10.1089/chi.2011.0122; Fernandes M, 2010, PREV MED, V50, pS30, DOI 10.1016/j.ypmed.2009.09.022; Fitzhugh EC, 2010, AM J PREV MED, V39, P259, DOI 10.1016/j.amepre.2010.05.010; Fjortoft I, 2010, SCAND J PUBLIC HEALT, V38, P28, DOI 10.1177/1403494810384909; Ford MA, 2008, J AM COLL HEALTH, V57, P242, DOI 10.3200/JACH.57.2.242-244; Frank LD, 2007, SOC SCI MED, V65, P1898, DOI 10.1016/j.socscimed.2007.05.053; French SA, 2001, ANNU REV PUBL HEALTH, V22, P309, DOI 10.1146/annurev.publhealth.22.1.309; Frerichs L, 2012, CURR NUTR REP, V1, P228; Frerichs L, 2015, AM J PUBLIC HEALTH, V105, pE46, DOI 10.2105/AJPH.2014.302453; Garcia JM, 2014, MED SCI SPORT EXER, V46, P513, DOI 10.1249/01.mss.0000495005.45665.db; Geraghty AB, 2009, AM J PREV MED, V37, pS420, DOI 10.1016/j.amepre.2009.09.009; Giddens A., 1979, CENTRAL PROBLEMS SOC; Giles-Corti B, 2005, EXERC SPORT SCI REV, V33, P175, DOI 10.1097/00003677-200510000-00005; Giles-Corti B, 2011, HEALTH PLACE, V17, P545, DOI 10.1016/j.healthplace.2010.12.011; Glickman D, 2012, ACC PROGR OB PREV SO, P333; Gomez-Feliciano L, 2009, AM J PREV MED, V37, pS361, DOI 10.1016/j.amepre.2009.09.003; Gorman N, 2007, OBESITY, V15, P2521, DOI 10.1038/oby.2007.300; Gostin LO, 2007, JAMA-J AM MED ASSOC, V297, P87, DOI 10.1001/jama.297.1.87; Gouvali MK, 2006, APPL ERGON, V37, P765, DOI 10.1016/j.apergo.2005.11.009; Grantmakers in Health, 2007, REV OB EP POL STRAT; Guerra PH, 2013, CLINICS, V68, P1263, DOI 10.6061/clinics/2013(09)14; Gump P. V., 1987, HDB ENV PSYCHOL, P691; Hagle M, 2013, ARCH DESIGN REV HOUS, V92, P20; Hall Edward T, 1992, HIDDEN DIMENSION; Handy SL, 2002, AM J PREV MED, V23, P64, DOI 10.1016/S0749-3797(02)00475-0; Hanks AS, 2013, J PEDIATR-US, V162, P867, DOI 10.1016/j.jpeds.2012.12.031; Harris KC, 2009, CAN MED ASSOC J, V180, P719, DOI 10.1503/cmaj.080966; Harrison F, 2012, HEALTH PLACE, V18, P639, DOI 10.1016/j.healthplace.2011.12.009; Harrison F, 2011, SOC SCI MED, V72, P1411, DOI 10.1016/j.socscimed.2011.02.023; Haug E, 2010, HEALTH EDUC RES, V25, P248, DOI 10.1093/her/cyn050; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Heelan KA, 2005, CHILD CARE HLTH DEV, V31, P341, DOI 10.1111/j.1365-2214.2005.00513.x; Heinrich Katie M, 2011, Hawaii Med J, V70, P21; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hillier B., 1989, SOCIAL LOGIC SPACE; Hobin E, 2012, INT J PUBLIC HEALTH, V57, P699, DOI 10.1007/s00038-012-0336-2; Hooper PL, 2013, J PHYS ACT HEALTH, V10, P792, DOI 10.1123/jpah.10.6.792; Huang TT, 2009, PREV CHRONIC DIS, V6; Huang TTK, 2007, J LAW MED ETHICS, V35, P148, DOI 10.1111/j.1748-720X.2007.00119.x; Huang TTK, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120084; Huberty JL, 2011, J PHYS ACT HEALTH, V8, pS249, DOI 10.1123/jpah.8.s2.s249; Huberty JL, 2009, AM J PREV MED, V37, pS428, DOI 10.1016/j.amepre.2009.09.024; Ittelson W.H., 1973, ENV COGNITION, P141; Jones NR, 2010, HEALTH PLACE, V16, P776, DOI 10.1016/j.healthplace.2010.04.002; Kayser B, 2008, PREV MED, V46, P8, DOI 10.1016/j.ypmed.2007.08.016; Kerr J, 2006, MED SCI SPORT EXER, V38, P787, DOI 10.1249/01.mss.0000210208.63565.73; Kim S, 2010, PREV MED, V50, pS80, DOI 10.1016/j.ypmed.2009.07.025; King AC, 1995, HEALTH EDUC QUART, V22, P499, DOI 10.1177/109019819502200407; King AC, 2002, AM J PREV MED, V23, P15, DOI 10.1016/S0749-3797(02)00470-1; KLESGES RC, 1990, HEALTH PSYCHOL, V9, P435, DOI 10.1037/0278-6133.9.4.435; Kriemler S, 2011, BRIT J SPORT MED, V45, P923, DOI 10.1136/bjsports-2011-090186; Kumanyika S, 2006, FUTURE CHILD, V16, P187, DOI 10.1353/foc.2006.0005; Lackney JA, 1994, CTR ARCHITECTURE URB, pR94; Lanningham-Foster L, 2008, OBESITY, V16, P1849, DOI 10.1038/oby.2008.282; Lee KK, 2012, AM J PREV MED, V42, P136, DOI 10.1016/j.amepre.2011.10.005; Lee KK, 2012, HEALTH PLACE, V18, P5, DOI 10.1016/j.healthplace.2011.09.009; Lee KK, 2014, DEV ACTIVE DESIGN IN; Lee SM, 2008, HEALTH PROMOT PRACT, V9, P246, DOI 10.1177/1524839907301403; Levine JA, 2006, ARTERIOSCL THROM VAS, V26, P729, DOI 10.1161/01.ATV.0000205848.83210.73; Levine JA, 2004, NUTR REV, V62, pS82, DOI 10.1111/j.1753-4887.2004.tb00094.x; Levine JA, 1999, SCIENCE, V283, P212, DOI 10.1126/science.283.5399.212; Lewis A, 2012, BRIT J HEALTH PSYCH, V17, P631, DOI 10.1111/j.2044-8287.2011.02060.x; Loucaides CA, 2009, J PHYS ACT HEALTH, V6, P722, DOI 10.1123/jpah.6.6.722; Martin JJ, 2008, J SPORT EXERCISE PSY, V30, P378, DOI 10.1123/jsep.30.4.378; Martin K, 2012, AUST NZ J PUBL HEAL, V36, P469, DOI 10.1111/j.1753-6405.2012.00914.x; Martin SH, 2002, J ENVIRON PSYCHOL, V22, P139, DOI 10.1006/jevp.2001.0239; Martinez Maldonado Roberto, 2012, Intelligent Tutoring Systems. Proceedings 11th International Conference (ITS 2012), P482, DOI 10.1007/978-3-642-30950-2_62; Maxwell LE, 2003, ENVIRON BEHAV, V35, P566, DOI 10.1177/0013916503035004007; McAlister A.L., 2008, HLTH BEHAV HLTH ED T; Millstein RA, 2011, PEDIATR EXERC SCI, V23, P487, DOI 10.1123/pes.23.4.487; Mitra R, 2010, HEALTH PLACE, V16, P646, DOI 10.1016/j.healthplace.2010.01.009; Nelson KM, 2008, J PUBLIC HEALTH MAN, V14, P266, DOI 10.1097/01.PHH.0000316485.49888.f6; Nettlefold L, 2011, BRIT J SPORT MED, V45, P813, DOI 10.1136/bjsm.2009.068072; Nicaise V, 2012, PEDIATR EXERC SCI, V24, P507, DOI 10.1123/pes.24.4.507; Nichols A, 2013, EVALUATION OF COMMUN; Nicoll GA, 2013, ACTIVE DESIGN AFFORD; Nicoll G, 2007, AM J HEALTH PROMOT, V21, P346, DOI 10.4278/0890-1171-21.4s.346; Nielsen G, 2010, J PHYS ACT HEALTH, V7, P490, DOI 10.1123/jpah.7.4.490; Nocon M, 2010, SCAND J PUBLIC HEALT, V38, P633, DOI 10.1177/1403494810375865; [NYC Department of Health and Mental Hygiene Society for Public Health Education Johns Hopkins Center for Injury Research and Policy], 2013, ACT DES SUPPL PROM S; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ozer EJ, 2007, HEALTH EDUC BEHAV, V34, P846, DOI 10.1177/1090198106289002; Panter JR, 2010, J EPIDEMIOL COMMUN H, V64, P41, DOI 10.1136/jech.2009.086918; Panter JR, 2010, AM J PREV MED, V38, P268, DOI 10.1016/j.amepre.2009.10.040; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; *PHYS ACT GUID ADV, 2008, PHYS ACT GUID ADV CO, P1; Poole ES, 2011, UBICOMP'11: PROCEEDINGS OF THE 2011 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P395; Professional Glidden, 2013, ARCHIT REC, V201, P262; Rasberry CN, 2011, PREV MED, V52, pS10, DOI 10.1016/j.ypmed.2011.01.027; Ridgers ND, 2007, PREV MED, V44, P393, DOI 10.1016/j.ypmed.2007.01.009; Ridgers ND, 2012, AM J PREV MED, V43, P320, DOI 10.1016/j.amepre.2012.05.019; Ruff RR, 2014, PREV MED, V60, P60, DOI 10.1016/j.ypmed.2013.12.006; Sallis JF, 2001, AM J PUBLIC HEALTH, V91, P618, DOI 10.2105/AJPH.91.4.618; Sallis JF, 2008, HLTH BEHAV HLTH ED T, DOI DOI 10.1111/J.1442-9993.2008.01952.X; Salmon J, 2007, AM J HEALTH PROMOT, V22, P107, DOI 10.4278/0890-1171-22.2.107; Schasberger MG, 2009, AM J PREV MED, V37, pS336, DOI 10.1016/j.amepre.2009.09.012; School Planning and Management, 2014, ANN SCH CONTR REP; Schroder I, 1997, COLLEGIUM ANTROPOL, V21, P397; Scott MM, 2007, PREV MED, V44, P398, DOI 10.1016/j.ypmed.2006.12.010; Scott MM, 2007, J URBAN HEALTH, V84, P346, DOI 10.1007/s11524-007-9179-1; Silva KS, 2011, J PHYS ACT HEALTH, V8, P750, DOI 10.1123/jpah.8.6.750; Sirard JR, 2008, J NUTR EDUC BEHAV, V40, P324, DOI 10.1016/j.jneb.2007.12.002; Sirard JR, 2008, AM J LIFESTYLE MED, V2, P372, DOI 10.1177/1559827608320127; Sirard JR, 2005, MED SCI SPORT EXER, V37, P2062, DOI 10.1249/01.mss.0000179102.17183.6b; Skala KA, 2012, J PHYS ACT HEALTH, V9, P481, DOI 10.1123/jpah.9.4.481; Smith TJ, 2013, WORK, V44, pS39, DOI 10.3233/WOR-121493; Stone MR, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-5; Story M, 2009, MILBANK Q, V87, P71, DOI 10.1111/j.1468-0009.2009.00548.x; Stratton G, 2005, PREV MED, V41, P828, DOI 10.1016/j.ypmed.2005.07.009; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tanner CK, 2009, J EDUC ADMIN, V47, P381, DOI 10.1108/09578230910955809; Teske JA, 2008, NEUROENDOCRINOLOGY, V87, P71, DOI 10.1159/000110802; The Third Teacher, 2010, 3 TEACHER OWP P CANN; Thompson D, 2014, JMIR RES PROTOC, V3, DOI 10.2196/resprot.3074; Timperio A, 2006, AM J PREV MED, V30, P45, DOI 10.1016/j.amepre.2005.08.047; Toftager M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099369; Toftager M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-777; Trilk JL, 2011, HEALTH PLACE, V17, P651, DOI 10.1016/j.healthplace.2011.01.005; Trowbridge MJ, 2013, AM J PREV MED, V44, P489, DOI 10.1016/j.amepre.2013.01.010; U. S. Green Building Council, LEED DES ACT OCC; Dyck D, 2009, PREV MED, V48, P516, DOI 10.1016/j.ypmed.2009.03.005; Van Sluijs EMF, 2011, INT J PEDIATR OBES, V6, pE574, DOI 10.3109/17477166.2010.518239; Verstraete SJM, 2006, EUR J PUBLIC HEALTH, V16, P415, DOI 10.1093/eurpub/ckl008; Voorhees CC, 2010, MED SCI SPORT EXER, V42, P1253, DOI 10.1249/MSS.0b013e3181cd5dfd; Watson Margaret, 2008, Prev Chronic Dis, V5, pA90; Wechsler H, 2000, PREV MED, V31, pS121, DOI 10.1006/pmed.2000.0649; WEINSTEIN CS, 1979, REV EDUC RES, V49, P577, DOI 10.3102/00346543049004577; Wells NM, 2014, PREV MED, V69, pS27, DOI 10.1016/j.ypmed.2014.10.012; Wendel AM, 2009, PREV MED, V48, P513, DOI 10.1016/j.ypmed.2009.05.010; Willenberg LJ, 2010, J SCI MED SPORT, V13, P210, DOI 10.1016/j.jsams.2009.02.011; Williams AJ, 2012, HEALTH PLACE, V18, P504, DOI 10.1016/j.healthplace.2012.02.004; Zhu XM, 2008, AM J PREV MED, V34, P282, DOI 10.1016/j.amepre.2008.01.024; Zhu XM, 2009, J PUBLIC HEALTH POL, V30, pS177, DOI 10.1057/jphp.2008.51; Zimring C, 2005, AM J PREV MED, V28, P186, DOI 10.1016/j.amepre.2004.10.025	188	26	27	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0132597	10.1371/journal.pone.0132597	http://dx.doi.org/10.1371/journal.pone.0132597			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230850	Green Published, gold			2022-12-27	WOS:000358838400018
J	Dukers-Muijrers, NHTM; Theunissen, KATM; Wolffs, PT; Kok, G; Hoebe, CJPA				Dukers-Muijrers, Nicole H. T. M.; Theunissen, Kevin A. T. M.; Wolffs, Petra T.; Kok, Gerjo; Hoebe, Christian J. P. A.			Acceptance of Home-Based Chlamydia Genital and Anorectal Testing Using Short Message Service (SMS) in Previously Tested Young People and Their Social and Sexual Networks	PLOS ONE			English	Article							TAKEN VAGINAL SWABS; OF-THE-LITERATURE; NEISSERIA-GONORRHOEAE; TRANSMITTED-DISEASES; UROGENITAL CHLAMYDIA; SCREENING-PROGRAM; TRACHOMATIS; WOMEN; ACCEPTABILITY; RISK	Background Control strategies for Chlamydia trachomatis (CT) are most effective when targeting people at highest risk. We assessed test acceptance of home-collection test kits offered by short messaging services (SMS) texts, in high-risk young people, i.e. those who had previously tested CT positive (positive indices), or negative reporting more than 3 sex partners (negative indices), and their sexual and social networks. Methods Young (16 to 25 years old) heterosexuals who previously tested positive (n=536) or negative (n=536) in our STI clinic received, 3 to 20 months after their initial screening, an SMS inviting them to re-test. They were offered a free home-collection test kit including a genital (men and women) and anorectal (women only) test, and a test kit to pass on to a friend or sex partner (peer). SMS reminders were sent in case of non-response. We assessed proportions of tests requested and returned, peers tested, and positivity. Associations with the individual's initial screening result and other factors were explored using logistic regression. Results Of 1072 people invited to retest, 34.4% (n=369) requested a test. Of these, 55.8% (n=206) retested. Overall, retest participation was higher in positive (22%) than in negative indices (16%) (p<0.001); it was also higher in women and in those aged >22 years. Positivity was 13% and 7% in positive and negative indices, respectively. One in 3 retesters also had a peer tested. Of tested peers (n=87), 84% were friends, 31% were first-time testers, and 7% tested positive. Conclusion Acceptance of a relatively low-cost strategy for genital and anorectal testing, i.e. using SMS and home-collection test kits, was highest in individuals who previously tested CT positive suggesting that implementation for this group may be considered. By further including a peer-led testing component, undetected CT positives can be identified in the social networks surrounding a high-risk individual.	[Dukers-Muijrers, Nicole H. T. M.; Theunissen, Kevin A. T. M.; Hoebe, Christian J. P. A.] South Limburg Publ Hlth Serv, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands; [Dukers-Muijrers, Nicole H. T. M.; Wolffs, Petra T.; Hoebe, Christian J. P. A.] MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands; [Kok, Gerjo] Maastricht Univ, Dept Work & Social Psychol, Maastricht, Netherlands	Maastricht University; Maastricht University	Dukers-Muijrers, NHTM (corresponding author), South Limburg Publ Hlth Serv, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands.	nicole.dukers@ggdzl.nl	Dukers-Muijrers, Nicole/M-7178-2014	Hoebe, Christian/0000-0003-1815-0974; Dukers-Muijrers, Nicole/0000-0003-4896-758X; Wolffs, Petra/0000-0002-5326-3985				Balfe M, 2010, SOCIOL HEALTH ILL, V32, P1041, DOI 10.1111/j.1467-9566.2010.01281.x; Bilardi JE, 2010, SEX TRANSM DIS, V37, P563, DOI 10.1097/OLQ.0b013e3181d707f1; Blake DR, 2003, ARCH PEDIAT ADOL MED, V157, P523, DOI 10.1001/archpedi.157.6.523; Burton J, 2014, SEX TRANSM INFECT, V90, P11, DOI 10.1136/sextrans-2013-051228; Busse P, 2010, COMMUN RES, V37, P239, DOI 10.1177/0093650209356393; Centers for Disease Control and Prevention, SUMM REV LIT PROG PR; Cunningham SD, 2009, PERSPECT SEX REPRO H, V41, P225, DOI 10.1363/4122509; Desai M, 2015, SEX TRANSM INFECT, V91, P314, DOI 10.1136/sextrans-2014-051930; Dokkum NFB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-176; Doshi JS, 2008, INT J STD AIDS, V19, P507, DOI 10.1258/ijsa.2008.008056; Downing SG, 2013, SEX TRANSM INFECT, V89, P16, DOI 10.1136/sextrans-2011-050454; Dukers-Muijrers NHTM, 2013, SEX TRANSM INFECT, V89, P25, DOI 10.1136/sextrans-2011-050467; European Centre for Disease Prevention and Control, 2014, CHLAM CONTR EUR LIT; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Gaydos CA, 2013, INT J STD AIDS, V24, P736, DOI 10.1177/0956462413483252; Gotz HM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-239; Gotz HM, 2005, SEX TRANSM DIS, V32, P557, DOI 10.1097/01.olq.0000175416.15905.db; Gotz HM, 2014, SEX TRANSM INFECT, V90, P195, DOI 10.1136/sextrans-2013-051254; Guy R, 2013, SEX TRANSM INFECT, V89, P11, DOI 10.1136/sextrans-2011-050370; Guy R, 2012, SEX TRANSM DIS, V39, P136, DOI 10.1097/OLQ.0b013e31823ed4ec; Guy R, 2011, SEX HEALTH, V8, P242, DOI 10.1071/SH10086; Hoebe CJPA, 2006, SEX TRANSM DIS, V33, P491, DOI 10.1097/01.olq.0000204619.87066.28; Hosenfeld CB, 2009, SEX TRANSM DIS, V36, P478, DOI 10.1097/OLQ.0b013e3181a2a933; Jamil MS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-189; Kegg S, 2004, COMMUNICATION, V15; Kotchick BA, 2001, CLIN PSYCHOL REV, V21, P493, DOI 10.1016/S0272-7358(99)00070-7; Loaring J, 2013, J FAM PLAN REPROD H, V39, P21, DOI 10.1136/jfprhc-2011-100151; Lunny C, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-7; Masek BJ, 2009, J CLIN MICROBIOL, V47, P1663, DOI 10.1128/JCM.02387-08; Newby KV, 2012, BRIT J HEALTH PSYCH, V17, P144, DOI 10.1111/j.2044-8287.2011.02027.x; Odesanmi TY, 2013, SEX HEALTH, V10, P559, DOI 10.1071/SH13029; Ostergaard L, 2003, SEX TRANSM INFECT, V79, P358, DOI 10.1136/sti.79.5.358; Pavlin NL, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-221; Peters RPH, 2014, SEX TRANSM DIS, V41, P564, DOI 10.1097/OLQ.0000000000000175; Rose SB, 2010, AUST NZ J PUBL HEAL, V34, P517, DOI 10.1111/j.1753-6405.2010.00600.x; Senior K, 2012, LANCET INFECT DIS, V12, P517, DOI 10.1016/S1473-3099(12)70161-5; Smith KS, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-223; Theunissen KATM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-996; Torrone E, 2014, MMWR-MORBID MORTAL W, V63, P834; Trebach JD, 2015, SEX TRANSM DIS, V42, P233, DOI 10.1097/OLQ.0000000000000248; van der Helm JJ, 2009, SEX TRANSM DIS, V36, P493, DOI 10.1097/OLQ.0b013e3181a44b8c; van Liere GAFS, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-274; Youm Y, 2002, SEX TRANSM DIS, V29, P689, DOI 10.1097/00007435-200211000-00012	43	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133575	10.1371/journal.pone.0133575	http://dx.doi.org/10.1371/journal.pone.0133575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230085	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400043
J	Liu, SC; Xia, L; Zhang, J; Lu, XH; Hu, DK; Zhang, HT; Li, HJ				Liu, Shuang-Chun; Xia, Lei; Zhang, Jin; Lu, Xue-Hong; Hu, Da-Kang; Zhang, Hai-Tao; Li, Hai-Jun			Gout and Risk of Myocardial Infarction: A Systematic Review and Meta-Analysis of Cohort Studies	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; US GENERAL-POPULATION; MIDDLE-AGED MEN; SERUM URIC-ACID; CARDIOVASCULAR MORTALITY; GLOMERULAR HYPERTENSION; INDEPENDENT IMPACT; ALL-CAUSE; HYPERURICEMIA; INFLAMMATION	Introduction A high incidence of myocardial infarction among patients with gout has been suggested by several observational studies. We performed a meta-analysis to evaluate the association between gout and the risk of myocardial infarction. Materials and Methods The PubMed and Embase databases were searched from inception to October 2014 for cohort studies that evaluating the association between gout and the risk of myocardial infarction. Summary estimates were derived using a random-effects model and reported as relative risks (RRs) with 95% confidence intervals (CIs). Results Five studies involving 8,656,413 participants with a total of 1000 MI events were included. Overall, gout was associated with an increased risk of myocardial infarction (RR 1.45; 95% CI, 1.19-1.75; p<0.001), and the association referred to non-fatal myocardial infarction (RR 1.29; 95% CI, 1.19-1.39; p<0.001) but not fatal myocardial infarction (RR 1.11; 95% CI, 0.96-1.28; p = 0.174). The increased risk was observed in both women (RR 1.62; 95% CI, 1.18-2.21; p = 0.003) and men (RR 1.45; 95% CI, 1.21-1.74; p<0.001). Stratified analysis revealed a gradual increase in myocardial infarction risk with a younger age of gout onset (age 20-44 years old (RR 2.82; 95% CI, 1.38-5.79; p = 0.05); 45-69 years old (RR 1.85; 95% CI, 1.22-2.82; p = 0.04); >= 70 years old (RR 1.52; 95% CI, 1.22-1.88; p<0.001)). Conclusion This meta-analysis suggests that patients with gout have an increased risk of myocardial infarction.	[Liu, Shuang-Chun; Zhang, Jin; Hu, Da-Kang] Taizhou Municipal Hosp, Dept Clin Lab, Taizhou, Zhejiang, Peoples R China; [Xia, Lei] Shanghai Jiao Tong Univ, Dept Urinary Surg, Affiliated Renji Hosp, Sch Med, Shanghai 200030, Peoples R China; [Lu, Xue-Hong] Taizhou Municipal Hosp, Dept Pediat, Taizhou, Zhejiang, Peoples R China; [Zhang, Hai-Tao] Taizhou Municipal Hosp, Dept Urinary Surg, Taizhou, Zhejiang, Peoples R China; [Li, Hai-Jun] Taizhou Municipal Hosp, Dept Neurol, Taizhou, Zhejiang, Peoples R China	Taizhou University; Shanghai Jiao Tong University; Taizhou University; Taizhou University; Taizhou University	Zhang, HT (corresponding author), Taizhou Municipal Hosp, Dept Urinary Surg, Taizhou, Zhejiang, Peoples R China.	tzzhanghaitao@hotmail.com; lhjyy@126.com			Medical Science and Technology Support of Zhejiang Province [2013ZHB015]	Medical Science and Technology Support of Zhejiang Province	The present study was supported by Medical Science and Technology Support of Zhejiang Province (2013ZHB015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annemans L, 2008, ANN RHEUM DIS, V67, P960, DOI 10.1136/ard.2007.076232; Arromdee E, 2002, J RHEUMATOL, V29, P2403; Ballocca F, 2014, EUR J PREV CARDIOL; Bardin T, 2014, ANN RHEUM DIS, V73, P787, DOI 10.1136/annrheumdis-2014-eular.5164; Becker MA, 2006, RHEUM DIS CLIN N AM, V32, P275, DOI 10.1016/j.rdc.2006.02.005; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Brodov Y, 2010, AM J CARDIOL, V106, P1717, DOI 10.1016/j.amjcard.2010.07.046; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; Clarson LE, 2015, EUR J PREV CARDIOL, V22, P335, DOI 10.1177/2047487313514895; Dalbeth N, 2005, RHEUMATOLOGY, V44, P1090, DOI [10.1093/rheumatology/keh640, 10.1186/ar2952]; De Vera MA, 2010, ANN RHEUM DIS, V69, P1162, DOI 10.1136/ard.2009.122770; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Edwards N Lawrence, 2008, Cleve Clin J Med, V75 Suppl 5, pS13; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; FREEDMAN DS, 1995, AM J EPIDEMIOL, V141, P637, DOI 10.1093/oxfordjournals.aje.a117479; Gersch C, 2008, NUCLEOS NUCLEOT NUCL, V27, P967, DOI 10.1080/15257770802257952; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gur M, 2013, J CARDIOL, V61, P144, DOI 10.1016/j.jjcc.2012.08.023; Halligan C, 2005, CURR RHEUMATOL REV, V1, P193, DOI 10.2174/1573397054023128; Hartling L, 2013, J CLIN EPIDEMIOL, V66, P982, DOI 10.1016/j.jclinepi.2013.03.003; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kanellis J, 2005, SEMIN NEPHROL, V25, P39, DOI 10.1016/j.semnephrol.2004.09.007; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; Krishnan E, 2008, ARCH INTERN MED, V168, P1104, DOI 10.1001/archinte.168.10.1104; Krishnan E, 2006, ARTHRITIS RHEUM-US, V54, P2688, DOI 10.1002/art.22014; Kuo CF, 2013, RHEUMATOLOGY, V52, P111, DOI 10.1093/rheumatology/kes169; Kuo CF, 2010, RHEUMATOLOGY, V49, P141, DOI 10.1093/rheumatology/kep364; LEE J, 1995, AM J EPIDEMIOL, V142, P288, DOI 10.1093/oxfordjournals.aje.a117634; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Netea MG, 1997, BLOOD, V89, P577, DOI 10.1182/blood.V89.2.577; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; PASCUAL E, 1991, ARTHRITIS RHEUM, V34, P141, DOI 10.1002/art.1780340203; PUIG JG, 1991, ARCH INTERN MED, V151, P726, DOI 10.1001/archinte.151.4.726; Roddy E, 2007, NAT CLIN PRACT RHEUM, V3, P443, DOI 10.1038/ncprheum0556; Sanchez-Lozada LG, 2002, AM J PHYSIOL-RENAL, V283, pF1105, DOI 10.1152/ajprenal.00170.2002; Sanchez-Lozada LG, 2005, KIDNEY INT, V67, P237, DOI 10.1111/j.1523-1755.2005.00074.x; Seminog OO, 2013, RHEUMATOLOGY, V52, P2251, DOI 10.1093/rheumatology/ket293; So A, 2010, NAT REV RHEUMATOL, V6, P386, DOI 10.1038/nrrheum.2010.78; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tiong AY, 2005, AM HEART J, V150, P11, DOI 10.1016/j.ahj.2004.12.019; Verdecchia P, 2000, HYPERTENSION, V36, P1072, DOI 10.1161/01.HYP.36.6.1072; Weaver Arthur L, 2008, Cleve Clin J Med, V75 Suppl 5, pS9; Wells G., 2013, NEWCASTLE OTTAWA SCA; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization (WHO), 2011, 10 LEAD CAUS DEATH B; Xu Jiaquan, 2010, Natl Vital Stat Rep, V58, P1; Zhu YY, 2012, AM J MED, V125, P679, DOI 10.1016/j.amjmed.2011.09.033; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	53	22	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134088	10.1371/journal.pone.0134088	http://dx.doi.org/10.1371/journal.pone.0134088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230580	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400070
J	Winder, EM; Bonheyo, GT				Winder, Eric M.; Bonheyo, George T.			DNA Persistence in a Sink Drain Environment	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; PCR; MICROCOSMS; BIOFILMS; MATRIX; TISSUE	Biofilms are organized structures composed mainly of cells and extracellular polymeric substances produced by the constituent microorganisms. Ubiquitous in nature, biofilms have an innate ability to capture and retain passing material and may therefore act as natural collectors of contaminants or signatures of upstream activities. To determine the persistence and detectability of DNA passing through a sink drain environment, Bacillus anthracis strain Ames35 was cultured (6.35 x 10(7) CFU/mL), sterilized, and disposed of by addition to a sink drain apparatus with an established biofilm. The sink drain apparatus was sampled before and for several days after the addition of the sterilized B. anthracis culture to detect the presence of B. anthracis DNA. Multiple PCR primer pairs were used to screen for chromosomal and plasmid DNA with primers targeting shorter sequences showing greater amplification efficiency and success. PCR amplification and detection of target sequences indicate persistence of chromosomal DNA and plasmid DNA in the biofilm for 5 or more and 14 or more days, respectively.	[Winder, Eric M.; Bonheyo, George T.] Pacific NW Natl Lab, Sequim, WA 98382 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Winder, EM (corresponding author), Pacific NW Natl Lab, Sequim, WA 98382 USA.	eric.winder@pnnl.gov	Bonheyo, George/AAU-6018-2020	Bonheyo, George/0000-0001-8853-5744; Winder, Eric/0000-0003-3707-7549	Intelligence Community Postdoctoral Research Fellowship Program	Intelligence Community Postdoctoral Research Fellowship Program	This project was supported by a grant from the Intelligence Community Postdoctoral Research Fellowship Program. All statements of fact, opinion, or analysis expressed are those of the author and do not reflect the official positions or views of the Intelligence Community or any other United States Government agency. Nothing in the contents should be construed as asserting or implying United States Government authentication of information or Intelligence Community endorsement of the author's views.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Butler JM, 2003, DEV REDUCED SIZE STR, V48, P11; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Cheun HI, 2001, J APPL MICROBIOL, V91, P421, DOI 10.1046/j.1365-2672.2001.01395.x; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Flores GE, 2013, ENVIRON MICROBIOL, V15, P588, DOI 10.1111/1462-2920.12036; Geigl EM, 2002, ARCHAEOMETRY, V44, P337, DOI 10.1111/1475-4754.t01-1-00066; Jackson PJ, 1998, P NATL ACAD SCI USA, V95, P1224, DOI 10.1073/pnas.95.3.1224; Jaeger K-E, 2003, ENCY ENV MICROBIOLOG; Matsukawa M, 2004, J BACTERIOL, V186, P4449, DOI 10.1128/JB.186.14.4449-4456.2004; McBain AJ, 2003, APPL ENVIRON MICROB, V69, P5433, DOI 10.1128/AEM.69.9.5433-5442.2003; McBain AJ, 2003, APPL ENVIRON MICROB, V69, P177, DOI 10.1128/AEM.69.1.177-185.2003; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Ramisse V, 1999, J APPL MICROBIOL, V87, P224, DOI 10.1046/j.1365-2672.1999.00874.x; Simmon KE, 2004, J MICROBIOL METH, V56, P143, DOI 10.1016/j.mimet.2003.10.003; Straub T, 2013, J MICROBIOL METH, V92, P9, DOI 10.1016/j.mimet.2012.10.013; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Volokhov D, 2004, DIAGN MICR INFEC DIS, V49, P163, DOI 10.1016/j.diagmicrobio.2004.03.015; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487	20	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134798	10.1371/journal.pone.0134798	http://dx.doi.org/10.1371/journal.pone.0134798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230525	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400169
J	Yang, GL; Xu, ZP; Lu, W; Li, X; Sun, CW; Guo, J; Xue, P; Guan, F				Yang, Ganglong; Xu, Zhipeng; Lu, Wei; Li, Xiang; Sun, Chengwen; Guo, Jia; Xue, Peng; Guan, Feng			Quantitative Analysis of Differential Proteome Expression in Bladder Cancer vs. Normal Bladder Cells Using SILAC Method	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; ICAM-1 EXPRESSION; URINARY-BLADDER; CARCINOMA; IDENTIFICATION; BIOMARKERS; TISSUES; OVARIAN; CULTURE	The best way to increase patient survival rate is to identify patients who are likely to progress to muscle-invasive or metastatic disease upfront and treat them more aggressively. The human cell lines HCV29 (normal bladder epithelia), KK47 (low grade nonmuscle invasive bladder cancer, NMIBC), and YTS1 (metastatic bladder cancer) have been widely used in studies of molecular mechanisms and cell signaling during bladder cancer (BC) progression. However, little attention has been paid to global quantitative proteome analysis of these three cell lines. We labeled HCV29, KK47, and YTS1 cells by the SILAC method using three stable isotopes each of arginine and lysine. Labeled proteins were analyzed by 2D ultrahigh-resolution liquid chromatography LTQ Orbitrap mass spectrometry. Among 3721 unique identified and annotated proteins in KK47 and YTS1 cells, 36 were significantly upregulated and 74 were significantly downregulated with >95% confidence. Differential expression of these proteins was confirmed by western blotting, quantitative RT-PCR, and cell staining with specific antibodies. Gene ontology (GO) term and pathway analysis indicated that the differentially regulated proteins were involved in DNA replication and molecular transport, cell growth and proliferation, cellular movement, immune cell trafficking, and cell death and survival. These proteins and the advanced proteome techniques described here will be useful for further elucidation of molecular mechanisms in BC and other types of cancer.	[Yang, Ganglong; Lu, Wei; Guo, Jia; Guan, Feng] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Carbohydrate Chem & Biotechnol, Wuxi, Peoples R China; [Xu, Zhipeng] Shaanxi Prov Peoples Hosp, Xian, Peoples R China; [Li, Xiang] Jiangnan Univ, Wuxi Med Sch, Wuxi, Peoples R China; [Sun, Chengwen] Jiangnan Univ, Affiliated Hosp, Dept Urol, Wuxi, Peoples R China; [Xue, Peng] Chinese Acad Sci, Inst Biophys, Lab Prote, Beijing 100080, Peoples R China	Jiangnan University; Xi'an Medical University; Jiangnan University; Jiangnan University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Xue, P (corresponding author), Chinese Acad Sci, Inst Biophys, Lab Prote, Beijing 100080, Peoples R China.	xuepeng@moon.ibp.ac.cn; fengguan@jiangnan.edu.cn	Yang, Ganglong/GPP-4135-2022		National Science Foundation for Young Scientists of China [81402115, 81201572]; Natural Science Foundation of Jiangsu Province, China [BK20140172]; 111 Project of China [111-2-06]	National Science Foundation for Young Scientists of China; Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); 111 Project of China(Ministry of Education, China - 111 Project)	This work was supported by the National Science Foundation for Young Scientists of China (No. 81402115, 81201572), the Natural Science Foundation of Jiangsu Province, China (No. BK20140172) and the 111 Project of China (No. 111-2-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2014, TRENDS CELL BIOL, V24, P257, DOI 10.1016/j.tcb.2013.10.010; Arnold JM, 2001, BRIT J CANCER, V85, P1351, DOI 10.1054/bjoc.2001.2075; Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; Berard AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051939; Buitrago D, 2012, ANN SURG ONCOL, V19, P973, DOI 10.1245/s10434-011-2029-0; Caceres NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058285; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Chen JS, 2010, FEBS J, V277, P3028, DOI 10.1111/j.1742-4658.2010.07712.x; Cheng L, 2014, CRIT REV ONCOL HEMAT, V89, P73, DOI 10.1016/j.critrevonc.2013.08.008; Coombs KM, 2010, J VIROL, V84, P10888, DOI 10.1128/JVI.00431-10; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Despierre E, 2013, GYNECOL ONCOL, V130, P192, DOI 10.1016/j.ygyno.2013.03.024; Goodison S, 2013, MOL DIAGN THER, V17, P71, DOI 10.1007/s40291-013-0023-x; Goodison S, 2009, EXPERT REV PROTEOMIC, V6, P507, DOI 10.1586/EPR.09.70; HISAZUMI H, 1979, JPN J UROL, V70, P485, DOI 10.5980/jpnjurol1928.70.5_485; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kakizaki H, 1986, Nihon Hinyokika Gakkai Zasshi, V77, P1790; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Khaled H, 2013, J ADV RES, V4, P461, DOI 10.1016/j.jare.2013.06.007; Kreunin P, 2007, J PROTEOME RES, V6, P2631, DOI 10.1021/pr0700807; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Lawlor K, 2009, J PROTEOME RES, V8, P1489, DOI 10.1021/pr8008572; Lei T, 2013, CLIN GENITOURIN CANC, V11, P56, DOI 10.1016/j.clgc.2012.06.003; Linden M, 2012, PROTEOMICS, V12, P135, DOI 10.1002/pmic.201000810; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maruo Y, 2002, INT J CANCER, V100, P486, DOI 10.1002/ijc.10514; MASTERS JRW, 1986, CANCER RES, V46, P3630; Matic I, 2011, J PROTEOME RES, V10, P4869, DOI 10.1021/pr2004715; Moreira JMA, 2004, MOL CELL PROTEOMICS, V3, P410, DOI 10.1074/mcp.M300134-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Quan H, 2011, CELL PHYSIOL BIOCHEM, V27, P91, DOI 10.1159/000325209; Rong YF, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-68; Schroder C, 2011, J CANCER RES CLIN, V137, P1193, DOI 10.1007/s00432-011-0984-2; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Takakura D, 2014, PROTEOMICS, V14, P196, DOI 10.1002/pmic.201300332; Tian Y, 2011, ANAL CHEM, V83, P7013, DOI 10.1021/ac200815q; Usami Y, 2013, INT J CANCER, V133, P568, DOI 10.1002/ijc.28066; Volkmer JP, 2012, P NATL ACAD SCI USA, V109, P2078, DOI 10.1073/pnas.1120605109; Wang P, 2014, UROLOGY, V84, P1351, DOI 10.1016/j.urology.2014.07.029; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weissman I, 2005, JAMA-J AM MED ASSOC, V294, P1359, DOI 10.1001/jama.294.11.1359; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Yang GL, 2015, J PROTEOME RES, V14, P639, DOI 10.1021/pr5006026; Yang GL, 2013, PROTEOMICS, V13, P1481, DOI 10.1002/pmic.201200259; Yang GL, 2013, PROTEOMICS, V13, P878, DOI 10.1002/pmic.201200018	49	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134727	10.1371/journal.pone.0134727	http://dx.doi.org/10.1371/journal.pone.0134727			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230496	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400157
J	Fraessdorf, J; Hollmann, MW; Hanschmann, I; Heinen, A; Weber, NC; Preckel, B; Huhn, R				Fraessdorf, Jan; Hollmann, Markus W.; Hanschmann, Iris; Heinen, Andre; Weber, Nina C.; Preckel, Benedikt; Huhn, Ragnar			Role of Endogenous Opioid System in Ischemic-Induced Late Preconditioning	PLOS ONE			English	Article							INDUCED DELAYED CARDIOPROTECTION; INTACT RAT-HEART; IN-VIVO; GENE-EXPRESSION; MET-ENKEPHALIN; LATE-PHASE; RECEPTOR; INJURY; INVOLVEMENT; CYCLOOXYGENASE-2	Background Opioid receptors (OR) are involved in myocardial late preconditioning (LPC) induced by morphine and delta 1-opioid receptor (delta 1-OR) agonists. The role of OR in ischemic-induced LPC is unknown. We investigated whether 1) OR are involved in the trigger and/or mediation phase of LPC and 2) a time course effect on the expression of different opioid receptors and their endogenous ligands exists. Methods Male Wistar rats were randomly allocated to four groups (each group n = 8). Awake animals were ischemic preconditioned by a 5 minutes coronary occlusion. 24 hours later, anesthetized animals underwent 25 minutes coronary occlusion followed by 2 hours of reperfusion. The role of OR was investigated by treatment with intraperitoneal naloxone (Nal) 10 minutes prior to LPC (Nal-LPC; trigger phase) or 10 min prior to sustained ischemia (LPC-Nal; mediation phase). Results LPC reduced infarct size from 61 +/- 10% in controls to 25 +/- 9% (P<0.001). Naloxone during trigger or mediation phase completely abolished LPC-induced cardioprotection (59 +/- 9% and 62 +/- 9%; P<0.001 vs. LPC). 8, 12 and 24 hours after the ischemic stimulus, expression of delta-OR in the heart was increased, whereas mu-opioid receptor (mu-OR) and kappa-opioid receptor (kappa-OR) were not. Plasma concentrations of beta-endorphin and leu-enkephalin but not dynorphin were increased by LPC. Conclusion Ischemic LPC is triggererd and mediated by OR. Expression of delta-OR and plasma levels of endogenous opioid peptides are increased after ischemic LPC.	[Fraessdorf, Jan; Hanschmann, Iris; Huhn, Ragnar] Univ Hosp Duesseldorf, Dept Anesthesiol, Dusseldorf, Germany; [Fraessdorf, Jan; Hollmann, Markus W.; Weber, Nina C.; Preckel, Benedikt] Univ Amsterdam, Acad Med Ctr, Dept Anesthesiol, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Heinen, Andre] Univ Dusseldorf, Dept Cardiovasacular Physiol, Dusseldorf, Germany	University of Amsterdam; Academic Medical Center Amsterdam; Heinrich Heine University Dusseldorf	Hollmann, MW (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Anesthesiol, Lab Expt Intens Care & Anesthesiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	M.W.Hollmann@amc.uva.nl	Weber, Nina/CAH-0231-2022	Weber, Nina/0000-0003-1111-9042; Preckel, Benedikt/0000-0003-4412-9183	Medical Faculty of the Heinrich-Heine-University Duesseldorf, Germany [FoKo 9772215]	Medical Faculty of the Heinrich-Heine-University Duesseldorf, Germany	This work was supported by a Research Fund (FoKo 9772215) from the Medical Faculty of the Heinrich-Heine-University Duesseldorf, Germany.	Bao N, 2007, CIRC J, V71, P1622, DOI 10.1253/circj.71.1622; Baxter GF, 1997, BASIC RES CARDIOL, V92, P159; Bell SP, 2000, J AM COLL CARDIOL, V36, P2296, DOI 10.1016/S0735-1097(00)01011-1; Bolli R, 2000, CIRC RES, V87, P972, DOI 10.1161/01.RES.87.11.972; CLEMENTJONES V, 1980, NATURE, V283, P295, DOI 10.1038/283295a0; Frassdorf J, 2005, ANESTH ANALG, V101, P934, DOI 10.1213/01.ane.0000172130.70274.84; Frassdorf J, 2009, BRIT J ANAESTH, V103, P89, DOI 10.1093/bja/aep141; Fryer RM, 1999, CIRC RES, V84, P846; Gao CJ, 2012, NEUROSCIENCE, V202, P352, DOI 10.1016/j.neuroscience.2011.11.060; Guo Y, 2005, AM J PHYSIOL-HEART C, V289, pH2251, DOI 10.1152/ajpheart.00341.2005; Guo Y, 2000, BASIC RES CARDIOL, V95, P479, DOI 10.1007/s003950070024; HOWLETT TA, 1984, BRIT MED J, V288, P1950, DOI 10.1136/bmj.288.6435.1950; Huhn R, 2009, BRIT J ANAESTH, V102, P614, DOI 10.1093/bja/aep042; Jackson KE, 2001, AUTON NEUROSCI-BASIC, V94, P84, DOI 10.1016/S1566-0702(01)00351-4; Jiang XJ, 2006, LIFE SCI, V78, P2543, DOI 10.1016/j.lfs.2005.10.032; Jiang XJ, 2005, J AM COLL CARDIOL, V45, P1707, DOI 10.1016/j.jacc.2005.02.046; Jiang XJ, 2004, ANESTHESIOLOGY, V101, P82, DOI 10.1097/00000542-200407000-00014; KLONER RA, 1995, CIRCULATION, V91, P37, DOI 10.1161/01.CIR.91.1.37; Ma MC, 2005, J BIOL CHEM, V280, P16208, DOI 10.1074/jbc.M408055200; McLaughlin PJ, 1998, DEV DYNAM, V211, P153, DOI 10.1002/(SICI)1097-0177(199802)211:2<153::AID-AJA4>3.3.CO;2-O; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; PARADIS P, 1992, BIOCHEM CELL BIOL, V70, P593, DOI 10.1139/o92-090; RAYNOR K, 1994, MOL PHARMACOL, V45, P330; SCHULTZ JEJ, 1995, AM J PHYSIOL-HEART C, V268, pH2157, DOI 10.1152/ajpheart.1995.268.5.H2157; Schultz JJ, 1997, J MOL CELL CARDIOL, V29, P2187, DOI 10.1006/jmcc.1997.0454; Ventura C, 1998, J BIOL CHEM, V273, P13383, DOI 10.1074/jbc.273.22.13383; VENTURA C, 1994, J BIOL CHEM, V269, P5384; Weber NC, 2005, BRIT J PHARMACOL, V146, P445, DOI 10.1038/sj.bjp.0706324; Weber NC, 2008, ANESTH ANALG, V107, P1807, DOI 10.1213/ane.Ob013e31818874bf; Wu S, 1999, CIRC RES, V84, P1388; Zhang Y, 2004, ANESTHESIOLOGY, V101, P918, DOI 10.1097/00000542-200410000-00017	31	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134283	10.1371/journal.pone.0134283	http://dx.doi.org/10.1371/journal.pone.0134283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226627	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700067
J	Lador, F; Herve, P; Bringard, A; Gunther, S; Garcia, G; Savale, L; Ferretti, G; Soccal, PM; Chemla, D; Humbert, M; Simonneau, G; Sitbon, O				Lador, Frederic; Herve, Philippe; Bringard, Aurellen; Guenther, Sven; Garcia, Gilles; Savale, Laurent; Ferretti, Guido; Soccal, Paola M.; Chemla, Denis; Humbert, Marc; Simonneau, Gerald; Sitbon, Olivier			Non-Invasive Determination of Cardiac Output in Pre-Capillary Pulmonary Hypertension	PLOS ONE			English	Article							PULSE PRESSURE PROFILES; ARTERIAL-HYPERTENSION; STRESS ECHOCARDIOGRAPHY; EXERCISE; CIRCULATION; FLOW; HEMODYNAMICS; MODELFLOW(R); RESISTANCE; CONTOUR	Background Cardiac output (CO) is a major diagnostic and prognostic factor in pre-capillary pulmonary hypertension (PH). Reference methods for CO determination, like thermodilution (TD), require invasive procedures and allow only steady-state measurements. The Modelflow (MF) method is an appealing technique for this purpose as it allows non-invasive and beat-by-beat determination of CO. Methods We aimed to compare CO values obtained simultaneously from non-invasive pulse wave analysis by MF (COMF) and by TD (COTD) to determine its precision and accuracy in precapillary PH. The study was performed on 50 patients with pulmonary arterial hypertension (PAH) or chronic thrombo-embolic PH (CTEPH). CO was determined at rest in all patients (n = 50) and during nitric oxide vasoreactivity test, fluid challenge or exercise (n = 48). Results Baseline COMF and COTD were 6.18 +/- 1.95 and 5.46 +/- 1.95 L.min(-1), respectively. Accuracy and precision were 0.72 and 1.04 L.min-1, respectively. Limits of agreement (LoA) ranged from -1.32 to 2.76 L.min-1. Percentage error (PE) was +/- 35.7%. Overall sensitivity and specificity of COMF for directional change were 95.2% and 82.4%, (n = 48) and 93.3% and 100% for directional changes during exercise (n = 16), respectively. After application of a correction factor (1.17 +/- 0.25), neither proportional nor fixed bias was found for subsequent CO determination (n = 48). Accuracy was -0.03 L.min(-1) and precision 0.61 L.min(-1). LoA ranged from -1.23 to 1.17 L.min(-1) and PE was +/- 19.8%. Conclusions After correction against a reference method, MF is precise and accurate enough to determine absolute values and beat-by-beat relative changes of CO in pre-capillary PH.	[Lador, Frederic; Soccal, Paola M.] Hop Univ Geneve, Programme Hypertens Pulm, Serv Pneumol, Geneva, Switzerland; [Herve, Philippe; Guenther, Sven; Garcia, Gilles; Savale, Laurent; Humbert, Marc; Simonneau, Gerald; Sitbon, Olivier] Hop Bicetre, AP HP, Ctr Reference Hypertens Pulm Severe,Serv Pneumol, Dept Hosp Univ DHU Thorax Innovat TORINO, Le Kremlin Bicetre, France; [Herve, Philippe] Ctr Chirurg Marie Lannelongue, Le Plessis Robinson, France; [Bringard, Aurellen] Univ Geneva, Dept Neurosci Fondamentales, Ctr Med Univ, Geneva, Switzerland; [Guenther, Sven; Garcia, Gilles; Savale, Laurent; Humbert, Marc; Simonneau, Gerald; Sitbon, Olivier] Univ Paris 11, Fac Med, Le Kremlin Bicetre, France; [Ferretti, Guido] Univ Brescia, Dipartimento Sci Clin & Sperimentali, Brescia, Italy; [Chemla, Denis] Univ Paris 11, Fac Med, Dept Physiol, EA4533,APHP, Le Kremlin Bicetre, France	University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Hopital Marie Lannelongue; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; University of Brescia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Lador, F (corresponding author), Hop Univ Geneve, Programme Hypertens Pulm, Serv Pneumol, Geneva, Switzerland.	Frederic.lador@hcuge.ch	Günther, Sven/P-4177-2017; GÜNTHER, Sven/W-7090-2019; Savale, Laurent/AAJ-9781-2020; Humbert, Marc/ABD-5112-2021; Humbert, Marc/AAC-8459-2019; Simonneau, Gerald/ABE-6614-2020; Sitbon, Olivier/I-3623-2019	Günther, Sven/0000-0001-8388-6131; GÜNTHER, Sven/0000-0001-8388-6131; Humbert, Marc/0000-0003-0703-2892; Sitbon, Olivier/0000-0002-1942-1951; CHEMLA, Denis/0000-0001-7479-9896	European Respiratory Society (RESPIRE postdoctoral fellowship program - European Commission Seventh Framework Program (FP7)-Marie Curie Actions) [MC-1630-2010]	European Respiratory Society (RESPIRE postdoctoral fellowship program - European Commission Seventh Framework Program (FP7)-Marie Curie Actions)	This study was supported by an educational grant from the European Respiratory Society (RESPIRE postdoctoral fellowship program-Co-funded by the European Commission Seventh Framework Program (FP7)-Marie Curie Actions; MC-1630-2010) to Frederic Lador.	Argiento P, 2010, EUR RESPIR J, V35, P1273, DOI 10.1183/09031936.00076009; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cecconi M, 2009, CRIT CARE, V13, DOI 10.1186/cc7129; Chaouat A, 2014, EUR RESPIR J, V44, P704, DOI 10.1183/09031936.00153613; Critchley LAH, 1999, J CLIN MONIT COMPUT, V15, P85, DOI 10.1023/A:1009982611386; de Wilde RBP, 2009, ANAESTHESIA, V64, P762, DOI 10.1111/j.1365-2044.2009.05934.x; Garcia-Alvarez A, 2011, EUR HEART J, V32, P2438, DOI 10.1093/eurheartj/ehr173; Grunig E, 2009, CIRCULATION, V119, P1747, DOI 10.1161/CIRCULATIONAHA.108.800938; Hedelin P, 2011, CLIN PHYSIOL FUNCT I, V31, P39, DOI [10.1111/j.1475-097X.2010.00977.x, DOI 10.1111/J.1475-097X.2010.00977.X]; Herve P, 2015, EUR RESP J; Hoeper MM, 2006, J AM COLL CARDIOL, V48, P2546, DOI 10.1016/j.jacc.2006.07.061; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Hoeper MM, 1999, AM J RESP CRIT CARE, V160, P535, DOI 10.1164/ajrccm.160.2.9811062; Houtman S, 1999, CLIN PHYSIOL, V19, P230, DOI 10.1046/j.1365-2281.1999.00166.x; Jakovljevic DG, 2014, BEST PRACT RES-CLIN, V28, P381, DOI 10.1016/j.bpa.2014.09.003; Kenfack MA, 2004, CLIN SCI, V106, P365, DOI 10.1042/CS20030303; Lador F, 2013, SEMIN RESP CRIT CARE, V34, P654, DOI 10.1055/s-0033-1356549; Lau EMT, 2014, CHEST, V146, P959, DOI 10.1378/chest.13-2300; McLaughlin VV, 2013, J AM COLL CARDIOL, V62, pD73, DOI 10.1016/j.jacc.2013.10.034; Provencher S, 2008, EUR RESPIR J, V32, P393, DOI 10.1183/09031936.00009008; Reeves JT, 2005, AM J PHYSIOL-LUNG C, V288, pL419, DOI 10.1152/ajplung.00162.2004; Remmen JJ, 2002, CLIN SCI, V103, P143, DOI 10.1042/CS20010357; Rich JD, 2013, EUR RESPIR J, V42, P125, DOI 10.1183/09031936.00102212; Saggar R, 2010, ARTHRITIS RHEUM-US, V62, P3741, DOI 10.1002/art.27695; Schloglhofer T, 2014, CAN J ANESTH, V61, P452, DOI 10.1007/s12630-014-0135-8; Swift AJ, 2013, JACC-CARDIOVASC IMAG, V6, P1036, DOI 10.1016/j.jcmg.2013.01.013; Tam E, 2004, CLIN SCI, V106, P371, DOI 10.1042/CS20030302; van Lieshout JJ, 2003, EUR J APPL PHYSIOL, V90, P131, DOI 10.1007/s00421-003-0901-8; van Lieshout JJ, 2003, CLIN SCI, V104, P239; Warburton DER, 1999, SPORTS MED, V27, P23, DOI 10.2165/00007256-199927010-00003; WESSELING KH, 1993, J APPL PHYSIOL, V74, P2566, DOI 10.1152/jappl.1993.74.5.2566; York D, 2004, AM J PHYS, V72, P367, DOI 10.1119/1.1632486	32	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134221	10.1371/journal.pone.0134221	http://dx.doi.org/10.1371/journal.pone.0134221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226280	Green Published, Green Submitted, gold			2022-12-27	WOS:000358837700064
J	So, NN; Franks, B; Lim, S; Curley, JP				So, Nina; Franks, Becca; Lim, Sean; Curley, James P.			A Social Network Approach Reveals Associations between Mouse Social Dominance and Brain Gene Expression	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; AGGRESSIVE-BEHAVIOR; MEDIAL AMYGDALA; ANIMAL-MODELS; MALE-MICE; AGONISTIC ENCOUNTERS; CENTRAL NUCLEUS; HOUSE MICE; STRESS; SYSTEM	Modelling complex social behavior in the laboratory is challenging and requires analyses of dyadic interactions occurring over time in a physically and socially complex environment. In the current study, we approached the analyses of complex social interactions in group-housed male CD1 mice living in a large vivarium. Intensive observations of social interactions during a 3-week period indicated that male mice form a highly linear and steep dominance hierarchy that is maintained by fighting and chasing behaviors. Individual animals were classified as dominant, sub-dominant or subordinate according to their David's Scores and I& SI ranking. Using a novel dynamic temporal Glicko rating method, we ascertained that the dominance hierarchy was stable across time. Using social network analyses, we characterized the behavior of individuals within 66 unique relationships in the social group. We identified two individual network metrics, Kleinberg's Hub Centrality and Bonacich's Power Centrality, as accurate predictors of individual dominance and power. Comparing across behaviors, we establish that agonistic, grooming and sniffing social networks possess their own distinctive characteristics in terms of density, average path length, reciprocity out-degree centralization and out-closeness centralization. Though grooming ties between individuals were largely independent of other social networks, sniffing relationships were highly predictive of the directionality of agonistic relationships. Individual variation in dominance status was associated with brain gene expression, with more dominant individuals having higher levels of corticotropin releasing factor mRNA in the medial and central nuclei of the amygdala and the medial preoptic area of the hypothalamus, as well as higher levels of hippocampal glucocorticoid receptor and brain-derived neurotrophic factor mRNA. This study demonstrates the potential and significance of combining complex social housing and intensive behavioral characterization of group-living animals with the utilization of novel statistical methods to further our understanding of the neurobiological basis of social behavior at the individual, relationship and group levels.	[So, Nina; Franks, Becca; Lim, Sean; Curley, James P.] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [So, Nina] Columbia Univ, Doctoral Program Neurobiol & Behav, New York, NY 10025 USA; [Franks, Becca] UBC Anim Welf Program, Vancouver, BC V6T 1Z4, Canada	Columbia University; Columbia University	Curley, JP (corresponding author), Columbia Univ, Dept Psychol, New York, NY 10027 USA.	jc3181@columbia.edu		Curley, James/0000-0001-5546-007X	Psychology Department, Columbia University	Psychology Department, Columbia University	This research was supported by the Psychology Department, Columbia University.	Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; Adams DB, 2006, NEUROSCI BIOBEHAV R, V30, P304, DOI 10.1016/j.neubiorev.2005.09.004; [Anonymous], 2014, R LANG ENV STAT COMP; APPLEBY MC, 1983, ANIM BEHAV, V31, P600, DOI 10.1016/S0003-3472(83)80084-0; Arakawa H, 2007, BEHAV BRAIN RES, V176, P27, DOI 10.1016/j.bbr.2006.07.027; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Bauman MD, 2004, J COGNITIVE NEUROSCI, V16, P1388, DOI 10.1162/0898929042304741; BENTON D, 1980, ANIM BEHAV, V28, P1274, DOI 10.1016/S0003-3472(80)80115-1; BERRY R J, 1970, Field Studies, V3, P219; Bickart KC, 2014, NEUROPSYCHOLOGIA, V63, P235, DOI 10.1016/j.neuropsychologia.2014.08.013; Blanchard RJ, 2001, PHYSIOL BEHAV, V73, P261, DOI 10.1016/S0031-9384(01)00449-8; Boden B, 2013, PROCEEDINGS OF THE 22ND ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM'13), DOI 10.1145/2505515.2508200; BOLHUIS JJ, 1984, PHYSIOL BEHAV, V32, P575, DOI 10.1016/0031-9384(84)90311-1; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; Branchi I, 2013, PSYCHONEUROENDOCRINO, V38, P522, DOI 10.1016/j.psyneuen.2012.07.010; Brodkin ES, 2007, BEHAV BRAIN RES, V176, P53, DOI 10.1016/j.bbr.2006.06.025; BRONSON FH, 1973, PHYSIOL BEHAV, V10, P947, DOI 10.1016/0031-9384(73)90065-6; Butts C.T., 2014, SNA TOOLS SOCIAL NET; Butts CT, 2011, SOCIOL METHODOL, V41, P299, DOI 10.1111/j.1467-9531.2011.01246.x; CANTERAS NS, 1995, J COMP NEUROL, V360, P213, DOI 10.1002/cne.903600203; Carpenter RE, 2009, NEUROSCIENCE, V158, P412, DOI 10.1016/j.neuroscience.2008.10.014; Carpenter RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096632; Cooper MA, 2010, PHYSIOL BEHAV, V101, P527, DOI 10.1016/j.physbeh.2010.08.003; Cowansage Kiriana K, 2010, Curr Mol Pharmacol, V3, P12; Croft DP, 2011, TRENDS ECOL EVOL, V26, P502, DOI 10.1016/j.tree.2011.05.012; Crowcroft P, 1955, J MAMMAL, P299; CROWCROFT PETER, 1963, PROC ZOOL SOC LONDON, V140, P517; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Cumbo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105001; Curley J, 2015, COMPETE ANAL COMPETI; David H.A., 1988, METHOD PAIRED COMP; DAVID HA, 1987, BIOMETRIKA, V74, P432, DOI 10.2307/2336160; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; De Vries H, 2006, ANIM BEHAV, V71, P585, DOI 10.1016/j.anbehav.2005.05.015; De Vries H, 1998, ANIM BEHAV, V55, P827, DOI 10.1006/anbe.1997.0708; DEVRIES H, 1995, ANIM BEHAV, V50, P1375, DOI 10.1016/0003-3472(95)80053-0; Donaldson ZR, 2015, BIOL PSYCHIAT, V77, P15, DOI 10.1016/j.biopsych.2014.02.004; ELKABIR DR, 1990, REGUL PEPTIDES, V28, P199, DOI 10.1016/0167-0115(90)90018-R; Elo A. E., 1978, RATING CHESSPLAYERS; ELY DL, 1978, HORM BEHAV, V10, P156, DOI 10.1016/0018-506X(78)90005-3; Fekete EM, 2007, FRONT NEUROENDOCRIN, V28, P1, DOI 10.1016/j.yfrne.2006.09.002; Fiore M, 2003, EUR J NEUROSCI, V17, P1455, DOI 10.1046/j.1460-9568.2003.02573.x; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Freund J, 2013, SCIENCE, V340, P756, DOI 10.1126/science.1235294; Gammell MP, 2003, ANIM BEHAV, V66, P601, DOI 10.1006/anbe.2003.2226; Gray SJ, 2000, ANIM BEHAV, V60, P765, DOI 10.1006/anbe.2000.1527; HAEMISCH A, 1994, PHYSIOL BEHAV, V56, P1041, DOI 10.1016/0031-9384(94)90341-7; Hanneman R.A., 2005, INTRO SOCIAL NETWORK; HAYASHI S, 1993, J ETHOL, V11, P77, DOI 10.1007/BF02350040; Heinrichs SC, 2004, J PHARMACOL EXP THER, V311, P427, DOI 10.1124/jpet.103.052092; Heinrichs SC, 2003, BRAIN RES, V994, P107, DOI 10.1016/j.brainres.2003.09.028; HILAKIVICLARKE LA, 1992, J COMP PSYCHOL, V106, P184, DOI 10.1037/0735-7036.106.2.184; HINDE RA, 1976, MAN, V11, P1, DOI 10.2307/2800384; Hong WZ, 2014, CELL, V158, P1348, DOI 10.1016/j.cell.2014.07.049; Hostetler CM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00092; Huang SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103733; HURST JL, 1993, ANIM BEHAV, V45, P997, DOI 10.1006/anbe.1993.1117; Husson F, 2015, FACTOMINER MULTIVARI; Insel TR, 1998, BIOL PSYCHIAT, V44, P207, DOI 10.1016/S0006-3223(98)00094-8; JONES RB, 1973, ANIM BEHAV, V21, P707, DOI 10.1016/S0003-3472(73)80095-8; Kalueff AV, 2006, BEHAV PROCESS, V71, P8, DOI 10.1016/j.beproc.2005.09.004; Kas MJ, 2014, PSYCHOPHARMACOLOGY, V231, P1125, DOI 10.1007/s00213-013-3268-5; Kasahara M, 2011, BEHAV BRAIN RES, V218, P357, DOI 10.1016/j.bbr.2010.12.029; Kleinberg J., 1998, P 9 ACM SIAM S DISCR; KRACKHARDT D, 1987, SOC NETWORKS, V9, P171, DOI 10.1016/0378-8733(87)90012-8; Kumaran D, 2012, NEURON, V76, P653, DOI 10.1016/j.neuron.2012.09.035; Kutsukake N, 2006, ANIM BEHAV, V72, P1059, DOI 10.1016/j.anbehav.2006.02.016; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Lehmann J, 2007, ANIM BEHAV, V74, P1617, DOI 10.1016/j.anbehav.2006.10.025; Lehmann J, 2011, AM J PRIMATOL, V73, P775, DOI 10.1002/ajp.20967; Leiva D., 2011, STEEPNESS TESTING ST; Lewejohann L, 2010, BEHAV BRAIN RES, V211, P220, DOI 10.1016/j.bbr.2010.03.035; Lewejohann L, 2009, BEHAV RES METHODS, V41, P850, DOI 10.3758/BRM.41.3.850; LIEBSCH G, 1995, REGUL PEPTIDES, V59, P229, DOI 10.1016/0167-0115(95)00099-W; LOUCH CD, 1967, GEN COMP ENDOCR, V8, P441, DOI 10.1016/S0016-6480(67)80006-6; Lowry CA, 2006, GEN COMP ENDOCR, V146, P19, DOI 10.1016/j.ygcen.2005.12.006; LUITEN PGM, 1985, BRAIN RES, V332, P283, DOI 10.1016/0006-8993(85)90597-9; Machado CJ, 2006, BEHAV NEUROSCI, V120, P761, DOI 10.1037/0735-7044.120.4.761; MACKINTO.JH, 1970, ANIM BEHAV, V18, P177, DOI 10.1016/0003-3472(70)90088-6; Markham CM, 2008, LEARN MEMORY, V15, P6, DOI 10.1101/lm.768208; Martinez M, 1998, EUR J NEUROSCI, V10, P20, DOI 10.1046/j.1460-9568.1998.00011.x; Maruska KP, 2013, J NEUROENDOCRINOL, V25, P145, DOI 10.1111/j.1365-2826.2012.02382.x; Mashoodh R, 2012, P NATL ACAD SCI USA, V109, P17232, DOI 10.1073/pnas.1121083109; MONDRAGON R, 1987, BEHAV NEURAL BIOL, V47, P384, DOI 10.1016/S0163-1047(87)90500-0; Motta SC, 2009, P NATL ACAD SCI USA, V106, P4870, DOI 10.1073/pnas.0900939106; Noonan MP, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001940; Ohayon S, 2013, J NEUROSCI METH, V219, P10, DOI 10.1016/j.jneumeth.2013.05.013; Pan YL, 2010, HORM BEHAV, V58, P478, DOI 10.1016/j.yhbeh.2010.05.001; Pardo-Bellver C, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00033; Paxinos G, 2012, PAXINOS FRANKLINS MO; Perony N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002786; Pizarro JM, 2004, BRAIN RES, V1025, P10, DOI 10.1016/j.brainres.2004.06.085; POOLE TB, 1973, ANIM BEHAV, V21, P788, DOI 10.1016/S0003-3472(73)80105-8; Poole TB, 1976, ANIM BEHAV, V23, P470; POSHIVALOV VP, 1980, BRIT J PHARMACOL, V70, P367, DOI 10.1111/j.1476-5381.1980.tb08712.x; Robison CL, 2004, ANN NY ACAD SCI, V1032, P324, DOI 10.1196/annals.1314.052; Rodriguiz RM, 2004, BEHAV BRAIN RES, V148, P185, DOI 10.1016/S0166-4328(03)00187-6; ROSEN JB, 1991, BEHAV NEUROSCI, V105, P817, DOI 10.1037/0735-7044.105.6.817; ROSVOLD HE, 1954, J COMP PHYSIOL PSYCH, V47, P173, DOI 10.1037/h0058870; Shemesh Y, 2013, ELIFE, V2, DOI [10.7554/eLife.00759, 10.7554/eLife.03602]; Shizuka D, 2012, ANIM BEHAV, V83, P925, DOI 10.1016/j.anbehav.2012.01.011; Stephenson A., 2014, PLAYERRATINGS DYNAMI; Sueur C, 2011, AM J PRIMATOL, V73, P703, DOI 10.1002/ajp.20915; Taylor SL, 2011, BEHAV NEUROSCI, V125, P911, DOI 10.1037/a0026172; Timmer M, 2011, NEUROPSYCHOPHARMACOL, V36, P2349, DOI 10.1038/npp.2011.125; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Uhrich J, 1938, J COMP PSYCHOL, V25, P373, DOI 10.1037/h0056350; Usunoff KG, 2009, CELLS TISSUES ORGANS, V190, P256, DOI 10.1159/000209233; van Hoof J.A.R.A.M., 1987, Perspectives in Vertebrate Science, V4, P219; Van Loo PLP, 2004, LAB ANIM-UK, V38, P169, DOI 10.1258/002367704322968858; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; VOCHTELOO JD, 1987, PHYSIOL BEHAV, V41, P99, DOI 10.1016/0031-9384(87)90137-5; Wang F, 2014, TRENDS NEUROSCI, V37, P674, DOI 10.1016/j.tins.2014.07.005; Weissbrod A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3018; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020	116	75	75	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0134509	10.1371/journal.pone.0134509	http://dx.doi.org/10.1371/journal.pone.0134509			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226265	Green Published, gold, Green Submitted			2022-12-27	WOS:000358837700104
J	Antonissen, G; Devreese, M; De Baere, S; Hellebuyck, T; Van de Maele, I; Rouffaer, L; Stemkens, HJJ; De Backer, P; Martel, A; Croubels, S				Antonissen, Gunther; Devreese, Mathias; De Baere, Siegrid; Hellebuyck, Tom; Van de Maele, Isabel; Rouffaer, Lieze; Stemkens, Hendrickus J. J.; De Backer, Patrick; Martel, An; Croubels, Siska			Comparative Pharmacokinetics and Allometric Scaling of Carboplatin in Different Avian Species	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; GLOMERULAR-FILTRATION; PLASMA; TUMOR; CLEARANCE; CISPLATIN; TOXICITY; DRUGS	The use of chemotherapeutics as a possible treatment strategy in avian oncology is steadily increasing over the last years. Despite this, literature reports regarding dosing strategies and pharmacokinetic behaviour of chemotherapeutics in avian species are lacking. The aim of the present study was to investigate the pharmacokinetics of carboplatin in a representative species of the order of Galliformes, Anseriformes, Columbiformes and Psittaciformes. Eight chickens, ducks and pigeons and twenty-eight parakeets were administered carboplatin intravenously (5 mg/kg body weight). A specific and sensitive liquid chromatographytandem mass spectrometry method was developed and validated for quantification of the free carboplatin in plasma of the four birds species (limit of quantification: 20 ng/mL for chicken and duck, 50 ng/mL for pigeon and 100 ng/mL for parakeets). Non-compartmental pharmacokinetic analysis and allometric scaling demonstrated a significant correlation (R-2 = 0.9769) between body weight (BW) and elimination half-life (T-1/2el). T-1/2el ranged from 0.41 h in parakeets (BW: 61 +/- 8 g) to 1.16 h chickens (BW: 1909 +/- 619 g). T-1/2el is a good parameter for dose optimization of carboplatin in other avian species, since also the previously reported T-1/2el in cockatoos (average BW: 769 +/- 68 g) of 1.00 h corresponds to the results obtained in the present study.	[Antonissen, Gunther; Devreese, Mathias; De Baere, Siegrid; De Backer, Patrick; Croubels, Siska] Univ Ghent, Fac Vet Med, Dept Pharmacol Toxicol & Biochem, Merelbeke, Belgium; [Antonissen, Gunther; Hellebuyck, Tom; Rouffaer, Lieze; Stemkens, Hendrickus J. J.; Martel, An] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Van de Maele, Isabel] Univ Ghent, Fac Vet Med, Dept Small Anim Med & Clin Biol, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University	Antonissen, G (corresponding author), Univ Ghent, Fac Vet Med, Dept Pharmacol Toxicol & Biochem, Merelbeke, Belgium.	Gunther.Antonissen@UGent.be		Devreese, Mathias/0000-0003-2512-4176; Antonissen, Gunther/0000-0001-8832-1498; Croubels, Siska/0000-0001-6357-3517				ADOLPH EF, 1949, SCIENCE, V109, P579, DOI 10.1126/science.109.2841.579; [Anonymous], 2015, STUD EV MET RES KIN; Baert K, 2003, COMP BIOCHEM PHYS C, V134, P25, DOI 10.1016/S1532-0456(02)00184-9; Bailey DB, 2004, AM J VET RES, V65, P1502, DOI 10.2460/ajvr.2004.65.1502; Bradford C, 2009, J AVIAN MED SURG, V23, P214, DOI 10.1647/2008-015.1; CALVERT AH, 1989, J CLIN ONCOL, V7, P1748, DOI 10.1200/JCO.1989.7.11.1748; Childs-Sanford SE, 2006, VET COMP ONCOL, V4, P51, DOI 10.1111/j.1476-5810.2006.00087.x; Citac Eurachem, 2000, J EUR UNION, VL221, P8; DALEYYATES PT, 1985, BIOCHEM PHARMACOL, V34, P1423, DOI 10.1016/0006-2952(85)90679-3; De Baere S, 2011, J CHROMATOGR B, V879, P2403, DOI 10.1016/j.jchromb.2011.06.036; Desjardins C, 2008, J CHROMATOGR B, V875, P373, DOI 10.1016/j.jchromb.2008.09.013; Filippich L, 2004, AUST VET J, V82, P366, DOI 10.1111/j.1751-0813.2004.tb11106.x; Filippich LJ, 2004, SEMIN AVIAN EXOT PET, V13, P25, DOI 10.1053/S1055-937X(03)00055-0; Flammer K, 2005, J AVIAN MED SURG, V19, P216, DOI 10.1647/2004-007.1; GAVER RC, 1988, CANCER CHEMOTH PHARM, V21, P197; Graham Jennifer E, 2004, Vet Clin North Am Exot Anim Pract, V7, P757, DOI 10.1016/j.cvex.2004.04.004; Guo P, 2003, J CHROMATOGR B, V783, P43, DOI 10.1016/S1570-0232(02)00489-0; HARLAND SJ, 1984, CANCER RES, V44, P1693; Heitzman R. J, 1994, 14126EN; Ito H, 2013, J CHROMATOGR B, V917, P18, DOI 10.1016/j.jchromb.2012.11.024; Jiang HL, 2011, J CHROMATOGR B, V879, P2162, DOI 10.1016/j.jchromb.2011.05.057; Kent Michael S, 2004, Vet Clin North Am Exot Anim Pract, V7, P807, DOI 10.1016/j.cvex.2004.04.006; Kloft C, 2002, J CLIN PHARMACOL, V42, P762, DOI 10.1177/009127002401102704; Macwhirter P., 2002, Exotic DVM, V4, P11; Mahmood I, 1999, J PHARM SCI-US, V88, P1101, DOI 10.1021/js9902163; Mete A, 2013, AVIAN DIS, V57, P311, DOI 10.1637/10382-092312-Case.1; Mo JX, 2014, ANAL BIOANAL CHEM, V406, P2659, DOI 10.1007/s00216-014-7684-0; PAGE RL, 1993, J VET INTERN MED, V7, P235, DOI 10.1111/j.1939-1676.1993.tb01013.x; Reavill Drury R, 2004, Vet Clin North Am Exot Anim Pract, V7, P537, DOI 10.1016/j.cvex.2004.04.008; REID HAC, 1993, AVIAN DIS, V37, P1158, DOI 10.2307/1591930; Riviere JE, 1997, J VET PHARMACOL THER, V20, P453, DOI 10.1046/j.1365-2885.1997.00095.x; Screnci D, 2000, BRIT J CANCER, V82, P966, DOI 10.1054/bjoc.1999.1026; Shimonohara N, 2013, AVIAN DIS, V57, P133, DOI 10.1637/10244-051012-Case.1; SIDDIK ZH, 1987, BIOCHEM PHARMACOL, V36, P1925, DOI 10.1016/0006-2952(87)90490-4; Sooriyaarachchi M, 2011, METALLOMICS, V3, P49, DOI 10.1039/c0mt00058b; SORENSEN BT, 1992, CANCER CHEMOTH PHARM, V30, P317, DOI 10.1007/BF00686302; Speer BL, 2001, P EUR C AV MED SURG, P20; VANDERVIJGH WJF, 1991, CLIN PHARMACOKINET, V21, P242, DOI 10.2165/00003088-199121040-00002; YOKOTA SD, 1985, RENAL PHYSIOL BIOCH, V8, P193; Zehnder AM, 2011, P 32 ANN ASS AV VET, P27	40	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2015	10	7							e0134177	10.1371/journal.pone.0134177	http://dx.doi.org/10.1371/journal.pone.0134177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JM	26222777	gold, Green Published, Green Submitted			2022-12-27	WOS:000358836800110
J	Brinkmann, BH; Patterson, EE; Vite, C; Vasoli, VM; Crepeau, D; Stead, M; Howbert, JJ; Cherkassky, V; Wagenaar, JB; Litt, B; Worrell, GA				Brinkmann, Benjamin H.; Patterson, Edward E.; Vite, Charles; Vasoli, Vincent M.; Crepeau, Daniel; Stead, Matt; Howbert, J. Jeffry; Cherkassky, Vladimir; Wagenaar, Joost B.; Litt, Brian; Worrell, Gregory A.			Forecasting Seizures Using Intracranial EEG Measures and SVM in Naturally Occurring Canine Epilepsy	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; TEMPORAL-LOBE; ANTIEPILEPTIC DRUGS; ANIMAL-MODELS; PREDICTION; ELECTROENCEPHALOGRAPHY; SYSTEM; BRAIN; DOGS; LEVETIRACETAM	Management of drug resistant focal epilepsy would be greatly assisted by a reliable warning system capable of alerting patients prior to seizures to allow the patient to adjust activities or medication. Such a system requires successful identification of a preictal, or seizure-prone state. Identification of preictal states in continuous long-duration intracranial electroenceph-alographic (iEEG) recordings of dogs with naturally occurring epilepsy was investigated using a support vector machine (SVM) algorithm. The dogs studied were implanted with a 16-channel ambulatory iEEG recording device with average channel reference for a mean (st. dev.) of 380.4 (+87.5) days producing 220.2 (+104.1) days of intracranial EEG recorded at 400 Hz for analysis. The iEEG records had 51.6 (+52.8) seizures identified, of which 35.8 (+30.4) seizures were preceded by more than 4 hours of seizure-free data. Recorded iEEG data were stratified into 11 contiguous, non-overlapping frequency bands and binned into one-minute synchrony features for analysis. Performance of the SVM classifier was assessed using a 5-fold cross validation approach, where preictal training data were taken from 90 minute windows with a 5 minute pre-seizure offset. Analysis of the optimal preictal training time was performed by repeating the cross validation over a range of preictal windows and comparing results. We show that the optimization of feature selection varies for each subject, i.e. algorithms are subject specific, but achieve prediction performance significantly better than a time-matched Poisson random predictor (p<0.05) in 5/5 dogs analyzed.	[Brinkmann, Benjamin H.; Vasoli, Vincent M.; Crepeau, Daniel; Stead, Matt; Worrell, Gregory A.] Mayo Clin, Mayo Syst Electrophysiol Lab, Rochester, MN 55905 USA; [Patterson, Edward E.] Univ Minnesota, Ctr Vet Med, St Paul, MN 55108 USA; [Vite, Charles] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Howbert, J. Jeffry] NeuroVista Inc, Seattle, WA USA; [Cherkassky, Vladimir] Univ Minnesota, Dept Elect & Comp Engn, St Paul, MN 55108 USA; [Wagenaar, Joost B.; Litt, Brian] Univ Penn, Penn Ctr Neuroengn & Therapeut, Philadelphia, PA 19104 USA	Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania; University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania	Brinkmann, BH (corresponding author), Mayo Clin, Mayo Syst Electrophysiol Lab, Rochester, MN 55905 USA.	brinkmann.benjamin@mayo.edu		Brinkmann, Benjamin/0000-0002-2392-8608; Vasoli, Vincent/0000-0001-8004-748X; Wagenaar, Joost/0000-0003-0837-7120	National Institute of Neurological Disorders and Stroke at National Institutes of Health [U01-NS073557, R01-NS630391]; Mayo Clinic; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS073557, R01NS092882, U24NS063930] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010939] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke at National Institutes of Health; Mayo Clinic; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute of Neurological Disorders and Stroke at National Institutes of Health (U01-NS073557, R01-NS630391), and Mayo Clinic supported this work. The authors are grateful for the access provided by NeuroVista to parts of its internal statistical data analysis pipeline. The funding agencies had no part in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson PD, 1999, EPILEPSIA, V40, P1484, DOI 10.1111/j.1528-1157.1999.tb02030.x; Andrzejak RG, 2009, CLIN NEUROPHYSIOL, V120, P1465, DOI 10.1016/j.clinph.2009.05.019; Badawy R, 2009, BRAIN, V132, P1013, DOI 10.1093/brain/awp017; Baumgartner C, 1998, J NUCL MED, V39, P978; Berendt M, 1999, ACTA NEUROL SCAND, V99, P276, DOI 10.1111/j.1600-0404.1999.tb00676.x; Bragin A, 2002, J NEUROSCI, V22, P2012, DOI 10.1523/JNEUROSCI.22-05-02012.2002; Brinkmann BH, 2009, J NEUROSCI METH, V180, P185, DOI 10.1016/j.jneumeth.2009.03.022; Caruana R., 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865; Chandler K, 2006, VET J, V172, P207, DOI 10.1016/j.tvjl.2005.07.001; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cherkassky V, 2004, NEURAL NETWORKS, V17, P113, DOI 10.1016/S0893-6080(03)00169-2; Cherkassky V, 2013, PREDICTIVE LEARNING; Cherkassky V, 2011, IEEE T NEURAL NETWOR, V22, P1241, DOI 10.1109/TNN.2011.2157522; Coles LD, 2013, EPILEPSY RES, V106, P456, DOI 10.1016/j.eplepsyres.2013.06.007; Cook MJ, 2013, LANCET NEUROL, V12, P563, DOI 10.1016/S1474-4422(13)70075-9; Davis KA, 2011, EPILEPSY RES, V96, P116, DOI 10.1016/j.eplepsyres.2011.05.011; Dudek FE, 2011, EPILEPSY RES, V97, P324, DOI 10.1016/j.eplepsyres.2011.10.017; DUNCAN JS, 1987, EPILEPSIA, V28, P259, DOI 10.1111/j.1528-1157.1987.tb04216.x; Engel Jerome Jr, 2003, Epilepsy Curr, V3, P37, DOI 10.1046/j.1535-7597.2003.03201.x; Federico P, 2005, BRAIN, V128, P1811, DOI 10.1093/brain/awh533; Gadhoumi K, 2013, CLIN NEUROPHYSIOL, V124, P1745, DOI 10.1016/j.clinph.2013.04.006; Gowers S, 1885, EPILEPSY OTHER CHRON; Howbert JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081920; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; Long S, 2014, J VET INTERN MED, V28, P189, DOI 10.1111/jvim.12235; MARCIANI MG, 1986, EPILEPSIA, V27, P423, DOI 10.1111/j.1528-1157.1986.tb03562.x; Mormann F, 2005, CLIN NEUROPHYSIOL, V116, P569, DOI 10.1016/j.clinph.2004.08.025; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Murray G, 1994, GLOBAL COMP ASSESSME; Park Y, 2011, EPILEPSIA, V52, P1761, DOI 10.1111/j.1528-1167.2011.03138.x; Patterson EE, 2008, J VET PHARMACOL THER, V31, P253, DOI 10.1111/j.1365-2885.2008.00948.x; Patterson EE, 2014, ILAR J, V55, P182, DOI 10.1093/ilar/ilu021; Pellegrino FC, 2004, CLIN NEUROPHYSIOL, V115, P477, DOI 10.1016/S1388-2457(03)00347-X; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; PODELL M, 1993, J VET INTERN MED, V7, P318, DOI 10.1111/j.1939-1676.1993.tb01025.x; Potschka H, 2013, EPILEPSIA, V54, P571, DOI 10.1111/epi.12138; Schulze-Bonhage A, 2010, EPILEPSY BEHAV, V18, P388, DOI 10.1016/j.yebeh.2010.05.008; Snyder DE, 2008, J NEURAL ENG, V5, P392, DOI 10.1088/1741-2560/5/4/004; Stacey W, 2011, EPILEPSY RES, V97, P243, DOI 10.1016/j.eplepsyres.2011.07.012; Teixeira C, 2012, IEEE ENG MED BIO, P6530, DOI 10.1109/EMBC.2012.6347490; Thomas WB, 2010, VET CLIN N AM-SMALL, V40, P161, DOI 10.1016/j.cvsm.2009.09.004; Van Gompel JJ, 2008, NEUROSURGERY, V63, P498, DOI 10.1227/01.NEU.0000324996.37228.F8; Vapnik V, 2009, NEURAL NETWORKS, V22, P544, DOI 10.1016/j.neunet.2009.06.042; Vermeulen J, 1995, EPILEPSY RES, V22, P65, DOI 10.1016/0920-1211(95)00047-X; Volk HA, 2008, VET J, V176, P310, DOI 10.1016/j.tvjl.2007.03.002; Warren CP, 2010, J NEUROPHYSIOL, V104, P3530, DOI 10.1152/jn.00368.2010; Weinand ME, 1997, J NEUROSURG, V86, P226, DOI 10.3171/jns.1997.86.2.0226; Weintraub D, 2007, EPILEPSY BEHAV, V10, P105, DOI 10.1016/j.yebeh.2006.08.008; Witt JA, 2013, EPILEPSY BEHAV, V29, P141, DOI 10.1016/j.yebeh.2013.07.013; Worrell GA, 2008, BRAIN, V131, P928, DOI 10.1093/brain/awn006	50	54	56	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133900	10.1371/journal.pone.0133900	http://dx.doi.org/10.1371/journal.pone.0133900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241907	Green Published, Green Submitted, gold			2022-12-27	WOS:000358942700028
J	Dhanjal, JK; Sreenidhi, AK; Bafna, K; Katiyar, SP; Goyal, S; Grover, A; Sundar, D				Dhanjal, Jaspreet Kaur; Sreenidhi, Anith Kumar; Bafna, Khushboo; Katiyar, Shashank Prakash; Goyal, Sukriti; Grover, Abhinav; Sundar, Durai			Computational Structure-Based De Novo Design of Hypothetical Inhibitors against the Anti-Inflammatory Target COX-2	PLOS ONE			English	Article							POTENTIAL FUNCTIONS; ACCURATE DOCKING; FORCE-FIELD; PROTEIN; CYCLOOXYGENASE; GLIDE; ENVIRONMENT; PEPTIDES; MODEL	Cyclooxygenase-2 (COX-2) produces prostaglandins in inflamed tissues and hence has been considered as an important target for the development of anti-inflammatory drugs since long. Administration of traditional non-steroidal anti-inflammatory drugs (NSAIDs) and other COX-2 selective inhibitors (COXIBS) for the treat of inflammation has been found to be associated with side effects, which mainly includes gastro-intestinal (GI) toxicity. The present study involves developing a virtual library of novel molecules with high druglikeliness using structure-based de novo drug designing and 2D fingerprinting approach. A library of 2657 drug like molecules was generated. 2D fingerprinting based screening of the designed library gave a unique set of compounds. Molecular docking approach was then used to identify two compounds highly specific for COX-2 isoform. Molecular dynamics simulations of protein-ligand complexes revealed that the candidate ligands were dynamically stable within the cyclooxygenase binding site of COX-2. The ligands were further analyzed for their druglikeliness, ADMET properties and synthetic accessibility using knowledge based set of rules. The results revealed that the molecules are predicted to selectively bind to COX-2 enzyme thereby potentially overcoming the limitations posed by the drugs in clinical use.	[Dhanjal, Jaspreet Kaur; Sreenidhi, Anith Kumar; Bafna, Khushboo; Katiyar, Shashank Prakash; Sundar, Durai] Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India; [Sreenidhi, Anith Kumar] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India; [Goyal, Sukriti] Banasthali Univ, Apaji Inst Math & Appl Comp Technol, Tonk, Rajasthan, India; [Grover, Abhinav] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; University of Hyderabad; Banasthali Vidyapith; Jawaharlal Nehru University, New Delhi	Sundar, D (corresponding author), Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India.	sundar@dbeb.iitd.ac.in	Dhanjal, Jaspreet Kaur/AAQ-3504-2020	Dhanjal, Jaspreet Kaur/0000-0003-4226-3063; Sundar, Durai/0000-0002-6549-6663; Katiyar, Shashank/0000-0002-8496-5103; Bafna, Khushboo/0000-0002-1893-1175	IIT Delhi	IIT Delhi	We thank Atul Nag (Summer Faculty Research Fellow-2011 at IIT Delhi) for the development of an algorithm to calculate the Tanimoto coefficients and Akanksha Gupta for her contribution to this work. We also thank Yaxia Yuan, Peking University, Beijing, China, for his guidance with designing the library of molecules using LigBuilder. We are also thankful to Yoshifumi Fukunishi of the 3D Drug Design Team at the Molecular Profiling Research Center for Drug Discovery of National Institute of Advanced Industrial Science and Technology (AIST), Tokyo, Japan, for assistance with the calculation of SA scores. AKS was a Summer Research Fellow in the laboratory of DS under the Summer Research Fellowship Program of IIT Delhi for M.Tech/M.E. students 2012. The authors acknowledge the DBT Bioinformatics facility at the Distributed Information Sub Centre, Department of Biochemical Engineering and Biotechnology, IIT Delhi and the Bioinformatics Infrastructure Facility at the School of Life Sciences, University of Hyderabad, supported by the Department of Biotechnology (DBT), Govt. of India.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2008, SYBYL; Bowers KJ, 2006, P 2006 ACMIEEE C SUP, P4343; Brooks PM, 2000, MED J AUSTRALIA, V173, P433, DOI 10.5694/j.1326-5377.2000.tb139277.x; Chandrasekharan NV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-241; Cheng FX, 2012, J CHEM INF MODEL, V52, P3099, DOI 10.1021/ci300367a; Claria J, 2003, CURR PHARM DESIGN, V9, P2177, DOI 10.2174/1381612033454054; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Du J, 2011, J COMPUT CHEM, V32, P2800, DOI 10.1002/jcc.21859; Duan JX, 2010, J MOL GRAPH MODEL, V29, P157, DOI 10.1016/j.jmgm.2010.05.008; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Fukunishi Y, 2014, J CHEM INFORM MODELI; GIERCKSKY KE, 1989, SCAND J GASTROENTERO, V24, P3, DOI 10.3109/00365528909091168; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Goodsell DS, 2000, STEM CELLS, V18, P227, DOI 10.1634/stemcells.18-3-227; Gromiha MM, 2004, J MOL BIOL, V337, P285, DOI 10.1016/j.jmb.2004.01.033; Grover A, 2012, BBA-PROTEINS PROTEOM, V1824, P1476, DOI 10.1016/j.bbapap.2012.05.016; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo ZJ, 2010, CHEM BIOL DRUG DES, V75, P348, DOI 10.1111/j.1747-0285.2010.00951.x; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Ingrassia S, 2005, TECHNOMETRICS, V47, P297, DOI 10.1198/004017005000000058; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Kurumbail RG, 2001, CURR OPIN STRUC BIOL, V11, P752, DOI 10.1016/S0959-440X(01)00277-9; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Mand NP, 2012, ARTIFICIAL NEURAL NE; MILLER AS, 1992, MED BIOL ENG COMPUT, V30, P449, DOI 10.1007/BF02457822; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Rao PNP, 2008, J PHARM PHARM SCI, V11, P81, DOI 10.18433/J3T886; ROTH GJ, 1975, P NATL ACAD SCI USA, V72, P3073, DOI 10.1073/pnas.72.8.3073; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Wang RX, 2000, J MOL MODEL, V6, P498, DOI 10.1007/s0089400060498; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Willett P, 2006, DRUG DISCOV TODAY, V11, P1046, DOI 10.1016/j.drudis.2006.10.005; Yuan YX, 2011, J CHEM INF MODEL, V51, P1083, DOI 10.1021/ci100350u	46	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134691	10.1371/journal.pone.0134691	http://dx.doi.org/10.1371/journal.pone.0134691			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241744	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942700058
J	Mutsaerts, HJMM; van Dalen, JW; Heijtel, DFR; Groot, PFC; Majoie, CBLM; Petersen, ET; Richard, E; Nederveen, AJ				Mutsaerts, H. J. M. M.; van Dalen, J. W.; Heijtel, D. F. R.; Groot, P. F. C.; Majoie, C. B. L. M.; Petersen, E. T.; Richard, E.; Nederveen, A. J.			Cerebral Perfusion Measurements in Elderly with Hypertension Using Arterial Spin Labeling	PLOS ONE			English	Article							BRAIN; MRI; AGE; REPRODUCIBILITY; HEMODYNAMICS; EFFICIENCY; ALGORITHM	Purpose The current study assesses the feasibility and value of crushed cerebral blood flow (CBFcrushed) and arterial transit time (ATT) estimations for large clinical imaging studies in elderly with hypertension. Material and Methods Two pseudo-continuous arterial spin labeling (ASL) scans with (CBFcrushed) and without flow crushers (CBFnon-crushed) were performed in 186 elderly with hypertension, from which CBF and ATT maps were calculated. Standard flow territory maps were subdivided into proximal, intermediate and distal flow territories, based on the measured ATT. The coefficient of variation (CV) and physiological correlations with age and gender were compared between the three perfusion parameters. Results There was no difference in CV between CBFcrushed and CBFnon-crushed (15-24%, p>0.4) but the CV of ATT (4-9%) was much smaller. The total gray matter correlations with age and gender were most significant with ATT (p =.016 and p<.001 respectively), in between for CBFcrushed (p =.206 and p =.019) and least significant for CBFnon-crushed (p =.236 and p =.100). Conclusion These data show the feasibility and added value of combined measurements of both crushed CBF and ATT for group analyses in elderly with hypertension. The obtained flow territories provide knowledge on vascular anatomy of elderly with hypertension and can be used in future studies to investigate regional vascular effects.	[Mutsaerts, H. J. M. M.; Heijtel, D. F. R.; Groot, P. F. C.; Majoie, C. B. L. M.; Nederveen, A. J.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [van Dalen, J. W.; Richard, E.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Petersen, E. T.] Copenhagen Univ Hosp Hvidovre, Danish Res Ctr Magnet Resonance, Ctr Funct & Diagnost Imaging & Res, Hvidovre, Denmark; [Richard, E.] Radboud Univ Nijmegen, Dept Neurol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Copenhagen; Radboud University Nijmegen	Mutsaerts, HJMM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Radiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	hjmutsaerts@amc.uva.nl	Mutsaerts, Henk JMM/T-8656-2017; Richard, Edo/A-7065-2015; Richard, Edo/AAT-7173-2020; Richard, Edo/N-8460-2016; Petersen, Esben Thade/Q-8266-2019; van Dalen, Jan Willem/K-9169-2018	Mutsaerts, Henk JMM/0000-0003-0894-0307; Richard, Edo/0000-0002-7250-3390; Richard, Edo/0000-0002-7250-3390; Richard, Edo/0000-0002-7250-3390; Petersen, Esben Thade/0000-0001-7529-3432; van Dalen, Jan Willem/0000-0002-3439-8841; Nederveen, Aart/0000-0002-5477-973X	Dutch Ministry of Health, Welfare and Sports [50-50110-98-020]; Dutch Innovation fund of collaborative health insurances [05-234]; Netherlands Organization for Health Research and Development [62000015]; "Internationale Stichting Alzheimer Onderzoek" (ISAO) [10507]; Dutch non-governmental organization NutsOhra	Dutch Ministry of Health, Welfare and Sports; Dutch Innovation fund of collaborative health insurances; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); "Internationale Stichting Alzheimer Onderzoek" (ISAO); Dutch non-governmental organization NutsOhra	This study was carried out within the context of the preDIVA study which was supported by the Dutch Ministry of Health, Welfare and Sports (grant# 50-50110-98-020), the Dutch Innovation fund of collaborative health insurances grant# 05-234 and the Netherlands Organization for Health Research and Development (grant# 62000015). The MRI substudy was supported by the "Internationale Stichting Alzheimer Onderzoek" (ISAO, grant# 10507) and the Dutch non-governmental organization NutsOhra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chalela JA, 2000, STROKE, V31, P680, DOI 10.1161/01.STR.31.3.680; Chen JJ, 2011, NEUROIMAGE, V55, P468, DOI 10.1016/j.neuroimage.2010.12.032; Chen YF, 2012, MAGN RESON MATER PHY, V25, P135, DOI 10.1007/s10334-011-0276-5; Dai WY, 2013, MAGN RESON MED, V69, P1014, DOI 10.1002/mrm.24335; de la Torre JC, 2012, J ALZHEIMERS DIS, V32, P553, DOI 10.3233/JAD-2012-120793; de Leeuw FE, 2000, J NEUROL, V247, P291, DOI 10.1007/s004150050586; Detre JA, 2012, J MAGN RESON IMAGING, V35, P1026, DOI 10.1002/jmri.23581; Donahue J, 2014, J NEURORADIOLOGY, V41, P234, DOI 10.1016/j.neurad.2013.11.002; Garcia DM, 2005, MAGN RESON MED, V54, P366, DOI 10.1002/mrm.20556; Heijtel DFR, 2014, NEUROIMAGE, V92, P182, DOI 10.1016/j.neuroimage.2014.02.011; Hendrikse J, 2008, RADIOLOGY, V246, P572, DOI 10.1148/radiol.2461062100; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Lawrence KSS, 2005, MAGN RESON MED, V53, P425, DOI 10.1002/mrm.20364; Liu YN, 2012, MAGN RESON MED, V68, P912, DOI 10.1002/mrm.23286; MacIntosh BJ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00060; Nowinski WL, 2011, NEUROIMAGE, V55, P986, DOI 10.1016/j.neuroimage.2010.12.079; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Petersen ET, 2010, NEUROIMAGE, V49, P104, DOI 10.1016/j.neuroimage.2009.07.068; Richard E, 2009, ALZ DIS ASSOC DIS, V23, P198, DOI 10.1097/WAD.0b013e31819783a4; Sadaghiani S, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00020; Shin WY, 2007, MAGN RESON MED, V58, P1232, DOI 10.1002/mrm.21420; Szabo K, 2009, STROKE, V40, P2042, DOI 10.1161/STROKEAHA.108.536144; Tatu L, 1998, NEUROLOGY, V50, P1699, DOI 10.1212/WNL.50.6.1699; van Raamt AF, 2006, CEREBROVASC DIS, V22, P217, DOI 10.1159/000094007; Wang JJ, 2003, MAGN RESON MED, V50, P599, DOI 10.1002/mrm.10559; Wang JJ, 2002, MAGN RESON MED, V48, P242, DOI 10.1002/mrm.10211; Wentland AL, 2010, AM J NEURORADIOL, V31, P448, DOI 10.3174/ajnr.A1858; [张旭东 Zhang Xudong], 2012, [计量学报, Acta Metrologica Sinica], V33, P1	33	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133717	10.1371/journal.pone.0133717	http://dx.doi.org/10.1371/journal.pone.0133717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241897	Green Submitted, Green Published, gold			2022-12-27	WOS:000358942700020
J	McElcheran, CE; Yang, BS; Anderson, KJT; Golenstani-Rad, L; Graham, SJ				McElcheran, Clare E.; Yang, Benson; Anderson, Kevan J. T.; Golenstani-Rad, Laleh; Graham, Simon J.			Investigation of Parallel Radiofrequency Transmission for the Reduction of Heating in Long Conductive Leads in 3 Tesla Magnetic Resonance Imaging	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; ABSORPTION RATE; RF TRANSMISSION; MRI SAFETY; EXCITATION; IMPLANT; DEVICES; DESIGN; WIRES; ARRAY	Deep Brain Stimulation (DBS) is increasingly used to treat a variety of brain diseases by sending electrical impulses to deep brain nuclei through long, electrically conductive leads. Magnetic resonance imaging (MRI) of patients pre- and post-implantation is desirable to target and position the implant, to evaluate possible side-effects and to examine DBS patients who have other health conditions. Although MRI is the preferred modality for pre-operative planning, MRI post-implantation is limited due to the risk of high local power deposition, and therefore tissue heating, at the tip of the lead. The localized power deposition arises from currents induced in the leads caused by coupling with the radiofrequency (RF) transmission field during imaging. In the present work, parallel RF transmission (pTx) is used to tailor the RF electric field to suppress coupling effects. Electromagnetic simulations were performed for three pTx coil configurations with 2, 4, and 8-elements, respectively. Optimal input voltages to minimize coupling, while maintaining RF magnetic field homogeneity, were determined for all configurations using a Nelder-Mead optimization algorithm. Resulting electric and magnetic fields were compared to that of a 16-rung birdcage coil. Experimental validation was performed with a custom-built 4-element pTx coil. In simulation, 95-99% reduction of the electric field at the tip of the lead was observed between the various pTx coil configurations and the birdcage coil. Maximal reduction in E-field was obtained with the 8-element pTx coil. Magnetic field homogeneity was comparable to the birdcage coil for the 4- and 8-element pTx configurations. In experiment, a temperature increase of 2+/-0.15 degrees C was observed at the tip of the wire using the birdcage coil, whereas negligible increase (0.2+/-0.15 degrees C) was observed with the optimized pTx system. Although further research is required, these initial results suggest that the concept of optimizing pTx to reduce DBS heating effects holds considerable promise.	[McElcheran, Clare E.; Yang, Benson; Anderson, Kevan J. T.; Graham, Simon J.] Sunnybrook Hlth Sci Inst, Phys Sci Platform, Toronto, ON, Canada; [McElcheran, Clare E.; Graham, Simon J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Golenstani-Rad, Laleh] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Charlestown, MA USA	University of Toronto; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Harvard University; Massachusetts General Hospital	McElcheran, CE (corresponding author), Sunnybrook Hlth Sci Inst, Phys Sci Platform, Toronto, ON, Canada.	mcelcher@sri.utoronto.ca		Golestani Rad, Laleh/0000-0003-3869-6114	Natural Sciences and Engineering Research Council of Canada (NSERC) [1010219]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this research was provided by a Discovery Grant awarded to Dr. Graham from the Natural Sciences and Engineering Research Council of Canada (NSERC: grant number 1010219, http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acikel V, 2011, MED PHYS, V38, P6623, DOI 10.1118/1.3662865; Amjad A, 2005, IEEE T MAGNETICS, V41; Armenean C, 2004, MAGN RESON MED, V52, P1200, DOI 10.1002/mrm.20246; Bain P., 2009, DEEP BRAIN STIMULATI; Baker KB, 2004, J MAGN RESON IMAGING, V20, P315, DOI 10.1002/jmri.20103; Baker KB, 2006, J MAGN RESON IMAGING, V24, P1236, DOI 10.1002/jmri.20769; Bottomley PA, 2010, MRI SAFE IMPLANTED L; Bottomley PA, 2010, MED PHYS, V37, P3828, DOI 10.1118/1.3439590; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Busch MHJ, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-35; Chen Xiaoqing, 2013, Evid Based Complement Alternat Med, V2013, P504563, DOI 10.1155/2013/504563; Cho ZH, 2010, J NEUROSURG, V113, P639, DOI 10.3171/2010.3.JNS091385; Collins CM, 2011, MAGN RESON MED, V65, P1470, DOI 10.1002/mrm.22845; Collins CM, 2005, MAGN RESON MED, V54, P1327, DOI 10.1002/mrm.20729; Deniz CM, 2012, MAGN RESON MED, V67, P164, DOI 10.1002/mrm.23004; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; El-Sharkawy AMM, 2012, MED PHYS, V39, P2334, DOI 10.1118/1.3700169; Elwassif MM, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046009; Eryaman Y, 2015, MAGN RESON MED, V73, P1896, DOI 10.1002/mrm.25324; Eryaman Y, 2013, MAGN RESON MED, V69, P845, DOI 10.1002/mrm.24316; Eryaman Y, 2011, MAGN RESON MED, V65, P1305, DOI 10.1002/mrm.22724; Etezadi-Amoli M, 2015, MAGN RESON MED, V74, P1790, DOI 10.1002/mrm.25543; Finelli DA, 2002, AM J NEURORADIOL, V23, P1795; Graesslin I, 2013, MAGN RESON MED, V70, P1440, DOI 10.1002/mrm.24558; Gray RW, 2005, MAGN RESON IMAGING, V23, P887, DOI 10.1016/j.mri.2005.07.005; Grill WM, 2005, EXPERT REV MED DEVIC, V2, P409, DOI 10.1586/17434440.2.4.409; Katscher U, 2009, IEEE T MED IMAGING, V28, P1365, DOI 10.1109/TMI.2009.2015757; Konings MK, 2000, J MAGN RESON IMAGING, V12, P79, DOI 10.1002/1522-2586(200007)12:1<79::AID-JMRI9>3.0.CO;2-T; Lattanzi R, 2009, MAGN RESON MED, V61, P315, DOI 10.1002/mrm.21782; McElcheran C, 2014, REDUCED HEATING ELEC; Michael Bachschmidt TJK, 2015, MAGNETIC RESONANCE I; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nitz WR, 2001, J MAGN RESON IMAGING, V13, P105, DOI 10.1002/1522-2586(200101)13:1<105::AID-JMRI1016>3.0.CO;2-0; Nitz WR, 2005, INVEST RADIOL, V40, P773, DOI 10.1097/01.rli.0000185898.59140.91; Nordbeck P, 2008, MAGN RESON MED, V60, P312, DOI 10.1002/mrm.21475; Nordbeck P, 2009, MAGN RESON MED, V61, P570, DOI 10.1002/mrm.21881; Nyenhuis JA, 2005, IEEE T DEVICE MAT RE, V5, P467, DOI 10.1109/TDMR.2005.859033; Nyenhuis JA, 1999, IEEE T MAGNETICS, V35; Overall WR, 2010, MAGN RESON MED, V64, P823, DOI 10.1002/mrm.22468; Park SM, 2005, IEEE T MAGN, V41, P4197, DOI 10.1109/TMAG.2005.854803; Park SM, 2007, J MAGN RESON IMAGING, V26, P1278, DOI 10.1002/jmri.21159; PENNES HH, 1948, J APPL PHYSIOL, V1, P93, DOI 10.1152/jappl.1948.1.2.93; Pooley RA, 2014, TEMPERATURE MEASUREM; Prasad SK, 2004, HEART, V90, P1241, DOI 10.1136/hrt.2003.021154; Roguin A, 2008, EUROPACE, V10, P334, DOI 10.1093/europace/eun021; Serano P, 2015, SCI REP-UK, V5, DOI 10.1038/srep09805; Setsompop K, 2008, MAGN RESON MED, V59, P908, DOI 10.1002/mrm.21513; Setsompop K, 2006, MAGN RESON MED, V56, P1163, DOI 10.1002/mrm.21042; Shrivastava D, 2010, J MAGN RESON IMAGING, V32, P600, DOI 10.1002/jmri.22292; Ullmann P, 2005, MAGNET RESON MED, V54, P994, DOI 10.1002/mrm.20646; van den Bergen B, 2007, PHYS MED BIOL, V52, P5429, DOI 10.1088/0031-9155/52/17/022; Von Morze C, 2007, CONCEPT MAGN RESON B, V31B, P37, DOI 10.1002/cmr.b.20078; Wang ZW, 2007, J MAGN RESON IMAGING, V26, P437, DOI 10.1002/jmri.20977; Zanchi MG, 2010, IEEE T MED IMAGING, V29, P169, DOI 10.1109/TMI.2009.2031558; Zhang ZH, 2007, MAGN RESON MED, V57, P842, DOI 10.1002/mrm.21221; Zhao T, 2011, FAST B1 MAPPING METH; Zhu YD, 2004, MAGNET RESON MED, V51, P775, DOI 10.1002/mrm.20011	57	36	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2015	10	8							e0134379	10.1371/journal.pone.0134379	http://dx.doi.org/10.1371/journal.pone.0134379			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1UY	26237218	gold, Green Published, Green Submitted			2022-12-27	WOS:000358942400025
J	Calpena, E; Palau, F; Espinos, C; Galindo, MI				Calpena, Eduardo; Palau, Francesc; Espinos, Carmen; Galindo, Mximo Ibo			Evolutionary History of the Smyd Gene Family in Metazoans: A Framework to Identify the Orthologs of Human Smyd Genes in Drosophila and Other Animal Species	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; METHYLTRANSFERASE; PROTEIN; DOMAIN; SET; EXPRESSION; NEOFUNCTIONALIZATION; SUBFUNCTIONALIZATION; IDENTIFICATION; TRANSCRIPTION	The Smyd gene family code for proteins containing a conserved core consisting of a SET domain interrupted by a MYND zinc finger. Smyd proteins are important in epigenetic control of development and carcinogenesis, through posttranslational modifications in histones and other proteins. Previous reports indicated that the Smyd family is quite variable in metazoans, so a rigorous phylogenetic reconstruction of this complex gene family is of central importance to understand its evolutionary history and functional diversification or conservation. We have performed a phylogenetic analysis of Smyd protein sequences, and our results show that the extant metazoan Smyd genes can be classified in three main classes, Smyd3 (which includes chordate-specific Smyd1 and Smyd2 genes), Smyd4 and Smyd5. In addition, there is an arthropod-specific class, SmydA. While the evolutionary history of the Smyd3 and Smyd5 classes is relatively simple, the Smyd4 class has suffered several events of gene loss, gene duplication and lineage-specific expansions in the animal phyla included in our analysis. A more specific study of the four Smyd4 genes in Drosophila melanogaster shows that they are not redundant, since their patterns of expression are different and knock-down of individual genes can have dramatic phenotypes despite the presence of the other family members.	[Calpena, Eduardo; Palau, Francesc; Espinos, Carmen; Galindo, Mximo Ibo] CIPF, Program Rare & Genet Dis, Valencia, Spain; [Calpena, Eduardo; Palau, Francesc; Espinos, Carmen; Galindo, Mximo Ibo] Inst Salud Carlos III, CIBERER, Valencia, Spain	Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Galindo, MI (corresponding author), CIPF, Program Rare & Genet Dis, Valencia, Spain.	igalindo@cipf.es	Espinós, Carmen/A-9369-2014; Calpena, Eduardo/HCI-9261-2022; Galindo, Máximo Ibo/A-5299-2010; Palau, Francesc/A-9391-2014	Espinós, Carmen/0000-0003-4435-1809; Calpena, Eduardo/0000-0001-6399-6528; Galindo, Máximo Ibo/0000-0001-8448-9760; Palau, Francesc/0000-0002-8635-5421	Ministerio de Economia y Competitividad [AP2009-0642]; International Rare Diseases Research Consortium; Instituto de Salud Carlos III [IR11/TREAT-CMT]; FEDER funds [PI12/00453]; Centro de Investigacion Principe Felipe [CPII14/00002]; Instituto de Salud Carlos III through Biomedical Network Research Center for Rare Diseases (CIBERER); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079918, R01DK098370] Funding Source: NIH RePORTER	Ministerio de Economia y Competitividad(Spanish Government); International Rare Diseases Research Consortium; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER funds(European Commission); Centro de Investigacion Principe Felipe; Instituto de Salud Carlos III through Biomedical Network Research Center for Rare Diseases (CIBERER); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	EC has a FPU studentship funded by the Ministerio de Economia y Competitividad (AP2009-0642), http://www.idi.mineco.gob.es. FP, CE and MIG are supported a collaborative grant from International Rare Diseases Research Consortium and Instituto de Salud Carlos III (IR11/TREAT-CMT), http://www.treat-cmt.es/index.php/en. CE has a project grant from the National R+D+I Plan, co-funded with FEDER funds (PI12/00453), http://www.eng.isciii.es/ISCIII/es/general/index.shtml. CE has a "Miguel Servet" contract funded by the Instituto de Salud Carlos III and Centro de Investigacion Principe Felipe (CPII14/00002), http://www.eng.isciii.es/ISCIII/es/general/index.shtml; http://www.cipf.es. FP is supported by funding from Instituto de Salud Carlos III through Biomedical Network Research Center for Rare Diseases (CIBERER), http://www.ciberer.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2011, J MOL CELL BIOL, V3, P301, DOI 10.1093/jmcb/mjr025; Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Cao ZJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3602; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Donlin LT, 2012, GENE DEV, V26, P114, DOI 10.1101/gad.177758.111; Du SJ, 2014, ANAT REC, V297, P1650, DOI 10.1002/ar.22972; Force A, 1999, GENETICS, V151, P1531; Fujii T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023491; Gao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086808; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Green EM, 2012, NUCLEUS-PHILA, V3, P335, DOI 10.4161/nucl.20695; Gu X, 2003, GENETICA, V118, P133, DOI 10.1023/A:1024197424306; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hamamoto R, 2006, CANCER SCI, V97, P113, DOI 10.1111/j.1349-7006.2006.00146.x; Hamamoto R, 2014, CANCER LETT, V351, P126, DOI 10.1016/j.canlet.2014.05.014; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hu LP, 2009, CANCER RES, V69, P4067, DOI 10.1158/0008-5472.CAN-08-4097; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Just S, 2011, J CELL SCI, V124, P3127, DOI 10.1242/jcs.084772; Kateb F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054715; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kim H, 2009, J BIOL CHEM, V284, P19867, DOI 10.1074/jbc.M109.021485; Leinhart K, 2011, GENES-BASEL, V2, P210, DOI 10.3390/genes2010210; Lespinet O, 2002, GENOME RES, V12, P1048, DOI 10.1101/gr.174302; Del Amo VL, 2015, HUM MOL GENET, V24, P21, DOI 10.1093/hmg/ddu416; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Minguillon C, 2002, GENE, V287, P121, DOI 10.1016/S0378-1119(01)00828-9; Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; Saddic LA, 2010, J BIOL CHEM, V285, P37733, DOI 10.1074/jbc.M110.137612; Satoh N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1729; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Sirinupong N, 2010, J BIOL CHEM, V285, P40635, DOI 10.1074/jbc.M110.168187; Spellmon N, 2015, INT J MOL SCI, V16, P1406, DOI 10.3390/ijms16011406; Stender JD, 2012, MOL CELL, V48, P28, DOI 10.1016/j.molcel.2012.07.020; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Thompson EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003008; Van Aller GS, 2012, EPIGENETICS-US, V7, P340, DOI 10.4161/epi.19506; Veerappan CS, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-190; Vibranovski MD, 2005, J MOL EVOL, V61, P341, DOI 10.1007/s00239-004-0318-y; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wolff Tanya, 2011, Cold Spring Harb Protoc, V2011, P1383, DOI 10.1101/pdb.prot066506; Woods S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003330; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang LS, 2012, NEW PHYTOL, V195, P248, DOI 10.1111/j.1469-8137.2012.04143.x; Zhang X, 2013, P NATL ACAD SCI USA, V110, P17284, DOI 10.1073/pnas.1307959110; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	57	16	16	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134106	10.1371/journal.pone.0134106	http://dx.doi.org/10.1371/journal.pone.0134106			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230726	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400072
J	Cronin, DT; Woloszynek, S; Morra, WA; Honarvar, S; Linder, JM; Gonder, MK; O'Connor, MP; Hearn, GW				Cronin, Drew T.; Woloszynek, Stephen; Morra, Wayne A.; Honarvar, Shaya; Linder, Joshua M.; Gonder, Mary Katherine; O'Connor, Michael P.; Hearn, Gail W.			Long-Term Urban Market Dynamics Reveal Increased Bushmeat Carcass Volume despite Economic Growth and Proactive Environmental Legislation on Bioko Island, Equatorial Guinea	PLOS ONE			English	Article							HUNTING SUSTAINABILITY; WILDLIFE CONSUMPTION; CONSERVATION; WEST; IMPACT; TRADE; EXPLOITATION; BIODIVERSITY; FOREST; REGRESSION	Bushmeat hunting is extensive in west and central Africa as both a means for subsistence and for commercial gain. Commercial hunting represents one of the primary threats to wildlife in the region, and confounding factors have made it challenging to examine how external factors influence the commercial bushmeat trade. Bioko Island, Equatorial Guinea is a small island with large tracts of intact forest that support sizeable populations of commercially valuable vertebrates, especially endemic primates. The island also has a low human population and has experienced dramatic economic growth and rapid development since the mid-1990's. From October 1997 - September 2010, we monitored the largest bushmeat market on Bioko in Malabo, recording over 197,000 carcasses for sale. We used these data to analyze the dynamics of the market in relation to political events, environmental legislation, and rapid economic growth. Our findings suggest that bushmeat hunting and availability increased in parallel with the growth of Equatorial Guinea's GDP and disposable income of its citizens. During this 13-year study, the predominant mode of capture shifted from trapping to shotguns. Consequently, carcass volume and rates of taxa typically captured with shotguns increased significantly, most notably including intensified hunting of Bioko's unique and endangered monkey fauna. Attempts to limit bushmeat sales, including a 2007 ban on primate hunting and trade, were only transiently effective. The hunting ban was not enforced, and was quickly followed by a marked increase in bushmeat hunting compared to hunting rates prior to the ban. Our results emphasize the negative impact that rapid development and unenforced legislation have had on Bioko's wildlife, and demonstrate the need for strong governmental support if conservation strategies are to be successful at preventing extinctions of tropical wildlife.	[Cronin, Drew T.; Woloszynek, Stephen; Honarvar, Shaya; Gonder, Mary Katherine; O'Connor, Michael P.; Hearn, Gail W.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Cronin, Drew T.; O'Connor, Michael P.; Hearn, Gail W.] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA; [Cronin, Drew T.; Gonder, Mary Katherine; O'Connor, Michael P.; Hearn, Gail W.] Bioko Biodivers Protect Program, Malabo, Bioko Norte, Equat Guinea; [Woloszynek, Stephen] Drexel Univ, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA; [Morra, Wayne A.] Arcadia Univ, Sch Global Business, Glenside, PA USA; [Honarvar, Shaya] Purdue Univ, Indiana Univ, Dept Biol, Ft Wayne, IN USA; [Linder, Joshua M.] James Madison Univ, Dept Sociol & Anthropol, Harrisonburg, VA 22807 USA	Drexel University; Drexel University; Drexel University; Purdue University System; Indiana University Purdue University Fort Wayne; James Madison University	Cronin, DT (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	dtc33@drexel.edu			ExxonMobil Foundation; Mobil Equatorial Guinea, Inc.; Margot Marsh Biodiversity Foundation; Conservation International; Los Angeles Zoo; National Geographic Conservation Trust; Phoebe Haas Charitable Trust B; Sally Hunter Challenge Fund; Office Of Internatl Science &Engineering [1243524] Funding Source: National Science Foundation	ExxonMobil Foundation(Exxon Mobil Corporation); Mobil Equatorial Guinea, Inc.(Exxon Mobil Corporation); Margot Marsh Biodiversity Foundation; Conservation International; Los Angeles Zoo; National Geographic Conservation Trust(National Geographic Society); Phoebe Haas Charitable Trust B; Sally Hunter Challenge Fund; Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the ExxonMobil Foundation, Mobil Equatorial Guinea, Inc., the Margot Marsh Biodiversity Foundation, Conservation International, the Los Angeles Zoo, the National Geographic Conservation Trust, the Phoebe Haas Charitable Trust B, and the Sally Hunter Challenge Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy KA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0303; Albrechtsen L, 2007, ENVIRON SCI POLICY, V10, P654, DOI 10.1016/j.envsci.2007.04.007; Albrechtsen L, 2005, ENVIRON CONSERV, V32, P340, DOI 10.1017/S0376892906002694; Allebone-Webb SM, 2011, CONSERV BIOL, V25, P597, DOI 10.1111/j.1523-1739.2011.01681.x; [Anonymous], 2007, PUB L; [Anonymous], 2013, EQ GUIN; Astaras C., 2009, ECOLOGY STATUS DRILL; Barnes JI, 1996, ECOL ECON, V18, P215, DOI 10.1016/0921-8009(96)00035-3; Bennett EL, 2007, CONSERV BIOL, V21, P884, DOI 10.1111/j.1523-1739.2006.00595.x; Bennett EL, 2011, ORYX, V45, P476, DOI 10.1017/S003060531000178X; Biggs D, 2013, SCIENCE, V339, P1038, DOI 10.1126/science.1229998; Bowen-Jones E, 2003, AREA, V35, P390, DOI 10.1111/j.0004-0894.2003.00189.x; BOX GEP, 1975, J AM STAT ASSOC, V70, P70, DOI 10.2307/2285379; Box GEP, 2008, TIME SERIS ANAL FORC; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; BRING J, 1994, AM STAT, V48, P209, DOI 10.2307/2684719; Brooks EGE, 2010, BIOL CONSERV, V143, P2808, DOI 10.1016/j.biocon.2010.07.030; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Burton M, 1999, ECOL ECON, V30, P93, DOI 10.1016/S0921-8009(98)00102-5; Butynski Thomas M., 2009, Primate Conservation, V24, P99; BUTYNSKI TM, 1994, BIODIVERS CONSERV, V3, P893, DOI 10.1007/BF00129665; Chan KS, 2012, TIME SERIES ANAL; Chapman CA, 2006, AFR J ECOL, V44, P116, DOI 10.1111/j.1365-2028.2006.00636.x; CIA, 2013, WORLD FACT BOOK 2013; Cleveland R.B., 1990, J OFF STAT, V6, P3; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; COLELL M, 1994, BIODIVERS CONSERV, V3, P939, DOI 10.1007/BF00129668; Corlett RT, 2007, BIOTROPICA, V39, P292, DOI 10.1111/j.1744-7429.2007.00271.x; Cowlishaw G, 2005, J APPL ECOL, V42, P460, DOI 10.1111/j.1365-2664.2005.01046.x; Cronin D. T., 2014, PRIMATES PERIL WORLD, P17; Cronin D. T., 2010, OPPORTUNITIES LOST R; Cronin D. T., 2013, AFRICAN PRIMATES, V8, P1; Cronin D. T., 2013, THESIS DREXEL U PHIL; Cronin DT, 2015, S FUT BIOD GRAN CLAD; Crookes DJ, 2005, ENVIRON CONSERV, V32, P333, DOI 10.1017/S037689290500250X; Cryer JD, 2008, SPRINGER TEXTS STAT, P1; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Drury Rebecca, 2011, Conservation & Society, V9, P247, DOI 10.4103/0972-4923.86995; East T, 2005, BIOL CONSERV, V126, P206, DOI 10.1016/j.biocon.2005.05.012; Environmental Regulation Law in the Republic of Equatorial Guinea, 2003, PUB L; FA JE, 1995, CONSERV BIOL, V9, P1107, DOI 10.1046/j.1523-1739.1995.951107.x; Fa JE, 2002, CONSERV BIOL, V16, P232, DOI 10.1046/j.1523-1739.2002.00275.x; Fa JE, 2002, HUM ECOL, V30, P397, DOI 10.1023/A:1016524703607; Fa JE, 2000, BIOL RESOURCE MANAGE, P168; Fa JE, 2000, CONSERV BIOL, V14, P1602, DOI [10.1111/j.1523-1739.2000.99067.x, 10.1046/j.1523-1739.2000.99067.x]; Fa JE, 1997, J ANIM ECOL, V66, P98, DOI 10.2307/5968; Fa JE, 2006, BIOL CONSERV, V129, P497, DOI 10.1016/j.biocon.2005.11.031; Fa JE, 2015, SCI REP-UK, V5, DOI 10.1038/srep08168; Fa JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112367; Gill DJC, 2012, CONSERV BIOL, V26, P1052, DOI 10.1111/j.1523-1739.2012.01876.x; Golden CD, 2011, P NATL ACAD SCI USA, V108, P19653, DOI 10.1073/pnas.1112586108; Vega MG, 2013, CONSERV BIOL, V27, P576, DOI 10.1111/cobi.12067; Groves CP, 2007, J ANTHROPOL SCI, V85, P7; Grubb P, 2003, INT J PRIMATOL, V24, P1301, DOI 10.1023/B:IJOP.0000005994.86792.b9; Hearn G, 2006, MONKEYS TROUBLE RAPI; Henschel P, 2011, J ZOOL, V285, P11, DOI 10.1111/j.1469-7998.2011.00826.x; Hilborn R, 2006, SCIENCE, V314, P1266, DOI 10.1126/science.1132780; IUCN, 2013, IUCN RED LIST THREAT; JUSTE J, 1995, J APPL ECOL, V32, P454, DOI 10.2307/2404644; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Kumpel NF, 2009, ANIM CONSERV, V12, P531, DOI 10.1111/j.1469-1795.2009.00279.x; Kumpel N. F., 2006, THESIS U LONDON LOND; Kumpel NF, 2008, INT J PRIMATOL, V29, P1065, DOI [10.1007/s10764-008-9254-9, 10.1007/s10764-008-9277-2]; Lahm SA, 1993, THESIS NEW YORK U NE; Laurance WF, 2014, NATURE, V513, P229, DOI 10.1038/nature13717; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Ley de &Aacute;reas Protegidas, 2000, PUB L; Macdonald DW, 2012, BIOL CONSERV, V147, P107, DOI 10.1016/j.biocon.2011.12.018; Maisels F, 2001, ORYX, V35, P322, DOI 10.1017/S0030605300032087; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; MATLAB, 2013, MATLAB VERSION 8 1 0; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; Miron JA, 1998, J DRUG ISSUES, V28, P741, DOI 10.1177/002204269802800310; Morra W, 2009, ECOL ECON, V68, P2619, DOI 10.1016/j.ecolecon.2009.04.015; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nasi R., 2008, CBD Technical Series, V33, P1; Nosti J., 1947, NOTAS GEOGRAFICAS FI; Oates J.F., 2005, ADV APPL BIODIVERS S, P1; Oates J. F., 1999, MYTH REALITY RAIN FO; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2021, R LANGUAGE ENV STAT; Rao P.V., 1998, STAT RES METHODS LIF; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Reid J., 2005, EC MONKEY TRADE BIOK; Rivalan P, 2007, NATURE, V447, P529, DOI 10.1038/447529a; Robinson JG, 2004, ANIM CONSERV, V7, P397, DOI 10.1017/S1367943004001532; Robinson JG, 1999, SCIENCE, V284, P595, DOI 10.1126/science.284.5414.595; Robinson JG, 2002, ORYX, V36, P332, DOI 10.1017/S0030605302000662; Robinson JG, 2000, BIOL RESOURCE MANAGE, P13; Rowcliffe JM, 2003, J APPL ECOL, V40, P872, DOI 10.1046/j.1365-2664.2003.00841.x; Schaaf CD, 1990, DRILL MANDRILLUS LEU; Schulte-Herbruggen B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072807; Struhsaker TT, 2005, INT J PRIMATOL, V26, P525, DOI 10.1007/s10764-005-4364-0; Tranquilli S, 2012, CONSERV LETT, V5, P48, DOI 10.1111/j.1755-263X.2011.00211.x; U. S. Census Bureau, X 12 ARIMA; Warchol GL, 2004, CRIM JUSTICE STUD CR, V1, P57, DOI DOI 10.1080/08884310420001679334; Wilkie DS, 2011, ANN NY ACAD SCI, V1223, P120, DOI 10.1111/j.1749-6632.2010.05908.x; Wilkie DS, 1999, BIODIVERS CONSERV, V8, P927, DOI 10.1023/A:1008877309871; Willcox AS, 2007, BIOL CONSERV, V134, P251, DOI 10.1016/j.biocon.2006.08.016; Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789; Zafra-Calvo N, 2010, BIOL CONSERV, V143, P787, DOI 10.1016/j.biocon.2009.12.022; Zuur Alain F., 2009, P1	104	23	24	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134464	10.1371/journal.pone.0134464	http://dx.doi.org/10.1371/journal.pone.0134464			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO0JY	26230504	gold, Green Published, Green Submitted			2022-12-27	WOS:000358838400124
J	Fujita, J; Kohsaka, S; Ueda, I; Inohara, T; Maekawa, Y; Kawamura, A; Kanazawa, H; Hayashida, K; Tabei, R; Tohyama, S; Seki, T; Suzuki, M; Sano, M; Fukuda, K				Fujita, Jun; Kohsaka, Shun; Ueda, Ikuko; Inohara, Taku; Maekawa, Yuichiro; Kawamura, Akio; Kanazawa, Hideaki; Hayashida, Kentaro; Tabei, Ryota; Tohyama, Shugo; Seki, Tomohisa; Suzuki, Masahiro; Sano, Motoaki; Fukuda, Keiichi			The Prevalence of Clinically Significant Ischemia in Patients Undergoing Percutaneous Coronary Intervention: A Report from the Multicenter Registry	PLOS ONE			English	Article							MYOCARDIAL-PERFUSION SCINTIGRAPHY; OPTIMAL MEDICAL THERAPY; ARTERY-DISEASE; OUTCOMES; INFARCTION; REVASCULARIZATION; IMPACT; QUANTIFICATION; ASSOCIATION; ANGIOGRAPHY	Background Myocardial perfusion scintigraphy (MPS) plays an important role in the evaluation and quantification of myocardial ischemia, and those with significant ischemia (SI) benefit most from revascularization procedures. This study aimed to identify the clinical factors and anatomical features associated with SI in patients with stable ischemic heart disease (SIHD). Methods and Results Data were analyzed from 4197 SIHD patients undergoing percutaneous coronary intervention (PCI). Ischemia was based on MPS findings prior to PCI, with SI defined as an ischemic region of more than 10% of the total left ventricular area. Logistic regression analysis was performed to identify any clinical factors associated with SI. MPS was used to evaluate 1070 (25.5%) patients pre-procedurally. Patients with a history of heart failure, stroke, or anginal symptoms with Canadian Cardiovascular Society class 2 or more were more likely to have SI (odds ratio [OR] 1.63, p = 0.025, OR: 1.85, p = 0.009, and OR: 1.49, p = 0.003, respectively). When angiographic variables were considered, a proximal left anterior descending artery (pLAD) lesion was the sole factor associated with SI (OR: 1.45, p = 0.012). Importantly, those with SI had more in-hospital complications (p = 0.006), most notably post-PCI infarcts (p = 0.008). Conclusions Patients' background data, such as stronger anginal symptoms or a pLAD lesion, were associated with SI. Patients with SI must be treated with PCI to improve their long-term prognosis; however, procedure-related complications happen more frequently in SI patients than in non-SI patients. Physicians must give their full attention when performing the PCI procedure in SI patients to minimize their complication rate.	[Fujita, Jun; Kohsaka, Shun; Ueda, Ikuko; Inohara, Taku; Maekawa, Yuichiro; Kawamura, Akio; Kanazawa, Hideaki; Hayashida, Kentaro; Tabei, Ryota; Tohyama, Shugo; Seki, Tomohisa; Sano, Motoaki; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Tokyo 1608582, Japan; [Suzuki, Masahiro] Natl Hosp Org Saitama Natl Hosp, Wako, Saitama 3510102, Japan	Keio University	Fujita, J (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	jfujita@a6.keio.jp; cardiotx@gmail.com	Fukuda, Keiichi/L-3777-2013; Hayashida, Kentaro/M-4967-2019; Sano, Motoaki/L-3405-2013; Seki, Tomohisa/L-3524-2013	Hayashida, Kentaro/0000-0002-1750-1982; Kohsaka, Shun/0000-0003-3779-2972; Seki, Tomohisa/0000-0002-4281-135X	Ministry of Education, Culture, Sports, Science, and Technology, Japan (KAKENHI) [21790751]	Ministry of Education, Culture, Sports, Science, and Technology, Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (KAKENHI No. 21790751) (to S.K.), https://www.jsps.go.jp/jgrantsinaid/.	Anagnostopoulos C, 2012, HEART, V98, P353, DOI 10.1136/heartjnl-2011-300678; ARONOW WS, 1994, AM J CARDIOL, V74, P64, DOI 10.1016/0002-9149(94)90493-6; Berger PB, 1999, CIRCULATION, V100, P14, DOI 10.1161/01.CIR.100.1.14; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9; Burtt DM, 1996, STRATEGIC APPROACHES, P519; Douglas PS, 2015, NEW ENGL J MED, V372, P1291, DOI 10.1056/NEJMoa1415516; Fihn SD, 2012, CIRCULATION, V126, pE354, DOI 10.1161/CIR.0b013e318277d6a0; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [DOI 10.1056/NEJMOA0805796, 10.1056/NEJMoa0805796]; Gupta N, 2014, AM J CARDIOL, V113, P1087, DOI 10.1016/j.amjcard.2013.12.014; Hachamovitch R, 2011, EUR HEART J, V32, P1012, DOI 10.1093/eurheartj/ehq500; Hankey GJ, 2000, STROKE, V31, P2080, DOI 10.1161/01.STR.31.9.2080; Herrmann J, 2005, EUR HEART J, V26, P2493, DOI 10.1093/eurheartj/ehi455; Inohara T, 2014, JACC-CARDIOVASC INTE, V7, P1000, DOI 10.1016/j.jcin.2014.06.006; ISKANDRIAN AS, 1993, J AM COLL CARDIOL, V22, P665, DOI 10.1016/0735-1097(93)90174-Y; Jose PO, 2014, J AM COLL CARDIOL, V64, P2486, DOI 10.1016/j.jacc.2014.08.048; Kini A, 1999, J AM COLL CARDIOL, V34, P663, DOI 10.1016/S0735-1097(99)00298-3; Kinnaird TD, 2003, AM J CARDIOL, V92, P930, DOI 10.1016/S0002-9149(03)00972-X; KLEIN LW, 1986, AM J CARDIOL, V58, P42, DOI 10.1016/0002-9149(86)90238-9; Kong TQ, 1997, JAMA-J AM MED ASSOC, V277, P461, DOI 10.1001/jama.277.6.461; LADENHEIM ML, 1986, J AM COLL CARDIOL, V7, P464, DOI 10.1016/S0735-1097(86)80454-5; Loong CY, 2004, HEART, V90, pV2, DOI 10.1136/hrt.2003.013581; MAHMARIAN JJ, 1991, J AM COLL CARDIOL, V17, P355, DOI 10.1016/S0735-1097(10)80099-3; Mehran R, 2011, JACC-CARDIOVASC INTE, V4, P654, DOI 10.1016/j.jcin.2011.02.011; Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741; Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570; Naganuma T, 2014, JACC-CARDIOVASC INTE, V7, P354, DOI 10.1016/j.jcin.2013.11.014; Nagel E, 2014, EUR HEART J-CARD IMG, V15, P610, DOI 10.1093/ehjci/jeu029; Ohno Y, 2013, J AM COLL CARDIOL, V62, P1260, DOI 10.1016/j.jacc.2013.03.086; Rozanski A, 2013, J AM COLL CARDIOL, V61, P1054, DOI 10.1016/j.jacc.2012.11.056; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Shaw LJ, 2014, JACC-CARDIOVASC IMAG, V7, P593, DOI 10.1016/j.jcmg.2013.10.021; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611	33	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133568	10.1371/journal.pone.0133568	http://dx.doi.org/10.1371/journal.pone.0133568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26231033	Green Submitted, Green Published, gold			2022-12-27	WOS:000358838400042
J	Gilbert, M; Conchedda, G; Van Boeckel, TP; Cinardi, G; Linard, C; Nicolas, G; Thanapongtharm, W; D'Aietti, L; Wint, W; Newman, SH; Robinson, TP				Gilbert, Marius; Conchedda, Giulia; Van Boeckel, Thomas P.; Cinardi, Giuseppina; Linard, Catherine; Nicolas, Gaelle; Thanapongtharm, Weerapong; D'Aietti, Laura; Wint, William; Newman, Scott H.; Robinson, Timothy P.			Income Disparities and the Global Distribution of Intensively Farmed Chicken and Pigs	PLOS ONE			English	Article							INFLUENZA-VIRUS; ASIA; ANTIBIOTICS; DUCKS	The rapid transformation of the livestock sector in recent decades brought concerns on its impact on greenhouse gas emissions, disruptions to nitrogen and phosphorous cycles and on land use change, particularly deforestation for production of feed crops. Animal and human health are increasingly interlinked through emerging infectious diseases, zoonoses, and antimicrobial resistance. In many developing countries, the rapidity of change has also had social impacts with increased risk of marginalisation of smallholder farmers. However, both the impacts and benefits of livestock farming often differ between extensive (backyard farming mostly for home-consumption) and intensive, commercial production systems (larger herd or flock size, higher investments in inputs, a tendency towards market-orientation). A density of 10,000 chickens per km(2) has different environmental, epidemiological and societal implications if these birds are raised by 1,000 individual households or in a single industrial unit. Here, we introduce a novel relationship that links the national proportion of extensively raised animals to the gross domestic product (GDP) per capita (in purchasing power parity). This relationship is modelled and used together with the global distribution of rural population to disaggregate existing 10 km resolution global maps of chicken and pig distributions into extensive and intensive systems. Our results highlight countries and regions where extensive and intensive chicken and pig production systems are most important. We discuss the sources of uncertainties, the modelling assumptions and ways in which this approach could be developed to forecast future trajectories of intensification.	[Gilbert, Marius; Linard, Catherine; Nicolas, Gaelle; Thanapongtharm, Weerapong] Univ Libre Bruxelles, Biol Control & Spatial Ecol, Brussels, Belgium; [Gilbert, Marius; Linard, Catherine] Fonds Natl Rech Sci, Brussels, Belgium; [Conchedda, Giulia; Cinardi, Giuseppina; D'Aietti, Laura] Food & Agr Org United Nations FAO, Anim Prod & Hlth Div AGA, Rome, Italy; [Van Boeckel, Thomas P.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Thanapongtharm, Weerapong] Dept Livestock Dev, Bangkok, Thailand; [Wint, William] Environm Res Grp Oxford, Dept Zool, Oxford, England; [Newman, Scott H.] Food & Agr Org United Nations FAO, Emergency Ctr Control Transboundary Anim Dis ECTA, Hanoi, Vietnam; [Robinson, Timothy P.] ILRI, LSE, Nairobi, Kenya	Universite Libre de Bruxelles; Fonds de la Recherche Scientifique - FNRS; Food & Agriculture Organization of the United Nations (FAO); Princeton University; Food & Agriculture Organization of the United Nations (FAO); CGIAR; International Livestock Research Institute (ILRI)	Gilbert, M (corresponding author), Univ Libre Bruxelles, Biol Control & Spatial Ecol, Brussels, Belgium.	mgilbert@ulb.ac.be	Linard, Catherine/AAF-1670-2021		Fonds National de la Recherche Scientifique; CGIAR Research Programmes on the Humidtropics; Climate Change, Agriculture and Food Security (CCAFS); Agriculture for Nutrition and Health (A4NH); Fulbright Belgium program; Science and Technology Directorate, Department of Homeland Security [HSHQDC-12-C-00058]; NIH NIAID grant [1R01AI101028-01A1]; United States Agency for International Development's Emerging Pandemic Threat (EPT+) program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101028] Funding Source: NIH RePORTER	Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); CGIAR Research Programmes on the Humidtropics(CGIAR); Climate Change, Agriculture and Food Security (CCAFS); Agriculture for Nutrition and Health (A4NH); Fulbright Belgium program(CGIAR); Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); NIH NIAID grant(CGIAR); United States Agency for International Development's Emerging Pandemic Threat (EPT+) program(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MG is funded by the "Fonds National de la Recherche Scientifique". TR is funded by the CGIAR Research Programmes on the Humidtropics; Climate Change, Agriculture and Food Security (CCAFS) and Agriculture for Nutrition and Health (A4NH). TPVB is supported by the Fulbright Belgium program and the Science and Technology Directorate, Department of Homeland Security contract HSHQDC-12-C-00058. Part of the work was funded through the NIH NIAID grant (1R01AI101028-01A1) and the United States Agency for International Development's Emerging Pandemic Threat (EPT+) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandratos N., 2012, WORLD AGR 2030 2050; An TQ, 2011, EMERG INFECT DIS, V17, P1782, DOI 10.3201/eid1709.110411; Boeckel TPV, 2015, PNAS, DOI [10.1073/pnas.1503141112, DOI 10.1073/PNAS.1503141112]; Delgado CL, 1999, INTL FOOD POLICY RES; DeSA U, 2013, WORLD POP PROSP 2012; Dobson JE, 2000, PHOTOGRAMM ENG REM S, V66, P849; Dolman MA, 2012, LIVEST SCI, V149, P143, DOI 10.1016/j.livsci.2012.07.008; FAO, 2009, FAO STAT DAT; FAO, 2014, AV FLU FARM SYST INT; Fowler CW, 2003, P ROY SOC B-BIOL SCI, V270, P2579, DOI 10.1098/rspb.2003.2553; Gaskins HR, 2002, ANIM BIOTECHNOL, V13, P29, DOI 10.1081/ABIO-120005768; Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116; Gilbert M, 2012, SPAT SPATIO-TEMPORAL, V3, P173, DOI 10.1016/j.sste.2012.01.002; Graham JP, 2007, PUBLIC HEALTH REP, V122, P79, DOI 10.1177/003335490712200111; Leibler JH, 2009, ECOHEALTH, V6, P58, DOI 10.1007/s10393-009-0226-0; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; MacPherson DW, 2009, EMERGING INFECT DIS; McLeod A, 2009, WORLD POULTRY SCI J, V65, P191, DOI 10.1017/S0043933909000129; Mennerat A, 2010, EVOL BIOL, V37, P59, DOI 10.1007/s11692-010-9089-0; Monne I, 2014, J VIROL, V88, P4375, DOI 10.1128/JVI.03181-13; NBS GDP DATA, REV CHIN GDP 2004 20; Neumann K, 2009, LANDSCAPE ECOL, V24, P1207, DOI 10.1007/s10980-009-9357-5; Prosser DJ, 2011, AGR ECOSYST ENVIRON, V141, P381, DOI 10.1016/j.agee.2011.04.002; Pulliam JRC, 2012, J R SOC INTERFACE, V9, P89, DOI 10.1098/rsif.2011.0223; Robinson T.P., 2011, GLOBAL LIVESTOCK PRO; Robinson T.P., 2011, MAPPING SUPPLY DEMAN; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Smil V, 2002, ENZYME MICROB TECH, V30, P305, DOI 10.1016/S0141-0229(01)00504-X; Stegeman A, 2004, J INFECT DIS, V190, P2088, DOI 10.1086/425583; Steinfeld H, 2004, VET PARASITOL, V125, P19, DOI 10.1016/j.vetpar.2004.05.003; Steinfeld H., 2013, LIVESTOCK CHANGING L, V1; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Van Boeckel TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049528; Van Boeckel TP, 2012, AGR ECOSYST ENVIRON, V149, P144, DOI 10.1016/j.agee.2011.12.019; Van Boeckel TP, 2011, AGR ECOSYST ENVIRON, V141, P373, DOI 10.1016/j.agee.2011.04.013; Willer H, 2011, WORLD ORGANIC AGR 20; Wint W., 2007, GRIDDED LIVESTOCK WO; World Bank, 2014, DAT WORLD BANK; Zimmerman D.R., 1986, J ANIM SCI, V62, P6, DOI [10.2527/1986.62Supplement_36s, DOI 10.2527/1986.62SUPPLEMENT_36S]	40	53	54	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0133381	10.1371/journal.pone.0133381	http://dx.doi.org/10.1371/journal.pone.0133381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230336	Green Published, Green Submitted, gold			2022-12-27	WOS:000358838400034
J	Lichtenstein, L; Sommerlandt, FMJ; Spaethe, J				Lichtenstein, Leonie; Sommerlandt, Frank M. J.; Spaethe, Johannes			Dumb and Lazy? A Comparison of Color Learning and Memory Retrieval in Drones and Workers of the Buff-Tailed Bumblebee, Bombus terrestris, by Means of PER Conditioning	PLOS ONE			English	Article							HONEYBEE APIS-MELLIFERA; PROBOSCIS EXTENSION; INFORMATION-TRANSFER; SEXUAL-DIMORPHISM; VISUAL-ATTENTION; SOCIAL INSECTS; STINGLESS BEE; ANTENNAL LOBE; DISCRIMINATION; PSYCHOPHYSICS	More than 100 years ago, Karl von Frisch showed that honeybee workers learn and discriminate colors. Since then, many studies confirmed the color learning capabilities of females from various hymenopteran species. Yet, little is known about visual learning and memory in males despite the fact that in most bee species males must take care of their own needs and must find rewarding flowers to obtain food. Here we used the proboscis extension response (PER) paradigm to study the color learning capacities of workers and drones of the bumblebee, Bombus terrestris. Light stimuli were paired with sucrose reward delivered to the insects' antennae and inducing a reflexive extension of the proboscis. We evaluated color learning (i.e. conditioned PER to color stimuli) in absolute and differential conditioning protocols and mid-term memory retention was measured two hours after conditioning. Different monochromatic light stimuli in combination with neutral density filters were used to ensure that the bumblebees could only use chromatic and not achromatic (e.g. brightness) information. Furthermore, we tested if bees were able to transfer the learned information from the PER conditioning to a novel discrimination task in a Y-maze. Both workers and drones were capable of learning and discriminating between monochromatic light stimuli and retrieved the learned stimulus after two hours. Drones performed as well as workers during conditioning and in the memory test, but failed in the transfer test in contrast to workers. Our data clearly show that bumblebees can learn to associate a color stimulus with a sugar reward in PER conditioning and that both workers and drones reach similar acquisition and mid-term retention performances. Additionally, we provide evidence that only workers transfer the learned information from a Pavlovian to an operant situation.	[Lichtenstein, Leonie; Sommerlandt, Frank M. J.; Spaethe, Johannes] Univ Wurzburg, Dept Behav Physiol & Sociobiol, D-97070 Wurzburg, Germany	University of Wurzburg	Lichtenstein, L (corresponding author), Univ Wurzburg, Dept Behav Physiol & Sociobiol, D-97070 Wurzburg, Germany.	leonie.lichtenstein@uni-wuerzburg.de	Spaethe, Johannes/B-8826-2014	Spaethe, Johannes/0000-0002-0734-2869	German Research Foundation (DFG) [SFB 1047]; Free State of Bavaria (Elitenetzwerk Bayern); University of Wurzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); Free State of Bavaria (Elitenetzwerk Bayern); University of Wurzburg	This work was supported by a research grant by the German Research Foundation (DFG), collaborative research center SFB 1047 "Insect timing", project B3 to JS and a PhD research scholarship offered by the Free State of Bavaria (Elitenetzwerk Bayern) to FMJS. This publication was funded by the German Research Foundation (DFG) and the University of Wurzburg in the funding program Open Access Publishing.	[Anonymous], BEEING SMART OLFACTO; Avargues-Weber A, 2011, ANNU REV ENTOMOL, V56, P423, DOI 10.1146/annurev-ento-120709-144855; Becker MM, 2000, J APICULT RES, V39, P149, DOI 10.1080/00218839.2000.11101035; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Boomsma JJ, 2005, ANNU REV ENTOMOL, V50, P395, DOI 10.1146/annurev.ento.50.071803.130416; Carcaud J, 2009, J EXP BIOL, V212, P620, DOI 10.1242/jeb.026641; Chaffiol A, 2005, J EXP BIOL, V208, P3731, DOI 10.1242/jeb.01796; Chang RC, 2004, Q J EXP PSYCHOL-B, V57, P1, DOI 10.1080/02724990344000015; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; de Brito Sanchez MG, 2015, J EXP BIOL, V218, P949, DOI 10.1242/jeb.117333; Dinges CW, 2013, J EXP BIOL, V216, P4124, DOI 10.1242/jeb.090100; Dobrin SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037666; Dornhaus A, 2004, APIDOLOGIE, V35, P183, DOI 10.1051/apido:2004002; Dornhaus A, 1999, NATURE, V401, P38, DOI 10.1038/43372; Dyer AG, 2008, J COMP PHYSIOL A, V194, P617, DOI 10.1007/s00359-008-0335-1; Dyer AG, 2004, NATURWISSENSCHAFTEN, V91, P224, DOI 10.1007/s00114-004-0508-x; ERBER J, 1980, PHYSIOL ENTOMOL, V5, P343, DOI 10.1111/j.1365-3032.1980.tb00244.x; Farina WM, 2005, P ROY SOC B-BIOL SCI, V272, P1923, DOI 10.1098/rspb.2005.3172; Free J. B., 1957, British Journal of Animal Behaviour, V5, P7, DOI 10.1016/S0950-5601(57)80038-0; Frisch von K., 1965, TANZSPRACHE ORIENTIE, DOI DOI 10.1007/978-3-642-94916-6; Gerber B, 1996, ANIM BEHAV, V52, P1079, DOI 10.1006/anbe.1996.0255; GIURFA M, 1995, J COMP PHYSIOL A, V177, P247; Giurfa M, 2004, NATURWISSENSCHAFTEN, V91, P228, DOI 10.1007/s00114-004-0530-z; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Goulson D, 2009, BUMBLEBEES BEHAV ECO, V2nd; Gruter C, 2014, TRENDS ECOL EVOL, V29, P177, DOI 10.1016/j.tree.2014.01.004; Grunbaum L, 1998, J NEUROSCI, V18, P4384; Gumbert A, 2000, BEHAV ECOL SOCIOBIOL, V48, P36, DOI 10.1007/s002650000213; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; HELVERSEN OV, 1972, J COMP PHYSIOL, V80, P439, DOI 10.1007/BF00696438; Hori S, 2006, J COMP PHYSIOL A, V192, P691, DOI 10.1007/s00359-005-0091-4; Jernigan CM, 2014, J EXP BIOL, V217, P337, DOI 10.1242/jeb.091355; Kuwabara M., 1957, Journal of the Faculty of Science Hokkaido University Zoology, V13, P458; Laloi D, 1999, ENTOMOL EXP APPL, V90, P123, DOI 10.1023/A:1003598301272; Matsumoto Y, 2012, J NEUROSCI METH, V211, P159, DOI 10.1016/j.jneumeth.2012.08.018; Mc Cabe SI, 2009, J COMP PHYSIOL A, V195, P113, DOI 10.1007/s00359-008-0391-6; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Menzel R, 2001, LEARN MEMORY, V8, P198, DOI 10.1101/lm.40001; Menzel R, 1979, COMP PHYSL EVOLUTION, P504; Michener C.D., 2007, BEES WORLD, Vsecond; Morawetz L, 2013, J COMP PHYSIOL A, V199, P817, DOI 10.1007/s00359-013-0843-5; Morawetz L, 2012, J EXP BIOL, V215, P2515, DOI 10.1242/jeb.066399; Moritz RFA, 2004, ANIM BEHAV, V67, P681, DOI 10.1016/j.anbehav.2003.08.004; Moritz RFA, 1996, ETHOLOGY, V102, P580; Mota T, 2011, LEARN MEMORY, V18, P144, DOI 10.1101/lm.2073511; Nagaraja N., 2014, Journal of Entomological Research, V38, P165; Nagaraja N., 2013, Journal of Entomological Research, V37, P29; Niggebrugge C, 2009, J EXP BIOL, V212, P1344, DOI 10.1242/jeb.021881; NIXON HL, 1952, PROC R SOC SER B-BIO, V140, P43, DOI 10.1098/rspb.1952.0042; Ogilvie JE, 2015, ARTHROPOD-PLANT INTE, V9, P205, DOI 10.1007/s11829-015-9368-x; Ostevik Katherine L., 2010, Journal of Pollination Ecology, V2, P21; Paxton RJ, 2005, APIDOLOGIE, V36, P145, DOI 10.1051/apido:2005007; Pelz C, 1997, J EXP BIOL, V200, P837; Raine N.E., 2005, ULUDAG BEE J, V5, P145; Riveros AJ, 2012, ANIM COGN, V15, P1183, DOI 10.1007/s10071-012-0542-6; Riveros AJ, 2009, NATURWISSENSCHAFTEN, V96, P851, DOI 10.1007/s00114-009-0532-y; Roselino AC, 2015, J COMP NEUROL, V523, P1461, DOI 10.1002/cne.23744; ROWELL GA, 1986, APIDOLOGIE, V17, P137, DOI 10.1051/apido:19860206; Sandoz JC, 2000, ANIM BEHAV, V59, P1025, DOI 10.1006/anbe.2000.1395; Schubert M, 2002, ANIM BEHAV, V64, P175, DOI 10.1006/anbe.2002.3055; SHOREY HH, 1973, ANNU REV ENTOMOL, V18, P349, DOI 10.1146/annurev.en.18.010173.002025; Skorupski P, 2007, J COMP PHYSIOL A, V193, P485, DOI 10.1007/s00359-006-0206-6; Sommerlandt FMJ, 2014, APIDOLOGIE, V45, P106, DOI 10.1007/s13592-013-0227-4; Streinzer M, 2013, J COMP NEUROL, V521, P2742, DOI 10.1002/cne.23312; Thompson D. W., 1907, HIST ANIMALS ARISTOT; von Frisch K., 1953, DANCING BEES ACCOUNT; von Frisch Karl, 1927, LEBEN BIENEN; Winston, 1987, BIOL HONEYBEE; Wolf S, 2014, APIDOLOGIE, V45, P440, DOI 10.1007/s13592-013-0259-9	70	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2015	10	7							e0134248	10.1371/journal.pone.0134248	http://dx.doi.org/10.1371/journal.pone.0134248			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JY	26230643	Green Published, gold, Green Submitted			2022-12-27	WOS:000358838400093
J	Fleming, JC; Schmehl, DR; Ellis, JD				Fleming, James C.; Schmehl, Daniel R.; Ellis, James D.			Characterizing the Impact of Commercial Pollen Substitute Diets on the Level of Nosema spp. in Honey Bees (Apis mellifera L.)	PLOS ONE			English	Article							PESTICIDES; HYMENOPTERA; INFECTION; EXPOSURE; CERANAE; APIDAE; RESPONSIVENESS; FLUVALINATE; NUTRITION; SUCROSE	Western honey bee (Apis mellifera L.) populations face declines commonly attributed to pesticide, pathogen, and parasite stress. One way beekeepers combat these stressors is by providing supplemental protein diets to honey bee colonies to ensure adequate colony nutrition. However Nosema spp., a microsporidian parasite of the honey bee, is thought to be associated closely with a colony's nutritional intake, thus possibly negating any benefit the bees otherwise would have received from a nutritional supplement. Through three objectives, we examined how adult bees' consumption of wildflower pollen or commercial pollen substitute diets affected Nosema levels in the bees' midguts. For our first objective, we investigated how method of inoculation with Nosema affects infection levels in inoculated bees. Bees were infected with spores of Nosema four days after emergence. On day 15, bees were collected from the cages and Nosema spores were quantified. We found that inoculation through the pollen diet resulted in the highest Nosema levels in inoculated bees. In our second and third objectives, we provided the test diets to caged, newly emerged bees for a period of 15 days. Bees consuming pollen and a sucrose solution had more Nosema in their midguts than did bees consuming the sucrose solution alone (control). The overall volume of diet consumed by the bees did not correlate with the level of Nosema in their midguts. The level of Nosema was higher in bees fed certain commercial pollen substitute diets than in bees fed wildflower pollen. Our study illustrates how providing nutritional supplements to adult honey bees can impact the intensity of Nosema in their midguts.	[Fleming, James C.; Schmehl, Daniel R.; Ellis, James D.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Schmehl, DR (corresponding author), Bayer CropSci, 2 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	daniel.schmehl@bayer.com	Ellis, James/L-7985-2013	Ellis, James/0000-0003-0318-8646; Schmehl, Daniel/0000-0003-1591-8722				Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Bigliardi E, 2001, MICROBES INFECT, V3, P373, DOI 10.1016/S1286-4579(01)01393-4; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; CANTWELL G E, 1970, American Bee Journal, V110, P222; Ciarlo TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040848; Collins AM, 2004, J APICULT RES, V43, P128, DOI 10.1080/00218839.2004.11101123; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; DeGrandi-Hoffman G, 2010, J INSECT PHYSIOL, V56, P1184, DOI 10.1016/j.jinsphys.2010.03.017; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Eilers EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021363; Eiri DM, 2012, J EXP BIOL, V215, P2022, DOI 10.1242/jeb.068718; EWALD PW, 1983, ANNU REV ECOL SYST, V14, P465, DOI 10.1146/annurev.es.14.110183.002341; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Fries I., 2013, J APICULT RES, V52, P1, DOI [10.3896/ IBRA. 1.52.1.14, DOI 10.3896/IBRA.1.52.1.14]; Frost EH, 2013, J EXP BIOL, V216, P2931, DOI 10.1242/jeb.086538; Gisder S, 2011, ENVIRON MICROBIOL, V13, P404, DOI 10.1111/j.1462-2920.2010.02346.x; Haarmann T, 2002, J ECON ENTOMOL, V95, P28, DOI 10.1603/0022-0493-95.1.28; Haydak MH, 1935, J ECON ENTOMOL, V28, P657, DOI 10.1093/jee/28.4.657; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hrassnigg N, 2005, APIDOLOGIE, V36, P255, DOI 10.1051/apido:2005015; Malone LA, 1998, J INVERTEBR PATHOL, V71, P169, DOI 10.1006/jipa.1997.4715; Matheson A, 1996, BEE WORLD, V77, P45, DOI 10.1080/0005772X.1996.11099281; Mattila HR, 2006, J ECON ENTOMOL, V99, P604, DOI 10.1603/0022-0493-99.3.604; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Naug D, 2009, APIDOLOGIE, V40, P595, DOI 10.1051/apido/2009039; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Neumann P, 2013, J APICULT RES, V52, P1, DOI [10.3896/IBRA.1.52.1.04, DOI 10.3896/IBRA.1.52.1.04]; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; OLSEN PE, 1986, J INVERTEBR PATHOL, V47, P65, DOI 10.1016/0022-2011(86)90164-3; PICKARD RS, 1989, J APICULT RES, V28, P93; Porrini MP, 2011, J APICULT RES, V50, P35, DOI 10.3896/IBRA.1.50.1.04; RINDERER TE, 1977, J ECON ENTOMOL, V70, P431, DOI 10.1093/jee/70.4.431; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Schmehl DR, 2014, J INSECT PHYSIOL, V71, P177, DOI 10.1016/j.jinsphys.2014.10.002; Standifer L.N., 1977, ANN ENTOMOL SOC AM, V70, P691; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; Vojvodic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072106; WAHL O, 1983, OECOLOGIA, V59, P106, DOI 10.1007/BF00388082; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Zander E., 1909, M NCH BIENENZ, V31, P196, DOI DOI 10.1016/J.BBAGEN.2015.01.008; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547	44	35	37	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0132014	10.1371/journal.pone.0132014	http://dx.doi.org/10.1371/journal.pone.0132014			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26226229	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700004
J	Shinzato, T				Shinzato, Takashi			Self-Averaging Property of Minimal Investment Risk of Mean-Variance Model	PLOS ONE			English	Article							STATISTICAL-MECHANICS; PORTFOLIO	In portfolio optimization problems, the minimum expected investment risk is not always smaller than the expected minimal investment risk. That is, using a well-known approach from operations research, it is possible to derive a strategy that minimizes the expected investment risk, but this strategy does not always result in the best rate of return on assets. Prior to making investment decisions, it is important to an investor to know the potential minimal investment risk (or the expected minimal investment risk) and to determine the strategy that will maximize the return on assets. We use the self-averaging property to analyze the potential minimal investment risk and the concentrated investment level for the strategy that gives the best rate of return. We compare the results from our method with the results obtained by the operations research approach and with those obtained by a numerical simulation using the optimal portfolio. The results of our method and the numerical simulation are in agreement, but they differ from that of the operations research approach.	Hitotsubashi Univ, Mori Arinori Ctr Higher Educ & Global Mobil, Kunitachi, Tokyo 186, Japan	Hitotsubashi University	Shinzato, T (corresponding author), Hitotsubashi Univ, Mori Arinori Ctr Higher Educ & Global Mobil, Kunitachi, Tokyo 186, Japan.	takashi.shinzato@r.hit-u.ac.jp		Shinzato, Takashi/0000-0001-9719-454X	Akita prefectural university; National Institute of Informatics, Japan [50]; Japan Institute of Life Insurance; Kyoto university institute of economic research foundation; Zengin Foundation for Studies on Economics and Finance [1414]; institute of statistical mathematics [2068]; Kampo foundation;  [24710169];  [15K20999]	Akita prefectural university; National Institute of Informatics, Japan; Japan Institute of Life Insurance; Kyoto university institute of economic research foundation; Zengin Foundation for Studies on Economics and Finance; institute of statistical mathematics; Kampo foundation; ; 	There have been significant financial supports for this work as follows: 1. Grant-in-Aid for Young Scientists (B) Research Project Number: 24710169 (https://kaken.nii.ac.jp/d/p/24710169.en.html); 2. Akita prefectural university (2014), President project for young scientists; 3. Grant-in-Aid for Young Scientists (B) Research Project Number: 15K20999 (https://kaken.nii.ac.jp/d/p/15K20999.en.html); 4. The National Institute of Informatics, Japan (2014), Research Project Number: 50 (http://www.nii.ac.jp/kenkyou/files/b/1234/kyoudoukenkyu_ichiran/h26_ichiran.pdf); 5. Japan Institute of Life Insurance (2015), Research Project Number: 5 (http://www.jili.or.jp/pdf/150604.pdf); 6. Kyoto university institute of economic research foundation (2015) (http://www.fd.kier.kyoto-u.ac.jp/grant/grant.html); 7. Zengin Foundation for Studies on Economics and Finance (2015), Research Project Number: 1414 (http://www.jade.dti.ne.jp/bankfund/table2014.pdf); 8. The institute of statistical mathematics (2015), Research Project Number: 2068 (http://kyodo.ism.ac.jp/public_system/member/saitaku-kadai.php?n=H27 9); and Kampo foundation (2015), Researching Project Number: 2 (http://www.kampozaidan.or.jp/CL01_02/185_S1.pdf).	AMIT DJ, 1987, ANN PHYS-NEW YORK, V173, P30, DOI 10.1016/0003-4916(87)90092-3; Bai Z., 2010, SPECTRAL ANAL LARGE; Ciliberti S, 2007, EUR PHYS J B, V57, P175, DOI 10.1140/epjb/e2007-00130-7; Dixit A.K., 1994, INVESTMENT UNCERTAIN, DOI DOI 10.1515/9781400830176; Gallager R., 1968, INFORM THEORY RELIAB; KONNO H, 1991, MANAGE SCI, V37, P519, DOI 10.1287/mnsc.37.5.519; Luenberger D. G., 1997, INVESTMENT SCI; Ma S.-K., 2000, MODERN THEORY CRITIC; Marchenko VA., 1967, MAT SB, V114, P507, DOI [10.1070/SM1967v001n04ABEH001994, DOI 10.1070/SM1967V001N04ABEH001994]; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Nishimori H., 2001, STAT PHYS SPIN GLASS; Nishimori H., 2011, ELEMENTS PHASE TRANS; Ogure K, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/03/P03010; Pafka S, 2003, PHYSICA A, V319, P487, DOI 10.1016/S0378-4371(02)01499-1; Rockafellar R. T., 2000, J RISK, V2, P21, DOI 10.21314/JOR.2000.038; Shinzato T., 2010, TECHNICAL REPORT IEI, V110, P257; Shinzato T., 2010, PREPRINT; Shinzato T, 2014, B RIMS, P26; Shinzato T, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/32/324013; Tanaka T., 2007, INTERDISCIP INF SCI, V13, P17, DOI [10.4036/iis.2007.17, DOI 10.4036/IIS.2007.17]; Touchette H, 2009, PHYS REP, V478, P1, DOI 10.1016/j.physrep.2009.05.002; Tulino A., 2004, RANDOM MATRIX THEORY; Wakai R., 2014, J JAPAN IND MANAGEME, V65, P17	24	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2015	10	7							e0133846	10.1371/journal.pone.0133846	http://dx.doi.org/10.1371/journal.pone.0133846			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO0JT	26225761	Green Submitted, Green Published, gold			2022-12-27	WOS:000358837700040
